"","pmid","doi","title","abstract","year","month","day","jabbrv","journal","keywords","lastname","firstname","address","email"
"1","34261543","10.1186/s40733-021-00075-z","Asthma and COVID-19: a dangerous liaison?","The coronavirus disease 2019 (COVID-19) pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), provoked the most striking international public health crisis of our time. COVID-19 can cause a range of breathing problems, from mild to critical, with potential evolution to respiratory failure and acute respiratory distress syndrome. Elderly adults and those affected with chronic cardiovascular, metabolic, and respiratory conditions carry a higher risk of severe CO","2021","07","18","Asthma Res Pract","Asthma research and practice","Asthma; Biological agents; Biologics; COVID-19; Immunotherapy; Phenotypes; SARS-COV-2; Therapy","Lombardi","Carlo","Departmental Unit of Allergology, Immunology &amp","carlo.lombardi@poliambulanza.it"
"2","34261543","10.1186/s40733-021-00075-z","Asthma and COVID-19: a dangerous liaison?","The coronavirus disease 2019 (COVID-19) pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), provoked the most striking international public health crisis of our time. COVID-19 can cause a range of breathing problems, from mild to critical, with potential evolution to respiratory failure and acute respiratory distress syndrome. Elderly adults and those affected with chronic cardiovascular, metabolic, and respiratory conditions carry a higher risk of severe CO","2021","07","18","Asthma Res Pract","Asthma research and practice","Asthma; Biological agents; Biologics; COVID-19; Immunotherapy; Phenotypes; SARS-COV-2; Therapy","Gani","Federica","Allergy Outpatients Clinic, Turin, Italy",NA
"3","34261543","10.1186/s40733-021-00075-z","Asthma and COVID-19: a dangerous liaison?","The coronavirus disease 2019 (COVID-19) pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), provoked the most striking international public health crisis of our time. COVID-19 can cause a range of breathing problems, from mild to critical, with potential evolution to respiratory failure and acute respiratory distress syndrome. Elderly adults and those affected with chronic cardiovascular, metabolic, and respiratory conditions carry a higher risk of severe CO","2021","07","18","Asthma Res Pract","Asthma research and practice","Asthma; Biological agents; Biologics; COVID-19; Immunotherapy; Phenotypes; SARS-COV-2; Therapy","Berti","Alvise","Ospedale Santa Chiara and Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy",NA
"4","34261543","10.1186/s40733-021-00075-z","Asthma and COVID-19: a dangerous liaison?","The coronavirus disease 2019 (COVID-19) pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), provoked the most striking international public health crisis of our time. COVID-19 can cause a range of breathing problems, from mild to critical, with potential evolution to respiratory failure and acute respiratory distress syndrome. Elderly adults and those affected with chronic cardiovascular, metabolic, and respiratory conditions carry a higher risk of severe CO","2021","07","18","Asthma Res Pract","Asthma research and practice","Asthma; Biological agents; Biologics; COVID-19; Immunotherapy; Phenotypes; SARS-COV-2; Therapy","Comberiati","Pasquale","Department of Clinical and Experimental Medicine, Section of Pediatrics, University of Pisa, Pisa, Italy",NA
"5","34261543","10.1186/s40733-021-00075-z","Asthma and COVID-19: a dangerous liaison?","The coronavirus disease 2019 (COVID-19) pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), provoked the most striking international public health crisis of our time. COVID-19 can cause a range of breathing problems, from mild to critical, with potential evolution to respiratory failure and acute respiratory distress syndrome. Elderly adults and those affected with chronic cardiovascular, metabolic, and respiratory conditions carry a higher risk of severe CO","2021","07","18","Asthma Res Pract","Asthma research and practice","Asthma; Biological agents; Biologics; COVID-19; Immunotherapy; Phenotypes; SARS-COV-2; Therapy","Peroni","Diego","Thoracic Disease Research Unit, Mayo Clinic, Rochester, MN, USA",NA
"6","34261543","10.1186/s40733-021-00075-z","Asthma and COVID-19: a dangerous liaison?","The coronavirus disease 2019 (COVID-19) pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), provoked the most striking international public health crisis of our time. COVID-19 can cause a range of breathing problems, from mild to critical, with potential evolution to respiratory failure and acute respiratory distress syndrome. Elderly adults and those affected with chronic cardiovascular, metabolic, and respiratory conditions carry a higher risk of severe CO","2021","07","18","Asthma Res Pract","Asthma research and practice","Asthma; Biological agents; Biologics; COVID-19; Immunotherapy; Phenotypes; SARS-COV-2; Therapy","Cottini","Marcello","Allergy and Pneumology Outpatient Clinic, Bergamo, Italy",NA
"7","34261523","10.1186/s13104-021-05686-6","Health service experiences and preferences of frail home care clients and their family and friend caregivers during the COVID-19 pandemic.","The COVID-19 pandemic has brought about a major upheaval in the lives of older adults and their family/friend caregivers, including those utilizing home care services. In this article, we focus on results from a qualitative component added to a pragmatic randomized controlled trial that focuses on the experiences of our study participants during COVID-19. A total of 29 participants responded to the COVID-19 related questions focused on their health services experiences and preferences from March","2021","07","16","BMC Res Notes","BMC research notes","COVID-19; Frailty; Home care; Older adults; Remote monitoring; Aged; COVID-19; Caregivers; Frail Elderly; Friends; Home Care Services; Humans; Ontario; Pandemics; SARS-CoV-2","Weeks","Lori E","School of Nursing, Dalhousie University, Halifax, NS, B3H 4R2, Canada. lori.weeks@dal","lori.weeks@dal.ca"
"8","34261523","10.1186/s13104-021-05686-6","Health service experiences and preferences of frail home care clients and their family and friend caregivers during the COVID-19 pandemic.","The COVID-19 pandemic has brought about a major upheaval in the lives of older adults and their family/friend caregivers, including those utilizing home care services. In this article, we focus on results from a qualitative component added to a pragmatic randomized controlled trial that focuses on the experiences of our study participants during COVID-19. A total of 29 participants responded to the COVID-19 related questions focused on their health services experiences and preferences from March","2021","07","16","BMC Res Notes","BMC research notes","COVID-19; Frailty; Home care; Older adults; Remote monitoring; Aged; COVID-19; Caregivers; Frail Elderly; Friends; Home Care Services; Humans; Ontario; Pandemics; SARS-CoV-2","Nesto","Sue","School of Occupational Therapy, Dalhousie University, Halifax, NS, B3H 4R2, Canada",NA
"9","34261523","10.1186/s13104-021-05686-6","Health service experiences and preferences of frail home care clients and their family and friend caregivers during the COVID-19 pandemic.","The COVID-19 pandemic has brought about a major upheaval in the lives of older adults and their family/friend caregivers, including those utilizing home care services. In this article, we focus on results from a qualitative component added to a pragmatic randomized controlled trial that focuses on the experiences of our study participants during COVID-19. A total of 29 participants responded to the COVID-19 related questions focused on their health services experiences and preferences from March","2021","07","16","BMC Res Notes","BMC research notes","COVID-19; Frailty; Home care; Older adults; Remote monitoring; Aged; COVID-19; Caregivers; Frail Elderly; Friends; Home Care Services; Humans; Ontario; Pandemics; SARS-CoV-2","Hiebert","Bradley","Arthur Labatt School of Nursing, Western University, London, ON, Canada",NA
"10","34261523","10.1186/s13104-021-05686-6","Health service experiences and preferences of frail home care clients and their family and friend caregivers during the COVID-19 pandemic.","The COVID-19 pandemic has brought about a major upheaval in the lives of older adults and their family/friend caregivers, including those utilizing home care services. In this article, we focus on results from a qualitative component added to a pragmatic randomized controlled trial that focuses on the experiences of our study participants during COVID-19. A total of 29 participants responded to the COVID-19 related questions focused on their health services experiences and preferences from March","2021","07","16","BMC Res Notes","BMC research notes","COVID-19; Frailty; Home care; Older adults; Remote monitoring; Aged; COVID-19; Caregivers; Frail Elderly; Friends; Home Care Services; Humans; Ontario; Pandemics; SARS-CoV-2","Warner","Grace","School of Occupational Therapy, Dalhousie University, Halifax, NS, B3H 4R2, Canada",NA
"11","34261523","10.1186/s13104-021-05686-6","Health service experiences and preferences of frail home care clients and their family and friend caregivers during the COVID-19 pandemic.","The COVID-19 pandemic has brought about a major upheaval in the lives of older adults and their family/friend caregivers, including those utilizing home care services. In this article, we focus on results from a qualitative component added to a pragmatic randomized controlled trial that focuses on the experiences of our study participants during COVID-19. A total of 29 participants responded to the COVID-19 related questions focused on their health services experiences and preferences from March","2021","07","16","BMC Res Notes","BMC research notes","COVID-19; Frailty; Home care; Older adults; Remote monitoring; Aged; COVID-19; Caregivers; Frail Elderly; Friends; Home Care Services; Humans; Ontario; Pandemics; SARS-CoV-2","Luciano","Wendy","School of Occupational Therapy, Dalhousie University, Halifax, NS, B3H 4R2, Canada",NA
"12","34261523","10.1186/s13104-021-05686-6","Health service experiences and preferences of frail home care clients and their family and friend caregivers during the COVID-19 pandemic.","The COVID-19 pandemic has brought about a major upheaval in the lives of older adults and their family/friend caregivers, including those utilizing home care services. In this article, we focus on results from a qualitative component added to a pragmatic randomized controlled trial that focuses on the experiences of our study participants during COVID-19. A total of 29 participants responded to the COVID-19 related questions focused on their health services experiences and preferences from March","2021","07","16","BMC Res Notes","BMC research notes","COVID-19; Frailty; Home care; Older adults; Remote monitoring; Aged; COVID-19; Caregivers; Frail Elderly; Friends; Home Care Services; Humans; Ontario; Pandemics; SARS-CoV-2","Ledoux","Kathleen","Arthur Labatt School of Nursing, Western University, London, ON, Canada",NA
"13","34261523","10.1186/s13104-021-05686-6","Health service experiences and preferences of frail home care clients and their family and friend caregivers during the COVID-19 pandemic.","The COVID-19 pandemic has brought about a major upheaval in the lives of older adults and their family/friend caregivers, including those utilizing home care services. In this article, we focus on results from a qualitative component added to a pragmatic randomized controlled trial that focuses on the experiences of our study participants during COVID-19. A total of 29 participants responded to the COVID-19 related questions focused on their health services experiences and preferences from March","2021","07","16","BMC Res Notes","BMC research notes","COVID-19; Frailty; Home care; Older adults; Remote monitoring; Aged; COVID-19; Caregivers; Frail Elderly; Friends; Home Care Services; Humans; Ontario; Pandemics; SARS-CoV-2","Donelle","Lorie","Arthur Labatt School of Nursing, Western University, London, ON, Canada",NA
"14","34261512","10.1186/s12995-021-00316-0","Presentation of a participatory approach to develop preventive measures to reduce COVID-19 transmission in child care.","It can be suspected that work in child care facilities is associated with an elevated exposure risk towards SARS-CoV-2 infections. It is still unclear under which conditions employees in those facilities can safely pursue their work. Preventive workplace-related measures to reduce transmission dynamics in this work environment need to be developed. These measures need to build on a solid scientific foundation and be ready for practical use at the same time. Therefore, the aim of the study is to ","2021","07","18","J Occup Med Toxicol","Journal of occupational medicine and toxicology (London, England)","COVID-19 transmission; Participation; Preventive measures; Work design","Diebig","Mathias","Institute of Occupational, Social and Environmental Medicine, Heinrich Heine University Düsseldorf, Universitätsstr. 1, 40225, Düsseldorf, Germany. mathias.diebig@hhu","mathias.diebig@hhu.de"
"15","34261512","10.1186/s12995-021-00316-0","Presentation of a participatory approach to develop preventive measures to reduce COVID-19 transmission in child care.","It can be suspected that work in child care facilities is associated with an elevated exposure risk towards SARS-CoV-2 infections. It is still unclear under which conditions employees in those facilities can safely pursue their work. Preventive workplace-related measures to reduce transmission dynamics in this work environment need to be developed. These measures need to build on a solid scientific foundation and be ready for practical use at the same time. Therefore, the aim of the study is to ","2021","07","18","J Occup Med Toxicol","Journal of occupational medicine and toxicology (London, England)","COVID-19 transmission; Participation; Preventive measures; Work design","Gritzka","Susan","Institute of Occupational, Social and Environmental Medicine, Heinrich Heine University Düsseldorf, Universitätsstr. 1, 40225, Düsseldorf, Germany",NA
"16","34261512","10.1186/s12995-021-00316-0","Presentation of a participatory approach to develop preventive measures to reduce COVID-19 transmission in child care.","It can be suspected that work in child care facilities is associated with an elevated exposure risk towards SARS-CoV-2 infections. It is still unclear under which conditions employees in those facilities can safely pursue their work. Preventive workplace-related measures to reduce transmission dynamics in this work environment need to be developed. These measures need to build on a solid scientific foundation and be ready for practical use at the same time. Therefore, the aim of the study is to ","2021","07","18","J Occup Med Toxicol","Journal of occupational medicine and toxicology (London, England)","COVID-19 transmission; Participation; Preventive measures; Work design","Dragano","Nico","Institute of Medical Sociology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"17","34261512","10.1186/s12995-021-00316-0","Presentation of a participatory approach to develop preventive measures to reduce COVID-19 transmission in child care.","It can be suspected that work in child care facilities is associated with an elevated exposure risk towards SARS-CoV-2 infections. It is still unclear under which conditions employees in those facilities can safely pursue their work. Preventive workplace-related measures to reduce transmission dynamics in this work environment need to be developed. These measures need to build on a solid scientific foundation and be ready for practical use at the same time. Therefore, the aim of the study is to ","2021","07","18","J Occup Med Toxicol","Journal of occupational medicine and toxicology (London, England)","COVID-19 transmission; Participation; Preventive measures; Work design","Angerer","Peter","Institute of Occupational, Social and Environmental Medicine, Heinrich Heine University Düsseldorf, Universitätsstr. 1, 40225, Düsseldorf, Germany",NA
"18","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Huang","Rui","Department of Infectious Diseases, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China",NA
"19","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Zhu","Li","Department of Infectious Diseases, The Affiliated Infectious Diseases Hospital of Soochow University, Suzhou, China",NA
"20","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Xue","Leyang","Department of Critical Medicine, Huai'an No. 4 People's Hospital, Huai'an, China",NA
"21","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Yan","Xuebing","Department of Infectious Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China",NA
"22","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Wang","Jian","Department of Infectious Diseases, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China",NA
"23","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Huang","Songping","Department of Infectious Diseases, Nantong Third People's Hospital, Nantong University, Nantong, China",NA
"24","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Zhang","Biao","Department of Quality Control Office, Huai'an No. 4 People's Hospital, Huai'an, China",NA
"25","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Xu","Tianmin","Department of Infectious Diseases, The Third People's Hospital of Changzhou, Changzhou, China",NA
"26","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Ji","Fang","Department of Infectious Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China",NA
"27","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Li","Chunyang","Department of Infectious Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China",NA
"28","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Ming","Fang","Department of Infectious Diseases, Nantong Third People's Hospital, Nantong University, Nantong, China",NA
"29","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Zhao","Yun","Department of Infectious Diseases, The Third People's Hospital of Yangzhou, Yangzhou, China",NA
"30","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Li","Yang","Department of Infectious Diseases, Taizhou People's Hospital, Taizhou, China",NA
"31","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Cheng","Juan","Department of Infectious Diseases, Yancheng Second People's Hospital, Yancheng, China",NA
"32","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Wang","Yinling","Department of Infectious Diseases, The Affiliated Infectious Diseases Hospital of Soochow University, Suzhou, China",NA
"33","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Shao","Huaping","Department of Infectious Diseases, The People's Hospital of Suqian, Suqian, China",NA
"34","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Hong","Shuqin","Nursing Department, Huai'an No. 4 People's Hospital, Huai'an, China",NA
"35","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Chen","Kang","Department of Tuberculosis, The Third People's Hospital of Changzhou, Changzhou, China",NA
"36","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Zhao","Xiang-An","Department of Gastroenterology, Northern Jiangsu People's Hospital, Clinical Medical College of Yangzhou University, Yangzhou, China",NA
"37","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Sang","Dawen","Department of Infectious Diseases, Yancheng Second People's Hospital, Yancheng, China",NA
"38","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Zou","Lei","Department of Infectious Diseases, Yancheng Second People's Hospital, Yancheng, China",NA
"39","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Zhao","Haiyan","Department of Infectious Diseases, The People's Hospital of Suqian, Suqian, China",NA
"40","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Guan","Xinying","Department of Neurology, The Affiliated Hospital of Kangda College of Nanjing Medical University, The First People's Hospital of Lianyungang, Lianyungang, China",NA
"41","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Chen","Xiaobing","Department of Emergency, The Affiliated Hospital of Kangda College of Nanjing Medical University, The First People's Hospital of Lianyungang, Lianyungang, China",NA
"42","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Xu","Biyun","Department of Biostatistics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China",NA
"43","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Xia","Juan","Department of Infectious Diseases, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China",NA
"44","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Chen","Yuxin","Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China",NA
"45","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Yan","Xiaomin","Department of Infectious Diseases, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China",NA
"46","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Wei","Jie","Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China",NA
"47","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Liu","Jiacheng","Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China",NA
"48","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Liu","Longgen","Department of Infectious Diseases, The Third People's Hospital of Changzhou, Changzhou, China. ssewllg@163","ssewllg@163.com"
"49","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Zhu","Chuanwu","Department of Infectious Diseases, The Affiliated Infectious Diseases Hospital of Soochow University, Suzhou, China. zhuchw@126","zhuchw@126.com"
"50","34261488","10.1186/s12985-021-01615-y","Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study.","The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities of Jiangsu province, China. The factors associated with the clearance of SARS-CoV-2 were investigated. A total of 328 hospitalized patients with COVID-19 were retrospectively recruited. The epidemiological, clinical, laboratory, radiology and treatment data were collec","2021","07","23","Virol J","Virology journal","Clearance; Coronavirus disease 2019; SARS-CoV-2; Viral; Adult; Aged; COVID-19; China; Duration of Therapy; Female; Hospitalization; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; SARS-CoV-2; Virus Shedding; Young Adult","Wu","Chao","Department of Infectious Diseases, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China. dr.wu@nju.edu","dr.wu@nju.edu.cn"
"51","34261487","10.1186/s12987-021-00267-y","SARS-CoV-2: is there neuroinvasion?","SARS-CoV-2, a coronavirus (CoV), is known to cause acute respiratory distress syndrome, and a number of non-respiratory complications, particularly in older male patients with prior health conditions, such as obesity, diabetes and hypertension. These prior health conditions are associated with vascular dysfunction, and the CoV disease 2019 (COVID-19) complications include multiorgan failure and neurological problems. While the main route of entry into the body is inhalation, this virus has been ","2021","07","22","Fluids Barriers CNS","Fluids and barriers of the CNS","ACE2; Aging; Bloodbrain barrier (BBB); COVID-19; Cerebrospinal fluid (CSF); Choroid plexus; Diabetes; Hypertension; MMP9; Obesity; COVID-19; Humans; Nervous System Diseases; Prognosis; Risk Factors","McQuaid","Conor","Department of Neuroscience, University of Rochester, URMC, 601 Elmwood Avenue, Rochester, NY, 14642, USA",NA
"52","34261487","10.1186/s12987-021-00267-y","SARS-CoV-2: is there neuroinvasion?","SARS-CoV-2, a coronavirus (CoV), is known to cause acute respiratory distress syndrome, and a number of non-respiratory complications, particularly in older male patients with prior health conditions, such as obesity, diabetes and hypertension. These prior health conditions are associated with vascular dysfunction, and the CoV disease 2019 (COVID-19) complications include multiorgan failure and neurological problems. While the main route of entry into the body is inhalation, this virus has been ","2021","07","22","Fluids Barriers CNS","Fluids and barriers of the CNS","ACE2; Aging; Bloodbrain barrier (BBB); COVID-19; Cerebrospinal fluid (CSF); Choroid plexus; Diabetes; Hypertension; MMP9; Obesity; COVID-19; Humans; Nervous System Diseases; Prognosis; Risk Factors","Brady","Molly","Department of Neuroscience, University of Rochester, URMC, 601 Elmwood Avenue, Rochester, NY, 14642, USA",NA
"53","34261487","10.1186/s12987-021-00267-y","SARS-CoV-2: is there neuroinvasion?","SARS-CoV-2, a coronavirus (CoV), is known to cause acute respiratory distress syndrome, and a number of non-respiratory complications, particularly in older male patients with prior health conditions, such as obesity, diabetes and hypertension. These prior health conditions are associated with vascular dysfunction, and the CoV disease 2019 (COVID-19) complications include multiorgan failure and neurological problems. While the main route of entry into the body is inhalation, this virus has been ","2021","07","22","Fluids Barriers CNS","Fluids and barriers of the CNS","ACE2; Aging; Bloodbrain barrier (BBB); COVID-19; Cerebrospinal fluid (CSF); Choroid plexus; Diabetes; Hypertension; MMP9; Obesity; COVID-19; Humans; Nervous System Diseases; Prognosis; Risk Factors","Deane","Rashid","Department of Neuroscience, University of Rochester, URMC, 601 Elmwood Avenue, Rochester, NY, 14642, USA. Rashid_Deane@urmc.Rochester","Deane@urmc.Rochester.edu"
"54","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Fares","Wasfi","Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia. fwasfi@yahoo","fwasfi@yahoo.fr"
"55","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Chouikha","Anissa","Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia",NA
"56","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Ghedira","Kais","Laboratory of Bioinformatics, Biomathematics and Biostatistics (BIMS), Institut Pasteur Tunis, Tunis, Tunisia",NA
"57","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Gdoura","Meriam","Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia",NA
"58","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Rezig","Dorra","Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia",NA
"59","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Boubaker","Sondes Haddad","Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia",NA
"60","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Dhifallah","Imen Ben","Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia",NA
"61","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Touzi","Henda","Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia",NA
"62","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Hammami","Walid","Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia",NA
"63","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Meddeb","Zina","Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia",NA
"64","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Sadraoui","Amel","Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia",NA
"65","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Hogga","Nahed","Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia",NA
"66","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Abouda","Imen","Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia",NA
"67","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Kwasiborski","Aurélia","Laboratory for Urgent Response to Biological Threats (CIBU), Environment and Infectious Risks (ERI) research and expertise unit, Institut Pasteur, Paris, France",NA
"68","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Hourdel","Véronique","Laboratory for Urgent Response to Biological Threats (CIBU), Environment and Infectious Risks (ERI) research and expertise unit, Institut Pasteur, Paris, France",NA
"69","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Mikaty","Guillain","Laboratory for Urgent Response to Biological Threats (CIBU), Environment and Infectious Risks (ERI) research and expertise unit, Institut Pasteur, Paris, France",NA
"70","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Caro","Valérie","Laboratory for Urgent Response to Biological Threats (CIBU), Environment and Infectious Risks (ERI) research and expertise unit, Institut Pasteur, Paris, France",NA
"71","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Manuguerra","Jean-Claude","Laboratory for Urgent Response to Biological Threats (CIBU), Environment and Infectious Risks (ERI) research and expertise unit, Institut Pasteur, Paris, France",NA
"72","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Alaya","Nissaf Ben","National Observatory for New and Emerging Diseases, Ministry of Health, Tunis, Tunisia",NA
"73","34261445","10.1186/s12864-021-07870-1","Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.","In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes s","2021","07","16","BMC Genomics","BMC genomics","Genotype; SARS-CoV-2; SNPs; Tunisia; Whole genome sequencing; COVID-19; Genome, Viral; Humans; Pandemics; Phylogeny; SARS-CoV-2; Tunisia; Whole Genome Sequencing","Triki","Henda","Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia",NA
"74","34261439","10.1186/s12874-021-01340-8","Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.","Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. We used the hospital-based open Khorshid COVID Cohort (KCC) s","2021","07","21","BMC Med Res Methodol","BMC medical research methodology","COVID-19; Cause-specific hazard regression; Mortality; Prognosis; Risk assessment; Risk chart; COVID-19; Cohort Studies; Hospital Mortality; Hospitalization; Humans; Iran; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2","Marateb","Hamid Reza","Biomedical Engineering Department, Engineering Faculty, University of Isfahan, Isfahan, Iran. h.marateb@eng.ui.ac","h.marateb@eng.ui.ac.ir"
"75","34261439","10.1186/s12874-021-01340-8","Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.","Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. We used the hospital-based open Khorshid COVID Cohort (KCC) s","2021","07","21","BMC Med Res Methodol","BMC medical research methodology","COVID-19; Cause-specific hazard regression; Mortality; Prognosis; Risk assessment; Risk chart; COVID-19; Cohort Studies; Hospital Mortality; Hospitalization; Humans; Iran; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2","von Cube","Maja","Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany",NA
"76","34261439","10.1186/s12874-021-01340-8","Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.","Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. We used the hospital-based open Khorshid COVID Cohort (KCC) s","2021","07","21","BMC Med Res Methodol","BMC medical research methodology","COVID-19; Cause-specific hazard regression; Mortality; Prognosis; Risk assessment; Risk chart; COVID-19; Cohort Studies; Hospital Mortality; Hospitalization; Humans; Iran; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2","Sami","Ramin","Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"77","34261439","10.1186/s12874-021-01340-8","Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.","Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. We used the hospital-based open Khorshid COVID Cohort (KCC) s","2021","07","21","BMC Med Res Methodol","BMC medical research methodology","COVID-19; Cause-specific hazard regression; Mortality; Prognosis; Risk assessment; Risk chart; COVID-19; Cohort Studies; Hospital Mortality; Hospitalization; Humans; Iran; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2","Haghjooy Javanmard","Shaghayegh","Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"78","34261439","10.1186/s12874-021-01340-8","Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.","Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. We used the hospital-based open Khorshid COVID Cohort (KCC) s","2021","07","21","BMC Med Res Methodol","BMC medical research methodology","COVID-19; Cause-specific hazard regression; Mortality; Prognosis; Risk assessment; Risk chart; COVID-19; Cohort Studies; Hospital Mortality; Hospitalization; Humans; Iran; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2","Mansourian","Marjan","Biomedical Engineering Research Centre (CREB), Automatic Control Department (ESAII), Universitat Politècnica de Catalunya-Barcelona Tech (UPC)Building H, Floor 4, Av. Diagonal 647, 08028, Barcelona, Spain. marjan.mansourian@upc","marjan.mansourian@upc.edu"
"79","34261439","10.1186/s12874-021-01340-8","Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.","Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. We used the hospital-based open Khorshid COVID Cohort (KCC) s","2021","07","21","BMC Med Res Methodol","BMC medical research methodology","COVID-19; Cause-specific hazard regression; Mortality; Prognosis; Risk assessment; Risk chart; COVID-19; Cohort Studies; Hospital Mortality; Hospitalization; Humans; Iran; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2","Amra","Babak","Bamdad Respiratory Research Center, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"80","34261439","10.1186/s12874-021-01340-8","Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.","Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. We used the hospital-based open Khorshid COVID Cohort (KCC) s","2021","07","21","BMC Med Res Methodol","BMC medical research methodology","COVID-19; Cause-specific hazard regression; Mortality; Prognosis; Risk assessment; Risk chart; COVID-19; Cohort Studies; Hospital Mortality; Hospitalization; Humans; Iran; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2","Soltaninejad","Forogh","The Respiratory Research Center, Pulmonary Division, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"81","34261439","10.1186/s12874-021-01340-8","Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.","Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. We used the hospital-based open Khorshid COVID Cohort (KCC) s","2021","07","21","BMC Med Res Methodol","BMC medical research methodology","COVID-19; Cause-specific hazard regression; Mortality; Prognosis; Risk assessment; Risk chart; COVID-19; Cohort Studies; Hospital Mortality; Hospitalization; Humans; Iran; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2","Mortazavi","Mojgan","Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"82","34261439","10.1186/s12874-021-01340-8","Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.","Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. We used the hospital-based open Khorshid COVID Cohort (KCC) s","2021","07","21","BMC Med Res Methodol","BMC medical research methodology","COVID-19; Cause-specific hazard regression; Mortality; Prognosis; Risk assessment; Risk chart; COVID-19; Cohort Studies; Hospital Mortality; Hospitalization; Humans; Iran; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2","Adibi","Peyman","Isfahan Gastroenterology and Hepatology Research Center (lGHRC), Isfahan University of Medical Sciences, Isfahan, Iran",NA
"83","34261439","10.1186/s12874-021-01340-8","Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.","Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. We used the hospital-based open Khorshid COVID Cohort (KCC) s","2021","07","21","BMC Med Res Methodol","BMC medical research methodology","COVID-19; Cause-specific hazard regression; Mortality; Prognosis; Risk assessment; Risk chart; COVID-19; Cohort Studies; Hospital Mortality; Hospitalization; Humans; Iran; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2","Khademi","Nilufar","School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"84","34261439","10.1186/s12874-021-01340-8","Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.","Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. We used the hospital-based open Khorshid COVID Cohort (KCC) s","2021","07","21","BMC Med Res Methodol","BMC medical research methodology","COVID-19; Cause-specific hazard regression; Mortality; Prognosis; Risk assessment; Risk chart; COVID-19; Cohort Studies; Hospital Mortality; Hospitalization; Humans; Iran; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2","Sadat Hosseini","Nastaran","School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"85","34261439","10.1186/s12874-021-01340-8","Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.","Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. We used the hospital-based open Khorshid COVID Cohort (KCC) s","2021","07","21","BMC Med Res Methodol","BMC medical research methodology","COVID-19; Cause-specific hazard regression; Mortality; Prognosis; Risk assessment; Risk chart; COVID-19; Cohort Studies; Hospital Mortality; Hospitalization; Humans; Iran; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2","Toghyani","Arash","School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"86","34261439","10.1186/s12874-021-01340-8","Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.","Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. We used the hospital-based open Khorshid COVID Cohort (KCC) s","2021","07","21","BMC Med Res Methodol","BMC medical research methodology","COVID-19; Cause-specific hazard regression; Mortality; Prognosis; Risk assessment; Risk chart; COVID-19; Cohort Studies; Hospital Mortality; Hospitalization; Humans; Iran; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2","Hassannejad","Razieh","Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran",NA
"87","34261439","10.1186/s12874-021-01340-8","Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.","Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. We used the hospital-based open Khorshid COVID Cohort (KCC) s","2021","07","21","BMC Med Res Methodol","BMC medical research methodology","COVID-19; Cause-specific hazard regression; Mortality; Prognosis; Risk assessment; Risk chart; COVID-19; Cohort Studies; Hospital Mortality; Hospitalization; Humans; Iran; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2","Mañanas","Miquel Angel","Biomedical Engineering Research Centre (CREB), Automatic Control Department (ESAII), Universitat Politècnica de Catalunya-Barcelona Tech (UPC)Building H, Floor 4, Av. Diagonal 647, 08028, Barcelona, Spain",NA
"88","34261439","10.1186/s12874-021-01340-8","Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.","Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. We used the hospital-based open Khorshid COVID Cohort (KCC) s","2021","07","21","BMC Med Res Methodol","BMC medical research methodology","COVID-19; Cause-specific hazard regression; Mortality; Prognosis; Risk assessment; Risk chart; COVID-19; Cohort Studies; Hospital Mortality; Hospitalization; Humans; Iran; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2","Binder","Harald","Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany",NA
"89","34261439","10.1186/s12874-021-01340-8","Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study.","Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. We used the hospital-based open Khorshid COVID Cohort (KCC) s","2021","07","21","BMC Med Res Methodol","BMC medical research methodology","COVID-19; Cause-specific hazard regression; Mortality; Prognosis; Risk assessment; Risk chart; COVID-19; Cohort Studies; Hospital Mortality; Hospitalization; Humans; Iran; Retrospective Studies; Risk Assessment; Risk Factors; SARS-CoV-2","Wolkewitz","Martin","Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany",NA
"90","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Varettoni","Marzia","Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"91","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Mangiacavalli","Silvia","Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"92","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Rattotti","Sara","Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"93","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Cartia","Claudio Salvatore","Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"94","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Cavalloni","Chiara","Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"95","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Rossetti","Franca","Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"96","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Ferretti","Virginia Valeria","Department of Molecular Medicine, University of Pavia, Pavia, Italy",NA
"97","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Bergamini","Fabio","Service of Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"98","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Trotti","Chiara","Service of Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"99","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Fiorelli","Nicolas","Service of Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"100","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Pagani","Giuseppina","Service of Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"101","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Zerbi","Caterina","Service of Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"102","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Ferrari","Jacqueline","Service of Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"103","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Cristinelli","Caterina","Service of Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"104","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Muzzi","Alba","Medical Direction, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"105","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Marena","Carlo","Medical Direction, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"106","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Baldanti","Fausto","Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"107","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Bruno","Raffaele","Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy",NA
"108","34261423","10.1080/10428194.2021.1953019","Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.",NA,"2021","07","15","Leuk Lymphoma","Leukemia &amp; lymphoma",NA,"Arcaini","Luca","Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"109","34261360","10.1302/2633-1462.27.BJO-2021-0044.R1","The orthopaedic waiting list crisis : two sides of the story.","Due to widespread cancellations in elective orthopaedic procedures, the number of patients on waiting list for surgery is rising. We aim to determine and quantify if disparities exist between inpatient and day-case orthopaedic waiting list numbers; we also aim to determine if there is a 'hidden burden' that already exists due to reductions in elective secondary care referrals. Retrospective data were collected between 1 April 2020 and 31 December 2020 and compared with the same nine-month period","2021","07","15","Bone Jt Open","Bone &amp; joint open","COVID-19; Daycase; Hidden burden; Inpatient; Waiting lists","Hampton","Matthew","Rotherham District General Hospital, Rotherham NHS Foundation Trust, Rotherham, UK",NA
"110","34261360","10.1302/2633-1462.27.BJO-2021-0044.R1","The orthopaedic waiting list crisis : two sides of the story.","Due to widespread cancellations in elective orthopaedic procedures, the number of patients on waiting list for surgery is rising. We aim to determine and quantify if disparities exist between inpatient and day-case orthopaedic waiting list numbers; we also aim to determine if there is a 'hidden burden' that already exists due to reductions in elective secondary care referrals. Retrospective data were collected between 1 April 2020 and 31 December 2020 and compared with the same nine-month period","2021","07","15","Bone Jt Open","Bone &amp; joint open","COVID-19; Daycase; Hidden burden; Inpatient; Waiting lists","Riley","Ella","University of Sheffield Medical School, Sheffield, UK",NA
"111","34261360","10.1302/2633-1462.27.BJO-2021-0044.R1","The orthopaedic waiting list crisis : two sides of the story.","Due to widespread cancellations in elective orthopaedic procedures, the number of patients on waiting list for surgery is rising. We aim to determine and quantify if disparities exist between inpatient and day-case orthopaedic waiting list numbers; we also aim to determine if there is a 'hidden burden' that already exists due to reductions in elective secondary care referrals. Retrospective data were collected between 1 April 2020 and 31 December 2020 and compared with the same nine-month period","2021","07","15","Bone Jt Open","Bone &amp; joint open","COVID-19; Daycase; Hidden burden; Inpatient; Waiting lists","Garneti","Naren","Rotherham District General Hospital, Rotherham NHS Foundation Trust, Rotherham, UK",NA
"112","34261360","10.1302/2633-1462.27.BJO-2021-0044.R1","The orthopaedic waiting list crisis : two sides of the story.","Due to widespread cancellations in elective orthopaedic procedures, the number of patients on waiting list for surgery is rising. We aim to determine and quantify if disparities exist between inpatient and day-case orthopaedic waiting list numbers; we also aim to determine if there is a 'hidden burden' that already exists due to reductions in elective secondary care referrals. Retrospective data were collected between 1 April 2020 and 31 December 2020 and compared with the same nine-month period","2021","07","15","Bone Jt Open","Bone &amp; joint open","COVID-19; Daycase; Hidden burden; Inpatient; Waiting lists","Anderson","Alexander","Rotherham District General Hospital, Rotherham NHS Foundation Trust, Rotherham, UK",NA
"113","34261360","10.1302/2633-1462.27.BJO-2021-0044.R1","The orthopaedic waiting list crisis : two sides of the story.","Due to widespread cancellations in elective orthopaedic procedures, the number of patients on waiting list for surgery is rising. We aim to determine and quantify if disparities exist between inpatient and day-case orthopaedic waiting list numbers; we also aim to determine if there is a 'hidden burden' that already exists due to reductions in elective secondary care referrals. Retrospective data were collected between 1 April 2020 and 31 December 2020 and compared with the same nine-month period","2021","07","15","Bone Jt Open","Bone &amp; joint open","COVID-19; Daycase; Hidden burden; Inpatient; Waiting lists","Wembridge","Kevin","Rotherham District General Hospital, Rotherham NHS Foundation Trust, Rotherham, UK",NA
"114","34261345","10.1176/appi.neuropsych.21050116","Functional Neurological Disorder After SARS-CoV-2 Vaccines: Two Case Reports and Discussion of Potential Public Health Implications.",NA,"2021","07","15","J Neuropsychiatry Clin Neurosci","The Journal of neuropsychiatry and clinical neurosciences",NA,"Butler","Matthew","Neuropsychiatry Research and Education Group, Institute of Psychiatry, Psychology and Neuroscience, King's College London (Butler, Pollak, Nicholson)",NA
"115","34261345","10.1176/appi.neuropsych.21050116","Functional Neurological Disorder After SARS-CoV-2 Vaccines: Two Case Reports and Discussion of Potential Public Health Implications.",NA,"2021","07","15","J Neuropsychiatry Clin Neurosci","The Journal of neuropsychiatry and clinical neurosciences",NA,"Coebergh","Jan","Neuropsychiatry Research and Education Group, Institute of Psychiatry, Psychology and Neuroscience, King's College London (Butler, Pollak, Nicholson)",NA
"116","34261345","10.1176/appi.neuropsych.21050116","Functional Neurological Disorder After SARS-CoV-2 Vaccines: Two Case Reports and Discussion of Potential Public Health Implications.",NA,"2021","07","15","J Neuropsychiatry Clin Neurosci","The Journal of neuropsychiatry and clinical neurosciences",NA,"Safavi","Farinaz","Neuropsychiatry Research and Education Group, Institute of Psychiatry, Psychology and Neuroscience, King's College London (Butler, Pollak, Nicholson)",NA
"117","34261345","10.1176/appi.neuropsych.21050116","Functional Neurological Disorder After SARS-CoV-2 Vaccines: Two Case Reports and Discussion of Potential Public Health Implications.",NA,"2021","07","15","J Neuropsychiatry Clin Neurosci","The Journal of neuropsychiatry and clinical neurosciences",NA,"Carson","Alan","Neuropsychiatry Research and Education Group, Institute of Psychiatry, Psychology and Neuroscience, King's College London (Butler, Pollak, Nicholson)",NA
"118","34261345","10.1176/appi.neuropsych.21050116","Functional Neurological Disorder After SARS-CoV-2 Vaccines: Two Case Reports and Discussion of Potential Public Health Implications.",NA,"2021","07","15","J Neuropsychiatry Clin Neurosci","The Journal of neuropsychiatry and clinical neurosciences",NA,"Hallett","Mark","Neuropsychiatry Research and Education Group, Institute of Psychiatry, Psychology and Neuroscience, King's College London (Butler, Pollak, Nicholson)",NA
"119","34261345","10.1176/appi.neuropsych.21050116","Functional Neurological Disorder After SARS-CoV-2 Vaccines: Two Case Reports and Discussion of Potential Public Health Implications.",NA,"2021","07","15","J Neuropsychiatry Clin Neurosci","The Journal of neuropsychiatry and clinical neurosciences",NA,"Michael","Benedict","Neuropsychiatry Research and Education Group, Institute of Psychiatry, Psychology and Neuroscience, King's College London (Butler, Pollak, Nicholson)",NA
"120","34261345","10.1176/appi.neuropsych.21050116","Functional Neurological Disorder After SARS-CoV-2 Vaccines: Two Case Reports and Discussion of Potential Public Health Implications.",NA,"2021","07","15","J Neuropsychiatry Clin Neurosci","The Journal of neuropsychiatry and clinical neurosciences",NA,"Pollak","Thomas A","Neuropsychiatry Research and Education Group, Institute of Psychiatry, Psychology and Neuroscience, King's College London (Butler, Pollak, Nicholson)",NA
"121","34261345","10.1176/appi.neuropsych.21050116","Functional Neurological Disorder After SARS-CoV-2 Vaccines: Two Case Reports and Discussion of Potential Public Health Implications.",NA,"2021","07","15","J Neuropsychiatry Clin Neurosci","The Journal of neuropsychiatry and clinical neurosciences",NA,"Solomon","Tom","Neuropsychiatry Research and Education Group, Institute of Psychiatry, Psychology and Neuroscience, King's College London (Butler, Pollak, Nicholson)",NA
"122","34261345","10.1176/appi.neuropsych.21050116","Functional Neurological Disorder After SARS-CoV-2 Vaccines: Two Case Reports and Discussion of Potential Public Health Implications.",NA,"2021","07","15","J Neuropsychiatry Clin Neurosci","The Journal of neuropsychiatry and clinical neurosciences",NA,"Stone","Jon","Neuropsychiatry Research and Education Group, Institute of Psychiatry, Psychology and Neuroscience, King's College London (Butler, Pollak, Nicholson)",NA
"123","34261345","10.1176/appi.neuropsych.21050116","Functional Neurological Disorder After SARS-CoV-2 Vaccines: Two Case Reports and Discussion of Potential Public Health Implications.",NA,"2021","07","15","J Neuropsychiatry Clin Neurosci","The Journal of neuropsychiatry and clinical neurosciences",NA,"Nicholson","Timothy R","Neuropsychiatry Research and Education Group, Institute of Psychiatry, Psychology and Neuroscience, King's College London (Butler, Pollak, Nicholson)",NA
"124","34261339","10.1177/00033197211032784","Impact of Hypertension on the Prognosis of COVID-19 Disease and Uncertainties that Need to be Clarified.",NA,"2021","07","15","Angiology","Angiology",NA,"Sanlialp","Sara Cetin","The Department of Cardiology, 430817Servergazi State Hospital, Denizli, Turkey",NA
"125","34261339","10.1177/00033197211032784","Impact of Hypertension on the Prognosis of COVID-19 Disease and Uncertainties that Need to be Clarified.",NA,"2021","07","15","Angiology","Angiology",NA,"Sanlialp","Musa","The Department of Cardiology, 558907Denizli State Hospital, Denizli, Turkey",NA
"126","34261334","10.1177/00469580211031382","A Public Safety Compliance Model of Safety Behaviors in the Age of the COVID-19 Pandemic.","The outbreak of COVID-19 has placed a heavy burden on society, threatening the future of the entire world as the pandemic has hit health systems and economic sectors hard. Where time moves fast, continuing curfews and lockdown is impossible. This paper assembles three main safety behaviors, social distancing, wearing a facemask, and hygiene in one model (PSC Triangle) to be practiced by the public. Integrating public safety compliance with these behaviors is the main recommendation to slow the s","2021","07","16","Inquiry","Inquiry : a journal of medical care organization, provision and financing","COVID-19; model; pandemic; public safety compliance; safety behaviors","Al-Bsheish","Mohammad","Batterjee Medical College, Jeddah, Saudi Arabia",NA
"127","34261334","10.1177/00469580211031382","A Public Safety Compliance Model of Safety Behaviors in the Age of the COVID-19 Pandemic.","The outbreak of COVID-19 has placed a heavy burden on society, threatening the future of the entire world as the pandemic has hit health systems and economic sectors hard. Where time moves fast, continuing curfews and lockdown is impossible. This paper assembles three main safety behaviors, social distancing, wearing a facemask, and hygiene in one model (PSC Triangle) to be practiced by the public. Integrating public safety compliance with these behaviors is the main recommendation to slow the s","2021","07","16","Inquiry","Inquiry : a journal of medical care organization, provision and financing","COVID-19; model; pandemic; public safety compliance; safety behaviors","Jarrar","Mu'taman","Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia",NA
"128","34261334","10.1177/00469580211031382","A Public Safety Compliance Model of Safety Behaviors in the Age of the COVID-19 Pandemic.","The outbreak of COVID-19 has placed a heavy burden on society, threatening the future of the entire world as the pandemic has hit health systems and economic sectors hard. Where time moves fast, continuing curfews and lockdown is impossible. This paper assembles three main safety behaviors, social distancing, wearing a facemask, and hygiene in one model (PSC Triangle) to be practiced by the public. Integrating public safety compliance with these behaviors is the main recommendation to slow the s","2021","07","16","Inquiry","Inquiry : a journal of medical care organization, provision and financing","COVID-19; model; pandemic; public safety compliance; safety behaviors","Scarbrough","Amanda","Sam Houston State University, Huntsville, TX, USA",NA
"129","34261300","10.5808/gi.20058","Comparative study: nonsynonymous and synonymous substitution of SARS-CoV-2, SARS-CoV, and MERS-CoV genome.","The direction of evolution can estimate based on the variation among nonsynonymous to synonymous substitution. The simulative study investigated the nucleotide sequence of closely related strains of respiratory syndrome viruses, codon-by-codon with maximum likelihood analysis, z selection, and the divergence time. The simulated results, dN/dS &gt; 1 signify that an entire substitution model tends towards the hypothesis's positive evolution. The effect of transition/transversion proportion, Z-tes","2021","07","18","Genomics Inform","Genomics &amp; informatics","divergence time; respiratory syndrome; synonymous and nonsynonymous change; transition/transversion ratio","Sohpal","Vipan Kumar","Department of Chemical &amp",NA
"130","34261299","10.5808/gi.20078","A protein interactions map of multiple organ systems associated with COVID-19 disease.","Coronavirus disease 2019 (COVID-19) is an on-going pandemic disease infecting millions of people across the globe. Recent reports of reduction in antibody levels and the re-emergence of the disease in recovered patients necessitated the understanding of the pandemic at the core level. The cases of multiple organ failures emphasized the consideration of different organ systems while managing the disease. The present study employed RNA sequencing data to determine the disease associated differenti","2021","07","18","Genomics Inform","Genomics &amp; informatics","COVID-19; RNA-Seq; cluster analysis; gene ontology; protein interaction maps","Bharne","Dhammapal","Department of Biotechnology and Bioinformatics, University of Hyderabad, Hyderabad 500046, India",NA
"131","34261188","10.1111/psyg.12746","Death and dying are not dirty words: palliative care and the older person in the COVID-19 pandemic.",NA,"2021","07","14","Psychogeriatrics","Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society",NA,"Lapid","Maria I","Department of Psychiatry &amp",NA
"132","34261188","10.1111/psyg.12746","Death and dying are not dirty words: palliative care and the older person in the COVID-19 pandemic.",NA,"2021","07","14","Psychogeriatrics","Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society",NA,"Peisah","Carmelle","University New South Wales - Kensington Campus",NA
"133","34261172","10.1055/s-0041-1731679","Using Log Data to Measure Provider EHR Activity at a Cancer Center during Rapid Telemedicine Deployment.","Accurate metrics of provider activity within the electronic health record (EHR) are critical to understand workflow efficiency and target optimization initiatives. We utilized newly described, log-based core metrics at a tertiary cancer center during rapid escalation of telemedicine secondary to initial coronavirus disease-2019 (COVID-19) peak onset of social distancing restrictions at our medical center (COVID-19 peak). These metrics evaluate the impact on total EHR time, work outside of work, ","2021","07","19","Appl Clin Inform","Applied clinical informatics",NA,"Moore","Colin","Department of Clinical Informatics and Clinical Systems, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States",NA
"134","34261172","10.1055/s-0041-1731679","Using Log Data to Measure Provider EHR Activity at a Cancer Center during Rapid Telemedicine Deployment.","Accurate metrics of provider activity within the electronic health record (EHR) are critical to understand workflow efficiency and target optimization initiatives. We utilized newly described, log-based core metrics at a tertiary cancer center during rapid escalation of telemedicine secondary to initial coronavirus disease-2019 (COVID-19) peak onset of social distancing restrictions at our medical center (COVID-19 peak). These metrics evaluate the impact on total EHR time, work outside of work, ","2021","07","19","Appl Clin Inform","Applied clinical informatics",NA,"Valenti","Amber","Cerner Corporation, North Kansas City, Missouri, United States",NA
"135","34261172","10.1055/s-0041-1731679","Using Log Data to Measure Provider EHR Activity at a Cancer Center during Rapid Telemedicine Deployment.","Accurate metrics of provider activity within the electronic health record (EHR) are critical to understand workflow efficiency and target optimization initiatives. We utilized newly described, log-based core metrics at a tertiary cancer center during rapid escalation of telemedicine secondary to initial coronavirus disease-2019 (COVID-19) peak onset of social distancing restrictions at our medical center (COVID-19 peak). These metrics evaluate the impact on total EHR time, work outside of work, ","2021","07","19","Appl Clin Inform","Applied clinical informatics",NA,"Robinson","Edmondo","Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States",NA
"136","34261172","10.1055/s-0041-1731679","Using Log Data to Measure Provider EHR Activity at a Cancer Center during Rapid Telemedicine Deployment.","Accurate metrics of provider activity within the electronic health record (EHR) are critical to understand workflow efficiency and target optimization initiatives. We utilized newly described, log-based core metrics at a tertiary cancer center during rapid escalation of telemedicine secondary to initial coronavirus disease-2019 (COVID-19) peak onset of social distancing restrictions at our medical center (COVID-19 peak). These metrics evaluate the impact on total EHR time, work outside of work, ","2021","07","19","Appl Clin Inform","Applied clinical informatics",NA,"Perkins","Randa","Department of Clinical Informatics and Clinical Systems, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States",NA
"137","34261146","10.1055/a-1526-9979","Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave."," The aim of this retrospective study was to investigate the implementation of measures to prevent perioperative COVID-19 in thoracic surgery during the first wave of the COVID-19 pandemic 2020 allowing a continued surgical treatment of patients.  The implemented preventive measures in patient management of the thoracic surgery department of the Asklepios Lung Clinic Munich-Gauting, Germany were retrospectively analyzed. Postoperative COVID-19 incidence before and after implementation of preventi","2021","07","14","Pneumologie","Pneumologie (Stuttgart, Germany)",NA,"Stoleriu","Mircea Gabriel","Center for Thoracic Surgery Munich, Ludwig-Maximilians-University of Munich (LMU) and Asklepios Lung Clinic Munich-Gauting, Munich and Gauting, Germany",NA
"138","34261146","10.1055/a-1526-9979","Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave."," The aim of this retrospective study was to investigate the implementation of measures to prevent perioperative COVID-19 in thoracic surgery during the first wave of the COVID-19 pandemic 2020 allowing a continued surgical treatment of patients.  The implemented preventive measures in patient management of the thoracic surgery department of the Asklepios Lung Clinic Munich-Gauting, Germany were retrospectively analyzed. Postoperative COVID-19 incidence before and after implementation of preventi","2021","07","14","Pneumologie","Pneumologie (Stuttgart, Germany)",NA,"Gerckens","Michael","Comprehensive Pneumology Center, Helmholtz Center Munich, Munich, Germany, Member of the German Lung Research Center",NA
"139","34261146","10.1055/a-1526-9979","Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave."," The aim of this retrospective study was to investigate the implementation of measures to prevent perioperative COVID-19 in thoracic surgery during the first wave of the COVID-19 pandemic 2020 allowing a continued surgical treatment of patients.  The implemented preventive measures in patient management of the thoracic surgery department of the Asklepios Lung Clinic Munich-Gauting, Germany were retrospectively analyzed. Postoperative COVID-19 incidence before and after implementation of preventi","2021","07","14","Pneumologie","Pneumologie (Stuttgart, Germany)",NA,"Ströh","Katja","Center for Thoracic Surgery Munich, Ludwig-Maximilians-University of Munich (LMU) and Asklepios Lung Clinic Munich-Gauting, Munich and Gauting, Germany",NA
"140","34261146","10.1055/a-1526-9979","Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave."," The aim of this retrospective study was to investigate the implementation of measures to prevent perioperative COVID-19 in thoracic surgery during the first wave of the COVID-19 pandemic 2020 allowing a continued surgical treatment of patients.  The implemented preventive measures in patient management of the thoracic surgery department of the Asklepios Lung Clinic Munich-Gauting, Germany were retrospectively analyzed. Postoperative COVID-19 incidence before and after implementation of preventi","2021","07","14","Pneumologie","Pneumologie (Stuttgart, Germany)",NA,"Kovács","Julia","Center for Thoracic Surgery Munich, Ludwig-Maximilians-University of Munich (LMU) and Asklepios Lung Clinic Munich-Gauting, Munich and Gauting, Germany",NA
"141","34261146","10.1055/a-1526-9979","Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave."," The aim of this retrospective study was to investigate the implementation of measures to prevent perioperative COVID-19 in thoracic surgery during the first wave of the COVID-19 pandemic 2020 allowing a continued surgical treatment of patients.  The implemented preventive measures in patient management of the thoracic surgery department of the Asklepios Lung Clinic Munich-Gauting, Germany were retrospectively analyzed. Postoperative COVID-19 incidence before and after implementation of preventi","2021","07","14","Pneumologie","Pneumologie (Stuttgart, Germany)",NA,"Samm","Nicole","Center for Thoracic Surgery Munich, Ludwig-Maximilians-University of Munich (LMU) and Asklepios Lung Clinic Munich-Gauting, Munich and Gauting, Germany",NA
"142","34261146","10.1055/a-1526-9979","Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave."," The aim of this retrospective study was to investigate the implementation of measures to prevent perioperative COVID-19 in thoracic surgery during the first wave of the COVID-19 pandemic 2020 allowing a continued surgical treatment of patients.  The implemented preventive measures in patient management of the thoracic surgery department of the Asklepios Lung Clinic Munich-Gauting, Germany were retrospectively analyzed. Postoperative COVID-19 incidence before and after implementation of preventi","2021","07","14","Pneumologie","Pneumologie (Stuttgart, Germany)",NA,"Obereisenbuchner","Florian","Department of Pneumology, Asklepios Lung Clinic Munich-Gauting, Gauting, Germany",NA
"143","34261146","10.1055/a-1526-9979","Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave."," The aim of this retrospective study was to investigate the implementation of measures to prevent perioperative COVID-19 in thoracic surgery during the first wave of the COVID-19 pandemic 2020 allowing a continued surgical treatment of patients.  The implemented preventive measures in patient management of the thoracic surgery department of the Asklepios Lung Clinic Munich-Gauting, Germany were retrospectively analyzed. Postoperative COVID-19 incidence before and after implementation of preventi","2021","07","14","Pneumologie","Pneumologie (Stuttgart, Germany)",NA,"Hetrodt","Justin","Department of Pneumology, Asklepios Lung Clinic Munich-Gauting, Gauting, Germany",NA
"144","34261146","10.1055/a-1526-9979","Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave."," The aim of this retrospective study was to investigate the implementation of measures to prevent perioperative COVID-19 in thoracic surgery during the first wave of the COVID-19 pandemic 2020 allowing a continued surgical treatment of patients.  The implemented preventive measures in patient management of the thoracic surgery department of the Asklepios Lung Clinic Munich-Gauting, Germany were retrospectively analyzed. Postoperative COVID-19 incidence before and after implementation of preventi","2021","07","14","Pneumologie","Pneumologie (Stuttgart, Germany)",NA,"Schmidt","Felicitas Maria","Department of Pneumology, Asklepios Lung Clinic Munich-Gauting, Gauting, Germany",NA
"145","34261146","10.1055/a-1526-9979","Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave."," The aim of this retrospective study was to investigate the implementation of measures to prevent perioperative COVID-19 in thoracic surgery during the first wave of the COVID-19 pandemic 2020 allowing a continued surgical treatment of patients.  The implemented preventive measures in patient management of the thoracic surgery department of the Asklepios Lung Clinic Munich-Gauting, Germany were retrospectively analyzed. Postoperative COVID-19 incidence before and after implementation of preventi","2021","07","14","Pneumologie","Pneumologie (Stuttgart, Germany)",NA,"Reinmuth","Niels","Department of Pneumology, Asklepios Lung Clinic Munich-Gauting, Gauting, Germany",NA
"146","34261146","10.1055/a-1526-9979","Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave."," The aim of this retrospective study was to investigate the implementation of measures to prevent perioperative COVID-19 in thoracic surgery during the first wave of the COVID-19 pandemic 2020 allowing a continued surgical treatment of patients.  The implemented preventive measures in patient management of the thoracic surgery department of the Asklepios Lung Clinic Munich-Gauting, Germany were retrospectively analyzed. Postoperative COVID-19 incidence before and after implementation of preventi","2021","07","14","Pneumologie","Pneumologie (Stuttgart, Germany)",NA,"Heiß-Neumann","Marion","Department of Pneumology, Asklepios Lung Clinic Munich-Gauting, Gauting, Germany",NA
"147","34261146","10.1055/a-1526-9979","Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave."," The aim of this retrospective study was to investigate the implementation of measures to prevent perioperative COVID-19 in thoracic surgery during the first wave of the COVID-19 pandemic 2020 allowing a continued surgical treatment of patients.  The implemented preventive measures in patient management of the thoracic surgery department of the Asklepios Lung Clinic Munich-Gauting, Germany were retrospectively analyzed. Postoperative COVID-19 incidence before and after implementation of preventi","2021","07","14","Pneumologie","Pneumologie (Stuttgart, Germany)",NA,"Stacher-Priehse","Elvira","Department of Pathology, Asklepios Lung Clinic Munich-Gauting, Gauting, Germany",NA
"148","34261146","10.1055/a-1526-9979","Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave."," The aim of this retrospective study was to investigate the implementation of measures to prevent perioperative COVID-19 in thoracic surgery during the first wave of the COVID-19 pandemic 2020 allowing a continued surgical treatment of patients.  The implemented preventive measures in patient management of the thoracic surgery department of the Asklepios Lung Clinic Munich-Gauting, Germany were retrospectively analyzed. Postoperative COVID-19 incidence before and after implementation of preventi","2021","07","14","Pneumologie","Pneumologie (Stuttgart, Germany)",NA,"Koch","Ina","Center for Thoracic Surgery Munich, Ludwig-Maximilians-University of Munich (LMU) and Asklepios Lung Clinic Munich-Gauting, Munich and Gauting, Germany",NA
"149","34261146","10.1055/a-1526-9979","Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave."," The aim of this retrospective study was to investigate the implementation of measures to prevent perioperative COVID-19 in thoracic surgery during the first wave of the COVID-19 pandemic 2020 allowing a continued surgical treatment of patients.  The implemented preventive measures in patient management of the thoracic surgery department of the Asklepios Lung Clinic Munich-Gauting, Germany were retrospectively analyzed. Postoperative COVID-19 incidence before and after implementation of preventi","2021","07","14","Pneumologie","Pneumologie (Stuttgart, Germany)",NA,"Behr","Jürgen","Comprehensive Pneumology Center, Helmholtz Center Munich, Munich, Germany, Member of the German Lung Research Center",NA
"150","34261146","10.1055/a-1526-9979","Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave."," The aim of this retrospective study was to investigate the implementation of measures to prevent perioperative COVID-19 in thoracic surgery during the first wave of the COVID-19 pandemic 2020 allowing a continued surgical treatment of patients.  The implemented preventive measures in patient management of the thoracic surgery department of the Asklepios Lung Clinic Munich-Gauting, Germany were retrospectively analyzed. Postoperative COVID-19 incidence before and after implementation of preventi","2021","07","14","Pneumologie","Pneumologie (Stuttgart, Germany)",NA,"Ketscher","Christian","Center for Thoracic Surgery Munich, Ludwig-Maximilians-University of Munich (LMU) and Asklepios Lung Clinic Munich-Gauting, Munich and Gauting, Germany",NA
"151","34261146","10.1055/a-1526-9979","Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave."," The aim of this retrospective study was to investigate the implementation of measures to prevent perioperative COVID-19 in thoracic surgery during the first wave of the COVID-19 pandemic 2020 allowing a continued surgical treatment of patients.  The implemented preventive measures in patient management of the thoracic surgery department of the Asklepios Lung Clinic Munich-Gauting, Germany were retrospectively analyzed. Postoperative COVID-19 incidence before and after implementation of preventi","2021","07","14","Pneumologie","Pneumologie (Stuttgart, Germany)",NA,"Grützner","Uwe","Center for Thoracic Surgery Munich, Ludwig-Maximilians-University of Munich (LMU) and Asklepios Lung Clinic Munich-Gauting, Munich and Gauting, Germany",NA
"152","34261146","10.1055/a-1526-9979","Prevention of COVID-19 in Thoracic Surgery Patients: Lessons Learned during the First Pandemic Wave."," The aim of this retrospective study was to investigate the implementation of measures to prevent perioperative COVID-19 in thoracic surgery during the first wave of the COVID-19 pandemic 2020 allowing a continued surgical treatment of patients.  The implemented preventive measures in patient management of the thoracic surgery department of the Asklepios Lung Clinic Munich-Gauting, Germany were retrospectively analyzed. Postoperative COVID-19 incidence before and after implementation of preventi","2021","07","14","Pneumologie","Pneumologie (Stuttgart, Germany)",NA,"Hatz","Rudolf","Center for Thoracic Surgery Munich, Ludwig-Maximilians-University of Munich (LMU) and Asklepios Lung Clinic Munich-Gauting, Munich and Gauting, Germany",NA
"153","34261133","10.1093/jamia/ocab130","Biomedical and health informatics continue to contribute to COVID-19 pandemic solutions and beyond.",NA,"2021","07","17","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA",NA,"Bakken","Suzanne","School of Nursing, Department of Biomedical Informatics, and Data Science Institute, Columbia University, New York, New York, USA",NA
"154","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Starr","Tyler N","Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA",NA
"155","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Czudnochowski","Nadine","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"156","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Liu","Zhuoming","Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, 63110, USA",NA
"157","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Zatta","Fabrizia","Humabs BioMed SA, a subsidiary of Vir Biotechnology, 6500, Bellinzona, Switzerland",NA
"158","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Park","Young-Jun","Department of Biochemistry, University of Washington, Seattle, WA, 98195, USA",NA
"159","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Addetia","Amin","Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA",NA
"160","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Pinto","Dora","Humabs BioMed SA, a subsidiary of Vir Biotechnology, 6500, Bellinzona, Switzerland",NA
"161","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Beltramello","Martina","Humabs BioMed SA, a subsidiary of Vir Biotechnology, 6500, Bellinzona, Switzerland",NA
"162","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Hernandez","Patrick","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"163","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Greaney","Allison J","Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA",NA
"164","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Marzi","Roberta","Humabs BioMed SA, a subsidiary of Vir Biotechnology, 6500, Bellinzona, Switzerland",NA
"165","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Glass","William G","Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA",NA
"166","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Zhang","Ivy","Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA",NA
"167","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Dingens","Adam S","Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA",NA
"168","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Bowen","John E","Department of Biochemistry, University of Washington, Seattle, WA, 98195, USA",NA
"169","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Tortorici","M Alejandra","Department of Biochemistry, University of Washington, Seattle, WA, 98195, USA",NA
"170","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Walls","Alexandra C","Department of Biochemistry, University of Washington, Seattle, WA, 98195, USA",NA
"171","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Wojcechowskyj","Jason A","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"172","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"De Marco","Anna","Humabs BioMed SA, a subsidiary of Vir Biotechnology, 6500, Bellinzona, Switzerland",NA
"173","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Rosen","Laura E","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"174","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Zhou","Jiayi","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"175","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Montiel-Ruiz","Martin","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"176","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Kaiser","Hannah","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"177","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Dillen","Josh","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"178","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Tucker","Heather","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"179","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Bassi","Jessica","Humabs BioMed SA, a subsidiary of Vir Biotechnology, 6500, Bellinzona, Switzerland",NA
"180","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Silacci-Fregni","Chiara","Humabs BioMed SA, a subsidiary of Vir Biotechnology, 6500, Bellinzona, Switzerland",NA
"181","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Housley","Michael P","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"182","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"di Iulio","Julia","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"183","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Lombardo","Gloria","Humabs BioMed SA, a subsidiary of Vir Biotechnology, 6500, Bellinzona, Switzerland",NA
"184","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Agostini","Maria","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"185","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Sprugasci","Nicole","Humabs BioMed SA, a subsidiary of Vir Biotechnology, 6500, Bellinzona, Switzerland",NA
"186","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Culap","Katja","Humabs BioMed SA, a subsidiary of Vir Biotechnology, 6500, Bellinzona, Switzerland",NA
"187","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Jaconi","Stefano","Humabs BioMed SA, a subsidiary of Vir Biotechnology, 6500, Bellinzona, Switzerland",NA
"188","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Meury","Marcel","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"189","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Dellota","Exequiel","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"190","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Abdelnabi","Rana","Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, Leuven, Belgium",NA
"191","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Foo","Shi-Yan Caroline","Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, Leuven, Belgium",NA
"192","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Cameroni","Elisabetta","Humabs BioMed SA, a subsidiary of Vir Biotechnology, 6500, Bellinzona, Switzerland",NA
"193","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Stumpf","Spencer","Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, 63110, USA",NA
"194","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Croll","Tristan I","Cambridge Institute for Medical Research, Department of Haematology, University of Cambridge, Cambridge, CB2 0XY, UK",NA
"195","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Nix","Jay C","Molecular Biology Consortium, Advanced Light Source, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA",NA
"196","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Havenar-Daughton","Colin","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"197","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Piccoli","Luca","Humabs BioMed SA, a subsidiary of Vir Biotechnology, 6500, Bellinzona, Switzerland",NA
"198","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Benigni","Fabio","Humabs BioMed SA, a subsidiary of Vir Biotechnology, 6500, Bellinzona, Switzerland",NA
"199","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Neyts","Johan","Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, Leuven, Belgium",NA
"200","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Telenti","Amalio","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"201","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Lempp","Florian A","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"202","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Pizzuto","Matteo S","Humabs BioMed SA, a subsidiary of Vir Biotechnology, 6500, Bellinzona, Switzerland",NA
"203","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Chodera","John D","Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA",NA
"204","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Hebner","Christy M","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"205","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Virgin","Herbert W","Vir Biotechnology, San Francisco, CA, 94158, USA",NA
"206","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Whelan","Sean P J","Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, 63110, USA",NA
"207","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Veesler","David","Department of Biochemistry, University of Washington, Seattle, WA, 98195, USA",NA
"208","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Corti","Davide","Humabs BioMed SA, a subsidiary of Vir Biotechnology, 6500, Bellinzona, Switzerland. dcorti@vir","dcorti@vir.bio"
"209","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Bloom","Jesse D","Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA. jbloom@fredhutch","jbloom@fredhutch.org"
"210","34261126","10.1038/s41586-021-03807-6","SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.","An ideal anti-SARS-CoV-2 antibody would resist viral escape<sup>1-3</sup>, have activity against diverse SARS-related coronaviruses (sarbecoviruses)<sup>4-7</sup>, and be highly protective through viral neutralization<sup>8-11</sup> and effector functions<sup>12,13</sup>. Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize escape, breadth, and potency across","2021","07","20","Nature","Nature",NA,"Snell","Gyorgy","Vir Biotechnology, San Francisco, CA, 94158, USA. gsnell@vir","gsnell@vir.bio"
"211","34261122","10.1097/NNE.0000000000001064","Meeting Undergraduate Nursing Students' Clinical Needs: A Comparison of Traditional Clinical, Face-to-Face Simulation, and Screen-Based Simulation Learning Environments.","Nurse educators expanded replacement of traditional clinical practice and face-to-face simulation experiences with screen-based simulation (SBS) during the COVID-19 (coronavirus disease 2019) pandemic. The purpose of this research was to understand the student experience when learning in 3 types of clinical education environments. This quantitative descriptive survey study used the Clinical Learning Environment Comparison Survey 2.0 (CLECS 2.0) to compare prelicensure nursing students' perceptio","2021","07","15","Nurse Educ","Nurse educator",NA,"Leighton","Kim","Author Affiliations: Executive Director (Dr Leighton), Itqan Clinical Simulation &amp",NA
"212","34261122","10.1097/NNE.0000000000001064","Meeting Undergraduate Nursing Students' Clinical Needs: A Comparison of Traditional Clinical, Face-to-Face Simulation, and Screen-Based Simulation Learning Environments.","Nurse educators expanded replacement of traditional clinical practice and face-to-face simulation experiences with screen-based simulation (SBS) during the COVID-19 (coronavirus disease 2019) pandemic. The purpose of this research was to understand the student experience when learning in 3 types of clinical education environments. This quantitative descriptive survey study used the Clinical Learning Environment Comparison Survey 2.0 (CLECS 2.0) to compare prelicensure nursing students' perceptio","2021","07","15","Nurse Educ","Nurse educator",NA,"Kardong-Edgren","Suzan","Author Affiliations: Executive Director (Dr Leighton), Itqan Clinical Simulation &amp",NA
"213","34261122","10.1097/NNE.0000000000001064","Meeting Undergraduate Nursing Students' Clinical Needs: A Comparison of Traditional Clinical, Face-to-Face Simulation, and Screen-Based Simulation Learning Environments.","Nurse educators expanded replacement of traditional clinical practice and face-to-face simulation experiences with screen-based simulation (SBS) during the COVID-19 (coronavirus disease 2019) pandemic. The purpose of this research was to understand the student experience when learning in 3 types of clinical education environments. This quantitative descriptive survey study used the Clinical Learning Environment Comparison Survey 2.0 (CLECS 2.0) to compare prelicensure nursing students' perceptio","2021","07","15","Nurse Educ","Nurse educator",NA,"Schneidereith","Tonya","Author Affiliations: Executive Director (Dr Leighton), Itqan Clinical Simulation &amp",NA
"214","34261122","10.1097/NNE.0000000000001064","Meeting Undergraduate Nursing Students' Clinical Needs: A Comparison of Traditional Clinical, Face-to-Face Simulation, and Screen-Based Simulation Learning Environments.","Nurse educators expanded replacement of traditional clinical practice and face-to-face simulation experiences with screen-based simulation (SBS) during the COVID-19 (coronavirus disease 2019) pandemic. The purpose of this research was to understand the student experience when learning in 3 types of clinical education environments. This quantitative descriptive survey study used the Clinical Learning Environment Comparison Survey 2.0 (CLECS 2.0) to compare prelicensure nursing students' perceptio","2021","07","15","Nurse Educ","Nurse educator",NA,"Foisy-Doll","Colette","Author Affiliations: Executive Director (Dr Leighton), Itqan Clinical Simulation &amp",NA
"215","34261122","10.1097/NNE.0000000000001064","Meeting Undergraduate Nursing Students' Clinical Needs: A Comparison of Traditional Clinical, Face-to-Face Simulation, and Screen-Based Simulation Learning Environments.","Nurse educators expanded replacement of traditional clinical practice and face-to-face simulation experiences with screen-based simulation (SBS) during the COVID-19 (coronavirus disease 2019) pandemic. The purpose of this research was to understand the student experience when learning in 3 types of clinical education environments. This quantitative descriptive survey study used the Clinical Learning Environment Comparison Survey 2.0 (CLECS 2.0) to compare prelicensure nursing students' perceptio","2021","07","15","Nurse Educ","Nurse educator",NA,"Wuestney","Katherine A","Author Affiliations: Executive Director (Dr Leighton), Itqan Clinical Simulation &amp",NA
"216","34261119","10.1097/NNE.0000000000001078","The Future Capacity of the Nursing Workforce: COVID-19 Pandemic's Impacts on New Nurses and Nursing Students Toward the Profession.","Nurses are concerned for their safety and conflicted about their career, because their duty to care for patients during the pandemic involved competing ethical obligations, including their own personal safety. The aim was to explore the impact of COVID-19 on new nurses and nursing students in terms of safety and interest in nursing specifically related to self-efficacy, geographic region case density, and frontline experience in health care. New nurses and nursing students (N = 472) responded to","2021","07","15","Nurse Educ","Nurse educator",NA,"Mannino","Jennifer Emilie","Author Affiliations: Professor (Drs Mannino, Cotter, Armstrong, and Moore), Barbara H. Hagan School of Nursing and Health Sciences, and Statistical Support Consultant (Dr Watters), Office of Graduate Academic Affairs, Molloy College, Rockville Centre - Nassau County, New York",NA
"217","34261119","10.1097/NNE.0000000000001078","The Future Capacity of the Nursing Workforce: COVID-19 Pandemic's Impacts on New Nurses and Nursing Students Toward the Profession.","Nurses are concerned for their safety and conflicted about their career, because their duty to care for patients during the pandemic involved competing ethical obligations, including their own personal safety. The aim was to explore the impact of COVID-19 on new nurses and nursing students in terms of safety and interest in nursing specifically related to self-efficacy, geographic region case density, and frontline experience in health care. New nurses and nursing students (N = 472) responded to","2021","07","15","Nurse Educ","Nurse educator",NA,"Watters","Pamela","Author Affiliations: Professor (Drs Mannino, Cotter, Armstrong, and Moore), Barbara H. Hagan School of Nursing and Health Sciences, and Statistical Support Consultant (Dr Watters), Office of Graduate Academic Affairs, Molloy College, Rockville Centre - Nassau County, New York",NA
"218","34261119","10.1097/NNE.0000000000001078","The Future Capacity of the Nursing Workforce: COVID-19 Pandemic's Impacts on New Nurses and Nursing Students Toward the Profession.","Nurses are concerned for their safety and conflicted about their career, because their duty to care for patients during the pandemic involved competing ethical obligations, including their own personal safety. The aim was to explore the impact of COVID-19 on new nurses and nursing students in terms of safety and interest in nursing specifically related to self-efficacy, geographic region case density, and frontline experience in health care. New nurses and nursing students (N = 472) responded to","2021","07","15","Nurse Educ","Nurse educator",NA,"Cotter","Elizabeth","Author Affiliations: Professor (Drs Mannino, Cotter, Armstrong, and Moore), Barbara H. Hagan School of Nursing and Health Sciences, and Statistical Support Consultant (Dr Watters), Office of Graduate Academic Affairs, Molloy College, Rockville Centre - Nassau County, New York",NA
"219","34261119","10.1097/NNE.0000000000001078","The Future Capacity of the Nursing Workforce: COVID-19 Pandemic's Impacts on New Nurses and Nursing Students Toward the Profession.","Nurses are concerned for their safety and conflicted about their career, because their duty to care for patients during the pandemic involved competing ethical obligations, including their own personal safety. The aim was to explore the impact of COVID-19 on new nurses and nursing students in terms of safety and interest in nursing specifically related to self-efficacy, geographic region case density, and frontline experience in health care. New nurses and nursing students (N = 472) responded to","2021","07","15","Nurse Educ","Nurse educator",NA,"Armstrong","Normadeane","Author Affiliations: Professor (Drs Mannino, Cotter, Armstrong, and Moore), Barbara H. Hagan School of Nursing and Health Sciences, and Statistical Support Consultant (Dr Watters), Office of Graduate Academic Affairs, Molloy College, Rockville Centre - Nassau County, New York",NA
"220","34261119","10.1097/NNE.0000000000001078","The Future Capacity of the Nursing Workforce: COVID-19 Pandemic's Impacts on New Nurses and Nursing Students Toward the Profession.","Nurses are concerned for their safety and conflicted about their career, because their duty to care for patients during the pandemic involved competing ethical obligations, including their own personal safety. The aim was to explore the impact of COVID-19 on new nurses and nursing students in terms of safety and interest in nursing specifically related to self-efficacy, geographic region case density, and frontline experience in health care. New nurses and nursing students (N = 472) responded to","2021","07","15","Nurse Educ","Nurse educator",NA,"Moore","Geraldine A","Author Affiliations: Professor (Drs Mannino, Cotter, Armstrong, and Moore), Barbara H. Hagan School of Nursing and Health Sciences, and Statistical Support Consultant (Dr Watters), Office of Graduate Academic Affairs, Molloy College, Rockville Centre - Nassau County, New York",NA
"221","34261119","10.1097/NNE.0000000000001078","The Future Capacity of the Nursing Workforce: COVID-19 Pandemic's Impacts on New Nurses and Nursing Students Toward the Profession.","Nurses are concerned for their safety and conflicted about their career, because their duty to care for patients during the pandemic involved competing ethical obligations, including their own personal safety. The aim was to explore the impact of COVID-19 on new nurses and nursing students in terms of safety and interest in nursing specifically related to self-efficacy, geographic region case density, and frontline experience in health care. New nurses and nursing students (N = 472) responded to","2021","07","15","Nurse Educ","Nurse educator",NA,"Bongiorno","Anne Watson","Author Affiliations: Professor (Drs Mannino, Cotter, Armstrong, and Moore), Barbara H. Hagan School of Nursing and Health Sciences, and Statistical Support Consultant (Dr Watters), Office of Graduate Academic Affairs, Molloy College, Rockville Centre - Nassau County, New York",NA
"222","34261119","10.1097/NNE.0000000000001078","The Future Capacity of the Nursing Workforce: COVID-19 Pandemic's Impacts on New Nurses and Nursing Students Toward the Profession.","Nurses are concerned for their safety and conflicted about their career, because their duty to care for patients during the pandemic involved competing ethical obligations, including their own personal safety. The aim was to explore the impact of COVID-19 on new nurses and nursing students in terms of safety and interest in nursing specifically related to self-efficacy, geographic region case density, and frontline experience in health care. New nurses and nursing students (N = 472) responded to","2021","07","15","Nurse Educ","Nurse educator",NA,"Kelley","Randy","Author Affiliations: Professor (Drs Mannino, Cotter, Armstrong, and Moore), Barbara H. Hagan School of Nursing and Health Sciences, and Statistical Support Consultant (Dr Watters), Office of Graduate Academic Affairs, Molloy College, Rockville Centre - Nassau County, New York",NA
"223","34261116","10.1097/BOR.0000000000000818","Clinical features of multisystem inflammatory syndrome in children.","To review diagnosis, clinical characteristics and treatment of multisystem inflammatory syndrome in children (MIS-C) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). MIS-C emerged in spring 2020 as a hyperinflammatory syndrome following SARS-CoV-2 exposure in children. Despite growing awareness of MIS-C, diagnosis remains challenging due to the range of phenotypes and severity. Fever accompanied by shock, cardiac dysfunction, gastrointestinal symptoms, or mucocutaneo","2021","07","14","Curr Opin Rheumatol","Current opinion in rheumatology",NA,"Roberts","Jordan E","Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA",NA
"224","34261116","10.1097/BOR.0000000000000818","Clinical features of multisystem inflammatory syndrome in children.","To review diagnosis, clinical characteristics and treatment of multisystem inflammatory syndrome in children (MIS-C) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). MIS-C emerged in spring 2020 as a hyperinflammatory syndrome following SARS-CoV-2 exposure in children. Despite growing awareness of MIS-C, diagnosis remains challenging due to the range of phenotypes and severity. Fever accompanied by shock, cardiac dysfunction, gastrointestinal symptoms, or mucocutaneo","2021","07","14","Curr Opin Rheumatol","Current opinion in rheumatology",NA,"Henderson","Lauren A","Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA",NA
"225","34261097","10.1097/QAD.0000000000003017","Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.","This study of SARS-CoV-2 mRNA vaccination in 14 persons with HIV demonstrated uniformly high anti-SARS-CoV-2 receptor binding domain antibody titers after two doses, despite varied titers after a single dose. The majority of vaccine reactions were mild and no adverse events occurred.","2021","07","16","AIDS","AIDS (London, England)",NA,"Ruddy","Jake A","Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD",NA
"226","34261097","10.1097/QAD.0000000000003017","Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.","This study of SARS-CoV-2 mRNA vaccination in 14 persons with HIV demonstrated uniformly high anti-SARS-CoV-2 receptor binding domain antibody titers after two doses, despite varied titers after a single dose. The majority of vaccine reactions were mild and no adverse events occurred.","2021","07","16","AIDS","AIDS (London, England)",NA,"Boyarsky","Brian J","Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD",NA
"227","34261097","10.1097/QAD.0000000000003017","Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.","This study of SARS-CoV-2 mRNA vaccination in 14 persons with HIV demonstrated uniformly high anti-SARS-CoV-2 receptor binding domain antibody titers after two doses, despite varied titers after a single dose. The majority of vaccine reactions were mild and no adverse events occurred.","2021","07","16","AIDS","AIDS (London, England)",NA,"Bailey","Justin R","Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD",NA
"228","34261097","10.1097/QAD.0000000000003017","Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.","This study of SARS-CoV-2 mRNA vaccination in 14 persons with HIV demonstrated uniformly high anti-SARS-CoV-2 receptor binding domain antibody titers after two doses, despite varied titers after a single dose. The majority of vaccine reactions were mild and no adverse events occurred.","2021","07","16","AIDS","AIDS (London, England)",NA,"Karaba","Andrew H","Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD",NA
"229","34261097","10.1097/QAD.0000000000003017","Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.","This study of SARS-CoV-2 mRNA vaccination in 14 persons with HIV demonstrated uniformly high anti-SARS-CoV-2 receptor binding domain antibody titers after two doses, despite varied titers after a single dose. The majority of vaccine reactions were mild and no adverse events occurred.","2021","07","16","AIDS","AIDS (London, England)",NA,"Garonzik-Wang","Jacqueline M","Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD",NA
"230","34261097","10.1097/QAD.0000000000003017","Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.","This study of SARS-CoV-2 mRNA vaccination in 14 persons with HIV demonstrated uniformly high anti-SARS-CoV-2 receptor binding domain antibody titers after two doses, despite varied titers after a single dose. The majority of vaccine reactions were mild and no adverse events occurred.","2021","07","16","AIDS","AIDS (London, England)",NA,"Segev","Dorry L","Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD",NA
"231","34261097","10.1097/QAD.0000000000003017","Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.","This study of SARS-CoV-2 mRNA vaccination in 14 persons with HIV demonstrated uniformly high anti-SARS-CoV-2 receptor binding domain antibody titers after two doses, despite varied titers after a single dose. The majority of vaccine reactions were mild and no adverse events occurred.","2021","07","16","AIDS","AIDS (London, England)",NA,"Durand","Christine M","Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD",NA
"232","34261097","10.1097/QAD.0000000000003017","Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.","This study of SARS-CoV-2 mRNA vaccination in 14 persons with HIV demonstrated uniformly high anti-SARS-CoV-2 receptor binding domain antibody titers after two doses, despite varied titers after a single dose. The majority of vaccine reactions were mild and no adverse events occurred.","2021","07","16","AIDS","AIDS (London, England)",NA,"Werbel","William A","Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD",NA
"233","34261078","10.2459/JCM.0000000000001228","In-hospital prognostic role of coronary atherosclerotic burden in COVID-19 patients.","Currently, there are few available data regarding a possible role for subclinical atherosclerosis as a risk factor for mortality in Coronavirus Disease 19 (COVID-19) patients. We used coronary artery calcium (CAC) score derived from chest computed tomography (CT) scan to assess the in-hospital prognostic role of CAC in patients affected by COVID-19 pneumonia. Electronic medical records of patients with confirmed diagnosis of COVID-19 were retrospectively reviewed. Patients with known coronary ar","2021","07","16","J Cardiovasc Med (Hagerstown)","Journal of cardiovascular medicine (Hagerstown, Md.)",NA,"Fazzari","Fabio","Department of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano Department of Biomedical Sciences, Humanitas University Department of Radiology, IRCCS Humanitas Research Hospital, Milan, Italy",NA
"234","34261078","10.2459/JCM.0000000000001228","In-hospital prognostic role of coronary atherosclerotic burden in COVID-19 patients.","Currently, there are few available data regarding a possible role for subclinical atherosclerosis as a risk factor for mortality in Coronavirus Disease 19 (COVID-19) patients. We used coronary artery calcium (CAC) score derived from chest computed tomography (CT) scan to assess the in-hospital prognostic role of CAC in patients affected by COVID-19 pneumonia. Electronic medical records of patients with confirmed diagnosis of COVID-19 were retrospectively reviewed. Patients with known coronary ar","2021","07","16","J Cardiovasc Med (Hagerstown)","Journal of cardiovascular medicine (Hagerstown, Md.)",NA,"Cozzi","Ottavia","Department of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano Department of Biomedical Sciences, Humanitas University Department of Radiology, IRCCS Humanitas Research Hospital, Milan, Italy",NA
"235","34261078","10.2459/JCM.0000000000001228","In-hospital prognostic role of coronary atherosclerotic burden in COVID-19 patients.","Currently, there are few available data regarding a possible role for subclinical atherosclerosis as a risk factor for mortality in Coronavirus Disease 19 (COVID-19) patients. We used coronary artery calcium (CAC) score derived from chest computed tomography (CT) scan to assess the in-hospital prognostic role of CAC in patients affected by COVID-19 pneumonia. Electronic medical records of patients with confirmed diagnosis of COVID-19 were retrospectively reviewed. Patients with known coronary ar","2021","07","16","J Cardiovasc Med (Hagerstown)","Journal of cardiovascular medicine (Hagerstown, Md.)",NA,"Maurina","Matteo","Department of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano Department of Biomedical Sciences, Humanitas University Department of Radiology, IRCCS Humanitas Research Hospital, Milan, Italy",NA
"236","34261078","10.2459/JCM.0000000000001228","In-hospital prognostic role of coronary atherosclerotic burden in COVID-19 patients.","Currently, there are few available data regarding a possible role for subclinical atherosclerosis as a risk factor for mortality in Coronavirus Disease 19 (COVID-19) patients. We used coronary artery calcium (CAC) score derived from chest computed tomography (CT) scan to assess the in-hospital prognostic role of CAC in patients affected by COVID-19 pneumonia. Electronic medical records of patients with confirmed diagnosis of COVID-19 were retrospectively reviewed. Patients with known coronary ar","2021","07","16","J Cardiovasc Med (Hagerstown)","Journal of cardiovascular medicine (Hagerstown, Md.)",NA,"Donghi","Valeria","Department of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano Department of Biomedical Sciences, Humanitas University Department of Radiology, IRCCS Humanitas Research Hospital, Milan, Italy",NA
"237","34261078","10.2459/JCM.0000000000001228","In-hospital prognostic role of coronary atherosclerotic burden in COVID-19 patients.","Currently, there are few available data regarding a possible role for subclinical atherosclerosis as a risk factor for mortality in Coronavirus Disease 19 (COVID-19) patients. We used coronary artery calcium (CAC) score derived from chest computed tomography (CT) scan to assess the in-hospital prognostic role of CAC in patients affected by COVID-19 pneumonia. Electronic medical records of patients with confirmed diagnosis of COVID-19 were retrospectively reviewed. Patients with known coronary ar","2021","07","16","J Cardiovasc Med (Hagerstown)","Journal of cardiovascular medicine (Hagerstown, Md.)",NA,"Indolfi","Eleonora","Department of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano Department of Biomedical Sciences, Humanitas University Department of Radiology, IRCCS Humanitas Research Hospital, Milan, Italy",NA
"238","34261078","10.2459/JCM.0000000000001228","In-hospital prognostic role of coronary atherosclerotic burden in COVID-19 patients.","Currently, there are few available data regarding a possible role for subclinical atherosclerosis as a risk factor for mortality in Coronavirus Disease 19 (COVID-19) patients. We used coronary artery calcium (CAC) score derived from chest computed tomography (CT) scan to assess the in-hospital prognostic role of CAC in patients affected by COVID-19 pneumonia. Electronic medical records of patients with confirmed diagnosis of COVID-19 were retrospectively reviewed. Patients with known coronary ar","2021","07","16","J Cardiovasc Med (Hagerstown)","Journal of cardiovascular medicine (Hagerstown, Md.)",NA,"Curzi","Mirko","Department of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano Department of Biomedical Sciences, Humanitas University Department of Radiology, IRCCS Humanitas Research Hospital, Milan, Italy",NA
"239","34261078","10.2459/JCM.0000000000001228","In-hospital prognostic role of coronary atherosclerotic burden in COVID-19 patients.","Currently, there are few available data regarding a possible role for subclinical atherosclerosis as a risk factor for mortality in Coronavirus Disease 19 (COVID-19) patients. We used coronary artery calcium (CAC) score derived from chest computed tomography (CT) scan to assess the in-hospital prognostic role of CAC in patients affected by COVID-19 pneumonia. Electronic medical records of patients with confirmed diagnosis of COVID-19 were retrospectively reviewed. Patients with known coronary ar","2021","07","16","J Cardiovasc Med (Hagerstown)","Journal of cardiovascular medicine (Hagerstown, Md.)",NA,"Leone","Pier Pasquale","Department of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano Department of Biomedical Sciences, Humanitas University Department of Radiology, IRCCS Humanitas Research Hospital, Milan, Italy",NA
"240","34261078","10.2459/JCM.0000000000001228","In-hospital prognostic role of coronary atherosclerotic burden in COVID-19 patients.","Currently, there are few available data regarding a possible role for subclinical atherosclerosis as a risk factor for mortality in Coronavirus Disease 19 (COVID-19) patients. We used coronary artery calcium (CAC) score derived from chest computed tomography (CT) scan to assess the in-hospital prognostic role of CAC in patients affected by COVID-19 pneumonia. Electronic medical records of patients with confirmed diagnosis of COVID-19 were retrospectively reviewed. Patients with known coronary ar","2021","07","16","J Cardiovasc Med (Hagerstown)","Journal of cardiovascular medicine (Hagerstown, Md.)",NA,"Cannata","Francesco","Department of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano Department of Biomedical Sciences, Humanitas University Department of Radiology, IRCCS Humanitas Research Hospital, Milan, Italy",NA
"241","34261078","10.2459/JCM.0000000000001228","In-hospital prognostic role of coronary atherosclerotic burden in COVID-19 patients.","Currently, there are few available data regarding a possible role for subclinical atherosclerosis as a risk factor for mortality in Coronavirus Disease 19 (COVID-19) patients. We used coronary artery calcium (CAC) score derived from chest computed tomography (CT) scan to assess the in-hospital prognostic role of CAC in patients affected by COVID-19 pneumonia. Electronic medical records of patients with confirmed diagnosis of COVID-19 were retrospectively reviewed. Patients with known coronary ar","2021","07","16","J Cardiovasc Med (Hagerstown)","Journal of cardiovascular medicine (Hagerstown, Md.)",NA,"Stefanini","Giulio G","Department of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano Department of Biomedical Sciences, Humanitas University Department of Radiology, IRCCS Humanitas Research Hospital, Milan, Italy",NA
"242","34261078","10.2459/JCM.0000000000001228","In-hospital prognostic role of coronary atherosclerotic burden in COVID-19 patients.","Currently, there are few available data regarding a possible role for subclinical atherosclerosis as a risk factor for mortality in Coronavirus Disease 19 (COVID-19) patients. We used coronary artery calcium (CAC) score derived from chest computed tomography (CT) scan to assess the in-hospital prognostic role of CAC in patients affected by COVID-19 pneumonia. Electronic medical records of patients with confirmed diagnosis of COVID-19 were retrospectively reviewed. Patients with known coronary ar","2021","07","16","J Cardiovasc Med (Hagerstown)","Journal of cardiovascular medicine (Hagerstown, Md.)",NA,"Chiti","Arturo","Department of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano Department of Biomedical Sciences, Humanitas University Department of Radiology, IRCCS Humanitas Research Hospital, Milan, Italy",NA
"243","34261078","10.2459/JCM.0000000000001228","In-hospital prognostic role of coronary atherosclerotic burden in COVID-19 patients.","Currently, there are few available data regarding a possible role for subclinical atherosclerosis as a risk factor for mortality in Coronavirus Disease 19 (COVID-19) patients. We used coronary artery calcium (CAC) score derived from chest computed tomography (CT) scan to assess the in-hospital prognostic role of CAC in patients affected by COVID-19 pneumonia. Electronic medical records of patients with confirmed diagnosis of COVID-19 were retrospectively reviewed. Patients with known coronary ar","2021","07","16","J Cardiovasc Med (Hagerstown)","Journal of cardiovascular medicine (Hagerstown, Md.)",NA,"Bragato","Renato Maria","Department of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano Department of Biomedical Sciences, Humanitas University Department of Radiology, IRCCS Humanitas Research Hospital, Milan, Italy",NA
"244","34261078","10.2459/JCM.0000000000001228","In-hospital prognostic role of coronary atherosclerotic burden in COVID-19 patients.","Currently, there are few available data regarding a possible role for subclinical atherosclerosis as a risk factor for mortality in Coronavirus Disease 19 (COVID-19) patients. We used coronary artery calcium (CAC) score derived from chest computed tomography (CT) scan to assess the in-hospital prognostic role of CAC in patients affected by COVID-19 pneumonia. Electronic medical records of patients with confirmed diagnosis of COVID-19 were retrospectively reviewed. Patients with known coronary ar","2021","07","16","J Cardiovasc Med (Hagerstown)","Journal of cardiovascular medicine (Hagerstown, Md.)",NA,"Monti","Lorenzo","Department of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano Department of Biomedical Sciences, Humanitas University Department of Radiology, IRCCS Humanitas Research Hospital, Milan, Italy",NA
"245","34261078","10.2459/JCM.0000000000001228","In-hospital prognostic role of coronary atherosclerotic burden in COVID-19 patients.","Currently, there are few available data regarding a possible role for subclinical atherosclerosis as a risk factor for mortality in Coronavirus Disease 19 (COVID-19) patients. We used coronary artery calcium (CAC) score derived from chest computed tomography (CT) scan to assess the in-hospital prognostic role of CAC in patients affected by COVID-19 pneumonia. Electronic medical records of patients with confirmed diagnosis of COVID-19 were retrospectively reviewed. Patients with known coronary ar","2021","07","16","J Cardiovasc Med (Hagerstown)","Journal of cardiovascular medicine (Hagerstown, Md.)",NA,"Rossi","Alexia","Department of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano Department of Biomedical Sciences, Humanitas University Department of Radiology, IRCCS Humanitas Research Hospital, Milan, Italy",NA
"246","34261075","10.1159/000517460","The Impact of Stress on Health in Childhood and Adolescence in the Era of the COVID-19 Pandemic.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is posing many challenges to global health. Efforts from the whole scientific community have shed light on the pathogenetic mechanisms and the clinical features of SARS-CoV-2 infection as well as on potential therapeutic strategies. The consequences of stress related to social isolation and anxiety generated by the pandemic on mental and physical health are colla","2021","07","14","Horm Res Paediatr","Hormone research in paediatrics","Adolescence; Childhood; Coronavirus disease 2019; Severe acute respiratory syndrome coronavirus 2; Stress","Cianfarani","Stefano","Dipartimento Pediatrico Universitario Ospedaliero, IRCCS ""Bambino Gesù"" Children's Hospital, Rome, Italy",NA
"247","34261075","10.1159/000517460","The Impact of Stress on Health in Childhood and Adolescence in the Era of the COVID-19 Pandemic.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is posing many challenges to global health. Efforts from the whole scientific community have shed light on the pathogenetic mechanisms and the clinical features of SARS-CoV-2 infection as well as on potential therapeutic strategies. The consequences of stress related to social isolation and anxiety generated by the pandemic on mental and physical health are colla","2021","07","14","Horm Res Paediatr","Hormone research in paediatrics","Adolescence; Childhood; Coronavirus disease 2019; Severe acute respiratory syndrome coronavirus 2; Stress","Pampanini","Valentina","Dipartimento Pediatrico Universitario Ospedaliero, IRCCS ""Bambino Gesù"" Children's Hospital, Rome, Italy",NA
"248","34261069","10.1159/000517032","Interventions to Support Informal Caregivers of People with Chronic Obstructive Pulmonary Disease: A Systematic Literature Review.","Chronic obstructive pulmonary disease (COPD) imposes tremendous challenges for both patients and informal caregivers. Caregivers are key players in the management of COPD. Recently, COVID-19 further increased reliance on informal caregivers who urgently need specific support. This systematic literature review aimed to systematically describe the content and explore the effects of interventions to support informal caregivers of people with COPD. A mixed-methods systematic review was conducted. Pu","2021","07","14","Respiration","Respiration; international review of thoracic diseases","Caregiving; Carer; Chronic obstructive pulmonary disease; Loved ones; Significant others; Therapeutics","Marques","Alda","Lab3R-Respiratory Research and Rehabilitation Laboratory, School of Health Sciences, University of Aveiro (ESSUA), Aveiro, Portugal",NA
"249","34261069","10.1159/000517032","Interventions to Support Informal Caregivers of People with Chronic Obstructive Pulmonary Disease: A Systematic Literature Review.","Chronic obstructive pulmonary disease (COPD) imposes tremendous challenges for both patients and informal caregivers. Caregivers are key players in the management of COPD. Recently, COVID-19 further increased reliance on informal caregivers who urgently need specific support. This systematic literature review aimed to systematically describe the content and explore the effects of interventions to support informal caregivers of people with COPD. A mixed-methods systematic review was conducted. Pu","2021","07","14","Respiration","Respiration; international review of thoracic diseases","Caregiving; Carer; Chronic obstructive pulmonary disease; Loved ones; Significant others; Therapeutics","Cruz","Joana","School of Health Sciences (ESSLei), Polytechnic of Leiria, Leiria, Portugal",NA
"250","34261069","10.1159/000517032","Interventions to Support Informal Caregivers of People with Chronic Obstructive Pulmonary Disease: A Systematic Literature Review.","Chronic obstructive pulmonary disease (COPD) imposes tremendous challenges for both patients and informal caregivers. Caregivers are key players in the management of COPD. Recently, COVID-19 further increased reliance on informal caregivers who urgently need specific support. This systematic literature review aimed to systematically describe the content and explore the effects of interventions to support informal caregivers of people with COPD. A mixed-methods systematic review was conducted. Pu","2021","07","14","Respiration","Respiration; international review of thoracic diseases","Caregiving; Carer; Chronic obstructive pulmonary disease; Loved ones; Significant others; Therapeutics","Brooks","Dina","Respiratory Medicine, West Park Healthcare Centre, Toronto, Ontario, Canada",NA
"251","34261058","10.1159/000517430","Seraph-100 Hemoperfusion in SARS-CoV-2-Infected Patients Early in Critical Illness: A Case Series.","There is an urgent need for therapeutic interventions to alter the course of critically ill coronavirus disease 2019 (CO-VID-19) patients. We report our experience with the Seraph-100 Microbind Affinity Blood Filter (Seraph-100) in 4 patients with COVID-19 early in the course of their critical respiratory illnesses. Patients were diagnosed with COVID-19 and were admitted to intensive care with worsening respiratory failure but did not require dialysis or vasopressors. Patients had to have a PaO2","2021","07","14","Blood Purif","Blood purification","Case report; Coronavirus disease 2019; Critical illness; Extracorporeal sorbent hemoperfusion; Seraph-100","Rifkin","Brian S","Hattiesburg Clinic Department of Nephrology, Hattiesburg, Mississippi, USA",NA
"252","34261058","10.1159/000517430","Seraph-100 Hemoperfusion in SARS-CoV-2-Infected Patients Early in Critical Illness: A Case Series.","There is an urgent need for therapeutic interventions to alter the course of critically ill coronavirus disease 2019 (CO-VID-19) patients. We report our experience with the Seraph-100 Microbind Affinity Blood Filter (Seraph-100) in 4 patients with COVID-19 early in the course of their critical respiratory illnesses. Patients were diagnosed with COVID-19 and were admitted to intensive care with worsening respiratory failure but did not require dialysis or vasopressors. Patients had to have a PaO2","2021","07","14","Blood Purif","Blood purification","Case report; Coronavirus disease 2019; Critical illness; Extracorporeal sorbent hemoperfusion; Seraph-100","Stewart","Ian J","Department of Medicine, Uniformed Services University, Bethesda, Maryland, USA",NA
"253","34260977","10.1016/j.rmed.2021.106531","Low dose lung radiotherapy for COVID-19 pneumonia: A potential treatment.","The covid-19 pandemic has been affecting many countries across the world and lost precious lives. Most patients suffer from respiratory disease which progresses to the severe acute respiratory syndrome, termed as SARS-CoV-2 pneumonia. A systemic inflammatory response occurs in SARS-CoV-2 pneumonia severely ill patients, The inflammation process if uncontrolled has a detrimental effect, and the release of cytokines play an important role leading to lung fibrosis. Radiation therapy used in low dos","2021","07","21","Respir Med","Respiratory medicine","COVID-19 pneumonia; Inflammation; Low dose radiation therapy; Macrophages","Gupta","Sweety","Department of Radiation Oncology, AIIMS, Rishikesh, India. Electronic address: sweety.rt@aiimsrishikesh.edu","sweety.rt@aiimsrishikesh.edu.in"
"254","34260977","10.1016/j.rmed.2021.106531","Low dose lung radiotherapy for COVID-19 pneumonia: A potential treatment.","The covid-19 pandemic has been affecting many countries across the world and lost precious lives. Most patients suffer from respiratory disease which progresses to the severe acute respiratory syndrome, termed as SARS-CoV-2 pneumonia. A systemic inflammatory response occurs in SARS-CoV-2 pneumonia severely ill patients, The inflammation process if uncontrolled has a detrimental effect, and the release of cytokines play an important role leading to lung fibrosis. Radiation therapy used in low dos","2021","07","21","Respir Med","Respiratory medicine","COVID-19 pneumonia; Inflammation; Low dose radiation therapy; Macrophages","Ahuja","Rachit","Department of Radiation Oncology, AIIMS, Rishikesh, India",NA
"255","34260977","10.1016/j.rmed.2021.106531","Low dose lung radiotherapy for COVID-19 pneumonia: A potential treatment.","The covid-19 pandemic has been affecting many countries across the world and lost precious lives. Most patients suffer from respiratory disease which progresses to the severe acute respiratory syndrome, termed as SARS-CoV-2 pneumonia. A systemic inflammatory response occurs in SARS-CoV-2 pneumonia severely ill patients, The inflammation process if uncontrolled has a detrimental effect, and the release of cytokines play an important role leading to lung fibrosis. Radiation therapy used in low dos","2021","07","21","Respir Med","Respiratory medicine","COVID-19 pneumonia; Inflammation; Low dose radiation therapy; Macrophages","Sharma","Nidhi","Department of Radiation Oncology, AIIMS, Rishikesh, India",NA
"256","34260977","10.1016/j.rmed.2021.106531","Low dose lung radiotherapy for COVID-19 pneumonia: A potential treatment.","The covid-19 pandemic has been affecting many countries across the world and lost precious lives. Most patients suffer from respiratory disease which progresses to the severe acute respiratory syndrome, termed as SARS-CoV-2 pneumonia. A systemic inflammatory response occurs in SARS-CoV-2 pneumonia severely ill patients, The inflammation process if uncontrolled has a detrimental effect, and the release of cytokines play an important role leading to lung fibrosis. Radiation therapy used in low dos","2021","07","21","Respir Med","Respiratory medicine","COVID-19 pneumonia; Inflammation; Low dose radiation therapy; Macrophages","Singh","Pragya","Department of Radiation Oncology, AIIMS, Rishikesh, India",NA
"257","34260977","10.1016/j.rmed.2021.106531","Low dose lung radiotherapy for COVID-19 pneumonia: A potential treatment.","The covid-19 pandemic has been affecting many countries across the world and lost precious lives. Most patients suffer from respiratory disease which progresses to the severe acute respiratory syndrome, termed as SARS-CoV-2 pneumonia. A systemic inflammatory response occurs in SARS-CoV-2 pneumonia severely ill patients, The inflammation process if uncontrolled has a detrimental effect, and the release of cytokines play an important role leading to lung fibrosis. Radiation therapy used in low dos","2021","07","21","Respir Med","Respiratory medicine","COVID-19 pneumonia; Inflammation; Low dose radiation therapy; Macrophages","Verma","Swati","Department of Radiation Oncology, AIIMS, Rishikesh, India",NA
"258","34260977","10.1016/j.rmed.2021.106531","Low dose lung radiotherapy for COVID-19 pneumonia: A potential treatment.","The covid-19 pandemic has been affecting many countries across the world and lost precious lives. Most patients suffer from respiratory disease which progresses to the severe acute respiratory syndrome, termed as SARS-CoV-2 pneumonia. A systemic inflammatory response occurs in SARS-CoV-2 pneumonia severely ill patients, The inflammation process if uncontrolled has a detrimental effect, and the release of cytokines play an important role leading to lung fibrosis. Radiation therapy used in low dos","2021","07","21","Respir Med","Respiratory medicine","COVID-19 pneumonia; Inflammation; Low dose radiation therapy; Macrophages","Gupta","Manoj","Department of Radiation Oncology, AIIMS, Rishikesh, India",NA
"259","34260976","10.1016/j.rmed.2021.106532","Rapid access rehabilitation after exacerbations of COPD - A qualitative study.","Rehabilitation after acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is beneficial, but its feasibility is questionable. Feasibility is potentiated by stakeholder involvement during program development. We aimed to explore the perspectives of various stakeholders towards an innovative rapid access rehabilitation (RAR) program for patients immediately following hospitalization for an AECOPD. Semi-structured interviews were conducted with patients recently hospitalized for AE","2021","07","21","Respir Med","Respiratory medicine","COPD; Exacerbations; Hospitalizations; Perspectives; Rehabilitation","Oliveira","Ana","School of Rehabilitation Sciences, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada",NA
"260","34260976","10.1016/j.rmed.2021.106532","Rapid access rehabilitation after exacerbations of COPD - A qualitative study.","Rehabilitation after acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is beneficial, but its feasibility is questionable. Feasibility is potentiated by stakeholder involvement during program development. We aimed to explore the perspectives of various stakeholders towards an innovative rapid access rehabilitation (RAR) program for patients immediately following hospitalization for an AECOPD. Semi-structured interviews were conducted with patients recently hospitalized for AE","2021","07","21","Respir Med","Respiratory medicine","COPD; Exacerbations; Hospitalizations; Perspectives; Rehabilitation","Quach","Shirley","Westpark Healthcare Centre, Toronto, Ontario, Canada",NA
"261","34260976","10.1016/j.rmed.2021.106532","Rapid access rehabilitation after exacerbations of COPD - A qualitative study.","Rehabilitation after acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is beneficial, but its feasibility is questionable. Feasibility is potentiated by stakeholder involvement during program development. We aimed to explore the perspectives of various stakeholders towards an innovative rapid access rehabilitation (RAR) program for patients immediately following hospitalization for an AECOPD. Semi-structured interviews were conducted with patients recently hospitalized for AE","2021","07","21","Respir Med","Respiratory medicine","COPD; Exacerbations; Hospitalizations; Perspectives; Rehabilitation","Alsubheen","Sanaa","School of Rehabilitation Sciences, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada",NA
"262","34260976","10.1016/j.rmed.2021.106532","Rapid access rehabilitation after exacerbations of COPD - A qualitative study.","Rehabilitation after acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is beneficial, but its feasibility is questionable. Feasibility is potentiated by stakeholder involvement during program development. We aimed to explore the perspectives of various stakeholders towards an innovative rapid access rehabilitation (RAR) program for patients immediately following hospitalization for an AECOPD. Semi-structured interviews were conducted with patients recently hospitalized for AE","2021","07","21","Respir Med","Respiratory medicine","COPD; Exacerbations; Hospitalizations; Perspectives; Rehabilitation","Dasouki","Sabrina","Westpark Healthcare Centre, Toronto, Ontario, Canada",NA
"263","34260976","10.1016/j.rmed.2021.106532","Rapid access rehabilitation after exacerbations of COPD - A qualitative study.","Rehabilitation after acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is beneficial, but its feasibility is questionable. Feasibility is potentiated by stakeholder involvement during program development. We aimed to explore the perspectives of various stakeholders towards an innovative rapid access rehabilitation (RAR) program for patients immediately following hospitalization for an AECOPD. Semi-structured interviews were conducted with patients recently hospitalized for AE","2021","07","21","Respir Med","Respiratory medicine","COPD; Exacerbations; Hospitalizations; Perspectives; Rehabilitation","Walker","Jan","Westpark Healthcare Centre, Toronto, Ontario, Canada",NA
"264","34260976","10.1016/j.rmed.2021.106532","Rapid access rehabilitation after exacerbations of COPD - A qualitative study.","Rehabilitation after acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is beneficial, but its feasibility is questionable. Feasibility is potentiated by stakeholder involvement during program development. We aimed to explore the perspectives of various stakeholders towards an innovative rapid access rehabilitation (RAR) program for patients immediately following hospitalization for an AECOPD. Semi-structured interviews were conducted with patients recently hospitalized for AE","2021","07","21","Respir Med","Respiratory medicine","COPD; Exacerbations; Hospitalizations; Perspectives; Rehabilitation","Brooks","Dina","School of Rehabilitation Sciences, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada",NA
"265","34260976","10.1016/j.rmed.2021.106532","Rapid access rehabilitation after exacerbations of COPD - A qualitative study.","Rehabilitation after acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is beneficial, but its feasibility is questionable. Feasibility is potentiated by stakeholder involvement during program development. We aimed to explore the perspectives of various stakeholders towards an innovative rapid access rehabilitation (RAR) program for patients immediately following hospitalization for an AECOPD. Semi-structured interviews were conducted with patients recently hospitalized for AE","2021","07","21","Respir Med","Respiratory medicine","COPD; Exacerbations; Hospitalizations; Perspectives; Rehabilitation","Goldstein","Roger","Westpark Healthcare Centre, Toronto, Ontario, Canada","Roger.goldstein@westpark.org"
"266","34260968","10.1016/j.bios.2021.113486","A mask-based diagnostic platform for point-of-care screening of Covid-19.","Diagnostics of SARS-CoV-2 infection using real-time reverse-transcription polymerase chain reaction (RT-PCR) on nasopharyngeal swabs is now well-established, with saliva-based testing being lately more widely implemented for being more adapted for self-testing approaches. In this study, we introduce a different concept based on exhaled breath condensate (EBC), readily collected by a mask-based sampling device, and detection with an electrochemical biosensor with a modular architecture that enabl","2021","07","23","Biosens Bioelectron","Biosensors &amp; bioelectronics","Aptamers; Detection; Electrochemistry; Exhaled breath condensate (EBC); Real-time reverse-transcription polymerase chain reaction (RT-PCR); SARS-CoV-2","Daniels","John","Diagmetrics Inc., 30 Renees Way Madison, Connecticut, 06443, USA",NA
"267","34260968","10.1016/j.bios.2021.113486","A mask-based diagnostic platform for point-of-care screening of Covid-19.","Diagnostics of SARS-CoV-2 infection using real-time reverse-transcription polymerase chain reaction (RT-PCR) on nasopharyngeal swabs is now well-established, with saliva-based testing being lately more widely implemented for being more adapted for self-testing approaches. In this study, we introduce a different concept based on exhaled breath condensate (EBC), readily collected by a mask-based sampling device, and detection with an electrochemical biosensor with a modular architecture that enabl","2021","07","23","Biosens Bioelectron","Biosensors &amp; bioelectronics","Aptamers; Detection; Electrochemistry; Exhaled breath condensate (EBC); Real-time reverse-transcription polymerase chain reaction (RT-PCR); SARS-CoV-2","Wadekar","Shekhar","Diagmetrics Inc., 30 Renees Way Madison, Connecticut, 06443, USA",NA
"268","34260968","10.1016/j.bios.2021.113486","A mask-based diagnostic platform for point-of-care screening of Covid-19.","Diagnostics of SARS-CoV-2 infection using real-time reverse-transcription polymerase chain reaction (RT-PCR) on nasopharyngeal swabs is now well-established, with saliva-based testing being lately more widely implemented for being more adapted for self-testing approaches. In this study, we introduce a different concept based on exhaled breath condensate (EBC), readily collected by a mask-based sampling device, and detection with an electrochemical biosensor with a modular architecture that enabl","2021","07","23","Biosens Bioelectron","Biosensors &amp; bioelectronics","Aptamers; Detection; Electrochemistry; Exhaled breath condensate (EBC); Real-time reverse-transcription polymerase chain reaction (RT-PCR); SARS-CoV-2","DeCubellis","Ken","Diagmetrics Inc., 30 Renees Way Madison, Connecticut, 06443, USA",NA
"269","34260968","10.1016/j.bios.2021.113486","A mask-based diagnostic platform for point-of-care screening of Covid-19.","Diagnostics of SARS-CoV-2 infection using real-time reverse-transcription polymerase chain reaction (RT-PCR) on nasopharyngeal swabs is now well-established, with saliva-based testing being lately more widely implemented for being more adapted for self-testing approaches. In this study, we introduce a different concept based on exhaled breath condensate (EBC), readily collected by a mask-based sampling device, and detection with an electrochemical biosensor with a modular architecture that enabl","2021","07","23","Biosens Bioelectron","Biosensors &amp; bioelectronics","Aptamers; Detection; Electrochemistry; Exhaled breath condensate (EBC); Real-time reverse-transcription polymerase chain reaction (RT-PCR); SARS-CoV-2","Jackson","George W","Base Pair Biotechnologies, Inc., 8619 Broadway St., Suite 100, Pearland, TX, USA",NA
"270","34260968","10.1016/j.bios.2021.113486","A mask-based diagnostic platform for point-of-care screening of Covid-19.","Diagnostics of SARS-CoV-2 infection using real-time reverse-transcription polymerase chain reaction (RT-PCR) on nasopharyngeal swabs is now well-established, with saliva-based testing being lately more widely implemented for being more adapted for self-testing approaches. In this study, we introduce a different concept based on exhaled breath condensate (EBC), readily collected by a mask-based sampling device, and detection with an electrochemical biosensor with a modular architecture that enabl","2021","07","23","Biosens Bioelectron","Biosensors &amp; bioelectronics","Aptamers; Detection; Electrochemistry; Exhaled breath condensate (EBC); Real-time reverse-transcription polymerase chain reaction (RT-PCR); SARS-CoV-2","Chiu","Alexander S","Base Pair Biotechnologies, Inc., 8619 Broadway St., Suite 100, Pearland, TX, USA",NA
"271","34260968","10.1016/j.bios.2021.113486","A mask-based diagnostic platform for point-of-care screening of Covid-19.","Diagnostics of SARS-CoV-2 infection using real-time reverse-transcription polymerase chain reaction (RT-PCR) on nasopharyngeal swabs is now well-established, with saliva-based testing being lately more widely implemented for being more adapted for self-testing approaches. In this study, we introduce a different concept based on exhaled breath condensate (EBC), readily collected by a mask-based sampling device, and detection with an electrochemical biosensor with a modular architecture that enabl","2021","07","23","Biosens Bioelectron","Biosensors &amp; bioelectronics","Aptamers; Detection; Electrochemistry; Exhaled breath condensate (EBC); Real-time reverse-transcription polymerase chain reaction (RT-PCR); SARS-CoV-2","Pagneux","Quentin","Univ. Lille, CNRS, Centrale Lille, Univ. Polytechnique Hauts-de-France, UMR 8520 - IEMN, F-59000, Lille, France",NA
"272","34260968","10.1016/j.bios.2021.113486","A mask-based diagnostic platform for point-of-care screening of Covid-19.","Diagnostics of SARS-CoV-2 infection using real-time reverse-transcription polymerase chain reaction (RT-PCR) on nasopharyngeal swabs is now well-established, with saliva-based testing being lately more widely implemented for being more adapted for self-testing approaches. In this study, we introduce a different concept based on exhaled breath condensate (EBC), readily collected by a mask-based sampling device, and detection with an electrochemical biosensor with a modular architecture that enabl","2021","07","23","Biosens Bioelectron","Biosensors &amp; bioelectronics","Aptamers; Detection; Electrochemistry; Exhaled breath condensate (EBC); Real-time reverse-transcription polymerase chain reaction (RT-PCR); SARS-CoV-2","Saada","Hiba","Univ. Lille, CNRS, Centrale Lille, Univ. Polytechnique Hauts-de-France, UMR 8520 - IEMN, F-59000, Lille, France",NA
"273","34260968","10.1016/j.bios.2021.113486","A mask-based diagnostic platform for point-of-care screening of Covid-19.","Diagnostics of SARS-CoV-2 infection using real-time reverse-transcription polymerase chain reaction (RT-PCR) on nasopharyngeal swabs is now well-established, with saliva-based testing being lately more widely implemented for being more adapted for self-testing approaches. In this study, we introduce a different concept based on exhaled breath condensate (EBC), readily collected by a mask-based sampling device, and detection with an electrochemical biosensor with a modular architecture that enabl","2021","07","23","Biosens Bioelectron","Biosensors &amp; bioelectronics","Aptamers; Detection; Electrochemistry; Exhaled breath condensate (EBC); Real-time reverse-transcription polymerase chain reaction (RT-PCR); SARS-CoV-2","Engelmann","Ilka","Univ. Lille, CNRS, Centrale Lille, Univ. Polytechnique Hauts-de-France, UMR 8520 - IEMN, F-59000, Lille, France",NA
"274","34260968","10.1016/j.bios.2021.113486","A mask-based diagnostic platform for point-of-care screening of Covid-19.","Diagnostics of SARS-CoV-2 infection using real-time reverse-transcription polymerase chain reaction (RT-PCR) on nasopharyngeal swabs is now well-established, with saliva-based testing being lately more widely implemented for being more adapted for self-testing approaches. In this study, we introduce a different concept based on exhaled breath condensate (EBC), readily collected by a mask-based sampling device, and detection with an electrochemical biosensor with a modular architecture that enabl","2021","07","23","Biosens Bioelectron","Biosensors &amp; bioelectronics","Aptamers; Detection; Electrochemistry; Exhaled breath condensate (EBC); Real-time reverse-transcription polymerase chain reaction (RT-PCR); SARS-CoV-2","Ogiez","Judith","Univ Lille, CHU Lille, Laboratoire de Virologie ULR3610, F-59000, Lille, France",NA
"275","34260968","10.1016/j.bios.2021.113486","A mask-based diagnostic platform for point-of-care screening of Covid-19.","Diagnostics of SARS-CoV-2 infection using real-time reverse-transcription polymerase chain reaction (RT-PCR) on nasopharyngeal swabs is now well-established, with saliva-based testing being lately more widely implemented for being more adapted for self-testing approaches. In this study, we introduce a different concept based on exhaled breath condensate (EBC), readily collected by a mask-based sampling device, and detection with an electrochemical biosensor with a modular architecture that enabl","2021","07","23","Biosens Bioelectron","Biosensors &amp; bioelectronics","Aptamers; Detection; Electrochemistry; Exhaled breath condensate (EBC); Real-time reverse-transcription polymerase chain reaction (RT-PCR); SARS-CoV-2","Loze-Warot","Delphine","CerbaHealthCare Biomedical Laboratory, CERBALLIANCE Lille, 17/24 Rue de La Digue, 59000, Lille, France",NA
"276","34260968","10.1016/j.bios.2021.113486","A mask-based diagnostic platform for point-of-care screening of Covid-19.","Diagnostics of SARS-CoV-2 infection using real-time reverse-transcription polymerase chain reaction (RT-PCR) on nasopharyngeal swabs is now well-established, with saliva-based testing being lately more widely implemented for being more adapted for self-testing approaches. In this study, we introduce a different concept based on exhaled breath condensate (EBC), readily collected by a mask-based sampling device, and detection with an electrochemical biosensor with a modular architecture that enabl","2021","07","23","Biosens Bioelectron","Biosensors &amp; bioelectronics","Aptamers; Detection; Electrochemistry; Exhaled breath condensate (EBC); Real-time reverse-transcription polymerase chain reaction (RT-PCR); SARS-CoV-2","Boukherroub","Rabah","Univ. Lille, CNRS, Centrale Lille, Univ. Polytechnique Hauts-de-France, UMR 8520 - IEMN, F-59000, Lille, France",NA
"277","34260968","10.1016/j.bios.2021.113486","A mask-based diagnostic platform for point-of-care screening of Covid-19.","Diagnostics of SARS-CoV-2 infection using real-time reverse-transcription polymerase chain reaction (RT-PCR) on nasopharyngeal swabs is now well-established, with saliva-based testing being lately more widely implemented for being more adapted for self-testing approaches. In this study, we introduce a different concept based on exhaled breath condensate (EBC), readily collected by a mask-based sampling device, and detection with an electrochemical biosensor with a modular architecture that enabl","2021","07","23","Biosens Bioelectron","Biosensors &amp; bioelectronics","Aptamers; Detection; Electrochemistry; Exhaled breath condensate (EBC); Real-time reverse-transcription polymerase chain reaction (RT-PCR); SARS-CoV-2","Szunerits","Sabine","Univ. Lille, CNRS, Centrale Lille, Univ. Polytechnique Hauts-de-France, UMR 8520 - IEMN, F-59000, Lille, France. Electronic address: sabine.szunerits@univ-lille",NA
"278","34260965","10.1016/j.celrep.2021.109414","Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.","Although T cells are likely players in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity, little is known about the phenotypic features of SARS-CoV-2-specific T cells associated with recovery from severe coronavirus disease 2019 (COVID-19). We analyze T cells from 34 individuals with COVID-19 with severity ranging from mild (outpatient) to critical, culminating in death. Relative to individuals who succumbed, individuals who recovered from severe COVID-19 harbor elevated and ","2021","07","23","Cell Rep","Cell reports","CD127; COVID-19; CXCR4; SARS-CoV-2; T cells; lung","Neidleman","Jason","Gladstone Institutes, San Francisco, CA 94158, USA",NA
"279","34260965","10.1016/j.celrep.2021.109414","Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.","Although T cells are likely players in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity, little is known about the phenotypic features of SARS-CoV-2-specific T cells associated with recovery from severe coronavirus disease 2019 (COVID-19). We analyze T cells from 34 individuals with COVID-19 with severity ranging from mild (outpatient) to critical, culminating in death. Relative to individuals who succumbed, individuals who recovered from severe COVID-19 harbor elevated and ","2021","07","23","Cell Rep","Cell reports","CD127; COVID-19; CXCR4; SARS-CoV-2; T cells; lung","Luo","Xiaoyu","Gladstone Institutes, San Francisco, CA 94158, USA",NA
"280","34260965","10.1016/j.celrep.2021.109414","Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.","Although T cells are likely players in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity, little is known about the phenotypic features of SARS-CoV-2-specific T cells associated with recovery from severe coronavirus disease 2019 (COVID-19). We analyze T cells from 34 individuals with COVID-19 with severity ranging from mild (outpatient) to critical, culminating in death. Relative to individuals who succumbed, individuals who recovered from severe COVID-19 harbor elevated and ","2021","07","23","Cell Rep","Cell reports","CD127; COVID-19; CXCR4; SARS-CoV-2; T cells; lung","George","Ashley F","Gladstone Institutes, San Francisco, CA 94158, USA",NA
"281","34260965","10.1016/j.celrep.2021.109414","Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.","Although T cells are likely players in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity, little is known about the phenotypic features of SARS-CoV-2-specific T cells associated with recovery from severe coronavirus disease 2019 (COVID-19). We analyze T cells from 34 individuals with COVID-19 with severity ranging from mild (outpatient) to critical, culminating in death. Relative to individuals who succumbed, individuals who recovered from severe COVID-19 harbor elevated and ","2021","07","23","Cell Rep","Cell reports","CD127; COVID-19; CXCR4; SARS-CoV-2; T cells; lung","McGregor","Matthew","Gladstone Institutes, San Francisco, CA 94158, USA",NA
"282","34260965","10.1016/j.celrep.2021.109414","Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.","Although T cells are likely players in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity, little is known about the phenotypic features of SARS-CoV-2-specific T cells associated with recovery from severe coronavirus disease 2019 (COVID-19). We analyze T cells from 34 individuals with COVID-19 with severity ranging from mild (outpatient) to critical, culminating in death. Relative to individuals who succumbed, individuals who recovered from severe COVID-19 harbor elevated and ","2021","07","23","Cell Rep","Cell reports","CD127; COVID-19; CXCR4; SARS-CoV-2; T cells; lung","Yang","Junkai","Deptartments of Medicine and Pediatrics, Lowance Center for Human Immunology, Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA",NA
"283","34260965","10.1016/j.celrep.2021.109414","Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.","Although T cells are likely players in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity, little is known about the phenotypic features of SARS-CoV-2-specific T cells associated with recovery from severe coronavirus disease 2019 (COVID-19). We analyze T cells from 34 individuals with COVID-19 with severity ranging from mild (outpatient) to critical, culminating in death. Relative to individuals who succumbed, individuals who recovered from severe COVID-19 harbor elevated and ","2021","07","23","Cell Rep","Cell reports","CD127; COVID-19; CXCR4; SARS-CoV-2; T cells; lung","Yun","Cassandra","Department of Laboratory Medicine, University of California, San Francisco, CA 94110, USA",NA
"284","34260965","10.1016/j.celrep.2021.109414","Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.","Although T cells are likely players in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity, little is known about the phenotypic features of SARS-CoV-2-specific T cells associated with recovery from severe coronavirus disease 2019 (COVID-19). We analyze T cells from 34 individuals with COVID-19 with severity ranging from mild (outpatient) to critical, culminating in death. Relative to individuals who succumbed, individuals who recovered from severe COVID-19 harbor elevated and ","2021","07","23","Cell Rep","Cell reports","CD127; COVID-19; CXCR4; SARS-CoV-2; T cells; lung","Murray","Victoria","Zuckerberg San Francisco General Hospital and the University of California, San Francisco, CA 94110, USA",NA
"285","34260965","10.1016/j.celrep.2021.109414","Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.","Although T cells are likely players in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity, little is known about the phenotypic features of SARS-CoV-2-specific T cells associated with recovery from severe coronavirus disease 2019 (COVID-19). We analyze T cells from 34 individuals with COVID-19 with severity ranging from mild (outpatient) to critical, culminating in death. Relative to individuals who succumbed, individuals who recovered from severe COVID-19 harbor elevated and ","2021","07","23","Cell Rep","Cell reports","CD127; COVID-19; CXCR4; SARS-CoV-2; T cells; lung","Gill","Gurjot","Zuckerberg San Francisco General Hospital and the University of California, San Francisco, CA 94110, USA",NA
"286","34260965","10.1016/j.celrep.2021.109414","Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.","Although T cells are likely players in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity, little is known about the phenotypic features of SARS-CoV-2-specific T cells associated with recovery from severe coronavirus disease 2019 (COVID-19). We analyze T cells from 34 individuals with COVID-19 with severity ranging from mild (outpatient) to critical, culminating in death. Relative to individuals who succumbed, individuals who recovered from severe COVID-19 harbor elevated and ","2021","07","23","Cell Rep","Cell reports","CD127; COVID-19; CXCR4; SARS-CoV-2; T cells; lung","Greene","Warner C","Gladstone Institutes, San Francisco, CA 94158, USA",NA
"287","34260965","10.1016/j.celrep.2021.109414","Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.","Although T cells are likely players in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity, little is known about the phenotypic features of SARS-CoV-2-specific T cells associated with recovery from severe coronavirus disease 2019 (COVID-19). We analyze T cells from 34 individuals with COVID-19 with severity ranging from mild (outpatient) to critical, culminating in death. Relative to individuals who succumbed, individuals who recovered from severe COVID-19 harbor elevated and ","2021","07","23","Cell Rep","Cell reports","CD127; COVID-19; CXCR4; SARS-CoV-2; T cells; lung","Vasquez","Joshua","Department of Medicine, University of California, San Francisco, CA 94110, USA",NA
"288","34260965","10.1016/j.celrep.2021.109414","Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.","Although T cells are likely players in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity, little is known about the phenotypic features of SARS-CoV-2-specific T cells associated with recovery from severe coronavirus disease 2019 (COVID-19). We analyze T cells from 34 individuals with COVID-19 with severity ranging from mild (outpatient) to critical, culminating in death. Relative to individuals who succumbed, individuals who recovered from severe COVID-19 harbor elevated and ","2021","07","23","Cell Rep","Cell reports","CD127; COVID-19; CXCR4; SARS-CoV-2; T cells; lung","Lee","Sulggi A","Zuckerberg San Francisco General Hospital and the University of California, San Francisco, CA 94110, USA",NA
"289","34260965","10.1016/j.celrep.2021.109414","Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.","Although T cells are likely players in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity, little is known about the phenotypic features of SARS-CoV-2-specific T cells associated with recovery from severe coronavirus disease 2019 (COVID-19). We analyze T cells from 34 individuals with COVID-19 with severity ranging from mild (outpatient) to critical, culminating in death. Relative to individuals who succumbed, individuals who recovered from severe COVID-19 harbor elevated and ","2021","07","23","Cell Rep","Cell reports","CD127; COVID-19; CXCR4; SARS-CoV-2; T cells; lung","Ghosn","Eliver","Deptartments of Medicine and Pediatrics, Lowance Center for Human Immunology, Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA. Electronic address: eliver.ghosn@emory","eliver.ghosn@emory.edu"
"290","34260965","10.1016/j.celrep.2021.109414","Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.","Although T cells are likely players in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity, little is known about the phenotypic features of SARS-CoV-2-specific T cells associated with recovery from severe coronavirus disease 2019 (COVID-19). We analyze T cells from 34 individuals with COVID-19 with severity ranging from mild (outpatient) to critical, culminating in death. Relative to individuals who succumbed, individuals who recovered from severe COVID-19 harbor elevated and ","2021","07","23","Cell Rep","Cell reports","CD127; COVID-19; CXCR4; SARS-CoV-2; T cells; lung","Lynch","Kara L","Department of Laboratory Medicine, University of California, San Francisco, CA 94110, USA. Electronic address: kara.lynch@ucsf","kara.lynch@ucsf.edu"
"291","34260965","10.1016/j.celrep.2021.109414","Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.","Although T cells are likely players in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity, little is known about the phenotypic features of SARS-CoV-2-specific T cells associated with recovery from severe coronavirus disease 2019 (COVID-19). We analyze T cells from 34 individuals with COVID-19 with severity ranging from mild (outpatient) to critical, culminating in death. Relative to individuals who succumbed, individuals who recovered from severe COVID-19 harbor elevated and ","2021","07","23","Cell Rep","Cell reports","CD127; COVID-19; CXCR4; SARS-CoV-2; T cells; lung","Roan","Nadia R","Gladstone Institutes, San Francisco, CA 94158, USA","nadia.roan@gladstone.ucsf.edu"
"292","34260961","10.1016/j.envres.2021.111673","Effects of chronic exposure to ambient air pollutants, demographic, and socioeconomic factors on COVID-19 morbidity: The Israeli case study.","Recent studies conducted in several OECD countries have shown that chronic exposure to elevated levels of air pollutants (especially PM2.5, PM10 and NOx), might negatively impact COVID-19 morbidity and mortality rates. The aim of this study was to examine the association between chronic exposure to air pollution in Israeli cities and towns, their demographic and socioeconomic status, and COVID-19 morbidity, during the three local morbidity waves. We examined the associations between: (a) annual ","2021","07","24","Environ Res","Environmental research","COVID-19; Environmental exposure; NOx; PM(10); PM(2.5); Population density; Socioeconomic-cluster; Vaccination campaign","Levi","Adi","School of Sciences, Achva Academic College, Yinon, Israel",NA
"293","34260961","10.1016/j.envres.2021.111673","Effects of chronic exposure to ambient air pollutants, demographic, and socioeconomic factors on COVID-19 morbidity: The Israeli case study.","Recent studies conducted in several OECD countries have shown that chronic exposure to elevated levels of air pollutants (especially PM2.5, PM10 and NOx), might negatively impact COVID-19 morbidity and mortality rates. The aim of this study was to examine the association between chronic exposure to air pollution in Israeli cities and towns, their demographic and socioeconomic status, and COVID-19 morbidity, during the three local morbidity waves. We examined the associations between: (a) annual ","2021","07","24","Environ Res","Environmental research","COVID-19; Environmental exposure; NOx; PM(10); PM(2.5); Population density; Socioeconomic-cluster; Vaccination campaign","Barnett-Itzhaki","Zohar","School of Engineering, Ruppin Academic Center, Emek Hefer, Israel","zoharba@ruppin.ac.il"
"294","34260956","10.1016/j.ijid.2021.07.022","High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for heard immunity!","Herd immunity is considered a relevant aspect of the COVID-19 epidemiology. In this regard, seroprevalence studies are essential to understand how far the countries and regions would be from that potential point. We analyzed seroprevalence data from nine studies in South America, a region that, as is known, has been strongly affected by COVID-19. Seroprevalence values <U+200B><U+200B>were high, with percentages that reach up to 70.0% (95%CI 67.0-73.4%) in Iquitos, Peru. A meta-analysis of such data allowed to","2021","07","21","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Epidemiology; Herd immunity; SARS-CoV-2; Seroprevalence; South America","Núñez-Zapata","Susy Fanny","Master Program on Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru","10061538@cientifica.edu.pe"
"295","34260956","10.1016/j.ijid.2021.07.022","High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for heard immunity!","Herd immunity is considered a relevant aspect of the COVID-19 epidemiology. In this regard, seroprevalence studies are essential to understand how far the countries and regions would be from that potential point. We analyzed seroprevalence data from nine studies in South America, a region that, as is known, has been strongly affected by COVID-19. Seroprevalence values <U+200B><U+200B>were high, with percentages that reach up to 70.0% (95%CI 67.0-73.4%) in Iquitos, Peru. A meta-analysis of such data allowed to","2021","07","21","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Epidemiology; Herd immunity; SARS-CoV-2; Seroprevalence; South America","Benites-Peralta","Bruno","Master Program on Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru",NA
"296","34260956","10.1016/j.ijid.2021.07.022","High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for heard immunity!","Herd immunity is considered a relevant aspect of the COVID-19 epidemiology. In this regard, seroprevalence studies are essential to understand how far the countries and regions would be from that potential point. We analyzed seroprevalence data from nine studies in South America, a region that, as is known, has been strongly affected by COVID-19. Seroprevalence values <U+200B><U+200B>were high, with percentages that reach up to 70.0% (95%CI 67.0-73.4%) in Iquitos, Peru. A meta-analysis of such data allowed to","2021","07","21","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Epidemiology; Herd immunity; SARS-CoV-2; Seroprevalence; South America","Mayta-Tristan","Percy","Master Program on Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru",NA
"297","34260956","10.1016/j.ijid.2021.07.022","High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for heard immunity!","Herd immunity is considered a relevant aspect of the COVID-19 epidemiology. In this regard, seroprevalence studies are essential to understand how far the countries and regions would be from that potential point. We analyzed seroprevalence data from nine studies in South America, a region that, as is known, has been strongly affected by COVID-19. Seroprevalence values <U+200B><U+200B>were high, with percentages that reach up to 70.0% (95%CI 67.0-73.4%) in Iquitos, Peru. A meta-analysis of such data allowed to","2021","07","21","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; Epidemiology; Herd immunity; SARS-CoV-2; Seroprevalence; South America","Rodríguez-Morales","Alfonso J","Master Program on Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru","arodriguezmo@cientifica.edu"
"298","34260951","10.1016/j.cmi.2021.07.008","Viral populations of SARS-CoV-2 in upper respiratory tract, placenta, amniotic fluid and umbilical cord blood support viral replication in placenta.","A woman at the first stage of labour infected with SARS-CoV-2 was admitted to our hospital with symptomatology compatible with mild respiratory disease. Respiratory and non-respiratory samples from the mother were all positive for the virus, but not from the baby. Laboratory tests rejected vertical transmission. Whole-genome sequencing was performed on maternal samples, and revealed all 4 consensus sequences were identical. Unique minor viral variants were observed in every tissue, suggesting th","2021","07","21","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Amniotic fluid; Blood cord; Placenta; Pregnancy; Quasispecies; SARS-CoV-2; Vertical transmission","Piñana","Maria","Microbiology Department, Vall D'Hebron Institut de Recerca (VHIR), Vall D'Hebron Hospital Universitari, Vall D'Hebron Barcelona Hospital Campus, Barcelona, Spain",NA
"299","34260951","10.1016/j.cmi.2021.07.008","Viral populations of SARS-CoV-2 in upper respiratory tract, placenta, amniotic fluid and umbilical cord blood support viral replication in placenta.","A woman at the first stage of labour infected with SARS-CoV-2 was admitted to our hospital with symptomatology compatible with mild respiratory disease. Respiratory and non-respiratory samples from the mother were all positive for the virus, but not from the baby. Laboratory tests rejected vertical transmission. Whole-genome sequencing was performed on maternal samples, and revealed all 4 consensus sequences were identical. Unique minor viral variants were observed in every tissue, suggesting th","2021","07","21","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Amniotic fluid; Blood cord; Placenta; Pregnancy; Quasispecies; SARS-CoV-2; Vertical transmission","Abril","Josep F","Computational Genomics Lab",NA
"300","34260951","10.1016/j.cmi.2021.07.008","Viral populations of SARS-CoV-2 in upper respiratory tract, placenta, amniotic fluid and umbilical cord blood support viral replication in placenta.","A woman at the first stage of labour infected with SARS-CoV-2 was admitted to our hospital with symptomatology compatible with mild respiratory disease. Respiratory and non-respiratory samples from the mother were all positive for the virus, but not from the baby. Laboratory tests rejected vertical transmission. Whole-genome sequencing was performed on maternal samples, and revealed all 4 consensus sequences were identical. Unique minor viral variants were observed in every tissue, suggesting th","2021","07","21","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Amniotic fluid; Blood cord; Placenta; Pregnancy; Quasispecies; SARS-CoV-2; Vertical transmission","Andrés","Cristina","Microbiology Department, Vall D'Hebron Institut de Recerca (VHIR), Vall D'Hebron Hospital Universitari, Vall D'Hebron Barcelona Hospital Campus, Barcelona, Spain",NA
"301","34260951","10.1016/j.cmi.2021.07.008","Viral populations of SARS-CoV-2 in upper respiratory tract, placenta, amniotic fluid and umbilical cord blood support viral replication in placenta.","A woman at the first stage of labour infected with SARS-CoV-2 was admitted to our hospital with symptomatology compatible with mild respiratory disease. Respiratory and non-respiratory samples from the mother were all positive for the virus, but not from the baby. Laboratory tests rejected vertical transmission. Whole-genome sequencing was performed on maternal samples, and revealed all 4 consensus sequences were identical. Unique minor viral variants were observed in every tissue, suggesting th","2021","07","21","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Amniotic fluid; Blood cord; Placenta; Pregnancy; Quasispecies; SARS-CoV-2; Vertical transmission","Silgado","Aroa","Microbiology Department, Vall D'Hebron Institut de Recerca (VHIR), Vall D'Hebron Hospital Universitari, Vall D'Hebron Barcelona Hospital Campus, Barcelona, Spain",NA
"302","34260951","10.1016/j.cmi.2021.07.008","Viral populations of SARS-CoV-2 in upper respiratory tract, placenta, amniotic fluid and umbilical cord blood support viral replication in placenta.","A woman at the first stage of labour infected with SARS-CoV-2 was admitted to our hospital with symptomatology compatible with mild respiratory disease. Respiratory and non-respiratory samples from the mother were all positive for the virus, but not from the baby. Laboratory tests rejected vertical transmission. Whole-genome sequencing was performed on maternal samples, and revealed all 4 consensus sequences were identical. Unique minor viral variants were observed in every tissue, suggesting th","2021","07","21","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Amniotic fluid; Blood cord; Placenta; Pregnancy; Quasispecies; SARS-CoV-2; Vertical transmission","Navarro","Alexandra","Pathology Department, Hospital Universitari Vall D'Hebron, Barcelona, Spain",NA
"303","34260951","10.1016/j.cmi.2021.07.008","Viral populations of SARS-CoV-2 in upper respiratory tract, placenta, amniotic fluid and umbilical cord blood support viral replication in placenta.","A woman at the first stage of labour infected with SARS-CoV-2 was admitted to our hospital with symptomatology compatible with mild respiratory disease. Respiratory and non-respiratory samples from the mother were all positive for the virus, but not from the baby. Laboratory tests rejected vertical transmission. Whole-genome sequencing was performed on maternal samples, and revealed all 4 consensus sequences were identical. Unique minor viral variants were observed in every tissue, suggesting th","2021","07","21","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Amniotic fluid; Blood cord; Placenta; Pregnancy; Quasispecies; SARS-CoV-2; Vertical transmission","Suy","Anna","Maternal Fetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall D'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain",NA
"304","34260951","10.1016/j.cmi.2021.07.008","Viral populations of SARS-CoV-2 in upper respiratory tract, placenta, amniotic fluid and umbilical cord blood support viral replication in placenta.","A woman at the first stage of labour infected with SARS-CoV-2 was admitted to our hospital with symptomatology compatible with mild respiratory disease. Respiratory and non-respiratory samples from the mother were all positive for the virus, but not from the baby. Laboratory tests rejected vertical transmission. Whole-genome sequencing was performed on maternal samples, and revealed all 4 consensus sequences were identical. Unique minor viral variants were observed in every tissue, suggesting th","2021","07","21","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Amniotic fluid; Blood cord; Placenta; Pregnancy; Quasispecies; SARS-CoV-2; Vertical transmission","Sulleiro","Elena","Microbiology Department, Vall D'Hebron Institut de Recerca (VHIR), Vall D'Hebron Hospital Universitari, Vall D'Hebron Barcelona Hospital Campus, Barcelona, Spain",NA
"305","34260951","10.1016/j.cmi.2021.07.008","Viral populations of SARS-CoV-2 in upper respiratory tract, placenta, amniotic fluid and umbilical cord blood support viral replication in placenta.","A woman at the first stage of labour infected with SARS-CoV-2 was admitted to our hospital with symptomatology compatible with mild respiratory disease. Respiratory and non-respiratory samples from the mother were all positive for the virus, but not from the baby. Laboratory tests rejected vertical transmission. Whole-genome sequencing was performed on maternal samples, and revealed all 4 consensus sequences were identical. Unique minor viral variants were observed in every tissue, suggesting th","2021","07","21","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Amniotic fluid; Blood cord; Placenta; Pregnancy; Quasispecies; SARS-CoV-2; Vertical transmission","Pumarola","Tomàs","Microbiology Department, Vall D'Hebron Institut de Recerca (VHIR), Vall D'Hebron Hospital Universitari, Vall D'Hebron Barcelona Hospital Campus, Barcelona, Spain",NA
"306","34260951","10.1016/j.cmi.2021.07.008","Viral populations of SARS-CoV-2 in upper respiratory tract, placenta, amniotic fluid and umbilical cord blood support viral replication in placenta.","A woman at the first stage of labour infected with SARS-CoV-2 was admitted to our hospital with symptomatology compatible with mild respiratory disease. Respiratory and non-respiratory samples from the mother were all positive for the virus, but not from the baby. Laboratory tests rejected vertical transmission. Whole-genome sequencing was performed on maternal samples, and revealed all 4 consensus sequences were identical. Unique minor viral variants were observed in every tissue, suggesting th","2021","07","21","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Amniotic fluid; Blood cord; Placenta; Pregnancy; Quasispecies; SARS-CoV-2; Vertical transmission","Quer","Josep","Microbiology Department, Vall D'Hebron Institut de Recerca (VHIR), Vall D'Hebron Hospital Universitari, Vall D'Hebron Barcelona Hospital Campus, Barcelona, Spain","Josep.quer@vhir.org"
"307","34260951","10.1016/j.cmi.2021.07.008","Viral populations of SARS-CoV-2 in upper respiratory tract, placenta, amniotic fluid and umbilical cord blood support viral replication in placenta.","A woman at the first stage of labour infected with SARS-CoV-2 was admitted to our hospital with symptomatology compatible with mild respiratory disease. Respiratory and non-respiratory samples from the mother were all positive for the virus, but not from the baby. Laboratory tests rejected vertical transmission. Whole-genome sequencing was performed on maternal samples, and revealed all 4 consensus sequences were identical. Unique minor viral variants were observed in every tissue, suggesting th","2021","07","21","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Amniotic fluid; Blood cord; Placenta; Pregnancy; Quasispecies; SARS-CoV-2; Vertical transmission","Antón","Andrés","Microbiology Department, Vall D'Hebron Institut de Recerca (VHIR), Vall D'Hebron Hospital Universitari, Vall D'Hebron Barcelona Hospital Campus, Barcelona, Spain",NA
"308","34260903","10.1016/j.micpath.2021.105086","Partial protection of Sinopharm vaccine against SARS COV2 during recent outbreak in Bahrain.","In order to impart immunity against SARS COV 2 in the community, the oil rich countries of the Gulf Cooperation Council (GCC) provided citizens and expatriates with free vaccination. Different types of vaccination brands were utilized for this purpose. The purpose of this study is to determine the efficacy of the different types of vaccinations used. This is an observational analytical case study of one Bahraini family who were vaccinated with 1st, 2nd or no dose. Out of 22 double dose recipient","2021","07","24","Microb Pathog","Microbial pathogenesis","GCC; S protein; SARS CoV 2; Vaccines; WHO","Jahromi","Mohamed","Prime Autoimmunity Center, Manama, Bahrain. Electronic address: mjahromi@yahoo","mjahromi@yahoo.com"
"309","34260903","10.1016/j.micpath.2021.105086","Partial protection of Sinopharm vaccine against SARS COV2 during recent outbreak in Bahrain.","In order to impart immunity against SARS COV 2 in the community, the oil rich countries of the Gulf Cooperation Council (GCC) provided citizens and expatriates with free vaccination. Different types of vaccination brands were utilized for this purpose. The purpose of this study is to determine the efficacy of the different types of vaccinations used. This is an observational analytical case study of one Bahraini family who were vaccinated with 1st, 2nd or no dose. Out of 22 double dose recipient","2021","07","24","Microb Pathog","Microbial pathogenesis","GCC; S protein; SARS CoV 2; Vaccines; WHO","Al Sheikh","Mona Hmoud","Physiology Department, Imam Abdul Rahman University, Dhahran, Saudi Arabia. Electronic address: msheikh@iau.edu","msheikh@iau.edu.sa"
"310","34260902","10.1016/j.anai.2021.07.006","Anaphylaxis-related knowledge and concerns in Canadian families during COVID-19.",NA,"2021","07","24","Ann Allergy Asthma Immunol","Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology","COVID-19; anaphylaxis; epinephrine autoinjector","Gabrielli","Sofianne","Division of Pediatric Allergy and Clinical Immunology, McGill University Health Centre, 1001 blvd. Decarie, Montreal, Quebec, H4A 3J1, Canada. Electronic address: sofiannegabrielli@gmail","sofiannegabrielli@gmail.com"
"311","34260902","10.1016/j.anai.2021.07.006","Anaphylaxis-related knowledge and concerns in Canadian families during COVID-19.",NA,"2021","07","24","Ann Allergy Asthma Immunol","Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology","COVID-19; anaphylaxis; epinephrine autoinjector","Protudjer","Jennifer Lp","Department of Pediatrics and Child Health, Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada",NA
"312","34260902","10.1016/j.anai.2021.07.006","Anaphylaxis-related knowledge and concerns in Canadian families during COVID-19.",NA,"2021","07","24","Ann Allergy Asthma Immunol","Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology","COVID-19; anaphylaxis; epinephrine autoinjector","Gooding","Gregory","Division of Pediatric Allergy and Clinical Immunology, McGill University Health Centre, 1001 blvd. Decarie, Montreal, Quebec, H4A 3J1, Canada",NA
"313","34260902","10.1016/j.anai.2021.07.006","Anaphylaxis-related knowledge and concerns in Canadian families during COVID-19.",NA,"2021","07","24","Ann Allergy Asthma Immunol","Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology","COVID-19; anaphylaxis; epinephrine autoinjector","Gerdts","Jennifer","Executive Director, Food Allergy Canada, Toronto, Ontario, Canada",NA
"314","34260902","10.1016/j.anai.2021.07.006","Anaphylaxis-related knowledge and concerns in Canadian families during COVID-19.",NA,"2021","07","24","Ann Allergy Asthma Immunol","Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology","COVID-19; anaphylaxis; epinephrine autoinjector","Ben-Shoshan","Moshe","Division of Pediatric Allergy and Clinical Immunology, McGill University Health Centre, 1001 blvd. Decarie, Montreal, Quebec, H4A 3J1, Canada",NA
"315","34260880","10.1016/j.immuni.2021.06.017","COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead.","Development COVID-19 vaccines in a record time has been an unprecedented global scientific achievement. However, the world has failed to ensure equitable access to what should have been a global public good. What options remain available to African countries to ensure immunization of their populations and ultimately overcome the pandemic?","2021","07","22","Immunity","Immunity","Africa; COVID-19; COVID-19 Vaccines; Global Health; Health Services Accessibility; Humans; SARS-CoV-2; Vaccination","Massinga Loembé","Marguerite","Africa Centers for Disease Control and Prevention, P.O. Box 3243, Addis Ababa, Ethiopia",NA
"316","34260880","10.1016/j.immuni.2021.06.017","COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead.","Development COVID-19 vaccines in a record time has been an unprecedented global scientific achievement. However, the world has failed to ensure equitable access to what should have been a global public good. What options remain available to African countries to ensure immunization of their populations and ultimately overcome the pandemic?","2021","07","22","Immunity","Immunity","Africa; COVID-19; COVID-19 Vaccines; Global Health; Health Services Accessibility; Humans; SARS-CoV-2; Vaccination","Nkengasong","John N","Africa Centers for Disease Control and Prevention, P.O. Box 3243, Addis Ababa, Ethiopia. Electronic address: NkengasongJ@africa-union",NA
"317","34260855","10.1021/acschemneuro.1c00353","Neurological Manifestations in COVID-19 Patients: A Meta-Analysis.","Common symptoms such as dizziness, headache, olfactory dysfunction, nausea, vomiting, etc. in COVID-19 patients have indicated the involvement of the nervous system. However, the exact association of the nervous system with COVID-19 infection is still unclear. Thus, we have conducted a meta-analysis of clinical studies associated with neurological problems in COVID-19 patients. We have searched for electronic databases with MeSH terms, and the studies for analysis were selected based on inclusio","2021","07","21","ACS Chem Neurosci","ACS chemical neuroscience","COVID-19; central nervous system; meta-analysis; neurological manifestations; peripheral nervous system; prevalence","D","Vitalakumar","Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)-Raeberali, Lucknow 226002, India",NA
"318","34260855","10.1021/acschemneuro.1c00353","Neurological Manifestations in COVID-19 Patients: A Meta-Analysis.","Common symptoms such as dizziness, headache, olfactory dysfunction, nausea, vomiting, etc. in COVID-19 patients have indicated the involvement of the nervous system. However, the exact association of the nervous system with COVID-19 infection is still unclear. Thus, we have conducted a meta-analysis of clinical studies associated with neurological problems in COVID-19 patients. We have searched for electronic databases with MeSH terms, and the studies for analysis were selected based on inclusio","2021","07","21","ACS Chem Neurosci","ACS chemical neuroscience","COVID-19; central nervous system; meta-analysis; neurological manifestations; peripheral nervous system; prevalence","Sharma","Ankita","Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER)-Raeberali, Lucknow 226002, India",NA
"319","34260855","10.1021/acschemneuro.1c00353","Neurological Manifestations in COVID-19 Patients: A Meta-Analysis.","Common symptoms such as dizziness, headache, olfactory dysfunction, nausea, vomiting, etc. in COVID-19 patients have indicated the involvement of the nervous system. However, the exact association of the nervous system with COVID-19 infection is still unclear. Thus, we have conducted a meta-analysis of clinical studies associated with neurological problems in COVID-19 patients. We have searched for electronic databases with MeSH terms, and the studies for analysis were selected based on inclusio","2021","07","21","ACS Chem Neurosci","ACS chemical neuroscience","COVID-19; central nervous system; meta-analysis; neurological manifestations; peripheral nervous system; prevalence","Kumar","Anoop","Department of Pharmacology and Clinical Research, Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR), Delhi Pharmaceutical Sciences &amp",NA
"320","34260855","10.1021/acschemneuro.1c00353","Neurological Manifestations in COVID-19 Patients: A Meta-Analysis.","Common symptoms such as dizziness, headache, olfactory dysfunction, nausea, vomiting, etc. in COVID-19 patients have indicated the involvement of the nervous system. However, the exact association of the nervous system with COVID-19 infection is still unclear. Thus, we have conducted a meta-analysis of clinical studies associated with neurological problems in COVID-19 patients. We have searched for electronic databases with MeSH terms, and the studies for analysis were selected based on inclusio","2021","07","21","ACS Chem Neurosci","ACS chemical neuroscience","COVID-19; central nervous system; meta-analysis; neurological manifestations; peripheral nervous system; prevalence","Flora","S J S","Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)-Raeberali, Lucknow 226002, India",NA
"321","34260850","10.1056/NEJMc2110716","Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.",NA,"2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Normark","Johan","Umeå University, Umeå, Sweden",NA
"322","34260850","10.1056/NEJMc2110716","Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.",NA,"2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Vikström","Linnea","Umeå University, Umeå, Sweden",NA
"323","34260850","10.1056/NEJMc2110716","Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.",NA,"2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Gwon","Yong-Dae","Umeå University, Umeå, Sweden",NA
"324","34260850","10.1056/NEJMc2110716","Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.",NA,"2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Persson","Ida-Lisa","Umeå University, Umeå, Sweden",NA
"325","34260850","10.1056/NEJMc2110716","Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.",NA,"2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Edin","Alicia","Umeå University, Umeå, Sweden",NA
"326","34260850","10.1056/NEJMc2110716","Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.",NA,"2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Björsell","Tove","Umeå University, Umeå, Sweden",NA
"327","34260850","10.1056/NEJMc2110716","Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.",NA,"2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Dernstedt","Andy","Umeå University, Umeå, Sweden",NA
"328","34260850","10.1056/NEJMc2110716","Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.",NA,"2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Christ","Wanda","Karolinska Institutet, Stockholm, Sweden",NA
"329","34260850","10.1056/NEJMc2110716","Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.",NA,"2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Tevell","Staffan","Region Värmland, Karlstad, Sweden",NA
"330","34260850","10.1056/NEJMc2110716","Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.",NA,"2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Evander","Magnus","Umeå University, Umeå, Sweden",NA
"331","34260850","10.1056/NEJMc2110716","Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.",NA,"2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Klingström","Jonas","Karolinska Institutet, Stockholm, Sweden",NA
"332","34260850","10.1056/NEJMc2110716","Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.",NA,"2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Ahlm","Clas","Umeå University, Umeå, Sweden mattias.forsell@umu","mattias.forsell@umu.se"
"333","34260850","10.1056/NEJMc2110716","Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.",NA,"2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Forsell","Mattias","Umeå University, Umeå, Sweden mattias.forsell@umu","mattias.forsell@umu.se"
"334","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Dougan","Michael","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"335","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Nirula","Ajay","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"336","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Azizad","Masoud","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"337","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Mocherla","Bharat","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"338","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Gottlieb","Robert L","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"339","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Chen","Peter","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"340","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Hebert","Corey","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"341","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Perry","Russell","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"342","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Boscia","Joseph","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"343","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Heller","Barry","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"344","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Morris","Jason","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"345","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Crystal","Chad","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"346","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Igbinadolor","Awawu","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"347","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Huhn","Gregory","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"348","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Cardona","Jose","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"349","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Shawa","Imad","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"350","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Kumar","Princy","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"351","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Adams","Andrew C","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"352","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Van Naarden","Jacob","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"353","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Custer","Kenneth L","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"354","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Durante","Michael","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"355","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Oakley","Gerard","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"356","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Schade","Andrew E","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"357","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Holzer","Timothy R","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"358","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Ebert","Philip J","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"359","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Higgs","Richard E","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"360","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Kallewaard","Nicole L","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"361","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Sabo","Janelle","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"362","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Patel","Dipak R","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"363","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Dabora","Matan C","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"364","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Klekotka","Paul","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"365","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Shen","Lei","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"366","34260849","10.1056/NEJMoa2102685","Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.","Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. In this phase 3 trial, we randomly assigned, in a 1:1 ratio, a cohort of ambulatory patients with mild or moderate Covid-19 who were at high risk for progression to severe disease to receive a single ","2021","07","14","N Engl J Med","The New England journal of medicine",NA,"Skovronsky","Daniel M","From Massachusetts General Hospital and Harvard Medical School, Boston (M. Dougan)",NA
"367","34260844","10.1056/NEJMe2111903","Audio Interview: Monoclonal Antibodies and Vaccine Boosts.",NA,"2021","07","22","N Engl J Med","The New England journal of medicine","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Humans; Immunization, Passive; Immunization, Secondary; Immunogenicity, Vaccine; Immunoglobulins; Immunologic Factors; Infusions, Intravenous; SARS-CoV-2; Time-to-Treatment; Viral Load; Virus Replication","Rubin","Eric J",NA,NA
"368","34260844","10.1056/NEJMe2111903","Audio Interview: Monoclonal Antibodies and Vaccine Boosts.",NA,"2021","07","22","N Engl J Med","The New England journal of medicine","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Humans; Immunization, Passive; Immunization, Secondary; Immunogenicity, Vaccine; Immunoglobulins; Immunologic Factors; Infusions, Intravenous; SARS-CoV-2; Time-to-Treatment; Viral Load; Virus Replication","Baden","Lindsey R",NA,NA
"369","34260844","10.1056/NEJMe2111903","Audio Interview: Monoclonal Antibodies and Vaccine Boosts.",NA,"2021","07","22","N Engl J Med","The New England journal of medicine","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Humans; Immunization, Passive; Immunization, Secondary; Immunogenicity, Vaccine; Immunoglobulins; Immunologic Factors; Infusions, Intravenous; SARS-CoV-2; Time-to-Treatment; Viral Load; Virus Replication","Morrissey","Stephen",NA,NA
"370","34260827","10.1002/ueg2.12121","COVID-19 in gastroenterology and hepatology: Where will we be?",NA,"2021","07","14","United European Gastroenterol J","United European gastroenterology journal",NA,"Lantinga","Marten A","Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, the Netherlands",NA
"371","34260827","10.1002/ueg2.12121","COVID-19 in gastroenterology and hepatology: Where will we be?",NA,"2021","07","14","United European Gastroenterol J","United European gastroenterology journal",NA,"Mönkemüller","Klaus","University of Belgrade, Belgrade, Serbia",NA
"372","34260823","10.1111/crj.13422","Pulmonary Telerehabilitation and Efficacy among Discharged COVID-19 Patients: Rational and Design of a Prospective Real-world Study.","The novel coronavirus disease 2019 (COVID-19) could cause physical and psychological dysfunction in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients. Pulmonary telerehabilitation is strongly recommended due to the contagious nature of the disease, but its efficacy and benefit need to be comprehensively evaluated. An eight-week pulmonary telerehabilitation program is designed in a real-world and prospective manner, aiming to assess the efficacy of remote rehabilitati","2021","07","14","Clin Respir J","The clinical respiratory journal","COVID-19; Comparative effectiveness research; Real-world study; SARS-CoV-2; Telerehabilitation","Lei","Jieping","Data and Project Management Unit, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, P. R. China",NA
"373","34260823","10.1111/crj.13422","Pulmonary Telerehabilitation and Efficacy among Discharged COVID-19 Patients: Rational and Design of a Prospective Real-world Study.","The novel coronavirus disease 2019 (COVID-19) could cause physical and psychological dysfunction in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients. Pulmonary telerehabilitation is strongly recommended due to the contagious nature of the disease, but its efficacy and benefit need to be comprehensively evaluated. An eight-week pulmonary telerehabilitation program is designed in a real-world and prospective manner, aiming to assess the efficacy of remote rehabilitati","2021","07","14","Clin Respir J","The clinical respiratory journal","COVID-19; Comparative effectiveness research; Real-world study; SARS-CoV-2; Telerehabilitation","Yang","Lulu","Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, P. R. China",NA
"374","34260823","10.1111/crj.13422","Pulmonary Telerehabilitation and Efficacy among Discharged COVID-19 Patients: Rational and Design of a Prospective Real-world Study.","The novel coronavirus disease 2019 (COVID-19) could cause physical and psychological dysfunction in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients. Pulmonary telerehabilitation is strongly recommended due to the contagious nature of the disease, but its efficacy and benefit need to be comprehensively evaluated. An eight-week pulmonary telerehabilitation program is designed in a real-world and prospective manner, aiming to assess the efficacy of remote rehabilitati","2021","07","14","Clin Respir J","The clinical respiratory journal","COVID-19; Comparative effectiveness research; Real-world study; SARS-CoV-2; Telerehabilitation","Wen","Geyi","Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, P. R. China",NA
"375","34260823","10.1111/crj.13422","Pulmonary Telerehabilitation and Efficacy among Discharged COVID-19 Patients: Rational and Design of a Prospective Real-world Study.","The novel coronavirus disease 2019 (COVID-19) could cause physical and psychological dysfunction in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients. Pulmonary telerehabilitation is strongly recommended due to the contagious nature of the disease, but its efficacy and benefit need to be comprehensively evaluated. An eight-week pulmonary telerehabilitation program is designed in a real-world and prospective manner, aiming to assess the efficacy of remote rehabilitati","2021","07","14","Clin Respir J","The clinical respiratory journal","COVID-19; Comparative effectiveness research; Real-world study; SARS-CoV-2; Telerehabilitation","Qumu","Shiwei","Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, P. R. China",NA
"376","34260823","10.1111/crj.13422","Pulmonary Telerehabilitation and Efficacy among Discharged COVID-19 Patients: Rational and Design of a Prospective Real-world Study.","The novel coronavirus disease 2019 (COVID-19) could cause physical and psychological dysfunction in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients. Pulmonary telerehabilitation is strongly recommended due to the contagious nature of the disease, but its efficacy and benefit need to be comprehensively evaluated. An eight-week pulmonary telerehabilitation program is designed in a real-world and prospective manner, aiming to assess the efficacy of remote rehabilitati","2021","07","14","Clin Respir J","The clinical respiratory journal","COVID-19; Comparative effectiveness research; Real-world study; SARS-CoV-2; Telerehabilitation","Ren","Xiaoxia","Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, P. R. China",NA
"377","34260823","10.1111/crj.13422","Pulmonary Telerehabilitation and Efficacy among Discharged COVID-19 Patients: Rational and Design of a Prospective Real-world Study.","The novel coronavirus disease 2019 (COVID-19) could cause physical and psychological dysfunction in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients. Pulmonary telerehabilitation is strongly recommended due to the contagious nature of the disease, but its efficacy and benefit need to be comprehensively evaluated. An eight-week pulmonary telerehabilitation program is designed in a real-world and prospective manner, aiming to assess the efficacy of remote rehabilitati","2021","07","14","Clin Respir J","The clinical respiratory journal","COVID-19; Comparative effectiveness research; Real-world study; SARS-CoV-2; Telerehabilitation","Yang","Ting","Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, P. R. China",NA
"378","34260818","10.1111/jth.15462","Physician Experiences in Management of COVID-19-Associated Coagulopathy in Pregnancy: Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis.","Coronavirus disease 2019 (COVID-19) occurs following infection with the potentially fatal, severe-acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2) virus. Infection can be complicated by coagulopathy, at times featuring thrombocytopenia and thrombosis alongside other coagulation abnormalities, also termed COVID-19 associated coagulopathy (CAC). Data concerning CAC in pregnancy is limited. Better understanding of physician experiences is essential to identify current practice patterns and kno","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; anticoagulant; coagulopathy; pregnancy; thrombosis","Jevtic","Stefan D","Department of Medicine, McMaster University, Hamilton, ON, Canada",NA
"379","34260818","10.1111/jth.15462","Physician Experiences in Management of COVID-19-Associated Coagulopathy in Pregnancy: Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis.","Coronavirus disease 2019 (COVID-19) occurs following infection with the potentially fatal, severe-acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2) virus. Infection can be complicated by coagulopathy, at times featuring thrombocytopenia and thrombosis alongside other coagulation abnormalities, also termed COVID-19 associated coagulopathy (CAC). Data concerning CAC in pregnancy is limited. Better understanding of physician experiences is essential to identify current practice patterns and kno","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; anticoagulant; coagulopathy; pregnancy; thrombosis","Malinowski","A Kinga","Department of Obstetrics and Gynaecology, Division of Maternal-Fetal Medicine, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada",NA
"380","34260818","10.1111/jth.15462","Physician Experiences in Management of COVID-19-Associated Coagulopathy in Pregnancy: Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis.","Coronavirus disease 2019 (COVID-19) occurs following infection with the potentially fatal, severe-acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2) virus. Infection can be complicated by coagulopathy, at times featuring thrombocytopenia and thrombosis alongside other coagulation abnormalities, also termed COVID-19 associated coagulopathy (CAC). Data concerning CAC in pregnancy is limited. Better understanding of physician experiences is essential to identify current practice patterns and kno","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; anticoagulant; coagulopathy; pregnancy; thrombosis","Othman","Maha","Department of Biomedical and Molecular Sciences, School of Medicine, Queen's University, Kingston, Canada",NA
"381","34260818","10.1111/jth.15462","Physician Experiences in Management of COVID-19-Associated Coagulopathy in Pregnancy: Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis.","Coronavirus disease 2019 (COVID-19) occurs following infection with the potentially fatal, severe-acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2) virus. Infection can be complicated by coagulopathy, at times featuring thrombocytopenia and thrombosis alongside other coagulation abnormalities, also termed COVID-19 associated coagulopathy (CAC). Data concerning CAC in pregnancy is limited. Better understanding of physician experiences is essential to identify current practice patterns and kno","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; anticoagulant; coagulopathy; pregnancy; thrombosis","Kadir","Rezan A Abdul","Department of Obstetrics and Gynaecology, The Royal Free NHS Foundation Hospital",NA
"382","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Li","Ang","Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA",NA
"383","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Kuderer","Nicole M","Advanced Cancer Research Group, Seattle, WA, USA",NA
"384","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Hsu","Chih-Yuan","Department of Biomedical Informatics, Vanderbilt University, Nashville, TN, USA",NA
"385","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Shyr","Yu","Department of Biomedical Informatics, Vanderbilt University, Nashville, TN, USA",NA
"386","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Warner","Jeremy L","Department of Biomedical Informatics, Vanderbilt University, Nashville, TN, USA",NA
"387","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Shah","Dimpy P","Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, TX, USA",NA
"388","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Kumar","Vaibhav","Section of Hematology-Oncology, University of North Carolina, Chapel Hill, NC, USA",NA
"389","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Shah","Surbhi","Division of Hematology, Oncology, and Transplantation, University of Minnesota, MN, USA",NA
"390","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Kulkarni","Amit A","Division of Hematology, Oncology, and Transplantation, University of Minnesota, MN, USA",NA
"391","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Fu","Julie","Hematology Oncology, Tufts Medical Center Cancer Center, Boston &amp",NA
"392","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Gulati","Shuchi","Division of Hematology/Oncology, University of Cincinnati, Cincinnati, OH, USA",NA
"393","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Zon","Rebecca L","Division of Hematology, Brigham and Women's Hospital Boston, MA, USA",NA
"394","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Li","Monica","Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA",NA
"395","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Desai","Aakash","Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA",NA
"396","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Egan","Pamela C","Brown University and Lifespan Cancer Institute, Providence, RI, USA",NA
"397","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Bakouny","Ziad","Dana-Farber Cancer Institute, Boston, MA, USA",NA
"398","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Kc","Devendra","Hartford HealthCare Cancer Institute, Hartford, CT, USA",NA
"399","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Hwang","Clara","Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, MI, USA",NA
"400","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Akpan","Imo J","Herbert Irving Comprehensive Cancer Center at Columbia University, New York, NY, USA",NA
"401","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","McKay","Rana R","Moores Cancer Center at the University of California, San Diego, CA, USA",NA
"402","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Girard","Jennifer","University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA",NA
"403","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Schmidt","Andrew L","Dana-Farber Cancer Institute, Boston, MA, USA",NA
"404","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Halmos","Balazs","Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA",NA
"405","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Thompson","Michael A","Aurora Cancer Care, Advocate Aurora Health, Milwaukee, WI, USA",NA
"406","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Patel","Jaymin M","Beth Israel Deaconess Medical Center (BIDMC), Boston, MA, USA",NA
"407","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Pennell","Nathan A","Cleveland Clinic, Cleveland, OH, USA",NA
"408","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Peters","Solange","Lausanne University Hospital, Lausanne, Switzerland",NA
"409","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Elshoury","Amro","Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA",NA
"410","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","de Lima Lopes","Gilbero","Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA",NA
"411","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Stover","Daniel G","Ohio State University Comprehensive Cancer Center, Columbus, OH, USA",NA
"412","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Grivas","Petros","University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, WA, USA",NA
"413","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Rini","Brian I","Department of Medicine, Division of Hematology/Oncology, Vanderbilt University, Nashville, TN, USA",NA
"414","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Painter","Corrie A","Broad Institute of MIT and Harvard, Cambridge, MA, USA",NA
"415","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Mishra","Sanjay","Department of Medicine, Division of Hematology/Oncology, Vanderbilt University, Nashville, TN, USA",NA
"416","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Connors","Jean M","Division of Hematology, Brigham and Women's Hospital Boston, MA, USA",NA
"417","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Lyman","Gary H","University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, WA, USA",NA
"418","34260813","10.1111/jth.15463","The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19."," Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM) for VTE in patients with both cancer and COVID-19 is lacking.  Among patients with cancer in the CCC19 cohort study, we assessed the incidence of VTE and ATE within 90 days of COVID-19 associated hospitalization. A multivariable logistic regression model specifically for VTE was buil","2021","07","14","J Thromb Haemost","Journal of thrombosis and haemostasis : JTH","COVID-19; Clinical Decision Rules; SARS-CoV-2; Thrombosis; Venous Thromboembolism","Rosovsky","Rachel P","Division of Hematology/Oncology, Massachusetts General Hospital, Boston",NA
"419","34260803","10.1111/hepr.13696","Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients:a series of 43 cases.","COVID-19 is characterized by pneumonia with secondary damage to multiple organs including the liver. Liver injury (elevated ALT and AST) often correlates with disease severity in COVID-19 patients. The aim of this study is to identify pathological microthrombi in COVID-19 patient livers by correlating their morphology with liver injury, and examine hyperfibrinogenemia and von Willebrand factor(vWF) as mechanisms of their formation. Forty three post-mortem liver biopsy samples from COVID-19 patie","2021","07","14","Hepatol Res","Hepatology research : the official journal of the Japan Society of Hepatology",NA,"Kondo","Reiichiro","Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA",NA
"420","34260803","10.1111/hepr.13696","Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients:a series of 43 cases.","COVID-19 is characterized by pneumonia with secondary damage to multiple organs including the liver. Liver injury (elevated ALT and AST) often correlates with disease severity in COVID-19 patients. The aim of this study is to identify pathological microthrombi in COVID-19 patient livers by correlating their morphology with liver injury, and examine hyperfibrinogenemia and von Willebrand factor(vWF) as mechanisms of their formation. Forty three post-mortem liver biopsy samples from COVID-19 patie","2021","07","14","Hepatol Res","Hepatology research : the official journal of the Japan Society of Hepatology",NA,"Kawaguchi","Nao","Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA",NA
"421","34260803","10.1111/hepr.13696","Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients:a series of 43 cases.","COVID-19 is characterized by pneumonia with secondary damage to multiple organs including the liver. Liver injury (elevated ALT and AST) often correlates with disease severity in COVID-19 patients. The aim of this study is to identify pathological microthrombi in COVID-19 patient livers by correlating their morphology with liver injury, and examine hyperfibrinogenemia and von Willebrand factor(vWF) as mechanisms of their formation. Forty three post-mortem liver biopsy samples from COVID-19 patie","2021","07","14","Hepatol Res","Hepatology research : the official journal of the Japan Society of Hepatology",NA,"McConnell","Matthew J","Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA",NA
"422","34260803","10.1111/hepr.13696","Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients:a series of 43 cases.","COVID-19 is characterized by pneumonia with secondary damage to multiple organs including the liver. Liver injury (elevated ALT and AST) often correlates with disease severity in COVID-19 patients. The aim of this study is to identify pathological microthrombi in COVID-19 patient livers by correlating their morphology with liver injury, and examine hyperfibrinogenemia and von Willebrand factor(vWF) as mechanisms of their formation. Forty three post-mortem liver biopsy samples from COVID-19 patie","2021","07","14","Hepatol Res","Hepatology research : the official journal of the Japan Society of Hepatology",NA,"Sonzogni","Aurelio","Department of Pathology, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy",NA
"423","34260803","10.1111/hepr.13696","Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients:a series of 43 cases.","COVID-19 is characterized by pneumonia with secondary damage to multiple organs including the liver. Liver injury (elevated ALT and AST) often correlates with disease severity in COVID-19 patients. The aim of this study is to identify pathological microthrombi in COVID-19 patient livers by correlating their morphology with liver injury, and examine hyperfibrinogenemia and von Willebrand factor(vWF) as mechanisms of their formation. Forty three post-mortem liver biopsy samples from COVID-19 patie","2021","07","14","Hepatol Res","Hepatology research : the official journal of the Japan Society of Hepatology",NA,"Licini","Lisa","Department of Pathology, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy",NA
"424","34260803","10.1111/hepr.13696","Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients:a series of 43 cases.","COVID-19 is characterized by pneumonia with secondary damage to multiple organs including the liver. Liver injury (elevated ALT and AST) often correlates with disease severity in COVID-19 patients. The aim of this study is to identify pathological microthrombi in COVID-19 patient livers by correlating their morphology with liver injury, and examine hyperfibrinogenemia and von Willebrand factor(vWF) as mechanisms of their formation. Forty three post-mortem liver biopsy samples from COVID-19 patie","2021","07","14","Hepatol Res","Hepatology research : the official journal of the Japan Society of Hepatology",NA,"Valle","Clarissa","Department of Radiology, ASST Papa Giovanni XXIII, Bergamo, Italy",NA
"425","34260803","10.1111/hepr.13696","Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients:a series of 43 cases.","COVID-19 is characterized by pneumonia with secondary damage to multiple organs including the liver. Liver injury (elevated ALT and AST) often correlates with disease severity in COVID-19 patients. The aim of this study is to identify pathological microthrombi in COVID-19 patient livers by correlating their morphology with liver injury, and examine hyperfibrinogenemia and von Willebrand factor(vWF) as mechanisms of their formation. Forty three post-mortem liver biopsy samples from COVID-19 patie","2021","07","14","Hepatol Res","Hepatology research : the official journal of the Japan Society of Hepatology",NA,"Bonaffini","Pietro A","Department of Radiology, ASST Papa Giovanni XXIII, Bergamo, Italy",NA
"426","34260803","10.1111/hepr.13696","Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients:a series of 43 cases.","COVID-19 is characterized by pneumonia with secondary damage to multiple organs including the liver. Liver injury (elevated ALT and AST) often correlates with disease severity in COVID-19 patients. The aim of this study is to identify pathological microthrombi in COVID-19 patient livers by correlating their morphology with liver injury, and examine hyperfibrinogenemia and von Willebrand factor(vWF) as mechanisms of their formation. Forty three post-mortem liver biopsy samples from COVID-19 patie","2021","07","14","Hepatol Res","Hepatology research : the official journal of the Japan Society of Hepatology",NA,"Sironi","Sandro","Department of Radiology, ASST Papa Giovanni XXIII, Bergamo, Italy",NA
"427","34260803","10.1111/hepr.13696","Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients:a series of 43 cases.","COVID-19 is characterized by pneumonia with secondary damage to multiple organs including the liver. Liver injury (elevated ALT and AST) often correlates with disease severity in COVID-19 patients. The aim of this study is to identify pathological microthrombi in COVID-19 patient livers by correlating their morphology with liver injury, and examine hyperfibrinogenemia and von Willebrand factor(vWF) as mechanisms of their formation. Forty three post-mortem liver biopsy samples from COVID-19 patie","2021","07","14","Hepatol Res","Hepatology research : the official journal of the Japan Society of Hepatology",NA,"Alessio","Maria Grazia","Department of Laboratory Medicine, ASST Papa Giovanni XXIII, Bergamo, Italy",NA
"428","34260803","10.1111/hepr.13696","Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients:a series of 43 cases.","COVID-19 is characterized by pneumonia with secondary damage to multiple organs including the liver. Liver injury (elevated ALT and AST) often correlates with disease severity in COVID-19 patients. The aim of this study is to identify pathological microthrombi in COVID-19 patient livers by correlating their morphology with liver injury, and examine hyperfibrinogenemia and von Willebrand factor(vWF) as mechanisms of their formation. Forty three post-mortem liver biopsy samples from COVID-19 patie","2021","07","14","Hepatol Res","Hepatology research : the official journal of the Japan Society of Hepatology",NA,"Previtali","Giulia","Department of Laboratory Medicine, ASST Papa Giovanni XXIII, Bergamo, Italy",NA
"429","34260803","10.1111/hepr.13696","Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients:a series of 43 cases.","COVID-19 is characterized by pneumonia with secondary damage to multiple organs including the liver. Liver injury (elevated ALT and AST) often correlates with disease severity in COVID-19 patients. The aim of this study is to identify pathological microthrombi in COVID-19 patient livers by correlating their morphology with liver injury, and examine hyperfibrinogenemia and von Willebrand factor(vWF) as mechanisms of their formation. Forty three post-mortem liver biopsy samples from COVID-19 patie","2021","07","14","Hepatol Res","Hepatology research : the official journal of the Japan Society of Hepatology",NA,"Seghezzi","Michela","Department of Laboratory Medicine, ASST Papa Giovanni XXIII, Bergamo, Italy",NA
"430","34260803","10.1111/hepr.13696","Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients:a series of 43 cases.","COVID-19 is characterized by pneumonia with secondary damage to multiple organs including the liver. Liver injury (elevated ALT and AST) often correlates with disease severity in COVID-19 patients. The aim of this study is to identify pathological microthrombi in COVID-19 patient livers by correlating their morphology with liver injury, and examine hyperfibrinogenemia and von Willebrand factor(vWF) as mechanisms of their formation. Forty three post-mortem liver biopsy samples from COVID-19 patie","2021","07","14","Hepatol Res","Hepatology research : the official journal of the Japan Society of Hepatology",NA,"Zhang","Xuchen","Department of Pathology, Yale University School of Medicine, New Haven, CT, USA",NA
"431","34260803","10.1111/hepr.13696","Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients:a series of 43 cases.","COVID-19 is characterized by pneumonia with secondary damage to multiple organs including the liver. Liver injury (elevated ALT and AST) often correlates with disease severity in COVID-19 patients. The aim of this study is to identify pathological microthrombi in COVID-19 patient livers by correlating their morphology with liver injury, and examine hyperfibrinogenemia and von Willebrand factor(vWF) as mechanisms of their formation. Forty three post-mortem liver biopsy samples from COVID-19 patie","2021","07","14","Hepatol Res","Hepatology research : the official journal of the Japan Society of Hepatology",NA,"Sun","Zhaoli","Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, U",NA
"432","34260803","10.1111/hepr.13696","Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients:a series of 43 cases.","COVID-19 is characterized by pneumonia with secondary damage to multiple organs including the liver. Liver injury (elevated ALT and AST) often correlates with disease severity in COVID-19 patients. The aim of this study is to identify pathological microthrombi in COVID-19 patient livers by correlating their morphology with liver injury, and examine hyperfibrinogenemia and von Willebrand factor(vWF) as mechanisms of their formation. Forty three post-mortem liver biopsy samples from COVID-19 patie","2021","07","14","Hepatol Res","Hepatology research : the official journal of the Japan Society of Hepatology",NA,"Utsumi","Teruo","Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA",NA
"433","34260803","10.1111/hepr.13696","Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients:a series of 43 cases.","COVID-19 is characterized by pneumonia with secondary damage to multiple organs including the liver. Liver injury (elevated ALT and AST) often correlates with disease severity in COVID-19 patients. The aim of this study is to identify pathological microthrombi in COVID-19 patient livers by correlating their morphology with liver injury, and examine hyperfibrinogenemia and von Willebrand factor(vWF) as mechanisms of their formation. Forty three post-mortem liver biopsy samples from COVID-19 patie","2021","07","14","Hepatol Res","Hepatology research : the official journal of the Japan Society of Hepatology",NA,"Strazzabosco","Mario","Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA",NA
"434","34260803","10.1111/hepr.13696","Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients:a series of 43 cases.","COVID-19 is characterized by pneumonia with secondary damage to multiple organs including the liver. Liver injury (elevated ALT and AST) often correlates with disease severity in COVID-19 patients. The aim of this study is to identify pathological microthrombi in COVID-19 patient livers by correlating their morphology with liver injury, and examine hyperfibrinogenemia and von Willebrand factor(vWF) as mechanisms of their formation. Forty three post-mortem liver biopsy samples from COVID-19 patie","2021","07","14","Hepatol Res","Hepatology research : the official journal of the Japan Society of Hepatology",NA,"Iwakiri","Yasuko","Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA",NA
"435","34260781","10.1002/rmv.2192","The effectiveness of non-contact thermal screening as a means of identifying cases of Covid-19: a rapid review of the evidence.","The aim of this rapid review is to summarise the evidence on non-contact thermal screening as a method through which to identify cases and reduce the spread of coronavirus disease (Covid-19). The rapid review was conducted in accordance with Cochrane guidelines, with a systematic search of published peer-reviewed articles and non-peer-reviewed pre-prints undertaken from 1 January 2000 up to 7 October 2020. Eleven studies were included. One observational study and two mathematical modelling studi","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; coronavirus; mass screening; thermal screening; COVID-19; COVID-19 Testing; Fever; Humans; Mass Screening","Cardwell","Karen","Health Technology Assessment Directorate, Health Information and Quality Authority, Smithfield, Dublin, Ireland",NA
"436","34260781","10.1002/rmv.2192","The effectiveness of non-contact thermal screening as a means of identifying cases of Covid-19: a rapid review of the evidence.","The aim of this rapid review is to summarise the evidence on non-contact thermal screening as a method through which to identify cases and reduce the spread of coronavirus disease (Covid-19). The rapid review was conducted in accordance with Cochrane guidelines, with a systematic search of published peer-reviewed articles and non-peer-reviewed pre-prints undertaken from 1 January 2000 up to 7 October 2020. Eleven studies were included. One observational study and two mathematical modelling studi","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; coronavirus; mass screening; thermal screening; COVID-19; COVID-19 Testing; Fever; Humans; Mass Screening","Jordan","Karen","Health Technology Assessment Directorate, Health Information and Quality Authority, Smithfield, Dublin, Ireland",NA
"437","34260781","10.1002/rmv.2192","The effectiveness of non-contact thermal screening as a means of identifying cases of Covid-19: a rapid review of the evidence.","The aim of this rapid review is to summarise the evidence on non-contact thermal screening as a method through which to identify cases and reduce the spread of coronavirus disease (Covid-19). The rapid review was conducted in accordance with Cochrane guidelines, with a systematic search of published peer-reviewed articles and non-peer-reviewed pre-prints undertaken from 1 January 2000 up to 7 October 2020. Eleven studies were included. One observational study and two mathematical modelling studi","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; coronavirus; mass screening; thermal screening; COVID-19; COVID-19 Testing; Fever; Humans; Mass Screening","Byrne","Paula","Health Technology Assessment Directorate, Health Information and Quality Authority, Smithfield, Dublin, Ireland",NA
"438","34260781","10.1002/rmv.2192","The effectiveness of non-contact thermal screening as a means of identifying cases of Covid-19: a rapid review of the evidence.","The aim of this rapid review is to summarise the evidence on non-contact thermal screening as a method through which to identify cases and reduce the spread of coronavirus disease (Covid-19). The rapid review was conducted in accordance with Cochrane guidelines, with a systematic search of published peer-reviewed articles and non-peer-reviewed pre-prints undertaken from 1 January 2000 up to 7 October 2020. Eleven studies were included. One observational study and two mathematical modelling studi","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; coronavirus; mass screening; thermal screening; COVID-19; COVID-19 Testing; Fever; Humans; Mass Screening","Smith","Susan M","Department of General Practice, Royal College of Surgeons in Ireland, Dublin, Ireland",NA
"439","34260781","10.1002/rmv.2192","The effectiveness of non-contact thermal screening as a means of identifying cases of Covid-19: a rapid review of the evidence.","The aim of this rapid review is to summarise the evidence on non-contact thermal screening as a method through which to identify cases and reduce the spread of coronavirus disease (Covid-19). The rapid review was conducted in accordance with Cochrane guidelines, with a systematic search of published peer-reviewed articles and non-peer-reviewed pre-prints undertaken from 1 January 2000 up to 7 October 2020. Eleven studies were included. One observational study and two mathematical modelling studi","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; coronavirus; mass screening; thermal screening; COVID-19; COVID-19 Testing; Fever; Humans; Mass Screening","Harrington","Patricia","Health Technology Assessment Directorate, Health Information and Quality Authority, Smithfield, Dublin, Ireland",NA
"440","34260781","10.1002/rmv.2192","The effectiveness of non-contact thermal screening as a means of identifying cases of Covid-19: a rapid review of the evidence.","The aim of this rapid review is to summarise the evidence on non-contact thermal screening as a method through which to identify cases and reduce the spread of coronavirus disease (Covid-19). The rapid review was conducted in accordance with Cochrane guidelines, with a systematic search of published peer-reviewed articles and non-peer-reviewed pre-prints undertaken from 1 January 2000 up to 7 October 2020. Eleven studies were included. One observational study and two mathematical modelling studi","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; coronavirus; mass screening; thermal screening; COVID-19; COVID-19 Testing; Fever; Humans; Mass Screening","Ryan","Mairin","Health Technology Assessment Directorate, Health Information and Quality Authority, Smithfield, Dublin, Ireland",NA
"441","34260781","10.1002/rmv.2192","The effectiveness of non-contact thermal screening as a means of identifying cases of Covid-19: a rapid review of the evidence.","The aim of this rapid review is to summarise the evidence on non-contact thermal screening as a method through which to identify cases and reduce the spread of coronavirus disease (Covid-19). The rapid review was conducted in accordance with Cochrane guidelines, with a systematic search of published peer-reviewed articles and non-peer-reviewed pre-prints undertaken from 1 January 2000 up to 7 October 2020. Eleven studies were included. One observational study and two mathematical modelling studi","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; coronavirus; mass screening; thermal screening; COVID-19; COVID-19 Testing; Fever; Humans; Mass Screening","O'Neill","Michelle","Health Technology Assessment Directorate, Health Information and Quality Authority, Smithfield, Dublin, Ireland",NA
"442","34260780","10.1002/rmv.2195","A systematic meta-analysis of immune signatures in patients with COVID-19.","Currently severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission has been on the rise worldwide. Predicting outcome in COVID-19 remains challenging, and the search for more robust predictors continues. We made a systematic meta-analysis on the current literature from 1 January 2020 to 15 August 2020 that independently evaluated 32 circulatory immunological signatures that were compared between patients with different disease severity was made. Their roles as predictors of dise","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; antibody; cytokines; disease severity; innate immunity; meta-analysis; Antibodies, Viral; B-Lymphocytes; COVID-19; Cytokines; Humans; Killer Cells, Natural; Leukocytes; SARS-CoV-2; Severity of Illness Index; T-Lymphocytes","Liu","Kun","Department of Epidemiology, Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Air Force Medical University, Xi'an, China",NA
"443","34260780","10.1002/rmv.2195","A systematic meta-analysis of immune signatures in patients with COVID-19.","Currently severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission has been on the rise worldwide. Predicting outcome in COVID-19 remains challenging, and the search for more robust predictors continues. We made a systematic meta-analysis on the current literature from 1 January 2020 to 15 August 2020 that independently evaluated 32 circulatory immunological signatures that were compared between patients with different disease severity was made. Their roles as predictors of dise","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; antibody; cytokines; disease severity; innate immunity; meta-analysis; Antibodies, Viral; B-Lymphocytes; COVID-19; Cytokines; Humans; Killer Cells, Natural; Leukocytes; SARS-CoV-2; Severity of Illness Index; T-Lymphocytes","Yang","Tong","State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China",NA
"444","34260780","10.1002/rmv.2195","A systematic meta-analysis of immune signatures in patients with COVID-19.","Currently severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission has been on the rise worldwide. Predicting outcome in COVID-19 remains challenging, and the search for more robust predictors continues. We made a systematic meta-analysis on the current literature from 1 January 2020 to 15 August 2020 that independently evaluated 32 circulatory immunological signatures that were compared between patients with different disease severity was made. Their roles as predictors of dise","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; antibody; cytokines; disease severity; innate immunity; meta-analysis; Antibodies, Viral; B-Lymphocytes; COVID-19; Cytokines; Humans; Killer Cells, Natural; Leukocytes; SARS-CoV-2; Severity of Illness Index; T-Lymphocytes","Peng","Xue-Fang","State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China",NA
"445","34260780","10.1002/rmv.2195","A systematic meta-analysis of immune signatures in patients with COVID-19.","Currently severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission has been on the rise worldwide. Predicting outcome in COVID-19 remains challenging, and the search for more robust predictors continues. We made a systematic meta-analysis on the current literature from 1 January 2020 to 15 August 2020 that independently evaluated 32 circulatory immunological signatures that were compared between patients with different disease severity was made. Their roles as predictors of dise","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; antibody; cytokines; disease severity; innate immunity; meta-analysis; Antibodies, Viral; B-Lymphocytes; COVID-19; Cytokines; Humans; Killer Cells, Natural; Leukocytes; SARS-CoV-2; Severity of Illness Index; T-Lymphocytes","Lv","Shou-Ming","State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China",NA
"446","34260780","10.1002/rmv.2195","A systematic meta-analysis of immune signatures in patients with COVID-19.","Currently severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission has been on the rise worldwide. Predicting outcome in COVID-19 remains challenging, and the search for more robust predictors continues. We made a systematic meta-analysis on the current literature from 1 January 2020 to 15 August 2020 that independently evaluated 32 circulatory immunological signatures that were compared between patients with different disease severity was made. Their roles as predictors of dise","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; antibody; cytokines; disease severity; innate immunity; meta-analysis; Antibodies, Viral; B-Lymphocytes; COVID-19; Cytokines; Humans; Killer Cells, Natural; Leukocytes; SARS-CoV-2; Severity of Illness Index; T-Lymphocytes","Ye","Xiao-Lei","State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China",NA
"447","34260780","10.1002/rmv.2195","A systematic meta-analysis of immune signatures in patients with COVID-19.","Currently severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission has been on the rise worldwide. Predicting outcome in COVID-19 remains challenging, and the search for more robust predictors continues. We made a systematic meta-analysis on the current literature from 1 January 2020 to 15 August 2020 that independently evaluated 32 circulatory immunological signatures that were compared between patients with different disease severity was made. Their roles as predictors of dise","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; antibody; cytokines; disease severity; innate immunity; meta-analysis; Antibodies, Viral; B-Lymphocytes; COVID-19; Cytokines; Humans; Killer Cells, Natural; Leukocytes; SARS-CoV-2; Severity of Illness Index; T-Lymphocytes","Zhao","Tian-Shuo","Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, China",NA
"448","34260780","10.1002/rmv.2195","A systematic meta-analysis of immune signatures in patients with COVID-19.","Currently severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission has been on the rise worldwide. Predicting outcome in COVID-19 remains challenging, and the search for more robust predictors continues. We made a systematic meta-analysis on the current literature from 1 January 2020 to 15 August 2020 that independently evaluated 32 circulatory immunological signatures that were compared between patients with different disease severity was made. Their roles as predictors of dise","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; antibody; cytokines; disease severity; innate immunity; meta-analysis; Antibodies, Viral; B-Lymphocytes; COVID-19; Cytokines; Humans; Killer Cells, Natural; Leukocytes; SARS-CoV-2; Severity of Illness Index; T-Lymphocytes","Li","Jia-Chen","State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China",NA
"449","34260780","10.1002/rmv.2195","A systematic meta-analysis of immune signatures in patients with COVID-19.","Currently severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission has been on the rise worldwide. Predicting outcome in COVID-19 remains challenging, and the search for more robust predictors continues. We made a systematic meta-analysis on the current literature from 1 January 2020 to 15 August 2020 that independently evaluated 32 circulatory immunological signatures that were compared between patients with different disease severity was made. Their roles as predictors of dise","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; antibody; cytokines; disease severity; innate immunity; meta-analysis; Antibodies, Viral; B-Lymphocytes; COVID-19; Cytokines; Humans; Killer Cells, Natural; Leukocytes; SARS-CoV-2; Severity of Illness Index; T-Lymphocytes","Shao","Zhong-Jun","Department of Epidemiology, Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Air Force Medical University, Xi'an, China",NA
"450","34260780","10.1002/rmv.2195","A systematic meta-analysis of immune signatures in patients with COVID-19.","Currently severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission has been on the rise worldwide. Predicting outcome in COVID-19 remains challenging, and the search for more robust predictors continues. We made a systematic meta-analysis on the current literature from 1 January 2020 to 15 August 2020 that independently evaluated 32 circulatory immunological signatures that were compared between patients with different disease severity was made. Their roles as predictors of dise","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; antibody; cytokines; disease severity; innate immunity; meta-analysis; Antibodies, Viral; B-Lymphocytes; COVID-19; Cytokines; Humans; Killer Cells, Natural; Leukocytes; SARS-CoV-2; Severity of Illness Index; T-Lymphocytes","Lu","Qing-Bin","Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, China",NA
"451","34260780","10.1002/rmv.2195","A systematic meta-analysis of immune signatures in patients with COVID-19.","Currently severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission has been on the rise worldwide. Predicting outcome in COVID-19 remains challenging, and the search for more robust predictors continues. We made a systematic meta-analysis on the current literature from 1 January 2020 to 15 August 2020 that independently evaluated 32 circulatory immunological signatures that were compared between patients with different disease severity was made. Their roles as predictors of dise","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; antibody; cytokines; disease severity; innate immunity; meta-analysis; Antibodies, Viral; B-Lymphocytes; COVID-19; Cytokines; Humans; Killer Cells, Natural; Leukocytes; SARS-CoV-2; Severity of Illness Index; T-Lymphocytes","Li","Jing-Yun","State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China",NA
"452","34260780","10.1002/rmv.2195","A systematic meta-analysis of immune signatures in patients with COVID-19.","Currently severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission has been on the rise worldwide. Predicting outcome in COVID-19 remains challenging, and the search for more robust predictors continues. We made a systematic meta-analysis on the current literature from 1 January 2020 to 15 August 2020 that independently evaluated 32 circulatory immunological signatures that were compared between patients with different disease severity was made. Their roles as predictors of dise","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; antibody; cytokines; disease severity; innate immunity; meta-analysis; Antibodies, Viral; B-Lymphocytes; COVID-19; Cytokines; Humans; Killer Cells, Natural; Leukocytes; SARS-CoV-2; Severity of Illness Index; T-Lymphocytes","Liu","Wei","State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China",NA
"453","34260778","10.1002/rmv.2199","Immunity and inflammatory biomarkers in COVID-19: A systematic review.","Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Patients can be asymptomatic or present respiratory and gastrointestinal symptoms, and even multiple-organ failure which can lead to death. The balance between an effective antiviral response and dysregulated immune response is the key factor determining the severity of COVID-19 progression. A systematic review was performed using the NCBI-PubMed database t","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; SARS-COV-2; cytokine; immune response; inflammatory response; Biomarkers; COVID-19; Humans; Immunity; Inflammation","Iwamura","Ana Paula D","Genetics of Rare Diseases, Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba, Paraná, Brazil",NA
"454","34260778","10.1002/rmv.2199","Immunity and inflammatory biomarkers in COVID-19: A systematic review.","Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Patients can be asymptomatic or present respiratory and gastrointestinal symptoms, and even multiple-organ failure which can lead to death. The balance between an effective antiviral response and dysregulated immune response is the key factor determining the severity of COVID-19 progression. A systematic review was performed using the NCBI-PubMed database t","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; SARS-COV-2; cytokine; immune response; inflammatory response; Biomarkers; COVID-19; Humans; Immunity; Inflammation","Tavares da Silva","Marielen R","Genetics of Rare Diseases, Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba, Paraná, Brazil",NA
"455","34260778","10.1002/rmv.2199","Immunity and inflammatory biomarkers in COVID-19: A systematic review.","Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Patients can be asymptomatic or present respiratory and gastrointestinal symptoms, and even multiple-organ failure which can lead to death. The balance between an effective antiviral response and dysregulated immune response is the key factor determining the severity of COVID-19 progression. A systematic review was performed using the NCBI-PubMed database t","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; SARS-COV-2; cytokine; immune response; inflammatory response; Biomarkers; COVID-19; Humans; Immunity; Inflammation","Hümmelgen","Ana Luísa","Genetics of Rare Diseases, Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba, Paraná, Brazil",NA
"456","34260778","10.1002/rmv.2199","Immunity and inflammatory biomarkers in COVID-19: A systematic review.","Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Patients can be asymptomatic or present respiratory and gastrointestinal symptoms, and even multiple-organ failure which can lead to death. The balance between an effective antiviral response and dysregulated immune response is the key factor determining the severity of COVID-19 progression. A systematic review was performed using the NCBI-PubMed database t","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; SARS-COV-2; cytokine; immune response; inflammatory response; Biomarkers; COVID-19; Humans; Immunity; Inflammation","Soeiro Pereira","Paulo V","Department of Pathology, Universidade Federal do Maranhão, Maranhão, Brazil",NA
"457","34260778","10.1002/rmv.2199","Immunity and inflammatory biomarkers in COVID-19: A systematic review.","Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Patients can be asymptomatic or present respiratory and gastrointestinal symptoms, and even multiple-organ failure which can lead to death. The balance between an effective antiviral response and dysregulated immune response is the key factor determining the severity of COVID-19 progression. A systematic review was performed using the NCBI-PubMed database t","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; SARS-COV-2; cytokine; immune response; inflammatory response; Biomarkers; COVID-19; Humans; Immunity; Inflammation","Falcai","Angela","Laboratory of Environmental Microbiology, Universidade CEUMA, Maranhão, Brazil",NA
"458","34260778","10.1002/rmv.2199","Immunity and inflammatory biomarkers in COVID-19: A systematic review.","Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Patients can be asymptomatic or present respiratory and gastrointestinal symptoms, and even multiple-organ failure which can lead to death. The balance between an effective antiviral response and dysregulated immune response is the key factor determining the severity of COVID-19 progression. A systematic review was performed using the NCBI-PubMed database t","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; SARS-COV-2; cytokine; immune response; inflammatory response; Biomarkers; COVID-19; Humans; Immunity; Inflammation","Grumach","Anete Sevciovic","Clinical Immunology, Faculdade de Medicina do ABC, Brazil",NA
"459","34260778","10.1002/rmv.2199","Immunity and inflammatory biomarkers in COVID-19: A systematic review.","Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Patients can be asymptomatic or present respiratory and gastrointestinal symptoms, and even multiple-organ failure which can lead to death. The balance between an effective antiviral response and dysregulated immune response is the key factor determining the severity of COVID-19 progression. A systematic review was performed using the NCBI-PubMed database t","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; SARS-COV-2; cytokine; immune response; inflammatory response; Biomarkers; COVID-19; Humans; Immunity; Inflammation","Goudouris","Ekaterini","Pediatrics Department, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil",NA
"460","34260778","10.1002/rmv.2199","Immunity and inflammatory biomarkers in COVID-19: A systematic review.","Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Patients can be asymptomatic or present respiratory and gastrointestinal symptoms, and even multiple-organ failure which can lead to death. The balance between an effective antiviral response and dysregulated immune response is the key factor determining the severity of COVID-19 progression. A systematic review was performed using the NCBI-PubMed database t","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; SARS-COV-2; cytokine; immune response; inflammatory response; Biomarkers; COVID-19; Humans; Immunity; Inflammation","Neto","Antônio Condino","Department of Immunology, Biomecial Sciences Institute, Universidade de São Paulo, São Paulo, Brazil",NA
"461","34260778","10.1002/rmv.2199","Immunity and inflammatory biomarkers in COVID-19: A systematic review.","Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Patients can be asymptomatic or present respiratory and gastrointestinal symptoms, and even multiple-organ failure which can lead to death. The balance between an effective antiviral response and dysregulated immune response is the key factor determining the severity of COVID-19 progression. A systematic review was performed using the NCBI-PubMed database t","2021","07","23","Rev Med Virol","Reviews in medical virology","COVID-19; SARS-COV-2; cytokine; immune response; inflammatory response; Biomarkers; COVID-19; Humans; Immunity; Inflammation","Prando","Carolina","Genetics of Rare Diseases, Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba, Paraná, Brazil",NA
"462","34260777","10.1002/rmv.2200","Population-based prevalence surveys during the Covid-19 pandemic: A systematic review.","Population-based prevalence surveys of Covid-19 contribute to establish the burden of infection, the role of asymptomatic and mild infections in transmission, and allow more precise decisions about reopen policies. We performed a systematic review to evaluate qualitative aspects of these studies, assessing their reliability and compiling practices that can influence the methodological quality. We searched MEDLINE, EMBASE, bioRxiv and medRxiv, and included cross-sectional studies using molecular ","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; cross-sectional studies; epidemiology; infectious diseases; prevalence; severe acute respiratory syndrome coronavirus 2; COVID-19; COVID-19 Testing; Humans; Mass Screening; Population Surveillance; Prevalence","Franceschi","Vinícius Bonetti","Graduate Program in Cell and Molecular Biology (PPGBCM), Center of Biotechnology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil",NA
"463","34260777","10.1002/rmv.2200","Population-based prevalence surveys during the Covid-19 pandemic: A systematic review.","Population-based prevalence surveys of Covid-19 contribute to establish the burden of infection, the role of asymptomatic and mild infections in transmission, and allow more precise decisions about reopen policies. We performed a systematic review to evaluate qualitative aspects of these studies, assessing their reliability and compiling practices that can influence the methodological quality. We searched MEDLINE, EMBASE, bioRxiv and medRxiv, and included cross-sectional studies using molecular ","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; cross-sectional studies; epidemiology; infectious diseases; prevalence; severe acute respiratory syndrome coronavirus 2; COVID-19; COVID-19 Testing; Humans; Mass Screening; Population Surveillance; Prevalence","Santos","Andressa Schneiders","Undergraduate Program in Biomedicine, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Rio Grande do Sul, Brazil",NA
"464","34260777","10.1002/rmv.2200","Population-based prevalence surveys during the Covid-19 pandemic: A systematic review.","Population-based prevalence surveys of Covid-19 contribute to establish the burden of infection, the role of asymptomatic and mild infections in transmission, and allow more precise decisions about reopen policies. We performed a systematic review to evaluate qualitative aspects of these studies, assessing their reliability and compiling practices that can influence the methodological quality. We searched MEDLINE, EMBASE, bioRxiv and medRxiv, and included cross-sectional studies using molecular ","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; cross-sectional studies; epidemiology; infectious diseases; prevalence; severe acute respiratory syndrome coronavirus 2; COVID-19; COVID-19 Testing; Humans; Mass Screening; Population Surveillance; Prevalence","Glaeser","Andressa Barreto","Graduate Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Rio Grande do Sul, Brazil",NA
"465","34260777","10.1002/rmv.2200","Population-based prevalence surveys during the Covid-19 pandemic: A systematic review.","Population-based prevalence surveys of Covid-19 contribute to establish the burden of infection, the role of asymptomatic and mild infections in transmission, and allow more precise decisions about reopen policies. We performed a systematic review to evaluate qualitative aspects of these studies, assessing their reliability and compiling practices that can influence the methodological quality. We searched MEDLINE, EMBASE, bioRxiv and medRxiv, and included cross-sectional studies using molecular ","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; cross-sectional studies; epidemiology; infectious diseases; prevalence; severe acute respiratory syndrome coronavirus 2; COVID-19; COVID-19 Testing; Humans; Mass Screening; Population Surveillance; Prevalence","Paiz","Janini Cristina","Graduate Program in Epidemiology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil",NA
"466","34260777","10.1002/rmv.2200","Population-based prevalence surveys during the Covid-19 pandemic: A systematic review.","Population-based prevalence surveys of Covid-19 contribute to establish the burden of infection, the role of asymptomatic and mild infections in transmission, and allow more precise decisions about reopen policies. We performed a systematic review to evaluate qualitative aspects of these studies, assessing their reliability and compiling practices that can influence the methodological quality. We searched MEDLINE, EMBASE, bioRxiv and medRxiv, and included cross-sectional studies using molecular ","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; cross-sectional studies; epidemiology; infectious diseases; prevalence; severe acute respiratory syndrome coronavirus 2; COVID-19; COVID-19 Testing; Humans; Mass Screening; Population Surveillance; Prevalence","Caldana","Gabriel Dickin","Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Rio Grande do Sul, Brazil",NA
"467","34260777","10.1002/rmv.2200","Population-based prevalence surveys during the Covid-19 pandemic: A systematic review.","Population-based prevalence surveys of Covid-19 contribute to establish the burden of infection, the role of asymptomatic and mild infections in transmission, and allow more precise decisions about reopen policies. We performed a systematic review to evaluate qualitative aspects of these studies, assessing their reliability and compiling practices that can influence the methodological quality. We searched MEDLINE, EMBASE, bioRxiv and medRxiv, and included cross-sectional studies using molecular ","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; cross-sectional studies; epidemiology; infectious diseases; prevalence; severe acute respiratory syndrome coronavirus 2; COVID-19; COVID-19 Testing; Humans; Mass Screening; Population Surveillance; Prevalence","Machado Lessa","Carem Luana","Graduate Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Rio Grande do Sul, Brazil",NA
"468","34260777","10.1002/rmv.2200","Population-based prevalence surveys during the Covid-19 pandemic: A systematic review.","Population-based prevalence surveys of Covid-19 contribute to establish the burden of infection, the role of asymptomatic and mild infections in transmission, and allow more precise decisions about reopen policies. We performed a systematic review to evaluate qualitative aspects of these studies, assessing their reliability and compiling practices that can influence the methodological quality. We searched MEDLINE, EMBASE, bioRxiv and medRxiv, and included cross-sectional studies using molecular ","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; cross-sectional studies; epidemiology; infectious diseases; prevalence; severe acute respiratory syndrome coronavirus 2; COVID-19; COVID-19 Testing; Humans; Mass Screening; Population Surveillance; Prevalence","de Menezes Mayer","Amanda","Graduate Program in Cell and Molecular Biology (PPGBCM), Center of Biotechnology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil",NA
"469","34260777","10.1002/rmv.2200","Population-based prevalence surveys during the Covid-19 pandemic: A systematic review.","Population-based prevalence surveys of Covid-19 contribute to establish the burden of infection, the role of asymptomatic and mild infections in transmission, and allow more precise decisions about reopen policies. We performed a systematic review to evaluate qualitative aspects of these studies, assessing their reliability and compiling practices that can influence the methodological quality. We searched MEDLINE, EMBASE, bioRxiv and medRxiv, and included cross-sectional studies using molecular ","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; cross-sectional studies; epidemiology; infectious diseases; prevalence; severe acute respiratory syndrome coronavirus 2; COVID-19; COVID-19 Testing; Humans; Mass Screening; Population Surveillance; Prevalence","Küchle","Julia Gonçalves","Undergraduate Program in Biomedical Informatics, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Rio Grande do Sul, Brazil",NA
"470","34260777","10.1002/rmv.2200","Population-based prevalence surveys during the Covid-19 pandemic: A systematic review.","Population-based prevalence surveys of Covid-19 contribute to establish the burden of infection, the role of asymptomatic and mild infections in transmission, and allow more precise decisions about reopen policies. We performed a systematic review to evaluate qualitative aspects of these studies, assessing their reliability and compiling practices that can influence the methodological quality. We searched MEDLINE, EMBASE, bioRxiv and medRxiv, and included cross-sectional studies using molecular ","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; cross-sectional studies; epidemiology; infectious diseases; prevalence; severe acute respiratory syndrome coronavirus 2; COVID-19; COVID-19 Testing; Humans; Mass Screening; Population Surveillance; Prevalence","Gazzola Zen","Paulo Ricardo","Graduate Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Rio Grande do Sul, Brazil",NA
"471","34260777","10.1002/rmv.2200","Population-based prevalence surveys during the Covid-19 pandemic: A systematic review.","Population-based prevalence surveys of Covid-19 contribute to establish the burden of infection, the role of asymptomatic and mild infections in transmission, and allow more precise decisions about reopen policies. We performed a systematic review to evaluate qualitative aspects of these studies, assessing their reliability and compiling practices that can influence the methodological quality. We searched MEDLINE, EMBASE, bioRxiv and medRxiv, and included cross-sectional studies using molecular ","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; cross-sectional studies; epidemiology; infectious diseases; prevalence; severe acute respiratory syndrome coronavirus 2; COVID-19; COVID-19 Testing; Humans; Mass Screening; Population Surveillance; Prevalence","Vigo","Alvaro","Graduate Program in Epidemiology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil",NA
"472","34260777","10.1002/rmv.2200","Population-based prevalence surveys during the Covid-19 pandemic: A systematic review.","Population-based prevalence surveys of Covid-19 contribute to establish the burden of infection, the role of asymptomatic and mild infections in transmission, and allow more precise decisions about reopen policies. We performed a systematic review to evaluate qualitative aspects of these studies, assessing their reliability and compiling practices that can influence the methodological quality. We searched MEDLINE, EMBASE, bioRxiv and medRxiv, and included cross-sectional studies using molecular ","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; cross-sectional studies; epidemiology; infectious diseases; prevalence; severe acute respiratory syndrome coronavirus 2; COVID-19; COVID-19 Testing; Humans; Mass Screening; Population Surveillance; Prevalence","Winck","Ana Trindade","Department of Exact and Social Applied Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Rio Grande do Sul, Brazil",NA
"473","34260777","10.1002/rmv.2200","Population-based prevalence surveys during the Covid-19 pandemic: A systematic review.","Population-based prevalence surveys of Covid-19 contribute to establish the burden of infection, the role of asymptomatic and mild infections in transmission, and allow more precise decisions about reopen policies. We performed a systematic review to evaluate qualitative aspects of these studies, assessing their reliability and compiling practices that can influence the methodological quality. We searched MEDLINE, EMBASE, bioRxiv and medRxiv, and included cross-sectional studies using molecular ","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; cross-sectional studies; epidemiology; infectious diseases; prevalence; severe acute respiratory syndrome coronavirus 2; COVID-19; COVID-19 Testing; Humans; Mass Screening; Population Surveillance; Prevalence","Rotta","Liane Nanci","Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Rio Grande do Sul, Brazil",NA
"474","34260777","10.1002/rmv.2200","Population-based prevalence surveys during the Covid-19 pandemic: A systematic review.","Population-based prevalence surveys of Covid-19 contribute to establish the burden of infection, the role of asymptomatic and mild infections in transmission, and allow more precise decisions about reopen policies. We performed a systematic review to evaluate qualitative aspects of these studies, assessing their reliability and compiling practices that can influence the methodological quality. We searched MEDLINE, EMBASE, bioRxiv and medRxiv, and included cross-sectional studies using molecular ","2021","07","23","Rev Med Virol","Reviews in medical virology","Covid-19; SARS-CoV-2; cross-sectional studies; epidemiology; infectious diseases; prevalence; severe acute respiratory syndrome coronavirus 2; COVID-19; COVID-19 Testing; Humans; Mass Screening; Population Surveillance; Prevalence","Thompson","Claudia Elizabeth","Graduate Program in Cell and Molecular Biology (PPGBCM), Center of Biotechnology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil",NA
"475","34260773","10.1002/rmv.2278","The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis.","Parkinson's disease (PD) patients who contracted Coronavirus disease 2019 (Covid-19) had a decline in motor functions; nevertheless, there is limited evidence on whether PD patients have a higher risk for contracting Covid-19 or have worse outcomes. This is the first systematic review and meta-analysis to review the impact of PD on the prognosis of Covid-19 patients. We performed a systematic search through seven electronic databases under the recommendations of the Preferred Reporting Items for","2021","07","14","Rev Med Virol","Reviews in medical virology","Covid-19; MLS; Parkinson's disease; SARS-CoV-2; length of stay; mortality","El-Qushayri","Amr Ehab","Faculty of Medicine, Minia University, Minia, Egypt",NA
"476","34260773","10.1002/rmv.2278","The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis.","Parkinson's disease (PD) patients who contracted Coronavirus disease 2019 (Covid-19) had a decline in motor functions; nevertheless, there is limited evidence on whether PD patients have a higher risk for contracting Covid-19 or have worse outcomes. This is the first systematic review and meta-analysis to review the impact of PD on the prognosis of Covid-19 patients. We performed a systematic search through seven electronic databases under the recommendations of the Preferred Reporting Items for","2021","07","14","Rev Med Virol","Reviews in medical virology","Covid-19; MLS; Parkinson's disease; SARS-CoV-2; length of stay; mortality","Ghozy","Sherief","Faculty of Medicine, Mansoura University, Mansoura, Egypt",NA
"477","34260773","10.1002/rmv.2278","The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis.","Parkinson's disease (PD) patients who contracted Coronavirus disease 2019 (Covid-19) had a decline in motor functions; nevertheless, there is limited evidence on whether PD patients have a higher risk for contracting Covid-19 or have worse outcomes. This is the first systematic review and meta-analysis to review the impact of PD on the prognosis of Covid-19 patients. We performed a systematic search through seven electronic databases under the recommendations of the Preferred Reporting Items for","2021","07","14","Rev Med Virol","Reviews in medical virology","Covid-19; MLS; Parkinson's disease; SARS-CoV-2; length of stay; mortality","Reda","Abdullah","Faculty of Medicine, Al-Azhar University, Cairo, Egypt",NA
"478","34260773","10.1002/rmv.2278","The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis.","Parkinson's disease (PD) patients who contracted Coronavirus disease 2019 (Covid-19) had a decline in motor functions; nevertheless, there is limited evidence on whether PD patients have a higher risk for contracting Covid-19 or have worse outcomes. This is the first systematic review and meta-analysis to review the impact of PD on the prognosis of Covid-19 patients. We performed a systematic search through seven electronic databases under the recommendations of the Preferred Reporting Items for","2021","07","14","Rev Med Virol","Reviews in medical virology","Covid-19; MLS; Parkinson's disease; SARS-CoV-2; length of stay; mortality","Kamel","Ahmed Mostafa Ahmed","Faculty of Pharmacy, Minia University, Minia, Egypt",NA
"479","34260773","10.1002/rmv.2278","The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis.","Parkinson's disease (PD) patients who contracted Coronavirus disease 2019 (Covid-19) had a decline in motor functions; nevertheless, there is limited evidence on whether PD patients have a higher risk for contracting Covid-19 or have worse outcomes. This is the first systematic review and meta-analysis to review the impact of PD on the prognosis of Covid-19 patients. We performed a systematic search through seven electronic databases under the recommendations of the Preferred Reporting Items for","2021","07","14","Rev Med Virol","Reviews in medical virology","Covid-19; MLS; Parkinson's disease; SARS-CoV-2; length of stay; mortality","Abbas","Alzhraa Salah","Faculty of Medicine, Minia University, Minia, Egypt",NA
"480","34260773","10.1002/rmv.2278","The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis.","Parkinson's disease (PD) patients who contracted Coronavirus disease 2019 (Covid-19) had a decline in motor functions; nevertheless, there is limited evidence on whether PD patients have a higher risk for contracting Covid-19 or have worse outcomes. This is the first systematic review and meta-analysis to review the impact of PD on the prognosis of Covid-19 patients. We performed a systematic search through seven electronic databases under the recommendations of the Preferred Reporting Items for","2021","07","14","Rev Med Virol","Reviews in medical virology","Covid-19; MLS; Parkinson's disease; SARS-CoV-2; length of stay; mortality","Dmytriw","Adam A","Neuroradiology and Neurointervention Service, Brigham and Women's Hospital, Boston, Massachusetts, USA",NA
"481","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Koch","Erica","Department of Hematology and Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile",NA
"482","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Villanueva","Francisco","Department of Hematology and Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile",NA
"483","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Marchetti","Michael A","Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA",NA
"484","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Abarzúa","Álvaro","Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile",NA
"485","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Cárdenas","Consuelo","Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile",NA
"486","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Castro","Juan Camilo","Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile",NA
"487","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Dominguez","Francisco","Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile",NA
"488","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Droppelmann","Katherine","Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile",NA
"489","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Droppelmann","Nicolás","Department of Surgery, Clinica Universidad de Los Andes, Santiago, Chile",NA
"490","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Galindo","Héctor","Department of Hematology and Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile",NA
"491","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","León","Augusto","Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile",NA
"492","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Madrid","Jorge","Department of Hematology and Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile",NA
"493","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Molgó","Montserrat","Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile",NA
"494","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Mondaca","Sebastián","Department of Hematology and Oncology, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile",NA
"495","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Montero","Pablo","Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile",NA
"496","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Uribe","Pablo","Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile",NA
"497","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Villaseca","Miguel A","Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile",NA
"498","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Vinés","Eugenio","Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile",NA
"499","34260770","10.1111/jdv.17522","Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study.","Early detection of melanoma is an important intervention to reduce morbidity and mortality.<sup>1, 2</sup> The COVID-19 pandemic has affected timely access to healthcare, potentially affecting patient outcomes. Marson et al. showed that the incidence of melanoma decreased during the pandemic using United States data.<sup>3</sup> Lallas et al. demonstrated an overall 30.1% decrease in cancers diagnosed during the pandemic in Greece.<sup>4</sup> We sought to evaluate whether melanomas diagnosed du","2021","07","14","J Eur Acad Dermatol Venereol","Journal of the European Academy of Dermatology and Venereology : JEADV","Breslow thickness; COVID-19; diagnosis; melanoma; pandemic; skin cancer; stage","Navarrete-Dechent","Cristian","Melanoma and Skin Cancer Unit, Escuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile",NA
"500","34260764","10.1002/jcla.23911","Low serum level of apolipoprotein A1 may predict the severity of COVID-19: A retrospective study.","Dyslipidemia has been observed in patients with coronavirus disease 2019 (COVID-19). This study aimed to investigate blood lipid profiles in patients with COVID-19 and to explore their predictive values for COVID-19 severity. A total of 142 consecutive patients with COVID-19 were included in this single-center retrospective study. Blood lipid profile characteristics were investigated in patients with COVID-19 in comparison with 77 age- and gender-matched healthy subjects, their predictive values","2021","07","14","J Clin Lab Anal","Journal of clinical laboratory analysis","ApoA1; COVID-19; SARS-CoV-2; blood lipid; disease severity","Zhu","Zhe","Department of Blood Transfusion, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo, China",NA
"501","34260764","10.1002/jcla.23911","Low serum level of apolipoprotein A1 may predict the severity of COVID-19: A retrospective study.","Dyslipidemia has been observed in patients with coronavirus disease 2019 (COVID-19). This study aimed to investigate blood lipid profiles in patients with COVID-19 and to explore their predictive values for COVID-19 severity. A total of 142 consecutive patients with COVID-19 were included in this single-center retrospective study. Blood lipid profile characteristics were investigated in patients with COVID-19 in comparison with 77 age- and gender-matched healthy subjects, their predictive values","2021","07","14","J Clin Lab Anal","Journal of clinical laboratory analysis","ApoA1; COVID-19; SARS-CoV-2; blood lipid; disease severity","Yang","Yayun","Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, China",NA
"502","34260764","10.1002/jcla.23911","Low serum level of apolipoprotein A1 may predict the severity of COVID-19: A retrospective study.","Dyslipidemia has been observed in patients with coronavirus disease 2019 (COVID-19). This study aimed to investigate blood lipid profiles in patients with COVID-19 and to explore their predictive values for COVID-19 severity. A total of 142 consecutive patients with COVID-19 were included in this single-center retrospective study. Blood lipid profile characteristics were investigated in patients with COVID-19 in comparison with 77 age- and gender-matched healthy subjects, their predictive values","2021","07","14","J Clin Lab Anal","Journal of clinical laboratory analysis","ApoA1; COVID-19; SARS-CoV-2; blood lipid; disease severity","Fan","Lingyan","Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, China",NA
"503","34260764","10.1002/jcla.23911","Low serum level of apolipoprotein A1 may predict the severity of COVID-19: A retrospective study.","Dyslipidemia has been observed in patients with coronavirus disease 2019 (COVID-19). This study aimed to investigate blood lipid profiles in patients with COVID-19 and to explore their predictive values for COVID-19 severity. A total of 142 consecutive patients with COVID-19 were included in this single-center retrospective study. Blood lipid profile characteristics were investigated in patients with COVID-19 in comparison with 77 age- and gender-matched healthy subjects, their predictive values","2021","07","14","J Clin Lab Anal","Journal of clinical laboratory analysis","ApoA1; COVID-19; SARS-CoV-2; blood lipid; disease severity","Ye","Shuyuan","Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, China",NA
"504","34260764","10.1002/jcla.23911","Low serum level of apolipoprotein A1 may predict the severity of COVID-19: A retrospective study.","Dyslipidemia has been observed in patients with coronavirus disease 2019 (COVID-19). This study aimed to investigate blood lipid profiles in patients with COVID-19 and to explore their predictive values for COVID-19 severity. A total of 142 consecutive patients with COVID-19 were included in this single-center retrospective study. Blood lipid profile characteristics were investigated in patients with COVID-19 in comparison with 77 age- and gender-matched healthy subjects, their predictive values","2021","07","14","J Clin Lab Anal","Journal of clinical laboratory analysis","ApoA1; COVID-19; SARS-CoV-2; blood lipid; disease severity","Lou","Kehong","Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, China",NA
"505","34260764","10.1002/jcla.23911","Low serum level of apolipoprotein A1 may predict the severity of COVID-19: A retrospective study.","Dyslipidemia has been observed in patients with coronavirus disease 2019 (COVID-19). This study aimed to investigate blood lipid profiles in patients with COVID-19 and to explore their predictive values for COVID-19 severity. A total of 142 consecutive patients with COVID-19 were included in this single-center retrospective study. Blood lipid profile characteristics were investigated in patients with COVID-19 in comparison with 77 age- and gender-matched healthy subjects, their predictive values","2021","07","14","J Clin Lab Anal","Journal of clinical laboratory analysis","ApoA1; COVID-19; SARS-CoV-2; blood lipid; disease severity","Hua","Xin","Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, China",NA
"506","34260764","10.1002/jcla.23911","Low serum level of apolipoprotein A1 may predict the severity of COVID-19: A retrospective study.","Dyslipidemia has been observed in patients with coronavirus disease 2019 (COVID-19). This study aimed to investigate blood lipid profiles in patients with COVID-19 and to explore their predictive values for COVID-19 severity. A total of 142 consecutive patients with COVID-19 were included in this single-center retrospective study. Blood lipid profile characteristics were investigated in patients with COVID-19 in comparison with 77 age- and gender-matched healthy subjects, their predictive values","2021","07","14","J Clin Lab Anal","Journal of clinical laboratory analysis","ApoA1; COVID-19; SARS-CoV-2; blood lipid; disease severity","Huang","Zuoan","Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, China",NA
"507","34260764","10.1002/jcla.23911","Low serum level of apolipoprotein A1 may predict the severity of COVID-19: A retrospective study.","Dyslipidemia has been observed in patients with coronavirus disease 2019 (COVID-19). This study aimed to investigate blood lipid profiles in patients with COVID-19 and to explore their predictive values for COVID-19 severity. A total of 142 consecutive patients with COVID-19 were included in this single-center retrospective study. Blood lipid profile characteristics were investigated in patients with COVID-19 in comparison with 77 age- and gender-matched healthy subjects, their predictive values","2021","07","14","J Clin Lab Anal","Journal of clinical laboratory analysis","ApoA1; COVID-19; SARS-CoV-2; blood lipid; disease severity","Shi","Qiaoyun","Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, China",NA
"508","34260764","10.1002/jcla.23911","Low serum level of apolipoprotein A1 may predict the severity of COVID-19: A retrospective study.","Dyslipidemia has been observed in patients with coronavirus disease 2019 (COVID-19). This study aimed to investigate blood lipid profiles in patients with COVID-19 and to explore their predictive values for COVID-19 severity. A total of 142 consecutive patients with COVID-19 were included in this single-center retrospective study. Blood lipid profile characteristics were investigated in patients with COVID-19 in comparison with 77 age- and gender-matched healthy subjects, their predictive values","2021","07","14","J Clin Lab Anal","Journal of clinical laboratory analysis","ApoA1; COVID-19; SARS-CoV-2; blood lipid; disease severity","Gao","Guosheng","Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, China",NA
"509","34260761","10.1002/jmv.27213","The association between biochemically confirmed thyroid gland disorder and morbidity and mortality in patients with COVID-19.",NA,"2021","07","19","J Med Virol","Journal of medical virology",NA,"Abobaker","Anis","York Teaching Hospital NHS Foundation trust, Scarborough, UK",NA
"510","34260761","10.1002/jmv.27213","The association between biochemically confirmed thyroid gland disorder and morbidity and mortality in patients with COVID-19.",NA,"2021","07","19","J Med Virol","Journal of medical virology",NA,"Darrat","Milad","Regional Centre For Diabetes and Endocrinology, Royal Victoria Hospital, Belfast, UK",NA
"511","34260751","10.1002/jcop.22668","The mediating role of psychological distress on the link between socio-ecological factors and quality of life of Filipino adults during COVID-19 crisis.","Anchored on the Ecological Systems Theory, this study aimed to determine how psychological distress operates as an underlying mechanism in the impact of socio-ecological factors on the quality of life of Filipino adults during coronavirus disease 2019 (COVID-19) crisis. A cross-sectional online survey was conducted to assess perceptions of 401 adults on socio-ecological factors (i.e., safety at home, trust in public institutions, and financial difficulties), psychological distress, and quality o","2021","07","14","J Community Psychol","Journal of community psychology","COVID-19; Philippines; psychological distress; quality of life; socio-ecological factors","Aruta","John Jamir Benzon R","Counseling and Educational Psychology Department, Br. Andrew Gonzalez FSC College of Education, De La Salle University, Manila, Philippines",NA
"512","34260751","10.1002/jcop.22668","The mediating role of psychological distress on the link between socio-ecological factors and quality of life of Filipino adults during COVID-19 crisis.","Anchored on the Ecological Systems Theory, this study aimed to determine how psychological distress operates as an underlying mechanism in the impact of socio-ecological factors on the quality of life of Filipino adults during coronavirus disease 2019 (COVID-19) crisis. A cross-sectional online survey was conducted to assess perceptions of 401 adults on socio-ecological factors (i.e., safety at home, trust in public institutions, and financial difficulties), psychological distress, and quality o","2021","07","14","J Community Psychol","Journal of community psychology","COVID-19; Philippines; psychological distress; quality of life; socio-ecological factors","Callueng","Carmelo","School Psychology Program, Rowan University, Glassboro, New Jersey, USA",NA
"513","34260751","10.1002/jcop.22668","The mediating role of psychological distress on the link between socio-ecological factors and quality of life of Filipino adults during COVID-19 crisis.","Anchored on the Ecological Systems Theory, this study aimed to determine how psychological distress operates as an underlying mechanism in the impact of socio-ecological factors on the quality of life of Filipino adults during coronavirus disease 2019 (COVID-19) crisis. A cross-sectional online survey was conducted to assess perceptions of 401 adults on socio-ecological factors (i.e., safety at home, trust in public institutions, and financial difficulties), psychological distress, and quality o","2021","07","14","J Community Psychol","Journal of community psychology","COVID-19; Philippines; psychological distress; quality of life; socio-ecological factors","Antazo","Benedict G","Department of Psychology, Jose Rizal University, Mandaluyong City, National Capital Region, Philippines",NA
"514","34260751","10.1002/jcop.22668","The mediating role of psychological distress on the link between socio-ecological factors and quality of life of Filipino adults during COVID-19 crisis.","Anchored on the Ecological Systems Theory, this study aimed to determine how psychological distress operates as an underlying mechanism in the impact of socio-ecological factors on the quality of life of Filipino adults during coronavirus disease 2019 (COVID-19) crisis. A cross-sectional online survey was conducted to assess perceptions of 401 adults on socio-ecological factors (i.e., safety at home, trust in public institutions, and financial difficulties), psychological distress, and quality o","2021","07","14","J Community Psychol","Journal of community psychology","COVID-19; Philippines; psychological distress; quality of life; socio-ecological factors","Ballada","Christine Joy A","Counseling and Educational Psychology Department, Br. Andrew Gonzalez FSC College of Education, De La Salle University, Manila, Philippines",NA
"515","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Schüffler","Peter J","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"516","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Geneslaw","Luke","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"517","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Yarlagadda","D Vijay K","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"518","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Hanna","Matthew G","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"519","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Samboy","Jennifer","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"520","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Stamelos","Evangelos","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"521","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Vanderbilt","Chad","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"522","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Philip","John","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"523","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Jean","Marc-Henri","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"524","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Corsale","Lorraine","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"525","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Manzo","Allyne","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"526","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Paramasivam","Neeraj H G","Department of Information Systems, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"527","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Ziegler","John S","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"528","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Gao","Jianjiong","Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"529","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Perin","Juan C","Department of Information Systems, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"530","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Kim","Young Suk","School of Medicine, Stanford University, Stanford, California, USA",NA
"531","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Bhanot","Umeshkumar K","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"532","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Roehrl","Michael H A","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"533","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Ardon","Orly","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"534","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Chiang","Sarah","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"535","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Giri","Dilip D","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"536","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Sigel","Carlie S","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"537","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Tan","Lee K","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"538","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Murray","Melissa","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"539","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Virgo","Christina","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"540","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","England","Christine","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"541","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Yagi","Yukako","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"542","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Sirintrapun","S Joseph","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"543","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Klimstra","David","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"544","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Hameed","Meera","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"545","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Reuter","Victor E","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"546","34260720","10.1093/jamia/ocab085","Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.","Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a cl","2021","07","14","J Am Med Inform Assoc","Journal of the American Medical Informatics Association : JAMIA","artificial intelligence; computational pathology; digital pathology; honest broker, pathology; whole slide imaging","Fuchs","Thomas J","Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA",NA
"547","34260717","10.1093/infdis/jiab368","SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.","The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that two key mutations seen in the receptor binding domain L452R and E484Q would have additive effects on evasion of neutralising antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R o","2021","07","14","J Infect Dis","The Journal of infectious diseases","B.1.617; COVID-19; Indian variant; SARS-CoV-2; antibody escape; evasion; fitness; infectivity; neutralising antibodies; resistance; spike mutation","Ferreira","Isabella","Cambridge Institute of Therapeutic Immunology &amp",NA
"548","34260717","10.1093/infdis/jiab368","SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.","The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that two key mutations seen in the receptor binding domain L452R and E484Q would have additive effects on evasion of neutralising antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R o","2021","07","14","J Infect Dis","The Journal of infectious diseases","B.1.617; COVID-19; Indian variant; SARS-CoV-2; antibody escape; evasion; fitness; infectivity; neutralising antibodies; resistance; spike mutation","Kemp","Steven","Cambridge Institute of Therapeutic Immunology &amp",NA
"549","34260717","10.1093/infdis/jiab368","SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.","The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that two key mutations seen in the receptor binding domain L452R and E484Q would have additive effects on evasion of neutralising antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R o","2021","07","14","J Infect Dis","The Journal of infectious diseases","B.1.617; COVID-19; Indian variant; SARS-CoV-2; antibody escape; evasion; fitness; infectivity; neutralising antibodies; resistance; spike mutation","Datir","Rawlings","Cambridge Institute of Therapeutic Immunology &amp",NA
"550","34260717","10.1093/infdis/jiab368","SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.","The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that two key mutations seen in the receptor binding domain L452R and E484Q would have additive effects on evasion of neutralising antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R o","2021","07","14","J Infect Dis","The Journal of infectious diseases","B.1.617; COVID-19; Indian variant; SARS-CoV-2; antibody escape; evasion; fitness; infectivity; neutralising antibodies; resistance; spike mutation","Saito","Akatsuki","Department of Veterinary Medicine, Faculty of Agriculture, Graduate School of Medicine and Veterinary Medicine, Center for Animal Disease Control, University of Miyazaki, Miyazaki, Japan",NA
"551","34260717","10.1093/infdis/jiab368","SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.","The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that two key mutations seen in the receptor binding domain L452R and E484Q would have additive effects on evasion of neutralising antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R o","2021","07","14","J Infect Dis","The Journal of infectious diseases","B.1.617; COVID-19; Indian variant; SARS-CoV-2; antibody escape; evasion; fitness; infectivity; neutralising antibodies; resistance; spike mutation","Meng","Bo","Cambridge Institute of Therapeutic Immunology &amp",NA
"552","34260717","10.1093/infdis/jiab368","SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.","The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that two key mutations seen in the receptor binding domain L452R and E484Q would have additive effects on evasion of neutralising antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R o","2021","07","14","J Infect Dis","The Journal of infectious diseases","B.1.617; COVID-19; Indian variant; SARS-CoV-2; antibody escape; evasion; fitness; infectivity; neutralising antibodies; resistance; spike mutation","Rakshit","Partha","National Centre for Disease Control, Delhi, India",NA
"553","34260717","10.1093/infdis/jiab368","SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.","The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that two key mutations seen in the receptor binding domain L452R and E484Q would have additive effects on evasion of neutralising antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R o","2021","07","14","J Infect Dis","The Journal of infectious diseases","B.1.617; COVID-19; Indian variant; SARS-CoV-2; antibody escape; evasion; fitness; infectivity; neutralising antibodies; resistance; spike mutation","Takaori-Kondo","Akifumi","Department of Hematology and Oncology, Kyoto University, Kyoto, Japan",NA
"554","34260717","10.1093/infdis/jiab368","SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.","The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that two key mutations seen in the receptor binding domain L452R and E484Q would have additive effects on evasion of neutralising antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R o","2021","07","14","J Infect Dis","The Journal of infectious diseases","B.1.617; COVID-19; Indian variant; SARS-CoV-2; antibody escape; evasion; fitness; infectivity; neutralising antibodies; resistance; spike mutation","Kosugi","Yusuke","Division of Systems Virology, Institute of Medical Science, University of Tokyo, Japan",NA
"555","34260717","10.1093/infdis/jiab368","SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.","The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that two key mutations seen in the receptor binding domain L452R and E484Q would have additive effects on evasion of neutralising antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R o","2021","07","14","J Infect Dis","The Journal of infectious diseases","B.1.617; COVID-19; Indian variant; SARS-CoV-2; antibody escape; evasion; fitness; infectivity; neutralising antibodies; resistance; spike mutation","Uriu","Keiya","Division of Systems Virology, Institute of Medical Science, University of Tokyo, Japan",NA
"556","34260717","10.1093/infdis/jiab368","SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.","The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that two key mutations seen in the receptor binding domain L452R and E484Q would have additive effects on evasion of neutralising antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R o","2021","07","14","J Infect Dis","The Journal of infectious diseases","B.1.617; COVID-19; Indian variant; SARS-CoV-2; antibody escape; evasion; fitness; infectivity; neutralising antibodies; resistance; spike mutation","Kimura","Izumi","Division of Systems Virology, Institute of Medical Science, University of Tokyo, Japan",NA
"557","34260717","10.1093/infdis/jiab368","SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.","The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that two key mutations seen in the receptor binding domain L452R and E484Q would have additive effects on evasion of neutralising antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R o","2021","07","14","J Infect Dis","The Journal of infectious diseases","B.1.617; COVID-19; Indian variant; SARS-CoV-2; antibody escape; evasion; fitness; infectivity; neutralising antibodies; resistance; spike mutation","Shirakawa","Kotaro","Division of Systems Virology, Institute of Medical Science, University of Tokyo, Japan",NA
"558","34260717","10.1093/infdis/jiab368","SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.","The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that two key mutations seen in the receptor binding domain L452R and E484Q would have additive effects on evasion of neutralising antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R o","2021","07","14","J Infect Dis","The Journal of infectious diseases","B.1.617; COVID-19; Indian variant; SARS-CoV-2; antibody escape; evasion; fitness; infectivity; neutralising antibodies; resistance; spike mutation","Abdullahi","Adam","Cambridge Institute of Therapeutic Immunology &amp",NA
"559","34260717","10.1093/infdis/jiab368","SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.","The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that two key mutations seen in the receptor binding domain L452R and E484Q would have additive effects on evasion of neutralising antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R o","2021","07","14","J Infect Dis","The Journal of infectious diseases","B.1.617; COVID-19; Indian variant; SARS-CoV-2; antibody escape; evasion; fitness; infectivity; neutralising antibodies; resistance; spike mutation","Agarwal","Anurag","CSIR Institute of Genomics and Integrative Biology, Delhi, India",NA
"560","34260717","10.1093/infdis/jiab368","SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.","The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that two key mutations seen in the receptor binding domain L452R and E484Q would have additive effects on evasion of neutralising antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R o","2021","07","14","J Infect Dis","The Journal of infectious diseases","B.1.617; COVID-19; Indian variant; SARS-CoV-2; antibody escape; evasion; fitness; infectivity; neutralising antibodies; resistance; spike mutation","Ozono","Seiya","Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan",NA
"561","34260717","10.1093/infdis/jiab368","SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.","The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that two key mutations seen in the receptor binding domain L452R and E484Q would have additive effects on evasion of neutralising antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R o","2021","07","14","J Infect Dis","The Journal of infectious diseases","B.1.617; COVID-19; Indian variant; SARS-CoV-2; antibody escape; evasion; fitness; infectivity; neutralising antibodies; resistance; spike mutation","Tokunaga","Kenzo","Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan",NA
"562","34260717","10.1093/infdis/jiab368","SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.","The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that two key mutations seen in the receptor binding domain L452R and E484Q would have additive effects on evasion of neutralising antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R o","2021","07","14","J Infect Dis","The Journal of infectious diseases","B.1.617; COVID-19; Indian variant; SARS-CoV-2; antibody escape; evasion; fitness; infectivity; neutralising antibodies; resistance; spike mutation","Sato","Kei","Division of Systems Virology, Institute of Medical Science, University of Tokyo, Japan",NA
"563","34260717","10.1093/infdis/jiab368","SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion.","The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020. There have been fears that two key mutations seen in the receptor binding domain L452R and E484Q would have additive effects on evasion of neutralising antibodies. We report that spike bearing L452R and E484Q confers modestly reduced sensitivity to BNT162b2 mRNA vaccine-elicited antibodies following either first or second dose. The effect is similar in magnitude to the loss of sensitivity conferred by L452R o","2021","07","14","J Infect Dis","The Journal of infectious diseases","B.1.617; COVID-19; Indian variant; SARS-CoV-2; antibody escape; evasion; fitness; infectivity; neutralising antibodies; resistance; spike mutation","Gupta","Ravindra K","Cambridge Institute of Therapeutic Immunology &amp",NA
"564","34260716","10.1093/cid/ciab630","Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection.","Although interim results from several large placebo-controlled phase 3 trials demonstrated high vaccine efficacy (VE) against symptomatic COVID-19, it is unknown how effective the vaccines are in preventing people from becoming asymptomatically in- fected and potentially spreading the virus unwittingly. It is more difficult to evaluate VE against SARS-CoV-2 infection than against symptomatic COVID-19 because infection is not observed directly but rather is known to occur between two antibody or ","2021","07","20","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","RT-PCR; asymptomatic infection; seroconversion; symptomatic COVID-19; viral RNA; waning efficacy","Lin","Dan-Yu","Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA",NA
"565","34260716","10.1093/cid/ciab630","Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection.","Although interim results from several large placebo-controlled phase 3 trials demonstrated high vaccine efficacy (VE) against symptomatic COVID-19, it is unknown how effective the vaccines are in preventing people from becoming asymptomatically in- fected and potentially spreading the virus unwittingly. It is more difficult to evaluate VE against SARS-CoV-2 infection than against symptomatic COVID-19 because infection is not observed directly but rather is known to occur between two antibody or ","2021","07","20","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","RT-PCR; asymptomatic infection; seroconversion; symptomatic COVID-19; viral RNA; waning efficacy","Gu","Yu","Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA",NA
"566","34260716","10.1093/cid/ciab630","Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection.","Although interim results from several large placebo-controlled phase 3 trials demonstrated high vaccine efficacy (VE) against symptomatic COVID-19, it is unknown how effective the vaccines are in preventing people from becoming asymptomatically in- fected and potentially spreading the virus unwittingly. It is more difficult to evaluate VE against SARS-CoV-2 infection than against symptomatic COVID-19 because infection is not observed directly but rather is known to occur between two antibody or ","2021","07","20","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","RT-PCR; asymptomatic infection; seroconversion; symptomatic COVID-19; viral RNA; waning efficacy","Zeng","Donglin","Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA",NA
"567","34260716","10.1093/cid/ciab630","Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection.","Although interim results from several large placebo-controlled phase 3 trials demonstrated high vaccine efficacy (VE) against symptomatic COVID-19, it is unknown how effective the vaccines are in preventing people from becoming asymptomatically in- fected and potentially spreading the virus unwittingly. It is more difficult to evaluate VE against SARS-CoV-2 infection than against symptomatic COVID-19 because infection is not observed directly but rather is known to occur between two antibody or ","2021","07","20","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","RT-PCR; asymptomatic infection; seroconversion; symptomatic COVID-19; viral RNA; waning efficacy","Janes","Holly E","Vaccine and Infectious Disease Division, Fred Hutch, Seattle, Washington, USA",NA
"568","34260716","10.1093/cid/ciab630","Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection.","Although interim results from several large placebo-controlled phase 3 trials demonstrated high vaccine efficacy (VE) against symptomatic COVID-19, it is unknown how effective the vaccines are in preventing people from becoming asymptomatically in- fected and potentially spreading the virus unwittingly. It is more difficult to evaluate VE against SARS-CoV-2 infection than against symptomatic COVID-19 because infection is not observed directly but rather is known to occur between two antibody or ","2021","07","20","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","RT-PCR; asymptomatic infection; seroconversion; symptomatic COVID-19; viral RNA; waning efficacy","Gilbert","Peter B","Vaccine and Infectious Disease Division, Fred Hutch, Seattle, Washington, USA",NA
"569","34260714","10.1182/blood.2020008243","Is it time for PET-guided therapy in follicular lymphoma.","18F-fluorodeoxyglucose (FDG) Positron Emission Tomography-Computerised Tomography (PET) is now established as the gold-standard imaging modality for both staging and response assessment of follicular lymphoma (FL). In this Perspective, we propose where PET can, and cannot, guide clinicians in their therapeutic approach. PET at diagnosis/pre-treatment is important for staging, with greater sensitivity compared to standard CT and consequent improved outcomes in truly limited stage FL. Small datase","2021","07","14","Blood","Blood",NA,"Trotman","Judith","Concord Repatriation General Hospital and University of Sydney, Concord, Australia",NA
"570","34260714","10.1182/blood.2020008243","Is it time for PET-guided therapy in follicular lymphoma.","18F-fluorodeoxyglucose (FDG) Positron Emission Tomography-Computerised Tomography (PET) is now established as the gold-standard imaging modality for both staging and response assessment of follicular lymphoma (FL). In this Perspective, we propose where PET can, and cannot, guide clinicians in their therapeutic approach. PET at diagnosis/pre-treatment is important for staging, with greater sensitivity compared to standard CT and consequent improved outcomes in truly limited stage FL. Small datase","2021","07","14","Blood","Blood",NA,"Pettitt","Andrew R","University of Liverpool, Liverpool, United Kingdom",NA
"571","34260692","10.1093/ajhp/zxab288","Evaluation of discharge prescribing after rescheduling of gabapentin as a controlled substance.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Gabapentin has increasingly been ","2021","07","14","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","controlled substances; gabapentin; opioid; substance-related disorders","Robbins","Melody J","Department of Pharmacy, Sentara Norfolk General Hospital, Norfolk, VA, USA",NA
"572","34260692","10.1093/ajhp/zxab288","Evaluation of discharge prescribing after rescheduling of gabapentin as a controlled substance.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Gabapentin has increasingly been ","2021","07","14","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","controlled substances; gabapentin; opioid; substance-related disorders","Floroff","Catherine","Department of Pharmacy, Sentara Norfolk General Hospital, Norfolk, VA, USA",NA
"573","34260692","10.1093/ajhp/zxab288","Evaluation of discharge prescribing after rescheduling of gabapentin as a controlled substance.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Gabapentin has increasingly been ","2021","07","14","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","controlled substances; gabapentin; opioid; substance-related disorders","Ingemi","Amanda","Department of Pharmacy, Sentara Norfolk General Hospital, Norfolk, VA, USA",NA
"574","34260692","10.1093/ajhp/zxab288","Evaluation of discharge prescribing after rescheduling of gabapentin as a controlled substance.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Gabapentin has increasingly been ","2021","07","14","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","controlled substances; gabapentin; opioid; substance-related disorders","Kaplan","Marcus C","Department of Pharmacy, Sentara Norfolk General Hospital, Norfolk, VA, USA",NA
"575","34260685","10.1093/ajhp/zxab287","Impact of smart pump-electronic health record interoperability on patient safety and finances at a community hospital.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Integrating smart pumps with an e","2021","07","14","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","electronic health record; infusion; interoperability; intravenous; smart pump","Wei","Wenfei","Department of Pharmacy, Houston Methodist Hospital System, Houston, TX, USA",NA
"576","34260685","10.1093/ajhp/zxab287","Impact of smart pump-electronic health record interoperability on patient safety and finances at a community hospital.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Integrating smart pumps with an e","2021","07","14","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","electronic health record; infusion; interoperability; intravenous; smart pump","Coffey","William","Department of Pharmacy, Houston Methodist Hospital System, Houston, TX, USA",NA
"577","34260685","10.1093/ajhp/zxab287","Impact of smart pump-electronic health record interoperability on patient safety and finances at a community hospital.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Integrating smart pumps with an e","2021","07","14","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","electronic health record; infusion; interoperability; intravenous; smart pump","Adeola","Mobolaji","Department of Pharmacy, Houston Methodist Hospital System, Houston, TX, USA",NA
"578","34260685","10.1093/ajhp/zxab287","Impact of smart pump-electronic health record interoperability on patient safety and finances at a community hospital.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Integrating smart pumps with an e","2021","07","14","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","electronic health record; infusion; interoperability; intravenous; smart pump","Abbasi","Ghalib","Department of Pharmacy, Houston Methodist Hospital System, Houston, TX, USA",NA
"579","34260684","10.1093/bib/bbab262","Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the newly discovered coronavirus, SARS-CoV-2. Increased severity of COVID-19 has been observed in patients with diabetes mellitus (DM). This study aimed to identify common transcriptional signatures, regulators and pathways between COVID-19 and DM. We have integrated human whole-genome transcriptomic datasets from COVID-19 and DM, followed by functional assessment with gene ontology (GO) and pathway analyses. In peripheral bl","2021","07","14","Brief Bioinform","Briefings in bioinformatics","COVID-19; blood gene expression; diabetes mellitus; molecular pathways; transcriptional signatures","Rahman","Md Rezanur","Department of Biotechnology and Genetic Engineering, Faculty of Biological Sciences, Islamic University, Kushtia, Bangladesh",NA
"580","34260684","10.1093/bib/bbab262","Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the newly discovered coronavirus, SARS-CoV-2. Increased severity of COVID-19 has been observed in patients with diabetes mellitus (DM). This study aimed to identify common transcriptional signatures, regulators and pathways between COVID-19 and DM. We have integrated human whole-genome transcriptomic datasets from COVID-19 and DM, followed by functional assessment with gene ontology (GO) and pathway analyses. In peripheral bl","2021","07","14","Brief Bioinform","Briefings in bioinformatics","COVID-19; blood gene expression; diabetes mellitus; molecular pathways; transcriptional signatures","Islam","Tania","Department of Biotechnology and Genetic Engineering, Faculty of Biological Sciences, Islamic University, Kushtia, Bangladesh",NA
"581","34260684","10.1093/bib/bbab262","Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the newly discovered coronavirus, SARS-CoV-2. Increased severity of COVID-19 has been observed in patients with diabetes mellitus (DM). This study aimed to identify common transcriptional signatures, regulators and pathways between COVID-19 and DM. We have integrated human whole-genome transcriptomic datasets from COVID-19 and DM, followed by functional assessment with gene ontology (GO) and pathway analyses. In peripheral bl","2021","07","14","Brief Bioinform","Briefings in bioinformatics","COVID-19; blood gene expression; diabetes mellitus; molecular pathways; transcriptional signatures","Shahjaman","Md","Department of Statistics, Begum Rokeya University, Rangpur, Bangladesh",NA
"582","34260684","10.1093/bib/bbab262","Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the newly discovered coronavirus, SARS-CoV-2. Increased severity of COVID-19 has been observed in patients with diabetes mellitus (DM). This study aimed to identify common transcriptional signatures, regulators and pathways between COVID-19 and DM. We have integrated human whole-genome transcriptomic datasets from COVID-19 and DM, followed by functional assessment with gene ontology (GO) and pathway analyses. In peripheral bl","2021","07","14","Brief Bioinform","Briefings in bioinformatics","COVID-19; blood gene expression; diabetes mellitus; molecular pathways; transcriptional signatures","Islam","Md Rafiqul","Faculty of Health, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Brisbane, Australia",NA
"583","34260684","10.1093/bib/bbab262","Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the newly discovered coronavirus, SARS-CoV-2. Increased severity of COVID-19 has been observed in patients with diabetes mellitus (DM). This study aimed to identify common transcriptional signatures, regulators and pathways between COVID-19 and DM. We have integrated human whole-genome transcriptomic datasets from COVID-19 and DM, followed by functional assessment with gene ontology (GO) and pathway analyses. In peripheral bl","2021","07","14","Brief Bioinform","Briefings in bioinformatics","COVID-19; blood gene expression; diabetes mellitus; molecular pathways; transcriptional signatures","Lombardo","Salvo Danilo","CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, AKH BT 25.3, A-1090 Vienna, Austria",NA
"584","34260684","10.1093/bib/bbab262","Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the newly discovered coronavirus, SARS-CoV-2. Increased severity of COVID-19 has been observed in patients with diabetes mellitus (DM). This study aimed to identify common transcriptional signatures, regulators and pathways between COVID-19 and DM. We have integrated human whole-genome transcriptomic datasets from COVID-19 and DM, followed by functional assessment with gene ontology (GO) and pathway analyses. In peripheral bl","2021","07","14","Brief Bioinform","Briefings in bioinformatics","COVID-19; blood gene expression; diabetes mellitus; molecular pathways; transcriptional signatures","Bramanti","Placido","IRCCS Centro Neurolesi ""Bonino-Pulejo"", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy",NA
"585","34260684","10.1093/bib/bbab262","Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the newly discovered coronavirus, SARS-CoV-2. Increased severity of COVID-19 has been observed in patients with diabetes mellitus (DM). This study aimed to identify common transcriptional signatures, regulators and pathways between COVID-19 and DM. We have integrated human whole-genome transcriptomic datasets from COVID-19 and DM, followed by functional assessment with gene ontology (GO) and pathway analyses. In peripheral bl","2021","07","14","Brief Bioinform","Briefings in bioinformatics","COVID-19; blood gene expression; diabetes mellitus; molecular pathways; transcriptional signatures","Ciurleo","Rosella","IRCCS Centro Neurolesi ""Bonino-Pulejo"", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy",NA
"586","34260684","10.1093/bib/bbab262","Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the newly discovered coronavirus, SARS-CoV-2. Increased severity of COVID-19 has been observed in patients with diabetes mellitus (DM). This study aimed to identify common transcriptional signatures, regulators and pathways between COVID-19 and DM. We have integrated human whole-genome transcriptomic datasets from COVID-19 and DM, followed by functional assessment with gene ontology (GO) and pathway analyses. In peripheral bl","2021","07","14","Brief Bioinform","Briefings in bioinformatics","COVID-19; blood gene expression; diabetes mellitus; molecular pathways; transcriptional signatures","Bramanti","Alessia","IRCCS Centro Neurolesi ""Bonino-Pulejo"", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy",NA
"587","34260684","10.1093/bib/bbab262","Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the newly discovered coronavirus, SARS-CoV-2. Increased severity of COVID-19 has been observed in patients with diabetes mellitus (DM). This study aimed to identify common transcriptional signatures, regulators and pathways between COVID-19 and DM. We have integrated human whole-genome transcriptomic datasets from COVID-19 and DM, followed by functional assessment with gene ontology (GO) and pathway analyses. In peripheral bl","2021","07","14","Brief Bioinform","Briefings in bioinformatics","COVID-19; blood gene expression; diabetes mellitus; molecular pathways; transcriptional signatures","Tchorbanov","Andrey","Laboratory of Experimental Immunology, Institute of Microbiology , Bulgarian Academy of Sciences, Sofia, Bulgaria",NA
"588","34260684","10.1093/bib/bbab262","Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the newly discovered coronavirus, SARS-CoV-2. Increased severity of COVID-19 has been observed in patients with diabetes mellitus (DM). This study aimed to identify common transcriptional signatures, regulators and pathways between COVID-19 and DM. We have integrated human whole-genome transcriptomic datasets from COVID-19 and DM, followed by functional assessment with gene ontology (GO) and pathway analyses. In peripheral bl","2021","07","14","Brief Bioinform","Briefings in bioinformatics","COVID-19; blood gene expression; diabetes mellitus; molecular pathways; transcriptional signatures","Fisicaro","Francesco","Department of Biomedical and Biotechnological Sciences, University of Catania, 95124 Catania CT, Italy",NA
"589","34260684","10.1093/bib/bbab262","Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the newly discovered coronavirus, SARS-CoV-2. Increased severity of COVID-19 has been observed in patients with diabetes mellitus (DM). This study aimed to identify common transcriptional signatures, regulators and pathways between COVID-19 and DM. We have integrated human whole-genome transcriptomic datasets from COVID-19 and DM, followed by functional assessment with gene ontology (GO) and pathway analyses. In peripheral bl","2021","07","14","Brief Bioinform","Briefings in bioinformatics","COVID-19; blood gene expression; diabetes mellitus; molecular pathways; transcriptional signatures","Fagone","Paolo","Department of Biomedical and Biotechnological Sciences, University of Catania, 95124 Catania CT, Italy",NA
"590","34260684","10.1093/bib/bbab262","Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the newly discovered coronavirus, SARS-CoV-2. Increased severity of COVID-19 has been observed in patients with diabetes mellitus (DM). This study aimed to identify common transcriptional signatures, regulators and pathways between COVID-19 and DM. We have integrated human whole-genome transcriptomic datasets from COVID-19 and DM, followed by functional assessment with gene ontology (GO) and pathway analyses. In peripheral bl","2021","07","14","Brief Bioinform","Briefings in bioinformatics","COVID-19; blood gene expression; diabetes mellitus; molecular pathways; transcriptional signatures","Nicoletti","Ferdinando","Department of Biomedical and Biotechnological Sciences, University of Catania, 95124 Catania CT, Italy",NA
"591","34260684","10.1093/bib/bbab262","Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the newly discovered coronavirus, SARS-CoV-2. Increased severity of COVID-19 has been observed in patients with diabetes mellitus (DM). This study aimed to identify common transcriptional signatures, regulators and pathways between COVID-19 and DM. We have integrated human whole-genome transcriptomic datasets from COVID-19 and DM, followed by functional assessment with gene ontology (GO) and pathway analyses. In peripheral bl","2021","07","14","Brief Bioinform","Briefings in bioinformatics","COVID-19; blood gene expression; diabetes mellitus; molecular pathways; transcriptional signatures","Pennisi","Manuela","Department of Biomedical and Biotechnological Sciences, University of Catania, 95124 Catania CT, Italy",NA
"592","34260666","10.1371/journal.ppat.1009753","COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes.","To understand the diversity of immune responses to SARS-CoV-2 and distinguish features that predispose individuals to severe COVID-19, we developed a mechanistic, within-host mathematical model and virtual patient cohort. Our results suggest that virtual patients with low production rates of infected cell derived IFN subsequently experienced highly inflammatory disease phenotypes, compared to those with early and robust IFN responses. In these in silico patients, the maximum concentration of IL-","2021","07","20","PLoS Pathog","PLoS pathogens",NA,"Jenner","Adrianne L","Sainte-Justine University Hospital Research Centre, Montréal, Québec, Canada",NA
"593","34260666","10.1371/journal.ppat.1009753","COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes.","To understand the diversity of immune responses to SARS-CoV-2 and distinguish features that predispose individuals to severe COVID-19, we developed a mechanistic, within-host mathematical model and virtual patient cohort. Our results suggest that virtual patients with low production rates of infected cell derived IFN subsequently experienced highly inflammatory disease phenotypes, compared to those with early and robust IFN responses. In these in silico patients, the maximum concentration of IL-","2021","07","20","PLoS Pathog","PLoS pathogens",NA,"Aogo","Rosemary A","Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America",NA
"594","34260666","10.1371/journal.ppat.1009753","COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes.","To understand the diversity of immune responses to SARS-CoV-2 and distinguish features that predispose individuals to severe COVID-19, we developed a mechanistic, within-host mathematical model and virtual patient cohort. Our results suggest that virtual patients with low production rates of infected cell derived IFN subsequently experienced highly inflammatory disease phenotypes, compared to those with early and robust IFN responses. In these in silico patients, the maximum concentration of IL-","2021","07","20","PLoS Pathog","PLoS pathogens",NA,"Alfonso","Sofia","Department of Physiology, McGill University, Montréal, Québec, Canada",NA
"595","34260666","10.1371/journal.ppat.1009753","COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes.","To understand the diversity of immune responses to SARS-CoV-2 and distinguish features that predispose individuals to severe COVID-19, we developed a mechanistic, within-host mathematical model and virtual patient cohort. Our results suggest that virtual patients with low production rates of infected cell derived IFN subsequently experienced highly inflammatory disease phenotypes, compared to those with early and robust IFN responses. In these in silico patients, the maximum concentration of IL-","2021","07","20","PLoS Pathog","PLoS pathogens",NA,"Crowe","Vivienne","Department of Mathematics and Statistics, Concordia University, Montréal, Québec, Canada",NA
"596","34260666","10.1371/journal.ppat.1009753","COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes.","To understand the diversity of immune responses to SARS-CoV-2 and distinguish features that predispose individuals to severe COVID-19, we developed a mechanistic, within-host mathematical model and virtual patient cohort. Our results suggest that virtual patients with low production rates of infected cell derived IFN subsequently experienced highly inflammatory disease phenotypes, compared to those with early and robust IFN responses. In these in silico patients, the maximum concentration of IL-","2021","07","20","PLoS Pathog","PLoS pathogens",NA,"Deng","Xiaoyan","Sainte-Justine University Hospital Research Centre, Montréal, Québec, Canada",NA
"597","34260666","10.1371/journal.ppat.1009753","COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes.","To understand the diversity of immune responses to SARS-CoV-2 and distinguish features that predispose individuals to severe COVID-19, we developed a mechanistic, within-host mathematical model and virtual patient cohort. Our results suggest that virtual patients with low production rates of infected cell derived IFN subsequently experienced highly inflammatory disease phenotypes, compared to those with early and robust IFN responses. In these in silico patients, the maximum concentration of IL-","2021","07","20","PLoS Pathog","PLoS pathogens",NA,"Smith","Amanda P","Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America",NA
"598","34260666","10.1371/journal.ppat.1009753","COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes.","To understand the diversity of immune responses to SARS-CoV-2 and distinguish features that predispose individuals to severe COVID-19, we developed a mechanistic, within-host mathematical model and virtual patient cohort. Our results suggest that virtual patients with low production rates of infected cell derived IFN subsequently experienced highly inflammatory disease phenotypes, compared to those with early and robust IFN responses. In these in silico patients, the maximum concentration of IL-","2021","07","20","PLoS Pathog","PLoS pathogens",NA,"Morel","Penelope A","Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America",NA
"599","34260666","10.1371/journal.ppat.1009753","COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes.","To understand the diversity of immune responses to SARS-CoV-2 and distinguish features that predispose individuals to severe COVID-19, we developed a mechanistic, within-host mathematical model and virtual patient cohort. Our results suggest that virtual patients with low production rates of infected cell derived IFN subsequently experienced highly inflammatory disease phenotypes, compared to those with early and robust IFN responses. In these in silico patients, the maximum concentration of IL-","2021","07","20","PLoS Pathog","PLoS pathogens",NA,"Davis","Courtney L","Natural Science Division, Pepperdine University, Malibu, California, United States of America",NA
"600","34260666","10.1371/journal.ppat.1009753","COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes.","To understand the diversity of immune responses to SARS-CoV-2 and distinguish features that predispose individuals to severe COVID-19, we developed a mechanistic, within-host mathematical model and virtual patient cohort. Our results suggest that virtual patients with low production rates of infected cell derived IFN subsequently experienced highly inflammatory disease phenotypes, compared to those with early and robust IFN responses. In these in silico patients, the maximum concentration of IL-","2021","07","20","PLoS Pathog","PLoS pathogens",NA,"Smith","Amber M","Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America",NA
"601","34260666","10.1371/journal.ppat.1009753","COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes.","To understand the diversity of immune responses to SARS-CoV-2 and distinguish features that predispose individuals to severe COVID-19, we developed a mechanistic, within-host mathematical model and virtual patient cohort. Our results suggest that virtual patients with low production rates of infected cell derived IFN subsequently experienced highly inflammatory disease phenotypes, compared to those with early and robust IFN responses. In these in silico patients, the maximum concentration of IL-","2021","07","20","PLoS Pathog","PLoS pathogens",NA,"Craig","Morgan","Sainte-Justine University Hospital Research Centre, Montréal, Québec, Canada",NA
"602","34260657","10.1371/journal.pone.0254648","Food disgust sensitivity predicts disease-preventing behaviour beyond the food domain in the COVID-19 pandemic in Germany.","In the fight against the COVID-19 pandemic, personal hygiene behaviours such as proper handwashing have gained significantly more attention and interpersonal contact is performed with great care. Disgust, as a disease-avoidance mechanism, can play an important role in the promotion of hygiene behaviour. We know from previous research that pathogen disgust can be a predictor of an individual's behaviour in the pandemic. Given that the pandemic greatly affects our food and eating behaviour, the cu","2021","07","22","PLoS One","PloS one","Adult; Aged; Anxiety; COVID-19; Disgust; Feeding Behavior; Female; Germany; Humans; Hygiene; Internet; Male; Middle Aged; Pandemics; Surveys and Questionnaires; Young Adult","Ammann","Jeanine","Department of Health Science and Technology (D-HEST), Consumer Behaviour, ETH Zurich, Zurich, Switzerland",NA
"603","34260657","10.1371/journal.pone.0254648","Food disgust sensitivity predicts disease-preventing behaviour beyond the food domain in the COVID-19 pandemic in Germany.","In the fight against the COVID-19 pandemic, personal hygiene behaviours such as proper handwashing have gained significantly more attention and interpersonal contact is performed with great care. Disgust, as a disease-avoidance mechanism, can play an important role in the promotion of hygiene behaviour. We know from previous research that pathogen disgust can be a predictor of an individual's behaviour in the pandemic. Given that the pandemic greatly affects our food and eating behaviour, the cu","2021","07","22","PLoS One","PloS one","Adult; Aged; Anxiety; COVID-19; Disgust; Feeding Behavior; Female; Germany; Humans; Hygiene; Internet; Male; Middle Aged; Pandemics; Surveys and Questionnaires; Young Adult","Casagrande","Meret","Department of Health Science and Technology (D-HEST), Consumer Behaviour, ETH Zurich, Zurich, Switzerland",NA
"604","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Davis","Greg","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"605","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","York","Allen J","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"606","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Bacon","Willis Clark","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"607","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Lin","Suh-Chin","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"608","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","McNeal","Monica Malone","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"609","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Yarawsky","Alexander E","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"610","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Maciag","Joseph J","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"611","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Miller","Jeanette L C","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"612","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Locker","Kathryn C S","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"613","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Bailey","Michelle","Hoxworth Blood Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America",NA
"614","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Stone","Rebecca","Hoxworth Blood Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America",NA
"615","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Hall","Michael","Hoxworth Blood Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America",NA
"616","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Gonzalez","Judith","Hoxworth Blood Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America",NA
"617","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Sproles","Alyssa","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"618","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Woodle","E Steve","Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America",NA
"619","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Safier","Kristen","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"620","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Justus","Kristine A","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"621","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Spearman","Paul","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"622","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Ware","Russell E","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"623","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Cancelas","Jose A","Hoxworth Blood Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America",NA
"624","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Jordan","Michael B","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"625","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Herr","Andrew B","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"626","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Hildeman","David A","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"627","34260645","10.1371/journal.pone.0254667","Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.","The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA ß-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein show","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral; Blood Donors; COVID-19; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ohio; Pandemics; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Young Adult","Molkentin","Jeffery D","Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United State of America",NA
"628","34260644","10.1371/journal.pone.0254339","The management of COVID-19 cases through telemedicine in Brazil.","In Dec 2020 Brazil became one of the worldwide epicenters of the COVID-19 pandemic with more than 7.2M reported cases. Brazil has a large territory with unequal distribution of healthcare resources including physicians. Resource limitation has been one of the main factors hampering Brazil's response to the COVID-19 crisis. Telemedicine has been an effective approach for COVID-19 management as it allows to reduce the risk of cross-contamination and provides support to remote rural locations. Here","2021","07","22","PLoS One","PloS one","Brazil; COVID-19; Healthcare Disparities; Humans; Physicians; Primary Health Care; Remote Consultation; Rural Health; Telemedicine","Montelongo","Alfredo","TelessaudeRS, Department of Epidemiology, School of Medicine, UFRGS, Porto Alegre, Brazil",NA
"629","34260644","10.1371/journal.pone.0254339","The management of COVID-19 cases through telemedicine in Brazil.","In Dec 2020 Brazil became one of the worldwide epicenters of the COVID-19 pandemic with more than 7.2M reported cases. Brazil has a large territory with unequal distribution of healthcare resources including physicians. Resource limitation has been one of the main factors hampering Brazil's response to the COVID-19 crisis. Telemedicine has been an effective approach for COVID-19 management as it allows to reduce the risk of cross-contamination and provides support to remote rural locations. Here","2021","07","22","PLoS One","PloS one","Brazil; COVID-19; Healthcare Disparities; Humans; Physicians; Primary Health Care; Remote Consultation; Rural Health; Telemedicine","Becker","João Luiz","Management School, Fundação Getulio Vargas (FGV/EASP), Rio de Janeiro, Brazil",NA
"630","34260644","10.1371/journal.pone.0254339","The management of COVID-19 cases through telemedicine in Brazil.","In Dec 2020 Brazil became one of the worldwide epicenters of the COVID-19 pandemic with more than 7.2M reported cases. Brazil has a large territory with unequal distribution of healthcare resources including physicians. Resource limitation has been one of the main factors hampering Brazil's response to the COVID-19 crisis. Telemedicine has been an effective approach for COVID-19 management as it allows to reduce the risk of cross-contamination and provides support to remote rural locations. Here","2021","07","22","PLoS One","PloS one","Brazil; COVID-19; Healthcare Disparities; Humans; Physicians; Primary Health Care; Remote Consultation; Rural Health; Telemedicine","Roman","Rudi","TelessaudeRS, Department of Epidemiology, School of Medicine, UFRGS, Porto Alegre, Brazil",NA
"631","34260644","10.1371/journal.pone.0254339","The management of COVID-19 cases through telemedicine in Brazil.","In Dec 2020 Brazil became one of the worldwide epicenters of the COVID-19 pandemic with more than 7.2M reported cases. Brazil has a large territory with unequal distribution of healthcare resources including physicians. Resource limitation has been one of the main factors hampering Brazil's response to the COVID-19 crisis. Telemedicine has been an effective approach for COVID-19 management as it allows to reduce the risk of cross-contamination and provides support to remote rural locations. Here","2021","07","22","PLoS One","PloS one","Brazil; COVID-19; Healthcare Disparities; Humans; Physicians; Primary Health Care; Remote Consultation; Rural Health; Telemedicine","de Oliveira","Elise Botteselle","TelessaudeRS, Department of Epidemiology, School of Medicine, UFRGS, Porto Alegre, Brazil",NA
"632","34260644","10.1371/journal.pone.0254339","The management of COVID-19 cases through telemedicine in Brazil.","In Dec 2020 Brazil became one of the worldwide epicenters of the COVID-19 pandemic with more than 7.2M reported cases. Brazil has a large territory with unequal distribution of healthcare resources including physicians. Resource limitation has been one of the main factors hampering Brazil's response to the COVID-19 crisis. Telemedicine has been an effective approach for COVID-19 management as it allows to reduce the risk of cross-contamination and provides support to remote rural locations. Here","2021","07","22","PLoS One","PloS one","Brazil; COVID-19; Healthcare Disparities; Humans; Physicians; Primary Health Care; Remote Consultation; Rural Health; Telemedicine","Umpierre","Roberto Nunes","TelessaudeRS, Department of Epidemiology, School of Medicine, UFRGS, Porto Alegre, Brazil",NA
"633","34260644","10.1371/journal.pone.0254339","The management of COVID-19 cases through telemedicine in Brazil.","In Dec 2020 Brazil became one of the worldwide epicenters of the COVID-19 pandemic with more than 7.2M reported cases. Brazil has a large territory with unequal distribution of healthcare resources including physicians. Resource limitation has been one of the main factors hampering Brazil's response to the COVID-19 crisis. Telemedicine has been an effective approach for COVID-19 management as it allows to reduce the risk of cross-contamination and provides support to remote rural locations. Here","2021","07","22","PLoS One","PloS one","Brazil; COVID-19; Healthcare Disparities; Humans; Physicians; Primary Health Care; Remote Consultation; Rural Health; Telemedicine","Gonçalves","Marcelo Rodrigues","TelessaudeRS, Department of Epidemiology, School of Medicine, UFRGS, Porto Alegre, Brazil",NA
"634","34260644","10.1371/journal.pone.0254339","The management of COVID-19 cases through telemedicine in Brazil.","In Dec 2020 Brazil became one of the worldwide epicenters of the COVID-19 pandemic with more than 7.2M reported cases. Brazil has a large territory with unequal distribution of healthcare resources including physicians. Resource limitation has been one of the main factors hampering Brazil's response to the COVID-19 crisis. Telemedicine has been an effective approach for COVID-19 management as it allows to reduce the risk of cross-contamination and provides support to remote rural locations. Here","2021","07","22","PLoS One","PloS one","Brazil; COVID-19; Healthcare Disparities; Humans; Physicians; Primary Health Care; Remote Consultation; Rural Health; Telemedicine","Silva","Rodolfo","TelessaudeRS, Department of Epidemiology, School of Medicine, UFRGS, Porto Alegre, Brazil",NA
"635","34260644","10.1371/journal.pone.0254339","The management of COVID-19 cases through telemedicine in Brazil.","In Dec 2020 Brazil became one of the worldwide epicenters of the COVID-19 pandemic with more than 7.2M reported cases. Brazil has a large territory with unequal distribution of healthcare resources including physicians. Resource limitation has been one of the main factors hampering Brazil's response to the COVID-19 crisis. Telemedicine has been an effective approach for COVID-19 management as it allows to reduce the risk of cross-contamination and provides support to remote rural locations. Here","2021","07","22","PLoS One","PloS one","Brazil; COVID-19; Healthcare Disparities; Humans; Physicians; Primary Health Care; Remote Consultation; Rural Health; Telemedicine","Doniec","Katarzyna","Department of Sociology, University of Cambridge, Cambridge, United Kingdom",NA
"636","34260644","10.1371/journal.pone.0254339","The management of COVID-19 cases through telemedicine in Brazil.","In Dec 2020 Brazil became one of the worldwide epicenters of the COVID-19 pandemic with more than 7.2M reported cases. Brazil has a large territory with unequal distribution of healthcare resources including physicians. Resource limitation has been one of the main factors hampering Brazil's response to the COVID-19 crisis. Telemedicine has been an effective approach for COVID-19 management as it allows to reduce the risk of cross-contamination and provides support to remote rural locations. Here","2021","07","22","PLoS One","PloS one","Brazil; COVID-19; Healthcare Disparities; Humans; Physicians; Primary Health Care; Remote Consultation; Rural Health; Telemedicine","Yetisen","Ali K","Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, United Kingdom",NA
"637","34260643","10.1371/journal.pone.0254540","Environmental stability of porcine respiratory coronavirus in aquatic environments.","Coronaviruses (CoVs) are a family of viruses that are best known as the causative agents of human diseases like the common cold, Middle East Respiratory Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS) and COVID-19. CoVs spread by human-to-human transmission via droplets or direct contact. There is, however, concern about potential waterborne transmission of SARS-CoV-2, the virus responsible for COVID-19, as it has been found in wastewater facilities and rivers. To date, little is known","2021","07","22","PLoS One","PloS one","Animals; Cells, Cultured; Coronavirus Infections; Filtration; Male; Pilot Projects; Porcine Respiratory Coronavirus; Rivers; Swine; Testis; Time Factors; Viral Load; Waste Water; Water Microbiology","De Rijcke","Maarten","Flanders Marine Institute (VLIZ), InnovOcean Site, Oostende, Belgium",NA
"638","34260643","10.1371/journal.pone.0254540","Environmental stability of porcine respiratory coronavirus in aquatic environments.","Coronaviruses (CoVs) are a family of viruses that are best known as the causative agents of human diseases like the common cold, Middle East Respiratory Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS) and COVID-19. CoVs spread by human-to-human transmission via droplets or direct contact. There is, however, concern about potential waterborne transmission of SARS-CoV-2, the virus responsible for COVID-19, as it has been found in wastewater facilities and rivers. To date, little is known","2021","07","22","PLoS One","PloS one","Animals; Cells, Cultured; Coronavirus Infections; Filtration; Male; Pilot Projects; Porcine Respiratory Coronavirus; Rivers; Swine; Testis; Time Factors; Viral Load; Waste Water; Water Microbiology","Shaikh","Hisham Mohammed","Flanders Marine Institute (VLIZ), InnovOcean Site, Oostende, Belgium",NA
"639","34260643","10.1371/journal.pone.0254540","Environmental stability of porcine respiratory coronavirus in aquatic environments.","Coronaviruses (CoVs) are a family of viruses that are best known as the causative agents of human diseases like the common cold, Middle East Respiratory Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS) and COVID-19. CoVs spread by human-to-human transmission via droplets or direct contact. There is, however, concern about potential waterborne transmission of SARS-CoV-2, the virus responsible for COVID-19, as it has been found in wastewater facilities and rivers. To date, little is known","2021","07","22","PLoS One","PloS one","Animals; Cells, Cultured; Coronavirus Infections; Filtration; Male; Pilot Projects; Porcine Respiratory Coronavirus; Rivers; Swine; Testis; Time Factors; Viral Load; Waste Water; Water Microbiology","Mees","Jan","Flanders Marine Institute (VLIZ), InnovOcean Site, Oostende, Belgium",NA
"640","34260643","10.1371/journal.pone.0254540","Environmental stability of porcine respiratory coronavirus in aquatic environments.","Coronaviruses (CoVs) are a family of viruses that are best known as the causative agents of human diseases like the common cold, Middle East Respiratory Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS) and COVID-19. CoVs spread by human-to-human transmission via droplets or direct contact. There is, however, concern about potential waterborne transmission of SARS-CoV-2, the virus responsible for COVID-19, as it has been found in wastewater facilities and rivers. To date, little is known","2021","07","22","PLoS One","PloS one","Animals; Cells, Cultured; Coronavirus Infections; Filtration; Male; Pilot Projects; Porcine Respiratory Coronavirus; Rivers; Swine; Testis; Time Factors; Viral Load; Waste Water; Water Microbiology","Nauwynck","Hans","Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium",NA
"641","34260643","10.1371/journal.pone.0254540","Environmental stability of porcine respiratory coronavirus in aquatic environments.","Coronaviruses (CoVs) are a family of viruses that are best known as the causative agents of human diseases like the common cold, Middle East Respiratory Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS) and COVID-19. CoVs spread by human-to-human transmission via droplets or direct contact. There is, however, concern about potential waterborne transmission of SARS-CoV-2, the virus responsible for COVID-19, as it has been found in wastewater facilities and rivers. To date, little is known","2021","07","22","PLoS One","PloS one","Animals; Cells, Cultured; Coronavirus Infections; Filtration; Male; Pilot Projects; Porcine Respiratory Coronavirus; Rivers; Swine; Testis; Time Factors; Viral Load; Waste Water; Water Microbiology","Vandegehuchte","Michiel Bert","Flanders Marine Institute (VLIZ), InnovOcean Site, Oostende, Belgium",NA
"642","34260638","10.1371/journal.pone.0254563","Sero-surveillance for SARS-CoV-2 infection among healthcare providers in four hospitals in Thailand one year after the first community outbreak.","Thailand was the first country outside China to report SARS-CoV-2 infected cases. Since the detection of the first imported case on January 12th, 2020 to the time this report was written, Thailand experienced two waves of community outbreaks (March-April 2020 and December 2020-March 2021). We examined prevalence of SARS-CoV-2 seropositivity among healthcare providers (HCPs) in four hospitals approximately one year after SARS-CoV-2 first detected in Thailand. By March 2021, these hospitals have t","2021","07","22","PLoS One","PloS one","Adult; Antibodies, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Female; Health Personnel; Humans; Male; Middle Aged; Population Surveillance; Prospective Studies; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Thailand","Kittikraisak","Wanitchaya","Influenza Program, Thailand Ministry of Public Health - U.S. Centers for Disease Control and Prevention, Nonthaburi, Thailand",NA
"643","34260638","10.1371/journal.pone.0254563","Sero-surveillance for SARS-CoV-2 infection among healthcare providers in four hospitals in Thailand one year after the first community outbreak.","Thailand was the first country outside China to report SARS-CoV-2 infected cases. Since the detection of the first imported case on January 12th, 2020 to the time this report was written, Thailand experienced two waves of community outbreaks (March-April 2020 and December 2020-March 2021). We examined prevalence of SARS-CoV-2 seropositivity among healthcare providers (HCPs) in four hospitals approximately one year after SARS-CoV-2 first detected in Thailand. By March 2021, these hospitals have t","2021","07","22","PLoS One","PloS one","Adult; Antibodies, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Female; Health Personnel; Humans; Male; Middle Aged; Population Surveillance; Prospective Studies; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Thailand","Piyaraj","Phunlerd","Phramongkutklao College of Medicine, Bangkok, Thailand",NA
"644","34260638","10.1371/journal.pone.0254563","Sero-surveillance for SARS-CoV-2 infection among healthcare providers in four hospitals in Thailand one year after the first community outbreak.","Thailand was the first country outside China to report SARS-CoV-2 infected cases. Since the detection of the first imported case on January 12th, 2020 to the time this report was written, Thailand experienced two waves of community outbreaks (March-April 2020 and December 2020-March 2021). We examined prevalence of SARS-CoV-2 seropositivity among healthcare providers (HCPs) in four hospitals approximately one year after SARS-CoV-2 first detected in Thailand. By March 2021, these hospitals have t","2021","07","22","PLoS One","PloS one","Adult; Antibodies, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Female; Health Personnel; Humans; Male; Middle Aged; Population Surveillance; Prospective Studies; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Thailand","Vachiraphan","Apichat","Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand",NA
"645","34260638","10.1371/journal.pone.0254563","Sero-surveillance for SARS-CoV-2 infection among healthcare providers in four hospitals in Thailand one year after the first community outbreak.","Thailand was the first country outside China to report SARS-CoV-2 infected cases. Since the detection of the first imported case on January 12th, 2020 to the time this report was written, Thailand experienced two waves of community outbreaks (March-April 2020 and December 2020-March 2021). We examined prevalence of SARS-CoV-2 seropositivity among healthcare providers (HCPs) in four hospitals approximately one year after SARS-CoV-2 first detected in Thailand. By March 2021, these hospitals have t","2021","07","22","PLoS One","PloS one","Adult; Antibodies, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Female; Health Personnel; Humans; Male; Middle Aged; Population Surveillance; Prospective Studies; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Thailand","Wongrapee","Thanapat","Phaholpolpayuhasena Hospital, Kanchanaburi, Thailand",NA
"646","34260638","10.1371/journal.pone.0254563","Sero-surveillance for SARS-CoV-2 infection among healthcare providers in four hospitals in Thailand one year after the first community outbreak.","Thailand was the first country outside China to report SARS-CoV-2 infected cases. Since the detection of the first imported case on January 12th, 2020 to the time this report was written, Thailand experienced two waves of community outbreaks (March-April 2020 and December 2020-March 2021). We examined prevalence of SARS-CoV-2 seropositivity among healthcare providers (HCPs) in four hospitals approximately one year after SARS-CoV-2 first detected in Thailand. By March 2021, these hospitals have t","2021","07","22","PLoS One","PloS one","Adult; Antibodies, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Female; Health Personnel; Humans; Male; Middle Aged; Population Surveillance; Prospective Studies; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Thailand","Punjasamanvong","Somsak","Rayong Hospital, Rayong, Thailand",NA
"647","34260638","10.1371/journal.pone.0254563","Sero-surveillance for SARS-CoV-2 infection among healthcare providers in four hospitals in Thailand one year after the first community outbreak.","Thailand was the first country outside China to report SARS-CoV-2 infected cases. Since the detection of the first imported case on January 12th, 2020 to the time this report was written, Thailand experienced two waves of community outbreaks (March-April 2020 and December 2020-March 2021). We examined prevalence of SARS-CoV-2 seropositivity among healthcare providers (HCPs) in four hospitals approximately one year after SARS-CoV-2 first detected in Thailand. By March 2021, these hospitals have t","2021","07","22","PLoS One","PloS one","Adult; Antibodies, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Female; Health Personnel; Humans; Male; Middle Aged; Population Surveillance; Prospective Studies; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Thailand","Hunsawong","Taweewun","Virology Department, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand",NA
"648","34260638","10.1371/journal.pone.0254563","Sero-surveillance for SARS-CoV-2 infection among healthcare providers in four hospitals in Thailand one year after the first community outbreak.","Thailand was the first country outside China to report SARS-CoV-2 infected cases. Since the detection of the first imported case on January 12th, 2020 to the time this report was written, Thailand experienced two waves of community outbreaks (March-April 2020 and December 2020-March 2021). We examined prevalence of SARS-CoV-2 seropositivity among healthcare providers (HCPs) in four hospitals approximately one year after SARS-CoV-2 first detected in Thailand. By March 2021, these hospitals have t","2021","07","22","PLoS One","PloS one","Adult; Antibodies, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Female; Health Personnel; Humans; Male; Middle Aged; Population Surveillance; Prospective Studies; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Thailand","Sinthuwattanawibool","Chalinthorn","Influenza Program, Thailand Ministry of Public Health - U.S. Centers for Disease Control and Prevention, Nonthaburi, Thailand",NA
"649","34260638","10.1371/journal.pone.0254563","Sero-surveillance for SARS-CoV-2 infection among healthcare providers in four hospitals in Thailand one year after the first community outbreak.","Thailand was the first country outside China to report SARS-CoV-2 infected cases. Since the detection of the first imported case on January 12th, 2020 to the time this report was written, Thailand experienced two waves of community outbreaks (March-April 2020 and December 2020-March 2021). We examined prevalence of SARS-CoV-2 seropositivity among healthcare providers (HCPs) in four hospitals approximately one year after SARS-CoV-2 first detected in Thailand. By March 2021, these hospitals have t","2021","07","22","PLoS One","PloS one","Adult; Antibodies, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Female; Health Personnel; Humans; Male; Middle Aged; Population Surveillance; Prospective Studies; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Thailand","Leepiyasakulchai","Chaniya","Faculty of Medical Technology, Mahidol University, Nakhon Pathom, Thailand",NA
"650","34260638","10.1371/journal.pone.0254563","Sero-surveillance for SARS-CoV-2 infection among healthcare providers in four hospitals in Thailand one year after the first community outbreak.","Thailand was the first country outside China to report SARS-CoV-2 infected cases. Since the detection of the first imported case on January 12th, 2020 to the time this report was written, Thailand experienced two waves of community outbreaks (March-April 2020 and December 2020-March 2021). We examined prevalence of SARS-CoV-2 seropositivity among healthcare providers (HCPs) in four hospitals approximately one year after SARS-CoV-2 first detected in Thailand. By March 2021, these hospitals have t","2021","07","22","PLoS One","PloS one","Adult; Antibodies, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Female; Health Personnel; Humans; Male; Middle Aged; Population Surveillance; Prospective Studies; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Thailand","Yoocharoen","Pornsak","Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand",NA
"651","34260638","10.1371/journal.pone.0254563","Sero-surveillance for SARS-CoV-2 infection among healthcare providers in four hospitals in Thailand one year after the first community outbreak.","Thailand was the first country outside China to report SARS-CoV-2 infected cases. Since the detection of the first imported case on January 12th, 2020 to the time this report was written, Thailand experienced two waves of community outbreaks (March-April 2020 and December 2020-March 2021). We examined prevalence of SARS-CoV-2 seropositivity among healthcare providers (HCPs) in four hospitals approximately one year after SARS-CoV-2 first detected in Thailand. By March 2021, these hospitals have t","2021","07","22","PLoS One","PloS one","Adult; Antibodies, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Female; Health Personnel; Humans; Male; Middle Aged; Population Surveillance; Prospective Studies; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Thailand","Azziz-Baumgartner","Eduardo","Influenza Division, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America",NA
"652","34260638","10.1371/journal.pone.0254563","Sero-surveillance for SARS-CoV-2 infection among healthcare providers in four hospitals in Thailand one year after the first community outbreak.","Thailand was the first country outside China to report SARS-CoV-2 infected cases. Since the detection of the first imported case on January 12th, 2020 to the time this report was written, Thailand experienced two waves of community outbreaks (March-April 2020 and December 2020-March 2021). We examined prevalence of SARS-CoV-2 seropositivity among healthcare providers (HCPs) in four hospitals approximately one year after SARS-CoV-2 first detected in Thailand. By March 2021, these hospitals have t","2021","07","22","PLoS One","PloS one","Adult; Antibodies, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Female; Health Personnel; Humans; Male; Middle Aged; Population Surveillance; Prospective Studies; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Thailand","Mott","Joshua A","Influenza Program, Thailand Ministry of Public Health - U.S. Centers for Disease Control and Prevention, Nonthaburi, Thailand",NA
"653","34260638","10.1371/journal.pone.0254563","Sero-surveillance for SARS-CoV-2 infection among healthcare providers in four hospitals in Thailand one year after the first community outbreak.","Thailand was the first country outside China to report SARS-CoV-2 infected cases. Since the detection of the first imported case on January 12th, 2020 to the time this report was written, Thailand experienced two waves of community outbreaks (March-April 2020 and December 2020-March 2021). We examined prevalence of SARS-CoV-2 seropositivity among healthcare providers (HCPs) in four hospitals approximately one year after SARS-CoV-2 first detected in Thailand. By March 2021, these hospitals have t","2021","07","22","PLoS One","PloS one","Adult; Antibodies, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Female; Health Personnel; Humans; Male; Middle Aged; Population Surveillance; Prospective Studies; SARS-CoV-2; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus; Thailand","Chottanapund","Suthat","Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand",NA
"654","34260637","10.1371/journal.pone.0252509","Implementation of an open-source robotic platform for SARS-CoV-2 testing by real-time RT-PCR.","The current global pandemic due to the SARS-CoV-2 has pushed the limits of global health systems across all aspects of clinical care, including laboratory diagnostics. Supply chain disruptions and rapidly-shifting markets have resulted in flash-scarcity of commercial laboratory reagents; this has motivated health care providers to search for alternative workflows to cope with the international increase in demand for SARS-CoV-2 testing. The aim of this study is to present a reproducible workflow ","2021","07","22","PLoS One","PloS one","COVID-19 Nucleic Acid Testing; Clinical Coding; Early Diagnosis; Humans; RNA, Viral; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Robotics; SARS-CoV-2; Workflow","Villanueva-Cañas","José Luis","Molecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain",NA
"655","34260637","10.1371/journal.pone.0252509","Implementation of an open-source robotic platform for SARS-CoV-2 testing by real-time RT-PCR.","The current global pandemic due to the SARS-CoV-2 has pushed the limits of global health systems across all aspects of clinical care, including laboratory diagnostics. Supply chain disruptions and rapidly-shifting markets have resulted in flash-scarcity of commercial laboratory reagents; this has motivated health care providers to search for alternative workflows to cope with the international increase in demand for SARS-CoV-2 testing. The aim of this study is to present a reproducible workflow ","2021","07","22","PLoS One","PloS one","COVID-19 Nucleic Acid Testing; Clinical Coding; Early Diagnosis; Humans; RNA, Viral; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Robotics; SARS-CoV-2; Workflow","Gonzalez-Roca","Eva","Molecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain",NA
"656","34260637","10.1371/journal.pone.0252509","Implementation of an open-source robotic platform for SARS-CoV-2 testing by real-time RT-PCR.","The current global pandemic due to the SARS-CoV-2 has pushed the limits of global health systems across all aspects of clinical care, including laboratory diagnostics. Supply chain disruptions and rapidly-shifting markets have resulted in flash-scarcity of commercial laboratory reagents; this has motivated health care providers to search for alternative workflows to cope with the international increase in demand for SARS-CoV-2 testing. The aim of this study is to present a reproducible workflow ","2021","07","22","PLoS One","PloS one","COVID-19 Nucleic Acid Testing; Clinical Coding; Early Diagnosis; Humans; RNA, Viral; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Robotics; SARS-CoV-2; Workflow","Gastaminza Unanue","Aitor","Independent engineer, Barcelona, Spain",NA
"657","34260637","10.1371/journal.pone.0252509","Implementation of an open-source robotic platform for SARS-CoV-2 testing by real-time RT-PCR.","The current global pandemic due to the SARS-CoV-2 has pushed the limits of global health systems across all aspects of clinical care, including laboratory diagnostics. Supply chain disruptions and rapidly-shifting markets have resulted in flash-scarcity of commercial laboratory reagents; this has motivated health care providers to search for alternative workflows to cope with the international increase in demand for SARS-CoV-2 testing. The aim of this study is to present a reproducible workflow ","2021","07","22","PLoS One","PloS one","COVID-19 Nucleic Acid Testing; Clinical Coding; Early Diagnosis; Humans; RNA, Viral; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Robotics; SARS-CoV-2; Workflow","Titos","Esther","Molecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain",NA
"658","34260637","10.1371/journal.pone.0252509","Implementation of an open-source robotic platform for SARS-CoV-2 testing by real-time RT-PCR.","The current global pandemic due to the SARS-CoV-2 has pushed the limits of global health systems across all aspects of clinical care, including laboratory diagnostics. Supply chain disruptions and rapidly-shifting markets have resulted in flash-scarcity of commercial laboratory reagents; this has motivated health care providers to search for alternative workflows to cope with the international increase in demand for SARS-CoV-2 testing. The aim of this study is to present a reproducible workflow ","2021","07","22","PLoS One","PloS one","COVID-19 Nucleic Acid Testing; Clinical Coding; Early Diagnosis; Humans; RNA, Viral; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Robotics; SARS-CoV-2; Workflow","Martínez Yoldi","Miguel Julián","Molecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain",NA
"659","34260637","10.1371/journal.pone.0252509","Implementation of an open-source robotic platform for SARS-CoV-2 testing by real-time RT-PCR.","The current global pandemic due to the SARS-CoV-2 has pushed the limits of global health systems across all aspects of clinical care, including laboratory diagnostics. Supply chain disruptions and rapidly-shifting markets have resulted in flash-scarcity of commercial laboratory reagents; this has motivated health care providers to search for alternative workflows to cope with the international increase in demand for SARS-CoV-2 testing. The aim of this study is to present a reproducible workflow ","2021","07","22","PLoS One","PloS one","COVID-19 Nucleic Acid Testing; Clinical Coding; Early Diagnosis; Humans; RNA, Viral; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Robotics; SARS-CoV-2; Workflow","Vergara Gómez","Andrea","Molecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain",NA
"660","34260637","10.1371/journal.pone.0252509","Implementation of an open-source robotic platform for SARS-CoV-2 testing by real-time RT-PCR.","The current global pandemic due to the SARS-CoV-2 has pushed the limits of global health systems across all aspects of clinical care, including laboratory diagnostics. Supply chain disruptions and rapidly-shifting markets have resulted in flash-scarcity of commercial laboratory reagents; this has motivated health care providers to search for alternative workflows to cope with the international increase in demand for SARS-CoV-2 testing. The aim of this study is to present a reproducible workflow ","2021","07","22","PLoS One","PloS one","COVID-19 Nucleic Acid Testing; Clinical Coding; Early Diagnosis; Humans; RNA, Viral; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Robotics; SARS-CoV-2; Workflow","Puig-Butillé","Joan Anton","Molecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain",NA
"661","34260633","10.1371/journal.pone.0254456","The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach.","Vaccination programs aim to control the COVID-19 pandemic. However, the relative impacts of vaccine coverage, effectiveness, and capacity in the context of nonpharmaceutical interventions such as mask use and physical distancing on the spread of SARS-CoV-2 are unclear. Our objective was to examine the impact of vaccination on the control of SARS-CoV-2 using our previously developed agent-based simulation model. We applied our agent-based model to replicate COVID-19-related events in 1) Dane Coun","2021","07","22","PLoS One","PloS one","COVID-19; COVID-19 Vaccines; Computer Simulation; Humans; Masks; Patient Compliance; Physical Distancing; Respiratory Protective Devices; United States; Urban Health; Vaccination Coverage","Alagoz","Oguzhan","Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States of America",NA
"662","34260633","10.1371/journal.pone.0254456","The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach.","Vaccination programs aim to control the COVID-19 pandemic. However, the relative impacts of vaccine coverage, effectiveness, and capacity in the context of nonpharmaceutical interventions such as mask use and physical distancing on the spread of SARS-CoV-2 are unclear. Our objective was to examine the impact of vaccination on the control of SARS-CoV-2 using our previously developed agent-based simulation model. We applied our agent-based model to replicate COVID-19-related events in 1) Dane Coun","2021","07","22","PLoS One","PloS one","COVID-19; COVID-19 Vaccines; Computer Simulation; Humans; Masks; Patient Compliance; Physical Distancing; Respiratory Protective Devices; United States; Urban Health; Vaccination Coverage","Sethi","Ajay K","Department of Population Health Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States of America",NA
"663","34260633","10.1371/journal.pone.0254456","The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach.","Vaccination programs aim to control the COVID-19 pandemic. However, the relative impacts of vaccine coverage, effectiveness, and capacity in the context of nonpharmaceutical interventions such as mask use and physical distancing on the spread of SARS-CoV-2 are unclear. Our objective was to examine the impact of vaccination on the control of SARS-CoV-2 using our previously developed agent-based simulation model. We applied our agent-based model to replicate COVID-19-related events in 1) Dane Coun","2021","07","22","PLoS One","PloS one","COVID-19; COVID-19 Vaccines; Computer Simulation; Humans; Masks; Patient Compliance; Physical Distancing; Respiratory Protective Devices; United States; Urban Health; Vaccination Coverage","Patterson","Brian W","Berbee Walsh Department of Emergency Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, United States of America",NA
"664","34260633","10.1371/journal.pone.0254456","The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach.","Vaccination programs aim to control the COVID-19 pandemic. However, the relative impacts of vaccine coverage, effectiveness, and capacity in the context of nonpharmaceutical interventions such as mask use and physical distancing on the spread of SARS-CoV-2 are unclear. Our objective was to examine the impact of vaccination on the control of SARS-CoV-2 using our previously developed agent-based simulation model. We applied our agent-based model to replicate COVID-19-related events in 1) Dane Coun","2021","07","22","PLoS One","PloS one","COVID-19; COVID-19 Vaccines; Computer Simulation; Humans; Masks; Patient Compliance; Physical Distancing; Respiratory Protective Devices; United States; Urban Health; Vaccination Coverage","Churpek","Matthew","Pulmonary and Critical Care Division in the Department of Medicine, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, Wisconsin, United States of America",NA
"665","34260633","10.1371/journal.pone.0254456","The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach.","Vaccination programs aim to control the COVID-19 pandemic. However, the relative impacts of vaccine coverage, effectiveness, and capacity in the context of nonpharmaceutical interventions such as mask use and physical distancing on the spread of SARS-CoV-2 are unclear. Our objective was to examine the impact of vaccination on the control of SARS-CoV-2 using our previously developed agent-based simulation model. We applied our agent-based model to replicate COVID-19-related events in 1) Dane Coun","2021","07","22","PLoS One","PloS one","COVID-19; COVID-19 Vaccines; Computer Simulation; Humans; Masks; Patient Compliance; Physical Distancing; Respiratory Protective Devices; United States; Urban Health; Vaccination Coverage","Alhanaee","Ghalib","Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States of America",NA
"666","34260633","10.1371/journal.pone.0254456","The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach.","Vaccination programs aim to control the COVID-19 pandemic. However, the relative impacts of vaccine coverage, effectiveness, and capacity in the context of nonpharmaceutical interventions such as mask use and physical distancing on the spread of SARS-CoV-2 are unclear. Our objective was to examine the impact of vaccination on the control of SARS-CoV-2 using our previously developed agent-based simulation model. We applied our agent-based model to replicate COVID-19-related events in 1) Dane Coun","2021","07","22","PLoS One","PloS one","COVID-19; COVID-19 Vaccines; Computer Simulation; Humans; Masks; Patient Compliance; Physical Distancing; Respiratory Protective Devices; United States; Urban Health; Vaccination Coverage","Scaria","Elizabeth","Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States of America",NA
"667","34260633","10.1371/journal.pone.0254456","The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach.","Vaccination programs aim to control the COVID-19 pandemic. However, the relative impacts of vaccine coverage, effectiveness, and capacity in the context of nonpharmaceutical interventions such as mask use and physical distancing on the spread of SARS-CoV-2 are unclear. Our objective was to examine the impact of vaccination on the control of SARS-CoV-2 using our previously developed agent-based simulation model. We applied our agent-based model to replicate COVID-19-related events in 1) Dane Coun","2021","07","22","PLoS One","PloS one","COVID-19; COVID-19 Vaccines; Computer Simulation; Humans; Masks; Patient Compliance; Physical Distancing; Respiratory Protective Devices; United States; Urban Health; Vaccination Coverage","Safdar","Nasia","Infectious Diseases Division in the Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, United States of America",NA
"668","34260632","10.1371/journal.pone.0254228","Pre-hospital causes for delayed arrival in acute ischemic stroke before and during the COVID-19 pandemic: A study at two stroke centers in Egypt.","In the current study we investigated the causes of pre-hospital delay as this can compromise the patient's chance to receive thrombolytic therapy and thus impact stroke outcome. We surveyed 254 patients regarding reasons for delayed and early arrival to hospital after acute ischemic stroke. The survey was performed over five months, spanning a period pre- and during COVID-19 (between December 7, 2019 and May 10, 2020). A total of 71.2% of patients arrived beyond four hours of onset of ischemic s","2021","07","22","PLoS One","PloS one","Aged; Brain Ischemia; COVID-19; Egypt; Emergency Service, Hospital; Female; Hospitalization; Humans; Ischemic Stroke; Male; Middle Aged; Time Factors; Time-to-Treatment","Aref","Hany M","Neurology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"669","34260632","10.1371/journal.pone.0254228","Pre-hospital causes for delayed arrival in acute ischemic stroke before and during the COVID-19 pandemic: A study at two stroke centers in Egypt.","In the current study we investigated the causes of pre-hospital delay as this can compromise the patient's chance to receive thrombolytic therapy and thus impact stroke outcome. We surveyed 254 patients regarding reasons for delayed and early arrival to hospital after acute ischemic stroke. The survey was performed over five months, spanning a period pre- and during COVID-19 (between December 7, 2019 and May 10, 2020). A total of 71.2% of patients arrived beyond four hours of onset of ischemic s","2021","07","22","PLoS One","PloS one","Aged; Brain Ischemia; COVID-19; Egypt; Emergency Service, Hospital; Female; Hospitalization; Humans; Ischemic Stroke; Male; Middle Aged; Time Factors; Time-to-Treatment","Shokri","Hossam","Neurology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"670","34260632","10.1371/journal.pone.0254228","Pre-hospital causes for delayed arrival in acute ischemic stroke before and during the COVID-19 pandemic: A study at two stroke centers in Egypt.","In the current study we investigated the causes of pre-hospital delay as this can compromise the patient's chance to receive thrombolytic therapy and thus impact stroke outcome. We surveyed 254 patients regarding reasons for delayed and early arrival to hospital after acute ischemic stroke. The survey was performed over five months, spanning a period pre- and during COVID-19 (between December 7, 2019 and May 10, 2020). A total of 71.2% of patients arrived beyond four hours of onset of ischemic s","2021","07","22","PLoS One","PloS one","Aged; Brain Ischemia; COVID-19; Egypt; Emergency Service, Hospital; Female; Hospitalization; Humans; Ischemic Stroke; Male; Middle Aged; Time Factors; Time-to-Treatment","Roushdy","Tamer M","Neurology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"671","34260632","10.1371/journal.pone.0254228","Pre-hospital causes for delayed arrival in acute ischemic stroke before and during the COVID-19 pandemic: A study at two stroke centers in Egypt.","In the current study we investigated the causes of pre-hospital delay as this can compromise the patient's chance to receive thrombolytic therapy and thus impact stroke outcome. We surveyed 254 patients regarding reasons for delayed and early arrival to hospital after acute ischemic stroke. The survey was performed over five months, spanning a period pre- and during COVID-19 (between December 7, 2019 and May 10, 2020). A total of 71.2% of patients arrived beyond four hours of onset of ischemic s","2021","07","22","PLoS One","PloS one","Aged; Brain Ischemia; COVID-19; Egypt; Emergency Service, Hospital; Female; Hospitalization; Humans; Ischemic Stroke; Male; Middle Aged; Time Factors; Time-to-Treatment","Fathalla","Fatma","Neurology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"672","34260632","10.1371/journal.pone.0254228","Pre-hospital causes for delayed arrival in acute ischemic stroke before and during the COVID-19 pandemic: A study at two stroke centers in Egypt.","In the current study we investigated the causes of pre-hospital delay as this can compromise the patient's chance to receive thrombolytic therapy and thus impact stroke outcome. We surveyed 254 patients regarding reasons for delayed and early arrival to hospital after acute ischemic stroke. The survey was performed over five months, spanning a period pre- and during COVID-19 (between December 7, 2019 and May 10, 2020). A total of 71.2% of patients arrived beyond four hours of onset of ischemic s","2021","07","22","PLoS One","PloS one","Aged; Brain Ischemia; COVID-19; Egypt; Emergency Service, Hospital; Female; Hospitalization; Humans; Ischemic Stroke; Male; Middle Aged; Time Factors; Time-to-Treatment","El Nahas","Nevine M","Neurology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"673","34260602","10.1371/journal.pone.0252658","If you build it, will they come? Social, economic, and psychological determinants of COVID-19 testing decisions.","The efficacy of testing and tracing programs to reduce COVID-19 transmission hinges not only on widespread access to testing, but also on the public's willingness to participate in them. To the extent that testing intentions are patterned by social determinants of health, this constitutes an understudied mechanism of disparities in COVID-19 morbidity and mortality. Using data from a representative household probability sample, the Person to Person Health Interview Study (n = 935), sociodemograph","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Decision Making; Female; Humans; Male; Middle Aged; Multivariate Analysis; Public Health; Severity of Illness Index; Socioeconomic Factors; Surveys and Questionnaires; United States; Young Adult","Perry","Brea L","Department of Sociology, College of Arts and Sciences, Indiana University, Bloomington, IN, United States of America",NA
"674","34260602","10.1371/journal.pone.0252658","If you build it, will they come? Social, economic, and psychological determinants of COVID-19 testing decisions.","The efficacy of testing and tracing programs to reduce COVID-19 transmission hinges not only on widespread access to testing, but also on the public's willingness to participate in them. To the extent that testing intentions are patterned by social determinants of health, this constitutes an understudied mechanism of disparities in COVID-19 morbidity and mortality. Using data from a representative household probability sample, the Person to Person Health Interview Study (n = 935), sociodemograph","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Decision Making; Female; Humans; Male; Middle Aged; Multivariate Analysis; Public Health; Severity of Illness Index; Socioeconomic Factors; Surveys and Questionnaires; United States; Young Adult","Aronson","Brian","Department of Sociology, College of Arts and Sciences, Indiana University, Bloomington, IN, United States of America",NA
"675","34260602","10.1371/journal.pone.0252658","If you build it, will they come? Social, economic, and psychological determinants of COVID-19 testing decisions.","The efficacy of testing and tracing programs to reduce COVID-19 transmission hinges not only on widespread access to testing, but also on the public's willingness to participate in them. To the extent that testing intentions are patterned by social determinants of health, this constitutes an understudied mechanism of disparities in COVID-19 morbidity and mortality. Using data from a representative household probability sample, the Person to Person Health Interview Study (n = 935), sociodemograph","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Decision Making; Female; Humans; Male; Middle Aged; Multivariate Analysis; Public Health; Severity of Illness Index; Socioeconomic Factors; Surveys and Questionnaires; United States; Young Adult","Railey","Ashley F","Department of Sociology, College of Arts and Sciences, Indiana University, Bloomington, IN, United States of America",NA
"676","34260602","10.1371/journal.pone.0252658","If you build it, will they come? Social, economic, and psychological determinants of COVID-19 testing decisions.","The efficacy of testing and tracing programs to reduce COVID-19 transmission hinges not only on widespread access to testing, but also on the public's willingness to participate in them. To the extent that testing intentions are patterned by social determinants of health, this constitutes an understudied mechanism of disparities in COVID-19 morbidity and mortality. Using data from a representative household probability sample, the Person to Person Health Interview Study (n = 935), sociodemograph","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Decision Making; Female; Humans; Male; Middle Aged; Multivariate Analysis; Public Health; Severity of Illness Index; Socioeconomic Factors; Surveys and Questionnaires; United States; Young Adult","Ludema","Christina","Department of Epidemiology and Biostatistics, School of Public Health, Indiana University, Bloomington, IN, United States of America",NA
"677","34260594","10.1371/journal.pone.0253854","Socioeconomic disparities in cancer incidence and mortality in England and the impact of age-at-diagnosis on cancer mortality.","We identify socioeconomic disparities by region in cancer morbidity and mortality in England for all-cancer and type-specific cancers, and use incidence data to quantify the impact of cancer diagnosis delays on cancer deaths between 2001-2016. We obtain population cancer morbidity and mortality rates at various age, year, gender, deprivation, and region levels based on a Bayesian approach. A significant increase in type-specific cancer deaths, which can also vary among regions, is shown as a res","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Bayes Theorem; Child; Child, Preschool; Delayed Diagnosis; England; Female; Health Status Disparities; Humans; Incidence; Infant; Infant, Newborn; Intestinal Neoplasms; Lung Neoplasms; Male; Middle Aged; Prostatic Neoplasms; Sex Characteristics; Socioeconomic Factors; Young Adult","Arik","Ayse","Mathematical and Computer Sciences, Heriot-Watt University, Edinburgh, United Kingdom",NA
"678","34260594","10.1371/journal.pone.0253854","Socioeconomic disparities in cancer incidence and mortality in England and the impact of age-at-diagnosis on cancer mortality.","We identify socioeconomic disparities by region in cancer morbidity and mortality in England for all-cancer and type-specific cancers, and use incidence data to quantify the impact of cancer diagnosis delays on cancer deaths between 2001-2016. We obtain population cancer morbidity and mortality rates at various age, year, gender, deprivation, and region levels based on a Bayesian approach. A significant increase in type-specific cancer deaths, which can also vary among regions, is shown as a res","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Bayes Theorem; Child; Child, Preschool; Delayed Diagnosis; England; Female; Health Status Disparities; Humans; Incidence; Infant; Infant, Newborn; Intestinal Neoplasms; Lung Neoplasms; Male; Middle Aged; Prostatic Neoplasms; Sex Characteristics; Socioeconomic Factors; Young Adult","Dodd","Erengul","Mathematical Sciences, University of Southampton, Southampton, United Kingdom",NA
"679","34260594","10.1371/journal.pone.0253854","Socioeconomic disparities in cancer incidence and mortality in England and the impact of age-at-diagnosis on cancer mortality.","We identify socioeconomic disparities by region in cancer morbidity and mortality in England for all-cancer and type-specific cancers, and use incidence data to quantify the impact of cancer diagnosis delays on cancer deaths between 2001-2016. We obtain population cancer morbidity and mortality rates at various age, year, gender, deprivation, and region levels based on a Bayesian approach. A significant increase in type-specific cancer deaths, which can also vary among regions, is shown as a res","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Bayes Theorem; Child; Child, Preschool; Delayed Diagnosis; England; Female; Health Status Disparities; Humans; Incidence; Infant; Infant, Newborn; Intestinal Neoplasms; Lung Neoplasms; Male; Middle Aged; Prostatic Neoplasms; Sex Characteristics; Socioeconomic Factors; Young Adult","Cairns","Andrew","Mathematical and Computer Sciences, Heriot-Watt University, Edinburgh, United Kingdom",NA
"680","34260594","10.1371/journal.pone.0253854","Socioeconomic disparities in cancer incidence and mortality in England and the impact of age-at-diagnosis on cancer mortality.","We identify socioeconomic disparities by region in cancer morbidity and mortality in England for all-cancer and type-specific cancers, and use incidence data to quantify the impact of cancer diagnosis delays on cancer deaths between 2001-2016. We obtain population cancer morbidity and mortality rates at various age, year, gender, deprivation, and region levels based on a Bayesian approach. A significant increase in type-specific cancer deaths, which can also vary among regions, is shown as a res","2021","07","22","PLoS One","PloS one","Adolescent; Adult; Aged; Aged, 80 and over; Bayes Theorem; Child; Child, Preschool; Delayed Diagnosis; England; Female; Health Status Disparities; Humans; Incidence; Infant; Infant, Newborn; Intestinal Neoplasms; Lung Neoplasms; Male; Middle Aged; Prostatic Neoplasms; Sex Characteristics; Socioeconomic Factors; Young Adult","Streftaris","George","Mathematical and Computer Sciences, Heriot-Watt University, Edinburgh, United Kingdom",NA
"681","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Naumov","Vladimir","Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong",NA
"682","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Putin","Evgeny","Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong",NA
"683","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Pushkov","Stefan","Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong",NA
"684","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Kozlova","Ekaterina","Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong",NA
"685","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Romantsov","Konstantin","Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong",NA
"686","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Kalashnikov","Alexander","Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong",NA
"687","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Galkin","Fedor","Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong",NA
"688","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Tihonova","Nina","Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong",NA
"689","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Shneyderman","Anastasia","Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong",NA
"690","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Galkin","Egor","Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong",NA
"691","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Zinkevich","Arsenii","Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong",NA
"692","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Cope","Stephanie M","Intel Corporation, Santa Clara, California, United States of America",NA
"693","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Sethuraman","Ramanathan","Intel Corporation, Bangalore India",NA
"694","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Oprea","Tudor I","Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States of America",NA
"695","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Pearson","Alexander T","Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, Ilinois, United States of America",NA
"696","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Tay","Savas","Pritzker School of Molecular Engineering, University of Chicago, Chicago, Ilinois, United States of America",NA
"697","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Agrawal","Nishant","Department of Surgery, Section of Otolaryngology-Head and Neck Surgery, University of Chicago, Chicago, Ilinois, United States of America",NA
"698","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Dubovenko","Alexey","Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong",NA
"699","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Vanhaelen","Quentin","Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong",NA
"700","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Ozerov","Ivan","Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong",NA
"701","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Aliper","Alex","Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong",NA
"702","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Izumchenko","Evgeny","Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, Ilinois, United States of America",NA
"703","34260589","10.1371/journal.pcbi.1009183","COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.","Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in December 2019 in Wuhan, China. It was quickly established that both the symptoms and the disease severity may vary from one case to another and several strains of SARS-CoV-2 have been identified. To gain a better understanding of the wide variety of SARS-CoV-2 strains and their associated symptoms, thousands of SARS-CoV-2 genomes have been sequenced in dozens of countries. In this article, we intro","2021","07","14","PLoS Comput Biol","PLoS computational biology",NA,"Zhavoronkov","Alex","Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong",NA
"704","34260577","10.24875/ACM.21000023","[Código Infarto en una unidad de cuidados intermedios cardiológicos en época de COVID-19].",NA,"2021","07","14","Arch Cardiol Mex","Archivos de cardiologia de Mexico",NA,"Farráis-Villalba","Marcos","Servicio de Cardiología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España",NA
"705","34260577","10.24875/ACM.21000023","[Código Infarto en una unidad de cuidados intermedios cardiológicos en época de COVID-19].",NA,"2021","07","14","Arch Cardiol Mex","Archivos de cardiologia de Mexico",NA,"Lorenzo-González","Javier","Servicio de Cardiología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España",NA
"706","34260577","10.24875/ACM.21000023","[Código Infarto en una unidad de cuidados intermedios cardiológicos en época de COVID-19].",NA,"2021","07","14","Arch Cardiol Mex","Archivos de cardiologia de Mexico",NA,"Torres-González","Nerea","Servicio de Cardiología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España",NA
"707","34260577","10.24875/ACM.21000023","[Código Infarto en una unidad de cuidados intermedios cardiológicos en época de COVID-19].",NA,"2021","07","14","Arch Cardiol Mex","Archivos de cardiologia de Mexico",NA,"Facenda-Lorenzo","María","Servicio de Cardiología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España",NA
"708","34260577","10.24875/ACM.21000023","[Código Infarto en una unidad de cuidados intermedios cardiológicos en época de COVID-19].",NA,"2021","07","14","Arch Cardiol Mex","Archivos de cardiologia de Mexico",NA,"Ramos-López","María","Servicio de Cardiología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España",NA
"709","34260577","10.24875/ACM.21000023","[Código Infarto en una unidad de cuidados intermedios cardiológicos en época de COVID-19].",NA,"2021","07","14","Arch Cardiol Mex","Archivos de cardiologia de Mexico",NA,"Hernández-Afonso","Julio S","Servicio de Cardiología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España",NA
"710","34260565","10.1097/MD.0000000000026646","The educational and psychological impact of the COVID-19 pandemic on medical students: A descriptive survey at the American University of Beirut.","The SARS- CoV-2 virus has been a public health crisis since its emergence in 2019. It has affected nearly all aspects of life. Education has been particularly hit, and a lot of effort has been put to implement more and more virtual platforms through online classes, meetings and conferences. Medical education has also been affected, especially because of the need for hands-on education, specifically in the clinical setting of the last 2 years. This had a huge psychological impact on the medical s","2021","07","20","Medicine (Baltimore)","Medicine","Adult; Attitude of Health Personnel; COVID-19; Education, Distance; Education, Medical; Female; Humans; Lebanon; Male; Medical Staff, Hospital; Occupational Stress; SARS-CoV-2; Schools, Medical; Students, Medical; Surveys and Questionnaires","Bachir","Bachir","Faculty of Medicine, American University of Beirut, Beirut, Lebanon",NA
"711","34260565","10.1097/MD.0000000000026646","The educational and psychological impact of the COVID-19 pandemic on medical students: A descriptive survey at the American University of Beirut.","The SARS- CoV-2 virus has been a public health crisis since its emergence in 2019. It has affected nearly all aspects of life. Education has been particularly hit, and a lot of effort has been put to implement more and more virtual platforms through online classes, meetings and conferences. Medical education has also been affected, especially because of the need for hands-on education, specifically in the clinical setting of the last 2 years. This had a huge psychological impact on the medical s","2021","07","20","Medicine (Baltimore)","Medicine","Adult; Attitude of Health Personnel; COVID-19; Education, Distance; Education, Medical; Female; Humans; Lebanon; Male; Medical Staff, Hospital; Occupational Stress; SARS-CoV-2; Schools, Medical; Students, Medical; Surveys and Questionnaires","Naji","Amal","Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon",NA
"712","34260565","10.1097/MD.0000000000026646","The educational and psychological impact of the COVID-19 pandemic on medical students: A descriptive survey at the American University of Beirut.","The SARS- CoV-2 virus has been a public health crisis since its emergence in 2019. It has affected nearly all aspects of life. Education has been particularly hit, and a lot of effort has been put to implement more and more virtual platforms through online classes, meetings and conferences. Medical education has also been affected, especially because of the need for hands-on education, specifically in the clinical setting of the last 2 years. This had a huge psychological impact on the medical s","2021","07","20","Medicine (Baltimore)","Medicine","Adult; Attitude of Health Personnel; COVID-19; Education, Distance; Education, Medical; Female; Humans; Lebanon; Male; Medical Staff, Hospital; Occupational Stress; SARS-CoV-2; Schools, Medical; Students, Medical; Surveys and Questionnaires","Tfayli","Arafat","Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon",NA
"713","34260556","10.1097/MD.0000000000026634","Effects of dynamic response to coronavirus disease outbreak in a regional emergency medical center: A retrospective study.","Emergency departments (EDs) are on the frontline of the coronavirus disease (COVID-19) outbreak. To resolve the abrupt overloading of COVID-19-suspected patients in a community, each ED needs to respond in various ways. In our hospital, we increased the isolation beds through temporary remodeling and by performing in-hospital COVID-19 polymerase chain reaction testing rather than outsourcing them. The aim of this study was to verify the effects of our response to the newly developed viral outbre","2021","07","20","Medicine (Baltimore)","Medicine","Adult; Aged; COVID-19; Continuity of Patient Care; Disease Outbreaks; Emergency Medical Services; Emergency Service, Hospital; Female; Humans; Infection Control; Male; Middle Aged; Patient Isolation; Republic of Korea; Retrospective Studies; SARS-CoV-2","Oh","Ye Jin","Department of Emergency Medicine, School of Medicine, Daegu Catholic University, Daegu, Republic of Korea",NA
"714","34260556","10.1097/MD.0000000000026634","Effects of dynamic response to coronavirus disease outbreak in a regional emergency medical center: A retrospective study.","Emergency departments (EDs) are on the frontline of the coronavirus disease (COVID-19) outbreak. To resolve the abrupt overloading of COVID-19-suspected patients in a community, each ED needs to respond in various ways. In our hospital, we increased the isolation beds through temporary remodeling and by performing in-hospital COVID-19 polymerase chain reaction testing rather than outsourcing them. The aim of this study was to verify the effects of our response to the newly developed viral outbre","2021","07","20","Medicine (Baltimore)","Medicine","Adult; Aged; COVID-19; Continuity of Patient Care; Disease Outbreaks; Emergency Medical Services; Emergency Service, Hospital; Female; Humans; Infection Control; Male; Middle Aged; Patient Isolation; Republic of Korea; Retrospective Studies; SARS-CoV-2","Kim","Gyun Moo","Department of Emergency Medicine, School of Medicine, Daegu Catholic University, Daegu, Republic of Korea",NA
"715","34260556","10.1097/MD.0000000000026634","Effects of dynamic response to coronavirus disease outbreak in a regional emergency medical center: A retrospective study.","Emergency departments (EDs) are on the frontline of the coronavirus disease (COVID-19) outbreak. To resolve the abrupt overloading of COVID-19-suspected patients in a community, each ED needs to respond in various ways. In our hospital, we increased the isolation beds through temporary remodeling and by performing in-hospital COVID-19 polymerase chain reaction testing rather than outsourcing them. The aim of this study was to verify the effects of our response to the newly developed viral outbre","2021","07","20","Medicine (Baltimore)","Medicine","Adult; Aged; COVID-19; Continuity of Patient Care; Disease Outbreaks; Emergency Medical Services; Emergency Service, Hospital; Female; Humans; Infection Control; Male; Middle Aged; Patient Isolation; Republic of Korea; Retrospective Studies; SARS-CoV-2","Ko","Seung Hyun","Department of Emergency Medicine, School of Medicine, Daegu Catholic University, Daegu, Republic of Korea",NA
"716","34260556","10.1097/MD.0000000000026634","Effects of dynamic response to coronavirus disease outbreak in a regional emergency medical center: A retrospective study.","Emergency departments (EDs) are on the frontline of the coronavirus disease (COVID-19) outbreak. To resolve the abrupt overloading of COVID-19-suspected patients in a community, each ED needs to respond in various ways. In our hospital, we increased the isolation beds through temporary remodeling and by performing in-hospital COVID-19 polymerase chain reaction testing rather than outsourcing them. The aim of this study was to verify the effects of our response to the newly developed viral outbre","2021","07","20","Medicine (Baltimore)","Medicine","Adult; Aged; COVID-19; Continuity of Patient Care; Disease Outbreaks; Emergency Medical Services; Emergency Service, Hospital; Female; Humans; Infection Control; Male; Middle Aged; Patient Isolation; Republic of Korea; Retrospective Studies; SARS-CoV-2","Seo","Young Woo","Department of Emergency Medicine, School of Medicine, Daegu Catholic University, Daegu, Republic of Korea",NA
"717","34260556","10.1097/MD.0000000000026634","Effects of dynamic response to coronavirus disease outbreak in a regional emergency medical center: A retrospective study.","Emergency departments (EDs) are on the frontline of the coronavirus disease (COVID-19) outbreak. To resolve the abrupt overloading of COVID-19-suspected patients in a community, each ED needs to respond in various ways. In our hospital, we increased the isolation beds through temporary remodeling and by performing in-hospital COVID-19 polymerase chain reaction testing rather than outsourcing them. The aim of this study was to verify the effects of our response to the newly developed viral outbre","2021","07","20","Medicine (Baltimore)","Medicine","Adult; Aged; COVID-19; Continuity of Patient Care; Disease Outbreaks; Emergency Medical Services; Emergency Service, Hospital; Female; Humans; Infection Control; Male; Middle Aged; Patient Isolation; Republic of Korea; Retrospective Studies; SARS-CoV-2","Lee","Suk Hee","Department of Emergency Medicine, School of Medicine, Daegu Catholic University, Daegu, Republic of Korea",NA
"718","34260556","10.1097/MD.0000000000026634","Effects of dynamic response to coronavirus disease outbreak in a regional emergency medical center: A retrospective study.","Emergency departments (EDs) are on the frontline of the coronavirus disease (COVID-19) outbreak. To resolve the abrupt overloading of COVID-19-suspected patients in a community, each ED needs to respond in various ways. In our hospital, we increased the isolation beds through temporary remodeling and by performing in-hospital COVID-19 polymerase chain reaction testing rather than outsourcing them. The aim of this study was to verify the effects of our response to the newly developed viral outbre","2021","07","20","Medicine (Baltimore)","Medicine","Adult; Aged; COVID-19; Continuity of Patient Care; Disease Outbreaks; Emergency Medical Services; Emergency Service, Hospital; Female; Humans; Infection Control; Male; Middle Aged; Patient Isolation; Republic of Korea; Retrospective Studies; SARS-CoV-2","Jang","Tae Chang","Department of Emergency Medicine, School of Medicine, Daegu Catholic University, Daegu, Republic of Korea",NA
"719","34260531","10.1097/MD.0000000000026538","Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy.","Corrected QT (QTc) interval prolongation has been associated with poor patient prognosis. In this study, we assessed the effects of different drugs and cardiac injury on QTc interval prolongation in patients with coronavirus disease 2019 (COVID-19).The study cohort consisted of 395 confirmed COVID-19 cases from the Wuhan Union Hospital West Campus. All hospitalized patients were treated with chloroquine/hydroxychloroquine (CQ/HCQ), lopinavir/ritonavir (LPV/r), quinolones, interferon, Arbidol, or","2021","07","20","Medicine (Baltimore)","Medicine","Aged; Antiviral Agents; COVID-19; Chloroquine; Drug Therapy, Combination; Drugs, Chinese Herbal; Electrocardiography; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Indoles; Interferons; Long QT Syndrome; Lopinavir; Male; Middle Aged; Odds Ratio; Quinolones; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index","Ding","Jiaxing","Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"720","34260531","10.1097/MD.0000000000026538","Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy.","Corrected QT (QTc) interval prolongation has been associated with poor patient prognosis. In this study, we assessed the effects of different drugs and cardiac injury on QTc interval prolongation in patients with coronavirus disease 2019 (COVID-19).The study cohort consisted of 395 confirmed COVID-19 cases from the Wuhan Union Hospital West Campus. All hospitalized patients were treated with chloroquine/hydroxychloroquine (CQ/HCQ), lopinavir/ritonavir (LPV/r), quinolones, interferon, Arbidol, or","2021","07","20","Medicine (Baltimore)","Medicine","Aged; Antiviral Agents; COVID-19; Chloroquine; Drug Therapy, Combination; Drugs, Chinese Herbal; Electrocardiography; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Indoles; Interferons; Long QT Syndrome; Lopinavir; Male; Middle Aged; Odds Ratio; Quinolones; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index","Liu","Wei","Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"721","34260531","10.1097/MD.0000000000026538","Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy.","Corrected QT (QTc) interval prolongation has been associated with poor patient prognosis. In this study, we assessed the effects of different drugs and cardiac injury on QTc interval prolongation in patients with coronavirus disease 2019 (COVID-19).The study cohort consisted of 395 confirmed COVID-19 cases from the Wuhan Union Hospital West Campus. All hospitalized patients were treated with chloroquine/hydroxychloroquine (CQ/HCQ), lopinavir/ritonavir (LPV/r), quinolones, interferon, Arbidol, or","2021","07","20","Medicine (Baltimore)","Medicine","Aged; Antiviral Agents; COVID-19; Chloroquine; Drug Therapy, Combination; Drugs, Chinese Herbal; Electrocardiography; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Indoles; Interferons; Long QT Syndrome; Lopinavir; Male; Middle Aged; Odds Ratio; Quinolones; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index","Guan","Hongquan","Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"722","34260531","10.1097/MD.0000000000026538","Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy.","Corrected QT (QTc) interval prolongation has been associated with poor patient prognosis. In this study, we assessed the effects of different drugs and cardiac injury on QTc interval prolongation in patients with coronavirus disease 2019 (COVID-19).The study cohort consisted of 395 confirmed COVID-19 cases from the Wuhan Union Hospital West Campus. All hospitalized patients were treated with chloroquine/hydroxychloroquine (CQ/HCQ), lopinavir/ritonavir (LPV/r), quinolones, interferon, Arbidol, or","2021","07","20","Medicine (Baltimore)","Medicine","Aged; Antiviral Agents; COVID-19; Chloroquine; Drug Therapy, Combination; Drugs, Chinese Herbal; Electrocardiography; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Indoles; Interferons; Long QT Syndrome; Lopinavir; Male; Middle Aged; Odds Ratio; Quinolones; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index","Feng","Yu","Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"723","34260531","10.1097/MD.0000000000026538","Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy.","Corrected QT (QTc) interval prolongation has been associated with poor patient prognosis. In this study, we assessed the effects of different drugs and cardiac injury on QTc interval prolongation in patients with coronavirus disease 2019 (COVID-19).The study cohort consisted of 395 confirmed COVID-19 cases from the Wuhan Union Hospital West Campus. All hospitalized patients were treated with chloroquine/hydroxychloroquine (CQ/HCQ), lopinavir/ritonavir (LPV/r), quinolones, interferon, Arbidol, or","2021","07","20","Medicine (Baltimore)","Medicine","Aged; Antiviral Agents; COVID-19; Chloroquine; Drug Therapy, Combination; Drugs, Chinese Herbal; Electrocardiography; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Indoles; Interferons; Long QT Syndrome; Lopinavir; Male; Middle Aged; Odds Ratio; Quinolones; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index","Bao","Yintu","Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"724","34260531","10.1097/MD.0000000000026538","Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy.","Corrected QT (QTc) interval prolongation has been associated with poor patient prognosis. In this study, we assessed the effects of different drugs and cardiac injury on QTc interval prolongation in patients with coronavirus disease 2019 (COVID-19).The study cohort consisted of 395 confirmed COVID-19 cases from the Wuhan Union Hospital West Campus. All hospitalized patients were treated with chloroquine/hydroxychloroquine (CQ/HCQ), lopinavir/ritonavir (LPV/r), quinolones, interferon, Arbidol, or","2021","07","20","Medicine (Baltimore)","Medicine","Aged; Antiviral Agents; COVID-19; Chloroquine; Drug Therapy, Combination; Drugs, Chinese Herbal; Electrocardiography; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Indoles; Interferons; Long QT Syndrome; Lopinavir; Male; Middle Aged; Odds Ratio; Quinolones; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index","Li","Huili","Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"725","34260531","10.1097/MD.0000000000026538","Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy.","Corrected QT (QTc) interval prolongation has been associated with poor patient prognosis. In this study, we assessed the effects of different drugs and cardiac injury on QTc interval prolongation in patients with coronavirus disease 2019 (COVID-19).The study cohort consisted of 395 confirmed COVID-19 cases from the Wuhan Union Hospital West Campus. All hospitalized patients were treated with chloroquine/hydroxychloroquine (CQ/HCQ), lopinavir/ritonavir (LPV/r), quinolones, interferon, Arbidol, or","2021","07","20","Medicine (Baltimore)","Medicine","Aged; Antiviral Agents; COVID-19; Chloroquine; Drug Therapy, Combination; Drugs, Chinese Herbal; Electrocardiography; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Indoles; Interferons; Long QT Syndrome; Lopinavir; Male; Middle Aged; Odds Ratio; Quinolones; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index","Wang","Xuehua","Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"726","34260531","10.1097/MD.0000000000026538","Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy.","Corrected QT (QTc) interval prolongation has been associated with poor patient prognosis. In this study, we assessed the effects of different drugs and cardiac injury on QTc interval prolongation in patients with coronavirus disease 2019 (COVID-19).The study cohort consisted of 395 confirmed COVID-19 cases from the Wuhan Union Hospital West Campus. All hospitalized patients were treated with chloroquine/hydroxychloroquine (CQ/HCQ), lopinavir/ritonavir (LPV/r), quinolones, interferon, Arbidol, or","2021","07","20","Medicine (Baltimore)","Medicine","Aged; Antiviral Agents; COVID-19; Chloroquine; Drug Therapy, Combination; Drugs, Chinese Herbal; Electrocardiography; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Indoles; Interferons; Long QT Syndrome; Lopinavir; Male; Middle Aged; Odds Ratio; Quinolones; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index","Zhou","Zihua","Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"727","34260531","10.1097/MD.0000000000026538","Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy.","Corrected QT (QTc) interval prolongation has been associated with poor patient prognosis. In this study, we assessed the effects of different drugs and cardiac injury on QTc interval prolongation in patients with coronavirus disease 2019 (COVID-19).The study cohort consisted of 395 confirmed COVID-19 cases from the Wuhan Union Hospital West Campus. All hospitalized patients were treated with chloroquine/hydroxychloroquine (CQ/HCQ), lopinavir/ritonavir (LPV/r), quinolones, interferon, Arbidol, or","2021","07","20","Medicine (Baltimore)","Medicine","Aged; Antiviral Agents; COVID-19; Chloroquine; Drug Therapy, Combination; Drugs, Chinese Herbal; Electrocardiography; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Indoles; Interferons; Long QT Syndrome; Lopinavir; Male; Middle Aged; Odds Ratio; Quinolones; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index","Chen","Zhijian","Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"728","34260529","10.1097/MD.0000000000026532","An artificial neural network model to predict the mortality of COVID-19 patients using routine blood samples at the time of hospital admission: Development and validation study.",NA,"2021","07","22","Medicine (Baltimore)","Medicine","Biomarkers; COVID-19; China; Female; Hospitalization; Humans; Male; Neural Networks, Computer; Predictive Value of Tests; Prognosis; Republic of Korea; SARS-CoV-2","Lin","Ju-Kuo","Department of Ophthalmology, Chi-Mei Medical Center, Yong Kang, Tainan City, Taiwan",NA
"729","34260529","10.1097/MD.0000000000026532","An artificial neural network model to predict the mortality of COVID-19 patients using routine blood samples at the time of hospital admission: Development and validation study.",NA,"2021","07","22","Medicine (Baltimore)","Medicine","Biomarkers; COVID-19; China; Female; Hospitalization; Humans; Male; Neural Networks, Computer; Predictive Value of Tests; Prognosis; Republic of Korea; SARS-CoV-2","Chien","Tsair-Wei","Department of Medical Research, Chi-Mei Medical Center, Tainan, Taiwan",NA
"730","34260529","10.1097/MD.0000000000026532","An artificial neural network model to predict the mortality of COVID-19 patients using routine blood samples at the time of hospital admission: Development and validation study.",NA,"2021","07","22","Medicine (Baltimore)","Medicine","Biomarkers; COVID-19; China; Female; Hospitalization; Humans; Male; Neural Networks, Computer; Predictive Value of Tests; Prognosis; Republic of Korea; SARS-CoV-2","Wang","Lin-Yen","Department of Pediatrics, Chi-Mei Medical Center, Tainan, Taiwan",NA
"731","34260529","10.1097/MD.0000000000026532","An artificial neural network model to predict the mortality of COVID-19 patients using routine blood samples at the time of hospital admission: Development and validation study.",NA,"2021","07","22","Medicine (Baltimore)","Medicine","Biomarkers; COVID-19; China; Female; Hospitalization; Humans; Male; Neural Networks, Computer; Predictive Value of Tests; Prognosis; Republic of Korea; SARS-CoV-2","Chou","Willy","Department of Physical Medicine and Rehabilitation, Chung San Medical University Hospital, Taichung, Taiwan",NA
"732","34260527","10.1097/MD.0000000000026503","Lymphocyte blood levels that remain low can predict the death of patients with COVID-19.","The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been rapidly spreading on a global scale and poses a great threat to human health. However, efficient indicators for disease severity have not been fully investigated. Here, we aim to investigate whether dynamic changes of lymphocyte counts can predict the deterioration of patients with COVID-19.We collected data from 2923 patients with laboratory-confirmed COVID-19. Pat","2021","07","20","Medicine (Baltimore)","Medicine","Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Time Factors; Young Adult","Zhang","Hong-Jun","Department of Respiratory and Critical Care Medicine, Xi'an Chest Hospital, Xi'an, Shaanxi, PR China",NA
"733","34260527","10.1097/MD.0000000000026503","Lymphocyte blood levels that remain low can predict the death of patients with COVID-19.","The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been rapidly spreading on a global scale and poses a great threat to human health. However, efficient indicators for disease severity have not been fully investigated. Here, we aim to investigate whether dynamic changes of lymphocyte counts can predict the deterioration of patients with COVID-19.We collected data from 2923 patients with laboratory-confirmed COVID-19. Pat","2021","07","20","Medicine (Baltimore)","Medicine","Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Time Factors; Young Adult","Qi","Gang-Qiang","Department of Respiratory and Critical Care Medicine, Xi'an Chest Hospital, Xi'an, Shaanxi, PR China",NA
"734","34260527","10.1097/MD.0000000000026503","Lymphocyte blood levels that remain low can predict the death of patients with COVID-19.","The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been rapidly spreading on a global scale and poses a great threat to human health. However, efficient indicators for disease severity have not been fully investigated. Here, we aim to investigate whether dynamic changes of lymphocyte counts can predict the deterioration of patients with COVID-19.We collected data from 2923 patients with laboratory-confirmed COVID-19. Pat","2021","07","20","Medicine (Baltimore)","Medicine","Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Time Factors; Young Adult","Gu","Xing","Department of Respiratory and Critical Care Medicine, Xi'an Chest Hospital, Xi'an, Shaanxi, PR China",NA
"735","34260527","10.1097/MD.0000000000026503","Lymphocyte blood levels that remain low can predict the death of patients with COVID-19.","The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been rapidly spreading on a global scale and poses a great threat to human health. However, efficient indicators for disease severity have not been fully investigated. Here, we aim to investigate whether dynamic changes of lymphocyte counts can predict the deterioration of patients with COVID-19.We collected data from 2923 patients with laboratory-confirmed COVID-19. Pat","2021","07","20","Medicine (Baltimore)","Medicine","Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Time Factors; Young Adult","Zhang","Xiao-Yan","Department of Respiratory and Critical Care Medicine, Xi'an Chest Hospital, Xi'an, Shaanxi, PR China",NA
"736","34260527","10.1097/MD.0000000000026503","Lymphocyte blood levels that remain low can predict the death of patients with COVID-19.","The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been rapidly spreading on a global scale and poses a great threat to human health. However, efficient indicators for disease severity have not been fully investigated. Here, we aim to investigate whether dynamic changes of lymphocyte counts can predict the deterioration of patients with COVID-19.We collected data from 2923 patients with laboratory-confirmed COVID-19. Pat","2021","07","20","Medicine (Baltimore)","Medicine","Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Time Factors; Young Adult","Fang","Yan-Feng","Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital, the Air Force Medical University, Xi'an, Shaanxi, PR China",NA
"737","34260527","10.1097/MD.0000000000026503","Lymphocyte blood levels that remain low can predict the death of patients with COVID-19.","The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been rapidly spreading on a global scale and poses a great threat to human health. However, efficient indicators for disease severity have not been fully investigated. Here, we aim to investigate whether dynamic changes of lymphocyte counts can predict the deterioration of patients with COVID-19.We collected data from 2923 patients with laboratory-confirmed COVID-19. Pat","2021","07","20","Medicine (Baltimore)","Medicine","Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Time Factors; Young Adult","Jiang","Hong","Department of Infectious Diseases, Second Affiliated Hospital, the Air Force Medical University, Xi'an, Shaanxi, PR China",NA
"738","34260527","10.1097/MD.0000000000026503","Lymphocyte blood levels that remain low can predict the death of patients with COVID-19.","The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been rapidly spreading on a global scale and poses a great threat to human health. However, efficient indicators for disease severity have not been fully investigated. Here, we aim to investigate whether dynamic changes of lymphocyte counts can predict the deterioration of patients with COVID-19.We collected data from 2923 patients with laboratory-confirmed COVID-19. Pat","2021","07","20","Medicine (Baltimore)","Medicine","Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; COVID-19; Female; Hospital Mortality; Hospitalization; Humans; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Time Factors; Young Adult","Zhao","Yan-Jun","Department of Respiratory and Critical Care Medicine, Xi'an Chest Hospital, Xi'an, Shaanxi, PR China",NA
"739","34260516","10.1097/MAO.0000000000003233","SUDDEN SENSORINEURAL HEARING LOSS AND COVID-19: AN EVOLVING DISCUSSION.",NA,"2021","07","19","Otol Neurotol","Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology","COVID-19; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; SARS-CoV-2","Chern","Alexander","Department of Otolaryngology-Head &amp",NA
"740","34260516","10.1097/MAO.0000000000003233","SUDDEN SENSORINEURAL HEARING LOSS AND COVID-19: AN EVOLVING DISCUSSION.",NA,"2021","07","19","Otol Neurotol","Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology","COVID-19; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; SARS-CoV-2","Famuyide","Akinrinola O","Department of Otolaryngology-Head &amp",NA
"741","34260516","10.1097/MAO.0000000000003233","SUDDEN SENSORINEURAL HEARING LOSS AND COVID-19: AN EVOLVING DISCUSSION.",NA,"2021","07","19","Otol Neurotol","Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology","COVID-19; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; SARS-CoV-2","Moonis","Gul","Department of Radiology, Columbia University Irving Medical Center, New York, New York",NA
"742","34260516","10.1097/MAO.0000000000003233","SUDDEN SENSORINEURAL HEARING LOSS AND COVID-19: AN EVOLVING DISCUSSION.",NA,"2021","07","19","Otol Neurotol","Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology","COVID-19; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; SARS-CoV-2","Lalwani","Anil K","Department of Otolaryngology-Head &amp",NA
"743","34260515","10.1097/MAO.0000000000003232","INTRALABYRINTHINE HEMORRHAGE IN A PATIENT WITH COVID-19 - A CHALLENGE FOR AN OTOLOGIST.",NA,"2021","07","19","Otol Neurotol","Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology","COVID-19; Hemorrhage; Humans; Labyrinth Diseases; Otolaryngologists; SARS-CoV-2","Narozny","Waldemar","Department of Otolaryngology Medical University of Gdansk, Poland",NA
"744","34260515","10.1097/MAO.0000000000003232","INTRALABYRINTHINE HEMORRHAGE IN A PATIENT WITH COVID-19 - A CHALLENGE FOR AN OTOLOGIST.",NA,"2021","07","19","Otol Neurotol","Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology","COVID-19; Hemorrhage; Humans; Labyrinth Diseases; Otolaryngologists; SARS-CoV-2","Tretiakow","Dmitry","Department of Otolaryngology Medical University of Gdansk, Poland",NA
"745","34260515","10.1097/MAO.0000000000003232","INTRALABYRINTHINE HEMORRHAGE IN A PATIENT WITH COVID-19 - A CHALLENGE FOR AN OTOLOGIST.",NA,"2021","07","19","Otol Neurotol","Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology","COVID-19; Hemorrhage; Humans; Labyrinth Diseases; Otolaryngologists; SARS-CoV-2","Skorek","Andrzej","Department of Otolaryngology Medical University of Gdansk, Poland",NA
"746","34260501","10.1097/INF.0000000000003240","Acute Abdomen and Appendicitis in 1010 Pediatric Patients With COVID-19 or MIS-C: A Multinational Experience from Latin America.","To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Yock-Corrales","Adriana","From the Pediatric Emergency Department, Hospital Nacional de Niños ""Dr. Carlos Sáenz Herrera"", CCSS, San José, Costa Rica",NA
"747","34260501","10.1097/INF.0000000000003240","Acute Abdomen and Appendicitis in 1010 Pediatric Patients With COVID-19 or MIS-C: A Multinational Experience from Latin America.","To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Lenzi","Jacopo","From the Pediatric Emergency Department, Hospital Nacional de Niños ""Dr. Carlos Sáenz Herrera"", CCSS, San José, Costa Rica",NA
"748","34260501","10.1097/INF.0000000000003240","Acute Abdomen and Appendicitis in 1010 Pediatric Patients With COVID-19 or MIS-C: A Multinational Experience from Latin America.","To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Ulloa-Gutiérrez","Rolando","From the Pediatric Emergency Department, Hospital Nacional de Niños ""Dr. Carlos Sáenz Herrera"", CCSS, San José, Costa Rica",NA
"749","34260501","10.1097/INF.0000000000003240","Acute Abdomen and Appendicitis in 1010 Pediatric Patients With COVID-19 or MIS-C: A Multinational Experience from Latin America.","To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Gómez-Vargas","Jessica","From the Pediatric Emergency Department, Hospital Nacional de Niños ""Dr. Carlos Sáenz Herrera"", CCSS, San José, Costa Rica",NA
"750","34260501","10.1097/INF.0000000000003240","Acute Abdomen and Appendicitis in 1010 Pediatric Patients With COVID-19 or MIS-C: A Multinational Experience from Latin America.","To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Antúnez-Montes","Omar Yassef","From the Pediatric Emergency Department, Hospital Nacional de Niños ""Dr. Carlos Sáenz Herrera"", CCSS, San José, Costa Rica",NA
"751","34260501","10.1097/INF.0000000000003240","Acute Abdomen and Appendicitis in 1010 Pediatric Patients With COVID-19 or MIS-C: A Multinational Experience from Latin America.","To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Rios Aida","Jorge Alberto","From the Pediatric Emergency Department, Hospital Nacional de Niños ""Dr. Carlos Sáenz Herrera"", CCSS, San José, Costa Rica",NA
"752","34260501","10.1097/INF.0000000000003240","Acute Abdomen and Appendicitis in 1010 Pediatric Patients With COVID-19 or MIS-C: A Multinational Experience from Latin America.","To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Del Aguila","Olguita","From the Pediatric Emergency Department, Hospital Nacional de Niños ""Dr. Carlos Sáenz Herrera"", CCSS, San José, Costa Rica",NA
"753","34260501","10.1097/INF.0000000000003240","Acute Abdomen and Appendicitis in 1010 Pediatric Patients With COVID-19 or MIS-C: A Multinational Experience from Latin America.","To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Arteaga-Menchaca","Erick","From the Pediatric Emergency Department, Hospital Nacional de Niños ""Dr. Carlos Sáenz Herrera"", CCSS, San José, Costa Rica",NA
"754","34260501","10.1097/INF.0000000000003240","Acute Abdomen and Appendicitis in 1010 Pediatric Patients With COVID-19 or MIS-C: A Multinational Experience from Latin America.","To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Campos","Francisco","From the Pediatric Emergency Department, Hospital Nacional de Niños ""Dr. Carlos Sáenz Herrera"", CCSS, San José, Costa Rica",NA
"755","34260501","10.1097/INF.0000000000003240","Acute Abdomen and Appendicitis in 1010 Pediatric Patients With COVID-19 or MIS-C: A Multinational Experience from Latin America.","To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Uribe","Fadia","From the Pediatric Emergency Department, Hospital Nacional de Niños ""Dr. Carlos Sáenz Herrera"", CCSS, San José, Costa Rica",NA
"756","34260501","10.1097/INF.0000000000003240","Acute Abdomen and Appendicitis in 1010 Pediatric Patients With COVID-19 or MIS-C: A Multinational Experience from Latin America.","To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Diaz","Roger Hernando","From the Pediatric Emergency Department, Hospital Nacional de Niños ""Dr. Carlos Sáenz Herrera"", CCSS, San José, Costa Rica",NA
"757","34260501","10.1097/INF.0000000000003240","Acute Abdomen and Appendicitis in 1010 Pediatric Patients With COVID-19 or MIS-C: A Multinational Experience from Latin America.","To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Buitrago","Andrea Parra","From the Pediatric Emergency Department, Hospital Nacional de Niños ""Dr. Carlos Sáenz Herrera"", CCSS, San José, Costa Rica",NA
"758","34260501","10.1097/INF.0000000000003240","Acute Abdomen and Appendicitis in 1010 Pediatric Patients With COVID-19 or MIS-C: A Multinational Experience from Latin America.","To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Londoño","Lina Maria Betancur","From the Pediatric Emergency Department, Hospital Nacional de Niños ""Dr. Carlos Sáenz Herrera"", CCSS, San José, Costa Rica",NA
"759","34260501","10.1097/INF.0000000000003240","Acute Abdomen and Appendicitis in 1010 Pediatric Patients With COVID-19 or MIS-C: A Multinational Experience from Latin America.","To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Kozicki","Verónica","From the Pediatric Emergency Department, Hospital Nacional de Niños ""Dr. Carlos Sáenz Herrera"", CCSS, San José, Costa Rica",NA
"760","34260501","10.1097/INF.0000000000003240","Acute Abdomen and Appendicitis in 1010 Pediatric Patients With COVID-19 or MIS-C: A Multinational Experience from Latin America.","To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Brizuela","Martin","From the Pediatric Emergency Department, Hospital Nacional de Niños ""Dr. Carlos Sáenz Herrera"", CCSS, San José, Costa Rica",NA
"761","34260501","10.1097/INF.0000000000003240","Acute Abdomen and Appendicitis in 1010 Pediatric Patients With COVID-19 or MIS-C: A Multinational Experience from Latin America.","To date, there are only sporadic reports of acute abdomen and appendicitis in children with coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C). Children 17 years of age or younger assessed in 5 Latin American countries with a diagnosis of microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and children fulfilling MIS-C definition were included. For children with acute abdomen, we investigate main radiologic","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Buonsenso","Danilo","From the Pediatric Emergency Department, Hospital Nacional de Niños ""Dr. Carlos Sáenz Herrera"", CCSS, San José, Costa Rica",NA
"762","34260492","10.1097/INF.0000000000003263","Safety and Tolerability of Monoclonal Antibody Therapies for Treatment of COVID-19 in Pediatric Patients.","There is a little data regarding safety or efficacy of monoclonal antibody treatment for mild-to-moderate COVID-19 in pediatric patients despite it being frequently used in adults. This retrospective study of 17 patients with mild-to-moderate COVID-19 who received monoclonal antibody therapy found that the treatment was well tolerated, safe, and may be effective in halting progression to severe disease.","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Mak","Gregory","From the National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, Maryland Division of Infectious Diseases Division of Pharmacy Services, Children's National Hospital Department of Pediatrics, The George Washington University School of Medicine and Health Science, Washington, DC. DOI: 10.1097/INF.0000000000003263",NA
"763","34260492","10.1097/INF.0000000000003263","Safety and Tolerability of Monoclonal Antibody Therapies for Treatment of COVID-19 in Pediatric Patients.","There is a little data regarding safety or efficacy of monoclonal antibody treatment for mild-to-moderate COVID-19 in pediatric patients despite it being frequently used in adults. This retrospective study of 17 patients with mild-to-moderate COVID-19 who received monoclonal antibody therapy found that the treatment was well tolerated, safe, and may be effective in halting progression to severe disease.","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Dassner","Aimee M","From the National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, Maryland Division of Infectious Diseases Division of Pharmacy Services, Children's National Hospital Department of Pediatrics, The George Washington University School of Medicine and Health Science, Washington, DC. DOI: 10.1097/INF.0000000000003263",NA
"764","34260492","10.1097/INF.0000000000003263","Safety and Tolerability of Monoclonal Antibody Therapies for Treatment of COVID-19 in Pediatric Patients.","There is a little data regarding safety or efficacy of monoclonal antibody treatment for mild-to-moderate COVID-19 in pediatric patients despite it being frequently used in adults. This retrospective study of 17 patients with mild-to-moderate COVID-19 who received monoclonal antibody therapy found that the treatment was well tolerated, safe, and may be effective in halting progression to severe disease.","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Hammer","Benjamin M","From the National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, Maryland Division of Infectious Diseases Division of Pharmacy Services, Children's National Hospital Department of Pediatrics, The George Washington University School of Medicine and Health Science, Washington, DC. DOI: 10.1097/INF.0000000000003263",NA
"765","34260492","10.1097/INF.0000000000003263","Safety and Tolerability of Monoclonal Antibody Therapies for Treatment of COVID-19 in Pediatric Patients.","There is a little data regarding safety or efficacy of monoclonal antibody treatment for mild-to-moderate COVID-19 in pediatric patients despite it being frequently used in adults. This retrospective study of 17 patients with mild-to-moderate COVID-19 who received monoclonal antibody therapy found that the treatment was well tolerated, safe, and may be effective in halting progression to severe disease.","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Hanisch","Benjamin R","From the National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, Maryland Division of Infectious Diseases Division of Pharmacy Services, Children's National Hospital Department of Pediatrics, The George Washington University School of Medicine and Health Science, Washington, DC. DOI: 10.1097/INF.0000000000003263",NA
"766","34260481","10.1097/INF.0000000000003260","Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.","Cardiovascular complications with myocarditis in multisystem inflammatory syndrome in children (MIS-C) associated with severe acute respiratory syndrome coronavirus 2 infection have been reported, but the optimal therapeutic strategy remains unknown. A retrospective cohort study included 19 patients with acute left ventricular systolic dysfunction associated with MIS-C, average years of age 13.2 ± 3.8, treated from April 2020 to April 2021. Treatment failure (TF) was observed in 8 patients (in t","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Vukomanovic","Vladislav","From the Cardiology Department, Mother and Child Health Institute of Serbia School of Medicine, University of Belgrade Immunology Department, Mother and Child Health Institute of Serbia Intensive Care Unit, Mother and Child Health Institute of Serbia Surgery Department, Mother and Child Health Institute of Serbia Institute of Medical Physiology ""Rihard Burian"", Belgrade, Serbia",NA
"767","34260481","10.1097/INF.0000000000003260","Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.","Cardiovascular complications with myocarditis in multisystem inflammatory syndrome in children (MIS-C) associated with severe acute respiratory syndrome coronavirus 2 infection have been reported, but the optimal therapeutic strategy remains unknown. A retrospective cohort study included 19 patients with acute left ventricular systolic dysfunction associated with MIS-C, average years of age 13.2 ± 3.8, treated from April 2020 to April 2021. Treatment failure (TF) was observed in 8 patients (in t","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Krasic","Stasa","From the Cardiology Department, Mother and Child Health Institute of Serbia School of Medicine, University of Belgrade Immunology Department, Mother and Child Health Institute of Serbia Intensive Care Unit, Mother and Child Health Institute of Serbia Surgery Department, Mother and Child Health Institute of Serbia Institute of Medical Physiology ""Rihard Burian"", Belgrade, Serbia",NA
"768","34260481","10.1097/INF.0000000000003260","Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.","Cardiovascular complications with myocarditis in multisystem inflammatory syndrome in children (MIS-C) associated with severe acute respiratory syndrome coronavirus 2 infection have been reported, but the optimal therapeutic strategy remains unknown. A retrospective cohort study included 19 patients with acute left ventricular systolic dysfunction associated with MIS-C, average years of age 13.2 ± 3.8, treated from April 2020 to April 2021. Treatment failure (TF) was observed in 8 patients (in t","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Prijic","Sergej","From the Cardiology Department, Mother and Child Health Institute of Serbia School of Medicine, University of Belgrade Immunology Department, Mother and Child Health Institute of Serbia Intensive Care Unit, Mother and Child Health Institute of Serbia Surgery Department, Mother and Child Health Institute of Serbia Institute of Medical Physiology ""Rihard Burian"", Belgrade, Serbia",NA
"769","34260481","10.1097/INF.0000000000003260","Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.","Cardiovascular complications with myocarditis in multisystem inflammatory syndrome in children (MIS-C) associated with severe acute respiratory syndrome coronavirus 2 infection have been reported, but the optimal therapeutic strategy remains unknown. A retrospective cohort study included 19 patients with acute left ventricular systolic dysfunction associated with MIS-C, average years of age 13.2 ± 3.8, treated from April 2020 to April 2021. Treatment failure (TF) was observed in 8 patients (in t","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Ninic","Sanja","From the Cardiology Department, Mother and Child Health Institute of Serbia School of Medicine, University of Belgrade Immunology Department, Mother and Child Health Institute of Serbia Intensive Care Unit, Mother and Child Health Institute of Serbia Surgery Department, Mother and Child Health Institute of Serbia Institute of Medical Physiology ""Rihard Burian"", Belgrade, Serbia",NA
"770","34260481","10.1097/INF.0000000000003260","Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.","Cardiovascular complications with myocarditis in multisystem inflammatory syndrome in children (MIS-C) associated with severe acute respiratory syndrome coronavirus 2 infection have been reported, but the optimal therapeutic strategy remains unknown. A retrospective cohort study included 19 patients with acute left ventricular systolic dysfunction associated with MIS-C, average years of age 13.2 ± 3.8, treated from April 2020 to April 2021. Treatment failure (TF) was observed in 8 patients (in t","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Popovic","Sasa","From the Cardiology Department, Mother and Child Health Institute of Serbia School of Medicine, University of Belgrade Immunology Department, Mother and Child Health Institute of Serbia Intensive Care Unit, Mother and Child Health Institute of Serbia Surgery Department, Mother and Child Health Institute of Serbia Institute of Medical Physiology ""Rihard Burian"", Belgrade, Serbia",NA
"771","34260481","10.1097/INF.0000000000003260","Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.","Cardiovascular complications with myocarditis in multisystem inflammatory syndrome in children (MIS-C) associated with severe acute respiratory syndrome coronavirus 2 infection have been reported, but the optimal therapeutic strategy remains unknown. A retrospective cohort study included 19 patients with acute left ventricular systolic dysfunction associated with MIS-C, average years of age 13.2 ± 3.8, treated from April 2020 to April 2021. Treatment failure (TF) was observed in 8 patients (in t","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Petrovic","Gordana","From the Cardiology Department, Mother and Child Health Institute of Serbia School of Medicine, University of Belgrade Immunology Department, Mother and Child Health Institute of Serbia Intensive Care Unit, Mother and Child Health Institute of Serbia Surgery Department, Mother and Child Health Institute of Serbia Institute of Medical Physiology ""Rihard Burian"", Belgrade, Serbia",NA
"772","34260481","10.1097/INF.0000000000003260","Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.","Cardiovascular complications with myocarditis in multisystem inflammatory syndrome in children (MIS-C) associated with severe acute respiratory syndrome coronavirus 2 infection have been reported, but the optimal therapeutic strategy remains unknown. A retrospective cohort study included 19 patients with acute left ventricular systolic dysfunction associated with MIS-C, average years of age 13.2 ± 3.8, treated from April 2020 to April 2021. Treatment failure (TF) was observed in 8 patients (in t","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Ristic","Snezana","From the Cardiology Department, Mother and Child Health Institute of Serbia School of Medicine, University of Belgrade Immunology Department, Mother and Child Health Institute of Serbia Intensive Care Unit, Mother and Child Health Institute of Serbia Surgery Department, Mother and Child Health Institute of Serbia Institute of Medical Physiology ""Rihard Burian"", Belgrade, Serbia",NA
"773","34260481","10.1097/INF.0000000000003260","Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.","Cardiovascular complications with myocarditis in multisystem inflammatory syndrome in children (MIS-C) associated with severe acute respiratory syndrome coronavirus 2 infection have been reported, but the optimal therapeutic strategy remains unknown. A retrospective cohort study included 19 patients with acute left ventricular systolic dysfunction associated with MIS-C, average years of age 13.2 ± 3.8, treated from April 2020 to April 2021. Treatment failure (TF) was observed in 8 patients (in t","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Simic","Radoje","From the Cardiology Department, Mother and Child Health Institute of Serbia School of Medicine, University of Belgrade Immunology Department, Mother and Child Health Institute of Serbia Intensive Care Unit, Mother and Child Health Institute of Serbia Surgery Department, Mother and Child Health Institute of Serbia Institute of Medical Physiology ""Rihard Burian"", Belgrade, Serbia",NA
"774","34260481","10.1097/INF.0000000000003260","Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.","Cardiovascular complications with myocarditis in multisystem inflammatory syndrome in children (MIS-C) associated with severe acute respiratory syndrome coronavirus 2 infection have been reported, but the optimal therapeutic strategy remains unknown. A retrospective cohort study included 19 patients with acute left ventricular systolic dysfunction associated with MIS-C, average years of age 13.2 ± 3.8, treated from April 2020 to April 2021. Treatment failure (TF) was observed in 8 patients (in t","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Cerovic","Ivana","From the Cardiology Department, Mother and Child Health Institute of Serbia School of Medicine, University of Belgrade Immunology Department, Mother and Child Health Institute of Serbia Intensive Care Unit, Mother and Child Health Institute of Serbia Surgery Department, Mother and Child Health Institute of Serbia Institute of Medical Physiology ""Rihard Burian"", Belgrade, Serbia",NA
"775","34260481","10.1097/INF.0000000000003260","Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.","Cardiovascular complications with myocarditis in multisystem inflammatory syndrome in children (MIS-C) associated with severe acute respiratory syndrome coronavirus 2 infection have been reported, but the optimal therapeutic strategy remains unknown. A retrospective cohort study included 19 patients with acute left ventricular systolic dysfunction associated with MIS-C, average years of age 13.2 ± 3.8, treated from April 2020 to April 2021. Treatment failure (TF) was observed in 8 patients (in t","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Nesic","Dejan","From the Cardiology Department, Mother and Child Health Institute of Serbia School of Medicine, University of Belgrade Immunology Department, Mother and Child Health Institute of Serbia Intensive Care Unit, Mother and Child Health Institute of Serbia Surgery Department, Mother and Child Health Institute of Serbia Institute of Medical Physiology ""Rihard Burian"", Belgrade, Serbia",NA
"776","34260480","10.1097/INF.0000000000003270","DELAYED BRONCHIOLITIS EPIDEMIC IN FRENCH PRIMARY CARE SETTING DRIVEN BY RESPIRATORY SYNCYTIAL VIRUS: PRELIMINARY DATA FROM THE OURSYN STUDY, MARCH 2021.","We report early results from a prospective primary care bronchiolitis surveillance study in France in which a 10-week delayed epidemic was detected from February to March 2021. Among 225 children under 2 years with swab testing for a first bronchiolitis episode, 55% had a positive test for RSV, 0 for influenza, and 1 for severe acute respiratory syndrome coronavirus 2.","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Rybak","Alexis","From *ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France AFPA, Association Française de Pédiatrie Ambulatoire, Saint-Germain-en-Laye, France Assistance Publique - Hôpitaux de Paris, Pediatric Emergency Department, Robert Debré University Hospital, Université de Paris, Paris, France INSERM, ECEVE, UMRS 1123, Université de Paris, Paris, France niversité Paris Est, IMRB-GRC GEMINI Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, Créteil, France Sanofi Pasteur, Lyon, France",NA
"777","34260480","10.1097/INF.0000000000003270","DELAYED BRONCHIOLITIS EPIDEMIC IN FRENCH PRIMARY CARE SETTING DRIVEN BY RESPIRATORY SYNCYTIAL VIRUS: PRELIMINARY DATA FROM THE OURSYN STUDY, MARCH 2021.","We report early results from a prospective primary care bronchiolitis surveillance study in France in which a 10-week delayed epidemic was detected from February to March 2021. Among 225 children under 2 years with swab testing for a first bronchiolitis episode, 55% had a positive test for RSV, 0 for influenza, and 1 for severe acute respiratory syndrome coronavirus 2.","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Levy","Corinne","From *ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France AFPA, Association Française de Pédiatrie Ambulatoire, Saint-Germain-en-Laye, France Assistance Publique - Hôpitaux de Paris, Pediatric Emergency Department, Robert Debré University Hospital, Université de Paris, Paris, France INSERM, ECEVE, UMRS 1123, Université de Paris, Paris, France niversité Paris Est, IMRB-GRC GEMINI Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, Créteil, France Sanofi Pasteur, Lyon, France",NA
"778","34260480","10.1097/INF.0000000000003270","DELAYED BRONCHIOLITIS EPIDEMIC IN FRENCH PRIMARY CARE SETTING DRIVEN BY RESPIRATORY SYNCYTIAL VIRUS: PRELIMINARY DATA FROM THE OURSYN STUDY, MARCH 2021.","We report early results from a prospective primary care bronchiolitis surveillance study in France in which a 10-week delayed epidemic was detected from February to March 2021. Among 225 children under 2 years with swab testing for a first bronchiolitis episode, 55% had a positive test for RSV, 0 for influenza, and 1 for severe acute respiratory syndrome coronavirus 2.","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Jung","Camille","From *ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France AFPA, Association Française de Pédiatrie Ambulatoire, Saint-Germain-en-Laye, France Assistance Publique - Hôpitaux de Paris, Pediatric Emergency Department, Robert Debré University Hospital, Université de Paris, Paris, France INSERM, ECEVE, UMRS 1123, Université de Paris, Paris, France niversité Paris Est, IMRB-GRC GEMINI Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, Créteil, France Sanofi Pasteur, Lyon, France",NA
"779","34260480","10.1097/INF.0000000000003270","DELAYED BRONCHIOLITIS EPIDEMIC IN FRENCH PRIMARY CARE SETTING DRIVEN BY RESPIRATORY SYNCYTIAL VIRUS: PRELIMINARY DATA FROM THE OURSYN STUDY, MARCH 2021.","We report early results from a prospective primary care bronchiolitis surveillance study in France in which a 10-week delayed epidemic was detected from February to March 2021. Among 225 children under 2 years with swab testing for a first bronchiolitis episode, 55% had a positive test for RSV, 0 for influenza, and 1 for severe acute respiratory syndrome coronavirus 2.","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Béchet","Stéphane","From *ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France AFPA, Association Française de Pédiatrie Ambulatoire, Saint-Germain-en-Laye, France Assistance Publique - Hôpitaux de Paris, Pediatric Emergency Department, Robert Debré University Hospital, Université de Paris, Paris, France INSERM, ECEVE, UMRS 1123, Université de Paris, Paris, France niversité Paris Est, IMRB-GRC GEMINI Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, Créteil, France Sanofi Pasteur, Lyon, France",NA
"780","34260480","10.1097/INF.0000000000003270","DELAYED BRONCHIOLITIS EPIDEMIC IN FRENCH PRIMARY CARE SETTING DRIVEN BY RESPIRATORY SYNCYTIAL VIRUS: PRELIMINARY DATA FROM THE OURSYN STUDY, MARCH 2021.","We report early results from a prospective primary care bronchiolitis surveillance study in France in which a 10-week delayed epidemic was detected from February to March 2021. Among 225 children under 2 years with swab testing for a first bronchiolitis episode, 55% had a positive test for RSV, 0 for influenza, and 1 for severe acute respiratory syndrome coronavirus 2.","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Batard","Christophe","From *ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France AFPA, Association Française de Pédiatrie Ambulatoire, Saint-Germain-en-Laye, France Assistance Publique - Hôpitaux de Paris, Pediatric Emergency Department, Robert Debré University Hospital, Université de Paris, Paris, France INSERM, ECEVE, UMRS 1123, Université de Paris, Paris, France niversité Paris Est, IMRB-GRC GEMINI Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, Créteil, France Sanofi Pasteur, Lyon, France",NA
"781","34260480","10.1097/INF.0000000000003270","DELAYED BRONCHIOLITIS EPIDEMIC IN FRENCH PRIMARY CARE SETTING DRIVEN BY RESPIRATORY SYNCYTIAL VIRUS: PRELIMINARY DATA FROM THE OURSYN STUDY, MARCH 2021.","We report early results from a prospective primary care bronchiolitis surveillance study in France in which a 10-week delayed epidemic was detected from February to March 2021. Among 225 children under 2 years with swab testing for a first bronchiolitis episode, 55% had a positive test for RSV, 0 for influenza, and 1 for severe acute respiratory syndrome coronavirus 2.","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Hassid","Frédéric","From *ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France AFPA, Association Française de Pédiatrie Ambulatoire, Saint-Germain-en-Laye, France Assistance Publique - Hôpitaux de Paris, Pediatric Emergency Department, Robert Debré University Hospital, Université de Paris, Paris, France INSERM, ECEVE, UMRS 1123, Université de Paris, Paris, France niversité Paris Est, IMRB-GRC GEMINI Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, Créteil, France Sanofi Pasteur, Lyon, France",NA
"782","34260480","10.1097/INF.0000000000003270","DELAYED BRONCHIOLITIS EPIDEMIC IN FRENCH PRIMARY CARE SETTING DRIVEN BY RESPIRATORY SYNCYTIAL VIRUS: PRELIMINARY DATA FROM THE OURSYN STUDY, MARCH 2021.","We report early results from a prospective primary care bronchiolitis surveillance study in France in which a 10-week delayed epidemic was detected from February to March 2021. Among 225 children under 2 years with swab testing for a first bronchiolitis episode, 55% had a positive test for RSV, 0 for influenza, and 1 for severe acute respiratory syndrome coronavirus 2.","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Zouari","Morched","From *ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France AFPA, Association Française de Pédiatrie Ambulatoire, Saint-Germain-en-Laye, France Assistance Publique - Hôpitaux de Paris, Pediatric Emergency Department, Robert Debré University Hospital, Université de Paris, Paris, France INSERM, ECEVE, UMRS 1123, Université de Paris, Paris, France niversité Paris Est, IMRB-GRC GEMINI Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, Créteil, France Sanofi Pasteur, Lyon, France",NA
"783","34260480","10.1097/INF.0000000000003270","DELAYED BRONCHIOLITIS EPIDEMIC IN FRENCH PRIMARY CARE SETTING DRIVEN BY RESPIRATORY SYNCYTIAL VIRUS: PRELIMINARY DATA FROM THE OURSYN STUDY, MARCH 2021.","We report early results from a prospective primary care bronchiolitis surveillance study in France in which a 10-week delayed epidemic was detected from February to March 2021. Among 225 children under 2 years with swab testing for a first bronchiolitis episode, 55% had a positive test for RSV, 0 for influenza, and 1 for severe acute respiratory syndrome coronavirus 2.","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Cahn-Sellem","Fabienne","From *ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France AFPA, Association Française de Pédiatrie Ambulatoire, Saint-Germain-en-Laye, France Assistance Publique - Hôpitaux de Paris, Pediatric Emergency Department, Robert Debré University Hospital, Université de Paris, Paris, France INSERM, ECEVE, UMRS 1123, Université de Paris, Paris, France niversité Paris Est, IMRB-GRC GEMINI Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, Créteil, France Sanofi Pasteur, Lyon, France",NA
"784","34260480","10.1097/INF.0000000000003270","DELAYED BRONCHIOLITIS EPIDEMIC IN FRENCH PRIMARY CARE SETTING DRIVEN BY RESPIRATORY SYNCYTIAL VIRUS: PRELIMINARY DATA FROM THE OURSYN STUDY, MARCH 2021.","We report early results from a prospective primary care bronchiolitis surveillance study in France in which a 10-week delayed epidemic was detected from February to March 2021. Among 225 children under 2 years with swab testing for a first bronchiolitis episode, 55% had a positive test for RSV, 0 for influenza, and 1 for severe acute respiratory syndrome coronavirus 2.","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Bangert","Mathieu","From *ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France AFPA, Association Française de Pédiatrie Ambulatoire, Saint-Germain-en-Laye, France Assistance Publique - Hôpitaux de Paris, Pediatric Emergency Department, Robert Debré University Hospital, Université de Paris, Paris, France INSERM, ECEVE, UMRS 1123, Université de Paris, Paris, France niversité Paris Est, IMRB-GRC GEMINI Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, Créteil, France Sanofi Pasteur, Lyon, France",NA
"785","34260480","10.1097/INF.0000000000003270","DELAYED BRONCHIOLITIS EPIDEMIC IN FRENCH PRIMARY CARE SETTING DRIVEN BY RESPIRATORY SYNCYTIAL VIRUS: PRELIMINARY DATA FROM THE OURSYN STUDY, MARCH 2021.","We report early results from a prospective primary care bronchiolitis surveillance study in France in which a 10-week delayed epidemic was detected from February to March 2021. Among 225 children under 2 years with swab testing for a first bronchiolitis episode, 55% had a positive test for RSV, 0 for influenza, and 1 for severe acute respiratory syndrome coronavirus 2.","2021","07","16","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Cohen","Robert","From *ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France AFPA, Association Française de Pédiatrie Ambulatoire, Saint-Germain-en-Laye, France Assistance Publique - Hôpitaux de Paris, Pediatric Emergency Department, Robert Debré University Hospital, Université de Paris, Paris, France INSERM, ECEVE, UMRS 1123, Université de Paris, Paris, France niversité Paris Est, IMRB-GRC GEMINI Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, Créteil, France Sanofi Pasteur, Lyon, France",NA
"786","34260439","10.1097/NNA.0000000000001032","COVID-19: The Lived Experience of Critical Care Nurses.","The goal of this qualitative phenomenological study was to explore in-depth, critical care nurses' (CCNs) lived experience while caring for coronavirus disease 2019 (COVID-19) patients during the pandemic. CCNs play an important role during pandemics characterized by highly contagious, life-threatening disease. Understanding the experience of CCNs during a pandemic is particularly important because of the high rate of burnout within this group, as well as a shortage of these caregivers across th","2021","07","16","J Nurs Adm","The Journal of nursing administration",NA,"Brockopp","Dorothy","Author Affiliations: Coordinator (Dr Brockopp) and Research Consultant (Drs Monroe and Davies), Nursing and Allied Health Research Office, and Clinical Nurse (Ms Cawood) and Director (Ms Cantrell), Intensive Care Unit, Baptist Health Lexington, Kentucky",NA
"787","34260439","10.1097/NNA.0000000000001032","COVID-19: The Lived Experience of Critical Care Nurses.","The goal of this qualitative phenomenological study was to explore in-depth, critical care nurses' (CCNs) lived experience while caring for coronavirus disease 2019 (COVID-19) patients during the pandemic. CCNs play an important role during pandemics characterized by highly contagious, life-threatening disease. Understanding the experience of CCNs during a pandemic is particularly important because of the high rate of burnout within this group, as well as a shortage of these caregivers across th","2021","07","16","J Nurs Adm","The Journal of nursing administration",NA,"Monroe","Martha","Author Affiliations: Coordinator (Dr Brockopp) and Research Consultant (Drs Monroe and Davies), Nursing and Allied Health Research Office, and Clinical Nurse (Ms Cawood) and Director (Ms Cantrell), Intensive Care Unit, Baptist Health Lexington, Kentucky",NA
"788","34260439","10.1097/NNA.0000000000001032","COVID-19: The Lived Experience of Critical Care Nurses.","The goal of this qualitative phenomenological study was to explore in-depth, critical care nurses' (CCNs) lived experience while caring for coronavirus disease 2019 (COVID-19) patients during the pandemic. CCNs play an important role during pandemics characterized by highly contagious, life-threatening disease. Understanding the experience of CCNs during a pandemic is particularly important because of the high rate of burnout within this group, as well as a shortage of these caregivers across th","2021","07","16","J Nurs Adm","The Journal of nursing administration",NA,"Davies","Claire C","Author Affiliations: Coordinator (Dr Brockopp) and Research Consultant (Drs Monroe and Davies), Nursing and Allied Health Research Office, and Clinical Nurse (Ms Cawood) and Director (Ms Cantrell), Intensive Care Unit, Baptist Health Lexington, Kentucky",NA
"789","34260439","10.1097/NNA.0000000000001032","COVID-19: The Lived Experience of Critical Care Nurses.","The goal of this qualitative phenomenological study was to explore in-depth, critical care nurses' (CCNs) lived experience while caring for coronavirus disease 2019 (COVID-19) patients during the pandemic. CCNs play an important role during pandemics characterized by highly contagious, life-threatening disease. Understanding the experience of CCNs during a pandemic is particularly important because of the high rate of burnout within this group, as well as a shortage of these caregivers across th","2021","07","16","J Nurs Adm","The Journal of nursing administration",NA,"Cawood","Meghan","Author Affiliations: Coordinator (Dr Brockopp) and Research Consultant (Drs Monroe and Davies), Nursing and Allied Health Research Office, and Clinical Nurse (Ms Cawood) and Director (Ms Cantrell), Intensive Care Unit, Baptist Health Lexington, Kentucky",NA
"790","34260439","10.1097/NNA.0000000000001032","COVID-19: The Lived Experience of Critical Care Nurses.","The goal of this qualitative phenomenological study was to explore in-depth, critical care nurses' (CCNs) lived experience while caring for coronavirus disease 2019 (COVID-19) patients during the pandemic. CCNs play an important role during pandemics characterized by highly contagious, life-threatening disease. Understanding the experience of CCNs during a pandemic is particularly important because of the high rate of burnout within this group, as well as a shortage of these caregivers across th","2021","07","16","J Nurs Adm","The Journal of nursing administration",NA,"Cantrell","Donita","Author Affiliations: Coordinator (Dr Brockopp) and Research Consultant (Drs Monroe and Davies), Nursing and Allied Health Research Office, and Clinical Nurse (Ms Cawood) and Director (Ms Cantrell), Intensive Care Unit, Baptist Health Lexington, Kentucky",NA
"791","34260375","10.2196/31544","Correction: Quantifying Online News Media Coverage of the COVID-19 Pandemic: Text Mining Study and Resource.","[This corrects the article DOI: 10.2196/28253.].","2021","07","14","J Med Internet Res","Journal of medical Internet research",NA,"Krawczyk","Konrad","Department of Mathematics and Computer Science, University of Southern Denmark, Odense, Denmark",NA
"792","34260375","10.2196/31544","Correction: Quantifying Online News Media Coverage of the COVID-19 Pandemic: Text Mining Study and Resource.","[This corrects the article DOI: 10.2196/28253.].","2021","07","14","J Med Internet Res","Journal of medical Internet research",NA,"Chelkowski","Tadeusz","Department of Management in the Network Society, Kozminski University, Warsaw, Poland",NA
"793","34260375","10.2196/31544","Correction: Quantifying Online News Media Coverage of the COVID-19 Pandemic: Text Mining Study and Resource.","[This corrects the article DOI: 10.2196/28253.].","2021","07","14","J Med Internet Res","Journal of medical Internet research",NA,"Laydon","Daniel J","Department of Infectious Disease Epidemiology, MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom",NA
"794","34260375","10.2196/31544","Correction: Quantifying Online News Media Coverage of the COVID-19 Pandemic: Text Mining Study and Resource.","[This corrects the article DOI: 10.2196/28253.].","2021","07","14","J Med Internet Res","Journal of medical Internet research",NA,"Mishra","Swapnil","Department of Infectious Disease Epidemiology, MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom",NA
"795","34260375","10.2196/31544","Correction: Quantifying Online News Media Coverage of the COVID-19 Pandemic: Text Mining Study and Resource.","[This corrects the article DOI: 10.2196/28253.].","2021","07","14","J Med Internet Res","Journal of medical Internet research",NA,"Xifara","Denise","Nupinion, London, United Kingdom",NA
"796","34260375","10.2196/31544","Correction: Quantifying Online News Media Coverage of the COVID-19 Pandemic: Text Mining Study and Resource.","[This corrects the article DOI: 10.2196/28253.].","2021","07","14","J Med Internet Res","Journal of medical Internet research",NA,"Gibert","Benjamin","Nupinion, London, United Kingdom",NA
"797","34260375","10.2196/31544","Correction: Quantifying Online News Media Coverage of the COVID-19 Pandemic: Text Mining Study and Resource.","[This corrects the article DOI: 10.2196/28253.].","2021","07","14","J Med Internet Res","Journal of medical Internet research",NA,"Flaxman","Seth","Department of Mathematics, Imperial College London, London, United Kingdom",NA
"798","34260375","10.2196/31544","Correction: Quantifying Online News Media Coverage of the COVID-19 Pandemic: Text Mining Study and Resource.","[This corrects the article DOI: 10.2196/28253.].","2021","07","14","J Med Internet Res","Journal of medical Internet research",NA,"Mellan","Thomas","Department of Infectious Disease Epidemiology, MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom",NA
"799","34260375","10.2196/31544","Correction: Quantifying Online News Media Coverage of the COVID-19 Pandemic: Text Mining Study and Resource.","[This corrects the article DOI: 10.2196/28253.].","2021","07","14","J Med Internet Res","Journal of medical Internet research",NA,"Schwämmle","Veit","Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark",NA
"800","34260375","10.2196/31544","Correction: Quantifying Online News Media Coverage of the COVID-19 Pandemic: Text Mining Study and Resource.","[This corrects the article DOI: 10.2196/28253.].","2021","07","14","J Med Internet Res","Journal of medical Internet research",NA,"Röttger","Richard","Department of Mathematics and Computer Science, University of Southern Denmark, Odense, Denmark",NA
"801","34260375","10.2196/31544","Correction: Quantifying Online News Media Coverage of the COVID-19 Pandemic: Text Mining Study and Resource.","[This corrects the article DOI: 10.2196/28253.].","2021","07","14","J Med Internet Res","Journal of medical Internet research",NA,"Hadsund","Johannes T","Department of Mathematics and Computer Science, University of Southern Denmark, Odense, Denmark",NA
"802","34260375","10.2196/31544","Correction: Quantifying Online News Media Coverage of the COVID-19 Pandemic: Text Mining Study and Resource.","[This corrects the article DOI: 10.2196/28253.].","2021","07","14","J Med Internet Res","Journal of medical Internet research",NA,"Bhatt","Samir","Department of Infectious Disease Epidemiology, MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom",NA
"803","34260338","10.1080/17538157.2021.1951274","The more the merrier! Barriers and facilitators to the general public's use of a COVID-19 contact tracing app in New Zealand.","Contact tracing for infectious diseases can be partially automated using mobile applications. However, the success of these tools is dependent on significant uptake and frequent use by the public. This study explored the barriers and facilitators to the New Zealand (NZ) general public's use of the COVID-19 contact NZ COVID Tracer app. Adults (=18 years, N = 373) in NZ. Qualitative and quantitative data were gathered from a nation-wide online survey. App use and frequency of use were prese","2021","07","14","Inform Health Soc Care","Informatics for health &amp; social care","Coronavirus; contact tracing; mobile apps; perceptions; public health","Gasteiger","Norina","Department of Psychological Medicine, University of Auckland, Auckland, New Zealand",NA
"804","34260338","10.1080/17538157.2021.1951274","The more the merrier! Barriers and facilitators to the general public's use of a COVID-19 contact tracing app in New Zealand.","Contact tracing for infectious diseases can be partially automated using mobile applications. However, the success of these tools is dependent on significant uptake and frequent use by the public. This study explored the barriers and facilitators to the New Zealand (NZ) general public's use of the COVID-19 contact NZ COVID Tracer app. Adults (=18 years, N = 373) in NZ. Qualitative and quantitative data were gathered from a nation-wide online survey. App use and frequency of use were prese","2021","07","14","Inform Health Soc Care","Informatics for health &amp; social care","Coronavirus; contact tracing; mobile apps; perceptions; public health","Gasteiger","Chiara","Department of Psychological Medicine, University of Auckland, Auckland, New Zealand",NA
"805","34260338","10.1080/17538157.2021.1951274","The more the merrier! Barriers and facilitators to the general public's use of a COVID-19 contact tracing app in New Zealand.","Contact tracing for infectious diseases can be partially automated using mobile applications. However, the success of these tools is dependent on significant uptake and frequent use by the public. This study explored the barriers and facilitators to the New Zealand (NZ) general public's use of the COVID-19 contact NZ COVID Tracer app. Adults (=18 years, N = 373) in NZ. Qualitative and quantitative data were gathered from a nation-wide online survey. App use and frequency of use were prese","2021","07","14","Inform Health Soc Care","Informatics for health &amp; social care","Coronavirus; contact tracing; mobile apps; perceptions; public health","Vedhara","Kavita","Division of Primary Care, University of Nottingham, University Park, Nottingham, United Kingdom",NA
"806","34260338","10.1080/17538157.2021.1951274","The more the merrier! Barriers and facilitators to the general public's use of a COVID-19 contact tracing app in New Zealand.","Contact tracing for infectious diseases can be partially automated using mobile applications. However, the success of these tools is dependent on significant uptake and frequent use by the public. This study explored the barriers and facilitators to the New Zealand (NZ) general public's use of the COVID-19 contact NZ COVID Tracer app. Adults (=18 years, N = 373) in NZ. Qualitative and quantitative data were gathered from a nation-wide online survey. App use and frequency of use were prese","2021","07","14","Inform Health Soc Care","Informatics for health &amp; social care","Coronavirus; contact tracing; mobile apps; perceptions; public health","Broadbent","Elizabeth","Department of Psychological Medicine, University of Auckland, Auckland, New Zealand",NA
"807","34260328","10.1080/09537104.2021.1952179","Platelet-leukocyte interactions in the pathogenesis of viral infections.","Evolving evidence demonstrates that platelets have major roles in viral syndromes through previously unrecognized viral sensing and effector functions. Activated platelets and increased platelet-leukocyte aggregates are observed in clinical and experimental viral infections. The mechanisms and outcomes of platelet-leukocyte interactions depend on the interacting leukocyte as well as on the pathogen and pathological conditions. In this review, we discuss the mechanisms involved in platelet intera","2021","07","14","Platelets","Platelets","COVID-19; Dengue; HIV; Influenza; platelet-leukocyte aggregates; platelets","Hottz","Eugenio D","Laboratory of Immunothrombosis, Department of Biochemistry, Institute of Biological Sciences, Federal University of Juiz de Fora, Juiz de Fora, MG, Brazil",NA
"808","34260328","10.1080/09537104.2021.1952179","Platelet-leukocyte interactions in the pathogenesis of viral infections.","Evolving evidence demonstrates that platelets have major roles in viral syndromes through previously unrecognized viral sensing and effector functions. Activated platelets and increased platelet-leukocyte aggregates are observed in clinical and experimental viral infections. The mechanisms and outcomes of platelet-leukocyte interactions depend on the interacting leukocyte as well as on the pathogen and pathological conditions. In this review, we discuss the mechanisms involved in platelet intera","2021","07","14","Platelets","Platelets","COVID-19; Dengue; HIV; Influenza; platelet-leukocyte aggregates; platelets","Quirino-Teixeira","Anna Cecíllia","Laboratory of Immunothrombosis, Department of Biochemistry, Institute of Biological Sciences, Federal University of Juiz de Fora, Juiz de Fora, MG, Brazil",NA
"809","34260328","10.1080/09537104.2021.1952179","Platelet-leukocyte interactions in the pathogenesis of viral infections.","Evolving evidence demonstrates that platelets have major roles in viral syndromes through previously unrecognized viral sensing and effector functions. Activated platelets and increased platelet-leukocyte aggregates are observed in clinical and experimental viral infections. The mechanisms and outcomes of platelet-leukocyte interactions depend on the interacting leukocyte as well as on the pathogen and pathological conditions. In this review, we discuss the mechanisms involved in platelet intera","2021","07","14","Platelets","Platelets","COVID-19; Dengue; HIV; Influenza; platelet-leukocyte aggregates; platelets","Merij","Laura Botelho","Laboratory of Immunothrombosis, Department of Biochemistry, Institute of Biological Sciences, Federal University of Juiz de Fora, Juiz de Fora, MG, Brazil",NA
"810","34260328","10.1080/09537104.2021.1952179","Platelet-leukocyte interactions in the pathogenesis of viral infections.","Evolving evidence demonstrates that platelets have major roles in viral syndromes through previously unrecognized viral sensing and effector functions. Activated platelets and increased platelet-leukocyte aggregates are observed in clinical and experimental viral infections. The mechanisms and outcomes of platelet-leukocyte interactions depend on the interacting leukocyte as well as on the pathogen and pathological conditions. In this review, we discuss the mechanisms involved in platelet intera","2021","07","14","Platelets","Platelets","COVID-19; Dengue; HIV; Influenza; platelet-leukocyte aggregates; platelets","Pinheiro","Mariana Brandi Mendonça","Laboratory of Immunothrombosis, Department of Biochemistry, Institute of Biological Sciences, Federal University of Juiz de Fora, Juiz de Fora, MG, Brazil",NA
"811","34260328","10.1080/09537104.2021.1952179","Platelet-leukocyte interactions in the pathogenesis of viral infections.","Evolving evidence demonstrates that platelets have major roles in viral syndromes through previously unrecognized viral sensing and effector functions. Activated platelets and increased platelet-leukocyte aggregates are observed in clinical and experimental viral infections. The mechanisms and outcomes of platelet-leukocyte interactions depend on the interacting leukocyte as well as on the pathogen and pathological conditions. In this review, we discuss the mechanisms involved in platelet intera","2021","07","14","Platelets","Platelets","COVID-19; Dengue; HIV; Influenza; platelet-leukocyte aggregates; platelets","Rozini","Stephane Vicente","Laboratory of Immunothrombosis, Department of Biochemistry, Institute of Biological Sciences, Federal University of Juiz de Fora, Juiz de Fora, MG, Brazil",NA
"812","34260328","10.1080/09537104.2021.1952179","Platelet-leukocyte interactions in the pathogenesis of viral infections.","Evolving evidence demonstrates that platelets have major roles in viral syndromes through previously unrecognized viral sensing and effector functions. Activated platelets and increased platelet-leukocyte aggregates are observed in clinical and experimental viral infections. The mechanisms and outcomes of platelet-leukocyte interactions depend on the interacting leukocyte as well as on the pathogen and pathological conditions. In this review, we discuss the mechanisms involved in platelet intera","2021","07","14","Platelets","Platelets","COVID-19; Dengue; HIV; Influenza; platelet-leukocyte aggregates; platelets","Bozza","Fernando A","Laboratory of Clinical Research in Intensive Care Medicine, National Institute of Infectious Disease Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro , Brazil",NA
"813","34260328","10.1080/09537104.2021.1952179","Platelet-leukocyte interactions in the pathogenesis of viral infections.","Evolving evidence demonstrates that platelets have major roles in viral syndromes through previously unrecognized viral sensing and effector functions. Activated platelets and increased platelet-leukocyte aggregates are observed in clinical and experimental viral infections. The mechanisms and outcomes of platelet-leukocyte interactions depend on the interacting leukocyte as well as on the pathogen and pathological conditions. In this review, we discuss the mechanisms involved in platelet intera","2021","07","14","Platelets","Platelets","COVID-19; Dengue; HIV; Influenza; platelet-leukocyte aggregates; platelets","Bozza","Patrícia T","Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil",NA
"814","34260323","10.1259/bjr.20201220","The eyes see what the mind seeks: a systematic review of abdominal imaging findings in patients with COVID-19.","With the increasing recognition of gastrointestinal (GI) manifestation of coronavirus disease-19 (COVID-19), various abdominal imaging findings are increasingly being noted. We scoped the existing literature on the abdominal imaging findings in COVID-19. A systematic literature search was performed on PubMed, Embase, Google scholar and World Health Organization COVID-19 database. 35 studies were included in the final descriptive synthesis. Among the studies reporting positive abdominal imaging f","2021","07","21","Br J Radiol","The British journal of radiology",NA,"Agarwal","Lokesh","Department of Gastrointestinal Surgery and Liver Transplantation, All India Institute of Medical Sciences (AIIMS), New Delhi, India",NA
"815","34260323","10.1259/bjr.20201220","The eyes see what the mind seeks: a systematic review of abdominal imaging findings in patients with COVID-19.","With the increasing recognition of gastrointestinal (GI) manifestation of coronavirus disease-19 (COVID-19), various abdominal imaging findings are increasingly being noted. We scoped the existing literature on the abdominal imaging findings in COVID-19. A systematic literature search was performed on PubMed, Embase, Google scholar and World Health Organization COVID-19 database. 35 studies were included in the final descriptive synthesis. Among the studies reporting positive abdominal imaging f","2021","07","21","Br J Radiol","The British journal of radiology",NA,"Agarwal","Ayushi","Department of Radiodiagnosis and Interventional Radiology, All India Institute of Medical Sciences (AIIMS), New Delhi, India",NA
"816","34260323","10.1259/bjr.20201220","The eyes see what the mind seeks: a systematic review of abdominal imaging findings in patients with COVID-19.","With the increasing recognition of gastrointestinal (GI) manifestation of coronavirus disease-19 (COVID-19), various abdominal imaging findings are increasingly being noted. We scoped the existing literature on the abdominal imaging findings in COVID-19. A systematic literature search was performed on PubMed, Embase, Google scholar and World Health Organization COVID-19 database. 35 studies were included in the final descriptive synthesis. Among the studies reporting positive abdominal imaging f","2021","07","21","Br J Radiol","The British journal of radiology",NA,"Advani","Shailesh","Department of Oncology, Lombardi Comprehensive cancer Center, Georgetown University, Washington, DC, Washington, DC, USA",NA
"817","34260323","10.1259/bjr.20201220","The eyes see what the mind seeks: a systematic review of abdominal imaging findings in patients with COVID-19.","With the increasing recognition of gastrointestinal (GI) manifestation of coronavirus disease-19 (COVID-19), various abdominal imaging findings are increasingly being noted. We scoped the existing literature on the abdominal imaging findings in COVID-19. A systematic literature search was performed on PubMed, Embase, Google scholar and World Health Organization COVID-19 database. 35 studies were included in the final descriptive synthesis. Among the studies reporting positive abdominal imaging f","2021","07","21","Br J Radiol","The British journal of radiology",NA,"Katiyar","Varidh","Department of Neurosurgery, All India Institute of Medical Sciences (AIIMS), New Delhi, India",NA
"818","34260323","10.1259/bjr.20201220","The eyes see what the mind seeks: a systematic review of abdominal imaging findings in patients with COVID-19.","With the increasing recognition of gastrointestinal (GI) manifestation of coronavirus disease-19 (COVID-19), various abdominal imaging findings are increasingly being noted. We scoped the existing literature on the abdominal imaging findings in COVID-19. A systematic literature search was performed on PubMed, Embase, Google scholar and World Health Organization COVID-19 database. 35 studies were included in the final descriptive synthesis. Among the studies reporting positive abdominal imaging f","2021","07","21","Br J Radiol","The British journal of radiology",NA,"Chaturvedi","Aprajita","Department of Surgery, All India Institute of Medical Sciences (AIIMS), New Delhi, India",NA
"819","34260323","10.1259/bjr.20201220","The eyes see what the mind seeks: a systematic review of abdominal imaging findings in patients with COVID-19.","With the increasing recognition of gastrointestinal (GI) manifestation of coronavirus disease-19 (COVID-19), various abdominal imaging findings are increasingly being noted. We scoped the existing literature on the abdominal imaging findings in COVID-19. A systematic literature search was performed on PubMed, Embase, Google scholar and World Health Organization COVID-19 database. 35 studies were included in the final descriptive synthesis. Among the studies reporting positive abdominal imaging f","2021","07","21","Br J Radiol","The British journal of radiology",NA,"Madhusudhan","Kumble Seetharama","Department of Radiodiagnosis and Interventional Radiology, All India Institute of Medical Sciences (AIIMS), New Delhi, India",NA
"820","34260313","10.1377/hlthaff.2021.00323","Larger Nursing Home Staff Size Linked To Higher Number Of COVID-19 Cases In 2020.","Staff in skilled nursing facilities (SNFs) are essential health care workers, yet they can also be a source of COVID-19 transmission. We used detailed staffing data to examine the relationship between a novel measure of staff size (that is, the number of unique employees working daily), conventional measures of staffing quality, and COVID-19 outcomes among SNFs in the United States without confirmed COVID-19 cases by June 2020. By the end of September 2020, sample SNFs in the lowest quartile of ","2021","07","23","Health Aff (Millwood)","Health affairs (Project Hope)",NA,"McGarry","Brian E","Brian E. McGarry (brian_mcgarry@urmc.rochester.edu) is an assistant professor in the Department of Medicine, University of Rochester, in Rochester, New York","mcgarry@urmc.rochester.edu"
"821","34260313","10.1377/hlthaff.2021.00323","Larger Nursing Home Staff Size Linked To Higher Number Of COVID-19 Cases In 2020.","Staff in skilled nursing facilities (SNFs) are essential health care workers, yet they can also be a source of COVID-19 transmission. We used detailed staffing data to examine the relationship between a novel measure of staff size (that is, the number of unique employees working daily), conventional measures of staffing quality, and COVID-19 outcomes among SNFs in the United States without confirmed COVID-19 cases by June 2020. By the end of September 2020, sample SNFs in the lowest quartile of ","2021","07","23","Health Aff (Millwood)","Health affairs (Project Hope)",NA,"Gandhi","Ashvin D","Ashvin D. Gandhi is an assistant professor at the University of California Los Angeles Anderson School of Management, in Los Angeles, California",NA
"822","34260313","10.1377/hlthaff.2021.00323","Larger Nursing Home Staff Size Linked To Higher Number Of COVID-19 Cases In 2020.","Staff in skilled nursing facilities (SNFs) are essential health care workers, yet they can also be a source of COVID-19 transmission. We used detailed staffing data to examine the relationship between a novel measure of staff size (that is, the number of unique employees working daily), conventional measures of staffing quality, and COVID-19 outcomes among SNFs in the United States without confirmed COVID-19 cases by June 2020. By the end of September 2020, sample SNFs in the lowest quartile of ","2021","07","23","Health Aff (Millwood)","Health affairs (Project Hope)",NA,"Grabowski","David C","David C. Grabowski is a professor of health care policy at Harvard Medical School, in Boston, Massachusetts",NA
"823","34260313","10.1377/hlthaff.2021.00323","Larger Nursing Home Staff Size Linked To Higher Number Of COVID-19 Cases In 2020.","Staff in skilled nursing facilities (SNFs) are essential health care workers, yet they can also be a source of COVID-19 transmission. We used detailed staffing data to examine the relationship between a novel measure of staff size (that is, the number of unique employees working daily), conventional measures of staffing quality, and COVID-19 outcomes among SNFs in the United States without confirmed COVID-19 cases by June 2020. By the end of September 2020, sample SNFs in the lowest quartile of ","2021","07","23","Health Aff (Millwood)","Health affairs (Project Hope)",NA,"Barnett","Michael Lawrence","Michael Lawrence Barnett is an assistant professor of health policy and management, Harvard T. H. Chan School of Public Health, in Boston, Massachusetts, and an assistant professor of medicine at Harvard Medical School",NA
"824","34260295","10.1177/00368504211029812","Perception towards E-learning and COVID-19 on the mental health status of university students in Malaysia.","The COVID-19 pandemic has disrupted the lives of all including university students. With the preventive measures to reduce the transmission of COVID-19, all face-to-face teaching and learning are converted to e-learning. The COVID-19 pandemic and the implementation of e-learning may influence these students' mental conditions. This study aimed to determine the association of factors with mental health status (depression, anxiety and stress) among university students in Malaysia. Study participan","2021","07","16","Sci Prog","Science progress","COVID-19; anxiety; depression; e-learning; mental status; stress; university students","Moy","Foong Ming","Centre of Evidence Based Practice, Department of Social &amp",NA
"825","34260295","10.1177/00368504211029812","Perception towards E-learning and COVID-19 on the mental health status of university students in Malaysia.","The COVID-19 pandemic has disrupted the lives of all including university students. With the preventive measures to reduce the transmission of COVID-19, all face-to-face teaching and learning are converted to e-learning. The COVID-19 pandemic and the implementation of e-learning may influence these students' mental conditions. This study aimed to determine the association of factors with mental health status (depression, anxiety and stress) among university students in Malaysia. Study participan","2021","07","16","Sci Prog","Science progress","COVID-19; anxiety; depression; e-learning; mental status; stress; university students","Ng","Yit Han","Centre of Evidence Based Practice, Department of Social &amp",NA
"826","34260276","10.1128/JCM.01167-21","Considerations from the College of American Pathologists for implementation of an assay for SARS-CoV-2 testing after a change in regulatory status.","The U.S. Food &amp; Drug Administration FDA regulates the marketing of manufacturers' in vitro diagnostic tests IVDs including assays for the detection of SARS-CoV-2. The U.S. government's Clinical Laboratory Improvement Amendments CLIA of 1988 regulate the studies that a clinical diagnostic laboratory needs to perform for an IVD before placing it into use. Until recently, the FDA has authorized the marketing of SARS-CoV-2 IVDs exclusively through the Emergency Use Authorization EUA pathw","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Peaper","David R","Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT",NA
"827","34260276","10.1128/JCM.01167-21","Considerations from the College of American Pathologists for implementation of an assay for SARS-CoV-2 testing after a change in regulatory status.","The U.S. Food &amp; Drug Administration FDA regulates the marketing of manufacturers' in vitro diagnostic tests IVDs including assays for the detection of SARS-CoV-2. The U.S. government's Clinical Laboratory Improvement Amendments CLIA of 1988 regulate the studies that a clinical diagnostic laboratory needs to perform for an IVD before placing it into use. Until recently, the FDA has authorized the marketing of SARS-CoV-2 IVDs exclusively through the Emergency Use Authorization EUA pathw","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Rhoads","Daniel D","Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH",NA
"828","34260276","10.1128/JCM.01167-21","Considerations from the College of American Pathologists for implementation of an assay for SARS-CoV-2 testing after a change in regulatory status.","The U.S. Food &amp; Drug Administration FDA regulates the marketing of manufacturers' in vitro diagnostic tests IVDs including assays for the detection of SARS-CoV-2. The U.S. government's Clinical Laboratory Improvement Amendments CLIA of 1988 regulate the studies that a clinical diagnostic laboratory needs to perform for an IVD before placing it into use. Until recently, the FDA has authorized the marketing of SARS-CoV-2 IVDs exclusively through the Emergency Use Authorization EUA pathw","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Sullivan","Kaede V","Department of Pathology and Laboratory Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA",NA
"829","34260276","10.1128/JCM.01167-21","Considerations from the College of American Pathologists for implementation of an assay for SARS-CoV-2 testing after a change in regulatory status.","The U.S. Food &amp; Drug Administration FDA regulates the marketing of manufacturers' in vitro diagnostic tests IVDs including assays for the detection of SARS-CoV-2. The U.S. government's Clinical Laboratory Improvement Amendments CLIA of 1988 regulate the studies that a clinical diagnostic laboratory needs to perform for an IVD before placing it into use. Until recently, the FDA has authorized the marketing of SARS-CoV-2 IVDs exclusively through the Emergency Use Authorization EUA pathw","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Couturier","Marc R","Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA",NA
"830","34260276","10.1128/JCM.01167-21","Considerations from the College of American Pathologists for implementation of an assay for SARS-CoV-2 testing after a change in regulatory status.","The U.S. Food &amp; Drug Administration FDA regulates the marketing of manufacturers' in vitro diagnostic tests IVDs including assays for the detection of SARS-CoV-2. The U.S. government's Clinical Laboratory Improvement Amendments CLIA of 1988 regulate the studies that a clinical diagnostic laboratory needs to perform for an IVD before placing it into use. Until recently, the FDA has authorized the marketing of SARS-CoV-2 IVDs exclusively through the Emergency Use Authorization EUA pathw","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Humphries","Romney M","Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN",NA
"831","34260276","10.1128/JCM.01167-21","Considerations from the College of American Pathologists for implementation of an assay for SARS-CoV-2 testing after a change in regulatory status.","The U.S. Food &amp; Drug Administration FDA regulates the marketing of manufacturers' in vitro diagnostic tests IVDs including assays for the detection of SARS-CoV-2. The U.S. government's Clinical Laboratory Improvement Amendments CLIA of 1988 regulate the studies that a clinical diagnostic laboratory needs to perform for an IVD before placing it into use. Until recently, the FDA has authorized the marketing of SARS-CoV-2 IVDs exclusively through the Emergency Use Authorization EUA pathw","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Martin","Isabella W","Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center",NA
"832","34260276","10.1128/JCM.01167-21","Considerations from the College of American Pathologists for implementation of an assay for SARS-CoV-2 testing after a change in regulatory status.","The U.S. Food &amp; Drug Administration FDA regulates the marketing of manufacturers' in vitro diagnostic tests IVDs including assays for the detection of SARS-CoV-2. The U.S. government's Clinical Laboratory Improvement Amendments CLIA of 1988 regulate the studies that a clinical diagnostic laboratory needs to perform for an IVD before placing it into use. Until recently, the FDA has authorized the marketing of SARS-CoV-2 IVDs exclusively through the Emergency Use Authorization EUA pathw","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Nolte","Frederick S","Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC",NA
"833","34260276","10.1128/JCM.01167-21","Considerations from the College of American Pathologists for implementation of an assay for SARS-CoV-2 testing after a change in regulatory status.","The U.S. Food &amp; Drug Administration FDA regulates the marketing of manufacturers' in vitro diagnostic tests IVDs including assays for the detection of SARS-CoV-2. The U.S. government's Clinical Laboratory Improvement Amendments CLIA of 1988 regulate the studies that a clinical diagnostic laboratory needs to perform for an IVD before placing it into use. Until recently, the FDA has authorized the marketing of SARS-CoV-2 IVDs exclusively through the Emergency Use Authorization EUA pathw","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Rowlinson","Marie-Claire","Florida Department of Health, Bureau of Public Health Laboratories, Jacksonville, FL",NA
"834","34260276","10.1128/JCM.01167-21","Considerations from the College of American Pathologists for implementation of an assay for SARS-CoV-2 testing after a change in regulatory status.","The U.S. Food &amp; Drug Administration FDA regulates the marketing of manufacturers' in vitro diagnostic tests IVDs including assays for the detection of SARS-CoV-2. The U.S. government's Clinical Laboratory Improvement Amendments CLIA of 1988 regulate the studies that a clinical diagnostic laboratory needs to perform for an IVD before placing it into use. Until recently, the FDA has authorized the marketing of SARS-CoV-2 IVDs exclusively through the Emergency Use Authorization EUA pathw","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"She","Rosemary C","Department of Pathology, Keck School of Medicine of the University of Southern California, Los Angeles, CA",NA
"835","34260276","10.1128/JCM.01167-21","Considerations from the College of American Pathologists for implementation of an assay for SARS-CoV-2 testing after a change in regulatory status.","The U.S. Food &amp; Drug Administration FDA regulates the marketing of manufacturers' in vitro diagnostic tests IVDs including assays for the detection of SARS-CoV-2. The U.S. government's Clinical Laboratory Improvement Amendments CLIA of 1988 regulate the studies that a clinical diagnostic laboratory needs to perform for an IVD before placing it into use. Until recently, the FDA has authorized the marketing of SARS-CoV-2 IVDs exclusively through the Emergency Use Authorization EUA pathw","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Simner","Patricia J","Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"836","34260276","10.1128/JCM.01167-21","Considerations from the College of American Pathologists for implementation of an assay for SARS-CoV-2 testing after a change in regulatory status.","The U.S. Food &amp; Drug Administration FDA regulates the marketing of manufacturers' in vitro diagnostic tests IVDs including assays for the detection of SARS-CoV-2. The U.S. government's Clinical Laboratory Improvement Amendments CLIA of 1988 regulate the studies that a clinical diagnostic laboratory needs to perform for an IVD before placing it into use. Until recently, the FDA has authorized the marketing of SARS-CoV-2 IVDs exclusively through the Emergency Use Authorization EUA pathw","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Theel","Elitza S","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN",NA
"837","34260276","10.1128/JCM.01167-21","Considerations from the College of American Pathologists for implementation of an assay for SARS-CoV-2 testing after a change in regulatory status.","The U.S. Food &amp; Drug Administration FDA regulates the marketing of manufacturers' in vitro diagnostic tests IVDs including assays for the detection of SARS-CoV-2. The U.S. government's Clinical Laboratory Improvement Amendments CLIA of 1988 regulate the studies that a clinical diagnostic laboratory needs to perform for an IVD before placing it into use. Until recently, the FDA has authorized the marketing of SARS-CoV-2 IVDs exclusively through the Emergency Use Authorization EUA pathw","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Wojewoda","Christina M","Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, VT",NA
"838","34260272","10.1128/JCM.00288-21","Performance of the Abbott SARS-CoV-2 IgG II Quantitative antibody assay including the new Variants of Concern (VOC 202012/V1 (UK) and VOC 202012/V2 (South Africa)): And first steps towards global harmonization of COVID-19 antibody methods.","Background In the initial stages of the SARS-CoV-2 (COVID-19) pandemic a plethora of new serology tests were developed and introduced to the global market. Many were not evaluated rigorously and there is a significant lack of concordance in results across methods. To enable meaningful clinical decisions to be made, robustly evaluated, quantitative serology methods are needed. These should be harmonized to a primary reference material, allowing for the comparison of trial data and i","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"English","Emma","Faculty of Medicine and Health, University of East Anglia, Norfolk, NR4 7TJ, UK",NA
"839","34260272","10.1128/JCM.00288-21","Performance of the Abbott SARS-CoV-2 IgG II Quantitative antibody assay including the new Variants of Concern (VOC 202012/V1 (UK) and VOC 202012/V2 (South Africa)): And first steps towards global harmonization of COVID-19 antibody methods.","Background In the initial stages of the SARS-CoV-2 (COVID-19) pandemic a plethora of new serology tests were developed and introduced to the global market. Many were not evaluated rigorously and there is a significant lack of concordance in results across methods. To enable meaningful clinical decisions to be made, robustly evaluated, quantitative serology methods are needed. These should be harmonized to a primary reference material, allowing for the comparison of trial data and i","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Cook","Laura E","Department of Clinical Biochemistry and Immunology, Norfolk and Norwich University Hospital, Norfolk, NR4 7UY",NA
"840","34260272","10.1128/JCM.00288-21","Performance of the Abbott SARS-CoV-2 IgG II Quantitative antibody assay including the new Variants of Concern (VOC 202012/V1 (UK) and VOC 202012/V2 (South Africa)): And first steps towards global harmonization of COVID-19 antibody methods.","Background In the initial stages of the SARS-CoV-2 (COVID-19) pandemic a plethora of new serology tests were developed and introduced to the global market. Many were not evaluated rigorously and there is a significant lack of concordance in results across methods. To enable meaningful clinical decisions to be made, robustly evaluated, quantitative serology methods are needed. These should be harmonized to a primary reference material, allowing for the comparison of trial data and i","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Piec","Isabelle","Faculty of Medicine and Health, University of East Anglia, Norfolk, NR4 7TJ, UK",NA
"841","34260272","10.1128/JCM.00288-21","Performance of the Abbott SARS-CoV-2 IgG II Quantitative antibody assay including the new Variants of Concern (VOC 202012/V1 (UK) and VOC 202012/V2 (South Africa)): And first steps towards global harmonization of COVID-19 antibody methods.","Background In the initial stages of the SARS-CoV-2 (COVID-19) pandemic a plethora of new serology tests were developed and introduced to the global market. Many were not evaluated rigorously and there is a significant lack of concordance in results across methods. To enable meaningful clinical decisions to be made, robustly evaluated, quantitative serology methods are needed. These should be harmonized to a primary reference material, allowing for the comparison of trial data and i","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Dervisevic","Samir","Faculty of Medicine and Health, University of East Anglia, Norfolk, NR4 7TJ, UK",NA
"842","34260272","10.1128/JCM.00288-21","Performance of the Abbott SARS-CoV-2 IgG II Quantitative antibody assay including the new Variants of Concern (VOC 202012/V1 (UK) and VOC 202012/V2 (South Africa)): And first steps towards global harmonization of COVID-19 antibody methods.","Background In the initial stages of the SARS-CoV-2 (COVID-19) pandemic a plethora of new serology tests were developed and introduced to the global market. Many were not evaluated rigorously and there is a significant lack of concordance in results across methods. To enable meaningful clinical decisions to be made, robustly evaluated, quantitative serology methods are needed. These should be harmonized to a primary reference material, allowing for the comparison of trial data and i","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Fraser","William D","Faculty of Medicine and Health, University of East Anglia, Norfolk, NR4 7TJ, UK",NA
"843","34260272","10.1128/JCM.00288-21","Performance of the Abbott SARS-CoV-2 IgG II Quantitative antibody assay including the new Variants of Concern (VOC 202012/V1 (UK) and VOC 202012/V2 (South Africa)): And first steps towards global harmonization of COVID-19 antibody methods.","Background In the initial stages of the SARS-CoV-2 (COVID-19) pandemic a plethora of new serology tests were developed and introduced to the global market. Many were not evaluated rigorously and there is a significant lack of concordance in results across methods. To enable meaningful clinical decisions to be made, robustly evaluated, quantitative serology methods are needed. These should be harmonized to a primary reference material, allowing for the comparison of trial data and i","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"John","W Garry","Faculty of Medicine and Health, University of East Anglia, Norfolk, NR4 7TJ, UK",NA
"844","34260271","10.1128/JCM.01001-21","EARLY LABORATORY DIAGNOSIS OF COVID-19 BY ANTIGEN DETECTION IN BLOOD SAMPLES OF THE SARS-COV-2 NUCLEOCAPSID PROTEIN.","The purpose of this study was to characterize the diagnostic performance of a newly developed enzyme-linked immunosorbent assay (ELISA) for detection of SARS-CoV-2 nucleocapsid protein (NP) in blood. Blood samples were collected during hospitalization of 165 inpatients with PCR-confirmed SARS-CoV-2 infection, and from 505 outpatients with relevant symptoms of COVID-19 simultaneously with PCR-testing. For the 143 inpatients who had their first blood sample collected within 2 weeks after PCR-confi","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Thudium","Rebekka F","University of Copenhagen, Rigshospitalet, Department of Infectious Diseases, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark",NA
"845","34260271","10.1128/JCM.01001-21","EARLY LABORATORY DIAGNOSIS OF COVID-19 BY ANTIGEN DETECTION IN BLOOD SAMPLES OF THE SARS-COV-2 NUCLEOCAPSID PROTEIN.","The purpose of this study was to characterize the diagnostic performance of a newly developed enzyme-linked immunosorbent assay (ELISA) for detection of SARS-CoV-2 nucleocapsid protein (NP) in blood. Blood samples were collected during hospitalization of 165 inpatients with PCR-confirmed SARS-CoV-2 infection, and from 505 outpatients with relevant symptoms of COVID-19 simultaneously with PCR-testing. For the 143 inpatients who had their first blood sample collected within 2 weeks after PCR-confi","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Stoico","Malene P","Aalborg University Hospital, Department of Molecular Diagnostics, Reberbansgade 15, DK-9000 Aalborg, Denmark",NA
"846","34260271","10.1128/JCM.01001-21","EARLY LABORATORY DIAGNOSIS OF COVID-19 BY ANTIGEN DETECTION IN BLOOD SAMPLES OF THE SARS-COV-2 NUCLEOCAPSID PROTEIN.","The purpose of this study was to characterize the diagnostic performance of a newly developed enzyme-linked immunosorbent assay (ELISA) for detection of SARS-CoV-2 nucleocapsid protein (NP) in blood. Blood samples were collected during hospitalization of 165 inpatients with PCR-confirmed SARS-CoV-2 infection, and from 505 outpatients with relevant symptoms of COVID-19 simultaneously with PCR-testing. For the 143 inpatients who had their first blood sample collected within 2 weeks after PCR-confi","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Høgdall","Estrid","Bio- and Genome Bank Denmark, Department of Pathology, Herlev and Gentofte Hospital, University of Copenhagen, Borgmester Ib Juuls Vej 73, DK-2730 Herlev, Denmark",NA
"847","34260271","10.1128/JCM.01001-21","EARLY LABORATORY DIAGNOSIS OF COVID-19 BY ANTIGEN DETECTION IN BLOOD SAMPLES OF THE SARS-COV-2 NUCLEOCAPSID PROTEIN.","The purpose of this study was to characterize the diagnostic performance of a newly developed enzyme-linked immunosorbent assay (ELISA) for detection of SARS-CoV-2 nucleocapsid protein (NP) in blood. Blood samples were collected during hospitalization of 165 inpatients with PCR-confirmed SARS-CoV-2 infection, and from 505 outpatients with relevant symptoms of COVID-19 simultaneously with PCR-testing. For the 143 inpatients who had their first blood sample collected within 2 weeks after PCR-confi","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Høgh","Julie","University of Copenhagen, Rigshospitalet, Department of Infectious Diseases, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark",NA
"848","34260271","10.1128/JCM.01001-21","EARLY LABORATORY DIAGNOSIS OF COVID-19 BY ANTIGEN DETECTION IN BLOOD SAMPLES OF THE SARS-COV-2 NUCLEOCAPSID PROTEIN.","The purpose of this study was to characterize the diagnostic performance of a newly developed enzyme-linked immunosorbent assay (ELISA) for detection of SARS-CoV-2 nucleocapsid protein (NP) in blood. Blood samples were collected during hospitalization of 165 inpatients with PCR-confirmed SARS-CoV-2 infection, and from 505 outpatients with relevant symptoms of COVID-19 simultaneously with PCR-testing. For the 143 inpatients who had their first blood sample collected within 2 weeks after PCR-confi","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Krarup","Henrik B","Aalborg University Hospital, Department of Molecular Diagnostics, Reberbansgade 15, DK-9000 Aalborg, Denmark",NA
"849","34260271","10.1128/JCM.01001-21","EARLY LABORATORY DIAGNOSIS OF COVID-19 BY ANTIGEN DETECTION IN BLOOD SAMPLES OF THE SARS-COV-2 NUCLEOCAPSID PROTEIN.","The purpose of this study was to characterize the diagnostic performance of a newly developed enzyme-linked immunosorbent assay (ELISA) for detection of SARS-CoV-2 nucleocapsid protein (NP) in blood. Blood samples were collected during hospitalization of 165 inpatients with PCR-confirmed SARS-CoV-2 infection, and from 505 outpatients with relevant symptoms of COVID-19 simultaneously with PCR-testing. For the 143 inpatients who had their first blood sample collected within 2 weeks after PCR-confi","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Larsen","Margit A H","University of Copenhagen, Rigshospitalet, Department of Clinical Immunology, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark",NA
"850","34260271","10.1128/JCM.01001-21","EARLY LABORATORY DIAGNOSIS OF COVID-19 BY ANTIGEN DETECTION IN BLOOD SAMPLES OF THE SARS-COV-2 NUCLEOCAPSID PROTEIN.","The purpose of this study was to characterize the diagnostic performance of a newly developed enzyme-linked immunosorbent assay (ELISA) for detection of SARS-CoV-2 nucleocapsid protein (NP) in blood. Blood samples were collected during hospitalization of 165 inpatients with PCR-confirmed SARS-CoV-2 infection, and from 505 outpatients with relevant symptoms of COVID-19 simultaneously with PCR-testing. For the 143 inpatients who had their first blood sample collected within 2 weeks after PCR-confi","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Madsen","Poul H","Aalborg University Hospital, Department of Molecular Diagnostics, Reberbansgade 15, DK-9000 Aalborg, Denmark",NA
"851","34260271","10.1128/JCM.01001-21","EARLY LABORATORY DIAGNOSIS OF COVID-19 BY ANTIGEN DETECTION IN BLOOD SAMPLES OF THE SARS-COV-2 NUCLEOCAPSID PROTEIN.","The purpose of this study was to characterize the diagnostic performance of a newly developed enzyme-linked immunosorbent assay (ELISA) for detection of SARS-CoV-2 nucleocapsid protein (NP) in blood. Blood samples were collected during hospitalization of 165 inpatients with PCR-confirmed SARS-CoV-2 infection, and from 505 outpatients with relevant symptoms of COVID-19 simultaneously with PCR-testing. For the 143 inpatients who had their first blood sample collected within 2 weeks after PCR-confi","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Nielsen","Susanne D","University of Copenhagen, Rigshospitalet, Department of Infectious Diseases, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark",NA
"852","34260271","10.1128/JCM.01001-21","EARLY LABORATORY DIAGNOSIS OF COVID-19 BY ANTIGEN DETECTION IN BLOOD SAMPLES OF THE SARS-COV-2 NUCLEOCAPSID PROTEIN.","The purpose of this study was to characterize the diagnostic performance of a newly developed enzyme-linked immunosorbent assay (ELISA) for detection of SARS-CoV-2 nucleocapsid protein (NP) in blood. Blood samples were collected during hospitalization of 165 inpatients with PCR-confirmed SARS-CoV-2 infection, and from 505 outpatients with relevant symptoms of COVID-19 simultaneously with PCR-testing. For the 143 inpatients who had their first blood sample collected within 2 weeks after PCR-confi","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Ostrowski","Sisse R","University of Copenhagen, Rigshospitalet, Department of Clinical Immunology, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark",NA
"853","34260271","10.1128/JCM.01001-21","EARLY LABORATORY DIAGNOSIS OF COVID-19 BY ANTIGEN DETECTION IN BLOOD SAMPLES OF THE SARS-COV-2 NUCLEOCAPSID PROTEIN.","The purpose of this study was to characterize the diagnostic performance of a newly developed enzyme-linked immunosorbent assay (ELISA) for detection of SARS-CoV-2 nucleocapsid protein (NP) in blood. Blood samples were collected during hospitalization of 165 inpatients with PCR-confirmed SARS-CoV-2 infection, and from 505 outpatients with relevant symptoms of COVID-19 simultaneously with PCR-testing. For the 143 inpatients who had their first blood sample collected within 2 weeks after PCR-confi","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Palombini","Amanda","Solsten Diagnostics International, Langdyssen 5, DK-8200 Aarhus N, Denmark",NA
"854","34260271","10.1128/JCM.01001-21","EARLY LABORATORY DIAGNOSIS OF COVID-19 BY ANTIGEN DETECTION IN BLOOD SAMPLES OF THE SARS-COV-2 NUCLEOCAPSID PROTEIN.","The purpose of this study was to characterize the diagnostic performance of a newly developed enzyme-linked immunosorbent assay (ELISA) for detection of SARS-CoV-2 nucleocapsid protein (NP) in blood. Blood samples were collected during hospitalization of 165 inpatients with PCR-confirmed SARS-CoV-2 infection, and from 505 outpatients with relevant symptoms of COVID-19 simultaneously with PCR-testing. For the 143 inpatients who had their first blood sample collected within 2 weeks after PCR-confi","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Rasmussen","Daniel B","University of Copenhagen, Rigshospitalet, Department of Infectious Diseases, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark",NA
"855","34260271","10.1128/JCM.01001-21","EARLY LABORATORY DIAGNOSIS OF COVID-19 BY ANTIGEN DETECTION IN BLOOD SAMPLES OF THE SARS-COV-2 NUCLEOCAPSID PROTEIN.","The purpose of this study was to characterize the diagnostic performance of a newly developed enzyme-linked immunosorbent assay (ELISA) for detection of SARS-CoV-2 nucleocapsid protein (NP) in blood. Blood samples were collected during hospitalization of 165 inpatients with PCR-confirmed SARS-CoV-2 infection, and from 505 outpatients with relevant symptoms of COVID-19 simultaneously with PCR-testing. For the 143 inpatients who had their first blood sample collected within 2 weeks after PCR-confi","2021","07","14","J Clin Microbiol","Journal of clinical microbiology",NA,"Foged","Niels T","Solsten Diagnostics International, Langdyssen 5, DK-8200 Aarhus N, Denmark",NA
"856","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Chen","Da-Yuan","Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA",NA
"857","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Khan","Nazimuddin","Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA",NA
"858","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Close","Brianna J","Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA",NA
"859","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Goel","Raghuveera K","Center for Network Systems Biology, Boston University, Boston, MA, USA",NA
"860","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Blum","Benjamin","Center for Network Systems Biology, Boston University, Boston, MA, USA",NA
"861","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Tavares","Alexander H","Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA",NA
"862","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Kenney","Devin","National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA",NA
"863","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Conway","Hasahn L","Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA",NA
"864","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Ewoldt","Jourdan K","Department of Biomedical Engineering, Boston University, Boston, MA, USA",NA
"865","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Chitalia","Vipul C","Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA, USA",NA
"866","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Crossland","Nicholas A","National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA",NA
"867","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Chen","Christopher S","Department of Biomedical Engineering, Boston University, Boston, MA, USA",NA
"868","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Kotton","Darrell N","Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, USA",NA
"869","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Baker","Susan C","Department of Microbiology and Immunology, Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA",NA
"870","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Fuchs","Serge Y","Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA",NA
"871","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Connor","John H","Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA",NA
"872","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Douam","Florian","National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA",NA
"873","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Emili","Andrew","Center for Network Systems Biology, Boston University, Boston, MA, USA",NA
"874","34260266","10.1128/JVI.00862-21","SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.","SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of i","2021","07","14","J Virol","Journal of virology",NA,"Saeed","Mohsan","Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA",NA
"875","34260262","10.2105/AJPH.2021.306352","Prisons and COVID-19 Spread in the United States.","Objectives. To empirically evaluate the relationship between presence of a state or federal prison and COVID-19 case and death counts. Methods. We merged data on locations of federal and state prisons and of local and county jails with daily case and death counts in the United States. We used a selection-on-observables design to estimate the correlation between prisons and COVID-19 spread, controlling for known correlates of COVID-19. Results. We found empirical evidence tha","2021","07","14","Am J Public Health","American journal of public health",NA,"Sims","Kaitlyn M","Kaitlyn M. Sims, Jeremy Foltz, and Marin Elisabeth Skidmore are with the Department of Agricultural and Applied Economics, University of Wisconsin, Madison. Marin Elisabeth Skidmore is also with the Nelson Institute for Environmental Studies, University of Wisconsin, Madison",NA
"876","34260262","10.2105/AJPH.2021.306352","Prisons and COVID-19 Spread in the United States.","Objectives. To empirically evaluate the relationship between presence of a state or federal prison and COVID-19 case and death counts. Methods. We merged data on locations of federal and state prisons and of local and county jails with daily case and death counts in the United States. We used a selection-on-observables design to estimate the correlation between prisons and COVID-19 spread, controlling for known correlates of COVID-19. Results. We found empirical evidence tha","2021","07","14","Am J Public Health","American journal of public health",NA,"Foltz","Jeremy","Kaitlyn M. Sims, Jeremy Foltz, and Marin Elisabeth Skidmore are with the Department of Agricultural and Applied Economics, University of Wisconsin, Madison. Marin Elisabeth Skidmore is also with the Nelson Institute for Environmental Studies, University of Wisconsin, Madison",NA
"877","34260262","10.2105/AJPH.2021.306352","Prisons and COVID-19 Spread in the United States.","Objectives. To empirically evaluate the relationship between presence of a state or federal prison and COVID-19 case and death counts. Methods. We merged data on locations of federal and state prisons and of local and county jails with daily case and death counts in the United States. We used a selection-on-observables design to estimate the correlation between prisons and COVID-19 spread, controlling for known correlates of COVID-19. Results. We found empirical evidence tha","2021","07","14","Am J Public Health","American journal of public health",NA,"Skidmore","Elisabeth","Kaitlyn M. Sims, Jeremy Foltz, and Marin Elisabeth Skidmore are with the Department of Agricultural and Applied Economics, University of Wisconsin, Madison. Marin Elisabeth Skidmore is also with the Nelson Institute for Environmental Studies, University of Wisconsin, Madison",NA
"878","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Malladi","Sameer Kumar","Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru 560012, India",NA
"879","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Patel","Unnatiben Rajeshbhai","Mynvax Private Limited, ES12, Entrepreneurship Centre, SID, Indian Institute of Science, Bengaluru 560012, India",NA
"880","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Rajmani","Raju S","Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru 560012, India",NA
"881","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Singh","Randhir","Mynvax Private Limited, ES12, Entrepreneurship Centre, SID, Indian Institute of Science, Bengaluru 560012, India",NA
"882","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Pandey","Suman","Mynvax Private Limited, ES12, Entrepreneurship Centre, SID, Indian Institute of Science, Bengaluru 560012, India",NA
"883","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Kumar","Sahil","Virology Unit, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India",NA
"884","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Khaleeq","Sara","Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru 560012, India",NA
"885","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","van Vuren","Petrus Jansen","Australian Centre for Disease Preparedness (ACDP), Commonwealth Scientific and Industrial Research Organisation (CSIRO), 5 Portarlington Road, Geelong 3220, Victoria, Australia",NA
"886","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Riddell","Shane","Australian Centre for Disease Preparedness (ACDP), Commonwealth Scientific and Industrial Research Organisation (CSIRO), 5 Portarlington Road, Geelong 3220, Victoria, Australia",NA
"887","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Goldie","Sarah","Australian Centre for Disease Preparedness (ACDP), Commonwealth Scientific and Industrial Research Organisation (CSIRO), 5 Portarlington Road, Geelong 3220, Victoria, Australia",NA
"888","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Gayathri","Savitha","Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru 560012, India",NA
"889","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Chakraborty","Debajyoti","Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru 560012, India",NA
"890","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Kalita","Parismita","Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru 560012, India",NA
"891","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Pramanick","Ishika","Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru 560012, India",NA
"892","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Agarwal","Nupur","Mynvax Private Limited, ES12, Entrepreneurship Centre, SID, Indian Institute of Science, Bengaluru 560012, India",NA
"893","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Reddy","Poorvi","Mynvax Private Limited, ES12, Entrepreneurship Centre, SID, Indian Institute of Science, Bengaluru 560012, India",NA
"894","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Girish","Nidhi","Mynvax Private Limited, ES12, Entrepreneurship Centre, SID, Indian Institute of Science, Bengaluru 560012, India",NA
"895","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Upadhyaya","Aditya","Mynvax Private Limited, ES12, Entrepreneurship Centre, SID, Indian Institute of Science, Bengaluru 560012, India",NA
"896","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Khan","Mohammad Suhail","Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru 560012, India",NA
"897","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Kanjo","Kawkab","Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru 560012, India",NA
"898","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Bhat","Madhuraj","Mynvax Private Limited, ES12, Entrepreneurship Centre, SID, Indian Institute of Science, Bengaluru 560012, India",NA
"899","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Mani","Shailendra","Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Third Milestone, Gurugram-Faridabad Expressway, Faridabad 121001, India",NA
"900","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Bhattacharyya","Sankar","Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Third Milestone, Gurugram-Faridabad Expressway, Faridabad 121001, India",NA
"901","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Siddiqui","Samreen","Max Super Speciality Hospital (A Unit of Devki Devi Foundation), Max Healthcare, Delhi 1100017, India",NA
"902","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Tyagi","Akansha","Max Super Speciality Hospital (A Unit of Devki Devi Foundation), Max Healthcare, Delhi 1100017, India",NA
"903","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Jha","Sujeet","Max Super Speciality Hospital (A Unit of Devki Devi Foundation), Max Healthcare, Delhi 1100017, India",NA
"904","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Pandey","Rajesh","Integrative Genomics of Host-Pathogen (INGEN-HOPE) Laboratory, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road, Delhi 110007, India",NA
"905","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Tripathi","Shashank","Department of Microbiology &amp",NA
"906","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Dutta","Somnath","Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru 560012, India",NA
"907","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","McAuley","Alexander J","Australian Centre for Disease Preparedness (ACDP), Commonwealth Scientific and Industrial Research Organisation (CSIRO), 5 Portarlington Road, Geelong 3220, Victoria, Australia",NA
"908","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Singanallur","Nagendrakumar Balasubramanian","Australian Centre for Disease Preparedness (ACDP), Commonwealth Scientific and Industrial Research Organisation (CSIRO), 5 Portarlington Road, Geelong 3220, Victoria, Australia",NA
"909","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Vasan","Seshadri S","Australian Centre for Disease Preparedness (ACDP), Commonwealth Scientific and Industrial Research Organisation (CSIRO), 5 Portarlington Road, Geelong 3220, Victoria, Australia",NA
"910","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Ringe","Rajesh P","Virology Unit, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India",NA
"911","34260218","10.1021/acsinfecdis.1c00276","Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.","The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We designed a trimeric, highly thermotolerant glycan engineered RBD by fusion to a heterologous, poorly immunogenic disulfide linked trimerization domain derived from cartilage matrix protein. The protein expressed at a yield of ~80-100 mg/L in transiently transfected Expi293 cells, as well as CHO and HEK293 stable cell lines and formed homogeneous disulfide-linked trimers. When lyophilized, these p","2021","07","14","ACS Infect Dis","ACS infectious diseases","glycosylation; oligomerization; thermostable; vaccine; variant of concern","Varadarajan","Raghavan","Molecular Biophysics Unit (MBU), Indian Institute of Science, Bengaluru 560012, India",NA
"912","34260192","","Calculated decisions: ACEP ED COVID-19 management tool.","This supplement reviews the ACEP ED COVID-19 Management Tool, an emergency department classification and management tool for adult patients (aged =18 years) with suspected or confirmed SARS-CoV-2.","2021","07","22","Emerg Med Pract","Emergency medicine practice","COVID-19; Disease Management; Emergency Service, Hospital; Humans; Pandemics; SARS-CoV-2","Steel","Peter A D","Department of Emergency Medicine, New York-Presbyterian/Weill Cornell Medical Center, New York, NY",NA
"913","34260192","","Calculated decisions: ACEP ED COVID-19 management tool.","This supplement reviews the ACEP ED COVID-19 Management Tool, an emergency department classification and management tool for adult patients (aged =18 years) with suspected or confirmed SARS-CoV-2.","2021","07","22","Emerg Med Pract","Emergency medicine practice","COVID-19; Disease Management; Emergency Service, Hospital; Humans; Pandemics; SARS-CoV-2","Carpenter","Christopher R","Department of Emergency Medicine, Washington University School of Medicine in St. Louis, Saint Louis, MO",NA
"914","34260192","","Calculated decisions: ACEP ED COVID-19 management tool.","This supplement reviews the ACEP ED COVID-19 Management Tool, an emergency department classification and management tool for adult patients (aged =18 years) with suspected or confirmed SARS-CoV-2.","2021","07","22","Emerg Med Pract","Emergency medicine practice","COVID-19; Disease Management; Emergency Service, Hospital; Humans; Pandemics; SARS-CoV-2","Fengler","Brian","Department of Emergency Medicine, University of Tennessee Medical Center, Murfreesboro, TN",NA
"915","34260192","","Calculated decisions: ACEP ED COVID-19 management tool.","This supplement reviews the ACEP ED COVID-19 Management Tool, an emergency department classification and management tool for adult patients (aged =18 years) with suspected or confirmed SARS-CoV-2.","2021","07","22","Emerg Med Pract","Emergency medicine practice","COVID-19; Disease Management; Emergency Service, Hospital; Humans; Pandemics; SARS-CoV-2","Cantrill","Stephen","Department of Emergency Medicine, Denver Health, Denver, CO",NA
"916","34260192","","Calculated decisions: ACEP ED COVID-19 management tool.","This supplement reviews the ACEP ED COVID-19 Management Tool, an emergency department classification and management tool for adult patients (aged =18 years) with suspected or confirmed SARS-CoV-2.","2021","07","22","Emerg Med Pract","Emergency medicine practice","COVID-19; Disease Management; Emergency Service, Hospital; Humans; Pandemics; SARS-CoV-2","Schneider","Sandy","Department of Emergency Medicine, North Shore University Hospital, Manhasset, NY",NA
"917","34260177","10.1590/S1677-5538.IBJU.2020.1092","Trends in urological emergencies in the Era of COVID-19.","To evaluate trends in emergency room (ER) urological conditions during COVID-19 pandemic lockdown. Retrospective analyses of renal colic, hematuria, and urinary retention in ER's admissions of a tertiary hospital during the lockdown period (March 19 to May 4, 2020) in Israel. Patient's demographics and clinical characteristics were compared to those in corresponding periods during 2017-2019, with estimated changes in ER arrival and waiting times, utilization of imaging tests, numbers of hospital","2021","07","19","Int Braz J Urol","International braz j urol : official journal of the Brazilian Society of Urology","Covid-19; Emergencies; trends [Subheading]; COVID-19; Communicable Disease Control; Emergencies; Emergency Service, Hospital; Humans; Pandemics; Retrospective Studies; SARS-CoV-2","Frumer","Michael","Department of Urology, Rabin Medical Center, Petach Tikva, Israel",NA
"918","34260177","10.1590/S1677-5538.IBJU.2020.1092","Trends in urological emergencies in the Era of COVID-19.","To evaluate trends in emergency room (ER) urological conditions during COVID-19 pandemic lockdown. Retrospective analyses of renal colic, hematuria, and urinary retention in ER's admissions of a tertiary hospital during the lockdown period (March 19 to May 4, 2020) in Israel. Patient's demographics and clinical characteristics were compared to those in corresponding periods during 2017-2019, with estimated changes in ER arrival and waiting times, utilization of imaging tests, numbers of hospital","2021","07","19","Int Braz J Urol","International braz j urol : official journal of the Brazilian Society of Urology","Covid-19; Emergencies; trends [Subheading]; COVID-19; Communicable Disease Control; Emergencies; Emergency Service, Hospital; Humans; Pandemics; Retrospective Studies; SARS-CoV-2","Aharony","Shachar M","Department of Urology, Rabin Medical Center, Petach Tikva, Israel",NA
"919","34260177","10.1590/S1677-5538.IBJU.2020.1092","Trends in urological emergencies in the Era of COVID-19.","To evaluate trends in emergency room (ER) urological conditions during COVID-19 pandemic lockdown. Retrospective analyses of renal colic, hematuria, and urinary retention in ER's admissions of a tertiary hospital during the lockdown period (March 19 to May 4, 2020) in Israel. Patient's demographics and clinical characteristics were compared to those in corresponding periods during 2017-2019, with estimated changes in ER arrival and waiting times, utilization of imaging tests, numbers of hospital","2021","07","19","Int Braz J Urol","International braz j urol : official journal of the Brazilian Society of Urology","Covid-19; Emergencies; trends [Subheading]; COVID-19; Communicable Disease Control; Emergencies; Emergency Service, Hospital; Humans; Pandemics; Retrospective Studies; SARS-CoV-2","Shoshany","Ohad","Department of Urology, Rabin Medical Center, Petach Tikva, Israel",NA
"920","34260177","10.1590/S1677-5538.IBJU.2020.1092","Trends in urological emergencies in the Era of COVID-19.","To evaluate trends in emergency room (ER) urological conditions during COVID-19 pandemic lockdown. Retrospective analyses of renal colic, hematuria, and urinary retention in ER's admissions of a tertiary hospital during the lockdown period (March 19 to May 4, 2020) in Israel. Patient's demographics and clinical characteristics were compared to those in corresponding periods during 2017-2019, with estimated changes in ER arrival and waiting times, utilization of imaging tests, numbers of hospital","2021","07","19","Int Braz J Urol","International braz j urol : official journal of the Brazilian Society of Urology","Covid-19; Emergencies; trends [Subheading]; COVID-19; Communicable Disease Control; Emergencies; Emergency Service, Hospital; Humans; Pandemics; Retrospective Studies; SARS-CoV-2","Kedar","Daniel","Department of Urology, Rabin Medical Center, Petach Tikva, Israel",NA
"921","34260177","10.1590/S1677-5538.IBJU.2020.1092","Trends in urological emergencies in the Era of COVID-19.","To evaluate trends in emergency room (ER) urological conditions during COVID-19 pandemic lockdown. Retrospective analyses of renal colic, hematuria, and urinary retention in ER's admissions of a tertiary hospital during the lockdown period (March 19 to May 4, 2020) in Israel. Patient's demographics and clinical characteristics were compared to those in corresponding periods during 2017-2019, with estimated changes in ER arrival and waiting times, utilization of imaging tests, numbers of hospital","2021","07","19","Int Braz J Urol","International braz j urol : official journal of the Brazilian Society of Urology","Covid-19; Emergencies; trends [Subheading]; COVID-19; Communicable Disease Control; Emergencies; Emergency Service, Hospital; Humans; Pandemics; Retrospective Studies; SARS-CoV-2","Baniel","Jack","Department of Urology, Rabin Medical Center, Petach Tikva, Israel",NA
"922","34260177","10.1590/S1677-5538.IBJU.2020.1092","Trends in urological emergencies in the Era of COVID-19.","To evaluate trends in emergency room (ER) urological conditions during COVID-19 pandemic lockdown. Retrospective analyses of renal colic, hematuria, and urinary retention in ER's admissions of a tertiary hospital during the lockdown period (March 19 to May 4, 2020) in Israel. Patient's demographics and clinical characteristics were compared to those in corresponding periods during 2017-2019, with estimated changes in ER arrival and waiting times, utilization of imaging tests, numbers of hospital","2021","07","19","Int Braz J Urol","International braz j urol : official journal of the Brazilian Society of Urology","Covid-19; Emergencies; trends [Subheading]; COVID-19; Communicable Disease Control; Emergencies; Emergency Service, Hospital; Humans; Pandemics; Retrospective Studies; SARS-CoV-2","Golan","Shay","Department of Urology, Rabin Medical Center, Petach Tikva, Israel",NA
"923","34260159","10.15252/emmm.202114532","Individual COVID-19 disease trajectories revealed by plasma proteomics.","Since the start of 2020, the world has been upended by the pandemic caused by the severe acute respiratory coronavirus type 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19). It has not only led to a tragic loss of life and terrible economic costs but has also been met with an unprecedented response of the scientific and medical communities. In an effort to better understand this viral infection, scientists around the world generated the largest surge in research in docu","2021","07","14","EMBO Mol Med","EMBO molecular medicine",NA,"Memon","Danish","European Bioinformatics Institute (EMBL-EBI), Cambridge, UK",NA
"924","34260159","10.15252/emmm.202114532","Individual COVID-19 disease trajectories revealed by plasma proteomics.","Since the start of 2020, the world has been upended by the pandemic caused by the severe acute respiratory coronavirus type 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19). It has not only led to a tragic loss of life and terrible economic costs but has also been met with an unprecedented response of the scientific and medical communities. In an effort to better understand this viral infection, scientists around the world generated the largest surge in research in docu","2021","07","14","EMBO Mol Med","EMBO molecular medicine",NA,"Barrio-Hernandez","Inigo","European Bioinformatics Institute (EMBL-EBI), Cambridge, UK",NA
"925","34260159","10.15252/emmm.202114532","Individual COVID-19 disease trajectories revealed by plasma proteomics.","Since the start of 2020, the world has been upended by the pandemic caused by the severe acute respiratory coronavirus type 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19). It has not only led to a tragic loss of life and terrible economic costs but has also been met with an unprecedented response of the scientific and medical communities. In an effort to better understand this viral infection, scientists around the world generated the largest surge in research in docu","2021","07","14","EMBO Mol Med","EMBO molecular medicine",NA,"Beltrao","Pedro","European Bioinformatics Institute (EMBL-EBI), Cambridge, UK",NA
"926","34260144","10.1111/ijcp.14631","Evaluation of dyspnea severity and sleep quality in patients with novel coronavirus.","Dyspnea, a common symptom of novel coronavirus, can negatively affect sleep quality. The aim of this study was to evaluate the relationship between dyspnea severity and sleep quality in patients with COVID-19. A cross-sectional design was used. Using the researcher's mobile phone, data were collected via an online questionnaire from patients (n = 100) who agreed to participate in the study. The data-collection form comprised three parts: a patient descriptive information form, the Dyspnea-12 Que","2021","07","21","Int J Clin Pract","International journal of clinical practice",NA,"Gungor","Serap","Kahramanmaras Sutcu Imam University, Vocational School of Health Services, Kahramanmaras, Turkey",NA
"927","34260144","10.1111/ijcp.14631","Evaluation of dyspnea severity and sleep quality in patients with novel coronavirus.","Dyspnea, a common symptom of novel coronavirus, can negatively affect sleep quality. The aim of this study was to evaluate the relationship between dyspnea severity and sleep quality in patients with COVID-19. A cross-sectional design was used. Using the researcher's mobile phone, data were collected via an online questionnaire from patients (n = 100) who agreed to participate in the study. The data-collection form comprised three parts: a patient descriptive information form, the Dyspnea-12 Que","2021","07","21","Int J Clin Pract","International journal of clinical practice",NA,"Tosun","Betul","Faculty of Health Sciences, School of Nursing, Hasan Kalyoncu University, Gaziantep, Turkey",NA
"928","34260144","10.1111/ijcp.14631","Evaluation of dyspnea severity and sleep quality in patients with novel coronavirus.","Dyspnea, a common symptom of novel coronavirus, can negatively affect sleep quality. The aim of this study was to evaluate the relationship between dyspnea severity and sleep quality in patients with COVID-19. A cross-sectional design was used. Using the researcher's mobile phone, data were collected via an online questionnaire from patients (n = 100) who agreed to participate in the study. The data-collection form comprised three parts: a patient descriptive information form, the Dyspnea-12 Que","2021","07","21","Int J Clin Pract","International journal of clinical practice",NA,"Unal","Nursemin","Faculty of Health Sciences, School of Nursing, Ankara Medipol University, Ankara, Turkey",NA
"929","34260144","10.1111/ijcp.14631","Evaluation of dyspnea severity and sleep quality in patients with novel coronavirus.","Dyspnea, a common symptom of novel coronavirus, can negatively affect sleep quality. The aim of this study was to evaluate the relationship between dyspnea severity and sleep quality in patients with COVID-19. A cross-sectional design was used. Using the researcher's mobile phone, data were collected via an online questionnaire from patients (n = 100) who agreed to participate in the study. The data-collection form comprised three parts: a patient descriptive information form, the Dyspnea-12 Que","2021","07","21","Int J Clin Pract","International journal of clinical practice",NA,"Dusak","Ismail","Sanliurfa Mehmet Akif Inan Education and Research Hospital, Sanliurfa, Turkey",NA
"930","34260094","10.1002/jmv.27211","Viral infections amidst COVID-19 in Africa: Implications and recommendations.","Viral infections have been on the rise for the past decades. The impact of the viruses worsened amidst the pandemic burdening the already overwhelmed health care system in African countries. This article sheds light on how the coronavirus together with the already existing viral infections, some of which re-emerged, impacted the continent. The strategies in place such as immunization, education, will have to be strengthened in all African countries to reduce the burden. Furthermore, governments ","2021","07","22","J Med Virol","Journal of medical virology","Africa; COVID-19; immunization; viral infections","Uwishema","Olivier","Oli Health Magazine Organization, Research and Education, Kigali, Rwanda",NA
"931","34260094","10.1002/jmv.27211","Viral infections amidst COVID-19 in Africa: Implications and recommendations.","Viral infections have been on the rise for the past decades. The impact of the viruses worsened amidst the pandemic burdening the already overwhelmed health care system in African countries. This article sheds light on how the coronavirus together with the already existing viral infections, some of which re-emerged, impacted the continent. The strategies in place such as immunization, education, will have to be strengthened in all African countries to reduce the burden. Furthermore, governments ","2021","07","22","J Med Virol","Journal of medical virology","Africa; COVID-19; immunization; viral infections","Adanur","Irem","Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey",NA
"932","34260094","10.1002/jmv.27211","Viral infections amidst COVID-19 in Africa: Implications and recommendations.","Viral infections have been on the rise for the past decades. The impact of the viruses worsened amidst the pandemic burdening the already overwhelmed health care system in African countries. This article sheds light on how the coronavirus together with the already existing viral infections, some of which re-emerged, impacted the continent. The strategies in place such as immunization, education, will have to be strengthened in all African countries to reduce the burden. Furthermore, governments ","2021","07","22","J Med Virol","Journal of medical virology","Africa; COVID-19; immunization; viral infections","Babatunde","Abdulhammed Opeyemi","Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria",NA
"933","34260094","10.1002/jmv.27211","Viral infections amidst COVID-19 in Africa: Implications and recommendations.","Viral infections have been on the rise for the past decades. The impact of the viruses worsened amidst the pandemic burdening the already overwhelmed health care system in African countries. This article sheds light on how the coronavirus together with the already existing viral infections, some of which re-emerged, impacted the continent. The strategies in place such as immunization, education, will have to be strengthened in all African countries to reduce the burden. Furthermore, governments ","2021","07","22","J Med Virol","Journal of medical virology","Africa; COVID-19; immunization; viral infections","Hasan","Mohammad Mehedi","Department of Biochemistry and Molecular Biology, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh",NA
"934","34260094","10.1002/jmv.27211","Viral infections amidst COVID-19 in Africa: Implications and recommendations.","Viral infections have been on the rise for the past decades. The impact of the viruses worsened amidst the pandemic burdening the already overwhelmed health care system in African countries. This article sheds light on how the coronavirus together with the already existing viral infections, some of which re-emerged, impacted the continent. The strategies in place such as immunization, education, will have to be strengthened in all African countries to reduce the burden. Furthermore, governments ","2021","07","22","J Med Virol","Journal of medical virology","Africa; COVID-19; immunization; viral infections","Elmahi","Osman Kamal Osman","Faculty of Medicine, Ibn Sina University, Khartoum, Sudan",NA
"935","34260094","10.1002/jmv.27211","Viral infections amidst COVID-19 in Africa: Implications and recommendations.","Viral infections have been on the rise for the past decades. The impact of the viruses worsened amidst the pandemic burdening the already overwhelmed health care system in African countries. This article sheds light on how the coronavirus together with the already existing viral infections, some of which re-emerged, impacted the continent. The strategies in place such as immunization, education, will have to be strengthened in all African countries to reduce the burden. Furthermore, governments ","2021","07","22","J Med Virol","Journal of medical virology","Africa; COVID-19; immunization; viral infections","Olajumoke","Kolawole Barakat","Kwara State Polytechnic, Ilorin, Nigeria",NA
"936","34260094","10.1002/jmv.27211","Viral infections amidst COVID-19 in Africa: Implications and recommendations.","Viral infections have been on the rise for the past decades. The impact of the viruses worsened amidst the pandemic burdening the already overwhelmed health care system in African countries. This article sheds light on how the coronavirus together with the already existing viral infections, some of which re-emerged, impacted the continent. The strategies in place such as immunization, education, will have to be strengthened in all African countries to reduce the burden. Furthermore, governments ","2021","07","22","J Med Virol","Journal of medical virology","Africa; COVID-19; immunization; viral infections","Aborode","Abdullahi Tunde","Healthy Africans Platform, Research and Development, Ibadan, Nigeria",NA
"937","34260094","10.1002/jmv.27211","Viral infections amidst COVID-19 in Africa: Implications and recommendations.","Viral infections have been on the rise for the past decades. The impact of the viruses worsened amidst the pandemic burdening the already overwhelmed health care system in African countries. This article sheds light on how the coronavirus together with the already existing viral infections, some of which re-emerged, impacted the continent. The strategies in place such as immunization, education, will have to be strengthened in all African countries to reduce the burden. Furthermore, governments ","2021","07","22","J Med Virol","Journal of medical virology","Africa; COVID-19; immunization; viral infections","Emmanuella","Nzeribe","Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana",NA
"938","34260094","10.1002/jmv.27211","Viral infections amidst COVID-19 in Africa: Implications and recommendations.","Viral infections have been on the rise for the past decades. The impact of the viruses worsened amidst the pandemic burdening the already overwhelmed health care system in African countries. This article sheds light on how the coronavirus together with the already existing viral infections, some of which re-emerged, impacted the continent. The strategies in place such as immunization, education, will have to be strengthened in all African countries to reduce the burden. Furthermore, governments ","2021","07","22","J Med Virol","Journal of medical virology","Africa; COVID-19; immunization; viral infections","Costa","Ana Carla Dos Santos","Department of Internal Medicine, Federal University of Bahia, Salvador, Bahia, Brazil",NA
"939","34260094","10.1002/jmv.27211","Viral infections amidst COVID-19 in Africa: Implications and recommendations.","Viral infections have been on the rise for the past decades. The impact of the viruses worsened amidst the pandemic burdening the already overwhelmed health care system in African countries. This article sheds light on how the coronavirus together with the already existing viral infections, some of which re-emerged, impacted the continent. The strategies in place such as immunization, education, will have to be strengthened in all African countries to reduce the burden. Furthermore, governments ","2021","07","22","J Med Virol","Journal of medical virology","Africa; COVID-19; immunization; viral infections","Ahmad","Shoaib","Department of Medicine and General Surgery, Punjab Medical College, Faisalabad, Pakistan",NA
"940","34260094","10.1002/jmv.27211","Viral infections amidst COVID-19 in Africa: Implications and recommendations.","Viral infections have been on the rise for the past decades. The impact of the viruses worsened amidst the pandemic burdening the already overwhelmed health care system in African countries. This article sheds light on how the coronavirus together with the already existing viral infections, some of which re-emerged, impacted the continent. The strategies in place such as immunization, education, will have to be strengthened in all African countries to reduce the burden. Furthermore, governments ","2021","07","22","J Med Virol","Journal of medical virology","Africa; COVID-19; immunization; viral infections","Essar","Mohammad Yasir","Faculty of Dentistry, Kabul University of Medical Sciences, Kabul, Afghanistan",NA
"941","34260088","10.1002/jmv.27210","SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate?","Lineage B.1.617+, also known as G/452R.V3 and now denoted by WHO with the Greek letters d and <U+03BA>, is a recently described SARS-CoV-2 variant under investigation (VUI) firstly identified in October 2020 in India. As of May 2021, three sublineages labelled as B.1.617.1 (<U+03BA>), B.1.617.2 ((d) and B.1.617.3 have been already identified, and their potential impact on the current pandemic is being studied. This variant has 13 amino acid changes, three in its spike protein, which are currently of particula","2021","07","14","J Med Virol","Journal of medical virology","B.1.617 d and <U+03BA> variants; SARS-CoV-2; electrostatics potential changes","Pascarella","Stefano","Department of Biochemical sciences ""A. Rossi Fanelli"", Sapienza University of Rome, 00185, Rome, Italy",NA
"942","34260088","10.1002/jmv.27210","SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate?","Lineage B.1.617+, also known as G/452R.V3 and now denoted by WHO with the Greek letters d and <U+03BA>, is a recently described SARS-CoV-2 variant under investigation (VUI) firstly identified in October 2020 in India. As of May 2021, three sublineages labelled as B.1.617.1 (<U+03BA>), B.1.617.2 ((d) and B.1.617.3 have been already identified, and their potential impact on the current pandemic is being studied. This variant has 13 amino acid changes, three in its spike protein, which are currently of particula","2021","07","14","J Med Virol","Journal of medical virology","B.1.617 d and <U+03BA> variants; SARS-CoV-2; electrostatics potential changes","Ciccozzi","Massimo","Medical Statistic and Molecular Epidemiology Unit, University of Biomedical Campus, Rome, Italy",NA
"943","34260088","10.1002/jmv.27210","SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate?","Lineage B.1.617+, also known as G/452R.V3 and now denoted by WHO with the Greek letters d and <U+03BA>, is a recently described SARS-CoV-2 variant under investigation (VUI) firstly identified in October 2020 in India. As of May 2021, three sublineages labelled as B.1.617.1 (<U+03BA>), B.1.617.2 ((d) and B.1.617.3 have been already identified, and their potential impact on the current pandemic is being studied. This variant has 13 amino acid changes, three in its spike protein, which are currently of particula","2021","07","14","J Med Virol","Journal of medical virology","B.1.617 d and <U+03BA> variants; SARS-CoV-2; electrostatics potential changes","Zella","Davide","Institute of Human Virology and Global Virus Network Center, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA",NA
"944","34260088","10.1002/jmv.27210","SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate?","Lineage B.1.617+, also known as G/452R.V3 and now denoted by WHO with the Greek letters d and <U+03BA>, is a recently described SARS-CoV-2 variant under investigation (VUI) firstly identified in October 2020 in India. As of May 2021, three sublineages labelled as B.1.617.1 (<U+03BA>), B.1.617.2 ((d) and B.1.617.3 have been already identified, and their potential impact on the current pandemic is being studied. This variant has 13 amino acid changes, three in its spike protein, which are currently of particula","2021","07","14","J Med Virol","Journal of medical virology","B.1.617 d and <U+03BA> variants; SARS-CoV-2; electrostatics potential changes","Bianchi","Martina","Department of Biochemical sciences ""A. Rossi Fanelli"", Sapienza University of Rome, 00185, Rome, Italy",NA
"945","34260088","10.1002/jmv.27210","SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate?","Lineage B.1.617+, also known as G/452R.V3 and now denoted by WHO with the Greek letters d and <U+03BA>, is a recently described SARS-CoV-2 variant under investigation (VUI) firstly identified in October 2020 in India. As of May 2021, three sublineages labelled as B.1.617.1 (<U+03BA>), B.1.617.2 ((d) and B.1.617.3 have been already identified, and their potential impact on the current pandemic is being studied. This variant has 13 amino acid changes, three in its spike protein, which are currently of particula","2021","07","14","J Med Virol","Journal of medical virology","B.1.617 d and <U+03BA> variants; SARS-CoV-2; electrostatics potential changes","Benetti","Francesca","Institute of Human Virology and Global Virus Network Center, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA",NA
"946","34260088","10.1002/jmv.27210","SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate?","Lineage B.1.617+, also known as G/452R.V3 and now denoted by WHO with the Greek letters d and <U+03BA>, is a recently described SARS-CoV-2 variant under investigation (VUI) firstly identified in October 2020 in India. As of May 2021, three sublineages labelled as B.1.617.1 (<U+03BA>), B.1.617.2 ((d) and B.1.617.3 have been already identified, and their potential impact on the current pandemic is being studied. This variant has 13 amino acid changes, three in its spike protein, which are currently of particula","2021","07","14","J Med Virol","Journal of medical virology","B.1.617 d and <U+03BA> variants; SARS-CoV-2; electrostatics potential changes","Benvenuto","Domenico","Medical Statistic and Molecular Epidemiology Unit, University of Biomedical Campus, Rome, Italy",NA
"947","34260088","10.1002/jmv.27210","SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate?","Lineage B.1.617+, also known as G/452R.V3 and now denoted by WHO with the Greek letters d and <U+03BA>, is a recently described SARS-CoV-2 variant under investigation (VUI) firstly identified in October 2020 in India. As of May 2021, three sublineages labelled as B.1.617.1 (<U+03BA>), B.1.617.2 ((d) and B.1.617.3 have been already identified, and their potential impact on the current pandemic is being studied. This variant has 13 amino acid changes, three in its spike protein, which are currently of particula","2021","07","14","J Med Virol","Journal of medical virology","B.1.617 d and <U+03BA> variants; SARS-CoV-2; electrostatics potential changes","Broccolo","Francesco","Department of Clinical Medicine and Prevention, University of Milano-Bicocca",NA
"948","34260088","10.1002/jmv.27210","SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate?","Lineage B.1.617+, also known as G/452R.V3 and now denoted by WHO with the Greek letters d and <U+03BA>, is a recently described SARS-CoV-2 variant under investigation (VUI) firstly identified in October 2020 in India. As of May 2021, three sublineages labelled as B.1.617.1 (<U+03BA>), B.1.617.2 ((d) and B.1.617.3 have been already identified, and their potential impact on the current pandemic is being studied. This variant has 13 amino acid changes, three in its spike protein, which are currently of particula","2021","07","14","J Med Virol","Journal of medical virology","B.1.617 d and <U+03BA> variants; SARS-CoV-2; electrostatics potential changes","Cauda","Roberto","Istituto Clinica di Malattie Infettive, Università Cattolica del Sacro Cuore, Rome, Italy",NA
"949","34260088","10.1002/jmv.27210","SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate?","Lineage B.1.617+, also known as G/452R.V3 and now denoted by WHO with the Greek letters d and <U+03BA>, is a recently described SARS-CoV-2 variant under investigation (VUI) firstly identified in October 2020 in India. As of May 2021, three sublineages labelled as B.1.617.1 (<U+03BA>), B.1.617.2 ((d) and B.1.617.3 have been already identified, and their potential impact on the current pandemic is being studied. This variant has 13 amino acid changes, three in its spike protein, which are currently of particula","2021","07","14","J Med Virol","Journal of medical virology","B.1.617 d and <U+03BA> variants; SARS-CoV-2; electrostatics potential changes","Caruso","Arnaldo","Department of Microbiology and Virology, Spedali Civili, Piazzale Spedali Civili, 1, 25123, Brescia, Italy",NA
"950","34260088","10.1002/jmv.27210","SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate?","Lineage B.1.617+, also known as G/452R.V3 and now denoted by WHO with the Greek letters d and <U+03BA>, is a recently described SARS-CoV-2 variant under investigation (VUI) firstly identified in October 2020 in India. As of May 2021, three sublineages labelled as B.1.617.1 (<U+03BA>), B.1.617.2 ((d) and B.1.617.3 have been already identified, and their potential impact on the current pandemic is being studied. This variant has 13 amino acid changes, three in its spike protein, which are currently of particula","2021","07","14","J Med Virol","Journal of medical virology","B.1.617 d and <U+03BA> variants; SARS-CoV-2; electrostatics potential changes","Angeletti","Silvia","Unit of Clinical Laboratory Science, University Campus Bio-Medico of Rome, Rome, Italy",NA
"951","34260088","10.1002/jmv.27210","SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate?","Lineage B.1.617+, also known as G/452R.V3 and now denoted by WHO with the Greek letters d and <U+03BA>, is a recently described SARS-CoV-2 variant under investigation (VUI) firstly identified in October 2020 in India. As of May 2021, three sublineages labelled as B.1.617.1 (<U+03BA>), B.1.617.2 ((d) and B.1.617.3 have been already identified, and their potential impact on the current pandemic is being studied. This variant has 13 amino acid changes, three in its spike protein, which are currently of particula","2021","07","14","J Med Virol","Journal of medical virology","B.1.617 d and <U+03BA> variants; SARS-CoV-2; electrostatics potential changes","Giovanetti","Marta","Laboratório de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil",NA
"952","34260088","10.1002/jmv.27210","SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate?","Lineage B.1.617+, also known as G/452R.V3 and now denoted by WHO with the Greek letters d and <U+03BA>, is a recently described SARS-CoV-2 variant under investigation (VUI) firstly identified in October 2020 in India. As of May 2021, three sublineages labelled as B.1.617.1 (<U+03BA>), B.1.617.2 ((d) and B.1.617.3 have been already identified, and their potential impact on the current pandemic is being studied. This variant has 13 amino acid changes, three in its spike protein, which are currently of particula","2021","07","14","J Med Virol","Journal of medical virology","B.1.617 d and <U+03BA> variants; SARS-CoV-2; electrostatics potential changes","Cassone","Antonio","Center of of Genomics, Genetics and Biology, Siena, Italy",NA
"953","34260086","10.1002/jmv.27204","Effect of Different Storage Conditions on Covid-19 RT-PCR Results.","Reliable and rapid detection of SARS-CoV-2 in laboratory setting is critical to control the pandemic. We aimed to evaluated PCR efficiency of nasopharyngeal swabs stored in viral transport medium (VTM) in different temperatures. Ninety swabs taken into VTM were analyzed at first hour, then divided into 2 groups with similar numbers of positive and negative samples. Positive samples of each group were also sub-grouped according to Fam CT values as low CT (&lt;25), medium CT (25-32) and high CT (3","2021","07","14","J Med Virol","Journal of medical virology","Coronavirus; Covid-19; Polymerase Chain Reaction; RT-PCR; SARS-CoV-2; Viral Transport Medium","Gulec","Elif Yilmaz","Department of Medical Genetics, Health Sciences University, Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey",NA
"954","34260086","10.1002/jmv.27204","Effect of Different Storage Conditions on Covid-19 RT-PCR Results.","Reliable and rapid detection of SARS-CoV-2 in laboratory setting is critical to control the pandemic. We aimed to evaluated PCR efficiency of nasopharyngeal swabs stored in viral transport medium (VTM) in different temperatures. Ninety swabs taken into VTM were analyzed at first hour, then divided into 2 groups with similar numbers of positive and negative samples. Positive samples of each group were also sub-grouped according to Fam CT values as low CT (&lt;25), medium CT (25-32) and high CT (3","2021","07","14","J Med Virol","Journal of medical virology","Coronavirus; Covid-19; Polymerase Chain Reaction; RT-PCR; SARS-CoV-2; Viral Transport Medium","Cesur","Nevra Pelin","Covid-19 Diagnostic Center, TUSEB, Turkey Institutes of Health COVID-19 Diagnostic Center, Health Sciences University, Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey",NA
"955","34260086","10.1002/jmv.27204","Effect of Different Storage Conditions on Covid-19 RT-PCR Results.","Reliable and rapid detection of SARS-CoV-2 in laboratory setting is critical to control the pandemic. We aimed to evaluated PCR efficiency of nasopharyngeal swabs stored in viral transport medium (VTM) in different temperatures. Ninety swabs taken into VTM were analyzed at first hour, then divided into 2 groups with similar numbers of positive and negative samples. Positive samples of each group were also sub-grouped according to Fam CT values as low CT (&lt;25), medium CT (25-32) and high CT (3","2021","07","14","J Med Virol","Journal of medical virology","Coronavirus; Covid-19; Polymerase Chain Reaction; RT-PCR; SARS-CoV-2; Viral Transport Medium","Fazlioglu","Gonca Yesilyurt","Covid-19 Diagnostic Center, TUSEB, Turkey Institutes of Health COVID-19 Diagnostic Center, Health Sciences University, Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey",NA
"956","34260086","10.1002/jmv.27204","Effect of Different Storage Conditions on Covid-19 RT-PCR Results.","Reliable and rapid detection of SARS-CoV-2 in laboratory setting is critical to control the pandemic. We aimed to evaluated PCR efficiency of nasopharyngeal swabs stored in viral transport medium (VTM) in different temperatures. Ninety swabs taken into VTM were analyzed at first hour, then divided into 2 groups with similar numbers of positive and negative samples. Positive samples of each group were also sub-grouped according to Fam CT values as low CT (&lt;25), medium CT (25-32) and high CT (3","2021","07","14","J Med Virol","Journal of medical virology","Coronavirus; Covid-19; Polymerase Chain Reaction; RT-PCR; SARS-CoV-2; Viral Transport Medium","Kazezoglu","Cemal","Covid-19 Diagnostic Center, Health Sciences University, Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey",NA
"957","34260081","10.1002/jmv.27202","Probable viremia and positive placental swabs for SARS-CoV-2 in a preterm pregnant woman with mild COVID-19.","This study aimed to report a case of mild novel coronavirus disease (COVID-19) in a pregnant woman with probable viremia, as reverse transcription polymerase chain reaction (RT-PCR) testing of endometrial and placental swabs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was positive. We present the case of a 26-year-old multigravida at 35 weeks 2 days of gestation, who had extensive thigh and abdominal cellulitis, and was tested SARS-CoV-2 positive by RT-PCR performed on sampl","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; SARS-CoV-2; placenta; pregnancy; vertical transmission","Akdemir","Yesim","Department of Obstetrics and Gynaecology, School of Medicine, Zonguldak Bulent Ecevit University, Zonguldak, Turkey",NA
"958","34260081","10.1002/jmv.27202","Probable viremia and positive placental swabs for SARS-CoV-2 in a preterm pregnant woman with mild COVID-19.","This study aimed to report a case of mild novel coronavirus disease (COVID-19) in a pregnant woman with probable viremia, as reverse transcription polymerase chain reaction (RT-PCR) testing of endometrial and placental swabs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was positive. We present the case of a 26-year-old multigravida at 35 weeks 2 days of gestation, who had extensive thigh and abdominal cellulitis, and was tested SARS-CoV-2 positive by RT-PCR performed on sampl","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; SARS-CoV-2; placenta; pregnancy; vertical transmission","Haciseyitoglu","Demet","Department of Microbiology, School of Medicine, Zonguldak Bulent Ecevit University, Zonguldak, Turkey",NA
"959","34260081","10.1002/jmv.27202","Probable viremia and positive placental swabs for SARS-CoV-2 in a preterm pregnant woman with mild COVID-19.","This study aimed to report a case of mild novel coronavirus disease (COVID-19) in a pregnant woman with probable viremia, as reverse transcription polymerase chain reaction (RT-PCR) testing of endometrial and placental swabs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was positive. We present the case of a 26-year-old multigravida at 35 weeks 2 days of gestation, who had extensive thigh and abdominal cellulitis, and was tested SARS-CoV-2 positive by RT-PCR performed on sampl","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; SARS-CoV-2; placenta; pregnancy; vertical transmission","Celebi","Guven","Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Zonguldak Bulent Ecevit University, Zonguldak, Turkey",NA
"960","34260081","10.1002/jmv.27202","Probable viremia and positive placental swabs for SARS-CoV-2 in a preterm pregnant woman with mild COVID-19.","This study aimed to report a case of mild novel coronavirus disease (COVID-19) in a pregnant woman with probable viremia, as reverse transcription polymerase chain reaction (RT-PCR) testing of endometrial and placental swabs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was positive. We present the case of a 26-year-old multigravida at 35 weeks 2 days of gestation, who had extensive thigh and abdominal cellulitis, and was tested SARS-CoV-2 positive by RT-PCR performed on sampl","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; SARS-CoV-2; placenta; pregnancy; vertical transmission","Aydemir","Cumhur","Department of Pediatrics and Neonatal Critical Care, School of Medicine, Zonguldak Bulent Ecevit University, Zonguldak, Turkey",NA
"961","34260081","10.1002/jmv.27202","Probable viremia and positive placental swabs for SARS-CoV-2 in a preterm pregnant woman with mild COVID-19.","This study aimed to report a case of mild novel coronavirus disease (COVID-19) in a pregnant woman with probable viremia, as reverse transcription polymerase chain reaction (RT-PCR) testing of endometrial and placental swabs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was positive. We present the case of a 26-year-old multigravida at 35 weeks 2 days of gestation, who had extensive thigh and abdominal cellulitis, and was tested SARS-CoV-2 positive by RT-PCR performed on sampl","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; SARS-CoV-2; placenta; pregnancy; vertical transmission","Bahadir","Burak","Department of Pathology, School of Medicine, Zonguldak Bulent Ecevit University, Zonguldak, Turkey",NA
"962","34260081","10.1002/jmv.27202","Probable viremia and positive placental swabs for SARS-CoV-2 in a preterm pregnant woman with mild COVID-19.","This study aimed to report a case of mild novel coronavirus disease (COVID-19) in a pregnant woman with probable viremia, as reverse transcription polymerase chain reaction (RT-PCR) testing of endometrial and placental swabs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was positive. We present the case of a 26-year-old multigravida at 35 weeks 2 days of gestation, who had extensive thigh and abdominal cellulitis, and was tested SARS-CoV-2 positive by RT-PCR performed on sampl","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; SARS-CoV-2; placenta; pregnancy; vertical transmission","Cakir","Anil Turhan","Department of Obstetrics and Gynaecology, School of Medicine, Zonguldak Bulent Ecevit University, Zonguldak, Turkey",NA
"963","34260081","10.1002/jmv.27202","Probable viremia and positive placental swabs for SARS-CoV-2 in a preterm pregnant woman with mild COVID-19.","This study aimed to report a case of mild novel coronavirus disease (COVID-19) in a pregnant woman with probable viremia, as reverse transcription polymerase chain reaction (RT-PCR) testing of endometrial and placental swabs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was positive. We present the case of a 26-year-old multigravida at 35 weeks 2 days of gestation, who had extensive thigh and abdominal cellulitis, and was tested SARS-CoV-2 positive by RT-PCR performed on sampl","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; SARS-CoV-2; placenta; pregnancy; vertical transmission","Barut","Aykut","Department of Obstetrics and Gynaecology, School of Medicine, Zonguldak Bulent Ecevit University, Zonguldak, Turkey",NA
"964","34260081","10.1002/jmv.27202","Probable viremia and positive placental swabs for SARS-CoV-2 in a preterm pregnant woman with mild COVID-19.","This study aimed to report a case of mild novel coronavirus disease (COVID-19) in a pregnant woman with probable viremia, as reverse transcription polymerase chain reaction (RT-PCR) testing of endometrial and placental swabs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was positive. We present the case of a 26-year-old multigravida at 35 weeks 2 days of gestation, who had extensive thigh and abdominal cellulitis, and was tested SARS-CoV-2 positive by RT-PCR performed on sampl","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; SARS-CoV-2; placenta; pregnancy; vertical transmission","Ozmen","Ulku","Department of Obstetrics and Gynaecology, School of Medicine, Zonguldak Bulent Ecevit University, Zonguldak, Turkey",NA
"965","34260078","10.1002/jmv.27209","Evaluation of Rapid Antibody Test and Chest Computed Tomography Results of COVID-19 Patients: A Retrospective Study.","The purpose of this study was to evaluate the SARS-CoV-2 IgM/IgG rapid antibody test results in symptomatic patients with COVID-19 and their chest computed tomography (CT) data. A total of 320 patients admitted to our hospital for different durations due to COVID-19 were included in the study. Serum samples were obtained within 0 to 7 days from COVID-19 patients confirmed by RT-PCR and chest CT scan. According to the SARS-CoV-2 RT-PCR results, the patients included in the study were divided into","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; RT-PCR; SARS-CoV-2; chest CT; lateral flow; rapid diagnosis","Ozturk","Ali","Department of Medical Microbiology, Nigde Omer Halisdemir University Faculty of Medicine, Nigde, Turkey",NA
"966","34260078","10.1002/jmv.27209","Evaluation of Rapid Antibody Test and Chest Computed Tomography Results of COVID-19 Patients: A Retrospective Study.","The purpose of this study was to evaluate the SARS-CoV-2 IgM/IgG rapid antibody test results in symptomatic patients with COVID-19 and their chest computed tomography (CT) data. A total of 320 patients admitted to our hospital for different durations due to COVID-19 were included in the study. Serum samples were obtained within 0 to 7 days from COVID-19 patients confirmed by RT-PCR and chest CT scan. According to the SARS-CoV-2 RT-PCR results, the patients included in the study were divided into","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; RT-PCR; SARS-CoV-2; chest CT; lateral flow; rapid diagnosis","Bozok","Taylan","Department of Medical Microbiology, Nigde Omer Halisdemir University Training and Research Hospital, Nigde, Turkey",NA
"967","34260078","10.1002/jmv.27209","Evaluation of Rapid Antibody Test and Chest Computed Tomography Results of COVID-19 Patients: A Retrospective Study.","The purpose of this study was to evaluate the SARS-CoV-2 IgM/IgG rapid antibody test results in symptomatic patients with COVID-19 and their chest computed tomography (CT) data. A total of 320 patients admitted to our hospital for different durations due to COVID-19 were included in the study. Serum samples were obtained within 0 to 7 days from COVID-19 patients confirmed by RT-PCR and chest CT scan. According to the SARS-CoV-2 RT-PCR results, the patients included in the study were divided into","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; RT-PCR; SARS-CoV-2; chest CT; lateral flow; rapid diagnosis","Bozok","Tugce Simsek","Department of Infectious Diseases and Clinical Microbiology, Nigde Omer Halisdemir University Training and Research Hospital, Nigde, Turkey",NA
"968","34260073","10.1002/jmv.27207","Mucormycosis or black fungus infection is a new scare in South Asian countries during the COVID-19 pandemic: Associated risk factors and preventive measures.",NA,"2021","07","22","J Med Virol","Journal of medical virology",NA,"Rahman","Fahad I","Department of Clinical Pharmacy and Pharmacology, University of Dhaka, Dhaka, Bangladesh",NA
"969","34260073","10.1002/jmv.27207","Mucormycosis or black fungus infection is a new scare in South Asian countries during the COVID-19 pandemic: Associated risk factors and preventive measures.",NA,"2021","07","22","J Med Virol","Journal of medical virology",NA,"Islam","Md Rabiul","Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh",NA
"970","34260073","10.1002/jmv.27207","Mucormycosis or black fungus infection is a new scare in South Asian countries during the COVID-19 pandemic: Associated risk factors and preventive measures.",NA,"2021","07","22","J Med Virol","Journal of medical virology",NA,"Bhuiyan","Mohiuddin A","Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh",NA
"971","34260066","10.1002/jmv.27200","SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.",NA,"2021","07","21","J Med Virol","Journal of medical virology","SARS-CoV-2; cancer patient; neutralization humoral response; reinfection","Borgogna","Cinzia","Virology Unit, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy",NA
"972","34260066","10.1002/jmv.27200","SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.",NA,"2021","07","21","J Med Virol","Journal of medical virology","SARS-CoV-2; cancer patient; neutralization humoral response; reinfection","De Andrea","Marco","Viral Pathogenesis Unit, Department of Public Health and Pediatric Sciences, University of Turin, Turin, Italy",NA
"973","34260066","10.1002/jmv.27200","SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.",NA,"2021","07","21","J Med Virol","Journal of medical virology","SARS-CoV-2; cancer patient; neutralization humoral response; reinfection","Griffante","Gloria","Virology Unit, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy",NA
"974","34260066","10.1002/jmv.27200","SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.",NA,"2021","07","21","J Med Virol","Journal of medical virology","SARS-CoV-2; cancer patient; neutralization humoral response; reinfection","Lai","Alessia","Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy",NA
"975","34260066","10.1002/jmv.27200","SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.",NA,"2021","07","21","J Med Virol","Journal of medical virology","SARS-CoV-2; cancer patient; neutralization humoral response; reinfection","Bergna","Annalisa","Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy",NA
"976","34260066","10.1002/jmv.27200","SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.",NA,"2021","07","21","J Med Virol","Journal of medical virology","SARS-CoV-2; cancer patient; neutralization humoral response; reinfection","Galli","Massimo","Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy",NA
"977","34260066","10.1002/jmv.27200","SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.",NA,"2021","07","21","J Med Virol","Journal of medical virology","SARS-CoV-2; cancer patient; neutralization humoral response; reinfection","Zehender","Gianguglielmo","Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy",NA
"978","34260066","10.1002/jmv.27200","SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.",NA,"2021","07","21","J Med Virol","Journal of medical virology","SARS-CoV-2; cancer patient; neutralization humoral response; reinfection","Castello","Luigi","Division of Internal and Emergency Medicine, Department of Translational Medicine, University of Piemonte Orientale and ""Maggiore della Carità"" Hospital, Novara, Italy",NA
"979","34260066","10.1002/jmv.27200","SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.",NA,"2021","07","21","J Med Virol","Journal of medical virology","SARS-CoV-2; cancer patient; neutralization humoral response; reinfection","Ravanini","Paolo","Unit of Microbiology and Virology, Department of Laboratory Medicine, ""Maggiore della Carità"" Hospital, Novara, Italy",NA
"980","34260066","10.1002/jmv.27200","SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.",NA,"2021","07","21","J Med Virol","Journal of medical virology","SARS-CoV-2; cancer patient; neutralization humoral response; reinfection","Cattrini","Carlo","Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and ""Maggiore della Carità"" Hospital, Novara, Italy",NA
"981","34260066","10.1002/jmv.27200","SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.",NA,"2021","07","21","J Med Virol","Journal of medical virology","SARS-CoV-2; cancer patient; neutralization humoral response; reinfection","Mennitto","Alessia","Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and ""Maggiore della Carità"" Hospital, Novara, Italy",NA
"982","34260066","10.1002/jmv.27200","SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.",NA,"2021","07","21","J Med Virol","Journal of medical virology","SARS-CoV-2; cancer patient; neutralization humoral response; reinfection","Gennari","Alessandra","Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and ""Maggiore della Carità"" Hospital, Novara, Italy",NA
"983","34260066","10.1002/jmv.27200","SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.",NA,"2021","07","21","J Med Virol","Journal of medical virology","SARS-CoV-2; cancer patient; neutralization humoral response; reinfection","Gariglio","Marisa","Virology Unit, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy",NA
"984","34260055","10.1007/s15010-021-01661-2","Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study.","To investigate the prevalence, incidence and characteristics of bacterial infections and their impact on outcome in critically ill patients infected with COVID-19. We conducted a prospective observational study in eight Italian ICUs from February to May 2020; data were collected through an interactive electronic database. Kaplan-Meier analysis (limit product method) was used to identify the occurrence of infections and risk of acquisition. During the study period 248 patients were recruited in t","2021","07","17","Infection","Infection","COVID-19; Co-infection; Critically ill patients; Secondary bacterial infection","De Santis","Vincenzo","Department of Anesthesia and Intensive Care Medicine, Ospedale Santa Maria Delle Croci, Viale Randi, 5, 48121, Ravenna, Italy. vincenzo.desantis@auslromagna","vincenzo.desantis@auslromagna.it"
"985","34260055","10.1007/s15010-021-01661-2","Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study.","To investigate the prevalence, incidence and characteristics of bacterial infections and their impact on outcome in critically ill patients infected with COVID-19. We conducted a prospective observational study in eight Italian ICUs from February to May 2020; data were collected through an interactive electronic database. Kaplan-Meier analysis (limit product method) was used to identify the occurrence of infections and risk of acquisition. During the study period 248 patients were recruited in t","2021","07","17","Infection","Infection","COVID-19; Co-infection; Critically ill patients; Secondary bacterial infection","Corona","Alberto","Emergency Anesthesia and Intensive Care Medicine Department, Esine and Edolo Hospital, ASST Valcamonica, Brescia, Italy",NA
"986","34260055","10.1007/s15010-021-01661-2","Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study.","To investigate the prevalence, incidence and characteristics of bacterial infections and their impact on outcome in critically ill patients infected with COVID-19. We conducted a prospective observational study in eight Italian ICUs from February to May 2020; data were collected through an interactive electronic database. Kaplan-Meier analysis (limit product method) was used to identify the occurrence of infections and risk of acquisition. During the study period 248 patients were recruited in t","2021","07","17","Infection","Infection","COVID-19; Co-infection; Critically ill patients; Secondary bacterial infection","Vitale","Domenico","Department of Anesthesia and Intensive Care Medicine, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy",NA
"987","34260055","10.1007/s15010-021-01661-2","Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study.","To investigate the prevalence, incidence and characteristics of bacterial infections and their impact on outcome in critically ill patients infected with COVID-19. We conducted a prospective observational study in eight Italian ICUs from February to May 2020; data were collected through an interactive electronic database. Kaplan-Meier analysis (limit product method) was used to identify the occurrence of infections and risk of acquisition. During the study period 248 patients were recruited in t","2021","07","17","Infection","Infection","COVID-19; Co-infection; Critically ill patients; Secondary bacterial infection","Nencini","Cecilia","Department of Anesthesia and Intensive Care Medicine, Ospedale Santa Maria Delle Croci, Viale Randi, 5, 48121, Ravenna, Italy",NA
"988","34260055","10.1007/s15010-021-01661-2","Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study.","To investigate the prevalence, incidence and characteristics of bacterial infections and their impact on outcome in critically ill patients infected with COVID-19. We conducted a prospective observational study in eight Italian ICUs from February to May 2020; data were collected through an interactive electronic database. Kaplan-Meier analysis (limit product method) was used to identify the occurrence of infections and risk of acquisition. During the study period 248 patients were recruited in t","2021","07","17","Infection","Infection","COVID-19; Co-infection; Critically ill patients; Secondary bacterial infection","Potalivo","Antonella","Department of Anesthesia and Intensive Care Medicine, Ospedale ""Infermi"" Rimini, Rimini, Italy",NA
"989","34260055","10.1007/s15010-021-01661-2","Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study.","To investigate the prevalence, incidence and characteristics of bacterial infections and their impact on outcome in critically ill patients infected with COVID-19. We conducted a prospective observational study in eight Italian ICUs from February to May 2020; data were collected through an interactive electronic database. Kaplan-Meier analysis (limit product method) was used to identify the occurrence of infections and risk of acquisition. During the study period 248 patients were recruited in t","2021","07","17","Infection","Infection","COVID-19; Co-infection; Critically ill patients; Secondary bacterial infection","Prete","Anna","Department of Anesthesia and Intensive Care Medicine, Ospedale Santa Maria Delle Croci, Viale Randi, 5, 48121, Ravenna, Italy",NA
"990","34260055","10.1007/s15010-021-01661-2","Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study.","To investigate the prevalence, incidence and characteristics of bacterial infections and their impact on outcome in critically ill patients infected with COVID-19. We conducted a prospective observational study in eight Italian ICUs from February to May 2020; data were collected through an interactive electronic database. Kaplan-Meier analysis (limit product method) was used to identify the occurrence of infections and risk of acquisition. During the study period 248 patients were recruited in t","2021","07","17","Infection","Infection","COVID-19; Co-infection; Critically ill patients; Secondary bacterial infection","Zani","Gianluca","Department of Anesthesia and Intensive Care Medicine, Ospedale Santa Maria Delle Croci, Viale Randi, 5, 48121, Ravenna, Italy",NA
"991","34260055","10.1007/s15010-021-01661-2","Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study.","To investigate the prevalence, incidence and characteristics of bacterial infections and their impact on outcome in critically ill patients infected with COVID-19. We conducted a prospective observational study in eight Italian ICUs from February to May 2020; data were collected through an interactive electronic database. Kaplan-Meier analysis (limit product method) was used to identify the occurrence of infections and risk of acquisition. During the study period 248 patients were recruited in t","2021","07","17","Infection","Infection","COVID-19; Co-infection; Critically ill patients; Secondary bacterial infection","Malfatto","Anna","Department of Anesthesia and Intensive Care Medicine, Ospedale di Bentivoglio Azienda USL Bologna, Bologna, Italy",NA
"992","34260055","10.1007/s15010-021-01661-2","Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study.","To investigate the prevalence, incidence and characteristics of bacterial infections and their impact on outcome in critically ill patients infected with COVID-19. We conducted a prospective observational study in eight Italian ICUs from February to May 2020; data were collected through an interactive electronic database. Kaplan-Meier analysis (limit product method) was used to identify the occurrence of infections and risk of acquisition. During the study period 248 patients were recruited in t","2021","07","17","Infection","Infection","COVID-19; Co-infection; Critically ill patients; Secondary bacterial infection","Tritapepe","Luigi","Department of Anesthesia and Intensive Care Medicine, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy",NA
"993","34260055","10.1007/s15010-021-01661-2","Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study.","To investigate the prevalence, incidence and characteristics of bacterial infections and their impact on outcome in critically ill patients infected with COVID-19. We conducted a prospective observational study in eight Italian ICUs from February to May 2020; data were collected through an interactive electronic database. Kaplan-Meier analysis (limit product method) was used to identify the occurrence of infections and risk of acquisition. During the study period 248 patients were recruited in t","2021","07","17","Infection","Infection","COVID-19; Co-infection; Critically ill patients; Secondary bacterial infection","Taddei","Stefania","Department of Anesthesia and Intensive Care Medicine, Ospedale di Bentivoglio Azienda USL Bologna, Bologna, Italy",NA
"994","34260055","10.1007/s15010-021-01661-2","Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study.","To investigate the prevalence, incidence and characteristics of bacterial infections and their impact on outcome in critically ill patients infected with COVID-19. We conducted a prospective observational study in eight Italian ICUs from February to May 2020; data were collected through an interactive electronic database. Kaplan-Meier analysis (limit product method) was used to identify the occurrence of infections and risk of acquisition. During the study period 248 patients were recruited in t","2021","07","17","Infection","Infection","COVID-19; Co-infection; Critically ill patients; Secondary bacterial infection","Locatelli","Alessandro","Department of Anesthesia and Intensive Care Medicine, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy",NA
"995","34260055","10.1007/s15010-021-01661-2","Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study.","To investigate the prevalence, incidence and characteristics of bacterial infections and their impact on outcome in critically ill patients infected with COVID-19. We conducted a prospective observational study in eight Italian ICUs from February to May 2020; data were collected through an interactive electronic database. Kaplan-Meier analysis (limit product method) was used to identify the occurrence of infections and risk of acquisition. During the study period 248 patients were recruited in t","2021","07","17","Infection","Infection","COVID-19; Co-infection; Critically ill patients; Secondary bacterial infection","Sambri","Vittorio","UOC Microbiology and Medical Laboratory, AUSL Romagna, Cesena, Italy",NA
"996","34260055","10.1007/s15010-021-01661-2","Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study.","To investigate the prevalence, incidence and characteristics of bacterial infections and their impact on outcome in critically ill patients infected with COVID-19. We conducted a prospective observational study in eight Italian ICUs from February to May 2020; data were collected through an interactive electronic database. Kaplan-Meier analysis (limit product method) was used to identify the occurrence of infections and risk of acquisition. During the study period 248 patients were recruited in t","2021","07","17","Infection","Infection","COVID-19; Co-infection; Critically ill patients; Secondary bacterial infection","Fusari","Maurizio","Department of Anesthesia and Intensive Care Medicine, Ospedale Santa Maria Delle Croci, Viale Randi, 5, 48121, Ravenna, Italy",NA
"997","34260055","10.1007/s15010-021-01661-2","Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study.","To investigate the prevalence, incidence and characteristics of bacterial infections and their impact on outcome in critically ill patients infected with COVID-19. We conducted a prospective observational study in eight Italian ICUs from February to May 2020; data were collected through an interactive electronic database. Kaplan-Meier analysis (limit product method) was used to identify the occurrence of infections and risk of acquisition. During the study period 248 patients were recruited in t","2021","07","17","Infection","Infection","COVID-19; Co-infection; Critically ill patients; Secondary bacterial infection","Singer","Mervyn","Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK",NA
"998","34260038","10.1007/s40121-021-00486-8","Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital.","Invasive pulmonary aspergillosis is an emerging complication among intensive care unit (ICU) patients with COVID-19 (CAPA). In the present study, all CAPA cases during the first year of the pandemic were reviewed in critically ill patients at a 650-bed tertiary Greek COVID-19 reference hospital. Data regarding patients admitted to the ICU of Attikon Hospital in Athens, Greece, between 22 March 2020 and 28 February 2021 with a positive PCR for SARS-CoV-2 infection were reviewed. Clinical and micr","2021","07","17","Infect Dis Ther","Infectious diseases and therapy","ARDS; Aspergillosis; COVID-19; Lung infection; MDR gram-negative co-infections","Paramythiotou","Elisabeth","nd Department of Critical Care, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece",NA
"999","34260038","10.1007/s40121-021-00486-8","Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital.","Invasive pulmonary aspergillosis is an emerging complication among intensive care unit (ICU) patients with COVID-19 (CAPA). In the present study, all CAPA cases during the first year of the pandemic were reviewed in critically ill patients at a 650-bed tertiary Greek COVID-19 reference hospital. Data regarding patients admitted to the ICU of Attikon Hospital in Athens, Greece, between 22 March 2020 and 28 February 2021 with a positive PCR for SARS-CoV-2 infection were reviewed. Clinical and micr","2021","07","17","Infect Dis Ther","Infectious diseases and therapy","ARDS; Aspergillosis; COVID-19; Lung infection; MDR gram-negative co-infections","Dimopoulos","George","nd Department of Critical Care, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece",NA
"1000","34260038","10.1007/s40121-021-00486-8","Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital.","Invasive pulmonary aspergillosis is an emerging complication among intensive care unit (ICU) patients with COVID-19 (CAPA). In the present study, all CAPA cases during the first year of the pandemic were reviewed in critically ill patients at a 650-bed tertiary Greek COVID-19 reference hospital. Data regarding patients admitted to the ICU of Attikon Hospital in Athens, Greece, between 22 March 2020 and 28 February 2021 with a positive PCR for SARS-CoV-2 infection were reviewed. Clinical and micr","2021","07","17","Infect Dis Ther","Infectious diseases and therapy","ARDS; Aspergillosis; COVID-19; Lung infection; MDR gram-negative co-infections","Koliakos","Nikolaos","nd Department of Critical Care, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece",NA
"1001","34260038","10.1007/s40121-021-00486-8","Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital.","Invasive pulmonary aspergillosis is an emerging complication among intensive care unit (ICU) patients with COVID-19 (CAPA). In the present study, all CAPA cases during the first year of the pandemic were reviewed in critically ill patients at a 650-bed tertiary Greek COVID-19 reference hospital. Data regarding patients admitted to the ICU of Attikon Hospital in Athens, Greece, between 22 March 2020 and 28 February 2021 with a positive PCR for SARS-CoV-2 infection were reviewed. Clinical and micr","2021","07","17","Infect Dis Ther","Infectious diseases and therapy","ARDS; Aspergillosis; COVID-19; Lung infection; MDR gram-negative co-infections","Siopi","Maria","Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 1 Rimini str, Haidari 124 62, Athens, Greece",NA
"1002","34260038","10.1007/s40121-021-00486-8","Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital.","Invasive pulmonary aspergillosis is an emerging complication among intensive care unit (ICU) patients with COVID-19 (CAPA). In the present study, all CAPA cases during the first year of the pandemic were reviewed in critically ill patients at a 650-bed tertiary Greek COVID-19 reference hospital. Data regarding patients admitted to the ICU of Attikon Hospital in Athens, Greece, between 22 March 2020 and 28 February 2021 with a positive PCR for SARS-CoV-2 infection were reviewed. Clinical and micr","2021","07","17","Infect Dis Ther","Infectious diseases and therapy","ARDS; Aspergillosis; COVID-19; Lung infection; MDR gram-negative co-infections","Vourli","Sophia","Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 1 Rimini str, Haidari 124 62, Athens, Greece",NA
"1003","34260038","10.1007/s40121-021-00486-8","Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital.","Invasive pulmonary aspergillosis is an emerging complication among intensive care unit (ICU) patients with COVID-19 (CAPA). In the present study, all CAPA cases during the first year of the pandemic were reviewed in critically ill patients at a 650-bed tertiary Greek COVID-19 reference hospital. Data regarding patients admitted to the ICU of Attikon Hospital in Athens, Greece, between 22 March 2020 and 28 February 2021 with a positive PCR for SARS-CoV-2 infection were reviewed. Clinical and micr","2021","07","17","Infect Dis Ther","Infectious diseases and therapy","ARDS; Aspergillosis; COVID-19; Lung infection; MDR gram-negative co-infections","Pournaras","Spyros","Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 1 Rimini str, Haidari 124 62, Athens, Greece",NA
"1004","34260038","10.1007/s40121-021-00486-8","Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital.","Invasive pulmonary aspergillosis is an emerging complication among intensive care unit (ICU) patients with COVID-19 (CAPA). In the present study, all CAPA cases during the first year of the pandemic were reviewed in critically ill patients at a 650-bed tertiary Greek COVID-19 reference hospital. Data regarding patients admitted to the ICU of Attikon Hospital in Athens, Greece, between 22 March 2020 and 28 February 2021 with a positive PCR for SARS-CoV-2 infection were reviewed. Clinical and micr","2021","07","17","Infect Dis Ther","Infectious diseases and therapy","ARDS; Aspergillosis; COVID-19; Lung infection; MDR gram-negative co-infections","Meletiadis","Joseph","Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 1 Rimini str, Haidari 124 62, Athens, Greece. jmeletiadis@med.uoa","jmeletiadis@med.uoa.gr"
"1005","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Cereda","Alberto","GVM Care &amp","alberto.cereda@email.it"
"1006","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Toselli","Marco","GVM Care &amp",NA
"1007","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Palmisano","Anna","IRCCS San Raffaele Scientific Institute, Milan, Italy",NA
"1008","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Vignale","Davide","IRCCS San Raffaele Scientific Institute, Milan, Italy",NA
"1009","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Leone","Riccardo","IRCCS San Raffaele Scientific Institute, Milan, Italy",NA
"1010","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Nicoletti","Valeria","IRCCS San Raffaele Scientific Institute, Milan, Italy",NA
"1011","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Gnasso","Chiara","IRCCS San Raffaele Scientific Institute, Milan, Italy",NA
"1012","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Mangieri","Antonio","GVM Care &amp",NA
"1013","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Khokhar","Arif","GVM Care &amp",NA
"1014","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Campo","Gianluca","Azienda Ospedaliero-Universitaria di Ferrara, Cona, FE, Italy",NA
"1015","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Scoccia","Alessandra","Azienda Ospedaliero-Universitaria di Ferrara, Cona, FE, Italy",NA
"1016","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Bertini","Matteo","Azienda Ospedaliero-Universitaria di Ferrara, Cona, FE, Italy",NA
"1017","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Loffi","Marco","Ospedale di Cremona, Cremona, Italy",NA
"1018","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Sergio","Pietro","Ospedale di Cremona, Cremona, Italy",NA
"1019","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Andreini","Daniele","Centro Cardiologico Monzino IRCCS, Milan, Italy",NA
"1020","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Pontone","Gianluca","Centro Cardiologico Monzino IRCCS, Milan, Italy",NA
"1021","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Iannopollo","Gianmarco","Ospedale Maggiore, Bologna, Italy",NA
"1022","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Nannini","Tommaso","Ospedale Maggiore, Bologna, Italy",NA
"1023","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Ippolito","Davide","San Gerardo Hospital, Monza, Italy",NA
"1024","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Bellani","Giacomo","San Gerardo Hospital, Monza, Italy",NA
"1025","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Patelli","Gianluigi","ASST Bolognini Hospital, Bergamo Est, Seriate, Italy",NA
"1026","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Besana","Francesca","ASST Bolognini Hospital, Bergamo Est, Seriate, Italy",NA
"1027","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Vignali","Luigi","Parma University Hospital, Parma, Italy",NA
"1028","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Sverzellati","Nicola","Parma University Hospital, Parma, Italy",NA
"1029","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Iannaccone","Mario","San Giovanni Bosco Hospital, ASL Citta di Torino, Turin, Italy",NA
"1030","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Vaudano","Paolo Giacomo","San Giovanni Bosco Hospital, ASL Citta di Torino, Turin, Italy",NA
"1031","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Sangiorgi","Giuseppe Massimo","Università degli Studi di Roma ""Tor Vergata"", Roma, Italy",NA
"1032","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Turchio","Piergiorgio","Guglielmo da Saliceto Hospital, Piacenza, Italy",NA
"1033","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Monello","Alberto","Guglielmo da Saliceto Hospital, Piacenza, Italy",NA
"1034","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Tumminello","Gabriele","Vita-Salute San Raffaele University, Milan, Italy",NA
"1035","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Maggioni","Aldo Pietro","GVM Care &amp",NA
"1036","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Rapezzi","Claudio","GVM Care &amp",NA
"1037","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Colombo","Antonio","GVM Care &amp",NA
"1038","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Giannini","Francesco","GVM Care &amp",NA
"1039","34260010","10.1007/s11357-021-00409-y","The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification.","Recent clinical and demographical studies on COVID-19 patients have demonstrated that men experience worse outcomes than women. However, in most cases, the data were not stratified according to gender, limiting the understanding of the real impact of gender on outcomes. This study aimed to evaluate the disaggregated in-hospital outcomes and explore the possible interactions between gender and cardiovascular calcifications. Data was derived from the sCORE-COVID-19 registry, an Italian multicentre","2021","07","17","Geroscience","GeroScience","COVID-19; Lung CT; Cardiovascular calcifications; Sars-CoV2; Sex bias","Esposito","Antonio","IRCCS San Raffaele Scientific Institute, Milan, Italy",NA
"1040","34259961","10.1007/s11882-021-01015-w","Clinical-Pathological Correlation of the Pathophysiology and Mechanism of Action of COVID-19 - a Primer for Clinicians.","Increasing knowledge of the pathogenesis of the SARS-CoV-2 infection and the complex interaction between host and viral factors have allowed clinicians to stratify the severity of COVID-19 infection. Epidemiological data has also helped to model viral carriage and infectivity. This review presents a comprehensive summary of the pathophysiology of COVID-19, the mechanisms of action of the SARS-CoV-2 virus, and the correlation with the clinical and biochemical characteristics of the disease. ACE2 ","2021","07","21","Curr Allergy Asthma Rep","Current allergy and asthma reports","COVID-19; Epidemiology; Mechanism of action; Pandemic; Pathogenesis; Pathophysiology","Chee","Jeremy","Department of Otolaryngology, Head &amp",NA
"1041","34259961","10.1007/s11882-021-01015-w","Clinical-Pathological Correlation of the Pathophysiology and Mechanism of Action of COVID-19 - a Primer for Clinicians.","Increasing knowledge of the pathogenesis of the SARS-CoV-2 infection and the complex interaction between host and viral factors have allowed clinicians to stratify the severity of COVID-19 infection. Epidemiological data has also helped to model viral carriage and infectivity. This review presents a comprehensive summary of the pathophysiology of COVID-19, the mechanisms of action of the SARS-CoV-2 virus, and the correlation with the clinical and biochemical characteristics of the disease. ACE2 ","2021","07","21","Curr Allergy Asthma Rep","Current allergy and asthma reports","COVID-19; Epidemiology; Mechanism of action; Pandemic; Pathogenesis; Pathophysiology","Loh","Woei Shyang","Department of Otolaryngology, Head &amp",NA
"1042","34259961","10.1007/s11882-021-01015-w","Clinical-Pathological Correlation of the Pathophysiology and Mechanism of Action of COVID-19 - a Primer for Clinicians.","Increasing knowledge of the pathogenesis of the SARS-CoV-2 infection and the complex interaction between host and viral factors have allowed clinicians to stratify the severity of COVID-19 infection. Epidemiological data has also helped to model viral carriage and infectivity. This review presents a comprehensive summary of the pathophysiology of COVID-19, the mechanisms of action of the SARS-CoV-2 virus, and the correlation with the clinical and biochemical characteristics of the disease. ACE2 ","2021","07","21","Curr Allergy Asthma Rep","Current allergy and asthma reports","COVID-19; Epidemiology; Mechanism of action; Pandemic; Pathogenesis; Pathophysiology","Liu","Zheng","Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China",NA
"1043","34259961","10.1007/s11882-021-01015-w","Clinical-Pathological Correlation of the Pathophysiology and Mechanism of Action of COVID-19 - a Primer for Clinicians.","Increasing knowledge of the pathogenesis of the SARS-CoV-2 infection and the complex interaction between host and viral factors have allowed clinicians to stratify the severity of COVID-19 infection. Epidemiological data has also helped to model viral carriage and infectivity. This review presents a comprehensive summary of the pathophysiology of COVID-19, the mechanisms of action of the SARS-CoV-2 virus, and the correlation with the clinical and biochemical characteristics of the disease. ACE2 ","2021","07","21","Curr Allergy Asthma Rep","Current allergy and asthma reports","COVID-19; Epidemiology; Mechanism of action; Pandemic; Pathogenesis; Pathophysiology","Mullol","Joaquim","Rhinology Unit &amp",NA
"1044","34259961","10.1007/s11882-021-01015-w","Clinical-Pathological Correlation of the Pathophysiology and Mechanism of Action of COVID-19 - a Primer for Clinicians.","Increasing knowledge of the pathogenesis of the SARS-CoV-2 infection and the complex interaction between host and viral factors have allowed clinicians to stratify the severity of COVID-19 infection. Epidemiological data has also helped to model viral carriage and infectivity. This review presents a comprehensive summary of the pathophysiology of COVID-19, the mechanisms of action of the SARS-CoV-2 virus, and the correlation with the clinical and biochemical characteristics of the disease. ACE2 ","2021","07","21","Curr Allergy Asthma Rep","Current allergy and asthma reports","COVID-19; Epidemiology; Mechanism of action; Pandemic; Pathogenesis; Pathophysiology","Wang","De Yun","Department of Otolaryngology, Head &amp","entwdy@nus.edu.sg"
"1045","34259950","10.1007/s11912-021-01081-3","The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic.","To give an overview of the role of social media (SoMe) in cardio-oncology during the COVID-19 pandemic. SoMe has been critical in fostering education, outreach, awareness, collaboration, dissemination of information, and advocacy in cardio-oncology. This has become increasingly evident during the COVID-19 pandemic, during which SoMe has helped share best practices, community, and research focused on the impact of COVID-19 in cardiology and hematology/oncology, with cardio-oncology at the interfa","2021","07","20","Curr Oncol Rep","Current oncology reports","Advocacy; COVID-19; Cardio-oncology; Health disparities; Pandemic; Social media","Kwan","Jennifer M","Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA",NA
"1046","34259950","10.1007/s11912-021-01081-3","The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic.","To give an overview of the role of social media (SoMe) in cardio-oncology during the COVID-19 pandemic. SoMe has been critical in fostering education, outreach, awareness, collaboration, dissemination of information, and advocacy in cardio-oncology. This has become increasingly evident during the COVID-19 pandemic, during which SoMe has helped share best practices, community, and research focused on the impact of COVID-19 in cardiology and hematology/oncology, with cardio-oncology at the interfa","2021","07","20","Curr Oncol Rep","Current oncology reports","Advocacy; COVID-19; Cardio-oncology; Health disparities; Pandemic; Social media","Henry","Mariana L","Dartmouth School of Medicine, Lebanon, NH, USA",NA
"1047","34259950","10.1007/s11912-021-01081-3","The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic.","To give an overview of the role of social media (SoMe) in cardio-oncology during the COVID-19 pandemic. SoMe has been critical in fostering education, outreach, awareness, collaboration, dissemination of information, and advocacy in cardio-oncology. This has become increasingly evident during the COVID-19 pandemic, during which SoMe has helped share best practices, community, and research focused on the impact of COVID-19 in cardiology and hematology/oncology, with cardio-oncology at the interfa","2021","07","20","Curr Oncol Rep","Current oncology reports","Advocacy; COVID-19; Cardio-oncology; Health disparities; Pandemic; Social media","Christophers","Briana","Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD program, New York, NY, USA",NA
"1048","34259950","10.1007/s11912-021-01081-3","The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic.","To give an overview of the role of social media (SoMe) in cardio-oncology during the COVID-19 pandemic. SoMe has been critical in fostering education, outreach, awareness, collaboration, dissemination of information, and advocacy in cardio-oncology. This has become increasingly evident during the COVID-19 pandemic, during which SoMe has helped share best practices, community, and research focused on the impact of COVID-19 in cardiology and hematology/oncology, with cardio-oncology at the interfa","2021","07","20","Curr Oncol Rep","Current oncology reports","Advocacy; COVID-19; Cardio-oncology; Health disparities; Pandemic; Social media","Tamirisa","Kamala","Texas Cardiac Arrhythmia Institute, Austin, TX, USA",NA
"1049","34259950","10.1007/s11912-021-01081-3","The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic.","To give an overview of the role of social media (SoMe) in cardio-oncology during the COVID-19 pandemic. SoMe has been critical in fostering education, outreach, awareness, collaboration, dissemination of information, and advocacy in cardio-oncology. This has become increasingly evident during the COVID-19 pandemic, during which SoMe has helped share best practices, community, and research focused on the impact of COVID-19 in cardiology and hematology/oncology, with cardio-oncology at the interfa","2021","07","20","Curr Oncol Rep","Current oncology reports","Advocacy; COVID-19; Cardio-oncology; Health disparities; Pandemic; Social media","Thamman","Ritu","University of Pittsburg, Pittsburg, PA, USA",NA
"1050","34259950","10.1007/s11912-021-01081-3","The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic.","To give an overview of the role of social media (SoMe) in cardio-oncology during the COVID-19 pandemic. SoMe has been critical in fostering education, outreach, awareness, collaboration, dissemination of information, and advocacy in cardio-oncology. This has become increasingly evident during the COVID-19 pandemic, during which SoMe has helped share best practices, community, and research focused on the impact of COVID-19 in cardiology and hematology/oncology, with cardio-oncology at the interfa","2021","07","20","Curr Oncol Rep","Current oncology reports","Advocacy; COVID-19; Cardio-oncology; Health disparities; Pandemic; Social media","Sadler","Diego","Cleveland Clinic, Weston, FL, USA",NA
"1051","34259950","10.1007/s11912-021-01081-3","The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic.","To give an overview of the role of social media (SoMe) in cardio-oncology during the COVID-19 pandemic. SoMe has been critical in fostering education, outreach, awareness, collaboration, dissemination of information, and advocacy in cardio-oncology. This has become increasingly evident during the COVID-19 pandemic, during which SoMe has helped share best practices, community, and research focused on the impact of COVID-19 in cardiology and hematology/oncology, with cardio-oncology at the interfa","2021","07","20","Curr Oncol Rep","Current oncology reports","Advocacy; COVID-19; Cardio-oncology; Health disparities; Pandemic; Social media","Aggarwal","Niti R","Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA",NA
"1052","34259950","10.1007/s11912-021-01081-3","The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic.","To give an overview of the role of social media (SoMe) in cardio-oncology during the COVID-19 pandemic. SoMe has been critical in fostering education, outreach, awareness, collaboration, dissemination of information, and advocacy in cardio-oncology. This has become increasingly evident during the COVID-19 pandemic, during which SoMe has helped share best practices, community, and research focused on the impact of COVID-19 in cardiology and hematology/oncology, with cardio-oncology at the interfa","2021","07","20","Curr Oncol Rep","Current oncology reports","Advocacy; COVID-19; Cardio-oncology; Health disparities; Pandemic; Social media","Cheng","Richard","Division of Cardiology, University of Washington, Seattle, WA, USA",NA
"1053","34259950","10.1007/s11912-021-01081-3","The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic.","To give an overview of the role of social media (SoMe) in cardio-oncology during the COVID-19 pandemic. SoMe has been critical in fostering education, outreach, awareness, collaboration, dissemination of information, and advocacy in cardio-oncology. This has become increasingly evident during the COVID-19 pandemic, during which SoMe has helped share best practices, community, and research focused on the impact of COVID-19 in cardiology and hematology/oncology, with cardio-oncology at the interfa","2021","07","20","Curr Oncol Rep","Current oncology reports","Advocacy; COVID-19; Cardio-oncology; Health disparities; Pandemic; Social media","Parwani","Purvi","Loma Linda University Health, Loma Linda, CA, USA",NA
"1054","34259950","10.1007/s11912-021-01081-3","The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic.","To give an overview of the role of social media (SoMe) in cardio-oncology during the COVID-19 pandemic. SoMe has been critical in fostering education, outreach, awareness, collaboration, dissemination of information, and advocacy in cardio-oncology. This has become increasingly evident during the COVID-19 pandemic, during which SoMe has helped share best practices, community, and research focused on the impact of COVID-19 in cardiology and hematology/oncology, with cardio-oncology at the interfa","2021","07","20","Curr Oncol Rep","Current oncology reports","Advocacy; COVID-19; Cardio-oncology; Health disparities; Pandemic; Social media","Dent","Susan","Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC, USA",NA
"1055","34259950","10.1007/s11912-021-01081-3","The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic.","To give an overview of the role of social media (SoMe) in cardio-oncology during the COVID-19 pandemic. SoMe has been critical in fostering education, outreach, awareness, collaboration, dissemination of information, and advocacy in cardio-oncology. This has become increasingly evident during the COVID-19 pandemic, during which SoMe has helped share best practices, community, and research focused on the impact of COVID-19 in cardiology and hematology/oncology, with cardio-oncology at the interfa","2021","07","20","Curr Oncol Rep","Current oncology reports","Advocacy; COVID-19; Cardio-oncology; Health disparities; Pandemic; Social media","Ismail-Khan","Roohi","Cardio-Oncology Program, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL, USA",NA
"1056","34259950","10.1007/s11912-021-01081-3","The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic.","To give an overview of the role of social media (SoMe) in cardio-oncology during the COVID-19 pandemic. SoMe has been critical in fostering education, outreach, awareness, collaboration, dissemination of information, and advocacy in cardio-oncology. This has become increasingly evident during the COVID-19 pandemic, during which SoMe has helped share best practices, community, and research focused on the impact of COVID-19 in cardiology and hematology/oncology, with cardio-oncology at the interfa","2021","07","20","Curr Oncol Rep","Current oncology reports","Advocacy; COVID-19; Cardio-oncology; Health disparities; Pandemic; Social media","Fradley","Michael G","Cardio-Oncology Center of Excellence, Division of Cardiology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA",NA
"1057","34259950","10.1007/s11912-021-01081-3","The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic.","To give an overview of the role of social media (SoMe) in cardio-oncology during the COVID-19 pandemic. SoMe has been critical in fostering education, outreach, awareness, collaboration, dissemination of information, and advocacy in cardio-oncology. This has become increasingly evident during the COVID-19 pandemic, during which SoMe has helped share best practices, community, and research focused on the impact of COVID-19 in cardiology and hematology/oncology, with cardio-oncology at the interfa","2021","07","20","Curr Oncol Rep","Current oncology reports","Advocacy; COVID-19; Cardio-oncology; Health disparities; Pandemic; Social media","Brown","Sherry-Ann","Cardio-Oncology Program, Division of Cardiovascular Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA. shbrown@mcw","shbrown@mcw.edu"
"1058","34259944","10.1007/s11926-021-01041-7","The Role of Antiphospholipid Antibodies in COVID-19.","Elevated levels of anti-phospholipid (aPL) antibodies are the most important criterion in the diagnosis of anti-phospholipid syndrome (APS) and are usually responsible for promoting the risk of thrombotic complications. Now, in the course of the global coronavirus disease 2019 (COVID-19) pandemic, measurable aPL antibodies have also been detected in a noticeable number of patients showing a variety ranging from studies with only isolated positive tests to cohorts with very high positivity. Thus,","2021","07","23","Curr Rheumatol Rep","Current rheumatology reports","Antiphopsholipd antibody; Antiphospholipid syndrom; Covid-19; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; COVID-19; Humans; Immunoglobulin G; Immunoglobulin M; Lupus Coagulation Inhibitor; SARS-CoV-2; beta 2-Glycoprotein I","Stelzer","Maximilian","School of Medicine, University of Tuebingen, Tuebingen, Germany",NA
"1059","34259944","10.1007/s11926-021-01041-7","The Role of Antiphospholipid Antibodies in COVID-19.","Elevated levels of anti-phospholipid (aPL) antibodies are the most important criterion in the diagnosis of anti-phospholipid syndrome (APS) and are usually responsible for promoting the risk of thrombotic complications. Now, in the course of the global coronavirus disease 2019 (COVID-19) pandemic, measurable aPL antibodies have also been detected in a noticeable number of patients showing a variety ranging from studies with only isolated positive tests to cohorts with very high positivity. Thus,","2021","07","23","Curr Rheumatol Rep","Current rheumatology reports","Antiphopsholipd antibody; Antiphospholipid syndrom; Covid-19; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; COVID-19; Humans; Immunoglobulin G; Immunoglobulin M; Lupus Coagulation Inhibitor; SARS-CoV-2; beta 2-Glycoprotein I","Henes","Jörg","Centre for Interdisciplinary Clinical Immunology, Rheumatology and Auto-inflammatory Diseases and Department of Internal Medicine II (Oncology, Hematology, Immunology, Rheumatology, Pulmology), University Hospital Tuebingen, Otfried-Mueller-Str. 10, DE 72076, Tuebingen, Germany",NA
"1060","34259944","10.1007/s11926-021-01041-7","The Role of Antiphospholipid Antibodies in COVID-19.","Elevated levels of anti-phospholipid (aPL) antibodies are the most important criterion in the diagnosis of anti-phospholipid syndrome (APS) and are usually responsible for promoting the risk of thrombotic complications. Now, in the course of the global coronavirus disease 2019 (COVID-19) pandemic, measurable aPL antibodies have also been detected in a noticeable number of patients showing a variety ranging from studies with only isolated positive tests to cohorts with very high positivity. Thus,","2021","07","23","Curr Rheumatol Rep","Current rheumatology reports","Antiphopsholipd antibody; Antiphospholipid syndrom; Covid-19; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; COVID-19; Humans; Immunoglobulin G; Immunoglobulin M; Lupus Coagulation Inhibitor; SARS-CoV-2; beta 2-Glycoprotein I","Saur","Sebastian","Centre for Interdisciplinary Clinical Immunology, Rheumatology and Auto-inflammatory Diseases and Department of Internal Medicine II (Oncology, Hematology, Immunology, Rheumatology, Pulmology), University Hospital Tuebingen, Otfried-Mueller-Str. 10, DE 72076, Tuebingen, Germany. sebastian.saur@med.uni-tuebingen","sebastian.saur@med.uni"
"1061","34259942","10.1186/s13613-021-00896-4","Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.","De-regulated host response to severe coronavirus disease 2019 (COVID-19), directly referring to the concept of sepsis-associated immunological dysregulation, seems to be a strong signature of severe COVID-19. Myeloid cells phenotyping is well recognized to diagnose critical illness-induced immunodepression in sepsis and has not been well characterized in COVID-19. The aim of this study is to review phenotypic characteristics of myeloid cells and evaluate their relations with the occurrence of se","2021","07","17","Ann Intensive Care","Annals of intensive care","COVID-19; Myeloid-derived suppressor cells; Secondary infection; Sepsis-induced immunodepression; mHLA-DR","Marais","Clémence","Pediatric « Adult COVID-19-Converted » Intensive Care and Neonatal Medicine, AP-HP Paris Saclay University, Bicêtre Hospital, 78, Rue du Général Leclerc, 94275, Le Kremlin-Bicêtre, France",NA
"1062","34259942","10.1186/s13613-021-00896-4","Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.","De-regulated host response to severe coronavirus disease 2019 (COVID-19), directly referring to the concept of sepsis-associated immunological dysregulation, seems to be a strong signature of severe COVID-19. Myeloid cells phenotyping is well recognized to diagnose critical illness-induced immunodepression in sepsis and has not been well characterized in COVID-19. The aim of this study is to review phenotypic characteristics of myeloid cells and evaluate their relations with the occurrence of se","2021","07","17","Ann Intensive Care","Annals of intensive care","COVID-19; Myeloid-derived suppressor cells; Secondary infection; Sepsis-induced immunodepression; mHLA-DR","Claude","Caroline","Pediatric « Adult COVID-19-Converted » Intensive Care and Neonatal Medicine, AP-HP Paris Saclay University, Bicêtre Hospital, 78, Rue du Général Leclerc, 94275, Le Kremlin-Bicêtre, France",NA
"1063","34259942","10.1186/s13613-021-00896-4","Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.","De-regulated host response to severe coronavirus disease 2019 (COVID-19), directly referring to the concept of sepsis-associated immunological dysregulation, seems to be a strong signature of severe COVID-19. Myeloid cells phenotyping is well recognized to diagnose critical illness-induced immunodepression in sepsis and has not been well characterized in COVID-19. The aim of this study is to review phenotypic characteristics of myeloid cells and evaluate their relations with the occurrence of se","2021","07","17","Ann Intensive Care","Annals of intensive care","COVID-19; Myeloid-derived suppressor cells; Secondary infection; Sepsis-induced immunodepression; mHLA-DR","Semaan","Nada","Pediatric « Adult COVID-19-Converted » Intensive Care and Neonatal Medicine, AP-HP Paris Saclay University, Bicêtre Hospital, 78, Rue du Général Leclerc, 94275, Le Kremlin-Bicêtre, France",NA
"1064","34259942","10.1186/s13613-021-00896-4","Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.","De-regulated host response to severe coronavirus disease 2019 (COVID-19), directly referring to the concept of sepsis-associated immunological dysregulation, seems to be a strong signature of severe COVID-19. Myeloid cells phenotyping is well recognized to diagnose critical illness-induced immunodepression in sepsis and has not been well characterized in COVID-19. The aim of this study is to review phenotypic characteristics of myeloid cells and evaluate their relations with the occurrence of se","2021","07","17","Ann Intensive Care","Annals of intensive care","COVID-19; Myeloid-derived suppressor cells; Secondary infection; Sepsis-induced immunodepression; mHLA-DR","Charbel","Ramy","Pediatric « Adult COVID-19-Converted » Intensive Care and Neonatal Medicine, AP-HP Paris Saclay University, Bicêtre Hospital, 78, Rue du Général Leclerc, 94275, Le Kremlin-Bicêtre, France",NA
"1065","34259942","10.1186/s13613-021-00896-4","Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.","De-regulated host response to severe coronavirus disease 2019 (COVID-19), directly referring to the concept of sepsis-associated immunological dysregulation, seems to be a strong signature of severe COVID-19. Myeloid cells phenotyping is well recognized to diagnose critical illness-induced immunodepression in sepsis and has not been well characterized in COVID-19. The aim of this study is to review phenotypic characteristics of myeloid cells and evaluate their relations with the occurrence of se","2021","07","17","Ann Intensive Care","Annals of intensive care","COVID-19; Myeloid-derived suppressor cells; Secondary infection; Sepsis-induced immunodepression; mHLA-DR","Barreault","Simon","Pediatric « Adult COVID-19-Converted » Intensive Care and Neonatal Medicine, AP-HP Paris Saclay University, Bicêtre Hospital, 78, Rue du Général Leclerc, 94275, Le Kremlin-Bicêtre, France",NA
"1066","34259942","10.1186/s13613-021-00896-4","Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.","De-regulated host response to severe coronavirus disease 2019 (COVID-19), directly referring to the concept of sepsis-associated immunological dysregulation, seems to be a strong signature of severe COVID-19. Myeloid cells phenotyping is well recognized to diagnose critical illness-induced immunodepression in sepsis and has not been well characterized in COVID-19. The aim of this study is to review phenotypic characteristics of myeloid cells and evaluate their relations with the occurrence of se","2021","07","17","Ann Intensive Care","Annals of intensive care","COVID-19; Myeloid-derived suppressor cells; Secondary infection; Sepsis-induced immunodepression; mHLA-DR","Travert","Brendan","Pediatric « Adult COVID-19-Converted » Intensive Care and Neonatal Medicine, AP-HP Paris Saclay University, Bicêtre Hospital, 78, Rue du Général Leclerc, 94275, Le Kremlin-Bicêtre, France",NA
"1067","34259942","10.1186/s13613-021-00896-4","Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.","De-regulated host response to severe coronavirus disease 2019 (COVID-19), directly referring to the concept of sepsis-associated immunological dysregulation, seems to be a strong signature of severe COVID-19. Myeloid cells phenotyping is well recognized to diagnose critical illness-induced immunodepression in sepsis and has not been well characterized in COVID-19. The aim of this study is to review phenotypic characteristics of myeloid cells and evaluate their relations with the occurrence of se","2021","07","17","Ann Intensive Care","Annals of intensive care","COVID-19; Myeloid-derived suppressor cells; Secondary infection; Sepsis-induced immunodepression; mHLA-DR","Piloquet","Jean-Eudes","Pediatric « Adult COVID-19-Converted » Intensive Care and Neonatal Medicine, AP-HP Paris Saclay University, Bicêtre Hospital, 78, Rue du Général Leclerc, 94275, Le Kremlin-Bicêtre, France",NA
"1068","34259942","10.1186/s13613-021-00896-4","Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.","De-regulated host response to severe coronavirus disease 2019 (COVID-19), directly referring to the concept of sepsis-associated immunological dysregulation, seems to be a strong signature of severe COVID-19. Myeloid cells phenotyping is well recognized to diagnose critical illness-induced immunodepression in sepsis and has not been well characterized in COVID-19. The aim of this study is to review phenotypic characteristics of myeloid cells and evaluate their relations with the occurrence of se","2021","07","17","Ann Intensive Care","Annals of intensive care","COVID-19; Myeloid-derived suppressor cells; Secondary infection; Sepsis-induced immunodepression; mHLA-DR","Demailly","Zoé","Medical Intensive Care, AP-HP Paris Saclay University, Bicêtre Hospital, Le Kremlin-Bicêtre, France",NA
"1069","34259942","10.1186/s13613-021-00896-4","Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.","De-regulated host response to severe coronavirus disease 2019 (COVID-19), directly referring to the concept of sepsis-associated immunological dysregulation, seems to be a strong signature of severe COVID-19. Myeloid cells phenotyping is well recognized to diagnose critical illness-induced immunodepression in sepsis and has not been well characterized in COVID-19. The aim of this study is to review phenotypic characteristics of myeloid cells and evaluate their relations with the occurrence of se","2021","07","17","Ann Intensive Care","Annals of intensive care","COVID-19; Myeloid-derived suppressor cells; Secondary infection; Sepsis-induced immunodepression; mHLA-DR","Morin","Luc","Pediatric « Adult COVID-19-Converted » Intensive Care and Neonatal Medicine, AP-HP Paris Saclay University, Bicêtre Hospital, 78, Rue du Général Leclerc, 94275, Le Kremlin-Bicêtre, France",NA
"1070","34259942","10.1186/s13613-021-00896-4","Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.","De-regulated host response to severe coronavirus disease 2019 (COVID-19), directly referring to the concept of sepsis-associated immunological dysregulation, seems to be a strong signature of severe COVID-19. Myeloid cells phenotyping is well recognized to diagnose critical illness-induced immunodepression in sepsis and has not been well characterized in COVID-19. The aim of this study is to review phenotypic characteristics of myeloid cells and evaluate their relations with the occurrence of se","2021","07","17","Ann Intensive Care","Annals of intensive care","COVID-19; Myeloid-derived suppressor cells; Secondary infection; Sepsis-induced immunodepression; mHLA-DR","Merchaoui","Zied","Pediatric « Adult COVID-19-Converted » Intensive Care and Neonatal Medicine, AP-HP Paris Saclay University, Bicêtre Hospital, 78, Rue du Général Leclerc, 94275, Le Kremlin-Bicêtre, France",NA
"1071","34259942","10.1186/s13613-021-00896-4","Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.","De-regulated host response to severe coronavirus disease 2019 (COVID-19), directly referring to the concept of sepsis-associated immunological dysregulation, seems to be a strong signature of severe COVID-19. Myeloid cells phenotyping is well recognized to diagnose critical illness-induced immunodepression in sepsis and has not been well characterized in COVID-19. The aim of this study is to review phenotypic characteristics of myeloid cells and evaluate their relations with the occurrence of se","2021","07","17","Ann Intensive Care","Annals of intensive care","COVID-19; Myeloid-derived suppressor cells; Secondary infection; Sepsis-induced immunodepression; mHLA-DR","Teboul","Jean-Louis","Medical Intensive Care, AP-HP Paris Saclay University, Bicêtre Hospital, Le Kremlin-Bicêtre, France",NA
"1072","34259942","10.1186/s13613-021-00896-4","Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.","De-regulated host response to severe coronavirus disease 2019 (COVID-19), directly referring to the concept of sepsis-associated immunological dysregulation, seems to be a strong signature of severe COVID-19. Myeloid cells phenotyping is well recognized to diagnose critical illness-induced immunodepression in sepsis and has not been well characterized in COVID-19. The aim of this study is to review phenotypic characteristics of myeloid cells and evaluate their relations with the occurrence of se","2021","07","17","Ann Intensive Care","Annals of intensive care","COVID-19; Myeloid-derived suppressor cells; Secondary infection; Sepsis-induced immunodepression; mHLA-DR","Durand","Philippe","Pediatric « Adult COVID-19-Converted » Intensive Care and Neonatal Medicine, AP-HP Paris Saclay University, Bicêtre Hospital, 78, Rue du Général Leclerc, 94275, Le Kremlin-Bicêtre, France",NA
"1073","34259942","10.1186/s13613-021-00896-4","Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.","De-regulated host response to severe coronavirus disease 2019 (COVID-19), directly referring to the concept of sepsis-associated immunological dysregulation, seems to be a strong signature of severe COVID-19. Myeloid cells phenotyping is well recognized to diagnose critical illness-induced immunodepression in sepsis and has not been well characterized in COVID-19. The aim of this study is to review phenotypic characteristics of myeloid cells and evaluate their relations with the occurrence of se","2021","07","17","Ann Intensive Care","Annals of intensive care","COVID-19; Myeloid-derived suppressor cells; Secondary infection; Sepsis-induced immunodepression; mHLA-DR","Miatello","Jordi","Pediatric « Adult COVID-19-Converted » Intensive Care and Neonatal Medicine, AP-HP Paris Saclay University, Bicêtre Hospital, 78, Rue du Général Leclerc, 94275, Le Kremlin-Bicêtre, France",NA
"1074","34259942","10.1186/s13613-021-00896-4","Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.","De-regulated host response to severe coronavirus disease 2019 (COVID-19), directly referring to the concept of sepsis-associated immunological dysregulation, seems to be a strong signature of severe COVID-19. Myeloid cells phenotyping is well recognized to diagnose critical illness-induced immunodepression in sepsis and has not been well characterized in COVID-19. The aim of this study is to review phenotypic characteristics of myeloid cells and evaluate their relations with the occurrence of se","2021","07","17","Ann Intensive Care","Annals of intensive care","COVID-19; Myeloid-derived suppressor cells; Secondary infection; Sepsis-induced immunodepression; mHLA-DR","Tissières","Pierre","Pediatric « Adult COVID-19-Converted » Intensive Care and Neonatal Medicine, AP-HP Paris Saclay University, Bicêtre Hospital, 78, Rue du Général Leclerc, 94275, Le Kremlin-Bicêtre, France. pierre.tissieres@aphp","pierre.tissieres@aphp.fr"
"1075","34259914","10.1007/s00705-021-05148-1","Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.","The aim of this study was to identify and validate a sensitive, high-throughput, and cost-effective SARS-CoV-2 real-time RT-PCR assay to be used as a surveillance and diagnostic tool for SARS-CoV-2 in a university surveillance program. We conducted a side-by-side clinical evaluation of a newly developed SARS-CoV-2 multiplex assay (EZ-SARS-CoV-2 Real-Time RT-PCR) with the commercial TaqPath COVID-19 Combo Kit, which has an Emergency Use Authorization from the FDA. The EZ-SARS-CoV-2 RT-PCR incorpo","2021","07","17","Arch Virol","Archives of virology",NA,"Laverack","Melissa","Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell COVID-19 Testing Laboratory, Animal Health Diagnostic Center, Cornell University, Ithaca, NY, USA",NA
"1076","34259914","10.1007/s00705-021-05148-1","Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.","The aim of this study was to identify and validate a sensitive, high-throughput, and cost-effective SARS-CoV-2 real-time RT-PCR assay to be used as a surveillance and diagnostic tool for SARS-CoV-2 in a university surveillance program. We conducted a side-by-side clinical evaluation of a newly developed SARS-CoV-2 multiplex assay (EZ-SARS-CoV-2 Real-Time RT-PCR) with the commercial TaqPath COVID-19 Combo Kit, which has an Emergency Use Authorization from the FDA. The EZ-SARS-CoV-2 RT-PCR incorpo","2021","07","17","Arch Virol","Archives of virology",NA,"Tallmadge","Rebecca L","Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell COVID-19 Testing Laboratory, Animal Health Diagnostic Center, Cornell University, Ithaca, NY, USA",NA
"1077","34259914","10.1007/s00705-021-05148-1","Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.","The aim of this study was to identify and validate a sensitive, high-throughput, and cost-effective SARS-CoV-2 real-time RT-PCR assay to be used as a surveillance and diagnostic tool for SARS-CoV-2 in a university surveillance program. We conducted a side-by-side clinical evaluation of a newly developed SARS-CoV-2 multiplex assay (EZ-SARS-CoV-2 Real-Time RT-PCR) with the commercial TaqPath COVID-19 Combo Kit, which has an Emergency Use Authorization from the FDA. The EZ-SARS-CoV-2 RT-PCR incorpo","2021","07","17","Arch Virol","Archives of virology",NA,"Venugopalan","Roopa","Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell COVID-19 Testing Laboratory, Animal Health Diagnostic Center, Cornell University, Ithaca, NY, USA",NA
"1078","34259914","10.1007/s00705-021-05148-1","Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.","The aim of this study was to identify and validate a sensitive, high-throughput, and cost-effective SARS-CoV-2 real-time RT-PCR assay to be used as a surveillance and diagnostic tool for SARS-CoV-2 in a university surveillance program. We conducted a side-by-side clinical evaluation of a newly developed SARS-CoV-2 multiplex assay (EZ-SARS-CoV-2 Real-Time RT-PCR) with the commercial TaqPath COVID-19 Combo Kit, which has an Emergency Use Authorization from the FDA. The EZ-SARS-CoV-2 RT-PCR incorpo","2021","07","17","Arch Virol","Archives of virology",NA,"Cronk","Brittany","Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell COVID-19 Testing Laboratory, Animal Health Diagnostic Center, Cornell University, Ithaca, NY, USA",NA
"1079","34259914","10.1007/s00705-021-05148-1","Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.","The aim of this study was to identify and validate a sensitive, high-throughput, and cost-effective SARS-CoV-2 real-time RT-PCR assay to be used as a surveillance and diagnostic tool for SARS-CoV-2 in a university surveillance program. We conducted a side-by-side clinical evaluation of a newly developed SARS-CoV-2 multiplex assay (EZ-SARS-CoV-2 Real-Time RT-PCR) with the commercial TaqPath COVID-19 Combo Kit, which has an Emergency Use Authorization from the FDA. The EZ-SARS-CoV-2 RT-PCR incorpo","2021","07","17","Arch Virol","Archives of virology",NA,"Zhang","XiuLin","Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell COVID-19 Testing Laboratory, Animal Health Diagnostic Center, Cornell University, Ithaca, NY, USA",NA
"1080","34259914","10.1007/s00705-021-05148-1","Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.","The aim of this study was to identify and validate a sensitive, high-throughput, and cost-effective SARS-CoV-2 real-time RT-PCR assay to be used as a surveillance and diagnostic tool for SARS-CoV-2 in a university surveillance program. We conducted a side-by-side clinical evaluation of a newly developed SARS-CoV-2 multiplex assay (EZ-SARS-CoV-2 Real-Time RT-PCR) with the commercial TaqPath COVID-19 Combo Kit, which has an Emergency Use Authorization from the FDA. The EZ-SARS-CoV-2 RT-PCR incorpo","2021","07","17","Arch Virol","Archives of virology",NA,"Rauh","Rolf","Tetracore Inc., Rockville, MD, USA",NA
"1081","34259914","10.1007/s00705-021-05148-1","Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.","The aim of this study was to identify and validate a sensitive, high-throughput, and cost-effective SARS-CoV-2 real-time RT-PCR assay to be used as a surveillance and diagnostic tool for SARS-CoV-2 in a university surveillance program. We conducted a side-by-side clinical evaluation of a newly developed SARS-CoV-2 multiplex assay (EZ-SARS-CoV-2 Real-Time RT-PCR) with the commercial TaqPath COVID-19 Combo Kit, which has an Emergency Use Authorization from the FDA. The EZ-SARS-CoV-2 RT-PCR incorpo","2021","07","17","Arch Virol","Archives of virology",NA,"Saunders","Amy","Tetracore Inc., Rockville, MD, USA",NA
"1082","34259914","10.1007/s00705-021-05148-1","Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.","The aim of this study was to identify and validate a sensitive, high-throughput, and cost-effective SARS-CoV-2 real-time RT-PCR assay to be used as a surveillance and diagnostic tool for SARS-CoV-2 in a university surveillance program. We conducted a side-by-side clinical evaluation of a newly developed SARS-CoV-2 multiplex assay (EZ-SARS-CoV-2 Real-Time RT-PCR) with the commercial TaqPath COVID-19 Combo Kit, which has an Emergency Use Authorization from the FDA. The EZ-SARS-CoV-2 RT-PCR incorpo","2021","07","17","Arch Virol","Archives of virology",NA,"Nelson","William M","Tetracore Inc., Rockville, MD, USA",NA
"1083","34259914","10.1007/s00705-021-05148-1","Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.","The aim of this study was to identify and validate a sensitive, high-throughput, and cost-effective SARS-CoV-2 real-time RT-PCR assay to be used as a surveillance and diagnostic tool for SARS-CoV-2 in a university surveillance program. We conducted a side-by-side clinical evaluation of a newly developed SARS-CoV-2 multiplex assay (EZ-SARS-CoV-2 Real-Time RT-PCR) with the commercial TaqPath COVID-19 Combo Kit, which has an Emergency Use Authorization from the FDA. The EZ-SARS-CoV-2 RT-PCR incorpo","2021","07","17","Arch Virol","Archives of virology",NA,"Plocharczyk","Elizabeth","Cayuga Medical Center, Cayuga Health System, Ithaca, NY, USA",NA
"1084","34259914","10.1007/s00705-021-05148-1","Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.","The aim of this study was to identify and validate a sensitive, high-throughput, and cost-effective SARS-CoV-2 real-time RT-PCR assay to be used as a surveillance and diagnostic tool for SARS-CoV-2 in a university surveillance program. We conducted a side-by-side clinical evaluation of a newly developed SARS-CoV-2 multiplex assay (EZ-SARS-CoV-2 Real-Time RT-PCR) with the commercial TaqPath COVID-19 Combo Kit, which has an Emergency Use Authorization from the FDA. The EZ-SARS-CoV-2 RT-PCR incorpo","2021","07","17","Arch Virol","Archives of virology",NA,"Diel","Diego G","Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell COVID-19 Testing Laboratory, Animal Health Diagnostic Center, Cornell University, Ithaca, NY, USA. dgdiel@cornell","dgdiel@cornell.edu"
"1085","34259902","10.1007/s00391-021-01931-6","[COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities].","Care facilities are particularly challenged by the COVID-19 pandemic. Besides others this includes human and structural resources. This cross-sectional study evaluated the occurrence of infections, psychosocial stress and the different strategies to handle the COVID-19 pandemic in care facilities. Data collection took place in 7 care facilities in Baden-Württemberg, Germany between 17 July and 25 August 2020. This included a SARS-CoV-2 PCR and antibody testing and a questionnaire for residents a","2021","07","17","Z Gerontol Geriatr","Zeitschrift fur Gerontologie und Geriatrie","COVID-19; Care facilities; Psychological burden; Risk populations; SARS-CoV-2","Perkhofer","Lukas","Klinik für Innere Medizin 1, Universitätsklinikum Ulm, Ulm, Deutschland",NA
"1086","34259902","10.1007/s00391-021-01931-6","[COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities].","Care facilities are particularly challenged by the COVID-19 pandemic. Besides others this includes human and structural resources. This cross-sectional study evaluated the occurrence of infections, psychosocial stress and the different strategies to handle the COVID-19 pandemic in care facilities. Data collection took place in 7 care facilities in Baden-Württemberg, Germany between 17 July and 25 August 2020. This included a SARS-CoV-2 PCR and antibody testing and a questionnaire for residents a","2021","07","17","Z Gerontol Geriatr","Zeitschrift fur Gerontologie und Geriatrie","COVID-19; Care facilities; Psychological burden; Risk populations; SARS-CoV-2","Grünke","Peter","Klinik für Innere Medizin 1, Universitätsklinikum Ulm, Ulm, Deutschland",NA
"1087","34259902","10.1007/s00391-021-01931-6","[COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities].","Care facilities are particularly challenged by the COVID-19 pandemic. Besides others this includes human and structural resources. This cross-sectional study evaluated the occurrence of infections, psychosocial stress and the different strategies to handle the COVID-19 pandemic in care facilities. Data collection took place in 7 care facilities in Baden-Württemberg, Germany between 17 July and 25 August 2020. This included a SARS-CoV-2 PCR and antibody testing and a questionnaire for residents a","2021","07","17","Z Gerontol Geriatr","Zeitschrift fur Gerontologie und Geriatrie","COVID-19; Care facilities; Psychological burden; Risk populations; SARS-CoV-2","Gashi-Ymeri","Edonjeta","Klinik für Innere Medizin 1, Universitätsklinikum Ulm, Ulm, Deutschland",NA
"1088","34259902","10.1007/s00391-021-01931-6","[COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities].","Care facilities are particularly challenged by the COVID-19 pandemic. Besides others this includes human and structural resources. This cross-sectional study evaluated the occurrence of infections, psychosocial stress and the different strategies to handle the COVID-19 pandemic in care facilities. Data collection took place in 7 care facilities in Baden-Württemberg, Germany between 17 July and 25 August 2020. This included a SARS-CoV-2 PCR and antibody testing and a questionnaire for residents a","2021","07","17","Z Gerontol Geriatr","Zeitschrift fur Gerontologie und Geriatrie","COVID-19; Care facilities; Psychological burden; Risk populations; SARS-CoV-2","Grünke","Teresa","Klinik für Innere Medizin 1, Universitätsklinikum Ulm, Ulm, Deutschland",NA
"1089","34259902","10.1007/s00391-021-01931-6","[COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities].","Care facilities are particularly challenged by the COVID-19 pandemic. Besides others this includes human and structural resources. This cross-sectional study evaluated the occurrence of infections, psychosocial stress and the different strategies to handle the COVID-19 pandemic in care facilities. Data collection took place in 7 care facilities in Baden-Württemberg, Germany between 17 July and 25 August 2020. This included a SARS-CoV-2 PCR and antibody testing and a questionnaire for residents a","2021","07","17","Z Gerontol Geriatr","Zeitschrift fur Gerontologie und Geriatrie","COVID-19; Care facilities; Psychological burden; Risk populations; SARS-CoV-2","Kroschel","Joris","Zentrale Einrichtung Klinische Chemie, Universitätsklinikum Ulm, Ulm, Deutschland",NA
"1090","34259902","10.1007/s00391-021-01931-6","[COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities].","Care facilities are particularly challenged by the COVID-19 pandemic. Besides others this includes human and structural resources. This cross-sectional study evaluated the occurrence of infections, psychosocial stress and the different strategies to handle the COVID-19 pandemic in care facilities. Data collection took place in 7 care facilities in Baden-Württemberg, Germany between 17 July and 25 August 2020. This included a SARS-CoV-2 PCR and antibody testing and a questionnaire for residents a","2021","07","17","Z Gerontol Geriatr","Zeitschrift fur Gerontologie und Geriatrie","COVID-19; Care facilities; Psychological burden; Risk populations; SARS-CoV-2","Michel","Detlef","Institut für Virologie, Universitätsklinikum Ulm, Ulm, Deutschland",NA
"1091","34259902","10.1007/s00391-021-01931-6","[COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities].","Care facilities are particularly challenged by the COVID-19 pandemic. Besides others this includes human and structural resources. This cross-sectional study evaluated the occurrence of infections, psychosocial stress and the different strategies to handle the COVID-19 pandemic in care facilities. Data collection took place in 7 care facilities in Baden-Württemberg, Germany between 17 July and 25 August 2020. This included a SARS-CoV-2 PCR and antibody testing and a questionnaire for residents a","2021","07","17","Z Gerontol Geriatr","Zeitschrift fur Gerontologie und Geriatrie","COVID-19; Care facilities; Psychological burden; Risk populations; SARS-CoV-2","Pensel","Elke","Institut für Klinische Transfusionsmedizin und Immungenetik Ulm, Deutsches Rotes Kreuz Blutspendedienst Baden-Württemberg-Hessen und Universitätsklinikum Ulm, Ulm, Deutschland",NA
"1092","34259902","10.1007/s00391-021-01931-6","[COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities].","Care facilities are particularly challenged by the COVID-19 pandemic. Besides others this includes human and structural resources. This cross-sectional study evaluated the occurrence of infections, psychosocial stress and the different strategies to handle the COVID-19 pandemic in care facilities. Data collection took place in 7 care facilities in Baden-Württemberg, Germany between 17 July and 25 August 2020. This included a SARS-CoV-2 PCR and antibody testing and a questionnaire for residents a","2021","07","17","Z Gerontol Geriatr","Zeitschrift fur Gerontologie und Geriatrie","COVID-19; Care facilities; Psychological burden; Risk populations; SARS-CoV-2","Rost","Andreas","Kreis-Katastrophenschutz &amp",NA
"1093","34259902","10.1007/s00391-021-01931-6","[COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities].","Care facilities are particularly challenged by the COVID-19 pandemic. Besides others this includes human and structural resources. This cross-sectional study evaluated the occurrence of infections, psychosocial stress and the different strategies to handle the COVID-19 pandemic in care facilities. Data collection took place in 7 care facilities in Baden-Württemberg, Germany between 17 July and 25 August 2020. This included a SARS-CoV-2 PCR and antibody testing and a questionnaire for residents a","2021","07","17","Z Gerontol Geriatr","Zeitschrift fur Gerontologie und Geriatrie","COVID-19; Care facilities; Psychological burden; Risk populations; SARS-CoV-2","Denkinger","Michael","Institut für Geriatrische Forschung, Universitätsklinikum Ulm, Ulm, Deutschland",NA
"1094","34259902","10.1007/s00391-021-01931-6","[COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities].","Care facilities are particularly challenged by the COVID-19 pandemic. Besides others this includes human and structural resources. This cross-sectional study evaluated the occurrence of infections, psychosocial stress and the different strategies to handle the COVID-19 pandemic in care facilities. Data collection took place in 7 care facilities in Baden-Württemberg, Germany between 17 July and 25 August 2020. This included a SARS-CoV-2 PCR and antibody testing and a questionnaire for residents a","2021","07","17","Z Gerontol Geriatr","Zeitschrift fur Gerontologie und Geriatrie","COVID-19; Care facilities; Psychological burden; Risk populations; SARS-CoV-2","Dallmeier","Dhayana","AGAPLESION Bethesda Klinik Ulm, Ulm, Deutschland",NA
"1095","34259902","10.1007/s00391-021-01931-6","[COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities].","Care facilities are particularly challenged by the COVID-19 pandemic. Besides others this includes human and structural resources. This cross-sectional study evaluated the occurrence of infections, psychosocial stress and the different strategies to handle the COVID-19 pandemic in care facilities. Data collection took place in 7 care facilities in Baden-Württemberg, Germany between 17 July and 25 August 2020. This included a SARS-CoV-2 PCR and antibody testing and a questionnaire for residents a","2021","07","17","Z Gerontol Geriatr","Zeitschrift fur Gerontologie und Geriatrie","COVID-19; Care facilities; Psychological burden; Risk populations; SARS-CoV-2","Seufferlein","Thomas","Klinik für Innere Medizin 1, Universitätsklinikum Ulm, Ulm, Deutschland. Thomas.seufferlein@uniklinik-ulm",NA
"1096","34259885","10.1007/s00198-021-06031-0","Retraction Note to: Comment on an article: ""Osteoporosis in the age of COVID-19 patients"".",NA,"2021","07","17","Osteoporos Int","Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA",NA,"Ibrahimagic","O C","Department of Neurology, University Clinical Centre Tuzla, 75000, Tuzla, Bosnia and Herzegovina",NA
"1097","34259885","10.1007/s00198-021-06031-0","Retraction Note to: Comment on an article: ""Osteoporosis in the age of COVID-19 patients"".",NA,"2021","07","17","Osteoporos Int","Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA",NA,"Vujadinovic","A","Department of Orthopaedics and Traumatology, University Clinical Centre Tuzla, 75000, Tuzla, Bosnia and Herzegovina",NA
"1098","34259885","10.1007/s00198-021-06031-0","Retraction Note to: Comment on an article: ""Osteoporosis in the age of COVID-19 patients"".",NA,"2021","07","17","Osteoporos Int","Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA",NA,"Ercegovic","Z","Department of Neurosurgery, University Clinical Centre Tuzla, 75000, Tuzla, Bosnia and Herzegovina",NA
"1099","34259885","10.1007/s00198-021-06031-0","Retraction Note to: Comment on an article: ""Osteoporosis in the age of COVID-19 patients"".",NA,"2021","07","17","Osteoporos Int","Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA",NA,"Kunic","S","Department of Neurology, Primary Health Care Centre Tuzla, Albina i Franje Herljevica 1, 75000, Tuzla, Bosnia and Herzegovina. suljo.kunic@hotmail","suljo.kunic@hotmail.com"
"1100","34259885","10.1007/s00198-021-06031-0","Retraction Note to: Comment on an article: ""Osteoporosis in the age of COVID-19 patients"".",NA,"2021","07","17","Osteoporos Int","Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA",NA,"Smajlovic","D","Department of Neurology, University Clinical Centre Tuzla, 75000, Tuzla, Bosnia and Herzegovina",NA
"1101","34259885","10.1007/s00198-021-06031-0","Retraction Note to: Comment on an article: ""Osteoporosis in the age of COVID-19 patients"".",NA,"2021","07","17","Osteoporos Int","Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA",NA,"Dostovic","Z","Department of Neurology, University Clinical Centre Tuzla, 75000, Tuzla, Bosnia and Herzegovina",NA
"1102","34259880","10.1007/s00296-021-04932-1","Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection.","Multi-system inflammatory syndrome in children (MIS-C) associated with COVID-19 is a recently recognised potentially life-threatening entity. There is limited data on post-MIS-C sequelae. 21 children fulfilling the WHO criteria for MIS-C were included in our study. Data were collected at baseline and at 12-16 weeks post-discharge to look for any persistent sequelae mainly relating to the lungs or heart including coronary arteries. Fever was the most common presentation, found in 18 (85.7%) patie","2021","07","22","Rheumatol Int","Rheumatology international","Follow-up; MIS-C; Multi-inflammatory syndrome; Outcomes; Paediatric COVID-19","Patnaik","Sibabratta","Department of Pediatrics, Kalinga Institute of Medical Sciences, Bhubaneswar, India. drsbpatnaik45@gmail","drsbpatnaik45@gmail.com"
"1103","34259880","10.1007/s00296-021-04932-1","Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection.","Multi-system inflammatory syndrome in children (MIS-C) associated with COVID-19 is a recently recognised potentially life-threatening entity. There is limited data on post-MIS-C sequelae. 21 children fulfilling the WHO criteria for MIS-C were included in our study. Data were collected at baseline and at 12-16 weeks post-discharge to look for any persistent sequelae mainly relating to the lungs or heart including coronary arteries. Fever was the most common presentation, found in 18 (85.7%) patie","2021","07","22","Rheumatol Int","Rheumatology international","Follow-up; MIS-C; Multi-inflammatory syndrome; Outcomes; Paediatric COVID-19","Jain","Mukesh Kumar","Department of Pediatrics, Kalinga Institute of Medical Sciences, Bhubaneswar, India",NA
"1104","34259880","10.1007/s00296-021-04932-1","Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection.","Multi-system inflammatory syndrome in children (MIS-C) associated with COVID-19 is a recently recognised potentially life-threatening entity. There is limited data on post-MIS-C sequelae. 21 children fulfilling the WHO criteria for MIS-C were included in our study. Data were collected at baseline and at 12-16 weeks post-discharge to look for any persistent sequelae mainly relating to the lungs or heart including coronary arteries. Fever was the most common presentation, found in 18 (85.7%) patie","2021","07","22","Rheumatol Int","Rheumatology international","Follow-up; MIS-C; Multi-inflammatory syndrome; Outcomes; Paediatric COVID-19","Ahmed","Sakir","Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, Bhubaneswar, India",NA
"1105","34259880","10.1007/s00296-021-04932-1","Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection.","Multi-system inflammatory syndrome in children (MIS-C) associated with COVID-19 is a recently recognised potentially life-threatening entity. There is limited data on post-MIS-C sequelae. 21 children fulfilling the WHO criteria for MIS-C were included in our study. Data were collected at baseline and at 12-16 weeks post-discharge to look for any persistent sequelae mainly relating to the lungs or heart including coronary arteries. Fever was the most common presentation, found in 18 (85.7%) patie","2021","07","22","Rheumatol Int","Rheumatology international","Follow-up; MIS-C; Multi-inflammatory syndrome; Outcomes; Paediatric COVID-19","Dash","Arun Kumar","Department of Pediatrics, Kalinga Institute of Medical Sciences, Bhubaneswar, India",NA
"1106","34259880","10.1007/s00296-021-04932-1","Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection.","Multi-system inflammatory syndrome in children (MIS-C) associated with COVID-19 is a recently recognised potentially life-threatening entity. There is limited data on post-MIS-C sequelae. 21 children fulfilling the WHO criteria for MIS-C were included in our study. Data were collected at baseline and at 12-16 weeks post-discharge to look for any persistent sequelae mainly relating to the lungs or heart including coronary arteries. Fever was the most common presentation, found in 18 (85.7%) patie","2021","07","22","Rheumatol Int","Rheumatology international","Follow-up; MIS-C; Multi-inflammatory syndrome; Outcomes; Paediatric COVID-19","P","Ram Kumar","Department of Pediatrics, Kalinga Institute of Medical Sciences, Bhubaneswar, India",NA
"1107","34259880","10.1007/s00296-021-04932-1","Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection.","Multi-system inflammatory syndrome in children (MIS-C) associated with COVID-19 is a recently recognised potentially life-threatening entity. There is limited data on post-MIS-C sequelae. 21 children fulfilling the WHO criteria for MIS-C were included in our study. Data were collected at baseline and at 12-16 weeks post-discharge to look for any persistent sequelae mainly relating to the lungs or heart including coronary arteries. Fever was the most common presentation, found in 18 (85.7%) patie","2021","07","22","Rheumatol Int","Rheumatology international","Follow-up; MIS-C; Multi-inflammatory syndrome; Outcomes; Paediatric COVID-19","Sahoo","Bandya","Department of Pediatrics, Kalinga Institute of Medical Sciences, Bhubaneswar, India",NA
"1108","34259880","10.1007/s00296-021-04932-1","Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection.","Multi-system inflammatory syndrome in children (MIS-C) associated with COVID-19 is a recently recognised potentially life-threatening entity. There is limited data on post-MIS-C sequelae. 21 children fulfilling the WHO criteria for MIS-C were included in our study. Data were collected at baseline and at 12-16 weeks post-discharge to look for any persistent sequelae mainly relating to the lungs or heart including coronary arteries. Fever was the most common presentation, found in 18 (85.7%) patie","2021","07","22","Rheumatol Int","Rheumatology international","Follow-up; MIS-C; Multi-inflammatory syndrome; Outcomes; Paediatric COVID-19","Mishra","Reshmi","Department of Pediatrics, Kalinga Institute of Medical Sciences, Bhubaneswar, India",NA
"1109","34259880","10.1007/s00296-021-04932-1","Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection.","Multi-system inflammatory syndrome in children (MIS-C) associated with COVID-19 is a recently recognised potentially life-threatening entity. There is limited data on post-MIS-C sequelae. 21 children fulfilling the WHO criteria for MIS-C were included in our study. Data were collected at baseline and at 12-16 weeks post-discharge to look for any persistent sequelae mainly relating to the lungs or heart including coronary arteries. Fever was the most common presentation, found in 18 (85.7%) patie","2021","07","22","Rheumatol Int","Rheumatology international","Follow-up; MIS-C; Multi-inflammatory syndrome; Outcomes; Paediatric COVID-19","Behera","Manas Ranjan","Department of Pediatrics, Kalinga Institute of Medical Sciences, Bhubaneswar, India",NA
"1110","34259874","10.1093/schbul/sbab083","The COVID-19 Pandemic Introduces Diagnostic and Treatment Planning Complexity for Individuals at Clinical High Risk for Psychosis.","COVID-19 has led to a great deal of general suffering and an increased prevalence of psychiatric illness worldwide. Within the area of psychosis-risk syndromes, a highly heterogeneous clinical population, the picture is quite nuanced as the social restrictions resulting from the pandemic have reduced stress for some and increased it for others. Further, a number of pandemic-related societal and cultural changes have obfuscated the diagnostic and treatment landscape in this area as well. In this ","2021","07","14","Schizophr Bull","Schizophrenia bulletin","COVID-19; Coronavirus; attenuated psychosis syndrome; pandemic; prodrome; schizophrenia","Mittal","Vijay A","Department of Psychology, Northwestern University, Evanston, IL, USA",NA
"1111","34259874","10.1093/schbul/sbab083","The COVID-19 Pandemic Introduces Diagnostic and Treatment Planning Complexity for Individuals at Clinical High Risk for Psychosis.","COVID-19 has led to a great deal of general suffering and an increased prevalence of psychiatric illness worldwide. Within the area of psychosis-risk syndromes, a highly heterogeneous clinical population, the picture is quite nuanced as the social restrictions resulting from the pandemic have reduced stress for some and increased it for others. Further, a number of pandemic-related societal and cultural changes have obfuscated the diagnostic and treatment landscape in this area as well. In this ","2021","07","14","Schizophr Bull","Schizophrenia bulletin","COVID-19; Coronavirus; attenuated psychosis syndrome; pandemic; prodrome; schizophrenia","Walker","Elaine F","Department of Psychology, Emory University, Atlanta, GA, USA",NA
"1112","34259874","10.1093/schbul/sbab083","The COVID-19 Pandemic Introduces Diagnostic and Treatment Planning Complexity for Individuals at Clinical High Risk for Psychosis.","COVID-19 has led to a great deal of general suffering and an increased prevalence of psychiatric illness worldwide. Within the area of psychosis-risk syndromes, a highly heterogeneous clinical population, the picture is quite nuanced as the social restrictions resulting from the pandemic have reduced stress for some and increased it for others. Further, a number of pandemic-related societal and cultural changes have obfuscated the diagnostic and treatment landscape in this area as well. In this ","2021","07","14","Schizophr Bull","Schizophrenia bulletin","COVID-19; Coronavirus; attenuated psychosis syndrome; pandemic; prodrome; schizophrenia","Strauss","Gregory P","Department of Psychology, University of Georgia, Athens, GA, USA",NA
"1113","34259872","10.1093/mmy/myab039","The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workload.","Starting late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic of coronavirus-19 disease (COVID-19) with ~179 million cases and ~3.9 million deaths to date. COVID-19 ranges from asymptomatic infection to severe illness with acute respiratory distress requiring critical care in up to 40% of hospitalised patients. Numerous reports have identified COVID-19 associated pulmonary aspergillosis (CAPA) as an important infective complication of C","2021","07","14","Med Mycol","Medical mycology","COVID-19; Mycology Reference laboratory; SARS-CoV-2; candidemia; diagnosis; impact; invasive pulmonary aspergillosis","Borman","Andrew M","UK National Mycology Reference Laboratory, Public Health England South-West, Bristol BS10 5NB, United Kingdom",NA
"1114","34259872","10.1093/mmy/myab039","The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workload.","Starting late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic of coronavirus-19 disease (COVID-19) with ~179 million cases and ~3.9 million deaths to date. COVID-19 ranges from asymptomatic infection to severe illness with acute respiratory distress requiring critical care in up to 40% of hospitalised patients. Numerous reports have identified COVID-19 associated pulmonary aspergillosis (CAPA) as an important infective complication of C","2021","07","14","Med Mycol","Medical mycology","COVID-19; Mycology Reference laboratory; SARS-CoV-2; candidemia; diagnosis; impact; invasive pulmonary aspergillosis","Fraser","Mark","UK National Mycology Reference Laboratory, Public Health England South-West, Bristol BS10 5NB, United Kingdom",NA
"1115","34259872","10.1093/mmy/myab039","The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workload.","Starting late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic of coronavirus-19 disease (COVID-19) with ~179 million cases and ~3.9 million deaths to date. COVID-19 ranges from asymptomatic infection to severe illness with acute respiratory distress requiring critical care in up to 40% of hospitalised patients. Numerous reports have identified COVID-19 associated pulmonary aspergillosis (CAPA) as an important infective complication of C","2021","07","14","Med Mycol","Medical mycology","COVID-19; Mycology Reference laboratory; SARS-CoV-2; candidemia; diagnosis; impact; invasive pulmonary aspergillosis","Patterson","Zoe","UK National Mycology Reference Laboratory, Public Health England South-West, Bristol BS10 5NB, United Kingdom",NA
"1116","34259872","10.1093/mmy/myab039","The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workload.","Starting late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic of coronavirus-19 disease (COVID-19) with ~179 million cases and ~3.9 million deaths to date. COVID-19 ranges from asymptomatic infection to severe illness with acute respiratory distress requiring critical care in up to 40% of hospitalised patients. Numerous reports have identified COVID-19 associated pulmonary aspergillosis (CAPA) as an important infective complication of C","2021","07","14","Med Mycol","Medical mycology","COVID-19; Mycology Reference laboratory; SARS-CoV-2; candidemia; diagnosis; impact; invasive pulmonary aspergillosis","McLachlan","Sue","UK National Mycology Reference Laboratory, Public Health England South-West, Bristol BS10 5NB, United Kingdom",NA
"1117","34259872","10.1093/mmy/myab039","The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workload.","Starting late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic of coronavirus-19 disease (COVID-19) with ~179 million cases and ~3.9 million deaths to date. COVID-19 ranges from asymptomatic infection to severe illness with acute respiratory distress requiring critical care in up to 40% of hospitalised patients. Numerous reports have identified COVID-19 associated pulmonary aspergillosis (CAPA) as an important infective complication of C","2021","07","14","Med Mycol","Medical mycology","COVID-19; Mycology Reference laboratory; SARS-CoV-2; candidemia; diagnosis; impact; invasive pulmonary aspergillosis","Palmer","Michael D","UK National Mycology Reference Laboratory, Public Health England South-West, Bristol BS10 5NB, United Kingdom",NA
"1118","34259872","10.1093/mmy/myab039","The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workload.","Starting late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic of coronavirus-19 disease (COVID-19) with ~179 million cases and ~3.9 million deaths to date. COVID-19 ranges from asymptomatic infection to severe illness with acute respiratory distress requiring critical care in up to 40% of hospitalised patients. Numerous reports have identified COVID-19 associated pulmonary aspergillosis (CAPA) as an important infective complication of C","2021","07","14","Med Mycol","Medical mycology","COVID-19; Mycology Reference laboratory; SARS-CoV-2; candidemia; diagnosis; impact; invasive pulmonary aspergillosis","Mann","Ciara","UK National Mycology Reference Laboratory, Public Health England South-West, Bristol BS10 5NB, United Kingdom",NA
"1119","34259872","10.1093/mmy/myab039","The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workload.","Starting late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic of coronavirus-19 disease (COVID-19) with ~179 million cases and ~3.9 million deaths to date. COVID-19 ranges from asymptomatic infection to severe illness with acute respiratory distress requiring critical care in up to 40% of hospitalised patients. Numerous reports have identified COVID-19 associated pulmonary aspergillosis (CAPA) as an important infective complication of C","2021","07","14","Med Mycol","Medical mycology","COVID-19; Mycology Reference laboratory; SARS-CoV-2; candidemia; diagnosis; impact; invasive pulmonary aspergillosis","Oliver","Debra","UK National Mycology Reference Laboratory, Public Health England South-West, Bristol BS10 5NB, United Kingdom",NA
"1120","34259872","10.1093/mmy/myab039","The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workload.","Starting late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic of coronavirus-19 disease (COVID-19) with ~179 million cases and ~3.9 million deaths to date. COVID-19 ranges from asymptomatic infection to severe illness with acute respiratory distress requiring critical care in up to 40% of hospitalised patients. Numerous reports have identified COVID-19 associated pulmonary aspergillosis (CAPA) as an important infective complication of C","2021","07","14","Med Mycol","Medical mycology","COVID-19; Mycology Reference laboratory; SARS-CoV-2; candidemia; diagnosis; impact; invasive pulmonary aspergillosis","Brown","Phillipa","UK National Mycology Reference Laboratory, Public Health England South-West, Bristol BS10 5NB, United Kingdom",NA
"1121","34259872","10.1093/mmy/myab039","The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workload.","Starting late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic of coronavirus-19 disease (COVID-19) with ~179 million cases and ~3.9 million deaths to date. COVID-19 ranges from asymptomatic infection to severe illness with acute respiratory distress requiring critical care in up to 40% of hospitalised patients. Numerous reports have identified COVID-19 associated pulmonary aspergillosis (CAPA) as an important infective complication of C","2021","07","14","Med Mycol","Medical mycology","COVID-19; Mycology Reference laboratory; SARS-CoV-2; candidemia; diagnosis; impact; invasive pulmonary aspergillosis","Linton","Christopher J","UK National Mycology Reference Laboratory, Public Health England South-West, Bristol BS10 5NB, United Kingdom",NA
"1122","34259872","10.1093/mmy/myab039","The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workload.","Starting late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic of coronavirus-19 disease (COVID-19) with ~179 million cases and ~3.9 million deaths to date. COVID-19 ranges from asymptomatic infection to severe illness with acute respiratory distress requiring critical care in up to 40% of hospitalised patients. Numerous reports have identified COVID-19 associated pulmonary aspergillosis (CAPA) as an important infective complication of C","2021","07","14","Med Mycol","Medical mycology","COVID-19; Mycology Reference laboratory; SARS-CoV-2; candidemia; diagnosis; impact; invasive pulmonary aspergillosis","Dzietczyk","Agnieszka","UK National Mycology Reference Laboratory, Public Health England South-West, Bristol BS10 5NB, United Kingdom",NA
"1123","34259872","10.1093/mmy/myab039","The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workload.","Starting late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic of coronavirus-19 disease (COVID-19) with ~179 million cases and ~3.9 million deaths to date. COVID-19 ranges from asymptomatic infection to severe illness with acute respiratory distress requiring critical care in up to 40% of hospitalised patients. Numerous reports have identified COVID-19 associated pulmonary aspergillosis (CAPA) as an important infective complication of C","2021","07","14","Med Mycol","Medical mycology","COVID-19; Mycology Reference laboratory; SARS-CoV-2; candidemia; diagnosis; impact; invasive pulmonary aspergillosis","Hedley","Michelle","UK National Mycology Reference Laboratory, Public Health England South-West, Bristol BS10 5NB, United Kingdom",NA
"1124","34259872","10.1093/mmy/myab039","The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workload.","Starting late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic of coronavirus-19 disease (COVID-19) with ~179 million cases and ~3.9 million deaths to date. COVID-19 ranges from asymptomatic infection to severe illness with acute respiratory distress requiring critical care in up to 40% of hospitalised patients. Numerous reports have identified COVID-19 associated pulmonary aspergillosis (CAPA) as an important infective complication of C","2021","07","14","Med Mycol","Medical mycology","COVID-19; Mycology Reference laboratory; SARS-CoV-2; candidemia; diagnosis; impact; invasive pulmonary aspergillosis","Gough","Martin","UK National Mycology Reference Laboratory, Public Health England South-West, Bristol BS10 5NB, United Kingdom",NA
"1125","34259872","10.1093/mmy/myab039","The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workload.","Starting late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic of coronavirus-19 disease (COVID-19) with ~179 million cases and ~3.9 million deaths to date. COVID-19 ranges from asymptomatic infection to severe illness with acute respiratory distress requiring critical care in up to 40% of hospitalised patients. Numerous reports have identified COVID-19 associated pulmonary aspergillosis (CAPA) as an important infective complication of C","2021","07","14","Med Mycol","Medical mycology","COVID-19; Mycology Reference laboratory; SARS-CoV-2; candidemia; diagnosis; impact; invasive pulmonary aspergillosis","Johnson","Elizabeth M","UK National Mycology Reference Laboratory, Public Health England South-West, Bristol BS10 5NB, United Kingdom",NA
"1126","34259853","10.1001/jamanetworkopen.2021.18297","Physician-Delivered Messaging as a Tool to Increase COVID-19 Knowledge and Preventive Behaviors-Implications Beyond a Pandemic.",NA,"2021","07","19","JAMA Netw Open","JAMA network open","COVID-19; Health Behavior; Humans; Pandemics; Physicians; SARS-CoV-2","Langford","Aisha T","Department of Population Health, NYU Langone Health, New York, New York",NA
"1127","34259852","10.1001/jamanetworkopen.2021.17029","Changes in Admissions to Specialty Addiction Treatment Facilities in California During the COVID-19 Pandemic.",NA,"2021","07","23","JAMA Netw Open","JAMA network open","Adult; Behavior, Addictive; COVID-19; California; Female; Health Services Accessibility; Hospitalization; Humans; Male; Middle Aged; Pandemics; Patient Acceptance of Health Care; SARS-CoV-2; Substance Abuse Treatment Centers; Substance-Related Disorders; Young Adult","Mark","Tami L","RTI International, Rockville, Maryland",NA
"1128","34259852","10.1001/jamanetworkopen.2021.17029","Changes in Admissions to Specialty Addiction Treatment Facilities in California During the COVID-19 Pandemic.",NA,"2021","07","23","JAMA Netw Open","JAMA network open","Adult; Behavior, Addictive; COVID-19; California; Female; Health Services Accessibility; Hospitalization; Humans; Male; Middle Aged; Pandemics; Patient Acceptance of Health Care; SARS-CoV-2; Substance Abuse Treatment Centers; Substance-Related Disorders; Young Adult","Gibbons","Brent","RTI International, Rockville, Maryland",NA
"1129","34259852","10.1001/jamanetworkopen.2021.17029","Changes in Admissions to Specialty Addiction Treatment Facilities in California During the COVID-19 Pandemic.",NA,"2021","07","23","JAMA Netw Open","JAMA network open","Adult; Behavior, Addictive; COVID-19; California; Female; Health Services Accessibility; Hospitalization; Humans; Male; Middle Aged; Pandemics; Patient Acceptance of Health Care; SARS-CoV-2; Substance Abuse Treatment Centers; Substance-Related Disorders; Young Adult","Barnosky","Alan","RTI International, Rockville, Maryland",NA
"1130","34259852","10.1001/jamanetworkopen.2021.17029","Changes in Admissions to Specialty Addiction Treatment Facilities in California During the COVID-19 Pandemic.",NA,"2021","07","23","JAMA Netw Open","JAMA network open","Adult; Behavior, Addictive; COVID-19; California; Female; Health Services Accessibility; Hospitalization; Humans; Male; Middle Aged; Pandemics; Patient Acceptance of Health Care; SARS-CoV-2; Substance Abuse Treatment Centers; Substance-Related Disorders; Young Adult","Padwa","Howard","Department of Integrated Substance Abuse Programs, University of California, Los Angeles",NA
"1131","34259852","10.1001/jamanetworkopen.2021.17029","Changes in Admissions to Specialty Addiction Treatment Facilities in California During the COVID-19 Pandemic.",NA,"2021","07","23","JAMA Netw Open","JAMA network open","Adult; Behavior, Addictive; COVID-19; California; Female; Health Services Accessibility; Hospitalization; Humans; Male; Middle Aged; Pandemics; Patient Acceptance of Health Care; SARS-CoV-2; Substance Abuse Treatment Centers; Substance-Related Disorders; Young Adult","Joshi","Vandana","Department of Integrated Substance Abuse Programs, University of California, Los Angeles",NA
"1132","34259851","10.1001/jamanetworkopen.2021.17035","Factors Associated With Symptoms of Depression and Anxiety Among Women Experiencing Homelessness and Unstable Housing During the COVID-19 Pandemic.",NA,"2021","07","22","JAMA Netw Open","JAMA network open","Anxiety; Anxiety Disorders; COVID-19; Depression; Depressive Disorder; Female; Homeless Persons; Housing; Humans; Income; Middle Aged; Pandemics; Poverty; SARS-CoV-2; Social Class; Social Isolation; Vulnerable Populations","Riley","Elise D","Department of Medicine, University of California, San Francisco",NA
"1133","34259851","10.1001/jamanetworkopen.2021.17035","Factors Associated With Symptoms of Depression and Anxiety Among Women Experiencing Homelessness and Unstable Housing During the COVID-19 Pandemic.",NA,"2021","07","22","JAMA Netw Open","JAMA network open","Anxiety; Anxiety Disorders; COVID-19; Depression; Depressive Disorder; Female; Homeless Persons; Housing; Humans; Income; Middle Aged; Pandemics; Poverty; SARS-CoV-2; Social Class; Social Isolation; Vulnerable Populations","Dilworth","Samantha E","Department of Medicine, University of California, San Francisco",NA
"1134","34259851","10.1001/jamanetworkopen.2021.17035","Factors Associated With Symptoms of Depression and Anxiety Among Women Experiencing Homelessness and Unstable Housing During the COVID-19 Pandemic.",NA,"2021","07","22","JAMA Netw Open","JAMA network open","Anxiety; Anxiety Disorders; COVID-19; Depression; Depressive Disorder; Female; Homeless Persons; Housing; Humans; Income; Middle Aged; Pandemics; Poverty; SARS-CoV-2; Social Class; Social Isolation; Vulnerable Populations","Satre","Derek D","Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco",NA
"1135","34259851","10.1001/jamanetworkopen.2021.17035","Factors Associated With Symptoms of Depression and Anxiety Among Women Experiencing Homelessness and Unstable Housing During the COVID-19 Pandemic.",NA,"2021","07","22","JAMA Netw Open","JAMA network open","Anxiety; Anxiety Disorders; COVID-19; Depression; Depressive Disorder; Female; Homeless Persons; Housing; Humans; Income; Middle Aged; Pandemics; Poverty; SARS-CoV-2; Social Class; Social Isolation; Vulnerable Populations","Silverberg","Michael J","Division of Research, Kaiser Permanente Northern California, Oakland",NA
"1136","34259851","10.1001/jamanetworkopen.2021.17035","Factors Associated With Symptoms of Depression and Anxiety Among Women Experiencing Homelessness and Unstable Housing During the COVID-19 Pandemic.",NA,"2021","07","22","JAMA Netw Open","JAMA network open","Anxiety; Anxiety Disorders; COVID-19; Depression; Depressive Disorder; Female; Homeless Persons; Housing; Humans; Income; Middle Aged; Pandemics; Poverty; SARS-CoV-2; Social Class; Social Isolation; Vulnerable Populations","Neilands","Torsten B","Department of Medicine, University of California, San Francisco",NA
"1137","34259851","10.1001/jamanetworkopen.2021.17035","Factors Associated With Symptoms of Depression and Anxiety Among Women Experiencing Homelessness and Unstable Housing During the COVID-19 Pandemic.",NA,"2021","07","22","JAMA Netw Open","JAMA network open","Anxiety; Anxiety Disorders; COVID-19; Depression; Depressive Disorder; Female; Homeless Persons; Housing; Humans; Income; Middle Aged; Pandemics; Poverty; SARS-CoV-2; Social Class; Social Isolation; Vulnerable Populations","Mangurian","Christina","Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco",NA
"1138","34259851","10.1001/jamanetworkopen.2021.17035","Factors Associated With Symptoms of Depression and Anxiety Among Women Experiencing Homelessness and Unstable Housing During the COVID-19 Pandemic.",NA,"2021","07","22","JAMA Netw Open","JAMA network open","Anxiety; Anxiety Disorders; COVID-19; Depression; Depressive Disorder; Female; Homeless Persons; Housing; Humans; Income; Middle Aged; Pandemics; Poverty; SARS-CoV-2; Social Class; Social Isolation; Vulnerable Populations","Weiser","Sheri D","Department of Medicine, University of California, San Francisco",NA
"1139","34259847","10.1001/jamanetworkopen.2021.17060","Association of Socioeconomic Characteristics With Disparities in COVID-19 Outcomes in Japan.","Socioeconomic factors in the disparities in COVID-19 outcomes have been reported in studies from the US and other Western countries. However, no studies have documented national- or subnational-level outcome disparities in Asian countries. To assess the association between regional COVID-19 outcome disparities and socioeconomic characteristics in Japan. This cross-sectional study collected and analyzed confirmed COVID-19 cases and deaths (through February 13, 2021) as well as population and soci","2021","07","22","JAMA Netw Open","JAMA network open","Adult; Aged; COVID-19; Cross-Sectional Studies; Crowding; Educational Status; Employment; Family Characteristics; Female; Health Status Disparities; Humans; Income; Japan; Male; Middle Aged; Obesity; Occupations; Pandemics; Public Assistance; SARS-CoV-2; Smoking; Social Class; Socioeconomic Factors; Young Adult","Yoshikawa","Yuki","Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts",NA
"1140","34259847","10.1001/jamanetworkopen.2021.17060","Association of Socioeconomic Characteristics With Disparities in COVID-19 Outcomes in Japan.","Socioeconomic factors in the disparities in COVID-19 outcomes have been reported in studies from the US and other Western countries. However, no studies have documented national- or subnational-level outcome disparities in Asian countries. To assess the association between regional COVID-19 outcome disparities and socioeconomic characteristics in Japan. This cross-sectional study collected and analyzed confirmed COVID-19 cases and deaths (through February 13, 2021) as well as population and soci","2021","07","22","JAMA Netw Open","JAMA network open","Adult; Aged; COVID-19; Cross-Sectional Studies; Crowding; Educational Status; Employment; Family Characteristics; Female; Health Status Disparities; Humans; Income; Japan; Male; Middle Aged; Obesity; Occupations; Pandemics; Public Assistance; SARS-CoV-2; Smoking; Social Class; Socioeconomic Factors; Young Adult","Kawachi","Ichiro","Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts",NA
"1141","34259846","10.1001/jamanetworkopen.2021.17115","Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical Trial.","Social distancing is critical to the control of COVID-19, which has disproportionately affected the Black community. Physician-delivered messages may increase adherence to these behaviors. To determine whether messages delivered by physicians improve COVID-19 knowledge and preventive behaviors and to assess the differential effectiveness of messages tailored to the Black community. This randomized clinical trial of self-identified White and Black adults with less than a college education was con","2021","07","22","JAMA Netw Open","JAMA network open","Adult; African Americans; COVID-19; Communication; Cultural Competency; Educational Status; European Continental Ancestry Group; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Pandemics; Physical Distancing; Physicians; Public Health; Racism; SARS-CoV-2; Social Marketing; Surveys and Questionnaires; Young Adult","Torres","Carlos","Harvard Medical School, Boston, Massachusetts",NA
"1142","34259846","10.1001/jamanetworkopen.2021.17115","Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical Trial.","Social distancing is critical to the control of COVID-19, which has disproportionately affected the Black community. Physician-delivered messages may increase adherence to these behaviors. To determine whether messages delivered by physicians improve COVID-19 knowledge and preventive behaviors and to assess the differential effectiveness of messages tailored to the Black community. This randomized clinical trial of self-identified White and Black adults with less than a college education was con","2021","07","22","JAMA Netw Open","JAMA network open","Adult; African Americans; COVID-19; Communication; Cultural Competency; Educational Status; European Continental Ancestry Group; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Pandemics; Physical Distancing; Physicians; Public Health; Racism; SARS-CoV-2; Social Marketing; Surveys and Questionnaires; Young Adult","Ogbu-Nwobodo","Lucy","Harvard Medical School, Boston, Massachusetts",NA
"1143","34259846","10.1001/jamanetworkopen.2021.17115","Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical Trial.","Social distancing is critical to the control of COVID-19, which has disproportionately affected the Black community. Physician-delivered messages may increase adherence to these behaviors. To determine whether messages delivered by physicians improve COVID-19 knowledge and preventive behaviors and to assess the differential effectiveness of messages tailored to the Black community. This randomized clinical trial of self-identified White and Black adults with less than a college education was con","2021","07","22","JAMA Netw Open","JAMA network open","Adult; African Americans; COVID-19; Communication; Cultural Competency; Educational Status; European Continental Ancestry Group; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Pandemics; Physical Distancing; Physicians; Public Health; Racism; SARS-CoV-2; Social Marketing; Surveys and Questionnaires; Young Adult","Alsan","Marcella","Harvard Kennedy School of Government, Cambridge, Massachusetts",NA
"1144","34259846","10.1001/jamanetworkopen.2021.17115","Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical Trial.","Social distancing is critical to the control of COVID-19, which has disproportionately affected the Black community. Physician-delivered messages may increase adherence to these behaviors. To determine whether messages delivered by physicians improve COVID-19 knowledge and preventive behaviors and to assess the differential effectiveness of messages tailored to the Black community. This randomized clinical trial of self-identified White and Black adults with less than a college education was con","2021","07","22","JAMA Netw Open","JAMA network open","Adult; African Americans; COVID-19; Communication; Cultural Competency; Educational Status; European Continental Ancestry Group; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Pandemics; Physical Distancing; Physicians; Public Health; Racism; SARS-CoV-2; Social Marketing; Surveys and Questionnaires; Young Adult","Stanford","Fatima Cody","Harvard Medical School, Boston, Massachusetts",NA
"1145","34259846","10.1001/jamanetworkopen.2021.17115","Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical Trial.","Social distancing is critical to the control of COVID-19, which has disproportionately affected the Black community. Physician-delivered messages may increase adherence to these behaviors. To determine whether messages delivered by physicians improve COVID-19 knowledge and preventive behaviors and to assess the differential effectiveness of messages tailored to the Black community. This randomized clinical trial of self-identified White and Black adults with less than a college education was con","2021","07","22","JAMA Netw Open","JAMA network open","Adult; African Americans; COVID-19; Communication; Cultural Competency; Educational Status; European Continental Ancestry Group; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Pandemics; Physical Distancing; Physicians; Public Health; Racism; SARS-CoV-2; Social Marketing; Surveys and Questionnaires; Young Adult","Banerjee","Abhijit","Department of Economics, Massachusetts Institute of Technology, Cambridge",NA
"1146","34259846","10.1001/jamanetworkopen.2021.17115","Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical Trial.","Social distancing is critical to the control of COVID-19, which has disproportionately affected the Black community. Physician-delivered messages may increase adherence to these behaviors. To determine whether messages delivered by physicians improve COVID-19 knowledge and preventive behaviors and to assess the differential effectiveness of messages tailored to the Black community. This randomized clinical trial of self-identified White and Black adults with less than a college education was con","2021","07","22","JAMA Netw Open","JAMA network open","Adult; African Americans; COVID-19; Communication; Cultural Competency; Educational Status; European Continental Ancestry Group; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Pandemics; Physical Distancing; Physicians; Public Health; Racism; SARS-CoV-2; Social Marketing; Surveys and Questionnaires; Young Adult","Breza","Emily","Department of Economics, Harvard University, Cambridge, Massachusetts",NA
"1147","34259846","10.1001/jamanetworkopen.2021.17115","Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical Trial.","Social distancing is critical to the control of COVID-19, which has disproportionately affected the Black community. Physician-delivered messages may increase adherence to these behaviors. To determine whether messages delivered by physicians improve COVID-19 knowledge and preventive behaviors and to assess the differential effectiveness of messages tailored to the Black community. This randomized clinical trial of self-identified White and Black adults with less than a college education was con","2021","07","22","JAMA Netw Open","JAMA network open","Adult; African Americans; COVID-19; Communication; Cultural Competency; Educational Status; European Continental Ancestry Group; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Pandemics; Physical Distancing; Physicians; Public Health; Racism; SARS-CoV-2; Social Marketing; Surveys and Questionnaires; Young Adult","Chandrasekhar","Arun G","Department of Economics, Stanford University, Stanford, California",NA
"1148","34259846","10.1001/jamanetworkopen.2021.17115","Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical Trial.","Social distancing is critical to the control of COVID-19, which has disproportionately affected the Black community. Physician-delivered messages may increase adherence to these behaviors. To determine whether messages delivered by physicians improve COVID-19 knowledge and preventive behaviors and to assess the differential effectiveness of messages tailored to the Black community. This randomized clinical trial of self-identified White and Black adults with less than a college education was con","2021","07","22","JAMA Netw Open","JAMA network open","Adult; African Americans; COVID-19; Communication; Cultural Competency; Educational Status; European Continental Ancestry Group; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Pandemics; Physical Distancing; Physicians; Public Health; Racism; SARS-CoV-2; Social Marketing; Surveys and Questionnaires; Young Adult","Eichmeyer","Sarah","Department of Economics, Ludwig Maximilian University of Munich, Munich, Germany",NA
"1149","34259846","10.1001/jamanetworkopen.2021.17115","Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical Trial.","Social distancing is critical to the control of COVID-19, which has disproportionately affected the Black community. Physician-delivered messages may increase adherence to these behaviors. To determine whether messages delivered by physicians improve COVID-19 knowledge and preventive behaviors and to assess the differential effectiveness of messages tailored to the Black community. This randomized clinical trial of self-identified White and Black adults with less than a college education was con","2021","07","22","JAMA Netw Open","JAMA network open","Adult; African Americans; COVID-19; Communication; Cultural Competency; Educational Status; European Continental Ancestry Group; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Pandemics; Physical Distancing; Physicians; Public Health; Racism; SARS-CoV-2; Social Marketing; Surveys and Questionnaires; Young Adult","Karnani","Mohit","Department of Economics, Massachusetts Institute of Technology, Cambridge",NA
"1150","34259846","10.1001/jamanetworkopen.2021.17115","Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical Trial.","Social distancing is critical to the control of COVID-19, which has disproportionately affected the Black community. Physician-delivered messages may increase adherence to these behaviors. To determine whether messages delivered by physicians improve COVID-19 knowledge and preventive behaviors and to assess the differential effectiveness of messages tailored to the Black community. This randomized clinical trial of self-identified White and Black adults with less than a college education was con","2021","07","22","JAMA Netw Open","JAMA network open","Adult; African Americans; COVID-19; Communication; Cultural Competency; Educational Status; European Continental Ancestry Group; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Pandemics; Physical Distancing; Physicians; Public Health; Racism; SARS-CoV-2; Social Marketing; Surveys and Questionnaires; Young Adult","Loisel","Tristan","Paris School of Economics, Paris, France",NA
"1151","34259846","10.1001/jamanetworkopen.2021.17115","Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical Trial.","Social distancing is critical to the control of COVID-19, which has disproportionately affected the Black community. Physician-delivered messages may increase adherence to these behaviors. To determine whether messages delivered by physicians improve COVID-19 knowledge and preventive behaviors and to assess the differential effectiveness of messages tailored to the Black community. This randomized clinical trial of self-identified White and Black adults with less than a college education was con","2021","07","22","JAMA Netw Open","JAMA network open","Adult; African Americans; COVID-19; Communication; Cultural Competency; Educational Status; European Continental Ancestry Group; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Pandemics; Physical Distancing; Physicians; Public Health; Racism; SARS-CoV-2; Social Marketing; Surveys and Questionnaires; Young Adult","Goldsmith-Pinkham","Paul","Yale School of Management, New Haven, Connecticut",NA
"1152","34259846","10.1001/jamanetworkopen.2021.17115","Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical Trial.","Social distancing is critical to the control of COVID-19, which has disproportionately affected the Black community. Physician-delivered messages may increase adherence to these behaviors. To determine whether messages delivered by physicians improve COVID-19 knowledge and preventive behaviors and to assess the differential effectiveness of messages tailored to the Black community. This randomized clinical trial of self-identified White and Black adults with less than a college education was con","2021","07","22","JAMA Netw Open","JAMA network open","Adult; African Americans; COVID-19; Communication; Cultural Competency; Educational Status; European Continental Ancestry Group; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Pandemics; Physical Distancing; Physicians; Public Health; Racism; SARS-CoV-2; Social Marketing; Surveys and Questionnaires; Young Adult","Olken","Benjamin A","Department of Economics, Massachusetts Institute of Technology, Cambridge",NA
"1153","34259846","10.1001/jamanetworkopen.2021.17115","Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical Trial.","Social distancing is critical to the control of COVID-19, which has disproportionately affected the Black community. Physician-delivered messages may increase adherence to these behaviors. To determine whether messages delivered by physicians improve COVID-19 knowledge and preventive behaviors and to assess the differential effectiveness of messages tailored to the Black community. This randomized clinical trial of self-identified White and Black adults with less than a college education was con","2021","07","22","JAMA Netw Open","JAMA network open","Adult; African Americans; COVID-19; Communication; Cultural Competency; Educational Status; European Continental Ancestry Group; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Pandemics; Physical Distancing; Physicians; Public Health; Racism; SARS-CoV-2; Social Marketing; Surveys and Questionnaires; Young Adult","Vautrey","Pierre-Luc","Department of Economics, Massachusetts Institute of Technology, Cambridge",NA
"1154","34259846","10.1001/jamanetworkopen.2021.17115","Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical Trial.","Social distancing is critical to the control of COVID-19, which has disproportionately affected the Black community. Physician-delivered messages may increase adherence to these behaviors. To determine whether messages delivered by physicians improve COVID-19 knowledge and preventive behaviors and to assess the differential effectiveness of messages tailored to the Black community. This randomized clinical trial of self-identified White and Black adults with less than a college education was con","2021","07","22","JAMA Netw Open","JAMA network open","Adult; African Americans; COVID-19; Communication; Cultural Competency; Educational Status; European Continental Ancestry Group; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Pandemics; Physical Distancing; Physicians; Public Health; Racism; SARS-CoV-2; Social Marketing; Surveys and Questionnaires; Young Adult","Warner","Erica","Harvard Medical School, Boston, Massachusetts",NA
"1155","34259846","10.1001/jamanetworkopen.2021.17115","Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical Trial.","Social distancing is critical to the control of COVID-19, which has disproportionately affected the Black community. Physician-delivered messages may increase adherence to these behaviors. To determine whether messages delivered by physicians improve COVID-19 knowledge and preventive behaviors and to assess the differential effectiveness of messages tailored to the Black community. This randomized clinical trial of self-identified White and Black adults with less than a college education was con","2021","07","22","JAMA Netw Open","JAMA network open","Adult; African Americans; COVID-19; Communication; Cultural Competency; Educational Status; European Continental Ancestry Group; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Pandemics; Physical Distancing; Physicians; Public Health; Racism; SARS-CoV-2; Social Marketing; Surveys and Questionnaires; Young Adult","Duflo","Esther","Department of Economics, Massachusetts Institute of Technology, Cambridge",NA
"1156","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Costantino","Andrea","Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Gastroenterology and Endoscopy Unit, Milan, Italy",NA
"1157","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Noviello","Daniele","University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy",NA
"1158","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Conforti","Francesco Simone","Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Gastroenterology and Endoscopy Unit, Milan, Italy",NA
"1159","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Aloi","Marina","Sapienza University of Rome, Department of Pediatrics, Rome, Italy",NA
"1160","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Armuzzi","Alessandro","Fondazione Policlinico Universitario A. Gemelli IRCCS, Internal Medicine and Gastroenterology, Rome, Italy",NA
"1161","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Bossa","Fabrizio","Fondazione Casa Sollievo della Sofferenza, Gastroenterologia ed Endoscopia Digestiva, San Giovanni Rotondo, Italy",NA
"1162","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Ficari","Ferdinando","AUO Careggi, Dipartimento di Medicina Sperimentale Clinica Chirurgia Generale, Florence, Italy",NA
"1163","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Leone","Salvo","AMICI Onlus, Milan, Italy",NA
"1164","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Manguso","Francesco","AO Cardarelli, Surgical Department, Naples, Italy",NA
"1165","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Mocci","Giammarco","Azienda Ospedaliera ARNAS G. Brotzu, SC Gastroenterologia, Cagliari, Italy",NA
"1166","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Orlando","Ambrogio","""Villa Sofia-Cervello"" Hospital, IBD Unit, Palermo, Italy",NA
"1167","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Pironi","Loris","Policlinico Sant'Orsola Malpighi Centro IICB, Scienze Mediche, Bologna, Italy",NA
"1168","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Radice","Simona","Humanitas Research Hospital, IBD Unit, Milan, Italy",NA
"1169","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Rizzello","Fernando","Policlinico Sant'Orsola Malpighi, Department of Internal Medicine and Gastroenterology, Bologna, Italy",NA
"1170","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Tongiorgi","Alessandra","UO Gastroenterologia AOUP, Chirurgia Generale, Pisa, Italy",NA
"1171","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Costantino","Claudio","University of Palermo, Department of Health Promotion Sciences- Maternal and Infant Care- Internal Medicine and Excellence Specialties ""G. D'Alessandro,"" Palermo, Italy",NA
"1172","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Vecchi","Maurizio","Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Gastroenterology and Endoscopy Unit, Milan, Italy",NA
"1173","34259844","10.1093/ibd/izab172","COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.",NA,"2021","07","14","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID-19; COVID-19 vaccine; IBD; vaccine hesitancy","Caprioli","Flavio","Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Gastroenterology and Endoscopy Unit, Milan, Italy",NA
"1174","34259836","10.1001/jama.2021.11717","Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.",NA,"2021","07","14","JAMA","JAMA",NA,"Abbasi","Jennifer",NA,NA
"1175","34259801","10.1093/ajhp/zxab279","Healthcare system conversion to a biosimilar: Trials and tribulations.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. While biologic medications have t","2021","07","14","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","biological products; biosimilar pharmaceuticals; formulary; pharmacy and theraputics committee","Lam","Simon W","Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA",NA
"1176","34259801","10.1093/ajhp/zxab279","Healthcare system conversion to a biosimilar: Trials and tribulations.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. While biologic medications have t","2021","07","14","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","biological products; biosimilar pharmaceuticals; formulary; pharmacy and theraputics committee","Amoline","Kevin","Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA",NA
"1177","34259801","10.1093/ajhp/zxab279","Healthcare system conversion to a biosimilar: Trials and tribulations.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. While biologic medications have t","2021","07","14","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","biological products; biosimilar pharmaceuticals; formulary; pharmacy and theraputics committee","Marcum","Christopher","Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA",NA
"1178","34259801","10.1093/ajhp/zxab279","Healthcare system conversion to a biosimilar: Trials and tribulations.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. While biologic medications have t","2021","07","14","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","biological products; biosimilar pharmaceuticals; formulary; pharmacy and theraputics committee","Leonard","Mandy","Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA",NA
"1179","34259777","10.1590/1806-9282.67.Suppl1.20201094","Comments on ""Kawasaki and COVID-19 disease in children: a systematic review"".",NA,"2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Hosseini","Mohammad-Salar","Tabriz University of Medical Sciences, Student Research Committee - Tabriz, Iran",NA
"1180","34259777","10.1590/1806-9282.67.Suppl1.20201094","Comments on ""Kawasaki and COVID-19 disease in children: a systematic review"".",NA,"2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Akbarzadeh","Mohammad Amin","Tabriz University of Medical Sciences, Student Research Committee - Tabriz, Iran",NA
"1181","34259776","10.1590/1806-9282.67.Suppl1.20201063","The Impact of COVID-19 on the Cardiovascular System.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces coronavirus-19 disease (COVID-19), has affected many people in Brazil and worldwide. This disease predominantly affects the organs of the respiratory system, but it also damages the brain, liver, kidneys and especially the heart. In the heart, scientific evidence shows that this virus can damage the coronary arteries, generating microvascular dysfunction, favoring acute myocardial infarction. Furthermore, with the increased","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Aras Júnior","Roque","Universidade Federal da Bahia, Faculdade de Medicina - Salvador (BA), Brazil",NA
"1182","34259776","10.1590/1806-9282.67.Suppl1.20201063","The Impact of COVID-19 on the Cardiovascular System.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces coronavirus-19 disease (COVID-19), has affected many people in Brazil and worldwide. This disease predominantly affects the organs of the respiratory system, but it also damages the brain, liver, kidneys and especially the heart. In the heart, scientific evidence shows that this virus can damage the coronary arteries, generating microvascular dysfunction, favoring acute myocardial infarction. Furthermore, with the increased","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Durães","André","Universidade Federal da Bahia, Faculdade de Medicina - Salvador (BA), Brazil",NA
"1183","34259776","10.1590/1806-9282.67.Suppl1.20201063","The Impact of COVID-19 on the Cardiovascular System.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces coronavirus-19 disease (COVID-19), has affected many people in Brazil and worldwide. This disease predominantly affects the organs of the respiratory system, but it also damages the brain, liver, kidneys and especially the heart. In the heart, scientific evidence shows that this virus can damage the coronary arteries, generating microvascular dysfunction, favoring acute myocardial infarction. Furthermore, with the increased","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Roever","Leonardo","Universidade Federal de Uberlândia - Uberlândia (MG), Brazil",NA
"1184","34259776","10.1590/1806-9282.67.Suppl1.20201063","The Impact of COVID-19 on the Cardiovascular System.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces coronavirus-19 disease (COVID-19), has affected many people in Brazil and worldwide. This disease predominantly affects the organs of the respiratory system, but it also damages the brain, liver, kidneys and especially the heart. In the heart, scientific evidence shows that this virus can damage the coronary arteries, generating microvascular dysfunction, favoring acute myocardial infarction. Furthermore, with the increased","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Macedo","Cristiano","Universidade Federal da Bahia, Faculdade de Medicina - Salvador (BA), Brazil",NA
"1185","34259776","10.1590/1806-9282.67.Suppl1.20201063","The Impact of COVID-19 on the Cardiovascular System.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces coronavirus-19 disease (COVID-19), has affected many people in Brazil and worldwide. This disease predominantly affects the organs of the respiratory system, but it also damages the brain, liver, kidneys and especially the heart. In the heart, scientific evidence shows that this virus can damage the coronary arteries, generating microvascular dysfunction, favoring acute myocardial infarction. Furthermore, with the increased","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Aras","Marcela Gordilho","Universidade Federal da Bahia, Faculdade de Medicina - Salvador (BA), Brazil",NA
"1186","34259776","10.1590/1806-9282.67.Suppl1.20201063","The Impact of COVID-19 on the Cardiovascular System.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces coronavirus-19 disease (COVID-19), has affected many people in Brazil and worldwide. This disease predominantly affects the organs of the respiratory system, but it also damages the brain, liver, kidneys and especially the heart. In the heart, scientific evidence shows that this virus can damage the coronary arteries, generating microvascular dysfunction, favoring acute myocardial infarction. Furthermore, with the increased","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Nascimento","Luca","Universidade Federal da Bahia, Faculdade de Medicina - Salvador (BA), Brazil",NA
"1187","34259776","10.1590/1806-9282.67.Suppl1.20201063","The Impact of COVID-19 on the Cardiovascular System.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces coronavirus-19 disease (COVID-19), has affected many people in Brazil and worldwide. This disease predominantly affects the organs of the respiratory system, but it also damages the brain, liver, kidneys and especially the heart. In the heart, scientific evidence shows that this virus can damage the coronary arteries, generating microvascular dysfunction, favoring acute myocardial infarction. Furthermore, with the increased","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Improta-Caria","Alex Cleber","Universidade Federal da Bahia, Faculdade de Medicina, Programa de Pós-Graduação em Medicina e Saúde - Salvador (BA), Brazil",NA
"1188","34259776","10.1590/1806-9282.67.Suppl1.20201063","The Impact of COVID-19 on the Cardiovascular System.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces coronavirus-19 disease (COVID-19), has affected many people in Brazil and worldwide. This disease predominantly affects the organs of the respiratory system, but it also damages the brain, liver, kidneys and especially the heart. In the heart, scientific evidence shows that this virus can damage the coronary arteries, generating microvascular dysfunction, favoring acute myocardial infarction. Furthermore, with the increased","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"De Sousa","Ricardo Augusto Leoni","Universidade Federal dos Vales do Jequitinhonha e Mucuri, Programa Multicêntrico em Ciências Fisiológicas - Teófilo Otoni (MG), Brazil",NA
"1189","34259776","10.1590/1806-9282.67.Suppl1.20201063","The Impact of COVID-19 on the Cardiovascular System.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces coronavirus-19 disease (COVID-19), has affected many people in Brazil and worldwide. This disease predominantly affects the organs of the respiratory system, but it also damages the brain, liver, kidneys and especially the heart. In the heart, scientific evidence shows that this virus can damage the coronary arteries, generating microvascular dysfunction, favoring acute myocardial infarction. Furthermore, with the increased","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Gomes-Neto","Mansueto","Universidade Federal da Bahia, Faculdade de Medicina, Programa de Pós-Graduação em Medicina e Saúde - Salvador (BA), Brazil",NA
"1190","34259775","10.1590/1806-9282.67.Suppl1.20200968","Possible role of exogenous melatonin in preventing more serious COVID-19 infection in patients with type 2 diabetes mellitus.","COVID-19 infection is more severe in patients with type 2 diabetes mellitus (DM2). The severity of this viral infection is associated with an intense inflammatory activity. DM2 is a disease that also determines a greater degree of systemic inflammation. This is due to hyperglycemia, the higher prevalence of sleep disorders and also the low levels of melatonin, a substance with anti-inflammatory actions, in these patients. In this article, we suggest that exogenous melatonin may have an important","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Martorina","Wagner José","Universidade Federal de Minas Gerais, Postgraduate Program in Neurosciences - Belo Horizonte, Brazil",NA
"1191","34259775","10.1590/1806-9282.67.Suppl1.20200968","Possible role of exogenous melatonin in preventing more serious COVID-19 infection in patients with type 2 diabetes mellitus.","COVID-19 infection is more severe in patients with type 2 diabetes mellitus (DM2). The severity of this viral infection is associated with an intense inflammatory activity. DM2 is a disease that also determines a greater degree of systemic inflammation. This is due to hyperglycemia, the higher prevalence of sleep disorders and also the low levels of melatonin, a substance with anti-inflammatory actions, in these patients. In this article, we suggest that exogenous melatonin may have an important","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Tavares","Almir","Universidade Federal de Minas Gerais, Postgraduate Program in Neurosciences - Belo Horizonte, Brazil",NA
"1192","34259774","10.1590/1806-9282.67.Suppl1.20200917","The role of serum inflammatory markers, albumin, and hemoglobin in predicting the diagnosis in patients admitted to the emergency department with a pre-diagnosis of COVID-19.","Serum inflammatory markers and albumin levels provide an assumption for the severity of COVID-19 infection. Our objective was to investigate the determinant role of serum inflammatory markers, albumin, and hemoglobin (Hb) in predicting the diagnosis in patients with a pre-diagnosis of COVID-19. Demographic findings, complete blood count and serum biochemical values of the patients analyzed. Of the patients included in the study, 48 were COVID (+) and 253 were COVID (-). Statistically significant","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Akman","Canan","Canakkale Onsekiz Mart University, School of Medicine, Department of Emergency Medicine - Canakkale, Turkey",NA
"1193","34259774","10.1590/1806-9282.67.Suppl1.20200917","The role of serum inflammatory markers, albumin, and hemoglobin in predicting the diagnosis in patients admitted to the emergency department with a pre-diagnosis of COVID-19.","Serum inflammatory markers and albumin levels provide an assumption for the severity of COVID-19 infection. Our objective was to investigate the determinant role of serum inflammatory markers, albumin, and hemoglobin (Hb) in predicting the diagnosis in patients with a pre-diagnosis of COVID-19. Demographic findings, complete blood count and serum biochemical values of the patients analyzed. Of the patients included in the study, 48 were COVID (+) and 253 were COVID (-). Statistically significant","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Bakirdögen","Serkan","CanakkaleOnsekiz Mart University, School of Medicine, Department of Internal Medicine Division of Nephrology - Canakkale, Turkey",NA
"1194","34259773","10.1590/1806-9282.67.Suppl1.20200844","Comment on ""Current evidence of SARS-CoV-2 vertical transmission: an integrative review"".",NA,"2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Cai","Jianghui","University of Electronic Science and Technology of China, Chengdu Women's and Children's Central Hospital, School of Medicine, Department of Pharmacy - Chengdu, China",NA
"1195","34259773","10.1590/1806-9282.67.Suppl1.20200844","Comment on ""Current evidence of SARS-CoV-2 vertical transmission: an integrative review"".",NA,"2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Zhang","Hongxi","University of Electronic Science and Technology of China, Chengdu Women's and Children's Central Hospital, School of Medicine, Department of Pharmacy - Chengdu, China",NA
"1196","34259773","10.1590/1806-9282.67.Suppl1.20200844","Comment on ""Current evidence of SARS-CoV-2 vertical transmission: an integrative review"".",NA,"2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Tang","Mi","University of Electronic Science and Technology of China, Chengdu Women's and Children's Central Hospital, School of Medicine, Office of Good Clinical Practice - Chengdu, Sichuan, China",NA
"1197","34259773","10.1590/1806-9282.67.Suppl1.20200844","Comment on ""Current evidence of SARS-CoV-2 vertical transmission: an integrative review"".",NA,"2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Gan","Xiaoqin","University of Electronic Science and Technology of China, Chengdu Women's and Children's Central Hospital, School of Medicine, Office of Good Clinical Practice - Chengdu, Sichuan, China",NA
"1198","34259772","10.1590/1806-9282.67.Suppl1.20200834","Anticoagulation as prophylaxis of severe forms of COVID 19? A perspective.",NA,"2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Faria Oliveira","Gustavo Catizani","Biocor Instituto - Nova Lima (MG), Brasil",NA
"1199","34259772","10.1590/1806-9282.67.Suppl1.20200834","Anticoagulation as prophylaxis of severe forms of COVID 19? A perspective.",NA,"2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Bastos","Bruno","Universidade Federal do Vale do Jequitinhonha e Mucuri - Diamantina (MG), Brasil",NA
"1200","34259772","10.1590/1806-9282.67.Suppl1.20200834","Anticoagulation as prophylaxis of severe forms of COVID 19? A perspective.",NA,"2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Martorina","Wagner José","Biocor Instituto - Nova Lima (MG), Brasil",NA
"1201","34259771","10.1590/1806-9282.67.Suppl1.20200812","Comment on ''Can the neutrophil/lymphocyte ratio (NLR) have a role in the diagnosis of coronavirus 2019 disease (COVID-19)?''.",NA,"2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Bedel","Cihan","University of Health Sciences, Antalya Training and Research Hospital Physician, Department of Emergency Medicine - Antalya, Turkey",NA
"1202","34259771","10.1590/1806-9282.67.Suppl1.20200812","Comment on ''Can the neutrophil/lymphocyte ratio (NLR) have a role in the diagnosis of coronavirus 2019 disease (COVID-19)?''.",NA,"2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Korkut","Mustafa","University of Health Sciences, Antalya Training and Research Hospital Physician, Department of Emergency Medicine - Antalya, Turkey",NA
"1203","34259771","10.1590/1806-9282.67.Suppl1.20200812","Comment on ''Can the neutrophil/lymphocyte ratio (NLR) have a role in the diagnosis of coronavirus 2019 disease (COVID-19)?''.",NA,"2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Armagan","Hamit Hakan","Suleyman Demirel University, Faculty of Medicine, Department of Emergency Medicine - Isparta, Turkey",NA
"1204","34259770","10.1590/1806-9282.67.Suppl1.20200788","Roles of certain biochemical and hematological parameters in predicting mortality and ICU admission in COVID-19 patients.","In this study, we aimed to retrospectively analyze the roles of certain hematological and biochemical parameters in predicting mortality and intensive care unit admission in patients diagnosed with coronavirus disease 2019 (COVID-19). We analyzed the complete blood count and biochemical parameters of 186 COVID-19 patients by using the polymerase chain reaction test. Whether these parameters can be used to predict intensive care unit admission and mortality in the COVID-19 patients was investigat","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Bilgir","Ferda","Katip Celebi University Ataturk Training and Research Hospital, Department of Allergy and Immunology - Bozyaka/Izmir, Turkey",NA
"1205","34259770","10.1590/1806-9282.67.Suppl1.20200788","Roles of certain biochemical and hematological parameters in predicting mortality and ICU admission in COVID-19 patients.","In this study, we aimed to retrospectively analyze the roles of certain hematological and biochemical parameters in predicting mortality and intensive care unit admission in patients diagnosed with coronavirus disease 2019 (COVID-19). We analyzed the complete blood count and biochemical parameters of 186 COVID-19 patients by using the polymerase chain reaction test. Whether these parameters can be used to predict intensive care unit admission and mortality in the COVID-19 patients was investigat","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Çalik","Sebnem","Izmir Bozyaka Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology - Bozyaka/Izmir, Turkey",NA
"1206","34259770","10.1590/1806-9282.67.Suppl1.20200788","Roles of certain biochemical and hematological parameters in predicting mortality and ICU admission in COVID-19 patients.","In this study, we aimed to retrospectively analyze the roles of certain hematological and biochemical parameters in predicting mortality and intensive care unit admission in patients diagnosed with coronavirus disease 2019 (COVID-19). We analyzed the complete blood count and biochemical parameters of 186 COVID-19 patients by using the polymerase chain reaction test. Whether these parameters can be used to predict intensive care unit admission and mortality in the COVID-19 patients was investigat","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Demir","Ismail","Izmir Katip Çelebi University, Ataturk Training and Research Hospital, Department of Allergy and Immunology - Izmir, Turkey",NA
"1207","34259770","10.1590/1806-9282.67.Suppl1.20200788","Roles of certain biochemical and hematological parameters in predicting mortality and ICU admission in COVID-19 patients.","In this study, we aimed to retrospectively analyze the roles of certain hematological and biochemical parameters in predicting mortality and intensive care unit admission in patients diagnosed with coronavirus disease 2019 (COVID-19). We analyzed the complete blood count and biochemical parameters of 186 COVID-19 patients by using the polymerase chain reaction test. Whether these parameters can be used to predict intensive care unit admission and mortality in the COVID-19 patients was investigat","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Bilgir","Oktay","Izmir Katip Çelebi University, Ataturk Training and Research Hospital, Department of Allergy and Immunology - Izmir, Turkey",NA
"1208","34259769","10.1590/1806-9282.67.Suppl1.20200754","Potential impact of the COVID-19 in HIV-infected individuals: a systematic review Impact of the COVID-19 in HIV-Infected Individuals.","Although much has been studied about the SARS-Cov-2 virus, its effects, and the effectiveness of possible treatments, little is known about its interaction with other infectious diseases. The aim is to study its clinical features and morbidity, and mortality outcomes of COVID-19 patients with HIV/AIDS coinfection. MEDLINE, Web of Science, Embase, CINAHL, LILACS, Scopus, ClinicalTrials.gov, and Cochrane. Atudies in any language, published after 2019, were describing COVID-19 patients with HIV/AID","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"de Medeiros","Kleyton Santos","Universidade Federal do Rio Grande do Norte, Health Sciences Postgraduate Program, - Natal (RN), Brazil",NA
"1209","34259769","10.1590/1806-9282.67.Suppl1.20200754","Potential impact of the COVID-19 in HIV-infected individuals: a systematic review Impact of the COVID-19 in HIV-Infected Individuals.","Although much has been studied about the SARS-Cov-2 virus, its effects, and the effectiveness of possible treatments, little is known about its interaction with other infectious diseases. The aim is to study its clinical features and morbidity, and mortality outcomes of COVID-19 patients with HIV/AIDS coinfection. MEDLINE, Web of Science, Embase, CINAHL, LILACS, Scopus, ClinicalTrials.gov, and Cochrane. Atudies in any language, published after 2019, were describing COVID-19 patients with HIV/AID","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"da Silva","Luís Antônio Soares","Centro Universitário do Rio Grande do Norte - Natal (RN), Brazil",NA
"1210","34259769","10.1590/1806-9282.67.Suppl1.20200754","Potential impact of the COVID-19 in HIV-infected individuals: a systematic review Impact of the COVID-19 in HIV-Infected Individuals.","Although much has been studied about the SARS-Cov-2 virus, its effects, and the effectiveness of possible treatments, little is known about its interaction with other infectious diseases. The aim is to study its clinical features and morbidity, and mortality outcomes of COVID-19 patients with HIV/AIDS coinfection. MEDLINE, Web of Science, Embase, CINAHL, LILACS, Scopus, ClinicalTrials.gov, and Cochrane. Atudies in any language, published after 2019, were describing COVID-19 patients with HIV/AID","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Macêdo","Luíza Thomé de Araújo","Centro Universitário do Rio Grande do Norte - Natal (RN), Brazil",NA
"1211","34259769","10.1590/1806-9282.67.Suppl1.20200754","Potential impact of the COVID-19 in HIV-infected individuals: a systematic review Impact of the COVID-19 in HIV-Infected Individuals.","Although much has been studied about the SARS-Cov-2 virus, its effects, and the effectiveness of possible treatments, little is known about its interaction with other infectious diseases. The aim is to study its clinical features and morbidity, and mortality outcomes of COVID-19 patients with HIV/AIDS coinfection. MEDLINE, Web of Science, Embase, CINAHL, LILACS, Scopus, ClinicalTrials.gov, and Cochrane. Atudies in any language, published after 2019, were describing COVID-19 patients with HIV/AID","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Sarmento","Ayane Cristine","Universidade Federal do Rio Grande do Norte, Health Sciences Postgraduate Program, - Natal (RN), Brazil",NA
"1212","34259769","10.1590/1806-9282.67.Suppl1.20200754","Potential impact of the COVID-19 in HIV-infected individuals: a systematic review Impact of the COVID-19 in HIV-Infected Individuals.","Although much has been studied about the SARS-Cov-2 virus, its effects, and the effectiveness of possible treatments, little is known about its interaction with other infectious diseases. The aim is to study its clinical features and morbidity, and mortality outcomes of COVID-19 patients with HIV/AIDS coinfection. MEDLINE, Web of Science, Embase, CINAHL, LILACS, Scopus, ClinicalTrials.gov, and Cochrane. Atudies in any language, published after 2019, were describing COVID-19 patients with HIV/AID","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Costa","Ana Paula Ferreira","Universidade Federal do Rio Grande do Norte, Health Sciences Postgraduate Program, - Natal (RN), Brazil",NA
"1213","34259769","10.1590/1806-9282.67.Suppl1.20200754","Potential impact of the COVID-19 in HIV-infected individuals: a systematic review Impact of the COVID-19 in HIV-Infected Individuals.","Although much has been studied about the SARS-Cov-2 virus, its effects, and the effectiveness of possible treatments, little is known about its interaction with other infectious diseases. The aim is to study its clinical features and morbidity, and mortality outcomes of COVID-19 patients with HIV/AIDS coinfection. MEDLINE, Web of Science, Embase, CINAHL, LILACS, Scopus, ClinicalTrials.gov, and Cochrane. Atudies in any language, published after 2019, were describing COVID-19 patients with HIV/AID","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Eleutério","José","Universidade Federal do Ceará, Department of Obstetrics and Gynaecology - Fortaleza (CE), Brazil",NA
"1214","34259769","10.1590/1806-9282.67.Suppl1.20200754","Potential impact of the COVID-19 in HIV-infected individuals: a systematic review Impact of the COVID-19 in HIV-Infected Individuals.","Although much has been studied about the SARS-Cov-2 virus, its effects, and the effectiveness of possible treatments, little is known about its interaction with other infectious diseases. The aim is to study its clinical features and morbidity, and mortality outcomes of COVID-19 patients with HIV/AIDS coinfection. MEDLINE, Web of Science, Embase, CINAHL, LILACS, Scopus, ClinicalTrials.gov, and Cochrane. Atudies in any language, published after 2019, were describing COVID-19 patients with HIV/AID","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Gonçalves","Ana Katherine","Universidade Federal do Rio Grande do Norte, Health Sciences Postgraduate Program, - Natal (RN), Brazil",NA
"1215","34259768","10.1590/1806-9282.67.Suppl1.20200736","Conflicts of interest in the coronavirus (sars-cov-2) context: banalization of life-death or disinformation?",NA,"2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Makimoto Monteiro","Bruno Massayuki","Universidade Estadual de Mato Grosso do Sul, School of Medicine Scholar - Campo Grande (MS), Brazil",NA
"1216","34259768","10.1590/1806-9282.67.Suppl1.20200736","Conflicts of interest in the coronavirus (sars-cov-2) context: banalization of life-death or disinformation?",NA,"2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Pires de Souza","José Carlos Rosa","Universidade Estadual de Mato Grosso do Sul, School of Medicine Scholar - Campo Grande (MS), Brazil",NA
"1217","34259767","10.1590/1806-9282.67.Suppl1.20200725","Obesity and the COVID-19: Analysis of the clinical and epidemiological profiles of 138 individuals.","Coronavirus disease 2019 (COVID-19) is the disease caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In the ongoing obesity pandemic, its coexistence with COVID-19 becomes worrying and has a less favorable outcome. This study aimed to describe the clinical and epidemiological profiles of confirmed cases of COVID-19 in individuals with obesity in the state of Alagoas. The observational cross-sectional study involving 138 confirmed cases of COVID-19 who h","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"de Mélo","Kathleen Cézar","Universidade Federal de Alagoas, Departamento de Medicina - Alagoas (AL), Brazil",NA
"1218","34259767","10.1590/1806-9282.67.Suppl1.20200725","Obesity and the COVID-19: Analysis of the clinical and epidemiological profiles of 138 individuals.","Coronavirus disease 2019 (COVID-19) is the disease caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In the ongoing obesity pandemic, its coexistence with COVID-19 becomes worrying and has a less favorable outcome. This study aimed to describe the clinical and epidemiological profiles of confirmed cases of COVID-19 in individuals with obesity in the state of Alagoas. The observational cross-sectional study involving 138 confirmed cases of COVID-19 who h","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"de Souza Lôbo","Jéssica Luzia","Universidade Federal de Alagoas, Departamento de Medicina - Alagoas (AL), Brazil",NA
"1219","34259767","10.1590/1806-9282.67.Suppl1.20200725","Obesity and the COVID-19: Analysis of the clinical and epidemiological profiles of 138 individuals.","Coronavirus disease 2019 (COVID-19) is the disease caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In the ongoing obesity pandemic, its coexistence with COVID-19 becomes worrying and has a less favorable outcome. This study aimed to describe the clinical and epidemiological profiles of confirmed cases of COVID-19 in individuals with obesity in the state of Alagoas. The observational cross-sectional study involving 138 confirmed cases of COVID-19 who h","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"da Silva Junior","Adeilton Gonçalves","Núcleo de Epidemiologia - Juazeiro (BA), Brazil",NA
"1220","34259767","10.1590/1806-9282.67.Suppl1.20200725","Obesity and the COVID-19: Analysis of the clinical and epidemiological profiles of 138 individuals.","Coronavirus disease 2019 (COVID-19) is the disease caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In the ongoing obesity pandemic, its coexistence with COVID-19 becomes worrying and has a less favorable outcome. This study aimed to describe the clinical and epidemiological profiles of confirmed cases of COVID-19 in individuals with obesity in the state of Alagoas. The observational cross-sectional study involving 138 confirmed cases of COVID-19 who h","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"do Carmo","Rodrigo Feliciano","Universidade Federal do Vale do São Franscisco, Postgraduate Program in Health and Biological Sciences - Petrolina (PB), Brazil",NA
"1221","34259767","10.1590/1806-9282.67.Suppl1.20200725","Obesity and the COVID-19: Analysis of the clinical and epidemiological profiles of 138 individuals.","Coronavirus disease 2019 (COVID-19) is the disease caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In the ongoing obesity pandemic, its coexistence with COVID-19 becomes worrying and has a less favorable outcome. This study aimed to describe the clinical and epidemiological profiles of confirmed cases of COVID-19 in individuals with obesity in the state of Alagoas. The observational cross-sectional study involving 138 confirmed cases of COVID-19 who h","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"de Souza","Carlos Dornels Freire","Universidade Federal do Vale do São Franscisco, Postgraduate Program in Biosciences - Petrolina (PB), Brazil",NA
"1222","34259766","10.1590/1806-9282.67.Suppl1.20200721","COVID-19 pandemic information on Brazilian websites: credibility, coverage, and agreement with World Health Organization. Quality of COVID-19 online information in Brazil.","To assess the credibility and the quality content of COVID-19 pandemic information on Brazilian websites. We performed Google searches and screened the first 45 websites. The websites were categorized as academic, commercial, government, hospital, media, nongovernmental organizations, and professionals. The credibility was assessed by JAMA benchmark criteria and HONCODE. A checklist with WHO information about COVID-19 was developed to assess the quality content. For each website, the level of ag","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Sousa Filho","Luis Fernando","Universidade Federal de Sergipe, Department of Physical Therapy - São Cristovão (SE), Brazil",NA
"1223","34259766","10.1590/1806-9282.67.Suppl1.20200721","COVID-19 pandemic information on Brazilian websites: credibility, coverage, and agreement with World Health Organization. Quality of COVID-19 online information in Brazil.","To assess the credibility and the quality content of COVID-19 pandemic information on Brazilian websites. We performed Google searches and screened the first 45 websites. The websites were categorized as academic, commercial, government, hospital, media, nongovernmental organizations, and professionals. The credibility was assessed by JAMA benchmark criteria and HONCODE. A checklist with WHO information about COVID-19 was developed to assess the quality content. For each website, the level of ag","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Santos","Marta Maria Barbosa","Universidade Federal de Sergipe, Department of Physical Therapy - São Cristovão (SE), Brazil",NA
"1224","34259766","10.1590/1806-9282.67.Suppl1.20200721","COVID-19 pandemic information on Brazilian websites: credibility, coverage, and agreement with World Health Organization. Quality of COVID-19 online information in Brazil.","To assess the credibility and the quality content of COVID-19 pandemic information on Brazilian websites. We performed Google searches and screened the first 45 websites. The websites were categorized as academic, commercial, government, hospital, media, nongovernmental organizations, and professionals. The credibility was assessed by JAMA benchmark criteria and HONCODE. A checklist with WHO information about COVID-19 was developed to assess the quality content. For each website, the level of ag","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"da Silva Júnior","Walderi Monteiro","Universidade Federal de Sergipe, Department of Physical Therapy - São Cristovão (SE), Brazil",NA
"1225","34259765","10.1590/1806-9282.67.Suppl1.20200714","Bundle for pediatric COVID-19 sepsis.","COVID-19 infection can progress to severe respiratory infection and have high mortality rates. Several pathophysiological factors are observed in fatal cases, with mortality related to multiple organ failure, in addition to the evolution with high levels of serum ferritin, D-dimer, and C-reactive protein. These severe cases often meet the criteria for macrophage activation syndrome with changes in the host's inflammatory response and an inadequate resolution phase. In the present study, the bund","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Fernández-Sarmiento","Jaime","Universidad de la Sabana, Fundación Cardioinfantil-Instituto de Cardiologia, Departament of Pediatric Critical Care Medicine - Bogotá, Colombia",NA
"1226","34259765","10.1590/1806-9282.67.Suppl1.20200714","Bundle for pediatric COVID-19 sepsis.","COVID-19 infection can progress to severe respiratory infection and have high mortality rates. Several pathophysiological factors are observed in fatal cases, with mortality related to multiple organ failure, in addition to the evolution with high levels of serum ferritin, D-dimer, and C-reactive protein. These severe cases often meet the criteria for macrophage activation syndrome with changes in the host's inflammatory response and an inadequate resolution phase. In the present study, the bund","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"de Carvalho","Werther Brunow","Universidade de São Paulo, Instituto da Criança, Pediatrics Department - São Paulo (SP), Brazil",NA
"1227","34259764","10.1590/1806-9282.67.Suppl1.20200703","Association of ABO blood group and age with COVID-19 positive test.","The aim of this study is to evaluate the relation between the coronavirus (SARS-CoV-2) disease (COVID-19) and blood groups and the Rh factor. A total of 313 patients hospitalized in the Internal Medicine clinic, at the intensive care unit (ICU) were included in the study. The cases were divided into two groups: those who were COVID-19 positive and those negative, detected with real-time reverse transcription polymerase chain reaction testing. The demographic, clinical, ABO blood groups, and Rh f","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Nalbant","Ahmet","Sakarya University, Faculty of Medicine, Department of Internal Medicine - Serdivan/Sakarya, Turquia",NA
"1228","34259764","10.1590/1806-9282.67.Suppl1.20200703","Association of ABO blood group and age with COVID-19 positive test.","The aim of this study is to evaluate the relation between the coronavirus (SARS-CoV-2) disease (COVID-19) and blood groups and the Rh factor. A total of 313 patients hospitalized in the Internal Medicine clinic, at the intensive care unit (ICU) were included in the study. The cases were divided into two groups: those who were COVID-19 positive and those negative, detected with real-time reverse transcription polymerase chain reaction testing. The demographic, clinical, ABO blood groups, and Rh f","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Aydin","Ayhan","Sakarya University, Training and Research Hospital, Department of Internal Medicine - Adapazari, Turquia",NA
"1229","34259764","10.1590/1806-9282.67.Suppl1.20200703","Association of ABO blood group and age with COVID-19 positive test.","The aim of this study is to evaluate the relation between the coronavirus (SARS-CoV-2) disease (COVID-19) and blood groups and the Rh factor. A total of 313 patients hospitalized in the Internal Medicine clinic, at the intensive care unit (ICU) were included in the study. The cases were divided into two groups: those who were COVID-19 positive and those negative, detected with real-time reverse transcription polymerase chain reaction testing. The demographic, clinical, ABO blood groups, and Rh f","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Yaylaci","Selçuk","Sakarya University, Faculty of Medicine, Department of Internal Medicine - Serdivan/Sakarya, Turquia",NA
"1230","34259764","10.1590/1806-9282.67.Suppl1.20200703","Association of ABO blood group and age with COVID-19 positive test.","The aim of this study is to evaluate the relation between the coronavirus (SARS-CoV-2) disease (COVID-19) and blood groups and the Rh factor. A total of 313 patients hospitalized in the Internal Medicine clinic, at the intensive care unit (ICU) were included in the study. The cases were divided into two groups: those who were COVID-19 positive and those negative, detected with real-time reverse transcription polymerase chain reaction testing. The demographic, clinical, ABO blood groups, and Rh f","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Kaya","Tezcan","Sakarya University, Faculty of Medicine, Department of Internal Medicine - Serdivan/Sakarya, Turquia",NA
"1231","34259764","10.1590/1806-9282.67.Suppl1.20200703","Association of ABO blood group and age with COVID-19 positive test.","The aim of this study is to evaluate the relation between the coronavirus (SARS-CoV-2) disease (COVID-19) and blood groups and the Rh factor. A total of 313 patients hospitalized in the Internal Medicine clinic, at the intensive care unit (ICU) were included in the study. The cases were divided into two groups: those who were COVID-19 positive and those negative, detected with real-time reverse transcription polymerase chain reaction testing. The demographic, clinical, ABO blood groups, and Rh f","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Wermeulen","Charlotte Lynn","Federally Qualified Health, Community Health Clinic - New Kensington, United States of America",NA
"1232","34259764","10.1590/1806-9282.67.Suppl1.20200703","Association of ABO blood group and age with COVID-19 positive test.","The aim of this study is to evaluate the relation between the coronavirus (SARS-CoV-2) disease (COVID-19) and blood groups and the Rh factor. A total of 313 patients hospitalized in the Internal Medicine clinic, at the intensive care unit (ICU) were included in the study. The cases were divided into two groups: those who were COVID-19 positive and those negative, detected with real-time reverse transcription polymerase chain reaction testing. The demographic, clinical, ABO blood groups, and Rh f","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Cinemre","Hakan","Federally Qualified Health, Community Health Clinic - New Kensington, United States of America",NA
"1233","34259763","10.1590/1806-9282.67.Suppl1.20200678","Hematological predictors of novel Coronavirus infection.",NA,"2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Aktas","Gulali","Bolu Abant Izzet Baysal University, Department of Internal Medicine - Bolu, Turkey",NA
"1234","34259761","10.1590/1806-9282.67.Suppl1.20200673","Physical Exercise and Immune System: Perspectives on the COVID-19 pandemic.","Physical exercise training (PET) has been considered an excellent non-pharmacological strategy to prevent and treat several diseases. There are various benefits offered by PET, especially on the immune system, promoting changes in the morphology and function of cells, inducing changes in the expression pattern of pro and anti-inflammatory cytokines. However, these changes depend on the type, volume and intensity of PET and whether it is being evaluated acutely or chronically. In this context, PE","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Improta-Caria","Alex Cleber","Universidade Federal da Bahia, Faculdade de Medicina, Programa de Pós-Graduação em Medicina e Saúde - Salvador (BA), Brazil",NA
"1235","34259761","10.1590/1806-9282.67.Suppl1.20200673","Physical Exercise and Immune System: Perspectives on the COVID-19 pandemic.","Physical exercise training (PET) has been considered an excellent non-pharmacological strategy to prevent and treat several diseases. There are various benefits offered by PET, especially on the immune system, promoting changes in the morphology and function of cells, inducing changes in the expression pattern of pro and anti-inflammatory cytokines. However, these changes depend on the type, volume and intensity of PET and whether it is being evaluated acutely or chronically. In this context, PE","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Soci","Úrsula Paula Renó","Universidade de São Paulo, Escola de Educação Física e Esporte, Laboratório de Bioquímica e Biologia Molecular do Exercício - São Paulo (SP), Brazil",NA
"1236","34259761","10.1590/1806-9282.67.Suppl1.20200673","Physical Exercise and Immune System: Perspectives on the COVID-19 pandemic.","Physical exercise training (PET) has been considered an excellent non-pharmacological strategy to prevent and treat several diseases. There are various benefits offered by PET, especially on the immune system, promoting changes in the morphology and function of cells, inducing changes in the expression pattern of pro and anti-inflammatory cytokines. However, these changes depend on the type, volume and intensity of PET and whether it is being evaluated acutely or chronically. In this context, PE","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Pinho","Cristiano Silva","Universidade Federal da Bahia, Faculdade de Medicina, Programa de Pós-Graduação em Medicina e Saúde - Salvador (BA), Brazil",NA
"1237","34259761","10.1590/1806-9282.67.Suppl1.20200673","Physical Exercise and Immune System: Perspectives on the COVID-19 pandemic.","Physical exercise training (PET) has been considered an excellent non-pharmacological strategy to prevent and treat several diseases. There are various benefits offered by PET, especially on the immune system, promoting changes in the morphology and function of cells, inducing changes in the expression pattern of pro and anti-inflammatory cytokines. However, these changes depend on the type, volume and intensity of PET and whether it is being evaluated acutely or chronically. In this context, PE","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Aras Júnior","Roque","Universidade Federal da Bahia, Faculdade de Medicina, Programa de Pós-Graduação em Medicina e Saúde - Salvador (BA), Brazil",NA
"1238","34259761","10.1590/1806-9282.67.Suppl1.20200673","Physical Exercise and Immune System: Perspectives on the COVID-19 pandemic.","Physical exercise training (PET) has been considered an excellent non-pharmacological strategy to prevent and treat several diseases. There are various benefits offered by PET, especially on the immune system, promoting changes in the morphology and function of cells, inducing changes in the expression pattern of pro and anti-inflammatory cytokines. However, these changes depend on the type, volume and intensity of PET and whether it is being evaluated acutely or chronically. In this context, PE","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"De Sousa","Ricardo Augusto Leoni","Universidade Federal dos Vales do Jequitinhonha e Mucuri, Programa Multicêntrico de Pós-Graduação em Ciências Fisiológicas - Diamantina (MG), Brazil",NA
"1239","34259761","10.1590/1806-9282.67.Suppl1.20200673","Physical Exercise and Immune System: Perspectives on the COVID-19 pandemic.","Physical exercise training (PET) has been considered an excellent non-pharmacological strategy to prevent and treat several diseases. There are various benefits offered by PET, especially on the immune system, promoting changes in the morphology and function of cells, inducing changes in the expression pattern of pro and anti-inflammatory cytokines. However, these changes depend on the type, volume and intensity of PET and whether it is being evaluated acutely or chronically. In this context, PE","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Bessa","Theolis Costa Barbosa","Fundação Oswaldo Cruz, Instituto Gonçalo Moniz - Salvador (BA), Brazil",NA
"1240","34259760","10.1590/1806-9282.67.Suppl1.20200630","Comparison of neutrophil lymphocyte ratio, platelet lymphocyte ratio, and mean platelet volume and PCR test in COVID-19 patients.","The polymerase chain reaction test, used in the diagnosis of COVID-19, can be positive with delay, and thorax tomography is used for the diagnosis of the disease. We aimed to compare the relation between thorax tomography findings, PCR test results, and neutrophil lymphocyte ratio; platelet lymphocyte ratio and mean platelet volume neutrophil lymphocyte ratio; platelet lymphocyte ratio and mean platelet volume in COVID-19 patients. COVID-19 patients were divided into three groups, according to b","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Özsari","Süleyman","Bolu Provincial Health Directorate - Bolu, Turkey",NA
"1241","34259760","10.1590/1806-9282.67.Suppl1.20200630","Comparison of neutrophil lymphocyte ratio, platelet lymphocyte ratio, and mean platelet volume and PCR test in COVID-19 patients.","The polymerase chain reaction test, used in the diagnosis of COVID-19, can be positive with delay, and thorax tomography is used for the diagnosis of the disease. We aimed to compare the relation between thorax tomography findings, PCR test results, and neutrophil lymphocyte ratio; platelet lymphocyte ratio and mean platelet volume neutrophil lymphocyte ratio; platelet lymphocyte ratio and mean platelet volume in COVID-19 patients. COVID-19 patients were divided into three groups, according to b","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Özsari","Emine","Bolu Abant Izzet Baysal University, Medical School, Department of Chest Diesases - Bolu, Turkey",NA
"1242","34259760","10.1590/1806-9282.67.Suppl1.20200630","Comparison of neutrophil lymphocyte ratio, platelet lymphocyte ratio, and mean platelet volume and PCR test in COVID-19 patients.","The polymerase chain reaction test, used in the diagnosis of COVID-19, can be positive with delay, and thorax tomography is used for the diagnosis of the disease. We aimed to compare the relation between thorax tomography findings, PCR test results, and neutrophil lymphocyte ratio; platelet lymphocyte ratio and mean platelet volume neutrophil lymphocyte ratio; platelet lymphocyte ratio and mean platelet volume in COVID-19 patients. COVID-19 patients were divided into three groups, according to b","2021","07","14","Rev Assoc Med Bras (1992)","Revista da Associacao Medica Brasileira (1992)",NA,"Emin Demirkol","Muhammet","Bolu Provincial Health Directorate - Bolu, Turkey",NA
"1243","34259759","10.1590/0037-8682-0358-2021","Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.",NA,"2021","07","19","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Diabetic Ketoacidosis; Humans; Mucormycosis; SARS-CoV-2","Bonates","Paula","Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, AM, Brasil",NA
"1244","34259759","10.1590/0037-8682-0358-2021","Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.",NA,"2021","07","19","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Diabetic Ketoacidosis; Humans; Mucormycosis; SARS-CoV-2","João","Guilherme Augusto Pivoto","Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, AM, Brasil",NA
"1245","34259759","10.1590/0037-8682-0358-2021","Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.",NA,"2021","07","19","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Diabetic Ketoacidosis; Humans; Mucormycosis; SARS-CoV-2","Cruz","Kátia Santana","Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, AM, Brasil",NA
"1246","34259759","10.1590/0037-8682-0358-2021","Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.",NA,"2021","07","19","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Diabetic Ketoacidosis; Humans; Mucormycosis; SARS-CoV-2","Ferreira","Marcelo de Souza","Hospital e Pronto Socorro Dr. João Lúcio Pereira Machado, Manaus, AM, Brasil",NA
"1247","34259759","10.1590/0037-8682-0358-2021","Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.",NA,"2021","07","19","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Diabetic Ketoacidosis; Humans; Mucormycosis; SARS-CoV-2","Baía-da-Silva","Djane Clarys","Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, AM, Brasil",NA
"1248","34259759","10.1590/0037-8682-0358-2021","Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.",NA,"2021","07","19","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Diabetic Ketoacidosis; Humans; Mucormycosis; SARS-CoV-2","Farias","Maria Eduarda Leão de","Fundação Oswaldo Cruz, Instituto Leônidas &amp",NA
"1249","34259759","10.1590/0037-8682-0358-2021","Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.",NA,"2021","07","19","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Diabetic Ketoacidosis; Humans; Mucormycosis; SARS-CoV-2","Brito-Sousa","José Diego","Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, AM, Brasil",NA
"1250","34259759","10.1590/0037-8682-0358-2021","Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.",NA,"2021","07","19","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Diabetic Ketoacidosis; Humans; Mucormycosis; SARS-CoV-2","Santana","Monique Freire","Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, AM, Brasil",NA
"1251","34259759","10.1590/0037-8682-0358-2021","Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.",NA,"2021","07","19","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Diabetic Ketoacidosis; Humans; Mucormycosis; SARS-CoV-2","Oliveira","Luciana Aires de","Instituto Nacional de Pesquisas da Amazônia, Manaus, AM, Brasil",NA
"1252","34259759","10.1590/0037-8682-0358-2021","Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.",NA,"2021","07","19","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Diabetic Ketoacidosis; Humans; Mucormycosis; SARS-CoV-2","Cortez","Ana Cláudia Alves","Instituto Nacional de Pesquisas da Amazônia, Manaus, AM, Brasil",NA
"1253","34259759","10.1590/0037-8682-0358-2021","Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.",NA,"2021","07","19","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Diabetic Ketoacidosis; Humans; Mucormycosis; SARS-CoV-2","Souza","João Vicente Braga","Instituto Nacional de Pesquisas da Amazônia, Manaus, AM, Brasil",NA
"1254","34259759","10.1590/0037-8682-0358-2021","Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.",NA,"2021","07","19","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Diabetic Ketoacidosis; Humans; Mucormycosis; SARS-CoV-2","Lacerda","Marcus Vinicius Guimarães","Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, AM, Brasil",NA
"1255","34259726","10.1590/0034-7167-2021-0040","Coping strategies, concerns, and habits of Brazilian men in the COVID-19 context.","To describe coping strategies, concerns and habits of Brazilian men during the COVID-19 pandemic. Cross-sectional, descriptive and nationwide study, carried out in 2020 with a total of 1015 men living in Brazil. A descriptive statistic was used. Young (41.2%), black (61.4%), highly educated (66.8%), high income (33.2%), living with family/friends (49.7%) and formal workers (65.6%) predominated. As coping strategies predominated: exclusive use of the private health system (36.4%), support from fa","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","Adaptation, Psychological; Brazil; COVID-19; Cross-Sectional Studies; Habits; Humans; Male; Pandemics; SARS-CoV-2","Sousa","Anderson Reis de","Universidade Federal da Bahia. Salvador, Bahia, Brazil",NA
"1256","34259726","10.1590/0034-7167-2021-0040","Coping strategies, concerns, and habits of Brazilian men in the COVID-19 context.","To describe coping strategies, concerns and habits of Brazilian men during the COVID-19 pandemic. Cross-sectional, descriptive and nationwide study, carried out in 2020 with a total of 1015 men living in Brazil. A descriptive statistic was used. Young (41.2%), black (61.4%), highly educated (66.8%), high income (33.2%), living with family/friends (49.7%) and formal workers (65.6%) predominated. As coping strategies predominated: exclusive use of the private health system (36.4%), support from fa","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","Adaptation, Psychological; Brazil; COVID-19; Cross-Sectional Studies; Habits; Humans; Male; Pandemics; SARS-CoV-2","Teixeira","Jules Ramon Brito","Universidade Estadual de Feira de Santana. Feira de Santana, Bahia, Brazil",NA
"1257","34259726","10.1590/0034-7167-2021-0040","Coping strategies, concerns, and habits of Brazilian men in the COVID-19 context.","To describe coping strategies, concerns and habits of Brazilian men during the COVID-19 pandemic. Cross-sectional, descriptive and nationwide study, carried out in 2020 with a total of 1015 men living in Brazil. A descriptive statistic was used. Young (41.2%), black (61.4%), highly educated (66.8%), high income (33.2%), living with family/friends (49.7%) and formal workers (65.6%) predominated. As coping strategies predominated: exclusive use of the private health system (36.4%), support from fa","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","Adaptation, Psychological; Brazil; COVID-19; Cross-Sectional Studies; Habits; Humans; Male; Pandemics; SARS-CoV-2","Mota","Tilson Nunes","Universidade Federal da Bahia. Salvador, Bahia, Brazil",NA
"1258","34259726","10.1590/0034-7167-2021-0040","Coping strategies, concerns, and habits of Brazilian men in the COVID-19 context.","To describe coping strategies, concerns and habits of Brazilian men during the COVID-19 pandemic. Cross-sectional, descriptive and nationwide study, carried out in 2020 with a total of 1015 men living in Brazil. A descriptive statistic was used. Young (41.2%), black (61.4%), highly educated (66.8%), high income (33.2%), living with family/friends (49.7%) and formal workers (65.6%) predominated. As coping strategies predominated: exclusive use of the private health system (36.4%), support from fa","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","Adaptation, Psychological; Brazil; COVID-19; Cross-Sectional Studies; Habits; Humans; Male; Pandemics; SARS-CoV-2","Santana","Thiago da Silva","Universidade Estadual de Feira de Santana. Feira de Santana, Bahia, Brazil",NA
"1259","34259726","10.1590/0034-7167-2021-0040","Coping strategies, concerns, and habits of Brazilian men in the COVID-19 context.","To describe coping strategies, concerns and habits of Brazilian men during the COVID-19 pandemic. Cross-sectional, descriptive and nationwide study, carried out in 2020 with a total of 1015 men living in Brazil. A descriptive statistic was used. Young (41.2%), black (61.4%), highly educated (66.8%), high income (33.2%), living with family/friends (49.7%) and formal workers (65.6%) predominated. As coping strategies predominated: exclusive use of the private health system (36.4%), support from fa","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","Adaptation, Psychological; Brazil; COVID-19; Cross-Sectional Studies; Habits; Humans; Male; Pandemics; SARS-CoV-2","Santos","Sélton Diniz Dos","Universidade Estadual de Feira de Santana. Feira de Santana, Bahia, Brazil",NA
"1260","34259726","10.1590/0034-7167-2021-0040","Coping strategies, concerns, and habits of Brazilian men in the COVID-19 context.","To describe coping strategies, concerns and habits of Brazilian men during the COVID-19 pandemic. Cross-sectional, descriptive and nationwide study, carried out in 2020 with a total of 1015 men living in Brazil. A descriptive statistic was used. Young (41.2%), black (61.4%), highly educated (66.8%), high income (33.2%), living with family/friends (49.7%) and formal workers (65.6%) predominated. As coping strategies predominated: exclusive use of the private health system (36.4%), support from fa","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","Adaptation, Psychological; Brazil; COVID-19; Cross-Sectional Studies; Habits; Humans; Male; Pandemics; SARS-CoV-2","Merces","Magno Conceição das","Universidade do Estado da Bahia. Salvador, Bahia, Brazil",NA
"1261","34259726","10.1590/0034-7167-2021-0040","Coping strategies, concerns, and habits of Brazilian men in the COVID-19 context.","To describe coping strategies, concerns and habits of Brazilian men during the COVID-19 pandemic. Cross-sectional, descriptive and nationwide study, carried out in 2020 with a total of 1015 men living in Brazil. A descriptive statistic was used. Young (41.2%), black (61.4%), highly educated (66.8%), high income (33.2%), living with family/friends (49.7%) and formal workers (65.6%) predominated. As coping strategies predominated: exclusive use of the private health system (36.4%), support from fa","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","Adaptation, Psychological; Brazil; COVID-19; Cross-Sectional Studies; Habits; Humans; Male; Pandemics; SARS-CoV-2","Carvalho","Evanilda Souza de Santana","Universidade Estadual de Feira de Santana. Feira de Santana, Bahia, Brazil",NA
"1262","34259726","10.1590/0034-7167-2021-0040","Coping strategies, concerns, and habits of Brazilian men in the COVID-19 context.","To describe coping strategies, concerns and habits of Brazilian men during the COVID-19 pandemic. Cross-sectional, descriptive and nationwide study, carried out in 2020 with a total of 1015 men living in Brazil. A descriptive statistic was used. Young (41.2%), black (61.4%), highly educated (66.8%), high income (33.2%), living with family/friends (49.7%) and formal workers (65.6%) predominated. As coping strategies predominated: exclusive use of the private health system (36.4%), support from fa","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","Adaptation, Psychological; Brazil; COVID-19; Cross-Sectional Studies; Habits; Humans; Male; Pandemics; SARS-CoV-2","Sousa","Álvaro Francisco Lopes","Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil",NA
"1263","34259725","10.1590/0034-7167-2020-1306","Florence Nightingale: Legacy, present and perspectives in COVID-19 pandemic times.","Reflect on the influence of Florence Nightingale's teachings to face the COVID-19 pandemic and its repercussions for the future of the profession. Descriptive reflective study, carried out between May and July 2020, through narrative review on the theme and debates between the authors. The findings are divided into two chapters, namely: Environmental Theory and the teachings of Florence Nightingale in the face of the COVID-19 pandemic; and Florence Nightingale: legacy, present and perspectives. ","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; History of Nursing; History, 19th Century; Humans; Nursing; Pandemics; SARS-CoV-2","Breigeiron","Márcia Koja","Universidade Federal do Rio Grande do Sul. Porto Alegre, Rio Grande do Sul, Brazil",NA
"1264","34259725","10.1590/0034-7167-2020-1306","Florence Nightingale: Legacy, present and perspectives in COVID-19 pandemic times.","Reflect on the influence of Florence Nightingale's teachings to face the COVID-19 pandemic and its repercussions for the future of the profession. Descriptive reflective study, carried out between May and July 2020, through narrative review on the theme and debates between the authors. The findings are divided into two chapters, namely: Environmental Theory and the teachings of Florence Nightingale in the face of the COVID-19 pandemic; and Florence Nightingale: legacy, present and perspectives. ","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; History of Nursing; History, 19th Century; Humans; Nursing; Pandemics; SARS-CoV-2","Vaccari","Alessandra","Universidade Federal do Rio Grande do Sul. Porto Alegre, Rio Grande do Sul, Brazil",NA
"1265","34259725","10.1590/0034-7167-2020-1306","Florence Nightingale: Legacy, present and perspectives in COVID-19 pandemic times.","Reflect on the influence of Florence Nightingale's teachings to face the COVID-19 pandemic and its repercussions for the future of the profession. Descriptive reflective study, carried out between May and July 2020, through narrative review on the theme and debates between the authors. The findings are divided into two chapters, namely: Environmental Theory and the teachings of Florence Nightingale in the face of the COVID-19 pandemic; and Florence Nightingale: legacy, present and perspectives. ","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; History of Nursing; History, 19th Century; Humans; Nursing; Pandemics; SARS-CoV-2","Ribeiro","Sofia Panato","Hospital de Clínicas de Porto Alegre. Porto Alegre, Rio Grande do Sul, Brazil",NA
"1266","34259724","10.1590/0034-7167-2020-1164","Women and COVID-19: reflections for a sexual and reproductive rights-based obstetric care.","This essay aims to reflect on the repercussions of the pandemic in obstetric care in the light of sexual and reproductive rights, focusing on delivery and birth care. The reflection shows that the pandemic has accentuated the violation of these rights, which is evidenced by racial inequalities in maternal mortality, as well as restrictions and interventions in childbirth care without scientific evidence, detour of resources, interruption of services, reduced human resources, shortage of medicine","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; Delivery, Obstetric; Female; Health Services Accessibility; Humans; Pandemics; Pregnancy; Reproductive Rights; SARS-CoV-2","Paes","Luciana Braz de Oliveira","Universidade Federal de São Carlos. São Carlos, São Paulo, Brazil",NA
"1267","34259724","10.1590/0034-7167-2020-1164","Women and COVID-19: reflections for a sexual and reproductive rights-based obstetric care.","This essay aims to reflect on the repercussions of the pandemic in obstetric care in the light of sexual and reproductive rights, focusing on delivery and birth care. The reflection shows that the pandemic has accentuated the violation of these rights, which is evidenced by racial inequalities in maternal mortality, as well as restrictions and interventions in childbirth care without scientific evidence, detour of resources, interruption of services, reduced human resources, shortage of medicine","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; Delivery, Obstetric; Female; Health Services Accessibility; Humans; Pandemics; Pregnancy; Reproductive Rights; SARS-CoV-2","Salim","Natália Rejane","Universidade Federal de São Carlos. São Carlos, São Paulo, Brazil",NA
"1268","34259724","10.1590/0034-7167-2020-1164","Women and COVID-19: reflections for a sexual and reproductive rights-based obstetric care.","This essay aims to reflect on the repercussions of the pandemic in obstetric care in the light of sexual and reproductive rights, focusing on delivery and birth care. The reflection shows that the pandemic has accentuated the violation of these rights, which is evidenced by racial inequalities in maternal mortality, as well as restrictions and interventions in childbirth care without scientific evidence, detour of resources, interruption of services, reduced human resources, shortage of medicine","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; Delivery, Obstetric; Female; Health Services Accessibility; Humans; Pandemics; Pregnancy; Reproductive Rights; SARS-CoV-2","Stofel","Natália Sevilha","Universidade Federal de São Carlos. São Carlos, São Paulo, Brazil",NA
"1269","34259724","10.1590/0034-7167-2020-1164","Women and COVID-19: reflections for a sexual and reproductive rights-based obstetric care.","This essay aims to reflect on the repercussions of the pandemic in obstetric care in the light of sexual and reproductive rights, focusing on delivery and birth care. The reflection shows that the pandemic has accentuated the violation of these rights, which is evidenced by racial inequalities in maternal mortality, as well as restrictions and interventions in childbirth care without scientific evidence, detour of resources, interruption of services, reduced human resources, shortage of medicine","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","COVID-19; Delivery, Obstetric; Female; Health Services Accessibility; Humans; Pandemics; Pregnancy; Reproductive Rights; SARS-CoV-2","Fabbro","Márcia Regina Cangiani","Universidade Federal de São Carlos. São Carlos, São Paulo, Brazil",NA
"1270","34259723","10.1590/0034-7167-2020-1049","Coronavirus infection and nursing care for children and adolescents with cancer.","Reflect on the implications of COVID-19 for the nursing care of pediatric oncology patients. Theoretical and reflective essay, based on recent scientific publications and expert recommendations on the care of pediatric patients under cancer treatment in the context of the current pandemic. Reflected on the involvement of the pediatric population in general by COVID-19, the vulnerability of pediatric oncology patients to the complications of the disease and the likely challenges for their care. T","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","Adolescent; COVID-19; Child; Humans; Neoplasms; Nursing Care; Pandemics; SARS-CoV-2","Silva-Rodrigues","Fernanda Machado","Santa Casa de São Paulo, Faculdade de Ciências Médicas. São Paulo, São Paulo, Brazil",NA
"1271","34259723","10.1590/0034-7167-2020-1049","Coronavirus infection and nursing care for children and adolescents with cancer.","Reflect on the implications of COVID-19 for the nursing care of pediatric oncology patients. Theoretical and reflective essay, based on recent scientific publications and expert recommendations on the care of pediatric patients under cancer treatment in the context of the current pandemic. Reflected on the involvement of the pediatric population in general by COVID-19, the vulnerability of pediatric oncology patients to the complications of the disease and the likely challenges for their care. T","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","Adolescent; COVID-19; Child; Humans; Neoplasms; Nursing Care; Pandemics; SARS-CoV-2","Silva","Jennifer Kamila da","Instituto de Oncologia Pediátrica, Grupo de Assistência ao Adolescente e à Criança com Câncer. São Paulo, São Paulo, Brazil",NA
"1272","34259723","10.1590/0034-7167-2020-1049","Coronavirus infection and nursing care for children and adolescents with cancer.","Reflect on the implications of COVID-19 for the nursing care of pediatric oncology patients. Theoretical and reflective essay, based on recent scientific publications and expert recommendations on the care of pediatric patients under cancer treatment in the context of the current pandemic. Reflected on the involvement of the pediatric population in general by COVID-19, the vulnerability of pediatric oncology patients to the complications of the disease and the likely challenges for their care. T","2021","07","16","Rev Bras Enferm","Revista brasileira de enfermagem","Adolescent; COVID-19; Child; Humans; Neoplasms; Nursing Care; Pandemics; SARS-CoV-2","Felix","Adriana Maria da Silva","Santa Casa de São Paulo, Faculdade de Ciências Médicas. São Paulo, São Paulo, Brazil",NA
"1273","34259712","10.1590/0102-311X00039221","[Age-adjusted COVID-19 mortality in state capitals in different regions of Brazil].","The sharp growth in COVID-19 cases and deaths has created a heavy overburden on Brazil's health system, especially in the cities of Manaus (Amazonas State), Rio de Janeiro, and São Paulo. The description of the pandemic's impact has been based on absolute numbers and crude mortality rates, failing to consider the age distribution patterns in different regions of the country. This study aims to compare the crude mortality rates from COVID-19 with age-standardized rates in the state capitals and F","2021","07","19","Cad Saude Publica","Cadernos de saude publica","Age Distribution; Aged; Aged, 80 and over; Brazil; COVID-19; Cities; Humans; Middle Aged; Mortality; SARS-CoV-2","Silva","Gulnar Azevedo E","Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brasil",NA
"1274","34259712","10.1590/0102-311X00039221","[Age-adjusted COVID-19 mortality in state capitals in different regions of Brazil].","The sharp growth in COVID-19 cases and deaths has created a heavy overburden on Brazil's health system, especially in the cities of Manaus (Amazonas State), Rio de Janeiro, and São Paulo. The description of the pandemic's impact has been based on absolute numbers and crude mortality rates, failing to consider the age distribution patterns in different regions of the country. This study aims to compare the crude mortality rates from COVID-19 with age-standardized rates in the state capitals and F","2021","07","19","Cad Saude Publica","Cadernos de saude publica","Age Distribution; Aged; Aged, 80 and over; Brazil; COVID-19; Cities; Humans; Middle Aged; Mortality; SARS-CoV-2","Jardim","Beatriz Cordeiro","Instituto Nacional de Câncer José Alencar Gomes da Silva, Rio de Janeiro, Brasil",NA
"1275","34259712","10.1590/0102-311X00039221","[Age-adjusted COVID-19 mortality in state capitals in different regions of Brazil].","The sharp growth in COVID-19 cases and deaths has created a heavy overburden on Brazil's health system, especially in the cities of Manaus (Amazonas State), Rio de Janeiro, and São Paulo. The description of the pandemic's impact has been based on absolute numbers and crude mortality rates, failing to consider the age distribution patterns in different regions of the country. This study aims to compare the crude mortality rates from COVID-19 with age-standardized rates in the state capitals and F","2021","07","19","Cad Saude Publica","Cadernos de saude publica","Age Distribution; Aged; Aged, 80 and over; Brazil; COVID-19; Cities; Humans; Middle Aged; Mortality; SARS-CoV-2","Lotufo","Paulo Andrade","Hospital Universitário, Universidade de São Paulo, São Paulo, Brasil",NA
"1276","34259669","10.1097/CCM.0000000000005206","The Role of the Long-Term Acute Care Hospital Following Critical Illness-Has the Coronavirus Disease 2019 Pandemic Demonstrated Their Usefulness or Emphasized Their Downside?",NA,"2021","07","16","Crit Care Med","Critical care medicine",NA,"Morgan","Paul","Critical Care Directorate, University Hospital of Wales, Cardiff, Wales, United Kingdom, Cardiff and Vale University Local Health Board, Heath Park, Cardiff, Wales, United Kingdom",NA
"1277","34259668","10.1097/CCM.0000000000005207","Quantifying the Burden of Viral Sepsis During the Coronavirus Disease 2019 Pandemic and Beyond.",NA,"2021","07","16","Crit Care Med","Critical care medicine",NA,"Shappell","Claire N","Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, MA",NA
"1278","34259668","10.1097/CCM.0000000000005207","Quantifying the Burden of Viral Sepsis During the Coronavirus Disease 2019 Pandemic and Beyond.",NA,"2021","07","16","Crit Care Med","Critical care medicine",NA,"Klompas","Michael","Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, MA",NA
"1279","34259668","10.1097/CCM.0000000000005207","Quantifying the Burden of Viral Sepsis During the Coronavirus Disease 2019 Pandemic and Beyond.",NA,"2021","07","16","Crit Care Med","Critical care medicine",NA,"Rhee","Chanu","Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, MA",NA
"1280","34259667","10.1097/CCM.0000000000005185","Trends in ICU Mortality From Coronavirus Disease 2019: A Tale of Three Surges.","To determine the association between time period of hospitalization and hospital mortality among critically ill adults with coronavirus disease 2019. Observational cohort study from March 6, 2020, to January 31, 2021. ICUs at four hospitals within an academic health center network in Atlanta, GA. Adults greater than or equal to 18 years with coronavirus disease 2019 admitted to an ICU during the study period (i.e., Surge 1: March to April, Lull 1: May to June, Surge 2: July to August, Lull 2: Se","2021","07","16","Crit Care Med","Critical care medicine",NA,"Auld","Sara C","Emory Critical Care Center (ECCC), Atlanta, GA. Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA. Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA. Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA. Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA. Georgia Clinical and Translational Science Alliance (CTSA), Atlanta, GA. Office of Quality and Risk, Emory Healthcare, Atlanta, GA. Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA. Department of Surgery, Emory University School of Medicine, Atlanta, GA",NA
"1281","34259667","10.1097/CCM.0000000000005185","Trends in ICU Mortality From Coronavirus Disease 2019: A Tale of Three Surges.","To determine the association between time period of hospitalization and hospital mortality among critically ill adults with coronavirus disease 2019. Observational cohort study from March 6, 2020, to January 31, 2021. ICUs at four hospitals within an academic health center network in Atlanta, GA. Adults greater than or equal to 18 years with coronavirus disease 2019 admitted to an ICU during the study period (i.e., Surge 1: March to April, Lull 1: May to June, Surge 2: July to August, Lull 2: Se","2021","07","16","Crit Care Med","Critical care medicine",NA,"Harrington","Kristin R V","Emory Critical Care Center (ECCC), Atlanta, GA. Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA. Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA. Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA. Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA. Georgia Clinical and Translational Science Alliance (CTSA), Atlanta, GA. Office of Quality and Risk, Emory Healthcare, Atlanta, GA. Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA. Department of Surgery, Emory University School of Medicine, Atlanta, GA",NA
"1282","34259667","10.1097/CCM.0000000000005185","Trends in ICU Mortality From Coronavirus Disease 2019: A Tale of Three Surges.","To determine the association between time period of hospitalization and hospital mortality among critically ill adults with coronavirus disease 2019. Observational cohort study from March 6, 2020, to January 31, 2021. ICUs at four hospitals within an academic health center network in Atlanta, GA. Adults greater than or equal to 18 years with coronavirus disease 2019 admitted to an ICU during the study period (i.e., Surge 1: March to April, Lull 1: May to June, Surge 2: July to August, Lull 2: Se","2021","07","16","Crit Care Med","Critical care medicine",NA,"Adelman","Max W","Emory Critical Care Center (ECCC), Atlanta, GA. Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA. Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA. Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA. Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA. Georgia Clinical and Translational Science Alliance (CTSA), Atlanta, GA. Office of Quality and Risk, Emory Healthcare, Atlanta, GA. Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA. Department of Surgery, Emory University School of Medicine, Atlanta, GA",NA
"1283","34259667","10.1097/CCM.0000000000005185","Trends in ICU Mortality From Coronavirus Disease 2019: A Tale of Three Surges.","To determine the association between time period of hospitalization and hospital mortality among critically ill adults with coronavirus disease 2019. Observational cohort study from March 6, 2020, to January 31, 2021. ICUs at four hospitals within an academic health center network in Atlanta, GA. Adults greater than or equal to 18 years with coronavirus disease 2019 admitted to an ICU during the study period (i.e., Surge 1: March to April, Lull 1: May to June, Surge 2: July to August, Lull 2: Se","2021","07","16","Crit Care Med","Critical care medicine",NA,"Robichaux","Chad J","Emory Critical Care Center (ECCC), Atlanta, GA. Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA. Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA. Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA. Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA. Georgia Clinical and Translational Science Alliance (CTSA), Atlanta, GA. Office of Quality and Risk, Emory Healthcare, Atlanta, GA. Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA. Department of Surgery, Emory University School of Medicine, Atlanta, GA",NA
"1284","34259667","10.1097/CCM.0000000000005185","Trends in ICU Mortality From Coronavirus Disease 2019: A Tale of Three Surges.","To determine the association between time period of hospitalization and hospital mortality among critically ill adults with coronavirus disease 2019. Observational cohort study from March 6, 2020, to January 31, 2021. ICUs at four hospitals within an academic health center network in Atlanta, GA. Adults greater than or equal to 18 years with coronavirus disease 2019 admitted to an ICU during the study period (i.e., Surge 1: March to April, Lull 1: May to June, Surge 2: July to August, Lull 2: Se","2021","07","16","Crit Care Med","Critical care medicine",NA,"Overton","Elizabeth C","Emory Critical Care Center (ECCC), Atlanta, GA. Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA. Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA. Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA. Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA. Georgia Clinical and Translational Science Alliance (CTSA), Atlanta, GA. Office of Quality and Risk, Emory Healthcare, Atlanta, GA. Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA. Department of Surgery, Emory University School of Medicine, Atlanta, GA",NA
"1285","34259667","10.1097/CCM.0000000000005185","Trends in ICU Mortality From Coronavirus Disease 2019: A Tale of Three Surges.","To determine the association between time period of hospitalization and hospital mortality among critically ill adults with coronavirus disease 2019. Observational cohort study from March 6, 2020, to January 31, 2021. ICUs at four hospitals within an academic health center network in Atlanta, GA. Adults greater than or equal to 18 years with coronavirus disease 2019 admitted to an ICU during the study period (i.e., Surge 1: March to April, Lull 1: May to June, Surge 2: July to August, Lull 2: Se","2021","07","16","Crit Care Med","Critical care medicine",NA,"Caridi-Scheible","Mark","Emory Critical Care Center (ECCC), Atlanta, GA. Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA. Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA. Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA. Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA. Georgia Clinical and Translational Science Alliance (CTSA), Atlanta, GA. Office of Quality and Risk, Emory Healthcare, Atlanta, GA. Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA. Department of Surgery, Emory University School of Medicine, Atlanta, GA",NA
"1286","34259667","10.1097/CCM.0000000000005185","Trends in ICU Mortality From Coronavirus Disease 2019: A Tale of Three Surges.","To determine the association between time period of hospitalization and hospital mortality among critically ill adults with coronavirus disease 2019. Observational cohort study from March 6, 2020, to January 31, 2021. ICUs at four hospitals within an academic health center network in Atlanta, GA. Adults greater than or equal to 18 years with coronavirus disease 2019 admitted to an ICU during the study period (i.e., Surge 1: March to April, Lull 1: May to June, Surge 2: July to August, Lull 2: Se","2021","07","16","Crit Care Med","Critical care medicine",NA,"Coopersmith","Craig M","Emory Critical Care Center (ECCC), Atlanta, GA. Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA. Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA. Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA. Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA. Georgia Clinical and Translational Science Alliance (CTSA), Atlanta, GA. Office of Quality and Risk, Emory Healthcare, Atlanta, GA. Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA. Department of Surgery, Emory University School of Medicine, Atlanta, GA",NA
"1287","34259667","10.1097/CCM.0000000000005185","Trends in ICU Mortality From Coronavirus Disease 2019: A Tale of Three Surges.","To determine the association between time period of hospitalization and hospital mortality among critically ill adults with coronavirus disease 2019. Observational cohort study from March 6, 2020, to January 31, 2021. ICUs at four hospitals within an academic health center network in Atlanta, GA. Adults greater than or equal to 18 years with coronavirus disease 2019 admitted to an ICU during the study period (i.e., Surge 1: March to April, Lull 1: May to June, Surge 2: July to August, Lull 2: Se","2021","07","16","Crit Care Med","Critical care medicine",NA,"Murphy","David J","Emory Critical Care Center (ECCC), Atlanta, GA. Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA. Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA. Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA. Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA. Georgia Clinical and Translational Science Alliance (CTSA), Atlanta, GA. Office of Quality and Risk, Emory Healthcare, Atlanta, GA. Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA. Department of Surgery, Emory University School of Medicine, Atlanta, GA",NA
"1288","34259665","10.1097/CCM.0000000000005200","The Impact of Strict Public Health Restrictions on Pediatric Critical Illness.","To characterize the impact of public health interventions on the volume and characteristics of admissions to the PICU. Multicenter retrospective cohort study. Six U.S. referral PICUs during February 15, 2020-May 14, 2020, compared with the same months during 2017-2019 (baseline). PICU admissions excluding admissions for illnesses due to severe acute respiratory syndrome coronavirus 2 and readmissions during the same hospitalization. None. Primary outcome was admission volumes during the period o","2021","07","16","Crit Care Med","Critical care medicine",NA,"Maddux","Aline B","Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO. Section of Pediatric Critical Care Medicine, Children's Hospital Colorado, Aurora, CO. Department of Anesthesiology, Section of Pediatric Critical Care Medicine, Wake Forest School of Medicine, Winston Salem, NC. Nationwide Children's Hospital, Columbus, OH. Department of Pediatrics, Section of Pediatric Critical Care Medicine, The Ohio State University College of Medicine, Columbus, OH. Baylor College of Medicine, Houston, TX. Texas Children's Hospital, Houston, TX. Division of Pediatric Critical Care Medicine, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL. Ann &amp",NA
"1289","34259665","10.1097/CCM.0000000000005200","The Impact of Strict Public Health Restrictions on Pediatric Critical Illness.","To characterize the impact of public health interventions on the volume and characteristics of admissions to the PICU. Multicenter retrospective cohort study. Six U.S. referral PICUs during February 15, 2020-May 14, 2020, compared with the same months during 2017-2019 (baseline). PICU admissions excluding admissions for illnesses due to severe acute respiratory syndrome coronavirus 2 and readmissions during the same hospitalization. None. Primary outcome was admission volumes during the period o","2021","07","16","Crit Care Med","Critical care medicine",NA,"Campbell","Kristen","Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO. Section of Pediatric Critical Care Medicine, Children's Hospital Colorado, Aurora, CO. Department of Anesthesiology, Section of Pediatric Critical Care Medicine, Wake Forest School of Medicine, Winston Salem, NC. Nationwide Children's Hospital, Columbus, OH. Department of Pediatrics, Section of Pediatric Critical Care Medicine, The Ohio State University College of Medicine, Columbus, OH. Baylor College of Medicine, Houston, TX. Texas Children's Hospital, Houston, TX. Division of Pediatric Critical Care Medicine, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL. Ann &amp",NA
"1290","34259665","10.1097/CCM.0000000000005200","The Impact of Strict Public Health Restrictions on Pediatric Critical Illness.","To characterize the impact of public health interventions on the volume and characteristics of admissions to the PICU. Multicenter retrospective cohort study. Six U.S. referral PICUs during February 15, 2020-May 14, 2020, compared with the same months during 2017-2019 (baseline). PICU admissions excluding admissions for illnesses due to severe acute respiratory syndrome coronavirus 2 and readmissions during the same hospitalization. None. Primary outcome was admission volumes during the period o","2021","07","16","Crit Care Med","Critical care medicine",NA,"Woodruff","Alan G","Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO. Section of Pediatric Critical Care Medicine, Children's Hospital Colorado, Aurora, CO. Department of Anesthesiology, Section of Pediatric Critical Care Medicine, Wake Forest School of Medicine, Winston Salem, NC. Nationwide Children's Hospital, Columbus, OH. Department of Pediatrics, Section of Pediatric Critical Care Medicine, The Ohio State University College of Medicine, Columbus, OH. Baylor College of Medicine, Houston, TX. Texas Children's Hospital, Houston, TX. Division of Pediatric Critical Care Medicine, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL. Ann &amp",NA
"1291","34259665","10.1097/CCM.0000000000005200","The Impact of Strict Public Health Restrictions on Pediatric Critical Illness.","To characterize the impact of public health interventions on the volume and characteristics of admissions to the PICU. Multicenter retrospective cohort study. Six U.S. referral PICUs during February 15, 2020-May 14, 2020, compared with the same months during 2017-2019 (baseline). PICU admissions excluding admissions for illnesses due to severe acute respiratory syndrome coronavirus 2 and readmissions during the same hospitalization. None. Primary outcome was admission volumes during the period o","2021","07","16","Crit Care Med","Critical care medicine",NA,"LaVelle","Jaime","Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO. Section of Pediatric Critical Care Medicine, Children's Hospital Colorado, Aurora, CO. Department of Anesthesiology, Section of Pediatric Critical Care Medicine, Wake Forest School of Medicine, Winston Salem, NC. Nationwide Children's Hospital, Columbus, OH. Department of Pediatrics, Section of Pediatric Critical Care Medicine, The Ohio State University College of Medicine, Columbus, OH. Baylor College of Medicine, Houston, TX. Texas Children's Hospital, Houston, TX. Division of Pediatric Critical Care Medicine, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL. Ann &amp",NA
"1292","34259665","10.1097/CCM.0000000000005200","The Impact of Strict Public Health Restrictions on Pediatric Critical Illness.","To characterize the impact of public health interventions on the volume and characteristics of admissions to the PICU. Multicenter retrospective cohort study. Six U.S. referral PICUs during February 15, 2020-May 14, 2020, compared with the same months during 2017-2019 (baseline). PICU admissions excluding admissions for illnesses due to severe acute respiratory syndrome coronavirus 2 and readmissions during the same hospitalization. None. Primary outcome was admission volumes during the period o","2021","07","16","Crit Care Med","Critical care medicine",NA,"Lutmer","Jeffrey","Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO. Section of Pediatric Critical Care Medicine, Children's Hospital Colorado, Aurora, CO. Department of Anesthesiology, Section of Pediatric Critical Care Medicine, Wake Forest School of Medicine, Winston Salem, NC. Nationwide Children's Hospital, Columbus, OH. Department of Pediatrics, Section of Pediatric Critical Care Medicine, The Ohio State University College of Medicine, Columbus, OH. Baylor College of Medicine, Houston, TX. Texas Children's Hospital, Houston, TX. Division of Pediatric Critical Care Medicine, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL. Ann &amp",NA
"1293","34259665","10.1097/CCM.0000000000005200","The Impact of Strict Public Health Restrictions on Pediatric Critical Illness.","To characterize the impact of public health interventions on the volume and characteristics of admissions to the PICU. Multicenter retrospective cohort study. Six U.S. referral PICUs during February 15, 2020-May 14, 2020, compared with the same months during 2017-2019 (baseline). PICU admissions excluding admissions for illnesses due to severe acute respiratory syndrome coronavirus 2 and readmissions during the same hospitalization. None. Primary outcome was admission volumes during the period o","2021","07","16","Crit Care Med","Critical care medicine",NA,"Kennedy","Curt E","Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO. Section of Pediatric Critical Care Medicine, Children's Hospital Colorado, Aurora, CO. Department of Anesthesiology, Section of Pediatric Critical Care Medicine, Wake Forest School of Medicine, Winston Salem, NC. Nationwide Children's Hospital, Columbus, OH. Department of Pediatrics, Section of Pediatric Critical Care Medicine, The Ohio State University College of Medicine, Columbus, OH. Baylor College of Medicine, Houston, TX. Texas Children's Hospital, Houston, TX. Division of Pediatric Critical Care Medicine, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL. Ann &amp",NA
"1294","34259665","10.1097/CCM.0000000000005200","The Impact of Strict Public Health Restrictions on Pediatric Critical Illness.","To characterize the impact of public health interventions on the volume and characteristics of admissions to the PICU. Multicenter retrospective cohort study. Six U.S. referral PICUs during February 15, 2020-May 14, 2020, compared with the same months during 2017-2019 (baseline). PICU admissions excluding admissions for illnesses due to severe acute respiratory syndrome coronavirus 2 and readmissions during the same hospitalization. None. Primary outcome was admission volumes during the period o","2021","07","16","Crit Care Med","Critical care medicine",NA,"Malakooti","Marcelo","Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO. Section of Pediatric Critical Care Medicine, Children's Hospital Colorado, Aurora, CO. Department of Anesthesiology, Section of Pediatric Critical Care Medicine, Wake Forest School of Medicine, Winston Salem, NC. Nationwide Children's Hospital, Columbus, OH. Department of Pediatrics, Section of Pediatric Critical Care Medicine, The Ohio State University College of Medicine, Columbus, OH. Baylor College of Medicine, Houston, TX. Texas Children's Hospital, Houston, TX. Division of Pediatric Critical Care Medicine, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL. Ann &amp",NA
"1295","34259665","10.1097/CCM.0000000000005200","The Impact of Strict Public Health Restrictions on Pediatric Critical Illness.","To characterize the impact of public health interventions on the volume and characteristics of admissions to the PICU. Multicenter retrospective cohort study. Six U.S. referral PICUs during February 15, 2020-May 14, 2020, compared with the same months during 2017-2019 (baseline). PICU admissions excluding admissions for illnesses due to severe acute respiratory syndrome coronavirus 2 and readmissions during the same hospitalization. None. Primary outcome was admission volumes during the period o","2021","07","16","Crit Care Med","Critical care medicine",NA,"McGuire","John K","Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO. Section of Pediatric Critical Care Medicine, Children's Hospital Colorado, Aurora, CO. Department of Anesthesiology, Section of Pediatric Critical Care Medicine, Wake Forest School of Medicine, Winston Salem, NC. Nationwide Children's Hospital, Columbus, OH. Department of Pediatrics, Section of Pediatric Critical Care Medicine, The Ohio State University College of Medicine, Columbus, OH. Baylor College of Medicine, Houston, TX. Texas Children's Hospital, Houston, TX. Division of Pediatric Critical Care Medicine, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL. Ann &amp",NA
"1296","34259665","10.1097/CCM.0000000000005200","The Impact of Strict Public Health Restrictions on Pediatric Critical Illness.","To characterize the impact of public health interventions on the volume and characteristics of admissions to the PICU. Multicenter retrospective cohort study. Six U.S. referral PICUs during February 15, 2020-May 14, 2020, compared with the same months during 2017-2019 (baseline). PICU admissions excluding admissions for illnesses due to severe acute respiratory syndrome coronavirus 2 and readmissions during the same hospitalization. None. Primary outcome was admission volumes during the period o","2021","07","16","Crit Care Med","Critical care medicine",NA,"Shekerdemian","Lara","Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO. Section of Pediatric Critical Care Medicine, Children's Hospital Colorado, Aurora, CO. Department of Anesthesiology, Section of Pediatric Critical Care Medicine, Wake Forest School of Medicine, Winston Salem, NC. Nationwide Children's Hospital, Columbus, OH. Department of Pediatrics, Section of Pediatric Critical Care Medicine, The Ohio State University College of Medicine, Columbus, OH. Baylor College of Medicine, Houston, TX. Texas Children's Hospital, Houston, TX. Division of Pediatric Critical Care Medicine, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL. Ann &amp",NA
"1297","34259665","10.1097/CCM.0000000000005200","The Impact of Strict Public Health Restrictions on Pediatric Critical Illness.","To characterize the impact of public health interventions on the volume and characteristics of admissions to the PICU. Multicenter retrospective cohort study. Six U.S. referral PICUs during February 15, 2020-May 14, 2020, compared with the same months during 2017-2019 (baseline). PICU admissions excluding admissions for illnesses due to severe acute respiratory syndrome coronavirus 2 and readmissions during the same hospitalization. None. Primary outcome was admission volumes during the period o","2021","07","16","Crit Care Med","Critical care medicine",NA,"Harris","Z Leah","Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO. Section of Pediatric Critical Care Medicine, Children's Hospital Colorado, Aurora, CO. Department of Anesthesiology, Section of Pediatric Critical Care Medicine, Wake Forest School of Medicine, Winston Salem, NC. Nationwide Children's Hospital, Columbus, OH. Department of Pediatrics, Section of Pediatric Critical Care Medicine, The Ohio State University College of Medicine, Columbus, OH. Baylor College of Medicine, Houston, TX. Texas Children's Hospital, Houston, TX. Division of Pediatric Critical Care Medicine, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL. Ann &amp",NA
"1298","34259665","10.1097/CCM.0000000000005200","The Impact of Strict Public Health Restrictions on Pediatric Critical Illness.","To characterize the impact of public health interventions on the volume and characteristics of admissions to the PICU. Multicenter retrospective cohort study. Six U.S. referral PICUs during February 15, 2020-May 14, 2020, compared with the same months during 2017-2019 (baseline). PICU admissions excluding admissions for illnesses due to severe acute respiratory syndrome coronavirus 2 and readmissions during the same hospitalization. None. Primary outcome was admission volumes during the period o","2021","07","16","Crit Care Med","Critical care medicine",NA,"McCrory","Michael C","Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO. Section of Pediatric Critical Care Medicine, Children's Hospital Colorado, Aurora, CO. Department of Anesthesiology, Section of Pediatric Critical Care Medicine, Wake Forest School of Medicine, Winston Salem, NC. Nationwide Children's Hospital, Columbus, OH. Department of Pediatrics, Section of Pediatric Critical Care Medicine, The Ohio State University College of Medicine, Columbus, OH. Baylor College of Medicine, Houston, TX. Texas Children's Hospital, Houston, TX. Division of Pediatric Critical Care Medicine, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL. Ann &amp",NA
"1299","34259665","10.1097/CCM.0000000000005200","The Impact of Strict Public Health Restrictions on Pediatric Critical Illness.","To characterize the impact of public health interventions on the volume and characteristics of admissions to the PICU. Multicenter retrospective cohort study. Six U.S. referral PICUs during February 15, 2020-May 14, 2020, compared with the same months during 2017-2019 (baseline). PICU admissions excluding admissions for illnesses due to severe acute respiratory syndrome coronavirus 2 and readmissions during the same hospitalization. None. Primary outcome was admission volumes during the period o","2021","07","16","Crit Care Med","Critical care medicine",NA,"Carpenter","Todd C","Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO. Section of Pediatric Critical Care Medicine, Children's Hospital Colorado, Aurora, CO. Department of Anesthesiology, Section of Pediatric Critical Care Medicine, Wake Forest School of Medicine, Winston Salem, NC. Nationwide Children's Hospital, Columbus, OH. Department of Pediatrics, Section of Pediatric Critical Care Medicine, The Ohio State University College of Medicine, Columbus, OH. Baylor College of Medicine, Houston, TX. Texas Children's Hospital, Houston, TX. Division of Pediatric Critical Care Medicine, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL. Ann &amp",NA
"1300","34259663","10.1097/CCM.0000000000005195","Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis.","Coronavirus disease 2019 is a heterogeneous disease most frequently causing respiratory tract infection, which can induce respiratory failure and multiple organ dysfunction syndrome in its severe forms. The prevalence of coronavirus disease 2019-related sepsis is still unclear; we aimed to describe this in a systematic review. MEDLINE (PubMed), Cochrane, and Google Scholar databases were searched based on a prespecified protocol (International Prospective Register for Systematic Reviews: CRD4202","2021","07","16","Crit Care Med","Critical care medicine",NA,"Karakike","Eleni","th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece. Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany. Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany. Department of Internal Medicine and Center for Infectious Diseases, Radboud University, Nijmegen, The Netherlands. Department of Immunology and Metabolism, Life &amp",NA
"1301","34259663","10.1097/CCM.0000000000005195","Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis.","Coronavirus disease 2019 is a heterogeneous disease most frequently causing respiratory tract infection, which can induce respiratory failure and multiple organ dysfunction syndrome in its severe forms. The prevalence of coronavirus disease 2019-related sepsis is still unclear; we aimed to describe this in a systematic review. MEDLINE (PubMed), Cochrane, and Google Scholar databases were searched based on a prespecified protocol (International Prospective Register for Systematic Reviews: CRD4202","2021","07","16","Crit Care Med","Critical care medicine",NA,"Giamarellos-Bourboulis","Evangelos J","th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece. Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany. Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany. Department of Internal Medicine and Center for Infectious Diseases, Radboud University, Nijmegen, The Netherlands. Department of Immunology and Metabolism, Life &amp",NA
"1302","34259663","10.1097/CCM.0000000000005195","Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis.","Coronavirus disease 2019 is a heterogeneous disease most frequently causing respiratory tract infection, which can induce respiratory failure and multiple organ dysfunction syndrome in its severe forms. The prevalence of coronavirus disease 2019-related sepsis is still unclear; we aimed to describe this in a systematic review. MEDLINE (PubMed), Cochrane, and Google Scholar databases were searched based on a prespecified protocol (International Prospective Register for Systematic Reviews: CRD4202","2021","07","16","Crit Care Med","Critical care medicine",NA,"Kyprianou","Miltiades","th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece. Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany. Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany. Department of Internal Medicine and Center for Infectious Diseases, Radboud University, Nijmegen, The Netherlands. Department of Immunology and Metabolism, Life &amp",NA
"1303","34259663","10.1097/CCM.0000000000005195","Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis.","Coronavirus disease 2019 is a heterogeneous disease most frequently causing respiratory tract infection, which can induce respiratory failure and multiple organ dysfunction syndrome in its severe forms. The prevalence of coronavirus disease 2019-related sepsis is still unclear; we aimed to describe this in a systematic review. MEDLINE (PubMed), Cochrane, and Google Scholar databases were searched based on a prespecified protocol (International Prospective Register for Systematic Reviews: CRD4202","2021","07","16","Crit Care Med","Critical care medicine",NA,"Fleischmann-Struzek","Carolin","th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece. Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany. Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany. Department of Internal Medicine and Center for Infectious Diseases, Radboud University, Nijmegen, The Netherlands. Department of Immunology and Metabolism, Life &amp",NA
"1304","34259663","10.1097/CCM.0000000000005195","Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis.","Coronavirus disease 2019 is a heterogeneous disease most frequently causing respiratory tract infection, which can induce respiratory failure and multiple organ dysfunction syndrome in its severe forms. The prevalence of coronavirus disease 2019-related sepsis is still unclear; we aimed to describe this in a systematic review. MEDLINE (PubMed), Cochrane, and Google Scholar databases were searched based on a prespecified protocol (International Prospective Register for Systematic Reviews: CRD4202","2021","07","16","Crit Care Med","Critical care medicine",NA,"Pletz","Mathias W","th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece. Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany. Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany. Department of Internal Medicine and Center for Infectious Diseases, Radboud University, Nijmegen, The Netherlands. Department of Immunology and Metabolism, Life &amp",NA
"1305","34259663","10.1097/CCM.0000000000005195","Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis.","Coronavirus disease 2019 is a heterogeneous disease most frequently causing respiratory tract infection, which can induce respiratory failure and multiple organ dysfunction syndrome in its severe forms. The prevalence of coronavirus disease 2019-related sepsis is still unclear; we aimed to describe this in a systematic review. MEDLINE (PubMed), Cochrane, and Google Scholar databases were searched based on a prespecified protocol (International Prospective Register for Systematic Reviews: CRD4202","2021","07","16","Crit Care Med","Critical care medicine",NA,"Netea","Mihai G","th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece. Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany. Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany. Department of Internal Medicine and Center for Infectious Diseases, Radboud University, Nijmegen, The Netherlands. Department of Immunology and Metabolism, Life &amp",NA
"1306","34259663","10.1097/CCM.0000000000005195","Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis.","Coronavirus disease 2019 is a heterogeneous disease most frequently causing respiratory tract infection, which can induce respiratory failure and multiple organ dysfunction syndrome in its severe forms. The prevalence of coronavirus disease 2019-related sepsis is still unclear; we aimed to describe this in a systematic review. MEDLINE (PubMed), Cochrane, and Google Scholar databases were searched based on a prespecified protocol (International Prospective Register for Systematic Reviews: CRD4202","2021","07","16","Crit Care Med","Critical care medicine",NA,"Reinhart","Konrad","th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece. Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany. Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany. Department of Internal Medicine and Center for Infectious Diseases, Radboud University, Nijmegen, The Netherlands. Department of Immunology and Metabolism, Life &amp",NA
"1307","34259663","10.1097/CCM.0000000000005195","Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis.","Coronavirus disease 2019 is a heterogeneous disease most frequently causing respiratory tract infection, which can induce respiratory failure and multiple organ dysfunction syndrome in its severe forms. The prevalence of coronavirus disease 2019-related sepsis is still unclear; we aimed to describe this in a systematic review. MEDLINE (PubMed), Cochrane, and Google Scholar databases were searched based on a prespecified protocol (International Prospective Register for Systematic Reviews: CRD4202","2021","07","16","Crit Care Med","Critical care medicine",NA,"Kyriazopoulou","Evdoxia","th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece. Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany. Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany. Department of Internal Medicine and Center for Infectious Diseases, Radboud University, Nijmegen, The Netherlands. Department of Immunology and Metabolism, Life &amp",NA
"1308","34259661","10.1097/CCM.0000000000005211","Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia.","Vaccine-induced immune thrombotic thrombocytopenia is an unexpected consequence of the coronavirus disease 2019 pandemic era. We reviewed the pathogenesis, clinical presentation, diagnosis, and treatment of this rare side effect. Online search of published medical literature through PubMed, Scopus, Web of Science, and Google Scholar using the terms ""COVID-19,"" ""vaccine,"" ""thrombosis"" was performed. Articles were chosen for inclusion based on their relevance to coronavirus disease 2019, vaccine, ","2021","07","16","Crit Care Med","Critical care medicine",NA,"Iba","Toshiaki","Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. Department of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, NC. Department of Pathology and Molecular Medicine, and Department of Medicine, McMaster University, Hamilton, ON, Canada",NA
"1309","34259661","10.1097/CCM.0000000000005211","Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia.","Vaccine-induced immune thrombotic thrombocytopenia is an unexpected consequence of the coronavirus disease 2019 pandemic era. We reviewed the pathogenesis, clinical presentation, diagnosis, and treatment of this rare side effect. Online search of published medical literature through PubMed, Scopus, Web of Science, and Google Scholar using the terms ""COVID-19,"" ""vaccine,"" ""thrombosis"" was performed. Articles were chosen for inclusion based on their relevance to coronavirus disease 2019, vaccine, ","2021","07","16","Crit Care Med","Critical care medicine",NA,"Levy","Jerrold H","Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. Department of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, NC. Department of Pathology and Molecular Medicine, and Department of Medicine, McMaster University, Hamilton, ON, Canada",NA
"1310","34259661","10.1097/CCM.0000000000005211","Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia.","Vaccine-induced immune thrombotic thrombocytopenia is an unexpected consequence of the coronavirus disease 2019 pandemic era. We reviewed the pathogenesis, clinical presentation, diagnosis, and treatment of this rare side effect. Online search of published medical literature through PubMed, Scopus, Web of Science, and Google Scholar using the terms ""COVID-19,"" ""vaccine,"" ""thrombosis"" was performed. Articles were chosen for inclusion based on their relevance to coronavirus disease 2019, vaccine, ","2021","07","16","Crit Care Med","Critical care medicine",NA,"Warkentin","Theodore E","Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. Department of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, NC. Department of Pathology and Molecular Medicine, and Department of Medicine, McMaster University, Hamilton, ON, Canada",NA
"1311","34259660","10.1097/CCM.0000000000005184","Trends in 28-Day Mortality of Critical Care Patients With Coronavirus Disease 2019 in United Kingdom: A National Cohort Study, March 2020 to January 2021.","To determine whether the previously described trend of improving mortality in people with coronavirus disease 2019 in critical care during the first wave was maintained, plateaued, or reversed during the second wave in United Kingdom, when B117 became the dominant strain. National retrospective cohort study. All English hospital trusts (i.e., groups of hospitals functioning as single operational units), reporting critical care admissions (high dependency unit and ICU) to the Coronavirus Disease ","2021","07","16","Crit Care Med","Critical care medicine",NA,"Dennis","John M","University of Exeter Medical School, Institute of Biomedical &amp",NA
"1312","34259660","10.1097/CCM.0000000000005184","Trends in 28-Day Mortality of Critical Care Patients With Coronavirus Disease 2019 in United Kingdom: A National Cohort Study, March 2020 to January 2021.","To determine whether the previously described trend of improving mortality in people with coronavirus disease 2019 in critical care during the first wave was maintained, plateaued, or reversed during the second wave in United Kingdom, when B117 became the dominant strain. National retrospective cohort study. All English hospital trusts (i.e., groups of hospitals functioning as single operational units), reporting critical care admissions (high dependency unit and ICU) to the Coronavirus Disease ","2021","07","16","Crit Care Med","Critical care medicine",NA,"McGovern","Andrew P","University of Exeter Medical School, Institute of Biomedical &amp",NA
"1313","34259660","10.1097/CCM.0000000000005184","Trends in 28-Day Mortality of Critical Care Patients With Coronavirus Disease 2019 in United Kingdom: A National Cohort Study, March 2020 to January 2021.","To determine whether the previously described trend of improving mortality in people with coronavirus disease 2019 in critical care during the first wave was maintained, plateaued, or reversed during the second wave in United Kingdom, when B117 became the dominant strain. National retrospective cohort study. All English hospital trusts (i.e., groups of hospitals functioning as single operational units), reporting critical care admissions (high dependency unit and ICU) to the Coronavirus Disease ","2021","07","16","Crit Care Med","Critical care medicine",NA,"Thomas","Nicholas J","University of Exeter Medical School, Institute of Biomedical &amp",NA
"1314","34259660","10.1097/CCM.0000000000005184","Trends in 28-Day Mortality of Critical Care Patients With Coronavirus Disease 2019 in United Kingdom: A National Cohort Study, March 2020 to January 2021.","To determine whether the previously described trend of improving mortality in people with coronavirus disease 2019 in critical care during the first wave was maintained, plateaued, or reversed during the second wave in United Kingdom, when B117 became the dominant strain. National retrospective cohort study. All English hospital trusts (i.e., groups of hospitals functioning as single operational units), reporting critical care admissions (high dependency unit and ICU) to the Coronavirus Disease ","2021","07","16","Crit Care Med","Critical care medicine",NA,"Wilde","Harrison","University of Exeter Medical School, Institute of Biomedical &amp",NA
"1315","34259660","10.1097/CCM.0000000000005184","Trends in 28-Day Mortality of Critical Care Patients With Coronavirus Disease 2019 in United Kingdom: A National Cohort Study, March 2020 to January 2021.","To determine whether the previously described trend of improving mortality in people with coronavirus disease 2019 in critical care during the first wave was maintained, plateaued, or reversed during the second wave in United Kingdom, when B117 became the dominant strain. National retrospective cohort study. All English hospital trusts (i.e., groups of hospitals functioning as single operational units), reporting critical care admissions (high dependency unit and ICU) to the Coronavirus Disease ","2021","07","16","Crit Care Med","Critical care medicine",NA,"Vollmer","Sebastian J","University of Exeter Medical School, Institute of Biomedical &amp",NA
"1316","34259660","10.1097/CCM.0000000000005184","Trends in 28-Day Mortality of Critical Care Patients With Coronavirus Disease 2019 in United Kingdom: A National Cohort Study, March 2020 to January 2021.","To determine whether the previously described trend of improving mortality in people with coronavirus disease 2019 in critical care during the first wave was maintained, plateaued, or reversed during the second wave in United Kingdom, when B117 became the dominant strain. National retrospective cohort study. All English hospital trusts (i.e., groups of hospitals functioning as single operational units), reporting critical care admissions (high dependency unit and ICU) to the Coronavirus Disease ","2021","07","16","Crit Care Med","Critical care medicine",NA,"Mateen","Bilal A","University of Exeter Medical School, Institute of Biomedical &amp",NA
"1317","34259641","10.2196/27982","Age and Social Disparities in the Use of Telemedicine During the COVID-19 Pandemic in Japan: Cross-sectional Study.","The use of telemedicine outpatient visits has increased dramatically during the COVID-19 pandemic in many countries. Although disparities in access to telemedicine by age and socioeconomic status (SES) have been well-documented, evidence is limited as to how these disparities changed during the COVID-19 pandemic. Moreover, the equity of patient access to telemedicine has been scarcely reported in Japan, despite the huge potential for telemedicine expansion. We aimed to investigate changes due to","2021","07","23","J Med Internet Res","Journal of medical Internet research","COVID-19; Japan; access to care; disparity; telehealth; telemedicine","Miyawaki","Atsushi","Department of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan",NA
"1318","34259641","10.2196/27982","Age and Social Disparities in the Use of Telemedicine During the COVID-19 Pandemic in Japan: Cross-sectional Study.","The use of telemedicine outpatient visits has increased dramatically during the COVID-19 pandemic in many countries. Although disparities in access to telemedicine by age and socioeconomic status (SES) have been well-documented, evidence is limited as to how these disparities changed during the COVID-19 pandemic. Moreover, the equity of patient access to telemedicine has been scarcely reported in Japan, despite the huge potential for telemedicine expansion. We aimed to investigate changes due to","2021","07","23","J Med Internet Res","Journal of medical Internet research","COVID-19; Japan; access to care; disparity; telehealth; telemedicine","Tabuchi","Takahiro","Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan",NA
"1319","34259641","10.2196/27982","Age and Social Disparities in the Use of Telemedicine During the COVID-19 Pandemic in Japan: Cross-sectional Study.","The use of telemedicine outpatient visits has increased dramatically during the COVID-19 pandemic in many countries. Although disparities in access to telemedicine by age and socioeconomic status (SES) have been well-documented, evidence is limited as to how these disparities changed during the COVID-19 pandemic. Moreover, the equity of patient access to telemedicine has been scarcely reported in Japan, despite the huge potential for telemedicine expansion. We aimed to investigate changes due to","2021","07","23","J Med Internet Res","Journal of medical Internet research","COVID-19; Japan; access to care; disparity; telehealth; telemedicine","Ong","Michael K","Division of General Internal Medicine and Health Services Research, UCLA David Geffen School of Medicine, Los Angeles, CA, United States",NA
"1320","34259641","10.2196/27982","Age and Social Disparities in the Use of Telemedicine During the COVID-19 Pandemic in Japan: Cross-sectional Study.","The use of telemedicine outpatient visits has increased dramatically during the COVID-19 pandemic in many countries. Although disparities in access to telemedicine by age and socioeconomic status (SES) have been well-documented, evidence is limited as to how these disparities changed during the COVID-19 pandemic. Moreover, the equity of patient access to telemedicine has been scarcely reported in Japan, despite the huge potential for telemedicine expansion. We aimed to investigate changes due to","2021","07","23","J Med Internet Res","Journal of medical Internet research","COVID-19; Japan; access to care; disparity; telehealth; telemedicine","Tsugawa","Yusuke","Division of General Internal Medicine and Health Services Research, UCLA David Geffen School of Medicine, Los Angeles, CA, United States",NA
"1321","34259613","10.1080/21645515.2021.1930847","Emerging antibody-based products for infectious diseases: Planning for metric ton manufacturing.","This review focuses on the emerging monoclonal antibody market for infectious diseases and the metric ton scale manufacturing requirements to meet global demand. Increasing access to existing antibody-based products coupled with the unmet need in infectious disease will likely exceed the current existing global manufacturing capacity. Further, the large numbers of individuals infected during epidemics such as the ongoing COVID-19 pandemic emphasizes the need to plan for metric ton manufacturing ","2021","07","14","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","Monoclonal; manufacturing; passive immunization; scale","Whaley","Kevin J","Mapp Biopharmaceutical, San Diego, CA, USA",NA
"1322","34259613","10.1080/21645515.2021.1930847","Emerging antibody-based products for infectious diseases: Planning for metric ton manufacturing.","This review focuses on the emerging monoclonal antibody market for infectious diseases and the metric ton scale manufacturing requirements to meet global demand. Increasing access to existing antibody-based products coupled with the unmet need in infectious disease will likely exceed the current existing global manufacturing capacity. Further, the large numbers of individuals infected during epidemics such as the ongoing COVID-19 pandemic emphasizes the need to plan for metric ton manufacturing ","2021","07","14","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","Monoclonal; manufacturing; passive immunization; scale","Zeitlin","Larry","Mapp Biopharmaceutical, San Diego, CA, USA",NA
"1323","34259566","10.1128/CMR.00163-21","Erratum for Ramasamy and Subbian, ""Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis"".",NA,"2021","07","14","Clin Microbiol Rev","Clinical microbiology reviews",NA,"Ramasamy","Santhamani","Public Health Research Institute (PHRI) at New Jersey Medical School, Rutgers University, Newark, New Jersey, USA",NA
"1324","34259566","10.1128/CMR.00163-21","Erratum for Ramasamy and Subbian, ""Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis"".",NA,"2021","07","14","Clin Microbiol Rev","Clinical microbiology reviews",NA,"Subbian","Selvakumar","Public Health Research Institute (PHRI) at New Jersey Medical School, Rutgers University, Newark, New Jersey, USA",NA
"1325","34259552","10.1128/Spectrum.00086-21","Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19.","Although nasopharyngeal samples have been considered the gold standard for COVID-19 testing, variability in viral load across different anatomical sites could cause nasopharyngeal samples to be less sensitive than saliva or nasal samples in certain cases. Self-collected samples have logistical advantages over nasopharyngeal samples, making them amenable to population-scale screening. To evaluate sampling alternatives for population screening, we collected nasopharyngeal, saliva, and nasal sample","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; SARS-CoV-2; saliva; symptoms; testing","Johnson","Abigail J","Division of Epidemiology and Community Health, School of Public Health, University of Minnesotagrid.17635.36, Minneapolis, Minnesota, USA",NA
"1326","34259552","10.1128/Spectrum.00086-21","Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19.","Although nasopharyngeal samples have been considered the gold standard for COVID-19 testing, variability in viral load across different anatomical sites could cause nasopharyngeal samples to be less sensitive than saliva or nasal samples in certain cases. Self-collected samples have logistical advantages over nasopharyngeal samples, making them amenable to population-scale screening. To evaluate sampling alternatives for population screening, we collected nasopharyngeal, saliva, and nasal sample","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; SARS-CoV-2; saliva; symptoms; testing","Zhou","Shannon","BioTechnology Institute, College of Biological Sciences, University of Minnesotagrid.17635.36, Saint Paul, Minnesota, USA",NA
"1327","34259552","10.1128/Spectrum.00086-21","Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19.","Although nasopharyngeal samples have been considered the gold standard for COVID-19 testing, variability in viral load across different anatomical sites could cause nasopharyngeal samples to be less sensitive than saliva or nasal samples in certain cases. Self-collected samples have logistical advantages over nasopharyngeal samples, making them amenable to population-scale screening. To evaluate sampling alternatives for population screening, we collected nasopharyngeal, saliva, and nasal sample","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; SARS-CoV-2; saliva; symptoms; testing","Hoops","Susan L","Department of Computer Science and Engineering, University of Minnesotagrid.17635.36, Minneapolis, Minnesota, USA",NA
"1328","34259552","10.1128/Spectrum.00086-21","Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19.","Although nasopharyngeal samples have been considered the gold standard for COVID-19 testing, variability in viral load across different anatomical sites could cause nasopharyngeal samples to be less sensitive than saliva or nasal samples in certain cases. Self-collected samples have logistical advantages over nasopharyngeal samples, making them amenable to population-scale screening. To evaluate sampling alternatives for population screening, we collected nasopharyngeal, saliva, and nasal sample","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; SARS-CoV-2; saliva; symptoms; testing","Hillmann","Benjamin","Department of Computer Science and Engineering, University of Minnesotagrid.17635.36, Minneapolis, Minnesota, USA",NA
"1329","34259552","10.1128/Spectrum.00086-21","Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19.","Although nasopharyngeal samples have been considered the gold standard for COVID-19 testing, variability in viral load across different anatomical sites could cause nasopharyngeal samples to be less sensitive than saliva or nasal samples in certain cases. Self-collected samples have logistical advantages over nasopharyngeal samples, making them amenable to population-scale screening. To evaluate sampling alternatives for population screening, we collected nasopharyngeal, saliva, and nasal sample","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; SARS-CoV-2; saliva; symptoms; testing","Schomaker","Matthew","M Health Fairview, Minneapolis, Minnesota, USA",NA
"1330","34259552","10.1128/Spectrum.00086-21","Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19.","Although nasopharyngeal samples have been considered the gold standard for COVID-19 testing, variability in viral load across different anatomical sites could cause nasopharyngeal samples to be less sensitive than saliva or nasal samples in certain cases. Self-collected samples have logistical advantages over nasopharyngeal samples, making them amenable to population-scale screening. To evaluate sampling alternatives for population screening, we collected nasopharyngeal, saliva, and nasal sample","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; SARS-CoV-2; saliva; symptoms; testing","Kincaid","Robyn","M Health Fairview, Minneapolis, Minnesota, USA",NA
"1331","34259552","10.1128/Spectrum.00086-21","Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19.","Although nasopharyngeal samples have been considered the gold standard for COVID-19 testing, variability in viral load across different anatomical sites could cause nasopharyngeal samples to be less sensitive than saliva or nasal samples in certain cases. Self-collected samples have logistical advantages over nasopharyngeal samples, making them amenable to population-scale screening. To evaluate sampling alternatives for population screening, we collected nasopharyngeal, saliva, and nasal sample","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; SARS-CoV-2; saliva; symptoms; testing","Daniel","Jerry","University of Minnesota Genomics Center, University of Minnesota, Minneapolis, Minnesota, USA",NA
"1332","34259552","10.1128/Spectrum.00086-21","Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19.","Although nasopharyngeal samples have been considered the gold standard for COVID-19 testing, variability in viral load across different anatomical sites could cause nasopharyngeal samples to be less sensitive than saliva or nasal samples in certain cases. Self-collected samples have logistical advantages over nasopharyngeal samples, making them amenable to population-scale screening. To evaluate sampling alternatives for population screening, we collected nasopharyngeal, saliva, and nasal sample","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; SARS-CoV-2; saliva; symptoms; testing","Beckman","Kenneth","Department of Laboratory Medicine and Pathology, Division of Molecular Pathology and Genomics, University of Minnesotagrid.17635.36, Minneapolis, Minnesota, USA",NA
"1333","34259552","10.1128/Spectrum.00086-21","Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19.","Although nasopharyngeal samples have been considered the gold standard for COVID-19 testing, variability in viral load across different anatomical sites could cause nasopharyngeal samples to be less sensitive than saliva or nasal samples in certain cases. Self-collected samples have logistical advantages over nasopharyngeal samples, making them amenable to population-scale screening. To evaluate sampling alternatives for population screening, we collected nasopharyngeal, saliva, and nasal sample","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; SARS-CoV-2; saliva; symptoms; testing","Gohl","Daryl M","University of Minnesota Genomics Center, University of Minnesota, Minneapolis, Minnesota, USA",NA
"1334","34259552","10.1128/Spectrum.00086-21","Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19.","Although nasopharyngeal samples have been considered the gold standard for COVID-19 testing, variability in viral load across different anatomical sites could cause nasopharyngeal samples to be less sensitive than saliva or nasal samples in certain cases. Self-collected samples have logistical advantages over nasopharyngeal samples, making them amenable to population-scale screening. To evaluate sampling alternatives for population screening, we collected nasopharyngeal, saliva, and nasal sample","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; SARS-CoV-2; saliva; symptoms; testing","Yohe","Sophia","Department of Laboratory Medicine and Pathology, Division of Molecular Pathology and Genomics, University of Minnesotagrid.17635.36, Minneapolis, Minnesota, USA",NA
"1335","34259552","10.1128/Spectrum.00086-21","Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19.","Although nasopharyngeal samples have been considered the gold standard for COVID-19 testing, variability in viral load across different anatomical sites could cause nasopharyngeal samples to be less sensitive than saliva or nasal samples in certain cases. Self-collected samples have logistical advantages over nasopharyngeal samples, making them amenable to population-scale screening. To evaluate sampling alternatives for population screening, we collected nasopharyngeal, saliva, and nasal sample","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; SARS-CoV-2; saliva; symptoms; testing","Knights","Dan","BioTechnology Institute, College of Biological Sciences, University of Minnesotagrid.17635.36, Saint Paul, Minnesota, USA",NA
"1336","34259552","10.1128/Spectrum.00086-21","Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19.","Although nasopharyngeal samples have been considered the gold standard for COVID-19 testing, variability in viral load across different anatomical sites could cause nasopharyngeal samples to be less sensitive than saliva or nasal samples in certain cases. Self-collected samples have logistical advantages over nasopharyngeal samples, making them amenable to population-scale screening. To evaluate sampling alternatives for population screening, we collected nasopharyngeal, saliva, and nasal sample","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; SARS-CoV-2; saliva; symptoms; testing","Nelson","Andrew C","Department of Laboratory Medicine and Pathology, Division of Molecular Pathology and Genomics, University of Minnesotagrid.17635.36, Minneapolis, Minnesota, USA",NA
"1337","34259547","10.1128/Spectrum.00361-21","Self-Collected Gargle Lavage Allows Reliable Detection of SARS-CoV-2 in an Outpatient Setting.","Current procurement of specimens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection requires trained personnel and dedicated equipment. We compared standard nasopharyngeal swabs with self-collected gargle lavage fluid obtained from 80 mostly symptomatic outpatients. After RNA extraction, RT-PCR to detect SARS-CoV-2 was performed. Qualitative results obtained with the paired samples from individual outpatients were 100% congruent. Therefore, self-collected gargle lavage fl","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; RT-PCR; SARS-CoV-2; gargle lavage; outpatients","Zander","Johannes","Labor Dr. Brunner, Konstanz, Germany",NA
"1338","34259547","10.1128/Spectrum.00361-21","Self-Collected Gargle Lavage Allows Reliable Detection of SARS-CoV-2 in an Outpatient Setting.","Current procurement of specimens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection requires trained personnel and dedicated equipment. We compared standard nasopharyngeal swabs with self-collected gargle lavage fluid obtained from 80 mostly symptomatic outpatients. After RNA extraction, RT-PCR to detect SARS-CoV-2 was performed. Qualitative results obtained with the paired samples from individual outpatients were 100% congruent. Therefore, self-collected gargle lavage fl","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; RT-PCR; SARS-CoV-2; gargle lavage; outpatients","Scholtes","Stephan","Praxis Dr. S. Scholtes/C. Zeleny, Konstanz, Germany",NA
"1339","34259547","10.1128/Spectrum.00361-21","Self-Collected Gargle Lavage Allows Reliable Detection of SARS-CoV-2 in an Outpatient Setting.","Current procurement of specimens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection requires trained personnel and dedicated equipment. We compared standard nasopharyngeal swabs with self-collected gargle lavage fluid obtained from 80 mostly symptomatic outpatients. After RNA extraction, RT-PCR to detect SARS-CoV-2 was performed. Qualitative results obtained with the paired samples from individual outpatients were 100% congruent. Therefore, self-collected gargle lavage fl","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; RT-PCR; SARS-CoV-2; gargle lavage; outpatients","Ottinger","Maximilian","Praxis Maximilian Ottinger, Konstanz, Germany",NA
"1340","34259547","10.1128/Spectrum.00361-21","Self-Collected Gargle Lavage Allows Reliable Detection of SARS-CoV-2 in an Outpatient Setting.","Current procurement of specimens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection requires trained personnel and dedicated equipment. We compared standard nasopharyngeal swabs with self-collected gargle lavage fluid obtained from 80 mostly symptomatic outpatients. After RNA extraction, RT-PCR to detect SARS-CoV-2 was performed. Qualitative results obtained with the paired samples from individual outpatients were 100% congruent. Therefore, self-collected gargle lavage fl","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; RT-PCR; SARS-CoV-2; gargle lavage; outpatients","Kremer","Marcel","Labor Dr. Brunner, Konstanz, Germany",NA
"1341","34259547","10.1128/Spectrum.00361-21","Self-Collected Gargle Lavage Allows Reliable Detection of SARS-CoV-2 in an Outpatient Setting.","Current procurement of specimens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection requires trained personnel and dedicated equipment. We compared standard nasopharyngeal swabs with self-collected gargle lavage fluid obtained from 80 mostly symptomatic outpatients. After RNA extraction, RT-PCR to detect SARS-CoV-2 was performed. Qualitative results obtained with the paired samples from individual outpatients were 100% congruent. Therefore, self-collected gargle lavage fl","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; RT-PCR; SARS-CoV-2; gargle lavage; outpatients","Kharazi","Azadeh","Labor Dr. Brunner, Konstanz, Germany",NA
"1342","34259547","10.1128/Spectrum.00361-21","Self-Collected Gargle Lavage Allows Reliable Detection of SARS-CoV-2 in an Outpatient Setting.","Current procurement of specimens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection requires trained personnel and dedicated equipment. We compared standard nasopharyngeal swabs with self-collected gargle lavage fluid obtained from 80 mostly symptomatic outpatients. After RNA extraction, RT-PCR to detect SARS-CoV-2 was performed. Qualitative results obtained with the paired samples from individual outpatients were 100% congruent. Therefore, self-collected gargle lavage fl","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; RT-PCR; SARS-CoV-2; gargle lavage; outpatients","Stadler","Vanessa","Labor Dr. Brunner, Konstanz, Germany",NA
"1343","34259547","10.1128/Spectrum.00361-21","Self-Collected Gargle Lavage Allows Reliable Detection of SARS-CoV-2 in an Outpatient Setting.","Current procurement of specimens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection requires trained personnel and dedicated equipment. We compared standard nasopharyngeal swabs with self-collected gargle lavage fluid obtained from 80 mostly symptomatic outpatients. After RNA extraction, RT-PCR to detect SARS-CoV-2 was performed. Qualitative results obtained with the paired samples from individual outpatients were 100% congruent. Therefore, self-collected gargle lavage fl","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; RT-PCR; SARS-CoV-2; gargle lavage; outpatients","Bickmann","Julia","Labor Dr. Brunner, Konstanz, Germany",NA
"1344","34259547","10.1128/Spectrum.00361-21","Self-Collected Gargle Lavage Allows Reliable Detection of SARS-CoV-2 in an Outpatient Setting.","Current procurement of specimens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection requires trained personnel and dedicated equipment. We compared standard nasopharyngeal swabs with self-collected gargle lavage fluid obtained from 80 mostly symptomatic outpatients. After RNA extraction, RT-PCR to detect SARS-CoV-2 was performed. Qualitative results obtained with the paired samples from individual outpatients were 100% congruent. Therefore, self-collected gargle lavage fl","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; RT-PCR; SARS-CoV-2; gargle lavage; outpatients","Zeleny","Christian","Praxis Dr. S. Scholtes/C. Zeleny, Konstanz, Germany",NA
"1345","34259547","10.1128/Spectrum.00361-21","Self-Collected Gargle Lavage Allows Reliable Detection of SARS-CoV-2 in an Outpatient Setting.","Current procurement of specimens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection requires trained personnel and dedicated equipment. We compared standard nasopharyngeal swabs with self-collected gargle lavage fluid obtained from 80 mostly symptomatic outpatients. After RNA extraction, RT-PCR to detect SARS-CoV-2 was performed. Qualitative results obtained with the paired samples from individual outpatients were 100% congruent. Therefore, self-collected gargle lavage fl","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; RT-PCR; SARS-CoV-2; gargle lavage; outpatients","Kuiper","Johannes W P","Lehrstuhl Zellbiologie, Universität Konstanz, Konstanz, Germany",NA
"1346","34259547","10.1128/Spectrum.00361-21","Self-Collected Gargle Lavage Allows Reliable Detection of SARS-CoV-2 in an Outpatient Setting.","Current procurement of specimens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection requires trained personnel and dedicated equipment. We compared standard nasopharyngeal swabs with self-collected gargle lavage fluid obtained from 80 mostly symptomatic outpatients. After RNA extraction, RT-PCR to detect SARS-CoV-2 was performed. Qualitative results obtained with the paired samples from individual outpatients were 100% congruent. Therefore, self-collected gargle lavage fl","2021","07","14","Microbiol Spectr","Microbiology spectrum","COVID-19; RT-PCR; SARS-CoV-2; gargle lavage; outpatients","Hauck","Christof R","Lehrstuhl Zellbiologie, Universität Konstanz, Konstanz, Germany",NA
"1347","34259473","10.1097/AOG.0000000000004435","Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G Antibody Screening to Identify Infections Remote From Delivery Admission.",NA,"2021","07","23","Obstet Gynecol","Obstetrics and gynecology","Adolescent; Adult; Asymptomatic Infections; COVID-19; Female; Humans; Immunoglobulin G; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Retrospective Studies; SARS-CoV-2; Texas; Time Factors; Young Adult","Moutos","Christopher P","Division of Maternal-Fetal Medicine, the University of Texas Medical Branch at Galveston, Galveston, Texas",NA
"1348","34259473","10.1097/AOG.0000000000004435","Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G Antibody Screening to Identify Infections Remote From Delivery Admission.",NA,"2021","07","23","Obstet Gynecol","Obstetrics and gynecology","Adolescent; Adult; Asymptomatic Infections; COVID-19; Female; Humans; Immunoglobulin G; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Retrospective Studies; SARS-CoV-2; Texas; Time Factors; Young Adult","Beavers","Rosemary N","Division of Maternal-Fetal Medicine, the University of Texas Medical Branch at Galveston, Galveston, Texas",NA
"1349","34259473","10.1097/AOG.0000000000004435","Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G Antibody Screening to Identify Infections Remote From Delivery Admission.",NA,"2021","07","23","Obstet Gynecol","Obstetrics and gynecology","Adolescent; Adult; Asymptomatic Infections; COVID-19; Female; Humans; Immunoglobulin G; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Retrospective Studies; SARS-CoV-2; Texas; Time Factors; Young Adult","Younes","Lena","Division of Maternal-Fetal Medicine, the University of Texas Medical Branch at Galveston, Galveston, Texas",NA
"1350","34259473","10.1097/AOG.0000000000004435","Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G Antibody Screening to Identify Infections Remote From Delivery Admission.",NA,"2021","07","23","Obstet Gynecol","Obstetrics and gynecology","Adolescent; Adult; Asymptomatic Infections; COVID-19; Female; Humans; Immunoglobulin G; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Retrospective Studies; SARS-CoV-2; Texas; Time Factors; Young Adult","Nutter","Anna","Division of Maternal-Fetal Medicine, the University of Texas Medical Branch at Galveston, Galveston, Texas",NA
"1351","34259473","10.1097/AOG.0000000000004435","Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G Antibody Screening to Identify Infections Remote From Delivery Admission.",NA,"2021","07","23","Obstet Gynecol","Obstetrics and gynecology","Adolescent; Adult; Asymptomatic Infections; COVID-19; Female; Humans; Immunoglobulin G; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Retrospective Studies; SARS-CoV-2; Texas; Time Factors; Young Adult","DeGraffenreid","Corrie","Division of Maternal-Fetal Medicine, the University of Texas Medical Branch at Galveston, Galveston, Texas",NA
"1352","34259473","10.1097/AOG.0000000000004435","Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G Antibody Screening to Identify Infections Remote From Delivery Admission.",NA,"2021","07","23","Obstet Gynecol","Obstetrics and gynecology","Adolescent; Adult; Asymptomatic Infections; COVID-19; Female; Humans; Immunoglobulin G; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Retrospective Studies; SARS-CoV-2; Texas; Time Factors; Young Adult","Saade","George R","Division of Maternal-Fetal Medicine, the University of Texas Medical Branch at Galveston, Galveston, Texas",NA
"1353","34259473","10.1097/AOG.0000000000004435","Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G Antibody Screening to Identify Infections Remote From Delivery Admission.",NA,"2021","07","23","Obstet Gynecol","Obstetrics and gynecology","Adolescent; Adult; Asymptomatic Infections; COVID-19; Female; Humans; Immunoglobulin G; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Retrospective Studies; SARS-CoV-2; Texas; Time Factors; Young Adult","Saad","Antonio F","Division of Maternal-Fetal Medicine, the University of Texas Medical Branch at Galveston, Galveston, Texas",NA
"1354","34259426","10.3290/j.ohpd.b1693919","Influence of COVID-19 Restrictions on Patients' Self-reported Oral Health Care Needs.","To assess how current COVID-19 restrictions regarding elective dental procedures influence patients' self-reported oral health care needs at a University Hospital in Germany. Patients with COVID-19 induced cancellation of elective treatment appointments previously scheduled for the period March 16th to April 30th 2020 were contacted by telephone and questioned about the occurrence of oral health problems, pain, self-reported treatment needs, and the use of emergency dental services. Data were an","2021","07","16","Oral Health Prev Dent","Oral health &amp; preventive dentistry","COVID-19; oral health; pandemics; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Delivery of Health Care; Germany; Humans; Infant; Middle Aged; Oral Health; Retrospective Studies; SARS-CoV-2; Self Report; Time Factors; Young Adult","Sekundo","Caroline",NA,NA
"1355","34259426","10.3290/j.ohpd.b1693919","Influence of COVID-19 Restrictions on Patients' Self-reported Oral Health Care Needs.","To assess how current COVID-19 restrictions regarding elective dental procedures influence patients' self-reported oral health care needs at a University Hospital in Germany. Patients with COVID-19 induced cancellation of elective treatment appointments previously scheduled for the period March 16th to April 30th 2020 were contacted by telephone and questioned about the occurrence of oral health problems, pain, self-reported treatment needs, and the use of emergency dental services. Data were an","2021","07","16","Oral Health Prev Dent","Oral health &amp; preventive dentistry","COVID-19; oral health; pandemics; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Delivery of Health Care; Germany; Humans; Infant; Middle Aged; Oral Health; Retrospective Studies; SARS-CoV-2; Self Report; Time Factors; Young Adult","Langowski","Eva",NA,NA
"1356","34259426","10.3290/j.ohpd.b1693919","Influence of COVID-19 Restrictions on Patients' Self-reported Oral Health Care Needs.","To assess how current COVID-19 restrictions regarding elective dental procedures influence patients' self-reported oral health care needs at a University Hospital in Germany. Patients with COVID-19 induced cancellation of elective treatment appointments previously scheduled for the period March 16th to April 30th 2020 were contacted by telephone and questioned about the occurrence of oral health problems, pain, self-reported treatment needs, and the use of emergency dental services. Data were an","2021","07","16","Oral Health Prev Dent","Oral health &amp; preventive dentistry","COVID-19; oral health; pandemics; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Delivery of Health Care; Germany; Humans; Infant; Middle Aged; Oral Health; Retrospective Studies; SARS-CoV-2; Self Report; Time Factors; Young Adult","Frese","Cornelia",NA,NA
"1357","34259372","10.1111/jonm.13414","Curbing Nurses' Burnout during COVID-19: the roles of Servant Leadership and Psychological Safety.","This study examines the role of servant leadership through the mechanism of psychological safety in curbing nurses' burnout during the COVID-19 pandemic. During the COVID-19 pandemic, studies have shown an increased level of stress and burnout among healthcare workers, especially nurses. This study responds to the call for research to explore the mechanisms of servant leadership in predicting nurses' burnout by employing the perspective of conservation of resources theory. Through a cross-sectio","2021","07","14","J Nurs Manag","Journal of nursing management","COVID-19; conservation of resources theory; nurses burnout; psychological safety; servant leadership","Ma","Ying","Wuhan University of Technology, Wuhan, China",NA
"1358","34259372","10.1111/jonm.13414","Curbing Nurses' Burnout during COVID-19: the roles of Servant Leadership and Psychological Safety.","This study examines the role of servant leadership through the mechanism of psychological safety in curbing nurses' burnout during the COVID-19 pandemic. During the COVID-19 pandemic, studies have shown an increased level of stress and burnout among healthcare workers, especially nurses. This study responds to the call for research to explore the mechanisms of servant leadership in predicting nurses' burnout by employing the perspective of conservation of resources theory. Through a cross-sectio","2021","07","14","J Nurs Manag","Journal of nursing management","COVID-19; conservation of resources theory; nurses burnout; psychological safety; servant leadership","Faraz","Naveed Ahmad","Wuhan University of Technology, Wuhan, China",NA
"1359","34259372","10.1111/jonm.13414","Curbing Nurses' Burnout during COVID-19: the roles of Servant Leadership and Psychological Safety.","This study examines the role of servant leadership through the mechanism of psychological safety in curbing nurses' burnout during the COVID-19 pandemic. During the COVID-19 pandemic, studies have shown an increased level of stress and burnout among healthcare workers, especially nurses. This study responds to the call for research to explore the mechanisms of servant leadership in predicting nurses' burnout by employing the perspective of conservation of resources theory. Through a cross-sectio","2021","07","14","J Nurs Manag","Journal of nursing management","COVID-19; conservation of resources theory; nurses burnout; psychological safety; servant leadership","Ahmed","Fawad","Wuhan University of Technology, Wuhan, China",NA
"1360","34259372","10.1111/jonm.13414","Curbing Nurses' Burnout during COVID-19: the roles of Servant Leadership and Psychological Safety.","This study examines the role of servant leadership through the mechanism of psychological safety in curbing nurses' burnout during the COVID-19 pandemic. During the COVID-19 pandemic, studies have shown an increased level of stress and burnout among healthcare workers, especially nurses. This study responds to the call for research to explore the mechanisms of servant leadership in predicting nurses' burnout by employing the perspective of conservation of resources theory. Through a cross-sectio","2021","07","14","J Nurs Manag","Journal of nursing management","COVID-19; conservation of resources theory; nurses burnout; psychological safety; servant leadership","Iqbal","Muhammad Khalid","Knowledge unit of Business, Economics, Accountancy and Commerce, University of Management and Technology Sialkot Campus, Pakistan",NA
"1361","34259372","10.1111/jonm.13414","Curbing Nurses' Burnout during COVID-19: the roles of Servant Leadership and Psychological Safety.","This study examines the role of servant leadership through the mechanism of psychological safety in curbing nurses' burnout during the COVID-19 pandemic. During the COVID-19 pandemic, studies have shown an increased level of stress and burnout among healthcare workers, especially nurses. This study responds to the call for research to explore the mechanisms of servant leadership in predicting nurses' burnout by employing the perspective of conservation of resources theory. Through a cross-sectio","2021","07","14","J Nurs Manag","Journal of nursing management","COVID-19; conservation of resources theory; nurses burnout; psychological safety; servant leadership","Saeed","Umair","Business Administration Department, College of Sciences, Ministry of Higher Education, Ibri, Oman",NA
"1362","34259372","10.1111/jonm.13414","Curbing Nurses' Burnout during COVID-19: the roles of Servant Leadership and Psychological Safety.","This study examines the role of servant leadership through the mechanism of psychological safety in curbing nurses' burnout during the COVID-19 pandemic. During the COVID-19 pandemic, studies have shown an increased level of stress and burnout among healthcare workers, especially nurses. This study responds to the call for research to explore the mechanisms of servant leadership in predicting nurses' burnout by employing the perspective of conservation of resources theory. Through a cross-sectio","2021","07","14","J Nurs Manag","Journal of nursing management","COVID-19; conservation of resources theory; nurses burnout; psychological safety; servant leadership","Mughal","Muhammad Farhan","School of Management Sciences, Tianjin University of Finance and Economics, P.R. China",NA
"1363","34259372","10.1111/jonm.13414","Curbing Nurses' Burnout during COVID-19: the roles of Servant Leadership and Psychological Safety.","This study examines the role of servant leadership through the mechanism of psychological safety in curbing nurses' burnout during the COVID-19 pandemic. During the COVID-19 pandemic, studies have shown an increased level of stress and burnout among healthcare workers, especially nurses. This study responds to the call for research to explore the mechanisms of servant leadership in predicting nurses' burnout by employing the perspective of conservation of resources theory. Through a cross-sectio","2021","07","14","J Nurs Manag","Journal of nursing management","COVID-19; conservation of resources theory; nurses burnout; psychological safety; servant leadership","Raza","Ali","Knowledge unit of Business, Economics, Accountancy and Commerce, University of Management and Technology Sialkot Campus, Pakistan",NA
"1364","34259364","10.1111/ina.12870","To prevent SARS-CoV-2 transmission in designated quarantine hotel for travelers: Is the ventilation system a concern?",NA,"2021","07","14","Indoor Air","Indoor air","SARS-CoV-2; hotel; quarantine; transmission; ventilation system","Wong","Shuk-Ching","Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hong Kong Special Administrative Region, China",NA
"1365","34259364","10.1111/ina.12870","To prevent SARS-CoV-2 transmission in designated quarantine hotel for travelers: Is the ventilation system a concern?",NA,"2021","07","14","Indoor Air","Indoor air","SARS-CoV-2; hotel; quarantine; transmission; ventilation system","Chen","Hong","Department of Health, Infection Control Branch, Centre for Health Protection, Hong Kong Special Administrative Region, China",NA
"1366","34259364","10.1111/ina.12870","To prevent SARS-CoV-2 transmission in designated quarantine hotel for travelers: Is the ventilation system a concern?",NA,"2021","07","14","Indoor Air","Indoor air","SARS-CoV-2; hotel; quarantine; transmission; ventilation system","Lung","David Christopher","Department of Pathology, Hong Kong Children's Hospital/Queen Elizabeth Hospital, Hong Kong Special Administrative Region, China",NA
"1367","34259364","10.1111/ina.12870","To prevent SARS-CoV-2 transmission in designated quarantine hotel for travelers: Is the ventilation system a concern?",NA,"2021","07","14","Indoor Air","Indoor air","SARS-CoV-2; hotel; quarantine; transmission; ventilation system","Ho","Pak-Leung","Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China",NA
"1368","34259364","10.1111/ina.12870","To prevent SARS-CoV-2 transmission in designated quarantine hotel for travelers: Is the ventilation system a concern?",NA,"2021","07","14","Indoor Air","Indoor air","SARS-CoV-2; hotel; quarantine; transmission; ventilation system","Yuen","Kwok-Yung","Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China",NA
"1369","34259364","10.1111/ina.12870","To prevent SARS-CoV-2 transmission in designated quarantine hotel for travelers: Is the ventilation system a concern?",NA,"2021","07","14","Indoor Air","Indoor air","SARS-CoV-2; hotel; quarantine; transmission; ventilation system","Cheng","Vincent Chi-Chung","Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hong Kong Special Administrative Region, China",NA
"1370","34259363","10.1111/sdi.13000","Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India.","Maintenance hemodialysis (MHD) patients face disadvantages with higher risk of acquiring SARS-CoV-2 infection, atypical manifestations, and associated multiple comorbidities. We describe patients' outcomes with symptomatic COVID-19 on MHD in a large cohort of patients from India. Data were collected prospectively from hemodialysis units in 11 public and private hospitals between March 15, 2020, and July 31, 2020. The survival determinants were analyzed using stepwise backward elimination cox-reg","2021","07","14","Semin Dial","Seminars in dialysis",NA,"Prasad","Narayan","Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India",NA
"1371","34259363","10.1111/sdi.13000","Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India.","Maintenance hemodialysis (MHD) patients face disadvantages with higher risk of acquiring SARS-CoV-2 infection, atypical manifestations, and associated multiple comorbidities. We describe patients' outcomes with symptomatic COVID-19 on MHD in a large cohort of patients from India. Data were collected prospectively from hemodialysis units in 11 public and private hospitals between March 15, 2020, and July 31, 2020. The survival determinants were analyzed using stepwise backward elimination cox-reg","2021","07","14","Semin Dial","Seminars in dialysis",NA,"Behera","Manas Ranjan","Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India",NA
"1372","34259363","10.1111/sdi.13000","Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India.","Maintenance hemodialysis (MHD) patients face disadvantages with higher risk of acquiring SARS-CoV-2 infection, atypical manifestations, and associated multiple comorbidities. We describe patients' outcomes with symptomatic COVID-19 on MHD in a large cohort of patients from India. Data were collected prospectively from hemodialysis units in 11 public and private hospitals between March 15, 2020, and July 31, 2020. The survival determinants were analyzed using stepwise backward elimination cox-reg","2021","07","14","Semin Dial","Seminars in dialysis",NA,"Bhatt","Mansi","Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India",NA
"1373","34259363","10.1111/sdi.13000","Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India.","Maintenance hemodialysis (MHD) patients face disadvantages with higher risk of acquiring SARS-CoV-2 infection, atypical manifestations, and associated multiple comorbidities. We describe patients' outcomes with symptomatic COVID-19 on MHD in a large cohort of patients from India. Data were collected prospectively from hemodialysis units in 11 public and private hospitals between March 15, 2020, and July 31, 2020. The survival determinants were analyzed using stepwise backward elimination cox-reg","2021","07","14","Semin Dial","Seminars in dialysis",NA,"Agarwal","Sanjay Kumar","All India Institute of Medical Sciences, New Delhi, India",NA
"1374","34259363","10.1111/sdi.13000","Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India.","Maintenance hemodialysis (MHD) patients face disadvantages with higher risk of acquiring SARS-CoV-2 infection, atypical manifestations, and associated multiple comorbidities. We describe patients' outcomes with symptomatic COVID-19 on MHD in a large cohort of patients from India. Data were collected prospectively from hemodialysis units in 11 public and private hospitals between March 15, 2020, and July 31, 2020. The survival determinants were analyzed using stepwise backward elimination cox-reg","2021","07","14","Semin Dial","Seminars in dialysis",NA,"Gopalakrishnan","N","Madras Medical College, Chennai, India",NA
"1375","34259363","10.1111/sdi.13000","Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India.","Maintenance hemodialysis (MHD) patients face disadvantages with higher risk of acquiring SARS-CoV-2 infection, atypical manifestations, and associated multiple comorbidities. We describe patients' outcomes with symptomatic COVID-19 on MHD in a large cohort of patients from India. Data were collected prospectively from hemodialysis units in 11 public and private hospitals between March 15, 2020, and July 31, 2020. The survival determinants were analyzed using stepwise backward elimination cox-reg","2021","07","14","Semin Dial","Seminars in dialysis",NA,"Fernando","Edwin","Stanley Medical College, Chennai, India",NA
"1376","34259363","10.1111/sdi.13000","Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India.","Maintenance hemodialysis (MHD) patients face disadvantages with higher risk of acquiring SARS-CoV-2 infection, atypical manifestations, and associated multiple comorbidities. We describe patients' outcomes with symptomatic COVID-19 on MHD in a large cohort of patients from India. Data were collected prospectively from hemodialysis units in 11 public and private hospitals between March 15, 2020, and July 31, 2020. The survival determinants were analyzed using stepwise backward elimination cox-reg","2021","07","14","Semin Dial","Seminars in dialysis",NA,"Chaudhary","Arpita Roy","Postgraduate Institute of Medical Education and Research, Kolkata, India",NA
"1377","34259363","10.1111/sdi.13000","Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India.","Maintenance hemodialysis (MHD) patients face disadvantages with higher risk of acquiring SARS-CoV-2 infection, atypical manifestations, and associated multiple comorbidities. We describe patients' outcomes with symptomatic COVID-19 on MHD in a large cohort of patients from India. Data were collected prospectively from hemodialysis units in 11 public and private hospitals between March 15, 2020, and July 31, 2020. The survival determinants were analyzed using stepwise backward elimination cox-reg","2021","07","14","Semin Dial","Seminars in dialysis",NA,"Sahay","Manisha","Osmania General Hospital, Hyderabad, India",NA
"1378","34259363","10.1111/sdi.13000","Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India.","Maintenance hemodialysis (MHD) patients face disadvantages with higher risk of acquiring SARS-CoV-2 infection, atypical manifestations, and associated multiple comorbidities. We describe patients' outcomes with symptomatic COVID-19 on MHD in a large cohort of patients from India. Data were collected prospectively from hemodialysis units in 11 public and private hospitals between March 15, 2020, and July 31, 2020. The survival determinants were analyzed using stepwise backward elimination cox-reg","2021","07","14","Semin Dial","Seminars in dialysis",NA,"Singh","Shivendra","Institute of Medical Sciences, BHU, Varanasi, India",NA
"1379","34259363","10.1111/sdi.13000","Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India.","Maintenance hemodialysis (MHD) patients face disadvantages with higher risk of acquiring SARS-CoV-2 infection, atypical manifestations, and associated multiple comorbidities. We describe patients' outcomes with symptomatic COVID-19 on MHD in a large cohort of patients from India. Data were collected prospectively from hemodialysis units in 11 public and private hospitals between March 15, 2020, and July 31, 2020. The survival determinants were analyzed using stepwise backward elimination cox-reg","2021","07","14","Semin Dial","Seminars in dialysis",NA,"Jain","Apoorva","Sarojini Naidu Medical College, Agra, India",NA
"1380","34259363","10.1111/sdi.13000","Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India.","Maintenance hemodialysis (MHD) patients face disadvantages with higher risk of acquiring SARS-CoV-2 infection, atypical manifestations, and associated multiple comorbidities. We describe patients' outcomes with symptomatic COVID-19 on MHD in a large cohort of patients from India. Data were collected prospectively from hemodialysis units in 11 public and private hospitals between March 15, 2020, and July 31, 2020. The survival determinants were analyzed using stepwise backward elimination cox-reg","2021","07","14","Semin Dial","Seminars in dialysis",NA,"Tapiawala","Shruti","Global Hospital, Mumbai, India",NA
"1381","34259363","10.1111/sdi.13000","Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India.","Maintenance hemodialysis (MHD) patients face disadvantages with higher risk of acquiring SARS-CoV-2 infection, atypical manifestations, and associated multiple comorbidities. We describe patients' outcomes with symptomatic COVID-19 on MHD in a large cohort of patients from India. Data were collected prospectively from hemodialysis units in 11 public and private hospitals between March 15, 2020, and July 31, 2020. The survival determinants were analyzed using stepwise backward elimination cox-reg","2021","07","14","Semin Dial","Seminars in dialysis",NA,"Kamble","Aniket","Lancelot Kidney Hospital, Mumbai, India",NA
"1382","34259363","10.1111/sdi.13000","Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India.","Maintenance hemodialysis (MHD) patients face disadvantages with higher risk of acquiring SARS-CoV-2 infection, atypical manifestations, and associated multiple comorbidities. We describe patients' outcomes with symptomatic COVID-19 on MHD in a large cohort of patients from India. Data were collected prospectively from hemodialysis units in 11 public and private hospitals between March 15, 2020, and July 31, 2020. The survival determinants were analyzed using stepwise backward elimination cox-reg","2021","07","14","Semin Dial","Seminars in dialysis",NA,"Khanna","Umesh","Lancelot Kidney Hospital, Mumbai, India",NA
"1383","34259363","10.1111/sdi.13000","Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India.","Maintenance hemodialysis (MHD) patients face disadvantages with higher risk of acquiring SARS-CoV-2 infection, atypical manifestations, and associated multiple comorbidities. We describe patients' outcomes with symptomatic COVID-19 on MHD in a large cohort of patients from India. Data were collected prospectively from hemodialysis units in 11 public and private hospitals between March 15, 2020, and July 31, 2020. The survival determinants were analyzed using stepwise backward elimination cox-reg","2021","07","14","Semin Dial","Seminars in dialysis",NA,"Bohra","Rubina","Shri Aurobindo Medical College and Postgraduate Institute, Indore, India",NA
"1384","34259363","10.1111/sdi.13000","Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India.","Maintenance hemodialysis (MHD) patients face disadvantages with higher risk of acquiring SARS-CoV-2 infection, atypical manifestations, and associated multiple comorbidities. We describe patients' outcomes with symptomatic COVID-19 on MHD in a large cohort of patients from India. Data were collected prospectively from hemodialysis units in 11 public and private hospitals between March 15, 2020, and July 31, 2020. The survival determinants were analyzed using stepwise backward elimination cox-reg","2021","07","14","Semin Dial","Seminars in dialysis",NA,"Gupta","Anurag","Sir Ganga Ram Hospital, New Delhi, India",NA
"1385","34259363","10.1111/sdi.13000","Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India.","Maintenance hemodialysis (MHD) patients face disadvantages with higher risk of acquiring SARS-CoV-2 infection, atypical manifestations, and associated multiple comorbidities. We describe patients' outcomes with symptomatic COVID-19 on MHD in a large cohort of patients from India. Data were collected prospectively from hemodialysis units in 11 public and private hospitals between March 15, 2020, and July 31, 2020. The survival determinants were analyzed using stepwise backward elimination cox-reg","2021","07","14","Semin Dial","Seminars in dialysis",NA,"Anandh","Urmila","Yashoda Hospital, Hyderabad, India",NA
"1386","34259363","10.1111/sdi.13000","Outcomes of symptomatic coronavirus disease 19 in maintenance hemodialysis patient in India.","Maintenance hemodialysis (MHD) patients face disadvantages with higher risk of acquiring SARS-CoV-2 infection, atypical manifestations, and associated multiple comorbidities. We describe patients' outcomes with symptomatic COVID-19 on MHD in a large cohort of patients from India. Data were collected prospectively from hemodialysis units in 11 public and private hospitals between March 15, 2020, and July 31, 2020. The survival determinants were analyzed using stepwise backward elimination cox-reg","2021","07","14","Semin Dial","Seminars in dialysis",NA,"Jha","Vivekanand","George Institute India, University of New South Wales, Sydney, New South Wales, Australia",NA
"1387","34259314","10.1093/milmed/usab295","Too Hot to Handle: Early Temperature Management and Unique Treatment of Hyperpyrexia in SARS-CoV2 Encephalopathy.","A 45-year-old otherwise healthy active duty male was admitted to the medical intensive care unit for severe acute respiratory syndrome-coronavirus 2 (SARS-CoV2) encephalopathy associated with hyperpyrexia. Magnetic resonance imaging findings demonstrated cytotoxic lesions primarily at the midline of the splenium of corpus callosum (CLOCC). Similar cases involving hyperpyrexia in the setting of SARS-CoV2 infection have demonstrated exceedingly high-mortality outcomes. Three mechanisms exist as to","2021","07","14","Mil Med","Military medicine",NA,"Micci","Luca","Medical Intensive Care Unit, Walter Reed National Military Medical Center, Bethesda, MD 20814, USA",NA
"1388","34259314","10.1093/milmed/usab295","Too Hot to Handle: Early Temperature Management and Unique Treatment of Hyperpyrexia in SARS-CoV2 Encephalopathy.","A 45-year-old otherwise healthy active duty male was admitted to the medical intensive care unit for severe acute respiratory syndrome-coronavirus 2 (SARS-CoV2) encephalopathy associated with hyperpyrexia. Magnetic resonance imaging findings demonstrated cytotoxic lesions primarily at the midline of the splenium of corpus callosum (CLOCC). Similar cases involving hyperpyrexia in the setting of SARS-CoV2 infection have demonstrated exceedingly high-mortality outcomes. Three mechanisms exist as to","2021","07","14","Mil Med","Military medicine",NA,"DesRosiers","Taylor","Medical Intensive Care Unit, Walter Reed National Military Medical Center, Bethesda, MD 20814, USA",NA
"1389","34259262","10.1039/d1cs00317h","Chemical design principles of next-generation antiviral surface coatings.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has accelerated efforts to develop high-performance antiviral surface coatings while highlighting the need to build a strong mechanistic understanding of the chemical design principles that underpin antiviral surface coatings. Herein, we critically summarize the latest efforts to develop antiviral surface coatings that exhibit virus-inactivating functions through disrupting lipid envelopes or protein capsids. Particular attention is focuse","2021","07","16","Chem Soc Rev","Chemical Society reviews",NA,"Wang","Nan","Hubei Key Laboratory of Bioinorganic Chemistry &amp","t.majima@hust.edu.cn"
"1390","34259262","10.1039/d1cs00317h","Chemical design principles of next-generation antiviral surface coatings.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has accelerated efforts to develop high-performance antiviral surface coatings while highlighting the need to build a strong mechanistic understanding of the chemical design principles that underpin antiviral surface coatings. Herein, we critically summarize the latest efforts to develop antiviral surface coatings that exhibit virus-inactivating functions through disrupting lipid envelopes or protein capsids. Particular attention is focuse","2021","07","16","Chem Soc Rev","Chemical Society reviews",NA,"Ferhan","Abdul Rahim","School of Materials Science and Engineering, Nanyang Technological University, 639798, Singapore. njcho@ntu.edu","njcho@ntu.edu.sg"
"1391","34259262","10.1039/d1cs00317h","Chemical design principles of next-generation antiviral surface coatings.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has accelerated efforts to develop high-performance antiviral surface coatings while highlighting the need to build a strong mechanistic understanding of the chemical design principles that underpin antiviral surface coatings. Herein, we critically summarize the latest efforts to develop antiviral surface coatings that exhibit virus-inactivating functions through disrupting lipid envelopes or protein capsids. Particular attention is focuse","2021","07","16","Chem Soc Rev","Chemical Society reviews",NA,"Yoon","Bo Kyeong","School of Chemical Engineering and Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16419, Republic of Korea. jjackman@skku","jjackman@skku.edu"
"1392","34259262","10.1039/d1cs00317h","Chemical design principles of next-generation antiviral surface coatings.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has accelerated efforts to develop high-performance antiviral surface coatings while highlighting the need to build a strong mechanistic understanding of the chemical design principles that underpin antiviral surface coatings. Herein, we critically summarize the latest efforts to develop antiviral surface coatings that exhibit virus-inactivating functions through disrupting lipid envelopes or protein capsids. Particular attention is focuse","2021","07","16","Chem Soc Rev","Chemical Society reviews",NA,"Jackman","Joshua A","School of Chemical Engineering and Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16419, Republic of Korea. jjackman@skku","jjackman@skku.edu"
"1393","34259262","10.1039/d1cs00317h","Chemical design principles of next-generation antiviral surface coatings.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has accelerated efforts to develop high-performance antiviral surface coatings while highlighting the need to build a strong mechanistic understanding of the chemical design principles that underpin antiviral surface coatings. Herein, we critically summarize the latest efforts to develop antiviral surface coatings that exhibit virus-inactivating functions through disrupting lipid envelopes or protein capsids. Particular attention is focuse","2021","07","16","Chem Soc Rev","Chemical Society reviews",NA,"Cho","Nam-Joon","School of Materials Science and Engineering, Nanyang Technological University, 639798, Singapore. njcho@ntu.edu","njcho@ntu.edu.sg"
"1394","34259262","10.1039/d1cs00317h","Chemical design principles of next-generation antiviral surface coatings.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has accelerated efforts to develop high-performance antiviral surface coatings while highlighting the need to build a strong mechanistic understanding of the chemical design principles that underpin antiviral surface coatings. Herein, we critically summarize the latest efforts to develop antiviral surface coatings that exhibit virus-inactivating functions through disrupting lipid envelopes or protein capsids. Particular attention is focuse","2021","07","16","Chem Soc Rev","Chemical Society reviews",NA,"Majima","Tetsuro","Hubei Key Laboratory of Bioinorganic Chemistry &amp","t.majima@hust.edu.cn"
"1395","34259195","10.4103/ijmr.ijmr_1353_21","A focus on the spread of the delta variant of SARS-CoV-2 in India.",NA,"2021","07","14","Indian J Med Res","The Indian journal of medical research",NA,"Novelli","Giuseppe","Department of Biomedicine &amp",NA
"1396","34259195","10.4103/ijmr.ijmr_1353_21","A focus on the spread of the delta variant of SARS-CoV-2 in India.",NA,"2021","07","14","Indian J Med Res","The Indian journal of medical research",NA,"Colona","Vito Luigi","Department of Biomedicine &amp",NA
"1397","34259195","10.4103/ijmr.ijmr_1353_21","A focus on the spread of the delta variant of SARS-CoV-2 in India.",NA,"2021","07","14","Indian J Med Res","The Indian journal of medical research",NA,"Pandolfi","Pier Paolo","Department of Molecular Biotechnology &amp",NA
"1398","34259194","10.4103/ijmr.ijmr_1628_21","Clinical profile of hospitalized COVID-19 patients in first &amp; second wave of the pandemic: Insights from an Indian registry based observational study.",": India witnessed a massive second surge of COVID-19 cases since March 2021 after a period of decline from September 2020. Data collected under the National Clinical Registry for COVID-19 (NCRC) were analysed to describe the differences in demographic and clinical features of COVID-19 patients recruited during these two successive waves. : The NCRC, launched in September 2020, is an ongoing multicentre observational initiative, which provided the platform for the current investigation. Demograph","2021","07","14","Indian J Med Res","The Indian journal of medical research",NA,"Kumar","Gunjan","Clinical Studies, Trial &amp",NA
"1399","34259194","10.4103/ijmr.ijmr_1628_21","Clinical profile of hospitalized COVID-19 patients in first &amp; second wave of the pandemic: Insights from an Indian registry based observational study.",": India witnessed a massive second surge of COVID-19 cases since March 2021 after a period of decline from September 2020. Data collected under the National Clinical Registry for COVID-19 (NCRC) were analysed to describe the differences in demographic and clinical features of COVID-19 patients recruited during these two successive waves. : The NCRC, launched in September 2020, is an ongoing multicentre observational initiative, which provided the platform for the current investigation. Demograph","2021","07","14","Indian J Med Res","The Indian journal of medical research",NA,"Mukherjee","Aparna","Clinical Studies, Trial &amp",NA
"1400","34259194","10.4103/ijmr.ijmr_1628_21","Clinical profile of hospitalized COVID-19 patients in first &amp; second wave of the pandemic: Insights from an Indian registry based observational study.",": India witnessed a massive second surge of COVID-19 cases since March 2021 after a period of decline from September 2020. Data collected under the National Clinical Registry for COVID-19 (NCRC) were analysed to describe the differences in demographic and clinical features of COVID-19 patients recruited during these two successive waves. : The NCRC, launched in September 2020, is an ongoing multicentre observational initiative, which provided the platform for the current investigation. Demograph","2021","07","14","Indian J Med Res","The Indian journal of medical research",NA,"Sharma","Ravendra K","ICMR-National Institute of Medical Statistics, New Delhi, India",NA
"1401","34259194","10.4103/ijmr.ijmr_1628_21","Clinical profile of hospitalized COVID-19 patients in first &amp; second wave of the pandemic: Insights from an Indian registry based observational study.",": India witnessed a massive second surge of COVID-19 cases since March 2021 after a period of decline from September 2020. Data collected under the National Clinical Registry for COVID-19 (NCRC) were analysed to describe the differences in demographic and clinical features of COVID-19 patients recruited during these two successive waves. : The NCRC, launched in September 2020, is an ongoing multicentre observational initiative, which provided the platform for the current investigation. Demograph","2021","07","14","Indian J Med Res","The Indian journal of medical research",NA,"Menon","Geetha R","ICMR-National Institute of Medical Statistics, New Delhi, India",NA
"1402","34259194","10.4103/ijmr.ijmr_1628_21","Clinical profile of hospitalized COVID-19 patients in first &amp; second wave of the pandemic: Insights from an Indian registry based observational study.",": India witnessed a massive second surge of COVID-19 cases since March 2021 after a period of decline from September 2020. Data collected under the National Clinical Registry for COVID-19 (NCRC) were analysed to describe the differences in demographic and clinical features of COVID-19 patients recruited during these two successive waves. : The NCRC, launched in September 2020, is an ongoing multicentre observational initiative, which provided the platform for the current investigation. Demograph","2021","07","14","Indian J Med Res","The Indian journal of medical research",NA,"Sahu","Damodar","ICMR-National Institute of Medical Statistics, New Delhi, India",NA
"1403","34259194","10.4103/ijmr.ijmr_1628_21","Clinical profile of hospitalized COVID-19 patients in first &amp; second wave of the pandemic: Insights from an Indian registry based observational study.",": India witnessed a massive second surge of COVID-19 cases since March 2021 after a period of decline from September 2020. Data collected under the National Clinical Registry for COVID-19 (NCRC) were analysed to describe the differences in demographic and clinical features of COVID-19 patients recruited during these two successive waves. : The NCRC, launched in September 2020, is an ongoing multicentre observational initiative, which provided the platform for the current investigation. Demograph","2021","07","14","Indian J Med Res","The Indian journal of medical research",NA,"Wig","Naveet","Department of Medicine, All India Institute of Medical Sciences, New Delhi, India",NA
"1404","34259194","10.4103/ijmr.ijmr_1628_21","Clinical profile of hospitalized COVID-19 patients in first &amp; second wave of the pandemic: Insights from an Indian registry based observational study.",": India witnessed a massive second surge of COVID-19 cases since March 2021 after a period of decline from September 2020. Data collected under the National Clinical Registry for COVID-19 (NCRC) were analysed to describe the differences in demographic and clinical features of COVID-19 patients recruited during these two successive waves. : The NCRC, launched in September 2020, is an ongoing multicentre observational initiative, which provided the platform for the current investigation. Demograph","2021","07","14","Indian J Med Res","The Indian journal of medical research",NA,"Panda","Samiran","Division of Epidemiology &amp",NA
"1405","34259194","10.4103/ijmr.ijmr_1628_21","Clinical profile of hospitalized COVID-19 patients in first &amp; second wave of the pandemic: Insights from an Indian registry based observational study.",": India witnessed a massive second surge of COVID-19 cases since March 2021 after a period of decline from September 2020. Data collected under the National Clinical Registry for COVID-19 (NCRC) were analysed to describe the differences in demographic and clinical features of COVID-19 patients recruited during these two successive waves. : The NCRC, launched in September 2020, is an ongoing multicentre observational initiative, which provided the platform for the current investigation. Demograph","2021","07","14","Indian J Med Res","The Indian journal of medical research",NA,"Rao","Vishnu Vardhan","ICMR-National Institute of Medical Statistics, New Delhi, India",NA
"1406","34259194","10.4103/ijmr.ijmr_1628_21","Clinical profile of hospitalized COVID-19 patients in first &amp; second wave of the pandemic: Insights from an Indian registry based observational study.",": India witnessed a massive second surge of COVID-19 cases since March 2021 after a period of decline from September 2020. Data collected under the National Clinical Registry for COVID-19 (NCRC) were analysed to describe the differences in demographic and clinical features of COVID-19 patients recruited during these two successive waves. : The NCRC, launched in September 2020, is an ongoing multicentre observational initiative, which provided the platform for the current investigation. Demograph","2021","07","14","Indian J Med Res","The Indian journal of medical research",NA,"Singh","Sujeet","National Centre for Disease Control, New Delhi, India",NA
"1407","34259194","10.4103/ijmr.ijmr_1628_21","Clinical profile of hospitalized COVID-19 patients in first &amp; second wave of the pandemic: Insights from an Indian registry based observational study.",": India witnessed a massive second surge of COVID-19 cases since March 2021 after a period of decline from September 2020. Data collected under the National Clinical Registry for COVID-19 (NCRC) were analysed to describe the differences in demographic and clinical features of COVID-19 patients recruited during these two successive waves. : The NCRC, launched in September 2020, is an ongoing multicentre observational initiative, which provided the platform for the current investigation. Demograph","2021","07","14","Indian J Med Res","The Indian journal of medical research",NA,"Guleria","Randeep","All India Institute of Medical Sciences, New Delhi, India",NA
"1408","34259194","10.4103/ijmr.ijmr_1628_21","Clinical profile of hospitalized COVID-19 patients in first &amp; second wave of the pandemic: Insights from an Indian registry based observational study.",": India witnessed a massive second surge of COVID-19 cases since March 2021 after a period of decline from September 2020. Data collected under the National Clinical Registry for COVID-19 (NCRC) were analysed to describe the differences in demographic and clinical features of COVID-19 patients recruited during these two successive waves. : The NCRC, launched in September 2020, is an ongoing multicentre observational initiative, which provided the platform for the current investigation. Demograph","2021","07","14","Indian J Med Res","The Indian journal of medical research",NA,"Bhargava","Balram","Indian Council of Medical Research, New Delhi,, India",NA
"1409","34259190","10.4103/lungindia.lungindia_170_21","Differences in clinical and lab characteristics between adults and children hospitalized with COVID-19 infection over a 2-month period at a tertiary COVID care center: A cross-sectional study.",NA,"2021","07","14","Lung India","Lung India : official organ of Indian Chest Society",NA,"Rai","Deependra Kumar","Department of Pulmonary Medicine, AIIMS, Patna, Bihar, India",NA
"1410","34259190","10.4103/lungindia.lungindia_170_21","Differences in clinical and lab characteristics between adults and children hospitalized with COVID-19 infection over a 2-month period at a tertiary COVID care center: A cross-sectional study.",NA,"2021","07","14","Lung India","Lung India : official organ of Indian Chest Society",NA,"Sahay","Nishant","Department of Anaesthesiology, AIIMS, Patna, Bihar, India",NA
"1411","34259190","10.4103/lungindia.lungindia_170_21","Differences in clinical and lab characteristics between adults and children hospitalized with COVID-19 infection over a 2-month period at a tertiary COVID care center: A cross-sectional study.",NA,"2021","07","14","Lung India","Lung India : official organ of Indian Chest Society",NA,"Kumar","Ameet","Department of Pulmonary Medicine, AIIMS, Patna, Bihar, India",NA
"1412","34259182","10.4103/lungindia.lungindia_883_20","Placing the results of the SOLIDARITY trial with regards to remdesivir in perspective.","Remdesivir, a repurposed antiviral, was first accorded approval by the US Food Drug Administration (FDA) for the treatment of COVID-19 which necessitates hospitalization. However, the interim data of SOLIDARITY trial revealed no benefits with remdesivir for COVID-19 patients which led immediate debates in social media and the press about the utility of the drug. Both preclinical and clinical data demonstrated its efficacy in COVID-19. The recently concluded ACTT-1 trial showed its efficacy in re","2021","07","14","Lung India","Lung India : official organ of Indian Chest Society","Antivirals; clinical data; endpoints; timing of therapy; trial design","Bose","Debdipta","Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India",NA
"1413","34259182","10.4103/lungindia.lungindia_883_20","Placing the results of the SOLIDARITY trial with regards to remdesivir in perspective.","Remdesivir, a repurposed antiviral, was first accorded approval by the US Food Drug Administration (FDA) for the treatment of COVID-19 which necessitates hospitalization. However, the interim data of SOLIDARITY trial revealed no benefits with remdesivir for COVID-19 patients which led immediate debates in social media and the press about the utility of the drug. Both preclinical and clinical data demonstrated its efficacy in COVID-19. The recently concluded ACTT-1 trial showed its efficacy in re","2021","07","14","Lung India","Lung India : official organ of Indian Chest Society","Antivirals; clinical data; endpoints; timing of therapy; trial design","Gogtay","Nithya Jaideep","Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India",NA
"1414","34259182","10.4103/lungindia.lungindia_883_20","Placing the results of the SOLIDARITY trial with regards to remdesivir in perspective.","Remdesivir, a repurposed antiviral, was first accorded approval by the US Food Drug Administration (FDA) for the treatment of COVID-19 which necessitates hospitalization. However, the interim data of SOLIDARITY trial revealed no benefits with remdesivir for COVID-19 patients which led immediate debates in social media and the press about the utility of the drug. Both preclinical and clinical data demonstrated its efficacy in COVID-19. The recently concluded ACTT-1 trial showed its efficacy in re","2021","07","14","Lung India","Lung India : official organ of Indian Chest Society","Antivirals; clinical data; endpoints; timing of therapy; trial design","Rajan","Sujeet K","Department of Chest Medicine, Bombay Hospital and Research Center, Mumbai, Maharashtra, India",NA
"1415","34259181","10.4103/lungindia.lungindia_181_21","Should COVID-19 vaccination be made mandatory?",NA,"2021","07","14","Lung India","Lung India : official organ of Indian Chest Society",NA,"Iyengar","Karthikeyan P","Department of Orthopaedics, Southport and Ormskirk NHS Trust, Southport, UK",NA
"1416","34259181","10.4103/lungindia.lungindia_181_21","Should COVID-19 vaccination be made mandatory?",NA,"2021","07","14","Lung India","Lung India : official organ of Indian Chest Society",NA,"Singh","Bijayendra","Department of Orthopaedics, Canterbury Christ Church University, Medway NHS Foundation Trust, NY, UK",NA
"1417","34259181","10.4103/lungindia.lungindia_181_21","Should COVID-19 vaccination be made mandatory?",NA,"2021","07","14","Lung India","Lung India : official organ of Indian Chest Society",NA,"Vaishya","Raju","Department of Orthopaedics, Indraprastha Apollo Hospital, Sarita Vihar, New Delhi, India",NA
"1418","34259181","10.4103/lungindia.lungindia_181_21","Should COVID-19 vaccination be made mandatory?",NA,"2021","07","14","Lung India","Lung India : official organ of Indian Chest Society",NA,"Jain","Vijay Kumar","Department of Orthopaedics, Atal Bihari Vajpayee Institute of Medical Sciences, Dr Ram Manohar Lohia Hospital, New Delhi, India",NA
"1419","34259181","10.4103/lungindia.lungindia_181_21","Should COVID-19 vaccination be made mandatory?",NA,"2021","07","14","Lung India","Lung India : official organ of Indian Chest Society",NA,"Ish","Pranav","Department of Pulmonary, Critical Care and Sleep Medicine, VMMC and Safdarjung Hospital, New Delhi, India",NA
"1420","34259180","10.4103/lungindia.lungindia_187_21","COVID 19: Have we nailed it?",NA,"2021","07","14","Lung India","Lung India : official organ of Indian Chest Society",NA,"Gogia","Atul","Department of Internal Medicine, Sir Ganga Ram Hospital, New Delhi, India",NA
"1421","34259173","10.4103/lungindia.lungindia_919_20","Demystifying COVID-19 lung pathology: A clinicopathological study of postmortem core needle biopsy.","Atypical presentation of coronavirus disease-19 (COVID-19) from classic acute respiratory distress syndrome needs to be extensively evaluated to understand the pathophysiology to optimize the management protocol for severely ill patients to abrogate the terminal event. Autopsy core needle biopsies of lungs were obtained from 12 patients who died with COVID-19. Routine histopathological examination of lung tissue along with immunohistochemical analysis of C4d complement staining was studied. Form","2021","07","14","Lung India","Lung India : official organ of Indian Chest Society","COVID-19 pathology; lung biopsy; reverse transcription-polymerase chain reaction","Bhandari","Sudhir","Department of General Medicine, SMS Medical College and Attached Group of Hospital, Jaipur, Rajasthan, India",NA
"1422","34259173","10.4103/lungindia.lungindia_919_20","Demystifying COVID-19 lung pathology: A clinicopathological study of postmortem core needle biopsy.","Atypical presentation of coronavirus disease-19 (COVID-19) from classic acute respiratory distress syndrome needs to be extensively evaluated to understand the pathophysiology to optimize the management protocol for severely ill patients to abrogate the terminal event. Autopsy core needle biopsies of lungs were obtained from 12 patients who died with COVID-19. Routine histopathological examination of lung tissue along with immunohistochemical analysis of C4d complement staining was studied. Form","2021","07","14","Lung India","Lung India : official organ of Indian Chest Society","COVID-19 pathology; lung biopsy; reverse transcription-polymerase chain reaction","Solanki","Ranjana","Department of Pathology, SMS Medical College and Attached Group of Hospital, Jaipur, Rajasthan, India",NA
"1423","34259173","10.4103/lungindia.lungindia_919_20","Demystifying COVID-19 lung pathology: A clinicopathological study of postmortem core needle biopsy.","Atypical presentation of coronavirus disease-19 (COVID-19) from classic acute respiratory distress syndrome needs to be extensively evaluated to understand the pathophysiology to optimize the management protocol for severely ill patients to abrogate the terminal event. Autopsy core needle biopsies of lungs were obtained from 12 patients who died with COVID-19. Routine histopathological examination of lung tissue along with immunohistochemical analysis of C4d complement staining was studied. Form","2021","07","14","Lung India","Lung India : official organ of Indian Chest Society","COVID-19 pathology; lung biopsy; reverse transcription-polymerase chain reaction","Jindal","Arpita","Department of Pathology, SMS Medical College and Attached Group of Hospital, Jaipur, Rajasthan, India",NA
"1424","34259173","10.4103/lungindia.lungindia_919_20","Demystifying COVID-19 lung pathology: A clinicopathological study of postmortem core needle biopsy.","Atypical presentation of coronavirus disease-19 (COVID-19) from classic acute respiratory distress syndrome needs to be extensively evaluated to understand the pathophysiology to optimize the management protocol for severely ill patients to abrogate the terminal event. Autopsy core needle biopsies of lungs were obtained from 12 patients who died with COVID-19. Routine histopathological examination of lung tissue along with immunohistochemical analysis of C4d complement staining was studied. Form","2021","07","14","Lung India","Lung India : official organ of Indian Chest Society","COVID-19 pathology; lung biopsy; reverse transcription-polymerase chain reaction","Rankawat","Govind","Department of General Medicine, SMS Medical College and Attached Group of Hospital, Jaipur, Rajasthan, India",NA
"1425","34259173","10.4103/lungindia.lungindia_919_20","Demystifying COVID-19 lung pathology: A clinicopathological study of postmortem core needle biopsy.","Atypical presentation of coronavirus disease-19 (COVID-19) from classic acute respiratory distress syndrome needs to be extensively evaluated to understand the pathophysiology to optimize the management protocol for severely ill patients to abrogate the terminal event. Autopsy core needle biopsies of lungs were obtained from 12 patients who died with COVID-19. Routine histopathological examination of lung tissue along with immunohistochemical analysis of C4d complement staining was studied. Form","2021","07","14","Lung India","Lung India : official organ of Indian Chest Society","COVID-19 pathology; lung biopsy; reverse transcription-polymerase chain reaction","Pathak","Deepali","Department of Forensic Medicine, SMS Medical College and Attached Group of Hospital, Jaipur, Rajasthan, India",NA
"1426","34259173","10.4103/lungindia.lungindia_919_20","Demystifying COVID-19 lung pathology: A clinicopathological study of postmortem core needle biopsy.","Atypical presentation of coronavirus disease-19 (COVID-19) from classic acute respiratory distress syndrome needs to be extensively evaluated to understand the pathophysiology to optimize the management protocol for severely ill patients to abrogate the terminal event. Autopsy core needle biopsies of lungs were obtained from 12 patients who died with COVID-19. Routine histopathological examination of lung tissue along with immunohistochemical analysis of C4d complement staining was studied. Form","2021","07","14","Lung India","Lung India : official organ of Indian Chest Society","COVID-19 pathology; lung biopsy; reverse transcription-polymerase chain reaction","Bagarhatta","Meenu","Department of Radiodiagnosis, SMS Medical College and Attached Group of Hospital, Jaipur, Rajasthan, India",NA
"1427","34259173","10.4103/lungindia.lungindia_919_20","Demystifying COVID-19 lung pathology: A clinicopathological study of postmortem core needle biopsy.","Atypical presentation of coronavirus disease-19 (COVID-19) from classic acute respiratory distress syndrome needs to be extensively evaluated to understand the pathophysiology to optimize the management protocol for severely ill patients to abrogate the terminal event. Autopsy core needle biopsies of lungs were obtained from 12 patients who died with COVID-19. Routine histopathological examination of lung tissue along with immunohistochemical analysis of C4d complement staining was studied. Form","2021","07","14","Lung India","Lung India : official organ of Indian Chest Society","COVID-19 pathology; lung biopsy; reverse transcription-polymerase chain reaction","Singh","Ajeet","Department of General Medicine, SMS Medical College and Attached Group of Hospital, Jaipur, Rajasthan, India",NA
"1428","34259149","10.2174/1573405617666210713113439","Diagnosis of COVID-19 Using Machine Learning and Deep Learning: A Review.","This paper provides a systematic review of the application of artificial intelligence (AI) in the form of machine learning (ML) and deep learning (DL) techniques in fighting against the effects of novel coronavirus disease (COVID-19). The objective is to perform a scoping review on AI for COVID-19 using preferred reporting items of systematic reviews and meta-analysis (PRISMA) guidelines. A literature search was performed for relevant studies published from 1 January 2020 till 27 March 2021. Out","2021","07","14","Curr Med Imaging","Current medical imaging","Artificial intelligence; COVID-19; X-ray; computed tomography; coronavirus; deep learning; forecasting; machine learning; transfer learning; ultrasound imaging","Mondal","M Rubaiyat Hossain","Institute of ICT, Bangladesh University of Engineering and Technology, Dhaka-1205, Bangladesh",NA
"1429","34259149","10.2174/1573405617666210713113439","Diagnosis of COVID-19 Using Machine Learning and Deep Learning: A Review.","This paper provides a systematic review of the application of artificial intelligence (AI) in the form of machine learning (ML) and deep learning (DL) techniques in fighting against the effects of novel coronavirus disease (COVID-19). The objective is to perform a scoping review on AI for COVID-19 using preferred reporting items of systematic reviews and meta-analysis (PRISMA) guidelines. A literature search was performed for relevant studies published from 1 January 2020 till 27 March 2021. Out","2021","07","14","Curr Med Imaging","Current medical imaging","Artificial intelligence; COVID-19; X-ray; computed tomography; coronavirus; deep learning; forecasting; machine learning; transfer learning; ultrasound imaging","Bharati","Subrato","Institute of ICT, Bangladesh University of Engineering and Technology, Dhaka-1205, Bangladesh",NA
"1430","34259149","10.2174/1573405617666210713113439","Diagnosis of COVID-19 Using Machine Learning and Deep Learning: A Review.","This paper provides a systematic review of the application of artificial intelligence (AI) in the form of machine learning (ML) and deep learning (DL) techniques in fighting against the effects of novel coronavirus disease (COVID-19). The objective is to perform a scoping review on AI for COVID-19 using preferred reporting items of systematic reviews and meta-analysis (PRISMA) guidelines. A literature search was performed for relevant studies published from 1 January 2020 till 27 March 2021. Out","2021","07","14","Curr Med Imaging","Current medical imaging","Artificial intelligence; COVID-19; X-ray; computed tomography; coronavirus; deep learning; forecasting; machine learning; transfer learning; ultrasound imaging","Podder","Prajoy","Institute of ICT, Bangladesh University of Engineering and Technology, Dhaka-1205, Bangladesh",NA
"1431","34259124","10.1080/00224545.2021.1918618","Further evidence for motivated helplessness in the context of the COVID-19 outbreak: the case of Argentina before and during the pandemic.","According to the motivated helplessness hypothesis, a sense of helplessness in coping with threats in a specific domain can serve an anxiety-buffering function. The purpose of this study was to test this hypothesis in the context of the coronavirus (COVID-19) pandemic in Argentina, using data collected before and during the pandemic. Findings supported the motivated helplessness hypothesis: Whereas feelings of helplessness to avoid being infected with COVID-19 were positively related to fear of ","2021","07","14","J Soc Psychol","The Journal of social psychology","Anxiety; Covid-19; fear; health behavior; helplessness; motivation; threat","Lifshin","Uri","Interdisciplinary Center (IDC) Herzliya",NA
"1432","34259124","10.1080/00224545.2021.1918618","Further evidence for motivated helplessness in the context of the COVID-19 outbreak: the case of Argentina before and during the pandemic.","According to the motivated helplessness hypothesis, a sense of helplessness in coping with threats in a specific domain can serve an anxiety-buffering function. The purpose of this study was to test this hypothesis in the context of the coronavirus (COVID-19) pandemic in Argentina, using data collected before and during the pandemic. Findings supported the motivated helplessness hypothesis: Whereas feelings of helplessness to avoid being infected with COVID-19 were positively related to fear of ","2021","07","14","J Soc Psychol","The Journal of social psychology","Anxiety; Covid-19; fear; health behavior; helplessness; motivation; threat","Mikulincer","Mario","Interdisciplinary Center (IDC) Herzliya",NA
"1433","34259122","10.1080/10872981.2021.1953953","Augmented reality in medical education: students' experiences and learning outcomes.","Augmented reality (AR) is a relatively new technology that allows for digitally generated three-dimensional representations to be integrated with real environmental stimuli. AR can make use of smart phones, tablets, or other devices to achieve a highly stimulating learning environment and hands-on immersive experience. The use of AR in industry is becoming widespread with applications being developed for use not just for entertainment and gaming but also healthcare, retail and marketing, educati","2021","07","20","Med Educ Online","Medical education online","Augmented reality; education technology; learning outcomes; medical education; online learning; Augmented Reality; COVID-19; Clinical Competence; Computer-Assisted Instruction; Education, Distance; Education, Medical, Undergraduate; Humans; Learning; Schools, Medical; Students, Medical","Dhar","Poshmaal","Institute for Innovation in Mental and Physical Health and Clinical Translation, School of Medicine, Faculty of Health, Deakin University, Geelong, Australia",NA
"1434","34259122","10.1080/10872981.2021.1953953","Augmented reality in medical education: students' experiences and learning outcomes.","Augmented reality (AR) is a relatively new technology that allows for digitally generated three-dimensional representations to be integrated with real environmental stimuli. AR can make use of smart phones, tablets, or other devices to achieve a highly stimulating learning environment and hands-on immersive experience. The use of AR in industry is becoming widespread with applications being developed for use not just for entertainment and gaming but also healthcare, retail and marketing, educati","2021","07","20","Med Educ Online","Medical education online","Augmented reality; education technology; learning outcomes; medical education; online learning; Augmented Reality; COVID-19; Clinical Competence; Computer-Assisted Instruction; Education, Distance; Education, Medical, Undergraduate; Humans; Learning; Schools, Medical; Students, Medical","Rocks","Tetyana","Institute for Innovation in Mental and Physical Health and Clinical Translation, Food and Mood Centre, School of Medicine, Faculty of Health, Deakin University, Geelong, Australia",NA
"1435","34259122","10.1080/10872981.2021.1953953","Augmented reality in medical education: students' experiences and learning outcomes.","Augmented reality (AR) is a relatively new technology that allows for digitally generated three-dimensional representations to be integrated with real environmental stimuli. AR can make use of smart phones, tablets, or other devices to achieve a highly stimulating learning environment and hands-on immersive experience. The use of AR in industry is becoming widespread with applications being developed for use not just for entertainment and gaming but also healthcare, retail and marketing, educati","2021","07","20","Med Educ Online","Medical education online","Augmented reality; education technology; learning outcomes; medical education; online learning; Augmented Reality; COVID-19; Clinical Competence; Computer-Assisted Instruction; Education, Distance; Education, Medical, Undergraduate; Humans; Learning; Schools, Medical; Students, Medical","Samarasinghe","Rasika M","Institute for Innovation in Mental and Physical Health and Clinical Translation, School of Medicine, Faculty of Health, Deakin University, Geelong, Australia",NA
"1436","34259122","10.1080/10872981.2021.1953953","Augmented reality in medical education: students' experiences and learning outcomes.","Augmented reality (AR) is a relatively new technology that allows for digitally generated three-dimensional representations to be integrated with real environmental stimuli. AR can make use of smart phones, tablets, or other devices to achieve a highly stimulating learning environment and hands-on immersive experience. The use of AR in industry is becoming widespread with applications being developed for use not just for entertainment and gaming but also healthcare, retail and marketing, educati","2021","07","20","Med Educ Online","Medical education online","Augmented reality; education technology; learning outcomes; medical education; online learning; Augmented Reality; COVID-19; Clinical Competence; Computer-Assisted Instruction; Education, Distance; Education, Medical, Undergraduate; Humans; Learning; Schools, Medical; Students, Medical","Stephenson","Garth","Institute for Innovation in Mental and Physical Health and Clinical Translation, School of Medicine, Faculty of Health, Deakin University, Geelong, Australia",NA
"1437","34259122","10.1080/10872981.2021.1953953","Augmented reality in medical education: students' experiences and learning outcomes.","Augmented reality (AR) is a relatively new technology that allows for digitally generated three-dimensional representations to be integrated with real environmental stimuli. AR can make use of smart phones, tablets, or other devices to achieve a highly stimulating learning environment and hands-on immersive experience. The use of AR in industry is becoming widespread with applications being developed for use not just for entertainment and gaming but also healthcare, retail and marketing, educati","2021","07","20","Med Educ Online","Medical education online","Augmented reality; education technology; learning outcomes; medical education; online learning; Augmented Reality; COVID-19; Clinical Competence; Computer-Assisted Instruction; Education, Distance; Education, Medical, Undergraduate; Humans; Learning; Schools, Medical; Students, Medical","Smith","Craig","Institute for Innovation in Mental and Physical Health and Clinical Translation, School of Medicine, Faculty of Health, Deakin University, Geelong, Australia",NA
"1438","34259104","10.1080/10408398.2021.1952160","Africa and the Nexus of poverty, malnutrition and diseases.","This review examines the nexus of poverty, malnutrition and diseases in Africa, the challenges, implications and their mitigation. The paper takes a critical look at available literatures on the primary causes, modes, implications and solutions to the problems of poverty, malnutrition and diseases in Africa continent. Poverty and malnutrition are outcomes of uncontrolled rapid population growth, inefficient agricultural and industrial practices, high debt profile of many African countries due to","2021","07","14","Crit Rev Food Sci Nutr","Critical reviews in food science and nutrition","Africa; diseases; malnutrition; nexus; poverty","Adeyeye","Samuel Ayofemi O","Department of Food Technology, Hindustan Institute of Technology &amp",NA
"1439","34259104","10.1080/10408398.2021.1952160","Africa and the Nexus of poverty, malnutrition and diseases.","This review examines the nexus of poverty, malnutrition and diseases in Africa, the challenges, implications and their mitigation. The paper takes a critical look at available literatures on the primary causes, modes, implications and solutions to the problems of poverty, malnutrition and diseases in Africa continent. Poverty and malnutrition are outcomes of uncontrolled rapid population growth, inefficient agricultural and industrial practices, high debt profile of many African countries due to","2021","07","14","Crit Rev Food Sci Nutr","Critical reviews in food science and nutrition","Africa; diseases; malnutrition; nexus; poverty","Ashaolu","Tolulope J","Institute of Research and Development, Duy Tan University, Da Nang, Viet Nam",NA
"1440","34259104","10.1080/10408398.2021.1952160","Africa and the Nexus of poverty, malnutrition and diseases.","This review examines the nexus of poverty, malnutrition and diseases in Africa, the challenges, implications and their mitigation. The paper takes a critical look at available literatures on the primary causes, modes, implications and solutions to the problems of poverty, malnutrition and diseases in Africa continent. Poverty and malnutrition are outcomes of uncontrolled rapid population growth, inefficient agricultural and industrial practices, high debt profile of many African countries due to","2021","07","14","Crit Rev Food Sci Nutr","Critical reviews in food science and nutrition","Africa; diseases; malnutrition; nexus; poverty","Bolaji","Olusola T","Department of Food Technology, Lagos State Polytechnic, Ikorodu, Nigeria",NA
"1441","34259104","10.1080/10408398.2021.1952160","Africa and the Nexus of poverty, malnutrition and diseases.","This review examines the nexus of poverty, malnutrition and diseases in Africa, the challenges, implications and their mitigation. The paper takes a critical look at available literatures on the primary causes, modes, implications and solutions to the problems of poverty, malnutrition and diseases in Africa continent. Poverty and malnutrition are outcomes of uncontrolled rapid population growth, inefficient agricultural and industrial practices, high debt profile of many African countries due to","2021","07","14","Crit Rev Food Sci Nutr","Critical reviews in food science and nutrition","Africa; diseases; malnutrition; nexus; poverty","Abegunde","Titilope A","Department of Food Technology, Lagos State Polytechnic, Ikorodu, Nigeria",NA
"1442","34259104","10.1080/10408398.2021.1952160","Africa and the Nexus of poverty, malnutrition and diseases.","This review examines the nexus of poverty, malnutrition and diseases in Africa, the challenges, implications and their mitigation. The paper takes a critical look at available literatures on the primary causes, modes, implications and solutions to the problems of poverty, malnutrition and diseases in Africa continent. Poverty and malnutrition are outcomes of uncontrolled rapid population growth, inefficient agricultural and industrial practices, high debt profile of many African countries due to","2021","07","14","Crit Rev Food Sci Nutr","Critical reviews in food science and nutrition","Africa; diseases; malnutrition; nexus; poverty","Omoyajowo","Adetola O","Department of Food Science &amp",NA
"1443","34259091","10.1080/10717544.2021.1951893","An <i>in vitro</i> visual study of fugitive aerosols released during aerosol therapy to an invasively ventilated simulated patient.","COVID-19 can cause serious respiratory complications resulting in the need for invasive ventilatory support and concurrent aerosol therapy. Aerosol therapy is considered a high risk procedure for the transmission of patient derived infectious aerosol droplets. Critical-care workers are considered to be at a high risk of inhaling such infectious droplets. The objective of this work was to use noninvasive optical methods to visualize the potential release of aerosol droplets during aerosol therapy","2021","07","20","Drug Deliv","Drug delivery","COVID-19; Schlieren imaging; aerosol therapy; fugitive emissions; invasive ventilation; jet nebulizer; pressurized metered dose inhaler; vibrating mesh nebulizer; Aerosols; COVID-19; Combined Modality Therapy; Disease Transmission, Infectious; Drug Delivery Systems; Humans; Metered Dose Inhalers; Nebulizers and Vaporizers; Occupational Exposure; Research Design; Respiration, Artificial; Respiratory Therapy; Risk Management; SARS-CoV-2","Mac Giolla Eain","Marc","Research and Development, Science and Emerging Technologies, Aerogen, Galway, Ireland",NA
"1444","34259091","10.1080/10717544.2021.1951893","An <i>in vitro</i> visual study of fugitive aerosols released during aerosol therapy to an invasively ventilated simulated patient.","COVID-19 can cause serious respiratory complications resulting in the need for invasive ventilatory support and concurrent aerosol therapy. Aerosol therapy is considered a high risk procedure for the transmission of patient derived infectious aerosol droplets. Critical-care workers are considered to be at a high risk of inhaling such infectious droplets. The objective of this work was to use noninvasive optical methods to visualize the potential release of aerosol droplets during aerosol therapy","2021","07","20","Drug Deliv","Drug delivery","COVID-19; Schlieren imaging; aerosol therapy; fugitive emissions; invasive ventilation; jet nebulizer; pressurized metered dose inhaler; vibrating mesh nebulizer; Aerosols; COVID-19; Combined Modality Therapy; Disease Transmission, Infectious; Drug Delivery Systems; Humans; Metered Dose Inhalers; Nebulizers and Vaporizers; Occupational Exposure; Research Design; Respiration, Artificial; Respiratory Therapy; Risk Management; SARS-CoV-2","Joyce","Mary","Research and Development, Science and Emerging Technologies, Aerogen, Galway, Ireland",NA
"1445","34259091","10.1080/10717544.2021.1951893","An <i>in vitro</i> visual study of fugitive aerosols released during aerosol therapy to an invasively ventilated simulated patient.","COVID-19 can cause serious respiratory complications resulting in the need for invasive ventilatory support and concurrent aerosol therapy. Aerosol therapy is considered a high risk procedure for the transmission of patient derived infectious aerosol droplets. Critical-care workers are considered to be at a high risk of inhaling such infectious droplets. The objective of this work was to use noninvasive optical methods to visualize the potential release of aerosol droplets during aerosol therapy","2021","07","20","Drug Deliv","Drug delivery","COVID-19; Schlieren imaging; aerosol therapy; fugitive emissions; invasive ventilation; jet nebulizer; pressurized metered dose inhaler; vibrating mesh nebulizer; Aerosols; COVID-19; Combined Modality Therapy; Disease Transmission, Infectious; Drug Delivery Systems; Humans; Metered Dose Inhalers; Nebulizers and Vaporizers; Occupational Exposure; Research Design; Respiration, Artificial; Respiratory Therapy; Risk Management; SARS-CoV-2","MacLoughlin","Ronan","Research and Development, Science and Emerging Technologies, Aerogen, Galway, Ireland",NA
"1446","34259086","10.1177/23247096211031135","Simultaneous Left Ventricular Aneurysm and Ventricular Septal Rupture Complicating Delayed STEMI Presentation: A Case-Based Review of Post-MI Mechanical Complications Amid the COVID-19 Pandemic.","Amid the coronavirus disease 2019 (COVID-19) pandemic, there is an unprecedented increase in public avoidance of hospitals predominantly driven by fear of contracting the virus. Recent publications highlight a re-emergence of rare post-myocardial infarction complications. While mechanical complications are infrequent in the era of primary percutaneous coronary intervention, they are associated with high mortality rates. The concurrent occurrence of mechanical complications such as left ventricul","2021","07","20","J Investig Med High Impact Case Rep","Journal of investigative medicine high impact case reports","ST-segment elevation myocardial infarction; coronavirus disease 2019; delayed MI presentation; left ventricular aneurysm; mechanical complications; ventricular septal rupture; COVID-19; Cardiac Surgical Procedures; Coronary Artery Bypass; Heart Aneurysm; Humans; Male; Middle Aged; ST Elevation Myocardial Infarction; Time-to-Treatment; Treatment Outcome; Ventricular Septal Rupture","Goraya","Muhammad Hassan Naeem","Services Institute of Medical Sciences, Lahore, Pakistan",NA
"1447","34259086","10.1177/23247096211031135","Simultaneous Left Ventricular Aneurysm and Ventricular Septal Rupture Complicating Delayed STEMI Presentation: A Case-Based Review of Post-MI Mechanical Complications Amid the COVID-19 Pandemic.","Amid the coronavirus disease 2019 (COVID-19) pandemic, there is an unprecedented increase in public avoidance of hospitals predominantly driven by fear of contracting the virus. Recent publications highlight a re-emergence of rare post-myocardial infarction complications. While mechanical complications are infrequent in the era of primary percutaneous coronary intervention, they are associated with high mortality rates. The concurrent occurrence of mechanical complications such as left ventricul","2021","07","20","J Investig Med High Impact Case Rep","Journal of investigative medicine high impact case reports","ST-segment elevation myocardial infarction; coronavirus disease 2019; delayed MI presentation; left ventricular aneurysm; mechanical complications; ventricular septal rupture; COVID-19; Cardiac Surgical Procedures; Coronary Artery Bypass; Heart Aneurysm; Humans; Male; Middle Aged; ST Elevation Myocardial Infarction; Time-to-Treatment; Treatment Outcome; Ventricular Septal Rupture","Kalsoom","Sidra","Conemaugh Memorial Medical Center, Johnstown, PA, USA",NA
"1448","34259086","10.1177/23247096211031135","Simultaneous Left Ventricular Aneurysm and Ventricular Septal Rupture Complicating Delayed STEMI Presentation: A Case-Based Review of Post-MI Mechanical Complications Amid the COVID-19 Pandemic.","Amid the coronavirus disease 2019 (COVID-19) pandemic, there is an unprecedented increase in public avoidance of hospitals predominantly driven by fear of contracting the virus. Recent publications highlight a re-emergence of rare post-myocardial infarction complications. While mechanical complications are infrequent in the era of primary percutaneous coronary intervention, they are associated with high mortality rates. The concurrent occurrence of mechanical complications such as left ventricul","2021","07","20","J Investig Med High Impact Case Rep","Journal of investigative medicine high impact case reports","ST-segment elevation myocardial infarction; coronavirus disease 2019; delayed MI presentation; left ventricular aneurysm; mechanical complications; ventricular septal rupture; COVID-19; Cardiac Surgical Procedures; Coronary Artery Bypass; Heart Aneurysm; Humans; Male; Middle Aged; ST Elevation Myocardial Infarction; Time-to-Treatment; Treatment Outcome; Ventricular Septal Rupture","Almas","Talal","Royal College of Surgeons in Ireland, Dublin, Ireland",NA
"1449","34259086","10.1177/23247096211031135","Simultaneous Left Ventricular Aneurysm and Ventricular Septal Rupture Complicating Delayed STEMI Presentation: A Case-Based Review of Post-MI Mechanical Complications Amid the COVID-19 Pandemic.","Amid the coronavirus disease 2019 (COVID-19) pandemic, there is an unprecedented increase in public avoidance of hospitals predominantly driven by fear of contracting the virus. Recent publications highlight a re-emergence of rare post-myocardial infarction complications. While mechanical complications are infrequent in the era of primary percutaneous coronary intervention, they are associated with high mortality rates. The concurrent occurrence of mechanical complications such as left ventricul","2021","07","20","J Investig Med High Impact Case Rep","Journal of investigative medicine high impact case reports","ST-segment elevation myocardial infarction; coronavirus disease 2019; delayed MI presentation; left ventricular aneurysm; mechanical complications; ventricular septal rupture; COVID-19; Cardiac Surgical Procedures; Coronary Artery Bypass; Heart Aneurysm; Humans; Male; Middle Aged; ST Elevation Myocardial Infarction; Time-to-Treatment; Treatment Outcome; Ventricular Septal Rupture","Amin","Muhammad Kashif","Texas Tech University Health Sciences Center, Amarillo, TX, USA",NA
"1450","34259086","10.1177/23247096211031135","Simultaneous Left Ventricular Aneurysm and Ventricular Septal Rupture Complicating Delayed STEMI Presentation: A Case-Based Review of Post-MI Mechanical Complications Amid the COVID-19 Pandemic.","Amid the coronavirus disease 2019 (COVID-19) pandemic, there is an unprecedented increase in public avoidance of hospitals predominantly driven by fear of contracting the virus. Recent publications highlight a re-emergence of rare post-myocardial infarction complications. While mechanical complications are infrequent in the era of primary percutaneous coronary intervention, they are associated with high mortality rates. The concurrent occurrence of mechanical complications such as left ventricul","2021","07","20","J Investig Med High Impact Case Rep","Journal of investigative medicine high impact case reports","ST-segment elevation myocardial infarction; coronavirus disease 2019; delayed MI presentation; left ventricular aneurysm; mechanical complications; ventricular septal rupture; COVID-19; Cardiac Surgical Procedures; Coronary Artery Bypass; Heart Aneurysm; Humans; Male; Middle Aged; ST Elevation Myocardial Infarction; Time-to-Treatment; Treatment Outcome; Ventricular Septal Rupture","Hussain","Nadeem","Banner-University Medical Center, Tucson, AZ, USA",NA
"1451","34259086","10.1177/23247096211031135","Simultaneous Left Ventricular Aneurysm and Ventricular Septal Rupture Complicating Delayed STEMI Presentation: A Case-Based Review of Post-MI Mechanical Complications Amid the COVID-19 Pandemic.","Amid the coronavirus disease 2019 (COVID-19) pandemic, there is an unprecedented increase in public avoidance of hospitals predominantly driven by fear of contracting the virus. Recent publications highlight a re-emergence of rare post-myocardial infarction complications. While mechanical complications are infrequent in the era of primary percutaneous coronary intervention, they are associated with high mortality rates. The concurrent occurrence of mechanical complications such as left ventricul","2021","07","20","J Investig Med High Impact Case Rep","Journal of investigative medicine high impact case reports","ST-segment elevation myocardial infarction; coronavirus disease 2019; delayed MI presentation; left ventricular aneurysm; mechanical complications; ventricular septal rupture; COVID-19; Cardiac Surgical Procedures; Coronary Artery Bypass; Heart Aneurysm; Humans; Male; Middle Aged; ST Elevation Myocardial Infarction; Time-to-Treatment; Treatment Outcome; Ventricular Septal Rupture","Awan","Junaid Rasul","University Hospital Limerick, Limerick, Ireland",NA
"1452","34259086","10.1177/23247096211031135","Simultaneous Left Ventricular Aneurysm and Ventricular Septal Rupture Complicating Delayed STEMI Presentation: A Case-Based Review of Post-MI Mechanical Complications Amid the COVID-19 Pandemic.","Amid the coronavirus disease 2019 (COVID-19) pandemic, there is an unprecedented increase in public avoidance of hospitals predominantly driven by fear of contracting the virus. Recent publications highlight a re-emergence of rare post-myocardial infarction complications. While mechanical complications are infrequent in the era of primary percutaneous coronary intervention, they are associated with high mortality rates. The concurrent occurrence of mechanical complications such as left ventricul","2021","07","20","J Investig Med High Impact Case Rep","Journal of investigative medicine high impact case reports","ST-segment elevation myocardial infarction; coronavirus disease 2019; delayed MI presentation; left ventricular aneurysm; mechanical complications; ventricular septal rupture; COVID-19; Cardiac Surgical Procedures; Coronary Artery Bypass; Heart Aneurysm; Humans; Male; Middle Aged; ST Elevation Myocardial Infarction; Time-to-Treatment; Treatment Outcome; Ventricular Septal Rupture","Ehtesham","Maryam","Royal College of Surgeons in Ireland, Dublin, Ireland",NA
"1453","34259086","10.1177/23247096211031135","Simultaneous Left Ventricular Aneurysm and Ventricular Septal Rupture Complicating Delayed STEMI Presentation: A Case-Based Review of Post-MI Mechanical Complications Amid the COVID-19 Pandemic.","Amid the coronavirus disease 2019 (COVID-19) pandemic, there is an unprecedented increase in public avoidance of hospitals predominantly driven by fear of contracting the virus. Recent publications highlight a re-emergence of rare post-myocardial infarction complications. While mechanical complications are infrequent in the era of primary percutaneous coronary intervention, they are associated with high mortality rates. The concurrent occurrence of mechanical complications such as left ventricul","2021","07","20","J Investig Med High Impact Case Rep","Journal of investigative medicine high impact case reports","ST-segment elevation myocardial infarction; coronavirus disease 2019; delayed MI presentation; left ventricular aneurysm; mechanical complications; ventricular septal rupture; COVID-19; Cardiac Surgical Procedures; Coronary Artery Bypass; Heart Aneurysm; Humans; Male; Middle Aged; ST Elevation Myocardial Infarction; Time-to-Treatment; Treatment Outcome; Ventricular Septal Rupture","Niaz","Muhammad Ali","Royal College of Surgeons in Ireland, Dublin, Ireland",NA
"1454","34259086","10.1177/23247096211031135","Simultaneous Left Ventricular Aneurysm and Ventricular Septal Rupture Complicating Delayed STEMI Presentation: A Case-Based Review of Post-MI Mechanical Complications Amid the COVID-19 Pandemic.","Amid the coronavirus disease 2019 (COVID-19) pandemic, there is an unprecedented increase in public avoidance of hospitals predominantly driven by fear of contracting the virus. Recent publications highlight a re-emergence of rare post-myocardial infarction complications. While mechanical complications are infrequent in the era of primary percutaneous coronary intervention, they are associated with high mortality rates. The concurrent occurrence of mechanical complications such as left ventricul","2021","07","20","J Investig Med High Impact Case Rep","Journal of investigative medicine high impact case reports","ST-segment elevation myocardial infarction; coronavirus disease 2019; delayed MI presentation; left ventricular aneurysm; mechanical complications; ventricular septal rupture; COVID-19; Cardiac Surgical Procedures; Coronary Artery Bypass; Heart Aneurysm; Humans; Male; Middle Aged; ST Elevation Myocardial Infarction; Time-to-Treatment; Treatment Outcome; Ventricular Septal Rupture","Virk","Hafeez Ul Hassan","University Hospitals Cleveland Medical Center, Cleveland, OH, USA",NA
"1455","34259086","10.1177/23247096211031135","Simultaneous Left Ventricular Aneurysm and Ventricular Septal Rupture Complicating Delayed STEMI Presentation: A Case-Based Review of Post-MI Mechanical Complications Amid the COVID-19 Pandemic.","Amid the coronavirus disease 2019 (COVID-19) pandemic, there is an unprecedented increase in public avoidance of hospitals predominantly driven by fear of contracting the virus. Recent publications highlight a re-emergence of rare post-myocardial infarction complications. While mechanical complications are infrequent in the era of primary percutaneous coronary intervention, they are associated with high mortality rates. The concurrent occurrence of mechanical complications such as left ventricul","2021","07","20","J Investig Med High Impact Case Rep","Journal of investigative medicine high impact case reports","ST-segment elevation myocardial infarction; coronavirus disease 2019; delayed MI presentation; left ventricular aneurysm; mechanical complications; ventricular septal rupture; COVID-19; Cardiac Surgical Procedures; Coronary Artery Bypass; Heart Aneurysm; Humans; Male; Middle Aged; ST Elevation Myocardial Infarction; Time-to-Treatment; Treatment Outcome; Ventricular Septal Rupture","Filby","Steven J","University Hospitals Cleveland Medical Center, Cleveland, OH, USA",NA
"1456","34259082","10.1177/13591053211014597","Financial distress and suicidal behaviour during COVID-19: Family identification attenuates the negative relationship between COVID-related financial distress and mental Ill-health.","COVID-19 provides a 'perfect storm' of social and economic suicide risk-factors. Recent research has evidenced an initial impact of the pandemic upon suicide rates, but has yet to understand how elevated financial threat and social isolation may predict suicide ideation/behaviour, or which social factors promote resilience. This study addressed these shortcomings. An online longitudinal survey study (N = 370) which took place from May to September 2020 showed COVID-related financial distr","2021","07","14","J Health Psychol","Journal of health psychology","COVID-19; financial stress; loneliness; social cure; suicide","Stevenson","Clifford","Department of Psychology, Nottingham Trent University, Nottingham, UK",NA
"1457","34259082","10.1177/13591053211014597","Financial distress and suicidal behaviour during COVID-19: Family identification attenuates the negative relationship between COVID-related financial distress and mental Ill-health.","COVID-19 provides a 'perfect storm' of social and economic suicide risk-factors. Recent research has evidenced an initial impact of the pandemic upon suicide rates, but has yet to understand how elevated financial threat and social isolation may predict suicide ideation/behaviour, or which social factors promote resilience. This study addressed these shortcomings. An online longitudinal survey study (N = 370) which took place from May to September 2020 showed COVID-related financial distr","2021","07","14","J Health Psychol","Journal of health psychology","COVID-19; financial stress; loneliness; social cure; suicide","Wakefield","Juliet Ruth Helen","Department of Psychology, Nottingham Trent University, Nottingham, UK",NA
"1458","34259075","10.1177/10105395211014636","COVID-19 Infection Epidemic in the South Pacific Island of New Caledonia and in the Greater Paris: Where Is the Highest Wave?","New-Caledonia, an island located in the South-Pacific, was the first (overseas) French country hit by the coronavirus disease-2019 (COVID-19) pandemic to come out of lockdown. The epidemic was rapidly controlled. Analyzing the impact of an epidemic only makes sense if it is compared with a zone with a similar health care system. To compare epidemic evolution in New-Caledonia and Paris suburb. Health care organization is similar in New-Caledonia and Seine-Saint-Denis, based on an Emergency Medica","2021","07","14","Asia Pac J Public Health","Asia-Pacific journal of public health","epidemiology; health care services; health informatics; health systems; primary health care","Merlin","Elisabeth","SAMU de Nouvelle-Calédonie, Nouméa Cedex, France",NA
"1459","34259075","10.1177/10105395211014636","COVID-19 Infection Epidemic in the South Pacific Island of New Caledonia and in the Greater Paris: Where Is the Highest Wave?","New-Caledonia, an island located in the South-Pacific, was the first (overseas) French country hit by the coronavirus disease-2019 (COVID-19) pandemic to come out of lockdown. The epidemic was rapidly controlled. Analyzing the impact of an epidemic only makes sense if it is compared with a zone with a similar health care system. To compare epidemic evolution in New-Caledonia and Paris suburb. Health care organization is similar in New-Caledonia and Seine-Saint-Denis, based on an Emergency Medica","2021","07","14","Asia Pac J Public Health","Asia-Pacific journal of public health","epidemiology; health care services; health informatics; health systems; primary health care","Goix","Laurent","Université Paris 13, Sorbonne Paris Cité, Inserm U942, Bobigny, France",NA
"1460","34259075","10.1177/10105395211014636","COVID-19 Infection Epidemic in the South Pacific Island of New Caledonia and in the Greater Paris: Where Is the Highest Wave?","New-Caledonia, an island located in the South-Pacific, was the first (overseas) French country hit by the coronavirus disease-2019 (COVID-19) pandemic to come out of lockdown. The epidemic was rapidly controlled. Analyzing the impact of an epidemic only makes sense if it is compared with a zone with a similar health care system. To compare epidemic evolution in New-Caledonia and Paris suburb. Health care organization is similar in New-Caledonia and Seine-Saint-Denis, based on an Emergency Medica","2021","07","14","Asia Pac J Public Health","Asia-Pacific journal of public health","epidemiology; health care services; health informatics; health systems; primary health care","Moret","Caroline","SAMU de Nouvelle-Calédonie, Nouméa Cedex, France",NA
"1461","34259075","10.1177/10105395211014636","COVID-19 Infection Epidemic in the South Pacific Island of New Caledonia and in the Greater Paris: Where Is the Highest Wave?","New-Caledonia, an island located in the South-Pacific, was the first (overseas) French country hit by the coronavirus disease-2019 (COVID-19) pandemic to come out of lockdown. The epidemic was rapidly controlled. Analyzing the impact of an epidemic only makes sense if it is compared with a zone with a similar health care system. To compare epidemic evolution in New-Caledonia and Paris suburb. Health care organization is similar in New-Caledonia and Seine-Saint-Denis, based on an Emergency Medica","2021","07","14","Asia Pac J Public Health","Asia-Pacific journal of public health","epidemiology; health care services; health informatics; health systems; primary health care","Petrovic","Tomislav","Université Paris 13, Sorbonne Paris Cité, Inserm U942, Bobigny, France",NA
"1462","34259075","10.1177/10105395211014636","COVID-19 Infection Epidemic in the South Pacific Island of New Caledonia and in the Greater Paris: Where Is the Highest Wave?","New-Caledonia, an island located in the South-Pacific, was the first (overseas) French country hit by the coronavirus disease-2019 (COVID-19) pandemic to come out of lockdown. The epidemic was rapidly controlled. Analyzing the impact of an epidemic only makes sense if it is compared with a zone with a similar health care system. To compare epidemic evolution in New-Caledonia and Paris suburb. Health care organization is similar in New-Caledonia and Seine-Saint-Denis, based on an Emergency Medica","2021","07","14","Asia Pac J Public Health","Asia-Pacific journal of public health","epidemiology; health care services; health informatics; health systems; primary health care","Langeron","Frédéric","SAMU de Nouvelle-Calédonie, Nouméa Cedex, France",NA
"1463","34259075","10.1177/10105395211014636","COVID-19 Infection Epidemic in the South Pacific Island of New Caledonia and in the Greater Paris: Where Is the Highest Wave?","New-Caledonia, an island located in the South-Pacific, was the first (overseas) French country hit by the coronavirus disease-2019 (COVID-19) pandemic to come out of lockdown. The epidemic was rapidly controlled. Analyzing the impact of an epidemic only makes sense if it is compared with a zone with a similar health care system. To compare epidemic evolution in New-Caledonia and Paris suburb. Health care organization is similar in New-Caledonia and Seine-Saint-Denis, based on an Emergency Medica","2021","07","14","Asia Pac J Public Health","Asia-Pacific journal of public health","epidemiology; health care services; health informatics; health systems; primary health care","Chanzy","Erick","Université Paris 13, Sorbonne Paris Cité, Inserm U942, Bobigny, France",NA
"1464","34259075","10.1177/10105395211014636","COVID-19 Infection Epidemic in the South Pacific Island of New Caledonia and in the Greater Paris: Where Is the Highest Wave?","New-Caledonia, an island located in the South-Pacific, was the first (overseas) French country hit by the coronavirus disease-2019 (COVID-19) pandemic to come out of lockdown. The epidemic was rapidly controlled. Analyzing the impact of an epidemic only makes sense if it is compared with a zone with a similar health care system. To compare epidemic evolution in New-Caledonia and Paris suburb. Health care organization is similar in New-Caledonia and Seine-Saint-Denis, based on an Emergency Medica","2021","07","14","Asia Pac J Public Health","Asia-Pacific journal of public health","epidemiology; health care services; health informatics; health systems; primary health care","Aguadisch","Elise","Université Paris 13, Sorbonne Paris Cité, Inserm U942, Bobigny, France",NA
"1465","34259075","10.1177/10105395211014636","COVID-19 Infection Epidemic in the South Pacific Island of New Caledonia and in the Greater Paris: Where Is the Highest Wave?","New-Caledonia, an island located in the South-Pacific, was the first (overseas) French country hit by the coronavirus disease-2019 (COVID-19) pandemic to come out of lockdown. The epidemic was rapidly controlled. Analyzing the impact of an epidemic only makes sense if it is compared with a zone with a similar health care system. To compare epidemic evolution in New-Caledonia and Paris suburb. Health care organization is similar in New-Caledonia and Seine-Saint-Denis, based on an Emergency Medica","2021","07","14","Asia Pac J Public Health","Asia-Pacific journal of public health","epidemiology; health care services; health informatics; health systems; primary health care","Adnet","Frédéric","Université Paris 13, Sorbonne Paris Cité, Inserm U942, Bobigny, France",NA
"1466","34259075","10.1177/10105395211014636","COVID-19 Infection Epidemic in the South Pacific Island of New Caledonia and in the Greater Paris: Where Is the Highest Wave?","New-Caledonia, an island located in the South-Pacific, was the first (overseas) French country hit by the coronavirus disease-2019 (COVID-19) pandemic to come out of lockdown. The epidemic was rapidly controlled. Analyzing the impact of an epidemic only makes sense if it is compared with a zone with a similar health care system. To compare epidemic evolution in New-Caledonia and Paris suburb. Health care organization is similar in New-Caledonia and Seine-Saint-Denis, based on an Emergency Medica","2021","07","14","Asia Pac J Public Health","Asia-Pacific journal of public health","epidemiology; health care services; health informatics; health systems; primary health care","Reuter","Paul-Georges","Université Paris 13, Sorbonne Paris Cité, Inserm U942, Bobigny, France",NA
"1467","34259075","10.1177/10105395211014636","COVID-19 Infection Epidemic in the South Pacific Island of New Caledonia and in the Greater Paris: Where Is the Highest Wave?","New-Caledonia, an island located in the South-Pacific, was the first (overseas) French country hit by the coronavirus disease-2019 (COVID-19) pandemic to come out of lockdown. The epidemic was rapidly controlled. Analyzing the impact of an epidemic only makes sense if it is compared with a zone with a similar health care system. To compare epidemic evolution in New-Caledonia and Paris suburb. Health care organization is similar in New-Caledonia and Seine-Saint-Denis, based on an Emergency Medica","2021","07","14","Asia Pac J Public Health","Asia-Pacific journal of public health","epidemiology; health care services; health informatics; health systems; primary health care","Delvau","Nicolas","SAMU de Nouvelle-Calédonie, Nouméa Cedex, France",NA
"1468","34259075","10.1177/10105395211014636","COVID-19 Infection Epidemic in the South Pacific Island of New Caledonia and in the Greater Paris: Where Is the Highest Wave?","New-Caledonia, an island located in the South-Pacific, was the first (overseas) French country hit by the coronavirus disease-2019 (COVID-19) pandemic to come out of lockdown. The epidemic was rapidly controlled. Analyzing the impact of an epidemic only makes sense if it is compared with a zone with a similar health care system. To compare epidemic evolution in New-Caledonia and Paris suburb. Health care organization is similar in New-Caledonia and Seine-Saint-Denis, based on an Emergency Medica","2021","07","14","Asia Pac J Public Health","Asia-Pacific journal of public health","epidemiology; health care services; health informatics; health systems; primary health care","Lapostolle","Frédéric","Université Paris 13, Sorbonne Paris Cité, Inserm U942, Bobigny, France",NA
"1469","34259040","10.2214/AJR.21.26491","FDG-Avid Ipsilateral Iliac and Inguinal Lymphadenopathy After COVID-19 Vaccination With Thigh Injection.",NA,"2021","07","14","AJR Am J Roentgenol","AJR. American journal of roentgenology",NA,"Bass","David","University of Rochester Department of Imaging Sciences",NA
"1470","34259040","10.2214/AJR.21.26491","FDG-Avid Ipsilateral Iliac and Inguinal Lymphadenopathy After COVID-19 Vaccination With Thigh Injection.",NA,"2021","07","14","AJR Am J Roentgenol","AJR. American journal of roentgenology",NA,"Puri","Savita","University of Rochester Department of Imaging Sciences",NA
"1471","34258979","10.7754/Clin.Lab.2020.201144","Platelet Indices' Usefulness in Determining whether Patients with COVID-19 Should be Treated as an Outpatient or Inpatient: a Retrospective Study.","Coronavirus disease 2019 (COVID-19) has affected the health system around the world. It is necessary to facilitate health care services with useful parameters in patient follow-up. In this study, we wanted to determine whether platelet indices can be used as an assistant parameter in the clinician's decision-making process regarding which of the patients diagnosed with COVID-19 should be treated by hospitalization. This retrospective study was performed in a secondary care hospital in Mugla, Tur","2021","07","15","Clin Lab","Clinical laboratory","Blood Platelets; COVID-19; Humans; Infant; Mean Platelet Volume; Outpatients; Retrospective Studies; SARS-CoV-2; Turkey","Polat","Esra",NA,NA
"1472","34258979","10.7754/Clin.Lab.2020.201144","Platelet Indices' Usefulness in Determining whether Patients with COVID-19 Should be Treated as an Outpatient or Inpatient: a Retrospective Study.","Coronavirus disease 2019 (COVID-19) has affected the health system around the world. It is necessary to facilitate health care services with useful parameters in patient follow-up. In this study, we wanted to determine whether platelet indices can be used as an assistant parameter in the clinician's decision-making process regarding which of the patients diagnosed with COVID-19 should be treated by hospitalization. This retrospective study was performed in a secondary care hospital in Mugla, Tur","2021","07","15","Clin Lab","Clinical laboratory","Blood Platelets; COVID-19; Humans; Infant; Mean Platelet Volume; Outpatients; Retrospective Studies; SARS-CoV-2; Turkey","Demir","Mehmet C",NA,NA
"1473","34258973","10.7754/Clin.Lab.2020.201050","Serum 25(OH)D Deficiency and High D-Dimer Levels are Associated with COVID-19 Pneumonia.","To identify the risk factors for COVID-19 pneumonia and to characterize the epidemiology of the disease. This was a prospective study of consecutive patients with SARS-CoV-2 infection and respiratory symptoms, enrolled between April 12 and April 30 of 2020. Pneumonia was diagnosed on the basis of abnormal chest CT findings. At admission, we performed a complete blood count, as well as determining serum levels of CRP, procalcitonin, D-dimer, ferritin, LDH, and 25-hydroxyvitamin D (25[OH]D). Comor","2021","07","15","Clin Lab","Clinical laboratory","Adult; COVID-19; Fibrin Fibrinogen Degradation Products; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Risk Factors; SARS-CoV-2; Vitamin D; Young Adult","Sunnetcioglu","Aysel",NA,NA
"1474","34258973","10.7754/Clin.Lab.2020.201050","Serum 25(OH)D Deficiency and High D-Dimer Levels are Associated with COVID-19 Pneumonia.","To identify the risk factors for COVID-19 pneumonia and to characterize the epidemiology of the disease. This was a prospective study of consecutive patients with SARS-CoV-2 infection and respiratory symptoms, enrolled between April 12 and April 30 of 2020. Pneumonia was diagnosed on the basis of abnormal chest CT findings. At admission, we performed a complete blood count, as well as determining serum levels of CRP, procalcitonin, D-dimer, ferritin, LDH, and 25-hydroxyvitamin D (25[OH]D). Comor","2021","07","15","Clin Lab","Clinical laboratory","Adult; COVID-19; Fibrin Fibrinogen Degradation Products; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Risk Factors; SARS-CoV-2; Vitamin D; Young Adult","Sunnetcioglu","Mahmut",NA,NA
"1475","34258973","10.7754/Clin.Lab.2020.201050","Serum 25(OH)D Deficiency and High D-Dimer Levels are Associated with COVID-19 Pneumonia.","To identify the risk factors for COVID-19 pneumonia and to characterize the epidemiology of the disease. This was a prospective study of consecutive patients with SARS-CoV-2 infection and respiratory symptoms, enrolled between April 12 and April 30 of 2020. Pneumonia was diagnosed on the basis of abnormal chest CT findings. At admission, we performed a complete blood count, as well as determining serum levels of CRP, procalcitonin, D-dimer, ferritin, LDH, and 25-hydroxyvitamin D (25[OH]D). Comor","2021","07","15","Clin Lab","Clinical laboratory","Adult; COVID-19; Fibrin Fibrinogen Degradation Products; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Risk Factors; SARS-CoV-2; Vitamin D; Young Adult","Gurbuz","Esra",NA,NA
"1476","34258973","10.7754/Clin.Lab.2020.201050","Serum 25(OH)D Deficiency and High D-Dimer Levels are Associated with COVID-19 Pneumonia.","To identify the risk factors for COVID-19 pneumonia and to characterize the epidemiology of the disease. This was a prospective study of consecutive patients with SARS-CoV-2 infection and respiratory symptoms, enrolled between April 12 and April 30 of 2020. Pneumonia was diagnosed on the basis of abnormal chest CT findings. At admission, we performed a complete blood count, as well as determining serum levels of CRP, procalcitonin, D-dimer, ferritin, LDH, and 25-hydroxyvitamin D (25[OH]D). Comor","2021","07","15","Clin Lab","Clinical laboratory","Adult; COVID-19; Fibrin Fibrinogen Degradation Products; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Risk Factors; SARS-CoV-2; Vitamin D; Young Adult","Bedirhanoglu","Serhat",NA,NA
"1477","34258973","10.7754/Clin.Lab.2020.201050","Serum 25(OH)D Deficiency and High D-Dimer Levels are Associated with COVID-19 Pneumonia.","To identify the risk factors for COVID-19 pneumonia and to characterize the epidemiology of the disease. This was a prospective study of consecutive patients with SARS-CoV-2 infection and respiratory symptoms, enrolled between April 12 and April 30 of 2020. Pneumonia was diagnosed on the basis of abnormal chest CT findings. At admission, we performed a complete blood count, as well as determining serum levels of CRP, procalcitonin, D-dimer, ferritin, LDH, and 25-hydroxyvitamin D (25[OH]D). Comor","2021","07","15","Clin Lab","Clinical laboratory","Adult; COVID-19; Fibrin Fibrinogen Degradation Products; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Risk Factors; SARS-CoV-2; Vitamin D; Young Adult","Erginoguz","Adem",NA,NA
"1478","34258973","10.7754/Clin.Lab.2020.201050","Serum 25(OH)D Deficiency and High D-Dimer Levels are Associated with COVID-19 Pneumonia.","To identify the risk factors for COVID-19 pneumonia and to characterize the epidemiology of the disease. This was a prospective study of consecutive patients with SARS-CoV-2 infection and respiratory symptoms, enrolled between April 12 and April 30 of 2020. Pneumonia was diagnosed on the basis of abnormal chest CT findings. At admission, we performed a complete blood count, as well as determining serum levels of CRP, procalcitonin, D-dimer, ferritin, LDH, and 25-hydroxyvitamin D (25[OH]D). Comor","2021","07","15","Clin Lab","Clinical laboratory","Adult; COVID-19; Fibrin Fibrinogen Degradation Products; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Risk Factors; SARS-CoV-2; Vitamin D; Young Adult","Celik","Sabahatin",NA,NA
"1479","34258969","10.7754/Clin.Lab.2020.201138","Clinical and Laboratory Comparison of Covid-19 and Influenza A/B in Children.","The clinical picture of COVID-19 shows significant similarity with influenza. In this study, it was aimed to compare the clinical and laboratory findings between pediatric patients diagnosed with COVID-19 and those with influenza A or B, and to obtain data on the differential diagnosis of COVID-19 from influenza in children. The study included 104 patients with COVID-19, 140 patients with influenza A and 135 patients with in-fluenza B (379 patients in total) who were admitted to our tertiary hos","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Child; Humans; Influenza, Human; Laboratories; Respiratory Tract Infections; SARS-CoV-2","Temel","Hayrettin",NA,NA
"1480","34258969","10.7754/Clin.Lab.2020.201138","Clinical and Laboratory Comparison of Covid-19 and Influenza A/B in Children.","The clinical picture of COVID-19 shows significant similarity with influenza. In this study, it was aimed to compare the clinical and laboratory findings between pediatric patients diagnosed with COVID-19 and those with influenza A or B, and to obtain data on the differential diagnosis of COVID-19 from influenza in children. The study included 104 patients with COVID-19, 140 patients with influenza A and 135 patients with in-fluenza B (379 patients in total) who were admitted to our tertiary hos","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Child; Humans; Influenza, Human; Laboratories; Respiratory Tract Infections; SARS-CoV-2","Okur","Mesut",NA,NA
"1481","34258969","10.7754/Clin.Lab.2020.201138","Clinical and Laboratory Comparison of Covid-19 and Influenza A/B in Children.","The clinical picture of COVID-19 shows significant similarity with influenza. In this study, it was aimed to compare the clinical and laboratory findings between pediatric patients diagnosed with COVID-19 and those with influenza A or B, and to obtain data on the differential diagnosis of COVID-19 from influenza in children. The study included 104 patients with COVID-19, 140 patients with influenza A and 135 patients with in-fluenza B (379 patients in total) who were admitted to our tertiary hos","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Child; Humans; Influenza, Human; Laboratories; Respiratory Tract Infections; SARS-CoV-2","Gunduz","Mehmet",NA,NA
"1482","34258969","10.7754/Clin.Lab.2020.201138","Clinical and Laboratory Comparison of Covid-19 and Influenza A/B in Children.","The clinical picture of COVID-19 shows significant similarity with influenza. In this study, it was aimed to compare the clinical and laboratory findings between pediatric patients diagnosed with COVID-19 and those with influenza A or B, and to obtain data on the differential diagnosis of COVID-19 from influenza in children. The study included 104 patients with COVID-19, 140 patients with influenza A and 135 patients with in-fluenza B (379 patients in total) who were admitted to our tertiary hos","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Child; Humans; Influenza, Human; Laboratories; Respiratory Tract Infections; SARS-CoV-2","Comert","Murat",NA,NA
"1483","34258969","10.7754/Clin.Lab.2020.201138","Clinical and Laboratory Comparison of Covid-19 and Influenza A/B in Children.","The clinical picture of COVID-19 shows significant similarity with influenza. In this study, it was aimed to compare the clinical and laboratory findings between pediatric patients diagnosed with COVID-19 and those with influenza A or B, and to obtain data on the differential diagnosis of COVID-19 from influenza in children. The study included 104 patients with COVID-19, 140 patients with influenza A and 135 patients with in-fluenza B (379 patients in total) who were admitted to our tertiary hos","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Child; Humans; Influenza, Human; Laboratories; Respiratory Tract Infections; SARS-CoV-2","Erkesim","Remzi",NA,NA
"1484","34258969","10.7754/Clin.Lab.2020.201138","Clinical and Laboratory Comparison of Covid-19 and Influenza A/B in Children.","The clinical picture of COVID-19 shows significant similarity with influenza. In this study, it was aimed to compare the clinical and laboratory findings between pediatric patients diagnosed with COVID-19 and those with influenza A or B, and to obtain data on the differential diagnosis of COVID-19 from influenza in children. The study included 104 patients with COVID-19, 140 patients with influenza A and 135 patients with in-fluenza B (379 patients in total) who were admitted to our tertiary hos","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Child; Humans; Influenza, Human; Laboratories; Respiratory Tract Infections; SARS-CoV-2","Celebi","Merve",NA,NA
"1485","34258969","10.7754/Clin.Lab.2020.201138","Clinical and Laboratory Comparison of Covid-19 and Influenza A/B in Children.","The clinical picture of COVID-19 shows significant similarity with influenza. In this study, it was aimed to compare the clinical and laboratory findings between pediatric patients diagnosed with COVID-19 and those with influenza A or B, and to obtain data on the differential diagnosis of COVID-19 from influenza in children. The study included 104 patients with COVID-19, 140 patients with influenza A and 135 patients with in-fluenza B (379 patients in total) who were admitted to our tertiary hos","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Child; Humans; Influenza, Human; Laboratories; Respiratory Tract Infections; SARS-CoV-2","Istanbullu-Tosun","Ayse",NA,NA
"1486","34258969","10.7754/Clin.Lab.2020.201138","Clinical and Laboratory Comparison of Covid-19 and Influenza A/B in Children.","The clinical picture of COVID-19 shows significant similarity with influenza. In this study, it was aimed to compare the clinical and laboratory findings between pediatric patients diagnosed with COVID-19 and those with influenza A or B, and to obtain data on the differential diagnosis of COVID-19 from influenza in children. The study included 104 patients with COVID-19, 140 patients with influenza A and 135 patients with in-fluenza B (379 patients in total) who were admitted to our tertiary hos","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Child; Humans; Influenza, Human; Laboratories; Respiratory Tract Infections; SARS-CoV-2","Ulfer","Gozde",NA,NA
"1487","34258966","10.7754/Clin.Lab.2020.201124","Effects of Smoking on ACE2 Expression Pattern: Risk and Severity of SARS-CoV-2 Infection.","Respiratory epithelium expressing angiotensin-converting enzyme 2 (ACE2) is the entry for novel coronavirus (SARS-CoV-2), pathogen of the COVID-19 pneumonia outbreak, although a few recent studies have found different ACE2 expression in lung tissue of smokers. The effect of smoking on ACE2 expression and COVID-19 is still not clear. So, we did this research to determine the effect of smoking on ACE2 expression pattern and its relationship with the risk and severity of COVID-19. The clinical data","2021","07","15","Clin Lab","Clinical laboratory","Angiotensin-Converting Enzyme 2; COVID-19; China; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2; Smoking","Li","Wenjuan",NA,NA
"1488","34258966","10.7754/Clin.Lab.2020.201124","Effects of Smoking on ACE2 Expression Pattern: Risk and Severity of SARS-CoV-2 Infection.","Respiratory epithelium expressing angiotensin-converting enzyme 2 (ACE2) is the entry for novel coronavirus (SARS-CoV-2), pathogen of the COVID-19 pneumonia outbreak, although a few recent studies have found different ACE2 expression in lung tissue of smokers. The effect of smoking on ACE2 expression and COVID-19 is still not clear. So, we did this research to determine the effect of smoking on ACE2 expression pattern and its relationship with the risk and severity of COVID-19. The clinical data","2021","07","15","Clin Lab","Clinical laboratory","Angiotensin-Converting Enzyme 2; COVID-19; China; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2; Smoking","Zheng","Rui",NA,NA
"1489","34258966","10.7754/Clin.Lab.2020.201124","Effects of Smoking on ACE2 Expression Pattern: Risk and Severity of SARS-CoV-2 Infection.","Respiratory epithelium expressing angiotensin-converting enzyme 2 (ACE2) is the entry for novel coronavirus (SARS-CoV-2), pathogen of the COVID-19 pneumonia outbreak, although a few recent studies have found different ACE2 expression in lung tissue of smokers. The effect of smoking on ACE2 expression and COVID-19 is still not clear. So, we did this research to determine the effect of smoking on ACE2 expression pattern and its relationship with the risk and severity of COVID-19. The clinical data","2021","07","15","Clin Lab","Clinical laboratory","Angiotensin-Converting Enzyme 2; COVID-19; China; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2; Smoking","Liang","Rongpu",NA,NA
"1490","34258966","10.7754/Clin.Lab.2020.201124","Effects of Smoking on ACE2 Expression Pattern: Risk and Severity of SARS-CoV-2 Infection.","Respiratory epithelium expressing angiotensin-converting enzyme 2 (ACE2) is the entry for novel coronavirus (SARS-CoV-2), pathogen of the COVID-19 pneumonia outbreak, although a few recent studies have found different ACE2 expression in lung tissue of smokers. The effect of smoking on ACE2 expression and COVID-19 is still not clear. So, we did this research to determine the effect of smoking on ACE2 expression pattern and its relationship with the risk and severity of COVID-19. The clinical data","2021","07","15","Clin Lab","Clinical laboratory","Angiotensin-Converting Enzyme 2; COVID-19; China; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2; Smoking","Wu","Biao",NA,NA
"1491","34258966","10.7754/Clin.Lab.2020.201124","Effects of Smoking on ACE2 Expression Pattern: Risk and Severity of SARS-CoV-2 Infection.","Respiratory epithelium expressing angiotensin-converting enzyme 2 (ACE2) is the entry for novel coronavirus (SARS-CoV-2), pathogen of the COVID-19 pneumonia outbreak, although a few recent studies have found different ACE2 expression in lung tissue of smokers. The effect of smoking on ACE2 expression and COVID-19 is still not clear. So, we did this research to determine the effect of smoking on ACE2 expression pattern and its relationship with the risk and severity of COVID-19. The clinical data","2021","07","15","Clin Lab","Clinical laboratory","Angiotensin-Converting Enzyme 2; COVID-19; China; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2; Smoking","Wang","Chengqiang",NA,NA
"1492","34258966","10.7754/Clin.Lab.2020.201124","Effects of Smoking on ACE2 Expression Pattern: Risk and Severity of SARS-CoV-2 Infection.","Respiratory epithelium expressing angiotensin-converting enzyme 2 (ACE2) is the entry for novel coronavirus (SARS-CoV-2), pathogen of the COVID-19 pneumonia outbreak, although a few recent studies have found different ACE2 expression in lung tissue of smokers. The effect of smoking on ACE2 expression and COVID-19 is still not clear. So, we did this research to determine the effect of smoking on ACE2 expression pattern and its relationship with the risk and severity of COVID-19. The clinical data","2021","07","15","Clin Lab","Clinical laboratory","Angiotensin-Converting Enzyme 2; COVID-19; China; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2; Smoking","Zhuo","Li",NA,NA
"1493","34258966","10.7754/Clin.Lab.2020.201124","Effects of Smoking on ACE2 Expression Pattern: Risk and Severity of SARS-CoV-2 Infection.","Respiratory epithelium expressing angiotensin-converting enzyme 2 (ACE2) is the entry for novel coronavirus (SARS-CoV-2), pathogen of the COVID-19 pneumonia outbreak, although a few recent studies have found different ACE2 expression in lung tissue of smokers. The effect of smoking on ACE2 expression and COVID-19 is still not clear. So, we did this research to determine the effect of smoking on ACE2 expression pattern and its relationship with the risk and severity of COVID-19. The clinical data","2021","07","15","Clin Lab","Clinical laboratory","Angiotensin-Converting Enzyme 2; COVID-19; China; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2; Smoking","Wu","Maosheng",NA,NA
"1494","34258966","10.7754/Clin.Lab.2020.201124","Effects of Smoking on ACE2 Expression Pattern: Risk and Severity of SARS-CoV-2 Infection.","Respiratory epithelium expressing angiotensin-converting enzyme 2 (ACE2) is the entry for novel coronavirus (SARS-CoV-2), pathogen of the COVID-19 pneumonia outbreak, although a few recent studies have found different ACE2 expression in lung tissue of smokers. The effect of smoking on ACE2 expression and COVID-19 is still not clear. So, we did this research to determine the effect of smoking on ACE2 expression pattern and its relationship with the risk and severity of COVID-19. The clinical data","2021","07","15","Clin Lab","Clinical laboratory","Angiotensin-Converting Enzyme 2; COVID-19; China; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2; Smoking","Jie","Yusheng",NA,NA
"1495","34258966","10.7754/Clin.Lab.2020.201124","Effects of Smoking on ACE2 Expression Pattern: Risk and Severity of SARS-CoV-2 Infection.","Respiratory epithelium expressing angiotensin-converting enzyme 2 (ACE2) is the entry for novel coronavirus (SARS-CoV-2), pathogen of the COVID-19 pneumonia outbreak, although a few recent studies have found different ACE2 expression in lung tissue of smokers. The effect of smoking on ACE2 expression and COVID-19 is still not clear. So, we did this research to determine the effect of smoking on ACE2 expression pattern and its relationship with the risk and severity of COVID-19. The clinical data","2021","07","15","Clin Lab","Clinical laboratory","Angiotensin-Converting Enzyme 2; COVID-19; China; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2; Smoking","Lin","Bingliang",NA,NA
"1496","34258966","10.7754/Clin.Lab.2020.201124","Effects of Smoking on ACE2 Expression Pattern: Risk and Severity of SARS-CoV-2 Infection.","Respiratory epithelium expressing angiotensin-converting enzyme 2 (ACE2) is the entry for novel coronavirus (SARS-CoV-2), pathogen of the COVID-19 pneumonia outbreak, although a few recent studies have found different ACE2 expression in lung tissue of smokers. The effect of smoking on ACE2 expression and COVID-19 is still not clear. So, we did this research to determine the effect of smoking on ACE2 expression pattern and its relationship with the risk and severity of COVID-19. The clinical data","2021","07","15","Clin Lab","Clinical laboratory","Angiotensin-Converting Enzyme 2; COVID-19; China; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2; Smoking","Chang","Lihong",NA,NA
"1497","34258966","10.7754/Clin.Lab.2020.201124","Effects of Smoking on ACE2 Expression Pattern: Risk and Severity of SARS-CoV-2 Infection.","Respiratory epithelium expressing angiotensin-converting enzyme 2 (ACE2) is the entry for novel coronavirus (SARS-CoV-2), pathogen of the COVID-19 pneumonia outbreak, although a few recent studies have found different ACE2 expression in lung tissue of smokers. The effect of smoking on ACE2 expression and COVID-19 is still not clear. So, we did this research to determine the effect of smoking on ACE2 expression pattern and its relationship with the risk and severity of COVID-19. The clinical data","2021","07","15","Clin Lab","Clinical laboratory","Angiotensin-Converting Enzyme 2; COVID-19; China; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2; Smoking","Yang","Qintai",NA,NA
"1498","34258966","10.7754/Clin.Lab.2020.201124","Effects of Smoking on ACE2 Expression Pattern: Risk and Severity of SARS-CoV-2 Infection.","Respiratory epithelium expressing angiotensin-converting enzyme 2 (ACE2) is the entry for novel coronavirus (SARS-CoV-2), pathogen of the COVID-19 pneumonia outbreak, although a few recent studies have found different ACE2 expression in lung tissue of smokers. The effect of smoking on ACE2 expression and COVID-19 is still not clear. So, we did this research to determine the effect of smoking on ACE2 expression pattern and its relationship with the risk and severity of COVID-19. The clinical data","2021","07","15","Clin Lab","Clinical laboratory","Angiotensin-Converting Enzyme 2; COVID-19; China; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2; Smoking","Wei","Bo",NA,NA
"1499","34258966","10.7754/Clin.Lab.2020.201124","Effects of Smoking on ACE2 Expression Pattern: Risk and Severity of SARS-CoV-2 Infection.","Respiratory epithelium expressing angiotensin-converting enzyme 2 (ACE2) is the entry for novel coronavirus (SARS-CoV-2), pathogen of the COVID-19 pneumonia outbreak, although a few recent studies have found different ACE2 expression in lung tissue of smokers. The effect of smoking on ACE2 expression and COVID-19 is still not clear. So, we did this research to determine the effect of smoking on ACE2 expression pattern and its relationship with the risk and severity of COVID-19. The clinical data","2021","07","15","Clin Lab","Clinical laboratory","Angiotensin-Converting Enzyme 2; COVID-19; China; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2; Smoking","Zhou","Yuqi",NA,NA
"1500","34258963","10.7754/Clin.Lab.2020.201025","Comparative Performance of Four Nucleic Acid Amplification Tests for SARS-CoV-2 Virus.","COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which was discovered in 2019 and spread around the world in a short time. SARS-CoV-2 nucleic acid amplification tests (NAATs) have been rapidly developed and quickly applied to clinical testing of COVID-19. Aim of this study was to evaluate the performance of four NAAT assays. Limit of detection (LOD), precision, accuracy, analytical specificity and analytical interference studies on four NAATs (Daan, Sansure","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Clinical Laboratory Services; Humans; Limit of Detection; Nucleic Acid Amplification Techniques; SARS-CoV-2; Sensitivity and Specificity","Zhuang","Qi-Zhen",NA,NA
"1501","34258963","10.7754/Clin.Lab.2020.201025","Comparative Performance of Four Nucleic Acid Amplification Tests for SARS-CoV-2 Virus.","COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which was discovered in 2019 and spread around the world in a short time. SARS-CoV-2 nucleic acid amplification tests (NAATs) have been rapidly developed and quickly applied to clinical testing of COVID-19. Aim of this study was to evaluate the performance of four NAAT assays. Limit of detection (LOD), precision, accuracy, analytical specificity and analytical interference studies on four NAATs (Daan, Sansure","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Clinical Laboratory Services; Humans; Limit of Detection; Nucleic Acid Amplification Techniques; SARS-CoV-2; Sensitivity and Specificity","Li","Zhen-Zhen",NA,NA
"1502","34258963","10.7754/Clin.Lab.2020.201025","Comparative Performance of Four Nucleic Acid Amplification Tests for SARS-CoV-2 Virus.","COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which was discovered in 2019 and spread around the world in a short time. SARS-CoV-2 nucleic acid amplification tests (NAATs) have been rapidly developed and quickly applied to clinical testing of COVID-19. Aim of this study was to evaluate the performance of four NAAT assays. Limit of detection (LOD), precision, accuracy, analytical specificity and analytical interference studies on four NAATs (Daan, Sansure","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Clinical Laboratory Services; Humans; Limit of Detection; Nucleic Acid Amplification Techniques; SARS-CoV-2; Sensitivity and Specificity","Chao","Yan",NA,NA
"1503","34258963","10.7754/Clin.Lab.2020.201025","Comparative Performance of Four Nucleic Acid Amplification Tests for SARS-CoV-2 Virus.","COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which was discovered in 2019 and spread around the world in a short time. SARS-CoV-2 nucleic acid amplification tests (NAATs) have been rapidly developed and quickly applied to clinical testing of COVID-19. Aim of this study was to evaluate the performance of four NAAT assays. Limit of detection (LOD), precision, accuracy, analytical specificity and analytical interference studies on four NAATs (Daan, Sansure","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Clinical Laboratory Services; Humans; Limit of Detection; Nucleic Acid Amplification Techniques; SARS-CoV-2; Sensitivity and Specificity","Li","Fei",NA,NA
"1504","34258963","10.7754/Clin.Lab.2020.201025","Comparative Performance of Four Nucleic Acid Amplification Tests for SARS-CoV-2 Virus.","COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which was discovered in 2019 and spread around the world in a short time. SARS-CoV-2 nucleic acid amplification tests (NAATs) have been rapidly developed and quickly applied to clinical testing of COVID-19. Aim of this study was to evaluate the performance of four NAAT assays. Limit of detection (LOD), precision, accuracy, analytical specificity and analytical interference studies on four NAATs (Daan, Sansure","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Clinical Laboratory Services; Humans; Limit of Detection; Nucleic Acid Amplification Techniques; SARS-CoV-2; Sensitivity and Specificity","Ge","Yi-Yuan",NA,NA
"1505","34258963","10.7754/Clin.Lab.2020.201025","Comparative Performance of Four Nucleic Acid Amplification Tests for SARS-CoV-2 Virus.","COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which was discovered in 2019 and spread around the world in a short time. SARS-CoV-2 nucleic acid amplification tests (NAATs) have been rapidly developed and quickly applied to clinical testing of COVID-19. Aim of this study was to evaluate the performance of four NAAT assays. Limit of detection (LOD), precision, accuracy, analytical specificity and analytical interference studies on four NAATs (Daan, Sansure","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Clinical Laboratory Services; Humans; Limit of Detection; Nucleic Acid Amplification Techniques; SARS-CoV-2; Sensitivity and Specificity","Sha","Yan-Hua",NA,NA
"1506","34258963","10.7754/Clin.Lab.2020.201025","Comparative Performance of Four Nucleic Acid Amplification Tests for SARS-CoV-2 Virus.","COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which was discovered in 2019 and spread around the world in a short time. SARS-CoV-2 nucleic acid amplification tests (NAATs) have been rapidly developed and quickly applied to clinical testing of COVID-19. Aim of this study was to evaluate the performance of four NAAT assays. Limit of detection (LOD), precision, accuracy, analytical specificity and analytical interference studies on four NAATs (Daan, Sansure","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Clinical Laboratory Services; Humans; Limit of Detection; Nucleic Acid Amplification Techniques; SARS-CoV-2; Sensitivity and Specificity","Wang","Yi",NA,NA
"1507","34258963","10.7754/Clin.Lab.2020.201025","Comparative Performance of Four Nucleic Acid Amplification Tests for SARS-CoV-2 Virus.","COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which was discovered in 2019 and spread around the world in a short time. SARS-CoV-2 nucleic acid amplification tests (NAATs) have been rapidly developed and quickly applied to clinical testing of COVID-19. Aim of this study was to evaluate the performance of four NAAT assays. Limit of detection (LOD), precision, accuracy, analytical specificity and analytical interference studies on four NAATs (Daan, Sansure","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Clinical Laboratory Services; Humans; Limit of Detection; Nucleic Acid Amplification Techniques; SARS-CoV-2; Sensitivity and Specificity","Huang","Xian-Zhang",NA,NA
"1508","34258963","10.7754/Clin.Lab.2020.201025","Comparative Performance of Four Nucleic Acid Amplification Tests for SARS-CoV-2 Virus.","COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which was discovered in 2019 and spread around the world in a short time. SARS-CoV-2 nucleic acid amplification tests (NAATs) have been rapidly developed and quickly applied to clinical testing of COVID-19. Aim of this study was to evaluate the performance of four NAAT assays. Limit of detection (LOD), precision, accuracy, analytical specificity and analytical interference studies on four NAATs (Daan, Sansure","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Clinical Laboratory Services; Humans; Limit of Detection; Nucleic Acid Amplification Techniques; SARS-CoV-2; Sensitivity and Specificity","Ke","Pei-Feng",NA,NA
"1509","34258963","10.7754/Clin.Lab.2020.201025","Comparative Performance of Four Nucleic Acid Amplification Tests for SARS-CoV-2 Virus.","COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which was discovered in 2019 and spread around the world in a short time. SARS-CoV-2 nucleic acid amplification tests (NAATs) have been rapidly developed and quickly applied to clinical testing of COVID-19. Aim of this study was to evaluate the performance of four NAAT assays. Limit of detection (LOD), precision, accuracy, analytical specificity and analytical interference studies on four NAATs (Daan, Sansure","2021","07","15","Clin Lab","Clinical laboratory","COVID-19; Clinical Laboratory Services; Humans; Limit of Detection; Nucleic Acid Amplification Techniques; SARS-CoV-2; Sensitivity and Specificity","Xiong","Yu-Juan",NA,NA
"1510","34258956","10.4081/monaldi.2021.1694","Laboratory and demographic findings among patients with coronavirus disease 2019: A review.","Coronavirus disease 2019 (COVID-19) is the third known animal coronavirus, after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome coronavirus (MERS-CoV). The mean age of the infected patients was estimated to be between 50 and 69 years old. Accordingly, the COVID-19 mortality rate was calculated as 15%. In this regard, the essential component of prevention and planning is knowledge of laboratory and demographic findings among COVID-19 patients; therefore, the present","2021","07","14","Monaldi Arch Chest Dis","Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace",NA,"Mir","Atefeh","Clinical Research Center of Sabzevar Vasei Hospital, Sabzevar University of Medical Sciences, Sabzevar. atefe.mirr@gmail","atefe.mirr@gmail.com"
"1511","34258956","10.4081/monaldi.2021.1694","Laboratory and demographic findings among patients with coronavirus disease 2019: A review.","Coronavirus disease 2019 (COVID-19) is the third known animal coronavirus, after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome coronavirus (MERS-CoV). The mean age of the infected patients was estimated to be between 50 and 69 years old. Accordingly, the COVID-19 mortality rate was calculated as 15%. In this regard, the essential component of prevention and planning is knowledge of laboratory and demographic findings among COVID-19 patients; therefore, the present","2021","07","14","Monaldi Arch Chest Dis","Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace",NA,"Kalan Farmanfarma","Khadijeh","Department of Epidemiology, Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan. Kalan_farma@yahoo","farma@yahoo.com"
"1512","34258956","10.4081/monaldi.2021.1694","Laboratory and demographic findings among patients with coronavirus disease 2019: A review.","Coronavirus disease 2019 (COVID-19) is the third known animal coronavirus, after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome coronavirus (MERS-CoV). The mean age of the infected patients was estimated to be between 50 and 69 years old. Accordingly, the COVID-19 mortality rate was calculated as 15%. In this regard, the essential component of prevention and planning is knowledge of laboratory and demographic findings among COVID-19 patients; therefore, the present","2021","07","14","Monaldi Arch Chest Dis","Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace",NA,"Salehiniya","Hamid","Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand. alesaleh70@yahoo","alesaleh70@yahoo.com"
"1513","34258956","10.4081/monaldi.2021.1694","Laboratory and demographic findings among patients with coronavirus disease 2019: A review.","Coronavirus disease 2019 (COVID-19) is the third known animal coronavirus, after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome coronavirus (MERS-CoV). The mean age of the infected patients was estimated to be between 50 and 69 years old. Accordingly, the COVID-19 mortality rate was calculated as 15%. In this regard, the essential component of prevention and planning is knowledge of laboratory and demographic findings among COVID-19 patients; therefore, the present","2021","07","14","Monaldi Arch Chest Dis","Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace",NA,"Shakiba","Abolfazl","Department of Internal Medicine, School of Medicine, Leishmaniasis Research Center, Vasei Hospital, Sabzevar University of Medical Sciences, Sabzevar. ABOLFAZLSHAKIBA1360@GMAIL","ABOLFAZLSHAKIBA1360@GMAIL.COM"
"1514","34258956","10.4081/monaldi.2021.1694","Laboratory and demographic findings among patients with coronavirus disease 2019: A review.","Coronavirus disease 2019 (COVID-19) is the third known animal coronavirus, after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome coronavirus (MERS-CoV). The mean age of the infected patients was estimated to be between 50 and 69 years old. Accordingly, the COVID-19 mortality rate was calculated as 15%. In this regard, the essential component of prevention and planning is knowledge of laboratory and demographic findings among COVID-19 patients; therefore, the present","2021","07","14","Monaldi Arch Chest Dis","Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace",NA,"Mahdavifar","Neda","Department of Biostatistics and Epidemiology, School of Health, NonCommunicable Diseases Research Center, Sabzevar University of Medical Sciences, Sabzevar. n.mahdavifar90@gmail","n.mahdavifar90@gmail.com"
"1515","34258907","10.31083/j.rcm2202046","Chronic disease management in heart failure: focus on telemedicine and remote monitoring.","In the context of the COVID-19 pandemic, many barriers to telemedicine disappeared. Virtual visits and telemonitoring strategies became routine. Evidence is accumulating regarding the safety and efficacy of virtual visits to replace in-person visits. A structured approach to virtual encounters is recommended. Telemonitoring includes patient reported remote vital sign monitoring, information from wearable devices, cardiac implantable electronic devices and invasive remote hemodynamic monitoring. ","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Heart failure with reduced ejection fraction; Telemedicine; Telemonitoring; COVID-19; Chronic Disease; Healthcare Disparities; Heart Failure; Humans; Predictive Value of Tests; Prognosis; Race Factors; Remote Consultation; Remote Sensing Technology; Socioeconomic Factors; Telemedicine; Wearable Electronic Devices","Alvarez","Paulino","Section of Heart Failure &amp",NA
"1516","34258907","10.31083/j.rcm2202046","Chronic disease management in heart failure: focus on telemedicine and remote monitoring.","In the context of the COVID-19 pandemic, many barriers to telemedicine disappeared. Virtual visits and telemonitoring strategies became routine. Evidence is accumulating regarding the safety and efficacy of virtual visits to replace in-person visits. A structured approach to virtual encounters is recommended. Telemonitoring includes patient reported remote vital sign monitoring, information from wearable devices, cardiac implantable electronic devices and invasive remote hemodynamic monitoring. ","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Heart failure with reduced ejection fraction; Telemedicine; Telemonitoring; COVID-19; Chronic Disease; Healthcare Disparities; Heart Failure; Humans; Predictive Value of Tests; Prognosis; Race Factors; Remote Consultation; Remote Sensing Technology; Socioeconomic Factors; Telemedicine; Wearable Electronic Devices","Sianis","Alex","Department of Clinical Therapeutics, National Kapodistrian University of Athens, 15771 Attica, Greece",NA
"1517","34258907","10.31083/j.rcm2202046","Chronic disease management in heart failure: focus on telemedicine and remote monitoring.","In the context of the COVID-19 pandemic, many barriers to telemedicine disappeared. Virtual visits and telemonitoring strategies became routine. Evidence is accumulating regarding the safety and efficacy of virtual visits to replace in-person visits. A structured approach to virtual encounters is recommended. Telemonitoring includes patient reported remote vital sign monitoring, information from wearable devices, cardiac implantable electronic devices and invasive remote hemodynamic monitoring. ","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Heart failure with reduced ejection fraction; Telemedicine; Telemonitoring; COVID-19; Chronic Disease; Healthcare Disparities; Heart Failure; Humans; Predictive Value of Tests; Prognosis; Race Factors; Remote Consultation; Remote Sensing Technology; Socioeconomic Factors; Telemedicine; Wearable Electronic Devices","Brown","Jessica","Department of Nursing, Cleveland Clinic Foundation, Cleveland, OH 44195, USA",NA
"1518","34258907","10.31083/j.rcm2202046","Chronic disease management in heart failure: focus on telemedicine and remote monitoring.","In the context of the COVID-19 pandemic, many barriers to telemedicine disappeared. Virtual visits and telemonitoring strategies became routine. Evidence is accumulating regarding the safety and efficacy of virtual visits to replace in-person visits. A structured approach to virtual encounters is recommended. Telemonitoring includes patient reported remote vital sign monitoring, information from wearable devices, cardiac implantable electronic devices and invasive remote hemodynamic monitoring. ","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Heart failure with reduced ejection fraction; Telemedicine; Telemonitoring; COVID-19; Chronic Disease; Healthcare Disparities; Heart Failure; Humans; Predictive Value of Tests; Prognosis; Race Factors; Remote Consultation; Remote Sensing Technology; Socioeconomic Factors; Telemedicine; Wearable Electronic Devices","Ali","Abbas","Department of Internal Medicine, University of Iowa, Iowa City, IA 52246, USA",NA
"1519","34258907","10.31083/j.rcm2202046","Chronic disease management in heart failure: focus on telemedicine and remote monitoring.","In the context of the COVID-19 pandemic, many barriers to telemedicine disappeared. Virtual visits and telemonitoring strategies became routine. Evidence is accumulating regarding the safety and efficacy of virtual visits to replace in-person visits. A structured approach to virtual encounters is recommended. Telemonitoring includes patient reported remote vital sign monitoring, information from wearable devices, cardiac implantable electronic devices and invasive remote hemodynamic monitoring. ","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Heart failure with reduced ejection fraction; Telemedicine; Telemonitoring; COVID-19; Chronic Disease; Healthcare Disparities; Heart Failure; Humans; Predictive Value of Tests; Prognosis; Race Factors; Remote Consultation; Remote Sensing Technology; Socioeconomic Factors; Telemedicine; Wearable Electronic Devices","Briasoulis","Alexandros","Department of Clinical Therapeutics, National Kapodistrian University of Athens, 15771 Attica, Greece",NA
"1520","34258904","10.31083/j.rcm2202043","Cardiac manifestations of COVID-19.","COVID-19 is a novel viral infection caused by severe acute respiratory syndrome (SARS) beta-coronavirus. Epidemiological status changes dynamically as the pandemy is far from ending. Several complications of presented virus may be similar to those observed in other viral infections. Despite lacking data, the heart involvement may be comparable to cardiac complications observed previously in those with SARS as well as Middle East Respiratory Syndrome (MERS). In COVID-19 we observe elevated levels","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Cardiac manifestations; Coronavirus; Heart failure; SARS-CoV-2; COVID-19; Heart; Heart Diseases; Host-Pathogen Interactions; Humans; Prognosis; Risk Factors; SARS-CoV-2","Bielecka-Dabrowa","Agata","Department of Preventive Cardiology and Lipidology, Chair of Nephrology and Hypertension, Medical University of Lodz, Rzgowska 281/289, 93-338 Lodz, Poland",NA
"1521","34258904","10.31083/j.rcm2202043","Cardiac manifestations of COVID-19.","COVID-19 is a novel viral infection caused by severe acute respiratory syndrome (SARS) beta-coronavirus. Epidemiological status changes dynamically as the pandemy is far from ending. Several complications of presented virus may be similar to those observed in other viral infections. Despite lacking data, the heart involvement may be comparable to cardiac complications observed previously in those with SARS as well as Middle East Respiratory Syndrome (MERS). In COVID-19 we observe elevated levels","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Cardiac manifestations; Coronavirus; Heart failure; SARS-CoV-2; COVID-19; Heart; Heart Diseases; Host-Pathogen Interactions; Humans; Prognosis; Risk Factors; SARS-CoV-2","Cichocka-Radwan","Anna","Department of Cardiology and Congenital Diseases of Adults, Heart Failure Unit, Polish Mother's Memorial Hospital Research Institute (PMMHRI), Rzgowska 281/289, 93-338 Lodz, Poland",NA
"1522","34258904","10.31083/j.rcm2202043","Cardiac manifestations of COVID-19.","COVID-19 is a novel viral infection caused by severe acute respiratory syndrome (SARS) beta-coronavirus. Epidemiological status changes dynamically as the pandemy is far from ending. Several complications of presented virus may be similar to those observed in other viral infections. Despite lacking data, the heart involvement may be comparable to cardiac complications observed previously in those with SARS as well as Middle East Respiratory Syndrome (MERS). In COVID-19 we observe elevated levels","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Cardiac manifestations; Coronavirus; Heart failure; SARS-CoV-2; COVID-19; Heart; Heart Diseases; Host-Pathogen Interactions; Humans; Prognosis; Risk Factors; SARS-CoV-2","Lewek","Joanna","Department of Preventive Cardiology and Lipidology, Chair of Nephrology and Hypertension, Medical University of Lodz, Rzgowska 281/289, 93-338 Lodz, Poland",NA
"1523","34258904","10.31083/j.rcm2202043","Cardiac manifestations of COVID-19.","COVID-19 is a novel viral infection caused by severe acute respiratory syndrome (SARS) beta-coronavirus. Epidemiological status changes dynamically as the pandemy is far from ending. Several complications of presented virus may be similar to those observed in other viral infections. Despite lacking data, the heart involvement may be comparable to cardiac complications observed previously in those with SARS as well as Middle East Respiratory Syndrome (MERS). In COVID-19 we observe elevated levels","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Cardiac manifestations; Coronavirus; Heart failure; SARS-CoV-2; COVID-19; Heart; Heart Diseases; Host-Pathogen Interactions; Humans; Prognosis; Risk Factors; SARS-CoV-2","Pawliczak","Filip","Department of Preventive Cardiology and Lipidology, Chair of Nephrology and Hypertension, Medical University of Lodz, Rzgowska 281/289, 93-338 Lodz, Poland",NA
"1524","34258904","10.31083/j.rcm2202043","Cardiac manifestations of COVID-19.","COVID-19 is a novel viral infection caused by severe acute respiratory syndrome (SARS) beta-coronavirus. Epidemiological status changes dynamically as the pandemy is far from ending. Several complications of presented virus may be similar to those observed in other viral infections. Despite lacking data, the heart involvement may be comparable to cardiac complications observed previously in those with SARS as well as Middle East Respiratory Syndrome (MERS). In COVID-19 we observe elevated levels","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Cardiac manifestations; Coronavirus; Heart failure; SARS-CoV-2; COVID-19; Heart; Heart Diseases; Host-Pathogen Interactions; Humans; Prognosis; Risk Factors; SARS-CoV-2","Maciejewski","Marek","Department of Cardiology and Congenital Diseases of Adults, Heart Failure Unit, Polish Mother's Memorial Hospital Research Institute (PMMHRI), Rzgowska 281/289, 93-338 Lodz, Poland",NA
"1525","34258904","10.31083/j.rcm2202043","Cardiac manifestations of COVID-19.","COVID-19 is a novel viral infection caused by severe acute respiratory syndrome (SARS) beta-coronavirus. Epidemiological status changes dynamically as the pandemy is far from ending. Several complications of presented virus may be similar to those observed in other viral infections. Despite lacking data, the heart involvement may be comparable to cardiac complications observed previously in those with SARS as well as Middle East Respiratory Syndrome (MERS). In COVID-19 we observe elevated levels","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Cardiac manifestations; Coronavirus; Heart failure; SARS-CoV-2; COVID-19; Heart; Heart Diseases; Host-Pathogen Interactions; Humans; Prognosis; Risk Factors; SARS-CoV-2","Banach","Maciej","Department of Preventive Cardiology and Lipidology, Chair of Nephrology and Hypertension, Medical University of Lodz, Rzgowska 281/289, 93-338 Lodz, Poland",NA
"1526","34258902","10.31083/j.rcm2202041","COVID-19 and cardiovascular system-a comprehensive review.","Coronavirus disease 2019 (COVID-19), a mystified cryptic virus has challenged the mankind that has brought life to a standstill. Catastrophic loss of life, perplexed healthcare system and the downfall of global economy are some of the outcomes of this pandemic. Humans are raging a war with an unknown enemy. Infections, irrespective of age and gender, and more so in comorbidities are escalating at an alarming rate. Cardiovascular diseases, are the leading cause of death globally with an estimate ","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","ACE2; COVID-19; Cardiovascular disorders; Comorbidities; Antiviral Agents; COVID-19; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System; Comorbidity; Host-Pathogen Interactions; Humans; Prognosis; Risk Assessment; Risk Factors; SARS-CoV-2","AlShahrani","Ibrahim","Department of Paediatric Dentistry and Orthodontic Sciences, College of Dentistry, King Khalid University, 62529 Abha, Kingdom of Saudi Arabia",NA
"1527","34258902","10.31083/j.rcm2202041","COVID-19 and cardiovascular system-a comprehensive review.","Coronavirus disease 2019 (COVID-19), a mystified cryptic virus has challenged the mankind that has brought life to a standstill. Catastrophic loss of life, perplexed healthcare system and the downfall of global economy are some of the outcomes of this pandemic. Humans are raging a war with an unknown enemy. Infections, irrespective of age and gender, and more so in comorbidities are escalating at an alarming rate. Cardiovascular diseases, are the leading cause of death globally with an estimate ","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","ACE2; COVID-19; Cardiovascular disorders; Comorbidities; Antiviral Agents; COVID-19; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System; Comorbidity; Host-Pathogen Interactions; Humans; Prognosis; Risk Assessment; Risk Factors; SARS-CoV-2","Hosmani","Jagadish","Department of Diagnostic Dental Sciences, College of Dentistry, King Khalid University, 62529 Abha, Kingdom of Saudi Arabia",NA
"1528","34258902","10.31083/j.rcm2202041","COVID-19 and cardiovascular system-a comprehensive review.","Coronavirus disease 2019 (COVID-19), a mystified cryptic virus has challenged the mankind that has brought life to a standstill. Catastrophic loss of life, perplexed healthcare system and the downfall of global economy are some of the outcomes of this pandemic. Humans are raging a war with an unknown enemy. Infections, irrespective of age and gender, and more so in comorbidities are escalating at an alarming rate. Cardiovascular diseases, are the leading cause of death globally with an estimate ","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","ACE2; COVID-19; Cardiovascular disorders; Comorbidities; Antiviral Agents; COVID-19; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System; Comorbidity; Host-Pathogen Interactions; Humans; Prognosis; Risk Assessment; Risk Factors; SARS-CoV-2","Shankar","Vidya Gurram","Sree NRJV Specialists Dental Clinic, 560097 Bangalore, India",NA
"1529","34258902","10.31083/j.rcm2202041","COVID-19 and cardiovascular system-a comprehensive review.","Coronavirus disease 2019 (COVID-19), a mystified cryptic virus has challenged the mankind that has brought life to a standstill. Catastrophic loss of life, perplexed healthcare system and the downfall of global economy are some of the outcomes of this pandemic. Humans are raging a war with an unknown enemy. Infections, irrespective of age and gender, and more so in comorbidities are escalating at an alarming rate. Cardiovascular diseases, are the leading cause of death globally with an estimate ","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","ACE2; COVID-19; Cardiovascular disorders; Comorbidities; Antiviral Agents; COVID-19; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System; Comorbidity; Host-Pathogen Interactions; Humans; Prognosis; Risk Assessment; Risk Factors; SARS-CoV-2","AlShahrani","Abdulaziz","Department of Paediatric Dentistry and Orthodontic Sciences, College of Dentistry, King Khalid University, 62529 Abha, Kingdom of Saudi Arabia",NA
"1530","34258902","10.31083/j.rcm2202041","COVID-19 and cardiovascular system-a comprehensive review.","Coronavirus disease 2019 (COVID-19), a mystified cryptic virus has challenged the mankind that has brought life to a standstill. Catastrophic loss of life, perplexed healthcare system and the downfall of global economy are some of the outcomes of this pandemic. Humans are raging a war with an unknown enemy. Infections, irrespective of age and gender, and more so in comorbidities are escalating at an alarming rate. Cardiovascular diseases, are the leading cause of death globally with an estimate ","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","ACE2; COVID-19; Cardiovascular disorders; Comorbidities; Antiviral Agents; COVID-19; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System; Comorbidity; Host-Pathogen Interactions; Humans; Prognosis; Risk Assessment; Risk Factors; SARS-CoV-2","Togoo","Rafi Ahmad","Department of Paediatric Dentistry and Orthodontic Sciences, College of Dentistry, King Khalid University, 62529 Abha, Kingdom of Saudi Arabia",NA
"1531","34258902","10.31083/j.rcm2202041","COVID-19 and cardiovascular system-a comprehensive review.","Coronavirus disease 2019 (COVID-19), a mystified cryptic virus has challenged the mankind that has brought life to a standstill. Catastrophic loss of life, perplexed healthcare system and the downfall of global economy are some of the outcomes of this pandemic. Humans are raging a war with an unknown enemy. Infections, irrespective of age and gender, and more so in comorbidities are escalating at an alarming rate. Cardiovascular diseases, are the leading cause of death globally with an estimate ","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","ACE2; COVID-19; Cardiovascular disorders; Comorbidities; Antiviral Agents; COVID-19; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System; Comorbidity; Host-Pathogen Interactions; Humans; Prognosis; Risk Assessment; Risk Factors; SARS-CoV-2","Yassin","Syed M","Department of Paediatric Dentistry and Orthodontic Sciences, College of Dentistry, King Khalid University, 62529 Abha, Kingdom of Saudi Arabia",NA
"1532","34258902","10.31083/j.rcm2202041","COVID-19 and cardiovascular system-a comprehensive review.","Coronavirus disease 2019 (COVID-19), a mystified cryptic virus has challenged the mankind that has brought life to a standstill. Catastrophic loss of life, perplexed healthcare system and the downfall of global economy are some of the outcomes of this pandemic. Humans are raging a war with an unknown enemy. Infections, irrespective of age and gender, and more so in comorbidities are escalating at an alarming rate. Cardiovascular diseases, are the leading cause of death globally with an estimate ","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","ACE2; COVID-19; Cardiovascular disorders; Comorbidities; Antiviral Agents; COVID-19; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System; Comorbidity; Host-Pathogen Interactions; Humans; Prognosis; Risk Assessment; Risk Factors; SARS-CoV-2","Khan","Shahrukh","School of Nursing and Midwifery, Faculty of Health, Deakin University, 3217 Geelong, Australia",NA
"1533","34258902","10.31083/j.rcm2202041","COVID-19 and cardiovascular system-a comprehensive review.","Coronavirus disease 2019 (COVID-19), a mystified cryptic virus has challenged the mankind that has brought life to a standstill. Catastrophic loss of life, perplexed healthcare system and the downfall of global economy are some of the outcomes of this pandemic. Humans are raging a war with an unknown enemy. Infections, irrespective of age and gender, and more so in comorbidities are escalating at an alarming rate. Cardiovascular diseases, are the leading cause of death globally with an estimate ","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","ACE2; COVID-19; Cardiovascular disorders; Comorbidities; Antiviral Agents; COVID-19; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System; Comorbidity; Host-Pathogen Interactions; Humans; Prognosis; Risk Assessment; Risk Factors; SARS-CoV-2","Patil","Shankargouda","Department of Maxillofacial Surgery and Diagnostic Sciences, Division of Oral Pathology, College of Dentistry, Jazan University, 45142 Jazan, Saudi Arabia",NA
"1534","34258900","10.31083/j.rcm2202039","Revisiting pulmonary rehabilitation during COVID-19 pandemic: a narrative review.","There has been an apparent association between the risks of complications with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with a history of existing chronic respiratory diseases during the pandemic of coronavirus disease 2019 (COVID-19). SARS-CoV-2 poses a severe risk in cardiopulmonary management. Moreover, chronic respiratory diseases may further amplify the risk of morbidity and mortality among the afflicted population in the pandemic era.","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","Asthma; COPD; COVID; Exercise; Pulmonary rehabilitation; Asthma; COVID-19; Host-Pathogen Interactions; Humans; Lung; Pulmonary Disease, Chronic Obstructive; Recovery of Function; Respiratory Therapy; SARS-CoV-2; Time Factors; Treatment Outcome","Dixit","Snehil","Department of Medical Rehabilitation Sciences, College of Applied Medical Sciences, King Khalid University, 61421 Abha, Kingdom of Saudi Arabia",NA
"1535","34258900","10.31083/j.rcm2202039","Revisiting pulmonary rehabilitation during COVID-19 pandemic: a narrative review.","There has been an apparent association between the risks of complications with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with a history of existing chronic respiratory diseases during the pandemic of coronavirus disease 2019 (COVID-19). SARS-CoV-2 poses a severe risk in cardiopulmonary management. Moreover, chronic respiratory diseases may further amplify the risk of morbidity and mortality among the afflicted population in the pandemic era.","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","Asthma; COPD; COVID; Exercise; Pulmonary rehabilitation; Asthma; COVID-19; Host-Pathogen Interactions; Humans; Lung; Pulmonary Disease, Chronic Obstructive; Recovery of Function; Respiratory Therapy; SARS-CoV-2; Time Factors; Treatment Outcome","Borghi-Silva","Audrey","Cardiopulmonary Physiotherapy Laboratory, Physiotherapy Department, Federal University of Sao Carlos, 13565-905 Sao Carlos, Brazil",NA
"1536","34258900","10.31083/j.rcm2202039","Revisiting pulmonary rehabilitation during COVID-19 pandemic: a narrative review.","There has been an apparent association between the risks of complications with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with a history of existing chronic respiratory diseases during the pandemic of coronavirus disease 2019 (COVID-19). SARS-CoV-2 poses a severe risk in cardiopulmonary management. Moreover, chronic respiratory diseases may further amplify the risk of morbidity and mortality among the afflicted population in the pandemic era.","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","Asthma; COPD; COVID; Exercise; Pulmonary rehabilitation; Asthma; COVID-19; Host-Pathogen Interactions; Humans; Lung; Pulmonary Disease, Chronic Obstructive; Recovery of Function; Respiratory Therapy; SARS-CoV-2; Time Factors; Treatment Outcome","Bairapareddy","Kalyana Chakravarthy","College of Health sciences, University of Sharjah, 27272 Sharjah, United Arab Emirates",NA
"1537","34258896","10.31083/j.rcm2202035","Thrombotic risk in patients with COVID-19.","Emerging evidences prove that the ongoing pandemic of coronavirus disease 2019 (COVID-19) is strictly linked to coagulopathy even if pneumonia appears as the major clinical manifestation. The exact incidence of thromboembolic events is largely unknown, so that a relative significant number of studies have been performed in order to explore thrombotic risk in COVID-19 patients. Cytokine storm, mediated by pro-inflammatory interleukins, tumor necrosis factor a and elevated acute phase reactants, i","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Coagulopathy; Endothelitis; Pulmonary embolism; Thrombosis; Anticoagulants; Blood Coagulation; COVID-19; Host-Pathogen Interactions; Humans; Prognosis; Pulmonary Embolism; Risk Assessment; Risk Factors; SARS-CoV-2; Venous Thromboembolism; Venous Thrombosis","Pancaldi","Edoardo","Cardiology Unit, Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, 23123 Brescia, Italy",NA
"1538","34258896","10.31083/j.rcm2202035","Thrombotic risk in patients with COVID-19.","Emerging evidences prove that the ongoing pandemic of coronavirus disease 2019 (COVID-19) is strictly linked to coagulopathy even if pneumonia appears as the major clinical manifestation. The exact incidence of thromboembolic events is largely unknown, so that a relative significant number of studies have been performed in order to explore thrombotic risk in COVID-19 patients. Cytokine storm, mediated by pro-inflammatory interleukins, tumor necrosis factor a and elevated acute phase reactants, i","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Coagulopathy; Endothelitis; Pulmonary embolism; Thrombosis; Anticoagulants; Blood Coagulation; COVID-19; Host-Pathogen Interactions; Humans; Prognosis; Pulmonary Embolism; Risk Assessment; Risk Factors; SARS-CoV-2; Venous Thromboembolism; Venous Thrombosis","Pascariello","Greta","Cardiology Unit, Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, 23123 Brescia, Italy",NA
"1539","34258896","10.31083/j.rcm2202035","Thrombotic risk in patients with COVID-19.","Emerging evidences prove that the ongoing pandemic of coronavirus disease 2019 (COVID-19) is strictly linked to coagulopathy even if pneumonia appears as the major clinical manifestation. The exact incidence of thromboembolic events is largely unknown, so that a relative significant number of studies have been performed in order to explore thrombotic risk in COVID-19 patients. Cytokine storm, mediated by pro-inflammatory interleukins, tumor necrosis factor a and elevated acute phase reactants, i","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Coagulopathy; Endothelitis; Pulmonary embolism; Thrombosis; Anticoagulants; Blood Coagulation; COVID-19; Host-Pathogen Interactions; Humans; Prognosis; Pulmonary Embolism; Risk Assessment; Risk Factors; SARS-CoV-2; Venous Thromboembolism; Venous Thrombosis","Cimino","Giuliana","Cardiology Unit, Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, 23123 Brescia, Italy",NA
"1540","34258896","10.31083/j.rcm2202035","Thrombotic risk in patients with COVID-19.","Emerging evidences prove that the ongoing pandemic of coronavirus disease 2019 (COVID-19) is strictly linked to coagulopathy even if pneumonia appears as the major clinical manifestation. The exact incidence of thromboembolic events is largely unknown, so that a relative significant number of studies have been performed in order to explore thrombotic risk in COVID-19 patients. Cytokine storm, mediated by pro-inflammatory interleukins, tumor necrosis factor a and elevated acute phase reactants, i","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Coagulopathy; Endothelitis; Pulmonary embolism; Thrombosis; Anticoagulants; Blood Coagulation; COVID-19; Host-Pathogen Interactions; Humans; Prognosis; Pulmonary Embolism; Risk Assessment; Risk Factors; SARS-CoV-2; Venous Thromboembolism; Venous Thrombosis","Cersosimo","Angelica","Cardiology Unit, Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, 23123 Brescia, Italy",NA
"1541","34258896","10.31083/j.rcm2202035","Thrombotic risk in patients with COVID-19.","Emerging evidences prove that the ongoing pandemic of coronavirus disease 2019 (COVID-19) is strictly linked to coagulopathy even if pneumonia appears as the major clinical manifestation. The exact incidence of thromboembolic events is largely unknown, so that a relative significant number of studies have been performed in order to explore thrombotic risk in COVID-19 patients. Cytokine storm, mediated by pro-inflammatory interleukins, tumor necrosis factor a and elevated acute phase reactants, i","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Coagulopathy; Endothelitis; Pulmonary embolism; Thrombosis; Anticoagulants; Blood Coagulation; COVID-19; Host-Pathogen Interactions; Humans; Prognosis; Pulmonary Embolism; Risk Assessment; Risk Factors; SARS-CoV-2; Venous Thromboembolism; Venous Thrombosis","Amore","Ludovica","Cardiology Unit, Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, 23123 Brescia, Italy",NA
"1542","34258896","10.31083/j.rcm2202035","Thrombotic risk in patients with COVID-19.","Emerging evidences prove that the ongoing pandemic of coronavirus disease 2019 (COVID-19) is strictly linked to coagulopathy even if pneumonia appears as the major clinical manifestation. The exact incidence of thromboembolic events is largely unknown, so that a relative significant number of studies have been performed in order to explore thrombotic risk in COVID-19 patients. Cytokine storm, mediated by pro-inflammatory interleukins, tumor necrosis factor a and elevated acute phase reactants, i","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Coagulopathy; Endothelitis; Pulmonary embolism; Thrombosis; Anticoagulants; Blood Coagulation; COVID-19; Host-Pathogen Interactions; Humans; Prognosis; Pulmonary Embolism; Risk Assessment; Risk Factors; SARS-CoV-2; Venous Thromboembolism; Venous Thrombosis","Alghisi","Fabio","Cardiology Unit, Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, 23123 Brescia, Italy",NA
"1543","34258896","10.31083/j.rcm2202035","Thrombotic risk in patients with COVID-19.","Emerging evidences prove that the ongoing pandemic of coronavirus disease 2019 (COVID-19) is strictly linked to coagulopathy even if pneumonia appears as the major clinical manifestation. The exact incidence of thromboembolic events is largely unknown, so that a relative significant number of studies have been performed in order to explore thrombotic risk in COVID-19 patients. Cytokine storm, mediated by pro-inflammatory interleukins, tumor necrosis factor a and elevated acute phase reactants, i","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Coagulopathy; Endothelitis; Pulmonary embolism; Thrombosis; Anticoagulants; Blood Coagulation; COVID-19; Host-Pathogen Interactions; Humans; Prognosis; Pulmonary Embolism; Risk Assessment; Risk Factors; SARS-CoV-2; Venous Thromboembolism; Venous Thrombosis","Bernardi","Nicola","Cardiology Unit, Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, 23123 Brescia, Italy",NA
"1544","34258896","10.31083/j.rcm2202035","Thrombotic risk in patients with COVID-19.","Emerging evidences prove that the ongoing pandemic of coronavirus disease 2019 (COVID-19) is strictly linked to coagulopathy even if pneumonia appears as the major clinical manifestation. The exact incidence of thromboembolic events is largely unknown, so that a relative significant number of studies have been performed in order to explore thrombotic risk in COVID-19 patients. Cytokine storm, mediated by pro-inflammatory interleukins, tumor necrosis factor a and elevated acute phase reactants, i","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Coagulopathy; Endothelitis; Pulmonary embolism; Thrombosis; Anticoagulants; Blood Coagulation; COVID-19; Host-Pathogen Interactions; Humans; Prognosis; Pulmonary Embolism; Risk Assessment; Risk Factors; SARS-CoV-2; Venous Thromboembolism; Venous Thrombosis","Calvi","Emiliano","Cardiology Unit, Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, 23123 Brescia, Italy",NA
"1545","34258896","10.31083/j.rcm2202035","Thrombotic risk in patients with COVID-19.","Emerging evidences prove that the ongoing pandemic of coronavirus disease 2019 (COVID-19) is strictly linked to coagulopathy even if pneumonia appears as the major clinical manifestation. The exact incidence of thromboembolic events is largely unknown, so that a relative significant number of studies have been performed in order to explore thrombotic risk in COVID-19 patients. Cytokine storm, mediated by pro-inflammatory interleukins, tumor necrosis factor a and elevated acute phase reactants, i","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Coagulopathy; Endothelitis; Pulmonary embolism; Thrombosis; Anticoagulants; Blood Coagulation; COVID-19; Host-Pathogen Interactions; Humans; Prognosis; Pulmonary Embolism; Risk Assessment; Risk Factors; SARS-CoV-2; Venous Thromboembolism; Venous Thrombosis","Lombardi","Carlo Mario","Cardiology Unit, Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, 23123 Brescia, Italy",NA
"1546","34258896","10.31083/j.rcm2202035","Thrombotic risk in patients with COVID-19.","Emerging evidences prove that the ongoing pandemic of coronavirus disease 2019 (COVID-19) is strictly linked to coagulopathy even if pneumonia appears as the major clinical manifestation. The exact incidence of thromboembolic events is largely unknown, so that a relative significant number of studies have been performed in order to explore thrombotic risk in COVID-19 patients. Cytokine storm, mediated by pro-inflammatory interleukins, tumor necrosis factor a and elevated acute phase reactants, i","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Coagulopathy; Endothelitis; Pulmonary embolism; Thrombosis; Anticoagulants; Blood Coagulation; COVID-19; Host-Pathogen Interactions; Humans; Prognosis; Pulmonary Embolism; Risk Assessment; Risk Factors; SARS-CoV-2; Venous Thromboembolism; Venous Thrombosis","Vizzardi","Enrico","Cardiology Unit, Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, 23123 Brescia, Italy",NA
"1547","34258896","10.31083/j.rcm2202035","Thrombotic risk in patients with COVID-19.","Emerging evidences prove that the ongoing pandemic of coronavirus disease 2019 (COVID-19) is strictly linked to coagulopathy even if pneumonia appears as the major clinical manifestation. The exact incidence of thromboembolic events is largely unknown, so that a relative significant number of studies have been performed in order to explore thrombotic risk in COVID-19 patients. Cytokine storm, mediated by pro-inflammatory interleukins, tumor necrosis factor a and elevated acute phase reactants, i","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Coagulopathy; Endothelitis; Pulmonary embolism; Thrombosis; Anticoagulants; Blood Coagulation; COVID-19; Host-Pathogen Interactions; Humans; Prognosis; Pulmonary Embolism; Risk Assessment; Risk Factors; SARS-CoV-2; Venous Thromboembolism; Venous Thrombosis","Metra","Marco","Cardiology Unit, Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, 23123 Brescia, Italy",NA
"1548","34258895","10.31083/j.rcm2202034","Impact of the COVID-19 pandemic on the management of chronic heart failure.","The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented challenge. Meeting this has resulted in changes to working practices and the impact on the management of patients with heart failure with reduced ejection fraction (HFrEF) is largely unknown. We performed a retrospective, observational study contrasting patients diagnosed with HFrEF attending specialist heart failure clinics at a UK hospital, whose subsequent period of optimisation of medical therapy was during the COVID-19 pan","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","ACE-inhibitors; Heart failure; Specialist nursing; ß-blockers; Adrenergic beta-1 Receptor Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; COVID-19; Chronic Disease; Female; Heart Failure; Humans; Male; Ramipril; Retrospective Studies; Time Factors; Treatment Outcome","McGinlay","Melanie","Department of Cardiology, Leeds Teaching Hospitals NHS Trust, LS9 7TF Leeds, UK",NA
"1549","34258895","10.31083/j.rcm2202034","Impact of the COVID-19 pandemic on the management of chronic heart failure.","The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented challenge. Meeting this has resulted in changes to working practices and the impact on the management of patients with heart failure with reduced ejection fraction (HFrEF) is largely unknown. We performed a retrospective, observational study contrasting patients diagnosed with HFrEF attending specialist heart failure clinics at a UK hospital, whose subsequent period of optimisation of medical therapy was during the COVID-19 pan","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","ACE-inhibitors; Heart failure; Specialist nursing; ß-blockers; Adrenergic beta-1 Receptor Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; COVID-19; Chronic Disease; Female; Heart Failure; Humans; Male; Ramipril; Retrospective Studies; Time Factors; Treatment Outcome","Straw","Sam","Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, LS2 9JT Leeds, UK",NA
"1550","34258895","10.31083/j.rcm2202034","Impact of the COVID-19 pandemic on the management of chronic heart failure.","The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented challenge. Meeting this has resulted in changes to working practices and the impact on the management of patients with heart failure with reduced ejection fraction (HFrEF) is largely unknown. We performed a retrospective, observational study contrasting patients diagnosed with HFrEF attending specialist heart failure clinics at a UK hospital, whose subsequent period of optimisation of medical therapy was during the COVID-19 pan","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","ACE-inhibitors; Heart failure; Specialist nursing; ß-blockers; Adrenergic beta-1 Receptor Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; COVID-19; Chronic Disease; Female; Heart Failure; Humans; Male; Ramipril; Retrospective Studies; Time Factors; Treatment Outcome","Jagger","Jacob","Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, LS2 9JT Leeds, UK",NA
"1551","34258895","10.31083/j.rcm2202034","Impact of the COVID-19 pandemic on the management of chronic heart failure.","The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented challenge. Meeting this has resulted in changes to working practices and the impact on the management of patients with heart failure with reduced ejection fraction (HFrEF) is largely unknown. We performed a retrospective, observational study contrasting patients diagnosed with HFrEF attending specialist heart failure clinics at a UK hospital, whose subsequent period of optimisation of medical therapy was during the COVID-19 pan","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","ACE-inhibitors; Heart failure; Specialist nursing; ß-blockers; Adrenergic beta-1 Receptor Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; COVID-19; Chronic Disease; Female; Heart Failure; Humans; Male; Ramipril; Retrospective Studies; Time Factors; Treatment Outcome","Nouri","Bako","Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, LS2 9JT Leeds, UK",NA
"1552","34258895","10.31083/j.rcm2202034","Impact of the COVID-19 pandemic on the management of chronic heart failure.","The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented challenge. Meeting this has resulted in changes to working practices and the impact on the management of patients with heart failure with reduced ejection fraction (HFrEF) is largely unknown. We performed a retrospective, observational study contrasting patients diagnosed with HFrEF attending specialist heart failure clinics at a UK hospital, whose subsequent period of optimisation of medical therapy was during the COVID-19 pan","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","ACE-inhibitors; Heart failure; Specialist nursing; ß-blockers; Adrenergic beta-1 Receptor Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; COVID-19; Chronic Disease; Female; Heart Failure; Humans; Male; Ramipril; Retrospective Studies; Time Factors; Treatment Outcome","Gierula","John","Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, LS2 9JT Leeds, UK",NA
"1553","34258895","10.31083/j.rcm2202034","Impact of the COVID-19 pandemic on the management of chronic heart failure.","The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented challenge. Meeting this has resulted in changes to working practices and the impact on the management of patients with heart failure with reduced ejection fraction (HFrEF) is largely unknown. We performed a retrospective, observational study contrasting patients diagnosed with HFrEF attending specialist heart failure clinics at a UK hospital, whose subsequent period of optimisation of medical therapy was during the COVID-19 pan","2021","07","21","Rev Cardiovasc Med","Reviews in cardiovascular medicine","ACE-inhibitors; Heart failure; Specialist nursing; ß-blockers; Adrenergic beta-1 Receptor Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; COVID-19; Chronic Disease; Female; Heart Failure; Humans; Male; Ramipril; Retrospective Studies; Time Factors; Treatment Outcome","Witte","Klaus K","Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, LS2 9JT Leeds, UK",NA
"1554","34258894","10.31083/j.rcm2202033","A case of COVID-19 infection quickly relieved after nasal instillations and gargles with povidone iodine.","No abstract present.","2021","07","19","Rev Cardiovasc Med","Reviews in cardiovascular medicine","Anti-Infective Agents, Local; COVID-19; Humans; Mouthwashes; Povidone-Iodine; SARS-CoV-2","Blasi","Claudio","Medical Department-Sandro Pertini Hospital, Largo T. Solera n.10, 00199 Rome, Italy",NA
"1555","34258892","10.31083/j.rcm2202031","COVID-19 infection and cardiometabolic complications: short- and long-term treatment and management considerations.","No abstract present.","2021","07","19","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Cardiometabolic; Cardiovascular; Global health; Healthcare; Lifestyle; Public health; Underserved populations; COVID-19; Cardiovascular Diseases; Humans; SARS-CoV-2","Stoner","Lee","Department of Exercise and Sport Science, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA",NA
"1556","34258892","10.31083/j.rcm2202031","COVID-19 infection and cardiometabolic complications: short- and long-term treatment and management considerations.","No abstract present.","2021","07","19","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Cardiometabolic; Cardiovascular; Global health; Healthcare; Lifestyle; Public health; Underserved populations; COVID-19; Cardiovascular Diseases; Humans; SARS-CoV-2","Faghy","Mark","Healthy Living for Pandemic Event Protection (HL-PIVOT) Network, Chicago, IL 60612, USA",NA
"1557","34258892","10.31083/j.rcm2202031","COVID-19 infection and cardiometabolic complications: short- and long-term treatment and management considerations.","No abstract present.","2021","07","19","Rev Cardiovasc Med","Reviews in cardiovascular medicine","COVID-19; Cardiometabolic; Cardiovascular; Global health; Healthcare; Lifestyle; Public health; Underserved populations; COVID-19; Cardiovascular Diseases; Humans; SARS-CoV-2","Conners","Ryan","Healthy Living for Pandemic Event Protection (HL-PIVOT) Network, Chicago, IL 60612, USA",NA
"1558","34258873","10.1111/ijlh.13653","A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS-CoV-2 vaccine.","SARS-CoV-2 mRNA vaccine made by Pfizer and BioNTech was approved by the U.S. Food and Drug Administration for use under an Emergency Use Authorization for active immunization to prevent coronavirus disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on December 11, 2020 (1). Intolerance reactions to the vaccine identified in the initial study were usually transient and mild to moderate (2). More serious and rare cases of anaphylaxis were reported following the emergenc","2021","07","14","Int J Lab Hematol","International journal of laboratory hematology",NA,"Murdych","Tomas M","Mercy Hospital, Allina Health, 4050 Coon Rapids Blvd NW, 55433, Minneapolis, MN, United States",NA
"1559","34258844","10.1111/tid.13688","Is it safe to perform abdominal transplantation from SARS-CoV-2 polymerase chain reaction positive donors?",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Frattaroli","Paola","Department of Medicine, Division of Internal Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA",NA
"1560","34258844","10.1111/tid.13688","Is it safe to perform abdominal transplantation from SARS-CoV-2 polymerase chain reaction positive donors?",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Anjan","Shweta","Miami Transplant Institute, Jackson Health System, Miami, Florida, USA",NA
"1561","34258844","10.1111/tid.13688","Is it safe to perform abdominal transplantation from SARS-CoV-2 polymerase chain reaction positive donors?",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Coro","Ana","Miami Transplant Institute, Jackson Health System, Miami, Florida, USA",NA
"1562","34258844","10.1111/tid.13688","Is it safe to perform abdominal transplantation from SARS-CoV-2 polymerase chain reaction positive donors?",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Simkins","Jacques","Miami Transplant Institute, Jackson Health System, Miami, Florida, USA",NA
"1563","34258844","10.1111/tid.13688","Is it safe to perform abdominal transplantation from SARS-CoV-2 polymerase chain reaction positive donors?",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Vianna","Rodrigo","Miami Transplant Institute, Jackson Health System, Miami, Florida, USA",NA
"1564","34258844","10.1111/tid.13688","Is it safe to perform abdominal transplantation from SARS-CoV-2 polymerase chain reaction positive donors?",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Morsi","Mahmoud","Miami Transplant Institute, Jackson Health System, Miami, Florida, USA",NA
"1565","34258844","10.1111/tid.13688","Is it safe to perform abdominal transplantation from SARS-CoV-2 polymerase chain reaction positive donors?",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Abbo","Lilian","Miami Transplant Institute, Jackson Health System, Miami, Florida, USA",NA
"1566","34258844","10.1111/tid.13688","Is it safe to perform abdominal transplantation from SARS-CoV-2 polymerase chain reaction positive donors?",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Guerra","Giselle","Miami Transplant Institute, Jackson Health System, Miami, Florida, USA",NA
"1567","34258844","10.1111/tid.13688","Is it safe to perform abdominal transplantation from SARS-CoV-2 polymerase chain reaction positive donors?",NA,"2021","07","21","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society",NA,"Natori","Yoichiro","Miami Transplant Institute, Jackson Health System, Miami, Florida, USA",NA
"1568","34258829","10.1111/ped.14921","Urgent need to strengthen school health in Asia and the Pacific Islands.","In Asia and the Pacific Island region, strengthening of school health activities and measures is urgently recommended to deal with the impact of the increasing risk of potential school closures due to continuation of the coronavirus disease 2019 (COVID-19) pandemic in 2021. As the incidence of COVID-19 in 2020 was relatively low in these regions, many of the countries were able to avoid prolonged school closures. However, even if vaccination is expanded in the future and the pandemic tends to co","2021","07","14","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","Asia; COVID-19; Pacific Islands; school closures; school health","Kobayashi","Jun","Department of Global Health, Graduate School of Health Sciences, University of the Ryukyus, 207 Uehara, Nishihara-cho, Nakagami-gun, Okinawa, 903-0215, Japan",NA
"1569","34258829","10.1111/ped.14921","Urgent need to strengthen school health in Asia and the Pacific Islands.","In Asia and the Pacific Island region, strengthening of school health activities and measures is urgently recommended to deal with the impact of the increasing risk of potential school closures due to continuation of the coronavirus disease 2019 (COVID-19) pandemic in 2021. As the incidence of COVID-19 in 2020 was relatively low in these regions, many of the countries were able to avoid prolonged school closures. However, even if vaccination is expanded in the future and the pandemic tends to co","2021","07","14","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","Asia; COVID-19; Pacific Islands; school closures; school health","Takeuchi","Rie","Department of Global Health, Graduate School of Health Sciences, University of the Ryukyus, 207 Uehara, Nishihara-cho, Nakagami-gun, Okinawa, 903-0215, Japan",NA
"1570","34258829","10.1111/ped.14921","Urgent need to strengthen school health in Asia and the Pacific Islands.","In Asia and the Pacific Island region, strengthening of school health activities and measures is urgently recommended to deal with the impact of the increasing risk of potential school closures due to continuation of the coronavirus disease 2019 (COVID-19) pandemic in 2021. As the incidence of COVID-19 in 2020 was relatively low in these regions, many of the countries were able to avoid prolonged school closures. However, even if vaccination is expanded in the future and the pandemic tends to co","2021","07","14","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","Asia; COVID-19; Pacific Islands; school closures; school health","Toyama","Yuko","School of Health Sciences, Faculty of Medicine, University of the Ryukyus, 207 Uehara, Nishihara-cho, Nakagami-gun, Okinawa, 903-0215, Japan",NA
"1571","34258829","10.1111/ped.14921","Urgent need to strengthen school health in Asia and the Pacific Islands.","In Asia and the Pacific Island region, strengthening of school health activities and measures is urgently recommended to deal with the impact of the increasing risk of potential school closures due to continuation of the coronavirus disease 2019 (COVID-19) pandemic in 2021. As the incidence of COVID-19 in 2020 was relatively low in these regions, many of the countries were able to avoid prolonged school closures. However, even if vaccination is expanded in the future and the pandemic tends to co","2021","07","14","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","Asia; COVID-19; Pacific Islands; school closures; school health","Gregorio","Ernesto R","College of Public Health, University of the Philippines Manila, 625 Pedro Gil St, Ermita, Manila, Philippines",NA
"1572","34258829","10.1111/ped.14921","Urgent need to strengthen school health in Asia and the Pacific Islands.","In Asia and the Pacific Island region, strengthening of school health activities and measures is urgently recommended to deal with the impact of the increasing risk of potential school closures due to continuation of the coronavirus disease 2019 (COVID-19) pandemic in 2021. As the incidence of COVID-19 in 2020 was relatively low in these regions, many of the countries were able to avoid prolonged school closures. However, even if vaccination is expanded in the future and the pandemic tends to co","2021","07","14","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","Asia; COVID-19; Pacific Islands; school closures; school health","Kadriyan","Hamsu","Faculty of Medicine, Mataram University, Jl. Majapahit No. 62, Gomong, Kec. Selaparang, Kota Mataram, Nusa Tenggara Bar, 83115, Indonesia",NA
"1573","34258829","10.1111/ped.14921","Urgent need to strengthen school health in Asia and the Pacific Islands.","In Asia and the Pacific Island region, strengthening of school health activities and measures is urgently recommended to deal with the impact of the increasing risk of potential school closures due to continuation of the coronavirus disease 2019 (COVID-19) pandemic in 2021. As the incidence of COVID-19 in 2020 was relatively low in these regions, many of the countries were able to avoid prolonged school closures. However, even if vaccination is expanded in the future and the pandemic tends to co","2021","07","14","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","Asia; COVID-19; Pacific Islands; school closures; school health","Estrada","Crystal Amiel M","College of Public Health, University of the Philippines Manila, 625 Pedro Gil St, Ermita, Manila, Philippines",NA
"1574","34258829","10.1111/ped.14921","Urgent need to strengthen school health in Asia and the Pacific Islands.","In Asia and the Pacific Island region, strengthening of school health activities and measures is urgently recommended to deal with the impact of the increasing risk of potential school closures due to continuation of the coronavirus disease 2019 (COVID-19) pandemic in 2021. As the incidence of COVID-19 in 2020 was relatively low in these regions, many of the countries were able to avoid prolonged school closures. However, even if vaccination is expanded in the future and the pandemic tends to co","2021","07","14","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","Asia; COVID-19; Pacific Islands; school closures; school health","Motomura","Makoto","Faculty of Humanities and Social Sciences, University of the Ryukyus, 1 Senbaru, Nishihara-cho, Nakagami-gun, Okinawa, 903-0213, Japan",NA
"1575","34258829","10.1111/ped.14921","Urgent need to strengthen school health in Asia and the Pacific Islands.","In Asia and the Pacific Island region, strengthening of school health activities and measures is urgently recommended to deal with the impact of the increasing risk of potential school closures due to continuation of the coronavirus disease 2019 (COVID-19) pandemic in 2021. As the incidence of COVID-19 in 2020 was relatively low in these regions, many of the countries were able to avoid prolonged school closures. However, even if vaccination is expanded in the future and the pandemic tends to co","2021","07","14","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","Asia; COVID-19; Pacific Islands; school closures; school health","Wake","Norie","School of Health Sciences, Faculty of Medicine, University of the Ryukyus, 207 Uehara, Nishihara-cho, Nakagami-gun, Okinawa, 903-0215, Japan",NA
"1576","34258829","10.1111/ped.14921","Urgent need to strengthen school health in Asia and the Pacific Islands.","In Asia and the Pacific Island region, strengthening of school health activities and measures is urgently recommended to deal with the impact of the increasing risk of potential school closures due to continuation of the coronavirus disease 2019 (COVID-19) pandemic in 2021. As the incidence of COVID-19 in 2020 was relatively low in these regions, many of the countries were able to avoid prolonged school closures. However, even if vaccination is expanded in the future and the pandemic tends to co","2021","07","14","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","Asia; COVID-19; Pacific Islands; school closures; school health","Yamada","Kyoko","Global Education Institute, University of the Ryukyus, 1 Senbaru, Nishihara-cho, Nakagami-gun, Okinawa, 903-0213, Japan",NA
"1577","34258829","10.1111/ped.14921","Urgent need to strengthen school health in Asia and the Pacific Islands.","In Asia and the Pacific Island region, strengthening of school health activities and measures is urgently recommended to deal with the impact of the increasing risk of potential school closures due to continuation of the coronavirus disease 2019 (COVID-19) pandemic in 2021. As the incidence of COVID-19 in 2020 was relatively low in these regions, many of the countries were able to avoid prolonged school closures. However, even if vaccination is expanded in the future and the pandemic tends to co","2021","07","14","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","Asia; COVID-19; Pacific Islands; school closures; school health","Ishikawa","Ryuji","Faculty of Global and Regional Studies, University of the Ryukyus, 1 Senbaru, Nishihara-cho, Nakagami-gun, Okinawa, 903-0213, Japan",NA
"1578","34258829","10.1111/ped.14921","Urgent need to strengthen school health in Asia and the Pacific Islands.","In Asia and the Pacific Island region, strengthening of school health activities and measures is urgently recommended to deal with the impact of the increasing risk of potential school closures due to continuation of the coronavirus disease 2019 (COVID-19) pandemic in 2021. As the incidence of COVID-19 in 2020 was relatively low in these regions, many of the countries were able to avoid prolonged school closures. However, even if vaccination is expanded in the future and the pandemic tends to co","2021","07","14","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","Asia; COVID-19; Pacific Islands; school closures; school health","Takakura","Minoru","Department of Health Promotion &amp",NA
"1579","34258806","10.1111/jan.14978","The Experiences of Community-dwelling older adults during the COVID-19 Lockdown in Wuhan: A qualitative study.","To explore the experiences of community-dwelling older adults in Wuhan during the coronavirus disease 2019 lockdown. An empirical phenomenological approach was used to conduct a qualitative study. We performed semi-structured, in-depth telephone interviews between July 24 and August 2, 2020. A purposive sample of 18 participants (=65 years old) who lived in Wuhan during the lockdown was recruited, including both infected and uninfected people. Data summarization and theme categories refinement w","2021","07","14","J Adv Nurs","Journal of advanced nursing","Wuhan; coronavirus infection; experience; lockdown; nursing; older adults","Yang","Qing","Department of Nursing, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"1580","34258806","10.1111/jan.14978","The Experiences of Community-dwelling older adults during the COVID-19 Lockdown in Wuhan: A qualitative study.","To explore the experiences of community-dwelling older adults in Wuhan during the coronavirus disease 2019 lockdown. An empirical phenomenological approach was used to conduct a qualitative study. We performed semi-structured, in-depth telephone interviews between July 24 and August 2, 2020. A purposive sample of 18 participants (=65 years old) who lived in Wuhan during the lockdown was recruited, including both infected and uninfected people. Data summarization and theme categories refinement w","2021","07","14","J Adv Nurs","Journal of advanced nursing","Wuhan; coronavirus infection; experience; lockdown; nursing; older adults","Wang","Yuxin","School of Nursing, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"1581","34258806","10.1111/jan.14978","The Experiences of Community-dwelling older adults during the COVID-19 Lockdown in Wuhan: A qualitative study.","To explore the experiences of community-dwelling older adults in Wuhan during the coronavirus disease 2019 lockdown. An empirical phenomenological approach was used to conduct a qualitative study. We performed semi-structured, in-depth telephone interviews between July 24 and August 2, 2020. A purposive sample of 18 participants (=65 years old) who lived in Wuhan during the lockdown was recruited, including both infected and uninfected people. Data summarization and theme categories refinement w","2021","07","14","J Adv Nurs","Journal of advanced nursing","Wuhan; coronavirus infection; experience; lockdown; nursing; older adults","Tian","Chong","School of Nursing, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"1582","34258806","10.1111/jan.14978","The Experiences of Community-dwelling older adults during the COVID-19 Lockdown in Wuhan: A qualitative study.","To explore the experiences of community-dwelling older adults in Wuhan during the coronavirus disease 2019 lockdown. An empirical phenomenological approach was used to conduct a qualitative study. We performed semi-structured, in-depth telephone interviews between July 24 and August 2, 2020. A purposive sample of 18 participants (=65 years old) who lived in Wuhan during the lockdown was recruited, including both infected and uninfected people. Data summarization and theme categories refinement w","2021","07","14","J Adv Nurs","Journal of advanced nursing","Wuhan; coronavirus infection; experience; lockdown; nursing; older adults","Chen","Yuan","School of Nursing, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"1583","34258806","10.1111/jan.14978","The Experiences of Community-dwelling older adults during the COVID-19 Lockdown in Wuhan: A qualitative study.","To explore the experiences of community-dwelling older adults in Wuhan during the coronavirus disease 2019 lockdown. An empirical phenomenological approach was used to conduct a qualitative study. We performed semi-structured, in-depth telephone interviews between July 24 and August 2, 2020. A purposive sample of 18 participants (=65 years old) who lived in Wuhan during the lockdown was recruited, including both infected and uninfected people. Data summarization and theme categories refinement w","2021","07","14","J Adv Nurs","Journal of advanced nursing","Wuhan; coronavirus infection; experience; lockdown; nursing; older adults","Mao","Jing","School of Nursing, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"1584","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Cuneo","Antonio","Hematology Section, Department of Medical Sciences, University of Ferrara, Ferrara, Italy",NA
"1585","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Rigolin","Gian Matteo","Hematology Section, Department of Medical Sciences, University of Ferrara, Ferrara, Italy",NA
"1586","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Coscia","Marta","Division of Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Italy",NA
"1587","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Quaresmini","Giulia","USC Ematologia, ASST Papa Giovanni XXIII, Bergamo, Italy",NA
"1588","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Scarfò","Lydia","Università Vita-Salute San Raffaele, IRCCS Ospedale San Raffaele, Milan, Italy",NA
"1589","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Mauro","Francesca Romana","Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy",NA
"1590","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Motta","Marina","S.C. Ematologia, ASST Spedali Civili, Brescia, Italy",NA
"1591","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Quaglia","Francesca Maria","Department of Medicine, Section of Hematology, University of Verona, Verona, Italy",NA
"1592","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Trentin","Livio","Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, Italy",NA
"1593","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Ferrario","Andrea","UOC Ematologia Azienda Socio Sanitaria Territoriale dei Sette Laghi, Ospedale di Circolo di Varese, Varese, Italy",NA
"1594","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Laurenti","Luca","Hematology, Fondazione Universitaria Policlinico A. Gemelli, Rome, Italy",NA
"1595","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Reda","Gianluigi","U.O.C. Ematologia, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"1596","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Ferrari","Angela","Hematology, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy",NA
"1597","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Pietrasanta","Daniela","Division of Hematology, SC di Ematologia, Ospedale Civile SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy",NA
"1598","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Sportoletti","Paolo","Department of Medicine and Surgery, Institute of Hematology and Center for Hemato-Oncological Research, Ospedale S. Maria della Misericordia, Perugia, Italy",NA
"1599","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Re","Francesca","Hematology Unit, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy",NA
"1600","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","De Paoli","Lorenzo","SCDU Ematologia AOU Maggiore della Carità, Novara, Italy",NA
"1601","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Foglietta","Myriam","SC Ematologia Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy",NA
"1602","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Giordano","Annamaria","Hematology-Department of Emergency and Organ Transplantation, Azienda Ospedaliero Universitaria Policlinico, Bari, Italy",NA
"1603","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Marchetti","Monia","Hematology-Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo Alessandria, Alessandria, Italy",NA
"1604","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Farina","Lucia","Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy",NA
"1605","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Del Poeta","Giovanni","Hematology, S. Eugenio Hospital, University of Tor Vergata, Rome, Italy",NA
"1606","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Varettoni","Marzia","Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"1607","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Chiurazzi","Federico","Hematology Unit, University of Naples Federico II, Naples, Italy",NA
"1608","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Marasca","Roberto","Hematology Unit, University of Modena and Reggio Emilia, Modena, Italy",NA
"1609","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Malerba","Lara","UOC Ematologia e Centro trapianti AORMN Pesaro, Pesaro, Italy",NA
"1610","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Ibatici","Adalberto","Hematology and Bone Marrow Transplant, Policlinico San Martino, Genova, Italy",NA
"1611","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Tisi","Maria Chiara","Hematology, Azienda ULSS 8 Berica Dipartimento Strutturale Oncologia Clinica Vicenza, Vicenza, Italy",NA
"1612","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Stefoni","Vittorio","Department of Hematology and Oncology ""L. and A. Seràgnoli"", Bologna, Italy",NA
"1613","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Leone","Monica","Hematology, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy",NA
"1614","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Baratè","Claudia","Clinical and Experimental Medicine, Hematology Section, University of Pisa, Pisa, Italy",NA
"1615","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Olivieri","Jacopo","Hematology Unit, Azienda Ospedaliero Universitaria Santa Maria della Misericordia, Udine, Italy",NA
"1616","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Murru","Roberta","SC Ematologia e CTMO Ospedale Oncologico A. Businco, ARNAS ""G. Brotzu"", Cagliari, Italy",NA
"1617","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Gentile","Massimo","UOC Ematologia AO Cosenza, Cosenza, Italy",NA
"1618","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Sanna","Alessandro","Hemtology Unit, Azienda Ospedaliero Universitaria Careggi Firenze, Firenze, Italy",NA
"1619","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Gozzetti","Alessandro","Hematology Unit, University of Siena, Azienda Ospedaliera Universitaria Senese Siena, Siena, Italy",NA
"1620","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Gattei","Valter","Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy",NA
"1621","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Gottardi","Daniela","SCDU Ematologia Ospedale Mauriziano, Torino, Italy",NA
"1622","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Derenzini","Enrico","Oncohematology Division, IEO European Institute of Oncology IRCCS, Milan, Italy",NA
"1623","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Levato","Luciano","SOC Ematologia, Dipartimento di Ematologia Oncologia Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Catanzaro, Italy",NA
"1624","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Orsucci","Lorella","SC Ematologia, AUO Città della Scienza e della Salute di Torino, Torino, Italy",NA
"1625","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Penna","Giuseppa","UOC Ematologia Policlinico Universitario di Messina, Messina, Italy",NA
"1626","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Chiarenza","Annalisa","Divisione di Ematologia con Trapianto di Midollo Osseo, Azienda Ospedaliera Universitaria Policlinico ""G.Rodolico-S.Marco"", Catania, Italy",NA
"1627","34258787","10.1002/hon.2899","Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.",NA,"2021","07","14","Hematol Oncol","Hematological oncology","COVID-19; chronic lymphocytic leukemia; targeted agents; vaccination","Foà","Robin","Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy",NA
"1628","34258764","10.1002/ijgo.13825","Oncophone20 study: Patients' perception of telemedicine in the COVID-19 pandemic during follow-up visits for gynecological and breast cancers.","To analyze oncological patients' perception of telemedicine during the COVID-19 pandemic. A total of 345 women, of whom 267 experienced breast cancer and 78 experienced a gynecological cancer, were enrolled. Specific questionnaires about their experiences and feelings about telemedicine in the COVID-19 era were collected. In the breast group, ""Enhanced care"" showed moderate positive perception (mean 4.40) among less-educated women that was slightly lower among better-educated women (mean 4.14) w","2021","07","14","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; breast cancer; follow-up; gynecology oncology; telemedicine","Picardo","Elisa","AOU Citta della Salute e della Scienza di Torino, Department of Gynecology and Obstetrics, Sant'Anna Hospital, Torino, Italy",NA
"1629","34258764","10.1002/ijgo.13825","Oncophone20 study: Patients' perception of telemedicine in the COVID-19 pandemic during follow-up visits for gynecological and breast cancers.","To analyze oncological patients' perception of telemedicine during the COVID-19 pandemic. A total of 345 women, of whom 267 experienced breast cancer and 78 experienced a gynecological cancer, were enrolled. Specific questionnaires about their experiences and feelings about telemedicine in the COVID-19 era were collected. In the breast group, ""Enhanced care"" showed moderate positive perception (mean 4.40) among less-educated women that was slightly lower among better-educated women (mean 4.14) w","2021","07","14","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; breast cancer; follow-up; gynecology oncology; telemedicine","Baù","Maria G","AOU Citta della Salute e della Scienza di Torino, Department of Gynecology and Obstetrics, Sant'Anna Hospital, Torino, Italy",NA
"1630","34258764","10.1002/ijgo.13825","Oncophone20 study: Patients' perception of telemedicine in the COVID-19 pandemic during follow-up visits for gynecological and breast cancers.","To analyze oncological patients' perception of telemedicine during the COVID-19 pandemic. A total of 345 women, of whom 267 experienced breast cancer and 78 experienced a gynecological cancer, were enrolled. Specific questionnaires about their experiences and feelings about telemedicine in the COVID-19 era were collected. In the breast group, ""Enhanced care"" showed moderate positive perception (mean 4.40) among less-educated women that was slightly lower among better-educated women (mean 4.14) w","2021","07","14","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; breast cancer; follow-up; gynecology oncology; telemedicine","Anatrone","Caterina","AOU Citta della Salute e della Scienza di Torino, Department of Gynecology and Obstetrics, Sant'Anna Hospital, Torino, Italy",NA
"1631","34258764","10.1002/ijgo.13825","Oncophone20 study: Patients' perception of telemedicine in the COVID-19 pandemic during follow-up visits for gynecological and breast cancers.","To analyze oncological patients' perception of telemedicine during the COVID-19 pandemic. A total of 345 women, of whom 267 experienced breast cancer and 78 experienced a gynecological cancer, were enrolled. Specific questionnaires about their experiences and feelings about telemedicine in the COVID-19 era were collected. In the breast group, ""Enhanced care"" showed moderate positive perception (mean 4.40) among less-educated women that was slightly lower among better-educated women (mean 4.14) w","2021","07","14","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; breast cancer; follow-up; gynecology oncology; telemedicine","Mondino","Aurelia","AOU Citta della Salute e della Scienza di Torino, Department of Gynecology and Obstetrics, Sant'Anna Hospital, Torino, Italy",NA
"1632","34258764","10.1002/ijgo.13825","Oncophone20 study: Patients' perception of telemedicine in the COVID-19 pandemic during follow-up visits for gynecological and breast cancers.","To analyze oncological patients' perception of telemedicine during the COVID-19 pandemic. A total of 345 women, of whom 267 experienced breast cancer and 78 experienced a gynecological cancer, were enrolled. Specific questionnaires about their experiences and feelings about telemedicine in the COVID-19 era were collected. In the breast group, ""Enhanced care"" showed moderate positive perception (mean 4.40) among less-educated women that was slightly lower among better-educated women (mean 4.14) w","2021","07","14","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; breast cancer; follow-up; gynecology oncology; telemedicine","Surace","Alessandra","University of Turin, Surgical Sciences, Torino, Italy",NA
"1633","34258764","10.1002/ijgo.13825","Oncophone20 study: Patients' perception of telemedicine in the COVID-19 pandemic during follow-up visits for gynecological and breast cancers.","To analyze oncological patients' perception of telemedicine during the COVID-19 pandemic. A total of 345 women, of whom 267 experienced breast cancer and 78 experienced a gynecological cancer, were enrolled. Specific questionnaires about their experiences and feelings about telemedicine in the COVID-19 era were collected. In the breast group, ""Enhanced care"" showed moderate positive perception (mean 4.40) among less-educated women that was slightly lower among better-educated women (mean 4.14) w","2021","07","14","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; breast cancer; follow-up; gynecology oncology; telemedicine","Gallo","Federica","Epidemiology Unit, Health Direction, Local Health Authority 1, Cuneo, Italy",NA
"1634","34258764","10.1002/ijgo.13825","Oncophone20 study: Patients' perception of telemedicine in the COVID-19 pandemic during follow-up visits for gynecological and breast cancers.","To analyze oncological patients' perception of telemedicine during the COVID-19 pandemic. A total of 345 women, of whom 267 experienced breast cancer and 78 experienced a gynecological cancer, were enrolled. Specific questionnaires about their experiences and feelings about telemedicine in the COVID-19 era were collected. In the breast group, ""Enhanced care"" showed moderate positive perception (mean 4.40) among less-educated women that was slightly lower among better-educated women (mean 4.14) w","2021","07","14","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; breast cancer; follow-up; gynecology oncology; telemedicine","Danese","Saverio","AOU Citta della Salute e della Scienza di Torino, Department of Gynecology and Obstetrics, Sant'Anna Hospital, Torino, Italy",NA
"1635","34258764","10.1002/ijgo.13825","Oncophone20 study: Patients' perception of telemedicine in the COVID-19 pandemic during follow-up visits for gynecological and breast cancers.","To analyze oncological patients' perception of telemedicine during the COVID-19 pandemic. A total of 345 women, of whom 267 experienced breast cancer and 78 experienced a gynecological cancer, were enrolled. Specific questionnaires about their experiences and feelings about telemedicine in the COVID-19 era were collected. In the breast group, ""Enhanced care"" showed moderate positive perception (mean 4.40) among less-educated women that was slightly lower among better-educated women (mean 4.14) w","2021","07","14","Int J Gynaecol Obstet","International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","COVID-19; breast cancer; follow-up; gynecology oncology; telemedicine","Mitidieri","Marco","AOU Citta della Salute e della Scienza di Torino, Department of Gynecology and Obstetrics, Sant'Anna Hospital, Torino, Italy",NA
"1636","34258762","10.1111/bjd.20647","Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic.","A range of cutaneous manifestations has been described in association with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection during the coronavirus disease 2019 (COVID-19) pandemic <sup>1</sup> . Among them, chilblain like lesions (CLL) occurred more frequently than expected. A direct link was demonstrated thanks to the visualization of viral particles in the skin endothelial cells by electron microscopy <sup>2</sup> which was further questioned <sup>3</sup> . An indirect li","2021","07","14","Br J Dermatol","The British journal of dermatology",NA,"Cassius","C","Dermatology department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France",NA
"1637","34258762","10.1111/bjd.20647","Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic.","A range of cutaneous manifestations has been described in association with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection during the coronavirus disease 2019 (COVID-19) pandemic <sup>1</sup> . Among them, chilblain like lesions (CLL) occurred more frequently than expected. A direct link was demonstrated thanks to the visualization of viral particles in the skin endothelial cells by electron microscopy <sup>2</sup> which was further questioned <sup>3</sup> . An indirect li","2021","07","14","Br J Dermatol","The British journal of dermatology",NA,"Merandet","M","Université de Paris, Human immunology Pathophysiology Immunotherapy, INSERM U976, Institut de Recherche Saint-Louis, F-75010, Paris, France",NA
"1638","34258762","10.1111/bjd.20647","Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic.","A range of cutaneous manifestations has been described in association with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection during the coronavirus disease 2019 (COVID-19) pandemic <sup>1</sup> . Among them, chilblain like lesions (CLL) occurred more frequently than expected. A direct link was demonstrated thanks to the visualization of viral particles in the skin endothelial cells by electron microscopy <sup>2</sup> which was further questioned <sup>3</sup> . An indirect li","2021","07","14","Br J Dermatol","The British journal of dermatology",NA,"Frumholtz","L","Dermatology department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France",NA
"1639","34258762","10.1111/bjd.20647","Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic.","A range of cutaneous manifestations has been described in association with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection during the coronavirus disease 2019 (COVID-19) pandemic <sup>1</sup> . Among them, chilblain like lesions (CLL) occurred more frequently than expected. A direct link was demonstrated thanks to the visualization of viral particles in the skin endothelial cells by electron microscopy <sup>2</sup> which was further questioned <sup>3</sup> . An indirect li","2021","07","14","Br J Dermatol","The British journal of dermatology",NA,"Bergerat","D","Université de Paris, Human immunology Pathophysiology Immunotherapy, INSERM U976, Institut de Recherche Saint-Louis, F-75010, Paris, France",NA
"1640","34258762","10.1111/bjd.20647","Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic.","A range of cutaneous manifestations has been described in association with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection during the coronavirus disease 2019 (COVID-19) pandemic <sup>1</sup> . Among them, chilblain like lesions (CLL) occurred more frequently than expected. A direct link was demonstrated thanks to the visualization of viral particles in the skin endothelial cells by electron microscopy <sup>2</sup> which was further questioned <sup>3</sup> . An indirect li","2021","07","14","Br J Dermatol","The British journal of dermatology",NA,"Samri","A","Sorbonne Université, Inserm 1135, Centre d'immunologie et des maladies infectieuses, Cimi-Paris, F-75013, Paris, France",NA
"1641","34258762","10.1111/bjd.20647","Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic.","A range of cutaneous manifestations has been described in association with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection during the coronavirus disease 2019 (COVID-19) pandemic <sup>1</sup> . Among them, chilblain like lesions (CLL) occurred more frequently than expected. A direct link was demonstrated thanks to the visualization of viral particles in the skin endothelial cells by electron microscopy <sup>2</sup> which was further questioned <sup>3</sup> . An indirect li","2021","07","14","Br J Dermatol","The British journal of dermatology",NA,"Grolleau","C","Dermatology department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France",NA
"1642","34258762","10.1111/bjd.20647","Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic.","A range of cutaneous manifestations has been described in association with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection during the coronavirus disease 2019 (COVID-19) pandemic <sup>1</sup> . Among them, chilblain like lesions (CLL) occurred more frequently than expected. A direct link was demonstrated thanks to the visualization of viral particles in the skin endothelial cells by electron microscopy <sup>2</sup> which was further questioned <sup>3</sup> . An indirect li","2021","07","14","Br J Dermatol","The British journal of dermatology",NA,"Grzelak","L","Institut Pasteur, Virus and immunity unit, F-75015, Paris, France",NA
"1643","34258762","10.1111/bjd.20647","Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic.","A range of cutaneous manifestations has been described in association with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection during the coronavirus disease 2019 (COVID-19) pandemic <sup>1</sup> . Among them, chilblain like lesions (CLL) occurred more frequently than expected. A direct link was demonstrated thanks to the visualization of viral particles in the skin endothelial cells by electron microscopy <sup>2</sup> which was further questioned <sup>3</sup> . An indirect li","2021","07","14","Br J Dermatol","The British journal of dermatology",NA,"Schwartz","O","Institut Pasteur, Virus and immunity unit, F-75015, Paris, France",NA
"1644","34258762","10.1111/bjd.20647","Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic.","A range of cutaneous manifestations has been described in association with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection during the coronavirus disease 2019 (COVID-19) pandemic <sup>1</sup> . Among them, chilblain like lesions (CLL) occurred more frequently than expected. A direct link was demonstrated thanks to the visualization of viral particles in the skin endothelial cells by electron microscopy <sup>2</sup> which was further questioned <sup>3</sup> . An indirect li","2021","07","14","Br J Dermatol","The British journal of dermatology",NA,"Yatim","N","Dermatology department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France",NA
"1645","34258762","10.1111/bjd.20647","Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic.","A range of cutaneous manifestations has been described in association with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection during the coronavirus disease 2019 (COVID-19) pandemic <sup>1</sup> . Among them, chilblain like lesions (CLL) occurred more frequently than expected. A direct link was demonstrated thanks to the visualization of viral particles in the skin endothelial cells by electron microscopy <sup>2</sup> which was further questioned <sup>3</sup> . An indirect li","2021","07","14","Br J Dermatol","The British journal of dermatology",NA,"Moghadam","P","Dermatology department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France",NA
"1646","34258762","10.1111/bjd.20647","Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic.","A range of cutaneous manifestations has been described in association with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection during the coronavirus disease 2019 (COVID-19) pandemic <sup>1</sup> . Among them, chilblain like lesions (CLL) occurred more frequently than expected. A direct link was demonstrated thanks to the visualization of viral particles in the skin endothelial cells by electron microscopy <sup>2</sup> which was further questioned <sup>3</sup> . An indirect li","2021","07","14","Br J Dermatol","The British journal of dermatology",NA,"Jaume","L","Dermatology department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France",NA
"1647","34258762","10.1111/bjd.20647","Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic.","A range of cutaneous manifestations has been described in association with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection during the coronavirus disease 2019 (COVID-19) pandemic <sup>1</sup> . Among them, chilblain like lesions (CLL) occurred more frequently than expected. A direct link was demonstrated thanks to the visualization of viral particles in the skin endothelial cells by electron microscopy <sup>2</sup> which was further questioned <sup>3</sup> . An indirect li","2021","07","14","Br J Dermatol","The British journal of dermatology",NA,"Bagot","M","Dermatology department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France",NA
"1648","34258762","10.1111/bjd.20647","Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic.","A range of cutaneous manifestations has been described in association with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection during the coronavirus disease 2019 (COVID-19) pandemic <sup>1</sup> . Among them, chilblain like lesions (CLL) occurred more frequently than expected. A direct link was demonstrated thanks to the visualization of viral particles in the skin endothelial cells by electron microscopy <sup>2</sup> which was further questioned <sup>3</sup> . An indirect li","2021","07","14","Br J Dermatol","The British journal of dermatology",NA,"Legoff","J","Virology Department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France",NA
"1649","34258762","10.1111/bjd.20647","Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic.","A range of cutaneous manifestations has been described in association with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection during the coronavirus disease 2019 (COVID-19) pandemic <sup>1</sup> . Among them, chilblain like lesions (CLL) occurred more frequently than expected. A direct link was demonstrated thanks to the visualization of viral particles in the skin endothelial cells by electron microscopy <sup>2</sup> which was further questioned <sup>3</sup> . An indirect li","2021","07","14","Br J Dermatol","The British journal of dermatology",NA,"Delaugerre","C","Virology Department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France",NA
"1650","34258762","10.1111/bjd.20647","Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic.","A range of cutaneous manifestations has been described in association with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection during the coronavirus disease 2019 (COVID-19) pandemic <sup>1</sup> . Among them, chilblain like lesions (CLL) occurred more frequently than expected. A direct link was demonstrated thanks to the visualization of viral particles in the skin endothelial cells by electron microscopy <sup>2</sup> which was further questioned <sup>3</sup> . An indirect li","2021","07","14","Br J Dermatol","The British journal of dermatology",NA,"Bouaziz","J-D","Dermatology department, AP-HP, Hôpital Saint-Louis, F-75010, Paris, France",NA
"1651","34258762","10.1111/bjd.20647","Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic.","A range of cutaneous manifestations has been described in association with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection during the coronavirus disease 2019 (COVID-19) pandemic <sup>1</sup> . Among them, chilblain like lesions (CLL) occurred more frequently than expected. A direct link was demonstrated thanks to the visualization of viral particles in the skin endothelial cells by electron microscopy <sup>2</sup> which was further questioned <sup>3</sup> . An indirect li","2021","07","14","Br J Dermatol","The British journal of dermatology",NA,"Le Buanec","H","Université de Paris, Human immunology Pathophysiology Immunotherapy, INSERM U976, Institut de Recherche Saint-Louis, F-75010, Paris, France",NA
"1652","34258745","10.1007/978-981-16-0267-2_11","Covalent Antiviral Agents.","Nowadays, many viral infections have emerged and are taking a huge toll on human lives globally. Meanwhile, viral resistance to current drugs has drastically increased. Hence, there is a pressing need to design potent broad-spectrum antiviral agents to treat a variety of viral infections and overcome viral resistance. Covalent inhibitors have the potential to achieve both goals owing to their biochemical efficiency, prolonged duration of action, and the capability to inhibit shallow, solvent-exp","2021","07","15","Adv Exp Med Biol","Advances in experimental medicine and biology","Activities; Covalent antiviral agents; In silico study; Mechanisms; Structures; Antiviral Agents; COVID-19; Hepatitis C; Humans; SARS-CoV-2; Virus Diseases","Mirzaie","Sako","Advanced Pharmaceutics and Drug Delivery Laboratory, Leslie L. Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada. s.mirzaie@utoronto","s.mirzaie@utoronto.ca"
"1653","34258745","10.1007/978-981-16-0267-2_11","Covalent Antiviral Agents.","Nowadays, many viral infections have emerged and are taking a huge toll on human lives globally. Meanwhile, viral resistance to current drugs has drastically increased. Hence, there is a pressing need to design potent broad-spectrum antiviral agents to treat a variety of viral infections and overcome viral resistance. Covalent inhibitors have the potential to achieve both goals owing to their biochemical efficiency, prolonged duration of action, and the capability to inhibit shallow, solvent-exp","2021","07","15","Adv Exp Med Biol","Advances in experimental medicine and biology","Activities; Covalent antiviral agents; In silico study; Mechanisms; Structures; Antiviral Agents; COVID-19; Hepatitis C; Humans; SARS-CoV-2; Virus Diseases","Abdi","Fatemeh","Advanced Pharmaceutics and Drug Delivery Laboratory, Leslie L. Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada",NA
"1654","34258745","10.1007/978-981-16-0267-2_11","Covalent Antiviral Agents.","Nowadays, many viral infections have emerged and are taking a huge toll on human lives globally. Meanwhile, viral resistance to current drugs has drastically increased. Hence, there is a pressing need to design potent broad-spectrum antiviral agents to treat a variety of viral infections and overcome viral resistance. Covalent inhibitors have the potential to achieve both goals owing to their biochemical efficiency, prolonged duration of action, and the capability to inhibit shallow, solvent-exp","2021","07","15","Adv Exp Med Biol","Advances in experimental medicine and biology","Activities; Covalent antiviral agents; In silico study; Mechanisms; Structures; Antiviral Agents; COVID-19; Hepatitis C; Humans; SARS-CoV-2; Virus Diseases","GhavamiNejad","Amin","Advanced Pharmaceutics and Drug Delivery Laboratory, Leslie L. Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada",NA
"1655","34258745","10.1007/978-981-16-0267-2_11","Covalent Antiviral Agents.","Nowadays, many viral infections have emerged and are taking a huge toll on human lives globally. Meanwhile, viral resistance to current drugs has drastically increased. Hence, there is a pressing need to design potent broad-spectrum antiviral agents to treat a variety of viral infections and overcome viral resistance. Covalent inhibitors have the potential to achieve both goals owing to their biochemical efficiency, prolonged duration of action, and the capability to inhibit shallow, solvent-exp","2021","07","15","Adv Exp Med Biol","Advances in experimental medicine and biology","Activities; Covalent antiviral agents; In silico study; Mechanisms; Structures; Antiviral Agents; COVID-19; Hepatitis C; Humans; SARS-CoV-2; Virus Diseases","Lu","Brian","Advanced Pharmaceutics and Drug Delivery Laboratory, Leslie L. Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada",NA
"1656","34258745","10.1007/978-981-16-0267-2_11","Covalent Antiviral Agents.","Nowadays, many viral infections have emerged and are taking a huge toll on human lives globally. Meanwhile, viral resistance to current drugs has drastically increased. Hence, there is a pressing need to design potent broad-spectrum antiviral agents to treat a variety of viral infections and overcome viral resistance. Covalent inhibitors have the potential to achieve both goals owing to their biochemical efficiency, prolonged duration of action, and the capability to inhibit shallow, solvent-exp","2021","07","15","Adv Exp Med Biol","Advances in experimental medicine and biology","Activities; Covalent antiviral agents; In silico study; Mechanisms; Structures; Antiviral Agents; COVID-19; Hepatitis C; Humans; SARS-CoV-2; Virus Diseases","Wu","Xiao Yu","Advanced Pharmaceutics and Drug Delivery Laboratory, Leslie L. Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada",NA
"1657","34258743","10.1007/978-981-16-0267-2_9","Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.","Recent coronavirus outbreaks of SARS-CoV-1 (2002-2003), MERS-CoV (since 2012), and SARS-CoV-2 (since the end of 2019) are examples of how viruses can damage health care and generate havoc all over the world. Coronavirus can spread quickly from person to person causing high morbidity and mortality. Unfortunately, the antiviral armamentarium is insufficient to fight these infections. In this chapter, we provide a detailed summary of the current situation in the development of drugs directed agains","2021","07","15","Adv Exp Med Biol","Advances in experimental medicine and biology","Coronavirus; MERS-CoV; RNA polymerase; Remdesivir; SARS-CoV; Viral replication; Antiviral Agents; COVID-19; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; SARS-CoV-2","Huang","Tianguang","Department of Medicinal Chemistry, Key Laboratory of Chemical Biology, Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Jinan, China",NA
"1658","34258743","10.1007/978-981-16-0267-2_9","Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.","Recent coronavirus outbreaks of SARS-CoV-1 (2002-2003), MERS-CoV (since 2012), and SARS-CoV-2 (since the end of 2019) are examples of how viruses can damage health care and generate havoc all over the world. Coronavirus can spread quickly from person to person causing high morbidity and mortality. Unfortunately, the antiviral armamentarium is insufficient to fight these infections. In this chapter, we provide a detailed summary of the current situation in the development of drugs directed agains","2021","07","15","Adv Exp Med Biol","Advances in experimental medicine and biology","Coronavirus; MERS-CoV; RNA polymerase; Remdesivir; SARS-CoV; Viral replication; Antiviral Agents; COVID-19; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; SARS-CoV-2","Sun","Lin","Department of Medicinal Chemistry, Key Laboratory of Chemical Biology, Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Jinan, China",NA
"1659","34258743","10.1007/978-981-16-0267-2_9","Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.","Recent coronavirus outbreaks of SARS-CoV-1 (2002-2003), MERS-CoV (since 2012), and SARS-CoV-2 (since the end of 2019) are examples of how viruses can damage health care and generate havoc all over the world. Coronavirus can spread quickly from person to person causing high morbidity and mortality. Unfortunately, the antiviral armamentarium is insufficient to fight these infections. In this chapter, we provide a detailed summary of the current situation in the development of drugs directed agains","2021","07","15","Adv Exp Med Biol","Advances in experimental medicine and biology","Coronavirus; MERS-CoV; RNA polymerase; Remdesivir; SARS-CoV; Viral replication; Antiviral Agents; COVID-19; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; SARS-CoV-2","Kang","Dongwei","Department of Medicinal Chemistry, Key Laboratory of Chemical Biology, Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Jinan, China",NA
"1660","34258743","10.1007/978-981-16-0267-2_9","Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.","Recent coronavirus outbreaks of SARS-CoV-1 (2002-2003), MERS-CoV (since 2012), and SARS-CoV-2 (since the end of 2019) are examples of how viruses can damage health care and generate havoc all over the world. Coronavirus can spread quickly from person to person causing high morbidity and mortality. Unfortunately, the antiviral armamentarium is insufficient to fight these infections. In this chapter, we provide a detailed summary of the current situation in the development of drugs directed agains","2021","07","15","Adv Exp Med Biol","Advances in experimental medicine and biology","Coronavirus; MERS-CoV; RNA polymerase; Remdesivir; SARS-CoV; Viral replication; Antiviral Agents; COVID-19; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; SARS-CoV-2","Poongavanam","Vasanthanathan","Department of Physics, Chemistry, and Pharmacy, University of Southern Denmark, Odense, Denmark",NA
"1661","34258743","10.1007/978-981-16-0267-2_9","Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.","Recent coronavirus outbreaks of SARS-CoV-1 (2002-2003), MERS-CoV (since 2012), and SARS-CoV-2 (since the end of 2019) are examples of how viruses can damage health care and generate havoc all over the world. Coronavirus can spread quickly from person to person causing high morbidity and mortality. Unfortunately, the antiviral armamentarium is insufficient to fight these infections. In this chapter, we provide a detailed summary of the current situation in the development of drugs directed agains","2021","07","15","Adv Exp Med Biol","Advances in experimental medicine and biology","Coronavirus; MERS-CoV; RNA polymerase; Remdesivir; SARS-CoV; Viral replication; Antiviral Agents; COVID-19; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; SARS-CoV-2","Liu","Xinyong","Department of Medicinal Chemistry, Key Laboratory of Chemical Biology, Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Jinan, China",NA
"1662","34258743","10.1007/978-981-16-0267-2_9","Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.","Recent coronavirus outbreaks of SARS-CoV-1 (2002-2003), MERS-CoV (since 2012), and SARS-CoV-2 (since the end of 2019) are examples of how viruses can damage health care and generate havoc all over the world. Coronavirus can spread quickly from person to person causing high morbidity and mortality. Unfortunately, the antiviral armamentarium is insufficient to fight these infections. In this chapter, we provide a detailed summary of the current situation in the development of drugs directed agains","2021","07","15","Adv Exp Med Biol","Advances in experimental medicine and biology","Coronavirus; MERS-CoV; RNA polymerase; Remdesivir; SARS-CoV; Viral replication; Antiviral Agents; COVID-19; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; SARS-CoV-2","Zhan","Peng","Department of Medicinal Chemistry, Key Laboratory of Chemical Biology, Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Jinan, China",NA
"1663","34258743","10.1007/978-981-16-0267-2_9","Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.","Recent coronavirus outbreaks of SARS-CoV-1 (2002-2003), MERS-CoV (since 2012), and SARS-CoV-2 (since the end of 2019) are examples of how viruses can damage health care and generate havoc all over the world. Coronavirus can spread quickly from person to person causing high morbidity and mortality. Unfortunately, the antiviral armamentarium is insufficient to fight these infections. In this chapter, we provide a detailed summary of the current situation in the development of drugs directed agains","2021","07","15","Adv Exp Med Biol","Advances in experimental medicine and biology","Coronavirus; MERS-CoV; RNA polymerase; Remdesivir; SARS-CoV; Viral replication; Antiviral Agents; COVID-19; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; SARS-CoV-2","Menéndez-Arias","Luis","Centro de Biología Molecular ""Severo Ochoa"", Consejo Superior de Investigaciones Científicas &amp","lmenendez@cbm.csic.es"
"1664","34258716","10.1007/s10903-021-01230-7","COVID-19 Leads to Dramatic Changes in the Food Retail Environment in New York City: May-July 2020.","A systematic assessment of the effect of COVID-19 on the food retail environment-an important determinant of health-has not been conducted. Our objective was to assess the impact of COVID-19 on closures of restaurants, food retail stores, and fresh produce vendors in New York City (NYC). We conducted a cross-sectional study following the peak of COVID-19 in six neighborhoods in NYC. Two Chinese ethnic neighborhoods and four higher/lower resourced comparison neighborhoods were selected a priori b","2021","07","17","J Immigr Minor Health","Journal of immigrant and minority health","Asian American; COVID-19; Chinese American; Food retail environment; Immigrant health; New York City; Xenophobia","Yi","Stella S","Department of Population Health, NYU Grossman School of Medicine, 180 Madison Avenue, 8th Floor, Room 8-13, New York, NY, 10016, USA. Stella.Yi@nyulangone","Stella.Yi@nyulangone.org"
"1665","34258716","10.1007/s10903-021-01230-7","COVID-19 Leads to Dramatic Changes in the Food Retail Environment in New York City: May-July 2020.","A systematic assessment of the effect of COVID-19 on the food retail environment-an important determinant of health-has not been conducted. Our objective was to assess the impact of COVID-19 on closures of restaurants, food retail stores, and fresh produce vendors in New York City (NYC). We conducted a cross-sectional study following the peak of COVID-19 in six neighborhoods in NYC. Two Chinese ethnic neighborhoods and four higher/lower resourced comparison neighborhoods were selected a priori b","2021","07","17","J Immigr Minor Health","Journal of immigrant and minority health","Asian American; COVID-19; Chinese American; Food retail environment; Immigrant health; New York City; Xenophobia","Ali","Shahmir H","Department of Social and Behavioral Sciences, School of Global Public Health, New York University, New York, USA",NA
"1666","34258716","10.1007/s10903-021-01230-7","COVID-19 Leads to Dramatic Changes in the Food Retail Environment in New York City: May-July 2020.","A systematic assessment of the effect of COVID-19 on the food retail environment-an important determinant of health-has not been conducted. Our objective was to assess the impact of COVID-19 on closures of restaurants, food retail stores, and fresh produce vendors in New York City (NYC). We conducted a cross-sectional study following the peak of COVID-19 in six neighborhoods in NYC. Two Chinese ethnic neighborhoods and four higher/lower resourced comparison neighborhoods were selected a priori b","2021","07","17","J Immigr Minor Health","Journal of immigrant and minority health","Asian American; COVID-19; Chinese American; Food retail environment; Immigrant health; New York City; Xenophobia","Russo","Rienna G","Department of Population Health, NYU Grossman School of Medicine, 180 Madison Avenue, 8th Floor, Room 8-13, New York, NY, 10016, USA",NA
"1667","34258716","10.1007/s10903-021-01230-7","COVID-19 Leads to Dramatic Changes in the Food Retail Environment in New York City: May-July 2020.","A systematic assessment of the effect of COVID-19 on the food retail environment-an important determinant of health-has not been conducted. Our objective was to assess the impact of COVID-19 on closures of restaurants, food retail stores, and fresh produce vendors in New York City (NYC). We conducted a cross-sectional study following the peak of COVID-19 in six neighborhoods in NYC. Two Chinese ethnic neighborhoods and four higher/lower resourced comparison neighborhoods were selected a priori b","2021","07","17","J Immigr Minor Health","Journal of immigrant and minority health","Asian American; COVID-19; Chinese American; Food retail environment; Immigrant health; New York City; Xenophobia","Foster","Victoria","Department of Population Health, NYU Grossman School of Medicine, 180 Madison Avenue, 8th Floor, Room 8-13, New York, NY, 10016, USA",NA
"1668","34258716","10.1007/s10903-021-01230-7","COVID-19 Leads to Dramatic Changes in the Food Retail Environment in New York City: May-July 2020.","A systematic assessment of the effect of COVID-19 on the food retail environment-an important determinant of health-has not been conducted. Our objective was to assess the impact of COVID-19 on closures of restaurants, food retail stores, and fresh produce vendors in New York City (NYC). We conducted a cross-sectional study following the peak of COVID-19 in six neighborhoods in NYC. Two Chinese ethnic neighborhoods and four higher/lower resourced comparison neighborhoods were selected a priori b","2021","07","17","J Immigr Minor Health","Journal of immigrant and minority health","Asian American; COVID-19; Chinese American; Food retail environment; Immigrant health; New York City; Xenophobia","Radee","Ashley","NYU Grossman School of Medicine, New York, USA",NA
"1669","34258716","10.1007/s10903-021-01230-7","COVID-19 Leads to Dramatic Changes in the Food Retail Environment in New York City: May-July 2020.","A systematic assessment of the effect of COVID-19 on the food retail environment-an important determinant of health-has not been conducted. Our objective was to assess the impact of COVID-19 on closures of restaurants, food retail stores, and fresh produce vendors in New York City (NYC). We conducted a cross-sectional study following the peak of COVID-19 in six neighborhoods in NYC. Two Chinese ethnic neighborhoods and four higher/lower resourced comparison neighborhoods were selected a priori b","2021","07","17","J Immigr Minor Health","Journal of immigrant and minority health","Asian American; COVID-19; Chinese American; Food retail environment; Immigrant health; New York City; Xenophobia","Chong","Stella","Department of Population Health, NYU Grossman School of Medicine, 180 Madison Avenue, 8th Floor, Room 8-13, New York, NY, 10016, USA",NA
"1670","34258716","10.1007/s10903-021-01230-7","COVID-19 Leads to Dramatic Changes in the Food Retail Environment in New York City: May-July 2020.","A systematic assessment of the effect of COVID-19 on the food retail environment-an important determinant of health-has not been conducted. Our objective was to assess the impact of COVID-19 on closures of restaurants, food retail stores, and fresh produce vendors in New York City (NYC). We conducted a cross-sectional study following the peak of COVID-19 in six neighborhoods in NYC. Two Chinese ethnic neighborhoods and four higher/lower resourced comparison neighborhoods were selected a priori b","2021","07","17","J Immigr Minor Health","Journal of immigrant and minority health","Asian American; COVID-19; Chinese American; Food retail environment; Immigrant health; New York City; Xenophobia","Tsui","Felice","Columbia Mailman School of Public Health, New York, USA",NA
"1671","34258716","10.1007/s10903-021-01230-7","COVID-19 Leads to Dramatic Changes in the Food Retail Environment in New York City: May-July 2020.","A systematic assessment of the effect of COVID-19 on the food retail environment-an important determinant of health-has not been conducted. Our objective was to assess the impact of COVID-19 on closures of restaurants, food retail stores, and fresh produce vendors in New York City (NYC). We conducted a cross-sectional study following the peak of COVID-19 in six neighborhoods in NYC. Two Chinese ethnic neighborhoods and four higher/lower resourced comparison neighborhoods were selected a priori b","2021","07","17","J Immigr Minor Health","Journal of immigrant and minority health","Asian American; COVID-19; Chinese American; Food retail environment; Immigrant health; New York City; Xenophobia","Kranick","Julie","Department of Population Health, NYU Grossman School of Medicine, 180 Madison Avenue, 8th Floor, Room 8-13, New York, NY, 10016, USA",NA
"1672","34258716","10.1007/s10903-021-01230-7","COVID-19 Leads to Dramatic Changes in the Food Retail Environment in New York City: May-July 2020.","A systematic assessment of the effect of COVID-19 on the food retail environment-an important determinant of health-has not been conducted. Our objective was to assess the impact of COVID-19 on closures of restaurants, food retail stores, and fresh produce vendors in New York City (NYC). We conducted a cross-sectional study following the peak of COVID-19 in six neighborhoods in NYC. Two Chinese ethnic neighborhoods and four higher/lower resourced comparison neighborhoods were selected a priori b","2021","07","17","J Immigr Minor Health","Journal of immigrant and minority health","Asian American; COVID-19; Chinese American; Food retail environment; Immigrant health; New York City; Xenophobia","Lee","David","Department of Population Health, NYU Grossman School of Medicine, 180 Madison Avenue, 8th Floor, Room 8-13, New York, NY, 10016, USA",NA
"1673","34258716","10.1007/s10903-021-01230-7","COVID-19 Leads to Dramatic Changes in the Food Retail Environment in New York City: May-July 2020.","A systematic assessment of the effect of COVID-19 on the food retail environment-an important determinant of health-has not been conducted. Our objective was to assess the impact of COVID-19 on closures of restaurants, food retail stores, and fresh produce vendors in New York City (NYC). We conducted a cross-sectional study following the peak of COVID-19 in six neighborhoods in NYC. Two Chinese ethnic neighborhoods and four higher/lower resourced comparison neighborhoods were selected a priori b","2021","07","17","J Immigr Minor Health","Journal of immigrant and minority health","Asian American; COVID-19; Chinese American; Food retail environment; Immigrant health; New York City; Xenophobia","Imbruce","Valerie","Environmental Studies Program, Binghamton University, State University of New York, Binghamton, NY, USA",NA
"1674","34258716","10.1007/s10903-021-01230-7","COVID-19 Leads to Dramatic Changes in the Food Retail Environment in New York City: May-July 2020.","A systematic assessment of the effect of COVID-19 on the food retail environment-an important determinant of health-has not been conducted. Our objective was to assess the impact of COVID-19 on closures of restaurants, food retail stores, and fresh produce vendors in New York City (NYC). We conducted a cross-sectional study following the peak of COVID-19 in six neighborhoods in NYC. Two Chinese ethnic neighborhoods and four higher/lower resourced comparison neighborhoods were selected a priori b","2021","07","17","J Immigr Minor Health","Journal of immigrant and minority health","Asian American; COVID-19; Chinese American; Food retail environment; Immigrant health; New York City; Xenophobia","Mezzacca","Tamar Adjoian",", New York, USA",NA
"1675","34258692","10.1007/s40656-021-00441-3","Ageism in the COVID-19 pandemic: age-based discrimination in triage decisions and beyond.","Ageism has unfortunately become a salient phenomenon during the COVID-19 pandemic. In particular, triage decisions based on age have been hotly discussed. In this article, I first defend that, although there are ethical reasons (founded on the principles of benefit and fairness) to consider the age of patients in triage dilemmas, using age as a categorical exclusion is an unjustifiable ageist practice. Then, I argue that ageism during the pandemic has been fueled by media narratives and unfair a","2021","07","21","Hist Philos Life Sci","History and philosophy of the life sciences","Ageism; COVID-19; Triage; Ageism; COVID-19; Humans; SARS-CoV-2; Triage","Rueda","Jon","Department of Philosophy 1 and FiloLab-UGR Scientific Unit of Excellence, University of Granada, Granada, Spain. ruetxe@ugr","ruetxe@ugr.es"
"1676","34258664","10.1007/s00705-021-05166-z","Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.","The SARS-CoV-2 spike protein Q677P/H mutation and furin cleavage site (FCS) have been shown to affect cell tropism and virus transmissibility. Here, we analyzed the frequency of Q677P/H and FCS point mutations in 1,144,793 human and 1042 animal spike protein sequences and from those of the emergent variants B.1.1.7, B.1.351, P.1, B.1.429 + B.1.427, and B.1.525, which were deposited in the database of the GISAID Initiative. Different genetic polymorphisms, particularly P681H and A688V, were detec","2021","07","17","Arch Virol","Archives of virology",NA,"Nagy","Abdou","Department of Virology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Sharkia, 44511, Egypt. abdonagy@zu.edu","abdonagy@zu.edu.eg"
"1677","34258664","10.1007/s00705-021-05166-z","Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.","The SARS-CoV-2 spike protein Q677P/H mutation and furin cleavage site (FCS) have been shown to affect cell tropism and virus transmissibility. Here, we analyzed the frequency of Q677P/H and FCS point mutations in 1,144,793 human and 1042 animal spike protein sequences and from those of the emergent variants B.1.1.7, B.1.351, P.1, B.1.429 + B.1.427, and B.1.525, which were deposited in the database of the GISAID Initiative. Different genetic polymorphisms, particularly P681H and A688V, were detec","2021","07","17","Arch Virol","Archives of virology",NA,"Basiouni","Shereen","Clinical Pathology Department, Faculty of Veterinary Medicine, Benha University, Benha, Egypt",NA
"1678","34258664","10.1007/s00705-021-05166-z","Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.","The SARS-CoV-2 spike protein Q677P/H mutation and furin cleavage site (FCS) have been shown to affect cell tropism and virus transmissibility. Here, we analyzed the frequency of Q677P/H and FCS point mutations in 1,144,793 human and 1042 animal spike protein sequences and from those of the emergent variants B.1.1.7, B.1.351, P.1, B.1.429 + B.1.427, and B.1.525, which were deposited in the database of the GISAID Initiative. Different genetic polymorphisms, particularly P681H and A688V, were detec","2021","07","17","Arch Virol","Archives of virology",NA,"Parvin","Rokshana","Department of Pathology, Faculty of Veterinary Science, Bangladesh Agricultural University, Mymensingh, 2202, Bangladesh",NA
"1679","34258664","10.1007/s00705-021-05166-z","Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.","The SARS-CoV-2 spike protein Q677P/H mutation and furin cleavage site (FCS) have been shown to affect cell tropism and virus transmissibility. Here, we analyzed the frequency of Q677P/H and FCS point mutations in 1,144,793 human and 1042 animal spike protein sequences and from those of the emergent variants B.1.1.7, B.1.351, P.1, B.1.429 + B.1.427, and B.1.525, which were deposited in the database of the GISAID Initiative. Different genetic polymorphisms, particularly P681H and A688V, were detec","2021","07","17","Arch Virol","Archives of virology",NA,"Hafez","Hafez M","Institute of Poultry Diseases, Faculty of Veterinary Medicine, Free University, Berlin, Germany",NA
"1680","34258664","10.1007/s00705-021-05166-z","Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.","The SARS-CoV-2 spike protein Q677P/H mutation and furin cleavage site (FCS) have been shown to affect cell tropism and virus transmissibility. Here, we analyzed the frequency of Q677P/H and FCS point mutations in 1,144,793 human and 1042 animal spike protein sequences and from those of the emergent variants B.1.1.7, B.1.351, P.1, B.1.429 + B.1.427, and B.1.525, which were deposited in the database of the GISAID Initiative. Different genetic polymorphisms, particularly P681H and A688V, were detec","2021","07","17","Arch Virol","Archives of virology",NA,"Shehata","Awad A","Avian and Rabbit Diseases Department, Faculty of Veterinary Medicine, Sadat City University, Sadat City, Egypt. awad.shehata@vet.usc.edu","awad.shehata@vet.usc.edu.eg"
"1681","34258647","10.1007/s00104-021-01464-z","[Impact of COVID-19 on elective and emergency colorectal surgery].","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to far-reaching changes in the treatment reality in practically all fields of medicine. Recommendations on the perioperative management with respect to SARS-CoV-2 and presentation of the impact of the pandemic on colorectal surgery. A systematic literature search was carried out. Perioperative SARS-CoV-2 infections lead to a clearly increased postoperative mortality and must be avoided by a structured bundle of mea","2021","07","17","Chirurg","Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen","Appendicitis; Cancer screening; Colorectal cancer; Pandemic; SARS-CoV-2","Lock","Johan F","Klinik und Poliklinik für Allgemein-, Viszeral-, Transplantations-, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, 97080, Würzburg, Deutschland",NA
"1682","34258647","10.1007/s00104-021-01464-z","[Impact of COVID-19 on elective and emergency colorectal surgery].","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to far-reaching changes in the treatment reality in practically all fields of medicine. Recommendations on the perioperative management with respect to SARS-CoV-2 and presentation of the impact of the pandemic on colorectal surgery. A systematic literature search was carried out. Perioperative SARS-CoV-2 infections lead to a clearly increased postoperative mortality and must be avoided by a structured bundle of mea","2021","07","17","Chirurg","Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen","Appendicitis; Cancer screening; Colorectal cancer; Pandemic; SARS-CoV-2","Köhler","Franziska","Klinik und Poliklinik für Allgemein-, Viszeral-, Transplantations-, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, 97080, Würzburg, Deutschland",NA
"1683","34258647","10.1007/s00104-021-01464-z","[Impact of COVID-19 on elective and emergency colorectal surgery].","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to far-reaching changes in the treatment reality in practically all fields of medicine. Recommendations on the perioperative management with respect to SARS-CoV-2 and presentation of the impact of the pandemic on colorectal surgery. A systematic literature search was carried out. Perioperative SARS-CoV-2 infections lead to a clearly increased postoperative mortality and must be avoided by a structured bundle of mea","2021","07","17","Chirurg","Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen","Appendicitis; Cancer screening; Colorectal cancer; Pandemic; SARS-CoV-2","Germer","Christoph-Thomas","Klinik und Poliklinik für Allgemein-, Viszeral-, Transplantations-, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, 97080, Würzburg, Deutschland",NA
"1684","34258647","10.1007/s00104-021-01464-z","[Impact of COVID-19 on elective and emergency colorectal surgery].","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to far-reaching changes in the treatment reality in practically all fields of medicine. Recommendations on the perioperative management with respect to SARS-CoV-2 and presentation of the impact of the pandemic on colorectal surgery. A systematic literature search was carried out. Perioperative SARS-CoV-2 infections lead to a clearly increased postoperative mortality and must be avoided by a structured bundle of mea","2021","07","17","Chirurg","Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen","Appendicitis; Cancer screening; Colorectal cancer; Pandemic; SARS-CoV-2","Flemming","Sven","Klinik und Poliklinik für Allgemein-, Viszeral-, Transplantations-, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, 97080, Würzburg, Deutschland",NA
"1685","34258647","10.1007/s00104-021-01464-z","[Impact of COVID-19 on elective and emergency colorectal surgery].","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to far-reaching changes in the treatment reality in practically all fields of medicine. Recommendations on the perioperative management with respect to SARS-CoV-2 and presentation of the impact of the pandemic on colorectal surgery. A systematic literature search was carried out. Perioperative SARS-CoV-2 infections lead to a clearly increased postoperative mortality and must be avoided by a structured bundle of mea","2021","07","17","Chirurg","Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen","Appendicitis; Cancer screening; Colorectal cancer; Pandemic; SARS-CoV-2","Wiegering","Armin","Klinik und Poliklinik für Allgemein-, Viszeral-, Transplantations-, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, 97080, Würzburg, Deutschland. wiegering_a@ukw",NA
"1686","34258629","10.1007/s00103-021-03378-x","[Epidemiological approaches to address key research questions on COVID-19-an overview].","Epidemiology as a scientific discipline is predestined to address key problems in the COVID-19 pandemic. In order to do so, classic and new methods are used, and new challenges are emerging.This paper addresses the various phases of the population-based progression of SARS-CoV-2 infection and COVID-19. Based on a selective literature search, sample questions from studies conducted in Germany and internationally are presented, their respective epidemiological approaches discussed, and research ga","2021","07","17","Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz","Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz","Epidemiology; Pandemic; Research needs; Study designs","Zeeb","Hajo","Leibniz-Institut für Präventionsforschung und Epidemiologie - BIPS, Achterstr. 30, 28359, Bremen, Deutschland. zeeb@leibniz-bips",NA
"1687","34258629","10.1007/s00103-021-03378-x","[Epidemiological approaches to address key research questions on COVID-19-an overview].","Epidemiology as a scientific discipline is predestined to address key problems in the COVID-19 pandemic. In order to do so, classic and new methods are used, and new challenges are emerging.This paper addresses the various phases of the population-based progression of SARS-CoV-2 infection and COVID-19. Based on a selective literature search, sample questions from studies conducted in Germany and internationally are presented, their respective epidemiological approaches discussed, and research ga","2021","07","17","Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz","Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz","Epidemiology; Pandemic; Research needs; Study designs","Ahrens","Wolfgang","Leibniz-Institut für Präventionsforschung und Epidemiologie - BIPS, Achterstr. 30, 28359, Bremen, Deutschland",NA
"1688","34258629","10.1007/s00103-021-03378-x","[Epidemiological approaches to address key research questions on COVID-19-an overview].","Epidemiology as a scientific discipline is predestined to address key problems in the COVID-19 pandemic. In order to do so, classic and new methods are used, and new challenges are emerging.This paper addresses the various phases of the population-based progression of SARS-CoV-2 infection and COVID-19. Based on a selective literature search, sample questions from studies conducted in Germany and internationally are presented, their respective epidemiological approaches discussed, and research ga","2021","07","17","Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz","Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz","Epidemiology; Pandemic; Research needs; Study designs","Haug","Ulrike","Leibniz-Institut für Präventionsforschung und Epidemiologie - BIPS, Achterstr. 30, 28359, Bremen, Deutschland",NA
"1689","34258629","10.1007/s00103-021-03378-x","[Epidemiological approaches to address key research questions on COVID-19-an overview].","Epidemiology as a scientific discipline is predestined to address key problems in the COVID-19 pandemic. In order to do so, classic and new methods are used, and new challenges are emerging.This paper addresses the various phases of the population-based progression of SARS-CoV-2 infection and COVID-19. Based on a selective literature search, sample questions from studies conducted in Germany and internationally are presented, their respective epidemiological approaches discussed, and research ga","2021","07","17","Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz","Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz","Epidemiology; Pandemic; Research needs; Study designs","Grabenhenrich","Linus","Abteilung Methodenentwicklung und Forschungsinfrastruktur (MF), Robert Koch-Institut, Berlin, Deutschland",NA
"1690","34258629","10.1007/s00103-021-03378-x","[Epidemiological approaches to address key research questions on COVID-19-an overview].","Epidemiology as a scientific discipline is predestined to address key problems in the COVID-19 pandemic. In order to do so, classic and new methods are used, and new challenges are emerging.This paper addresses the various phases of the population-based progression of SARS-CoV-2 infection and COVID-19. Based on a selective literature search, sample questions from studies conducted in Germany and internationally are presented, their respective epidemiological approaches discussed, and research ga","2021","07","17","Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz","Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz","Epidemiology; Pandemic; Research needs; Study designs","Pigeot","Iris","Leibniz-Institut für Präventionsforschung und Epidemiologie - BIPS, Achterstr. 30, 28359, Bremen, Deutschland",NA
"1691","34258628","10.1007/s00109-021-02113-y","The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis.","Pulmonary fibrosis is a chronic debilitating condition characterized by progressive deposition of connective tissue, leading to a steady restriction of lung elasticity, a decline in lung function, and a median survival of 4.5 years. The leading causes of pulmonary fibrosis are inhalation of foreign particles (such as silicosis and pneumoconiosis), infections (such as post COVID-19), autoimmune diseases (such as systemic autoimmune diseases of the connective tissue), and idiopathic pulmonary fibr","2021","07","17","J Mol Med (Berl)","Journal of molecular medicine (Berlin, Germany)","Cytokine; DAMP; Pulmonary fibrosis; TLR4","Bolourani","Siavash","Center for Immunology and Inflammation, Feinstein Institutes for Medical Research, 350 Community Dr, Manhasset, NY, 11030, USA",NA
"1692","34258628","10.1007/s00109-021-02113-y","The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis.","Pulmonary fibrosis is a chronic debilitating condition characterized by progressive deposition of connective tissue, leading to a steady restriction of lung elasticity, a decline in lung function, and a median survival of 4.5 years. The leading causes of pulmonary fibrosis are inhalation of foreign particles (such as silicosis and pneumoconiosis), infections (such as post COVID-19), autoimmune diseases (such as systemic autoimmune diseases of the connective tissue), and idiopathic pulmonary fibr","2021","07","17","J Mol Med (Berl)","Journal of molecular medicine (Berlin, Germany)","Cytokine; DAMP; Pulmonary fibrosis; TLR4","Brenner","Max","Center for Immunology and Inflammation, Feinstein Institutes for Medical Research, 350 Community Dr, Manhasset, NY, 11030, USA. mbrenner@northwell","mbrenner@northwell.edu"
"1693","34258628","10.1007/s00109-021-02113-y","The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis.","Pulmonary fibrosis is a chronic debilitating condition characterized by progressive deposition of connective tissue, leading to a steady restriction of lung elasticity, a decline in lung function, and a median survival of 4.5 years. The leading causes of pulmonary fibrosis are inhalation of foreign particles (such as silicosis and pneumoconiosis), infections (such as post COVID-19), autoimmune diseases (such as systemic autoimmune diseases of the connective tissue), and idiopathic pulmonary fibr","2021","07","17","J Mol Med (Berl)","Journal of molecular medicine (Berlin, Germany)","Cytokine; DAMP; Pulmonary fibrosis; TLR4","Wang","Ping","Center for Immunology and Inflammation, Feinstein Institutes for Medical Research, 350 Community Dr, Manhasset, NY, 11030, USA. pwang@northwell","pwang@northwell.edu"
"1694","34258625","10.1093/pubmed/fdab272","Tourism, shamanism and the pandemic.","There can be no doubt that tourism has contributed to the popular understanding of folk Christianity, including shamanistic practices that, since colonial times, have formed part of the dominant Filipino faith. However, faced with the pandemic, the island's co-existence with tourism risks losing vital economic lifeblood through commerce-driven spaces for cultural exchange and the psycho-noetic conditions that sustain the spiritual structure of folkloric practices threatened by the existential ri","2021","07","14","J Public Health (Oxf)","Journal of public health (Oxford, England)","behaviour; beliefs; public health","Rivas","Virgilio A","Polytechnic University of the Philippines, Manila 1016, Philippines",NA
"1695","34258624","10.1093/pubmed/fdab289","Dogs detect the virus: understanding Christian animal ethics vis-à-vis screening method for COVID-19 in humans.",NA,"2021","07","14","J Public Health (Oxf)","Journal of public health (Oxford, England)",NA,"Cordero","Dalmacito A","Theology and Religious Education Department, De La Salle University, 2401 Taft Avenue, 1004 Manila, Philippines",NA
"1696","34258622","10.1093/pubmed/fdab288","A godless coping mechanism during the COVID-19 pandemic.",NA,"2021","07","14","J Public Health (Oxf)","Journal of public health (Oxford, England)",NA,"Cordero","Dalmacito A","Theology and Religious Education Department, De La Salle University, 1004 Taft Avenue, Manila, Philippines",NA
"1697","34258611","10.1093/jnci/djab097","Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.","The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast cancer control through short-term declines in screening and delays in diagnosis and treatments. We projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030. Three established Cancer Intervention and Surveillance Modeling Network breast cancer models modeled reductions in mammography screening use, delays in symptomatic cancer diagnosis, and reduced use of chemotherapy for women with early-stage ","2021","07","14","J Natl Cancer Inst","Journal of the National Cancer Institute",NA,"Alagoz","Oguzhan","Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA",NA
"1698","34258611","10.1093/jnci/djab097","Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.","The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast cancer control through short-term declines in screening and delays in diagnosis and treatments. We projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030. Three established Cancer Intervention and Surveillance Modeling Network breast cancer models modeled reductions in mammography screening use, delays in symptomatic cancer diagnosis, and reduced use of chemotherapy for women with early-stage ","2021","07","14","J Natl Cancer Inst","Journal of the National Cancer Institute",NA,"Lowry","Kathryn P","Department of Radiology, University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA",NA
"1699","34258611","10.1093/jnci/djab097","Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.","The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast cancer control through short-term declines in screening and delays in diagnosis and treatments. We projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030. Three established Cancer Intervention and Surveillance Modeling Network breast cancer models modeled reductions in mammography screening use, delays in symptomatic cancer diagnosis, and reduced use of chemotherapy for women with early-stage ","2021","07","14","J Natl Cancer Inst","Journal of the National Cancer Institute",NA,"Kurian","Allison W","Departments of Medicine and of Epidemiology and Population Health, Stanford University, Stanford, CA, USA",NA
"1700","34258611","10.1093/jnci/djab097","Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.","The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast cancer control through short-term declines in screening and delays in diagnosis and treatments. We projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030. Three established Cancer Intervention and Surveillance Modeling Network breast cancer models modeled reductions in mammography screening use, delays in symptomatic cancer diagnosis, and reduced use of chemotherapy for women with early-stage ","2021","07","14","J Natl Cancer Inst","Journal of the National Cancer Institute",NA,"Mandelblatt","Jeanne S","Department of Oncology, Georgetown University Medical Center, Georgetown University, Washington, DC, USA",NA
"1701","34258611","10.1093/jnci/djab097","Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.","The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast cancer control through short-term declines in screening and delays in diagnosis and treatments. We projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030. Three established Cancer Intervention and Surveillance Modeling Network breast cancer models modeled reductions in mammography screening use, delays in symptomatic cancer diagnosis, and reduced use of chemotherapy for women with early-stage ","2021","07","14","J Natl Cancer Inst","Journal of the National Cancer Institute",NA,"Ergun","Mehmet A","Department of Industrial Engineering, Istanbul Technical University, Istanbul, Turkey",NA
"1702","34258611","10.1093/jnci/djab097","Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.","The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast cancer control through short-term declines in screening and delays in diagnosis and treatments. We projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030. Three established Cancer Intervention and Surveillance Modeling Network breast cancer models modeled reductions in mammography screening use, delays in symptomatic cancer diagnosis, and reduced use of chemotherapy for women with early-stage ","2021","07","14","J Natl Cancer Inst","Journal of the National Cancer Institute",NA,"Huang","Hui","Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA",NA
"1703","34258611","10.1093/jnci/djab097","Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.","The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast cancer control through short-term declines in screening and delays in diagnosis and treatments. We projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030. Three established Cancer Intervention and Surveillance Modeling Network breast cancer models modeled reductions in mammography screening use, delays in symptomatic cancer diagnosis, and reduced use of chemotherapy for women with early-stage ","2021","07","14","J Natl Cancer Inst","Journal of the National Cancer Institute",NA,"Lee","Sandra J","Department of Data Science, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA",NA
"1704","34258611","10.1093/jnci/djab097","Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.","The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast cancer control through short-term declines in screening and delays in diagnosis and treatments. We projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030. Three established Cancer Intervention and Surveillance Modeling Network breast cancer models modeled reductions in mammography screening use, delays in symptomatic cancer diagnosis, and reduced use of chemotherapy for women with early-stage ","2021","07","14","J Natl Cancer Inst","Journal of the National Cancer Institute",NA,"Schechter","Clyde B","Department of Family and Social Medicine, Albert Einstein College of Medicine, Bronx, NY, USA",NA
"1705","34258611","10.1093/jnci/djab097","Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.","The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast cancer control through short-term declines in screening and delays in diagnosis and treatments. We projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030. Three established Cancer Intervention and Surveillance Modeling Network breast cancer models modeled reductions in mammography screening use, delays in symptomatic cancer diagnosis, and reduced use of chemotherapy for women with early-stage ","2021","07","14","J Natl Cancer Inst","Journal of the National Cancer Institute",NA,"Tosteson","Anna N A","Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA",NA
"1706","34258611","10.1093/jnci/djab097","Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.","The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast cancer control through short-term declines in screening and delays in diagnosis and treatments. We projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030. Three established Cancer Intervention and Surveillance Modeling Network breast cancer models modeled reductions in mammography screening use, delays in symptomatic cancer diagnosis, and reduced use of chemotherapy for women with early-stage ","2021","07","14","J Natl Cancer Inst","Journal of the National Cancer Institute",NA,"Miglioretti","Diana L","Department of Public Health Sciences, University of California at Davis, Davis, CA, USA",NA
"1707","34258611","10.1093/jnci/djab097","Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.","The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast cancer control through short-term declines in screening and delays in diagnosis and treatments. We projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030. Three established Cancer Intervention and Surveillance Modeling Network breast cancer models modeled reductions in mammography screening use, delays in symptomatic cancer diagnosis, and reduced use of chemotherapy for women with early-stage ","2021","07","14","J Natl Cancer Inst","Journal of the National Cancer Institute",NA,"Trentham-Dietz","Amy","Department of Population Health Sciences and the Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA",NA
"1708","34258611","10.1093/jnci/djab097","Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.","The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast cancer control through short-term declines in screening and delays in diagnosis and treatments. We projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030. Three established Cancer Intervention and Surveillance Modeling Network breast cancer models modeled reductions in mammography screening use, delays in symptomatic cancer diagnosis, and reduced use of chemotherapy for women with early-stage ","2021","07","14","J Natl Cancer Inst","Journal of the National Cancer Institute",NA,"Nyante","Sarah J","Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA",NA
"1709","34258611","10.1093/jnci/djab097","Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.","The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast cancer control through short-term declines in screening and delays in diagnosis and treatments. We projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030. Three established Cancer Intervention and Surveillance Modeling Network breast cancer models modeled reductions in mammography screening use, delays in symptomatic cancer diagnosis, and reduced use of chemotherapy for women with early-stage ","2021","07","14","J Natl Cancer Inst","Journal of the National Cancer Institute",NA,"Kerlikowske","Karla","Departments of Medicine and Epidemiology/Biostatistics, University of California at San Francisco, San Francisco, CA, USA",NA
"1710","34258611","10.1093/jnci/djab097","Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.","The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast cancer control through short-term declines in screening and delays in diagnosis and treatments. We projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030. Three established Cancer Intervention and Surveillance Modeling Network breast cancer models modeled reductions in mammography screening use, delays in symptomatic cancer diagnosis, and reduced use of chemotherapy for women with early-stage ","2021","07","14","J Natl Cancer Inst","Journal of the National Cancer Institute",NA,"Sprague","Brian L","Department of Surgery and the University of Vermont Cancer Center, Larner College of Medicine, University of Vermont, Burlington, VT, USA",NA
"1711","34258611","10.1093/jnci/djab097","Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.","The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast cancer control through short-term declines in screening and delays in diagnosis and treatments. We projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030. Three established Cancer Intervention and Surveillance Modeling Network breast cancer models modeled reductions in mammography screening use, delays in symptomatic cancer diagnosis, and reduced use of chemotherapy for women with early-stage ","2021","07","14","J Natl Cancer Inst","Journal of the National Cancer Institute",NA,"Stout","Natasha K","Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA",NA
"1712","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Souza","William M","Virology Research Centre, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil",NA
"1713","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Amorim","Mariene R","Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1714","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Sesti-Costa","Renata","Brazilian Biosciences National Laboratory, Brazilian Centre for Research in Energy and Materials, Campinas, Brazil",NA
"1715","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Coimbra","Lais D","Brazilian Biosciences National Laboratory, Brazilian Centre for Research in Energy and Materials, Campinas, Brazil",NA
"1716","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Brunetti","Natalia S","Autoimmune Research Laboratory, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1717","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Toledo-Teixeira","Daniel A","Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1718","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"de Souza","Gabriela F","Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1719","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Muraro","Stefanie P","Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1720","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Parise","Pierina L","Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1721","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Barbosa","Priscilla P","Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1722","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Bispo-Dos-Santos","Karina","Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1723","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Mofatto","Luciana S","Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1724","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Simeoni","Camila L","Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1725","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Claro","Ingra M","Tropical Medicine Institute, Medical School, University of São Paulo, São Paulo, Brazil",NA
"1726","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Duarte","Adriana S S","Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil",NA
"1727","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Coletti","Thais M","Tropical Medicine Institute, Medical School, University of São Paulo, São Paulo, Brazil",NA
"1728","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Zangirolami","Audrey B","Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil",NA
"1729","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Costa-Lima","Carolina","Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil",NA
"1730","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Gomes","Arilson B S P","Laboratory of Immunoinflammation, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1731","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Buscaratti","Lucas I","Brazilian Laboratory on Silencing Technologies, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1732","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Sales","Flavia C","Tropical Medicine Institute, Medical School, University of São Paulo, São Paulo, Brazil",NA
"1733","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Costa","Vitor A","Hematology and Transfusion Medicine Center, University of Campinas, Campinas, Brazil",NA
"1734","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Franco","Lucas A M","Tropical Medicine Institute, Medical School, University of São Paulo, São Paulo, Brazil",NA
"1735","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Candido","Darlan S","Department of Zoology, University of Oxford, UK",NA
"1736","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Pybus","Oliver G","Department of Zoology, University of Oxford, UK",NA
"1737","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"de Jesus","Jaqueline G","Tropical Medicine Institute, Medical School, University of São Paulo, São Paulo, Brazil",NA
"1738","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Silva","Camila A M","Tropical Medicine Institute, Medical School, University of São Paulo, São Paulo, Brazil",NA
"1739","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Ramundo","Mariana S","Tropical Medicine Institute, Medical School, University of São Paulo, São Paulo, Brazil",NA
"1740","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Ferreira","Giulia M","Hematology and Transfusion Medicine Center, University of Campinas, Campinas, Brazil",NA
"1741","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Pinho","Mariana C","Tropical Medicine Institute, Medical School, University of São Paulo, São Paulo, Brazil",NA
"1742","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Souza","Leandro M","Tropical Medicine Institute, Medical School, University of São Paulo, São Paulo, Brazil",NA
"1743","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Rocha","Esmenia C","Tropical Medicine Institute, Medical School, University of São Paulo, São Paulo, Brazil",NA
"1744","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Andrade","Pamela S","Tropical Medicine Institute, Medical School, University of São Paulo, São Paulo, Brazil",NA
"1745","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Crispim","Myuki A E","Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas, Manaus, Brazil",NA
"1746","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Maktura","Grazielle C","Brazilian Laboratory on Silencing Technologies, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1747","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Manuli","Erika R","Tropical Medicine Institute, Medical School, University of São Paulo, São Paulo, Brazil",NA
"1748","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Santos","Magnun N N","Department of Clinical Pathology, School of Medical Sciences, University of Campinas, Campinas, Brazil",NA
"1749","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Camilo","Cecilia C","CDL Laboratório Santos e Vidal, Manaus, Brazil",NA
"1750","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Angerami","Rodrigo N","Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas, Brazil",NA
"1751","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Moretti","Maria L","Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas, Brazil",NA
"1752","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Spilki","Fernando R","One Health Laboratory, Feevale University, Novo Hamburgo, Brazil",NA
"1753","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Arns","Clarice W","Animal Virology Laboratory, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1754","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Addas-Carvalho","Marcelo","Hematology and Transfusion Medicine Center, University of Campinas, Campinas, Brazil",NA
"1755","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Benites","Bruno D","Hematology and Transfusion Medicine Center, University of Campinas, Campinas, Brazil",NA
"1756","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Vinolo","Marco A R","Laboratory of Immunoinflammation, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1757","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Mori","Marcelo A S","Experimental Medicine Research Cluster, University of Campinas, Campinas, Brazil",NA
"1758","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Gaburo","Nelson","DB Diagnósticos do Brasil, São Paulo, Brazil",NA
"1759","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Dye","Christopher","Department of Zoology, University of Oxford, UK",NA
"1760","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Marques-Souza","Henrique","Brazilian Laboratory on Silencing Technologies, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1761","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Marques","Rafael E","Brazilian Biosciences National Laboratory, Brazilian Centre for Research in Energy and Materials, Campinas, Brazil",NA
"1762","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Farias","Alessandro S","Autoimmune Research Laboratory, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1763","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Diamond","Michael S","Departments of Medicine, Molecular Microbiology, Pathology, and Immunology, Washington University School of Medicine, St Louis, MO, USA",NA
"1764","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Faria","Nuno R","Tropical Medicine Institute, Medical School, University of São Paulo, São Paulo, Brazil",NA
"1765","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Sabino","Ester C","Tropical Medicine Institute, Medical School, University of São Paulo, São Paulo, Brazil",NA
"1766","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Granja","Fabiana","Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1767","34258603","10.1016/S2666-5247(21)00129-4","Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.","Mutations accrued by SARS-CoV-2 lineage P.1-first detected in Brazil in early January, 2021-include amino acid changes in the receptor-binding domain of the viral spike protein that also are reported in other variants of concern, including B.1.1.7 and B.1.351. We aimed to investigate whether isolates of wild-type P.1 lineage SARS-CoV-2 can escape from neutralising antibodies generated by a polyclonal immune response. We did an immunological study to assess the neutralising effects of antibodies ","2021","07","15","Lancet Microbe","The Lancet. Microbe",NA,"Proença-Módena","Jose Luiz","Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil",NA
"1768","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Mahil","Satveer K","St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK",NA
"1769","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Bechman","Katie","Centre for Rheumatic Diseases, King's College London, London, UK",NA
"1770","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Raharja","Antony","St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK",NA
"1771","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Domingo-Vila","Clara","Department of Immunobiology, Faculty of Life Sciences &amp",NA
"1772","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Baudry","David","St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK",NA
"1773","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Brown","Matthew A","Centre for Rheumatic Diseases, King's College London, London, UK",NA
"1774","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Cope","Andrew P","Centre for Rheumatic Diseases, King's College London, London, UK",NA
"1775","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Dasandi","Tejus","St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK",NA
"1776","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Graham","Carl","Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK",NA
"1777","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Lechmere","Thomas","Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK",NA
"1778","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Malim","Michael H","Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK",NA
"1779","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Meynell","Freya","St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK",NA
"1780","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Pollock","Emily","Department of Immunobiology, Faculty of Life Sciences &amp",NA
"1781","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Seow","Jeffery","Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK",NA
"1782","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Sychowska","Kamila","Department of Immunobiology, Faculty of Life Sciences &amp",NA
"1783","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Barker","Jonathan N","St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK",NA
"1784","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Norton","Sam","Psychology Department, Institute for Psychiatry Psychology and Neuroscience, King's College London, London, UK",NA
"1785","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Galloway","James B","Centre for Rheumatic Diseases, King's College London, London, UK",NA
"1786","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Doores","Katie J","Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK",NA
"1787","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Tree","Timothy I M","Department of Immunobiology, Faculty of Life Sciences &amp",NA
"1788","34258590","10.1016/S2665-9913(21)00212-5","The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.","Patients on therapeutic immunosuppressants for immune-mediated inflammatory diseases were excluded from COVID-19 vaccine trials. We therefore aimed to evaluate humoral and cellular immune responses to COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) in patients taking methotrexate and commonly used targeted biological therapies, compared with healthy controls. Given the roll-out of extended interval vaccination programmes to maximise population coverage, we present findings after the first dose. In t","2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Smith","Catherine H","St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK",NA
"1789","34258589","10.1016/S2665-9913(21)00217-4","Impact of methotrexate on first-dose COVID-19 mRNA vaccination.",NA,"2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Connolly","Caoilfhionn M","Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA",NA
"1790","34258589","10.1016/S2665-9913(21)00217-4","Impact of methotrexate on first-dose COVID-19 mRNA vaccination.",NA,"2021","07","15","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Paik","Julie J","Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA",NA
"1791","34258586","10.1007/s42979-021-00764-9","Performance Evaluation of Soft Computing Approaches for Forecasting COVID-19 Pandemic Cases.","An unexpected outbreak of deadly Covid-19 in later part of 2019 not only endangered the economies of the world but also posed threats to the cultural, social and psychological barriers of mankind. As soon as the virus emerged, scientists and researchers from all over the world started investigating the dynamics of this disease. Despite extensive investments in research, no cure has been officially found to date. This uncertain situation rises severe threats to the survival of mankind. An ultimat","2021","07","15","SN Comput Sci","SN computer science","Artificial neural network (ANN); Autoregressive integrated moving average (ARIMA); COVID-19; Exponential smoothing (ETS); Gene expression programming (GEP); Long Short-Term Memory (LSTM); Time-series forecasting","Shoaib","Muhammad","Agricultural Engineering Department, Bahauddin Zakariya University, Multan, Pakistan",NA
"1792","34258586","10.1007/s42979-021-00764-9","Performance Evaluation of Soft Computing Approaches for Forecasting COVID-19 Pandemic Cases.","An unexpected outbreak of deadly Covid-19 in later part of 2019 not only endangered the economies of the world but also posed threats to the cultural, social and psychological barriers of mankind. As soon as the virus emerged, scientists and researchers from all over the world started investigating the dynamics of this disease. Despite extensive investments in research, no cure has been officially found to date. This uncertain situation rises severe threats to the survival of mankind. An ultimat","2021","07","15","SN Comput Sci","SN computer science","Artificial neural network (ANN); Autoregressive integrated moving average (ARIMA); COVID-19; Exponential smoothing (ETS); Gene expression programming (GEP); Long Short-Term Memory (LSTM); Time-series forecasting","Salahudin","Hamza","Agricultural Engineering Department, Bahauddin Zakariya University, Multan, Pakistan",NA
"1793","34258586","10.1007/s42979-021-00764-9","Performance Evaluation of Soft Computing Approaches for Forecasting COVID-19 Pandemic Cases.","An unexpected outbreak of deadly Covid-19 in later part of 2019 not only endangered the economies of the world but also posed threats to the cultural, social and psychological barriers of mankind. As soon as the virus emerged, scientists and researchers from all over the world started investigating the dynamics of this disease. Despite extensive investments in research, no cure has been officially found to date. This uncertain situation rises severe threats to the survival of mankind. An ultimat","2021","07","15","SN Comput Sci","SN computer science","Artificial neural network (ANN); Autoregressive integrated moving average (ARIMA); COVID-19; Exponential smoothing (ETS); Gene expression programming (GEP); Long Short-Term Memory (LSTM); Time-series forecasting","Hammad","Muhammad","Department of Agricultural Engineering, Bahauddin Zakariya University, Multan, Pakistan",NA
"1794","34258586","10.1007/s42979-021-00764-9","Performance Evaluation of Soft Computing Approaches for Forecasting COVID-19 Pandemic Cases.","An unexpected outbreak of deadly Covid-19 in later part of 2019 not only endangered the economies of the world but also posed threats to the cultural, social and psychological barriers of mankind. As soon as the virus emerged, scientists and researchers from all over the world started investigating the dynamics of this disease. Despite extensive investments in research, no cure has been officially found to date. This uncertain situation rises severe threats to the survival of mankind. An ultimat","2021","07","15","SN Comput Sci","SN computer science","Artificial neural network (ANN); Autoregressive integrated moving average (ARIMA); COVID-19; Exponential smoothing (ETS); Gene expression programming (GEP); Long Short-Term Memory (LSTM); Time-series forecasting","Ahmad","Shakil","NUST Institute of Civil Engineering, National University of Sciences and Technology, Islamabad, Pakistan",NA
"1795","34258586","10.1007/s42979-021-00764-9","Performance Evaluation of Soft Computing Approaches for Forecasting COVID-19 Pandemic Cases.","An unexpected outbreak of deadly Covid-19 in later part of 2019 not only endangered the economies of the world but also posed threats to the cultural, social and psychological barriers of mankind. As soon as the virus emerged, scientists and researchers from all over the world started investigating the dynamics of this disease. Despite extensive investments in research, no cure has been officially found to date. This uncertain situation rises severe threats to the survival of mankind. An ultimat","2021","07","15","SN Comput Sci","SN computer science","Artificial neural network (ANN); Autoregressive integrated moving average (ARIMA); COVID-19; Exponential smoothing (ETS); Gene expression programming (GEP); Long Short-Term Memory (LSTM); Time-series forecasting","Khan","Alamgir Akhtar","Department of Agricultural Engineering, MNS University of Agriculture, Multan, Pakistan",NA
"1796","34258586","10.1007/s42979-021-00764-9","Performance Evaluation of Soft Computing Approaches for Forecasting COVID-19 Pandemic Cases.","An unexpected outbreak of deadly Covid-19 in later part of 2019 not only endangered the economies of the world but also posed threats to the cultural, social and psychological barriers of mankind. As soon as the virus emerged, scientists and researchers from all over the world started investigating the dynamics of this disease. Despite extensive investments in research, no cure has been officially found to date. This uncertain situation rises severe threats to the survival of mankind. An ultimat","2021","07","15","SN Comput Sci","SN computer science","Artificial neural network (ANN); Autoregressive integrated moving average (ARIMA); COVID-19; Exponential smoothing (ETS); Gene expression programming (GEP); Long Short-Term Memory (LSTM); Time-series forecasting","Khan","Mudasser Muneer","Department of Civil Engineering, Bahauddin Zakariya University, Multan, Pakistan",NA
"1797","34258586","10.1007/s42979-021-00764-9","Performance Evaluation of Soft Computing Approaches for Forecasting COVID-19 Pandemic Cases.","An unexpected outbreak of deadly Covid-19 in later part of 2019 not only endangered the economies of the world but also posed threats to the cultural, social and psychological barriers of mankind. As soon as the virus emerged, scientists and researchers from all over the world started investigating the dynamics of this disease. Despite extensive investments in research, no cure has been officially found to date. This uncertain situation rises severe threats to the survival of mankind. An ultimat","2021","07","15","SN Comput Sci","SN computer science","Artificial neural network (ANN); Autoregressive integrated moving average (ARIMA); COVID-19; Exponential smoothing (ETS); Gene expression programming (GEP); Long Short-Term Memory (LSTM); Time-series forecasting","Baig","Muhammad Azhar Inam","Department of Agricultural Engineering, Bahauddin Zakariya University, Multan, Pakistan",NA
"1798","34258586","10.1007/s42979-021-00764-9","Performance Evaluation of Soft Computing Approaches for Forecasting COVID-19 Pandemic Cases.","An unexpected outbreak of deadly Covid-19 in later part of 2019 not only endangered the economies of the world but also posed threats to the cultural, social and psychological barriers of mankind. As soon as the virus emerged, scientists and researchers from all over the world started investigating the dynamics of this disease. Despite extensive investments in research, no cure has been officially found to date. This uncertain situation rises severe threats to the survival of mankind. An ultimat","2021","07","15","SN Comput Sci","SN computer science","Artificial neural network (ANN); Autoregressive integrated moving average (ARIMA); COVID-19; Exponential smoothing (ETS); Gene expression programming (GEP); Long Short-Term Memory (LSTM); Time-series forecasting","Ahmad","Fiaz","Department of Agricultural Engineering, Bahauddin Zakariya University, Multan, Pakistan",NA
"1799","34258586","10.1007/s42979-021-00764-9","Performance Evaluation of Soft Computing Approaches for Forecasting COVID-19 Pandemic Cases.","An unexpected outbreak of deadly Covid-19 in later part of 2019 not only endangered the economies of the world but also posed threats to the cultural, social and psychological barriers of mankind. As soon as the virus emerged, scientists and researchers from all over the world started investigating the dynamics of this disease. Despite extensive investments in research, no cure has been officially found to date. This uncertain situation rises severe threats to the survival of mankind. An ultimat","2021","07","15","SN Comput Sci","SN computer science","Artificial neural network (ANN); Autoregressive integrated moving average (ARIMA); COVID-19; Exponential smoothing (ETS); Gene expression programming (GEP); Long Short-Term Memory (LSTM); Time-series forecasting","Ullah","Muhammad Kaleem","Department of Civil Engineering, The University of Lahore, Lahore, Pakistan",NA
"1800","34258573","10.1016/j.metop.2021.100104","Did social isolation due to COVID-19 interfere with the quality of sleep and excessive daytime sleepiness in individuals with grade III obesity about to enter a surgical prehabilitation program? An observational study.","Social isolation (SI) can have negative effects on health, although little is known about the SI consequences on patients with grade III obesity and even less if they are entering a prehabilitation program. the present study analyzes the effects of SI determined by the SARS-CoV-2 pandemic in people with grade III obesity who about to enter a prehabilitation program for bariatric surgery. Five patients with grade III obesity who entered a prehabilitation program or which had to be stopped on Marc","2021","07","15","Metabol Open","Metabolism open","Anxiety; COVID-19; Depression; Disorders of excessive somnolence; Obesity; Sleep","de Medeiros","Gabriela","Curso de Fisioterapia, Universidade do Estado de Santa Catarina, Santa Catarina, Brazil",NA
"1801","34258573","10.1016/j.metop.2021.100104","Did social isolation due to COVID-19 interfere with the quality of sleep and excessive daytime sleepiness in individuals with grade III obesity about to enter a surgical prehabilitation program? An observational study.","Social isolation (SI) can have negative effects on health, although little is known about the SI consequences on patients with grade III obesity and even less if they are entering a prehabilitation program. the present study analyzes the effects of SI determined by the SARS-CoV-2 pandemic in people with grade III obesity who about to enter a prehabilitation program for bariatric surgery. Five patients with grade III obesity who entered a prehabilitation program or which had to be stopped on Marc","2021","07","15","Metabol Open","Metabolism open","Anxiety; COVID-19; Depression; Disorders of excessive somnolence; Obesity; Sleep","Artismo","Regiana Santos","Programa de Pós Graduação em Fisioterapia da Universidade do Estado de Santa Catarina, Santa Catarina, Brazil",NA
"1802","34258573","10.1016/j.metop.2021.100104","Did social isolation due to COVID-19 interfere with the quality of sleep and excessive daytime sleepiness in individuals with grade III obesity about to enter a surgical prehabilitation program? An observational study.","Social isolation (SI) can have negative effects on health, although little is known about the SI consequences on patients with grade III obesity and even less if they are entering a prehabilitation program. the present study analyzes the effects of SI determined by the SARS-CoV-2 pandemic in people with grade III obesity who about to enter a prehabilitation program for bariatric surgery. Five patients with grade III obesity who entered a prehabilitation program or which had to be stopped on Marc","2021","07","15","Metabol Open","Metabolism open","Anxiety; COVID-19; Depression; Disorders of excessive somnolence; Obesity; Sleep","Coelho","Pâmela","Curso de Fisioterapia, Universidade do Estado de Santa Catarina, Santa Catarina, Brazil",NA
"1803","34258573","10.1016/j.metop.2021.100104","Did social isolation due to COVID-19 interfere with the quality of sleep and excessive daytime sleepiness in individuals with grade III obesity about to enter a surgical prehabilitation program? An observational study.","Social isolation (SI) can have negative effects on health, although little is known about the SI consequences on patients with grade III obesity and even less if they are entering a prehabilitation program. the present study analyzes the effects of SI determined by the SARS-CoV-2 pandemic in people with grade III obesity who about to enter a prehabilitation program for bariatric surgery. Five patients with grade III obesity who entered a prehabilitation program or which had to be stopped on Marc","2021","07","15","Metabol Open","Metabolism open","Anxiety; COVID-19; Depression; Disorders of excessive somnolence; Obesity; Sleep","da Silveira","Bruna","Programa de Pós Graduação em Fisioterapia da Universidade do Estado de Santa Catarina, Santa Catarina, Brazil",NA
"1804","34258573","10.1016/j.metop.2021.100104","Did social isolation due to COVID-19 interfere with the quality of sleep and excessive daytime sleepiness in individuals with grade III obesity about to enter a surgical prehabilitation program? An observational study.","Social isolation (SI) can have negative effects on health, although little is known about the SI consequences on patients with grade III obesity and even less if they are entering a prehabilitation program. the present study analyzes the effects of SI determined by the SARS-CoV-2 pandemic in people with grade III obesity who about to enter a prehabilitation program for bariatric surgery. Five patients with grade III obesity who entered a prehabilitation program or which had to be stopped on Marc","2021","07","15","Metabol Open","Metabolism open","Anxiety; COVID-19; Depression; Disorders of excessive somnolence; Obesity; Sleep","Ponte Souza Filho","Vicente Paulo","Programa de Pós Graduação em Fisioterapia da Universidade do Estado de Santa Catarina, Santa Catarina, Brazil",NA
"1805","34258573","10.1016/j.metop.2021.100104","Did social isolation due to COVID-19 interfere with the quality of sleep and excessive daytime sleepiness in individuals with grade III obesity about to enter a surgical prehabilitation program? An observational study.","Social isolation (SI) can have negative effects on health, although little is known about the SI consequences on patients with grade III obesity and even less if they are entering a prehabilitation program. the present study analyzes the effects of SI determined by the SARS-CoV-2 pandemic in people with grade III obesity who about to enter a prehabilitation program for bariatric surgery. Five patients with grade III obesity who entered a prehabilitation program or which had to be stopped on Marc","2021","07","15","Metabol Open","Metabolism open","Anxiety; COVID-19; Depression; Disorders of excessive somnolence; Obesity; Sleep","Lorenzetti Branco","Joaquim Henrique","Programa de Pós Graduação em Fisioterapia da Universidade do Estado de Santa Catarina, Santa Catarina, Brazil",NA
"1806","34258573","10.1016/j.metop.2021.100104","Did social isolation due to COVID-19 interfere with the quality of sleep and excessive daytime sleepiness in individuals with grade III obesity about to enter a surgical prehabilitation program? An observational study.","Social isolation (SI) can have negative effects on health, although little is known about the SI consequences on patients with grade III obesity and even less if they are entering a prehabilitation program. the present study analyzes the effects of SI determined by the SARS-CoV-2 pandemic in people with grade III obesity who about to enter a prehabilitation program for bariatric surgery. Five patients with grade III obesity who entered a prehabilitation program or which had to be stopped on Marc","2021","07","15","Metabol Open","Metabolism open","Anxiety; COVID-19; Depression; Disorders of excessive somnolence; Obesity; Sleep","Matte","Darlan Laurício","Curso de Fisioterapia, Universidade do Estado de Santa Catarina, Santa Catarina, Brazil",NA
"1807","34258570","10.1016/j.eclinm.2021.100958","The impact of the COVID-19 pandemic on refugees and asylum seekers in Greece: A retrospective analysis of national surveillance data from 2020.","Migrants globally, including refugees and asylum seekers, have experienced adverse clinical and socioeconomic impacts of the COVID-19 pandemic. For approximately 56,000 refugees and asylum seekers in Reception and Identification Centers (RICs) and Reception Sites (RS) in Greece, living in severely substandard living conditions, prevention measures have been impossible with limited provision in terms of routine testing, surveillance, and access to healthcare. These migrant populations have experi","2021","07","15","EClinicalMedicine","EClinicalMedicine","COVID-19; Greece; Health inequalities; Migrant; Refugee; Vaccination","Kondilis","Elias","Laboratory of Primary Health Care, General Medicine and Health Services Research, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece",NA
"1808","34258570","10.1016/j.eclinm.2021.100958","The impact of the COVID-19 pandemic on refugees and asylum seekers in Greece: A retrospective analysis of national surveillance data from 2020.","Migrants globally, including refugees and asylum seekers, have experienced adverse clinical and socioeconomic impacts of the COVID-19 pandemic. For approximately 56,000 refugees and asylum seekers in Reception and Identification Centers (RICs) and Reception Sites (RS) in Greece, living in severely substandard living conditions, prevention measures have been impossible with limited provision in terms of routine testing, surveillance, and access to healthcare. These migrant populations have experi","2021","07","15","EClinicalMedicine","EClinicalMedicine","COVID-19; Greece; Health inequalities; Migrant; Refugee; Vaccination","Papamichail","Dimitris","Department of Public Health Policy, University of West Attica, Athens, Greece",NA
"1809","34258570","10.1016/j.eclinm.2021.100958","The impact of the COVID-19 pandemic on refugees and asylum seekers in Greece: A retrospective analysis of national surveillance data from 2020.","Migrants globally, including refugees and asylum seekers, have experienced adverse clinical and socioeconomic impacts of the COVID-19 pandemic. For approximately 56,000 refugees and asylum seekers in Reception and Identification Centers (RICs) and Reception Sites (RS) in Greece, living in severely substandard living conditions, prevention measures have been impossible with limited provision in terms of routine testing, surveillance, and access to healthcare. These migrant populations have experi","2021","07","15","EClinicalMedicine","EClinicalMedicine","COVID-19; Greece; Health inequalities; Migrant; Refugee; Vaccination","McCann","Sophie","Lancet Migration global collaboration to advance migration health, Institute for Global Health, University College London, 30 Guilford Street, London WC1N1EH, UK",NA
"1810","34258570","10.1016/j.eclinm.2021.100958","The impact of the COVID-19 pandemic on refugees and asylum seekers in Greece: A retrospective analysis of national surveillance data from 2020.","Migrants globally, including refugees and asylum seekers, have experienced adverse clinical and socioeconomic impacts of the COVID-19 pandemic. For approximately 56,000 refugees and asylum seekers in Reception and Identification Centers (RICs) and Reception Sites (RS) in Greece, living in severely substandard living conditions, prevention measures have been impossible with limited provision in terms of routine testing, surveillance, and access to healthcare. These migrant populations have experi","2021","07","15","EClinicalMedicine","EClinicalMedicine","COVID-19; Greece; Health inequalities; Migrant; Refugee; Vaccination","Carruthers","Elspeth","Lancet Migration global collaboration to advance migration health, Institute for Global Health, University College London, 30 Guilford Street, London WC1N1EH, UK",NA
"1811","34258570","10.1016/j.eclinm.2021.100958","The impact of the COVID-19 pandemic on refugees and asylum seekers in Greece: A retrospective analysis of national surveillance data from 2020.","Migrants globally, including refugees and asylum seekers, have experienced adverse clinical and socioeconomic impacts of the COVID-19 pandemic. For approximately 56,000 refugees and asylum seekers in Reception and Identification Centers (RICs) and Reception Sites (RS) in Greece, living in severely substandard living conditions, prevention measures have been impossible with limited provision in terms of routine testing, surveillance, and access to healthcare. These migrant populations have experi","2021","07","15","EClinicalMedicine","EClinicalMedicine","COVID-19; Greece; Health inequalities; Migrant; Refugee; Vaccination","Veizis","Apostolos","INTERSOS Hellas, 31 Ermou Street, Thessaloniki 546 24, Greece",NA
"1812","34258570","10.1016/j.eclinm.2021.100958","The impact of the COVID-19 pandemic on refugees and asylum seekers in Greece: A retrospective analysis of national surveillance data from 2020.","Migrants globally, including refugees and asylum seekers, have experienced adverse clinical and socioeconomic impacts of the COVID-19 pandemic. For approximately 56,000 refugees and asylum seekers in Reception and Identification Centers (RICs) and Reception Sites (RS) in Greece, living in severely substandard living conditions, prevention measures have been impossible with limited provision in terms of routine testing, surveillance, and access to healthcare. These migrant populations have experi","2021","07","15","EClinicalMedicine","EClinicalMedicine","COVID-19; Greece; Health inequalities; Migrant; Refugee; Vaccination","Orcutt","Miriam","Institute for Global Health, University College London, 30 Guilford Street, London WC1N1EH, UK",NA
"1813","34258570","10.1016/j.eclinm.2021.100958","The impact of the COVID-19 pandemic on refugees and asylum seekers in Greece: A retrospective analysis of national surveillance data from 2020.","Migrants globally, including refugees and asylum seekers, have experienced adverse clinical and socioeconomic impacts of the COVID-19 pandemic. For approximately 56,000 refugees and asylum seekers in Reception and Identification Centers (RICs) and Reception Sites (RS) in Greece, living in severely substandard living conditions, prevention measures have been impossible with limited provision in terms of routine testing, surveillance, and access to healthcare. These migrant populations have experi","2021","07","15","EClinicalMedicine","EClinicalMedicine","COVID-19; Greece; Health inequalities; Migrant; Refugee; Vaccination","Hargreaves","Sally","The Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, London, UK",NA
"1814","34258510","10.1007/s41666-021-00102-x","Investigating Public Discourses Around Gender and COVID-19: a Social Media Analysis of Twitter Data.","We collected over 50 million tweets referencing COVID-19 to understand the public's gendered discourses and concerns during the pandemic. We filtered the tweets based on English language and among three gender categories: men, women, and sexual and gender minorities. We used a mixed-method approach that included topic modelling, sentiment analysis, and text mining extraction procedures including words' mapping, proximity plots, top hashtags and mentions, and most retweeted posts. Our findings sh","2021","07","15","J Healthc Inform Res","Journal of healthcare informatics research","COVID-19; Gender; Public discourses; Social media; Twitter","Al-Rawi","Ahmed","School of Communication, Simon Fraser University, Schrum Science Centre-K 9653, Burnaby, BC V5A 1S6 Canada",NA
"1815","34258510","10.1007/s41666-021-00102-x","Investigating Public Discourses Around Gender and COVID-19: a Social Media Analysis of Twitter Data.","We collected over 50 million tweets referencing COVID-19 to understand the public's gendered discourses and concerns during the pandemic. We filtered the tweets based on English language and among three gender categories: men, women, and sexual and gender minorities. We used a mixed-method approach that included topic modelling, sentiment analysis, and text mining extraction procedures including words' mapping, proximity plots, top hashtags and mentions, and most retweeted posts. Our findings sh","2021","07","15","J Healthc Inform Res","Journal of healthcare informatics research","COVID-19; Gender; Public discourses; Social media; Twitter","Grepin","Karen","School of Public Health, Hong Kong University, Pok Fu Lam, Hong Kong",NA
"1816","34258510","10.1007/s41666-021-00102-x","Investigating Public Discourses Around Gender and COVID-19: a Social Media Analysis of Twitter Data.","We collected over 50 million tweets referencing COVID-19 to understand the public's gendered discourses and concerns during the pandemic. We filtered the tweets based on English language and among three gender categories: men, women, and sexual and gender minorities. We used a mixed-method approach that included topic modelling, sentiment analysis, and text mining extraction procedures including words' mapping, proximity plots, top hashtags and mentions, and most retweeted posts. Our findings sh","2021","07","15","J Healthc Inform Res","Journal of healthcare informatics research","COVID-19; Gender; Public discourses; Social media; Twitter","Li","Xiaosu","School of Communication, Simon Fraser University, Schrum Science Centre-K 9653, Burnaby, BC V5A 1S6 Canada",NA
"1817","34258510","10.1007/s41666-021-00102-x","Investigating Public Discourses Around Gender and COVID-19: a Social Media Analysis of Twitter Data.","We collected over 50 million tweets referencing COVID-19 to understand the public's gendered discourses and concerns during the pandemic. We filtered the tweets based on English language and among three gender categories: men, women, and sexual and gender minorities. We used a mixed-method approach that included topic modelling, sentiment analysis, and text mining extraction procedures including words' mapping, proximity plots, top hashtags and mentions, and most retweeted posts. Our findings sh","2021","07","15","J Healthc Inform Res","Journal of healthcare informatics research","COVID-19; Gender; Public discourses; Social media; Twitter","Morgan","Rosemary","Bloomberg School of Public Health, John Hopkins University, Baltimore, MD USA",NA
"1818","34258510","10.1007/s41666-021-00102-x","Investigating Public Discourses Around Gender and COVID-19: a Social Media Analysis of Twitter Data.","We collected over 50 million tweets referencing COVID-19 to understand the public's gendered discourses and concerns during the pandemic. We filtered the tweets based on English language and among three gender categories: men, women, and sexual and gender minorities. We used a mixed-method approach that included topic modelling, sentiment analysis, and text mining extraction procedures including words' mapping, proximity plots, top hashtags and mentions, and most retweeted posts. Our findings sh","2021","07","15","J Healthc Inform Res","Journal of healthcare informatics research","COVID-19; Gender; Public discourses; Social media; Twitter","Wenham","Clare","Department of Health Policy, London School of Economics, London, UK",NA
"1819","34258510","10.1007/s41666-021-00102-x","Investigating Public Discourses Around Gender and COVID-19: a Social Media Analysis of Twitter Data.","We collected over 50 million tweets referencing COVID-19 to understand the public's gendered discourses and concerns during the pandemic. We filtered the tweets based on English language and among three gender categories: men, women, and sexual and gender minorities. We used a mixed-method approach that included topic modelling, sentiment analysis, and text mining extraction procedures including words' mapping, proximity plots, top hashtags and mentions, and most retweeted posts. Our findings sh","2021","07","15","J Healthc Inform Res","Journal of healthcare informatics research","COVID-19; Gender; Public discourses; Social media; Twitter","Smith","Julia","Faculty of Health Sciences, Simon Fraser University, Schrum Science Centre-K 9653, Burnaby, BC V5A 1S6 Canada",NA
"1820","34258483","10.1016/j.idm.2021.06.007","Impact of school reopening on pandemic spread: A case study using an agent-based model for COVID-19.","This article examines the impact of partial/full reopening of school/college campuses on the spread of a pandemic using COVID-19 as a case study. The study uses an agent-based simulation model that replicates community spread in an urban region of U.S.A. via daily social mixing of susceptible and infected individuals. Data representing population demographics, SARS-CoV-2 epidemiology, and social interventions guides the model's behavior, which is calibrated and validated using data reported by t","2021","07","20","Infect Dis Model","Infectious Disease Modelling","Age-specific impact; Agent-based simulation model; COVID-19; SARS-CoV-2; School reopening; School transmission rate","Tatapudi","Hanisha","Department of Industrial and Management System Engineering, University of South Florida, Tampa, FL, USA",NA
"1821","34258483","10.1016/j.idm.2021.06.007","Impact of school reopening on pandemic spread: A case study using an agent-based model for COVID-19.","This article examines the impact of partial/full reopening of school/college campuses on the spread of a pandemic using COVID-19 as a case study. The study uses an agent-based simulation model that replicates community spread in an urban region of U.S.A. via daily social mixing of susceptible and infected individuals. Data representing population demographics, SARS-CoV-2 epidemiology, and social interventions guides the model's behavior, which is calibrated and validated using data reported by t","2021","07","20","Infect Dis Model","Infectious Disease Modelling","Age-specific impact; Agent-based simulation model; COVID-19; SARS-CoV-2; School reopening; School transmission rate","Das","Tapas K","Department of Industrial and Management System Engineering, University of South Florida, Tampa, FL, USA",NA
"1822","34258481","10.1016/j.ekir.2021.07.004","Atypical HUS triggered by infection with SARS-CoV2.",NA,"2021","07","15","Kidney Int Rep","Kidney international reports","SARS-CoV-2; aHUS; thrombotic microangiopathy","Kaufeld","J K","Department of Nephrology, Hannover Medical School, Hannover, Germany",NA
"1823","34258481","10.1016/j.ekir.2021.07.004","Atypical HUS triggered by infection with SARS-CoV2.",NA,"2021","07","15","Kidney Int Rep","Kidney international reports","SARS-CoV-2; aHUS; thrombotic microangiopathy","Reinhardt","M","Department of Nephrology, Hannover Medical School, Hannover, Germany",NA
"1824","34258481","10.1016/j.ekir.2021.07.004","Atypical HUS triggered by infection with SARS-CoV2.",NA,"2021","07","15","Kidney Int Rep","Kidney international reports","SARS-CoV-2; aHUS; thrombotic microangiopathy","Schröder","C","Department of Nephrology, Hannover Medical School, Hannover, Germany",NA
"1825","34258481","10.1016/j.ekir.2021.07.004","Atypical HUS triggered by infection with SARS-CoV2.",NA,"2021","07","15","Kidney Int Rep","Kidney international reports","SARS-CoV-2; aHUS; thrombotic microangiopathy","Bräsen","J H","Department of Pathology, Hannover Medical School, Hannover, Germany",NA
"1826","34258481","10.1016/j.ekir.2021.07.004","Atypical HUS triggered by infection with SARS-CoV2.",NA,"2021","07","15","Kidney Int Rep","Kidney international reports","SARS-CoV-2; aHUS; thrombotic microangiopathy","Wiech","T","Department of Pathology, University Hospital Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"1827","34258481","10.1016/j.ekir.2021.07.004","Atypical HUS triggered by infection with SARS-CoV2.",NA,"2021","07","15","Kidney Int Rep","Kidney international reports","SARS-CoV-2; aHUS; thrombotic microangiopathy","Brylka","P","Department of Internal Medicine, Katholisches Karl-Leisner-Klinikum, Kleve, Germany",NA
"1828","34258481","10.1016/j.ekir.2021.07.004","Atypical HUS triggered by infection with SARS-CoV2.",NA,"2021","07","15","Kidney Int Rep","Kidney international reports","SARS-CoV-2; aHUS; thrombotic microangiopathy","Khaled","A","Department of Internal Medicine, Katholisches Karl-Leisner-Klinikum, Kleve, Germany",NA
"1829","34258481","10.1016/j.ekir.2021.07.004","Atypical HUS triggered by infection with SARS-CoV2.",NA,"2021","07","15","Kidney Int Rep","Kidney international reports","SARS-CoV-2; aHUS; thrombotic microangiopathy","Bergmann","C","Center for Human Genetics, Labor Limbach, Mainz, Germany",NA
"1830","34258481","10.1016/j.ekir.2021.07.004","Atypical HUS triggered by infection with SARS-CoV2.",NA,"2021","07","15","Kidney Int Rep","Kidney international reports","SARS-CoV-2; aHUS; thrombotic microangiopathy","Haller","H","Department of Nephrology, Hannover Medical School, Hannover, Germany",NA
"1831","34258481","10.1016/j.ekir.2021.07.004","Atypical HUS triggered by infection with SARS-CoV2.",NA,"2021","07","15","Kidney Int Rep","Kidney international reports","SARS-CoV-2; aHUS; thrombotic microangiopathy","Gäckler","A","Department of Nephrology, University Hospital Essen, University Essen-Duisburg, Essen, Germany",NA
"1832","34258481","10.1016/j.ekir.2021.07.004","Atypical HUS triggered by infection with SARS-CoV2.",NA,"2021","07","15","Kidney Int Rep","Kidney international reports","SARS-CoV-2; aHUS; thrombotic microangiopathy","Schmidt","B M W","Department of Nephrology, Hannover Medical School, Hannover, Germany",NA
"1833","34258460","10.1016/j.heliyon.2021.e07406","Does digital literacy influence students' online risk? Evidence from Covid-19.","The adoption of online-based learning and the internet has had both a positive impact on students. This study aims to understand how digital literacy, parental mediation, and self-control affects online risk during the Covid-19 pandemic in Indonesia. This paper elaborated a quantitative method with SEM-PLS to raise the comprehension of the phenomenon studied. A questionnaire was voluntarily responded to approximately 300 elementary school students who engaged in online-based learning. The struct","2021","07","15","Heliyon","Heliyon","Digital literacy; Online risk; Parental mediation; Self-control","Purnama","Sigit","UIN Sunan Kalijaga, Yogyakarta, Indonesia",NA
"1834","34258460","10.1016/j.heliyon.2021.e07406","Does digital literacy influence students' online risk? Evidence from Covid-19.","The adoption of online-based learning and the internet has had both a positive impact on students. This study aims to understand how digital literacy, parental mediation, and self-control affects online risk during the Covid-19 pandemic in Indonesia. This paper elaborated a quantitative method with SEM-PLS to raise the comprehension of the phenomenon studied. A questionnaire was voluntarily responded to approximately 300 elementary school students who engaged in online-based learning. The struct","2021","07","15","Heliyon","Heliyon","Digital literacy; Online risk; Parental mediation; Self-control","Ulfah","Maulidya","Institut Agama Islam Negeri Syekh Nurjati, Cirebon, Indonesia",NA
"1835","34258460","10.1016/j.heliyon.2021.e07406","Does digital literacy influence students' online risk? Evidence from Covid-19.","The adoption of online-based learning and the internet has had both a positive impact on students. This study aims to understand how digital literacy, parental mediation, and self-control affects online risk during the Covid-19 pandemic in Indonesia. This paper elaborated a quantitative method with SEM-PLS to raise the comprehension of the phenomenon studied. A questionnaire was voluntarily responded to approximately 300 elementary school students who engaged in online-based learning. The struct","2021","07","15","Heliyon","Heliyon","Digital literacy; Online risk; Parental mediation; Self-control","Machali","Imam","UIN Sunan Kalijaga, Yogyakarta, Indonesia",NA
"1836","34258460","10.1016/j.heliyon.2021.e07406","Does digital literacy influence students' online risk? Evidence from Covid-19.","The adoption of online-based learning and the internet has had both a positive impact on students. This study aims to understand how digital literacy, parental mediation, and self-control affects online risk during the Covid-19 pandemic in Indonesia. This paper elaborated a quantitative method with SEM-PLS to raise the comprehension of the phenomenon studied. A questionnaire was voluntarily responded to approximately 300 elementary school students who engaged in online-based learning. The struct","2021","07","15","Heliyon","Heliyon","Digital literacy; Online risk; Parental mediation; Self-control","Wibowo","Agus","Faculty of Economics, Universitas Negeri Jakarta, Jakarta, Indonesia",NA
"1837","34258460","10.1016/j.heliyon.2021.e07406","Does digital literacy influence students' online risk? Evidence from Covid-19.","The adoption of online-based learning and the internet has had both a positive impact on students. This study aims to understand how digital literacy, parental mediation, and self-control affects online risk during the Covid-19 pandemic in Indonesia. This paper elaborated a quantitative method with SEM-PLS to raise the comprehension of the phenomenon studied. A questionnaire was voluntarily responded to approximately 300 elementary school students who engaged in online-based learning. The struct","2021","07","15","Heliyon","Heliyon","Digital literacy; Online risk; Parental mediation; Self-control","Narmaditya","Bagus Shandy","Faculty of Economics, Universitas Negeri Malang, Malang, Indonesia",NA
"1838","34258456","10.1016/j.heliyon.2021.e07388","Impact of online education on fear of academic delay and psychological distress among university students following one year of COVID-19 outbreak in Bangladesh.","Extreme fear of academic delay (FAD) and psychological distress among students have arisen as great public health concerns worldwide due to the devastating actions of coronavirus disease 2019 (COVID-19). The precise aim of this study was to assess the impact of ongoing online education on current university students' FAD and psychological stress symptoms following one year of calamitous COVID-19 outbreak in Bangladesh. A cross-sectional web-based survey was conducted from March 15 to 30, 2021, f","2021","07","15","Heliyon","Heliyon","Bangladesh; COVID-19 outbreak; Fear of academic delay (FAD); Psychological stress; e-learning","Hossain","Md Jamal","Department of Pharmacy, State University of Bangladesh, 77 Satmasjid Road, Dhanmondi, Dhaka 1205, Bangladesh",NA
"1839","34258456","10.1016/j.heliyon.2021.e07388","Impact of online education on fear of academic delay and psychological distress among university students following one year of COVID-19 outbreak in Bangladesh.","Extreme fear of academic delay (FAD) and psychological distress among students have arisen as great public health concerns worldwide due to the devastating actions of coronavirus disease 2019 (COVID-19). The precise aim of this study was to assess the impact of ongoing online education on current university students' FAD and psychological stress symptoms following one year of calamitous COVID-19 outbreak in Bangladesh. A cross-sectional web-based survey was conducted from March 15 to 30, 2021, f","2021","07","15","Heliyon","Heliyon","Bangladesh; COVID-19 outbreak; Fear of academic delay (FAD); Psychological stress; e-learning","Ahmmed","Foyez","Department of Statistics, Comilla University, Kotbari, Cumilla 3506, Bangladesh",NA
"1840","34258456","10.1016/j.heliyon.2021.e07388","Impact of online education on fear of academic delay and psychological distress among university students following one year of COVID-19 outbreak in Bangladesh.","Extreme fear of academic delay (FAD) and psychological distress among students have arisen as great public health concerns worldwide due to the devastating actions of coronavirus disease 2019 (COVID-19). The precise aim of this study was to assess the impact of ongoing online education on current university students' FAD and psychological stress symptoms following one year of calamitous COVID-19 outbreak in Bangladesh. A cross-sectional web-based survey was conducted from March 15 to 30, 2021, f","2021","07","15","Heliyon","Heliyon","Bangladesh; COVID-19 outbreak; Fear of academic delay (FAD); Psychological stress; e-learning","Rahman","S M Abdur","Department of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh",NA
"1841","34258456","10.1016/j.heliyon.2021.e07388","Impact of online education on fear of academic delay and psychological distress among university students following one year of COVID-19 outbreak in Bangladesh.","Extreme fear of academic delay (FAD) and psychological distress among students have arisen as great public health concerns worldwide due to the devastating actions of coronavirus disease 2019 (COVID-19). The precise aim of this study was to assess the impact of ongoing online education on current university students' FAD and psychological stress symptoms following one year of calamitous COVID-19 outbreak in Bangladesh. A cross-sectional web-based survey was conducted from March 15 to 30, 2021, f","2021","07","15","Heliyon","Heliyon","Bangladesh; COVID-19 outbreak; Fear of academic delay (FAD); Psychological stress; e-learning","Sanam","Sherejad","Department of Pharmacy, Stamford University Bangladesh, 51 Siddeswari Road, Ramna, Dhaka 1217, Bangladesh",NA
"1842","34258456","10.1016/j.heliyon.2021.e07388","Impact of online education on fear of academic delay and psychological distress among university students following one year of COVID-19 outbreak in Bangladesh.","Extreme fear of academic delay (FAD) and psychological distress among students have arisen as great public health concerns worldwide due to the devastating actions of coronavirus disease 2019 (COVID-19). The precise aim of this study was to assess the impact of ongoing online education on current university students' FAD and psychological stress symptoms following one year of calamitous COVID-19 outbreak in Bangladesh. A cross-sectional web-based survey was conducted from March 15 to 30, 2021, f","2021","07","15","Heliyon","Heliyon","Bangladesh; COVID-19 outbreak; Fear of academic delay (FAD); Psychological stress; e-learning","Emran","Talha Bin","Department of Pharmacy, BGC Trust University Bangladesh, Chittagong 4381, Bangladesh",NA
"1843","34258456","10.1016/j.heliyon.2021.e07388","Impact of online education on fear of academic delay and psychological distress among university students following one year of COVID-19 outbreak in Bangladesh.","Extreme fear of academic delay (FAD) and psychological distress among students have arisen as great public health concerns worldwide due to the devastating actions of coronavirus disease 2019 (COVID-19). The precise aim of this study was to assess the impact of ongoing online education on current university students' FAD and psychological stress symptoms following one year of calamitous COVID-19 outbreak in Bangladesh. A cross-sectional web-based survey was conducted from March 15 to 30, 2021, f","2021","07","15","Heliyon","Heliyon","Bangladesh; COVID-19 outbreak; Fear of academic delay (FAD); Psychological stress; e-learning","Mitra","Saikat","Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh",NA
"1844","34258388","10.1097/TXD.0000000000001178","Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report.","Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic","2021","07","15","Transplant Direct","Transplantation direct",NA,"Nguyen","Michelle C","Division of Transplant Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"1845","34258388","10.1097/TXD.0000000000001178","Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report.","Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic","2021","07","15","Transplant Direct","Transplantation direct",NA,"Lee","Eliza J","Division of Transplant Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"1846","34258388","10.1097/TXD.0000000000001178","Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report.","Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic","2021","07","15","Transplant Direct","Transplantation direct",NA,"Avery","Robin K","Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"1847","34258388","10.1097/TXD.0000000000001178","Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report.","Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic","2021","07","15","Transplant Direct","Transplantation direct",NA,"Dioverti-Prono","M Veronica","Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"1848","34258388","10.1097/TXD.0000000000001178","Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report.","Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic","2021","07","15","Transplant Direct","Transplantation direct",NA,"Shoham","Shmuel","Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"1849","34258388","10.1097/TXD.0000000000001178","Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report.","Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic","2021","07","15","Transplant Direct","Transplantation direct",NA,"Tobian","Aaron A R","Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"1850","34258388","10.1097/TXD.0000000000001178","Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report.","Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic","2021","07","15","Transplant Direct","Transplantation direct",NA,"Bloch","Evan M","Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"1851","34258388","10.1097/TXD.0000000000001178","Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report.","Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic","2021","07","15","Transplant Direct","Transplantation direct",NA,"Gurakar","Ahmet","Division of Gastroenterology and Hepatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD",NA
"1852","34258388","10.1097/TXD.0000000000001178","Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report.","Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic","2021","07","15","Transplant Direct","Transplantation direct",NA,"Rizkalla","Nicole A","Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"1853","34258388","10.1097/TXD.0000000000001178","Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report.","Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic","2021","07","15","Transplant Direct","Transplantation direct",NA,"Cameron","Andrew M","Division of Transplant Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"1854","34258388","10.1097/TXD.0000000000001178","Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report.","Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic","2021","07","15","Transplant Direct","Transplantation direct",NA,"King","Elizabeth A","Division of Transplant Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"1855","34258388","10.1097/TXD.0000000000001178","Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report.","Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic","2021","07","15","Transplant Direct","Transplantation direct",NA,"Ottmann","Shane","Division of Transplant Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"1856","34258388","10.1097/TXD.0000000000001178","Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report.","Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic","2021","07","15","Transplant Direct","Transplantation direct",NA,"Garonzik-Wang","Jacqueline M","Division of Transplant Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"1857","34258388","10.1097/TXD.0000000000001178","Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report.","Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic","2021","07","15","Transplant Direct","Transplantation direct",NA,"Wesson","Russel N","Division of Transplant Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"1858","34258388","10.1097/TXD.0000000000001178","Transplant of SARS-CoV-2-infected Living Donor Liver: Case Report.","Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic","2021","07","15","Transplant Direct","Transplantation direct",NA,"Philosophe","Benjamin","Division of Transplant Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD",NA
"1859","34258324","10.1093/ofid/ofab305","The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting.","Bamlanivimab, a monoclonal antibody targeting the spike protein of severe acute respiratory syndrome coronavirus 2, is available for ambulatory treatment of coronavirus disease 2019 (COVID-19). This real-world study confirms the efficacy of bamlanivimab in reducing hospital admissions and emergency department visits among high-risk outpatients with mild to moderate COVID-19 illness and reveals a trend toward improved mortality.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; bamlanivimab; outcomes; treatment","Corwin","Douglas S","Section of Pulmonary and Critical Care, Department of Medicine, St Luke's University Health Network, Bethlehem, Pennsylvania, USA",NA
"1860","34258324","10.1093/ofid/ofab305","The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting.","Bamlanivimab, a monoclonal antibody targeting the spike protein of severe acute respiratory syndrome coronavirus 2, is available for ambulatory treatment of coronavirus disease 2019 (COVID-19). This real-world study confirms the efficacy of bamlanivimab in reducing hospital admissions and emergency department visits among high-risk outpatients with mild to moderate COVID-19 illness and reveals a trend toward improved mortality.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; bamlanivimab; outcomes; treatment","Ender","Peter T","Section of Infectious Diseases, Department of Medicine, St. Luke's University Health Network, Bethlehem, Pennsylvania, USA",NA
"1861","34258324","10.1093/ofid/ofab305","The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting.","Bamlanivimab, a monoclonal antibody targeting the spike protein of severe acute respiratory syndrome coronavirus 2, is available for ambulatory treatment of coronavirus disease 2019 (COVID-19). This real-world study confirms the efficacy of bamlanivimab in reducing hospital admissions and emergency department visits among high-risk outpatients with mild to moderate COVID-19 illness and reveals a trend toward improved mortality.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; bamlanivimab; outcomes; treatment","Sahu","Nitasa","Section of Pulmonary and Critical Care, Department of Medicine, St Luke's University Health Network, Bethlehem, Pennsylvania, USA",NA
"1862","34258324","10.1093/ofid/ofab305","The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting.","Bamlanivimab, a monoclonal antibody targeting the spike protein of severe acute respiratory syndrome coronavirus 2, is available for ambulatory treatment of coronavirus disease 2019 (COVID-19). This real-world study confirms the efficacy of bamlanivimab in reducing hospital admissions and emergency department visits among high-risk outpatients with mild to moderate COVID-19 illness and reveals a trend toward improved mortality.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; bamlanivimab; outcomes; treatment","Durgham","Ryan A","Temple/St. Luke's School of Medicine, Bethlehem, Pennsylvania, USA",NA
"1863","34258324","10.1093/ofid/ofab305","The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting.","Bamlanivimab, a monoclonal antibody targeting the spike protein of severe acute respiratory syndrome coronavirus 2, is available for ambulatory treatment of coronavirus disease 2019 (COVID-19). This real-world study confirms the efficacy of bamlanivimab in reducing hospital admissions and emergency department visits among high-risk outpatients with mild to moderate COVID-19 illness and reveals a trend toward improved mortality.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; bamlanivimab; outcomes; treatment","McGorry","Dennis M","Department of Family Medicine, St. Luke's University Health Network, Bethlehem, Pennsylvania, USA",NA
"1864","34258324","10.1093/ofid/ofab305","The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting.","Bamlanivimab, a monoclonal antibody targeting the spike protein of severe acute respiratory syndrome coronavirus 2, is available for ambulatory treatment of coronavirus disease 2019 (COVID-19). This real-world study confirms the efficacy of bamlanivimab in reducing hospital admissions and emergency department visits among high-risk outpatients with mild to moderate COVID-19 illness and reveals a trend toward improved mortality.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; bamlanivimab; outcomes; treatment","Rahman","Awan","Section of Pulmonary and Critical Care, Department of Medicine, St Luke's University Health Network, Bethlehem, Pennsylvania, USA",NA
"1865","34258324","10.1093/ofid/ofab305","The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting.","Bamlanivimab, a monoclonal antibody targeting the spike protein of severe acute respiratory syndrome coronavirus 2, is available for ambulatory treatment of coronavirus disease 2019 (COVID-19). This real-world study confirms the efficacy of bamlanivimab in reducing hospital admissions and emergency department visits among high-risk outpatients with mild to moderate COVID-19 illness and reveals a trend toward improved mortality.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; bamlanivimab; outcomes; treatment","Stoltzfus","Jill","Graduate Medical Education, Data Management and Outcomes Assessment, St. Luke's University Health Network, Bethlehem, Pennsylvania, USA",NA
"1866","34258324","10.1093/ofid/ofab305","The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting.","Bamlanivimab, a monoclonal antibody targeting the spike protein of severe acute respiratory syndrome coronavirus 2, is available for ambulatory treatment of coronavirus disease 2019 (COVID-19). This real-world study confirms the efficacy of bamlanivimab in reducing hospital admissions and emergency department visits among high-risk outpatients with mild to moderate COVID-19 illness and reveals a trend toward improved mortality.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; bamlanivimab; outcomes; treatment","Jahre","Jeffrey A","Section of Infectious Diseases, Department of Medicine, St. Luke's University Health Network, Bethlehem, Pennsylvania, USA",NA
"1867","34258323","10.1093/ofid/ofab304","A National Public Health Workforce to Control COVID-19 and Address Health Disparities in the United States.","A large, well-trained public health workforce is needed to control coronavirus disease 2019 (COVID-19) in the United States in the short term and to address other disease burdens and health disparities in the long run. As the public health workforce declined following the 2008 financial crisis, many US jurisdictions struggled to hire a sufficient number of staff for roles initially including testing and contact tracing and more recently for vaccination. Ultimately, COVID-19 control will require ","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; contact tracing; public health workforce","Kilmarx","Peter H","Fogarty International Center, National Institutes of Health, Bethesda, Maryland, USA",NA
"1868","34258323","10.1093/ofid/ofab304","A National Public Health Workforce to Control COVID-19 and Address Health Disparities in the United States.","A large, well-trained public health workforce is needed to control coronavirus disease 2019 (COVID-19) in the United States in the short term and to address other disease burdens and health disparities in the long run. As the public health workforce declined following the 2008 financial crisis, many US jurisdictions struggled to hire a sufficient number of staff for roles initially including testing and contact tracing and more recently for vaccination. Ultimately, COVID-19 control will require ","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; contact tracing; public health workforce","Long","Theodore","New York City Health + Hospitals, New York, New York, USA",NA
"1869","34258323","10.1093/ofid/ofab304","A National Public Health Workforce to Control COVID-19 and Address Health Disparities in the United States.","A large, well-trained public health workforce is needed to control coronavirus disease 2019 (COVID-19) in the United States in the short term and to address other disease burdens and health disparities in the long run. As the public health workforce declined following the 2008 financial crisis, many US jurisdictions struggled to hire a sufficient number of staff for roles initially including testing and contact tracing and more recently for vaccination. Ultimately, COVID-19 control will require ","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; contact tracing; public health workforce","Reid","Michael J A","University of California San Francisco, San Francisco, California, USA",NA
"1870","34258322","10.1093/ofid/ofab299","Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.","Immune response after a single dose of BNT162b2 vaccine was markedly increased in subjects with previous severe acute respiratory syndrome coronavirus 2 infection, reaching similar immunoglobulin titers to those elicited by the full 2 doses in naive cases, and increased modestly after the second dose. These data may inform the priority of the boosting dose.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; health care workers; immune response; vaccine","Velasco","María","Infectious Diseases and Research Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain",NA
"1871","34258322","10.1093/ofid/ofab299","Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.","Immune response after a single dose of BNT162b2 vaccine was markedly increased in subjects with previous severe acute respiratory syndrome coronavirus 2 infection, reaching similar immunoglobulin titers to those elicited by the full 2 doses in naive cases, and increased modestly after the second dose. These data may inform the priority of the boosting dose.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; health care workers; immune response; vaccine","Galán","Maria Isabel","Occupational Health Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain",NA
"1872","34258322","10.1093/ofid/ofab299","Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.","Immune response after a single dose of BNT162b2 vaccine was markedly increased in subjects with previous severe acute respiratory syndrome coronavirus 2 infection, reaching similar immunoglobulin titers to those elicited by the full 2 doses in naive cases, and increased modestly after the second dose. These data may inform the priority of the boosting dose.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; health care workers; immune response; vaccine","Casas","Maria Luisa","Laboratory Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain",NA
"1873","34258322","10.1093/ofid/ofab299","Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.","Immune response after a single dose of BNT162b2 vaccine was markedly increased in subjects with previous severe acute respiratory syndrome coronavirus 2 infection, reaching similar immunoglobulin titers to those elicited by the full 2 doses in naive cases, and increased modestly after the second dose. These data may inform the priority of the boosting dose.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; health care workers; immune response; vaccine","Pérez-Fernández","Elia","Research Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain",NA
"1874","34258322","10.1093/ofid/ofab299","Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.","Immune response after a single dose of BNT162b2 vaccine was markedly increased in subjects with previous severe acute respiratory syndrome coronavirus 2 infection, reaching similar immunoglobulin titers to those elicited by the full 2 doses in naive cases, and increased modestly after the second dose. These data may inform the priority of the boosting dose.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; health care workers; immune response; vaccine","Martínez-Ponce","Diana","Occupational Health Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain",NA
"1875","34258322","10.1093/ofid/ofab299","Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.","Immune response after a single dose of BNT162b2 vaccine was markedly increased in subjects with previous severe acute respiratory syndrome coronavirus 2 infection, reaching similar immunoglobulin titers to those elicited by the full 2 doses in naive cases, and increased modestly after the second dose. These data may inform the priority of the boosting dose.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; health care workers; immune response; vaccine","González-Piñeiro","Beatriz","Information System Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain",NA
"1876","34258322","10.1093/ofid/ofab299","Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.","Immune response after a single dose of BNT162b2 vaccine was markedly increased in subjects with previous severe acute respiratory syndrome coronavirus 2 infection, reaching similar immunoglobulin titers to those elicited by the full 2 doses in naive cases, and increased modestly after the second dose. These data may inform the priority of the boosting dose.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; health care workers; immune response; vaccine","Castilla","Virgilio","Hospital Universitario Fundación Alcorcón, Madrid, Spain",NA
"1877","34258322","10.1093/ofid/ofab299","Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.","Immune response after a single dose of BNT162b2 vaccine was markedly increased in subjects with previous severe acute respiratory syndrome coronavirus 2 infection, reaching similar immunoglobulin titers to those elicited by the full 2 doses in naive cases, and increased modestly after the second dose. These data may inform the priority of the boosting dose.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; health care workers; immune response; vaccine","Guijarro","Carlos","Rey Juan Carlos University, Internal Medicine Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain",NA
"1878","34258320","10.1093/ofid/ofab295","Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution.","We report a coronavirus disease 2019 case with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 postdiagnosis. In addition, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treatment.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","CLL; SARS-CoV-2; persistent infection; viral evolution","Monrad","Ida","Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark",NA
"1879","34258320","10.1093/ofid/ofab295","Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution.","We report a coronavirus disease 2019 case with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 postdiagnosis. In addition, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treatment.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","CLL; SARS-CoV-2; persistent infection; viral evolution","Sahlertz","Signe Risgaard","Department of Medicine, Regional Hospital West Jutland, Herning, Denmark",NA
"1880","34258320","10.1093/ofid/ofab295","Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution.","We report a coronavirus disease 2019 case with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 postdiagnosis. In addition, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treatment.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","CLL; SARS-CoV-2; persistent infection; viral evolution","Nielsen","Stine Sofie Frank","Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark",NA
"1881","34258320","10.1093/ofid/ofab295","Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution.","We report a coronavirus disease 2019 case with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 postdiagnosis. In addition, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treatment.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","CLL; SARS-CoV-2; persistent infection; viral evolution","Pedersen","Louise Ørnskov","Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark",NA
"1882","34258320","10.1093/ofid/ofab295","Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution.","We report a coronavirus disease 2019 case with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 postdiagnosis. In addition, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treatment.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","CLL; SARS-CoV-2; persistent infection; viral evolution","Petersen","Mikkel Steen","Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark",NA
"1883","34258320","10.1093/ofid/ofab295","Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution.","We report a coronavirus disease 2019 case with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 postdiagnosis. In addition, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treatment.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","CLL; SARS-CoV-2; persistent infection; viral evolution","Kobel","Carl Mathias","Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark",NA
"1884","34258320","10.1093/ofid/ofab295","Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution.","We report a coronavirus disease 2019 case with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 postdiagnosis. In addition, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treatment.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","CLL; SARS-CoV-2; persistent infection; viral evolution","Tarpgaard","Irene Harder","Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark",NA
"1885","34258320","10.1093/ofid/ofab295","Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution.","We report a coronavirus disease 2019 case with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 postdiagnosis. In addition, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treatment.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","CLL; SARS-CoV-2; persistent infection; viral evolution","Storgaard","Merete","Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark",NA
"1886","34258320","10.1093/ofid/ofab295","Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution.","We report a coronavirus disease 2019 case with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 postdiagnosis. In addition, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treatment.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","CLL; SARS-CoV-2; persistent infection; viral evolution","Mortensen","Klaus Leth","Department of Medicine, Regional Hospital West Jutland, Herning, Denmark",NA
"1887","34258320","10.1093/ofid/ofab295","Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution.","We report a coronavirus disease 2019 case with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 postdiagnosis. In addition, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treatment.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","CLL; SARS-CoV-2; persistent infection; viral evolution","Schleimann","Mariane H","Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark",NA
"1888","34258320","10.1093/ofid/ofab295","Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution.","We report a coronavirus disease 2019 case with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 postdiagnosis. In addition, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treatment.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","CLL; SARS-CoV-2; persistent infection; viral evolution","Tolstrup","Martin","Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark",NA
"1889","34258320","10.1093/ofid/ofab295","Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution.","We report a coronavirus disease 2019 case with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 postdiagnosis. In addition, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treatment.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","CLL; SARS-CoV-2; persistent infection; viral evolution","Vibholm","Line K","Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark",NA
"1890","34258319","10.1093/ofid/ofab292","Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients.","Coronavirus disease 2019 (COVID-19) continues to stress the health care system. Neutralizing monoclonal antibodies (mAbs) were effective in reducing COVID-19-related hospitalizations and emergency department (ED) visits in their respective clinical trials. However, these results have yet to be reproduced in a practical setting following implementation of current US Food and Drug Administration (FDA) guidance. This retrospective cohort study included outpatients with confirmed COVID-19 infection,","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; casirivimab/imdevimab; monoclonal antibodies","Piccicacco","Nicholas","Department of Pharmacy, Tampa General Hospital, Tampa, Florida, USA",NA
"1891","34258319","10.1093/ofid/ofab292","Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients.","Coronavirus disease 2019 (COVID-19) continues to stress the health care system. Neutralizing monoclonal antibodies (mAbs) were effective in reducing COVID-19-related hospitalizations and emergency department (ED) visits in their respective clinical trials. However, these results have yet to be reproduced in a practical setting following implementation of current US Food and Drug Administration (FDA) guidance. This retrospective cohort study included outpatients with confirmed COVID-19 infection,","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; casirivimab/imdevimab; monoclonal antibodies","Zeitler","Kristen","Department of Pharmacy, Tampa General Hospital, Tampa, Florida, USA",NA
"1892","34258319","10.1093/ofid/ofab292","Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients.","Coronavirus disease 2019 (COVID-19) continues to stress the health care system. Neutralizing monoclonal antibodies (mAbs) were effective in reducing COVID-19-related hospitalizations and emergency department (ED) visits in their respective clinical trials. However, these results have yet to be reproduced in a practical setting following implementation of current US Food and Drug Administration (FDA) guidance. This retrospective cohort study included outpatients with confirmed COVID-19 infection,","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; casirivimab/imdevimab; monoclonal antibodies","Montero","Jose","Division of Infectious Diseases, Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, Florida, USA",NA
"1893","34258319","10.1093/ofid/ofab292","Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients.","Coronavirus disease 2019 (COVID-19) continues to stress the health care system. Neutralizing monoclonal antibodies (mAbs) were effective in reducing COVID-19-related hospitalizations and emergency department (ED) visits in their respective clinical trials. However, these results have yet to be reproduced in a practical setting following implementation of current US Food and Drug Administration (FDA) guidance. This retrospective cohort study included outpatients with confirmed COVID-19 infection,","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; casirivimab/imdevimab; monoclonal antibodies","Kumar","Ambuj","Division of General Medicine, Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, Florida, USA",NA
"1894","34258319","10.1093/ofid/ofab292","Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients.","Coronavirus disease 2019 (COVID-19) continues to stress the health care system. Neutralizing monoclonal antibodies (mAbs) were effective in reducing COVID-19-related hospitalizations and emergency department (ED) visits in their respective clinical trials. However, these results have yet to be reproduced in a practical setting following implementation of current US Food and Drug Administration (FDA) guidance. This retrospective cohort study included outpatients with confirmed COVID-19 infection,","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; casirivimab/imdevimab; monoclonal antibodies","Lakshmi","Seetha","Division of Infectious Diseases, Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, Florida, USA",NA
"1895","34258319","10.1093/ofid/ofab292","Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients.","Coronavirus disease 2019 (COVID-19) continues to stress the health care system. Neutralizing monoclonal antibodies (mAbs) were effective in reducing COVID-19-related hospitalizations and emergency department (ED) visits in their respective clinical trials. However, these results have yet to be reproduced in a practical setting following implementation of current US Food and Drug Administration (FDA) guidance. This retrospective cohort study included outpatients with confirmed COVID-19 infection,","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; casirivimab/imdevimab; monoclonal antibodies","Kim","Kami","Division of Infectious Diseases, Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, Florida, USA",NA
"1896","34258319","10.1093/ofid/ofab292","Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients.","Coronavirus disease 2019 (COVID-19) continues to stress the health care system. Neutralizing monoclonal antibodies (mAbs) were effective in reducing COVID-19-related hospitalizations and emergency department (ED) visits in their respective clinical trials. However, these results have yet to be reproduced in a practical setting following implementation of current US Food and Drug Administration (FDA) guidance. This retrospective cohort study included outpatients with confirmed COVID-19 infection,","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; casirivimab/imdevimab; monoclonal antibodies","Wein","David","Department of Emergency Medicine, Tampa General Hospital, Tampa, Florida, USA",NA
"1897","34258319","10.1093/ofid/ofab292","Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients.","Coronavirus disease 2019 (COVID-19) continues to stress the health care system. Neutralizing monoclonal antibodies (mAbs) were effective in reducing COVID-19-related hospitalizations and emergency department (ED) visits in their respective clinical trials. However, these results have yet to be reproduced in a practical setting following implementation of current US Food and Drug Administration (FDA) guidance. This retrospective cohort study included outpatients with confirmed COVID-19 infection,","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; casirivimab/imdevimab; monoclonal antibodies","Vasey","Tiffany","Department of Emergency Medicine, Tampa General Hospital, Tampa, Florida, USA",NA
"1898","34258319","10.1093/ofid/ofab292","Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients.","Coronavirus disease 2019 (COVID-19) continues to stress the health care system. Neutralizing monoclonal antibodies (mAbs) were effective in reducing COVID-19-related hospitalizations and emergency department (ED) visits in their respective clinical trials. However, these results have yet to be reproduced in a practical setting following implementation of current US Food and Drug Administration (FDA) guidance. This retrospective cohort study included outpatients with confirmed COVID-19 infection,","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; casirivimab/imdevimab; monoclonal antibodies","Vasey","Matthew","Department of Emergency Medicine, Tampa General Hospital, Tampa, Florida, USA",NA
"1899","34258319","10.1093/ofid/ofab292","Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients.","Coronavirus disease 2019 (COVID-19) continues to stress the health care system. Neutralizing monoclonal antibodies (mAbs) were effective in reducing COVID-19-related hospitalizations and emergency department (ED) visits in their respective clinical trials. However, these results have yet to be reproduced in a practical setting following implementation of current US Food and Drug Administration (FDA) guidance. This retrospective cohort study included outpatients with confirmed COVID-19 infection,","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; bamlanivimab; casirivimab/imdevimab; monoclonal antibodies","Oxner","Asa","Division of General Medicine, Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, Florida, USA",NA
"1900","34258316","10.1093/ofid/ofab284","Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis.","Statins up-regulate angiotensin-converting enzyme 2, the receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while also exhibiting pleiotropic antiviral, antithrombotic, and anti-inflammatory properties. Uncertainties exist about their effect on the course of SARS-CoV-2 infection. We sought to systematically review the literature and perform a meta-analysis to examine the association between prior statin use and outcomes of patients with coronavirus disease 2019 (COVID-19).","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; meta-analysis; mortality; statins","Yetmar","Zachary A","Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA",NA
"1901","34258316","10.1093/ofid/ofab284","Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis.","Statins up-regulate angiotensin-converting enzyme 2, the receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while also exhibiting pleiotropic antiviral, antithrombotic, and anti-inflammatory properties. Uncertainties exist about their effect on the course of SARS-CoV-2 infection. We sought to systematically review the literature and perform a meta-analysis to examine the association between prior statin use and outcomes of patients with coronavirus disease 2019 (COVID-19).","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; meta-analysis; mortality; statins","Chesdachai","Supavit","Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA",NA
"1902","34258316","10.1093/ofid/ofab284","Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis.","Statins up-regulate angiotensin-converting enzyme 2, the receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while also exhibiting pleiotropic antiviral, antithrombotic, and anti-inflammatory properties. Uncertainties exist about their effect on the course of SARS-CoV-2 infection. We sought to systematically review the literature and perform a meta-analysis to examine the association between prior statin use and outcomes of patients with coronavirus disease 2019 (COVID-19).","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; meta-analysis; mortality; statins","Kashour","Tarek","Department of Cardiac Sciences, King Fahad Cardiac Center, King Saud University Medical City, Riyadh, Saudi Arabia",NA
"1903","34258316","10.1093/ofid/ofab284","Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis.","Statins up-regulate angiotensin-converting enzyme 2, the receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while also exhibiting pleiotropic antiviral, antithrombotic, and anti-inflammatory properties. Uncertainties exist about their effect on the course of SARS-CoV-2 infection. We sought to systematically review the literature and perform a meta-analysis to examine the association between prior statin use and outcomes of patients with coronavirus disease 2019 (COVID-19).","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; meta-analysis; mortality; statins","Riaz","Muhammad","Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar",NA
"1904","34258316","10.1093/ofid/ofab284","Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis.","Statins up-regulate angiotensin-converting enzyme 2, the receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while also exhibiting pleiotropic antiviral, antithrombotic, and anti-inflammatory properties. Uncertainties exist about their effect on the course of SARS-CoV-2 infection. We sought to systematically review the literature and perform a meta-analysis to examine the association between prior statin use and outcomes of patients with coronavirus disease 2019 (COVID-19).","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; meta-analysis; mortality; statins","Gerberi","Danielle J","Mayo Clinic Libraries, Mayo Clinic, Rochester, Minnesota, USA",NA
"1905","34258316","10.1093/ofid/ofab284","Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis.","Statins up-regulate angiotensin-converting enzyme 2, the receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while also exhibiting pleiotropic antiviral, antithrombotic, and anti-inflammatory properties. Uncertainties exist about their effect on the course of SARS-CoV-2 infection. We sought to systematically review the literature and perform a meta-analysis to examine the association between prior statin use and outcomes of patients with coronavirus disease 2019 (COVID-19).","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; meta-analysis; mortality; statins","Badley","Andrew D","Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA",NA
"1906","34258316","10.1093/ofid/ofab284","Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis.","Statins up-regulate angiotensin-converting enzyme 2, the receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while also exhibiting pleiotropic antiviral, antithrombotic, and anti-inflammatory properties. Uncertainties exist about their effect on the course of SARS-CoV-2 infection. We sought to systematically review the literature and perform a meta-analysis to examine the association between prior statin use and outcomes of patients with coronavirus disease 2019 (COVID-19).","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; meta-analysis; mortality; statins","Berbari","Elie F","Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA",NA
"1907","34258316","10.1093/ofid/ofab284","Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis.","Statins up-regulate angiotensin-converting enzyme 2, the receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while also exhibiting pleiotropic antiviral, antithrombotic, and anti-inflammatory properties. Uncertainties exist about their effect on the course of SARS-CoV-2 infection. We sought to systematically review the literature and perform a meta-analysis to examine the association between prior statin use and outcomes of patients with coronavirus disease 2019 (COVID-19).","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; meta-analysis; mortality; statins","Tleyjeh","Imad M","Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA",NA
"1908","34258315","10.1093/ofid/ofab275","Visceral Adiposity and Severe COVID-19 Disease: Application of an Artificial Intelligence Algorithm to Improve Clinical Risk Prediction.","Obesity has been linked to severe clinical outcomes among people who are hospitalized with coronavirus disease 2019 (COVID-19). We tested the hypothesis that visceral adipose tissue (VAT) is associated with severe outcomes in patients hospitalized with COVID-19, independent of body mass index (BMI). We analyzed data from the Massachusetts General Hospital COVID-19 Data Registry, which included patients admitted with polymerase chain reaction-confirmed severe acute respiratory syndrome coronaviru","2021","07","16","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 disease; artificial intelligence; visceral adiposity","Goehler","Alexander","Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Boston, Massachusetts, USA",NA
"1909","34258315","10.1093/ofid/ofab275","Visceral Adiposity and Severe COVID-19 Disease: Application of an Artificial Intelligence Algorithm to Improve Clinical Risk Prediction.","Obesity has been linked to severe clinical outcomes among people who are hospitalized with coronavirus disease 2019 (COVID-19). We tested the hypothesis that visceral adipose tissue (VAT) is associated with severe outcomes in patients hospitalized with COVID-19, independent of body mass index (BMI). We analyzed data from the Massachusetts General Hospital COVID-19 Data Registry, which included patients admitted with polymerase chain reaction-confirmed severe acute respiratory syndrome coronaviru","2021","07","16","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 disease; artificial intelligence; visceral adiposity","Hsu","Tzu-Ming Harry","Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Boston, Massachusetts, USA",NA
"1910","34258315","10.1093/ofid/ofab275","Visceral Adiposity and Severe COVID-19 Disease: Application of an Artificial Intelligence Algorithm to Improve Clinical Risk Prediction.","Obesity has been linked to severe clinical outcomes among people who are hospitalized with coronavirus disease 2019 (COVID-19). We tested the hypothesis that visceral adipose tissue (VAT) is associated with severe outcomes in patients hospitalized with COVID-19, independent of body mass index (BMI). We analyzed data from the Massachusetts General Hospital COVID-19 Data Registry, which included patients admitted with polymerase chain reaction-confirmed severe acute respiratory syndrome coronaviru","2021","07","16","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 disease; artificial intelligence; visceral adiposity","Seiglie","Jacqueline A","Diabetes Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA",NA
"1911","34258315","10.1093/ofid/ofab275","Visceral Adiposity and Severe COVID-19 Disease: Application of an Artificial Intelligence Algorithm to Improve Clinical Risk Prediction.","Obesity has been linked to severe clinical outcomes among people who are hospitalized with coronavirus disease 2019 (COVID-19). We tested the hypothesis that visceral adipose tissue (VAT) is associated with severe outcomes in patients hospitalized with COVID-19, independent of body mass index (BMI). We analyzed data from the Massachusetts General Hospital COVID-19 Data Registry, which included patients admitted with polymerase chain reaction-confirmed severe acute respiratory syndrome coronaviru","2021","07","16","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 disease; artificial intelligence; visceral adiposity","Siedner","Mark J","Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA",NA
"1912","34258315","10.1093/ofid/ofab275","Visceral Adiposity and Severe COVID-19 Disease: Application of an Artificial Intelligence Algorithm to Improve Clinical Risk Prediction.","Obesity has been linked to severe clinical outcomes among people who are hospitalized with coronavirus disease 2019 (COVID-19). We tested the hypothesis that visceral adipose tissue (VAT) is associated with severe outcomes in patients hospitalized with COVID-19, independent of body mass index (BMI). We analyzed data from the Massachusetts General Hospital COVID-19 Data Registry, which included patients admitted with polymerase chain reaction-confirmed severe acute respiratory syndrome coronaviru","2021","07","16","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 disease; artificial intelligence; visceral adiposity","Lo","Janet","Metabolism Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA",NA
"1913","34258315","10.1093/ofid/ofab275","Visceral Adiposity and Severe COVID-19 Disease: Application of an Artificial Intelligence Algorithm to Improve Clinical Risk Prediction.","Obesity has been linked to severe clinical outcomes among people who are hospitalized with coronavirus disease 2019 (COVID-19). We tested the hypothesis that visceral adipose tissue (VAT) is associated with severe outcomes in patients hospitalized with COVID-19, independent of body mass index (BMI). We analyzed data from the Massachusetts General Hospital COVID-19 Data Registry, which included patients admitted with polymerase chain reaction-confirmed severe acute respiratory syndrome coronaviru","2021","07","16","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 disease; artificial intelligence; visceral adiposity","Triant","Virginia","Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA",NA
"1914","34258315","10.1093/ofid/ofab275","Visceral Adiposity and Severe COVID-19 Disease: Application of an Artificial Intelligence Algorithm to Improve Clinical Risk Prediction.","Obesity has been linked to severe clinical outcomes among people who are hospitalized with coronavirus disease 2019 (COVID-19). We tested the hypothesis that visceral adipose tissue (VAT) is associated with severe outcomes in patients hospitalized with COVID-19, independent of body mass index (BMI). We analyzed data from the Massachusetts General Hospital COVID-19 Data Registry, which included patients admitted with polymerase chain reaction-confirmed severe acute respiratory syndrome coronaviru","2021","07","16","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 disease; artificial intelligence; visceral adiposity","Hsu","John","Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA",NA
"1915","34258315","10.1093/ofid/ofab275","Visceral Adiposity and Severe COVID-19 Disease: Application of an Artificial Intelligence Algorithm to Improve Clinical Risk Prediction.","Obesity has been linked to severe clinical outcomes among people who are hospitalized with coronavirus disease 2019 (COVID-19). We tested the hypothesis that visceral adipose tissue (VAT) is associated with severe outcomes in patients hospitalized with COVID-19, independent of body mass index (BMI). We analyzed data from the Massachusetts General Hospital COVID-19 Data Registry, which included patients admitted with polymerase chain reaction-confirmed severe acute respiratory syndrome coronaviru","2021","07","16","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 disease; artificial intelligence; visceral adiposity","Foulkes","Andrea","The Biostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA",NA
"1916","34258315","10.1093/ofid/ofab275","Visceral Adiposity and Severe COVID-19 Disease: Application of an Artificial Intelligence Algorithm to Improve Clinical Risk Prediction.","Obesity has been linked to severe clinical outcomes among people who are hospitalized with coronavirus disease 2019 (COVID-19). We tested the hypothesis that visceral adipose tissue (VAT) is associated with severe outcomes in patients hospitalized with COVID-19, independent of body mass index (BMI). We analyzed data from the Massachusetts General Hospital COVID-19 Data Registry, which included patients admitted with polymerase chain reaction-confirmed severe acute respiratory syndrome coronaviru","2021","07","16","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 disease; artificial intelligence; visceral adiposity","Bassett","Ingrid","Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA",NA
"1917","34258315","10.1093/ofid/ofab275","Visceral Adiposity and Severe COVID-19 Disease: Application of an Artificial Intelligence Algorithm to Improve Clinical Risk Prediction.","Obesity has been linked to severe clinical outcomes among people who are hospitalized with coronavirus disease 2019 (COVID-19). We tested the hypothesis that visceral adipose tissue (VAT) is associated with severe outcomes in patients hospitalized with COVID-19, independent of body mass index (BMI). We analyzed data from the Massachusetts General Hospital COVID-19 Data Registry, which included patients admitted with polymerase chain reaction-confirmed severe acute respiratory syndrome coronaviru","2021","07","16","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 disease; artificial intelligence; visceral adiposity","Khorasani","Ramin","Center for Evidence-Based Imaging, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA",NA
"1918","34258315","10.1093/ofid/ofab275","Visceral Adiposity and Severe COVID-19 Disease: Application of an Artificial Intelligence Algorithm to Improve Clinical Risk Prediction.","Obesity has been linked to severe clinical outcomes among people who are hospitalized with coronavirus disease 2019 (COVID-19). We tested the hypothesis that visceral adipose tissue (VAT) is associated with severe outcomes in patients hospitalized with COVID-19, independent of body mass index (BMI). We analyzed data from the Massachusetts General Hospital COVID-19 Data Registry, which included patients admitted with polymerase chain reaction-confirmed severe acute respiratory syndrome coronaviru","2021","07","16","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 disease; artificial intelligence; visceral adiposity","Wexler","Deborah J","Diabetes Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA",NA
"1919","34258315","10.1093/ofid/ofab275","Visceral Adiposity and Severe COVID-19 Disease: Application of an Artificial Intelligence Algorithm to Improve Clinical Risk Prediction.","Obesity has been linked to severe clinical outcomes among people who are hospitalized with coronavirus disease 2019 (COVID-19). We tested the hypothesis that visceral adipose tissue (VAT) is associated with severe outcomes in patients hospitalized with COVID-19, independent of body mass index (BMI). We analyzed data from the Massachusetts General Hospital COVID-19 Data Registry, which included patients admitted with polymerase chain reaction-confirmed severe acute respiratory syndrome coronaviru","2021","07","16","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 disease; artificial intelligence; visceral adiposity","Szolovits","Peter","Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Boston, Massachusetts, USA",NA
"1920","34258315","10.1093/ofid/ofab275","Visceral Adiposity and Severe COVID-19 Disease: Application of an Artificial Intelligence Algorithm to Improve Clinical Risk Prediction.","Obesity has been linked to severe clinical outcomes among people who are hospitalized with coronavirus disease 2019 (COVID-19). We tested the hypothesis that visceral adipose tissue (VAT) is associated with severe outcomes in patients hospitalized with COVID-19, independent of body mass index (BMI). We analyzed data from the Massachusetts General Hospital COVID-19 Data Registry, which included patients admitted with polymerase chain reaction-confirmed severe acute respiratory syndrome coronaviru","2021","07","16","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 disease; artificial intelligence; visceral adiposity","Meigs","James B","Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA",NA
"1921","34258315","10.1093/ofid/ofab275","Visceral Adiposity and Severe COVID-19 Disease: Application of an Artificial Intelligence Algorithm to Improve Clinical Risk Prediction.","Obesity has been linked to severe clinical outcomes among people who are hospitalized with coronavirus disease 2019 (COVID-19). We tested the hypothesis that visceral adipose tissue (VAT) is associated with severe outcomes in patients hospitalized with COVID-19, independent of body mass index (BMI). We analyzed data from the Massachusetts General Hospital COVID-19 Data Registry, which included patients admitted with polymerase chain reaction-confirmed severe acute respiratory syndrome coronaviru","2021","07","16","Open Forum Infect Dis","Open forum infectious diseases","COVID-19 disease; artificial intelligence; visceral adiposity","Manne-Goehler","Jennifer","Medical Practice Evaluation Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA",NA
"1922","34258312","10.1093/ofid/ofab246","All That Coughs Is Not COVID-19: A Delayed Diagnosis of Disseminated Coccidioidomycosis Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Coccidioides immitis (and Coccidioides posadasii) are endemic fungi of the southwestern United States and northern Mexico. Uncomplicated, symptomatic Coccidioides infection most commonly causes a self-limited pneumonia; however, immunocompromised patients can manifest severe pneumonia with an additional risk of dissemination to bone, joints, soft tissues, and in the most severe cases, the central nervous system. In 2020, clinicians were challenged with a previously unseen vo","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; coccidiodomycosis; coinfection; valley fever","Chen","Joshua C","Division of Infectious Disease, University of Southern California, Los Angeles, California, USA",NA
"1923","34258312","10.1093/ofid/ofab246","All That Coughs Is Not COVID-19: A Delayed Diagnosis of Disseminated Coccidioidomycosis Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Coccidioides immitis (and Coccidioides posadasii) are endemic fungi of the southwestern United States and northern Mexico. Uncomplicated, symptomatic Coccidioides infection most commonly causes a self-limited pneumonia; however, immunocompromised patients can manifest severe pneumonia with an additional risk of dissemination to bone, joints, soft tissues, and in the most severe cases, the central nervous system. In 2020, clinicians were challenged with a previously unseen vo","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; coccidiodomycosis; coinfection; valley fever","Wong","Darren","Division of Infectious Disease, University of Southern California, Los Angeles, California, USA",NA
"1924","34258312","10.1093/ofid/ofab246","All That Coughs Is Not COVID-19: A Delayed Diagnosis of Disseminated Coccidioidomycosis Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Coccidioides immitis (and Coccidioides posadasii) are endemic fungi of the southwestern United States and northern Mexico. Uncomplicated, symptomatic Coccidioides infection most commonly causes a self-limited pneumonia; however, immunocompromised patients can manifest severe pneumonia with an additional risk of dissemination to bone, joints, soft tissues, and in the most severe cases, the central nervous system. In 2020, clinicians were challenged with a previously unseen vo","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; coccidiodomycosis; coinfection; valley fever","Rabi","Sina","Department of Dermatology, University of Southern California, Los Angeles, California, USA",NA
"1925","34258312","10.1093/ofid/ofab246","All That Coughs Is Not COVID-19: A Delayed Diagnosis of Disseminated Coccidioidomycosis Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Coccidioides immitis (and Coccidioides posadasii) are endemic fungi of the southwestern United States and northern Mexico. Uncomplicated, symptomatic Coccidioides infection most commonly causes a self-limited pneumonia; however, immunocompromised patients can manifest severe pneumonia with an additional risk of dissemination to bone, joints, soft tissues, and in the most severe cases, the central nervous system. In 2020, clinicians were challenged with a previously unseen vo","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; coccidiodomycosis; coinfection; valley fever","Worswick","Scott","Department of Dermatology, University of Southern California, Los Angeles, California, USA",NA
"1926","34258312","10.1093/ofid/ofab246","All That Coughs Is Not COVID-19: A Delayed Diagnosis of Disseminated Coccidioidomycosis Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Coccidioides immitis (and Coccidioides posadasii) are endemic fungi of the southwestern United States and northern Mexico. Uncomplicated, symptomatic Coccidioides infection most commonly causes a self-limited pneumonia; however, immunocompromised patients can manifest severe pneumonia with an additional risk of dissemination to bone, joints, soft tissues, and in the most severe cases, the central nervous system. In 2020, clinicians were challenged with a previously unseen vo","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; coccidiodomycosis; coinfection; valley fever","DeClerck","Brittney","Department of Pathology, University of Southern California, Los Angeles, California, USA",NA
"1927","34258312","10.1093/ofid/ofab246","All That Coughs Is Not COVID-19: A Delayed Diagnosis of Disseminated Coccidioidomycosis Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection.","Coccidioides immitis (and Coccidioides posadasii) are endemic fungi of the southwestern United States and northern Mexico. Uncomplicated, symptomatic Coccidioides infection most commonly causes a self-limited pneumonia; however, immunocompromised patients can manifest severe pneumonia with an additional risk of dissemination to bone, joints, soft tissues, and in the most severe cases, the central nervous system. In 2020, clinicians were challenged with a previously unseen vo","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; coccidiodomycosis; coinfection; valley fever","Gibb","Jean","Division of Infectious Disease, University of Southern California, Los Angeles, California, USA",NA
"1928","34258311","10.1093/ofid/ofab239","Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.","Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complements nucleic acid tests for patient diagnosis and enables monitoring of population susceptibility to inform the coronavirus disease 2019 (COVID-19) pandemic response. It is important to understand the reliability of assays with different antigen or antibody targets to detect humoral immunity after SARS-CoV-2 infection and to understand how antibody (Ab) binding assays compare to those detecting neutralizi","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","ELISA; SARS-CoV-2 antibodies; humoral immune response; neutralization test; serology","Nicholson","Suellen","Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"1929","34258311","10.1093/ofid/ofab239","Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.","Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complements nucleic acid tests for patient diagnosis and enables monitoring of population susceptibility to inform the coronavirus disease 2019 (COVID-19) pandemic response. It is important to understand the reliability of assays with different antigen or antibody targets to detect humoral immunity after SARS-CoV-2 infection and to understand how antibody (Ab) binding assays compare to those detecting neutralizi","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","ELISA; SARS-CoV-2 antibodies; humoral immune response; neutralization test; serology","Karapanagiotidis","Theo","Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"1930","34258311","10.1093/ofid/ofab239","Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.","Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complements nucleic acid tests for patient diagnosis and enables monitoring of population susceptibility to inform the coronavirus disease 2019 (COVID-19) pandemic response. It is important to understand the reliability of assays with different antigen or antibody targets to detect humoral immunity after SARS-CoV-2 infection and to understand how antibody (Ab) binding assays compare to those detecting neutralizi","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","ELISA; SARS-CoV-2 antibodies; humoral immune response; neutralization test; serology","Khvorov","Arseniy","WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"1931","34258311","10.1093/ofid/ofab239","Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.","Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complements nucleic acid tests for patient diagnosis and enables monitoring of population susceptibility to inform the coronavirus disease 2019 (COVID-19) pandemic response. It is important to understand the reliability of assays with different antigen or antibody targets to detect humoral immunity after SARS-CoV-2 infection and to understand how antibody (Ab) binding assays compare to those detecting neutralizi","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","ELISA; SARS-CoV-2 antibodies; humoral immune response; neutralization test; serology","Douros","Celia","Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"1932","34258311","10.1093/ofid/ofab239","Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.","Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complements nucleic acid tests for patient diagnosis and enables monitoring of population susceptibility to inform the coronavirus disease 2019 (COVID-19) pandemic response. It is important to understand the reliability of assays with different antigen or antibody targets to detect humoral immunity after SARS-CoV-2 infection and to understand how antibody (Ab) binding assays compare to those detecting neutralizi","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","ELISA; SARS-CoV-2 antibodies; humoral immune response; neutralization test; serology","Mordant","Francesca","Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"1933","34258311","10.1093/ofid/ofab239","Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.","Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complements nucleic acid tests for patient diagnosis and enables monitoring of population susceptibility to inform the coronavirus disease 2019 (COVID-19) pandemic response. It is important to understand the reliability of assays with different antigen or antibody targets to detect humoral immunity after SARS-CoV-2 infection and to understand how antibody (Ab) binding assays compare to those detecting neutralizi","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","ELISA; SARS-CoV-2 antibodies; humoral immune response; neutralization test; serology","Bond","Katherine","Department of Microbiology, Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"1934","34258311","10.1093/ofid/ofab239","Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.","Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complements nucleic acid tests for patient diagnosis and enables monitoring of population susceptibility to inform the coronavirus disease 2019 (COVID-19) pandemic response. It is important to understand the reliability of assays with different antigen or antibody targets to detect humoral immunity after SARS-CoV-2 infection and to understand how antibody (Ab) binding assays compare to those detecting neutralizi","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","ELISA; SARS-CoV-2 antibodies; humoral immune response; neutralization test; serology","Druce","Julian","Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"1935","34258311","10.1093/ofid/ofab239","Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.","Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complements nucleic acid tests for patient diagnosis and enables monitoring of population susceptibility to inform the coronavirus disease 2019 (COVID-19) pandemic response. It is important to understand the reliability of assays with different antigen or antibody targets to detect humoral immunity after SARS-CoV-2 infection and to understand how antibody (Ab) binding assays compare to those detecting neutralizi","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","ELISA; SARS-CoV-2 antibodies; humoral immune response; neutralization test; serology","Williamson","Deborah A","Department of Microbiology, Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"1936","34258311","10.1093/ofid/ofab239","Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.","Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complements nucleic acid tests for patient diagnosis and enables monitoring of population susceptibility to inform the coronavirus disease 2019 (COVID-19) pandemic response. It is important to understand the reliability of assays with different antigen or antibody targets to detect humoral immunity after SARS-CoV-2 infection and to understand how antibody (Ab) binding assays compare to those detecting neutralizi","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","ELISA; SARS-CoV-2 antibodies; humoral immune response; neutralization test; serology","Purcell","Damian","Department of Microbiology, Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"1937","34258311","10.1093/ofid/ofab239","Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.","Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complements nucleic acid tests for patient diagnosis and enables monitoring of population susceptibility to inform the coronavirus disease 2019 (COVID-19) pandemic response. It is important to understand the reliability of assays with different antigen or antibody targets to detect humoral immunity after SARS-CoV-2 infection and to understand how antibody (Ab) binding assays compare to those detecting neutralizi","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","ELISA; SARS-CoV-2 antibodies; humoral immune response; neutralization test; serology","Lewin","Sharon R","The Peter Doherty Institute for Infection and Immunity, Royal Melbourne Hospital and The University of Melbourne, Melbourne, Australia",NA
"1938","34258311","10.1093/ofid/ofab239","Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.","Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complements nucleic acid tests for patient diagnosis and enables monitoring of population susceptibility to inform the coronavirus disease 2019 (COVID-19) pandemic response. It is important to understand the reliability of assays with different antigen or antibody targets to detect humoral immunity after SARS-CoV-2 infection and to understand how antibody (Ab) binding assays compare to those detecting neutralizi","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","ELISA; SARS-CoV-2 antibodies; humoral immune response; neutralization test; serology","Sullivan","Sheena","WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"1939","34258311","10.1093/ofid/ofab239","Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.","Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complements nucleic acid tests for patient diagnosis and enables monitoring of population susceptibility to inform the coronavirus disease 2019 (COVID-19) pandemic response. It is important to understand the reliability of assays with different antigen or antibody targets to detect humoral immunity after SARS-CoV-2 infection and to understand how antibody (Ab) binding assays compare to those detecting neutralizi","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","ELISA; SARS-CoV-2 antibodies; humoral immune response; neutralization test; serology","Subbarao","Kanta","Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"1940","34258311","10.1093/ofid/ofab239","Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.","Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complements nucleic acid tests for patient diagnosis and enables monitoring of population susceptibility to inform the coronavirus disease 2019 (COVID-19) pandemic response. It is important to understand the reliability of assays with different antigen or antibody targets to detect humoral immunity after SARS-CoV-2 infection and to understand how antibody (Ab) binding assays compare to those detecting neutralizi","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","ELISA; SARS-CoV-2 antibodies; humoral immune response; neutralization test; serology","Catton","Mike","Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"1941","34258310","10.1093/ofid/ofab176","Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis.","We describe a case of prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a patient receiving ocrelizumab for multiple sclerosis. Viral RNA shedding, signs, and symptoms persisted for 69 days with resolution after administration of convalescent plasma and antiviral therapy. This case suggests risk for persistent SARS-CoV-2 infection in patients treated with anti-CD-20 monoclonal antibodies and supports a role for humoral immunity in disease resolution.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; humoral immunity; ocrelizumab","Gibson","Elena G","Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA",NA
"1942","34258310","10.1093/ofid/ofab176","Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis.","We describe a case of prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a patient receiving ocrelizumab for multiple sclerosis. Viral RNA shedding, signs, and symptoms persisted for 69 days with resolution after administration of convalescent plasma and antiviral therapy. This case suggests risk for persistent SARS-CoV-2 infection in patients treated with anti-CD-20 monoclonal antibodies and supports a role for humoral immunity in disease resolution.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; humoral immunity; ocrelizumab","Pender","Melissa","Division of Infectious Diseases, Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA",NA
"1943","34258310","10.1093/ofid/ofab176","Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis.","We describe a case of prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a patient receiving ocrelizumab for multiple sclerosis. Viral RNA shedding, signs, and symptoms persisted for 69 days with resolution after administration of convalescent plasma and antiviral therapy. This case suggests risk for persistent SARS-CoV-2 infection in patients treated with anti-CD-20 monoclonal antibodies and supports a role for humoral immunity in disease resolution.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; humoral immunity; ocrelizumab","Angerbauer","Michael","School of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA",NA
"1944","34258310","10.1093/ofid/ofab176","Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis.","We describe a case of prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a patient receiving ocrelizumab for multiple sclerosis. Viral RNA shedding, signs, and symptoms persisted for 69 days with resolution after administration of convalescent plasma and antiviral therapy. This case suggests risk for persistent SARS-CoV-2 infection in patients treated with anti-CD-20 monoclonal antibodies and supports a role for humoral immunity in disease resolution.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; humoral immunity; ocrelizumab","Cook","Craig","Pulmonary and Critical Care, University of Utah School of Medicine, Salt Lake City, Utah, USA",NA
"1945","34258310","10.1093/ofid/ofab176","Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis.","We describe a case of prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a patient receiving ocrelizumab for multiple sclerosis. Viral RNA shedding, signs, and symptoms persisted for 69 days with resolution after administration of convalescent plasma and antiviral therapy. This case suggests risk for persistent SARS-CoV-2 infection in patients treated with anti-CD-20 monoclonal antibodies and supports a role for humoral immunity in disease resolution.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; humoral immunity; ocrelizumab","Jones","Barbara","Pulmonary and Critical Care, University of Utah School of Medicine, Salt Lake City, Utah, USA",NA
"1946","34258310","10.1093/ofid/ofab176","Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis.","We describe a case of prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a patient receiving ocrelizumab for multiple sclerosis. Viral RNA shedding, signs, and symptoms persisted for 69 days with resolution after administration of convalescent plasma and antiviral therapy. This case suggests risk for persistent SARS-CoV-2 infection in patients treated with anti-CD-20 monoclonal antibodies and supports a role for humoral immunity in disease resolution.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; humoral immunity; ocrelizumab","Spivak","Adam M","Division of Infectious Diseases, Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA",NA
"1947","34258310","10.1093/ofid/ofab176","Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis.","We describe a case of prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a patient receiving ocrelizumab for multiple sclerosis. Viral RNA shedding, signs, and symptoms persisted for 69 days with resolution after administration of convalescent plasma and antiviral therapy. This case suggests risk for persistent SARS-CoV-2 infection in patients treated with anti-CD-20 monoclonal antibodies and supports a role for humoral immunity in disease resolution.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; humoral immunity; ocrelizumab","Spivak","Emily S","Division of Infectious Diseases, Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA",NA
"1948","34258310","10.1093/ofid/ofab176","Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis.","We describe a case of prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a patient receiving ocrelizumab for multiple sclerosis. Viral RNA shedding, signs, and symptoms persisted for 69 days with resolution after administration of convalescent plasma and antiviral therapy. This case suggests risk for persistent SARS-CoV-2 infection in patients treated with anti-CD-20 monoclonal antibodies and supports a role for humoral immunity in disease resolution.","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; humoral immunity; ocrelizumab","Swaminathan","Sankar","Division of Infectious Diseases, Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA",NA
"1949","34258309","10.1093/ofid/ofab110","Considerations for Assessment and Deployment of Rapid Antigen Tests for Diagnosis of Coronavirus Disease 2019.","Diagnostic testing is a critical tool to mitigate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, but molecular testing capacity remains limited. Rapid diagnostic tests (RDTs) that detect SARS-CoV-2 protein antigens (Ag) offer the potential to substantially expand testing capacity and to allow frequent, large-scale, population screening. Testing is simple, rapid (results generally available within 15 minutes), and applicable for diagnosis at point of care. However, imp","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID; SARS-CoV-2; antigen; diagnostic; point-of-care","Pollock","Nira R","Department of Laboratory Medicine, Boston Children's Hospital, Boston, Massachusetts, USA",NA
"1950","34258309","10.1093/ofid/ofab110","Considerations for Assessment and Deployment of Rapid Antigen Tests for Diagnosis of Coronavirus Disease 2019.","Diagnostic testing is a critical tool to mitigate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, but molecular testing capacity remains limited. Rapid diagnostic tests (RDTs) that detect SARS-CoV-2 protein antigens (Ag) offer the potential to substantially expand testing capacity and to allow frequent, large-scale, population screening. Testing is simple, rapid (results generally available within 15 minutes), and applicable for diagnosis at point of care. However, imp","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID; SARS-CoV-2; antigen; diagnostic; point-of-care","Lee","Francesca","Departments of Pathology and Internal Medicine, University of Texas, Southwestern Dallas, Texas, USA",NA
"1951","34258309","10.1093/ofid/ofab110","Considerations for Assessment and Deployment of Rapid Antigen Tests for Diagnosis of Coronavirus Disease 2019.","Diagnostic testing is a critical tool to mitigate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, but molecular testing capacity remains limited. Rapid diagnostic tests (RDTs) that detect SARS-CoV-2 protein antigens (Ag) offer the potential to substantially expand testing capacity and to allow frequent, large-scale, population screening. Testing is simple, rapid (results generally available within 15 minutes), and applicable for diagnosis at point of care. However, imp","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID; SARS-CoV-2; antigen; diagnostic; point-of-care","Ginocchio","Christine C","bioMérieux/BioFire Diagnostics, Salt Lake City, Utah, USA",NA
"1952","34258309","10.1093/ofid/ofab110","Considerations for Assessment and Deployment of Rapid Antigen Tests for Diagnosis of Coronavirus Disease 2019.","Diagnostic testing is a critical tool to mitigate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, but molecular testing capacity remains limited. Rapid diagnostic tests (RDTs) that detect SARS-CoV-2 protein antigens (Ag) offer the potential to substantially expand testing capacity and to allow frequent, large-scale, population screening. Testing is simple, rapid (results generally available within 15 minutes), and applicable for diagnosis at point of care. However, imp","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID; SARS-CoV-2; antigen; diagnostic; point-of-care","Yao","Joseph D","Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA",NA
"1953","34258309","10.1093/ofid/ofab110","Considerations for Assessment and Deployment of Rapid Antigen Tests for Diagnosis of Coronavirus Disease 2019.","Diagnostic testing is a critical tool to mitigate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, but molecular testing capacity remains limited. Rapid diagnostic tests (RDTs) that detect SARS-CoV-2 protein antigens (Ag) offer the potential to substantially expand testing capacity and to allow frequent, large-scale, population screening. Testing is simple, rapid (results generally available within 15 minutes), and applicable for diagnosis at point of care. However, imp","2021","07","15","Open Forum Infect Dis","Open forum infectious diseases","COVID; SARS-CoV-2; antigen; diagnostic; point-of-care","Humphries","Romney M","Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA",NA
"1954","34258306","10.14309/crj.0000000000000634","Orthotopic Liver Transplantation in a Cirrhotic Patient With Recent COVID-19 Infection.","The coronavirus disease 2019 (COVID-19) pandemic has led to a decrease in liver transplantation because of concerns regarding safety and healthcare resource utilization. There are scant data regarding the safety, optimal timing, and preferred postsurgical immunosuppression regimens for liver transplantation in patients recovered from COVID-19 infection. We describe our experience with one of the first reported cases of orthotopic liver transplantation in a patient who had recently recovered from","2021","07","15","ACG Case Rep J","ACG case reports journal",NA,"Gonzalez","Adalberto","Department of Gastroenterology and Hepatology, Cleveland Clinic Florida, Weston, FL",NA
"1955","34258306","10.14309/crj.0000000000000634","Orthotopic Liver Transplantation in a Cirrhotic Patient With Recent COVID-19 Infection.","The coronavirus disease 2019 (COVID-19) pandemic has led to a decrease in liver transplantation because of concerns regarding safety and healthcare resource utilization. There are scant data regarding the safety, optimal timing, and preferred postsurgical immunosuppression regimens for liver transplantation in patients recovered from COVID-19 infection. We describe our experience with one of the first reported cases of orthotopic liver transplantation in a patient who had recently recovered from","2021","07","15","ACG Case Rep J","ACG case reports journal",NA,"Zervos","Xaralambos","Department of Gastroenterology and Hepatology, Cleveland Clinic Florida, Weston, FL",NA
"1956","34258306","10.14309/crj.0000000000000634","Orthotopic Liver Transplantation in a Cirrhotic Patient With Recent COVID-19 Infection.","The coronavirus disease 2019 (COVID-19) pandemic has led to a decrease in liver transplantation because of concerns regarding safety and healthcare resource utilization. There are scant data regarding the safety, optimal timing, and preferred postsurgical immunosuppression regimens for liver transplantation in patients recovered from COVID-19 infection. We describe our experience with one of the first reported cases of orthotopic liver transplantation in a patient who had recently recovered from","2021","07","15","ACG Case Rep J","ACG case reports journal",NA,"Pinna","Antonio","Department of Transplant, Cleveland Clinic Florida, Weston, FL",NA
"1957","34258306","10.14309/crj.0000000000000634","Orthotopic Liver Transplantation in a Cirrhotic Patient With Recent COVID-19 Infection.","The coronavirus disease 2019 (COVID-19) pandemic has led to a decrease in liver transplantation because of concerns regarding safety and healthcare resource utilization. There are scant data regarding the safety, optimal timing, and preferred postsurgical immunosuppression regimens for liver transplantation in patients recovered from COVID-19 infection. We describe our experience with one of the first reported cases of orthotopic liver transplantation in a patient who had recently recovered from","2021","07","15","ACG Case Rep J","ACG case reports journal",NA,"Singh","Kanwarpreet Tandon","Department of Gastroenterology and Hepatology, Cleveland Clinic Florida, Weston, FL",NA
"1958","34258306","10.14309/crj.0000000000000634","Orthotopic Liver Transplantation in a Cirrhotic Patient With Recent COVID-19 Infection.","The coronavirus disease 2019 (COVID-19) pandemic has led to a decrease in liver transplantation because of concerns regarding safety and healthcare resource utilization. There are scant data regarding the safety, optimal timing, and preferred postsurgical immunosuppression regimens for liver transplantation in patients recovered from COVID-19 infection. We describe our experience with one of the first reported cases of orthotopic liver transplantation in a patient who had recently recovered from","2021","07","15","ACG Case Rep J","ACG case reports journal",NA,"Castaneda","Daniel","Department of Gastroenterology and Hepatology, Cleveland Clinic Florida, Weston, FL",NA
"1959","34258306","10.14309/crj.0000000000000634","Orthotopic Liver Transplantation in a Cirrhotic Patient With Recent COVID-19 Infection.","The coronavirus disease 2019 (COVID-19) pandemic has led to a decrease in liver transplantation because of concerns regarding safety and healthcare resource utilization. There are scant data regarding the safety, optimal timing, and preferred postsurgical immunosuppression regimens for liver transplantation in patients recovered from COVID-19 infection. We describe our experience with one of the first reported cases of orthotopic liver transplantation in a patient who had recently recovered from","2021","07","15","ACG Case Rep J","ACG case reports journal",NA,"Reino","Diego","Department of Transplant, Cleveland Clinic Florida, Weston, FL",NA
"1960","34258306","10.14309/crj.0000000000000634","Orthotopic Liver Transplantation in a Cirrhotic Patient With Recent COVID-19 Infection.","The coronavirus disease 2019 (COVID-19) pandemic has led to a decrease in liver transplantation because of concerns regarding safety and healthcare resource utilization. There are scant data regarding the safety, optimal timing, and preferred postsurgical immunosuppression regimens for liver transplantation in patients recovered from COVID-19 infection. We describe our experience with one of the first reported cases of orthotopic liver transplantation in a patient who had recently recovered from","2021","07","15","ACG Case Rep J","ACG case reports journal",NA,"Ebaid","Samer","Department of Transplant, Cleveland Clinic Florida, Weston, FL",NA
"1961","34258306","10.14309/crj.0000000000000634","Orthotopic Liver Transplantation in a Cirrhotic Patient With Recent COVID-19 Infection.","The coronavirus disease 2019 (COVID-19) pandemic has led to a decrease in liver transplantation because of concerns regarding safety and healthcare resource utilization. There are scant data regarding the safety, optimal timing, and preferred postsurgical immunosuppression regimens for liver transplantation in patients recovered from COVID-19 infection. We describe our experience with one of the first reported cases of orthotopic liver transplantation in a patient who had recently recovered from","2021","07","15","ACG Case Rep J","ACG case reports journal",NA,"McWilliams","Carla","Department of Infectious Disease, Cleveland Clinic Florida, Weston, Florida, Weston, FL",NA
"1962","34258306","10.14309/crj.0000000000000634","Orthotopic Liver Transplantation in a Cirrhotic Patient With Recent COVID-19 Infection.","The coronavirus disease 2019 (COVID-19) pandemic has led to a decrease in liver transplantation because of concerns regarding safety and healthcare resource utilization. There are scant data regarding the safety, optimal timing, and preferred postsurgical immunosuppression regimens for liver transplantation in patients recovered from COVID-19 infection. We describe our experience with one of the first reported cases of orthotopic liver transplantation in a patient who had recently recovered from","2021","07","15","ACG Case Rep J","ACG case reports journal",NA,"Donato","Christian","Department of Infectious Disease, Cleveland Clinic Florida, Weston, Florida, Weston, FL",NA
"1963","34258306","10.14309/crj.0000000000000634","Orthotopic Liver Transplantation in a Cirrhotic Patient With Recent COVID-19 Infection.","The coronavirus disease 2019 (COVID-19) pandemic has led to a decrease in liver transplantation because of concerns regarding safety and healthcare resource utilization. There are scant data regarding the safety, optimal timing, and preferred postsurgical immunosuppression regimens for liver transplantation in patients recovered from COVID-19 infection. We describe our experience with one of the first reported cases of orthotopic liver transplantation in a patient who had recently recovered from","2021","07","15","ACG Case Rep J","ACG case reports journal",NA,"Al Khalloufi","Kawtar","Department of Gastroenterology and Hepatology, Cleveland Clinic Florida, Weston, FL",NA
"1964","34258282","10.1155/2021/8853056","An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.","The recent outbreak of the deadly coronavirus disease 19 (COVID-19) pandemic poses serious health concerns around the world. The lack of approved drugs or vaccines continues to be a challenge and further necessitates the discovery of new therapeutic molecules. Computer-aided drug design has helped to expedite the drug discovery and development process by minimizing the cost and time. In this review article, we highlight two important categories of computer-aided drug design (CADD), viz., the lig","2021","07","19","Biomed Res Int","BioMed research international","Antiviral Agents; Artificial Intelligence; COVID-19; Drug Design; Drug Discovery; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; SARS-CoV-2","Gurung","Arun Bahadur","Department of Basic Sciences and Social Sciences, North-Eastern Hill University, Shillong, 793022 Meghalaya, India",NA
"1965","34258282","10.1155/2021/8853056","An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.","The recent outbreak of the deadly coronavirus disease 19 (COVID-19) pandemic poses serious health concerns around the world. The lack of approved drugs or vaccines continues to be a challenge and further necessitates the discovery of new therapeutic molecules. Computer-aided drug design has helped to expedite the drug discovery and development process by minimizing the cost and time. In this review article, we highlight two important categories of computer-aided drug design (CADD), viz., the lig","2021","07","19","Biomed Res Int","BioMed research international","Antiviral Agents; Artificial Intelligence; COVID-19; Drug Design; Drug Discovery; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; SARS-CoV-2","Ali","Mohammad Ajmal","Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia",NA
"1966","34258282","10.1155/2021/8853056","An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.","The recent outbreak of the deadly coronavirus disease 19 (COVID-19) pandemic poses serious health concerns around the world. The lack of approved drugs or vaccines continues to be a challenge and further necessitates the discovery of new therapeutic molecules. Computer-aided drug design has helped to expedite the drug discovery and development process by minimizing the cost and time. In this review article, we highlight two important categories of computer-aided drug design (CADD), viz., the lig","2021","07","19","Biomed Res Int","BioMed research international","Antiviral Agents; Artificial Intelligence; COVID-19; Drug Design; Drug Discovery; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; SARS-CoV-2","Lee","Joongku","Department of Environment and Forest Resources, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea",NA
"1967","34258282","10.1155/2021/8853056","An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.","The recent outbreak of the deadly coronavirus disease 19 (COVID-19) pandemic poses serious health concerns around the world. The lack of approved drugs or vaccines continues to be a challenge and further necessitates the discovery of new therapeutic molecules. Computer-aided drug design has helped to expedite the drug discovery and development process by minimizing the cost and time. In this review article, we highlight two important categories of computer-aided drug design (CADD), viz., the lig","2021","07","19","Biomed Res Int","BioMed research international","Antiviral Agents; Artificial Intelligence; COVID-19; Drug Design; Drug Discovery; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; SARS-CoV-2","Farah","Mohammad Abul","Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia",NA
"1968","34258282","10.1155/2021/8853056","An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.","The recent outbreak of the deadly coronavirus disease 19 (COVID-19) pandemic poses serious health concerns around the world. The lack of approved drugs or vaccines continues to be a challenge and further necessitates the discovery of new therapeutic molecules. Computer-aided drug design has helped to expedite the drug discovery and development process by minimizing the cost and time. In this review article, we highlight two important categories of computer-aided drug design (CADD), viz., the lig","2021","07","19","Biomed Res Int","BioMed research international","Antiviral Agents; Artificial Intelligence; COVID-19; Drug Design; Drug Discovery; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; SARS-CoV-2","Al-Anazi","Khalid Mashay","Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia",NA
"1969","34258278","10.1155/2021/6662027","Genome Features and <i>In Vitro</i> Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.","The aim of this work was to analyze the complete genome of probiotic bacteria Lactobacillus plantarum 8 RA 3, Lactobacillus fermentum 90 TC-4, Lactobacillus fermentum 39, Bifidobacterium bifidum 791, Bifidobacterium bifidum 1, and Bifidobacterium longum 379 and to test their activity against influenza A and SARS-CoV-2 viruses. To confirm the taxonomic affiliation of the bacterial strains, MALDI TOF mass spectrometry and biochemical test systems were used. Whole genome sequencing was performed on","2021","07","19","Biomed Res Int","BioMed research international","Animals; Bifidobacterium longum; COVID-19; Chlorocebus aethiops; Dogs; High-Throughput Nucleotide Sequencing; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactobacillus; Madin Darby Canine Kidney Cells; Probiotics; SARS-CoV-2; Vero Cells","Soloveva","Irina V","Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, 71, M. Yamskaya Street, Nizhny Novgorod 603950, Russia",NA
"1970","34258278","10.1155/2021/6662027","Genome Features and <i>In Vitro</i> Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.","The aim of this work was to analyze the complete genome of probiotic bacteria Lactobacillus plantarum 8 RA 3, Lactobacillus fermentum 90 TC-4, Lactobacillus fermentum 39, Bifidobacterium bifidum 791, Bifidobacterium bifidum 1, and Bifidobacterium longum 379 and to test their activity against influenza A and SARS-CoV-2 viruses. To confirm the taxonomic affiliation of the bacterial strains, MALDI TOF mass spectrometry and biochemical test systems were used. Whole genome sequencing was performed on","2021","07","19","Biomed Res Int","BioMed research international","Animals; Bifidobacterium longum; COVID-19; Chlorocebus aethiops; Dogs; High-Throughput Nucleotide Sequencing; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactobacillus; Madin Darby Canine Kidney Cells; Probiotics; SARS-CoV-2; Vero Cells","Ilyicheva","Tatyana N","Vector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia",NA
"1971","34258278","10.1155/2021/6662027","Genome Features and <i>In Vitro</i> Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.","The aim of this work was to analyze the complete genome of probiotic bacteria Lactobacillus plantarum 8 RA 3, Lactobacillus fermentum 90 TC-4, Lactobacillus fermentum 39, Bifidobacterium bifidum 791, Bifidobacterium bifidum 1, and Bifidobacterium longum 379 and to test their activity against influenza A and SARS-CoV-2 viruses. To confirm the taxonomic affiliation of the bacterial strains, MALDI TOF mass spectrometry and biochemical test systems were used. Whole genome sequencing was performed on","2021","07","19","Biomed Res Int","BioMed research international","Animals; Bifidobacterium longum; COVID-19; Chlorocebus aethiops; Dogs; High-Throughput Nucleotide Sequencing; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactobacillus; Madin Darby Canine Kidney Cells; Probiotics; SARS-CoV-2; Vero Cells","Marchenko","Vasiliy Yu","Vector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia",NA
"1972","34258278","10.1155/2021/6662027","Genome Features and <i>In Vitro</i> Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.","The aim of this work was to analyze the complete genome of probiotic bacteria Lactobacillus plantarum 8 RA 3, Lactobacillus fermentum 90 TC-4, Lactobacillus fermentum 39, Bifidobacterium bifidum 791, Bifidobacterium bifidum 1, and Bifidobacterium longum 379 and to test their activity against influenza A and SARS-CoV-2 viruses. To confirm the taxonomic affiliation of the bacterial strains, MALDI TOF mass spectrometry and biochemical test systems were used. Whole genome sequencing was performed on","2021","07","19","Biomed Res Int","BioMed research international","Animals; Bifidobacterium longum; COVID-19; Chlorocebus aethiops; Dogs; High-Throughput Nucleotide Sequencing; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactobacillus; Madin Darby Canine Kidney Cells; Probiotics; SARS-CoV-2; Vero Cells","Pyankov","Oleg V","Vector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia",NA
"1973","34258278","10.1155/2021/6662027","Genome Features and <i>In Vitro</i> Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.","The aim of this work was to analyze the complete genome of probiotic bacteria Lactobacillus plantarum 8 RA 3, Lactobacillus fermentum 90 TC-4, Lactobacillus fermentum 39, Bifidobacterium bifidum 791, Bifidobacterium bifidum 1, and Bifidobacterium longum 379 and to test their activity against influenza A and SARS-CoV-2 viruses. To confirm the taxonomic affiliation of the bacterial strains, MALDI TOF mass spectrometry and biochemical test systems were used. Whole genome sequencing was performed on","2021","07","19","Biomed Res Int","BioMed research international","Animals; Bifidobacterium longum; COVID-19; Chlorocebus aethiops; Dogs; High-Throughput Nucleotide Sequencing; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactobacillus; Madin Darby Canine Kidney Cells; Probiotics; SARS-CoV-2; Vero Cells","Tochilina","Anna G","Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, 71, M. Yamskaya Street, Nizhny Novgorod 603950, Russia",NA
"1974","34258278","10.1155/2021/6662027","Genome Features and <i>In Vitro</i> Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.","The aim of this work was to analyze the complete genome of probiotic bacteria Lactobacillus plantarum 8 RA 3, Lactobacillus fermentum 90 TC-4, Lactobacillus fermentum 39, Bifidobacterium bifidum 791, Bifidobacterium bifidum 1, and Bifidobacterium longum 379 and to test their activity against influenza A and SARS-CoV-2 viruses. To confirm the taxonomic affiliation of the bacterial strains, MALDI TOF mass spectrometry and biochemical test systems were used. Whole genome sequencing was performed on","2021","07","19","Biomed Res Int","BioMed research international","Animals; Bifidobacterium longum; COVID-19; Chlorocebus aethiops; Dogs; High-Throughput Nucleotide Sequencing; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactobacillus; Madin Darby Canine Kidney Cells; Probiotics; SARS-CoV-2; Vero Cells","Belova","Irina V","Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, 71, M. Yamskaya Street, Nizhny Novgorod 603950, Russia",NA
"1975","34258278","10.1155/2021/6662027","Genome Features and <i>In Vitro</i> Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.","The aim of this work was to analyze the complete genome of probiotic bacteria Lactobacillus plantarum 8 RA 3, Lactobacillus fermentum 90 TC-4, Lactobacillus fermentum 39, Bifidobacterium bifidum 791, Bifidobacterium bifidum 1, and Bifidobacterium longum 379 and to test their activity against influenza A and SARS-CoV-2 viruses. To confirm the taxonomic affiliation of the bacterial strains, MALDI TOF mass spectrometry and biochemical test systems were used. Whole genome sequencing was performed on","2021","07","19","Biomed Res Int","BioMed research international","Animals; Bifidobacterium longum; COVID-19; Chlorocebus aethiops; Dogs; High-Throughput Nucleotide Sequencing; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactobacillus; Madin Darby Canine Kidney Cells; Probiotics; SARS-CoV-2; Vero Cells","Zhirnov","Vladimir A","Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, 71, M. Yamskaya Street, Nizhny Novgorod 603950, Russia",NA
"1976","34258278","10.1155/2021/6662027","Genome Features and <i>In Vitro</i> Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.","The aim of this work was to analyze the complete genome of probiotic bacteria Lactobacillus plantarum 8 RA 3, Lactobacillus fermentum 90 TC-4, Lactobacillus fermentum 39, Bifidobacterium bifidum 791, Bifidobacterium bifidum 1, and Bifidobacterium longum 379 and to test their activity against influenza A and SARS-CoV-2 viruses. To confirm the taxonomic affiliation of the bacterial strains, MALDI TOF mass spectrometry and biochemical test systems were used. Whole genome sequencing was performed on","2021","07","19","Biomed Res Int","BioMed research international","Animals; Bifidobacterium longum; COVID-19; Chlorocebus aethiops; Dogs; High-Throughput Nucleotide Sequencing; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactobacillus; Madin Darby Canine Kidney Cells; Probiotics; SARS-CoV-2; Vero Cells","Bormotov","Nikolay I","Vector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia",NA
"1977","34258278","10.1155/2021/6662027","Genome Features and <i>In Vitro</i> Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.","The aim of this work was to analyze the complete genome of probiotic bacteria Lactobacillus plantarum 8 RA 3, Lactobacillus fermentum 90 TC-4, Lactobacillus fermentum 39, Bifidobacterium bifidum 791, Bifidobacterium bifidum 1, and Bifidobacterium longum 379 and to test their activity against influenza A and SARS-CoV-2 viruses. To confirm the taxonomic affiliation of the bacterial strains, MALDI TOF mass spectrometry and biochemical test systems were used. Whole genome sequencing was performed on","2021","07","19","Biomed Res Int","BioMed research international","Animals; Bifidobacterium longum; COVID-19; Chlorocebus aethiops; Dogs; High-Throughput Nucleotide Sequencing; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactobacillus; Madin Darby Canine Kidney Cells; Probiotics; SARS-CoV-2; Vero Cells","Skarnovich","Maksim O","Vector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia",NA
"1978","34258278","10.1155/2021/6662027","Genome Features and <i>In Vitro</i> Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.","The aim of this work was to analyze the complete genome of probiotic bacteria Lactobacillus plantarum 8 RA 3, Lactobacillus fermentum 90 TC-4, Lactobacillus fermentum 39, Bifidobacterium bifidum 791, Bifidobacterium bifidum 1, and Bifidobacterium longum 379 and to test their activity against influenza A and SARS-CoV-2 viruses. To confirm the taxonomic affiliation of the bacterial strains, MALDI TOF mass spectrometry and biochemical test systems were used. Whole genome sequencing was performed on","2021","07","19","Biomed Res Int","BioMed research international","Animals; Bifidobacterium longum; COVID-19; Chlorocebus aethiops; Dogs; High-Throughput Nucleotide Sequencing; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactobacillus; Madin Darby Canine Kidney Cells; Probiotics; SARS-CoV-2; Vero Cells","Durymanov","Aleksander G","Vector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia",NA
"1979","34258278","10.1155/2021/6662027","Genome Features and <i>In Vitro</i> Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.","The aim of this work was to analyze the complete genome of probiotic bacteria Lactobacillus plantarum 8 RA 3, Lactobacillus fermentum 90 TC-4, Lactobacillus fermentum 39, Bifidobacterium bifidum 791, Bifidobacterium bifidum 1, and Bifidobacterium longum 379 and to test their activity against influenza A and SARS-CoV-2 viruses. To confirm the taxonomic affiliation of the bacterial strains, MALDI TOF mass spectrometry and biochemical test systems were used. Whole genome sequencing was performed on","2021","07","19","Biomed Res Int","BioMed research international","Animals; Bifidobacterium longum; COVID-19; Chlorocebus aethiops; Dogs; High-Throughput Nucleotide Sequencing; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactobacillus; Madin Darby Canine Kidney Cells; Probiotics; SARS-CoV-2; Vero Cells","Molodtsova","Svetlana B","Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, 71, M. Yamskaya Street, Nizhny Novgorod 603950, Russia",NA
"1980","34258278","10.1155/2021/6662027","Genome Features and <i>In Vitro</i> Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.","The aim of this work was to analyze the complete genome of probiotic bacteria Lactobacillus plantarum 8 RA 3, Lactobacillus fermentum 90 TC-4, Lactobacillus fermentum 39, Bifidobacterium bifidum 791, Bifidobacterium bifidum 1, and Bifidobacterium longum 379 and to test their activity against influenza A and SARS-CoV-2 viruses. To confirm the taxonomic affiliation of the bacterial strains, MALDI TOF mass spectrometry and biochemical test systems were used. Whole genome sequencing was performed on","2021","07","19","Biomed Res Int","BioMed research international","Animals; Bifidobacterium longum; COVID-19; Chlorocebus aethiops; Dogs; High-Throughput Nucleotide Sequencing; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactobacillus; Madin Darby Canine Kidney Cells; Probiotics; SARS-CoV-2; Vero Cells","Filippova","Ekaterina I","Vector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia",NA
"1981","34258278","10.1155/2021/6662027","Genome Features and <i>In Vitro</i> Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.","The aim of this work was to analyze the complete genome of probiotic bacteria Lactobacillus plantarum 8 RA 3, Lactobacillus fermentum 90 TC-4, Lactobacillus fermentum 39, Bifidobacterium bifidum 791, Bifidobacterium bifidum 1, and Bifidobacterium longum 379 and to test their activity against influenza A and SARS-CoV-2 viruses. To confirm the taxonomic affiliation of the bacterial strains, MALDI TOF mass spectrometry and biochemical test systems were used. Whole genome sequencing was performed on","2021","07","19","Biomed Res Int","BioMed research international","Animals; Bifidobacterium longum; COVID-19; Chlorocebus aethiops; Dogs; High-Throughput Nucleotide Sequencing; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactobacillus; Madin Darby Canine Kidney Cells; Probiotics; SARS-CoV-2; Vero Cells","Ovchinnikova","Alena S","Vector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia",NA
"1982","34258278","10.1155/2021/6662027","Genome Features and <i>In Vitro</i> Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.","The aim of this work was to analyze the complete genome of probiotic bacteria Lactobacillus plantarum 8 RA 3, Lactobacillus fermentum 90 TC-4, Lactobacillus fermentum 39, Bifidobacterium bifidum 791, Bifidobacterium bifidum 1, and Bifidobacterium longum 379 and to test their activity against influenza A and SARS-CoV-2 viruses. To confirm the taxonomic affiliation of the bacterial strains, MALDI TOF mass spectrometry and biochemical test systems were used. Whole genome sequencing was performed on","2021","07","19","Biomed Res Int","BioMed research international","Animals; Bifidobacterium longum; COVID-19; Chlorocebus aethiops; Dogs; High-Throughput Nucleotide Sequencing; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactobacillus; Madin Darby Canine Kidney Cells; Probiotics; SARS-CoV-2; Vero Cells","Magerramova","Anastasia V","Vector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia",NA
"1983","34258278","10.1155/2021/6662027","Genome Features and <i>In Vitro</i> Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.","The aim of this work was to analyze the complete genome of probiotic bacteria Lactobacillus plantarum 8 RA 3, Lactobacillus fermentum 90 TC-4, Lactobacillus fermentum 39, Bifidobacterium bifidum 791, Bifidobacterium bifidum 1, and Bifidobacterium longum 379 and to test their activity against influenza A and SARS-CoV-2 viruses. To confirm the taxonomic affiliation of the bacterial strains, MALDI TOF mass spectrometry and biochemical test systems were used. Whole genome sequencing was performed on","2021","07","19","Biomed Res Int","BioMed research international","Animals; Bifidobacterium longum; COVID-19; Chlorocebus aethiops; Dogs; High-Throughput Nucleotide Sequencing; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactobacillus; Madin Darby Canine Kidney Cells; Probiotics; SARS-CoV-2; Vero Cells","Ryzhikov","Alexander B","Vector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia",NA
"1984","34258278","10.1155/2021/6662027","Genome Features and <i>In Vitro</i> Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.","The aim of this work was to analyze the complete genome of probiotic bacteria Lactobacillus plantarum 8 RA 3, Lactobacillus fermentum 90 TC-4, Lactobacillus fermentum 39, Bifidobacterium bifidum 791, Bifidobacterium bifidum 1, and Bifidobacterium longum 379 and to test their activity against influenza A and SARS-CoV-2 viruses. To confirm the taxonomic affiliation of the bacterial strains, MALDI TOF mass spectrometry and biochemical test systems were used. Whole genome sequencing was performed on","2021","07","19","Biomed Res Int","BioMed research international","Animals; Bifidobacterium longum; COVID-19; Chlorocebus aethiops; Dogs; High-Throughput Nucleotide Sequencing; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactobacillus; Madin Darby Canine Kidney Cells; Probiotics; SARS-CoV-2; Vero Cells","Maksyutov","Rinat A","Vector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia",NA
"1985","34258268","10.1155/2021/5595016","Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations.","COVID-19 is a pandemic disease worldwide. Although cutaneous manifestations may present in affected patients, there have been limited studies on the cutaneous findings and hair and nail abnormalities after discharge. To establish the cutaneous manifestations, hair and scalp disorders, and nail abnormalities in patients who recovered from COVID-19 infections. A retrospective chart review and telephone interviews were conducted to determine the cutaneous manifestations, hair and scalp disorders, a","2021","07","19","Biomed Res Int","BioMed research international","Adult; Aged; Aged, 80 and over; COVID-19; Female; Follow-Up Studies; Hair; Hair Diseases; Humans; Male; Middle Aged; Nail Diseases; Nails; Pandemics; SARS-CoV-2; Skin","Thuangtong","Rattapon","Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand",NA
"1986","34258268","10.1155/2021/5595016","Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations.","COVID-19 is a pandemic disease worldwide. Although cutaneous manifestations may present in affected patients, there have been limited studies on the cutaneous findings and hair and nail abnormalities after discharge. To establish the cutaneous manifestations, hair and scalp disorders, and nail abnormalities in patients who recovered from COVID-19 infections. A retrospective chart review and telephone interviews were conducted to determine the cutaneous manifestations, hair and scalp disorders, a","2021","07","19","Biomed Res Int","BioMed research international","Adult; Aged; Aged, 80 and over; COVID-19; Female; Follow-Up Studies; Hair; Hair Diseases; Humans; Male; Middle Aged; Nail Diseases; Nails; Pandemics; SARS-CoV-2; Skin","Angkasekwinai","Nasikarn","Division of Infectious Diseases and Tropical Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand",NA
"1987","34258268","10.1155/2021/5595016","Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations.","COVID-19 is a pandemic disease worldwide. Although cutaneous manifestations may present in affected patients, there have been limited studies on the cutaneous findings and hair and nail abnormalities after discharge. To establish the cutaneous manifestations, hair and scalp disorders, and nail abnormalities in patients who recovered from COVID-19 infections. A retrospective chart review and telephone interviews were conducted to determine the cutaneous manifestations, hair and scalp disorders, a","2021","07","19","Biomed Res Int","BioMed research international","Adult; Aged; Aged, 80 and over; COVID-19; Female; Follow-Up Studies; Hair; Hair Diseases; Humans; Male; Middle Aged; Nail Diseases; Nails; Pandemics; SARS-CoV-2; Skin","Leeyaphan","Charussri","Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand",NA
"1988","34258268","10.1155/2021/5595016","Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations.","COVID-19 is a pandemic disease worldwide. Although cutaneous manifestations may present in affected patients, there have been limited studies on the cutaneous findings and hair and nail abnormalities after discharge. To establish the cutaneous manifestations, hair and scalp disorders, and nail abnormalities in patients who recovered from COVID-19 infections. A retrospective chart review and telephone interviews were conducted to determine the cutaneous manifestations, hair and scalp disorders, a","2021","07","19","Biomed Res Int","BioMed research international","Adult; Aged; Aged, 80 and over; COVID-19; Female; Follow-Up Studies; Hair; Hair Diseases; Humans; Male; Middle Aged; Nail Diseases; Nails; Pandemics; SARS-CoV-2; Skin","Triwongwaranat","Daranporn","Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand",NA
"1989","34258268","10.1155/2021/5595016","Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations.","COVID-19 is a pandemic disease worldwide. Although cutaneous manifestations may present in affected patients, there have been limited studies on the cutaneous findings and hair and nail abnormalities after discharge. To establish the cutaneous manifestations, hair and scalp disorders, and nail abnormalities in patients who recovered from COVID-19 infections. A retrospective chart review and telephone interviews were conducted to determine the cutaneous manifestations, hair and scalp disorders, a","2021","07","19","Biomed Res Int","BioMed research international","Adult; Aged; Aged, 80 and over; COVID-19; Female; Follow-Up Studies; Hair; Hair Diseases; Humans; Male; Middle Aged; Nail Diseases; Nails; Pandemics; SARS-CoV-2; Skin","Thanomkitti","Kanchalit","Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand",NA
"1990","34258268","10.1155/2021/5595016","Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations.","COVID-19 is a pandemic disease worldwide. Although cutaneous manifestations may present in affected patients, there have been limited studies on the cutaneous findings and hair and nail abnormalities after discharge. To establish the cutaneous manifestations, hair and scalp disorders, and nail abnormalities in patients who recovered from COVID-19 infections. A retrospective chart review and telephone interviews were conducted to determine the cutaneous manifestations, hair and scalp disorders, a","2021","07","19","Biomed Res Int","BioMed research international","Adult; Aged; Aged, 80 and over; COVID-19; Female; Follow-Up Studies; Hair; Hair Diseases; Humans; Male; Middle Aged; Nail Diseases; Nails; Pandemics; SARS-CoV-2; Skin","Munprom","Kanyalak","Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand",NA
"1991","34258268","10.1155/2021/5595016","Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations.","COVID-19 is a pandemic disease worldwide. Although cutaneous manifestations may present in affected patients, there have been limited studies on the cutaneous findings and hair and nail abnormalities after discharge. To establish the cutaneous manifestations, hair and scalp disorders, and nail abnormalities in patients who recovered from COVID-19 infections. A retrospective chart review and telephone interviews were conducted to determine the cutaneous manifestations, hair and scalp disorders, a","2021","07","19","Biomed Res Int","BioMed research international","Adult; Aged; Aged, 80 and over; COVID-19; Female; Follow-Up Studies; Hair; Hair Diseases; Humans; Male; Middle Aged; Nail Diseases; Nails; Pandemics; SARS-CoV-2; Skin","Kulthanan","Kanokvalai","Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand",NA
"1992","34258267","10.1155/2021/5553173","Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring.","Real-time genome monitoring of the SARS-CoV-2 pandemic outbreak is of utmost importance for designing diagnostic tools, guiding antiviral treatment and vaccination strategies. In this study, we present an accurate method for temporal and geographical comparison of mutational events based on GISAID database genome sequencing. Among 42523 SARS-CoV-2 genomes analyzed, we found 23202 variants compared to the reference genome. The Ti/Tv (transition/transversion) ratio was used to filter out possible ","2021","07","19","Biomed Res Int","BioMed research international","COVID-19; Databases, Nucleic Acid; Evolution, Molecular; Genome, Viral; Humans; Mutation; Pandemics; Phylogeny; SARS-CoV-2","Hakmaoui","Abdelmalek","Center of Clinical Research, University Hospital Mohammed VI, Marrakech, Morocco",NA
"1993","34258267","10.1155/2021/5553173","Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring.","Real-time genome monitoring of the SARS-CoV-2 pandemic outbreak is of utmost importance for designing diagnostic tools, guiding antiviral treatment and vaccination strategies. In this study, we present an accurate method for temporal and geographical comparison of mutational events based on GISAID database genome sequencing. Among 42523 SARS-CoV-2 genomes analyzed, we found 23202 variants compared to the reference genome. The Ti/Tv (transition/transversion) ratio was used to filter out possible ","2021","07","19","Biomed Res Int","BioMed research international","COVID-19; Databases, Nucleic Acid; Evolution, Molecular; Genome, Viral; Humans; Mutation; Pandemics; Phylogeny; SARS-CoV-2","Khan","Faisal","Cumming School of Medicine, University of Calgary, Canada",NA
"1994","34258267","10.1155/2021/5553173","Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring.","Real-time genome monitoring of the SARS-CoV-2 pandemic outbreak is of utmost importance for designing diagnostic tools, guiding antiviral treatment and vaccination strategies. In this study, we present an accurate method for temporal and geographical comparison of mutational events based on GISAID database genome sequencing. Among 42523 SARS-CoV-2 genomes analyzed, we found 23202 variants compared to the reference genome. The Ti/Tv (transition/transversion) ratio was used to filter out possible ","2021","07","19","Biomed Res Int","BioMed research international","COVID-19; Databases, Nucleic Acid; Evolution, Molecular; Genome, Viral; Humans; Mutation; Pandemics; Phylogeny; SARS-CoV-2","Liacini","Abdelhamid","Immunogenetics Laboratory, Temple University and Hospital, Lewis Katz School of Medicine, USA",NA
"1995","34258267","10.1155/2021/5553173","Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring.","Real-time genome monitoring of the SARS-CoV-2 pandemic outbreak is of utmost importance for designing diagnostic tools, guiding antiviral treatment and vaccination strategies. In this study, we present an accurate method for temporal and geographical comparison of mutational events based on GISAID database genome sequencing. Among 42523 SARS-CoV-2 genomes analyzed, we found 23202 variants compared to the reference genome. The Ti/Tv (transition/transversion) ratio was used to filter out possible ","2021","07","19","Biomed Res Int","BioMed research international","COVID-19; Databases, Nucleic Acid; Evolution, Molecular; Genome, Viral; Humans; Mutation; Pandemics; Phylogeny; SARS-CoV-2","Kaur","Amanjot","Cumming School of Medicine, University of Calgary, Canada",NA
"1996","34258267","10.1155/2021/5553173","Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring.","Real-time genome monitoring of the SARS-CoV-2 pandemic outbreak is of utmost importance for designing diagnostic tools, guiding antiviral treatment and vaccination strategies. In this study, we present an accurate method for temporal and geographical comparison of mutational events based on GISAID database genome sequencing. Among 42523 SARS-CoV-2 genomes analyzed, we found 23202 variants compared to the reference genome. The Ti/Tv (transition/transversion) ratio was used to filter out possible ","2021","07","19","Biomed Res Int","BioMed research international","COVID-19; Databases, Nucleic Acid; Evolution, Molecular; Genome, Viral; Humans; Mutation; Pandemics; Phylogeny; SARS-CoV-2","Berka","Yacine","University of Calgary, Alberta, Canada",NA
"1997","34258267","10.1155/2021/5553173","Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring.","Real-time genome monitoring of the SARS-CoV-2 pandemic outbreak is of utmost importance for designing diagnostic tools, guiding antiviral treatment and vaccination strategies. In this study, we present an accurate method for temporal and geographical comparison of mutational events based on GISAID database genome sequencing. Among 42523 SARS-CoV-2 genomes analyzed, we found 23202 variants compared to the reference genome. The Ti/Tv (transition/transversion) ratio was used to filter out possible ","2021","07","19","Biomed Res Int","BioMed research international","COVID-19; Databases, Nucleic Acid; Evolution, Molecular; Genome, Viral; Humans; Mutation; Pandemics; Phylogeny; SARS-CoV-2","Machraoui","Safaa","Center of Clinical Research, University Hospital Mohammed VI, Marrakech, Morocco",NA
"1998","34258267","10.1155/2021/5553173","Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring.","Real-time genome monitoring of the SARS-CoV-2 pandemic outbreak is of utmost importance for designing diagnostic tools, guiding antiviral treatment and vaccination strategies. In this study, we present an accurate method for temporal and geographical comparison of mutational events based on GISAID database genome sequencing. Among 42523 SARS-CoV-2 genomes analyzed, we found 23202 variants compared to the reference genome. The Ti/Tv (transition/transversion) ratio was used to filter out possible ","2021","07","19","Biomed Res Int","BioMed research international","COVID-19; Databases, Nucleic Acid; Evolution, Molecular; Genome, Viral; Humans; Mutation; Pandemics; Phylogeny; SARS-CoV-2","Soualhine","Hafid","National Microbiology Laboratory Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, Canada",NA
"1999","34258267","10.1155/2021/5553173","Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring.","Real-time genome monitoring of the SARS-CoV-2 pandemic outbreak is of utmost importance for designing diagnostic tools, guiding antiviral treatment and vaccination strategies. In this study, we present an accurate method for temporal and geographical comparison of mutational events based on GISAID database genome sequencing. Among 42523 SARS-CoV-2 genomes analyzed, we found 23202 variants compared to the reference genome. The Ti/Tv (transition/transversion) ratio was used to filter out possible ","2021","07","19","Biomed Res Int","BioMed research international","COVID-19; Databases, Nucleic Acid; Evolution, Molecular; Genome, Viral; Humans; Mutation; Pandemics; Phylogeny; SARS-CoV-2","Berka","Noureddine","Department of Pathology and Lab Medicine, University of Calgary, Alberta, Canada",NA
"2000","34258267","10.1155/2021/5553173","Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring.","Real-time genome monitoring of the SARS-CoV-2 pandemic outbreak is of utmost importance for designing diagnostic tools, guiding antiviral treatment and vaccination strategies. In this study, we present an accurate method for temporal and geographical comparison of mutational events based on GISAID database genome sequencing. Among 42523 SARS-CoV-2 genomes analyzed, we found 23202 variants compared to the reference genome. The Ti/Tv (transition/transversion) ratio was used to filter out possible ","2021","07","19","Biomed Res Int","BioMed research international","COVID-19; Databases, Nucleic Acid; Evolution, Molecular; Genome, Viral; Humans; Mutation; Pandemics; Phylogeny; SARS-CoV-2","Rais","Hanane","Center of Clinical Research, University Hospital Mohammed VI, Marrakech, Morocco",NA
"2001","34258267","10.1155/2021/5553173","Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring.","Real-time genome monitoring of the SARS-CoV-2 pandemic outbreak is of utmost importance for designing diagnostic tools, guiding antiviral treatment and vaccination strategies. In this study, we present an accurate method for temporal and geographical comparison of mutational events based on GISAID database genome sequencing. Among 42523 SARS-CoV-2 genomes analyzed, we found 23202 variants compared to the reference genome. The Ti/Tv (transition/transversion) ratio was used to filter out possible ","2021","07","19","Biomed Res Int","BioMed research international","COVID-19; Databases, Nucleic Acid; Evolution, Molecular; Genome, Viral; Humans; Mutation; Pandemics; Phylogeny; SARS-CoV-2","Admou","Brahim","Center of Clinical Research, University Hospital Mohammed VI, Marrakech, Morocco",NA
"2002","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Arenas-De Larriva","Marisol","Dept of Bronchoscopy and Interventional Pulmonology, Hospital Universitario Reina Sofía, IMIBIC, Córdoba, Spain",NA
"2003","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Martín-DeLeon","Roberto","Dept of Pulmonology, Hospital Universitario Reina Sofía, IMIBIC, Córdoba, Spain",NA
"2004","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Urrutia Royo","Blanca","Pulmonary Dept, Thorax Clinic Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain",NA
"2005","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Fernández-Navamuel","Iker","Bronchoscopy and Interventional Pulmonology Unit, Pulmonology Dept, Hospital Fundacion Jimenez Diaz, ISS-FJD, CIBERES, Madrid, Spain",NA
"2006","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Gimenez Velando","Andrés","Bronchoscopy and Interventional Pulmonology Unit, Pulmonology Dept, Hospital Fundacion Jimenez Diaz, ISS-FJD, CIBERES, Madrid, Spain",NA
"2007","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Nuñez García","Laura","Bronchoscopy and Interventional Pulmonology Unit, Pulmonology Dept, Hospital Fundacion Jimenez Diaz, ISS-FJD, CIBERES, Madrid, Spain",NA
"2008","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Centeno Clemente","Carmen","Interventional Pulmonology Unit, Pulmonary Dept, Thorax Clinic Institute, Hospital Universitari Germans Trias i Pujol, UAB, IGTP, Badalona, Spain",NA
"2009","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Andreo García","Felipe","Interventional Pulmonology Unit, Pulmonary Dept, Thorax Clinic Institute, Hospital Universitari Germans Trias i Pujol, UAB, IGTP, Badalona, Spain",NA
"2010","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Rafecas Codern","Albert","Respiratory Dept, Hospital Santa Creu i Sant Pau, Barcelona, Spain",NA
"2011","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Fernández-Arias","Carmen","Respiratory Dept, Hospital Santa Creu i Sant Pau, Barcelona, Spain",NA
"2012","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Pajares Ruiz","Virginia","Respiratory Dept, Hospital Santa Creu i Sant Pau, Barcelona, Spain",NA
"2013","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Torrego Fernández","Alfons","Respiratory Dept, Hospital Santa Creu i Sant Pau, Barcelona, Spain",NA
"2014","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Rajas","Olga","Interventional Pulmonology Unit, Pulmonology Dept, Hospital Universitario de la Princesa, Instituto de Investigación Princesa, Madrid, Spain",NA
"2015","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Iturricastillo","Gorane","Pulmonology Dept, Hospital Universitario de la Princesa, Instituto de Investigación Princesa, Madrid, Spain",NA
"2016","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Garcia Lujan","Ricardo","Dept of Interventional Pulmonology, Hospital Universitario 12 Octubre and Hospital Univesitario Quirónsalud Madrid, Madrid, Spain",NA
"2017","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Comeche Casanova","Lorena","Dept of Pulmonology, Hospital Universitario Quirónsalud Madrid, Madrid, Spain",NA
"2018","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Sánchez-Font","Albert","Pulmonology Dept, Hospital del Mar, CIBERES, UAB, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain",NA
"2019","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Aguilar-Colindres","Ricardo","Pulmonology Dept, Hospital del Mar, CIBERES, Barcelona, Spain",NA
"2020","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Larrosa-Barrero","Roberto","Pulmonary Dept, Hospital Universitario Clínico San Carlos, Madrid, Spain",NA
"2021","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"García García","Ruth","Interventional Pulmonology Unit, Pulmonary Dept, Salamanca University Hospital, Salamanca, Spain",NA
"2022","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Cordovilla","Rosa","Interventional Pulmonology Unit, Pulmonary Dept, Salamanca University Hospital, Salamanca, Spain",NA
"2023","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Núñez-Ares","Ana","Interventional Pulmonology Unit, Pulmonary Dept, Albacete, Spain",NA
"2024","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Briones-Gómez","Andrés","Interventional Pulmonology Unit, Pulmonary Dept, Hospital Universitario y Politécnico La Fe, Valencia, Spain",NA
"2025","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Cases Viedma","Enrique","Interventional Pulmonology Unit, Pulmonary Dept, Hospital Universitario y Politécnico La Fe, Valencia, Spain",NA
"2026","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Franco","José","Pneumology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain",NA
"2027","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Cosano Povedano","Javier","Bronchoscopy and Interventional Pulmonology Unit, Pulmonology Dept, Hospital Universitario Reina Sofía, IMIBIC, Córdoba, Spain",NA
"2028","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Rodríguez-Perálvarez","Manuel Luis","Maimónides Institute of Biomedical Research of Córdoba (IMIBIC), CIBERehd, Córdoba, Spain",NA
"2029","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Cebrian Gallardo","Jose Joaquin","Dept of Pulmonology, Agencia sanitaria Costa del Sol, Marbella, Spain",NA
"2030","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Nuñez Delgado","Manuel","Dept of Bronchoscopy and Interventional Pulmonology, Hospital Álvaro Cunqueiro, CHUVI, Vigo, Spain",NA
"2031","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Pavón-Masa","María","Dept of Interventional Pulmonology, Hospital Universitario Virgen Macarena, Seville, Spain",NA
"2032","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Valdivia Salas","Maria Del Mar","Dept of Interventional Pulmonology, Hospital Universitario Santa Lucía, Cartagena, Spain",NA
"2033","34258257","10.1183/23120541.00165-2021","The role of bronchoscopy in patients with SARS-CoV-2 pneumonia.","The role of bronchoscopy in coronavirus disease 2019 (COVID-19) is a matter of debate. This observational multicentre study aimed to analyse the prognostic impact of bronchoscopic findings in a consecutive cohort of patients with suspected or confirmed COVID-19. Patients were enrolled at 17 hospitals from February to June 2020. Predictors of in-hospital mortality were assessed by multivariate logistic regression. A total of 1027 bronchoscopies were performed in 515 patients (age 61.5±11.2 years;","2021","07","15","ERJ Open Res","ERJ open research",NA,"Flandes","Javier","Bronchoscopy and Interventional Pulmonology Unit, Pulmonology Dept, Hospital Fundación Jimenez Diaz, ISS-FJD, CIBERES, Madrid, Spain",NA
"2034","34258246","10.1007/s12070-021-02689-4","Acute Fulminant Mucormycosis Triggered by Covid 19 Infection in a Young Patient.","Covid 19 infection can result in various opportunistic infections. Altered immune response, associated comorbid conditions like diabetes, prolonged steroid and broad spectrum antibiotics usage with ICU interventions lead to increased chance of such superadded infections in covid 19 patients. Here we report a case of 31 year old male with covid 19 infection who had new onset Diabetes Mellitus, developed severe acute fulminant Mucormycosis during the treatment for covid 19 infection. He presented ","2021","07","15","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","Cavernous sinus thrombosis; Corona virus SARS-CoV-2; Covid 19 infection; Frontal craniectomy; Ophthalmoplegia; Osteomyelitis; Rhino orbito cerebral mucormycosis","Eswaran","Sudhagar","Department of ENT, Head and Neck Surgery, Sri Ramachandra Institute of Higher Education and Research, Chennai, India",NA
"2035","34258246","10.1007/s12070-021-02689-4","Acute Fulminant Mucormycosis Triggered by Covid 19 Infection in a Young Patient.","Covid 19 infection can result in various opportunistic infections. Altered immune response, associated comorbid conditions like diabetes, prolonged steroid and broad spectrum antibiotics usage with ICU interventions lead to increased chance of such superadded infections in covid 19 patients. Here we report a case of 31 year old male with covid 19 infection who had new onset Diabetes Mellitus, developed severe acute fulminant Mucormycosis during the treatment for covid 19 infection. He presented ","2021","07","15","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","Cavernous sinus thrombosis; Corona virus SARS-CoV-2; Covid 19 infection; Frontal craniectomy; Ophthalmoplegia; Osteomyelitis; Rhino orbito cerebral mucormycosis","Balan","Sarath Kumar","Department of ENT, Head and Neck Surgery, Sri Ramachandra Institute of Higher Education and Research, Chennai, India",NA
"2036","34258246","10.1007/s12070-021-02689-4","Acute Fulminant Mucormycosis Triggered by Covid 19 Infection in a Young Patient.","Covid 19 infection can result in various opportunistic infections. Altered immune response, associated comorbid conditions like diabetes, prolonged steroid and broad spectrum antibiotics usage with ICU interventions lead to increased chance of such superadded infections in covid 19 patients. Here we report a case of 31 year old male with covid 19 infection who had new onset Diabetes Mellitus, developed severe acute fulminant Mucormycosis during the treatment for covid 19 infection. He presented ","2021","07","15","Indian J Otolaryngol Head Neck Surg","Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India","Cavernous sinus thrombosis; Corona virus SARS-CoV-2; Covid 19 infection; Frontal craniectomy; Ophthalmoplegia; Osteomyelitis; Rhino orbito cerebral mucormycosis","Saravanam","Prasanna Kumar","Department of ENT, Head and Neck Surgery, Sri Ramachandra Institute of Higher Education and Research, Chennai, India",NA
"2037","34258235","10.1016/j.toxrep.2021.07.004","Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage.","The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the SARS-CoV-2 B.1.1.7 Lineage. We leveraged the multi-center SuPAR in Adult Patients With COVID-19 (SPARCOL) study and identified patients who required admission to intensive care unit (ICU). Inclusion c","2021","07","22","Toxicol Rep","Toxicology reports","B.1.1.7 variant; Bradycardia; COVID-19; Intensive care unit; Outcome","Chalkias","Athanasios","University of Thessaly, School of Health Sciences, Faculty of Medicine, Department of Anesthesiology, Larisa, Greece",NA
"2038","34258235","10.1016/j.toxrep.2021.07.004","Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage.","The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the SARS-CoV-2 B.1.1.7 Lineage. We leveraged the multi-center SuPAR in Adult Patients With COVID-19 (SPARCOL) study and identified patients who required admission to intensive care unit (ICU). Inclusion c","2021","07","22","Toxicol Rep","Toxicology reports","B.1.1.7 variant; Bradycardia; COVID-19; Intensive care unit; Outcome","Pantazopoulos","Ioannis","University of Thessaly, School of Health Sciences, Faculty of Medicine, Department of Emergency Medicine, Larisa, Greece",NA
"2039","34258235","10.1016/j.toxrep.2021.07.004","Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage.","The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the SARS-CoV-2 B.1.1.7 Lineage. We leveraged the multi-center SuPAR in Adult Patients With COVID-19 (SPARCOL) study and identified patients who required admission to intensive care unit (ICU). Inclusion c","2021","07","22","Toxicol Rep","Toxicology reports","B.1.1.7 variant; Bradycardia; COVID-19; Intensive care unit; Outcome","Papagiannakis","Nikolaos","National and Kapodistrian University of Athens, Medical School, Eginition University Hospital, First Department of Neurology, Athens, Greece",NA
"2040","34258235","10.1016/j.toxrep.2021.07.004","Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage.","The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the SARS-CoV-2 B.1.1.7 Lineage. We leveraged the multi-center SuPAR in Adult Patients With COVID-19 (SPARCOL) study and identified patients who required admission to intensive care unit (ICU). Inclusion c","2021","07","22","Toxicol Rep","Toxicology reports","B.1.1.7 variant; Bradycardia; COVID-19; Intensive care unit; Outcome","Skoulakis","Anargyros","University of Thessaly, School of Health Sciences, Faculty of Medicine, Department of Anesthesiology, Larisa, Greece",NA
"2041","34258235","10.1016/j.toxrep.2021.07.004","Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage.","The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the SARS-CoV-2 B.1.1.7 Lineage. We leveraged the multi-center SuPAR in Adult Patients With COVID-19 (SPARCOL) study and identified patients who required admission to intensive care unit (ICU). Inclusion c","2021","07","22","Toxicol Rep","Toxicology reports","B.1.1.7 variant; Bradycardia; COVID-19; Intensive care unit; Outcome","Laou","Eleni","University of Thessaly, School of Health Sciences, Faculty of Medicine, Department of Anesthesiology, Larisa, Greece",NA
"2042","34258235","10.1016/j.toxrep.2021.07.004","Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage.","The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the SARS-CoV-2 B.1.1.7 Lineage. We leveraged the multi-center SuPAR in Adult Patients With COVID-19 (SPARCOL) study and identified patients who required admission to intensive care unit (ICU). Inclusion c","2021","07","22","Toxicol Rep","Toxicology reports","B.1.1.7 variant; Bradycardia; COVID-19; Intensive care unit; Outcome","Kolonia","Konstantina","University of Thessaly, School of Health Sciences, Faculty of Medicine, Department of Anesthesiology, Larisa, Greece",NA
"2043","34258235","10.1016/j.toxrep.2021.07.004","Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage.","The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the SARS-CoV-2 B.1.1.7 Lineage. We leveraged the multi-center SuPAR in Adult Patients With COVID-19 (SPARCOL) study and identified patients who required admission to intensive care unit (ICU). Inclusion c","2021","07","22","Toxicol Rep","Toxicology reports","B.1.1.7 variant; Bradycardia; COVID-19; Intensive care unit; Outcome","Ntalarizou","Nicoletta","University of Thessaly, School of Health Sciences, Faculty of Medicine, Department of Anesthesiology, Larisa, Greece",NA
"2044","34258235","10.1016/j.toxrep.2021.07.004","Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage.","The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the SARS-CoV-2 B.1.1.7 Lineage. We leveraged the multi-center SuPAR in Adult Patients With COVID-19 (SPARCOL) study and identified patients who required admission to intensive care unit (ICU). Inclusion c","2021","07","22","Toxicol Rep","Toxicology reports","B.1.1.7 variant; Bradycardia; COVID-19; Intensive care unit; Outcome","Tourlakopoulos","Konstantinos","University of Thessaly, School of Health Sciences, Faculty of Medicine, Department of Respiratory Medicine, Larisa, Greece",NA
"2045","34258235","10.1016/j.toxrep.2021.07.004","Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage.","The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the SARS-CoV-2 B.1.1.7 Lineage. We leveraged the multi-center SuPAR in Adult Patients With COVID-19 (SPARCOL) study and identified patients who required admission to intensive care unit (ICU). Inclusion c","2021","07","22","Toxicol Rep","Toxicology reports","B.1.1.7 variant; Bradycardia; COVID-19; Intensive care unit; Outcome","Pagonis","Athanasios","University of Thessaly, School of Health Sciences, Faculty of Medicine, Department of Respiratory Medicine, Larisa, Greece",NA
"2046","34258235","10.1016/j.toxrep.2021.07.004","Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage.","The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the SARS-CoV-2 B.1.1.7 Lineage. We leveraged the multi-center SuPAR in Adult Patients With COVID-19 (SPARCOL) study and identified patients who required admission to intensive care unit (ICU). Inclusion c","2021","07","22","Toxicol Rep","Toxicology reports","B.1.1.7 variant; Bradycardia; COVID-19; Intensive care unit; Outcome","Kampolis","Christos","Hippokrateion University Hospital, Department of Emergency Medicine, Athens, Greece",NA
"2047","34258235","10.1016/j.toxrep.2021.07.004","Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage.","The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the SARS-CoV-2 B.1.1.7 Lineage. We leveraged the multi-center SuPAR in Adult Patients With COVID-19 (SPARCOL) study and identified patients who required admission to intensive care unit (ICU). Inclusion c","2021","07","22","Toxicol Rep","Toxicology reports","B.1.1.7 variant; Bradycardia; COVID-19; Intensive care unit; Outcome","De Guadiana Romualdo","Luis García","Hospital Universitario Santa Lucía, Laboratory Medicine Department, Cartagena, Spain",NA
"2048","34258235","10.1016/j.toxrep.2021.07.004","Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage.","The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the SARS-CoV-2 B.1.1.7 Lineage. We leveraged the multi-center SuPAR in Adult Patients With COVID-19 (SPARCOL) study and identified patients who required admission to intensive care unit (ICU). Inclusion c","2021","07","22","Toxicol Rep","Toxicology reports","B.1.1.7 variant; Bradycardia; COVID-19; Intensive care unit; Outcome","Ragias","Dimitrios","University of Thessaly, School of Health Sciences, Faculty of Medicine, Department of Anesthesiology, Larisa, Greece",NA
"2049","34258235","10.1016/j.toxrep.2021.07.004","Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage.","The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the SARS-CoV-2 B.1.1.7 Lineage. We leveraged the multi-center SuPAR in Adult Patients With COVID-19 (SPARCOL) study and identified patients who required admission to intensive care unit (ICU). Inclusion c","2021","07","22","Toxicol Rep","Toxicology reports","B.1.1.7 variant; Bradycardia; COVID-19; Intensive care unit; Outcome","Eugen-Olsen","Jesper","Copenhagen University Hospital Hvidovre, Department of Clinical Research, Hvidovre, Denmark",NA
"2050","34258235","10.1016/j.toxrep.2021.07.004","Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage.","The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the SARS-CoV-2 B.1.1.7 Lineage. We leveraged the multi-center SuPAR in Adult Patients With COVID-19 (SPARCOL) study and identified patients who required admission to intensive care unit (ICU). Inclusion c","2021","07","22","Toxicol Rep","Toxicology reports","B.1.1.7 variant; Bradycardia; COVID-19; Intensive care unit; Outcome","Gourgoulianis","Konstantinos","University of Thessaly, School of Health Sciences, Faculty of Medicine, Department of Respiratory Medicine, Larisa, Greece",NA
"2051","34258235","10.1016/j.toxrep.2021.07.004","Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage.","The progress of COVID-19 from moderate to severe may be precipitous, while the characteristics of the disease are heterogenous. The aim of this study was to describe the development of sinus bradycardia in critically ill patients with COVID-19 and its association with outcome in outbreak due to the SARS-CoV-2 B.1.1.7 Lineage. We leveraged the multi-center SuPAR in Adult Patients With COVID-19 (SPARCOL) study and identified patients who required admission to intensive care unit (ICU). Inclusion c","2021","07","22","Toxicol Rep","Toxicology reports","B.1.1.7 variant; Bradycardia; COVID-19; Intensive care unit; Outcome","Arnaoutoglou","Eleni","University of Thessaly, School of Health Sciences, Faculty of Medicine, Department of Anesthesiology, Larisa, Greece",NA
"2052","34258181","10.1016/j.uclim.2021.100913","Impact of biomass induced black carbon particles in cascading COVID-19.","We explore the association of biomass-induced black carbon aerosolized virus with COVID-19 in one of the top-ranked polluted hot spot regions of the world, Delhi, at the time when other confounding factors were almost stable and the pandemic wave was on the declining stage. Delhi was worst affected by COVID-19. However, when it was fast returning back to normal after about 6 months with minimum fatalities, it suddenly encountered a reversal with a 10 fold increase in infection counts, coinciding","2021","07","15","Urban Clim","Urban climate","Black carbon; COVID-19; Microbes; PM2.5; Pyrogenic","Rathod","Aditi","Indian Institute of Tropical Meteorology, Pune 411008, India",NA
"2053","34258181","10.1016/j.uclim.2021.100913","Impact of biomass induced black carbon particles in cascading COVID-19.","We explore the association of biomass-induced black carbon aerosolized virus with COVID-19 in one of the top-ranked polluted hot spot regions of the world, Delhi, at the time when other confounding factors were almost stable and the pandemic wave was on the declining stage. Delhi was worst affected by COVID-19. However, when it was fast returning back to normal after about 6 months with minimum fatalities, it suddenly encountered a reversal with a 10 fold increase in infection counts, coinciding","2021","07","15","Urban Clim","Urban climate","Black carbon; COVID-19; Microbes; PM2.5; Pyrogenic","Beig","Gufran","Indian Institute of Tropical Meteorology, Pune 411008, India",NA
"2054","34258148","10.1007/s10389-021-01630-x","Impact of COVID-19 on the exercise habits of Pennsylvania residents and their families.","This study investigated how COVID-19 impacted the physical activity and sports participation of Pennsylvania residents and their children. Data were collected through an online survey of 525 Pennsylvania residents with a child between the ages of 3 and 17. Data were collected in October 2020. Nearly a third of respondents reported a decrease in their physical activity. Hispanics were more likely than non-Hispanics to report a decrease in their physical activity. Older children were more likely t","2021","07","15","Z Gesundh Wiss","Zeitschrift fur Gesundheitswissenschaften = Journal of public health","COVID-19; Ethnicity; Exercise; Gender; Socioeconomic status; Sports","Wallace","Lacey N","Department of Criminal Justice, Penn State Altoona, 101G Cypress Building, 3000 Ivyside Park, Altoona, PA 16601 USA",NA
"2055","34258131","10.7759/cureus.16171","Aortic Thrombosis and Acute Limb Ischemia Secondary to COVID Hypercoagulability.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or coronavirus disease 2019 (COVID-19), first identified in December 2019 in Wuhan, China, has rapidly spread worldwide, is now a public health emergency, and has been declared a pandemic. While SARS-CoV-2 is known to cause significant pulmonary disease, ranging from pneumonia to acute respiratory distress syndrome (ARDS), various extrapulmonary manifestations of COVID-19 have also been reported. Growing evidence suggests that COVID-19","2021","07","15","Cureus","Cureus","acute limb ischemia; aorta thrombosis; aortic thrombosis; arterial thrombus occlusion; coronavirus; covid 19; covid hypercoagulability; covid-19; covid-related hypercoagulability; thrombosis","Burley","Nicholas B","Internal Medicine, Sinai Hospital of Baltimore, Baltimore, USA",NA
"2056","34258131","10.7759/cureus.16171","Aortic Thrombosis and Acute Limb Ischemia Secondary to COVID Hypercoagulability.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or coronavirus disease 2019 (COVID-19), first identified in December 2019 in Wuhan, China, has rapidly spread worldwide, is now a public health emergency, and has been declared a pandemic. While SARS-CoV-2 is known to cause significant pulmonary disease, ranging from pneumonia to acute respiratory distress syndrome (ARDS), various extrapulmonary manifestations of COVID-19 have also been reported. Growing evidence suggests that COVID-19","2021","07","15","Cureus","Cureus","acute limb ischemia; aorta thrombosis; aortic thrombosis; arterial thrombus occlusion; coronavirus; covid 19; covid hypercoagulability; covid-19; covid-related hypercoagulability; thrombosis","Dy","Paul S","Internal Medicine, Sinai Hospital of Baltimore, Baltimore, USA",NA
"2057","34258131","10.7759/cureus.16171","Aortic Thrombosis and Acute Limb Ischemia Secondary to COVID Hypercoagulability.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or coronavirus disease 2019 (COVID-19), first identified in December 2019 in Wuhan, China, has rapidly spread worldwide, is now a public health emergency, and has been declared a pandemic. While SARS-CoV-2 is known to cause significant pulmonary disease, ranging from pneumonia to acute respiratory distress syndrome (ARDS), various extrapulmonary manifestations of COVID-19 have also been reported. Growing evidence suggests that COVID-19","2021","07","15","Cureus","Cureus","acute limb ischemia; aorta thrombosis; aortic thrombosis; arterial thrombus occlusion; coronavirus; covid 19; covid hypercoagulability; covid-19; covid-related hypercoagulability; thrombosis","Kalantri","Shreyas","Internal Medicine, Sinai Hospital of Baltimore, Baltimore, USA",NA
"2058","34258131","10.7759/cureus.16171","Aortic Thrombosis and Acute Limb Ischemia Secondary to COVID Hypercoagulability.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or coronavirus disease 2019 (COVID-19), first identified in December 2019 in Wuhan, China, has rapidly spread worldwide, is now a public health emergency, and has been declared a pandemic. While SARS-CoV-2 is known to cause significant pulmonary disease, ranging from pneumonia to acute respiratory distress syndrome (ARDS), various extrapulmonary manifestations of COVID-19 have also been reported. Growing evidence suggests that COVID-19","2021","07","15","Cureus","Cureus","acute limb ischemia; aorta thrombosis; aortic thrombosis; arterial thrombus occlusion; coronavirus; covid 19; covid hypercoagulability; covid-19; covid-related hypercoagulability; thrombosis","Razzaq","Kanwal","Internal Medicine, Sinai Hospital of Baltimore, Baltimore, USA",NA
"2059","34258124","10.7759/cureus.15462","Biomarkers Predictive of Extubation and Survival of COVID-19 Patients.","Purpose Many patients with COVID-19 who develop acute respiratory distress syndrome (ARDS) require prolonged periods of mechanical ventilation. Mechanical ventilation may amplify ventilator-associated complications and extend resource utilization. A better understanding of prognostic indicators could help in the planning and distribution of resources, particularly in resource-limited areas. We analyzed laboratory studies of intubated COVID-19 patients with the goal of identifying biomarkers that","2021","07","15","Cureus","Cureus","biomarkers; covid 19; extubation; intubation; platelet count","Topp","Gregory","Department of Medicine, Albany Medical College, Albany, USA",NA
"2060","34258124","10.7759/cureus.15462","Biomarkers Predictive of Extubation and Survival of COVID-19 Patients.","Purpose Many patients with COVID-19 who develop acute respiratory distress syndrome (ARDS) require prolonged periods of mechanical ventilation. Mechanical ventilation may amplify ventilator-associated complications and extend resource utilization. A better understanding of prognostic indicators could help in the planning and distribution of resources, particularly in resource-limited areas. We analyzed laboratory studies of intubated COVID-19 patients with the goal of identifying biomarkers that","2021","07","15","Cureus","Cureus","biomarkers; covid 19; extubation; intubation; platelet count","Bouyea","Megan","Department of Medicine, Albany Medical College, Albany, USA",NA
"2061","34258124","10.7759/cureus.15462","Biomarkers Predictive of Extubation and Survival of COVID-19 Patients.","Purpose Many patients with COVID-19 who develop acute respiratory distress syndrome (ARDS) require prolonged periods of mechanical ventilation. Mechanical ventilation may amplify ventilator-associated complications and extend resource utilization. A better understanding of prognostic indicators could help in the planning and distribution of resources, particularly in resource-limited areas. We analyzed laboratory studies of intubated COVID-19 patients with the goal of identifying biomarkers that","2021","07","15","Cureus","Cureus","biomarkers; covid 19; extubation; intubation; platelet count","Cochran-Caggiano","Nicholas","Department of Medicine, Albany Medical College, Albany, USA",NA
"2062","34258124","10.7759/cureus.15462","Biomarkers Predictive of Extubation and Survival of COVID-19 Patients.","Purpose Many patients with COVID-19 who develop acute respiratory distress syndrome (ARDS) require prolonged periods of mechanical ventilation. Mechanical ventilation may amplify ventilator-associated complications and extend resource utilization. A better understanding of prognostic indicators could help in the planning and distribution of resources, particularly in resource-limited areas. We analyzed laboratory studies of intubated COVID-19 patients with the goal of identifying biomarkers that","2021","07","15","Cureus","Cureus","biomarkers; covid 19; extubation; intubation; platelet count","Ata","Ashar","Department of Surgery, Albany Medical Center, Albany, USA",NA
"2063","34258124","10.7759/cureus.15462","Biomarkers Predictive of Extubation and Survival of COVID-19 Patients.","Purpose Many patients with COVID-19 who develop acute respiratory distress syndrome (ARDS) require prolonged periods of mechanical ventilation. Mechanical ventilation may amplify ventilator-associated complications and extend resource utilization. A better understanding of prognostic indicators could help in the planning and distribution of resources, particularly in resource-limited areas. We analyzed laboratory studies of intubated COVID-19 patients with the goal of identifying biomarkers that","2021","07","15","Cureus","Cureus","biomarkers; covid 19; extubation; intubation; platelet count","Torres","Pedro","Department of Surgery, Albany Medical Center, Albany, USA",NA
"2064","34258124","10.7759/cureus.15462","Biomarkers Predictive of Extubation and Survival of COVID-19 Patients.","Purpose Many patients with COVID-19 who develop acute respiratory distress syndrome (ARDS) require prolonged periods of mechanical ventilation. Mechanical ventilation may amplify ventilator-associated complications and extend resource utilization. A better understanding of prognostic indicators could help in the planning and distribution of resources, particularly in resource-limited areas. We analyzed laboratory studies of intubated COVID-19 patients with the goal of identifying biomarkers that","2021","07","15","Cureus","Cureus","biomarkers; covid 19; extubation; intubation; platelet count","Jacob","Jackcy","Department of Medicine, Albany Medical Center, Albany, USA",NA
"2065","34258124","10.7759/cureus.15462","Biomarkers Predictive of Extubation and Survival of COVID-19 Patients.","Purpose Many patients with COVID-19 who develop acute respiratory distress syndrome (ARDS) require prolonged periods of mechanical ventilation. Mechanical ventilation may amplify ventilator-associated complications and extend resource utilization. A better understanding of prognostic indicators could help in the planning and distribution of resources, particularly in resource-limited areas. We analyzed laboratory studies of intubated COVID-19 patients with the goal of identifying biomarkers that","2021","07","15","Cureus","Cureus","biomarkers; covid 19; extubation; intubation; platelet count","Wales","Danielle","Department of Medicine, Albany Medical Center, Albany, USA",NA
"2066","34258107","10.7759/cureus.15431","Acute Acalculous Cholecystitis Due to COVID-19, an Unusual Presentation.","Although the Coronavirus Disease 2019 (COVID-19) infection mainly affects the lung, its gastrointestinal (GI) involvements are also well-known, especially hepatic involvement presenting as mild to moderate transaminitis. However, COVID-19 infection presenting with gall bladder involvement with acalculous cholecystitis is extremely rare in the medical literature. So far, only two cases have been reported, and herein, we are reporting the third case of a patient who developed COVID-19 presenting a","2021","07","15","Cureus","Cureus","acalculus cholecystitis; acute cholecystitis; covid 19; covid 19 gi manifestation; covid 19 pneumonia","Abaleka","Fuad I","Internal Medicine, Richmond University Medical Center, Staten Island, USA",NA
"2067","34258107","10.7759/cureus.15431","Acute Acalculous Cholecystitis Due to COVID-19, an Unusual Presentation.","Although the Coronavirus Disease 2019 (COVID-19) infection mainly affects the lung, its gastrointestinal (GI) involvements are also well-known, especially hepatic involvement presenting as mild to moderate transaminitis. However, COVID-19 infection presenting with gall bladder involvement with acalculous cholecystitis is extremely rare in the medical literature. So far, only two cases have been reported, and herein, we are reporting the third case of a patient who developed COVID-19 presenting a","2021","07","15","Cureus","Cureus","acalculus cholecystitis; acute cholecystitis; covid 19; covid 19 gi manifestation; covid 19 pneumonia","Nigussie","Bisrat","Internal Medicine, Richmond University Medical Center, Staten Island, USA",NA
"2068","34258107","10.7759/cureus.15431","Acute Acalculous Cholecystitis Due to COVID-19, an Unusual Presentation.","Although the Coronavirus Disease 2019 (COVID-19) infection mainly affects the lung, its gastrointestinal (GI) involvements are also well-known, especially hepatic involvement presenting as mild to moderate transaminitis. However, COVID-19 infection presenting with gall bladder involvement with acalculous cholecystitis is extremely rare in the medical literature. So far, only two cases have been reported, and herein, we are reporting the third case of a patient who developed COVID-19 presenting a","2021","07","15","Cureus","Cureus","acalculus cholecystitis; acute cholecystitis; covid 19; covid 19 gi manifestation; covid 19 pneumonia","Bedanie","Genanew","Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, USA",NA
"2069","34258107","10.7759/cureus.15431","Acute Acalculous Cholecystitis Due to COVID-19, an Unusual Presentation.","Although the Coronavirus Disease 2019 (COVID-19) infection mainly affects the lung, its gastrointestinal (GI) involvements are also well-known, especially hepatic involvement presenting as mild to moderate transaminitis. However, COVID-19 infection presenting with gall bladder involvement with acalculous cholecystitis is extremely rare in the medical literature. So far, only two cases have been reported, and herein, we are reporting the third case of a patient who developed COVID-19 presenting a","2021","07","15","Cureus","Cureus","acalculus cholecystitis; acute cholecystitis; covid 19; covid 19 gi manifestation; covid 19 pneumonia","Mohammed","Amir","Internal Medicine, Wellstar Atlanta Medical Center, Atlanta, USA",NA
"2070","34258107","10.7759/cureus.15431","Acute Acalculous Cholecystitis Due to COVID-19, an Unusual Presentation.","Although the Coronavirus Disease 2019 (COVID-19) infection mainly affects the lung, its gastrointestinal (GI) involvements are also well-known, especially hepatic involvement presenting as mild to moderate transaminitis. However, COVID-19 infection presenting with gall bladder involvement with acalculous cholecystitis is extremely rare in the medical literature. So far, only two cases have been reported, and herein, we are reporting the third case of a patient who developed COVID-19 presenting a","2021","07","15","Cureus","Cureus","acalculus cholecystitis; acute cholecystitis; covid 19; covid 19 gi manifestation; covid 19 pneumonia","Galiboglu","Selin","Internal Medicine, Richmond University Medical Center, Staten Island, USA",NA
"2071","34258101","10.1557/s43579-021-00049-5","Periodic thermomechanical modulation of toll-like receptor expression and distribution in mesenchymal stromal cells.","Toll-like receptor (TLR) can trigger an immune response against virus including SARS-CoV-2. TLR expression/distribution is varying in mesenchymal stromal cells (MSCs) depending on their culture environments. Here, to explore the effect of periodic thermomechanical cues on TLRs, thermally controlled shape-memory polymer sheets with programmable actuation capacity were created. The proportion of MSCs expressing SARS-CoV-2-associated TLRs was increased upon stimulation. The TLR4/7 colocalization wa","2021","07","15","MRS Commun","MRS communications","Actuation; Antiviral; Biomaterial; COVID-19; Shape memory","Xu","Xun","Institute of Active Polymers and Berlin-Brandenburg Center for Regenerative Therapies, Helmholtz-Zentrum Hereon, 14513 Teltow, Germany",NA
"2072","34258101","10.1557/s43579-021-00049-5","Periodic thermomechanical modulation of toll-like receptor expression and distribution in mesenchymal stromal cells.","Toll-like receptor (TLR) can trigger an immune response against virus including SARS-CoV-2. TLR expression/distribution is varying in mesenchymal stromal cells (MSCs) depending on their culture environments. Here, to explore the effect of periodic thermomechanical cues on TLRs, thermally controlled shape-memory polymer sheets with programmable actuation capacity were created. The proportion of MSCs expressing SARS-CoV-2-associated TLRs was increased upon stimulation. The TLR4/7 colocalization wa","2021","07","15","MRS Commun","MRS communications","Actuation; Antiviral; Biomaterial; COVID-19; Shape memory","Nie","Yan","Institute of Active Polymers and Berlin-Brandenburg Center for Regenerative Therapies, Helmholtz-Zentrum Hereon, 14513 Teltow, Germany",NA
"2073","34258101","10.1557/s43579-021-00049-5","Periodic thermomechanical modulation of toll-like receptor expression and distribution in mesenchymal stromal cells.","Toll-like receptor (TLR) can trigger an immune response against virus including SARS-CoV-2. TLR expression/distribution is varying in mesenchymal stromal cells (MSCs) depending on their culture environments. Here, to explore the effect of periodic thermomechanical cues on TLRs, thermally controlled shape-memory polymer sheets with programmable actuation capacity were created. The proportion of MSCs expressing SARS-CoV-2-associated TLRs was increased upon stimulation. The TLR4/7 colocalization wa","2021","07","15","MRS Commun","MRS communications","Actuation; Antiviral; Biomaterial; COVID-19; Shape memory","Wang","Weiwei","Institute of Active Polymers and Berlin-Brandenburg Center for Regenerative Therapies, Helmholtz-Zentrum Hereon, 14513 Teltow, Germany",NA
"2074","34258101","10.1557/s43579-021-00049-5","Periodic thermomechanical modulation of toll-like receptor expression and distribution in mesenchymal stromal cells.","Toll-like receptor (TLR) can trigger an immune response against virus including SARS-CoV-2. TLR expression/distribution is varying in mesenchymal stromal cells (MSCs) depending on their culture environments. Here, to explore the effect of periodic thermomechanical cues on TLRs, thermally controlled shape-memory polymer sheets with programmable actuation capacity were created. The proportion of MSCs expressing SARS-CoV-2-associated TLRs was increased upon stimulation. The TLR4/7 colocalization wa","2021","07","15","MRS Commun","MRS communications","Actuation; Antiviral; Biomaterial; COVID-19; Shape memory","Ma","Nan","Institute of Active Polymers and Berlin-Brandenburg Center for Regenerative Therapies, Helmholtz-Zentrum Hereon, 14513 Teltow, Germany",NA
"2075","34258101","10.1557/s43579-021-00049-5","Periodic thermomechanical modulation of toll-like receptor expression and distribution in mesenchymal stromal cells.","Toll-like receptor (TLR) can trigger an immune response against virus including SARS-CoV-2. TLR expression/distribution is varying in mesenchymal stromal cells (MSCs) depending on their culture environments. Here, to explore the effect of periodic thermomechanical cues on TLRs, thermally controlled shape-memory polymer sheets with programmable actuation capacity were created. The proportion of MSCs expressing SARS-CoV-2-associated TLRs was increased upon stimulation. The TLR4/7 colocalization wa","2021","07","15","MRS Commun","MRS communications","Actuation; Antiviral; Biomaterial; COVID-19; Shape memory","Lendlein","Andreas","Institute of Active Polymers and Berlin-Brandenburg Center for Regenerative Therapies, Helmholtz-Zentrum Hereon, 14513 Teltow, Germany",NA
"2076","34258083","10.1155/2021/9912068","Vitamin D Toxicity Managed with Peritoneal Dialysis.","Vitamin D deficiency is a global health issue that afflicts more than one billion children and adults worldwide. Vitamin D supplementation has increased over the years, whether through medical prescriptions, over-the-counter, or online purchasing. This is driven by a more recognized association between vitamin D sufficiency status and lower risk of cancer. In addition, more recently, it is used as a potential prophylactic and treatment for COVID-19 infection. This can lead to toxicity from overi","2021","07","15","Case Rep Endocrinol","Case reports in endocrinology",NA,"Feghali","Krystel","Department of Endocrinology, Diabetes and Metabolism, University of Massachusetts Medical School, Baystate Medical Center, Springfield, MA, USA",NA
"2077","34258083","10.1155/2021/9912068","Vitamin D Toxicity Managed with Peritoneal Dialysis.","Vitamin D deficiency is a global health issue that afflicts more than one billion children and adults worldwide. Vitamin D supplementation has increased over the years, whether through medical prescriptions, over-the-counter, or online purchasing. This is driven by a more recognized association between vitamin D sufficiency status and lower risk of cancer. In addition, more recently, it is used as a potential prophylactic and treatment for COVID-19 infection. This can lead to toxicity from overi","2021","07","15","Case Rep Endocrinol","Case reports in endocrinology",NA,"Papamarkakis","Kostas","Division of Nephrology, University of Massachusetts Medical School, Baystate Medical Center, Springfield, MA, USA",NA
"2078","34258083","10.1155/2021/9912068","Vitamin D Toxicity Managed with Peritoneal Dialysis.","Vitamin D deficiency is a global health issue that afflicts more than one billion children and adults worldwide. Vitamin D supplementation has increased over the years, whether through medical prescriptions, over-the-counter, or online purchasing. This is driven by a more recognized association between vitamin D sufficiency status and lower risk of cancer. In addition, more recently, it is used as a potential prophylactic and treatment for COVID-19 infection. This can lead to toxicity from overi","2021","07","15","Case Rep Endocrinol","Case reports in endocrinology",NA,"Clark","Jackson","Division of Internal Medicine, University of Massachusetts Medical School, Baystate Medical Center, Springfield, MA, USA",NA
"2079","34258083","10.1155/2021/9912068","Vitamin D Toxicity Managed with Peritoneal Dialysis.","Vitamin D deficiency is a global health issue that afflicts more than one billion children and adults worldwide. Vitamin D supplementation has increased over the years, whether through medical prescriptions, over-the-counter, or online purchasing. This is driven by a more recognized association between vitamin D sufficiency status and lower risk of cancer. In addition, more recently, it is used as a potential prophylactic and treatment for COVID-19 infection. This can lead to toxicity from overi","2021","07","15","Case Rep Endocrinol","Case reports in endocrinology",NA,"Malhotra","Neha","Department of Endocrinology, Diabetes and Metabolism, University of Massachusetts Medical School, Baystate Medical Center, Springfield, MA, USA",NA
"2080","34258083","10.1155/2021/9912068","Vitamin D Toxicity Managed with Peritoneal Dialysis.","Vitamin D deficiency is a global health issue that afflicts more than one billion children and adults worldwide. Vitamin D supplementation has increased over the years, whether through medical prescriptions, over-the-counter, or online purchasing. This is driven by a more recognized association between vitamin D sufficiency status and lower risk of cancer. In addition, more recently, it is used as a potential prophylactic and treatment for COVID-19 infection. This can lead to toxicity from overi","2021","07","15","Case Rep Endocrinol","Case reports in endocrinology",NA,"Stoddart","Lanu","Division of Pathology, University of Massachusetts Medical School, Baystate Medical Center, Springfield, MA, USA",NA
"2081","34258083","10.1155/2021/9912068","Vitamin D Toxicity Managed with Peritoneal Dialysis.","Vitamin D deficiency is a global health issue that afflicts more than one billion children and adults worldwide. Vitamin D supplementation has increased over the years, whether through medical prescriptions, over-the-counter, or online purchasing. This is driven by a more recognized association between vitamin D sufficiency status and lower risk of cancer. In addition, more recently, it is used as a potential prophylactic and treatment for COVID-19 infection. This can lead to toxicity from overi","2021","07","15","Case Rep Endocrinol","Case reports in endocrinology",NA,"Osakwe","Ibitoro","Department of Endocrinology, Diabetes and Metabolism, University of Massachusetts Medical School, Baystate Medical Center, Springfield, MA, USA",NA
"2082","34258061","10.1155/2021/5533123","The Impact of COVID-19 on Hospitalised COPD Exacerbations in Malta.","Data was collected retrospectively from electronic hospital records during the periods 1st March until 10th May in 2019 and 2020. There was a marked decrease in AECOPD admissions in 2020, with a 54.2% drop in admissions (n = 119 in 2020 vs. n = 259 in 2019). There was no significant difference in patient demographics or medical comorbidities. In 2020, there was a significantly lower number of patients with AECOPD who received nebulised medications during admission (60.4% in 2020 vs. 84.9% in 201","2021","07","22","Pulm Med","Pulmonary medicine","Aged; COVID-19; Cross-Sectional Studies; Disease Progression; Female; Hospitalization; Humans; Male; Malta; Pulmonary Disease, Chronic Obstructive; Retrospective Studies","Farrugia","Yvette","Mater Dei Hospital, Triq id-Donaturi tad-Demm, Msida MSD2090, Malta",NA
"2083","34258061","10.1155/2021/5533123","The Impact of COVID-19 on Hospitalised COPD Exacerbations in Malta.","Data was collected retrospectively from electronic hospital records during the periods 1st March until 10th May in 2019 and 2020. There was a marked decrease in AECOPD admissions in 2020, with a 54.2% drop in admissions (n = 119 in 2020 vs. n = 259 in 2019). There was no significant difference in patient demographics or medical comorbidities. In 2020, there was a significantly lower number of patients with AECOPD who received nebulised medications during admission (60.4% in 2020 vs. 84.9% in 201","2021","07","22","Pulm Med","Pulmonary medicine","Aged; COVID-19; Cross-Sectional Studies; Disease Progression; Female; Hospitalization; Humans; Male; Malta; Pulmonary Disease, Chronic Obstructive; Retrospective Studies","Spiteri Meilak","Bernard Paul","Mater Dei Hospital, Triq id-Donaturi tad-Demm, Msida MSD2090, Malta",NA
"2084","34258061","10.1155/2021/5533123","The Impact of COVID-19 on Hospitalised COPD Exacerbations in Malta.","Data was collected retrospectively from electronic hospital records during the periods 1st March until 10th May in 2019 and 2020. There was a marked decrease in AECOPD admissions in 2020, with a 54.2% drop in admissions (n = 119 in 2020 vs. n = 259 in 2019). There was no significant difference in patient demographics or medical comorbidities. In 2020, there was a significantly lower number of patients with AECOPD who received nebulised medications during admission (60.4% in 2020 vs. 84.9% in 201","2021","07","22","Pulm Med","Pulmonary medicine","Aged; COVID-19; Cross-Sectional Studies; Disease Progression; Female; Hospitalization; Humans; Male; Malta; Pulmonary Disease, Chronic Obstructive; Retrospective Studies","Grech","Neil","Mater Dei Hospital, Triq id-Donaturi tad-Demm, Msida MSD2090, Malta",NA
"2085","34258061","10.1155/2021/5533123","The Impact of COVID-19 on Hospitalised COPD Exacerbations in Malta.","Data was collected retrospectively from electronic hospital records during the periods 1st March until 10th May in 2019 and 2020. There was a marked decrease in AECOPD admissions in 2020, with a 54.2% drop in admissions (n = 119 in 2020 vs. n = 259 in 2019). There was no significant difference in patient demographics or medical comorbidities. In 2020, there was a significantly lower number of patients with AECOPD who received nebulised medications during admission (60.4% in 2020 vs. 84.9% in 201","2021","07","22","Pulm Med","Pulmonary medicine","Aged; COVID-19; Cross-Sectional Studies; Disease Progression; Female; Hospitalization; Humans; Male; Malta; Pulmonary Disease, Chronic Obstructive; Retrospective Studies","Asciak","Rachelle","Mater Dei Hospital, Triq id-Donaturi tad-Demm, Msida MSD2090, Malta",NA
"2086","34258061","10.1155/2021/5533123","The Impact of COVID-19 on Hospitalised COPD Exacerbations in Malta.","Data was collected retrospectively from electronic hospital records during the periods 1st March until 10th May in 2019 and 2020. There was a marked decrease in AECOPD admissions in 2020, with a 54.2% drop in admissions (n = 119 in 2020 vs. n = 259 in 2019). There was no significant difference in patient demographics or medical comorbidities. In 2020, there was a significantly lower number of patients with AECOPD who received nebulised medications during admission (60.4% in 2020 vs. 84.9% in 201","2021","07","22","Pulm Med","Pulmonary medicine","Aged; COVID-19; Cross-Sectional Studies; Disease Progression; Female; Hospitalization; Humans; Male; Malta; Pulmonary Disease, Chronic Obstructive; Retrospective Studies","Camilleri","Liberato","Mater Dei Hospital, Triq id-Donaturi tad-Demm, Msida MSD2090, Malta",NA
"2087","34258061","10.1155/2021/5533123","The Impact of COVID-19 on Hospitalised COPD Exacerbations in Malta.","Data was collected retrospectively from electronic hospital records during the periods 1st March until 10th May in 2019 and 2020. There was a marked decrease in AECOPD admissions in 2020, with a 54.2% drop in admissions (n = 119 in 2020 vs. n = 259 in 2019). There was no significant difference in patient demographics or medical comorbidities. In 2020, there was a significantly lower number of patients with AECOPD who received nebulised medications during admission (60.4% in 2020 vs. 84.9% in 201","2021","07","22","Pulm Med","Pulmonary medicine","Aged; COVID-19; Cross-Sectional Studies; Disease Progression; Female; Hospitalization; Humans; Male; Malta; Pulmonary Disease, Chronic Obstructive; Retrospective Studies","Montefort","Stephen","Mater Dei Hospital, Triq id-Donaturi tad-Demm, Msida MSD2090, Malta",NA
"2088","34258061","10.1155/2021/5533123","The Impact of COVID-19 on Hospitalised COPD Exacerbations in Malta.","Data was collected retrospectively from electronic hospital records during the periods 1st March until 10th May in 2019 and 2020. There was a marked decrease in AECOPD admissions in 2020, with a 54.2% drop in admissions (n = 119 in 2020 vs. n = 259 in 2019). There was no significant difference in patient demographics or medical comorbidities. In 2020, there was a significantly lower number of patients with AECOPD who received nebulised medications during admission (60.4% in 2020 vs. 84.9% in 201","2021","07","22","Pulm Med","Pulmonary medicine","Aged; COVID-19; Cross-Sectional Studies; Disease Progression; Female; Hospitalization; Humans; Male; Malta; Pulmonary Disease, Chronic Obstructive; Retrospective Studies","Zammit","Christopher","Mater Dei Hospital, Triq id-Donaturi tad-Demm, Msida MSD2090, Malta",NA
"2089","34258059","10.1155/2021/5443083","Validation of the Acute Physiology and Chronic Health Evaluation (APACHE) II and IV Score in COVID-19 Patients.","Severity scoring systems are inherent to ICU practice for multiple purposes. Acute Physiology and Chronic Health Evaluation (APACHE) scoring systems are designed for ICU mortality prediction. This study aims to validate APACHE IV in COVID-19 patients admitted to the ICU. All COVID-19 patients admitted to the ICU between March 13, 2020, and October 17, 2020, were retrospectively analyzed. APACHE II and APACHE IV scores as well as SOFA scores were calculated within 24 hours after admission. Discri","2021","07","15","Crit Care Res Pract","Critical care research and practice",NA,"Vandenbrande","Jeroen","Department of Intensive Care and Anesthesiology, Jessa Hospital, Hasselt, Belgium",NA
"2090","34258059","10.1155/2021/5443083","Validation of the Acute Physiology and Chronic Health Evaluation (APACHE) II and IV Score in COVID-19 Patients.","Severity scoring systems are inherent to ICU practice for multiple purposes. Acute Physiology and Chronic Health Evaluation (APACHE) scoring systems are designed for ICU mortality prediction. This study aims to validate APACHE IV in COVID-19 patients admitted to the ICU. All COVID-19 patients admitted to the ICU between March 13, 2020, and October 17, 2020, were retrospectively analyzed. APACHE II and APACHE IV scores as well as SOFA scores were calculated within 24 hours after admission. Discri","2021","07","15","Crit Care Res Pract","Critical care research and practice",NA,"Verbrugge","Laurens","Department of Intensive Care and Anesthesiology, Jessa Hospital, Hasselt, Belgium",NA
"2091","34258059","10.1155/2021/5443083","Validation of the Acute Physiology and Chronic Health Evaluation (APACHE) II and IV Score in COVID-19 Patients.","Severity scoring systems are inherent to ICU practice for multiple purposes. Acute Physiology and Chronic Health Evaluation (APACHE) scoring systems are designed for ICU mortality prediction. This study aims to validate APACHE IV in COVID-19 patients admitted to the ICU. All COVID-19 patients admitted to the ICU between March 13, 2020, and October 17, 2020, were retrospectively analyzed. APACHE II and APACHE IV scores as well as SOFA scores were calculated within 24 hours after admission. Discri","2021","07","15","Crit Care Res Pract","Critical care research and practice",NA,"Bruckers","Liesbeth","I-BioStat, Data Science Institute, Hasselt University, Martelarenlaan 42, Hasselt 3500, Belgium",NA
"2092","34258059","10.1155/2021/5443083","Validation of the Acute Physiology and Chronic Health Evaluation (APACHE) II and IV Score in COVID-19 Patients.","Severity scoring systems are inherent to ICU practice for multiple purposes. Acute Physiology and Chronic Health Evaluation (APACHE) scoring systems are designed for ICU mortality prediction. This study aims to validate APACHE IV in COVID-19 patients admitted to the ICU. All COVID-19 patients admitted to the ICU between March 13, 2020, and October 17, 2020, were retrospectively analyzed. APACHE II and APACHE IV scores as well as SOFA scores were calculated within 24 hours after admission. Discri","2021","07","15","Crit Care Res Pract","Critical care research and practice",NA,"Geebelen","Laurien","Department of Intensive Care and Anesthesiology, Jessa Hospital, Hasselt, Belgium",NA
"2093","34258059","10.1155/2021/5443083","Validation of the Acute Physiology and Chronic Health Evaluation (APACHE) II and IV Score in COVID-19 Patients.","Severity scoring systems are inherent to ICU practice for multiple purposes. Acute Physiology and Chronic Health Evaluation (APACHE) scoring systems are designed for ICU mortality prediction. This study aims to validate APACHE IV in COVID-19 patients admitted to the ICU. All COVID-19 patients admitted to the ICU between March 13, 2020, and October 17, 2020, were retrospectively analyzed. APACHE II and APACHE IV scores as well as SOFA scores were calculated within 24 hours after admission. Discri","2021","07","15","Crit Care Res Pract","Critical care research and practice",NA,"Geerts","Ester","Department of Intensive Care and Anesthesiology, Jessa Hospital, Hasselt, Belgium",NA
"2094","34258059","10.1155/2021/5443083","Validation of the Acute Physiology and Chronic Health Evaluation (APACHE) II and IV Score in COVID-19 Patients.","Severity scoring systems are inherent to ICU practice for multiple purposes. Acute Physiology and Chronic Health Evaluation (APACHE) scoring systems are designed for ICU mortality prediction. This study aims to validate APACHE IV in COVID-19 patients admitted to the ICU. All COVID-19 patients admitted to the ICU between March 13, 2020, and October 17, 2020, were retrospectively analyzed. APACHE II and APACHE IV scores as well as SOFA scores were calculated within 24 hours after admission. Discri","2021","07","15","Crit Care Res Pract","Critical care research and practice",NA,"Callebaut","Ina","Department of Intensive Care and Anesthesiology, Jessa Hospital, Hasselt, Belgium",NA
"2095","34258059","10.1155/2021/5443083","Validation of the Acute Physiology and Chronic Health Evaluation (APACHE) II and IV Score in COVID-19 Patients.","Severity scoring systems are inherent to ICU practice for multiple purposes. Acute Physiology and Chronic Health Evaluation (APACHE) scoring systems are designed for ICU mortality prediction. This study aims to validate APACHE IV in COVID-19 patients admitted to the ICU. All COVID-19 patients admitted to the ICU between March 13, 2020, and October 17, 2020, were retrospectively analyzed. APACHE II and APACHE IV scores as well as SOFA scores were calculated within 24 hours after admission. Discri","2021","07","15","Crit Care Res Pract","Critical care research and practice",NA,"Gruyters","Ine","Department of Intensive Care and Anesthesiology, Jessa Hospital, Hasselt, Belgium",NA
"2096","34258059","10.1155/2021/5443083","Validation of the Acute Physiology and Chronic Health Evaluation (APACHE) II and IV Score in COVID-19 Patients.","Severity scoring systems are inherent to ICU practice for multiple purposes. Acute Physiology and Chronic Health Evaluation (APACHE) scoring systems are designed for ICU mortality prediction. This study aims to validate APACHE IV in COVID-19 patients admitted to the ICU. All COVID-19 patients admitted to the ICU between March 13, 2020, and October 17, 2020, were retrospectively analyzed. APACHE II and APACHE IV scores as well as SOFA scores were calculated within 24 hours after admission. Discri","2021","07","15","Crit Care Res Pract","Critical care research and practice",NA,"Heremans","Liesbeth","Department of Intensive Care and Anesthesiology, Jessa Hospital, Hasselt, Belgium",NA
"2097","34258059","10.1155/2021/5443083","Validation of the Acute Physiology and Chronic Health Evaluation (APACHE) II and IV Score in COVID-19 Patients.","Severity scoring systems are inherent to ICU practice for multiple purposes. Acute Physiology and Chronic Health Evaluation (APACHE) scoring systems are designed for ICU mortality prediction. This study aims to validate APACHE IV in COVID-19 patients admitted to the ICU. All COVID-19 patients admitted to the ICU between March 13, 2020, and October 17, 2020, were retrospectively analyzed. APACHE II and APACHE IV scores as well as SOFA scores were calculated within 24 hours after admission. Discri","2021","07","15","Crit Care Res Pract","Critical care research and practice",NA,"Dubois","Jasperina","Department of Intensive Care and Anesthesiology, Jessa Hospital, Hasselt, Belgium",NA
"2098","34258059","10.1155/2021/5443083","Validation of the Acute Physiology and Chronic Health Evaluation (APACHE) II and IV Score in COVID-19 Patients.","Severity scoring systems are inherent to ICU practice for multiple purposes. Acute Physiology and Chronic Health Evaluation (APACHE) scoring systems are designed for ICU mortality prediction. This study aims to validate APACHE IV in COVID-19 patients admitted to the ICU. All COVID-19 patients admitted to the ICU between March 13, 2020, and October 17, 2020, were retrospectively analyzed. APACHE II and APACHE IV scores as well as SOFA scores were calculated within 24 hours after admission. Discri","2021","07","15","Crit Care Res Pract","Critical care research and practice",NA,"Stessel","Bjorn","Department of Intensive Care and Anesthesiology, Jessa Hospital, Hasselt, Belgium",NA
"2099","34258053","10.1155/2021/9997631","Manifestations and Virus Detection in the Ocular Surface of Adult COVID-19 Patients: A Meta-Analysis.","This study aims to examine the prevalence rate of ocular manifestations and the positive rate for the real-time reverse transcriptase-polymerase chain reaction (RT-PCR) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in conjunctival/tear swabs among adult patients with coronavirus disease 2019 (COVID-19). PubMed and EMBASE were reviewed between December 1, 2019, and January 31, 2021, and only peer-reviewed clinical studies in our pooled analyses were included. Details regarding t","2021","07","15","J Ophthalmol","Journal of ophthalmology",NA,"Chen","Yu-Yen","Department of Ophthalmology, Taichung Veterans General Hospital, Taichung 407, Taiwan",NA
"2100","34258053","10.1155/2021/9997631","Manifestations and Virus Detection in the Ocular Surface of Adult COVID-19 Patients: A Meta-Analysis.","This study aims to examine the prevalence rate of ocular manifestations and the positive rate for the real-time reverse transcriptase-polymerase chain reaction (RT-PCR) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in conjunctival/tear swabs among adult patients with coronavirus disease 2019 (COVID-19). PubMed and EMBASE were reviewed between December 1, 2019, and January 31, 2021, and only peer-reviewed clinical studies in our pooled analyses were included. Details regarding t","2021","07","15","J Ophthalmol","Journal of ophthalmology",NA,"Yen","Yung-Feng","Section of Infectious Diseases, Taipei City Hospital, Taipei 103, Taiwan",NA
"2101","34258053","10.1155/2021/9997631","Manifestations and Virus Detection in the Ocular Surface of Adult COVID-19 Patients: A Meta-Analysis.","This study aims to examine the prevalence rate of ocular manifestations and the positive rate for the real-time reverse transcriptase-polymerase chain reaction (RT-PCR) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in conjunctival/tear swabs among adult patients with coronavirus disease 2019 (COVID-19). PubMed and EMBASE were reviewed between December 1, 2019, and January 31, 2021, and only peer-reviewed clinical studies in our pooled analyses were included. Details regarding t","2021","07","15","J Ophthalmol","Journal of ophthalmology",NA,"Huang","Li-Ying","School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei 242, Taiwan",NA
"2102","34258053","10.1155/2021/9997631","Manifestations and Virus Detection in the Ocular Surface of Adult COVID-19 Patients: A Meta-Analysis.","This study aims to examine the prevalence rate of ocular manifestations and the positive rate for the real-time reverse transcriptase-polymerase chain reaction (RT-PCR) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in conjunctival/tear swabs among adult patients with coronavirus disease 2019 (COVID-19). PubMed and EMBASE were reviewed between December 1, 2019, and January 31, 2021, and only peer-reviewed clinical studies in our pooled analyses were included. Details regarding t","2021","07","15","J Ophthalmol","Journal of ophthalmology",NA,"Chou","Pesus","School of Medicine, National Yang-Ming University, Taipei 112, Taiwan",NA
"2103","34258049","10.1155/2021/6612126","A Real-World Single-Centre Study of Patients with Diabetic Macular Oedema Who Wore a Home-Use Sleep Mask (Noctura 400) for One Year.","A ""Real-World"" single-centre observational study was carried out to analyse the effects of enhanced patient interaction with the use of the Noctura 400 sleep mask on a group of 26 diabetics displaying diabetic retinopathy (DR) and diabetic macular oedema (DMO), of which 24 completed the study. We hoped to find if patient compliance could be maintained and to determine the anatomical and functional consequences of consistent mask wear. While this study was ongoing, COVID-19 impacted on normal eye","2021","07","15","J Ophthalmol","Journal of ophthalmology",NA,"Meyer-Bothling","Ulrich","Ophthalmology Department, Ashford and St Peter's Hospital NHS Foundation Trust, London Road, Ashford TW15 3AA, UK",NA
"2104","34258049","10.1155/2021/6612126","A Real-World Single-Centre Study of Patients with Diabetic Macular Oedema Who Wore a Home-Use Sleep Mask (Noctura 400) for One Year.","A ""Real-World"" single-centre observational study was carried out to analyse the effects of enhanced patient interaction with the use of the Noctura 400 sleep mask on a group of 26 diabetics displaying diabetic retinopathy (DR) and diabetic macular oedema (DMO), of which 24 completed the study. We hoped to find if patient compliance could be maintained and to determine the anatomical and functional consequences of consistent mask wear. While this study was ongoing, COVID-19 impacted on normal eye","2021","07","15","J Ophthalmol","Journal of ophthalmology",NA,"Meyer-Bothling","Oliver","Ophthalmology Department, Ashford and St Peter's Hospital NHS Foundation Trust, London Road, Ashford TW15 3AA, UK",NA
"2105","34258049","10.1155/2021/6612126","A Real-World Single-Centre Study of Patients with Diabetic Macular Oedema Who Wore a Home-Use Sleep Mask (Noctura 400) for One Year.","A ""Real-World"" single-centre observational study was carried out to analyse the effects of enhanced patient interaction with the use of the Noctura 400 sleep mask on a group of 26 diabetics displaying diabetic retinopathy (DR) and diabetic macular oedema (DMO), of which 24 completed the study. We hoped to find if patient compliance could be maintained and to determine the anatomical and functional consequences of consistent mask wear. While this study was ongoing, COVID-19 impacted on normal eye","2021","07","15","J Ophthalmol","Journal of ophthalmology",NA,"Pinney","Marika","Ophthalmology Department, Ashford and St Peter's Hospital NHS Foundation Trust, London Road, Ashford TW15 3AA, UK",NA
"2106","34258031","10.1017/cts.2021.786","Development of the systematic observation of COVID-19 mitigation (SOCOM): Assessing face covering and distancing in schools.","During the COVID-19 pandemic, some K-12 schools resumed in-person classes with varying degrees of mitigation plans in the fall 2020. Physical distancing and face coverings can minimize SARS-CoV-2 spread, the virus that causes COVID-19. However, no research has focused on adherence to mitigation strategies during school days. Thus, we sought to develop a systematic observation protocol to capture COVID-19 mitigation strategy adherence in school environments: The Systematic Observation of COVID-19","2021","07","15","J Clin Transl Sci","Journal of clinical and translational science","SARS-CoV-2; direct observation; pediatric; prevention; school","Camplain","Ricky","Center for Health Equity Research, Northern Arizona University, Flagstaff, AZ, USA",NA
"2107","34258031","10.1017/cts.2021.786","Development of the systematic observation of COVID-19 mitigation (SOCOM): Assessing face covering and distancing in schools.","During the COVID-19 pandemic, some K-12 schools resumed in-person classes with varying degrees of mitigation plans in the fall 2020. Physical distancing and face coverings can minimize SARS-CoV-2 spread, the virus that causes COVID-19. However, no research has focused on adherence to mitigation strategies during school days. Thus, we sought to develop a systematic observation protocol to capture COVID-19 mitigation strategy adherence in school environments: The Systematic Observation of COVID-19","2021","07","15","J Clin Transl Sci","Journal of clinical and translational science","SARS-CoV-2; direct observation; pediatric; prevention; school","Lopez","Nanette V","Department of Health Sciences, Northern Arizona University, Flagstaff, AZ, USA",NA
"2108","34258031","10.1017/cts.2021.786","Development of the systematic observation of COVID-19 mitigation (SOCOM): Assessing face covering and distancing in schools.","During the COVID-19 pandemic, some K-12 schools resumed in-person classes with varying degrees of mitigation plans in the fall 2020. Physical distancing and face coverings can minimize SARS-CoV-2 spread, the virus that causes COVID-19. However, no research has focused on adherence to mitigation strategies during school days. Thus, we sought to develop a systematic observation protocol to capture COVID-19 mitigation strategy adherence in school environments: The Systematic Observation of COVID-19","2021","07","15","J Clin Transl Sci","Journal of clinical and translational science","SARS-CoV-2; direct observation; pediatric; prevention; school","Cooper","Dan M","Institute for Clinical and Translational Science, University of California Irvine, School of Medicine, Irvine, CA, USA",NA
"2109","34258031","10.1017/cts.2021.786","Development of the systematic observation of COVID-19 mitigation (SOCOM): Assessing face covering and distancing in schools.","During the COVID-19 pandemic, some K-12 schools resumed in-person classes with varying degrees of mitigation plans in the fall 2020. Physical distancing and face coverings can minimize SARS-CoV-2 spread, the virus that causes COVID-19. However, no research has focused on adherence to mitigation strategies during school days. Thus, we sought to develop a systematic observation protocol to capture COVID-19 mitigation strategy adherence in school environments: The Systematic Observation of COVID-19","2021","07","15","J Clin Transl Sci","Journal of clinical and translational science","SARS-CoV-2; direct observation; pediatric; prevention; school","McKenzie","Thomas L","School of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA, USA",NA
"2110","34258031","10.1017/cts.2021.786","Development of the systematic observation of COVID-19 mitigation (SOCOM): Assessing face covering and distancing in schools.","During the COVID-19 pandemic, some K-12 schools resumed in-person classes with varying degrees of mitigation plans in the fall 2020. Physical distancing and face coverings can minimize SARS-CoV-2 spread, the virus that causes COVID-19. However, no research has focused on adherence to mitigation strategies during school days. Thus, we sought to develop a systematic observation protocol to capture COVID-19 mitigation strategy adherence in school environments: The Systematic Observation of COVID-19","2021","07","15","J Clin Transl Sci","Journal of clinical and translational science","SARS-CoV-2; direct observation; pediatric; prevention; school","Zheng","Kai","Institute for Clinical and Translational Science, University of California Irvine, School of Medicine, Irvine, CA, USA",NA
"2111","34258031","10.1017/cts.2021.786","Development of the systematic observation of COVID-19 mitigation (SOCOM): Assessing face covering and distancing in schools.","During the COVID-19 pandemic, some K-12 schools resumed in-person classes with varying degrees of mitigation plans in the fall 2020. Physical distancing and face coverings can minimize SARS-CoV-2 spread, the virus that causes COVID-19. However, no research has focused on adherence to mitigation strategies during school days. Thus, we sought to develop a systematic observation protocol to capture COVID-19 mitigation strategy adherence in school environments: The Systematic Observation of COVID-19","2021","07","15","J Clin Transl Sci","Journal of clinical and translational science","SARS-CoV-2; direct observation; pediatric; prevention; school","Radom-Aizik","Shlomit","Pediatric Exercise and Genomics Research Center, Department of Pediatrics, University of California Irvine, School of Medicine, Irvine, CA, USA",NA
"2112","34258021","10.1098/rsos.210678","The limitations of polling data in understanding public support for COVID-19 lockdown policies.","Opinion polls regarding policies designed to tackle COVID-19 have shown public support has remained high throughout the first year of the pandemic in most places around the world. However, there is a risk that headline support over-simplifies people's views. We carried out a two-wave survey with six-month interval on a public sample (N = 212) in the UK, examining the factors that underpin lockdown policy support. We find that the majority of people support most public health measures intr","2021","07","15","R Soc Open Sci","Royal Society open science","COVID-19; attitude formation; policy; polling data; public support","Foad","Colin M G","Department of Psychology, Cardiff University, Cardiff CF10 3AT, UK",NA
"2113","34258021","10.1098/rsos.210678","The limitations of polling data in understanding public support for COVID-19 lockdown policies.","Opinion polls regarding policies designed to tackle COVID-19 have shown public support has remained high throughout the first year of the pandemic in most places around the world. However, there is a risk that headline support over-simplifies people's views. We carried out a two-wave survey with six-month interval on a public sample (N = 212) in the UK, examining the factors that underpin lockdown policy support. We find that the majority of people support most public health measures intr","2021","07","15","R Soc Open Sci","Royal Society open science","COVID-19; attitude formation; policy; polling data; public support","Whitmarsh","Lorraine","Department of Psychology, University of Bath, Bath, UK",NA
"2114","34258021","10.1098/rsos.210678","The limitations of polling data in understanding public support for COVID-19 lockdown policies.","Opinion polls regarding policies designed to tackle COVID-19 have shown public support has remained high throughout the first year of the pandemic in most places around the world. However, there is a risk that headline support over-simplifies people's views. We carried out a two-wave survey with six-month interval on a public sample (N = 212) in the UK, examining the factors that underpin lockdown policy support. We find that the majority of people support most public health measures intr","2021","07","15","R Soc Open Sci","Royal Society open science","COVID-19; attitude formation; policy; polling data; public support","Hanel","Paul H P","Department of Psychology, University of Essex, Colchester, Essex, UK",NA
"2115","34258021","10.1098/rsos.210678","The limitations of polling data in understanding public support for COVID-19 lockdown policies.","Opinion polls regarding policies designed to tackle COVID-19 have shown public support has remained high throughout the first year of the pandemic in most places around the world. However, there is a risk that headline support over-simplifies people's views. We carried out a two-wave survey with six-month interval on a public sample (N = 212) in the UK, examining the factors that underpin lockdown policy support. We find that the majority of people support most public health measures intr","2021","07","15","R Soc Open Sci","Royal Society open science","COVID-19; attitude formation; policy; polling data; public support","Haddock","Geoffrey","Department of Psychology, Cardiff University, Cardiff CF10 3AT, UK",NA
"2116","34258020","10.1017/gmh.2021.25","COVID-19 Vaccination: crucial roles and opportunities for the mental health professionals.","Besides addressing the increased prevalence of psychiatric disorders, social challenges, and building community resilience during the crisis, mental health professionals (MHPs) are in a unique position to assist the vaccination drive against coronavirus disease-2019 (COVID-19) in various nations. Vaccination programs are adversely affected by misinformation, fake news and vaccine hesitancy fuelled by social media. MHPs can enable this vital public health strategy by prioritizing vaccination for ","2021","07","15","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19 pandemic; mental health professionals; psychiatrists; public mental health; severe mental illness; vaccination","Banerjee","Debanjan","Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India",NA
"2117","34258020","10.1017/gmh.2021.25","COVID-19 Vaccination: crucial roles and opportunities for the mental health professionals.","Besides addressing the increased prevalence of psychiatric disorders, social challenges, and building community resilience during the crisis, mental health professionals (MHPs) are in a unique position to assist the vaccination drive against coronavirus disease-2019 (COVID-19) in various nations. Vaccination programs are adversely affected by misinformation, fake news and vaccine hesitancy fuelled by social media. MHPs can enable this vital public health strategy by prioritizing vaccination for ","2021","07","15","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19 pandemic; mental health professionals; psychiatrists; public mental health; severe mental illness; vaccination","Mukhopadhyay","Sanchari","Department of Integrative Medicine, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India",NA
"2118","34258020","10.1017/gmh.2021.25","COVID-19 Vaccination: crucial roles and opportunities for the mental health professionals.","Besides addressing the increased prevalence of psychiatric disorders, social challenges, and building community resilience during the crisis, mental health professionals (MHPs) are in a unique position to assist the vaccination drive against coronavirus disease-2019 (COVID-19) in various nations. Vaccination programs are adversely affected by misinformation, fake news and vaccine hesitancy fuelled by social media. MHPs can enable this vital public health strategy by prioritizing vaccination for ","2021","07","15","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19 pandemic; mental health professionals; psychiatrists; public mental health; severe mental illness; vaccination","Sahana Asmeen","Mariam","Department of Psychology, University of Dhaka, Dhaka, Bangladesh",NA
"2119","34258020","10.1017/gmh.2021.25","COVID-19 Vaccination: crucial roles and opportunities for the mental health professionals.","Besides addressing the increased prevalence of psychiatric disorders, social challenges, and building community resilience during the crisis, mental health professionals (MHPs) are in a unique position to assist the vaccination drive against coronavirus disease-2019 (COVID-19) in various nations. Vaccination programs are adversely affected by misinformation, fake news and vaccine hesitancy fuelled by social media. MHPs can enable this vital public health strategy by prioritizing vaccination for ","2021","07","15","Glob Ment Health (Camb)","Global mental health (Cambridge, England)","COVID-19 pandemic; mental health professionals; psychiatrists; public mental health; severe mental illness; vaccination","Javed","Afzal","Chairman Pakistan Psychiatric Research Centre, Fountain House Lahore, Pakistan &amp",NA
"2120","34258019","10.1093/jlb/lsab016","Public views about COVID-19 'Immunity Passports'.","Discovery of effective vaccines and increased confidence that infection confers extended protection against coronavirus disease (COVID-19) have renewed discussion of using immunity certificates or 'passports' to selectively reduce ongoing public health restrictions. To determine public views regarding government and private conferral of immunity privileges. National on-line survey fielded in June 2020. Participants were randomly asked about either government 'passports' or private 'certificates'","2021","07","14","J Law Biosci","Journal of law and the biosciences",NA,"Hall","Mark A","Wake Forest University Schools of Law and Medicine, Winston-Salem, NC 27109-7206, USA",NA
"2121","34258019","10.1093/jlb/lsab016","Public views about COVID-19 'Immunity Passports'.","Discovery of effective vaccines and increased confidence that infection confers extended protection against coronavirus disease (COVID-19) have renewed discussion of using immunity certificates or 'passports' to selectively reduce ongoing public health restrictions. To determine public views regarding government and private conferral of immunity privileges. National on-line survey fielded in June 2020. Participants were randomly asked about either government 'passports' or private 'certificates'","2021","07","14","J Law Biosci","Journal of law and the biosciences",NA,"Studdert","David M","Stanford University Schools of Law and Medicine, Stanford, CA, USA",NA
"2122","34257990","10.1002/ccr3.4503","Coombs-negative hemolytic anemia in a male with COVID-19.","This case illustrates the need to consider SARS-CoV-2 infection as a catalyst for Coombs-negative hemolytic anemia as well as the potential for IVIG to serve as an effective treatment for the condition.","2021","07","15","Clin Case Rep","Clinical case reports","acute medicine; emergency medicine; hematology; infectious diseases","Bae","Ju Young","Department of Medicine Greenwich Hospital Yale-New Haven Health System Greenwich CT USA",NA
"2123","34257990","10.1002/ccr3.4503","Coombs-negative hemolytic anemia in a male with COVID-19.","This case illustrates the need to consider SARS-CoV-2 infection as a catalyst for Coombs-negative hemolytic anemia as well as the potential for IVIG to serve as an effective treatment for the condition.","2021","07","15","Clin Case Rep","Clinical case reports","acute medicine; emergency medicine; hematology; infectious diseases","Jeon","June Evelyn","Department of Medicine Greenwich Hospital Yale-New Haven Health System Greenwich CT USA",NA
"2124","34257990","10.1002/ccr3.4503","Coombs-negative hemolytic anemia in a male with COVID-19.","This case illustrates the need to consider SARS-CoV-2 infection as a catalyst for Coombs-negative hemolytic anemia as well as the potential for IVIG to serve as an effective treatment for the condition.","2021","07","15","Clin Case Rep","Clinical case reports","acute medicine; emergency medicine; hematology; infectious diseases","Hussein","Khalil Ian","Department of Medicine Greenwich Hospital Yale-New Haven Health System Greenwich CT USA",NA
"2125","34257990","10.1002/ccr3.4503","Coombs-negative hemolytic anemia in a male with COVID-19.","This case illustrates the need to consider SARS-CoV-2 infection as a catalyst for Coombs-negative hemolytic anemia as well as the potential for IVIG to serve as an effective treatment for the condition.","2021","07","15","Clin Case Rep","Clinical case reports","acute medicine; emergency medicine; hematology; infectious diseases","Lee","Merlin Sung","Division of Hematology and Medical Oncology Greenwich Hospital Yale-New Haven Health System Greenwich CT USA",NA
"2126","34257986","10.1002/ccr3.4459","Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab-induced arthritis by methylprednisolone, baricitinib, and remdesivir.","COVID-19 in cancer patients on immunosuppressive agents for the treatment of immune-related adverse events of immune checkpoint inhibitors can rapidly deteriorate. The combination therapy with methylprednisolone, baricitinib, and remdesivir may be effective for critical COVID-19, and further clinical trials are warranted.","2021","07","15","Clin Case Rep","Clinical case reports","COVID-19; baricitinib; immune checkpoint inhibitor; immune-related adverse event; lung cancer","Oda","Naohiro","Department of Internal Medicine Fukuyama City Hospital Fukuyama Japan",NA
"2127","34257986","10.1002/ccr3.4459","Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab-induced arthritis by methylprednisolone, baricitinib, and remdesivir.","COVID-19 in cancer patients on immunosuppressive agents for the treatment of immune-related adverse events of immune checkpoint inhibitors can rapidly deteriorate. The combination therapy with methylprednisolone, baricitinib, and remdesivir may be effective for critical COVID-19, and further clinical trials are warranted.","2021","07","15","Clin Case Rep","Clinical case reports","COVID-19; baricitinib; immune checkpoint inhibitor; immune-related adverse event; lung cancer","Miyoshi","Keiji","Department of Respiratory Medicine Fukuyama Medical Center Fukuyama Japan",NA
"2128","34257986","10.1002/ccr3.4459","Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab-induced arthritis by methylprednisolone, baricitinib, and remdesivir.","COVID-19 in cancer patients on immunosuppressive agents for the treatment of immune-related adverse events of immune checkpoint inhibitors can rapidly deteriorate. The combination therapy with methylprednisolone, baricitinib, and remdesivir may be effective for critical COVID-19, and further clinical trials are warranted.","2021","07","15","Clin Case Rep","Clinical case reports","COVID-19; baricitinib; immune checkpoint inhibitor; immune-related adverse event; lung cancer","Morichika","Daisuke","Department of Respiratory Medicine Fukuyama Medical Center Fukuyama Japan",NA
"2129","34257986","10.1002/ccr3.4459","Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab-induced arthritis by methylprednisolone, baricitinib, and remdesivir.","COVID-19 in cancer patients on immunosuppressive agents for the treatment of immune-related adverse events of immune checkpoint inhibitors can rapidly deteriorate. The combination therapy with methylprednisolone, baricitinib, and remdesivir may be effective for critical COVID-19, and further clinical trials are warranted.","2021","07","15","Clin Case Rep","Clinical case reports","COVID-19; baricitinib; immune checkpoint inhibitor; immune-related adverse event; lung cancer","Beika","Yuka","Department of Respiratory Medicine Fukuyama Medical Center Fukuyama Japan",NA
"2130","34257986","10.1002/ccr3.4459","Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab-induced arthritis by methylprednisolone, baricitinib, and remdesivir.","COVID-19 in cancer patients on immunosuppressive agents for the treatment of immune-related adverse events of immune checkpoint inhibitors can rapidly deteriorate. The combination therapy with methylprednisolone, baricitinib, and remdesivir may be effective for critical COVID-19, and further clinical trials are warranted.","2021","07","15","Clin Case Rep","Clinical case reports","COVID-19; baricitinib; immune checkpoint inhibitor; immune-related adverse event; lung cancer","Taki","Takahiro","Department of Internal Medicine Fukuyama City Hospital Fukuyama Japan",NA
"2131","34257986","10.1002/ccr3.4459","Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab-induced arthritis by methylprednisolone, baricitinib, and remdesivir.","COVID-19 in cancer patients on immunosuppressive agents for the treatment of immune-related adverse events of immune checkpoint inhibitors can rapidly deteriorate. The combination therapy with methylprednisolone, baricitinib, and remdesivir may be effective for critical COVID-19, and further clinical trials are warranted.","2021","07","15","Clin Case Rep","Clinical case reports","COVID-19; baricitinib; immune checkpoint inhibitor; immune-related adverse event; lung cancer","Mitani","Reo","Department of Internal Medicine Fukuyama City Hospital Fukuyama Japan",NA
"2132","34257986","10.1002/ccr3.4459","Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab-induced arthritis by methylprednisolone, baricitinib, and remdesivir.","COVID-19 in cancer patients on immunosuppressive agents for the treatment of immune-related adverse events of immune checkpoint inhibitors can rapidly deteriorate. The combination therapy with methylprednisolone, baricitinib, and remdesivir may be effective for critical COVID-19, and further clinical trials are warranted.","2021","07","15","Clin Case Rep","Clinical case reports","COVID-19; baricitinib; immune checkpoint inhibitor; immune-related adverse event; lung cancer","Okada","Toshiaki","Department of Respiratory Medicine Fukuyama Medical Center Fukuyama Japan",NA
"2133","34257986","10.1002/ccr3.4459","Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab-induced arthritis by methylprednisolone, baricitinib, and remdesivir.","COVID-19 in cancer patients on immunosuppressive agents for the treatment of immune-related adverse events of immune checkpoint inhibitors can rapidly deteriorate. The combination therapy with methylprednisolone, baricitinib, and remdesivir may be effective for critical COVID-19, and further clinical trials are warranted.","2021","07","15","Clin Case Rep","Clinical case reports","COVID-19; baricitinib; immune checkpoint inhibitor; immune-related adverse event; lung cancer","Takata","Ichiro","Department of Internal Medicine Fukuyama City Hospital Fukuyama Japan",NA
"2134","34257979","10.1002/ccr3.4409","Post-COVID worsening of a Parkinson's disease patient.","Worsening of clinical symptoms after COVID-19 infection and misregulation of CD4 and CD8 T-cell numbers may be revealed in PD patients. Immunological changes may be a source of clinical worsening of the patient.","2021","07","15","Clin Case Rep","Clinical case reports","Parkinson's disease; Post-COVID-19; immunology; motor symptoms; nonmotor symptoms","Boika","Aliaksandr V","Department of Neurology and Neurosurgery Belarusian Medical Academy of Postgraduate Education Minsk Republic of Belarus",NA
"2135","34257979","10.1002/ccr3.4409","Post-COVID worsening of a Parkinson's disease patient.","Worsening of clinical symptoms after COVID-19 infection and misregulation of CD4 and CD8 T-cell numbers may be revealed in PD patients. Immunological changes may be a source of clinical worsening of the patient.","2021","07","15","Clin Case Rep","Clinical case reports","Parkinson's disease; Post-COVID-19; immunology; motor symptoms; nonmotor symptoms","Sialitski","Mikhail M","Department of Neurology and Neurosurgery Belarusian Medical Academy of Postgraduate Education Minsk Republic of Belarus",NA
"2136","34257979","10.1002/ccr3.4409","Post-COVID worsening of a Parkinson's disease patient.","Worsening of clinical symptoms after COVID-19 infection and misregulation of CD4 and CD8 T-cell numbers may be revealed in PD patients. Immunological changes may be a source of clinical worsening of the patient.","2021","07","15","Clin Case Rep","Clinical case reports","Parkinson's disease; Post-COVID-19; immunology; motor symptoms; nonmotor symptoms","Chyzhyk","Veranika A","Department of Neurology and Neurosurgery Belarusian Medical Academy of Postgraduate Education Minsk Republic of Belarus",NA
"2137","34257979","10.1002/ccr3.4409","Post-COVID worsening of a Parkinson's disease patient.","Worsening of clinical symptoms after COVID-19 infection and misregulation of CD4 and CD8 T-cell numbers may be revealed in PD patients. Immunological changes may be a source of clinical worsening of the patient.","2021","07","15","Clin Case Rep","Clinical case reports","Parkinson's disease; Post-COVID-19; immunology; motor symptoms; nonmotor symptoms","Ponomarev","Vladimir V","Department of Neurology and Neurosurgery Belarusian Medical Academy of Postgraduate Education Minsk Republic of Belarus",NA
"2138","34257979","10.1002/ccr3.4409","Post-COVID worsening of a Parkinson's disease patient.","Worsening of clinical symptoms after COVID-19 infection and misregulation of CD4 and CD8 T-cell numbers may be revealed in PD patients. Immunological changes may be a source of clinical worsening of the patient.","2021","07","15","Clin Case Rep","Clinical case reports","Parkinson's disease; Post-COVID-19; immunology; motor symptoms; nonmotor symptoms","Fomina","Elena G","The Republican Research and Practical Center for Epidemiology &amp",NA
"2139","34257978","10.1002/ccr3.4406","Clinical patterns of endothelial damage and thrombotic events in two patients with COVID-19: A case report.","Endotheliopathy causes COVID-19 conflicting complications.","2021","07","15","Clin Case Rep","Clinical case reports","COVID-19; blood coagulation disorders; endothelial cells","Moghimi","Minoosh","Department of Internal Medicine Zanjan University of Medical Sciences Zanjan Iran",NA
"2140","34257978","10.1002/ccr3.4406","Clinical patterns of endothelial damage and thrombotic events in two patients with COVID-19: A case report.","Endotheliopathy causes COVID-19 conflicting complications.","2021","07","15","Clin Case Rep","Clinical case reports","COVID-19; blood coagulation disorders; endothelial cells","Khodadadi","Kasra","Department of Internal Medicine Zanjan University of Medical Sciences Zanjan Iran",NA
"2141","34257978","10.1002/ccr3.4406","Clinical patterns of endothelial damage and thrombotic events in two patients with COVID-19: A case report.","Endotheliopathy causes COVID-19 conflicting complications.","2021","07","15","Clin Case Rep","Clinical case reports","COVID-19; blood coagulation disorders; endothelial cells","Sarvandi","Mehdi","Department of Internal Medicine Zanjan University of Medical Sciences Zanjan Iran",NA
"2142","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Sandberg","John Tyler","Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden",NA
"2143","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Varnaite","Renata","Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden",NA
"2144","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Christ","Wanda","Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden",NA
"2145","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Chen","Puran","Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden",NA
"2146","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Muvva","Jagadeeswara R","Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden",NA
"2147","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Maleki","Kimia T","Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden",NA
"2148","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","García","Marina","Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden",NA
"2149","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Dzidic","Majda","Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden",NA
"2150","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Folkesson","Elin","Department of Infectious Diseases Karolinska University Hospital Stockholm Sweden",NA
"2151","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Skagerberg","Magdalena","Department of Infectious Diseases Karolinska University Hospital Stockholm Sweden",NA
"2152","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Ahlén","Gustaf","Division of Clinical Microbiology, Department of Laboratory Medicine Karolinska Institutet Stockholm Sweden",NA
"2153","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Frelin","Lars","Division of Clinical Microbiology, Department of Laboratory Medicine Karolinska Institutet Stockholm Sweden",NA
"2154","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Sällberg","Matti","Division of Clinical Microbiology, Department of Laboratory Medicine Karolinska Institutet Stockholm Sweden",NA
"2155","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Eriksson","Lars I","Function Perioperative Medicine and Intensive Care Karolinska University Hospital Stockholm Sweden",NA
"2156","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Rooyackers","Olav","Function Perioperative Medicine and Intensive Care Karolinska University Hospital Stockholm Sweden",NA
"2157","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Sönnerborg","Anders","Department of Infectious Diseases Karolinska University Hospital Stockholm Sweden",NA
"2158","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Buggert","Marcus","Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden",NA
"2159","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Björkström","Niklas K","Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden",NA
"2160","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Aleman","Soo","Department of Infectious Diseases Karolinska University Hospital Stockholm Sweden",NA
"2161","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Strålin","Kristoffer","Department of Infectious Diseases Karolinska University Hospital Stockholm Sweden",NA
"2162","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Klingström","Jonas","Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden",NA
"2163","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Ljunggren","Hans-Gustaf","Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden",NA
"2164","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Blom","Kim","Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden",NA
"2165","34257967","10.1002/cti2.1306","SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.","Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic. Here, we conducted a longitudinal study on hospitalised moderate and severe COVID-19 patients from the acute phase of disease into convalescence at 5 and 9 months post-symptom onset. Utilising flow cytometry, serological assays","2021","07","15","Clin Transl Immunology","Clinical &amp; translational immunology","COVID-19; SARS-CoV-2; antibodies; antibody-secreting cells; circulating T follicular helper cells; germinal centres","Gredmark-Russ","Sara","Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden",NA
"2166","34257958","10.1016/j.amsu.2021.102515","Impact of the COVID-19 pandemic on Caribbean Medical Students: A cross-sectional study.","The COVID-19 pandemic has introduced a wide range of challenges to numerous institutions around the world. One of these vital programs being affected is Caribbean medical schools. To continue to train future physicians, Caribbean medical schools have been forced to deliver lectures through video chat, delaying clinical training years as well as exams. Reveal current shortcomings in medical education to improve future learning strategies based on student perspectives. To further explore the impac","2021","07","15","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19 pandemic; Caribbean; Medical; School; Students","Thind","Aaronvir Singh","Department of Genetics, Medical University of the Americas, Charlestown, Camps, Saint Kitts and Nevis",NA
"2167","34257958","10.1016/j.amsu.2021.102515","Impact of the COVID-19 pandemic on Caribbean Medical Students: A cross-sectional study.","The COVID-19 pandemic has introduced a wide range of challenges to numerous institutions around the world. One of these vital programs being affected is Caribbean medical schools. To continue to train future physicians, Caribbean medical schools have been forced to deliver lectures through video chat, delaying clinical training years as well as exams. Reveal current shortcomings in medical education to improve future learning strategies based on student perspectives. To further explore the impac","2021","07","15","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19 pandemic; Caribbean; Medical; School; Students","Singh","Harman","Department of Genetics, Medical University of the Americas, Charlestown, Camps, Saint Kitts and Nevis",NA
"2168","34257958","10.1016/j.amsu.2021.102515","Impact of the COVID-19 pandemic on Caribbean Medical Students: A cross-sectional study.","The COVID-19 pandemic has introduced a wide range of challenges to numerous institutions around the world. One of these vital programs being affected is Caribbean medical schools. To continue to train future physicians, Caribbean medical schools have been forced to deliver lectures through video chat, delaying clinical training years as well as exams. Reveal current shortcomings in medical education to improve future learning strategies based on student perspectives. To further explore the impac","2021","07","15","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19 pandemic; Caribbean; Medical; School; Students","Yerramsetty","Divya Lakshmi","Department of Genetics, Medical University of the Americas, Charlestown, Camps, Saint Kitts and Nevis",NA
"2169","34257958","10.1016/j.amsu.2021.102515","Impact of the COVID-19 pandemic on Caribbean Medical Students: A cross-sectional study.","The COVID-19 pandemic has introduced a wide range of challenges to numerous institutions around the world. One of these vital programs being affected is Caribbean medical schools. To continue to train future physicians, Caribbean medical schools have been forced to deliver lectures through video chat, delaying clinical training years as well as exams. Reveal current shortcomings in medical education to improve future learning strategies based on student perspectives. To further explore the impac","2021","07","15","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","COVID-19 pandemic; Caribbean; Medical; School; Students","Pandeya","Dipendra R","Department of Genetics, Medical University of the Americas, Charlestown, Camps, Saint Kitts and Nevis",NA
"2170","34257954","10.1016/j.amsu.2021.102550","Peripheral facial paralysis as the only symptom revealing sars cov 2 infection: Case report.","The SARS cov 2 infection was initially marked by its respiratory symptomatology. Nevertheless, other non-respiratory manifestations have been raised as atypical revealing symptoms, namely cardiac and neurological attacks. Several neurological manifestations have been described during this pandemic. We describe in this case report the clinical, biological and radiological characteristics of two patients presenting to the emergency department with facial paralysis revealing a Sars cov 2 viral infe","2021","07","20","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Corona virus; Facial paralysis; SARS COV2","Taouihar","S","Intensive Care Unit, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Oujda, Morocco",NA
"2171","34257954","10.1016/j.amsu.2021.102550","Peripheral facial paralysis as the only symptom revealing sars cov 2 infection: Case report.","The SARS cov 2 infection was initially marked by its respiratory symptomatology. Nevertheless, other non-respiratory manifestations have been raised as atypical revealing symptoms, namely cardiac and neurological attacks. Several neurological manifestations have been described during this pandemic. We describe in this case report the clinical, biological and radiological characteristics of two patients presenting to the emergency department with facial paralysis revealing a Sars cov 2 viral infe","2021","07","20","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Corona virus; Facial paralysis; SARS COV2","Bouabdallaoui","A","Intensive Care Unit, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Oujda, Morocco",NA
"2172","34257954","10.1016/j.amsu.2021.102550","Peripheral facial paralysis as the only symptom revealing sars cov 2 infection: Case report.","The SARS cov 2 infection was initially marked by its respiratory symptomatology. Nevertheless, other non-respiratory manifestations have been raised as atypical revealing symptoms, namely cardiac and neurological attacks. Several neurological manifestations have been described during this pandemic. We describe in this case report the clinical, biological and radiological characteristics of two patients presenting to the emergency department with facial paralysis revealing a Sars cov 2 viral infe","2021","07","20","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Corona virus; Facial paralysis; SARS COV2","Aabdi","M","Intensive Care Unit, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Oujda, Morocco",NA
"2173","34257954","10.1016/j.amsu.2021.102550","Peripheral facial paralysis as the only symptom revealing sars cov 2 infection: Case report.","The SARS cov 2 infection was initially marked by its respiratory symptomatology. Nevertheless, other non-respiratory manifestations have been raised as atypical revealing symptoms, namely cardiac and neurological attacks. Several neurological manifestations have been described during this pandemic. We describe in this case report the clinical, biological and radiological characteristics of two patients presenting to the emergency department with facial paralysis revealing a Sars cov 2 viral infe","2021","07","20","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Corona virus; Facial paralysis; SARS COV2","Kaouini","A El","Intensive Care Unit, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Oujda, Morocco",NA
"2174","34257954","10.1016/j.amsu.2021.102550","Peripheral facial paralysis as the only symptom revealing sars cov 2 infection: Case report.","The SARS cov 2 infection was initially marked by its respiratory symptomatology. Nevertheless, other non-respiratory manifestations have been raised as atypical revealing symptoms, namely cardiac and neurological attacks. Several neurological manifestations have been described during this pandemic. We describe in this case report the clinical, biological and radiological characteristics of two patients presenting to the emergency department with facial paralysis revealing a Sars cov 2 viral infe","2021","07","20","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Corona virus; Facial paralysis; SARS COV2","El Aidouni","G","Intensive Care Unit, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Oujda, Morocco",NA
"2175","34257954","10.1016/j.amsu.2021.102550","Peripheral facial paralysis as the only symptom revealing sars cov 2 infection: Case report.","The SARS cov 2 infection was initially marked by its respiratory symptomatology. Nevertheless, other non-respiratory manifestations have been raised as atypical revealing symptoms, namely cardiac and neurological attacks. Several neurological manifestations have been described during this pandemic. We describe in this case report the clinical, biological and radiological characteristics of two patients presenting to the emergency department with facial paralysis revealing a Sars cov 2 viral infe","2021","07","20","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Corona virus; Facial paralysis; SARS COV2","Merbouh","M","Intensive Care Unit, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Oujda, Morocco",NA
"2176","34257954","10.1016/j.amsu.2021.102550","Peripheral facial paralysis as the only symptom revealing sars cov 2 infection: Case report.","The SARS cov 2 infection was initially marked by its respiratory symptomatology. Nevertheless, other non-respiratory manifestations have been raised as atypical revealing symptoms, namely cardiac and neurological attacks. Several neurological manifestations have been described during this pandemic. We describe in this case report the clinical, biological and radiological characteristics of two patients presenting to the emergency department with facial paralysis revealing a Sars cov 2 viral infe","2021","07","20","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Corona virus; Facial paralysis; SARS COV2","Zaid","I","Intensive Care Unit, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Oujda, Morocco",NA
"2177","34257954","10.1016/j.amsu.2021.102550","Peripheral facial paralysis as the only symptom revealing sars cov 2 infection: Case report.","The SARS cov 2 infection was initially marked by its respiratory symptomatology. Nevertheless, other non-respiratory manifestations have been raised as atypical revealing symptoms, namely cardiac and neurological attacks. Several neurological manifestations have been described during this pandemic. We describe in this case report the clinical, biological and radiological characteristics of two patients presenting to the emergency department with facial paralysis revealing a Sars cov 2 viral infe","2021","07","20","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Corona virus; Facial paralysis; SARS COV2","Bkiyar","H","Intensive Care Unit, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Oujda, Morocco",NA
"2178","34257954","10.1016/j.amsu.2021.102550","Peripheral facial paralysis as the only symptom revealing sars cov 2 infection: Case report.","The SARS cov 2 infection was initially marked by its respiratory symptomatology. Nevertheless, other non-respiratory manifestations have been raised as atypical revealing symptoms, namely cardiac and neurological attacks. Several neurological manifestations have been described during this pandemic. We describe in this case report the clinical, biological and radiological characteristics of two patients presenting to the emergency department with facial paralysis revealing a Sars cov 2 viral infe","2021","07","20","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Corona virus; Facial paralysis; SARS COV2","Housni","B","Intensive Care Unit, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, Oujda, Morocco",NA
"2179","34257953","10.1007/s13755-021-00154-8","SpecMEn-DL: spectral mask enhancement with deep learning models to predict COVID-19 from lung ultrasound videos.","Lung Ultrasound (LUS) images are considered to be effective for detecting Coronavirus Disease (COVID-19) as an alternative to the existing reverse transcription-polymerase chain reaction (RT-PCR)-based detection scheme. However, the recent literature exhibits a shortage of works dealing with LUS image-based COVID-19 detection. In this paper, a spectral mask enhancement (SpecMEn) scheme is introduced along with a histogram equalization pre-processing stage to reduce the noise effect in LUS images","2021","07","15","Health Inf Sci Syst","Health information science and systems","COVID-19; Disease classification; Image processing; Lung ultrasound; Spectral mask","Sadik","Farhan","Department of Electrical and Electronic Engineering, Bangladesh University of Engineering and Technology, Dhaka, 1205 Bangladesh",NA
"2180","34257953","10.1007/s13755-021-00154-8","SpecMEn-DL: spectral mask enhancement with deep learning models to predict COVID-19 from lung ultrasound videos.","Lung Ultrasound (LUS) images are considered to be effective for detecting Coronavirus Disease (COVID-19) as an alternative to the existing reverse transcription-polymerase chain reaction (RT-PCR)-based detection scheme. However, the recent literature exhibits a shortage of works dealing with LUS image-based COVID-19 detection. In this paper, a spectral mask enhancement (SpecMEn) scheme is introduced along with a histogram equalization pre-processing stage to reduce the noise effect in LUS images","2021","07","15","Health Inf Sci Syst","Health information science and systems","COVID-19; Disease classification; Image processing; Lung ultrasound; Spectral mask","Dastider","Ankan Ghosh","Department of Electrical and Electronic Engineering, Bangladesh University of Engineering and Technology, Dhaka, 1205 Bangladesh",NA
"2181","34257953","10.1007/s13755-021-00154-8","SpecMEn-DL: spectral mask enhancement with deep learning models to predict COVID-19 from lung ultrasound videos.","Lung Ultrasound (LUS) images are considered to be effective for detecting Coronavirus Disease (COVID-19) as an alternative to the existing reverse transcription-polymerase chain reaction (RT-PCR)-based detection scheme. However, the recent literature exhibits a shortage of works dealing with LUS image-based COVID-19 detection. In this paper, a spectral mask enhancement (SpecMEn) scheme is introduced along with a histogram equalization pre-processing stage to reduce the noise effect in LUS images","2021","07","15","Health Inf Sci Syst","Health information science and systems","COVID-19; Disease classification; Image processing; Lung ultrasound; Spectral mask","Fattah","Shaikh Anowarul","Department of Electrical and Electronic Engineering, Bangladesh University of Engineering and Technology, Dhaka, 1205 Bangladesh",NA
"2182","34257834","10.1007/s40617-021-00622-3","Acceptability and Feasibility of Virtual Behavior Analysis Supervision.","The COVID-19 pandemic necessitated a rapid transition to virtual service delivery and supervision. This preliminary study examined acceptability and feasibility of virtual supervision for 94 BCBA/BCaBA trainees during COVID-19, including variables that affected perceived satisfaction, effectiveness, and supervision preference for this sample. Results indicate a decrease in accrual of direct client hours during the pandemic, with a third of participants reporting a decrease in individual supervis","2021","07","15","Behav Anal Pract","Behavior analysis in practice","COVID-19; satisfaction; supervision; virtual","Simmons","Christina A","Department of Psychology, Rowan University, 201 Mullica Hill Road, Robinson Hall Suite 117, Glassboro, NJ 08028 USA",NA
"2183","34257834","10.1007/s40617-021-00622-3","Acceptability and Feasibility of Virtual Behavior Analysis Supervision.","The COVID-19 pandemic necessitated a rapid transition to virtual service delivery and supervision. This preliminary study examined acceptability and feasibility of virtual supervision for 94 BCBA/BCaBA trainees during COVID-19, including variables that affected perceived satisfaction, effectiveness, and supervision preference for this sample. Results indicate a decrease in accrual of direct client hours during the pandemic, with a third of participants reporting a decrease in individual supervis","2021","07","15","Behav Anal Pract","Behavior analysis in practice","COVID-19; satisfaction; supervision; virtual","Ford","Kimberly R","Department of Psychology, Rowan University, 201 Mullica Hill Road, Robinson Hall Suite 117, Glassboro, NJ 08028 USA",NA
"2184","34257834","10.1007/s40617-021-00622-3","Acceptability and Feasibility of Virtual Behavior Analysis Supervision.","The COVID-19 pandemic necessitated a rapid transition to virtual service delivery and supervision. This preliminary study examined acceptability and feasibility of virtual supervision for 94 BCBA/BCaBA trainees during COVID-19, including variables that affected perceived satisfaction, effectiveness, and supervision preference for this sample. Results indicate a decrease in accrual of direct client hours during the pandemic, with a third of participants reporting a decrease in individual supervis","2021","07","15","Behav Anal Pract","Behavior analysis in practice","COVID-19; satisfaction; supervision; virtual","Salvatore","Giovanna L","Department of Psychology, Rowan University, 201 Mullica Hill Road, Robinson Hall Suite 117, Glassboro, NJ 08028 USA",NA
"2185","34257834","10.1007/s40617-021-00622-3","Acceptability and Feasibility of Virtual Behavior Analysis Supervision.","The COVID-19 pandemic necessitated a rapid transition to virtual service delivery and supervision. This preliminary study examined acceptability and feasibility of virtual supervision for 94 BCBA/BCaBA trainees during COVID-19, including variables that affected perceived satisfaction, effectiveness, and supervision preference for this sample. Results indicate a decrease in accrual of direct client hours during the pandemic, with a third of participants reporting a decrease in individual supervis","2021","07","15","Behav Anal Pract","Behavior analysis in practice","COVID-19; satisfaction; supervision; virtual","Moretti","Abigail E","Department of Psychology, Rowan University, 201 Mullica Hill Road, Robinson Hall Suite 117, Glassboro, NJ 08028 USA",NA
"2186","34257831","10.1021/acsmedchemlett.1c00140","Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.","Viral mRNA cap methyltransferases (MTases) are emerging targets for the development of broad-spectrum antiviral agents. In this work, we designed potential SARS-CoV-2 MTase Nsp14 and Nsp16 inhibitors by using bioisosteric substitution of the sulfonium and amino acid substructures of the cosubstrate S-adenosylmethionine (SAM), which serves as the methyl donor in the enzymatic reaction. The synthetically accessible target structures were prioritized using molecular docking. Testing of the inhibito","2021","07","15","ACS Med Chem Lett","ACS medicinal chemistry letters",NA,"Bobileva","Olga","Latvian Institute of Organic Synthesis, Aizkraukles 21, Riga LV-1006, Latvia",NA
"2187","34257831","10.1021/acsmedchemlett.1c00140","Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.","Viral mRNA cap methyltransferases (MTases) are emerging targets for the development of broad-spectrum antiviral agents. In this work, we designed potential SARS-CoV-2 MTase Nsp14 and Nsp16 inhibitors by using bioisosteric substitution of the sulfonium and amino acid substructures of the cosubstrate S-adenosylmethionine (SAM), which serves as the methyl donor in the enzymatic reaction. The synthetically accessible target structures were prioritized using molecular docking. Testing of the inhibito","2021","07","15","ACS Med Chem Lett","ACS medicinal chemistry letters",NA,"Bobrovs","Raitis","Latvian Institute of Organic Synthesis, Aizkraukles 21, Riga LV-1006, Latvia",NA
"2188","34257831","10.1021/acsmedchemlett.1c00140","Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.","Viral mRNA cap methyltransferases (MTases) are emerging targets for the development of broad-spectrum antiviral agents. In this work, we designed potential SARS-CoV-2 MTase Nsp14 and Nsp16 inhibitors by using bioisosteric substitution of the sulfonium and amino acid substructures of the cosubstrate S-adenosylmethionine (SAM), which serves as the methyl donor in the enzymatic reaction. The synthetically accessible target structures were prioritized using molecular docking. Testing of the inhibito","2021","07","15","ACS Med Chem Lett","ACS medicinal chemistry letters",NA,"Kanepe","Iveta","Latvian Institute of Organic Synthesis, Aizkraukles 21, Riga LV-1006, Latvia",NA
"2189","34257831","10.1021/acsmedchemlett.1c00140","Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.","Viral mRNA cap methyltransferases (MTases) are emerging targets for the development of broad-spectrum antiviral agents. In this work, we designed potential SARS-CoV-2 MTase Nsp14 and Nsp16 inhibitors by using bioisosteric substitution of the sulfonium and amino acid substructures of the cosubstrate S-adenosylmethionine (SAM), which serves as the methyl donor in the enzymatic reaction. The synthetically accessible target structures were prioritized using molecular docking. Testing of the inhibito","2021","07","15","ACS Med Chem Lett","ACS medicinal chemistry letters",NA,"Patetko","Liene","University of Latvia, Jelgavas 1, Riga LV-1004, Latvia",NA
"2190","34257831","10.1021/acsmedchemlett.1c00140","Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.","Viral mRNA cap methyltransferases (MTases) are emerging targets for the development of broad-spectrum antiviral agents. In this work, we designed potential SARS-CoV-2 MTase Nsp14 and Nsp16 inhibitors by using bioisosteric substitution of the sulfonium and amino acid substructures of the cosubstrate S-adenosylmethionine (SAM), which serves as the methyl donor in the enzymatic reaction. The synthetically accessible target structures were prioritized using molecular docking. Testing of the inhibito","2021","07","15","ACS Med Chem Lett","ACS medicinal chemistry letters",NA,"Kalnin","Gints","Latvian Biomedical Research and Study Centre, Ratsupites 1 k1, Riga LV-1067, Latvia",NA
"2191","34257831","10.1021/acsmedchemlett.1c00140","Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.","Viral mRNA cap methyltransferases (MTases) are emerging targets for the development of broad-spectrum antiviral agents. In this work, we designed potential SARS-CoV-2 MTase Nsp14 and Nsp16 inhibitors by using bioisosteric substitution of the sulfonium and amino acid substructures of the cosubstrate S-adenosylmethionine (SAM), which serves as the methyl donor in the enzymatic reaction. The synthetically accessible target structures were prioritized using molecular docking. Testing of the inhibito","2021","07","15","ACS Med Chem Lett","ACS medicinal chemistry letters",NA,"iovs","Mihails","Latvian Biomedical Research and Study Centre, Ratsupites 1 k1, Riga LV-1067, Latvia",NA
"2192","34257831","10.1021/acsmedchemlett.1c00140","Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.","Viral mRNA cap methyltransferases (MTases) are emerging targets for the development of broad-spectrum antiviral agents. In this work, we designed potential SARS-CoV-2 MTase Nsp14 and Nsp16 inhibitors by using bioisosteric substitution of the sulfonium and amino acid substructures of the cosubstrate S-adenosylmethionine (SAM), which serves as the methyl donor in the enzymatic reaction. The synthetically accessible target structures were prioritized using molecular docking. Testing of the inhibito","2021","07","15","ACS Med Chem Lett","ACS medicinal chemistry letters",NA,"Bula","Anna L","Latvian Institute of Organic Synthesis, Aizkraukles 21, Riga LV-1006, Latvia",NA
"2193","34257831","10.1021/acsmedchemlett.1c00140","Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.","Viral mRNA cap methyltransferases (MTases) are emerging targets for the development of broad-spectrum antiviral agents. In this work, we designed potential SARS-CoV-2 MTase Nsp14 and Nsp16 inhibitors by using bioisosteric substitution of the sulfonium and amino acid substructures of the cosubstrate S-adenosylmethionine (SAM), which serves as the methyl donor in the enzymatic reaction. The synthetically accessible target structures were prioritized using molecular docking. Testing of the inhibito","2021","07","15","ACS Med Chem Lett","ACS medicinal chemistry letters",NA,"Gri Nberga","Solveiga","Latvian Institute of Organic Synthesis, Aizkraukles 21, Riga LV-1006, Latvia",NA
"2194","34257831","10.1021/acsmedchemlett.1c00140","Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.","Viral mRNA cap methyltransferases (MTases) are emerging targets for the development of broad-spectrum antiviral agents. In this work, we designed potential SARS-CoV-2 MTase Nsp14 and Nsp16 inhibitors by using bioisosteric substitution of the sulfonium and amino acid substructures of the cosubstrate S-adenosylmethionine (SAM), which serves as the methyl donor in the enzymatic reaction. The synthetically accessible target structures were prioritized using molecular docking. Testing of the inhibito","2021","07","15","ACS Med Chem Lett","ACS medicinal chemistry letters",NA,"Borodukis","Ma Rtin","University of Latvia, Jelgavas 1, Riga LV-1004, Latvia",NA
"2195","34257831","10.1021/acsmedchemlett.1c00140","Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.","Viral mRNA cap methyltransferases (MTases) are emerging targets for the development of broad-spectrum antiviral agents. In this work, we designed potential SARS-CoV-2 MTase Nsp14 and Nsp16 inhibitors by using bioisosteric substitution of the sulfonium and amino acid substructures of the cosubstrate S-adenosylmethionine (SAM), which serves as the methyl donor in the enzymatic reaction. The synthetically accessible target structures were prioritized using molecular docking. Testing of the inhibito","2021","07","15","ACS Med Chem Lett","ACS medicinal chemistry letters",NA,"Ramata-Stunda","Anna","University of Latvia, Jelgavas 1, Riga LV-1004, Latvia",NA
"2196","34257831","10.1021/acsmedchemlett.1c00140","Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.","Viral mRNA cap methyltransferases (MTases) are emerging targets for the development of broad-spectrum antiviral agents. In this work, we designed potential SARS-CoV-2 MTase Nsp14 and Nsp16 inhibitors by using bioisosteric substitution of the sulfonium and amino acid substructures of the cosubstrate S-adenosylmethionine (SAM), which serves as the methyl donor in the enzymatic reaction. The synthetically accessible target structures were prioritized using molecular docking. Testing of the inhibito","2021","07","15","ACS Med Chem Lett","ACS medicinal chemistry letters",NA,"Rostoks","Nils","University of Latvia, Jelgavas 1, Riga LV-1004, Latvia",NA
"2197","34257831","10.1021/acsmedchemlett.1c00140","Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.","Viral mRNA cap methyltransferases (MTases) are emerging targets for the development of broad-spectrum antiviral agents. In this work, we designed potential SARS-CoV-2 MTase Nsp14 and Nsp16 inhibitors by using bioisosteric substitution of the sulfonium and amino acid substructures of the cosubstrate S-adenosylmethionine (SAM), which serves as the methyl donor in the enzymatic reaction. The synthetically accessible target structures were prioritized using molecular docking. Testing of the inhibito","2021","07","15","ACS Med Chem Lett","ACS medicinal chemistry letters",NA,"Jirgensons","Aigars","Latvian Institute of Organic Synthesis, Aizkraukles 21, Riga LV-1006, Latvia",NA
"2198","34257831","10.1021/acsmedchemlett.1c00140","Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.","Viral mRNA cap methyltransferases (MTases) are emerging targets for the development of broad-spectrum antiviral agents. In this work, we designed potential SARS-CoV-2 MTase Nsp14 and Nsp16 inhibitors by using bioisosteric substitution of the sulfonium and amino acid substructures of the cosubstrate S-adenosylmethionine (SAM), which serves as the methyl donor in the enzymatic reaction. The synthetically accessible target structures were prioritized using molecular docking. Testing of the inhibito","2021","07","15","ACS Med Chem Lett","ACS medicinal chemistry letters",NA,"Ta Rs","Kaspars","Latvian Biomedical Research and Study Centre, Ratsupites 1 k1, Riga LV-1067, Latvia",NA
"2199","34257831","10.1021/acsmedchemlett.1c00140","Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.","Viral mRNA cap methyltransferases (MTases) are emerging targets for the development of broad-spectrum antiviral agents. In this work, we designed potential SARS-CoV-2 MTase Nsp14 and Nsp16 inhibitors by using bioisosteric substitution of the sulfonium and amino acid substructures of the cosubstrate S-adenosylmethionine (SAM), which serves as the methyl donor in the enzymatic reaction. The synthetically accessible target structures were prioritized using molecular docking. Testing of the inhibito","2021","07","15","ACS Med Chem Lett","ACS medicinal chemistry letters",NA,"Jaudzems","Kristaps","Latvian Institute of Organic Synthesis, Aizkraukles 21, Riga LV-1006, Latvia",NA
"2200","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Zdravkovic","Marija","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2201","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Popadic","Viseslav","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2202","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Klasnja","Slobodan","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2203","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Pavlovic","Vedrana","Institute for Medical Statistics and Informatics, Faculty of Medicine University of Belgrade, Belgrade, Serbia",NA
"2204","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Aleksic","Aleksandra","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2205","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Milenkovic","Marija","Faculty of Medicine, University of Belgrade, Belgrade, Serbia",NA
"2206","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Crnokrak","Bogdan","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2207","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Balint","Bela","Institute of Cardiovascular Diseases ""Dedinje"", Belgrade, Serbia",NA
"2208","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Todorovic-Balint","Milena","Faculty of Medicine, University of Belgrade, Belgrade, Serbia",NA
"2209","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Mrda","Davor","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2210","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Zdravkovic","Darko","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2211","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Toskovic","Borislav","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2212","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Brankovic","Marija","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2213","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Markovic","Olivera","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2214","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Bjekic-Macut","Jelica","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2215","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Djuran","Predrag","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2216","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Memon","Lidija","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2217","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Stojanovic","Ana","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2218","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Brajkovic","Milica","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2219","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Todorovic","Zoran","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2220","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Hadzi-Djokic","Jovan","Faculty of Medicine, University of Belgrade, Belgrade, Serbia",NA
"2221","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Jovanovic","Igor","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2222","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Nikolic","Dejan","University Clinical Hospital Center, Bezanijska kosa, Belgrade, Serbia",NA
"2223","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Cvijanovic","Dane","University Clinical Center Zvezdara, Belgrade, Serbia",NA
"2224","34257816","10.1155/2021/6654388","Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.","Risk stratification is an important aspect of COVID-19 management, especially in patients admitted to ICU as it can provide more useful consumption of health resources, as well as prioritize critical care services in situations of overwhelming number of patients. A multivariable predictive model for mortality was developed using data solely from a derivation cohort of 160 COVID-19 patients with moderate to severe ARDS admitted to ICU. The regression coefficients from the final multivariate model","2021","07","19","Oxid Med Cell Longev","Oxidative medicine and cellular longevity","Adult; Aged; Aged, 80 and over; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Models, Biological; Oxygen; Respiration, Artificial; Risk Assessment; SARS-CoV-2","Milic","Natasa","Institute for Medical Statistics and Informatics, Faculty of Medicine University of Belgrade, Belgrade, Serbia",NA
"2225","34257762","10.1016/j.jdsr.2021.07.001","Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients.","Coronavirus disease 2019 (COVID 2019) is a highly transmissible pandemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The characteristics of the disease include a broad range of symptoms from mild to serious to death, with mild pneumonia to acute respiratory distress syndrome and complications in extrapulmonary organs. Taste impairment and salivary dysfunction are common early symptoms in COVID-19 patients. The mouth is a significant entry route for SARS-CoV-2,","2021","07","15","Jpn Dent Sci Rev","The Japanese dental science review","COVID-19; SARS-CoV-2; gustatory impairment; long COVID; pathogenesis; salivary gland disorder; taste impairment; xerostomia","Okada","Yasuo","Department of Pathology, The Nippon Dental University School of Life Dentistry at Niigata, 1-8 Hamaura-cho, Chuo-ku, Niigata 951-8580, Japan",NA
"2226","34257762","10.1016/j.jdsr.2021.07.001","Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients.","Coronavirus disease 2019 (COVID 2019) is a highly transmissible pandemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The characteristics of the disease include a broad range of symptoms from mild to serious to death, with mild pneumonia to acute respiratory distress syndrome and complications in extrapulmonary organs. Taste impairment and salivary dysfunction are common early symptoms in COVID-19 patients. The mouth is a significant entry route for SARS-CoV-2,","2021","07","15","Jpn Dent Sci Rev","The Japanese dental science review","COVID-19; SARS-CoV-2; gustatory impairment; long COVID; pathogenesis; salivary gland disorder; taste impairment; xerostomia","Yoshimura","Ken","Department of Anatomy, The Nippon Dental University School of Life Dentistry at Niigata, 1-8 Hamaura-cho, Chuo-ku, Niigata 951-8580, Japan",NA
"2227","34257762","10.1016/j.jdsr.2021.07.001","Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients.","Coronavirus disease 2019 (COVID 2019) is a highly transmissible pandemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The characteristics of the disease include a broad range of symptoms from mild to serious to death, with mild pneumonia to acute respiratory distress syndrome and complications in extrapulmonary organs. Taste impairment and salivary dysfunction are common early symptoms in COVID-19 patients. The mouth is a significant entry route for SARS-CoV-2,","2021","07","15","Jpn Dent Sci Rev","The Japanese dental science review","COVID-19; SARS-CoV-2; gustatory impairment; long COVID; pathogenesis; salivary gland disorder; taste impairment; xerostomia","Toya","Shuji","Oral and Maxillofacial Surgery, The Nippon Dental University Niigata Hospital, 1-8 Hamaura-cho, Chuo-ku, Niigata 951-8580, Japan",NA
"2228","34257762","10.1016/j.jdsr.2021.07.001","Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients.","Coronavirus disease 2019 (COVID 2019) is a highly transmissible pandemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The characteristics of the disease include a broad range of symptoms from mild to serious to death, with mild pneumonia to acute respiratory distress syndrome and complications in extrapulmonary organs. Taste impairment and salivary dysfunction are common early symptoms in COVID-19 patients. The mouth is a significant entry route for SARS-CoV-2,","2021","07","15","Jpn Dent Sci Rev","The Japanese dental science review","COVID-19; SARS-CoV-2; gustatory impairment; long COVID; pathogenesis; salivary gland disorder; taste impairment; xerostomia","Tsuchimochi","Makoto","The Nippon Dental University (Emeritus Professor), 1-9-20 Fujimi, Chiyoda-ku, Tokyo, 102-8159, Japan",NA
"2229","34257751","10.1016/j.jccase.2021.06.010","Left ventricular thrombus with normal systolic function secondary to the novel prothrombotic association of acute on chronic calcific pancreatitis and COVID-19.","In the presence of normal left ventricular systolic function, the development of left ventricular thrombus has seldom been documented in hypercoagulable conditions. Echocardiographic results of left ventricular thrombi can be differentiated from those found in cardiac tumors such as myxoma. Many other organs, including the central and peripheral nervous systems, as well as the cardiac and vascular systems, have recently been linked to thromboembolic events in coronavirus disease 2019 (COVID-19).","2021","07","15","J Cardiol Cases","Journal of cardiology cases","COVID-19; Chronic pancreatitis; Left ventricular function; Thromboembolism","Jariwala","Pankaj V","Department of Cardiology, Yashoda Hospital, Somajiguda, Hyderabad 500082, India",NA
"2230","34257751","10.1016/j.jccase.2021.06.010","Left ventricular thrombus with normal systolic function secondary to the novel prothrombotic association of acute on chronic calcific pancreatitis and COVID-19.","In the presence of normal left ventricular systolic function, the development of left ventricular thrombus has seldom been documented in hypercoagulable conditions. Echocardiographic results of left ventricular thrombi can be differentiated from those found in cardiac tumors such as myxoma. Many other organs, including the central and peripheral nervous systems, as well as the cardiac and vascular systems, have recently been linked to thromboembolic events in coronavirus disease 2019 (COVID-19).","2021","07","15","J Cardiol Cases","Journal of cardiology cases","COVID-19; Chronic pancreatitis; Left ventricular function; Thromboembolism","Jadhav","Kartik Pandurang","Department of Cardiology, Yashoda Hospital, Somajiguda, Hyderabad 500082, India",NA
"2231","34257751","10.1016/j.jccase.2021.06.010","Left ventricular thrombus with normal systolic function secondary to the novel prothrombotic association of acute on chronic calcific pancreatitis and COVID-19.","In the presence of normal left ventricular systolic function, the development of left ventricular thrombus has seldom been documented in hypercoagulable conditions. Echocardiographic results of left ventricular thrombi can be differentiated from those found in cardiac tumors such as myxoma. Many other organs, including the central and peripheral nervous systems, as well as the cardiac and vascular systems, have recently been linked to thromboembolic events in coronavirus disease 2019 (COVID-19).","2021","07","15","J Cardiol Cases","Journal of cardiology cases","COVID-19; Chronic pancreatitis; Left ventricular function; Thromboembolism","Aurangabadkar","Hrushikesh","Department of Nuclear Medicine, Yashoda Hospital, Somajiguda, Hyderabad, India",NA
"2232","34257751","10.1016/j.jccase.2021.06.010","Left ventricular thrombus with normal systolic function secondary to the novel prothrombotic association of acute on chronic calcific pancreatitis and COVID-19.","In the presence of normal left ventricular systolic function, the development of left ventricular thrombus has seldom been documented in hypercoagulable conditions. Echocardiographic results of left ventricular thrombi can be differentiated from those found in cardiac tumors such as myxoma. Many other organs, including the central and peripheral nervous systems, as well as the cardiac and vascular systems, have recently been linked to thromboembolic events in coronavirus disease 2019 (COVID-19).","2021","07","15","J Cardiol Cases","Journal of cardiology cases","COVID-19; Chronic pancreatitis; Left ventricular function; Thromboembolism","Dommata","Raghotam Reddy","Department of Pulmonology, Yashoda Hospital, Somajiguda, Hyderabad, India",NA
"2233","34257741","10.1155/2021/6655103","Assessment of Attentional Functioning in Health Professionals of a Brazilian Tertiary Referral Hospital for COVID-19.","This study is aimed at assessing differences in basic attentional functioning between substantial and minimal work-related exposure to COVID-19 patients in professionals working in a tertiary referral hospital in Rio de Janeiro, Brazil. Therefore, hospital employees performed a Continuous Visual Attention Test. This test consisted of a 90-second Go/No-Go task with 72 (80%) targets and 18 (20%) nontargets. For each participant, reaction time and intraindividual variability of reaction times of al","2021","07","15","Behav Neurol","Behavioural neurology","Adult; Attention; Brazil; COVID-19; Female; Health Personnel; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Reaction Time; SARS-CoV-2; Tertiary Care Centers; Work Schedule Tolerance; Young Adult","van Duinkerken","Eelco","Department of Neurology, University Hospital Gaffrée and Guinle, Federal University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil",NA
"2234","34257741","10.1155/2021/6655103","Assessment of Attentional Functioning in Health Professionals of a Brazilian Tertiary Referral Hospital for COVID-19.","This study is aimed at assessing differences in basic attentional functioning between substantial and minimal work-related exposure to COVID-19 patients in professionals working in a tertiary referral hospital in Rio de Janeiro, Brazil. Therefore, hospital employees performed a Continuous Visual Attention Test. This test consisted of a 90-second Go/No-Go task with 72 (80%) targets and 18 (20%) nontargets. For each participant, reaction time and intraindividual variability of reaction times of al","2021","07","15","Behav Neurol","Behavioural neurology","Adult; Attention; Brazil; COVID-19; Female; Health Personnel; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Reaction Time; SARS-CoV-2; Tertiary Care Centers; Work Schedule Tolerance; Young Adult","Schmidt","Guilherme J","Department of Neurology, University Hospital Gaffrée and Guinle, Federal University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil",NA
"2235","34257741","10.1155/2021/6655103","Assessment of Attentional Functioning in Health Professionals of a Brazilian Tertiary Referral Hospital for COVID-19.","This study is aimed at assessing differences in basic attentional functioning between substantial and minimal work-related exposure to COVID-19 patients in professionals working in a tertiary referral hospital in Rio de Janeiro, Brazil. Therefore, hospital employees performed a Continuous Visual Attention Test. This test consisted of a 90-second Go/No-Go task with 72 (80%) targets and 18 (20%) nontargets. For each participant, reaction time and intraindividual variability of reaction times of al","2021","07","15","Behav Neurol","Behavioural neurology","Adult; Attention; Brazil; COVID-19; Female; Health Personnel; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Reaction Time; SARS-CoV-2; Tertiary Care Centers; Work Schedule Tolerance; Young Adult","Gjorup","Ana Lúcia Taboada","Department of Internal Medicine, University Hospital Gaffrée and Guinle, Federal University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil",NA
"2236","34257741","10.1155/2021/6655103","Assessment of Attentional Functioning in Health Professionals of a Brazilian Tertiary Referral Hospital for COVID-19.","This study is aimed at assessing differences in basic attentional functioning between substantial and minimal work-related exposure to COVID-19 patients in professionals working in a tertiary referral hospital in Rio de Janeiro, Brazil. Therefore, hospital employees performed a Continuous Visual Attention Test. This test consisted of a 90-second Go/No-Go task with 72 (80%) targets and 18 (20%) nontargets. For each participant, reaction time and intraindividual variability of reaction times of al","2021","07","15","Behav Neurol","Behavioural neurology","Adult; Attention; Brazil; COVID-19; Female; Health Personnel; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Reaction Time; SARS-CoV-2; Tertiary Care Centers; Work Schedule Tolerance; Young Adult","Mello","Carolina Ribeiro","Department of Anesthesiology, University Hospital Gaffrée and Guinle, Federal University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil",NA
"2237","34257741","10.1155/2021/6655103","Assessment of Attentional Functioning in Health Professionals of a Brazilian Tertiary Referral Hospital for COVID-19.","This study is aimed at assessing differences in basic attentional functioning between substantial and minimal work-related exposure to COVID-19 patients in professionals working in a tertiary referral hospital in Rio de Janeiro, Brazil. Therefore, hospital employees performed a Continuous Visual Attention Test. This test consisted of a 90-second Go/No-Go task with 72 (80%) targets and 18 (20%) nontargets. For each participant, reaction time and intraindividual variability of reaction times of al","2021","07","15","Behav Neurol","Behavioural neurology","Adult; Attention; Brazil; COVID-19; Female; Health Personnel; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Reaction Time; SARS-CoV-2; Tertiary Care Centers; Work Schedule Tolerance; Young Adult","Marques","André Casarsa","Department of Internal Medicine, University Hospital Gaffrée and Guinle, Federal University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil",NA
"2238","34257741","10.1155/2021/6655103","Assessment of Attentional Functioning in Health Professionals of a Brazilian Tertiary Referral Hospital for COVID-19.","This study is aimed at assessing differences in basic attentional functioning between substantial and minimal work-related exposure to COVID-19 patients in professionals working in a tertiary referral hospital in Rio de Janeiro, Brazil. Therefore, hospital employees performed a Continuous Visual Attention Test. This test consisted of a 90-second Go/No-Go task with 72 (80%) targets and 18 (20%) nontargets. For each participant, reaction time and intraindividual variability of reaction times of al","2021","07","15","Behav Neurol","Behavioural neurology","Adult; Attention; Brazil; COVID-19; Female; Health Personnel; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Reaction Time; SARS-CoV-2; Tertiary Care Centers; Work Schedule Tolerance; Young Adult","do Carmo Filho","Áureo","Department of Internal Medicine, University Hospital Gaffrée and Guinle, Federal University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil",NA
"2239","34257741","10.1155/2021/6655103","Assessment of Attentional Functioning in Health Professionals of a Brazilian Tertiary Referral Hospital for COVID-19.","This study is aimed at assessing differences in basic attentional functioning between substantial and minimal work-related exposure to COVID-19 patients in professionals working in a tertiary referral hospital in Rio de Janeiro, Brazil. Therefore, hospital employees performed a Continuous Visual Attention Test. This test consisted of a 90-second Go/No-Go task with 72 (80%) targets and 18 (20%) nontargets. For each participant, reaction time and intraindividual variability of reaction times of al","2021","07","15","Behav Neurol","Behavioural neurology","Adult; Attention; Brazil; COVID-19; Female; Health Personnel; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Reaction Time; SARS-CoV-2; Tertiary Care Centers; Work Schedule Tolerance; Young Adult","Fukusawa","Paula Regina Yuri","Education and Research Unit, University Hospital Gaffrée and Guinle, EBSERH, Federal Ministry of Education and Culture, Brazil",NA
"2240","34257741","10.1155/2021/6655103","Assessment of Attentional Functioning in Health Professionals of a Brazilian Tertiary Referral Hospital for COVID-19.","This study is aimed at assessing differences in basic attentional functioning between substantial and minimal work-related exposure to COVID-19 patients in professionals working in a tertiary referral hospital in Rio de Janeiro, Brazil. Therefore, hospital employees performed a Continuous Visual Attention Test. This test consisted of a 90-second Go/No-Go task with 72 (80%) targets and 18 (20%) nontargets. For each participant, reaction time and intraindividual variability of reaction times of al","2021","07","15","Behav Neurol","Behavioural neurology","Adult; Attention; Brazil; COVID-19; Female; Health Personnel; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Reaction Time; SARS-CoV-2; Tertiary Care Centers; Work Schedule Tolerance; Young Adult","de Assis","Simone Gonçalves","Department of Neurology, University Hospital Gaffrée and Guinle, Federal University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil",NA
"2241","34257741","10.1155/2021/6655103","Assessment of Attentional Functioning in Health Professionals of a Brazilian Tertiary Referral Hospital for COVID-19.","This study is aimed at assessing differences in basic attentional functioning between substantial and minimal work-related exposure to COVID-19 patients in professionals working in a tertiary referral hospital in Rio de Janeiro, Brazil. Therefore, hospital employees performed a Continuous Visual Attention Test. This test consisted of a 90-second Go/No-Go task with 72 (80%) targets and 18 (20%) nontargets. For each participant, reaction time and intraindividual variability of reaction times of al","2021","07","15","Behav Neurol","Behavioural neurology","Adult; Attention; Brazil; COVID-19; Female; Health Personnel; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Reaction Time; SARS-CoV-2; Tertiary Care Centers; Work Schedule Tolerance; Young Adult","Tolentino","Júlio Cesar","Department of Internal Medicine, University Hospital Gaffrée and Guinle, Federal University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil",NA
"2242","34257741","10.1155/2021/6655103","Assessment of Attentional Functioning in Health Professionals of a Brazilian Tertiary Referral Hospital for COVID-19.","This study is aimed at assessing differences in basic attentional functioning between substantial and minimal work-related exposure to COVID-19 patients in professionals working in a tertiary referral hospital in Rio de Janeiro, Brazil. Therefore, hospital employees performed a Continuous Visual Attention Test. This test consisted of a 90-second Go/No-Go task with 72 (80%) targets and 18 (20%) nontargets. For each participant, reaction time and intraindividual variability of reaction times of al","2021","07","15","Behav Neurol","Behavioural neurology","Adult; Attention; Brazil; COVID-19; Female; Health Personnel; Humans; Infectious Disease Transmission, Patient-to-Professional; Male; Middle Aged; Reaction Time; SARS-CoV-2; Tertiary Care Centers; Work Schedule Tolerance; Young Adult","Schmidt","Sergio L","Department of Neurology, University Hospital Gaffrée and Guinle, Federal University of the State of Rio de Janeiro, Rio de Janeiro, RJ, Brazil",NA
"2243","34257737","10.1007/s11422-021-10035-x","Holding space for uncertainty and vulnerability: reclaiming humanity in teacher education through contemplative | equity pedagogy.","In this manuscript we describe our journey as two White coteachers conducting interpretive research with Black and Brown students in a remote-learning teacher preparation course in New York City. In the context of uncertainty, during the twin epidemics of COVID-19 and racial injustice, we explore how we reframed our contemplative pedagogy by embracing an equity-oriented framework. We share stories about moments of awakening drawn from spaces between us and our exceptional cohort of special educa","2021","07","15","Cult Stud Sci Educ","Cultural studies of science education","Contemplative pedagogy; Equity; Event-oriented inquiry; Reflective journaling; Teacher education","Powietrzynska","Malgorzata","Department of Secondary Education, Brooklyn College, 2900 Bedford Ave, Brooklyn, NY 11210 USA",NA
"2244","34257737","10.1007/s11422-021-10035-x","Holding space for uncertainty and vulnerability: reclaiming humanity in teacher education through contemplative | equity pedagogy.","In this manuscript we describe our journey as two White coteachers conducting interpretive research with Black and Brown students in a remote-learning teacher preparation course in New York City. In the context of uncertainty, during the twin epidemics of COVID-19 and racial injustice, we explore how we reframed our contemplative pedagogy by embracing an equity-oriented framework. We share stories about moments of awakening drawn from spaces between us and our exceptional cohort of special educa","2021","07","15","Cult Stud Sci Educ","Cultural studies of science education","Contemplative pedagogy; Equity; Event-oriented inquiry; Reflective journaling; Teacher education","Noble","Linda","Department of Secondary Education, Brooklyn College, 2900 Bedford Ave, Brooklyn, NY 11210 USA",NA
"2245","34257737","10.1007/s11422-021-10035-x","Holding space for uncertainty and vulnerability: reclaiming humanity in teacher education through contemplative | equity pedagogy.","In this manuscript we describe our journey as two White coteachers conducting interpretive research with Black and Brown students in a remote-learning teacher preparation course in New York City. In the context of uncertainty, during the twin epidemics of COVID-19 and racial injustice, we explore how we reframed our contemplative pedagogy by embracing an equity-oriented framework. We share stories about moments of awakening drawn from spaces between us and our exceptional cohort of special educa","2021","07","15","Cult Stud Sci Educ","Cultural studies of science education","Contemplative pedagogy; Equity; Event-oriented inquiry; Reflective journaling; Teacher education","O'Loughlin-Boncamper","Sharda","Department of Secondary Education, Brooklyn College, 2900 Bedford Ave, Brooklyn, NY 11210 USA",NA
"2246","34257737","10.1007/s11422-021-10035-x","Holding space for uncertainty and vulnerability: reclaiming humanity in teacher education through contemplative | equity pedagogy.","In this manuscript we describe our journey as two White coteachers conducting interpretive research with Black and Brown students in a remote-learning teacher preparation course in New York City. In the context of uncertainty, during the twin epidemics of COVID-19 and racial injustice, we explore how we reframed our contemplative pedagogy by embracing an equity-oriented framework. We share stories about moments of awakening drawn from spaces between us and our exceptional cohort of special educa","2021","07","15","Cult Stud Sci Educ","Cultural studies of science education","Contemplative pedagogy; Equity; Event-oriented inquiry; Reflective journaling; Teacher education","Azeez","Aundrey","Department of Secondary Education, Brooklyn College, 2900 Bedford Ave, Brooklyn, NY 11210 USA",NA
"2247","34257733","10.1007/s11625-021-00999-8","Risk management for pandemics: a novel approach: ""Hindsight is 20/20"" English proverb.","The impacts of the current COVID-19 pandemic illustrate the global-level sensitivity to such threats. As understanding of major hazards is generally based on past experience and there is a lack of good historical precedents, approaches and models currently employed to assess risks and guide responses generally lack transparency and are often associated with huge, unspecified uncertainties. Fundamental challenges arise from the strongly coupled nature of the impacts of a pandemic (i.e. not only o","2021","07","15","Sustain Sci","Sustainability science",NA,"McKinley","Ian G","McKinley Consulting, Badstrasse 20B, 5408 Ennetbaden, Switzerland",NA
"2248","34257733","10.1007/s11625-021-00999-8","Risk management for pandemics: a novel approach: ""Hindsight is 20/20"" English proverb.","The impacts of the current COVID-19 pandemic illustrate the global-level sensitivity to such threats. As understanding of major hazards is generally based on past experience and there is a lack of good historical precedents, approaches and models currently employed to assess risks and guide responses generally lack transparency and are often associated with huge, unspecified uncertainties. Fundamental challenges arise from the strongly coupled nature of the impacts of a pandemic (i.e. not only o","2021","07","15","Sustain Sci","Sustainability science",NA,"West","Julia M","McKinley Consulting, Badstrasse 20B, 5408 Ennetbaden, Switzerland",NA
"2249","34257733","10.1007/s11625-021-00999-8","Risk management for pandemics: a novel approach: ""Hindsight is 20/20"" English proverb.","The impacts of the current COVID-19 pandemic illustrate the global-level sensitivity to such threats. As understanding of major hazards is generally based on past experience and there is a lack of good historical precedents, approaches and models currently employed to assess risks and guide responses generally lack transparency and are often associated with huge, unspecified uncertainties. Fundamental challenges arise from the strongly coupled nature of the impacts of a pandemic (i.e. not only o","2021","07","15","Sustain Sci","Sustainability science",NA,"Hardie","Susie M L","McKinley Consulting, Badstrasse 20B, 5408 Ennetbaden, Switzerland",NA
"2250","34257657","10.1155/2021/6689669","Evaluation of the Risk of Clinical Deterioration among Inpatients with COVID-19.","This study aims to assess the risk of severe forms of COVID-19, based on clinical, laboratory, and imaging markers in patients initially admitted to the ward. This is a retrospective observational study, with data from electronic medical records of inpatients, with laboratory confirmation of COVID-19, between March and September 2020, in a hospital from Juiz de Fora-MG, Brazil. Participants (n = 74) were separated into two groups by clinical evolution: those who remained in the ward and t","2021","07","15","Adv Virol","Advances in virology",NA,"Costa","Víctor O","Medicine, Faculdade de Ciências Médicas e da Saúde de Juiz de Fora-SUPREMA, Juiz de Fora 36033-003, Brazil",NA
"2251","34257657","10.1155/2021/6689669","Evaluation of the Risk of Clinical Deterioration among Inpatients with COVID-19.","This study aims to assess the risk of severe forms of COVID-19, based on clinical, laboratory, and imaging markers in patients initially admitted to the ward. This is a retrospective observational study, with data from electronic medical records of inpatients, with laboratory confirmation of COVID-19, between March and September 2020, in a hospital from Juiz de Fora-MG, Brazil. Participants (n = 74) were separated into two groups by clinical evolution: those who remained in the ward and t","2021","07","15","Adv Virol","Advances in virology",NA,"Nicolini","Eveline M","Thoracic Surgery, Hospital Monte Sinai, Juiz de Fora 36033-318, Brazil",NA
"2252","34257657","10.1155/2021/6689669","Evaluation of the Risk of Clinical Deterioration among Inpatients with COVID-19.","This study aims to assess the risk of severe forms of COVID-19, based on clinical, laboratory, and imaging markers in patients initially admitted to the ward. This is a retrospective observational study, with data from electronic medical records of inpatients, with laboratory confirmation of COVID-19, between March and September 2020, in a hospital from Juiz de Fora-MG, Brazil. Participants (n = 74) were separated into two groups by clinical evolution: those who remained in the ward and t","2021","07","15","Adv Virol","Advances in virology",NA,"da Costa","Bruna M A","Nursing, Faculdade de Ciências Médicas e da Saúde de Juiz de Fora-Suprema, Juiz de Fora 36033-003, Brazil",NA
"2253","34257657","10.1155/2021/6689669","Evaluation of the Risk of Clinical Deterioration among Inpatients with COVID-19.","This study aims to assess the risk of severe forms of COVID-19, based on clinical, laboratory, and imaging markers in patients initially admitted to the ward. This is a retrospective observational study, with data from electronic medical records of inpatients, with laboratory confirmation of COVID-19, between March and September 2020, in a hospital from Juiz de Fora-MG, Brazil. Participants (n = 74) were separated into two groups by clinical evolution: those who remained in the ward and t","2021","07","15","Adv Virol","Advances in virology",NA,"Teixeira","Fabrício M","Medicine, Faculdade de Ciências Médicas e da Saúde de Juiz de Fora-SUPREMA, Juiz de Fora 36033-003, Brazil",NA
"2254","34257657","10.1155/2021/6689669","Evaluation of the Risk of Clinical Deterioration among Inpatients with COVID-19.","This study aims to assess the risk of severe forms of COVID-19, based on clinical, laboratory, and imaging markers in patients initially admitted to the ward. This is a retrospective observational study, with data from electronic medical records of inpatients, with laboratory confirmation of COVID-19, between March and September 2020, in a hospital from Juiz de Fora-MG, Brazil. Participants (n = 74) were separated into two groups by clinical evolution: those who remained in the ward and t","2021","07","15","Adv Virol","Advances in virology",NA,"Ferreira","Júlia P","Medicine, Faculdade de Ciências Médicas e da Saúde de Juiz de Fora-SUPREMA, Juiz de Fora 36033-003, Brazil",NA
"2255","34257657","10.1155/2021/6689669","Evaluation of the Risk of Clinical Deterioration among Inpatients with COVID-19.","This study aims to assess the risk of severe forms of COVID-19, based on clinical, laboratory, and imaging markers in patients initially admitted to the ward. This is a retrospective observational study, with data from electronic medical records of inpatients, with laboratory confirmation of COVID-19, between March and September 2020, in a hospital from Juiz de Fora-MG, Brazil. Participants (n = 74) were separated into two groups by clinical evolution: those who remained in the ward and t","2021","07","15","Adv Virol","Advances in virology",NA,"Moura","Marcos A","Infectology, Faculdade de Ciências Médicas e da Saúde de Juiz de Fora-Suprema, Juiz de Fora 36033-003, Brazil",NA
"2256","34257657","10.1155/2021/6689669","Evaluation of the Risk of Clinical Deterioration among Inpatients with COVID-19.","This study aims to assess the risk of severe forms of COVID-19, based on clinical, laboratory, and imaging markers in patients initially admitted to the ward. This is a retrospective observational study, with data from electronic medical records of inpatients, with laboratory confirmation of COVID-19, between March and September 2020, in a hospital from Juiz de Fora-MG, Brazil. Participants (n = 74) were separated into two groups by clinical evolution: those who remained in the ward and t","2021","07","15","Adv Virol","Advances in virology",NA,"Montessi","Jorge","Thoracic Surgery, Hospital Monte Sinai, Juiz de Fora 36033-318, Brazil",NA
"2257","34257657","10.1155/2021/6689669","Evaluation of the Risk of Clinical Deterioration among Inpatients with COVID-19.","This study aims to assess the risk of severe forms of COVID-19, based on clinical, laboratory, and imaging markers in patients initially admitted to the ward. This is a retrospective observational study, with data from electronic medical records of inpatients, with laboratory confirmation of COVID-19, between March and September 2020, in a hospital from Juiz de Fora-MG, Brazil. Participants (n = 74) were separated into two groups by clinical evolution: those who remained in the ward and t","2021","07","15","Adv Virol","Advances in virology",NA,"Campos","Rogério L","Psychiatrist and Emergency, Hospital Monte Sinai, Juiz de Fora 36033-318, Brazil",NA
"2258","34257657","10.1155/2021/6689669","Evaluation of the Risk of Clinical Deterioration among Inpatients with COVID-19.","This study aims to assess the risk of severe forms of COVID-19, based on clinical, laboratory, and imaging markers in patients initially admitted to the ward. This is a retrospective observational study, with data from electronic medical records of inpatients, with laboratory confirmation of COVID-19, between March and September 2020, in a hospital from Juiz de Fora-MG, Brazil. Participants (n = 74) were separated into two groups by clinical evolution: those who remained in the ward and t","2021","07","15","Adv Virol","Advances in virology",NA,"Guaraldo","Andrea N","Intensive Therapy, Hospital Monte Sinai, Juiz de Fora 36033-318, Brazil",NA
"2259","34257657","10.1155/2021/6689669","Evaluation of the Risk of Clinical Deterioration among Inpatients with COVID-19.","This study aims to assess the risk of severe forms of COVID-19, based on clinical, laboratory, and imaging markers in patients initially admitted to the ward. This is a retrospective observational study, with data from electronic medical records of inpatients, with laboratory confirmation of COVID-19, between March and September 2020, in a hospital from Juiz de Fora-MG, Brazil. Participants (n = 74) were separated into two groups by clinical evolution: those who remained in the ward and t","2021","07","15","Adv Virol","Advances in virology",NA,"Costa","Patrícia M","Intensive Therapy and Dermatology Hospital Monte Sinai, Juiz de Fora 36033-318, Brazil",NA
"2260","34257618","10.3389/pore.2021.1609774","Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis.","Objective: This study examined cumulative excess mortality in European countries in the year of the Covid-19 pandemic and characterized the dynamics of the pandemic in different countries, focusing on Hungary and the Central and Eastern European region. Methods: Age-standardized cumulative excess mortality was calculated based on weekly mortality data from the EUROSTAT database, and was compared between 2020 and the 2016-2019 reference period in European countries. Results: ","2021","07","22","Pathol Oncol Res","Pathology oncology research : POR","Hungary; age-standardized mortality rate; covid-19 pandemic; cumulative death; excess mortality; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Humans; Hungary; Infant; Infant, Newborn; Middle Aged; Mortality; Pandemics; SARS-CoV-2; Young Adult","Bogos","Krisztina","National Korányi Institute of Pulmonology, Budapest, Hungary",NA
"2261","34257618","10.3389/pore.2021.1609774","Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis.","Objective: This study examined cumulative excess mortality in European countries in the year of the Covid-19 pandemic and characterized the dynamics of the pandemic in different countries, focusing on Hungary and the Central and Eastern European region. Methods: Age-standardized cumulative excess mortality was calculated based on weekly mortality data from the EUROSTAT database, and was compared between 2020 and the 2016-2019 reference period in European countries. Results: ","2021","07","22","Pathol Oncol Res","Pathology oncology research : POR","Hungary; age-standardized mortality rate; covid-19 pandemic; cumulative death; excess mortality; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Humans; Hungary; Infant; Infant, Newborn; Middle Aged; Mortality; Pandemics; SARS-CoV-2; Young Adult","Kiss","Zoltan","nd Department of Medicine and Nephrological Center, Faculty of Medicine, University of Pécs, Pécs, Hungary",NA
"2262","34257618","10.3389/pore.2021.1609774","Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis.","Objective: This study examined cumulative excess mortality in European countries in the year of the Covid-19 pandemic and characterized the dynamics of the pandemic in different countries, focusing on Hungary and the Central and Eastern European region. Methods: Age-standardized cumulative excess mortality was calculated based on weekly mortality data from the EUROSTAT database, and was compared between 2020 and the 2016-2019 reference period in European countries. Results: ","2021","07","22","Pathol Oncol Res","Pathology oncology research : POR","Hungary; age-standardized mortality rate; covid-19 pandemic; cumulative death; excess mortality; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Humans; Hungary; Infant; Infant, Newborn; Middle Aged; Mortality; Pandemics; SARS-CoV-2; Young Adult","Kerpel Fronius","Anna","National Korányi Institute of Pulmonology, Budapest, Hungary",NA
"2263","34257618","10.3389/pore.2021.1609774","Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis.","Objective: This study examined cumulative excess mortality in European countries in the year of the Covid-19 pandemic and characterized the dynamics of the pandemic in different countries, focusing on Hungary and the Central and Eastern European region. Methods: Age-standardized cumulative excess mortality was calculated based on weekly mortality data from the EUROSTAT database, and was compared between 2020 and the 2016-2019 reference period in European countries. Results: ","2021","07","22","Pathol Oncol Res","Pathology oncology research : POR","Hungary; age-standardized mortality rate; covid-19 pandemic; cumulative death; excess mortality; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Humans; Hungary; Infant; Infant, Newborn; Middle Aged; Mortality; Pandemics; SARS-CoV-2; Young Adult","Temesi","Gabriella","National Korányi Institute of Pulmonology, Budapest, Hungary",NA
"2264","34257618","10.3389/pore.2021.1609774","Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis.","Objective: This study examined cumulative excess mortality in European countries in the year of the Covid-19 pandemic and characterized the dynamics of the pandemic in different countries, focusing on Hungary and the Central and Eastern European region. Methods: Age-standardized cumulative excess mortality was calculated based on weekly mortality data from the EUROSTAT database, and was compared between 2020 and the 2016-2019 reference period in European countries. Results: ","2021","07","22","Pathol Oncol Res","Pathology oncology research : POR","Hungary; age-standardized mortality rate; covid-19 pandemic; cumulative death; excess mortality; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Humans; Hungary; Infant; Infant, Newborn; Middle Aged; Mortality; Pandemics; SARS-CoV-2; Young Adult","Elek","Jeno","National Korányi Institute of Pulmonology, Budapest, Hungary",NA
"2265","34257618","10.3389/pore.2021.1609774","Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis.","Objective: This study examined cumulative excess mortality in European countries in the year of the Covid-19 pandemic and characterized the dynamics of the pandemic in different countries, focusing on Hungary and the Central and Eastern European region. Methods: Age-standardized cumulative excess mortality was calculated based on weekly mortality data from the EUROSTAT database, and was compared between 2020 and the 2016-2019 reference period in European countries. Results: ","2021","07","22","Pathol Oncol Res","Pathology oncology research : POR","Hungary; age-standardized mortality rate; covid-19 pandemic; cumulative death; excess mortality; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Humans; Hungary; Infant; Infant, Newborn; Middle Aged; Mortality; Pandemics; SARS-CoV-2; Young Adult","Madurka","Ildikó","National Korányi Institute of Pulmonology, Budapest, Hungary",NA
"2266","34257618","10.3389/pore.2021.1609774","Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis.","Objective: This study examined cumulative excess mortality in European countries in the year of the Covid-19 pandemic and characterized the dynamics of the pandemic in different countries, focusing on Hungary and the Central and Eastern European region. Methods: Age-standardized cumulative excess mortality was calculated based on weekly mortality data from the EUROSTAT database, and was compared between 2020 and the 2016-2019 reference period in European countries. Results: ","2021","07","22","Pathol Oncol Res","Pathology oncology research : POR","Hungary; age-standardized mortality rate; covid-19 pandemic; cumulative death; excess mortality; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Humans; Hungary; Infant; Infant, Newborn; Middle Aged; Mortality; Pandemics; SARS-CoV-2; Young Adult","Cselkó","Zsuzsanna","National Korányi Institute of Pulmonology, Budapest, Hungary",NA
"2267","34257618","10.3389/pore.2021.1609774","Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis.","Objective: This study examined cumulative excess mortality in European countries in the year of the Covid-19 pandemic and characterized the dynamics of the pandemic in different countries, focusing on Hungary and the Central and Eastern European region. Methods: Age-standardized cumulative excess mortality was calculated based on weekly mortality data from the EUROSTAT database, and was compared between 2020 and the 2016-2019 reference period in European countries. Results: ","2021","07","22","Pathol Oncol Res","Pathology oncology research : POR","Hungary; age-standardized mortality rate; covid-19 pandemic; cumulative death; excess mortality; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Humans; Hungary; Infant; Infant, Newborn; Middle Aged; Mortality; Pandemics; SARS-CoV-2; Young Adult","Csányi","Péter","National Korányi Institute of Pulmonology, Budapest, Hungary",NA
"2268","34257618","10.3389/pore.2021.1609774","Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis.","Objective: This study examined cumulative excess mortality in European countries in the year of the Covid-19 pandemic and characterized the dynamics of the pandemic in different countries, focusing on Hungary and the Central and Eastern European region. Methods: Age-standardized cumulative excess mortality was calculated based on weekly mortality data from the EUROSTAT database, and was compared between 2020 and the 2016-2019 reference period in European countries. Results: ","2021","07","22","Pathol Oncol Res","Pathology oncology research : POR","Hungary; age-standardized mortality rate; covid-19 pandemic; cumulative death; excess mortality; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Humans; Hungary; Infant; Infant, Newborn; Middle Aged; Mortality; Pandemics; SARS-CoV-2; Young Adult","Abonyi-Tóth","Zsolt","RxTarget Ltd., Szolnok, Hungary",NA
"2269","34257618","10.3389/pore.2021.1609774","Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis.","Objective: This study examined cumulative excess mortality in European countries in the year of the Covid-19 pandemic and characterized the dynamics of the pandemic in different countries, focusing on Hungary and the Central and Eastern European region. Methods: Age-standardized cumulative excess mortality was calculated based on weekly mortality data from the EUROSTAT database, and was compared between 2020 and the 2016-2019 reference period in European countries. Results: ","2021","07","22","Pathol Oncol Res","Pathology oncology research : POR","Hungary; age-standardized mortality rate; covid-19 pandemic; cumulative death; excess mortality; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Humans; Hungary; Infant; Infant, Newborn; Middle Aged; Mortality; Pandemics; SARS-CoV-2; Young Adult","Rokszin","György","RxTarget Ltd., Szolnok, Hungary",NA
"2270","34257618","10.3389/pore.2021.1609774","Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis.","Objective: This study examined cumulative excess mortality in European countries in the year of the Covid-19 pandemic and characterized the dynamics of the pandemic in different countries, focusing on Hungary and the Central and Eastern European region. Methods: Age-standardized cumulative excess mortality was calculated based on weekly mortality data from the EUROSTAT database, and was compared between 2020 and the 2016-2019 reference period in European countries. Results: ","2021","07","22","Pathol Oncol Res","Pathology oncology research : POR","Hungary; age-standardized mortality rate; covid-19 pandemic; cumulative death; excess mortality; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Humans; Hungary; Infant; Infant, Newborn; Middle Aged; Mortality; Pandemics; SARS-CoV-2; Young Adult","Barcza","Zsófia","Syntesia Medical Communications Ltd., Budapest, Hungary",NA
"2271","34257618","10.3389/pore.2021.1609774","Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis.","Objective: This study examined cumulative excess mortality in European countries in the year of the Covid-19 pandemic and characterized the dynamics of the pandemic in different countries, focusing on Hungary and the Central and Eastern European region. Methods: Age-standardized cumulative excess mortality was calculated based on weekly mortality data from the EUROSTAT database, and was compared between 2020 and the 2016-2019 reference period in European countries. Results: ","2021","07","22","Pathol Oncol Res","Pathology oncology research : POR","Hungary; age-standardized mortality rate; covid-19 pandemic; cumulative death; excess mortality; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Child, Preschool; Humans; Hungary; Infant; Infant, Newborn; Middle Aged; Mortality; Pandemics; SARS-CoV-2; Young Adult","Moldvay","Judit","st Department of Pulmonology, National Korányi Institute of Pulmonology, Semmelweis University, Budapest, Hungary",NA
"2272","34257580","10.3389/pore.2021.612969","Colorectal Cancer that Highly Express Both <i>ACE2</i> and <i>TMPRSS2</i>, Suggesting Severe Symptoms to SARS-CoV-2 Infection.","The epidemic of the novel, pathogenic SARS-coronavirus 2 (SARS-CoV-2) in the world pose a global health emergency. Cancer has been identified as a risk factor for the novel Coronavirus disease 2019 (COVID-19). The ACE2 and TMPRSS2 have been implicated in SARS-CoV-2 infection for mediating viral entry into the host cell. However, a systematic analysis of aberrant expression of ACE2 and TMPRSS2 was not yet reported in multiple human cancers. Here, we analyzed gene expre","2021","07","22","Pathol Oncol Res","Pathology oncology research : POR","ACE2; SARS-COV-2; TMPRSS2; cancer; colorectum; Angiotensin-Converting Enzyme 2; COVID-19; Colorectal Neoplasms; DNA Methylation; Databases, Genetic; Humans; SARS-CoV-2; Serine Endopeptidases; Transcriptome","Wang","Huai","Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Dali University, Dali, China",NA
"2273","34257580","10.3389/pore.2021.612969","Colorectal Cancer that Highly Express Both <i>ACE2</i> and <i>TMPRSS2</i>, Suggesting Severe Symptoms to SARS-CoV-2 Infection.","The epidemic of the novel, pathogenic SARS-coronavirus 2 (SARS-CoV-2) in the world pose a global health emergency. Cancer has been identified as a risk factor for the novel Coronavirus disease 2019 (COVID-19). The ACE2 and TMPRSS2 have been implicated in SARS-CoV-2 infection for mediating viral entry into the host cell. However, a systematic analysis of aberrant expression of ACE2 and TMPRSS2 was not yet reported in multiple human cancers. Here, we analyzed gene expre","2021","07","22","Pathol Oncol Res","Pathology oncology research : POR","ACE2; SARS-COV-2; TMPRSS2; cancer; colorectum; Angiotensin-Converting Enzyme 2; COVID-19; Colorectal Neoplasms; DNA Methylation; Databases, Genetic; Humans; SARS-CoV-2; Serine Endopeptidases; Transcriptome","Yang","Jiankang","Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Dali University, Dali, China",NA
"2274","34257512","10.1007/s10639-021-10630-z","Review of flipped learning in engineering education: Scientific mapping and research horizon.","The COVID-19 pandemic makes flipped learning more relevant to address the challenges of remote learning. Therefore, renewed attention is warranted in critically appraising the implications on which flipped learning is built. Though several studies have reviewed the flipped learning research in the past, the majority has qualitatively synthesized the flipped learning literature, thus, lacking the overall perspective provided quantitatively for appraising the existing state of affairs of flipped l","2021","07","15","Educ Inf Technol (Dordr)","Education and information technologies","Bibliometric analysis; Blended learning; Engineering education; Flipped classroom; Online learning; Scientific mapping","Al Mamun","Md Abdullah","Department of Technical and Vocational Education, Islamic University of Technology, Board Bazar, Gazipur, Bangladesh",NA
"2275","34257512","10.1007/s10639-021-10630-z","Review of flipped learning in engineering education: Scientific mapping and research horizon.","The COVID-19 pandemic makes flipped learning more relevant to address the challenges of remote learning. Therefore, renewed attention is warranted in critically appraising the implications on which flipped learning is built. Though several studies have reviewed the flipped learning research in the past, the majority has qualitatively synthesized the flipped learning literature, thus, lacking the overall perspective provided quantitatively for appraising the existing state of affairs of flipped l","2021","07","15","Educ Inf Technol (Dordr)","Education and information technologies","Bibliometric analysis; Blended learning; Engineering education; Flipped classroom; Online learning; Scientific mapping","Azad","Md Abul Kalam","Department of Business and Technology Management, Islamic University of Technology, Board Bazar, Gazipur, Bangladesh",NA
"2276","34257512","10.1007/s10639-021-10630-z","Review of flipped learning in engineering education: Scientific mapping and research horizon.","The COVID-19 pandemic makes flipped learning more relevant to address the challenges of remote learning. Therefore, renewed attention is warranted in critically appraising the implications on which flipped learning is built. Though several studies have reviewed the flipped learning research in the past, the majority has qualitatively synthesized the flipped learning literature, thus, lacking the overall perspective provided quantitatively for appraising the existing state of affairs of flipped l","2021","07","15","Educ Inf Technol (Dordr)","Education and information technologies","Bibliometric analysis; Blended learning; Engineering education; Flipped classroom; Online learning; Scientific mapping","Al Mamun","Md Abdullah","Department of Business and Technology Management, Islamic University of Technology, Board Bazar, Gazipur, Bangladesh",NA
"2277","34257512","10.1007/s10639-021-10630-z","Review of flipped learning in engineering education: Scientific mapping and research horizon.","The COVID-19 pandemic makes flipped learning more relevant to address the challenges of remote learning. Therefore, renewed attention is warranted in critically appraising the implications on which flipped learning is built. Though several studies have reviewed the flipped learning research in the past, the majority has qualitatively synthesized the flipped learning literature, thus, lacking the overall perspective provided quantitatively for appraising the existing state of affairs of flipped l","2021","07","15","Educ Inf Technol (Dordr)","Education and information technologies","Bibliometric analysis; Blended learning; Engineering education; Flipped classroom; Online learning; Scientific mapping","Boyle","Michael","School of Education, The University of Queensland, St Lucia, QLD 4072 Australia",NA
"2278","34257506","10.1007/s11831-021-09623-5","Mathematical Modeling and Numerical Simulation of Atherosclerosis Based on a Novel Surgeon's View.","This paper deals with the mathematical modeling of atherosclerosis based on a novel hypothesis proposed by a surgeon, Prof. Dr. Axel Haverich (Circulation 135(3):205-207, 2017). Atherosclerosis is referred as the thickening of the artery walls. Currently, there are two schools of thoughts for explaining the root of such phenomenon: thickening due to substance deposition and thickening as a result of inflammatory overgrowth. The hypothesis favored here is the second paradigm stating that the athe","2021","07","15","Arch Comput Methods Eng","Archives of computational methods in engineering : state of the art reviews",NA,"Soleimani","Meisam","Institute of Continuum Mechanics, Leibniz Universität Hannover, Hannover, Germany",NA
"2279","34257506","10.1007/s11831-021-09623-5","Mathematical Modeling and Numerical Simulation of Atherosclerosis Based on a Novel Surgeon's View.","This paper deals with the mathematical modeling of atherosclerosis based on a novel hypothesis proposed by a surgeon, Prof. Dr. Axel Haverich (Circulation 135(3):205-207, 2017). Atherosclerosis is referred as the thickening of the artery walls. Currently, there are two schools of thoughts for explaining the root of such phenomenon: thickening due to substance deposition and thickening as a result of inflammatory overgrowth. The hypothesis favored here is the second paradigm stating that the athe","2021","07","15","Arch Comput Methods Eng","Archives of computational methods in engineering : state of the art reviews",NA,"Haverich","Axel","Department of Cardiothoracic, Transplantation, and Vascular Surgery, Hannover Medical School (MHH), Hannover, Germany",NA
"2280","34257506","10.1007/s11831-021-09623-5","Mathematical Modeling and Numerical Simulation of Atherosclerosis Based on a Novel Surgeon's View.","This paper deals with the mathematical modeling of atherosclerosis based on a novel hypothesis proposed by a surgeon, Prof. Dr. Axel Haverich (Circulation 135(3):205-207, 2017). Atherosclerosis is referred as the thickening of the artery walls. Currently, there are two schools of thoughts for explaining the root of such phenomenon: thickening due to substance deposition and thickening as a result of inflammatory overgrowth. The hypothesis favored here is the second paradigm stating that the athe","2021","07","15","Arch Comput Methods Eng","Archives of computational methods in engineering : state of the art reviews",NA,"Wriggers","Peter","Institute of Continuum Mechanics, Leibniz Universität Hannover, Hannover, Germany",NA
"2281","34257504","10.1186/s42269-021-00582-2","An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system.","Coronavirus disease 19 is a viral infection caused by a novel coronavirus, SARS-CoV-2. It was first notified in Wuhan, China, is now spread into numerous part of the world. Thus, the world needs urgent support and encouragement to develop a vaccine or antiviral treatments to combat the atrocious outbreak. The origin of this virus is yet unknown; however, rapid transmission from human-to-human ""Anthroponosis"" has widely confirmed. The world is witnessing a continuous hike in SARS-CoV-2 infection.","2021","07","15","Bull Natl Res Cent","Bulletin of the National Research Centre","Acute respiratory syndrome; Angiotensin-converting enzyme 2; COVID-19; PAMPs; PRR; SARS; SARS-CoV-2","Hembram","Padmalochan","Department of Botany, Berhampur University, Bhanja Bihar, Berhampur, 760007 India",NA
"2282","34257500","10.1007/s11837-021-04783-y","A TMS Education Committee Report: Survey of Changes in Education Due to COVID-19.",NA,"2021","07","14","JOM (1989)","JOM (Warrendale, Pa. : 1989)",NA,NA,NA,NA,NA
"2283","34257498","10.1007/s12144-021-02037-3","The association between core job components, physical activity, and mental health in African academics in a post-COVID-19 context.","This study examined the association between core job components (i.e. teaching, research, and student assessment), physical activity (PA), and mental health in a post-COVID-19 context. An online questionnaire administered via Google Forms was used to gather data from 1064 African academics in four countries. A sensitivity analysis was applied to adjust for covariates. Data were analyzed with the hierarchical linear regression analysis. The average age of participants was 44 years. The study foun","2021","07","15","Curr Psychol","Current psychology (New Brunswick, N.J.)","Academics; Africa; assessment; neighborhood walkability; Mental health; Physical activity; Research; Teaching","Asiamah","Nestor","School of Health and Care Professions, University of Portsmouth, Winston Churchill Ave, Portsmouth, PO1 2UP UK",NA
"2284","34257498","10.1007/s12144-021-02037-3","The association between core job components, physical activity, and mental health in African academics in a post-COVID-19 context.","This study examined the association between core job components (i.e. teaching, research, and student assessment), physical activity (PA), and mental health in a post-COVID-19 context. An online questionnaire administered via Google Forms was used to gather data from 1064 African academics in four countries. A sensitivity analysis was applied to adjust for covariates. Data were analyzed with the hierarchical linear regression analysis. The average age of participants was 44 years. The study foun","2021","07","15","Curr Psychol","Current psychology (New Brunswick, N.J.)","Academics; Africa; assessment; neighborhood walkability; Mental health; Physical activity; Research; Teaching","Muhonja","Faith","School of Public Health, Mount Kenya University, Thika, Kenya",NA
"2285","34257498","10.1007/s12144-021-02037-3","The association between core job components, physical activity, and mental health in African academics in a post-COVID-19 context.","This study examined the association between core job components (i.e. teaching, research, and student assessment), physical activity (PA), and mental health in a post-COVID-19 context. An online questionnaire administered via Google Forms was used to gather data from 1064 African academics in four countries. A sensitivity analysis was applied to adjust for covariates. Data were analyzed with the hierarchical linear regression analysis. The average age of participants was 44 years. The study foun","2021","07","15","Curr Psychol","Current psychology (New Brunswick, N.J.)","Academics; Africa; assessment; neighborhood walkability; Mental health; Physical activity; Research; Teaching","Omisore","Akinlolu","Department of Community Medicine, Osun State University, Osogbo, Nigeria",NA
"2286","34257498","10.1007/s12144-021-02037-3","The association between core job components, physical activity, and mental health in African academics in a post-COVID-19 context.","This study examined the association between core job components (i.e. teaching, research, and student assessment), physical activity (PA), and mental health in a post-COVID-19 context. An online questionnaire administered via Google Forms was used to gather data from 1064 African academics in four countries. A sensitivity analysis was applied to adjust for covariates. Data were analyzed with the hierarchical linear regression analysis. The average age of participants was 44 years. The study foun","2021","07","15","Curr Psychol","Current psychology (New Brunswick, N.J.)","Academics; Africa; assessment; neighborhood walkability; Mental health; Physical activity; Research; Teaching","Opuni","Frank Frimpong","Department of Marketing, Accra Technical University, Accra, Ghana",NA
"2287","34257498","10.1007/s12144-021-02037-3","The association between core job components, physical activity, and mental health in African academics in a post-COVID-19 context.","This study examined the association between core job components (i.e. teaching, research, and student assessment), physical activity (PA), and mental health in a post-COVID-19 context. An online questionnaire administered via Google Forms was used to gather data from 1064 African academics in four countries. A sensitivity analysis was applied to adjust for covariates. Data were analyzed with the hierarchical linear regression analysis. The average age of participants was 44 years. The study foun","2021","07","15","Curr Psychol","Current psychology (New Brunswick, N.J.)","Academics; Africa; assessment; neighborhood walkability; Mental health; Physical activity; Research; Teaching","Mensah","Henry Kofi","Human Resources and Organizational Development, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana",NA
"2288","34257498","10.1007/s12144-021-02037-3","The association between core job components, physical activity, and mental health in African academics in a post-COVID-19 context.","This study examined the association between core job components (i.e. teaching, research, and student assessment), physical activity (PA), and mental health in a post-COVID-19 context. An online questionnaire administered via Google Forms was used to gather data from 1064 African academics in four countries. A sensitivity analysis was applied to adjust for covariates. Data were analyzed with the hierarchical linear regression analysis. The average age of participants was 44 years. The study foun","2021","07","15","Curr Psychol","Current psychology (New Brunswick, N.J.)","Academics; Africa; assessment; neighborhood walkability; Mental health; Physical activity; Research; Teaching","Danquah","Emelia","Logistics and Supply Chain Management, Koforidua Technical University, Koforidua, Ghana",NA
"2289","34257498","10.1007/s12144-021-02037-3","The association between core job components, physical activity, and mental health in African academics in a post-COVID-19 context.","This study examined the association between core job components (i.e. teaching, research, and student assessment), physical activity (PA), and mental health in a post-COVID-19 context. An online questionnaire administered via Google Forms was used to gather data from 1064 African academics in four countries. A sensitivity analysis was applied to adjust for covariates. Data were analyzed with the hierarchical linear regression analysis. The average age of participants was 44 years. The study foun","2021","07","15","Curr Psychol","Current psychology (New Brunswick, N.J.)","Academics; Africa; assessment; neighborhood walkability; Mental health; Physical activity; Research; Teaching","Agyemang","Simon Mawulorm","Department of Physical Education and Health, Abetifi Presbyterian College of Education, Abetifi, Ghana",NA
"2290","34257498","10.1007/s12144-021-02037-3","The association between core job components, physical activity, and mental health in African academics in a post-COVID-19 context.","This study examined the association between core job components (i.e. teaching, research, and student assessment), physical activity (PA), and mental health in a post-COVID-19 context. An online questionnaire administered via Google Forms was used to gather data from 1064 African academics in four countries. A sensitivity analysis was applied to adjust for covariates. Data were analyzed with the hierarchical linear regression analysis. The average age of participants was 44 years. The study foun","2021","07","15","Curr Psychol","Current psychology (New Brunswick, N.J.)","Academics; Africa; assessment; neighborhood walkability; Mental health; Physical activity; Research; Teaching","Agyemang","Irene","West African Postgraduate College of Pharmacists, Accra, Ghana",NA
"2291","34257498","10.1007/s12144-021-02037-3","The association between core job components, physical activity, and mental health in African academics in a post-COVID-19 context.","This study examined the association between core job components (i.e. teaching, research, and student assessment), physical activity (PA), and mental health in a post-COVID-19 context. An online questionnaire administered via Google Forms was used to gather data from 1064 African academics in four countries. A sensitivity analysis was applied to adjust for covariates. Data were analyzed with the hierarchical linear regression analysis. The average age of participants was 44 years. The study foun","2021","07","15","Curr Psychol","Current psychology (New Brunswick, N.J.)","Academics; Africa; assessment; neighborhood walkability; Mental health; Physical activity; Research; Teaching","Hatsu","Sylvester","Department of Computer Science, Accra Technical University, Accra, Ghana",NA
"2292","34257498","10.1007/s12144-021-02037-3","The association between core job components, physical activity, and mental health in African academics in a post-COVID-19 context.","This study examined the association between core job components (i.e. teaching, research, and student assessment), physical activity (PA), and mental health in a post-COVID-19 context. An online questionnaire administered via Google Forms was used to gather data from 1064 African academics in four countries. A sensitivity analysis was applied to adjust for covariates. Data were analyzed with the hierarchical linear regression analysis. The average age of participants was 44 years. The study foun","2021","07","15","Curr Psychol","Current psychology (New Brunswick, N.J.)","Academics; Africa; assessment; neighborhood walkability; Mental health; Physical activity; Research; Teaching","Baffoe","Rita Sarkodie","School of Business, Accra Technical University, Accra, Ghana",NA
"2293","34257498","10.1007/s12144-021-02037-3","The association between core job components, physical activity, and mental health in African academics in a post-COVID-19 context.","This study examined the association between core job components (i.e. teaching, research, and student assessment), physical activity (PA), and mental health in a post-COVID-19 context. An online questionnaire administered via Google Forms was used to gather data from 1064 African academics in four countries. A sensitivity analysis was applied to adjust for covariates. Data were analyzed with the hierarchical linear regression analysis. The average age of participants was 44 years. The study foun","2021","07","15","Curr Psychol","Current psychology (New Brunswick, N.J.)","Academics; Africa; assessment; neighborhood walkability; Mental health; Physical activity; Research; Teaching","Eku","Eric","Institute for Distance Education and E-learning, University of Education, Winneba, Ghana",NA
"2294","34257498","10.1007/s12144-021-02037-3","The association between core job components, physical activity, and mental health in African academics in a post-COVID-19 context.","This study examined the association between core job components (i.e. teaching, research, and student assessment), physical activity (PA), and mental health in a post-COVID-19 context. An online questionnaire administered via Google Forms was used to gather data from 1064 African academics in four countries. A sensitivity analysis was applied to adjust for covariates. Data were analyzed with the hierarchical linear regression analysis. The average age of participants was 44 years. The study foun","2021","07","15","Curr Psychol","Current psychology (New Brunswick, N.J.)","Academics; Africa; assessment; neighborhood walkability; Mental health; Physical activity; Research; Teaching","Manu","Christiana Afriyie","School of Business, Accra Technical University, Accra, Ghana",NA
"2295","34257485","10.6515/ACS.202107_37(4).20210628A","Addressing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following COVID-19 Vaccination: A Mini-Review of Practical Strategies.","In response to the COVID-19 pandemic, several vaccines were developed and rolled out at unprecedented speed, and notwithstanding this rapid pace of development, the results from initial clinical trials involving tens of thousands of adult subjects generally indicated that most vaccines were remarkably effective and safe, with no major safety warnings noted. However, with more than 2 billion vaccination doses administered to date, reports of rare adverse events following immunization (AEFI) are b","2021","07","15","Acta Cardiol Sin","Acta Cardiologica Sinica","Adverse events following immunization; COVID-19; Vaccine; Vaccine side effects; Vaccine-induced immune thrombotic thrombocytopenia; Vaccine-induced prothrombotic immune thrombocytopenia","Chen","Po-Wei","Institute of Clinical Medicine, College of Medicine, National Cheng Kung University",NA
"2296","34257485","10.6515/ACS.202107_37(4).20210628A","Addressing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following COVID-19 Vaccination: A Mini-Review of Practical Strategies.","In response to the COVID-19 pandemic, several vaccines were developed and rolled out at unprecedented speed, and notwithstanding this rapid pace of development, the results from initial clinical trials involving tens of thousands of adult subjects generally indicated that most vaccines were remarkably effective and safe, with no major safety warnings noted. However, with more than 2 billion vaccination doses administered to date, reports of rare adverse events following immunization (AEFI) are b","2021","07","15","Acta Cardiol Sin","Acta Cardiologica Sinica","Adverse events following immunization; COVID-19; Vaccine; Vaccine side effects; Vaccine-induced immune thrombotic thrombocytopenia; Vaccine-induced prothrombotic immune thrombocytopenia","Tsai","Zong-Yun","Institute of Clinical Medicine, College of Medicine, National Cheng Kung University",NA
"2297","34257485","10.6515/ACS.202107_37(4).20210628A","Addressing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following COVID-19 Vaccination: A Mini-Review of Practical Strategies.","In response to the COVID-19 pandemic, several vaccines were developed and rolled out at unprecedented speed, and notwithstanding this rapid pace of development, the results from initial clinical trials involving tens of thousands of adult subjects generally indicated that most vaccines were remarkably effective and safe, with no major safety warnings noted. However, with more than 2 billion vaccination doses administered to date, reports of rare adverse events following immunization (AEFI) are b","2021","07","15","Acta Cardiol Sin","Acta Cardiologica Sinica","Adverse events following immunization; COVID-19; Vaccine; Vaccine side effects; Vaccine-induced immune thrombotic thrombocytopenia; Vaccine-induced prothrombotic immune thrombocytopenia","Chao","Ting-Hsing","Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan",NA
"2298","34257485","10.6515/ACS.202107_37(4).20210628A","Addressing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following COVID-19 Vaccination: A Mini-Review of Practical Strategies.","In response to the COVID-19 pandemic, several vaccines were developed and rolled out at unprecedented speed, and notwithstanding this rapid pace of development, the results from initial clinical trials involving tens of thousands of adult subjects generally indicated that most vaccines were remarkably effective and safe, with no major safety warnings noted. However, with more than 2 billion vaccination doses administered to date, reports of rare adverse events following immunization (AEFI) are b","2021","07","15","Acta Cardiol Sin","Acta Cardiologica Sinica","Adverse events following immunization; COVID-19; Vaccine; Vaccine side effects; Vaccine-induced immune thrombotic thrombocytopenia; Vaccine-induced prothrombotic immune thrombocytopenia","Li","Yi-Heng","Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan",NA
"2299","34257485","10.6515/ACS.202107_37(4).20210628A","Addressing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following COVID-19 Vaccination: A Mini-Review of Practical Strategies.","In response to the COVID-19 pandemic, several vaccines were developed and rolled out at unprecedented speed, and notwithstanding this rapid pace of development, the results from initial clinical trials involving tens of thousands of adult subjects generally indicated that most vaccines were remarkably effective and safe, with no major safety warnings noted. However, with more than 2 billion vaccination doses administered to date, reports of rare adverse events following immunization (AEFI) are b","2021","07","15","Acta Cardiol Sin","Acta Cardiologica Sinica","Adverse events following immunization; COVID-19; Vaccine; Vaccine side effects; Vaccine-induced immune thrombotic thrombocytopenia; Vaccine-induced prothrombotic immune thrombocytopenia","Hou","Charles Jia-Yin","Mackay Medical College, New Taipei City",NA
"2300","34257485","10.6515/ACS.202107_37(4).20210628A","Addressing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following COVID-19 Vaccination: A Mini-Review of Practical Strategies.","In response to the COVID-19 pandemic, several vaccines were developed and rolled out at unprecedented speed, and notwithstanding this rapid pace of development, the results from initial clinical trials involving tens of thousands of adult subjects generally indicated that most vaccines were remarkably effective and safe, with no major safety warnings noted. However, with more than 2 billion vaccination doses administered to date, reports of rare adverse events following immunization (AEFI) are b","2021","07","15","Acta Cardiol Sin","Acta Cardiologica Sinica","Adverse events following immunization; COVID-19; Vaccine; Vaccine side effects; Vaccine-induced immune thrombotic thrombocytopenia; Vaccine-induced prothrombotic immune thrombocytopenia","Liu","Ping-Yen","Institute of Clinical Medicine, College of Medicine, National Cheng Kung University",NA
"2301","34257483","10.1007/s13410-021-00968-y","Glycemic control among children and adolescents with type 1 diabetes during COVID-19 pandemic in Egypt: a pilot study.","The COVID-19 pandemic and the consequences of lockdown significantly impacted glycemic control. To evaluate the impact of the pandemic and lockdown on glycemic control among Egyptian children and adolescents with type 1 diabetes. Cross-sectional study conducted through an online questionnaire. The participants were patients with type 1 diabetes and/or their caregivers. A total of 115 valid responses to the questionnaire were received. During the lockdown, almost 64% of patients showed worsening ","2021","07","15","Int J Diabetes Dev Ctries","International journal of diabetes in developing countries","COVID-19; Lockdown; Telemedicine; Type 1 diabetes","Elhenawy","Yasmine Ibrahim","Pediatric and Adolescent Diabetes Unit (PADU), Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"2302","34257483","10.1007/s13410-021-00968-y","Glycemic control among children and adolescents with type 1 diabetes during COVID-19 pandemic in Egypt: a pilot study.","The COVID-19 pandemic and the consequences of lockdown significantly impacted glycemic control. To evaluate the impact of the pandemic and lockdown on glycemic control among Egyptian children and adolescents with type 1 diabetes. Cross-sectional study conducted through an online questionnaire. The participants were patients with type 1 diabetes and/or their caregivers. A total of 115 valid responses to the questionnaire were received. During the lockdown, almost 64% of patients showed worsening ","2021","07","15","Int J Diabetes Dev Ctries","International journal of diabetes in developing countries","COVID-19; Lockdown; Telemedicine; Type 1 diabetes","Eltonbary","Khadiga Yehia","Pediatric and Adolescent Diabetes Unit (PADU), Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"2303","34257482","10.1007/s12663-021-01612-2","Resorting to alternate anesthesia techniques during Covid-19 crisis.",NA,"2021","07","15","J Maxillofac Oral Surg","Journal of maxillofacial and oral surgery","COVID-19; Oxygen crisis; Regional anesthesia","Shadamarshan","R Arunkumar","Vajra Corps Dental Unit, Jalandhar, India",NA
"2304","34257482","10.1007/s12663-021-01612-2","Resorting to alternate anesthesia techniques during Covid-19 crisis.",NA,"2021","07","15","J Maxillofac Oral Surg","Journal of maxillofacial and oral surgery","COVID-19; Oxygen crisis; Regional anesthesia","Agrawal","Nitesh","Military Hospital, Jalandhar Cantt, Jalandhar, Punjab India",NA
"2305","34257481","10.1016/j.tranpol.2021.07.004","Identifying areas of potential critical healthcare shortages: A case study of spatial accessibility to ICU beds during the COVID-19 pandemic in Florida.","Healthcare resource availability is potentially associated with COVID-19 mortality, and the potentially uneven geographical distribution of resources is a looming concern in the global pandemic. Given that access to healthcare resources is important to overall population health, assessing COVID-19 patients' access to healthcare resources is needed. This paper aims to examine the temporal variations in the spatial accessibility of the U.S. COVID-19 patients to medical facilities, identify areas t","2021","07","15","Transp Policy (Oxf)","Transport policy","3SFCA; Access to ICU beds; COVID-19; Space-time assessment; Spatial accessibility","Kim","Kyusik","Department of Geography, Florida State University, 600 W College Avenue, Tallahassee, FL, 32306, USA",NA
"2306","34257481","10.1016/j.tranpol.2021.07.004","Identifying areas of potential critical healthcare shortages: A case study of spatial accessibility to ICU beds during the COVID-19 pandemic in Florida.","Healthcare resource availability is potentially associated with COVID-19 mortality, and the potentially uneven geographical distribution of resources is a looming concern in the global pandemic. Given that access to healthcare resources is important to overall population health, assessing COVID-19 patients' access to healthcare resources is needed. This paper aims to examine the temporal variations in the spatial accessibility of the U.S. COVID-19 patients to medical facilities, identify areas t","2021","07","15","Transp Policy (Oxf)","Transport policy","3SFCA; Access to ICU beds; COVID-19; Space-time assessment; Spatial accessibility","Ghorbanzadeh","Mahyar","Department of Civil and Environmental Engineering, Florida A&amp",NA
"2307","34257481","10.1016/j.tranpol.2021.07.004","Identifying areas of potential critical healthcare shortages: A case study of spatial accessibility to ICU beds during the COVID-19 pandemic in Florida.","Healthcare resource availability is potentially associated with COVID-19 mortality, and the potentially uneven geographical distribution of resources is a looming concern in the global pandemic. Given that access to healthcare resources is important to overall population health, assessing COVID-19 patients' access to healthcare resources is needed. This paper aims to examine the temporal variations in the spatial accessibility of the U.S. COVID-19 patients to medical facilities, identify areas t","2021","07","15","Transp Policy (Oxf)","Transport policy","3SFCA; Access to ICU beds; COVID-19; Space-time assessment; Spatial accessibility","Horner","Mark W","Department of Geography, Florida State University, 600 W College Avenue, Tallahassee, FL, 32306, USA",NA
"2308","34257481","10.1016/j.tranpol.2021.07.004","Identifying areas of potential critical healthcare shortages: A case study of spatial accessibility to ICU beds during the COVID-19 pandemic in Florida.","Healthcare resource availability is potentially associated with COVID-19 mortality, and the potentially uneven geographical distribution of resources is a looming concern in the global pandemic. Given that access to healthcare resources is important to overall population health, assessing COVID-19 patients' access to healthcare resources is needed. This paper aims to examine the temporal variations in the spatial accessibility of the U.S. COVID-19 patients to medical facilities, identify areas t","2021","07","15","Transp Policy (Oxf)","Transport policy","3SFCA; Access to ICU beds; COVID-19; Space-time assessment; Spatial accessibility","Ozguven","Eren Erman","Department of Civil and Environmental Engineering, Florida A&amp",NA
"2309","34257478","10.1007/s00278-021-00524-3","[All in the mix? Blended psychotherapy as an example of digitalization in psychotherapy].","Over the last decades various approaches to digitalization of psychotherapy (PT) have been developed. The concept of blended PT, the combination of face to face and online interventions is one such example. While research interest on blended PT has greatly increased in the past years, the implementation of blended PT has lagged behind in German speaking countries. Also, due to the global pandemic caused by the coronavirus disease 2019 (COVID-19), blended PT and other online approaches seem to be","2021","07","15","Psychotherapeut (Berl)","Psychotherapeut","Combined modality therapy; Face to face psychotherapy; Internet-based intervention; Mental health; eHealth","Bielinski","Laura Luisa","Abteilung Klinische Psychologie und Psychotherapie, Institut für Psychologie, Universität Bern, Fabrikstr. 8, 3012 Bern, Schweiz",NA
"2310","34257478","10.1007/s00278-021-00524-3","[All in the mix? Blended psychotherapy as an example of digitalization in psychotherapy].","Over the last decades various approaches to digitalization of psychotherapy (PT) have been developed. The concept of blended PT, the combination of face to face and online interventions is one such example. While research interest on blended PT has greatly increased in the past years, the implementation of blended PT has lagged behind in German speaking countries. Also, due to the global pandemic caused by the coronavirus disease 2019 (COVID-19), blended PT and other online approaches seem to be","2021","07","15","Psychotherapeut (Berl)","Psychotherapeut","Combined modality therapy; Face to face psychotherapy; Internet-based intervention; Mental health; eHealth","Trimpop","Leonie","Lehrstuhl für Klinische Psychologie und Psychotherapie, Universität Witten/Herdecke, Witten, Deutschland",NA
"2311","34257478","10.1007/s00278-021-00524-3","[All in the mix? Blended psychotherapy as an example of digitalization in psychotherapy].","Over the last decades various approaches to digitalization of psychotherapy (PT) have been developed. The concept of blended PT, the combination of face to face and online interventions is one such example. While research interest on blended PT has greatly increased in the past years, the implementation of blended PT has lagged behind in German speaking countries. Also, due to the global pandemic caused by the coronavirus disease 2019 (COVID-19), blended PT and other online approaches seem to be","2021","07","15","Psychotherapeut (Berl)","Psychotherapeut","Combined modality therapy; Face to face psychotherapy; Internet-based intervention; Mental health; eHealth","Berger","Thomas","Abteilung Klinische Psychologie und Psychotherapie, Institut für Psychologie, Universität Bern, Fabrikstr. 8, 3012 Bern, Schweiz",NA
"2312","34257475","10.1016/j.physa.2021.126244","Customized bus passenger boarding and deboarding planning optimization model with the least number of contacts between passengers during COVID-19.","The COVID-19 epidemic has had a major impact on people's normal travel. Optimizing the control of the number of passengers boarding and deboarding the customized bus (CB) at CB stops can reduce the contact between passengers in the course of travel, which is meaningful for COVID-19 epidemic prevention and control. In this paper, a dynamic programming model based on nonlinear integer programming (NIP) is established to study the problem of boarding and alighting planning at various CB stops under","2021","07","15","Physica A","Physica A","COVID-19; Customized bus; Dynamic programming model; Nonlinear integer programming","Chen","Feng","The Key Laboratory of Road and Traffic Engineering, Ministry of Education, Tongji University, Shanghai, 201804, China",NA
"2313","34257475","10.1016/j.physa.2021.126244","Customized bus passenger boarding and deboarding planning optimization model with the least number of contacts between passengers during COVID-19.","The COVID-19 epidemic has had a major impact on people's normal travel. Optimizing the control of the number of passengers boarding and deboarding the customized bus (CB) at CB stops can reduce the contact between passengers in the course of travel, which is meaningful for COVID-19 epidemic prevention and control. In this paper, a dynamic programming model based on nonlinear integer programming (NIP) is established to study the problem of boarding and alighting planning at various CB stops under","2021","07","15","Physica A","Physica A","COVID-19; Customized bus; Dynamic programming model; Nonlinear integer programming","Peng","Haorong","The Key Laboratory of Road and Traffic Engineering, Ministry of Education, Tongji University, Shanghai, 201804, China",NA
"2314","34257475","10.1016/j.physa.2021.126244","Customized bus passenger boarding and deboarding planning optimization model with the least number of contacts between passengers during COVID-19.","The COVID-19 epidemic has had a major impact on people's normal travel. Optimizing the control of the number of passengers boarding and deboarding the customized bus (CB) at CB stops can reduce the contact between passengers in the course of travel, which is meaningful for COVID-19 epidemic prevention and control. In this paper, a dynamic programming model based on nonlinear integer programming (NIP) is established to study the problem of boarding and alighting planning at various CB stops under","2021","07","15","Physica A","Physica A","COVID-19; Customized bus; Dynamic programming model; Nonlinear integer programming","Ding","Wenlong","The Key Laboratory of Road and Traffic Engineering, Ministry of Education, Tongji University, Shanghai, 201804, China",NA
"2315","34257475","10.1016/j.physa.2021.126244","Customized bus passenger boarding and deboarding planning optimization model with the least number of contacts between passengers during COVID-19.","The COVID-19 epidemic has had a major impact on people's normal travel. Optimizing the control of the number of passengers boarding and deboarding the customized bus (CB) at CB stops can reduce the contact between passengers in the course of travel, which is meaningful for COVID-19 epidemic prevention and control. In this paper, a dynamic programming model based on nonlinear integer programming (NIP) is established to study the problem of boarding and alighting planning at various CB stops under","2021","07","15","Physica A","Physica A","COVID-19; Customized bus; Dynamic programming model; Nonlinear integer programming","Ma","Xiaoxiang","The Key Laboratory of Road and Traffic Engineering, Ministry of Education, Tongji University, Shanghai, 201804, China",NA
"2316","34257475","10.1016/j.physa.2021.126244","Customized bus passenger boarding and deboarding planning optimization model with the least number of contacts between passengers during COVID-19.","The COVID-19 epidemic has had a major impact on people's normal travel. Optimizing the control of the number of passengers boarding and deboarding the customized bus (CB) at CB stops can reduce the contact between passengers in the course of travel, which is meaningful for COVID-19 epidemic prevention and control. In this paper, a dynamic programming model based on nonlinear integer programming (NIP) is established to study the problem of boarding and alighting planning at various CB stops under","2021","07","15","Physica A","Physica A","COVID-19; Customized bus; Dynamic programming model; Nonlinear integer programming","Tang","Daizhong","School of Economics and Management, Tongji University, Shanghai, 200092, China",NA
"2317","34257475","10.1016/j.physa.2021.126244","Customized bus passenger boarding and deboarding planning optimization model with the least number of contacts between passengers during COVID-19.","The COVID-19 epidemic has had a major impact on people's normal travel. Optimizing the control of the number of passengers boarding and deboarding the customized bus (CB) at CB stops can reduce the contact between passengers in the course of travel, which is meaningful for COVID-19 epidemic prevention and control. In this paper, a dynamic programming model based on nonlinear integer programming (NIP) is established to study the problem of boarding and alighting planning at various CB stops under","2021","07","15","Physica A","Physica A","COVID-19; Customized bus; Dynamic programming model; Nonlinear integer programming","Ye","Yipeng","School of Economics &amp",NA
"2318","34257471","10.1016/j.bbe.2021.06.011","FractalCovNet architecture for COVID-19 Chest X-ray image Classification and CT-scan image Segmentation.","Precise and fast diagnosis of COVID-19 cases play a vital role in early stage of medical treatment and prevention. Automatic detection of COVID-19 cases using the chest X-ray images and chest CT-scan images will be helpful to reduce the impact of this pandemic on the human society. We have developed a novel FractalCovNet architecture using Fractal blocks and U-Net for segmentation of chest CT-scan images to localize the lesion region. The same FractalCovNet architecture is also used for classifi","2021","07","20","Biocybern Biomed Eng","Biocybernetics and biomedical engineering","COVID-19; CT-scan image segmentation; Chest X-ray classification; FractalCovNet; U-Net","Munusamy","Hemalatha","Department of Information Technology, Anna University, MIT Campus, Chennai, India",NA
"2319","34257471","10.1016/j.bbe.2021.06.011","FractalCovNet architecture for COVID-19 Chest X-ray image Classification and CT-scan image Segmentation.","Precise and fast diagnosis of COVID-19 cases play a vital role in early stage of medical treatment and prevention. Automatic detection of COVID-19 cases using the chest X-ray images and chest CT-scan images will be helpful to reduce the impact of this pandemic on the human society. We have developed a novel FractalCovNet architecture using Fractal blocks and U-Net for segmentation of chest CT-scan images to localize the lesion region. The same FractalCovNet architecture is also used for classifi","2021","07","20","Biocybern Biomed Eng","Biocybernetics and biomedical engineering","COVID-19; CT-scan image segmentation; Chest X-ray classification; FractalCovNet; U-Net","Karthikeyan","J M","Department of Information Technology, Anna University, MIT Campus, Chennai, India",NA
"2320","34257471","10.1016/j.bbe.2021.06.011","FractalCovNet architecture for COVID-19 Chest X-ray image Classification and CT-scan image Segmentation.","Precise and fast diagnosis of COVID-19 cases play a vital role in early stage of medical treatment and prevention. Automatic detection of COVID-19 cases using the chest X-ray images and chest CT-scan images will be helpful to reduce the impact of this pandemic on the human society. We have developed a novel FractalCovNet architecture using Fractal blocks and U-Net for segmentation of chest CT-scan images to localize the lesion region. The same FractalCovNet architecture is also used for classifi","2021","07","20","Biocybern Biomed Eng","Biocybernetics and biomedical engineering","COVID-19; CT-scan image segmentation; Chest X-ray classification; FractalCovNet; U-Net","Shriram","G","Department of Information Technology, Anna University, MIT Campus, Chennai, India",NA
"2321","34257471","10.1016/j.bbe.2021.06.011","FractalCovNet architecture for COVID-19 Chest X-ray image Classification and CT-scan image Segmentation.","Precise and fast diagnosis of COVID-19 cases play a vital role in early stage of medical treatment and prevention. Automatic detection of COVID-19 cases using the chest X-ray images and chest CT-scan images will be helpful to reduce the impact of this pandemic on the human society. We have developed a novel FractalCovNet architecture using Fractal blocks and U-Net for segmentation of chest CT-scan images to localize the lesion region. The same FractalCovNet architecture is also used for classifi","2021","07","20","Biocybern Biomed Eng","Biocybernetics and biomedical engineering","COVID-19; CT-scan image segmentation; Chest X-ray classification; FractalCovNet; U-Net","Thanga Revathi","S","Department of Computer Science and Engineering, SRM Institute of Science and Technology, Chennai, India",NA
"2322","34257471","10.1016/j.bbe.2021.06.011","FractalCovNet architecture for COVID-19 Chest X-ray image Classification and CT-scan image Segmentation.","Precise and fast diagnosis of COVID-19 cases play a vital role in early stage of medical treatment and prevention. Automatic detection of COVID-19 cases using the chest X-ray images and chest CT-scan images will be helpful to reduce the impact of this pandemic on the human society. We have developed a novel FractalCovNet architecture using Fractal blocks and U-Net for segmentation of chest CT-scan images to localize the lesion region. The same FractalCovNet architecture is also used for classifi","2021","07","20","Biocybern Biomed Eng","Biocybernetics and biomedical engineering","COVID-19; CT-scan image segmentation; Chest X-ray classification; FractalCovNet; U-Net","Aravindkumar","S","Department of Information Technology, Rajalakshmi Engineering College, Chennai, India",NA
"2323","34257460","10.1038/s41587-021-00983-8","Malaria vaccine wows and seeds COVID-19 vaccine effort.",NA,"2021","07","20","Nat Biotechnol","Nature biotechnology","Adjuvants, Pharmaceutic; COVID-19 Vaccines; Clinical Trials as Topic; Humans; Malaria Vaccines","Ledford","Heidi",", London, UK",NA
"2324","34257446","10.1038/d41586-020-02122-w","Daily briefing: How Vietnam acheived zero deaths from coronavirus.",NA,"2021","07","14","Nature","Nature",NA,"Graham","Flora",NA,NA
"2325","34257426","10.1038/s41587-021-00984-7","COVID-19 long haulers.",NA,"2021","07","17","Nat Biotechnol","Nature biotechnology",NA,"Schmidt","Charles",", Portland, ME, USA",NA
"2326","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Claude-Taupin","Aurore","Autophagy, Inflammation and Metabolic (AIM) Center of Biochemical Research Excellence, University of New Mexico Health Sciences Center, Albuquerque, NM, USA",NA
"2327","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Jia","Jingyue","Autophagy, Inflammation and Metabolic (AIM) Center of Biochemical Research Excellence, University of New Mexico Health Sciences Center, Albuquerque, NM, USA",NA
"2328","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Bhujabal","Zambarlal","Molecular Cancer Research Group, Institute of Medical Biology, University of Tromsø-The Arctic University of Norway, Tromsø, Norway",NA
"2329","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Garfa-Traoré","Meriem","Cell Imaging Platform, INSERM US24 Structure Fédérative de Recherche Necker, Université de Paris, Paris, France",NA
"2330","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Kumar","Suresh","Autophagy, Inflammation and Metabolic (AIM) Center of Biochemical Research Excellence, University of New Mexico Health Sciences Center, Albuquerque, NM, USA",NA
"2331","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"da Silva","Gustavo Peixoto Duarte","Autophagy, Inflammation and Metabolic (AIM) Center of Biochemical Research Excellence, University of New Mexico Health Sciences Center, Albuquerque, NM, USA",NA
"2332","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Javed","Ruheena","Autophagy, Inflammation and Metabolic (AIM) Center of Biochemical Research Excellence, University of New Mexico Health Sciences Center, Albuquerque, NM, USA",NA
"2333","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Gu","Yuexi","Autophagy, Inflammation and Metabolic (AIM) Center of Biochemical Research Excellence, University of New Mexico Health Sciences Center, Albuquerque, NM, USA",NA
"2334","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Allers","Lee","Autophagy, Inflammation and Metabolic (AIM) Center of Biochemical Research Excellence, University of New Mexico Health Sciences Center, Albuquerque, NM, USA",NA
"2335","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Peters","Ryan","Autophagy, Inflammation and Metabolic (AIM) Center of Biochemical Research Excellence, University of New Mexico Health Sciences Center, Albuquerque, NM, USA",NA
"2336","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Wang","Fulong","Autophagy, Inflammation and Metabolic (AIM) Center of Biochemical Research Excellence, University of New Mexico Health Sciences Center, Albuquerque, NM, USA",NA
"2337","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"da Costa","Luciana Jesus","Departamento de Virologia, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil",NA
"2338","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Pallikkuth","Sandeep","Department of Physics and Astronomy, University of New Mexico, Albuquerque, NM, USA",NA
"2339","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Lidke","Keith A","Department of Physics and Astronomy, University of New Mexico, Albuquerque, NM, USA",NA
"2340","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Mauthe","Mario","Department of Biomedical Sciences of Cells and Systems, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands",NA
"2341","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Verlhac","Pauline","Department of Biomedical Sciences of Cells and Systems, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands",NA
"2342","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Uchiyama","Yasuo","Department of Cellular and Molecular Neuropathology, Juntendo University Graduate School of Medicine, Tokyo, Japan",NA
"2343","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Salemi","Michelle","Proteomics Core Facility, UC Davis Genome Center, University of California, Davis, Davis, CA, USA",NA
"2344","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Phinney","Brett","Proteomics Core Facility, UC Davis Genome Center, University of California, Davis, Davis, CA, USA",NA
"2345","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Tooze","Sharon A","The Francis Crick Institute, Molecular Cell Biology of Autophagy Laboratory, London, UK",NA
"2346","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Mari","Muriel C","Department of Biomedical Sciences of Cells and Systems, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands",NA
"2347","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Johansen","Terje","Molecular Cancer Research Group, Institute of Medical Biology, University of Tromsø-The Arctic University of Norway, Tromsø, Norway",NA
"2348","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Reggiori","Fulvio","Department of Biomedical Sciences of Cells and Systems, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands",NA
"2349","34257406","10.1038/s41556-021-00706-w","ATG9A protects the plasma membrane from programmed and incidental permeabilization.","The integral membrane protein ATG9A plays a key role in autophagy. It displays a broad intracellular distribution and is present in numerous compartments, including the plasma membrane (PM). The reasons for the distribution of ATG9A to the PM and its role at the PM are not understood. Here, we show that ATG9A organizes, in concert with IQGAP1, components of the ESCRT system and uncover cooperation between ATG9A, IQGAP1 and ESCRTs in protection from PM damage. ESCRTs and ATG9A phenocopied each ot","2021","07","17","Nat Cell Biol","Nature cell biology",NA,"Deretic","Vojo","Autophagy, Inflammation and Metabolic (AIM) Center of Biochemical Research Excellence, University of New Mexico Health Sciences Center, Albuquerque, NM, USA. vderetic@salud.unm","vderetic@salud.unm.edu"
"2350","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Mourad","Mirella","Department of Obstetrics, Gynecology and Reproductive Science, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA",NA
"2351","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Jacob","Taylor","Department of Obstetrics, Gynecology and Reproductive Science, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA",NA
"2352","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Sadovsky","Elena","Magee-Womens Research Institute, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, 204 Craft Avenue, Pittsburgh, PA, 15213, USA",NA
"2353","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Bejerano","Shai","Department of Obstetrics, Gynecology and Reproductive Science, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA",NA
"2354","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Simone","Glicella Salazar-De","Department of Obstetrics, Gynecology and Reproductive Science, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA",NA
"2355","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Bagalkot","Tarique Rajasaheb","Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA",NA
"2356","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Zucker","Jason","Department of Medicine, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA",NA
"2357","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Yin","Michael T","Department of Medicine, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA",NA
"2358","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Chang","Jennifer Y","Department of Medicine, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA",NA
"2359","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Liu","Lihong","Department of Medicine, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA",NA
"2360","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Debelenko","Larisa","Department of Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA",NA
"2361","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Shawber","Carrie J","Department of Obstetrics, Gynecology and Reproductive Science, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA",NA
"2362","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Firestein","Morgan","Department of Psychiatry, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA",NA
"2363","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Ouyang","Yingshi","Magee-Womens Research Institute, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, 204 Craft Avenue, Pittsburgh, PA, 15213, USA",NA
"2364","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Gyamfi-Bannerman","Cynthia","Department of Obstetrics, Gynecology and Reproductive Science, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA",NA
"2365","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Penn","Anna","Department of Pediatrics, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA",NA
"2366","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Sorkin","Alexander","Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA",NA
"2367","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Wapner","Ronald","Department of Obstetrics, Gynecology and Reproductive Science, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA",NA
"2368","34257394","10.1038/s41598-021-93931-0","Placental response to maternal SARS-CoV-2 infection.","The coronavirus disease 2019 (COVID-19) pandemic affected people at all ages. Whereas pregnant women seemed to have a worse course of disease than age-matched non-pregnant women, the risk of feto-placental infection is low. Using a cohort of 66 COVID-19-positive women in late pregnancy, we correlated clinical parameters with disease severity, placental histopathology, and the expression of viral entry and Interferon-induced transmembrane (IFITM) antiviral transcripts. All newborns were negative ","2021","07","17","Sci Rep","Scientific reports",NA,"Sadovsky","Yoel","Magee-Womens Research Institute, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, 204 Craft Avenue, Pittsburgh, PA, 15213, USA. ysadovsky@mwri.magee","ysadovsky@mwri.magee.edu"
"2369","34257389","10.1038/s41370-021-00366-w","SARS-CoV-2 test positivity rate in Reno, Nevada: association with PM2.5 during the 2020 wildfire smoke events in the western United States.","Air pollution has been linked to increased susceptibility to SARS-CoV-2. Thus, it has been suggested that wildfire smoke events may exacerbate the COVID-19 pandemic. Our goal was to examine whether wildfire smoke from the 2020 wildfires in the western United States was associated with an increased rate of SARS-CoV-2 infections in Reno, Nevada. We conducted a time-series analysis using generalized additive models to examine the relationship between the SARS-CoV-2 test positivity rate at a large r","2021","07","17","J Expo Sci Environ Epidemiol","Journal of exposure science &amp; environmental epidemiology",NA,"Kiser","Daniel","Center for Genomic Medicine, Desert Research Institute, Reno, NV, USA. daniel.kiser@dri","daniel.kiser@dri.edu"
"2370","34257389","10.1038/s41370-021-00366-w","SARS-CoV-2 test positivity rate in Reno, Nevada: association with PM2.5 during the 2020 wildfire smoke events in the western United States.","Air pollution has been linked to increased susceptibility to SARS-CoV-2. Thus, it has been suggested that wildfire smoke events may exacerbate the COVID-19 pandemic. Our goal was to examine whether wildfire smoke from the 2020 wildfires in the western United States was associated with an increased rate of SARS-CoV-2 infections in Reno, Nevada. We conducted a time-series analysis using generalized additive models to examine the relationship between the SARS-CoV-2 test positivity rate at a large r","2021","07","17","J Expo Sci Environ Epidemiol","Journal of exposure science &amp; environmental epidemiology",NA,"Elhanan","Gai","Center for Genomic Medicine, Desert Research Institute, Reno, NV, USA",NA
"2371","34257389","10.1038/s41370-021-00366-w","SARS-CoV-2 test positivity rate in Reno, Nevada: association with PM2.5 during the 2020 wildfire smoke events in the western United States.","Air pollution has been linked to increased susceptibility to SARS-CoV-2. Thus, it has been suggested that wildfire smoke events may exacerbate the COVID-19 pandemic. Our goal was to examine whether wildfire smoke from the 2020 wildfires in the western United States was associated with an increased rate of SARS-CoV-2 infections in Reno, Nevada. We conducted a time-series analysis using generalized additive models to examine the relationship between the SARS-CoV-2 test positivity rate at a large r","2021","07","17","J Expo Sci Environ Epidemiol","Journal of exposure science &amp; environmental epidemiology",NA,"Metcalf","William J","Center for Genomic Medicine, Desert Research Institute, Reno, NV, USA",NA
"2372","34257389","10.1038/s41370-021-00366-w","SARS-CoV-2 test positivity rate in Reno, Nevada: association with PM2.5 during the 2020 wildfire smoke events in the western United States.","Air pollution has been linked to increased susceptibility to SARS-CoV-2. Thus, it has been suggested that wildfire smoke events may exacerbate the COVID-19 pandemic. Our goal was to examine whether wildfire smoke from the 2020 wildfires in the western United States was associated with an increased rate of SARS-CoV-2 infections in Reno, Nevada. We conducted a time-series analysis using generalized additive models to examine the relationship between the SARS-CoV-2 test positivity rate at a large r","2021","07","17","J Expo Sci Environ Epidemiol","Journal of exposure science &amp; environmental epidemiology",NA,"Schnieder","Brendan","Washoe County Health District Air Quality Management Division, Reno, NV, USA",NA
"2373","34257389","10.1038/s41370-021-00366-w","SARS-CoV-2 test positivity rate in Reno, Nevada: association with PM2.5 during the 2020 wildfire smoke events in the western United States.","Air pollution has been linked to increased susceptibility to SARS-CoV-2. Thus, it has been suggested that wildfire smoke events may exacerbate the COVID-19 pandemic. Our goal was to examine whether wildfire smoke from the 2020 wildfires in the western United States was associated with an increased rate of SARS-CoV-2 infections in Reno, Nevada. We conducted a time-series analysis using generalized additive models to examine the relationship between the SARS-CoV-2 test positivity rate at a large r","2021","07","17","J Expo Sci Environ Epidemiol","Journal of exposure science &amp; environmental epidemiology",NA,"Grzymski","Joseph J","Center for Genomic Medicine, Desert Research Institute, Reno, NV, USA",NA
"2374","34257381","10.1038/s41598-021-93836-y","The relationship between Google search interest for pulmonary symptoms and COVID-19 cases using dynamic conditional correlation analysis.","This study aims to evaluate the monitoring and predictive value of web-based symptoms (fever, cough, dyspnea) searches for COVID-19 spread. Daily search interests from Turkey, Italy, Spain, France, and the United Kingdom were obtained from Google Trends (GT) between January 1, 2020, and August 31, 2020. In addition to conventional correlational models, we studied the time-varying correlation between GT search and new case reports; we used dynamic conditional correlation (DCC) and sliding windows","2021","07","17","Sci Rep","Scientific reports",NA,"Cinarka","Halit","Yedikule Training and Research Hospital for Chest Diseases and Thoracic Surgery, University of Health Sciences Turkey, Istanbul, Turkey. halit.cinarka@sbu.edu","halit.cinarka@sbu.edu.tr"
"2375","34257381","10.1038/s41598-021-93836-y","The relationship between Google search interest for pulmonary symptoms and COVID-19 cases using dynamic conditional correlation analysis.","This study aims to evaluate the monitoring and predictive value of web-based symptoms (fever, cough, dyspnea) searches for COVID-19 spread. Daily search interests from Turkey, Italy, Spain, France, and the United Kingdom were obtained from Google Trends (GT) between January 1, 2020, and August 31, 2020. In addition to conventional correlational models, we studied the time-varying correlation between GT search and new case reports; we used dynamic conditional correlation (DCC) and sliding windows","2021","07","17","Sci Rep","Scientific reports",NA,"Uysal","Mehmet Atilla","Yedikule Training and Research Hospital for Chest Diseases and Thoracic Surgery, University of Health Sciences Turkey, Istanbul, Turkey",NA
"2376","34257381","10.1038/s41598-021-93836-y","The relationship between Google search interest for pulmonary symptoms and COVID-19 cases using dynamic conditional correlation analysis.","This study aims to evaluate the monitoring and predictive value of web-based symptoms (fever, cough, dyspnea) searches for COVID-19 spread. Daily search interests from Turkey, Italy, Spain, France, and the United Kingdom were obtained from Google Trends (GT) between January 1, 2020, and August 31, 2020. In addition to conventional correlational models, we studied the time-varying correlation between GT search and new case reports; we used dynamic conditional correlation (DCC) and sliding windows","2021","07","17","Sci Rep","Scientific reports",NA,"Cifter","Atilla","Department of Economics, Altinbas University, Istanbul, Turkey",NA
"2377","34257381","10.1038/s41598-021-93836-y","The relationship between Google search interest for pulmonary symptoms and COVID-19 cases using dynamic conditional correlation analysis.","This study aims to evaluate the monitoring and predictive value of web-based symptoms (fever, cough, dyspnea) searches for COVID-19 spread. Daily search interests from Turkey, Italy, Spain, France, and the United Kingdom were obtained from Google Trends (GT) between January 1, 2020, and August 31, 2020. In addition to conventional correlational models, we studied the time-varying correlation between GT search and new case reports; we used dynamic conditional correlation (DCC) and sliding windows","2021","07","17","Sci Rep","Scientific reports",NA,"Niksarlioglu","Elif Yelda","Yedikule Training and Research Hospital for Chest Diseases and Thoracic Surgery, University of Health Sciences Turkey, Istanbul, Turkey",NA
"2378","34257381","10.1038/s41598-021-93836-y","The relationship between Google search interest for pulmonary symptoms and COVID-19 cases using dynamic conditional correlation analysis.","This study aims to evaluate the monitoring and predictive value of web-based symptoms (fever, cough, dyspnea) searches for COVID-19 spread. Daily search interests from Turkey, Italy, Spain, France, and the United Kingdom were obtained from Google Trends (GT) between January 1, 2020, and August 31, 2020. In addition to conventional correlational models, we studied the time-varying correlation between GT search and new case reports; we used dynamic conditional correlation (DCC) and sliding windows","2021","07","17","Sci Rep","Scientific reports",NA,"Çarkoglu","Asli","Department of Psychology, Kadir Has University, Istanbul, Turkey",NA
"2379","34257380","10.1038/s41598-021-93924-z","A longitudinal analysis of COVID-19 lockdown stringency on sleep and resting heart rate measures across 20 countries.","Lockdowns imposed to stem the spread of COVID-19 massively disrupted the daily routines of many worldwide, but studies to date have been mostly confined to observations within a limited number of countries, based on subjective reports and surveys from specific time periods during the pandemic. We investigated associations between lockdown stringency and objective sleep and resting-heart rate measures in ~ 113,000 users of a consumer sleep tracker across 20 countries from Jan to Jul 2020, compare","2021","07","17","Sci Rep","Scientific reports",NA,"Ong","Ju Lynn","Centre for Sleep and Cognition, Human Potential Program, Yong Loo Lin School of Medicine, National University of Singapore, 12 Science Drive 2, Singapore, 117549, Singapore",NA
"2380","34257380","10.1038/s41598-021-93924-z","A longitudinal analysis of COVID-19 lockdown stringency on sleep and resting heart rate measures across 20 countries.","Lockdowns imposed to stem the spread of COVID-19 massively disrupted the daily routines of many worldwide, but studies to date have been mostly confined to observations within a limited number of countries, based on subjective reports and surveys from specific time periods during the pandemic. We investigated associations between lockdown stringency and objective sleep and resting-heart rate measures in ~ 113,000 users of a consumer sleep tracker across 20 countries from Jan to Jul 2020, compare","2021","07","17","Sci Rep","Scientific reports",NA,"Lau","TeYang","Centre for Sleep and Cognition, Human Potential Program, Yong Loo Lin School of Medicine, National University of Singapore, 12 Science Drive 2, Singapore, 117549, Singapore",NA
"2381","34257380","10.1038/s41598-021-93924-z","A longitudinal analysis of COVID-19 lockdown stringency on sleep and resting heart rate measures across 20 countries.","Lockdowns imposed to stem the spread of COVID-19 massively disrupted the daily routines of many worldwide, but studies to date have been mostly confined to observations within a limited number of countries, based on subjective reports and surveys from specific time periods during the pandemic. We investigated associations between lockdown stringency and objective sleep and resting-heart rate measures in ~ 113,000 users of a consumer sleep tracker across 20 countries from Jan to Jul 2020, compare","2021","07","17","Sci Rep","Scientific reports",NA,"Karsikas","Mari","Oura Health, Oulu, Finland",NA
"2382","34257380","10.1038/s41598-021-93924-z","A longitudinal analysis of COVID-19 lockdown stringency on sleep and resting heart rate measures across 20 countries.","Lockdowns imposed to stem the spread of COVID-19 massively disrupted the daily routines of many worldwide, but studies to date have been mostly confined to observations within a limited number of countries, based on subjective reports and surveys from specific time periods during the pandemic. We investigated associations between lockdown stringency and objective sleep and resting-heart rate measures in ~ 113,000 users of a consumer sleep tracker across 20 countries from Jan to Jul 2020, compare","2021","07","17","Sci Rep","Scientific reports",NA,"Kinnunen","Hannu","Oura Health, Oulu, Finland",NA
"2383","34257380","10.1038/s41598-021-93924-z","A longitudinal analysis of COVID-19 lockdown stringency on sleep and resting heart rate measures across 20 countries.","Lockdowns imposed to stem the spread of COVID-19 massively disrupted the daily routines of many worldwide, but studies to date have been mostly confined to observations within a limited number of countries, based on subjective reports and surveys from specific time periods during the pandemic. We investigated associations between lockdown stringency and objective sleep and resting-heart rate measures in ~ 113,000 users of a consumer sleep tracker across 20 countries from Jan to Jul 2020, compare","2021","07","17","Sci Rep","Scientific reports",NA,"Chee","Michael W L","Centre for Sleep and Cognition, Human Potential Program, Yong Loo Lin School of Medicine, National University of Singapore, 12 Science Drive 2, Singapore, 117549, Singapore. michael.chee@nus.edu","michael.chee@nus.edu.sg"
"2384","34257366","10.1038/s41598-021-93739-y","Effect of prone position on respiratory parameters, intubation and death rate in COVID-19 patients: systematic review and meta-analysis.","Prone position (PP) is known to improve oxygenation and reduce mortality in COVID-19 patients. This systematic review and meta-analysis aimed to determine the effects of PP on respiratory parameters and outcomes. PubMed, EMBASE, ProQuest, SCOPUS, Web of Sciences, Cochrane library, and Google Scholar were searched up to 1st January 2021. Twenty-eight studies were included. The Cochran's Q-test and I<sup>2</sup> statistic were assessed heterogeneity, the random-effects model was estimated the pool","2021","07","17","Sci Rep","Scientific reports",NA,"Behesht Aeen","Fatemeh","Student Research Committee, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran",NA
"2385","34257366","10.1038/s41598-021-93739-y","Effect of prone position on respiratory parameters, intubation and death rate in COVID-19 patients: systematic review and meta-analysis.","Prone position (PP) is known to improve oxygenation and reduce mortality in COVID-19 patients. This systematic review and meta-analysis aimed to determine the effects of PP on respiratory parameters and outcomes. PubMed, EMBASE, ProQuest, SCOPUS, Web of Sciences, Cochrane library, and Google Scholar were searched up to 1st January 2021. Twenty-eight studies were included. The Cochran's Q-test and I<sup>2</sup> statistic were assessed heterogeneity, the random-effects model was estimated the pool","2021","07","17","Sci Rep","Scientific reports",NA,"Pakzad","Reza","Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran",NA
"2386","34257366","10.1038/s41598-021-93739-y","Effect of prone position on respiratory parameters, intubation and death rate in COVID-19 patients: systematic review and meta-analysis.","Prone position (PP) is known to improve oxygenation and reduce mortality in COVID-19 patients. This systematic review and meta-analysis aimed to determine the effects of PP on respiratory parameters and outcomes. PubMed, EMBASE, ProQuest, SCOPUS, Web of Sciences, Cochrane library, and Google Scholar were searched up to 1st January 2021. Twenty-eight studies were included. The Cochran's Q-test and I<sup>2</sup> statistic were assessed heterogeneity, the random-effects model was estimated the pool","2021","07","17","Sci Rep","Scientific reports",NA,"Goudarzi Rad","Mohammad","Master of Critical Care Nursing, Tehran University of Medical Sciences, Tehran, Iran",NA
"2387","34257366","10.1038/s41598-021-93739-y","Effect of prone position on respiratory parameters, intubation and death rate in COVID-19 patients: systematic review and meta-analysis.","Prone position (PP) is known to improve oxygenation and reduce mortality in COVID-19 patients. This systematic review and meta-analysis aimed to determine the effects of PP on respiratory parameters and outcomes. PubMed, EMBASE, ProQuest, SCOPUS, Web of Sciences, Cochrane library, and Google Scholar were searched up to 1st January 2021. Twenty-eight studies were included. The Cochran's Q-test and I<sup>2</sup> statistic were assessed heterogeneity, the random-effects model was estimated the pool","2021","07","17","Sci Rep","Scientific reports",NA,"Abdi","Fatemeh","School of Nursing and Midwifery, Alborz University of Medical Sciences, Karaj, Iran. abdi@sbmu.ac","abdi@sbmu.ac.ir"
"2388","34257366","10.1038/s41598-021-93739-y","Effect of prone position on respiratory parameters, intubation and death rate in COVID-19 patients: systematic review and meta-analysis.","Prone position (PP) is known to improve oxygenation and reduce mortality in COVID-19 patients. This systematic review and meta-analysis aimed to determine the effects of PP on respiratory parameters and outcomes. PubMed, EMBASE, ProQuest, SCOPUS, Web of Sciences, Cochrane library, and Google Scholar were searched up to 1st January 2021. Twenty-eight studies were included. The Cochran's Q-test and I<sup>2</sup> statistic were assessed heterogeneity, the random-effects model was estimated the pool","2021","07","17","Sci Rep","Scientific reports",NA,"Zaheri","Farzaneh","Midwifery Department, Kurdistan University of Medical Sciences, Sanandaj, Iran",NA
"2389","34257366","10.1038/s41598-021-93739-y","Effect of prone position on respiratory parameters, intubation and death rate in COVID-19 patients: systematic review and meta-analysis.","Prone position (PP) is known to improve oxygenation and reduce mortality in COVID-19 patients. This systematic review and meta-analysis aimed to determine the effects of PP on respiratory parameters and outcomes. PubMed, EMBASE, ProQuest, SCOPUS, Web of Sciences, Cochrane library, and Google Scholar were searched up to 1st January 2021. Twenty-eight studies were included. The Cochran's Q-test and I<sup>2</sup> statistic were assessed heterogeneity, the random-effects model was estimated the pool","2021","07","17","Sci Rep","Scientific reports",NA,"Mirzadeh","Narges","Department of Midwifery, School of Nursing and Midwifery, Bam University of Medical Sciences, Bam, Iran",NA
"2390","34257350","10.1038/s41598-021-93538-5","COVID-19 mitigation by digital contact tracing and contact prevention (app-based social exposure warnings).","A plethora of measures are being combined in the attempt to reduce SARS-CoV-2 spread. Due to its sustainability, contact tracing is one of the most frequently applied interventions worldwide, albeit with mixed results. We evaluate the performance of digital contact tracing for different infection detection rates and response time delays. We also introduce and analyze a novel strategy we call contact prevention, which emits high exposure warnings to smartphone users according to Bluetooth-based c","2021","07","17","Sci Rep","Scientific reports",NA,"Soldano","Germán J","Instituto de Investigaciones en Fisico-Química de Córdoba (INFIQC-CONICET), Córdoba, Argentina",NA
"2391","34257350","10.1038/s41598-021-93538-5","COVID-19 mitigation by digital contact tracing and contact prevention (app-based social exposure warnings).","A plethora of measures are being combined in the attempt to reduce SARS-CoV-2 spread. Due to its sustainability, contact tracing is one of the most frequently applied interventions worldwide, albeit with mixed results. We evaluate the performance of digital contact tracing for different infection detection rates and response time delays. We also introduce and analyze a novel strategy we call contact prevention, which emits high exposure warnings to smartphone users according to Bluetooth-based c","2021","07","17","Sci Rep","Scientific reports",NA,"Fraire","Juan A","Instituto de Estudios Avanzados En Ingenieria y Tecnología (IDIT-CONICET), Córdoba, Argentina",NA
"2392","34257350","10.1038/s41598-021-93538-5","COVID-19 mitigation by digital contact tracing and contact prevention (app-based social exposure warnings).","A plethora of measures are being combined in the attempt to reduce SARS-CoV-2 spread. Due to its sustainability, contact tracing is one of the most frequently applied interventions worldwide, albeit with mixed results. We evaluate the performance of digital contact tracing for different infection detection rates and response time delays. We also introduce and analyze a novel strategy we call contact prevention, which emits high exposure warnings to smartphone users according to Bluetooth-based c","2021","07","17","Sci Rep","Scientific reports",NA,"Finochietto","Jorge M","Instituto de Estudios Avanzados En Ingenieria y Tecnología (IDIT-CONICET), Córdoba, Argentina",NA
"2393","34257350","10.1038/s41598-021-93538-5","COVID-19 mitigation by digital contact tracing and contact prevention (app-based social exposure warnings).","A plethora of measures are being combined in the attempt to reduce SARS-CoV-2 spread. Due to its sustainability, contact tracing is one of the most frequently applied interventions worldwide, albeit with mixed results. We evaluate the performance of digital contact tracing for different infection detection rates and response time delays. We also introduce and analyze a novel strategy we call contact prevention, which emits high exposure warnings to smartphone users according to Bluetooth-based c","2021","07","17","Sci Rep","Scientific reports",NA,"Quiroga","Rodrigo","Instituto de Investigaciones en Fisico-Química de Córdoba (INFIQC-CONICET), Córdoba, Argentina. rquiroga@unc.edu","rquiroga@unc.edu.ar"
"2394","34257311","10.1038/s41467-021-24577-9","Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.","The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and circumvent viral escape from host immunity and antiviral therapeutics. Here, we employ genome-wide computational prediction and single-nucleotide resolution screening to reprogram CRISPR-Cas13b against SARS-CoV-2 genomic and subgenomic RNAs. Reprogrammed Cas13b effectors targeting accessible regions of Spike and ","2021","07","20","Nat Commun","Nature communications","Animals; Antiviral Agents; COVID-19; CRISPR-Cas Systems; Chlorocebus aethiops; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Development; Genome, Viral; HEK293 Cells; Humans; Mutation; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication","Fareh","Mohamed","Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia. Mohamed.fareh@petermac","Mohamed.fareh@petermac.org"
"2395","34257311","10.1038/s41467-021-24577-9","Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.","The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and circumvent viral escape from host immunity and antiviral therapeutics. Here, we employ genome-wide computational prediction and single-nucleotide resolution screening to reprogram CRISPR-Cas13b against SARS-CoV-2 genomic and subgenomic RNAs. Reprogrammed Cas13b effectors targeting accessible regions of Spike and ","2021","07","20","Nat Commun","Nature communications","Animals; Antiviral Agents; COVID-19; CRISPR-Cas Systems; Chlorocebus aethiops; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Development; Genome, Viral; HEK293 Cells; Humans; Mutation; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication","Zhao","Wei","The Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"2396","34257311","10.1038/s41467-021-24577-9","Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.","The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and circumvent viral escape from host immunity and antiviral therapeutics. Here, we employ genome-wide computational prediction and single-nucleotide resolution screening to reprogram CRISPR-Cas13b against SARS-CoV-2 genomic and subgenomic RNAs. Reprogrammed Cas13b effectors targeting accessible regions of Spike and ","2021","07","20","Nat Commun","Nature communications","Animals; Antiviral Agents; COVID-19; CRISPR-Cas Systems; Chlorocebus aethiops; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Development; Genome, Viral; HEK293 Cells; Humans; Mutation; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication","Hu","Wenxin","Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia",NA
"2397","34257311","10.1038/s41467-021-24577-9","Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.","The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and circumvent viral escape from host immunity and antiviral therapeutics. Here, we employ genome-wide computational prediction and single-nucleotide resolution screening to reprogram CRISPR-Cas13b against SARS-CoV-2 genomic and subgenomic RNAs. Reprogrammed Cas13b effectors targeting accessible regions of Spike and ","2021","07","20","Nat Commun","Nature communications","Animals; Antiviral Agents; COVID-19; CRISPR-Cas Systems; Chlorocebus aethiops; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Development; Genome, Viral; HEK293 Cells; Humans; Mutation; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication","Casan","Joshua M L","Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia",NA
"2398","34257311","10.1038/s41467-021-24577-9","Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.","The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and circumvent viral escape from host immunity and antiviral therapeutics. Here, we employ genome-wide computational prediction and single-nucleotide resolution screening to reprogram CRISPR-Cas13b against SARS-CoV-2 genomic and subgenomic RNAs. Reprogrammed Cas13b effectors targeting accessible regions of Spike and ","2021","07","20","Nat Commun","Nature communications","Animals; Antiviral Agents; COVID-19; CRISPR-Cas Systems; Chlorocebus aethiops; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Development; Genome, Viral; HEK293 Cells; Humans; Mutation; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication","Kumar","Amit","Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia",NA
"2399","34257311","10.1038/s41467-021-24577-9","Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.","The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and circumvent viral escape from host immunity and antiviral therapeutics. Here, we employ genome-wide computational prediction and single-nucleotide resolution screening to reprogram CRISPR-Cas13b against SARS-CoV-2 genomic and subgenomic RNAs. Reprogrammed Cas13b effectors targeting accessible regions of Spike and ","2021","07","20","Nat Commun","Nature communications","Animals; Antiviral Agents; COVID-19; CRISPR-Cas Systems; Chlorocebus aethiops; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Development; Genome, Viral; HEK293 Cells; Humans; Mutation; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication","Symons","Jori","The Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"2400","34257311","10.1038/s41467-021-24577-9","Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.","The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and circumvent viral escape from host immunity and antiviral therapeutics. Here, we employ genome-wide computational prediction and single-nucleotide resolution screening to reprogram CRISPR-Cas13b against SARS-CoV-2 genomic and subgenomic RNAs. Reprogrammed Cas13b effectors targeting accessible regions of Spike and ","2021","07","20","Nat Commun","Nature communications","Animals; Antiviral Agents; COVID-19; CRISPR-Cas Systems; Chlorocebus aethiops; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Development; Genome, Viral; HEK293 Cells; Humans; Mutation; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication","Zerbato","Jennifer M","The Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"2401","34257311","10.1038/s41467-021-24577-9","Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.","The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and circumvent viral escape from host immunity and antiviral therapeutics. Here, we employ genome-wide computational prediction and single-nucleotide resolution screening to reprogram CRISPR-Cas13b against SARS-CoV-2 genomic and subgenomic RNAs. Reprogrammed Cas13b effectors targeting accessible regions of Spike and ","2021","07","20","Nat Commun","Nature communications","Animals; Antiviral Agents; COVID-19; CRISPR-Cas Systems; Chlorocebus aethiops; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Development; Genome, Viral; HEK293 Cells; Humans; Mutation; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication","Fong","Danielle","The Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"2402","34257311","10.1038/s41467-021-24577-9","Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.","The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and circumvent viral escape from host immunity and antiviral therapeutics. Here, we employ genome-wide computational prediction and single-nucleotide resolution screening to reprogram CRISPR-Cas13b against SARS-CoV-2 genomic and subgenomic RNAs. Reprogrammed Cas13b effectors targeting accessible regions of Spike and ","2021","07","20","Nat Commun","Nature communications","Animals; Antiviral Agents; COVID-19; CRISPR-Cas Systems; Chlorocebus aethiops; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Development; Genome, Viral; HEK293 Cells; Humans; Mutation; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication","Voskoboinik","Ilia","Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia",NA
"2403","34257311","10.1038/s41467-021-24577-9","Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.","The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and circumvent viral escape from host immunity and antiviral therapeutics. Here, we employ genome-wide computational prediction and single-nucleotide resolution screening to reprogram CRISPR-Cas13b against SARS-CoV-2 genomic and subgenomic RNAs. Reprogrammed Cas13b effectors targeting accessible regions of Spike and ","2021","07","20","Nat Commun","Nature communications","Animals; Antiviral Agents; COVID-19; CRISPR-Cas Systems; Chlorocebus aethiops; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Development; Genome, Viral; HEK293 Cells; Humans; Mutation; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication","Ekert","Paul G","Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia",NA
"2404","34257311","10.1038/s41467-021-24577-9","Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.","The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and circumvent viral escape from host immunity and antiviral therapeutics. Here, we employ genome-wide computational prediction and single-nucleotide resolution screening to reprogram CRISPR-Cas13b against SARS-CoV-2 genomic and subgenomic RNAs. Reprogrammed Cas13b effectors targeting accessible regions of Spike and ","2021","07","20","Nat Commun","Nature communications","Animals; Antiviral Agents; COVID-19; CRISPR-Cas Systems; Chlorocebus aethiops; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Development; Genome, Viral; HEK293 Cells; Humans; Mutation; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication","Rudraraju","Rajeev","The Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"2405","34257311","10.1038/s41467-021-24577-9","Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.","The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and circumvent viral escape from host immunity and antiviral therapeutics. Here, we employ genome-wide computational prediction and single-nucleotide resolution screening to reprogram CRISPR-Cas13b against SARS-CoV-2 genomic and subgenomic RNAs. Reprogrammed Cas13b effectors targeting accessible regions of Spike and ","2021","07","20","Nat Commun","Nature communications","Animals; Antiviral Agents; COVID-19; CRISPR-Cas Systems; Chlorocebus aethiops; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Development; Genome, Viral; HEK293 Cells; Humans; Mutation; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication","Purcell","Damian F J","Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"2406","34257311","10.1038/s41467-021-24577-9","Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.","The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and circumvent viral escape from host immunity and antiviral therapeutics. Here, we employ genome-wide computational prediction and single-nucleotide resolution screening to reprogram CRISPR-Cas13b against SARS-CoV-2 genomic and subgenomic RNAs. Reprogrammed Cas13b effectors targeting accessible regions of Spike and ","2021","07","20","Nat Commun","Nature communications","Animals; Antiviral Agents; COVID-19; CRISPR-Cas Systems; Chlorocebus aethiops; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Development; Genome, Viral; HEK293 Cells; Humans; Mutation; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication","Lewin","Sharon R","The Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. sharon.lewin@unimelb.edu","sharon.lewin@unimelb.edu.au"
"2407","34257311","10.1038/s41467-021-24577-9","Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.","The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and circumvent viral escape from host immunity and antiviral therapeutics. Here, we employ genome-wide computational prediction and single-nucleotide resolution screening to reprogram CRISPR-Cas13b against SARS-CoV-2 genomic and subgenomic RNAs. Reprogrammed Cas13b effectors targeting accessible regions of Spike and ","2021","07","20","Nat Commun","Nature communications","Animals; Antiviral Agents; COVID-19; CRISPR-Cas Systems; Chlorocebus aethiops; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Development; Genome, Viral; HEK293 Cells; Humans; Mutation; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication","Trapani","Joseph A","Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia",NA
"2408","34257266","10.1038/s41394-021-00420-7","Clinical features and prognosis of COVID-19/SARS-CoV-2 infections in persons with spinal cord injury: a review of current literature.","Focused literature review. Objective of the study was to perform a literature search and summarise the clinical features and prognosis of persons with spinal cord injury (SCI) infected with COVID-19 from the published articles. India. PubMed, CENTRAL and MEDLINE were systematically searched using specific keywords. The study assessed 2747 scientific studies involving COVID-19 and SCI for possible inclusion in a meta-analysis of SCI and SARS-COV-2. Studies involving persons with SCI who were test","2021","07","22","Spinal Cord Ser Cases","Spinal cord series and cases","COVID-19; Humans; Prognosis; Spinal Cord Injuries","Barman","Apurba","Department of Physical Medicine and Rehabilitation, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India. apurvaa23@gmail","apurvaa23@gmail.com"
"2409","34257266","10.1038/s41394-021-00420-7","Clinical features and prognosis of COVID-19/SARS-CoV-2 infections in persons with spinal cord injury: a review of current literature.","Focused literature review. Objective of the study was to perform a literature search and summarise the clinical features and prognosis of persons with spinal cord injury (SCI) infected with COVID-19 from the published articles. India. PubMed, CENTRAL and MEDLINE were systematically searched using specific keywords. The study assessed 2747 scientific studies involving COVID-19 and SCI for possible inclusion in a meta-analysis of SCI and SARS-COV-2. Studies involving persons with SCI who were test","2021","07","22","Spinal Cord Ser Cases","Spinal cord series and cases","COVID-19; Humans; Prognosis; Spinal Cord Injuries","Roy","Sankha Subhra","Department of Physical Medicine and Rehabilitation, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India",NA
"2410","34257266","10.1038/s41394-021-00420-7","Clinical features and prognosis of COVID-19/SARS-CoV-2 infections in persons with spinal cord injury: a review of current literature.","Focused literature review. Objective of the study was to perform a literature search and summarise the clinical features and prognosis of persons with spinal cord injury (SCI) infected with COVID-19 from the published articles. India. PubMed, CENTRAL and MEDLINE were systematically searched using specific keywords. The study assessed 2747 scientific studies involving COVID-19 and SCI for possible inclusion in a meta-analysis of SCI and SARS-COV-2. Studies involving persons with SCI who were test","2021","07","22","Spinal Cord Ser Cases","Spinal cord series and cases","COVID-19; Humans; Prognosis; Spinal Cord Injuries","Sasidharan","Sreeja Kamala","Department of Physical Medicine and Rehabilitation, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India",NA
"2411","34257266","10.1038/s41394-021-00420-7","Clinical features and prognosis of COVID-19/SARS-CoV-2 infections in persons with spinal cord injury: a review of current literature.","Focused literature review. Objective of the study was to perform a literature search and summarise the clinical features and prognosis of persons with spinal cord injury (SCI) infected with COVID-19 from the published articles. India. PubMed, CENTRAL and MEDLINE were systematically searched using specific keywords. The study assessed 2747 scientific studies involving COVID-19 and SCI for possible inclusion in a meta-analysis of SCI and SARS-COV-2. Studies involving persons with SCI who were test","2021","07","22","Spinal Cord Ser Cases","Spinal cord series and cases","COVID-19; Humans; Prognosis; Spinal Cord Injuries","Sahoo","Jagannatha","Department of Physical Medicine and Rehabilitation, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India",NA
"2412","34257214","10.1213/ANE.0000000000005621","Aspirin Use, Mechanical Ventilation, and Inhospital Mortality in Coronavirus Disease 2019: Are We Missing Something?",NA,"2021","07","22","Anesth Analg","Anesthesia and analgesia","Aspirin; COVID-19; Hospital Mortality; Humans; Respiration, Artificial; Retrospective Studies; SARS-CoV-2","Senthilnathan","Muthapillai","Department of Anaesthesiology and Critical Care, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India",NA
"2413","34257214","10.1213/ANE.0000000000005621","Aspirin Use, Mechanical Ventilation, and Inhospital Mortality in Coronavirus Disease 2019: Are We Missing Something?",NA,"2021","07","22","Anesth Analg","Anesthesia and analgesia","Aspirin; COVID-19; Hospital Mortality; Humans; Respiration, Artificial; Retrospective Studies; SARS-CoV-2","Ravi","Ramya","Department of Anaesthesia, Ng Teng Fong General Hospital, Singapore, ravivalarramya@gmail","ravivalarramya@gmail.com"
"2414","34257214","10.1213/ANE.0000000000005621","Aspirin Use, Mechanical Ventilation, and Inhospital Mortality in Coronavirus Disease 2019: Are We Missing Something?",NA,"2021","07","22","Anesth Analg","Anesthesia and analgesia","Aspirin; COVID-19; Hospital Mortality; Humans; Respiration, Artificial; Retrospective Studies; SARS-CoV-2","Sivakumar","Ranjith Kumar","Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong",NA
"2415","34257214","10.1213/ANE.0000000000005621","Aspirin Use, Mechanical Ventilation, and Inhospital Mortality in Coronavirus Disease 2019: Are We Missing Something?",NA,"2021","07","22","Anesth Analg","Anesthesia and analgesia","Aspirin; COVID-19; Hospital Mortality; Humans; Respiration, Artificial; Retrospective Studies; SARS-CoV-2","Majella","Marie Gilbert","The National Institute of Epidemiology, Chennai, India",NA
"2416","34257214","10.1213/ANE.0000000000005621","Aspirin Use, Mechanical Ventilation, and Inhospital Mortality in Coronavirus Disease 2019: Are We Missing Something?",NA,"2021","07","22","Anesth Analg","Anesthesia and analgesia","Aspirin; COVID-19; Hospital Mortality; Humans; Respiration, Artificial; Retrospective Studies; SARS-CoV-2","Chidambaram","Vignesh","Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland",NA
"2417","34257212","10.1213/ANE.0000000000005612","A Practical Guide for Anesthesia Providers in the Endoscopy Suite During the Coronavirus Disease 2019 Pandemic: Unmitigated Coughing and Aerosol Generation During Open-Face Endoscopies.",NA,"2021","07","21","Anesth Analg","Anesthesia and analgesia","Aerosols; Bronchoscopy; COVID-19; Cough; Endoscopy, Gastrointestinal; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Inhalation Exposure; Occupational Exposure; Occupational Health; Risk Assessment; Risk Factors; SARS-CoV-2","Gonzalez","René Miguel","Department of Anesthesiology, Southern Ocean Medical Center (Retired), Stafford Township, New Jersey, rgonzo12380@gmail","rgonzo12380@gmail.com"
"2418","34257184","10.1097/PHM.0000000000001807","Hospitalized Patients With COVID-19 and Neurological Complications Experience More Frequent Decline in Functioning and Greater Rehabilitation Needs.","The coronavirus disease 2019 has been reported to cause various serious neurological sequelae. However, there is little information available about the impact of the disease and its complications on patients' functional status and their postacute needs. Hence, this study was performed to address the current gap in knowledge about the function and postacute needs of those with neurological complications of coronavirus disease 2019. A prospective chart review was completed for 319 patients admitte","2021","07","15","Am J Phys Med Rehabil","American journal of physical medicine &amp; rehabilitation",NA,"Claflin","Edward S","From the Department of Physical Medicine and Rehabilitation, Michigan Medicine, Ann Arbor, Michigan (ESC, AKD, AB, JS, ER, CK, ALK)",NA
"2419","34257184","10.1097/PHM.0000000000001807","Hospitalized Patients With COVID-19 and Neurological Complications Experience More Frequent Decline in Functioning and Greater Rehabilitation Needs.","The coronavirus disease 2019 has been reported to cause various serious neurological sequelae. However, there is little information available about the impact of the disease and its complications on patients' functional status and their postacute needs. Hence, this study was performed to address the current gap in knowledge about the function and postacute needs of those with neurological complications of coronavirus disease 2019. A prospective chart review was completed for 319 patients admitte","2021","07","15","Am J Phys Med Rehabil","American journal of physical medicine &amp; rehabilitation",NA,"Daunter","Alecia K","From the Department of Physical Medicine and Rehabilitation, Michigan Medicine, Ann Arbor, Michigan (ESC, AKD, AB, JS, ER, CK, ALK)",NA
"2420","34257184","10.1097/PHM.0000000000001807","Hospitalized Patients With COVID-19 and Neurological Complications Experience More Frequent Decline in Functioning and Greater Rehabilitation Needs.","The coronavirus disease 2019 has been reported to cause various serious neurological sequelae. However, there is little information available about the impact of the disease and its complications on patients' functional status and their postacute needs. Hence, this study was performed to address the current gap in knowledge about the function and postacute needs of those with neurological complications of coronavirus disease 2019. A prospective chart review was completed for 319 patients admitte","2021","07","15","Am J Phys Med Rehabil","American journal of physical medicine &amp; rehabilitation",NA,"Bowman","Angeline","From the Department of Physical Medicine and Rehabilitation, Michigan Medicine, Ann Arbor, Michigan (ESC, AKD, AB, JS, ER, CK, ALK)",NA
"2421","34257184","10.1097/PHM.0000000000001807","Hospitalized Patients With COVID-19 and Neurological Complications Experience More Frequent Decline in Functioning and Greater Rehabilitation Needs.","The coronavirus disease 2019 has been reported to cause various serious neurological sequelae. However, there is little information available about the impact of the disease and its complications on patients' functional status and their postacute needs. Hence, this study was performed to address the current gap in knowledge about the function and postacute needs of those with neurological complications of coronavirus disease 2019. A prospective chart review was completed for 319 patients admitte","2021","07","15","Am J Phys Med Rehabil","American journal of physical medicine &amp; rehabilitation",NA,"Startup","Joshua","From the Department of Physical Medicine and Rehabilitation, Michigan Medicine, Ann Arbor, Michigan (ESC, AKD, AB, JS, ER, CK, ALK)",NA
"2422","34257184","10.1097/PHM.0000000000001807","Hospitalized Patients With COVID-19 and Neurological Complications Experience More Frequent Decline in Functioning and Greater Rehabilitation Needs.","The coronavirus disease 2019 has been reported to cause various serious neurological sequelae. However, there is little information available about the impact of the disease and its complications on patients' functional status and their postacute needs. Hence, this study was performed to address the current gap in knowledge about the function and postacute needs of those with neurological complications of coronavirus disease 2019. A prospective chart review was completed for 319 patients admitte","2021","07","15","Am J Phys Med Rehabil","American journal of physical medicine &amp; rehabilitation",NA,"Reed","Eboni","From the Department of Physical Medicine and Rehabilitation, Michigan Medicine, Ann Arbor, Michigan (ESC, AKD, AB, JS, ER, CK, ALK)",NA
"2423","34257184","10.1097/PHM.0000000000001807","Hospitalized Patients With COVID-19 and Neurological Complications Experience More Frequent Decline in Functioning and Greater Rehabilitation Needs.","The coronavirus disease 2019 has been reported to cause various serious neurological sequelae. However, there is little information available about the impact of the disease and its complications on patients' functional status and their postacute needs. Hence, this study was performed to address the current gap in knowledge about the function and postacute needs of those with neurological complications of coronavirus disease 2019. A prospective chart review was completed for 319 patients admitte","2021","07","15","Am J Phys Med Rehabil","American journal of physical medicine &amp; rehabilitation",NA,"Krishnan","Chandramouli","From the Department of Physical Medicine and Rehabilitation, Michigan Medicine, Ann Arbor, Michigan (ESC, AKD, AB, JS, ER, CK, ALK)",NA
"2424","34257184","10.1097/PHM.0000000000001807","Hospitalized Patients With COVID-19 and Neurological Complications Experience More Frequent Decline in Functioning and Greater Rehabilitation Needs.","The coronavirus disease 2019 has been reported to cause various serious neurological sequelae. However, there is little information available about the impact of the disease and its complications on patients' functional status and their postacute needs. Hence, this study was performed to address the current gap in knowledge about the function and postacute needs of those with neurological complications of coronavirus disease 2019. A prospective chart review was completed for 319 patients admitte","2021","07","15","Am J Phys Med Rehabil","American journal of physical medicine &amp; rehabilitation",NA,"Kratz","Anna L","From the Department of Physical Medicine and Rehabilitation, Michigan Medicine, Ann Arbor, Michigan (ESC, AKD, AB, JS, ER, CK, ALK)",NA
"2425","34257144","10.1126/scitranslmed.abi8452","A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.","The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies in the serum of an individual indicates prior infection or vaccination. However, it provides limited insight into the protective nature of this immune response. Neutralizing antibodies recognizing the viral spike protein are more revealing, yet their measurement traditionally requires virus- and cell-based systems that are costly, time-consuming, inflexible, and potentially biohazardous. Here, we pr","2021","07","14","Sci Transl Med","Science translational medicine",NA,"Fenwick","Craig","Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland",NA
"2426","34257144","10.1126/scitranslmed.abi8452","A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.","The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies in the serum of an individual indicates prior infection or vaccination. However, it provides limited insight into the protective nature of this immune response. Neutralizing antibodies recognizing the viral spike protein are more revealing, yet their measurement traditionally requires virus- and cell-based systems that are costly, time-consuming, inflexible, and potentially biohazardous. Here, we pr","2021","07","14","Sci Transl Med","Science translational medicine",NA,"Turelli","Priscilla","School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland",NA
"2427","34257144","10.1126/scitranslmed.abi8452","A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.","The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies in the serum of an individual indicates prior infection or vaccination. However, it provides limited insight into the protective nature of this immune response. Neutralizing antibodies recognizing the viral spike protein are more revealing, yet their measurement traditionally requires virus- and cell-based systems that are costly, time-consuming, inflexible, and potentially biohazardous. Here, we pr","2021","07","14","Sci Transl Med","Science translational medicine",NA,"Pellaton","Céline","Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland",NA
"2428","34257144","10.1126/scitranslmed.abi8452","A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.","The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies in the serum of an individual indicates prior infection or vaccination. However, it provides limited insight into the protective nature of this immune response. Neutralizing antibodies recognizing the viral spike protein are more revealing, yet their measurement traditionally requires virus- and cell-based systems that are costly, time-consuming, inflexible, and potentially biohazardous. Here, we pr","2021","07","14","Sci Transl Med","Science translational medicine",NA,"Farina","Alex","Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland",NA
"2429","34257144","10.1126/scitranslmed.abi8452","A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.","The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies in the serum of an individual indicates prior infection or vaccination. However, it provides limited insight into the protective nature of this immune response. Neutralizing antibodies recognizing the viral spike protein are more revealing, yet their measurement traditionally requires virus- and cell-based systems that are costly, time-consuming, inflexible, and potentially biohazardous. Here, we pr","2021","07","14","Sci Transl Med","Science translational medicine",NA,"Campos","Jérémy","Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland",NA
"2430","34257144","10.1126/scitranslmed.abi8452","A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.","The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies in the serum of an individual indicates prior infection or vaccination. However, it provides limited insight into the protective nature of this immune response. Neutralizing antibodies recognizing the viral spike protein are more revealing, yet their measurement traditionally requires virus- and cell-based systems that are costly, time-consuming, inflexible, and potentially biohazardous. Here, we pr","2021","07","14","Sci Transl Med","Science translational medicine",NA,"Raclot","Charlène","School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland",NA
"2431","34257144","10.1126/scitranslmed.abi8452","A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.","The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies in the serum of an individual indicates prior infection or vaccination. However, it provides limited insight into the protective nature of this immune response. Neutralizing antibodies recognizing the viral spike protein are more revealing, yet their measurement traditionally requires virus- and cell-based systems that are costly, time-consuming, inflexible, and potentially biohazardous. Here, we pr","2021","07","14","Sci Transl Med","Science translational medicine",NA,"Pojer","Florence","School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland",NA
"2432","34257144","10.1126/scitranslmed.abi8452","A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.","The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies in the serum of an individual indicates prior infection or vaccination. However, it provides limited insight into the protective nature of this immune response. Neutralizing antibodies recognizing the viral spike protein are more revealing, yet their measurement traditionally requires virus- and cell-based systems that are costly, time-consuming, inflexible, and potentially biohazardous. Here, we pr","2021","07","14","Sci Transl Med","Science translational medicine",NA,"Cagno","Valeria","Department of Microbiology and Molecular Medicine, University of Geneva, 1211 Geneva, Switzerland",NA
"2433","34257144","10.1126/scitranslmed.abi8452","A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.","The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies in the serum of an individual indicates prior infection or vaccination. However, it provides limited insight into the protective nature of this immune response. Neutralizing antibodies recognizing the viral spike protein are more revealing, yet their measurement traditionally requires virus- and cell-based systems that are costly, time-consuming, inflexible, and potentially biohazardous. Here, we pr","2021","07","14","Sci Transl Med","Science translational medicine",NA,"Nusslé","Semira Gonseth","Centre for Primary Care and Public Health, University of Lausanne, 1011 Lausanne, Switzerland",NA
"2434","34257144","10.1126/scitranslmed.abi8452","A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.","The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies in the serum of an individual indicates prior infection or vaccination. However, it provides limited insight into the protective nature of this immune response. Neutralizing antibodies recognizing the viral spike protein are more revealing, yet their measurement traditionally requires virus- and cell-based systems that are costly, time-consuming, inflexible, and potentially biohazardous. Here, we pr","2021","07","14","Sci Transl Med","Science translational medicine",NA,"D'Acremont","Valerie","Centre for Primary Care and Public Health, University of Lausanne, 1011 Lausanne, Switzerland",NA
"2435","34257144","10.1126/scitranslmed.abi8452","A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.","The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies in the serum of an individual indicates prior infection or vaccination. However, it provides limited insight into the protective nature of this immune response. Neutralizing antibodies recognizing the viral spike protein are more revealing, yet their measurement traditionally requires virus- and cell-based systems that are costly, time-consuming, inflexible, and potentially biohazardous. Here, we pr","2021","07","14","Sci Transl Med","Science translational medicine",NA,"Fehr","Jan","University of Zurich, Epidemiology, Biostatistics and Prevention Institute, 8001 Zurich, Switzerland",NA
"2436","34257144","10.1126/scitranslmed.abi8452","A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.","The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies in the serum of an individual indicates prior infection or vaccination. However, it provides limited insight into the protective nature of this immune response. Neutralizing antibodies recognizing the viral spike protein are more revealing, yet their measurement traditionally requires virus- and cell-based systems that are costly, time-consuming, inflexible, and potentially biohazardous. Here, we pr","2021","07","14","Sci Transl Med","Science translational medicine",NA,"Puhan","Milo","University of Zurich, Epidemiology, Biostatistics and Prevention Institute, 8001 Zurich, Switzerland",NA
"2437","34257144","10.1126/scitranslmed.abi8452","A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.","The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies in the serum of an individual indicates prior infection or vaccination. However, it provides limited insight into the protective nature of this immune response. Neutralizing antibodies recognizing the viral spike protein are more revealing, yet their measurement traditionally requires virus- and cell-based systems that are costly, time-consuming, inflexible, and potentially biohazardous. Here, we pr","2021","07","14","Sci Transl Med","Science translational medicine",NA,"Pantaleo","Giuseppe","Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland. didier.trono@epfl.ch giuseppe.pantaleo@chuv","didier.trono@epfl.ch"
"2438","34257144","10.1126/scitranslmed.abi8452","A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.","The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies in the serum of an individual indicates prior infection or vaccination. However, it provides limited insight into the protective nature of this immune response. Neutralizing antibodies recognizing the viral spike protein are more revealing, yet their measurement traditionally requires virus- and cell-based systems that are costly, time-consuming, inflexible, and potentially biohazardous. Here, we pr","2021","07","14","Sci Transl Med","Science translational medicine",NA,"Trono","Didier","School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland. didier.trono@epfl.ch giuseppe.pantaleo@chuv","didier.trono@epfl.ch"
"2439","34257140","10.1136/bmjgh-2021-006731","Informal collectives and access to healthcare during India's COVID-19 second wave crisis.",NA,"2021","07","16","BMJ Glob Health","BMJ global health","COVID-19; health systems; public health; COVID-19; Delivery of Health Care; Humans; India; Public Health; SARS-CoV-2","Faruqui","Neha","School of Public Health, University of Sydney, Sydney, New South Wales, Australia",NA
"2440","34257140","10.1136/bmjgh-2021-006731","Informal collectives and access to healthcare during India's COVID-19 second wave crisis.",NA,"2021","07","16","BMJ Glob Health","BMJ global health","COVID-19; health systems; public health; COVID-19; Delivery of Health Care; Humans; India; Public Health; SARS-CoV-2","Raman","V R","Public Health Resource Network, New Delhi, India weareraman@phrnindia","weareraman@phrnindia.org"
"2441","34257140","10.1136/bmjgh-2021-006731","Informal collectives and access to healthcare during India's COVID-19 second wave crisis.",NA,"2021","07","16","BMJ Glob Health","BMJ global health","COVID-19; health systems; public health; COVID-19; Delivery of Health Care; Humans; India; Public Health; SARS-CoV-2","Shiv","Jeevika","Social Worker and Lawyer, New Delhi, India",NA
"2442","34257140","10.1136/bmjgh-2021-006731","Informal collectives and access to healthcare during India's COVID-19 second wave crisis.",NA,"2021","07","16","BMJ Glob Health","BMJ global health","COVID-19; health systems; public health; COVID-19; Delivery of Health Care; Humans; India; Public Health; SARS-CoV-2","Chaturvedi","Sonam","OP Jindal Global University, Sonipat, Haryana, India",NA
"2443","34257140","10.1136/bmjgh-2021-006731","Informal collectives and access to healthcare during India's COVID-19 second wave crisis.",NA,"2021","07","16","BMJ Glob Health","BMJ global health","COVID-19; health systems; public health; COVID-19; Delivery of Health Care; Humans; India; Public Health; SARS-CoV-2","Muzumdar","Maitree","Independent Filmmaker and Lawyer, Gujarat, India",NA
"2444","34257140","10.1136/bmjgh-2021-006731","Informal collectives and access to healthcare during India's COVID-19 second wave crisis.",NA,"2021","07","16","BMJ Glob Health","BMJ global health","COVID-19; health systems; public health; COVID-19; Delivery of Health Care; Humans; India; Public Health; SARS-CoV-2","Prasad","Vandana","Public Health Resource Network, Noida, Uttar Pradesh, India",NA
"2445","34257135","10.1136/bcr-2021-244507","COVID-19: a confirmed case of reinfection in a nurse.","We describe the case of a 63-year-old man who is reported to have the first confirmed case of COVID-19 reinfection in Campania Region, Italy. We found that the two episodes were caused by virus strains with clearly different genome sequences. The patient, a retired nurse, had a very low level of antibodies IgG directed against the spike protein 14 days after his first Pfizer/BioNTek vaccine shot.","2021","07","15","BMJ Case Rep","BMJ case reports","COVID-19; adult intensive care; immunological products and vaccines; pneumonia (infectious disease); COVID-19; Humans; Immunoglobulin G; Italy; Male; Middle Aged; Reinfection; SARS-CoV-2","Scarpati","Giuliana","Università degli Studi di Salerno, Dipartimento di Medicina, Chirurgia, Odontoiatria ""Scuola Medica Salernitana"", Baronissi, Baronissi (SA), Italy",NA
"2446","34257135","10.1136/bcr-2021-244507","COVID-19: a confirmed case of reinfection in a nurse.","We describe the case of a 63-year-old man who is reported to have the first confirmed case of COVID-19 reinfection in Campania Region, Italy. We found that the two episodes were caused by virus strains with clearly different genome sequences. The patient, a retired nurse, had a very low level of antibodies IgG directed against the spike protein 14 days after his first Pfizer/BioNTek vaccine shot.","2021","07","15","BMJ Case Rep","BMJ case reports","COVID-19; adult intensive care; immunological products and vaccines; pneumonia (infectious disease); COVID-19; Humans; Immunoglobulin G; Italy; Male; Middle Aged; Reinfection; SARS-CoV-2","Piazza","Ornella","Università degli Studi di Salerno, Dipartimento di Medicina, Chirurgia, Odontoiatria ""Scuola Medica Salernitana"", Baronissi, Baronissi (SA), Italy opiazza@unisa","opiazza@unisa.it"
"2447","34257135","10.1136/bcr-2021-244507","COVID-19: a confirmed case of reinfection in a nurse.","We describe the case of a 63-year-old man who is reported to have the first confirmed case of COVID-19 reinfection in Campania Region, Italy. We found that the two episodes were caused by virus strains with clearly different genome sequences. The patient, a retired nurse, had a very low level of antibodies IgG directed against the spike protein 14 days after his first Pfizer/BioNTek vaccine shot.","2021","07","15","BMJ Case Rep","BMJ case reports","COVID-19; adult intensive care; immunological products and vaccines; pneumonia (infectious disease); COVID-19; Humans; Immunoglobulin G; Italy; Male; Middle Aged; Reinfection; SARS-CoV-2","Pagliano","Pasquale","Università degli Studi di Salerno, Dipartimento di Medicina, Chirurgia, Odontoiatria ""Scuola Medica Salernitana"", Baronissi, Baronissi (SA), Italy",NA
"2448","34257135","10.1136/bcr-2021-244507","COVID-19: a confirmed case of reinfection in a nurse.","We describe the case of a 63-year-old man who is reported to have the first confirmed case of COVID-19 reinfection in Campania Region, Italy. We found that the two episodes were caused by virus strains with clearly different genome sequences. The patient, a retired nurse, had a very low level of antibodies IgG directed against the spike protein 14 days after his first Pfizer/BioNTek vaccine shot.","2021","07","15","BMJ Case Rep","BMJ case reports","COVID-19; adult intensive care; immunological products and vaccines; pneumonia (infectious disease); COVID-19; Humans; Immunoglobulin G; Italy; Male; Middle Aged; Reinfection; SARS-CoV-2","Rizzo","Francesca","Università degli Studi di Salerno, Dipartimento di Medicina, Chirurgia, Odontoiatria ""Scuola Medica Salernitana"", Baronissi, Baronissi (SA), Italy",NA
"2449","34257129","10.1136/bcr-2021-243894","Thrombosis and thrombocytopaenia after ChAdOx1 nCoV-19 vaccination: a single UK centre experience.","We report clinical findings of three patients presenting with thrombosis and thrombocytopaenia 10-16 days following the first dose of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2. All patients presented to a major university teaching hospital in the UK over a 5-day period and were found to have high-titre antibodies against platelet factor 4 (PF4) without previous exposure to heparin. All three patients presented with extensive venous thrombosis, significant thrombocytopaenia, elevated D-dimer","2021","07","15","BMJ Case Rep","BMJ case reports","vaccination/immunisation; venous thromboembolism; COVID-19; COVID-19 Vaccines; Humans; SARS-CoV-2; Thrombocytopenia; Thrombosis; United Kingdom; Vaccination","Bano","Fehmida","Haematology, University Hospitals of North Staffordshire NHS Trust, Stoke-on-Trent, UK fehmida.bano@uhnm.nhs","fehmida.bano@uhnm.nhs.uk"
"2450","34257129","10.1136/bcr-2021-243894","Thrombosis and thrombocytopaenia after ChAdOx1 nCoV-19 vaccination: a single UK centre experience.","We report clinical findings of three patients presenting with thrombosis and thrombocytopaenia 10-16 days following the first dose of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2. All patients presented to a major university teaching hospital in the UK over a 5-day period and were found to have high-titre antibodies against platelet factor 4 (PF4) without previous exposure to heparin. All three patients presented with extensive venous thrombosis, significant thrombocytopaenia, elevated D-dimer","2021","07","15","BMJ Case Rep","BMJ case reports","vaccination/immunisation; venous thromboembolism; COVID-19; COVID-19 Vaccines; Humans; SARS-CoV-2; Thrombocytopenia; Thrombosis; United Kingdom; Vaccination","Badugama","Buddikha","Haematology, University Hospitals of North Staffordshire NHS Trust, Stoke-on-Trent, UK",NA
"2451","34257129","10.1136/bcr-2021-243894","Thrombosis and thrombocytopaenia after ChAdOx1 nCoV-19 vaccination: a single UK centre experience.","We report clinical findings of three patients presenting with thrombosis and thrombocytopaenia 10-16 days following the first dose of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2. All patients presented to a major university teaching hospital in the UK over a 5-day period and were found to have high-titre antibodies against platelet factor 4 (PF4) without previous exposure to heparin. All three patients presented with extensive venous thrombosis, significant thrombocytopaenia, elevated D-dimer","2021","07","15","BMJ Case Rep","BMJ case reports","vaccination/immunisation; venous thromboembolism; COVID-19; COVID-19 Vaccines; Humans; SARS-CoV-2; Thrombocytopenia; Thrombosis; United Kingdom; Vaccination","Chandra","Deepak","Haematology, University Hospitals of North Staffordshire NHS Trust, Stoke-on-Trent, UK",NA
"2452","34257116","10.1136/bcr-2021-242632","Brugada pattern in an afebrile patient with acute COVID-19.","COVID-19 has been associated with significant risk for cardiac arrhythmias, particularly in patients with underlying cardiac conditions or prior histories of arrhythmia. It has been shown that a Brugada pattern can be unmasked in febrile patients with COVID-19. Herein we report a unique case of an afebrile patient without known prior history of Brugada presenting with Brugada pattern on ECG.","2021","07","15","BMJ Case Rep","BMJ case reports","COVID-19; arrhythmias; Arrhythmias, Cardiac; Brugada Syndrome; COVID-19; Electrocardiography; Humans; SARS-CoV-2","Adedeji","Omowunmi M","Internal Medicine, The George Washington University Hospital, Washington, DC, USA oadedeji@mfa.gwu","oadedeji@mfa.gwu.edu"
"2453","34257116","10.1136/bcr-2021-242632","Brugada pattern in an afebrile patient with acute COVID-19.","COVID-19 has been associated with significant risk for cardiac arrhythmias, particularly in patients with underlying cardiac conditions or prior histories of arrhythmia. It has been shown that a Brugada pattern can be unmasked in febrile patients with COVID-19. Herein we report a unique case of an afebrile patient without known prior history of Brugada presenting with Brugada pattern on ECG.","2021","07","15","BMJ Case Rep","BMJ case reports","COVID-19; arrhythmias; Arrhythmias, Cardiac; Brugada Syndrome; COVID-19; Electrocardiography; Humans; SARS-CoV-2","Falk","Zachary","Internal Medicine, The George Washington University Hospital, Washington, DC, USA",NA
"2454","34257116","10.1136/bcr-2021-242632","Brugada pattern in an afebrile patient with acute COVID-19.","COVID-19 has been associated with significant risk for cardiac arrhythmias, particularly in patients with underlying cardiac conditions or prior histories of arrhythmia. It has been shown that a Brugada pattern can be unmasked in febrile patients with COVID-19. Herein we report a unique case of an afebrile patient without known prior history of Brugada presenting with Brugada pattern on ECG.","2021","07","15","BMJ Case Rep","BMJ case reports","COVID-19; arrhythmias; Arrhythmias, Cardiac; Brugada Syndrome; COVID-19; Electrocardiography; Humans; SARS-CoV-2","Tracy","Cynthia M","Cardiology, The George Washington University Hospital, Washington, DC, USA",NA
"2455","34257116","10.1136/bcr-2021-242632","Brugada pattern in an afebrile patient with acute COVID-19.","COVID-19 has been associated with significant risk for cardiac arrhythmias, particularly in patients with underlying cardiac conditions or prior histories of arrhythmia. It has been shown that a Brugada pattern can be unmasked in febrile patients with COVID-19. Herein we report a unique case of an afebrile patient without known prior history of Brugada presenting with Brugada pattern on ECG.","2021","07","15","BMJ Case Rep","BMJ case reports","COVID-19; arrhythmias; Arrhythmias, Cardiac; Brugada Syndrome; COVID-19; Electrocardiography; Humans; SARS-CoV-2","Batarseh","Alberto","Internal Medicine, The George Washington University Hospital, Washington, DC, USA",NA
"2456","34257109","10.1136/bcr-2020-240581","Coinfection of SARS-CoV-2 and MTB: how not to miss the wood for the trees.","Scarce data exist about the coinfection of SARS-CoV-2 and Mycobacterium tuberculosis (MTB). A young woman who was undergoing treatment for multiple sclerosis was brought to our hospital with a COVID-19 positive status. On further evaluation, her chest X-ray showed right upper and mid-zone opacity, which lead to the suspicion of MTB. Her sputum came positive for acid-fast bacilli (AFB) staining and cartridge-based nucleic acid amplification test (CBNAAT) confirmed it, and rifampicin resist","2021","07","15","BMJ Case Rep","BMJ case reports","COVID-19; tuberculosis; COVID-19; Coinfection; Female; Humans; Mycobacterium tuberculosis; SARS-CoV-2; Sensitivity and Specificity; Sputum; Tuberculosis, Pulmonary","Jacob","Jeny","General Medicine, KS Hegde Medical Academy, Mangalore, Karnataka, India",NA
"2457","34257109","10.1136/bcr-2020-240581","Coinfection of SARS-CoV-2 and MTB: how not to miss the wood for the trees.","Scarce data exist about the coinfection of SARS-CoV-2 and Mycobacterium tuberculosis (MTB). A young woman who was undergoing treatment for multiple sclerosis was brought to our hospital with a COVID-19 positive status. On further evaluation, her chest X-ray showed right upper and mid-zone opacity, which lead to the suspicion of MTB. Her sputum came positive for acid-fast bacilli (AFB) staining and cartridge-based nucleic acid amplification test (CBNAAT) confirmed it, and rifampicin resist","2021","07","15","BMJ Case Rep","BMJ case reports","COVID-19; tuberculosis; COVID-19; Coinfection; Female; Humans; Mycobacterium tuberculosis; SARS-CoV-2; Sensitivity and Specificity; Sputum; Tuberculosis, Pulmonary","Venkataram","Rajesh","Department of Pulmonary Medicine, KS Hegde Medical Academy, Mangalore, Karnataka, India rajdocmmc@gmail","rajdocmmc@gmail.com"
"2458","34257109","10.1136/bcr-2020-240581","Coinfection of SARS-CoV-2 and MTB: how not to miss the wood for the trees.","Scarce data exist about the coinfection of SARS-CoV-2 and Mycobacterium tuberculosis (MTB). A young woman who was undergoing treatment for multiple sclerosis was brought to our hospital with a COVID-19 positive status. On further evaluation, her chest X-ray showed right upper and mid-zone opacity, which lead to the suspicion of MTB. Her sputum came positive for acid-fast bacilli (AFB) staining and cartridge-based nucleic acid amplification test (CBNAAT) confirmed it, and rifampicin resist","2021","07","15","BMJ Case Rep","BMJ case reports","COVID-19; tuberculosis; COVID-19; Coinfection; Female; Humans; Mycobacterium tuberculosis; SARS-CoV-2; Sensitivity and Specificity; Sputum; Tuberculosis, Pulmonary","Hosmane","Giridhar Belur","Pulmonary Medicine, KS Hegde Medical Academy, Mangalore, Karnataka, India",NA
"2459","34257103","10.1136/archdischild-2021-322156","Titres and neutralising capacity of SARS-CoV-2-specific antibodies in human milk: a systematic review.","Synthesise evidence on production of SARS-CoV-2 antibodies in human milk of individuals who had COVID-19, and antibodies' ability to neutralise SARS-CoV-2 infectivity. A systematic review of studies published from 1 December 2019 to 16 February 2021 without study design restrictions. Data were sourced from PubMed, MEDLINE, Embase, CNKI, CINAHL and WHO COVID-19 database. Search was also performed through reviewing references of selected articles, Google Scholar and preprint servers. Studies that ","2021","07","17","Arch Dis Child Fetal Neonatal Ed","Archives of disease in childhood. Fetal and neonatal edition","COVID-19; neonatology; virology","Low","Jia Ming","Neonatology, Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore",NA
"2460","34257103","10.1136/archdischild-2021-322156","Titres and neutralising capacity of SARS-CoV-2-specific antibodies in human milk: a systematic review.","Synthesise evidence on production of SARS-CoV-2 antibodies in human milk of individuals who had COVID-19, and antibodies' ability to neutralise SARS-CoV-2 infectivity. A systematic review of studies published from 1 December 2019 to 16 February 2021 without study design restrictions. Data were sourced from PubMed, MEDLINE, Embase, CNKI, CINAHL and WHO COVID-19 database. Search was also performed through reviewing references of selected articles, Google Scholar and preprint servers. Studies that ","2021","07","17","Arch Dis Child Fetal Neonatal Ed","Archives of disease in childhood. Fetal and neonatal edition","COVID-19; neonatology; virology","Low","Yue Wey","Yong Loo Lin School of Medicine, National University of Singapore, Singapore",NA
"2461","34257103","10.1136/archdischild-2021-322156","Titres and neutralising capacity of SARS-CoV-2-specific antibodies in human milk: a systematic review.","Synthesise evidence on production of SARS-CoV-2 antibodies in human milk of individuals who had COVID-19, and antibodies' ability to neutralise SARS-CoV-2 infectivity. A systematic review of studies published from 1 December 2019 to 16 February 2021 without study design restrictions. Data were sourced from PubMed, MEDLINE, Embase, CNKI, CINAHL and WHO COVID-19 database. Search was also performed through reviewing references of selected articles, Google Scholar and preprint servers. Studies that ","2021","07","17","Arch Dis Child Fetal Neonatal Ed","Archives of disease in childhood. Fetal and neonatal edition","COVID-19; neonatology; virology","Zhong","Youjia","Paediatrics, National University Singapore, Yong Loo Lin School of Medicine, Singapore",NA
"2462","34257103","10.1136/archdischild-2021-322156","Titres and neutralising capacity of SARS-CoV-2-specific antibodies in human milk: a systematic review.","Synthesise evidence on production of SARS-CoV-2 antibodies in human milk of individuals who had COVID-19, and antibodies' ability to neutralise SARS-CoV-2 infectivity. A systematic review of studies published from 1 December 2019 to 16 February 2021 without study design restrictions. Data were sourced from PubMed, MEDLINE, Embase, CNKI, CINAHL and WHO COVID-19 database. Search was also performed through reviewing references of selected articles, Google Scholar and preprint servers. Studies that ","2021","07","17","Arch Dis Child Fetal Neonatal Ed","Archives of disease in childhood. Fetal and neonatal edition","COVID-19; neonatology; virology","Lee","Cheuk Yiu Charlotte","Alice Lee Centre for Nursing Studies, National University of Singapore, Singapore",NA
"2463","34257103","10.1136/archdischild-2021-322156","Titres and neutralising capacity of SARS-CoV-2-specific antibodies in human milk: a systematic review.","Synthesise evidence on production of SARS-CoV-2 antibodies in human milk of individuals who had COVID-19, and antibodies' ability to neutralise SARS-CoV-2 infectivity. A systematic review of studies published from 1 December 2019 to 16 February 2021 without study design restrictions. Data were sourced from PubMed, MEDLINE, Embase, CNKI, CINAHL and WHO COVID-19 database. Search was also performed through reviewing references of selected articles, Google Scholar and preprint servers. Studies that ","2021","07","17","Arch Dis Child Fetal Neonatal Ed","Archives of disease in childhood. Fetal and neonatal edition","COVID-19; neonatology; virology","Chan","Ming","Alice Lee Centre for Nursing Studies, National University of Singapore, Singapore",NA
"2464","34257103","10.1136/archdischild-2021-322156","Titres and neutralising capacity of SARS-CoV-2-specific antibodies in human milk: a systematic review.","Synthesise evidence on production of SARS-CoV-2 antibodies in human milk of individuals who had COVID-19, and antibodies' ability to neutralise SARS-CoV-2 infectivity. A systematic review of studies published from 1 December 2019 to 16 February 2021 without study design restrictions. Data were sourced from PubMed, MEDLINE, Embase, CNKI, CINAHL and WHO COVID-19 database. Search was also performed through reviewing references of selected articles, Google Scholar and preprint servers. Studies that ","2021","07","17","Arch Dis Child Fetal Neonatal Ed","Archives of disease in childhood. Fetal and neonatal edition","COVID-19; neonatology; virology","Ng","Nicholas Beng Hui","Paediatrics, National University Singapore, Yong Loo Lin School of Medicine, Singapore",NA
"2465","34257103","10.1136/archdischild-2021-322156","Titres and neutralising capacity of SARS-CoV-2-specific antibodies in human milk: a systematic review.","Synthesise evidence on production of SARS-CoV-2 antibodies in human milk of individuals who had COVID-19, and antibodies' ability to neutralise SARS-CoV-2 infectivity. A systematic review of studies published from 1 December 2019 to 16 February 2021 without study design restrictions. Data were sourced from PubMed, MEDLINE, Embase, CNKI, CINAHL and WHO COVID-19 database. Search was also performed through reviewing references of selected articles, Google Scholar and preprint servers. Studies that ","2021","07","17","Arch Dis Child Fetal Neonatal Ed","Archives of disease in childhood. Fetal and neonatal edition","COVID-19; neonatology; virology","Amin","Zubair","Neonatology, Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore paeza@nus.edu","paeza@nus.edu.sg"
"2466","34257103","10.1136/archdischild-2021-322156","Titres and neutralising capacity of SARS-CoV-2-specific antibodies in human milk: a systematic review.","Synthesise evidence on production of SARS-CoV-2 antibodies in human milk of individuals who had COVID-19, and antibodies' ability to neutralise SARS-CoV-2 infectivity. A systematic review of studies published from 1 December 2019 to 16 February 2021 without study design restrictions. Data were sourced from PubMed, MEDLINE, Embase, CNKI, CINAHL and WHO COVID-19 database. Search was also performed through reviewing references of selected articles, Google Scholar and preprint servers. Studies that ","2021","07","17","Arch Dis Child Fetal Neonatal Ed","Archives of disease in childhood. Fetal and neonatal edition","COVID-19; neonatology; virology","Ng","Yvonne Peng Mei","Neonatology, Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore",NA
"2467","34257096","10.1136/bmjopen-2021-049703","National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates.","An initial report of findings from 1.14 million SARS CoV-2 serology tests in National Health Service (NHS) staff to compare NHS staff seroconversion with community seroconversion rates at a regional level. A national cross-sectional survey. A SARS-CoV-2 antibody testing programme offered across all NHS Trusts. 1.14 million NHS staff. SARS-CoV-2 antibody testing. SARS-CoV-2 antibody testing was used to estimate the seroprevalence of SARS-CoV-2 in NHS staff by region, compared with community serop","2021","07","16","BMJ Open","BMJ open","COVID-19; epidemiology; infectious diseases; public health; Antibodies, Viral; COVID-19; Cross-Sectional Studies; England; Health Personnel; Humans; SARS-CoV-2; Seroconversion; Seroepidemiologic Studies; State Medicine","Coltart","Cordelia E M","Institute for Global Health, University College London, London, UK aidan.fowler@dhsc.gov.uk cordelia.coltart@ucl.ac","aidan.fowler@dhsc.gov.uk"
"2468","34257096","10.1136/bmjopen-2021-049703","National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates.","An initial report of findings from 1.14 million SARS CoV-2 serology tests in National Health Service (NHS) staff to compare NHS staff seroconversion with community seroconversion rates at a regional level. A national cross-sectional survey. A SARS-CoV-2 antibody testing programme offered across all NHS Trusts. 1.14 million NHS staff. SARS-CoV-2 antibody testing. SARS-CoV-2 antibody testing was used to estimate the seroprevalence of SARS-CoV-2 in NHS staff by region, compared with community serop","2021","07","16","BMJ Open","BMJ open","COVID-19; epidemiology; infectious diseases; public health; Antibodies, Viral; COVID-19; Cross-Sectional Studies; England; Health Personnel; Humans; SARS-CoV-2; Seroconversion; Seroepidemiologic Studies; State Medicine","Wells","David","COVID-19 Testing cell, NHS England and NHS Improvement, London, UK",NA
"2469","34257096","10.1136/bmjopen-2021-049703","National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates.","An initial report of findings from 1.14 million SARS CoV-2 serology tests in National Health Service (NHS) staff to compare NHS staff seroconversion with community seroconversion rates at a regional level. A national cross-sectional survey. A SARS-CoV-2 antibody testing programme offered across all NHS Trusts. 1.14 million NHS staff. SARS-CoV-2 antibody testing. SARS-CoV-2 antibody testing was used to estimate the seroprevalence of SARS-CoV-2 in NHS staff by region, compared with community serop","2021","07","16","BMJ Open","BMJ open","COVID-19; epidemiology; infectious diseases; public health; Antibodies, Viral; COVID-19; Cross-Sectional Studies; England; Health Personnel; Humans; SARS-CoV-2; Seroconversion; Seroepidemiologic Studies; State Medicine","Sutherland","Esther","COVID-19 Infection Survey, Office for National Statistics, Newport, UK",NA
"2470","34257096","10.1136/bmjopen-2021-049703","National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates.","An initial report of findings from 1.14 million SARS CoV-2 serology tests in National Health Service (NHS) staff to compare NHS staff seroconversion with community seroconversion rates at a regional level. A national cross-sectional survey. A SARS-CoV-2 antibody testing programme offered across all NHS Trusts. 1.14 million NHS staff. SARS-CoV-2 antibody testing. SARS-CoV-2 antibody testing was used to estimate the seroprevalence of SARS-CoV-2 in NHS staff by region, compared with community serop","2021","07","16","BMJ Open","BMJ open","COVID-19; epidemiology; infectious diseases; public health; Antibodies, Viral; COVID-19; Cross-Sectional Studies; England; Health Personnel; Humans; SARS-CoV-2; Seroconversion; Seroepidemiologic Studies; State Medicine","Fowler","Aidan","Chief Medical Officer's Office, Department of Health and Social Care, London, UK aidan.fowler@dhsc.gov.uk cordelia.coltart@ucl.ac","aidan.fowler@dhsc.gov.uk"
"2471","34257095","10.1136/bmjopen-2021-049369","Intention to have the seasonal influenza vaccination during the COVID-19 pandemic among eligible adults in the UK: a cross-sectional survey.","To investigate the likelihood of having the seasonal influenza vaccination during the COVID-19 pandemic in individuals who were eligible to receive it. We conducted a cross-sectional online survey in July 2020. We included predictors informed by previous research, in the following categories: sociodemographic variables; uptake of influenza vaccine last winter and beliefs about vaccination. 570 participants (mean age: 53.07; 56.3% female, 87.0% white) who were eligible for the free seasonal influ","2021","07","16","BMJ Open","BMJ open","COVID-19; preventive medicine; public health; Adult; COVID-19; Cross-Sectional Studies; Female; Humans; Influenza Vaccines; Influenza, Human; Intention; Male; Middle Aged; Pandemics; SARS-CoV-2; Seasons; Surveys and Questionnaires; United Kingdom; Vaccination","Sherman","Susan M","School of Psychology, Keele University, Keele, UK s.m.sherman@keele.ac","s.m.sherman@keele.ac.uk"
"2472","34257095","10.1136/bmjopen-2021-049369","Intention to have the seasonal influenza vaccination during the COVID-19 pandemic among eligible adults in the UK: a cross-sectional survey.","To investigate the likelihood of having the seasonal influenza vaccination during the COVID-19 pandemic in individuals who were eligible to receive it. We conducted a cross-sectional online survey in July 2020. We included predictors informed by previous research, in the following categories: sociodemographic variables; uptake of influenza vaccine last winter and beliefs about vaccination. 570 participants (mean age: 53.07; 56.3% female, 87.0% white) who were eligible for the free seasonal influ","2021","07","16","BMJ Open","BMJ open","COVID-19; preventive medicine; public health; Adult; COVID-19; Cross-Sectional Studies; Female; Humans; Influenza Vaccines; Influenza, Human; Intention; Male; Middle Aged; Pandemics; SARS-CoV-2; Seasons; Surveys and Questionnaires; United Kingdom; Vaccination","Sim","Julius","School of Medicine, Keele University, Keele, UK",NA
"2473","34257095","10.1136/bmjopen-2021-049369","Intention to have the seasonal influenza vaccination during the COVID-19 pandemic among eligible adults in the UK: a cross-sectional survey.","To investigate the likelihood of having the seasonal influenza vaccination during the COVID-19 pandemic in individuals who were eligible to receive it. We conducted a cross-sectional online survey in July 2020. We included predictors informed by previous research, in the following categories: sociodemographic variables; uptake of influenza vaccine last winter and beliefs about vaccination. 570 participants (mean age: 53.07; 56.3% female, 87.0% white) who were eligible for the free seasonal influ","2021","07","16","BMJ Open","BMJ open","COVID-19; preventive medicine; public health; Adult; COVID-19; Cross-Sectional Studies; Female; Humans; Influenza Vaccines; Influenza, Human; Intention; Male; Middle Aged; Pandemics; SARS-CoV-2; Seasons; Surveys and Questionnaires; United Kingdom; Vaccination","Amlôt","Richard","NIHR Health Protection Research Unit in Emergency Preparedness and Response, King's College London, London, UK",NA
"2474","34257095","10.1136/bmjopen-2021-049369","Intention to have the seasonal influenza vaccination during the COVID-19 pandemic among eligible adults in the UK: a cross-sectional survey.","To investigate the likelihood of having the seasonal influenza vaccination during the COVID-19 pandemic in individuals who were eligible to receive it. We conducted a cross-sectional online survey in July 2020. We included predictors informed by previous research, in the following categories: sociodemographic variables; uptake of influenza vaccine last winter and beliefs about vaccination. 570 participants (mean age: 53.07; 56.3% female, 87.0% white) who were eligible for the free seasonal influ","2021","07","16","BMJ Open","BMJ open","COVID-19; preventive medicine; public health; Adult; COVID-19; Cross-Sectional Studies; Female; Humans; Influenza Vaccines; Influenza, Human; Intention; Male; Middle Aged; Pandemics; SARS-CoV-2; Seasons; Surveys and Questionnaires; United Kingdom; Vaccination","Cutts","Megan","School of Psychology, Keele University, Keele, UK",NA
"2475","34257095","10.1136/bmjopen-2021-049369","Intention to have the seasonal influenza vaccination during the COVID-19 pandemic among eligible adults in the UK: a cross-sectional survey.","To investigate the likelihood of having the seasonal influenza vaccination during the COVID-19 pandemic in individuals who were eligible to receive it. We conducted a cross-sectional online survey in July 2020. We included predictors informed by previous research, in the following categories: sociodemographic variables; uptake of influenza vaccine last winter and beliefs about vaccination. 570 participants (mean age: 53.07; 56.3% female, 87.0% white) who were eligible for the free seasonal influ","2021","07","16","BMJ Open","BMJ open","COVID-19; preventive medicine; public health; Adult; COVID-19; Cross-Sectional Studies; Female; Humans; Influenza Vaccines; Influenza, Human; Intention; Male; Middle Aged; Pandemics; SARS-CoV-2; Seasons; Surveys and Questionnaires; United Kingdom; Vaccination","Dasch","Hannah","Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK",NA
"2476","34257095","10.1136/bmjopen-2021-049369","Intention to have the seasonal influenza vaccination during the COVID-19 pandemic among eligible adults in the UK: a cross-sectional survey.","To investigate the likelihood of having the seasonal influenza vaccination during the COVID-19 pandemic in individuals who were eligible to receive it. We conducted a cross-sectional online survey in July 2020. We included predictors informed by previous research, in the following categories: sociodemographic variables; uptake of influenza vaccine last winter and beliefs about vaccination. 570 participants (mean age: 53.07; 56.3% female, 87.0% white) who were eligible for the free seasonal influ","2021","07","16","BMJ Open","BMJ open","COVID-19; preventive medicine; public health; Adult; COVID-19; Cross-Sectional Studies; Female; Humans; Influenza Vaccines; Influenza, Human; Intention; Male; Middle Aged; Pandemics; SARS-CoV-2; Seasons; Surveys and Questionnaires; United Kingdom; Vaccination","Rubin","G James","NIHR Health Protection Research Unit in Emergency Preparedness and Response, King's College London, London, UK",NA
"2477","34257095","10.1136/bmjopen-2021-049369","Intention to have the seasonal influenza vaccination during the COVID-19 pandemic among eligible adults in the UK: a cross-sectional survey.","To investigate the likelihood of having the seasonal influenza vaccination during the COVID-19 pandemic in individuals who were eligible to receive it. We conducted a cross-sectional online survey in July 2020. We included predictors informed by previous research, in the following categories: sociodemographic variables; uptake of influenza vaccine last winter and beliefs about vaccination. 570 participants (mean age: 53.07; 56.3% female, 87.0% white) who were eligible for the free seasonal influ","2021","07","16","BMJ Open","BMJ open","COVID-19; preventive medicine; public health; Adult; COVID-19; Cross-Sectional Studies; Female; Humans; Influenza Vaccines; Influenza, Human; Intention; Male; Middle Aged; Pandemics; SARS-CoV-2; Seasons; Surveys and Questionnaires; United Kingdom; Vaccination","Sevdalis","Nick","Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK",NA
"2478","34257095","10.1136/bmjopen-2021-049369","Intention to have the seasonal influenza vaccination during the COVID-19 pandemic among eligible adults in the UK: a cross-sectional survey.","To investigate the likelihood of having the seasonal influenza vaccination during the COVID-19 pandemic in individuals who were eligible to receive it. We conducted a cross-sectional online survey in July 2020. We included predictors informed by previous research, in the following categories: sociodemographic variables; uptake of influenza vaccine last winter and beliefs about vaccination. 570 participants (mean age: 53.07; 56.3% female, 87.0% white) who were eligible for the free seasonal influ","2021","07","16","BMJ Open","BMJ open","COVID-19; preventive medicine; public health; Adult; COVID-19; Cross-Sectional Studies; Female; Humans; Influenza Vaccines; Influenza, Human; Intention; Male; Middle Aged; Pandemics; SARS-CoV-2; Seasons; Surveys and Questionnaires; United Kingdom; Vaccination","Smith","Louise E","NIHR Health Protection Research Unit in Emergency Preparedness and Response, King's College London, London, UK",NA
"2479","34257092","10.1136/bmjopen-2020-046112","Are the rights of people with disabilities included in international guidance on WASH during the COVID-19 pandemic? Content analysis using EquiFrame.","People with disabilities are at increased risk from COVID-19. Access to water, sanitation and hygiene (WASH) services and facilities is a fundamental right for all, and is vital in stopping the transmission of COVID-19. However, people with disabilities often face difficulties accessing WASH. Various international organisations have published guidance and recommendations on WASH service provision during the COVID-19 pandemic, and this must include information of relevance to people with disabili","2021","07","16","BMJ Open","BMJ open","COVID-19; Health policy; international health services; public health; COVID-19; Disabled Persons; Humans; Hygiene; Pandemics; SARS-CoV-2; Sanitation; Water","Scherer","Nathaniel","Clinical Research Department, London School of Hygiene &amp","nathaniel.scherer@lshtm.ac.uk"
"2480","34257092","10.1136/bmjopen-2020-046112","Are the rights of people with disabilities included in international guidance on WASH during the COVID-19 pandemic? Content analysis using EquiFrame.","People with disabilities are at increased risk from COVID-19. Access to water, sanitation and hygiene (WASH) services and facilities is a fundamental right for all, and is vital in stopping the transmission of COVID-19. However, people with disabilities often face difficulties accessing WASH. Various international organisations have published guidance and recommendations on WASH service provision during the COVID-19 pandemic, and this must include information of relevance to people with disabili","2021","07","16","BMJ Open","BMJ open","COVID-19; Health policy; international health services; public health; COVID-19; Disabled Persons; Humans; Hygiene; Pandemics; SARS-CoV-2; Sanitation; Water","Mactaggart","Islay","Clinical Research Department, London School of Hygiene &amp",NA
"2481","34257092","10.1136/bmjopen-2020-046112","Are the rights of people with disabilities included in international guidance on WASH during the COVID-19 pandemic? Content analysis using EquiFrame.","People with disabilities are at increased risk from COVID-19. Access to water, sanitation and hygiene (WASH) services and facilities is a fundamental right for all, and is vital in stopping the transmission of COVID-19. However, people with disabilities often face difficulties accessing WASH. Various international organisations have published guidance and recommendations on WASH service provision during the COVID-19 pandemic, and this must include information of relevance to people with disabili","2021","07","16","BMJ Open","BMJ open","COVID-19; Health policy; international health services; public health; COVID-19; Disabled Persons; Humans; Hygiene; Pandemics; SARS-CoV-2; Sanitation; Water","Huggett","Chelsea","WaterAid Australia, Melbourne, Victoria, Australia",NA
"2482","34257092","10.1136/bmjopen-2020-046112","Are the rights of people with disabilities included in international guidance on WASH during the COVID-19 pandemic? Content analysis using EquiFrame.","People with disabilities are at increased risk from COVID-19. Access to water, sanitation and hygiene (WASH) services and facilities is a fundamental right for all, and is vital in stopping the transmission of COVID-19. However, people with disabilities often face difficulties accessing WASH. Various international organisations have published guidance and recommendations on WASH service provision during the COVID-19 pandemic, and this must include information of relevance to people with disabili","2021","07","16","BMJ Open","BMJ open","COVID-19; Health policy; international health services; public health; COVID-19; Disabled Persons; Humans; Hygiene; Pandemics; SARS-CoV-2; Sanitation; Water","Pheng","Pharozin","WaterAid Cambodia, Phnom Penh, Cambodia",NA
"2483","34257092","10.1136/bmjopen-2020-046112","Are the rights of people with disabilities included in international guidance on WASH during the COVID-19 pandemic? Content analysis using EquiFrame.","People with disabilities are at increased risk from COVID-19. Access to water, sanitation and hygiene (WASH) services and facilities is a fundamental right for all, and is vital in stopping the transmission of COVID-19. However, people with disabilities often face difficulties accessing WASH. Various international organisations have published guidance and recommendations on WASH service provision during the COVID-19 pandemic, and this must include information of relevance to people with disabili","2021","07","16","BMJ Open","BMJ open","COVID-19; Health policy; international health services; public health; COVID-19; Disabled Persons; Humans; Hygiene; Pandemics; SARS-CoV-2; Sanitation; Water","Rahman","Mahfuj-Ur","WaterAid Bangladesh, Dhaka, Bangladesh",NA
"2484","34257092","10.1136/bmjopen-2020-046112","Are the rights of people with disabilities included in international guidance on WASH during the COVID-19 pandemic? Content analysis using EquiFrame.","People with disabilities are at increased risk from COVID-19. Access to water, sanitation and hygiene (WASH) services and facilities is a fundamental right for all, and is vital in stopping the transmission of COVID-19. However, people with disabilities often face difficulties accessing WASH. Various international organisations have published guidance and recommendations on WASH service provision during the COVID-19 pandemic, and this must include information of relevance to people with disabili","2021","07","16","BMJ Open","BMJ open","COVID-19; Health policy; international health services; public health; COVID-19; Disabled Persons; Humans; Hygiene; Pandemics; SARS-CoV-2; Sanitation; Water","Wilbur","Jane","Clinical Research Department, London School of Hygiene &amp",NA
"2485","34257090","10.9778/cmajo.20200244","Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.","As in other jurisdictions, the demographics of people infected with SARS-CoV-2 changed in Quebec over the course of the first COVID-19 pandemic wave, and affected those living in residential care facilities (RCFs) disproportionately. We evaluated the association between clinical characteristics and outcomes of hospitalized patients with COVID-19, comparing those did or did not live in RCFs. We conducted a retrospective case series of all consecutive adults (= 18 yr) admitted to the Jewish Genera","2021","07","15","CMAJ Open","CMAJ open",NA,"Mah","Jordan","Faculty of Medicine (Mah, Lieu, M. Palayew, Alipour, Kong, Yang, Wilchesky, Lipes, Greenaway), McGill University",NA
"2486","34257090","10.9778/cmajo.20200244","Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.","As in other jurisdictions, the demographics of people infected with SARS-CoV-2 changed in Quebec over the course of the first COVID-19 pandemic wave, and affected those living in residential care facilities (RCFs) disproportionately. We evaluated the association between clinical characteristics and outcomes of hospitalized patients with COVID-19, comparing those did or did not live in RCFs. We conducted a retrospective case series of all consecutive adults (= 18 yr) admitted to the Jewish Genera","2021","07","15","CMAJ Open","CMAJ open",NA,"Lieu","Anthony","Faculty of Medicine (Mah, Lieu, M. Palayew, Alipour, Kong, Yang, Wilchesky, Lipes, Greenaway), McGill University",NA
"2487","34257090","10.9778/cmajo.20200244","Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.","As in other jurisdictions, the demographics of people infected with SARS-CoV-2 changed in Quebec over the course of the first COVID-19 pandemic wave, and affected those living in residential care facilities (RCFs) disproportionately. We evaluated the association between clinical characteristics and outcomes of hospitalized patients with COVID-19, comparing those did or did not live in RCFs. We conducted a retrospective case series of all consecutive adults (= 18 yr) admitted to the Jewish Genera","2021","07","15","CMAJ Open","CMAJ open",NA,"Palayew","Mark","Faculty of Medicine (Mah, Lieu, M. Palayew, Alipour, Kong, Yang, Wilchesky, Lipes, Greenaway), McGill University",NA
"2488","34257090","10.9778/cmajo.20200244","Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.","As in other jurisdictions, the demographics of people infected with SARS-CoV-2 changed in Quebec over the course of the first COVID-19 pandemic wave, and affected those living in residential care facilities (RCFs) disproportionately. We evaluated the association between clinical characteristics and outcomes of hospitalized patients with COVID-19, comparing those did or did not live in RCFs. We conducted a retrospective case series of all consecutive adults (= 18 yr) admitted to the Jewish Genera","2021","07","15","CMAJ Open","CMAJ open",NA,"Alipour","Pouria","Faculty of Medicine (Mah, Lieu, M. Palayew, Alipour, Kong, Yang, Wilchesky, Lipes, Greenaway), McGill University",NA
"2489","34257090","10.9778/cmajo.20200244","Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.","As in other jurisdictions, the demographics of people infected with SARS-CoV-2 changed in Quebec over the course of the first COVID-19 pandemic wave, and affected those living in residential care facilities (RCFs) disproportionately. We evaluated the association between clinical characteristics and outcomes of hospitalized patients with COVID-19, comparing those did or did not live in RCFs. We conducted a retrospective case series of all consecutive adults (= 18 yr) admitted to the Jewish Genera","2021","07","15","CMAJ Open","CMAJ open",NA,"Kong","Ling Yuan","Faculty of Medicine (Mah, Lieu, M. Palayew, Alipour, Kong, Yang, Wilchesky, Lipes, Greenaway), McGill University",NA
"2490","34257090","10.9778/cmajo.20200244","Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.","As in other jurisdictions, the demographics of people infected with SARS-CoV-2 changed in Quebec over the course of the first COVID-19 pandemic wave, and affected those living in residential care facilities (RCFs) disproportionately. We evaluated the association between clinical characteristics and outcomes of hospitalized patients with COVID-19, comparing those did or did not live in RCFs. We conducted a retrospective case series of all consecutive adults (= 18 yr) admitted to the Jewish Genera","2021","07","15","CMAJ Open","CMAJ open",NA,"Song","Sunny","Faculty of Medicine (Mah, Lieu, M. Palayew, Alipour, Kong, Yang, Wilchesky, Lipes, Greenaway), McGill University",NA
"2491","34257090","10.9778/cmajo.20200244","Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.","As in other jurisdictions, the demographics of people infected with SARS-CoV-2 changed in Quebec over the course of the first COVID-19 pandemic wave, and affected those living in residential care facilities (RCFs) disproportionately. We evaluated the association between clinical characteristics and outcomes of hospitalized patients with COVID-19, comparing those did or did not live in RCFs. We conducted a retrospective case series of all consecutive adults (= 18 yr) admitted to the Jewish Genera","2021","07","15","CMAJ Open","CMAJ open",NA,"Palayew","Adam","Faculty of Medicine (Mah, Lieu, M. Palayew, Alipour, Kong, Yang, Wilchesky, Lipes, Greenaway), McGill University",NA
"2492","34257090","10.9778/cmajo.20200244","Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.","As in other jurisdictions, the demographics of people infected with SARS-CoV-2 changed in Quebec over the course of the first COVID-19 pandemic wave, and affected those living in residential care facilities (RCFs) disproportionately. We evaluated the association between clinical characteristics and outcomes of hospitalized patients with COVID-19, comparing those did or did not live in RCFs. We conducted a retrospective case series of all consecutive adults (= 18 yr) admitted to the Jewish Genera","2021","07","15","CMAJ Open","CMAJ open",NA,"Tutt-Guérette","Marc Antoine","Faculty of Medicine (Mah, Lieu, M. Palayew, Alipour, Kong, Yang, Wilchesky, Lipes, Greenaway), McGill University",NA
"2493","34257090","10.9778/cmajo.20200244","Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.","As in other jurisdictions, the demographics of people infected with SARS-CoV-2 changed in Quebec over the course of the first COVID-19 pandemic wave, and affected those living in residential care facilities (RCFs) disproportionately. We evaluated the association between clinical characteristics and outcomes of hospitalized patients with COVID-19, comparing those did or did not live in RCFs. We conducted a retrospective case series of all consecutive adults (= 18 yr) admitted to the Jewish Genera","2021","07","15","CMAJ Open","CMAJ open",NA,"Yang","Stephen Su","Faculty of Medicine (Mah, Lieu, M. Palayew, Alipour, Kong, Yang, Wilchesky, Lipes, Greenaway), McGill University",NA
"2494","34257090","10.9778/cmajo.20200244","Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.","As in other jurisdictions, the demographics of people infected with SARS-CoV-2 changed in Quebec over the course of the first COVID-19 pandemic wave, and affected those living in residential care facilities (RCFs) disproportionately. We evaluated the association between clinical characteristics and outcomes of hospitalized patients with COVID-19, comparing those did or did not live in RCFs. We conducted a retrospective case series of all consecutive adults (= 18 yr) admitted to the Jewish Genera","2021","07","15","CMAJ Open","CMAJ open",NA,"Wilchesky","Machelle","Faculty of Medicine (Mah, Lieu, M. Palayew, Alipour, Kong, Yang, Wilchesky, Lipes, Greenaway), McGill University",NA
"2495","34257090","10.9778/cmajo.20200244","Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.","As in other jurisdictions, the demographics of people infected with SARS-CoV-2 changed in Quebec over the course of the first COVID-19 pandemic wave, and affected those living in residential care facilities (RCFs) disproportionately. We evaluated the association between clinical characteristics and outcomes of hospitalized patients with COVID-19, comparing those did or did not live in RCFs. We conducted a retrospective case series of all consecutive adults (= 18 yr) admitted to the Jewish Genera","2021","07","15","CMAJ Open","CMAJ open",NA,"Lipes","Jed","Faculty of Medicine (Mah, Lieu, M. Palayew, Alipour, Kong, Yang, Wilchesky, Lipes, Greenaway), McGill University",NA
"2496","34257090","10.9778/cmajo.20200244","Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.","As in other jurisdictions, the demographics of people infected with SARS-CoV-2 changed in Quebec over the course of the first COVID-19 pandemic wave, and affected those living in residential care facilities (RCFs) disproportionately. We evaluated the association between clinical characteristics and outcomes of hospitalized patients with COVID-19, comparing those did or did not live in RCFs. We conducted a retrospective case series of all consecutive adults (= 18 yr) admitted to the Jewish Genera","2021","07","15","CMAJ Open","CMAJ open",NA,"Azoulay","Laurent","Faculty of Medicine (Mah, Lieu, M. Palayew, Alipour, Kong, Yang, Wilchesky, Lipes, Greenaway), McGill University",NA
"2497","34257090","10.9778/cmajo.20200244","Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.","As in other jurisdictions, the demographics of people infected with SARS-CoV-2 changed in Quebec over the course of the first COVID-19 pandemic wave, and affected those living in residential care facilities (RCFs) disproportionately. We evaluated the association between clinical characteristics and outcomes of hospitalized patients with COVID-19, comparing those did or did not live in RCFs. We conducted a retrospective case series of all consecutive adults (= 18 yr) admitted to the Jewish Genera","2021","07","15","CMAJ Open","CMAJ open",NA,"Greenaway","Christina","Faculty of Medicine (Mah, Lieu, M. Palayew, Alipour, Kong, Yang, Wilchesky, Lipes, Greenaway), McGill University","ca.greenaway@mcgill.ca"
"2498","34257067","10.3399/BJGPO.2021.0036","Maintaining face-to-face contact during the COVID-19 pandemic: a longitudinal qualitative investigation in UK primary care.","In March 2020 the COVID-19 pandemic required a rapid reconfiguration of UK general practice to minimise face-to-face contact with patients to reduce infection risk. However, some face-to-face contact remained necessary and practices needed to ensure such contact could continue safely. To examine how practices determined when face-to-face contact was necessary and how face-to-face consultations were reconfigured to reduce COVID-19 infection risk. Qualitative interview study in general practices i","2021","07","14","BJGP Open","BJGP open","COVID-19; consultations; face-to-face consulting; general practitioners","Turner","Andrew","National Institute for Health Research Applied Research Collaboration West (NIHR ARC West), University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK andrew.turner@bristol.ac","andrew.turner@bristol.ac.uk"
"2499","34257067","10.3399/BJGPO.2021.0036","Maintaining face-to-face contact during the COVID-19 pandemic: a longitudinal qualitative investigation in UK primary care.","In March 2020 the COVID-19 pandemic required a rapid reconfiguration of UK general practice to minimise face-to-face contact with patients to reduce infection risk. However, some face-to-face contact remained necessary and practices needed to ensure such contact could continue safely. To examine how practices determined when face-to-face contact was necessary and how face-to-face consultations were reconfigured to reduce COVID-19 infection risk. Qualitative interview study in general practices i","2021","07","14","BJGP Open","BJGP open","COVID-19; consultations; face-to-face consulting; general practitioners","Scott","Anne","Centre for Academic Primary Care (CAPC), University of Bristol, Bristol Medical School, Canynge Hall, Bristol, UK",NA
"2500","34257067","10.3399/BJGPO.2021.0036","Maintaining face-to-face contact during the COVID-19 pandemic: a longitudinal qualitative investigation in UK primary care.","In March 2020 the COVID-19 pandemic required a rapid reconfiguration of UK general practice to minimise face-to-face contact with patients to reduce infection risk. However, some face-to-face contact remained necessary and practices needed to ensure such contact could continue safely. To examine how practices determined when face-to-face contact was necessary and how face-to-face consultations were reconfigured to reduce COVID-19 infection risk. Qualitative interview study in general practices i","2021","07","14","BJGP Open","BJGP open","COVID-19; consultations; face-to-face consulting; general practitioners","Horwood","Jeremy","National Institute for Health Research Applied Research Collaboration West (NIHR ARC West), University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK",NA
"2501","34257067","10.3399/BJGPO.2021.0036","Maintaining face-to-face contact during the COVID-19 pandemic: a longitudinal qualitative investigation in UK primary care.","In March 2020 the COVID-19 pandemic required a rapid reconfiguration of UK general practice to minimise face-to-face contact with patients to reduce infection risk. However, some face-to-face contact remained necessary and practices needed to ensure such contact could continue safely. To examine how practices determined when face-to-face contact was necessary and how face-to-face consultations were reconfigured to reduce COVID-19 infection risk. Qualitative interview study in general practices i","2021","07","14","BJGP Open","BJGP open","COVID-19; consultations; face-to-face consulting; general practitioners","Salisbury","Chris","National Institute for Health Research Applied Research Collaboration West (NIHR ARC West), University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK",NA
"2502","34257067","10.3399/BJGPO.2021.0036","Maintaining face-to-face contact during the COVID-19 pandemic: a longitudinal qualitative investigation in UK primary care.","In March 2020 the COVID-19 pandemic required a rapid reconfiguration of UK general practice to minimise face-to-face contact with patients to reduce infection risk. However, some face-to-face contact remained necessary and practices needed to ensure such contact could continue safely. To examine how practices determined when face-to-face contact was necessary and how face-to-face consultations were reconfigured to reduce COVID-19 infection risk. Qualitative interview study in general practices i","2021","07","14","BJGP Open","BJGP open","COVID-19; consultations; face-to-face consulting; general practitioners","Denholm","Rachel","Centre for Academic Primary Care (CAPC), University of Bristol, Bristol Medical School, Canynge Hall, Bristol, UK",NA
"2503","34257067","10.3399/BJGPO.2021.0036","Maintaining face-to-face contact during the COVID-19 pandemic: a longitudinal qualitative investigation in UK primary care.","In March 2020 the COVID-19 pandemic required a rapid reconfiguration of UK general practice to minimise face-to-face contact with patients to reduce infection risk. However, some face-to-face contact remained necessary and practices needed to ensure such contact could continue safely. To examine how practices determined when face-to-face contact was necessary and how face-to-face consultations were reconfigured to reduce COVID-19 infection risk. Qualitative interview study in general practices i","2021","07","14","BJGP Open","BJGP open","COVID-19; consultations; face-to-face consulting; general practitioners","Scott","Lauren J","National Institute for Health Research Applied Research Collaboration West (NIHR ARC West), University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK",NA
"2504","34257067","10.3399/BJGPO.2021.0036","Maintaining face-to-face contact during the COVID-19 pandemic: a longitudinal qualitative investigation in UK primary care.","In March 2020 the COVID-19 pandemic required a rapid reconfiguration of UK general practice to minimise face-to-face contact with patients to reduce infection risk. However, some face-to-face contact remained necessary and practices needed to ensure such contact could continue safely. To examine how practices determined when face-to-face contact was necessary and how face-to-face consultations were reconfigured to reduce COVID-19 infection risk. Qualitative interview study in general practices i","2021","07","14","BJGP Open","BJGP open","COVID-19; consultations; face-to-face consulting; general practitioners","Iyer","Geeta","North Somerset, and South Gloucestershire Clinical Commissioning Group (BNSSG CCG), Bristol, UK",NA
"2505","34257067","10.3399/BJGPO.2021.0036","Maintaining face-to-face contact during the COVID-19 pandemic: a longitudinal qualitative investigation in UK primary care.","In March 2020 the COVID-19 pandemic required a rapid reconfiguration of UK general practice to minimise face-to-face contact with patients to reduce infection risk. However, some face-to-face contact remained necessary and practices needed to ensure such contact could continue safely. To examine how practices determined when face-to-face contact was necessary and how face-to-face consultations were reconfigured to reduce COVID-19 infection risk. Qualitative interview study in general practices i","2021","07","14","BJGP Open","BJGP open","COVID-19; consultations; face-to-face consulting; general practitioners","MacLeod","John","National Institute for Health Research Applied Research Collaboration West (NIHR ARC West), University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK",NA
"2506","34257067","10.3399/BJGPO.2021.0036","Maintaining face-to-face contact during the COVID-19 pandemic: a longitudinal qualitative investigation in UK primary care.","In March 2020 the COVID-19 pandemic required a rapid reconfiguration of UK general practice to minimise face-to-face contact with patients to reduce infection risk. However, some face-to-face contact remained necessary and practices needed to ensure such contact could continue safely. To examine how practices determined when face-to-face contact was necessary and how face-to-face consultations were reconfigured to reduce COVID-19 infection risk. Qualitative interview study in general practices i","2021","07","14","BJGP Open","BJGP open","COVID-19; consultations; face-to-face consulting; general practitioners","Murphy","Mairead","Centre for Academic Primary Care (CAPC), University of Bristol, Bristol Medical School, Canynge Hall, Bristol, UK",NA
"2507","34257064","10.1136/bmjspcare-2021-003260","Vulnerability of patients on immunosuppressive therapy to SARS-CoV-2 reinfection.",NA,"2021","07","14","BMJ Support Palliat Care","BMJ supportive &amp; palliative care","COVID-19; pharmacology; respiratory conditions; rheumatology; supportive care","Pathania","Yashdeep Singh","Department of Dermatology, Venereology and Leprology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India yashdeepsinghpathania@gmail","yashdeepsinghpathania@gmail.com"
"2508","34257062","10.1136/bmj.n1737","Donuts, drugs, booze, and guns: what governments are offering people to take covid-19 vaccines.",NA,"2021","07","15","BMJ","BMJ (Clinical research ed.)",NA,"Tinari","Serena","Bern, Switzerland",NA
"2509","34257062","10.1136/bmj.n1737","Donuts, drugs, booze, and guns: what governments are offering people to take covid-19 vaccines.",NA,"2021","07","15","BMJ","BMJ (Clinical research ed.)",NA,"Riva","Catherine","Bern, Switzerland",NA
"2510","34257050","10.1016/j.pcd.2021.06.013","COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring.","There has been little data published related to glucose control in adolescents and young adults with type 1 diabetes (T1D) during lockdown, but rarely focusing on telemedicine's role. During this unpreceded period, glucose control and self-monitoring improved in our young patients, with better results associated with telemedicine.","2021","07","14","Prim Care Diabetes","Primary care diabetes","Adolescent; COVID-19; Continuous glucose monitoring; Telemedicine; Type 1 diabetes","Salabelle","Claire","Diabetes Department, Sud-Francilien Hospital, Corbeil-Essonnes, France",NA
"2511","34257050","10.1016/j.pcd.2021.06.013","COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring.","There has been little data published related to glucose control in adolescents and young adults with type 1 diabetes (T1D) during lockdown, but rarely focusing on telemedicine's role. During this unpreceded period, glucose control and self-monitoring improved in our young patients, with better results associated with telemedicine.","2021","07","14","Prim Care Diabetes","Primary care diabetes","Adolescent; COVID-19; Continuous glucose monitoring; Telemedicine; Type 1 diabetes","Ly Sall","Khadijatou","Diabetes Department, Sud-Francilien Hospital, Corbeil-Essonnes, France",NA
"2512","34257050","10.1016/j.pcd.2021.06.013","COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring.","There has been little data published related to glucose control in adolescents and young adults with type 1 diabetes (T1D) during lockdown, but rarely focusing on telemedicine's role. During this unpreceded period, glucose control and self-monitoring improved in our young patients, with better results associated with telemedicine.","2021","07","14","Prim Care Diabetes","Primary care diabetes","Adolescent; COVID-19; Continuous glucose monitoring; Telemedicine; Type 1 diabetes","Eroukhmanoff","Juliette","Diabetes Department, Sud-Francilien Hospital, Corbeil-Essonnes, France",NA
"2513","34257050","10.1016/j.pcd.2021.06.013","COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring.","There has been little data published related to glucose control in adolescents and young adults with type 1 diabetes (T1D) during lockdown, but rarely focusing on telemedicine's role. During this unpreceded period, glucose control and self-monitoring improved in our young patients, with better results associated with telemedicine.","2021","07","14","Prim Care Diabetes","Primary care diabetes","Adolescent; COVID-19; Continuous glucose monitoring; Telemedicine; Type 1 diabetes","Franc","Sylvia","Diabetes Department, Sud-Francilien Hospital, Corbeil-Essonnes, France",NA
"2514","34257050","10.1016/j.pcd.2021.06.013","COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring.","There has been little data published related to glucose control in adolescents and young adults with type 1 diabetes (T1D) during lockdown, but rarely focusing on telemedicine's role. During this unpreceded period, glucose control and self-monitoring improved in our young patients, with better results associated with telemedicine.","2021","07","14","Prim Care Diabetes","Primary care diabetes","Adolescent; COVID-19; Continuous glucose monitoring; Telemedicine; Type 1 diabetes","Oumbiche","Hamida","Diabetes Department, Sud-Francilien Hospital, Corbeil-Essonnes, France",NA
"2515","34257050","10.1016/j.pcd.2021.06.013","COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring.","There has been little data published related to glucose control in adolescents and young adults with type 1 diabetes (T1D) during lockdown, but rarely focusing on telemedicine's role. During this unpreceded period, glucose control and self-monitoring improved in our young patients, with better results associated with telemedicine.","2021","07","14","Prim Care Diabetes","Primary care diabetes","Adolescent; COVID-19; Continuous glucose monitoring; Telemedicine; Type 1 diabetes","Zrafi","Wael Salem","Paris-Saclay University, France",NA
"2516","34257050","10.1016/j.pcd.2021.06.013","COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring.","There has been little data published related to glucose control in adolescents and young adults with type 1 diabetes (T1D) during lockdown, but rarely focusing on telemedicine's role. During this unpreceded period, glucose control and self-monitoring improved in our young patients, with better results associated with telemedicine.","2021","07","14","Prim Care Diabetes","Primary care diabetes","Adolescent; COVID-19; Continuous glucose monitoring; Telemedicine; Type 1 diabetes","Dang Duy","Thanh Lan","Pediatrics Department, Sud-Francilien Hospital, Corbeil-Essonnes, France",NA
"2517","34257050","10.1016/j.pcd.2021.06.013","COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring.","There has been little data published related to glucose control in adolescents and young adults with type 1 diabetes (T1D) during lockdown, but rarely focusing on telemedicine's role. During this unpreceded period, glucose control and self-monitoring improved in our young patients, with better results associated with telemedicine.","2021","07","14","Prim Care Diabetes","Primary care diabetes","Adolescent; COVID-19; Continuous glucose monitoring; Telemedicine; Type 1 diabetes","Valentim","Clarisse","Diabetes Department, Sud-Francilien Hospital, Corbeil-Essonnes, France",NA
"2518","34257050","10.1016/j.pcd.2021.06.013","COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring.","There has been little data published related to glucose control in adolescents and young adults with type 1 diabetes (T1D) during lockdown, but rarely focusing on telemedicine's role. During this unpreceded period, glucose control and self-monitoring improved in our young patients, with better results associated with telemedicine.","2021","07","14","Prim Care Diabetes","Primary care diabetes","Adolescent; COVID-19; Continuous glucose monitoring; Telemedicine; Type 1 diabetes","Gaston","Floriane","Diabetes Department, Sud-Francilien Hospital, Corbeil-Essonnes, France",NA
"2519","34257050","10.1016/j.pcd.2021.06.013","COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring.","There has been little data published related to glucose control in adolescents and young adults with type 1 diabetes (T1D) during lockdown, but rarely focusing on telemedicine's role. During this unpreceded period, glucose control and self-monitoring improved in our young patients, with better results associated with telemedicine.","2021","07","14","Prim Care Diabetes","Primary care diabetes","Adolescent; COVID-19; Continuous glucose monitoring; Telemedicine; Type 1 diabetes","Fernandes","Sylvie","Diabetes Department, Sud-Francilien Hospital, Corbeil-Essonnes, France",NA
"2520","34257050","10.1016/j.pcd.2021.06.013","COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring.","There has been little data published related to glucose control in adolescents and young adults with type 1 diabetes (T1D) during lockdown, but rarely focusing on telemedicine's role. During this unpreceded period, glucose control and self-monitoring improved in our young patients, with better results associated with telemedicine.","2021","07","14","Prim Care Diabetes","Primary care diabetes","Adolescent; COVID-19; Continuous glucose monitoring; Telemedicine; Type 1 diabetes","Faucherand","Marie","Diabetes Department, Sud-Francilien Hospital, Corbeil-Essonnes, France",NA
"2521","34257050","10.1016/j.pcd.2021.06.013","COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring.","There has been little data published related to glucose control in adolescents and young adults with type 1 diabetes (T1D) during lockdown, but rarely focusing on telemedicine's role. During this unpreceded period, glucose control and self-monitoring improved in our young patients, with better results associated with telemedicine.","2021","07","14","Prim Care Diabetes","Primary care diabetes","Adolescent; COVID-19; Continuous glucose monitoring; Telemedicine; Type 1 diabetes","Penfornis","Alfred","Diabetes Department, Sud-Francilien Hospital, Corbeil-Essonnes, France",NA
"2522","34257050","10.1016/j.pcd.2021.06.013","COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring.","There has been little data published related to glucose control in adolescents and young adults with type 1 diabetes (T1D) during lockdown, but rarely focusing on telemedicine's role. During this unpreceded period, glucose control and self-monitoring improved in our young patients, with better results associated with telemedicine.","2021","07","14","Prim Care Diabetes","Primary care diabetes","Adolescent; COVID-19; Continuous glucose monitoring; Telemedicine; Type 1 diabetes","Amadou","Coralie","Diabetes Department, Sud-Francilien Hospital, Corbeil-Essonnes, France",NA
"2523","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Gou","Wanglong","College of Life Sciences, Zhejiang University, Hangzhou 310058, China",NA
"2524","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Fu","Yuanqing","Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou 310024, China",NA
"2525","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Yue","Liang","Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou 310024, China",NA
"2526","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Chen","Geng-Dong","Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou 510275, China",NA
"2527","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Cai","Xue","Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou 310024, China",NA
"2528","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Shuai","Menglei","Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou 310024, China",NA
"2529","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Xu","Fengzhe","Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou 310024, China",NA
"2530","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Yi","Xiao","Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou 310024, China",NA
"2531","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Chen","Hao","Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou 310024, China",NA
"2532","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Zhu","Yi","Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou 310024, China",NA
"2533","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Xiao","Mian-Li","Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou 510275, China",NA
"2534","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Jiang","Zengliang","Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou 310024, China",NA
"2535","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Miao","Zelei","Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou 310024, China",NA
"2536","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Xiao","Congmei","Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou 310024, China",NA
"2537","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Shen","Bo","Taizhou Hospital, Wenzhou Medical University, Linhai 325035, China",NA
"2538","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Wu","Xiaomai","Taizhou Hospital, Wenzhou Medical University, Linhai 325035, China",NA
"2539","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Zhao","Haihong","Taizhou Hospital, Wenzhou Medical University, Linhai 325035, China",NA
"2540","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Ling","Wenhua","Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou 510275, China",NA
"2541","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Wang","Jun","CAS Key Laboratory for Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China. Electronic address: junwang@im.ac","junwang@im.ac.cn"
"2542","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Chen","Yu-Ming","Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou 510275, China. Electronic address: chenyum@mail.sysu.edu","chenyum@mail.sysu.edu.cn"
"2543","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Guo","Tiannan","Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou 310024, China","guotiannan@westlake.edu.cn"
"2544","34257044","10.1016/j.jgg.2021.04.002","Gut microbiota, inflammation, and molecular signatures of host response to infection.","Gut microbial dysbiosis has been linked to many noncommunicable diseases. However, little is known about specific gut microbiota composition and its correlated metabolites associated with molecular signatures underlying host response to infection. Here, we describe the construction of a proteomic risk score based on 20 blood proteomic biomarkers, which have recently been identified as molecular signatures predicting the progression of the COVID-19. We demonstrate that in our cohort of 990 health","2021","07","14","J Genet Genomics","Journal of genetics and genomics = Yi chuan xue bao","COVID-19; Gut microbiota; Host infection response; Proinflammatory cytokines; Proteomic biomarkers","Zheng","Ju-Sheng","College of Life Sciences, Zhejiang University, Hangzhou 310058, China","zhengjusheng@westlake.edu.cn"
"2545","34257040","10.1016/j.jcjq.2021.06.002","Workplace Violence Against Physicians Treating COVID-19 Patients in Peru: A Cross-Sectional Study.","The COVID-19 pandemic is an unprecedented challenge to health systems that has revealed shortcomings and increased unmet demands. Such situations might exacerbate workplace violence (WPV) against physicians, as has been reported in several parts of the world. To identify the frequency and characteristics of WPV suffered by physicians attending COVID-19 patients in Peru, a descriptive, cross-sectional study was conducted with an online survey of 200 physicians. Of the survey respondents, 84.5% ha","2021","07","17","Jt Comm J Qual Patient Saf","Joint Commission journal on quality and patient safety",NA,"Muñoz Del Carpio-Toia","Agueda",NA,NA
"2546","34257040","10.1016/j.jcjq.2021.06.002","Workplace Violence Against Physicians Treating COVID-19 Patients in Peru: A Cross-Sectional Study.","The COVID-19 pandemic is an unprecedented challenge to health systems that has revealed shortcomings and increased unmet demands. Such situations might exacerbate workplace violence (WPV) against physicians, as has been reported in several parts of the world. To identify the frequency and characteristics of WPV suffered by physicians attending COVID-19 patients in Peru, a descriptive, cross-sectional study was conducted with an online survey of 200 physicians. Of the survey respondents, 84.5% ha","2021","07","17","Jt Comm J Qual Patient Saf","Joint Commission journal on quality and patient safety",NA,"Begazo Muñoz Del Carpio","Lucía",NA,NA
"2547","34257040","10.1016/j.jcjq.2021.06.002","Workplace Violence Against Physicians Treating COVID-19 Patients in Peru: A Cross-Sectional Study.","The COVID-19 pandemic is an unprecedented challenge to health systems that has revealed shortcomings and increased unmet demands. Such situations might exacerbate workplace violence (WPV) against physicians, as has been reported in several parts of the world. To identify the frequency and characteristics of WPV suffered by physicians attending COVID-19 patients in Peru, a descriptive, cross-sectional study was conducted with an online survey of 200 physicians. Of the survey respondents, 84.5% ha","2021","07","17","Jt Comm J Qual Patient Saf","Joint Commission journal on quality and patient safety",NA,"Mayta-Tristan","Percy",NA,NA
"2548","34257040","10.1016/j.jcjq.2021.06.002","Workplace Violence Against Physicians Treating COVID-19 Patients in Peru: A Cross-Sectional Study.","The COVID-19 pandemic is an unprecedented challenge to health systems that has revealed shortcomings and increased unmet demands. Such situations might exacerbate workplace violence (WPV) against physicians, as has been reported in several parts of the world. To identify the frequency and characteristics of WPV suffered by physicians attending COVID-19 patients in Peru, a descriptive, cross-sectional study was conducted with an online survey of 200 physicians. Of the survey respondents, 84.5% ha","2021","07","17","Jt Comm J Qual Patient Saf","Joint Commission journal on quality and patient safety",NA,"Alarcón-Yaquetto","Dulce Esperanza",NA,NA
"2549","34257040","10.1016/j.jcjq.2021.06.002","Workplace Violence Against Physicians Treating COVID-19 Patients in Peru: A Cross-Sectional Study.","The COVID-19 pandemic is an unprecedented challenge to health systems that has revealed shortcomings and increased unmet demands. Such situations might exacerbate workplace violence (WPV) against physicians, as has been reported in several parts of the world. To identify the frequency and characteristics of WPV suffered by physicians attending COVID-19 patients in Peru, a descriptive, cross-sectional study was conducted with an online survey of 200 physicians. Of the survey respondents, 84.5% ha","2021","07","17","Jt Comm J Qual Patient Saf","Joint Commission journal on quality and patient safety",NA,"Málaga","Germán",NA,NA
"2550","34257036","10.1016/j.explore.2021.06.008","More Exercise linked to less severe Covid-19.",NA,"2021","07","17","Explore (NY)","Explore (New York, N.Y.)",NA,"Demarinis","Susie",NA,NA
"2551","34257034","10.1016/j.bjps.2021.05.020","Impact of COVID-19 on Aesthetic Plastic Surgery Practice in the United Kingdom.","The COVID-19 pandemic has transformed the delivery of medical and surgical services globally. Subsequently, all elective and aesthetic procedures have been cancelled or deferred in accordance with government-mandated quarantine measures. The Cosmetic Surgery Governance Forum (CSGF) is a network of aesthetic plastic surgery consultants which has enabled a sharing of expertise during challenging times. We conducted a cross-sectional survey to assess the impact of the COVID-19 pandemic on aesthetic","2021","07","17","J Plast Reconstr Aesthet Surg","Journal of plastic, reconstructive &amp; aesthetic surgery : JPRAS","Aesthetic Plastics surgery; Cosmetic Surgery Governance forum; Cosmetic surgery and Covid; Covid19; Plastic surgeons and Covid 19; Restart of aesthetic surgery; United Kingdome Aesthetic plasticsurgery","Joji","Nikita","Plastic Surgery Registrar, Cosmetic Surgery Governance forum (CSGF), UK",NA
"2552","34257034","10.1016/j.bjps.2021.05.020","Impact of COVID-19 on Aesthetic Plastic Surgery Practice in the United Kingdom.","The COVID-19 pandemic has transformed the delivery of medical and surgical services globally. Subsequently, all elective and aesthetic procedures have been cancelled or deferred in accordance with government-mandated quarantine measures. The Cosmetic Surgery Governance Forum (CSGF) is a network of aesthetic plastic surgery consultants which has enabled a sharing of expertise during challenging times. We conducted a cross-sectional survey to assess the impact of the COVID-19 pandemic on aesthetic","2021","07","17","J Plast Reconstr Aesthet Surg","Journal of plastic, reconstructive &amp; aesthetic surgery : JPRAS","Aesthetic Plastics surgery; Cosmetic Surgery Governance forum; Cosmetic surgery and Covid; Covid19; Plastic surgeons and Covid 19; Restart of aesthetic surgery; United Kingdome Aesthetic plasticsurgery","Nugent","Nora","Consultant Plastic Surgeon, Cosmetic Surgery Governance forum (CSGF), UK",NA
"2553","34257034","10.1016/j.bjps.2021.05.020","Impact of COVID-19 on Aesthetic Plastic Surgery Practice in the United Kingdom.","The COVID-19 pandemic has transformed the delivery of medical and surgical services globally. Subsequently, all elective and aesthetic procedures have been cancelled or deferred in accordance with government-mandated quarantine measures. The Cosmetic Surgery Governance Forum (CSGF) is a network of aesthetic plastic surgery consultants which has enabled a sharing of expertise during challenging times. We conducted a cross-sectional survey to assess the impact of the COVID-19 pandemic on aesthetic","2021","07","17","J Plast Reconstr Aesthet Surg","Journal of plastic, reconstructive &amp; aesthetic surgery : JPRAS","Aesthetic Plastics surgery; Cosmetic Surgery Governance forum; Cosmetic surgery and Covid; Covid19; Plastic surgeons and Covid 19; Restart of aesthetic surgery; United Kingdome Aesthetic plasticsurgery","Vadodaria","Shailesh","Consultant Plastic Surgeon, Cosmetic Surgery Governance forum (CSGF), UK",NA
"2554","34257034","10.1016/j.bjps.2021.05.020","Impact of COVID-19 on Aesthetic Plastic Surgery Practice in the United Kingdom.","The COVID-19 pandemic has transformed the delivery of medical and surgical services globally. Subsequently, all elective and aesthetic procedures have been cancelled or deferred in accordance with government-mandated quarantine measures. The Cosmetic Surgery Governance Forum (CSGF) is a network of aesthetic plastic surgery consultants which has enabled a sharing of expertise during challenging times. We conducted a cross-sectional survey to assess the impact of the COVID-19 pandemic on aesthetic","2021","07","17","J Plast Reconstr Aesthet Surg","Journal of plastic, reconstructive &amp; aesthetic surgery : JPRAS","Aesthetic Plastics surgery; Cosmetic Surgery Governance forum; Cosmetic surgery and Covid; Covid19; Plastic surgeons and Covid 19; Restart of aesthetic surgery; United Kingdome Aesthetic plasticsurgery","Sankar","Thangasamy K","Consultant Plastic Surgeon, Cosmetic Surgery Governance forum (CSGF), UK","t.sankar@nhs.net"
"2555","34257027","10.1016/j.dld.2021.06.014","Reply to: ""Characteristics and in-hospital outcomes of COVID-19 patients with acute or subacute liver failure"".",NA,"2021","07","17","Dig Liver Dis","Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver",NA,"Yousif","Walid Ibrahim","Alexandria University, Faculty of Medicine, Alexandria, Egypt",NA
"2556","34257025","10.1016/j.acra.2021.06.003","COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.","Following vaccination of Israeli population with Pfizer-BioNTech COVID-19 Vaccine, an unusual increase in axillary-lymphadenopathy was noted. This study assesses the rate and magnitude of this trend from breast-imaging standpoint. Participants undergoing breast-imaging, in whom isolated axillary-lymphadenopathy was detected were questioned regarding SARS-CoV-2 vaccine to the ipsilateral arm. Patients' and imaging characteristics were statistically compared. In order to perform a very short-term ","2021","07","17","Acad Radiol","Academic radiology","BRCA-carriers; COVID-19 vaccine; SARS-Cov-2; axillary lymphadenopathy; breast imaging","Faermann","Renata","Department of Diagnostic Imaging, Chaim Sheba Medical Center, Ramat Gan, Israel","rfaermann@gmail.com"
"2557","34257025","10.1016/j.acra.2021.06.003","COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.","Following vaccination of Israeli population with Pfizer-BioNTech COVID-19 Vaccine, an unusual increase in axillary-lymphadenopathy was noted. This study assesses the rate and magnitude of this trend from breast-imaging standpoint. Participants undergoing breast-imaging, in whom isolated axillary-lymphadenopathy was detected were questioned regarding SARS-CoV-2 vaccine to the ipsilateral arm. Patients' and imaging characteristics were statistically compared. In order to perform a very short-term ","2021","07","17","Acad Radiol","Academic radiology","BRCA-carriers; COVID-19 vaccine; SARS-Cov-2; axillary lymphadenopathy; breast imaging","Nissan","Noam","Department of Diagnostic Imaging, Chaim Sheba Medical Center, Ramat Gan, Israel",NA
"2558","34257025","10.1016/j.acra.2021.06.003","COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.","Following vaccination of Israeli population with Pfizer-BioNTech COVID-19 Vaccine, an unusual increase in axillary-lymphadenopathy was noted. This study assesses the rate and magnitude of this trend from breast-imaging standpoint. Participants undergoing breast-imaging, in whom isolated axillary-lymphadenopathy was detected were questioned regarding SARS-CoV-2 vaccine to the ipsilateral arm. Patients' and imaging characteristics were statistically compared. In order to perform a very short-term ","2021","07","17","Acad Radiol","Academic radiology","BRCA-carriers; COVID-19 vaccine; SARS-Cov-2; axillary lymphadenopathy; breast imaging","Halshtok-Neiman","Osnat","Department of Diagnostic Imaging, Chaim Sheba Medical Center, Ramat Gan, Israel",NA
"2559","34257025","10.1016/j.acra.2021.06.003","COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.","Following vaccination of Israeli population with Pfizer-BioNTech COVID-19 Vaccine, an unusual increase in axillary-lymphadenopathy was noted. This study assesses the rate and magnitude of this trend from breast-imaging standpoint. Participants undergoing breast-imaging, in whom isolated axillary-lymphadenopathy was detected were questioned regarding SARS-CoV-2 vaccine to the ipsilateral arm. Patients' and imaging characteristics were statistically compared. In order to perform a very short-term ","2021","07","17","Acad Radiol","Academic radiology","BRCA-carriers; COVID-19 vaccine; SARS-Cov-2; axillary lymphadenopathy; breast imaging","Shalmon","Anat","Department of Diagnostic Imaging, Chaim Sheba Medical Center, Ramat Gan, Israel",NA
"2560","34257025","10.1016/j.acra.2021.06.003","COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.","Following vaccination of Israeli population with Pfizer-BioNTech COVID-19 Vaccine, an unusual increase in axillary-lymphadenopathy was noted. This study assesses the rate and magnitude of this trend from breast-imaging standpoint. Participants undergoing breast-imaging, in whom isolated axillary-lymphadenopathy was detected were questioned regarding SARS-CoV-2 vaccine to the ipsilateral arm. Patients' and imaging characteristics were statistically compared. In order to perform a very short-term ","2021","07","17","Acad Radiol","Academic radiology","BRCA-carriers; COVID-19 vaccine; SARS-Cov-2; axillary lymphadenopathy; breast imaging","Gotlieb","Michael","Department of Diagnostic Imaging, Chaim Sheba Medical Center, Ramat Gan, Israel",NA
"2561","34257025","10.1016/j.acra.2021.06.003","COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.","Following vaccination of Israeli population with Pfizer-BioNTech COVID-19 Vaccine, an unusual increase in axillary-lymphadenopathy was noted. This study assesses the rate and magnitude of this trend from breast-imaging standpoint. Participants undergoing breast-imaging, in whom isolated axillary-lymphadenopathy was detected were questioned regarding SARS-CoV-2 vaccine to the ipsilateral arm. Patients' and imaging characteristics were statistically compared. In order to perform a very short-term ","2021","07","17","Acad Radiol","Academic radiology","BRCA-carriers; COVID-19 vaccine; SARS-Cov-2; axillary lymphadenopathy; breast imaging","Yagil","Yael","Department of Diagnostic Imaging, Chaim Sheba Medical Center, Ramat Gan, Israel",NA
"2562","34257025","10.1016/j.acra.2021.06.003","COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.","Following vaccination of Israeli population with Pfizer-BioNTech COVID-19 Vaccine, an unusual increase in axillary-lymphadenopathy was noted. This study assesses the rate and magnitude of this trend from breast-imaging standpoint. Participants undergoing breast-imaging, in whom isolated axillary-lymphadenopathy was detected were questioned regarding SARS-CoV-2 vaccine to the ipsilateral arm. Patients' and imaging characteristics were statistically compared. In order to perform a very short-term ","2021","07","17","Acad Radiol","Academic radiology","BRCA-carriers; COVID-19 vaccine; SARS-Cov-2; axillary lymphadenopathy; breast imaging","Samoocha","David","Department of Diagnostic Imaging, Chaim Sheba Medical Center, Ramat Gan, Israel",NA
"2563","34257025","10.1016/j.acra.2021.06.003","COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.","Following vaccination of Israeli population with Pfizer-BioNTech COVID-19 Vaccine, an unusual increase in axillary-lymphadenopathy was noted. This study assesses the rate and magnitude of this trend from breast-imaging standpoint. Participants undergoing breast-imaging, in whom isolated axillary-lymphadenopathy was detected were questioned regarding SARS-CoV-2 vaccine to the ipsilateral arm. Patients' and imaging characteristics were statistically compared. In order to perform a very short-term ","2021","07","17","Acad Radiol","Academic radiology","BRCA-carriers; COVID-19 vaccine; SARS-Cov-2; axillary lymphadenopathy; breast imaging","Friedman","Eitan","Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel",NA
"2564","34257025","10.1016/j.acra.2021.06.003","COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.","Following vaccination of Israeli population with Pfizer-BioNTech COVID-19 Vaccine, an unusual increase in axillary-lymphadenopathy was noted. This study assesses the rate and magnitude of this trend from breast-imaging standpoint. Participants undergoing breast-imaging, in whom isolated axillary-lymphadenopathy was detected were questioned regarding SARS-CoV-2 vaccine to the ipsilateral arm. Patients' and imaging characteristics were statistically compared. In order to perform a very short-term ","2021","07","17","Acad Radiol","Academic radiology","BRCA-carriers; COVID-19 vaccine; SARS-Cov-2; axillary lymphadenopathy; breast imaging","Sklair-Levy","Miri","Department of Diagnostic Imaging, Chaim Sheba Medical Center, Ramat Gan, Israel",NA
"2565","34257017","10.1016/j.sleep.2021.06.020","Uncharted territory: challenges and opportunities in pediatric sleep medicine during the COVID-19 pandemic and beyond part II: the sleep laboratory.",NA,"2021","07","17","Sleep Med","Sleep medicine",NA,"Katwa","Umakanth","Pulmonary Medicine Boston Children's Hospital, Boston MA, USA",NA
"2566","34257017","10.1016/j.sleep.2021.06.020","Uncharted territory: challenges and opportunities in pediatric sleep medicine during the COVID-19 pandemic and beyond part II: the sleep laboratory.",NA,"2021","07","17","Sleep Med","Sleep medicine",NA,"Owens","Judith","Neurology, Boston Children's Hospital, Boston MA, USA. Electronic address: owensleep@gmail","owensleep@gmail.com"
"2567","34257017","10.1016/j.sleep.2021.06.020","Uncharted territory: challenges and opportunities in pediatric sleep medicine during the COVID-19 pandemic and beyond part II: the sleep laboratory.",NA,"2021","07","17","Sleep Med","Sleep medicine",NA,"Sheldon","Stephen","Pulmonary Medicine, Lurie Children's Hospital, Chicago IL, USA",NA
"2568","34257017","10.1016/j.sleep.2021.06.020","Uncharted territory: challenges and opportunities in pediatric sleep medicine during the COVID-19 pandemic and beyond part II: the sleep laboratory.",NA,"2021","07","17","Sleep Med","Sleep medicine",NA,"Chen","Maida","Seattle Children's Hospital, Seattle, WA, USA",NA
"2569","34257017","10.1016/j.sleep.2021.06.020","Uncharted territory: challenges and opportunities in pediatric sleep medicine during the COVID-19 pandemic and beyond part II: the sleep laboratory.",NA,"2021","07","17","Sleep Med","Sleep medicine",NA,"Zhou","Eric","Neurology, Boston Children's Hospital, Boston MA, USA",NA
"2570","34257017","10.1016/j.sleep.2021.06.020","Uncharted territory: challenges and opportunities in pediatric sleep medicine during the COVID-19 pandemic and beyond part II: the sleep laboratory.",NA,"2021","07","17","Sleep Med","Sleep medicine",NA,"Hopkins","Bobbi","Child Neurology, Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA",NA
"2571","34257017","10.1016/j.sleep.2021.06.020","Uncharted territory: challenges and opportunities in pediatric sleep medicine during the COVID-19 pandemic and beyond part II: the sleep laboratory.",NA,"2021","07","17","Sleep Med","Sleep medicine",NA,"Palomo","Regina","Pulmonary Medicine, Lurie Children's Hospital, Chicago IL, USA",NA
"2572","34257017","10.1016/j.sleep.2021.06.020","Uncharted territory: challenges and opportunities in pediatric sleep medicine during the COVID-19 pandemic and beyond part II: the sleep laboratory.",NA,"2021","07","17","Sleep Med","Sleep medicine",NA,"Moore","Maile","Neurology, Boston Children's Hospital, Boston MA, USA",NA
"2573","34257003","10.1016/j.jagp.2021.06.004","Altered Mental Status: An Important but Overlooked Presenting Symptom of COVID-19 in Older Adults.","To determine whether altered mental status (AMS) as a presenting symptom in older adults with COVID-19 is independently associated with adverse outcomes. A retrospective single center observational study of admitted patients (n = 421) age greater than 60 and a positive COVID-19 test. Outcomes included mortality, intubation, acute respiratory distress syndrome, acute kidney injury, and acute cardiac injury. Multivariate regression analysis was used to determine if presenting with AMS was associat","2021","07","17","Am J Geriatr Psychiatry","The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","AKI; AMS; COVID-19; Geriatrics; intubation; mortality; pandemic","Oommen","Alvin","SUNY Downstate Health Sciences University, Brooklyn, NY. Electronic address: alvinjoyoommen@gmail","alvinjoyoommen@gmail.com"
"2574","34257003","10.1016/j.jagp.2021.06.004","Altered Mental Status: An Important but Overlooked Presenting Symptom of COVID-19 in Older Adults.","To determine whether altered mental status (AMS) as a presenting symptom in older adults with COVID-19 is independently associated with adverse outcomes. A retrospective single center observational study of admitted patients (n = 421) age greater than 60 and a positive COVID-19 test. Outcomes included mortality, intubation, acute respiratory distress syndrome, acute kidney injury, and acute cardiac injury. Multivariate regression analysis was used to determine if presenting with AMS was associat","2021","07","17","Am J Geriatr Psychiatry","The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","AKI; AMS; COVID-19; Geriatrics; intubation; mortality; pandemic","Thomas","Joel","SUNY Downstate Health Sciences University, Brooklyn, NY",NA
"2575","34257003","10.1016/j.jagp.2021.06.004","Altered Mental Status: An Important but Overlooked Presenting Symptom of COVID-19 in Older Adults.","To determine whether altered mental status (AMS) as a presenting symptom in older adults with COVID-19 is independently associated with adverse outcomes. A retrospective single center observational study of admitted patients (n = 421) age greater than 60 and a positive COVID-19 test. Outcomes included mortality, intubation, acute respiratory distress syndrome, acute kidney injury, and acute cardiac injury. Multivariate regression analysis was used to determine if presenting with AMS was associat","2021","07","17","Am J Geriatr Psychiatry","The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","AKI; AMS; COVID-19; Geriatrics; intubation; mortality; pandemic","Parmar","Priyanka","SUNY Downstate Health Sciences University, Brooklyn, NY",NA
"2576","34257003","10.1016/j.jagp.2021.06.004","Altered Mental Status: An Important but Overlooked Presenting Symptom of COVID-19 in Older Adults.","To determine whether altered mental status (AMS) as a presenting symptom in older adults with COVID-19 is independently associated with adverse outcomes. A retrospective single center observational study of admitted patients (n = 421) age greater than 60 and a positive COVID-19 test. Outcomes included mortality, intubation, acute respiratory distress syndrome, acute kidney injury, and acute cardiac injury. Multivariate regression analysis was used to determine if presenting with AMS was associat","2021","07","17","Am J Geriatr Psychiatry","The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","AKI; AMS; COVID-19; Geriatrics; intubation; mortality; pandemic","Rosengarten","Sabrina","SUNY Downstate Health Sciences University, Brooklyn, NY",NA
"2577","34257003","10.1016/j.jagp.2021.06.004","Altered Mental Status: An Important but Overlooked Presenting Symptom of COVID-19 in Older Adults.","To determine whether altered mental status (AMS) as a presenting symptom in older adults with COVID-19 is independently associated with adverse outcomes. A retrospective single center observational study of admitted patients (n = 421) age greater than 60 and a positive COVID-19 test. Outcomes included mortality, intubation, acute respiratory distress syndrome, acute kidney injury, and acute cardiac injury. Multivariate regression analysis was used to determine if presenting with AMS was associat","2021","07","17","Am J Geriatr Psychiatry","The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","AKI; AMS; COVID-19; Geriatrics; intubation; mortality; pandemic","Wilson","Clara","SUNY Downstate Health Sciences University, Brooklyn, NY",NA
"2578","34257003","10.1016/j.jagp.2021.06.004","Altered Mental Status: An Important but Overlooked Presenting Symptom of COVID-19 in Older Adults.","To determine whether altered mental status (AMS) as a presenting symptom in older adults with COVID-19 is independently associated with adverse outcomes. A retrospective single center observational study of admitted patients (n = 421) age greater than 60 and a positive COVID-19 test. Outcomes included mortality, intubation, acute respiratory distress syndrome, acute kidney injury, and acute cardiac injury. Multivariate regression analysis was used to determine if presenting with AMS was associat","2021","07","17","Am J Geriatr Psychiatry","The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","AKI; AMS; COVID-19; Geriatrics; intubation; mortality; pandemic","Maini","Rohan","SUNY Downstate Health Sciences University, Brooklyn, NY",NA
"2579","34257003","10.1016/j.jagp.2021.06.004","Altered Mental Status: An Important but Overlooked Presenting Symptom of COVID-19 in Older Adults.","To determine whether altered mental status (AMS) as a presenting symptom in older adults with COVID-19 is independently associated with adverse outcomes. A retrospective single center observational study of admitted patients (n = 421) age greater than 60 and a positive COVID-19 test. Outcomes included mortality, intubation, acute respiratory distress syndrome, acute kidney injury, and acute cardiac injury. Multivariate regression analysis was used to determine if presenting with AMS was associat","2021","07","17","Am J Geriatr Psychiatry","The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","AKI; AMS; COVID-19; Geriatrics; intubation; mortality; pandemic","Kim","Julie Minjae","SUNY Downstate Health Sciences University, Brooklyn, NY",NA
"2580","34257003","10.1016/j.jagp.2021.06.004","Altered Mental Status: An Important but Overlooked Presenting Symptom of COVID-19 in Older Adults.","To determine whether altered mental status (AMS) as a presenting symptom in older adults with COVID-19 is independently associated with adverse outcomes. A retrospective single center observational study of admitted patients (n = 421) age greater than 60 and a positive COVID-19 test. Outcomes included mortality, intubation, acute respiratory distress syndrome, acute kidney injury, and acute cardiac injury. Multivariate regression analysis was used to determine if presenting with AMS was associat","2021","07","17","Am J Geriatr Psychiatry","The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","AKI; AMS; COVID-19; Geriatrics; intubation; mortality; pandemic","Mecklenburg","Max","SUNY Downstate Health Sciences University, Brooklyn, NY",NA
"2581","34257003","10.1016/j.jagp.2021.06.004","Altered Mental Status: An Important but Overlooked Presenting Symptom of COVID-19 in Older Adults.","To determine whether altered mental status (AMS) as a presenting symptom in older adults with COVID-19 is independently associated with adverse outcomes. A retrospective single center observational study of admitted patients (n = 421) age greater than 60 and a positive COVID-19 test. Outcomes included mortality, intubation, acute respiratory distress syndrome, acute kidney injury, and acute cardiac injury. Multivariate regression analysis was used to determine if presenting with AMS was associat","2021","07","17","Am J Geriatr Psychiatry","The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","AKI; AMS; COVID-19; Geriatrics; intubation; mortality; pandemic","Daniel","Pia","Department of Emergency Medicine, SUNY Downstate Health Sciences University, Brooklyn, NY",NA
"2582","34257003","10.1016/j.jagp.2021.06.004","Altered Mental Status: An Important but Overlooked Presenting Symptom of COVID-19 in Older Adults.","To determine whether altered mental status (AMS) as a presenting symptom in older adults with COVID-19 is independently associated with adverse outcomes. A retrospective single center observational study of admitted patients (n = 421) age greater than 60 and a positive COVID-19 test. Outcomes included mortality, intubation, acute respiratory distress syndrome, acute kidney injury, and acute cardiac injury. Multivariate regression analysis was used to determine if presenting with AMS was associat","2021","07","17","Am J Geriatr Psychiatry","The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","AKI; AMS; COVID-19; Geriatrics; intubation; mortality; pandemic","Brietman","Igal","Department of Bariatric Surgery, State University of New York, Downstate Health Sciences University, Brooklyn, NY",NA
"2583","34256997","10.1053/j.jvca.2021.06.014","Trends in Cardiopulmonary Resuscitation Response Times in a Community Hospital in the COVID-19 Era.",NA,"2021","07","17","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia",NA,"Stawiarski","Kristin M","Section of Cardiovascular Medicine, Yale New Haven Health Bridgeport Hospital, Bridgeport, CT",NA
"2584","34256997","10.1053/j.jvca.2021.06.014","Trends in Cardiopulmonary Resuscitation Response Times in a Community Hospital in the COVID-19 Era.",NA,"2021","07","17","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia",NA,"Lau","Freddy Duarte","Section of Cardiovascular Medicine, Yale New Haven Health Bridgeport Hospital, Bridgeport, CT",NA
"2585","34256997","10.1053/j.jvca.2021.06.014","Trends in Cardiopulmonary Resuscitation Response Times in a Community Hospital in the COVID-19 Era.",NA,"2021","07","17","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia",NA,"Bindelglass","Gloria","Section of Cardiovascular Medicine, Yale New Haven Health Bridgeport Hospital, Bridgeport, CT",NA
"2586","34256997","10.1053/j.jvca.2021.06.014","Trends in Cardiopulmonary Resuscitation Response Times in a Community Hospital in the COVID-19 Era.",NA,"2021","07","17","J Cardiothorac Vasc Anesth","Journal of cardiothoracic and vascular anesthesia",NA,"Lancaster","Gilead","Section of Cardiovascular Medicine, Yale New Haven Health Bridgeport Hospital, Bridgeport, CT",NA
"2587","34256992","10.1016/j.purol.2021.02.007","[Outcomes following the triage of patients for urological cancer and non-cancer surgery during Covid-19 pandemic peak].","Faced with the first wave of Covid-19 pandemic, guidelines for surgical triage were developed to free up healthcare resources. The aim of our study was to assess clinical characteristics and surgical outcomes of triaged patients during the first Covid-19 crisis. We conducted a cohort-controlled, non-randomized, study in a University Hospital of south-eastern France. Data were collected prospectively from consecutive patients after triage during the period from March 15th to May 1st and compared ","2021","07","17","Prog Urol","Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie","Cancer; Chirurgie; Confinement; Covid-19; Emergency; Isolation period; RT-PCR; Surgery; Triage; Urgence","Durand","M","Service d'urologie, andrologie, transplantation rénale, hôpital Pasteur 2, France",NA
"2588","34256992","10.1016/j.purol.2021.02.007","[Outcomes following the triage of patients for urological cancer and non-cancer surgery during Covid-19 pandemic peak].","Faced with the first wave of Covid-19 pandemic, guidelines for surgical triage were developed to free up healthcare resources. The aim of our study was to assess clinical characteristics and surgical outcomes of triaged patients during the first Covid-19 crisis. We conducted a cohort-controlled, non-randomized, study in a University Hospital of south-eastern France. Data were collected prospectively from consecutive patients after triage during the period from March 15th to May 1st and compared ","2021","07","17","Prog Urol","Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie","Cancer; Chirurgie; Confinement; Covid-19; Emergency; Isolation period; RT-PCR; Surgery; Triage; Urgence","Bentellis","I","Service d'urologie, andrologie, transplantation rénale, hôpital Pasteur 2, France",NA
"2589","34256992","10.1016/j.purol.2021.02.007","[Outcomes following the triage of patients for urological cancer and non-cancer surgery during Covid-19 pandemic peak].","Faced with the first wave of Covid-19 pandemic, guidelines for surgical triage were developed to free up healthcare resources. The aim of our study was to assess clinical characteristics and surgical outcomes of triaged patients during the first Covid-19 crisis. We conducted a cohort-controlled, non-randomized, study in a University Hospital of south-eastern France. Data were collected prospectively from consecutive patients after triage during the period from March 15th to May 1st and compared ","2021","07","17","Prog Urol","Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie","Cancer; Chirurgie; Confinement; Covid-19; Emergency; Isolation period; RT-PCR; Surgery; Triage; Urgence","Barthe","F","Service d'urologie, andrologie, transplantation rénale, hôpital Pasteur 2, France",NA
"2590","34256992","10.1016/j.purol.2021.02.007","[Outcomes following the triage of patients for urological cancer and non-cancer surgery during Covid-19 pandemic peak].","Faced with the first wave of Covid-19 pandemic, guidelines for surgical triage were developed to free up healthcare resources. The aim of our study was to assess clinical characteristics and surgical outcomes of triaged patients during the first Covid-19 crisis. We conducted a cohort-controlled, non-randomized, study in a University Hospital of south-eastern France. Data were collected prospectively from consecutive patients after triage during the period from March 15th to May 1st and compared ","2021","07","17","Prog Urol","Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie","Cancer; Chirurgie; Confinement; Covid-19; Emergency; Isolation period; RT-PCR; Surgery; Triage; Urgence","Tibi","B","Service d'urologie, andrologie, transplantation rénale, hôpital Pasteur 2, France",NA
"2591","34256992","10.1016/j.purol.2021.02.007","[Outcomes following the triage of patients for urological cancer and non-cancer surgery during Covid-19 pandemic peak].","Faced with the first wave of Covid-19 pandemic, guidelines for surgical triage were developed to free up healthcare resources. The aim of our study was to assess clinical characteristics and surgical outcomes of triaged patients during the first Covid-19 crisis. We conducted a cohort-controlled, non-randomized, study in a University Hospital of south-eastern France. Data were collected prospectively from consecutive patients after triage during the period from March 15th to May 1st and compared ","2021","07","17","Prog Urol","Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie","Cancer; Chirurgie; Confinement; Covid-19; Emergency; Isolation period; RT-PCR; Surgery; Triage; Urgence","Shaikh","A","Service d'urologie, andrologie, transplantation rénale, hôpital Pasteur 2, France",NA
"2592","34256992","10.1016/j.purol.2021.02.007","[Outcomes following the triage of patients for urological cancer and non-cancer surgery during Covid-19 pandemic peak].","Faced with the first wave of Covid-19 pandemic, guidelines for surgical triage were developed to free up healthcare resources. The aim of our study was to assess clinical characteristics and surgical outcomes of triaged patients during the first Covid-19 crisis. We conducted a cohort-controlled, non-randomized, study in a University Hospital of south-eastern France. Data were collected prospectively from consecutive patients after triage during the period from March 15th to May 1st and compared ","2021","07","17","Prog Urol","Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie","Cancer; Chirurgie; Confinement; Covid-19; Emergency; Isolation period; RT-PCR; Surgery; Triage; Urgence","Mellouki","A","Service d'urologie, andrologie, transplantation rénale, hôpital Pasteur 2, France",NA
"2593","34256992","10.1016/j.purol.2021.02.007","[Outcomes following the triage of patients for urological cancer and non-cancer surgery during Covid-19 pandemic peak].","Faced with the first wave of Covid-19 pandemic, guidelines for surgical triage were developed to free up healthcare resources. The aim of our study was to assess clinical characteristics and surgical outcomes of triaged patients during the first Covid-19 crisis. We conducted a cohort-controlled, non-randomized, study in a University Hospital of south-eastern France. Data were collected prospectively from consecutive patients after triage during the period from March 15th to May 1st and compared ","2021","07","17","Prog Urol","Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie","Cancer; Chirurgie; Confinement; Covid-19; Emergency; Isolation period; RT-PCR; Surgery; Triage; Urgence","Berthet","J-P","Service de Chirurgie Thoracique, Hôpital Pasteur, CHU de Nice, Nice, France",NA
"2594","34256992","10.1016/j.purol.2021.02.007","[Outcomes following the triage of patients for urological cancer and non-cancer surgery during Covid-19 pandemic peak].","Faced with the first wave of Covid-19 pandemic, guidelines for surgical triage were developed to free up healthcare resources. The aim of our study was to assess clinical characteristics and surgical outcomes of triaged patients during the first Covid-19 crisis. We conducted a cohort-controlled, non-randomized, study in a University Hospital of south-eastern France. Data were collected prospectively from consecutive patients after triage during the period from March 15th to May 1st and compared ","2021","07","17","Prog Urol","Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie","Cancer; Chirurgie; Confinement; Covid-19; Emergency; Isolation period; RT-PCR; Surgery; Triage; Urgence","Legueult","K","Service de santé publique, hôpital de L'Archet, université de Nice, Nice, France",NA
"2595","34256992","10.1016/j.purol.2021.02.007","[Outcomes following the triage of patients for urological cancer and non-cancer surgery during Covid-19 pandemic peak].","Faced with the first wave of Covid-19 pandemic, guidelines for surgical triage were developed to free up healthcare resources. The aim of our study was to assess clinical characteristics and surgical outcomes of triaged patients during the first Covid-19 crisis. We conducted a cohort-controlled, non-randomized, study in a University Hospital of south-eastern France. Data were collected prospectively from consecutive patients after triage during the period from March 15th to May 1st and compared ","2021","07","17","Prog Urol","Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie","Cancer; Chirurgie; Confinement; Covid-19; Emergency; Isolation period; RT-PCR; Surgery; Triage; Urgence","Pradier","C","Service de santé publique, hôpital de L'Archet, université de Nice, Nice, France",NA
"2596","34256992","10.1016/j.purol.2021.02.007","[Outcomes following the triage of patients for urological cancer and non-cancer surgery during Covid-19 pandemic peak].","Faced with the first wave of Covid-19 pandemic, guidelines for surgical triage were developed to free up healthcare resources. The aim of our study was to assess clinical characteristics and surgical outcomes of triaged patients during the first Covid-19 crisis. We conducted a cohort-controlled, non-randomized, study in a University Hospital of south-eastern France. Data were collected prospectively from consecutive patients after triage during the period from March 15th to May 1st and compared ","2021","07","17","Prog Urol","Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie","Cancer; Chirurgie; Confinement; Covid-19; Emergency; Isolation period; RT-PCR; Surgery; Triage; Urgence","Piche","T","Université Nice Côte d'Azur, CHU Nice, Inserm, U1065, C3M, France",NA
"2597","34256992","10.1016/j.purol.2021.02.007","[Outcomes following the triage of patients for urological cancer and non-cancer surgery during Covid-19 pandemic peak].","Faced with the first wave of Covid-19 pandemic, guidelines for surgical triage were developed to free up healthcare resources. The aim of our study was to assess clinical characteristics and surgical outcomes of triaged patients during the first Covid-19 crisis. We conducted a cohort-controlled, non-randomized, study in a University Hospital of south-eastern France. Data were collected prospectively from consecutive patients after triage during the period from March 15th to May 1st and compared ","2021","07","17","Prog Urol","Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie","Cancer; Chirurgie; Confinement; Covid-19; Emergency; Isolation period; RT-PCR; Surgery; Triage; Urgence","Ahallal","Y","Service d'urologie, andrologie, transplantation rénale, hôpital Pasteur 2, France",NA
"2598","34256992","10.1016/j.purol.2021.02.007","[Outcomes following the triage of patients for urological cancer and non-cancer surgery during Covid-19 pandemic peak].","Faced with the first wave of Covid-19 pandemic, guidelines for surgical triage were developed to free up healthcare resources. The aim of our study was to assess clinical characteristics and surgical outcomes of triaged patients during the first Covid-19 crisis. We conducted a cohort-controlled, non-randomized, study in a University Hospital of south-eastern France. Data were collected prospectively from consecutive patients after triage during the period from March 15th to May 1st and compared ","2021","07","17","Prog Urol","Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie","Cancer; Chirurgie; Confinement; Covid-19; Emergency; Isolation period; RT-PCR; Surgery; Triage; Urgence","Chevallier","D","Service d'urologie, andrologie, transplantation rénale, hôpital Pasteur 2, France",NA
"2599","34256983","10.1016/j.ejim.2021.06.025","Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT).",NA,"2021","07","21","Eur J Intern Med","European journal of internal medicine","Adrenal hemorrhage; Adrenal insufficiency; AstraZeneca COVID-19 vaccination; ChAdOx1 nCoV-19 Vaccine; Immune thrombotic thrombocytopenia","Varona","Jose F","Departamento de Medicina Interna, Hospital Universitario HM Monteprincipe, HM Hospitales, Madrid, Spain","jfvarona@hmhospitales.com"
"2600","34256983","10.1016/j.ejim.2021.06.025","Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT).",NA,"2021","07","21","Eur J Intern Med","European journal of internal medicine","Adrenal hemorrhage; Adrenal insufficiency; AstraZeneca COVID-19 vaccination; ChAdOx1 nCoV-19 Vaccine; Immune thrombotic thrombocytopenia","García-Isidro","Millán","Departamento de Radiodiagnóstico, Hospital Universitario HM Monteprincipe, HM Hospitales, Madrid, Spain",NA
"2601","34256983","10.1016/j.ejim.2021.06.025","Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT).",NA,"2021","07","21","Eur J Intern Med","European journal of internal medicine","Adrenal hemorrhage; Adrenal insufficiency; AstraZeneca COVID-19 vaccination; ChAdOx1 nCoV-19 Vaccine; Immune thrombotic thrombocytopenia","Moeinvaziri","Mojdeh","Departamento de Radiodiagnóstico, Hospital Universitario HM Monteprincipe, HM Hospitales, Madrid, Spain",NA
"2602","34256983","10.1016/j.ejim.2021.06.025","Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT).",NA,"2021","07","21","Eur J Intern Med","European journal of internal medicine","Adrenal hemorrhage; Adrenal insufficiency; AstraZeneca COVID-19 vaccination; ChAdOx1 nCoV-19 Vaccine; Immune thrombotic thrombocytopenia","Ramos-López","María","Departamento de Radiodiagnóstico, Hospital Universitario HM Monteprincipe, HM Hospitales, Madrid, Spain",NA
"2603","34256983","10.1016/j.ejim.2021.06.025","Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT).",NA,"2021","07","21","Eur J Intern Med","European journal of internal medicine","Adrenal hemorrhage; Adrenal insufficiency; AstraZeneca COVID-19 vaccination; ChAdOx1 nCoV-19 Vaccine; Immune thrombotic thrombocytopenia","Fernández-Domínguez","Manuel","Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain",NA
"2605","34256973","10.1016/j.eimc.2021.06.012","Acute bronchiolitis during the COVID-19 pandemic.","The autumn and winter bronchiolitis epidemics have virtually disappeared in the first year of the COVID-19 pandemic. Our objectives were characterised bronchiolitis during fourth quarter of 2020 and the role played by SARS-CoV-2. Prospective multi-centre study performed in Madrid (Spain) between October and December 2020 including all children admitted with acute bronchiolitis. Clinical data were collected and multiplex PCR for respiratory viruses were performed. Thirty-three patients were hospi","2021","07","14","Enferm Infecc Microbiol Clin","Enfermedades infecciosas y microbiologia clinica","Bronchiolitis; Bronquiolitis; COVID-19; Children; Niños; Pandemia; Pandemic; Rhinovirus; Rinovirus; SARS-CoV-2; Sincitial respiratory virus; Virus sincitial respiratorio","Flores-Pérez","Patricia","Pediatric Department, Hospital Universitario Niño Jesús, Madrid, Spain",NA
"2606","34256973","10.1016/j.eimc.2021.06.012","Acute bronchiolitis during the COVID-19 pandemic.","The autumn and winter bronchiolitis epidemics have virtually disappeared in the first year of the COVID-19 pandemic. Our objectives were characterised bronchiolitis during fourth quarter of 2020 and the role played by SARS-CoV-2. Prospective multi-centre study performed in Madrid (Spain) between October and December 2020 including all children admitted with acute bronchiolitis. Clinical data were collected and multiplex PCR for respiratory viruses were performed. Thirty-three patients were hospi","2021","07","14","Enferm Infecc Microbiol Clin","Enfermedades infecciosas y microbiologia clinica","Bronchiolitis; Bronquiolitis; COVID-19; Children; Niños; Pandemia; Pandemic; Rhinovirus; Rinovirus; SARS-CoV-2; Sincitial respiratory virus; Virus sincitial respiratorio","Gerig","Nathalia","Pediatric Infectious Diseases Department, Hospital Universitario La Paz, Fundación IdiPaz, Traslational Research Network in Pediatric Infectious Diseases (RITIP), Madrid, Spain",NA
"2607","34256973","10.1016/j.eimc.2021.06.012","Acute bronchiolitis during the COVID-19 pandemic.","The autumn and winter bronchiolitis epidemics have virtually disappeared in the first year of the COVID-19 pandemic. Our objectives were characterised bronchiolitis during fourth quarter of 2020 and the role played by SARS-CoV-2. Prospective multi-centre study performed in Madrid (Spain) between October and December 2020 including all children admitted with acute bronchiolitis. Clinical data were collected and multiplex PCR for respiratory viruses were performed. Thirty-three patients were hospi","2021","07","14","Enferm Infecc Microbiol Clin","Enfermedades infecciosas y microbiologia clinica","Bronchiolitis; Bronquiolitis; COVID-19; Children; Niños; Pandemia; Pandemic; Rhinovirus; Rinovirus; SARS-CoV-2; Sincitial respiratory virus; Virus sincitial respiratorio","Cabrera-López","Mª Isabel","Pediatric Department, Hospital Universitario Niño Jesús, Madrid, Spain",NA
"2608","34256973","10.1016/j.eimc.2021.06.012","Acute bronchiolitis during the COVID-19 pandemic.","The autumn and winter bronchiolitis epidemics have virtually disappeared in the first year of the COVID-19 pandemic. Our objectives were characterised bronchiolitis during fourth quarter of 2020 and the role played by SARS-CoV-2. Prospective multi-centre study performed in Madrid (Spain) between October and December 2020 including all children admitted with acute bronchiolitis. Clinical data were collected and multiplex PCR for respiratory viruses were performed. Thirty-three patients were hospi","2021","07","14","Enferm Infecc Microbiol Clin","Enfermedades infecciosas y microbiologia clinica","Bronchiolitis; Bronquiolitis; COVID-19; Children; Niños; Pandemia; Pandemic; Rhinovirus; Rinovirus; SARS-CoV-2; Sincitial respiratory virus; Virus sincitial respiratorio","de Unzueta-Roch","José L","Pediatric Department, Hospital Universitario Niño Jesús, Madrid, Spain",NA
"2609","34256973","10.1016/j.eimc.2021.06.012","Acute bronchiolitis during the COVID-19 pandemic.","The autumn and winter bronchiolitis epidemics have virtually disappeared in the first year of the COVID-19 pandemic. Our objectives were characterised bronchiolitis during fourth quarter of 2020 and the role played by SARS-CoV-2. Prospective multi-centre study performed in Madrid (Spain) between October and December 2020 including all children admitted with acute bronchiolitis. Clinical data were collected and multiplex PCR for respiratory viruses were performed. Thirty-three patients were hospi","2021","07","14","Enferm Infecc Microbiol Clin","Enfermedades infecciosas y microbiologia clinica","Bronchiolitis; Bronquiolitis; COVID-19; Children; Niños; Pandemia; Pandemic; Rhinovirus; Rinovirus; SARS-CoV-2; Sincitial respiratory virus; Virus sincitial respiratorio","Del Rosal","Teresa","Pediatric Infectious Diseases Department, Hospital Universitario La Paz, Fundación IdiPaz, Traslational Research Network in Pediatric Infectious Diseases (RITIP), Madrid, Spain",NA
"2610","34256973","10.1016/j.eimc.2021.06.012","Acute bronchiolitis during the COVID-19 pandemic.","The autumn and winter bronchiolitis epidemics have virtually disappeared in the first year of the COVID-19 pandemic. Our objectives were characterised bronchiolitis during fourth quarter of 2020 and the role played by SARS-CoV-2. Prospective multi-centre study performed in Madrid (Spain) between October and December 2020 including all children admitted with acute bronchiolitis. Clinical data were collected and multiplex PCR for respiratory viruses were performed. Thirty-three patients were hospi","2021","07","14","Enferm Infecc Microbiol Clin","Enfermedades infecciosas y microbiologia clinica","Bronchiolitis; Bronquiolitis; COVID-19; Children; Niños; Pandemia; Pandemic; Rhinovirus; Rinovirus; SARS-CoV-2; Sincitial respiratory virus; Virus sincitial respiratorio","Calvo","Cristina","Pediatric Infectious Diseases Department, Hospital Universitario La Paz, Fundación IdiPaz, Traslational Research Network in Pediatric Infectious Diseases (RITIP), Madrid, Spain. Electronic address: ccalvorey@gmail","ccalvorey@gmail.com"
"2611","34256956","10.1016/j.bjoms.2020.11.017","Surgical training during the COVID-19 pandemic: preparing for future uncertainty.","The COVID-19 pandemic has brought unprecedented changes in healthcare and surgical training, with elective operating reduced or stopped, conferences rearranged and examinations cancelled. Trainees and trainers have adapted, creating innovative and resourceful ways to continue learning, enabling progression through surgical training. With rising COVID-19 cases across the world and further waves of infections likely, we reflect on recent changes to surgical training and discuss how best to support","2021","07","17","Br J Oral Maxillofac Surg","The British journal of oral &amp; maxillofacial surgery","COVID-19; Development; Education; Examinations; Surgery; Training","Ellis","R","Intercollegiate Committee for Basic Surgical Examinations, United Kingdom","Rickyellis@nhs.net"
"2612","34256956","10.1016/j.bjoms.2020.11.017","Surgical training during the COVID-19 pandemic: preparing for future uncertainty.","The COVID-19 pandemic has brought unprecedented changes in healthcare and surgical training, with elective operating reduced or stopped, conferences rearranged and examinations cancelled. Trainees and trainers have adapted, creating innovative and resourceful ways to continue learning, enabling progression through surgical training. With rising COVID-19 cases across the world and further waves of infections likely, we reflect on recent changes to surgical training and discuss how best to support","2021","07","17","Br J Oral Maxillofac Surg","The British journal of oral &amp; maxillofacial surgery","COVID-19; Development; Education; Examinations; Surgery; Training","Scrimgeour","D S G","Intercollegiate Committee for Basic Surgical Examinations, United Kingdom","duncan.scrimgeour@nhs.scot"
"2613","34256956","10.1016/j.bjoms.2020.11.017","Surgical training during the COVID-19 pandemic: preparing for future uncertainty.","The COVID-19 pandemic has brought unprecedented changes in healthcare and surgical training, with elective operating reduced or stopped, conferences rearranged and examinations cancelled. Trainees and trainers have adapted, creating innovative and resourceful ways to continue learning, enabling progression through surgical training. With rising COVID-19 cases across the world and further waves of infections likely, we reflect on recent changes to surgical training and discuss how best to support","2021","07","17","Br J Oral Maxillofac Surg","The British journal of oral &amp; maxillofacial surgery","COVID-19; Development; Education; Examinations; Surgery; Training","Brennan","P A","Intercollegiate Committee for Basic Surgical Examinations, United Kingdom","Peter.brennan@porthosp.nhs.uk"
"2614","34256936","10.1016/j.medcli.2021.05.013","Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients.","Strategies to determine who could be safely discharged home from the Emergency Department (ED) in COVID-19 are needed to decongestion healthcare systems. To describe the outcomes of an ED triage system for non-severe patients with suspected COVID-19 and possible pneumonia based on chest X-ray (CXR) upon admission. Retrospective, single-center study performed in Barcelona (Spain) during the COVID-19 peak in March-April 2020. Patients with COVID-19 symptoms and potential pneumonia, without respira","2021","07","17","Med Clin (Barc)","Medicina clinica","COVID-19; Emergencias; Emergency; Neumonía; Pneumonia; Radiografía; Radiography; Triage; Triaje","Sempere-González","Abiu","Emergency Department, University Hospital Vall d'Hebron, Barcelona, Spain",NA
"2615","34256936","10.1016/j.medcli.2021.05.013","Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients.","Strategies to determine who could be safely discharged home from the Emergency Department (ED) in COVID-19 are needed to decongestion healthcare systems. To describe the outcomes of an ED triage system for non-severe patients with suspected COVID-19 and possible pneumonia based on chest X-ray (CXR) upon admission. Retrospective, single-center study performed in Barcelona (Spain) during the COVID-19 peak in March-April 2020. Patients with COVID-19 symptoms and potential pneumonia, without respira","2021","07","17","Med Clin (Barc)","Medicina clinica","COVID-19; Emergencias; Emergency; Neumonía; Pneumonia; Radiografía; Radiography; Triage; Triaje","Llaneras-Artigues","Jordi","Emergency Department, University Hospital Vall d'Hebron, Barcelona, Spain",NA
"2616","34256936","10.1016/j.medcli.2021.05.013","Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients.","Strategies to determine who could be safely discharged home from the Emergency Department (ED) in COVID-19 are needed to decongestion healthcare systems. To describe the outcomes of an ED triage system for non-severe patients with suspected COVID-19 and possible pneumonia based on chest X-ray (CXR) upon admission. Retrospective, single-center study performed in Barcelona (Spain) during the COVID-19 peak in March-April 2020. Patients with COVID-19 symptoms and potential pneumonia, without respira","2021","07","17","Med Clin (Barc)","Medicina clinica","COVID-19; Emergencias; Emergency; Neumonía; Pneumonia; Radiografía; Radiography; Triage; Triaje","Pinal-Fernández","Iago","National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MA, USA",NA
"2617","34256936","10.1016/j.medcli.2021.05.013","Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients.","Strategies to determine who could be safely discharged home from the Emergency Department (ED) in COVID-19 are needed to decongestion healthcare systems. To describe the outcomes of an ED triage system for non-severe patients with suspected COVID-19 and possible pneumonia based on chest X-ray (CXR) upon admission. Retrospective, single-center study performed in Barcelona (Spain) during the COVID-19 peak in March-April 2020. Patients with COVID-19 symptoms and potential pneumonia, without respira","2021","07","17","Med Clin (Barc)","Medicina clinica","COVID-19; Emergencias; Emergency; Neumonía; Pneumonia; Radiografía; Radiography; Triage; Triaje","Cañas-Ruano","Esperanza","Emergency Department, University Hospital Vall d'Hebron, Barcelona, Spain",NA
"2618","34256936","10.1016/j.medcli.2021.05.013","Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients.","Strategies to determine who could be safely discharged home from the Emergency Department (ED) in COVID-19 are needed to decongestion healthcare systems. To describe the outcomes of an ED triage system for non-severe patients with suspected COVID-19 and possible pneumonia based on chest X-ray (CXR) upon admission. Retrospective, single-center study performed in Barcelona (Spain) during the COVID-19 peak in March-April 2020. Patients with COVID-19 symptoms and potential pneumonia, without respira","2021","07","17","Med Clin (Barc)","Medicina clinica","COVID-19; Emergencias; Emergency; Neumonía; Pneumonia; Radiografía; Radiography; Triage; Triaje","Orozco-Gálvez","Olimpia","Emergency Department, University Hospital Vall d'Hebron, Barcelona, Spain",NA
"2619","34256936","10.1016/j.medcli.2021.05.013","Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients.","Strategies to determine who could be safely discharged home from the Emergency Department (ED) in COVID-19 are needed to decongestion healthcare systems. To describe the outcomes of an ED triage system for non-severe patients with suspected COVID-19 and possible pneumonia based on chest X-ray (CXR) upon admission. Retrospective, single-center study performed in Barcelona (Spain) during the COVID-19 peak in March-April 2020. Patients with COVID-19 symptoms and potential pneumonia, without respira","2021","07","17","Med Clin (Barc)","Medicina clinica","COVID-19; Emergencias; Emergency; Neumonía; Pneumonia; Radiografía; Radiography; Triage; Triaje","Domingo-Baldrich","Eva","Emergency Department, University Hospital Vall d'Hebron, Barcelona, Spain",NA
"2620","34256936","10.1016/j.medcli.2021.05.013","Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients.","Strategies to determine who could be safely discharged home from the Emergency Department (ED) in COVID-19 are needed to decongestion healthcare systems. To describe the outcomes of an ED triage system for non-severe patients with suspected COVID-19 and possible pneumonia based on chest X-ray (CXR) upon admission. Retrospective, single-center study performed in Barcelona (Spain) during the COVID-19 peak in March-April 2020. Patients with COVID-19 symptoms and potential pneumonia, without respira","2021","07","17","Med Clin (Barc)","Medicina clinica","COVID-19; Emergencias; Emergency; Neumonía; Pneumonia; Radiografía; Radiography; Triage; Triaje","Michelena","Xabier","Emergency Department, University Hospital Vall d'Hebron, Barcelona, Spain",NA
"2621","34256936","10.1016/j.medcli.2021.05.013","Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients.","Strategies to determine who could be safely discharged home from the Emergency Department (ED) in COVID-19 are needed to decongestion healthcare systems. To describe the outcomes of an ED triage system for non-severe patients with suspected COVID-19 and possible pneumonia based on chest X-ray (CXR) upon admission. Retrospective, single-center study performed in Barcelona (Spain) during the COVID-19 peak in March-April 2020. Patients with COVID-19 symptoms and potential pneumonia, without respira","2021","07","17","Med Clin (Barc)","Medicina clinica","COVID-19; Emergencias; Emergency; Neumonía; Pneumonia; Radiografía; Radiography; Triage; Triaje","Meza","Beatriz","Emergency Department, University Hospital Vall d'Hebron, Barcelona, Spain",NA
"2622","34256936","10.1016/j.medcli.2021.05.013","Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients.","Strategies to determine who could be safely discharged home from the Emergency Department (ED) in COVID-19 are needed to decongestion healthcare systems. To describe the outcomes of an ED triage system for non-severe patients with suspected COVID-19 and possible pneumonia based on chest X-ray (CXR) upon admission. Retrospective, single-center study performed in Barcelona (Spain) during the COVID-19 peak in March-April 2020. Patients with COVID-19 symptoms and potential pneumonia, without respira","2021","07","17","Med Clin (Barc)","Medicina clinica","COVID-19; Emergencias; Emergency; Neumonía; Pneumonia; Radiografía; Radiography; Triage; Triaje","García-Vives","Eloi","Emergency Department, University Hospital Vall d'Hebron, Barcelona, Spain",NA
"2623","34256936","10.1016/j.medcli.2021.05.013","Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients.","Strategies to determine who could be safely discharged home from the Emergency Department (ED) in COVID-19 are needed to decongestion healthcare systems. To describe the outcomes of an ED triage system for non-severe patients with suspected COVID-19 and possible pneumonia based on chest X-ray (CXR) upon admission. Retrospective, single-center study performed in Barcelona (Spain) during the COVID-19 peak in March-April 2020. Patients with COVID-19 symptoms and potential pneumonia, without respira","2021","07","17","Med Clin (Barc)","Medicina clinica","COVID-19; Emergencias; Emergency; Neumonía; Pneumonia; Radiografía; Radiography; Triage; Triaje","Gil-Vila","Albert","Emergency Department, University Hospital Vall d'Hebron, Barcelona, Spain",NA
"2624","34256936","10.1016/j.medcli.2021.05.013","Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients.","Strategies to determine who could be safely discharged home from the Emergency Department (ED) in COVID-19 are needed to decongestion healthcare systems. To describe the outcomes of an ED triage system for non-severe patients with suspected COVID-19 and possible pneumonia based on chest X-ray (CXR) upon admission. Retrospective, single-center study performed in Barcelona (Spain) during the COVID-19 peak in March-April 2020. Patients with COVID-19 symptoms and potential pneumonia, without respira","2021","07","17","Med Clin (Barc)","Medicina clinica","COVID-19; Emergencias; Emergency; Neumonía; Pneumonia; Radiografía; Radiography; Triage; Triaje","Sarrapio-Lorenzo","Javier","Emergency Department, University Hospital Vall d'Hebron, Barcelona, Spain",NA
"2625","34256936","10.1016/j.medcli.2021.05.013","Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients.","Strategies to determine who could be safely discharged home from the Emergency Department (ED) in COVID-19 are needed to decongestion healthcare systems. To describe the outcomes of an ED triage system for non-severe patients with suspected COVID-19 and possible pneumonia based on chest X-ray (CXR) upon admission. Retrospective, single-center study performed in Barcelona (Spain) during the COVID-19 peak in March-April 2020. Patients with COVID-19 symptoms and potential pneumonia, without respira","2021","07","17","Med Clin (Barc)","Medicina clinica","COVID-19; Emergencias; Emergency; Neumonía; Pneumonia; Radiografía; Radiography; Triage; Triaje","Romero-Ruperto","Sheila","Emergency Department, University Hospital Vall d'Hebron, Barcelona, Spain",NA
"2626","34256936","10.1016/j.medcli.2021.05.013","Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients.","Strategies to determine who could be safely discharged home from the Emergency Department (ED) in COVID-19 are needed to decongestion healthcare systems. To describe the outcomes of an ED triage system for non-severe patients with suspected COVID-19 and possible pneumonia based on chest X-ray (CXR) upon admission. Retrospective, single-center study performed in Barcelona (Spain) during the COVID-19 peak in March-April 2020. Patients with COVID-19 symptoms and potential pneumonia, without respira","2021","07","17","Med Clin (Barc)","Medicina clinica","COVID-19; Emergencias; Emergency; Neumonía; Pneumonia; Radiografía; Radiography; Triage; Triaje","Sanpedro-Jiménez","Francesc","Emergency Department, University Hospital Vall d'Hebron, Barcelona, Spain",NA
"2627","34256936","10.1016/j.medcli.2021.05.013","Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients.","Strategies to determine who could be safely discharged home from the Emergency Department (ED) in COVID-19 are needed to decongestion healthcare systems. To describe the outcomes of an ED triage system for non-severe patients with suspected COVID-19 and possible pneumonia based on chest X-ray (CXR) upon admission. Retrospective, single-center study performed in Barcelona (Spain) during the COVID-19 peak in March-April 2020. Patients with COVID-19 symptoms and potential pneumonia, without respira","2021","07","17","Med Clin (Barc)","Medicina clinica","COVID-19; Emergencias; Emergency; Neumonía; Pneumonia; Radiografía; Radiography; Triage; Triaje","Arranz-Betegón","María","Emergency Department, University Hospital Vall d'Hebron, Barcelona, Spain",NA
"2628","34256936","10.1016/j.medcli.2021.05.013","Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients.","Strategies to determine who could be safely discharged home from the Emergency Department (ED) in COVID-19 are needed to decongestion healthcare systems. To describe the outcomes of an ED triage system for non-severe patients with suspected COVID-19 and possible pneumonia based on chest X-ray (CXR) upon admission. Retrospective, single-center study performed in Barcelona (Spain) during the COVID-19 peak in March-April 2020. Patients with COVID-19 symptoms and potential pneumonia, without respira","2021","07","17","Med Clin (Barc)","Medicina clinica","COVID-19; Emergencias; Emergency; Neumonía; Pneumonia; Radiografía; Radiography; Triage; Triaje","Fernández-Codina","Andreu","Emergency Department, University Hospital Vall d'Hebron, Barcelona, Spain","Andreu.fernandezcodina@wrh.on.ca"
"2629","34256928","10.1016/j.jstrokecerebrovasdis.2021.105982","Retraction notice to ""Impact of the COVID-19 Pandemic on Stroke Epidemiology and Clinical Stroke Practice in the US"" [Journal of Stroke and Cerebrovascular Diseases, Vol. 30, No. 4 (April), 2021: 105639].",NA,"2021","07","21","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association",NA,"Friedlich","Daniel","Stroke Director, Southwest Healthcare System, 36485 Inland Valley Drive, Wildomar, CA 92595, United States",NA
"2630","34256928","10.1016/j.jstrokecerebrovasdis.2021.105982","Retraction notice to ""Impact of the COVID-19 Pandemic on Stroke Epidemiology and Clinical Stroke Practice in the US"" [Journal of Stroke and Cerebrovascular Diseases, Vol. 30, No. 4 (April), 2021: 105639].",NA,"2021","07","21","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association",NA,"Newman","Tali","UCSD Research Assistant, 9500 Gilman Dr., La Jolla, CA 92093, United States",NA
"2631","34256928","10.1016/j.jstrokecerebrovasdis.2021.105982","Retraction notice to ""Impact of the COVID-19 Pandemic on Stroke Epidemiology and Clinical Stroke Practice in the US"" [Journal of Stroke and Cerebrovascular Diseases, Vol. 30, No. 4 (April), 2021: 105639].",NA,"2021","07","21","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association",NA,"Bricker","Stephanie","Stroke Coor- dinator, Southwest Healthcare Systems, 36485 Inland Valley Drive, Wildomar, CA 92595, United States",NA
"2632","34256902","10.20344/amp.16319","[Immune Response to Single-Dose Moderna Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2].",NA,"2021","07","14","Acta Med Port","Acta medica portuguesa","COVID-19/immunology; Health Personnel; Pandemic; SARS-CoV-2; Vaccines COVID-19/immunology","Moreira-Pinto","João","Conselho de Gestão. Hospital-Escola da Universidade Fernando Pessoa. Gondomar. EpiUnit. Instituto de Saúde Pública. Universidade do Porto. Porto. Portugal",NA
"2633","34256902","10.20344/amp.16319","[Immune Response to Single-Dose Moderna Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2].",NA,"2021","07","14","Acta Med Port","Acta medica portuguesa","COVID-19/immunology; Health Personnel; Pandemic; SARS-CoV-2; Vaccines COVID-19/immunology","Gregório","Susana","Conselho de Gestão. Hospital-Escola da Universidade Fernando Pessoa. Gondomar. Portugal",NA
"2634","34256902","10.20344/amp.16319","[Immune Response to Single-Dose Moderna Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2].",NA,"2021","07","14","Acta Med Port","Acta medica portuguesa","COVID-19/immunology; Health Personnel; Pandemic; SARS-CoV-2; Vaccines COVID-19/immunology","Camarinha","João","Conselho de Gestão. Hospital-Escola da Universidade Fernando Pessoa. Gondomar. Portugal",NA
"2635","34256902","10.20344/amp.16319","[Immune Response to Single-Dose Moderna Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2].",NA,"2021","07","14","Acta Med Port","Acta medica portuguesa","COVID-19/immunology; Health Personnel; Pandemic; SARS-CoV-2; Vaccines COVID-19/immunology","Soares","Bruno","Conselho de Gestão. Hospital-Escola da Universidade Fernando Pessoa. Gondomar. Portugal",NA
"2636","34256902","10.20344/amp.16319","[Immune Response to Single-Dose Moderna Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2].",NA,"2021","07","14","Acta Med Port","Acta medica portuguesa","COVID-19/immunology; Health Personnel; Pandemic; SARS-CoV-2; Vaccines COVID-19/immunology","Cunha Ramos","João","Medicina Laboratorial Dr. Carlos Torres - Grupo Unilabs Portugal. Porto. Portugal",NA
"2637","34256887","10.1192/bjo.2021.968","Patient adherence with infection control measures on a novel 'COVID-19 triage' psychiatric in-patient ward.","Intra-hospital transmission of coronavirus disease 2019 (COVID-19) is a major concern. Psychiatric in-patient units pose unique challenges for the prevention of transmission. 'COVID-triage' wards with strict infection control procedures have been implemented to prevent the spread of infection, but little is known about the extent to which psychiatric in-patients adhere to these procedures. To examine patient adherence with infection control measures on a novel 'COVID-triage' psychiatric in-patie","2021","07","17","BJPsych Open","BJPsych open","COVID-19; in-patient treatment; infection control; personality disorders; psychotic disorders","Williams","Ryan","South London and Maudsley NHS Foundation Trust, UK",NA
"2638","34256887","10.1192/bjo.2021.968","Patient adherence with infection control measures on a novel 'COVID-19 triage' psychiatric in-patient ward.","Intra-hospital transmission of coronavirus disease 2019 (COVID-19) is a major concern. Psychiatric in-patient units pose unique challenges for the prevention of transmission. 'COVID-triage' wards with strict infection control procedures have been implemented to prevent the spread of infection, but little is known about the extent to which psychiatric in-patients adhere to these procedures. To examine patient adherence with infection control measures on a novel 'COVID-triage' psychiatric in-patie","2021","07","17","BJPsych Open","BJPsych open","COVID-19; in-patient treatment; infection control; personality disorders; psychotic disorders","Tweed","John","South London and Maudsley NHS Foundation Trust, UK",NA
"2639","34256887","10.1192/bjo.2021.968","Patient adherence with infection control measures on a novel 'COVID-19 triage' psychiatric in-patient ward.","Intra-hospital transmission of coronavirus disease 2019 (COVID-19) is a major concern. Psychiatric in-patient units pose unique challenges for the prevention of transmission. 'COVID-triage' wards with strict infection control procedures have been implemented to prevent the spread of infection, but little is known about the extent to which psychiatric in-patients adhere to these procedures. To examine patient adherence with infection control measures on a novel 'COVID-triage' psychiatric in-patie","2021","07","17","BJPsych Open","BJPsych open","COVID-19; in-patient treatment; infection control; personality disorders; psychotic disorders","Rebolledo","Laura","South London and Maudsley NHS Foundation Trust, UK",NA
"2640","34256887","10.1192/bjo.2021.968","Patient adherence with infection control measures on a novel 'COVID-19 triage' psychiatric in-patient ward.","Intra-hospital transmission of coronavirus disease 2019 (COVID-19) is a major concern. Psychiatric in-patient units pose unique challenges for the prevention of transmission. 'COVID-triage' wards with strict infection control procedures have been implemented to prevent the spread of infection, but little is known about the extent to which psychiatric in-patients adhere to these procedures. To examine patient adherence with infection control measures on a novel 'COVID-triage' psychiatric in-patie","2021","07","17","BJPsych Open","BJPsych open","COVID-19; in-patient treatment; infection control; personality disorders; psychotic disorders","Khalid","Osman","South London and Maudsley NHS Foundation Trust, UK",NA
"2641","34256887","10.1192/bjo.2021.968","Patient adherence with infection control measures on a novel 'COVID-19 triage' psychiatric in-patient ward.","Intra-hospital transmission of coronavirus disease 2019 (COVID-19) is a major concern. Psychiatric in-patient units pose unique challenges for the prevention of transmission. 'COVID-triage' wards with strict infection control procedures have been implemented to prevent the spread of infection, but little is known about the extent to which psychiatric in-patients adhere to these procedures. To examine patient adherence with infection control measures on a novel 'COVID-triage' psychiatric in-patie","2021","07","17","BJPsych Open","BJPsych open","COVID-19; in-patient treatment; infection control; personality disorders; psychotic disorders","Agyeman","Josephine","South London and Maudsley NHS Foundation Trust, UK",NA
"2642","34256887","10.1192/bjo.2021.968","Patient adherence with infection control measures on a novel 'COVID-19 triage' psychiatric in-patient ward.","Intra-hospital transmission of coronavirus disease 2019 (COVID-19) is a major concern. Psychiatric in-patient units pose unique challenges for the prevention of transmission. 'COVID-triage' wards with strict infection control procedures have been implemented to prevent the spread of infection, but little is known about the extent to which psychiatric in-patients adhere to these procedures. To examine patient adherence with infection control measures on a novel 'COVID-triage' psychiatric in-patie","2021","07","17","BJPsych Open","BJPsych open","COVID-19; in-patient treatment; infection control; personality disorders; psychotic disorders","Pinto da Costa","Mariana","South London and Maudsley NHS Foundation Trust, UK",NA
"2643","34256885","10.1017/S1049023X21000728","911 EMS Activations by Pregnant Patients in Maryland (USA) during the COVID-19 Pandemic.","In the early phase of the coronavirus disease 2019 (COVID-19) pandemic, United States Emergency Medical Services (EMS) experienced a decrease in calls, and at the same time, an increase in out-of-hospital deaths. This finding led to a concern for the implications of potential delays in care for the obstetric population. This study examines the impact of the pandemic on prehospital care amongst pregnant women. A retrospective observational study was conducted comparing obstetric-related EMS activ","2021","07","14","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; maternal health; pandemics; pregnancy complications","Hadley","Megan E","Johns Hopkins School of Medicine, Baltimore, MarylandUSA",NA
"2644","34256885","10.1017/S1049023X21000728","911 EMS Activations by Pregnant Patients in Maryland (USA) during the COVID-19 Pandemic.","In the early phase of the coronavirus disease 2019 (COVID-19) pandemic, United States Emergency Medical Services (EMS) experienced a decrease in calls, and at the same time, an increase in out-of-hospital deaths. This finding led to a concern for the implications of potential delays in care for the obstetric population. This study examines the impact of the pandemic on prehospital care amongst pregnant women. A retrospective observational study was conducted comparing obstetric-related EMS activ","2021","07","14","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; maternal health; pandemics; pregnancy complications","Vaught","Arthur J","Maternal-Fetal Medicine and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, MarylandUSA",NA
"2645","34256885","10.1017/S1049023X21000728","911 EMS Activations by Pregnant Patients in Maryland (USA) during the COVID-19 Pandemic.","In the early phase of the coronavirus disease 2019 (COVID-19) pandemic, United States Emergency Medical Services (EMS) experienced a decrease in calls, and at the same time, an increase in out-of-hospital deaths. This finding led to a concern for the implications of potential delays in care for the obstetric population. This study examines the impact of the pandemic on prehospital care amongst pregnant women. A retrospective observational study was conducted comparing obstetric-related EMS activ","2021","07","14","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; maternal health; pandemics; pregnancy complications","Margolis","Asa M","Department of Emergency Medicine, Johns Hopkins School of Medicine, Baltimore, MarylandUSA",NA
"2646","34256885","10.1017/S1049023X21000728","911 EMS Activations by Pregnant Patients in Maryland (USA) during the COVID-19 Pandemic.","In the early phase of the coronavirus disease 2019 (COVID-19) pandemic, United States Emergency Medical Services (EMS) experienced a decrease in calls, and at the same time, an increase in out-of-hospital deaths. This finding led to a concern for the implications of potential delays in care for the obstetric population. This study examines the impact of the pandemic on prehospital care amongst pregnant women. A retrospective observational study was conducted comparing obstetric-related EMS activ","2021","07","14","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; maternal health; pandemics; pregnancy complications","Chizmar","Timothy P","Maryland Institute for Emergency Medical Services Systems, Baltimore, MarylandUSA",NA
"2647","34256885","10.1017/S1049023X21000728","911 EMS Activations by Pregnant Patients in Maryland (USA) during the COVID-19 Pandemic.","In the early phase of the coronavirus disease 2019 (COVID-19) pandemic, United States Emergency Medical Services (EMS) experienced a decrease in calls, and at the same time, an increase in out-of-hospital deaths. This finding led to a concern for the implications of potential delays in care for the obstetric population. This study examines the impact of the pandemic on prehospital care amongst pregnant women. A retrospective observational study was conducted comparing obstetric-related EMS activ","2021","07","14","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; maternal health; pandemics; pregnancy complications","Alemayehu","Teferra","Maryland Institute for Emergency Medical Services Systems, Baltimore, MarylandUSA",NA
"2648","34256885","10.1017/S1049023X21000728","911 EMS Activations by Pregnant Patients in Maryland (USA) during the COVID-19 Pandemic.","In the early phase of the coronavirus disease 2019 (COVID-19) pandemic, United States Emergency Medical Services (EMS) experienced a decrease in calls, and at the same time, an increase in out-of-hospital deaths. This finding led to a concern for the implications of potential delays in care for the obstetric population. This study examines the impact of the pandemic on prehospital care amongst pregnant women. A retrospective observational study was conducted comparing obstetric-related EMS activ","2021","07","14","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; maternal health; pandemics; pregnancy complications","Halscott","Torre","Maternal-Fetal Medicine and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, MarylandUSA",NA
"2649","34256885","10.1017/S1049023X21000728","911 EMS Activations by Pregnant Patients in Maryland (USA) during the COVID-19 Pandemic.","In the early phase of the coronavirus disease 2019 (COVID-19) pandemic, United States Emergency Medical Services (EMS) experienced a decrease in calls, and at the same time, an increase in out-of-hospital deaths. This finding led to a concern for the implications of potential delays in care for the obstetric population. This study examines the impact of the pandemic on prehospital care amongst pregnant women. A retrospective observational study was conducted comparing obstetric-related EMS activ","2021","07","14","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; maternal health; pandemics; pregnancy complications","Jenkins","J Lee","Department of Emergency Medicine, Johns Hopkins School of Medicine, Baltimore, MarylandUSA",NA
"2650","34256885","10.1017/S1049023X21000728","911 EMS Activations by Pregnant Patients in Maryland (USA) during the COVID-19 Pandemic.","In the early phase of the coronavirus disease 2019 (COVID-19) pandemic, United States Emergency Medical Services (EMS) experienced a decrease in calls, and at the same time, an increase in out-of-hospital deaths. This finding led to a concern for the implications of potential delays in care for the obstetric population. This study examines the impact of the pandemic on prehospital care amongst pregnant women. A retrospective observational study was conducted comparing obstetric-related EMS activ","2021","07","14","Prehosp Disaster Med","Prehospital and disaster medicine","Emergency Medical Services; maternal health; pandemics; pregnancy complications","Levy","Matthew J","Department of Emergency Medicine, Johns Hopkins School of Medicine, Baltimore, MarylandUSA",NA
"2651","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Agrupis","Kristal An","School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan",NA
"2652","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Smith","Chris","School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan. christopher.smith@lshtm.ac","christopher.smith@lshtm.ac.uk"
"2653","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Suzuki","Shuichi","School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan",NA
"2654","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Villanueva","Annavi Marie","School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan",NA
"2655","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Ariyoshi","Koya","Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan",NA
"2656","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Solante","Rontgene","San Lazaro Hospital, Manila, Philippines",NA
"2657","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Telan","Elizabeth Freda","San Lazaro Hospital, Manila, Philippines",NA
"2658","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Estrada","Kelly Anne","San Lazaro Hospital, Manila, Philippines",NA
"2659","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Uichanco","Ann Celestyn","San Lazaro Hospital, Manila, Philippines",NA
"2660","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Sagurit","Jocelyn","San Lazaro Hospital, Manila, Philippines",NA
"2661","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Calayo","Joy","San Lazaro Hospital, Manila, Philippines",NA
"2662","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Umipig","Dorcas","San Lazaro Hospital, Manila, Philippines",NA
"2663","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Dela Merced","Zita","San Lazaro Hospital, Manila, Philippines",NA
"2664","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Villarama","Fe","San Lazaro Hospital, Manila, Philippines",NA
"2665","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Dimaano","Efren","San Lazaro Hospital, Manila, Philippines",NA
"2666","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Villarama","Jose Benito","San Lazaro Hospital, Manila, Philippines",NA
"2667","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Lopez","Edmundo","San Lazaro Hospital, Manila, Philippines",NA
"2668","34256871","10.1186/s41182-021-00346-8","Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines.",NA,"2021","07","17","Trop Med Health","Tropical medicine and health",NA,"Sayo","Ana Ria","San Lazaro Hospital, Manila, Philippines",NA
"2669","34256865","10.1186/s41256-021-00201-7","The need for adaptable global guidance in health systems strengthening for musculoskeletal health: a qualitative study of international key informants.","Musculoskeletal (MSK) conditions, MSK pain and MSK injury/trauma are the largest contributors to the global burden of disability, yet global guidance to arrest the rising disability burden is lacking. We aimed to explore contemporary context, challenges and opportunities at a global level and relevant to health systems strengthening for MSK health, as identified by international key informants (KIs) to inform a global MSK health strategic response. An in-depth qualitative study was undertaken wi","2021","07","21","Glob Health Res Policy","Global health research and policy","Disability; Global health; Musculoskeletal; Rehabilitation; Strategy; Systems strengthening; Bone and Bones; Delivery of Health Care; Disabled Persons; Global Health; Muscles; Musculoskeletal Pain; World Health Organization","Briggs","Andrew M","Curtin School of Allied Health, Curtin University, Perth, Australia. A.Briggs@curtin.edu","A.Briggs@curtin.edu.au"
"2670","34256865","10.1186/s41256-021-00201-7","The need for adaptable global guidance in health systems strengthening for musculoskeletal health: a qualitative study of international key informants.","Musculoskeletal (MSK) conditions, MSK pain and MSK injury/trauma are the largest contributors to the global burden of disability, yet global guidance to arrest the rising disability burden is lacking. We aimed to explore contemporary context, challenges and opportunities at a global level and relevant to health systems strengthening for MSK health, as identified by international key informants (KIs) to inform a global MSK health strategic response. An in-depth qualitative study was undertaken wi","2021","07","21","Glob Health Res Policy","Global health research and policy","Disability; Global health; Musculoskeletal; Rehabilitation; Strategy; Systems strengthening; Bone and Bones; Delivery of Health Care; Disabled Persons; Global Health; Muscles; Musculoskeletal Pain; World Health Organization","Jordan","Joanne E","HealthSense (Aust) Pty Ltd, Melbourne, Australia",NA
"2671","34256865","10.1186/s41256-021-00201-7","The need for adaptable global guidance in health systems strengthening for musculoskeletal health: a qualitative study of international key informants.","Musculoskeletal (MSK) conditions, MSK pain and MSK injury/trauma are the largest contributors to the global burden of disability, yet global guidance to arrest the rising disability burden is lacking. We aimed to explore contemporary context, challenges and opportunities at a global level and relevant to health systems strengthening for MSK health, as identified by international key informants (KIs) to inform a global MSK health strategic response. An in-depth qualitative study was undertaken wi","2021","07","21","Glob Health Res Policy","Global health research and policy","Disability; Global health; Musculoskeletal; Rehabilitation; Strategy; Systems strengthening; Bone and Bones; Delivery of Health Care; Disabled Persons; Global Health; Muscles; Musculoskeletal Pain; World Health Organization","Kopansky-Giles","Deborah","Department of Research, Canadian Memorial Chiropractic College, Toronto, Canada",NA
"2672","34256865","10.1186/s41256-021-00201-7","The need for adaptable global guidance in health systems strengthening for musculoskeletal health: a qualitative study of international key informants.","Musculoskeletal (MSK) conditions, MSK pain and MSK injury/trauma are the largest contributors to the global burden of disability, yet global guidance to arrest the rising disability burden is lacking. We aimed to explore contemporary context, challenges and opportunities at a global level and relevant to health systems strengthening for MSK health, as identified by international key informants (KIs) to inform a global MSK health strategic response. An in-depth qualitative study was undertaken wi","2021","07","21","Glob Health Res Policy","Global health research and policy","Disability; Global health; Musculoskeletal; Rehabilitation; Strategy; Systems strengthening; Bone and Bones; Delivery of Health Care; Disabled Persons; Global Health; Muscles; Musculoskeletal Pain; World Health Organization","Sharma","Saurab","Department of Physiotherapy, Kathmandu University School of Medical Sciences, Dhulikhel, Nepal",NA
"2673","34256865","10.1186/s41256-021-00201-7","The need for adaptable global guidance in health systems strengthening for musculoskeletal health: a qualitative study of international key informants.","Musculoskeletal (MSK) conditions, MSK pain and MSK injury/trauma are the largest contributors to the global burden of disability, yet global guidance to arrest the rising disability burden is lacking. We aimed to explore contemporary context, challenges and opportunities at a global level and relevant to health systems strengthening for MSK health, as identified by international key informants (KIs) to inform a global MSK health strategic response. An in-depth qualitative study was undertaken wi","2021","07","21","Glob Health Res Policy","Global health research and policy","Disability; Global health; Musculoskeletal; Rehabilitation; Strategy; Systems strengthening; Bone and Bones; Delivery of Health Care; Disabled Persons; Global Health; Muscles; Musculoskeletal Pain; World Health Organization","March","Lyn","Department of Rheumatology, Royal North Shore Hospital, Sydney, Australia",NA
"2674","34256865","10.1186/s41256-021-00201-7","The need for adaptable global guidance in health systems strengthening for musculoskeletal health: a qualitative study of international key informants.","Musculoskeletal (MSK) conditions, MSK pain and MSK injury/trauma are the largest contributors to the global burden of disability, yet global guidance to arrest the rising disability burden is lacking. We aimed to explore contemporary context, challenges and opportunities at a global level and relevant to health systems strengthening for MSK health, as identified by international key informants (KIs) to inform a global MSK health strategic response. An in-depth qualitative study was undertaken wi","2021","07","21","Glob Health Res Policy","Global health research and policy","Disability; Global health; Musculoskeletal; Rehabilitation; Strategy; Systems strengthening; Bone and Bones; Delivery of Health Care; Disabled Persons; Global Health; Muscles; Musculoskeletal Pain; World Health Organization","Schneider","Carmen Huckel","Menzies Centre for Health Policy and Economics, Faculty of Medicine and Health, University of Sydney, Sydney, Australia",NA
"2675","34256865","10.1186/s41256-021-00201-7","The need for adaptable global guidance in health systems strengthening for musculoskeletal health: a qualitative study of international key informants.","Musculoskeletal (MSK) conditions, MSK pain and MSK injury/trauma are the largest contributors to the global burden of disability, yet global guidance to arrest the rising disability burden is lacking. We aimed to explore contemporary context, challenges and opportunities at a global level and relevant to health systems strengthening for MSK health, as identified by international key informants (KIs) to inform a global MSK health strategic response. An in-depth qualitative study was undertaken wi","2021","07","21","Glob Health Res Policy","Global health research and policy","Disability; Global health; Musculoskeletal; Rehabilitation; Strategy; Systems strengthening; Bone and Bones; Delivery of Health Care; Disabled Persons; Global Health; Muscles; Musculoskeletal Pain; World Health Organization","Mishrra","Swatee","Sydney Musculoskeletal, Bone &amp",NA
"2676","34256865","10.1186/s41256-021-00201-7","The need for adaptable global guidance in health systems strengthening for musculoskeletal health: a qualitative study of international key informants.","Musculoskeletal (MSK) conditions, MSK pain and MSK injury/trauma are the largest contributors to the global burden of disability, yet global guidance to arrest the rising disability burden is lacking. We aimed to explore contemporary context, challenges and opportunities at a global level and relevant to health systems strengthening for MSK health, as identified by international key informants (KIs) to inform a global MSK health strategic response. An in-depth qualitative study was undertaken wi","2021","07","21","Glob Health Res Policy","Global health research and policy","Disability; Global health; Musculoskeletal; Rehabilitation; Strategy; Systems strengthening; Bone and Bones; Delivery of Health Care; Disabled Persons; Global Health; Muscles; Musculoskeletal Pain; World Health Organization","Young","James J","Department of Research, Canadian Memorial Chiropractic College, Toronto, Canada",NA
"2677","34256865","10.1186/s41256-021-00201-7","The need for adaptable global guidance in health systems strengthening for musculoskeletal health: a qualitative study of international key informants.","Musculoskeletal (MSK) conditions, MSK pain and MSK injury/trauma are the largest contributors to the global burden of disability, yet global guidance to arrest the rising disability burden is lacking. We aimed to explore contemporary context, challenges and opportunities at a global level and relevant to health systems strengthening for MSK health, as identified by international key informants (KIs) to inform a global MSK health strategic response. An in-depth qualitative study was undertaken wi","2021","07","21","Glob Health Res Policy","Global health research and policy","Disability; Global health; Musculoskeletal; Rehabilitation; Strategy; Systems strengthening; Bone and Bones; Delivery of Health Care; Disabled Persons; Global Health; Muscles; Musculoskeletal Pain; World Health Organization","Slater","Helen","Curtin School of Allied Health, Curtin University, Perth, Australia",NA
"2678","34256858","10.1186/s41182-021-00349-5","Epidemic of plague amidst COVID-19 in Madagascar: efforts, challenges, and recommendations.","The plague has been wreaking havoc on people in Madagascar with the COVID-19 pandemic. Madagascar's healthcare sector is striving to respond to COVID-19 in the face of a plague outbreak that has created a new strain on the country's public health system. The goal and activities of the gradual epidemic of plague in Madagascar during COVID-19 are described in this research. In order to contain the plague and the COVID-19 pandemic in this country, we have suggested long-term recommendations that ca","2021","07","17","Trop Med Health","Tropical medicine and health","COVID-19; Epidemic; Madagascar; Pandemic; Plague; Slow","Aborode","Abdullahi Tunde","Healthy Africans Platform, Research and Development, Ibadan, Nigeria",NA
"2679","34256858","10.1186/s41182-021-00349-5","Epidemic of plague amidst COVID-19 in Madagascar: efforts, challenges, and recommendations.","The plague has been wreaking havoc on people in Madagascar with the COVID-19 pandemic. Madagascar's healthcare sector is striving to respond to COVID-19 in the face of a plague outbreak that has created a new strain on the country's public health system. The goal and activities of the gradual epidemic of plague in Madagascar during COVID-19 are described in this research. In order to contain the plague and the COVID-19 pandemic in this country, we have suggested long-term recommendations that ca","2021","07","17","Trop Med Health","Tropical medicine and health","COVID-19; Epidemic; Madagascar; Pandemic; Plague; Slow","Dos Santos Costa","Ana Carla","Federal University of Bahia, Salvador, Bahia, Brazil",NA
"2680","34256858","10.1186/s41182-021-00349-5","Epidemic of plague amidst COVID-19 in Madagascar: efforts, challenges, and recommendations.","The plague has been wreaking havoc on people in Madagascar with the COVID-19 pandemic. Madagascar's healthcare sector is striving to respond to COVID-19 in the face of a plague outbreak that has created a new strain on the country's public health system. The goal and activities of the gradual epidemic of plague in Madagascar during COVID-19 are described in this research. In order to contain the plague and the COVID-19 pandemic in this country, we have suggested long-term recommendations that ca","2021","07","17","Trop Med Health","Tropical medicine and health","COVID-19; Epidemic; Madagascar; Pandemic; Plague; Slow","Mohan","Anmol","Karachi Medical &amp",NA
"2681","34256858","10.1186/s41182-021-00349-5","Epidemic of plague amidst COVID-19 in Madagascar: efforts, challenges, and recommendations.","The plague has been wreaking havoc on people in Madagascar with the COVID-19 pandemic. Madagascar's healthcare sector is striving to respond to COVID-19 in the face of a plague outbreak that has created a new strain on the country's public health system. The goal and activities of the gradual epidemic of plague in Madagascar during COVID-19 are described in this research. In order to contain the plague and the COVID-19 pandemic in this country, we have suggested long-term recommendations that ca","2021","07","17","Trop Med Health","Tropical medicine and health","COVID-19; Epidemic; Madagascar; Pandemic; Plague; Slow","Goyal","Samarth","KMC Manipal, Manipal, India",NA
"2682","34256858","10.1186/s41182-021-00349-5","Epidemic of plague amidst COVID-19 in Madagascar: efforts, challenges, and recommendations.","The plague has been wreaking havoc on people in Madagascar with the COVID-19 pandemic. Madagascar's healthcare sector is striving to respond to COVID-19 in the face of a plague outbreak that has created a new strain on the country's public health system. The goal and activities of the gradual epidemic of plague in Madagascar during COVID-19 are described in this research. In order to contain the plague and the COVID-19 pandemic in this country, we have suggested long-term recommendations that ca","2021","07","17","Trop Med Health","Tropical medicine and health","COVID-19; Epidemic; Madagascar; Pandemic; Plague; Slow","Rabiu","Aishat Temitope","Faculty of Basic Medical Sciences, Kwara State University, Malete, Nigeria",NA
"2683","34256858","10.1186/s41182-021-00349-5","Epidemic of plague amidst COVID-19 in Madagascar: efforts, challenges, and recommendations.","The plague has been wreaking havoc on people in Madagascar with the COVID-19 pandemic. Madagascar's healthcare sector is striving to respond to COVID-19 in the face of a plague outbreak that has created a new strain on the country's public health system. The goal and activities of the gradual epidemic of plague in Madagascar during COVID-19 are described in this research. In order to contain the plague and the COVID-19 pandemic in this country, we have suggested long-term recommendations that ca","2021","07","17","Trop Med Health","Tropical medicine and health","COVID-19; Epidemic; Madagascar; Pandemic; Plague; Slow","Tsagkaris","Christos","University of Crete, Faculty of Medicine, Heraklion, Greece",NA
"2684","34256858","10.1186/s41182-021-00349-5","Epidemic of plague amidst COVID-19 in Madagascar: efforts, challenges, and recommendations.","The plague has been wreaking havoc on people in Madagascar with the COVID-19 pandemic. Madagascar's healthcare sector is striving to respond to COVID-19 in the face of a plague outbreak that has created a new strain on the country's public health system. The goal and activities of the gradual epidemic of plague in Madagascar during COVID-19 are described in this research. In order to contain the plague and the COVID-19 pandemic in this country, we have suggested long-term recommendations that ca","2021","07","17","Trop Med Health","Tropical medicine and health","COVID-19; Epidemic; Madagascar; Pandemic; Plague; Slow","Uwishema","Olivier","Oli Health Magazine Organization, Research and Education, Kigali, Rwanda. uwolivier1@ktu.edu","uwolivier1@ktu.edu.tr"
"2685","34256858","10.1186/s41182-021-00349-5","Epidemic of plague amidst COVID-19 in Madagascar: efforts, challenges, and recommendations.","The plague has been wreaking havoc on people in Madagascar with the COVID-19 pandemic. Madagascar's healthcare sector is striving to respond to COVID-19 in the face of a plague outbreak that has created a new strain on the country's public health system. The goal and activities of the gradual epidemic of plague in Madagascar during COVID-19 are described in this research. In order to contain the plague and the COVID-19 pandemic in this country, we have suggested long-term recommendations that ca","2021","07","17","Trop Med Health","Tropical medicine and health","COVID-19; Epidemic; Madagascar; Pandemic; Plague; Slow","Outani","Oumaima","Clinton Global Initiative University, New York, USA",NA
"2686","34256858","10.1186/s41182-021-00349-5","Epidemic of plague amidst COVID-19 in Madagascar: efforts, challenges, and recommendations.","The plague has been wreaking havoc on people in Madagascar with the COVID-19 pandemic. Madagascar's healthcare sector is striving to respond to COVID-19 in the face of a plague outbreak that has created a new strain on the country's public health system. The goal and activities of the gradual epidemic of plague in Madagascar during COVID-19 are described in this research. In order to contain the plague and the COVID-19 pandemic in this country, we have suggested long-term recommendations that ca","2021","07","17","Trop Med Health","Tropical medicine and health","COVID-19; Epidemic; Madagascar; Pandemic; Plague; Slow","Ahmad","Shoaib","Faculty of Medicine and Pharmacy of Rabat, Mohamed 5 University, Rabat, Morocco",NA
"2687","34256858","10.1186/s41182-021-00349-5","Epidemic of plague amidst COVID-19 in Madagascar: efforts, challenges, and recommendations.","The plague has been wreaking havoc on people in Madagascar with the COVID-19 pandemic. Madagascar's healthcare sector is striving to respond to COVID-19 in the face of a plague outbreak that has created a new strain on the country's public health system. The goal and activities of the gradual epidemic of plague in Madagascar during COVID-19 are described in this research. In order to contain the plague and the COVID-19 pandemic in this country, we have suggested long-term recommendations that ca","2021","07","17","Trop Med Health","Tropical medicine and health","COVID-19; Epidemic; Madagascar; Pandemic; Plague; Slow","Essar","Mohammad Yasir","District Head Quarters Teaching Hospital, Faisalabad, Pakistan",NA
"2688","34256840","10.1186/s40001-021-00544-4","The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization.","The aim of this study was to evaluate the expression of four up/down-regulated inflammatory miRNAs and their mRNA targets in the serum samples of COVID-19 patients with different grades. Also, we investigated the relative expression of these miRNAs and mRNAs during hospitalization. In this cross-sectional study, 5 mL of blood sample were taken from COVID-19 patients with different grades and during hospitalization from several health centers of Yazd, Tehran, and Zahedan province of Iran from Dec","2021","07","17","Eur J Med Res","European journal of medical research","COVID-19; Hospitalization; mRNA; miRNAs","Keikha","Reza","Infectious Diseases and Tropical Medicine Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran",NA
"2689","34256840","10.1186/s40001-021-00544-4","The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization.","The aim of this study was to evaluate the expression of four up/down-regulated inflammatory miRNAs and their mRNA targets in the serum samples of COVID-19 patients with different grades. Also, we investigated the relative expression of these miRNAs and mRNAs during hospitalization. In this cross-sectional study, 5 mL of blood sample were taken from COVID-19 patients with different grades and during hospitalization from several health centers of Yazd, Tehran, and Zahedan province of Iran from Dec","2021","07","17","Eur J Med Res","European journal of medical research","COVID-19; Hospitalization; mRNA; miRNAs","Hashemi-Shahri","Seyed Mohammad","Infectious Diseases and Tropical Medicine Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran",NA
"2690","34256840","10.1186/s40001-021-00544-4","The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization.","The aim of this study was to evaluate the expression of four up/down-regulated inflammatory miRNAs and their mRNA targets in the serum samples of COVID-19 patients with different grades. Also, we investigated the relative expression of these miRNAs and mRNAs during hospitalization. In this cross-sectional study, 5 mL of blood sample were taken from COVID-19 patients with different grades and during hospitalization from several health centers of Yazd, Tehran, and Zahedan province of Iran from Dec","2021","07","17","Eur J Med Res","European journal of medical research","COVID-19; Hospitalization; mRNA; miRNAs","Jebali","Ali","Department of Medical Nanotechnology, Faculty of Advanced Sciences and Technology, Tehran Medical Science, Islamic Azad University, Tehran, Iran. alijebal2011@gmail","alijebal2011@gmail.com"
"2691","34256831","10.1186/s13256-021-02961-9","Development of cavitary lung disease as a long-term complication of coronavirus disease 2019 in a young previously healthy patient: a case report.","Cavities are frequent manifestations of a wide variety of pathological processes involving the lung. There has been a growing body of evidence of coronavirus disease 2019 leading to a cavitary pulmonary disease. A healthy 29-year-old Filipino male presented to the hospital a couple of months after convalescence from coronavirus disease 2019 with severe pleuritic chest pain, fever, chills, and shortness of breath, and was found to have a cavitary lung lesion on chest computed tomography. While co","2021","07","15","J Med Case Rep","Journal of medical case reports","COVID-19; Cavitary lung lesion; Chest computed tomography; SARS-CoV-2; Adult; COVID-19; Humans; Lung; Male; SARS-CoV-2; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed","Egoryan","Goar","Department of Internal Medicine, AMITA Health Saint Francis Hospital, 355 Ridge Ave, Evanston, IL, 60202, USA. vivagoar23@gmail","vivagoar23@gmail.com"
"2692","34256831","10.1186/s13256-021-02961-9","Development of cavitary lung disease as a long-term complication of coronavirus disease 2019 in a young previously healthy patient: a case report.","Cavities are frequent manifestations of a wide variety of pathological processes involving the lung. There has been a growing body of evidence of coronavirus disease 2019 leading to a cavitary pulmonary disease. A healthy 29-year-old Filipino male presented to the hospital a couple of months after convalescence from coronavirus disease 2019 with severe pleuritic chest pain, fever, chills, and shortness of breath, and was found to have a cavitary lung lesion on chest computed tomography. While co","2021","07","15","J Med Case Rep","Journal of medical case reports","COVID-19; Cavitary lung lesion; Chest computed tomography; SARS-CoV-2; Adult; COVID-19; Humans; Lung; Male; SARS-CoV-2; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed","Hyser","Elise","Department of Internal Medicine, AMITA Health Saint Francis Hospital, 355 Ridge Ave, Evanston, IL, 60202, USA",NA
"2693","34256831","10.1186/s13256-021-02961-9","Development of cavitary lung disease as a long-term complication of coronavirus disease 2019 in a young previously healthy patient: a case report.","Cavities are frequent manifestations of a wide variety of pathological processes involving the lung. There has been a growing body of evidence of coronavirus disease 2019 leading to a cavitary pulmonary disease. A healthy 29-year-old Filipino male presented to the hospital a couple of months after convalescence from coronavirus disease 2019 with severe pleuritic chest pain, fever, chills, and shortness of breath, and was found to have a cavitary lung lesion on chest computed tomography. While co","2021","07","15","J Med Case Rep","Journal of medical case reports","COVID-19; Cavitary lung lesion; Chest computed tomography; SARS-CoV-2; Adult; COVID-19; Humans; Lung; Male; SARS-CoV-2; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed","Mushtaq","Ammar H","Department of Internal Medicine, AMITA Health Saint Francis Hospital, 355 Ridge Ave, Evanston, IL, 60202, USA",NA
"2694","34256831","10.1186/s13256-021-02961-9","Development of cavitary lung disease as a long-term complication of coronavirus disease 2019 in a young previously healthy patient: a case report.","Cavities are frequent manifestations of a wide variety of pathological processes involving the lung. There has been a growing body of evidence of coronavirus disease 2019 leading to a cavitary pulmonary disease. A healthy 29-year-old Filipino male presented to the hospital a couple of months after convalescence from coronavirus disease 2019 with severe pleuritic chest pain, fever, chills, and shortness of breath, and was found to have a cavitary lung lesion on chest computed tomography. While co","2021","07","15","J Med Case Rep","Journal of medical case reports","COVID-19; Cavitary lung lesion; Chest computed tomography; SARS-CoV-2; Adult; COVID-19; Humans; Lung; Male; SARS-CoV-2; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed","Yanez-Bello","Maria Adriana","Department of Internal Medicine, AMITA Health Saint Francis Hospital, 355 Ridge Ave, Evanston, IL, 60202, USA",NA
"2695","34256831","10.1186/s13256-021-02961-9","Development of cavitary lung disease as a long-term complication of coronavirus disease 2019 in a young previously healthy patient: a case report.","Cavities are frequent manifestations of a wide variety of pathological processes involving the lung. There has been a growing body of evidence of coronavirus disease 2019 leading to a cavitary pulmonary disease. A healthy 29-year-old Filipino male presented to the hospital a couple of months after convalescence from coronavirus disease 2019 with severe pleuritic chest pain, fever, chills, and shortness of breath, and was found to have a cavitary lung lesion on chest computed tomography. While co","2021","07","15","J Med Case Rep","Journal of medical case reports","COVID-19; Cavitary lung lesion; Chest computed tomography; SARS-CoV-2; Adult; COVID-19; Humans; Lung; Male; SARS-CoV-2; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed","Trelles-Garcia","Daniela Patricia","Department of Internal Medicine, AMITA Health Saint Francis Hospital, 355 Ridge Ave, Evanston, IL, 60202, USA",NA
"2696","34256831","10.1186/s13256-021-02961-9","Development of cavitary lung disease as a long-term complication of coronavirus disease 2019 in a young previously healthy patient: a case report.","Cavities are frequent manifestations of a wide variety of pathological processes involving the lung. There has been a growing body of evidence of coronavirus disease 2019 leading to a cavitary pulmonary disease. A healthy 29-year-old Filipino male presented to the hospital a couple of months after convalescence from coronavirus disease 2019 with severe pleuritic chest pain, fever, chills, and shortness of breath, and was found to have a cavitary lung lesion on chest computed tomography. While co","2021","07","15","J Med Case Rep","Journal of medical case reports","COVID-19; Cavitary lung lesion; Chest computed tomography; SARS-CoV-2; Adult; COVID-19; Humans; Lung; Male; SARS-CoV-2; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed","Friedman","Harvey J","Critical Care Units, AMITA Health Saint Francis Hospital, Evanston, IL, USA",NA
"2697","34256831","10.1186/s13256-021-02961-9","Development of cavitary lung disease as a long-term complication of coronavirus disease 2019 in a young previously healthy patient: a case report.","Cavities are frequent manifestations of a wide variety of pathological processes involving the lung. There has been a growing body of evidence of coronavirus disease 2019 leading to a cavitary pulmonary disease. A healthy 29-year-old Filipino male presented to the hospital a couple of months after convalescence from coronavirus disease 2019 with severe pleuritic chest pain, fever, chills, and shortness of breath, and was found to have a cavitary lung lesion on chest computed tomography. While co","2021","07","15","J Med Case Rep","Journal of medical case reports","COVID-19; Cavitary lung lesion; Chest computed tomography; SARS-CoV-2; Adult; COVID-19; Humans; Lung; Male; SARS-CoV-2; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed","Rodriguez-Nava","Guillermo","Department of Internal Medicine, AMITA Health Saint Francis Hospital, 355 Ridge Ave, Evanston, IL, 60202, USA",NA
"2698","34256824","10.1186/s13098-021-00695-8","Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies.","COVID-19 has stroke Brazil harshly, deaths by COVID-19 in Brazil represent almost 13% of the total deaths by COVID-19 in the world, even though Brazilian population represents only 2.6% of the world population. Our aim in this study was to evaluate death and intubation outcomes and risk factors associated with COVID-19, and treatment options focusing on diabetes patients and the use of metformin pre-admission and during hospitalization. In this Brazilian single-center study we evaluated 1170 pat","2021","07","17","Diabetol Metab Syndr","Diabetology &amp; metabolic syndrome","Brazil; COVID-19; Diabetes; Metformin; Survival","Tamura","Rodrigo Esaki","Department of Biological Sciences, Federal University of São Paulo, Rua Pedro de Toledo 669, 11º Andar, Diadema, SP, Brazil",NA
"2699","34256824","10.1186/s13098-021-00695-8","Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies.","COVID-19 has stroke Brazil harshly, deaths by COVID-19 in Brazil represent almost 13% of the total deaths by COVID-19 in the world, even though Brazilian population represents only 2.6% of the world population. Our aim in this study was to evaluate death and intubation outcomes and risk factors associated with COVID-19, and treatment options focusing on diabetes patients and the use of metformin pre-admission and during hospitalization. In this Brazilian single-center study we evaluated 1170 pat","2021","07","17","Diabetol Metab Syndr","Diabetology &amp; metabolic syndrome","Brazil; COVID-19; Diabetes; Metformin; Survival","Said","Said Muhammad","Thyroid Molecular Sciences Laboratory, Federal University of Sao Paulo, São Paulo, SP, Brazil",NA
"2700","34256824","10.1186/s13098-021-00695-8","Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies.","COVID-19 has stroke Brazil harshly, deaths by COVID-19 in Brazil represent almost 13% of the total deaths by COVID-19 in the world, even though Brazilian population represents only 2.6% of the world population. Our aim in this study was to evaluate death and intubation outcomes and risk factors associated with COVID-19, and treatment options focusing on diabetes patients and the use of metformin pre-admission and during hospitalization. In this Brazilian single-center study we evaluated 1170 pat","2021","07","17","Diabetol Metab Syndr","Diabetology &amp; metabolic syndrome","Brazil; COVID-19; Diabetes; Metformin; Survival","de Freitas","Leticia Mussin","Department of Biological Sciences, Federal University of São Paulo, Rua Pedro de Toledo 669, 11º Andar, Diadema, SP, Brazil",NA
"2701","34256824","10.1186/s13098-021-00695-8","Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies.","COVID-19 has stroke Brazil harshly, deaths by COVID-19 in Brazil represent almost 13% of the total deaths by COVID-19 in the world, even though Brazilian population represents only 2.6% of the world population. Our aim in this study was to evaluate death and intubation outcomes and risk factors associated with COVID-19, and treatment options focusing on diabetes patients and the use of metformin pre-admission and during hospitalization. In this Brazilian single-center study we evaluated 1170 pat","2021","07","17","Diabetol Metab Syndr","Diabetology &amp; metabolic syndrome","Brazil; COVID-19; Diabetes; Metformin; Survival","Rubio","Ileana Gabriela Sanchez","Department of Biological Sciences, Federal University of São Paulo, Rua Pedro de Toledo 669, 11º Andar, Diadema, SP, Brazil. ilerubio@gmail","ilerubio@gmail.com"
"2702","34256815","10.1186/s13052-021-01099-0","The Investigational Clinical Center: a clinical-supportive and patient-centered trial unit model. Ten years of experience through normal and pandemic times of a large pediatric trial center in Italy.","Evidence-based medicine relies on appropriately designed, conducted and reported clinical trials (CTs) to provide the best proofs of efficacy and safety for pharmacological and non-pharmacological treatments. Modern clinical research features high complexity and requires a high workload for the management of trials-related activities, often hampering physicians' participation to clinical trials. Dealing with children in clinical research adds complexity: rare diseases, parents or legal guardian ","2021","07","22","Ital J Pediatr","Italian journal of pediatrics","Clinical trial unit; Pediatric clinical research; Pediatrics; Research staff; Trial implementation; Trial management; COVID-19; Child; Clinical Trials as Topic; Humans; Italy; Pandemics; Parents; Patient-Centered Care; SARS-CoV-2; Time Factors","Pontrelli","Giuseppe","Academic Department of Pediatrics (DPUO), Clinical Trial Center, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. giuseppe.pontrelli@opbg","giuseppe.pontrelli@opbg.net"
"2703","34256815","10.1186/s13052-021-01099-0","The Investigational Clinical Center: a clinical-supportive and patient-centered trial unit model. Ten years of experience through normal and pandemic times of a large pediatric trial center in Italy.","Evidence-based medicine relies on appropriately designed, conducted and reported clinical trials (CTs) to provide the best proofs of efficacy and safety for pharmacological and non-pharmacological treatments. Modern clinical research features high complexity and requires a high workload for the management of trials-related activities, often hampering physicians' participation to clinical trials. Dealing with children in clinical research adds complexity: rare diseases, parents or legal guardian ","2021","07","22","Ital J Pediatr","Italian journal of pediatrics","Clinical trial unit; Pediatric clinical research; Pediatrics; Research staff; Trial implementation; Trial management; COVID-19; Child; Clinical Trials as Topic; Humans; Italy; Pandemics; Parents; Patient-Centered Care; SARS-CoV-2; Time Factors","Ciabattini","Marco","Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy",NA
"2704","34256815","10.1186/s13052-021-01099-0","The Investigational Clinical Center: a clinical-supportive and patient-centered trial unit model. Ten years of experience through normal and pandemic times of a large pediatric trial center in Italy.","Evidence-based medicine relies on appropriately designed, conducted and reported clinical trials (CTs) to provide the best proofs of efficacy and safety for pharmacological and non-pharmacological treatments. Modern clinical research features high complexity and requires a high workload for the management of trials-related activities, often hampering physicians' participation to clinical trials. Dealing with children in clinical research adds complexity: rare diseases, parents or legal guardian ","2021","07","22","Ital J Pediatr","Italian journal of pediatrics","Clinical trial unit; Pediatric clinical research; Pediatrics; Research staff; Trial implementation; Trial management; COVID-19; Child; Clinical Trials as Topic; Humans; Italy; Pandemics; Parents; Patient-Centered Care; SARS-CoV-2; Time Factors","De Crescenzo","Franco","Academic Department of Pediatrics (DPUO), Clinical Trial Center, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"2705","34256815","10.1186/s13052-021-01099-0","The Investigational Clinical Center: a clinical-supportive and patient-centered trial unit model. Ten years of experience through normal and pandemic times of a large pediatric trial center in Italy.","Evidence-based medicine relies on appropriately designed, conducted and reported clinical trials (CTs) to provide the best proofs of efficacy and safety for pharmacological and non-pharmacological treatments. Modern clinical research features high complexity and requires a high workload for the management of trials-related activities, often hampering physicians' participation to clinical trials. Dealing with children in clinical research adds complexity: rare diseases, parents or legal guardian ","2021","07","22","Ital J Pediatr","Italian journal of pediatrics","Clinical trial unit; Pediatric clinical research; Pediatrics; Research staff; Trial implementation; Trial management; COVID-19; Child; Clinical Trials as Topic; Humans; Italy; Pandemics; Parents; Patient-Centered Care; SARS-CoV-2; Time Factors","Biondi","Isabella","Academic Department of Pediatrics (DPUO), Clinical Trial Center, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"2706","34256815","10.1186/s13052-021-01099-0","The Investigational Clinical Center: a clinical-supportive and patient-centered trial unit model. Ten years of experience through normal and pandemic times of a large pediatric trial center in Italy.","Evidence-based medicine relies on appropriately designed, conducted and reported clinical trials (CTs) to provide the best proofs of efficacy and safety for pharmacological and non-pharmacological treatments. Modern clinical research features high complexity and requires a high workload for the management of trials-related activities, often hampering physicians' participation to clinical trials. Dealing with children in clinical research adds complexity: rare diseases, parents or legal guardian ","2021","07","22","Ital J Pediatr","Italian journal of pediatrics","Clinical trial unit; Pediatric clinical research; Pediatrics; Research staff; Trial implementation; Trial management; COVID-19; Child; Clinical Trials as Topic; Humans; Italy; Pandemics; Parents; Patient-Centered Care; SARS-CoV-2; Time Factors","Cocchiola","Rossana","Academic Department of Pediatrics (DPUO), Clinical Trial Center, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"2707","34256815","10.1186/s13052-021-01099-0","The Investigational Clinical Center: a clinical-supportive and patient-centered trial unit model. Ten years of experience through normal and pandemic times of a large pediatric trial center in Italy.","Evidence-based medicine relies on appropriately designed, conducted and reported clinical trials (CTs) to provide the best proofs of efficacy and safety for pharmacological and non-pharmacological treatments. Modern clinical research features high complexity and requires a high workload for the management of trials-related activities, often hampering physicians' participation to clinical trials. Dealing with children in clinical research adds complexity: rare diseases, parents or legal guardian ","2021","07","22","Ital J Pediatr","Italian journal of pediatrics","Clinical trial unit; Pediatric clinical research; Pediatrics; Research staff; Trial implementation; Trial management; COVID-19; Child; Clinical Trials as Topic; Humans; Italy; Pandemics; Parents; Patient-Centered Care; SARS-CoV-2; Time Factors","Copponi","Giorgia","Academic Department of Pediatrics (DPUO), Clinical Trial Center, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"2708","34256815","10.1186/s13052-021-01099-0","The Investigational Clinical Center: a clinical-supportive and patient-centered trial unit model. Ten years of experience through normal and pandemic times of a large pediatric trial center in Italy.","Evidence-based medicine relies on appropriately designed, conducted and reported clinical trials (CTs) to provide the best proofs of efficacy and safety for pharmacological and non-pharmacological treatments. Modern clinical research features high complexity and requires a high workload for the management of trials-related activities, often hampering physicians' participation to clinical trials. Dealing with children in clinical research adds complexity: rare diseases, parents or legal guardian ","2021","07","22","Ital J Pediatr","Italian journal of pediatrics","Clinical trial unit; Pediatric clinical research; Pediatrics; Research staff; Trial implementation; Trial management; COVID-19; Child; Clinical Trials as Topic; Humans; Italy; Pandemics; Parents; Patient-Centered Care; SARS-CoV-2; Time Factors","Frillici","Claudia","Academic Department of Pediatrics (DPUO), Clinical Trial Center, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"2709","34256815","10.1186/s13052-021-01099-0","The Investigational Clinical Center: a clinical-supportive and patient-centered trial unit model. Ten years of experience through normal and pandemic times of a large pediatric trial center in Italy.","Evidence-based medicine relies on appropriately designed, conducted and reported clinical trials (CTs) to provide the best proofs of efficacy and safety for pharmacological and non-pharmacological treatments. Modern clinical research features high complexity and requires a high workload for the management of trials-related activities, often hampering physicians' participation to clinical trials. Dealing with children in clinical research adds complexity: rare diseases, parents or legal guardian ","2021","07","22","Ital J Pediatr","Italian journal of pediatrics","Clinical trial unit; Pediatric clinical research; Pediatrics; Research staff; Trial implementation; Trial management; COVID-19; Child; Clinical Trials as Topic; Humans; Italy; Pandemics; Parents; Patient-Centered Care; SARS-CoV-2; Time Factors","Molinari","Francesca","Academic Department of Pediatrics (DPUO), Clinical Trial Center, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"2710","34256815","10.1186/s13052-021-01099-0","The Investigational Clinical Center: a clinical-supportive and patient-centered trial unit model. Ten years of experience through normal and pandemic times of a large pediatric trial center in Italy.","Evidence-based medicine relies on appropriately designed, conducted and reported clinical trials (CTs) to provide the best proofs of efficacy and safety for pharmacological and non-pharmacological treatments. Modern clinical research features high complexity and requires a high workload for the management of trials-related activities, often hampering physicians' participation to clinical trials. Dealing with children in clinical research adds complexity: rare diseases, parents or legal guardian ","2021","07","22","Ital J Pediatr","Italian journal of pediatrics","Clinical trial unit; Pediatric clinical research; Pediatrics; Research staff; Trial implementation; Trial management; COVID-19; Child; Clinical Trials as Topic; Humans; Italy; Pandemics; Parents; Patient-Centered Care; SARS-CoV-2; Time Factors","Rocchi","Francesca","INCiPiT (Italian Network for Pediatric Clinical Trials) National Hub, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"2711","34256815","10.1186/s13052-021-01099-0","The Investigational Clinical Center: a clinical-supportive and patient-centered trial unit model. Ten years of experience through normal and pandemic times of a large pediatric trial center in Italy.","Evidence-based medicine relies on appropriately designed, conducted and reported clinical trials (CTs) to provide the best proofs of efficacy and safety for pharmacological and non-pharmacological treatments. Modern clinical research features high complexity and requires a high workload for the management of trials-related activities, often hampering physicians' participation to clinical trials. Dealing with children in clinical research adds complexity: rare diseases, parents or legal guardian ","2021","07","22","Ital J Pediatr","Italian journal of pediatrics","Clinical trial unit; Pediatric clinical research; Pediatrics; Research staff; Trial implementation; Trial management; COVID-19; Child; Clinical Trials as Topic; Humans; Italy; Pandemics; Parents; Patient-Centered Care; SARS-CoV-2; Time Factors","Simonetti","Alessandra","Academic Department of Pediatrics (DPUO), Clinical Trial Center, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"2712","34256815","10.1186/s13052-021-01099-0","The Investigational Clinical Center: a clinical-supportive and patient-centered trial unit model. Ten years of experience through normal and pandemic times of a large pediatric trial center in Italy.","Evidence-based medicine relies on appropriately designed, conducted and reported clinical trials (CTs) to provide the best proofs of efficacy and safety for pharmacological and non-pharmacological treatments. Modern clinical research features high complexity and requires a high workload for the management of trials-related activities, often hampering physicians' participation to clinical trials. Dealing with children in clinical research adds complexity: rare diseases, parents or legal guardian ","2021","07","22","Ital J Pediatr","Italian journal of pediatrics","Clinical trial unit; Pediatric clinical research; Pediatrics; Research staff; Trial implementation; Trial management; COVID-19; Child; Clinical Trials as Topic; Humans; Italy; Pandemics; Parents; Patient-Centered Care; SARS-CoV-2; Time Factors","Rossi","Paolo","Academic Department of Pediatrics (DPUO), Clinical Trial Center, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"2713","34256815","10.1186/s13052-021-01099-0","The Investigational Clinical Center: a clinical-supportive and patient-centered trial unit model. Ten years of experience through normal and pandemic times of a large pediatric trial center in Italy.","Evidence-based medicine relies on appropriately designed, conducted and reported clinical trials (CTs) to provide the best proofs of efficacy and safety for pharmacological and non-pharmacological treatments. Modern clinical research features high complexity and requires a high workload for the management of trials-related activities, often hampering physicians' participation to clinical trials. Dealing with children in clinical research adds complexity: rare diseases, parents or legal guardian ","2021","07","22","Ital J Pediatr","Italian journal of pediatrics","Clinical trial unit; Pediatric clinical research; Pediatrics; Research staff; Trial implementation; Trial management; COVID-19; Child; Clinical Trials as Topic; Humans; Italy; Pandemics; Parents; Patient-Centered Care; SARS-CoV-2; Time Factors","Livadiotti","Susanna","Academic Department of Pediatrics (DPUO), Clinical Trial Center, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"2714","34256812","10.1186/s13075-021-02565-0","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predictors of COVID-19 and disease flare-ups. Cross-sectional phone survey from April 9, 2020, to July 2, 2020, during which patients with autoimmune diseases followed at the National Reference Center for Rare Autoimmun","2021","07","16","Arthritis Res Ther","Arthritis research &amp; therapy","Autoimmune diseases; COVID-19; Epidemiology; Immune system diseases; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; France; Humans; Incidence; SARS-CoV-2; Seroepidemiologic Studies","Felten","Renaud","Service de rhumatologie, Service de rhumatologie, Hôpitaux Universitaires de Strasbourg et Université de Strasbourg, 1 avenue Molière BP 83049, 67098, Strasbourg cedex, France",NA
"2715","34256812","10.1186/s13075-021-02565-0","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predictors of COVID-19 and disease flare-ups. Cross-sectional phone survey from April 9, 2020, to July 2, 2020, during which patients with autoimmune diseases followed at the National Reference Center for Rare Autoimmun","2021","07","16","Arthritis Res Ther","Arthritis research &amp; therapy","Autoimmune diseases; COVID-19; Epidemiology; Immune system diseases; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; France; Humans; Incidence; SARS-CoV-2; Seroepidemiologic Studies","Scherlinger","Marc","Service de rhumatologie, Service de rhumatologie, Hôpitaux Universitaires de Strasbourg et Université de Strasbourg, 1 avenue Molière BP 83049, 67098, Strasbourg cedex, France",NA
"2716","34256812","10.1186/s13075-021-02565-0","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predictors of COVID-19 and disease flare-ups. Cross-sectional phone survey from April 9, 2020, to July 2, 2020, during which patients with autoimmune diseases followed at the National Reference Center for Rare Autoimmun","2021","07","16","Arthritis Res Ther","Arthritis research &amp; therapy","Autoimmune diseases; COVID-19; Epidemiology; Immune system diseases; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; France; Humans; Incidence; SARS-CoV-2; Seroepidemiologic Studies","Guffroy","Aurélien","Centre National de Référence des Maladies Auto-Immunes Systémiques Rares Est Sud-Ouest (RESO), Strasbourg, France",NA
"2717","34256812","10.1186/s13075-021-02565-0","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predictors of COVID-19 and disease flare-ups. Cross-sectional phone survey from April 9, 2020, to July 2, 2020, during which patients with autoimmune diseases followed at the National Reference Center for Rare Autoimmun","2021","07","16","Arthritis Res Ther","Arthritis research &amp; therapy","Autoimmune diseases; COVID-19; Epidemiology; Immune system diseases; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; France; Humans; Incidence; SARS-CoV-2; Seroepidemiologic Studies","Poindron","Vincent","Centre National de Référence des Maladies Auto-Immunes Systémiques Rares Est Sud-Ouest (RESO), Strasbourg, France",NA
"2718","34256812","10.1186/s13075-021-02565-0","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predictors of COVID-19 and disease flare-ups. Cross-sectional phone survey from April 9, 2020, to July 2, 2020, during which patients with autoimmune diseases followed at the National Reference Center for Rare Autoimmun","2021","07","16","Arthritis Res Ther","Arthritis research &amp; therapy","Autoimmune diseases; COVID-19; Epidemiology; Immune system diseases; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; France; Humans; Incidence; SARS-CoV-2; Seroepidemiologic Studies","Meyer","Alain","Service de rhumatologie, Service de rhumatologie, Hôpitaux Universitaires de Strasbourg et Université de Strasbourg, 1 avenue Molière BP 83049, 67098, Strasbourg cedex, France",NA
"2719","34256812","10.1186/s13075-021-02565-0","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predictors of COVID-19 and disease flare-ups. Cross-sectional phone survey from April 9, 2020, to July 2, 2020, during which patients with autoimmune diseases followed at the National Reference Center for Rare Autoimmun","2021","07","16","Arthritis Res Ther","Arthritis research &amp; therapy","Autoimmune diseases; COVID-19; Epidemiology; Immune system diseases; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; France; Humans; Incidence; SARS-CoV-2; Seroepidemiologic Studies","Giannini","Margherita","Centre National de Référence des Maladies Auto-Immunes Systémiques Rares Est Sud-Ouest (RESO), Strasbourg, France",NA
"2720","34256812","10.1186/s13075-021-02565-0","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predictors of COVID-19 and disease flare-ups. Cross-sectional phone survey from April 9, 2020, to July 2, 2020, during which patients with autoimmune diseases followed at the National Reference Center for Rare Autoimmun","2021","07","16","Arthritis Res Ther","Arthritis research &amp; therapy","Autoimmune diseases; COVID-19; Epidemiology; Immune system diseases; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; France; Humans; Incidence; SARS-CoV-2; Seroepidemiologic Studies","Korganow","Anne-Sophie","Centre National de Référence des Maladies Auto-Immunes Systémiques Rares Est Sud-Ouest (RESO), Strasbourg, France",NA
"2721","34256812","10.1186/s13075-021-02565-0","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predictors of COVID-19 and disease flare-ups. Cross-sectional phone survey from April 9, 2020, to July 2, 2020, during which patients with autoimmune diseases followed at the National Reference Center for Rare Autoimmun","2021","07","16","Arthritis Res Ther","Arthritis research &amp; therapy","Autoimmune diseases; COVID-19; Epidemiology; Immune system diseases; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; France; Humans; Incidence; SARS-CoV-2; Seroepidemiologic Studies","Sordet","Christelle","Service de rhumatologie, Service de rhumatologie, Hôpitaux Universitaires de Strasbourg et Université de Strasbourg, 1 avenue Molière BP 83049, 67098, Strasbourg cedex, France",NA
"2722","34256812","10.1186/s13075-021-02565-0","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predictors of COVID-19 and disease flare-ups. Cross-sectional phone survey from April 9, 2020, to July 2, 2020, during which patients with autoimmune diseases followed at the National Reference Center for Rare Autoimmun","2021","07","16","Arthritis Res Ther","Arthritis research &amp; therapy","Autoimmune diseases; COVID-19; Epidemiology; Immune system diseases; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; France; Humans; Incidence; SARS-CoV-2; Seroepidemiologic Studies","Chatelus","Emmanuel","Service de rhumatologie, Service de rhumatologie, Hôpitaux Universitaires de Strasbourg et Université de Strasbourg, 1 avenue Molière BP 83049, 67098, Strasbourg cedex, France",NA
"2723","34256812","10.1186/s13075-021-02565-0","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predictors of COVID-19 and disease flare-ups. Cross-sectional phone survey from April 9, 2020, to July 2, 2020, during which patients with autoimmune diseases followed at the National Reference Center for Rare Autoimmun","2021","07","16","Arthritis Res Ther","Arthritis research &amp; therapy","Autoimmune diseases; COVID-19; Epidemiology; Immune system diseases; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; France; Humans; Incidence; SARS-CoV-2; Seroepidemiologic Studies","Javier","Rose-Marie","Service de rhumatologie, Service de rhumatologie, Hôpitaux Universitaires de Strasbourg et Université de Strasbourg, 1 avenue Molière BP 83049, 67098, Strasbourg cedex, France",NA
"2724","34256812","10.1186/s13075-021-02565-0","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predictors of COVID-19 and disease flare-ups. Cross-sectional phone survey from April 9, 2020, to July 2, 2020, during which patients with autoimmune diseases followed at the National Reference Center for Rare Autoimmun","2021","07","16","Arthritis Res Ther","Arthritis research &amp; therapy","Autoimmune diseases; COVID-19; Epidemiology; Immune system diseases; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; France; Humans; Incidence; SARS-CoV-2; Seroepidemiologic Studies","Meyer","Aurore","Centre National de Référence des Maladies Auto-Immunes Systémiques Rares Est Sud-Ouest (RESO), Strasbourg, France",NA
"2725","34256812","10.1186/s13075-021-02565-0","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predictors of COVID-19 and disease flare-ups. Cross-sectional phone survey from April 9, 2020, to July 2, 2020, during which patients with autoimmune diseases followed at the National Reference Center for Rare Autoimmun","2021","07","16","Arthritis Res Ther","Arthritis research &amp; therapy","Autoimmune diseases; COVID-19; Epidemiology; Immune system diseases; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; France; Humans; Incidence; SARS-CoV-2; Seroepidemiologic Studies","Pijnenburg","Luc","Service de rhumatologie, Service de rhumatologie, Hôpitaux Universitaires de Strasbourg et Université de Strasbourg, 1 avenue Molière BP 83049, 67098, Strasbourg cedex, France",NA
"2726","34256812","10.1186/s13075-021-02565-0","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predictors of COVID-19 and disease flare-ups. Cross-sectional phone survey from April 9, 2020, to July 2, 2020, during which patients with autoimmune diseases followed at the National Reference Center for Rare Autoimmun","2021","07","16","Arthritis Res Ther","Arthritis research &amp; therapy","Autoimmune diseases; COVID-19; Epidemiology; Immune system diseases; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; France; Humans; Incidence; SARS-CoV-2; Seroepidemiologic Studies","Kleinmann","Jean-François","Service de rhumatologie, Service de rhumatologie, Hôpitaux Universitaires de Strasbourg et Université de Strasbourg, 1 avenue Molière BP 83049, 67098, Strasbourg cedex, France",NA
"2727","34256812","10.1186/s13075-021-02565-0","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predictors of COVID-19 and disease flare-ups. Cross-sectional phone survey from April 9, 2020, to July 2, 2020, during which patients with autoimmune diseases followed at the National Reference Center for Rare Autoimmun","2021","07","16","Arthritis Res Ther","Arthritis research &amp; therapy","Autoimmune diseases; COVID-19; Epidemiology; Immune system diseases; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; France; Humans; Incidence; SARS-CoV-2; Seroepidemiologic Studies","Gottenberg","Jacques-Eric","Service de rhumatologie, Service de rhumatologie, Hôpitaux Universitaires de Strasbourg et Université de Strasbourg, 1 avenue Molière BP 83049, 67098, Strasbourg cedex, France",NA
"2728","34256812","10.1186/s13075-021-02565-0","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predictors of COVID-19 and disease flare-ups. Cross-sectional phone survey from April 9, 2020, to July 2, 2020, during which patients with autoimmune diseases followed at the National Reference Center for Rare Autoimmun","2021","07","16","Arthritis Res Ther","Arthritis research &amp; therapy","Autoimmune diseases; COVID-19; Epidemiology; Immune system diseases; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; France; Humans; Incidence; SARS-CoV-2; Seroepidemiologic Studies","Sibilia","Jean","Service de rhumatologie, Service de rhumatologie, Hôpitaux Universitaires de Strasbourg et Université de Strasbourg, 1 avenue Molière BP 83049, 67098, Strasbourg cedex, France",NA
"2729","34256812","10.1186/s13075-021-02565-0","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predictors of COVID-19 and disease flare-ups. Cross-sectional phone survey from April 9, 2020, to July 2, 2020, during which patients with autoimmune diseases followed at the National Reference Center for Rare Autoimmun","2021","07","16","Arthritis Res Ther","Arthritis research &amp; therapy","Autoimmune diseases; COVID-19; Epidemiology; Immune system diseases; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; France; Humans; Incidence; SARS-CoV-2; Seroepidemiologic Studies","Martin","Thierry","Centre National de Référence des Maladies Auto-Immunes Systémiques Rares Est Sud-Ouest (RESO), Strasbourg, France",NA
"2730","34256812","10.1186/s13075-021-02565-0","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COVID-19 infection in patients followed for rare autoimmune diseases as well as the predictors of COVID-19 and disease flare-ups. Cross-sectional phone survey from April 9, 2020, to July 2, 2020, during which patients with autoimmune diseases followed at the National Reference Center for Rare Autoimmun","2021","07","16","Arthritis Res Ther","Arthritis research &amp; therapy","Autoimmune diseases; COVID-19; Epidemiology; Immune system diseases; Autoimmune Diseases; COVID-19; Cross-Sectional Studies; France; Humans; Incidence; SARS-CoV-2; Seroepidemiologic Studies","Arnaud","Laurent","Service de rhumatologie, Service de rhumatologie, Hôpitaux Universitaires de Strasbourg et Université de Strasbourg, 1 avenue Molière BP 83049, 67098, Strasbourg cedex, France. laurent.arnaud@chru-strasbourg",NA
"2731","34256810","10.1186/s13063-021-05391-6","The effectiveness of a psycho-education intervention on mental health literacy in communities affected by the COVID-19 pandemic-a cluster randomized trial of 24 villages in central Uganda-a research protocol.","Literature shows a high prevalence of psychological distress (PD) as well as common mental disorders (CMD) such as major depressive disorders (MDD), generalized anxiety disorders (GAD), post-traumatic stress disorders (PTSD), and substance misuse disorders (SUD) among people exposed to disasters and pandemics like the COVID-19. Moreover, CMD are associated with increased mortality (mainly through suicide) and morbidity (loss of productivity). A number of countries have made deliberate efforts to","2021","07","15","Trials","Trials","Common mental disorders; Mental health literacy; Sub-Saharan Africa; Adult; COVID-19; Depressive Disorder, Major; Health Literacy; Humans; Mental Health; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; Uganda","Akena","Dickens","Department of Psychiatry, Makerere University College of Health Sciences, Kampala, Uganda. akendickens@yahoo.co","akendickens@yahoo.co.uk"
"2732","34256810","10.1186/s13063-021-05391-6","The effectiveness of a psycho-education intervention on mental health literacy in communities affected by the COVID-19 pandemic-a cluster randomized trial of 24 villages in central Uganda-a research protocol.","Literature shows a high prevalence of psychological distress (PD) as well as common mental disorders (CMD) such as major depressive disorders (MDD), generalized anxiety disorders (GAD), post-traumatic stress disorders (PTSD), and substance misuse disorders (SUD) among people exposed to disasters and pandemics like the COVID-19. Moreover, CMD are associated with increased mortality (mainly through suicide) and morbidity (loss of productivity). A number of countries have made deliberate efforts to","2021","07","15","Trials","Trials","Common mental disorders; Mental health literacy; Sub-Saharan Africa; Adult; COVID-19; Depressive Disorder, Major; Health Literacy; Humans; Mental Health; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; Uganda","Kiguba","Ronald","Department of Pharmacology, Makerere University College of Health Sciences, Kampala, Uganda",NA
"2733","34256810","10.1186/s13063-021-05391-6","The effectiveness of a psycho-education intervention on mental health literacy in communities affected by the COVID-19 pandemic-a cluster randomized trial of 24 villages in central Uganda-a research protocol.","Literature shows a high prevalence of psychological distress (PD) as well as common mental disorders (CMD) such as major depressive disorders (MDD), generalized anxiety disorders (GAD), post-traumatic stress disorders (PTSD), and substance misuse disorders (SUD) among people exposed to disasters and pandemics like the COVID-19. Moreover, CMD are associated with increased mortality (mainly through suicide) and morbidity (loss of productivity). A number of countries have made deliberate efforts to","2021","07","15","Trials","Trials","Common mental disorders; Mental health literacy; Sub-Saharan Africa; Adult; COVID-19; Depressive Disorder, Major; Health Literacy; Humans; Mental Health; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; Uganda","Muhwezi","Wilson W","Department of Psychiatry, Makerere University College of Health Sciences, Kampala, Uganda",NA
"2734","34256810","10.1186/s13063-021-05391-6","The effectiveness of a psycho-education intervention on mental health literacy in communities affected by the COVID-19 pandemic-a cluster randomized trial of 24 villages in central Uganda-a research protocol.","Literature shows a high prevalence of psychological distress (PD) as well as common mental disorders (CMD) such as major depressive disorders (MDD), generalized anxiety disorders (GAD), post-traumatic stress disorders (PTSD), and substance misuse disorders (SUD) among people exposed to disasters and pandemics like the COVID-19. Moreover, CMD are associated with increased mortality (mainly through suicide) and morbidity (loss of productivity). A number of countries have made deliberate efforts to","2021","07","15","Trials","Trials","Common mental disorders; Mental health literacy; Sub-Saharan Africa; Adult; COVID-19; Depressive Disorder, Major; Health Literacy; Humans; Mental Health; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; Uganda","Kwesiga","Brendan","Health Systems Strengthening Cluster, World Health Organization, Kenya Country Office, Nairobi, Kenya",NA
"2735","34256810","10.1186/s13063-021-05391-6","The effectiveness of a psycho-education intervention on mental health literacy in communities affected by the COVID-19 pandemic-a cluster randomized trial of 24 villages in central Uganda-a research protocol.","Literature shows a high prevalence of psychological distress (PD) as well as common mental disorders (CMD) such as major depressive disorders (MDD), generalized anxiety disorders (GAD), post-traumatic stress disorders (PTSD), and substance misuse disorders (SUD) among people exposed to disasters and pandemics like the COVID-19. Moreover, CMD are associated with increased mortality (mainly through suicide) and morbidity (loss of productivity). A number of countries have made deliberate efforts to","2021","07","15","Trials","Trials","Common mental disorders; Mental health literacy; Sub-Saharan Africa; Adult; COVID-19; Depressive Disorder, Major; Health Literacy; Humans; Mental Health; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; Uganda","Kigozi","Gwendolyne","Grants office, Makerere University College of Health Sciences, Kampala, Uganda",NA
"2736","34256810","10.1186/s13063-021-05391-6","The effectiveness of a psycho-education intervention on mental health literacy in communities affected by the COVID-19 pandemic-a cluster randomized trial of 24 villages in central Uganda-a research protocol.","Literature shows a high prevalence of psychological distress (PD) as well as common mental disorders (CMD) such as major depressive disorders (MDD), generalized anxiety disorders (GAD), post-traumatic stress disorders (PTSD), and substance misuse disorders (SUD) among people exposed to disasters and pandemics like the COVID-19. Moreover, CMD are associated with increased mortality (mainly through suicide) and morbidity (loss of productivity). A number of countries have made deliberate efforts to","2021","07","15","Trials","Trials","Common mental disorders; Mental health literacy; Sub-Saharan Africa; Adult; COVID-19; Depressive Disorder, Major; Health Literacy; Humans; Mental Health; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; Uganda","Nakasujja","Noeline","Department of Psychiatry, Makerere University College of Health Sciences, Kampala, Uganda",NA
"2737","34256810","10.1186/s13063-021-05391-6","The effectiveness of a psycho-education intervention on mental health literacy in communities affected by the COVID-19 pandemic-a cluster randomized trial of 24 villages in central Uganda-a research protocol.","Literature shows a high prevalence of psychological distress (PD) as well as common mental disorders (CMD) such as major depressive disorders (MDD), generalized anxiety disorders (GAD), post-traumatic stress disorders (PTSD), and substance misuse disorders (SUD) among people exposed to disasters and pandemics like the COVID-19. Moreover, CMD are associated with increased mortality (mainly through suicide) and morbidity (loss of productivity). A number of countries have made deliberate efforts to","2021","07","15","Trials","Trials","Common mental disorders; Mental health literacy; Sub-Saharan Africa; Adult; COVID-19; Depressive Disorder, Major; Health Literacy; Humans; Mental Health; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; Uganda","Lukwata","Hafsa","Department of Mental Health, Ministry of Health of Uganda, Kampala, Uganda",NA
"2738","34256791","10.1186/s12985-021-01610-3","Fluorescence of ocular surface in a Covid -19 patient after Favipiravir treatment: a case report.","Favipiravir is used in treatment of Covid-19 patients. We aimed to share of ocular surface fluorescence in a patient after Favipiravir treatment in this case report. A 20-year-old male patient declared no known systemic disease prior to Covid-19. He applied to us with blurry vision and blue light reflection after Covid-19 treatment with Favipiravir. We observed bilateral fluorescence on his eyes and fluorescence of his nails. Biomicroscopic examination was insignificant. We investigated the fluo","2021","07","23","Virol J","Virology journal","Covid-19; Favipiravir; Fluorescence; Ocular surface; Ultraviolet light; Adult; Amides; Antiviral Agents; COVID-19; Eye; Fluorescence; Humans; Male; Pyrazines; SARS-CoV-2","Doran","Mehmet Ali","Department of Ophthalmology, Tepecik Training and Research Hospital, Izmir, Turkey. malidoran75@gmail","malidoran75@gmail.com"
"2739","34256791","10.1186/s12985-021-01610-3","Fluorescence of ocular surface in a Covid -19 patient after Favipiravir treatment: a case report.","Favipiravir is used in treatment of Covid-19 patients. We aimed to share of ocular surface fluorescence in a patient after Favipiravir treatment in this case report. A 20-year-old male patient declared no known systemic disease prior to Covid-19. He applied to us with blurry vision and blue light reflection after Covid-19 treatment with Favipiravir. We observed bilateral fluorescence on his eyes and fluorescence of his nails. Biomicroscopic examination was insignificant. We investigated the fluo","2021","07","23","Virol J","Virology journal","Covid-19; Favipiravir; Fluorescence; Ocular surface; Ultraviolet light; Adult; Amides; Antiviral Agents; COVID-19; Eye; Fluorescence; Humans; Male; Pyrazines; SARS-CoV-2","Aytogan","Hasan","Department of Ophthalmology, Tepecik Training and Research Hospital, Izmir, Turkey",NA
"2740","34256791","10.1186/s12985-021-01610-3","Fluorescence of ocular surface in a Covid -19 patient after Favipiravir treatment: a case report.","Favipiravir is used in treatment of Covid-19 patients. We aimed to share of ocular surface fluorescence in a patient after Favipiravir treatment in this case report. A 20-year-old male patient declared no known systemic disease prior to Covid-19. He applied to us with blurry vision and blue light reflection after Covid-19 treatment with Favipiravir. We observed bilateral fluorescence on his eyes and fluorescence of his nails. Biomicroscopic examination was insignificant. We investigated the fluo","2021","07","23","Virol J","Virology journal","Covid-19; Favipiravir; Fluorescence; Ocular surface; Ultraviolet light; Adult; Amides; Antiviral Agents; COVID-19; Eye; Fluorescence; Humans; Male; Pyrazines; SARS-CoV-2","Ayintap","Emre","Department of Ophthalmology, Tepecik Training and Research Hospital, Izmir, Turkey",NA
"2741","34256785","10.1186/s12960-021-00627-7","Rebuilding to shape a better future: the role of young professionals in the public health workforce.","The COVID-19 pandemic has made clear the extreme needs of the public health workforce. As societies discuss how to build up the capacity and infrastructure of their systems, it is crucial that young professionals are involved. Previous attempts to incorporate young professionals into the public health workforce have wrestled with inaccessibility, tokenisation, and a lack of mentorship, leading to a loss of potential workforce members and a non-representative workforce that reinforces systemic so","2021","07","22","Hum Resour Health","Human resources for health","Capacity building; Equity; Health workforce; Mentorship; Public health; Students and young professionals; Adult; Age Factors; Ageism; COVID-19; Health Personnel; Health Planning; Health Services Needs and Demand; Health Workforce; Humans; Mentors; Pandemics; Personnel Selection; Public Health; Young Adult","Wong","Brian Li Han","Department of Population Science and Experimental Medicine, UCL Institute of Cardiovascular Science, Medical Research Council (MRC) Unit for Lifelong Health and Ageing at University College London (UCL), 5th Floor, 1-19 Torrington Place, Fitzrovia, London, WC1E 7HB, UK. b.wong@ucl.ac","b.wong@ucl.ac.uk"
"2742","34256785","10.1186/s12960-021-00627-7","Rebuilding to shape a better future: the role of young professionals in the public health workforce.","The COVID-19 pandemic has made clear the extreme needs of the public health workforce. As societies discuss how to build up the capacity and infrastructure of their systems, it is crucial that young professionals are involved. Previous attempts to incorporate young professionals into the public health workforce have wrestled with inaccessibility, tokenisation, and a lack of mentorship, leading to a loss of potential workforce members and a non-representative workforce that reinforces systemic so","2021","07","22","Hum Resour Health","Human resources for health","Capacity building; Equity; Health workforce; Mentorship; Public health; Students and young professionals; Adult; Age Factors; Ageism; COVID-19; Health Personnel; Health Planning; Health Services Needs and Demand; Health Workforce; Humans; Mentors; Pandemics; Personnel Selection; Public Health; Young Adult","Siepmann","Ines","Faculty of Health, Medicine, and Life Sciences, Maastricht University, Maastricht, The Netherlands",NA
"2743","34256785","10.1186/s12960-021-00627-7","Rebuilding to shape a better future: the role of young professionals in the public health workforce.","The COVID-19 pandemic has made clear the extreme needs of the public health workforce. As societies discuss how to build up the capacity and infrastructure of their systems, it is crucial that young professionals are involved. Previous attempts to incorporate young professionals into the public health workforce have wrestled with inaccessibility, tokenisation, and a lack of mentorship, leading to a loss of potential workforce members and a non-representative workforce that reinforces systemic so","2021","07","22","Hum Resour Health","Human resources for health","Capacity building; Equity; Health workforce; Mentorship; Public health; Students and young professionals; Adult; Age Factors; Ageism; COVID-19; Health Personnel; Health Planning; Health Services Needs and Demand; Health Workforce; Humans; Mentors; Pandemics; Personnel Selection; Public Health; Young Adult","Chen","Tara T","Department of Social Work, Tzu-Chi University, Hualien, Taiwan",NA
"2744","34256785","10.1186/s12960-021-00627-7","Rebuilding to shape a better future: the role of young professionals in the public health workforce.","The COVID-19 pandemic has made clear the extreme needs of the public health workforce. As societies discuss how to build up the capacity and infrastructure of their systems, it is crucial that young professionals are involved. Previous attempts to incorporate young professionals into the public health workforce have wrestled with inaccessibility, tokenisation, and a lack of mentorship, leading to a loss of potential workforce members and a non-representative workforce that reinforces systemic so","2021","07","22","Hum Resour Health","Human resources for health","Capacity building; Equity; Health workforce; Mentorship; Public health; Students and young professionals; Adult; Age Factors; Ageism; COVID-19; Health Personnel; Health Planning; Health Services Needs and Demand; Health Workforce; Humans; Mentors; Pandemics; Personnel Selection; Public Health; Young Adult","Fisher","Shelby","Department of Environmental and Occupational Health, École des Hautes Études en Santé Publique, Paris, France",NA
"2745","34256785","10.1186/s12960-021-00627-7","Rebuilding to shape a better future: the role of young professionals in the public health workforce.","The COVID-19 pandemic has made clear the extreme needs of the public health workforce. As societies discuss how to build up the capacity and infrastructure of their systems, it is crucial that young professionals are involved. Previous attempts to incorporate young professionals into the public health workforce have wrestled with inaccessibility, tokenisation, and a lack of mentorship, leading to a loss of potential workforce members and a non-representative workforce that reinforces systemic so","2021","07","22","Hum Resour Health","Human resources for health","Capacity building; Equity; Health workforce; Mentorship; Public health; Students and young professionals; Adult; Age Factors; Ageism; COVID-19; Health Personnel; Health Planning; Health Services Needs and Demand; Health Workforce; Humans; Mentors; Pandemics; Personnel Selection; Public Health; Young Adult","Weitzel","Tobias S","Department of Public Health, University of Copenhagen, Copenhagen, Denmark",NA
"2746","34256785","10.1186/s12960-021-00627-7","Rebuilding to shape a better future: the role of young professionals in the public health workforce.","The COVID-19 pandemic has made clear the extreme needs of the public health workforce. As societies discuss how to build up the capacity and infrastructure of their systems, it is crucial that young professionals are involved. Previous attempts to incorporate young professionals into the public health workforce have wrestled with inaccessibility, tokenisation, and a lack of mentorship, leading to a loss of potential workforce members and a non-representative workforce that reinforces systemic so","2021","07","22","Hum Resour Health","Human resources for health","Capacity building; Equity; Health workforce; Mentorship; Public health; Students and young professionals; Adult; Age Factors; Ageism; COVID-19; Health Personnel; Health Planning; Health Services Needs and Demand; Health Workforce; Humans; Mentors; Pandemics; Personnel Selection; Public Health; Young Adult","Nathan","Naomi L","Institute of Public Health, Jagiellonian University, Krakow, Poland",NA
"2747","34256785","10.1186/s12960-021-00627-7","Rebuilding to shape a better future: the role of young professionals in the public health workforce.","The COVID-19 pandemic has made clear the extreme needs of the public health workforce. As societies discuss how to build up the capacity and infrastructure of their systems, it is crucial that young professionals are involved. Previous attempts to incorporate young professionals into the public health workforce have wrestled with inaccessibility, tokenisation, and a lack of mentorship, leading to a loss of potential workforce members and a non-representative workforce that reinforces systemic so","2021","07","22","Hum Resour Health","Human resources for health","Capacity building; Equity; Health workforce; Mentorship; Public health; Students and young professionals; Adult; Age Factors; Ageism; COVID-19; Health Personnel; Health Planning; Health Services Needs and Demand; Health Workforce; Humans; Mentors; Pandemics; Personnel Selection; Public Health; Young Adult","Saminarsih","Diah S","Office of the Director-General, World Health Organization, Avenue Appia 20, 1202, Genève, Switzerland",NA
"2748","34256781","10.1186/s13017-021-00382-z","The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access.","The aim of this retrospective comparative study was to assess the impact of COVID-19 and delayed emergency department access on emergency surgery outcomes, by comparing the main clinical outcomes in the period March-May 2019 (group 1) with the same period during the national COVID-19 lockdown in Italy (March-May 2020, group 2). A comparison (groups 1 versus 2) and subgroup analysis were performed between patients' demographic, medical history, surgical, clinical and management characteristics. T","2021","07","23","World J Emerg Surg","World journal of emergency surgery : WJES","COVID-19 disease; Complications; Delayed access; Emergency surgery; Surgical care","Ciarleglio","Francesco A","General Surgery II &amp","francesco.ciarleglio@apss.tn.it"
"2749","34256781","10.1186/s13017-021-00382-z","The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access.","The aim of this retrospective comparative study was to assess the impact of COVID-19 and delayed emergency department access on emergency surgery outcomes, by comparing the main clinical outcomes in the period March-May 2019 (group 1) with the same period during the national COVID-19 lockdown in Italy (March-May 2020, group 2). A comparison (groups 1 versus 2) and subgroup analysis were performed between patients' demographic, medical history, surgical, clinical and management characteristics. T","2021","07","23","World J Emerg Surg","World journal of emergency surgery : WJES","COVID-19 disease; Complications; Delayed access; Emergency surgery; Surgical care","Rigoni","Marta","IRCS - Innovation and Clinical Health Research - Bruno Kessler Foundation (FBK), 38123, Trento, Italy",NA
"2750","34256781","10.1186/s13017-021-00382-z","The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access.","The aim of this retrospective comparative study was to assess the impact of COVID-19 and delayed emergency department access on emergency surgery outcomes, by comparing the main clinical outcomes in the period March-May 2019 (group 1) with the same period during the national COVID-19 lockdown in Italy (March-May 2020, group 2). A comparison (groups 1 versus 2) and subgroup analysis were performed between patients' demographic, medical history, surgical, clinical and management characteristics. T","2021","07","23","World J Emerg Surg","World journal of emergency surgery : WJES","COVID-19 disease; Complications; Delayed access; Emergency surgery; Surgical care","Mereu","Liliana","Obstetrics and Gynaecology Unit, Azienda Provinciale per i Servizi Sanitari (APSS), Santa Chiara Hospital, 38122, Trento, Italy",NA
"2751","34256781","10.1186/s13017-021-00382-z","The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access.","The aim of this retrospective comparative study was to assess the impact of COVID-19 and delayed emergency department access on emergency surgery outcomes, by comparing the main clinical outcomes in the period March-May 2019 (group 1) with the same period during the national COVID-19 lockdown in Italy (March-May 2020, group 2). A comparison (groups 1 versus 2) and subgroup analysis were performed between patients' demographic, medical history, surgical, clinical and management characteristics. T","2021","07","23","World J Emerg Surg","World journal of emergency surgery : WJES","COVID-19 disease; Complications; Delayed access; Emergency surgery; Surgical care","Tommaso","Cai","Urology Unit, APSS, Azienda Provinciale per i Servizi Sanitari (APSS), Santa Chiara Hospital, 38122, Trento, Italy",NA
"2752","34256781","10.1186/s13017-021-00382-z","The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access.","The aim of this retrospective comparative study was to assess the impact of COVID-19 and delayed emergency department access on emergency surgery outcomes, by comparing the main clinical outcomes in the period March-May 2019 (group 1) with the same period during the national COVID-19 lockdown in Italy (March-May 2020, group 2). A comparison (groups 1 versus 2) and subgroup analysis were performed between patients' demographic, medical history, surgical, clinical and management characteristics. T","2021","07","23","World J Emerg Surg","World journal of emergency surgery : WJES","COVID-19 disease; Complications; Delayed access; Emergency surgery; Surgical care","Carrara","Alessandro","General Surgery I &amp",NA
"2753","34256781","10.1186/s13017-021-00382-z","The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access.","The aim of this retrospective comparative study was to assess the impact of COVID-19 and delayed emergency department access on emergency surgery outcomes, by comparing the main clinical outcomes in the period March-May 2019 (group 1) with the same period during the national COVID-19 lockdown in Italy (March-May 2020, group 2). A comparison (groups 1 versus 2) and subgroup analysis were performed between patients' demographic, medical history, surgical, clinical and management characteristics. T","2021","07","23","World J Emerg Surg","World journal of emergency surgery : WJES","COVID-19 disease; Complications; Delayed access; Emergency surgery; Surgical care","Malossini","Gianni","Urology Unit, APSS, Azienda Provinciale per i Servizi Sanitari (APSS), Santa Chiara Hospital, 38122, Trento, Italy",NA
"2754","34256781","10.1186/s13017-021-00382-z","The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access.","The aim of this retrospective comparative study was to assess the impact of COVID-19 and delayed emergency department access on emergency surgery outcomes, by comparing the main clinical outcomes in the period March-May 2019 (group 1) with the same period during the national COVID-19 lockdown in Italy (March-May 2020, group 2). A comparison (groups 1 versus 2) and subgroup analysis were performed between patients' demographic, medical history, surgical, clinical and management characteristics. T","2021","07","23","World J Emerg Surg","World journal of emergency surgery : WJES","COVID-19 disease; Complications; Delayed access; Emergency surgery; Surgical care","Tateo","Saverio","Obstetrics and Gynaecology Unit, Azienda Provinciale per i Servizi Sanitari (APSS), Santa Chiara Hospital, 38122, Trento, Italy",NA
"2755","34256781","10.1186/s13017-021-00382-z","The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access.","The aim of this retrospective comparative study was to assess the impact of COVID-19 and delayed emergency department access on emergency surgery outcomes, by comparing the main clinical outcomes in the period March-May 2019 (group 1) with the same period during the national COVID-19 lockdown in Italy (March-May 2020, group 2). A comparison (groups 1 versus 2) and subgroup analysis were performed between patients' demographic, medical history, surgical, clinical and management characteristics. T","2021","07","23","World J Emerg Surg","World journal of emergency surgery : WJES","COVID-19 disease; Complications; Delayed access; Emergency surgery; Surgical care","Tirone","Giuseppe","General Surgery I &amp",NA
"2756","34256781","10.1186/s13017-021-00382-z","The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access.","The aim of this retrospective comparative study was to assess the impact of COVID-19 and delayed emergency department access on emergency surgery outcomes, by comparing the main clinical outcomes in the period March-May 2019 (group 1) with the same period during the national COVID-19 lockdown in Italy (March-May 2020, group 2). A comparison (groups 1 versus 2) and subgroup analysis were performed between patients' demographic, medical history, surgical, clinical and management characteristics. T","2021","07","23","World J Emerg Surg","World journal of emergency surgery : WJES","COVID-19 disease; Complications; Delayed access; Emergency surgery; Surgical care","Bjerklund Johansen","Truls E","Institute of Clinical Medicine, University of Oslo, Oslo, Norway",NA
"2757","34256781","10.1186/s13017-021-00382-z","The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access.","The aim of this retrospective comparative study was to assess the impact of COVID-19 and delayed emergency department access on emergency surgery outcomes, by comparing the main clinical outcomes in the period March-May 2019 (group 1) with the same period during the national COVID-19 lockdown in Italy (March-May 2020, group 2). A comparison (groups 1 versus 2) and subgroup analysis were performed between patients' demographic, medical history, surgical, clinical and management characteristics. T","2021","07","23","World J Emerg Surg","World journal of emergency surgery : WJES","COVID-19 disease; Complications; Delayed access; Emergency surgery; Surgical care","Benetollo","Pier Paolo","Provincial Health Care Agency Staff Management, Azienda Provinciale per i Servizi Sanitari (APSS), Santa Chiara Hospital, Trento, Italy",NA
"2758","34256781","10.1186/s13017-021-00382-z","The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access.","The aim of this retrospective comparative study was to assess the impact of COVID-19 and delayed emergency department access on emergency surgery outcomes, by comparing the main clinical outcomes in the period March-May 2019 (group 1) with the same period during the national COVID-19 lockdown in Italy (March-May 2020, group 2). A comparison (groups 1 versus 2) and subgroup analysis were performed between patients' demographic, medical history, surgical, clinical and management characteristics. T","2021","07","23","World J Emerg Surg","World journal of emergency surgery : WJES","COVID-19 disease; Complications; Delayed access; Emergency surgery; Surgical care","Ferro","Antonio","Provincial Health Care Agency Staff Management, Azienda Provinciale per i Servizi Sanitari (APSS), Santa Chiara Hospital, Trento, Italy",NA
"2759","34256781","10.1186/s13017-021-00382-z","The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access.","The aim of this retrospective comparative study was to assess the impact of COVID-19 and delayed emergency department access on emergency surgery outcomes, by comparing the main clinical outcomes in the period March-May 2019 (group 1) with the same period during the national COVID-19 lockdown in Italy (March-May 2020, group 2). A comparison (groups 1 versus 2) and subgroup analysis were performed between patients' demographic, medical history, surgical, clinical and management characteristics. T","2021","07","23","World J Emerg Surg","World journal of emergency surgery : WJES","COVID-19 disease; Complications; Delayed access; Emergency surgery; Surgical care","Guarrera","Giovanni Maria","Provincial Health Care Agency Staff Management, Azienda Provinciale per i Servizi Sanitari (APSS), Santa Chiara Hospital, Trento, Italy",NA
"2760","34256781","10.1186/s13017-021-00382-z","The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access.","The aim of this retrospective comparative study was to assess the impact of COVID-19 and delayed emergency department access on emergency surgery outcomes, by comparing the main clinical outcomes in the period March-May 2019 (group 1) with the same period during the national COVID-19 lockdown in Italy (March-May 2020, group 2). A comparison (groups 1 versus 2) and subgroup analysis were performed between patients' demographic, medical history, surgical, clinical and management characteristics. T","2021","07","23","World J Emerg Surg","World journal of emergency surgery : WJES","COVID-19 disease; Complications; Delayed access; Emergency surgery; Surgical care","Grattarola","Mario","Provincial Health Care Agency Staff Management, Azienda Provinciale per i Servizi Sanitari (APSS), Santa Chiara Hospital, Trento, Italy",NA
"2761","34256781","10.1186/s13017-021-00382-z","The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access.","The aim of this retrospective comparative study was to assess the impact of COVID-19 and delayed emergency department access on emergency surgery outcomes, by comparing the main clinical outcomes in the period March-May 2019 (group 1) with the same period during the national COVID-19 lockdown in Italy (March-May 2020, group 2). A comparison (groups 1 versus 2) and subgroup analysis were performed between patients' demographic, medical history, surgical, clinical and management characteristics. T","2021","07","23","World J Emerg Surg","World journal of emergency surgery : WJES","COVID-19 disease; Complications; Delayed access; Emergency surgery; Surgical care","Nollo","Giandomenico","IRCS - Innovation and Clinical Health Research - Bruno Kessler Foundation (FBK), 38123, Trento, Italy",NA
"2762","34256781","10.1186/s13017-021-00382-z","The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access.","The aim of this retrospective comparative study was to assess the impact of COVID-19 and delayed emergency department access on emergency surgery outcomes, by comparing the main clinical outcomes in the period March-May 2019 (group 1) with the same period during the national COVID-19 lockdown in Italy (March-May 2020, group 2). A comparison (groups 1 versus 2) and subgroup analysis were performed between patients' demographic, medical history, surgical, clinical and management characteristics. T","2021","07","23","World J Emerg Surg","World journal of emergency surgery : WJES","COVID-19 disease; Complications; Delayed access; Emergency surgery; Surgical care","Brolese","Alberto","General Surgery II &amp",NA
"2763","34256756","10.1186/s12913-021-06607-w","Dispensing antiretrovirals during Covid-19 lockdown: re-discovering community-based ART delivery models in Uganda.","The notion of health-system resilience has received little empirical attention in the current literature on the Covid-19 response. We set out to explore health-system resilience at the sub-national level in Uganda with regard to strategies for dispensing antiretrovirals during Covid-19 lockdown. We conducted a qualitative case-study of eight districts purposively selected from Eastern and Western Uganda. Between June and September 2020, we conducted qualitative interviews with district health te","2021","07","15","BMC Health Serv Res","BMC health services research","COVID-19; Communicable Disease Control; Delivery of Health Care; HIV Infections; Humans; SARS-CoV-2; Uganda","Zakumumpa","Henry","Makerere University, School of Public Health, Kampala, Uganda. zakumumpa.henry09@gmail","zakumumpa.henry09@gmail.com"
"2764","34256756","10.1186/s12913-021-06607-w","Dispensing antiretrovirals during Covid-19 lockdown: re-discovering community-based ART delivery models in Uganda.","The notion of health-system resilience has received little empirical attention in the current literature on the Covid-19 response. We set out to explore health-system resilience at the sub-national level in Uganda with regard to strategies for dispensing antiretrovirals during Covid-19 lockdown. We conducted a qualitative case-study of eight districts purposively selected from Eastern and Western Uganda. Between June and September 2020, we conducted qualitative interviews with district health te","2021","07","15","BMC Health Serv Res","BMC health services research","COVID-19; Communicable Disease Control; Delivery of Health Care; HIV Infections; Humans; SARS-CoV-2; Uganda","Tumwine","Christopher","Kabale University, School of Medicine, Kabale, Uganda",NA
"2765","34256756","10.1186/s12913-021-06607-w","Dispensing antiretrovirals during Covid-19 lockdown: re-discovering community-based ART delivery models in Uganda.","The notion of health-system resilience has received little empirical attention in the current literature on the Covid-19 response. We set out to explore health-system resilience at the sub-national level in Uganda with regard to strategies for dispensing antiretrovirals during Covid-19 lockdown. We conducted a qualitative case-study of eight districts purposively selected from Eastern and Western Uganda. Between June and September 2020, we conducted qualitative interviews with district health te","2021","07","15","BMC Health Serv Res","BMC health services research","COVID-19; Communicable Disease Control; Delivery of Health Care; HIV Infections; Humans; SARS-CoV-2; Uganda","Milliam","Kiconco","Department of Sociology, Kyambogo University, Kampala, Uganda",NA
"2766","34256756","10.1186/s12913-021-06607-w","Dispensing antiretrovirals during Covid-19 lockdown: re-discovering community-based ART delivery models in Uganda.","The notion of health-system resilience has received little empirical attention in the current literature on the Covid-19 response. We set out to explore health-system resilience at the sub-national level in Uganda with regard to strategies for dispensing antiretrovirals during Covid-19 lockdown. We conducted a qualitative case-study of eight districts purposively selected from Eastern and Western Uganda. Between June and September 2020, we conducted qualitative interviews with district health te","2021","07","15","BMC Health Serv Res","BMC health services research","COVID-19; Communicable Disease Control; Delivery of Health Care; HIV Infections; Humans; SARS-CoV-2; Uganda","Spicer","Neil","London School of Hygiene and Tropical Medicine, London, UK",NA
"2767","34256747","10.1186/s12890-021-01593-5","Role of respiratory intermediate care units during the SARS-CoV-2 pandemic.","The SARS-CoV2 pandemic increased exponentially the need for both Intensive (ICU) and Intermediate Care Units (RICU). The latter are of particular importance because they can play a dual role in critical and post-critical care of COVID-19 patients. Here, we describe the setup of 2 new RICUs in our institution to face the SARS-CoV-2 pandemic and discuss the clinical characteristics and outcomes of the patients attended. Retrospective analysis of the characteristics and outcomes of COVID-19 patient","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Intensive care; Intermediate care; RICU; Respiratory failure; SARS-CoV-2; Tracheostomy","Matute-Villacís","Mónica","Servei de Pneumologia i Al·lèrgia Respiratòria, Institut Clínic Respiratori, Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain",NA
"2768","34256747","10.1186/s12890-021-01593-5","Role of respiratory intermediate care units during the SARS-CoV-2 pandemic.","The SARS-CoV2 pandemic increased exponentially the need for both Intensive (ICU) and Intermediate Care Units (RICU). The latter are of particular importance because they can play a dual role in critical and post-critical care of COVID-19 patients. Here, we describe the setup of 2 new RICUs in our institution to face the SARS-CoV-2 pandemic and discuss the clinical characteristics and outcomes of the patients attended. Retrospective analysis of the characteristics and outcomes of COVID-19 patient","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Intensive care; Intermediate care; RICU; Respiratory failure; SARS-CoV-2; Tracheostomy","Moisés","Jorge","Servei de Pneumologia i Al·lèrgia Respiratòria, Institut Clínic Respiratori, Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain",NA
"2769","34256747","10.1186/s12890-021-01593-5","Role of respiratory intermediate care units during the SARS-CoV-2 pandemic.","The SARS-CoV2 pandemic increased exponentially the need for both Intensive (ICU) and Intermediate Care Units (RICU). The latter are of particular importance because they can play a dual role in critical and post-critical care of COVID-19 patients. Here, we describe the setup of 2 new RICUs in our institution to face the SARS-CoV-2 pandemic and discuss the clinical characteristics and outcomes of the patients attended. Retrospective analysis of the characteristics and outcomes of COVID-19 patient","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Intensive care; Intermediate care; RICU; Respiratory failure; SARS-CoV-2; Tracheostomy","Embid","Cristina","Servei de Pneumologia i Al·lèrgia Respiratòria, Institut Clínic Respiratori, Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain",NA
"2770","34256747","10.1186/s12890-021-01593-5","Role of respiratory intermediate care units during the SARS-CoV-2 pandemic.","The SARS-CoV2 pandemic increased exponentially the need for both Intensive (ICU) and Intermediate Care Units (RICU). The latter are of particular importance because they can play a dual role in critical and post-critical care of COVID-19 patients. Here, we describe the setup of 2 new RICUs in our institution to face the SARS-CoV-2 pandemic and discuss the clinical characteristics and outcomes of the patients attended. Retrospective analysis of the characteristics and outcomes of COVID-19 patient","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Intensive care; Intermediate care; RICU; Respiratory failure; SARS-CoV-2; Tracheostomy","Armas","Judith","Servei de Pneumologia i Al·lèrgia Respiratòria, Institut Clínic Respiratori, Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain",NA
"2771","34256747","10.1186/s12890-021-01593-5","Role of respiratory intermediate care units during the SARS-CoV-2 pandemic.","The SARS-CoV2 pandemic increased exponentially the need for both Intensive (ICU) and Intermediate Care Units (RICU). The latter are of particular importance because they can play a dual role in critical and post-critical care of COVID-19 patients. Here, we describe the setup of 2 new RICUs in our institution to face the SARS-CoV-2 pandemic and discuss the clinical characteristics and outcomes of the patients attended. Retrospective analysis of the characteristics and outcomes of COVID-19 patient","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Intensive care; Intermediate care; RICU; Respiratory failure; SARS-CoV-2; Tracheostomy","Fernández","Isabel","Servei de Pneumologia i Al·lèrgia Respiratòria, Institut Clínic Respiratori, Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain",NA
"2772","34256747","10.1186/s12890-021-01593-5","Role of respiratory intermediate care units during the SARS-CoV-2 pandemic.","The SARS-CoV2 pandemic increased exponentially the need for both Intensive (ICU) and Intermediate Care Units (RICU). The latter are of particular importance because they can play a dual role in critical and post-critical care of COVID-19 patients. Here, we describe the setup of 2 new RICUs in our institution to face the SARS-CoV-2 pandemic and discuss the clinical characteristics and outcomes of the patients attended. Retrospective analysis of the characteristics and outcomes of COVID-19 patient","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Intensive care; Intermediate care; RICU; Respiratory failure; SARS-CoV-2; Tracheostomy","Medina","Montserrat","Servei de Pneumologia i Al·lèrgia Respiratòria, Institut Clínic Respiratori, Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain",NA
"2773","34256747","10.1186/s12890-021-01593-5","Role of respiratory intermediate care units during the SARS-CoV-2 pandemic.","The SARS-CoV2 pandemic increased exponentially the need for both Intensive (ICU) and Intermediate Care Units (RICU). The latter are of particular importance because they can play a dual role in critical and post-critical care of COVID-19 patients. Here, we describe the setup of 2 new RICUs in our institution to face the SARS-CoV-2 pandemic and discuss the clinical characteristics and outcomes of the patients attended. Retrospective analysis of the characteristics and outcomes of COVID-19 patient","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Intensive care; Intermediate care; RICU; Respiratory failure; SARS-CoV-2; Tracheostomy","Ferrer","Miquel","Servei de Pneumologia i Al·lèrgia Respiratòria, Institut Clínic Respiratori, Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain",NA
"2774","34256747","10.1186/s12890-021-01593-5","Role of respiratory intermediate care units during the SARS-CoV-2 pandemic.","The SARS-CoV2 pandemic increased exponentially the need for both Intensive (ICU) and Intermediate Care Units (RICU). The latter are of particular importance because they can play a dual role in critical and post-critical care of COVID-19 patients. Here, we describe the setup of 2 new RICUs in our institution to face the SARS-CoV-2 pandemic and discuss the clinical characteristics and outcomes of the patients attended. Retrospective analysis of the characteristics and outcomes of COVID-19 patient","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Intensive care; Intermediate care; RICU; Respiratory failure; SARS-CoV-2; Tracheostomy","Sibila","Oriol","Servei de Pneumologia i Al·lèrgia Respiratòria, Institut Clínic Respiratori, Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain",NA
"2775","34256747","10.1186/s12890-021-01593-5","Role of respiratory intermediate care units during the SARS-CoV-2 pandemic.","The SARS-CoV2 pandemic increased exponentially the need for both Intensive (ICU) and Intermediate Care Units (RICU). The latter are of particular importance because they can play a dual role in critical and post-critical care of COVID-19 patients. Here, we describe the setup of 2 new RICUs in our institution to face the SARS-CoV-2 pandemic and discuss the clinical characteristics and outcomes of the patients attended. Retrospective analysis of the characteristics and outcomes of COVID-19 patient","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Intensive care; Intermediate care; RICU; Respiratory failure; SARS-CoV-2; Tracheostomy","Badia","Joan Ramón","Servei de Pneumologia i Al·lèrgia Respiratòria, Institut Clínic Respiratori, Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain. jrbadia@clinic","jrbadia@clinic.cat"
"2776","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Xiong","Lijuan","Department of Nosocomial Infection Management, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"2777","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Li","Qian","Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China",NA
"2778","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Cao","Xiongjing","Department of Nosocomial Infection Management, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"2779","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Xiong","Huangguo","Department of Nosocomial Infection Management, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"2780","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Huang","Ming","State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China",NA
"2781","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Yang","Fengwen","Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin, China",NA
"2782","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Liu","Qingquan","CCM, Medicine Bachelor Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China",NA
"2783","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Meng","Daquan","Department of Respiratory and Critical Care Medicine, NHC Key Laboratory of Pulmonary Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China",NA
"2784","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Zhou","Mei","Department of Respiratory and Critical Care Medicine, NHC Key Laboratory of Pulmonary Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China",NA
"2785","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Wang","Gang","Department of Rehabilitation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"2786","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Tong","Jun","Affiliated Wuhan Mental Health Center, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"2787","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Chen","Tengfei","CCM, Medicine Bachelor Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China",NA
"2788","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Zhang","Yanzhao","Department of Rehabilitation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"2789","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","He","Xinliang","Department of Respiratory and Critical Care Medicine, NHC Key Laboratory of Pulmonary Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China",NA
"2790","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Fan","Yunzhou","Department of Nosocomial Infection Management, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"2791","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Zhang","Yupeng","Department of Nosocomial Infection Management, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",NA
"2792","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Tang","Liang","Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China",NA
"2793","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Jin","Yang","Department of Respiratory and Critical Care Medicine, NHC Key Laboratory of Pulmonary Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China. whuhjy@126","whuhjy@126.com"
"2794","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Xia","Jiahong","Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China. jiahong.xia@hust.edu","jiahong.xia@hust.edu.cn"
"2795","34256745","10.1186/s12916-021-02042-0","Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.","Few studies had described the health consequences of patients with coronavirus disease 2019 (COVID-19) especially in those with severe infections after discharge from hospital. Moreover, no research had reported the health consequences in health care workers (HCWs) with COVID-19 after discharge. We aimed to investigate the health consequences in HCWs with severe COVID-19 after discharge from hospital in Hubei Province, China. We conducted an ambidirectional cohort study in ""Rehabilitation Care P","2021","07","21","BMC Med","BMC medicine","Antibody; COVID-19; Cytokine; Lymphocyte subsets; Novel coronavirus; Adult; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; China; Exercise Test; Female; Follow-Up Studies; Functional Status; Health Personnel; Humans; Interleukin-6; Male; Patient Discharge; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha","Hu","Yu","Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China. dr_huyu@126","huyu@126.com"
"2796","34256743","10.1186/s12890-021-01592-6","Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis.","To explore the long-term trajectories considering pneumonia volumes and lymphocyte counts with individual data in COVID-19. A cohort of 257 convalescent COVID-19 patients (131 male and 126 females) were included. Group-based multi-trajectory modelling was applied to identify different trajectories in terms of pneumonia lesion percentage and lymphocyte counts covering the time from onset to post-discharge follow-ups. We studied the basic characteristics and disease severity associated with the tr","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Clinical course; Group-based multi-trajectory modelling; Lymphocyte; Pneumonia","Shi","Nannan","Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, China",NA
"2797","34256743","10.1186/s12890-021-01592-6","Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis.","To explore the long-term trajectories considering pneumonia volumes and lymphocyte counts with individual data in COVID-19. A cohort of 257 convalescent COVID-19 patients (131 male and 126 females) were included. Group-based multi-trajectory modelling was applied to identify different trajectories in terms of pneumonia lesion percentage and lymphocyte counts covering the time from onset to post-discharge follow-ups. We studied the basic characteristics and disease severity associated with the tr","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Clinical course; Group-based multi-trajectory modelling; Lymphocyte; Pneumonia","Huang","Chao","Shanghai Key Laboratory of Artificial Intelligence for Medical Image and Knowledge Graph, Shanghai, 200051, China",NA
"2798","34256743","10.1186/s12890-021-01592-6","Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis.","To explore the long-term trajectories considering pneumonia volumes and lymphocyte counts with individual data in COVID-19. A cohort of 257 convalescent COVID-19 patients (131 male and 126 females) were included. Group-based multi-trajectory modelling was applied to identify different trajectories in terms of pneumonia lesion percentage and lymphocyte counts covering the time from onset to post-discharge follow-ups. We studied the basic characteristics and disease severity associated with the tr","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Clinical course; Group-based multi-trajectory modelling; Lymphocyte; Pneumonia","Zhang","Qi","Shanghai Key Laboratory of Artificial Intelligence for Medical Image and Knowledge Graph, Shanghai, 200051, China. qizhang.fdu@gmail","qizhang.fdu@gmail.com"
"2799","34256743","10.1186/s12890-021-01592-6","Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis.","To explore the long-term trajectories considering pneumonia volumes and lymphocyte counts with individual data in COVID-19. A cohort of 257 convalescent COVID-19 patients (131 male and 126 females) were included. Group-based multi-trajectory modelling was applied to identify different trajectories in terms of pneumonia lesion percentage and lymphocyte counts covering the time from onset to post-discharge follow-ups. We studied the basic characteristics and disease severity associated with the tr","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Clinical course; Group-based multi-trajectory modelling; Lymphocyte; Pneumonia","Shi","Chunzi","Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, China",NA
"2800","34256743","10.1186/s12890-021-01592-6","Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis.","To explore the long-term trajectories considering pneumonia volumes and lymphocyte counts with individual data in COVID-19. A cohort of 257 convalescent COVID-19 patients (131 male and 126 females) were included. Group-based multi-trajectory modelling was applied to identify different trajectories in terms of pneumonia lesion percentage and lymphocyte counts covering the time from onset to post-discharge follow-ups. We studied the basic characteristics and disease severity associated with the tr","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Clinical course; Group-based multi-trajectory modelling; Lymphocyte; Pneumonia","Liu","Fengjun","Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, China",NA
"2801","34256743","10.1186/s12890-021-01592-6","Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis.","To explore the long-term trajectories considering pneumonia volumes and lymphocyte counts with individual data in COVID-19. A cohort of 257 convalescent COVID-19 patients (131 male and 126 females) were included. Group-based multi-trajectory modelling was applied to identify different trajectories in terms of pneumonia lesion percentage and lymphocyte counts covering the time from onset to post-discharge follow-ups. We studied the basic characteristics and disease severity associated with the tr","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Clinical course; Group-based multi-trajectory modelling; Lymphocyte; Pneumonia","Song","Fengxiang","Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, China",NA
"2802","34256743","10.1186/s12890-021-01592-6","Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis.","To explore the long-term trajectories considering pneumonia volumes and lymphocyte counts with individual data in COVID-19. A cohort of 257 convalescent COVID-19 patients (131 male and 126 females) were included. Group-based multi-trajectory modelling was applied to identify different trajectories in terms of pneumonia lesion percentage and lymphocyte counts covering the time from onset to post-discharge follow-ups. We studied the basic characteristics and disease severity associated with the tr","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Clinical course; Group-based multi-trajectory modelling; Lymphocyte; Pneumonia","Hou","Qinguo","Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, China",NA
"2803","34256743","10.1186/s12890-021-01592-6","Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis.","To explore the long-term trajectories considering pneumonia volumes and lymphocyte counts with individual data in COVID-19. A cohort of 257 convalescent COVID-19 patients (131 male and 126 females) were included. Group-based multi-trajectory modelling was applied to identify different trajectories in terms of pneumonia lesion percentage and lymphocyte counts covering the time from onset to post-discharge follow-ups. We studied the basic characteristics and disease severity associated with the tr","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Clinical course; Group-based multi-trajectory modelling; Lymphocyte; Pneumonia","Shen","Jie","Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, China",NA
"2804","34256743","10.1186/s12890-021-01592-6","Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis.","To explore the long-term trajectories considering pneumonia volumes and lymphocyte counts with individual data in COVID-19. A cohort of 257 convalescent COVID-19 patients (131 male and 126 females) were included. Group-based multi-trajectory modelling was applied to identify different trajectories in terms of pneumonia lesion percentage and lymphocyte counts covering the time from onset to post-discharge follow-ups. We studied the basic characteristics and disease severity associated with the tr","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Clinical course; Group-based multi-trajectory modelling; Lymphocyte; Pneumonia","Shan","Fei","Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, China",NA
"2805","34256743","10.1186/s12890-021-01592-6","Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis.","To explore the long-term trajectories considering pneumonia volumes and lymphocyte counts with individual data in COVID-19. A cohort of 257 convalescent COVID-19 patients (131 male and 126 females) were included. Group-based multi-trajectory modelling was applied to identify different trajectories in terms of pneumonia lesion percentage and lymphocyte counts covering the time from onset to post-discharge follow-ups. We studied the basic characteristics and disease severity associated with the tr","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Clinical course; Group-based multi-trajectory modelling; Lymphocyte; Pneumonia","Su","Xiaoming","Institute of Healthcare Research, Yizhi, Shanghai, China",NA
"2806","34256743","10.1186/s12890-021-01592-6","Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis.","To explore the long-term trajectories considering pneumonia volumes and lymphocyte counts with individual data in COVID-19. A cohort of 257 convalescent COVID-19 patients (131 male and 126 females) were included. Group-based multi-trajectory modelling was applied to identify different trajectories in terms of pneumonia lesion percentage and lymphocyte counts covering the time from onset to post-discharge follow-ups. We studied the basic characteristics and disease severity associated with the tr","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Clinical course; Group-based multi-trajectory modelling; Lymphocyte; Pneumonia","Liu","Cheng","Shanghai Key Laboratory of Artificial Intelligence for Medical Image and Knowledge Graph, Shanghai, 200051, China",NA
"2807","34256743","10.1186/s12890-021-01592-6","Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis.","To explore the long-term trajectories considering pneumonia volumes and lymphocyte counts with individual data in COVID-19. A cohort of 257 convalescent COVID-19 patients (131 male and 126 females) were included. Group-based multi-trajectory modelling was applied to identify different trajectories in terms of pneumonia lesion percentage and lymphocyte counts covering the time from onset to post-discharge follow-ups. We studied the basic characteristics and disease severity associated with the tr","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Clinical course; Group-based multi-trajectory modelling; Lymphocyte; Pneumonia","Zhang","Zhiyong","Fudan University, Shanghai, China",NA
"2808","34256743","10.1186/s12890-021-01592-6","Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis.","To explore the long-term trajectories considering pneumonia volumes and lymphocyte counts with individual data in COVID-19. A cohort of 257 convalescent COVID-19 patients (131 male and 126 females) were included. Group-based multi-trajectory modelling was applied to identify different trajectories in terms of pneumonia lesion percentage and lymphocyte counts covering the time from onset to post-discharge follow-ups. We studied the basic characteristics and disease severity associated with the tr","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Clinical course; Group-based multi-trajectory modelling; Lymphocyte; Pneumonia","Shi","Lei","Shanghai Key Laboratory of Artificial Intelligence for Medical Image and Knowledge Graph, Shanghai, 200051, China",NA
"2809","34256743","10.1186/s12890-021-01592-6","Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis.","To explore the long-term trajectories considering pneumonia volumes and lymphocyte counts with individual data in COVID-19. A cohort of 257 convalescent COVID-19 patients (131 male and 126 females) were included. Group-based multi-trajectory modelling was applied to identify different trajectories in terms of pneumonia lesion percentage and lymphocyte counts covering the time from onset to post-discharge follow-ups. We studied the basic characteristics and disease severity associated with the tr","2021","07","17","BMC Pulm Med","BMC pulmonary medicine","COVID-19; Clinical course; Group-based multi-trajectory modelling; Lymphocyte; Pneumonia","Shi","Yuxin","Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, China. shiyx828288@163","shiyx828288@163.com"
"2810","34256735","10.1186/s12879-021-06359-2","A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.","SARS-CoV-2 has swept across the globe, causing millions of deaths worldwide. Though most survive, many experience symptoms of COVID-19 for months after acute infection. Successful prevention and treatment of acute COVID-19 infection and its associated sequelae is dependent on in-depth knowledge of viral pathology across the spectrum of patient phenotypes and physiologic responses. Longitudinal biobanking provides a valuable resource of clinically integrated, easily accessed, and quality-controll","2021","07","19","BMC Infect Dis","BMC infectious diseases","Biobank; Biorepository; COVID-19; Coronavirus; Long-hauler; Post-acute sequelae of COVID-19 (PASC); SARS-CoV-2; Adult; Aged; Biological Specimen Banks; COVID-19; COVID-19 Testing; Colorado; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; SARS-CoV-2; Specimen Handling; Survivors; Young Adult","LaVergne","Stephanie M","Department of Environmental and Radiological Health Sciences, Colorado State University, 1601 Campus Delivery, Fort Collins, CO, 80523, USA",NA
"2811","34256735","10.1186/s12879-021-06359-2","A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.","SARS-CoV-2 has swept across the globe, causing millions of deaths worldwide. Though most survive, many experience symptoms of COVID-19 for months after acute infection. Successful prevention and treatment of acute COVID-19 infection and its associated sequelae is dependent on in-depth knowledge of viral pathology across the spectrum of patient phenotypes and physiologic responses. Longitudinal biobanking provides a valuable resource of clinically integrated, easily accessed, and quality-controll","2021","07","19","BMC Infect Dis","BMC infectious diseases","Biobank; Biorepository; COVID-19; Coronavirus; Long-hauler; Post-acute sequelae of COVID-19 (PASC); SARS-CoV-2; Adult; Aged; Biological Specimen Banks; COVID-19; COVID-19 Testing; Colorado; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; SARS-CoV-2; Specimen Handling; Survivors; Young Adult","Stromberg","Sophia","Department of Food Science and Human Nutrition, Colorado State University, Fort Collins, CO, USA",NA
"2812","34256735","10.1186/s12879-021-06359-2","A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.","SARS-CoV-2 has swept across the globe, causing millions of deaths worldwide. Though most survive, many experience symptoms of COVID-19 for months after acute infection. Successful prevention and treatment of acute COVID-19 infection and its associated sequelae is dependent on in-depth knowledge of viral pathology across the spectrum of patient phenotypes and physiologic responses. Longitudinal biobanking provides a valuable resource of clinically integrated, easily accessed, and quality-controll","2021","07","19","BMC Infect Dis","BMC infectious diseases","Biobank; Biorepository; COVID-19; Coronavirus; Long-hauler; Post-acute sequelae of COVID-19 (PASC); SARS-CoV-2; Adult; Aged; Biological Specimen Banks; COVID-19; COVID-19 Testing; Colorado; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; SARS-CoV-2; Specimen Handling; Survivors; Young Adult","Baxter","Bridget A","Department of Environmental and Radiological Health Sciences, Colorado State University, 1601 Campus Delivery, Fort Collins, CO, 80523, USA",NA
"2813","34256735","10.1186/s12879-021-06359-2","A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.","SARS-CoV-2 has swept across the globe, causing millions of deaths worldwide. Though most survive, many experience symptoms of COVID-19 for months after acute infection. Successful prevention and treatment of acute COVID-19 infection and its associated sequelae is dependent on in-depth knowledge of viral pathology across the spectrum of patient phenotypes and physiologic responses. Longitudinal biobanking provides a valuable resource of clinically integrated, easily accessed, and quality-controll","2021","07","19","BMC Infect Dis","BMC infectious diseases","Biobank; Biorepository; COVID-19; Coronavirus; Long-hauler; Post-acute sequelae of COVID-19 (PASC); SARS-CoV-2; Adult; Aged; Biological Specimen Banks; COVID-19; COVID-19 Testing; Colorado; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; SARS-CoV-2; Specimen Handling; Survivors; Young Adult","Webb","Tracy L","Department of Clinical Sciences, Colorado State University, Fort Collins, CO, USA",NA
"2814","34256735","10.1186/s12879-021-06359-2","A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.","SARS-CoV-2 has swept across the globe, causing millions of deaths worldwide. Though most survive, many experience symptoms of COVID-19 for months after acute infection. Successful prevention and treatment of acute COVID-19 infection and its associated sequelae is dependent on in-depth knowledge of viral pathology across the spectrum of patient phenotypes and physiologic responses. Longitudinal biobanking provides a valuable resource of clinically integrated, easily accessed, and quality-controll","2021","07","19","BMC Infect Dis","BMC infectious diseases","Biobank; Biorepository; COVID-19; Coronavirus; Long-hauler; Post-acute sequelae of COVID-19 (PASC); SARS-CoV-2; Adult; Aged; Biological Specimen Banks; COVID-19; COVID-19 Testing; Colorado; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; SARS-CoV-2; Specimen Handling; Survivors; Young Adult","Dutt","Taru S","Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA",NA
"2815","34256735","10.1186/s12879-021-06359-2","A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.","SARS-CoV-2 has swept across the globe, causing millions of deaths worldwide. Though most survive, many experience symptoms of COVID-19 for months after acute infection. Successful prevention and treatment of acute COVID-19 infection and its associated sequelae is dependent on in-depth knowledge of viral pathology across the spectrum of patient phenotypes and physiologic responses. Longitudinal biobanking provides a valuable resource of clinically integrated, easily accessed, and quality-controll","2021","07","19","BMC Infect Dis","BMC infectious diseases","Biobank; Biorepository; COVID-19; Coronavirus; Long-hauler; Post-acute sequelae of COVID-19 (PASC); SARS-CoV-2; Adult; Aged; Biological Specimen Banks; COVID-19; COVID-19 Testing; Colorado; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; SARS-CoV-2; Specimen Handling; Survivors; Young Adult","Berry","Kailey","Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, USA",NA
"2816","34256735","10.1186/s12879-021-06359-2","A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.","SARS-CoV-2 has swept across the globe, causing millions of deaths worldwide. Though most survive, many experience symptoms of COVID-19 for months after acute infection. Successful prevention and treatment of acute COVID-19 infection and its associated sequelae is dependent on in-depth knowledge of viral pathology across the spectrum of patient phenotypes and physiologic responses. Longitudinal biobanking provides a valuable resource of clinically integrated, easily accessed, and quality-controll","2021","07","19","BMC Infect Dis","BMC infectious diseases","Biobank; Biorepository; COVID-19; Coronavirus; Long-hauler; Post-acute sequelae of COVID-19 (PASC); SARS-CoV-2; Adult; Aged; Biological Specimen Banks; COVID-19; COVID-19 Testing; Colorado; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; SARS-CoV-2; Specimen Handling; Survivors; Young Adult","Tipton","Madison","Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, USA",NA
"2817","34256735","10.1186/s12879-021-06359-2","A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.","SARS-CoV-2 has swept across the globe, causing millions of deaths worldwide. Though most survive, many experience symptoms of COVID-19 for months after acute infection. Successful prevention and treatment of acute COVID-19 infection and its associated sequelae is dependent on in-depth knowledge of viral pathology across the spectrum of patient phenotypes and physiologic responses. Longitudinal biobanking provides a valuable resource of clinically integrated, easily accessed, and quality-controll","2021","07","19","BMC Infect Dis","BMC infectious diseases","Biobank; Biorepository; COVID-19; Coronavirus; Long-hauler; Post-acute sequelae of COVID-19 (PASC); SARS-CoV-2; Adult; Aged; Biological Specimen Banks; COVID-19; COVID-19 Testing; Colorado; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; SARS-CoV-2; Specimen Handling; Survivors; Young Adult","Haberman","Jared","Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, USA",NA
"2818","34256735","10.1186/s12879-021-06359-2","A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.","SARS-CoV-2 has swept across the globe, causing millions of deaths worldwide. Though most survive, many experience symptoms of COVID-19 for months after acute infection. Successful prevention and treatment of acute COVID-19 infection and its associated sequelae is dependent on in-depth knowledge of viral pathology across the spectrum of patient phenotypes and physiologic responses. Longitudinal biobanking provides a valuable resource of clinically integrated, easily accessed, and quality-controll","2021","07","19","BMC Infect Dis","BMC infectious diseases","Biobank; Biorepository; COVID-19; Coronavirus; Long-hauler; Post-acute sequelae of COVID-19 (PASC); SARS-CoV-2; Adult; Aged; Biological Specimen Banks; COVID-19; COVID-19 Testing; Colorado; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; SARS-CoV-2; Specimen Handling; Survivors; Young Adult","Massey","Benjamin R","University of Colorado Anschutz School of Medicine, Aurora, CO, USA",NA
"2819","34256735","10.1186/s12879-021-06359-2","A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.","SARS-CoV-2 has swept across the globe, causing millions of deaths worldwide. Though most survive, many experience symptoms of COVID-19 for months after acute infection. Successful prevention and treatment of acute COVID-19 infection and its associated sequelae is dependent on in-depth knowledge of viral pathology across the spectrum of patient phenotypes and physiologic responses. Longitudinal biobanking provides a valuable resource of clinically integrated, easily accessed, and quality-controll","2021","07","19","BMC Infect Dis","BMC infectious diseases","Biobank; Biorepository; COVID-19; Coronavirus; Long-hauler; Post-acute sequelae of COVID-19 (PASC); SARS-CoV-2; Adult; Aged; Biological Specimen Banks; COVID-19; COVID-19 Testing; Colorado; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; SARS-CoV-2; Specimen Handling; Survivors; Young Adult","McFann","Kim","University of Colorado Health, Medical Center of the Rockies, Loveland, CO, USA",NA
"2820","34256735","10.1186/s12879-021-06359-2","A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.","SARS-CoV-2 has swept across the globe, causing millions of deaths worldwide. Though most survive, many experience symptoms of COVID-19 for months after acute infection. Successful prevention and treatment of acute COVID-19 infection and its associated sequelae is dependent on in-depth knowledge of viral pathology across the spectrum of patient phenotypes and physiologic responses. Longitudinal biobanking provides a valuable resource of clinically integrated, easily accessed, and quality-controll","2021","07","19","BMC Infect Dis","BMC infectious diseases","Biobank; Biorepository; COVID-19; Coronavirus; Long-hauler; Post-acute sequelae of COVID-19 (PASC); SARS-CoV-2; Adult; Aged; Biological Specimen Banks; COVID-19; COVID-19 Testing; Colorado; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; SARS-CoV-2; Specimen Handling; Survivors; Young Adult","Alnachoukati","Omar","University of Colorado Health, Medical Center of the Rockies, Loveland, CO, USA",NA
"2821","34256735","10.1186/s12879-021-06359-2","A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.","SARS-CoV-2 has swept across the globe, causing millions of deaths worldwide. Though most survive, many experience symptoms of COVID-19 for months after acute infection. Successful prevention and treatment of acute COVID-19 infection and its associated sequelae is dependent on in-depth knowledge of viral pathology across the spectrum of patient phenotypes and physiologic responses. Longitudinal biobanking provides a valuable resource of clinically integrated, easily accessed, and quality-controll","2021","07","19","BMC Infect Dis","BMC infectious diseases","Biobank; Biorepository; COVID-19; Coronavirus; Long-hauler; Post-acute sequelae of COVID-19 (PASC); SARS-CoV-2; Adult; Aged; Biological Specimen Banks; COVID-19; COVID-19 Testing; Colorado; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; SARS-CoV-2; Specimen Handling; Survivors; Young Adult","Zier","Linda","University of Colorado Health, Medical Center of the Rockies, Loveland, CO, USA",NA
"2822","34256735","10.1186/s12879-021-06359-2","A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.","SARS-CoV-2 has swept across the globe, causing millions of deaths worldwide. Though most survive, many experience symptoms of COVID-19 for months after acute infection. Successful prevention and treatment of acute COVID-19 infection and its associated sequelae is dependent on in-depth knowledge of viral pathology across the spectrum of patient phenotypes and physiologic responses. Longitudinal biobanking provides a valuable resource of clinically integrated, easily accessed, and quality-controll","2021","07","19","BMC Infect Dis","BMC infectious diseases","Biobank; Biorepository; COVID-19; Coronavirus; Long-hauler; Post-acute sequelae of COVID-19 (PASC); SARS-CoV-2; Adult; Aged; Biological Specimen Banks; COVID-19; COVID-19 Testing; Colorado; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; SARS-CoV-2; Specimen Handling; Survivors; Young Adult","Heacock","Thomas","University of Colorado Health, Medical Center of the Rockies, Loveland, CO, USA",NA
"2823","34256735","10.1186/s12879-021-06359-2","A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.","SARS-CoV-2 has swept across the globe, causing millions of deaths worldwide. Though most survive, many experience symptoms of COVID-19 for months after acute infection. Successful prevention and treatment of acute COVID-19 infection and its associated sequelae is dependent on in-depth knowledge of viral pathology across the spectrum of patient phenotypes and physiologic responses. Longitudinal biobanking provides a valuable resource of clinically integrated, easily accessed, and quality-controll","2021","07","19","BMC Infect Dis","BMC infectious diseases","Biobank; Biorepository; COVID-19; Coronavirus; Long-hauler; Post-acute sequelae of COVID-19 (PASC); SARS-CoV-2; Adult; Aged; Biological Specimen Banks; COVID-19; COVID-19 Testing; Colorado; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; SARS-CoV-2; Specimen Handling; Survivors; Young Adult","Ebel","Gregory D","Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA",NA
"2824","34256735","10.1186/s12879-021-06359-2","A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.","SARS-CoV-2 has swept across the globe, causing millions of deaths worldwide. Though most survive, many experience symptoms of COVID-19 for months after acute infection. Successful prevention and treatment of acute COVID-19 infection and its associated sequelae is dependent on in-depth knowledge of viral pathology across the spectrum of patient phenotypes and physiologic responses. Longitudinal biobanking provides a valuable resource of clinically integrated, easily accessed, and quality-controll","2021","07","19","BMC Infect Dis","BMC infectious diseases","Biobank; Biorepository; COVID-19; Coronavirus; Long-hauler; Post-acute sequelae of COVID-19 (PASC); SARS-CoV-2; Adult; Aged; Biological Specimen Banks; COVID-19; COVID-19 Testing; Colorado; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; SARS-CoV-2; Specimen Handling; Survivors; Young Adult","Henao-Tamayo","Marcela","Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA",NA
"2825","34256735","10.1186/s12879-021-06359-2","A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.","SARS-CoV-2 has swept across the globe, causing millions of deaths worldwide. Though most survive, many experience symptoms of COVID-19 for months after acute infection. Successful prevention and treatment of acute COVID-19 infection and its associated sequelae is dependent on in-depth knowledge of viral pathology across the spectrum of patient phenotypes and physiologic responses. Longitudinal biobanking provides a valuable resource of clinically integrated, easily accessed, and quality-controll","2021","07","19","BMC Infect Dis","BMC infectious diseases","Biobank; Biorepository; COVID-19; Coronavirus; Long-hauler; Post-acute sequelae of COVID-19 (PASC); SARS-CoV-2; Adult; Aged; Biological Specimen Banks; COVID-19; COVID-19 Testing; Colorado; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; SARS-CoV-2; Specimen Handling; Survivors; Young Adult","Dunn","Julie","University of Colorado Health, Medical Center of the Rockies, Loveland, CO, USA",NA
"2826","34256735","10.1186/s12879-021-06359-2","A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.","SARS-CoV-2 has swept across the globe, causing millions of deaths worldwide. Though most survive, many experience symptoms of COVID-19 for months after acute infection. Successful prevention and treatment of acute COVID-19 infection and its associated sequelae is dependent on in-depth knowledge of viral pathology across the spectrum of patient phenotypes and physiologic responses. Longitudinal biobanking provides a valuable resource of clinically integrated, easily accessed, and quality-controll","2021","07","19","BMC Infect Dis","BMC infectious diseases","Biobank; Biorepository; COVID-19; Coronavirus; Long-hauler; Post-acute sequelae of COVID-19 (PASC); SARS-CoV-2; Adult; Aged; Biological Specimen Banks; COVID-19; COVID-19 Testing; Colorado; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; SARS-CoV-2; Specimen Handling; Survivors; Young Adult","Ryan","Elizabeth P","Department of Environmental and Radiological Health Sciences, Colorado State University, 1601 Campus Delivery, Fort Collins, CO, 80523, USA. E.P.Ryan@colostate","E.P.Ryan@colostate.edu"
"2827","34256733","10.1186/s12879-021-06175-8","Mortality of a postpartum woman presented with massive vulvar edema in association with Covid-19: a case report with clinical and radiological findings.","In this case report, we presented a rare case of maternal death with massive vulvar edema and Covid-19 diagnosis. The case was a 20-year-old woman who was referred to with pain and massive vulvar edema by passing 7 days from her labor. The laboratory tests showed leukocytosis, lymphopenia, and elevated C-reactive protein levels. The high-resolution computed tomography was in favor of Covid-19 changes. Finally, she died because of respiratory distress, ON the 8th day postpartum. Given the increas","2021","07","19","BMC Infect Dis","BMC infectious diseases","Case report; Postpartum women; SARS-CoV-2; Vulvar diseases; COVID-19; COVID-19 Testing; Edema; Fatal Outcome; Female; Humans; Lymphopenia; Maternal Death; Postpartum Period; Pregnancy; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Vulvar Diseases; Young Adult","Alirezaei","Somayeh","Student Research Committee, School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"2828","34256733","10.1186/s12879-021-06175-8","Mortality of a postpartum woman presented with massive vulvar edema in association with Covid-19: a case report with clinical and radiological findings.","In this case report, we presented a rare case of maternal death with massive vulvar edema and Covid-19 diagnosis. The case was a 20-year-old woman who was referred to with pain and massive vulvar edema by passing 7 days from her labor. The laboratory tests showed leukocytosis, lymphopenia, and elevated C-reactive protein levels. The high-resolution computed tomography was in favor of Covid-19 changes. Finally, she died because of respiratory distress, ON the 8th day postpartum. Given the increas","2021","07","19","BMC Infect Dis","BMC infectious diseases","Case report; Postpartum women; SARS-CoV-2; Vulvar diseases; COVID-19; COVID-19 Testing; Edema; Fatal Outcome; Female; Humans; Lymphopenia; Maternal Death; Postpartum Period; Pregnancy; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Vulvar Diseases; Young Adult","Vatanchi","Atiye","Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. VatanchiA@mums.ac","VatanchiA@mums.ac.ir"
"2829","34256733","10.1186/s12879-021-06175-8","Mortality of a postpartum woman presented with massive vulvar edema in association with Covid-19: a case report with clinical and radiological findings.","In this case report, we presented a rare case of maternal death with massive vulvar edema and Covid-19 diagnosis. The case was a 20-year-old woman who was referred to with pain and massive vulvar edema by passing 7 days from her labor. The laboratory tests showed leukocytosis, lymphopenia, and elevated C-reactive protein levels. The high-resolution computed tomography was in favor of Covid-19 changes. Finally, she died because of respiratory distress, ON the 8th day postpartum. Given the increas","2021","07","19","BMC Infect Dis","BMC infectious diseases","Case report; Postpartum women; SARS-CoV-2; Vulvar diseases; COVID-19; COVID-19 Testing; Edema; Fatal Outcome; Female; Humans; Lymphopenia; Maternal Death; Postpartum Period; Pregnancy; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Vulvar Diseases; Young Adult","Pourali","Leila","Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"2830","34256733","10.1186/s12879-021-06175-8","Mortality of a postpartum woman presented with massive vulvar edema in association with Covid-19: a case report with clinical and radiological findings.","In this case report, we presented a rare case of maternal death with massive vulvar edema and Covid-19 diagnosis. The case was a 20-year-old woman who was referred to with pain and massive vulvar edema by passing 7 days from her labor. The laboratory tests showed leukocytosis, lymphopenia, and elevated C-reactive protein levels. The high-resolution computed tomography was in favor of Covid-19 changes. Finally, she died because of respiratory distress, ON the 8th day postpartum. Given the increas","2021","07","19","BMC Infect Dis","BMC infectious diseases","Case report; Postpartum women; SARS-CoV-2; Vulvar diseases; COVID-19; COVID-19 Testing; Edema; Fatal Outcome; Female; Humans; Lymphopenia; Maternal Death; Postpartum Period; Pregnancy; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Vulvar Diseases; Young Adult","Aminzadeh","Behzad","Department of Radiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"2831","34256733","10.1186/s12879-021-06175-8","Mortality of a postpartum woman presented with massive vulvar edema in association with Covid-19: a case report with clinical and radiological findings.","In this case report, we presented a rare case of maternal death with massive vulvar edema and Covid-19 diagnosis. The case was a 20-year-old woman who was referred to with pain and massive vulvar edema by passing 7 days from her labor. The laboratory tests showed leukocytosis, lymphopenia, and elevated C-reactive protein levels. The high-resolution computed tomography was in favor of Covid-19 changes. Finally, she died because of respiratory distress, ON the 8th day postpartum. Given the increas","2021","07","19","BMC Infect Dis","BMC infectious diseases","Case report; Postpartum women; SARS-CoV-2; Vulvar diseases; COVID-19; COVID-19 Testing; Edema; Fatal Outcome; Female; Humans; Lymphopenia; Maternal Death; Postpartum Period; Pregnancy; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Vulvar Diseases; Young Adult","Latifnejad Roudsari","Robab","Nursing and Midwifery Care Research Center, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"2832","34256728","10.1186/s12886-021-02028-9","Proning related bilateral anterior ischaemic optic neuropathy in a patient with COVID-19 related acute respiratory distress syndrome.","Non-arteritic ischaemic optic neuropathy (NAION) is a rare but harmful complication of prone positioning. Prone mechanical ventilation is a therapeutic strategy which has been used extensively during the COVID-19 pandemic to treat acutely hypoxemic patients with COVID-19 related acute respiratory distress syndrome (ARDS). Though a small number of cases of unilateral NAION have been reported in patients testing positive for the SARS-CoV-2 virus, we describe what is to our knowledge, the first rep","2021","07","15","BMC Ophthalmol","BMC ophthalmology","Compression ischaemic optic neuropathy; Critical care; Intensive care; Pneumonitis; Proning; SARS-CoV- 2; Vision loss; Visual impairment; COVID-19; Humans; Male; Middle Aged; Optic Neuropathy, Ischemic; Pandemics; Respiratory Distress Syndrome; SARS-CoV-2; Visual Acuity","Clarke","Kirsty Michelle","Department of Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London, UK. kirsty.clarke11@nhs","kirsty.clarke11@nhs.net"
"2833","34256728","10.1186/s12886-021-02028-9","Proning related bilateral anterior ischaemic optic neuropathy in a patient with COVID-19 related acute respiratory distress syndrome.","Non-arteritic ischaemic optic neuropathy (NAION) is a rare but harmful complication of prone positioning. Prone mechanical ventilation is a therapeutic strategy which has been used extensively during the COVID-19 pandemic to treat acutely hypoxemic patients with COVID-19 related acute respiratory distress syndrome (ARDS). Though a small number of cases of unilateral NAION have been reported in patients testing positive for the SARS-CoV-2 virus, we describe what is to our knowledge, the first rep","2021","07","15","BMC Ophthalmol","BMC ophthalmology","Compression ischaemic optic neuropathy; Critical care; Intensive care; Pneumonitis; Proning; SARS-CoV- 2; Vision loss; Visual impairment; COVID-19; Humans; Male; Middle Aged; Optic Neuropathy, Ischemic; Pandemics; Respiratory Distress Syndrome; SARS-CoV-2; Visual Acuity","Riga","Vivi","Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"2834","34256728","10.1186/s12886-021-02028-9","Proning related bilateral anterior ischaemic optic neuropathy in a patient with COVID-19 related acute respiratory distress syndrome.","Non-arteritic ischaemic optic neuropathy (NAION) is a rare but harmful complication of prone positioning. Prone mechanical ventilation is a therapeutic strategy which has been used extensively during the COVID-19 pandemic to treat acutely hypoxemic patients with COVID-19 related acute respiratory distress syndrome (ARDS). Though a small number of cases of unilateral NAION have been reported in patients testing positive for the SARS-CoV-2 virus, we describe what is to our knowledge, the first rep","2021","07","15","BMC Ophthalmol","BMC ophthalmology","Compression ischaemic optic neuropathy; Critical care; Intensive care; Pneumonitis; Proning; SARS-CoV- 2; Vision loss; Visual impairment; COVID-19; Humans; Male; Middle Aged; Optic Neuropathy, Ischemic; Pandemics; Respiratory Distress Syndrome; SARS-CoV-2; Visual Acuity","Shirodkar","Amy-Lee","Department of Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London, UK",NA
"2835","34256728","10.1186/s12886-021-02028-9","Proning related bilateral anterior ischaemic optic neuropathy in a patient with COVID-19 related acute respiratory distress syndrome.","Non-arteritic ischaemic optic neuropathy (NAION) is a rare but harmful complication of prone positioning. Prone mechanical ventilation is a therapeutic strategy which has been used extensively during the COVID-19 pandemic to treat acutely hypoxemic patients with COVID-19 related acute respiratory distress syndrome (ARDS). Though a small number of cases of unilateral NAION have been reported in patients testing positive for the SARS-CoV-2 virus, we describe what is to our knowledge, the first rep","2021","07","15","BMC Ophthalmol","BMC ophthalmology","Compression ischaemic optic neuropathy; Critical care; Intensive care; Pneumonitis; Proning; SARS-CoV- 2; Vision loss; Visual impairment; COVID-19; Humans; Male; Middle Aged; Optic Neuropathy, Ischemic; Pandemics; Respiratory Distress Syndrome; SARS-CoV-2; Visual Acuity","Meyer","Joel","Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"2836","34256718","10.1186/s12888-021-03326-8","Self-reported psychological problems and coping strategies: a web-based study in Peruvian population during COVID-19 pandemic.","The Coronavirus pandemic has disrupted health systems across the world and led to major shifts in individual behavior by forcing people into isolation in home settings. Its rapid spread has overwhelmed populations in all corners of Latin-American countries resulting in individual psychological reactions that may aggravate the health crisis. This study reports on demographics, self-reported psychological disturbances and associated coping styles during the COVID-19 pandemic for the Peruvian popul","2021","07","16","BMC Psychiatry","BMC psychiatry","Coping strategies; Mental health; Primary prevention; Psychological disturbances; Public health; Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Cross-Sectional Studies; Depression; Female; Humans; Internet; Male; Middle Aged; Pandemics; Peru; SARS-CoV-2; Self Report; Stress, Psychological; Surveys and Questionnaires; Young Adult","Ames-Guerrero","Rita J","School of Psychology, Universidad Católica de Santa María, Arequipa, Peru. rames@ucsm.edu","rames@ucsm.edu.pe"
"2837","34256718","10.1186/s12888-021-03326-8","Self-reported psychological problems and coping strategies: a web-based study in Peruvian population during COVID-19 pandemic.","The Coronavirus pandemic has disrupted health systems across the world and led to major shifts in individual behavior by forcing people into isolation in home settings. Its rapid spread has overwhelmed populations in all corners of Latin-American countries resulting in individual psychological reactions that may aggravate the health crisis. This study reports on demographics, self-reported psychological disturbances and associated coping styles during the COVID-19 pandemic for the Peruvian popul","2021","07","16","BMC Psychiatry","BMC psychiatry","Coping strategies; Mental health; Primary prevention; Psychological disturbances; Public health; Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Cross-Sectional Studies; Depression; Female; Humans; Internet; Male; Middle Aged; Pandemics; Peru; SARS-CoV-2; Self Report; Stress, Psychological; Surveys and Questionnaires; Young Adult","Barreda-Parra","Victoria A","School of Psychology, Universidad Nacional de San Agustín de Arequipa, Arequipa, Peru",NA
"2838","34256718","10.1186/s12888-021-03326-8","Self-reported psychological problems and coping strategies: a web-based study in Peruvian population during COVID-19 pandemic.","The Coronavirus pandemic has disrupted health systems across the world and led to major shifts in individual behavior by forcing people into isolation in home settings. Its rapid spread has overwhelmed populations in all corners of Latin-American countries resulting in individual psychological reactions that may aggravate the health crisis. This study reports on demographics, self-reported psychological disturbances and associated coping styles during the COVID-19 pandemic for the Peruvian popul","2021","07","16","BMC Psychiatry","BMC psychiatry","Coping strategies; Mental health; Primary prevention; Psychological disturbances; Public health; Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Cross-Sectional Studies; Depression; Female; Humans; Internet; Male; Middle Aged; Pandemics; Peru; SARS-CoV-2; Self Report; Stress, Psychological; Surveys and Questionnaires; Young Adult","Huamani-Cahua","Julio C","School of Psychology, Universidad Católica San Pablo, Arequipa, Peru",NA
"2839","34256718","10.1186/s12888-021-03326-8","Self-reported psychological problems and coping strategies: a web-based study in Peruvian population during COVID-19 pandemic.","The Coronavirus pandemic has disrupted health systems across the world and led to major shifts in individual behavior by forcing people into isolation in home settings. Its rapid spread has overwhelmed populations in all corners of Latin-American countries resulting in individual psychological reactions that may aggravate the health crisis. This study reports on demographics, self-reported psychological disturbances and associated coping styles during the COVID-19 pandemic for the Peruvian popul","2021","07","16","BMC Psychiatry","BMC psychiatry","Coping strategies; Mental health; Primary prevention; Psychological disturbances; Public health; Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Cross-Sectional Studies; Depression; Female; Humans; Internet; Male; Middle Aged; Pandemics; Peru; SARS-CoV-2; Self Report; Stress, Psychological; Surveys and Questionnaires; Young Adult","Banaszak-Holl","Jane","School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia",NA
"2840","34256717","10.1186/s12889-021-11295-6","The impact of the COVID-19 pandemic on stress, mental health and coping behavior in German University students - a longitudinal study before and after the onset of the pandemic.","The COVID-19 pandemic has led to massive restrictions in public and private lives, including a shut-down of face-to-face teaching at universities in Germany. We aimed to examine the impact of these changes on perceived stress, mental health and (study-)related health behavior of students in a longitudinal study. For two timepoints - the year before the COVID-19 pandemic (2019, n = 1377) and the year during the COVID-19 pandemic (2020, n = 1867) - we surveyed students of all faculties at one Germ","2021","07","16","BMC Public Health","BMC public health","Behavior patterns; COVID-19; Mental health; Preventive measures; Students; Adaptation, Psychological; Anxiety; COVID-19; Depression; Female; Germany; Humans; Longitudinal Studies; Male; Mental Health; Pandemics; SARS-CoV-2; Students; Universities","Voltmer","Edgar","Institute for Social Medicine and Epidemiology, University of Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany. edgar.voltmer@uksh","edgar.voltmer@uksh.de"
"2841","34256717","10.1186/s12889-021-11295-6","The impact of the COVID-19 pandemic on stress, mental health and coping behavior in German University students - a longitudinal study before and after the onset of the pandemic.","The COVID-19 pandemic has led to massive restrictions in public and private lives, including a shut-down of face-to-face teaching at universities in Germany. We aimed to examine the impact of these changes on perceived stress, mental health and (study-)related health behavior of students in a longitudinal study. For two timepoints - the year before the COVID-19 pandemic (2019, n = 1377) and the year during the COVID-19 pandemic (2020, n = 1867) - we surveyed students of all faculties at one Germ","2021","07","16","BMC Public Health","BMC public health","Behavior patterns; COVID-19; Mental health; Preventive measures; Students; Adaptation, Psychological; Anxiety; COVID-19; Depression; Female; Germany; Humans; Longitudinal Studies; Male; Mental Health; Pandemics; SARS-CoV-2; Students; Universities","Köslich-Strumann","Susen","Institute for Social Medicine and Epidemiology, University of Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany",NA
"2842","34256717","10.1186/s12889-021-11295-6","The impact of the COVID-19 pandemic on stress, mental health and coping behavior in German University students - a longitudinal study before and after the onset of the pandemic.","The COVID-19 pandemic has led to massive restrictions in public and private lives, including a shut-down of face-to-face teaching at universities in Germany. We aimed to examine the impact of these changes on perceived stress, mental health and (study-)related health behavior of students in a longitudinal study. For two timepoints - the year before the COVID-19 pandemic (2019, n = 1377) and the year during the COVID-19 pandemic (2020, n = 1867) - we surveyed students of all faculties at one Germ","2021","07","16","BMC Public Health","BMC public health","Behavior patterns; COVID-19; Mental health; Preventive measures; Students; Adaptation, Psychological; Anxiety; COVID-19; Depression; Female; Germany; Humans; Longitudinal Studies; Male; Mental Health; Pandemics; SARS-CoV-2; Students; Universities","Walther","Anna","Institute for Social Medicine and Epidemiology, University of Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany",NA
"2843","34256717","10.1186/s12889-021-11295-6","The impact of the COVID-19 pandemic on stress, mental health and coping behavior in German University students - a longitudinal study before and after the onset of the pandemic.","The COVID-19 pandemic has led to massive restrictions in public and private lives, including a shut-down of face-to-face teaching at universities in Germany. We aimed to examine the impact of these changes on perceived stress, mental health and (study-)related health behavior of students in a longitudinal study. For two timepoints - the year before the COVID-19 pandemic (2019, n = 1377) and the year during the COVID-19 pandemic (2020, n = 1867) - we surveyed students of all faculties at one Germ","2021","07","16","BMC Public Health","BMC public health","Behavior patterns; COVID-19; Mental health; Preventive measures; Students; Adaptation, Psychological; Anxiety; COVID-19; Depression; Female; Germany; Humans; Longitudinal Studies; Male; Mental Health; Pandemics; SARS-CoV-2; Students; Universities","Kasem","Mahmoud","Institute for Social Medicine and Epidemiology, University of Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany",NA
"2844","34256717","10.1186/s12889-021-11295-6","The impact of the COVID-19 pandemic on stress, mental health and coping behavior in German University students - a longitudinal study before and after the onset of the pandemic.","The COVID-19 pandemic has led to massive restrictions in public and private lives, including a shut-down of face-to-face teaching at universities in Germany. We aimed to examine the impact of these changes on perceived stress, mental health and (study-)related health behavior of students in a longitudinal study. For two timepoints - the year before the COVID-19 pandemic (2019, n = 1377) and the year during the COVID-19 pandemic (2020, n = 1867) - we surveyed students of all faculties at one Germ","2021","07","16","BMC Public Health","BMC public health","Behavior patterns; COVID-19; Mental health; Preventive measures; Students; Adaptation, Psychological; Anxiety; COVID-19; Depression; Female; Germany; Humans; Longitudinal Studies; Male; Mental Health; Pandemics; SARS-CoV-2; Students; Universities","Obst","Katrin","Institute for Social Medicine and Epidemiology, University of Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany",NA
"2845","34256717","10.1186/s12889-021-11295-6","The impact of the COVID-19 pandemic on stress, mental health and coping behavior in German University students - a longitudinal study before and after the onset of the pandemic.","The COVID-19 pandemic has led to massive restrictions in public and private lives, including a shut-down of face-to-face teaching at universities in Germany. We aimed to examine the impact of these changes on perceived stress, mental health and (study-)related health behavior of students in a longitudinal study. For two timepoints - the year before the COVID-19 pandemic (2019, n = 1377) and the year during the COVID-19 pandemic (2020, n = 1867) - we surveyed students of all faculties at one Germ","2021","07","16","BMC Public Health","BMC public health","Behavior patterns; COVID-19; Mental health; Preventive measures; Students; Adaptation, Psychological; Anxiety; COVID-19; Depression; Female; Germany; Humans; Longitudinal Studies; Male; Mental Health; Pandemics; SARS-CoV-2; Students; Universities","Kötter","Thomas","Institute of Family Medicine, University Medical Centre Schleswig-Holstein, Ratzeburger Allee 160, 23562, Lübeck, Germany",NA
"2846","34256681","10.1080/07391102.2021.1948448","Dietary factors and SARS-CoV-2 contagion: <i>in silico</i> studies on modulation of viral and host proteins by spice actives.","The SARS-CoV-2 contagion has had a huge impact on world population. It has been observed that despite massive spread of the contagion in India particularly during the second wave, the overall case fatality rates remain low. This prompted us to look into dietary factors that can possibly modulate the viral impact and/or host response. In silico studies were carried out on forty-two commonly used spices and their 637 known active compounds with an aim of identifying such compounds that may have pr","2021","07","14","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","Nsp13; SARS-CoV-2; TBK1; immunity; phytochemicals; spices; virtual screening","Srividya","Kottapalli","Division of Neuroscience and Ageing Biology, CSIR-Central Drug Research Institute, Lucknow, India",NA
"2847","34256681","10.1080/07391102.2021.1948448","Dietary factors and SARS-CoV-2 contagion: <i>in silico</i> studies on modulation of viral and host proteins by spice actives.","The SARS-CoV-2 contagion has had a huge impact on world population. It has been observed that despite massive spread of the contagion in India particularly during the second wave, the overall case fatality rates remain low. This prompted us to look into dietary factors that can possibly modulate the viral impact and/or host response. In silico studies were carried out on forty-two commonly used spices and their 637 known active compounds with an aim of identifying such compounds that may have pr","2021","07","14","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","Nsp13; SARS-CoV-2; TBK1; immunity; phytochemicals; spices; virtual screening","Mir","Snober S","Department of Bioengineering, Integral University, Lucknow, India",NA
"2848","34256681","10.1080/07391102.2021.1948448","Dietary factors and SARS-CoV-2 contagion: <i>in silico</i> studies on modulation of viral and host proteins by spice actives.","The SARS-CoV-2 contagion has had a huge impact on world population. It has been observed that despite massive spread of the contagion in India particularly during the second wave, the overall case fatality rates remain low. This prompted us to look into dietary factors that can possibly modulate the viral impact and/or host response. In silico studies were carried out on forty-two commonly used spices and their 637 known active compounds with an aim of identifying such compounds that may have pr","2021","07","14","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","Nsp13; SARS-CoV-2; TBK1; immunity; phytochemicals; spices; virtual screening","Thiyagarajan","Saravanamuthu","Institute of Bioinformatics and Applied Biotechnology (IBAB), Bengaluru, India",NA
"2849","34256681","10.1080/07391102.2021.1948448","Dietary factors and SARS-CoV-2 contagion: <i>in silico</i> studies on modulation of viral and host proteins by spice actives.","The SARS-CoV-2 contagion has had a huge impact on world population. It has been observed that despite massive spread of the contagion in India particularly during the second wave, the overall case fatality rates remain low. This prompted us to look into dietary factors that can possibly modulate the viral impact and/or host response. In silico studies were carried out on forty-two commonly used spices and their 637 known active compounds with an aim of identifying such compounds that may have pr","2021","07","14","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","Nsp13; SARS-CoV-2; TBK1; immunity; phytochemicals; spices; virtual screening","Nazir","Aamir","Division of Neuroscience and Ageing Biology, CSIR-Central Drug Research Institute, Lucknow, India",NA
"2850","34256651","10.1177/03331024211027568","High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients.","Psychosocial variables are key factors influencing psycho-physical equilibrium in migraine patients. Social isolation and vulnerability to stressors may prevent efficient psychological adjustment negatively affecting adaptation to life changes, as that imposed during Covid-19 lockdown. Here, we explored psychosocial dimensions and changes in clinical condition during Covid-19 lockdown in migraine patients, with regard to migraine type and headache impact. Sixty-four migraine patients (32 episodi","2021","07","14","Cephalalgia","Cephalalgia : an international journal of headache","Covid-19; chronic migraine; episodic migraine; headache impact; loneliness; perceived isolation","Cerami","Chiara","Scuola Universitaria Superiore IUSS Pavia, Pavia, Italy",NA
"2851","34256651","10.1177/03331024211027568","High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients.","Psychosocial variables are key factors influencing psycho-physical equilibrium in migraine patients. Social isolation and vulnerability to stressors may prevent efficient psychological adjustment negatively affecting adaptation to life changes, as that imposed during Covid-19 lockdown. Here, we explored psychosocial dimensions and changes in clinical condition during Covid-19 lockdown in migraine patients, with regard to migraine type and headache impact. Sixty-four migraine patients (32 episodi","2021","07","14","Cephalalgia","Cephalalgia : an international journal of headache","Covid-19; chronic migraine; episodic migraine; headache impact; loneliness; perceived isolation","Crespi","Chiara","Cognitive Computational Neuroscience Research Unit, IRCCS Mondino Foundation, Pavia, Italy",NA
"2852","34256651","10.1177/03331024211027568","High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients.","Psychosocial variables are key factors influencing psycho-physical equilibrium in migraine patients. Social isolation and vulnerability to stressors may prevent efficient psychological adjustment negatively affecting adaptation to life changes, as that imposed during Covid-19 lockdown. Here, we explored psychosocial dimensions and changes in clinical condition during Covid-19 lockdown in migraine patients, with regard to migraine type and headache impact. Sixty-four migraine patients (32 episodi","2021","07","14","Cephalalgia","Cephalalgia : an international journal of headache","Covid-19; chronic migraine; episodic migraine; headache impact; loneliness; perceived isolation","Bottiroli","Sara","Faculty of Law, Giustino Fortunato University, Benevento, Italy",NA
"2853","34256651","10.1177/03331024211027568","High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients.","Psychosocial variables are key factors influencing psycho-physical equilibrium in migraine patients. Social isolation and vulnerability to stressors may prevent efficient psychological adjustment negatively affecting adaptation to life changes, as that imposed during Covid-19 lockdown. Here, we explored psychosocial dimensions and changes in clinical condition during Covid-19 lockdown in migraine patients, with regard to migraine type and headache impact. Sixty-four migraine patients (32 episodi","2021","07","14","Cephalalgia","Cephalalgia : an international journal of headache","Covid-19; chronic migraine; episodic migraine; headache impact; loneliness; perceived isolation","Santi","Gaia Chiara","Scuola Universitaria Superiore IUSS Pavia, Pavia, Italy",NA
"2854","34256651","10.1177/03331024211027568","High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients.","Psychosocial variables are key factors influencing psycho-physical equilibrium in migraine patients. Social isolation and vulnerability to stressors may prevent efficient psychological adjustment negatively affecting adaptation to life changes, as that imposed during Covid-19 lockdown. Here, we explored psychosocial dimensions and changes in clinical condition during Covid-19 lockdown in migraine patients, with regard to migraine type and headache impact. Sixty-four migraine patients (32 episodi","2021","07","14","Cephalalgia","Cephalalgia : an international journal of headache","Covid-19; chronic migraine; episodic migraine; headache impact; loneliness; perceived isolation","Sances","Grazia","Headache Science and Neurorehabilitation Centre, IRCCS Mondino Foundation, Pavia, Italy",NA
"2855","34256651","10.1177/03331024211027568","High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients.","Psychosocial variables are key factors influencing psycho-physical equilibrium in migraine patients. Social isolation and vulnerability to stressors may prevent efficient psychological adjustment negatively affecting adaptation to life changes, as that imposed during Covid-19 lockdown. Here, we explored psychosocial dimensions and changes in clinical condition during Covid-19 lockdown in migraine patients, with regard to migraine type and headache impact. Sixty-four migraine patients (32 episodi","2021","07","14","Cephalalgia","Cephalalgia : an international journal of headache","Covid-19; chronic migraine; episodic migraine; headache impact; loneliness; perceived isolation","Allena","Marta","Headache Science and Neurorehabilitation Centre, IRCCS Mondino Foundation, Pavia, Italy",NA
"2856","34256651","10.1177/03331024211027568","High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients.","Psychosocial variables are key factors influencing psycho-physical equilibrium in migraine patients. Social isolation and vulnerability to stressors may prevent efficient psychological adjustment negatively affecting adaptation to life changes, as that imposed during Covid-19 lockdown. Here, we explored psychosocial dimensions and changes in clinical condition during Covid-19 lockdown in migraine patients, with regard to migraine type and headache impact. Sixty-four migraine patients (32 episodi","2021","07","14","Cephalalgia","Cephalalgia : an international journal of headache","Covid-19; chronic migraine; episodic migraine; headache impact; loneliness; perceived isolation","Vecchi","Tomaso","Department of Brain and Behavioral Sciences, 19001University of Pavia, University of Pavia, Pavia, Italy",NA
"2857","34256651","10.1177/03331024211027568","High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients.","Psychosocial variables are key factors influencing psycho-physical equilibrium in migraine patients. Social isolation and vulnerability to stressors may prevent efficient psychological adjustment negatively affecting adaptation to life changes, as that imposed during Covid-19 lockdown. Here, we explored psychosocial dimensions and changes in clinical condition during Covid-19 lockdown in migraine patients, with regard to migraine type and headache impact. Sixty-four migraine patients (32 episodi","2021","07","14","Cephalalgia","Cephalalgia : an international journal of headache","Covid-19; chronic migraine; episodic migraine; headache impact; loneliness; perceived isolation","Tassorelli","Cristina","Department of Brain and Behavioral Sciences, 19001University of Pavia, University of Pavia, Pavia, Italy",NA
"2858","34256643","10.1177/03913988211030517","Adjuvant hemoadsorption therapy in patients with severe COVID-19 and related organ failure requiring CRRT or ECMO therapy: A case series.","Severe cases of the COVID-19 are often associated with the development of a fulminant sepsis-like state with a concomitant cytokine release syndrome. Recently, immunomodulating approaches to treat such a hyperinflammation have come into focus, including the use of new extracorporeal organ support therapies such as CytoSorb hemoadsorption designed to remove cytokines and other circulating mediators from blood. Thirteen critically ill COVID-19 patients with ARDS who received either ECMO therapy an","2021","07","14","Int J Artif Organs","The International journal of artificial organs","Coronavirus disease 2019; CytoSorb; acute respiratory distress syndrome; continuous renal replacement therapy; extracorporeal membrane oxygenation; hemoadsorption; hyperinflammation","Wunderlich-Sperl","Florian","Clinical Department of Anesthesiology and Intensive Care Medicine, University Hospital St. Pölten-Lilienfeld, St. Pölten, Austria",NA
"2859","34256643","10.1177/03913988211030517","Adjuvant hemoadsorption therapy in patients with severe COVID-19 and related organ failure requiring CRRT or ECMO therapy: A case series.","Severe cases of the COVID-19 are often associated with the development of a fulminant sepsis-like state with a concomitant cytokine release syndrome. Recently, immunomodulating approaches to treat such a hyperinflammation have come into focus, including the use of new extracorporeal organ support therapies such as CytoSorb hemoadsorption designed to remove cytokines and other circulating mediators from blood. Thirteen critically ill COVID-19 patients with ARDS who received either ECMO therapy an","2021","07","14","Int J Artif Organs","The International journal of artificial organs","Coronavirus disease 2019; CytoSorb; acute respiratory distress syndrome; continuous renal replacement therapy; extracorporeal membrane oxygenation; hemoadsorption; hyperinflammation","Kautzky","Sebastian","Clinical Department of Anesthesiology and Intensive Care Medicine, University Hospital St. Pölten-Lilienfeld, St. Pölten, Austria",NA
"2860","34256643","10.1177/03913988211030517","Adjuvant hemoadsorption therapy in patients with severe COVID-19 and related organ failure requiring CRRT or ECMO therapy: A case series.","Severe cases of the COVID-19 are often associated with the development of a fulminant sepsis-like state with a concomitant cytokine release syndrome. Recently, immunomodulating approaches to treat such a hyperinflammation have come into focus, including the use of new extracorporeal organ support therapies such as CytoSorb hemoadsorption designed to remove cytokines and other circulating mediators from blood. Thirteen critically ill COVID-19 patients with ARDS who received either ECMO therapy an","2021","07","14","Int J Artif Organs","The International journal of artificial organs","Coronavirus disease 2019; CytoSorb; acute respiratory distress syndrome; continuous renal replacement therapy; extracorporeal membrane oxygenation; hemoadsorption; hyperinflammation","Pickem","Christian","Clinical Department of Anesthesiology and Intensive Care Medicine, University Hospital St. Pölten-Lilienfeld, St. Pölten, Austria",NA
"2861","34256643","10.1177/03913988211030517","Adjuvant hemoadsorption therapy in patients with severe COVID-19 and related organ failure requiring CRRT or ECMO therapy: A case series.","Severe cases of the COVID-19 are often associated with the development of a fulminant sepsis-like state with a concomitant cytokine release syndrome. Recently, immunomodulating approaches to treat such a hyperinflammation have come into focus, including the use of new extracorporeal organ support therapies such as CytoSorb hemoadsorption designed to remove cytokines and other circulating mediators from blood. Thirteen critically ill COVID-19 patients with ARDS who received either ECMO therapy an","2021","07","14","Int J Artif Organs","The International journal of artificial organs","Coronavirus disease 2019; CytoSorb; acute respiratory distress syndrome; continuous renal replacement therapy; extracorporeal membrane oxygenation; hemoadsorption; hyperinflammation","Hörmann","Christoph","Clinical Department of Anesthesiology and Intensive Care Medicine, University Hospital St. Pölten-Lilienfeld, St. Pölten, Austria",NA
"2862","34256632","10.1177/00048674211031489","COVID-19 and loneliness: A rapid systematic review.","Loneliness is known to be associated with both poorer physical and mental health, being associated with increased mortality. Responses throughout the world to the current COVID-19 pandemic all incorporate varying degrees of social distancing and isolation. There is an imperative to provide a timely review and synthesis of the impact of COVID-19 on loneliness in the general population. PubMed was searched using the key terms 'COVID-19', 'coronavirus', 'SARS-COV2' and 'loneliness'. Fifty-four arti","2021","07","14","Aust N Z J Psychiatry","The Australian and New Zealand journal of psychiatry","COVID-19; Loneliness; SARS-COV-2; coronavirus; mental health; mental illness","Pai","Nagesh","Graduate Medicine, School of Medicine, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW, Australia",NA
"2863","34256632","10.1177/00048674211031489","COVID-19 and loneliness: A rapid systematic review.","Loneliness is known to be associated with both poorer physical and mental health, being associated with increased mortality. Responses throughout the world to the current COVID-19 pandemic all incorporate varying degrees of social distancing and isolation. There is an imperative to provide a timely review and synthesis of the impact of COVID-19 on loneliness in the general population. PubMed was searched using the key terms 'COVID-19', 'coronavirus', 'SARS-COV2' and 'loneliness'. Fifty-four arti","2021","07","14","Aust N Z J Psychiatry","The Australian and New Zealand journal of psychiatry","COVID-19; Loneliness; SARS-COV-2; coronavirus; mental health; mental illness","Vella","Shae-Leigh","Graduate Medicine, School of Medicine, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW, Australia",NA
"2864","34256602","10.12968/jowc.2021.30.7.582","Wound hygiene survey: awareness, implementation, barriers and outcomes.","In light of the COVID-19 pandemic, which has resulted in changes to caseload management, access to training and education, and other additional pressures, a survey was developed to understand current awareness and implementation of the wound hygiene concept into practice one year on from its dissemination. Barriers to implementation and outcomes were also surveyed. The 26-question survey, a mixture of multiple choice and free-text, was developed by the Journal of Wound Care projects team, in con","2021","07","14","J Wound Care","Journal of wound care","biofilm; global survey; hard-to-heal wounds; implementation; wound hygiene","Murphy","Chris","The Ottawa Hospital Limb Preservation Centre, Ottawa, Canada",NA
"2865","34256602","10.12968/jowc.2021.30.7.582","Wound hygiene survey: awareness, implementation, barriers and outcomes.","In light of the COVID-19 pandemic, which has resulted in changes to caseload management, access to training and education, and other additional pressures, a survey was developed to understand current awareness and implementation of the wound hygiene concept into practice one year on from its dissemination. Barriers to implementation and outcomes were also surveyed. The 26-question survey, a mixture of multiple choice and free-text, was developed by the Journal of Wound Care projects team, in con","2021","07","14","J Wound Care","Journal of wound care","biofilm; global survey; hard-to-heal wounds; implementation; wound hygiene","Atkin","Leanne","Mid Yorkshire Hospitals NHS Trust and University of Huddersfield, UK",NA
"2866","34256602","10.12968/jowc.2021.30.7.582","Wound hygiene survey: awareness, implementation, barriers and outcomes.","In light of the COVID-19 pandemic, which has resulted in changes to caseload management, access to training and education, and other additional pressures, a survey was developed to understand current awareness and implementation of the wound hygiene concept into practice one year on from its dissemination. Barriers to implementation and outcomes were also surveyed. The 26-question survey, a mixture of multiple choice and free-text, was developed by the Journal of Wound Care projects team, in con","2021","07","14","J Wound Care","Journal of wound care","biofilm; global survey; hard-to-heal wounds; implementation; wound hygiene","Hurlow","Jenny","Advanced Wound Care, Southaven, Mississippi and West Memphis, Arkansas, US",NA
"2867","34256602","10.12968/jowc.2021.30.7.582","Wound hygiene survey: awareness, implementation, barriers and outcomes.","In light of the COVID-19 pandemic, which has resulted in changes to caseload management, access to training and education, and other additional pressures, a survey was developed to understand current awareness and implementation of the wound hygiene concept into practice one year on from its dissemination. Barriers to implementation and outcomes were also surveyed. The 26-question survey, a mixture of multiple choice and free-text, was developed by the Journal of Wound Care projects team, in con","2021","07","14","J Wound Care","Journal of wound care","biofilm; global survey; hard-to-heal wounds; implementation; wound hygiene","Swanson","Terry","Wound Management, Warrnambool, Victoria, Australia",NA
"2868","34256602","10.12968/jowc.2021.30.7.582","Wound hygiene survey: awareness, implementation, barriers and outcomes.","In light of the COVID-19 pandemic, which has resulted in changes to caseload management, access to training and education, and other additional pressures, a survey was developed to understand current awareness and implementation of the wound hygiene concept into practice one year on from its dissemination. Barriers to implementation and outcomes were also surveyed. The 26-question survey, a mixture of multiple choice and free-text, was developed by the Journal of Wound Care projects team, in con","2021","07","14","J Wound Care","Journal of wound care","biofilm; global survey; hard-to-heal wounds; implementation; wound hygiene","de Ceniga","Melina Vega","Galdakao-Usansolo Hospital, Bizkaia, Spain",NA
"2869","34256597","10.12968/jowc.2021.30.7.522","What is the impact of COVID-19 on tissue viability services and pressure ulceration?","This paper explores and reviews the relevant literature and examines the impact that the first wave of the COVID-19 pandemic has had on the tissue viability service (TVS) and the incidence of pressure ulcers (PUs) in a large UK teaching hospital NHS trust. A comparison has been undertaken of referral data to the TVS during two time periods-Oct-Dec 2019 and April-June 2020. Data show that the PU rate per 1000 beds increased from a pre-pandemic level of around 1 to over 2.7 in the first month of t","2021","07","14","J Wound Care","Journal of wound care","COVID-19; pressure ulcer; prone nursing; tissue viability; wound; wound care; wound healing","Vowden","Kathryn","University of Bradford, Bradford, UK",NA
"2870","34256597","10.12968/jowc.2021.30.7.522","What is the impact of COVID-19 on tissue viability services and pressure ulceration?","This paper explores and reviews the relevant literature and examines the impact that the first wave of the COVID-19 pandemic has had on the tissue viability service (TVS) and the incidence of pressure ulcers (PUs) in a large UK teaching hospital NHS trust. A comparison has been undertaken of referral data to the TVS during two time periods-Oct-Dec 2019 and April-June 2020. Data show that the PU rate per 1000 beds increased from a pre-pandemic level of around 1 to over 2.7 in the first month of t","2021","07","14","J Wound Care","Journal of wound care","COVID-19; pressure ulcer; prone nursing; tissue viability; wound; wound care; wound healing","Hill","Lisa","Leeds Teaching Hospitals Trust, Leeds, UK",NA
"2871","34256588","10.12968/jowc.2021.30.Sup7.S18","Fetal bovine acellular dermal matrix for the closure of diabetic foot ulcers: a prospective randomised controlled trial.","The purpose of this clinical trial was to evaluate the safety and efficacy of a fetal bovine acellular dermal matrix (FBADM) plus standard of care (SOC) for treating hard-to-heal diabetic foot ulcers (DFUs). A prospective, multi-centre, randomised controlled trial was carried out. The study included a 2-week run-in period, a 12-week treatment phase and a 4-week follow-up phase. The primary endpoint was complete wound closure at 12 weeks. Twenty-one US sites enrolled and randomised 226 patients w","2021","07","14","J Wound Care","Journal of wound care","ADM; acellular dermal matrix; diabetes; diabetic foot ulcers; dressing; extracellular matrix; fetal bovine acellular dermal matrix; randomised controlled trial; skin substitute; wound; wounds","Lantis","John C","Mount Sinai West Hospital, Icahn School of Medicine, New York, NY, US",NA
"2872","34256588","10.12968/jowc.2021.30.Sup7.S18","Fetal bovine acellular dermal matrix for the closure of diabetic foot ulcers: a prospective randomised controlled trial.","The purpose of this clinical trial was to evaluate the safety and efficacy of a fetal bovine acellular dermal matrix (FBADM) plus standard of care (SOC) for treating hard-to-heal diabetic foot ulcers (DFUs). A prospective, multi-centre, randomised controlled trial was carried out. The study included a 2-week run-in period, a 12-week treatment phase and a 4-week follow-up phase. The primary endpoint was complete wound closure at 12 weeks. Twenty-one US sites enrolled and randomised 226 patients w","2021","07","14","J Wound Care","Journal of wound care","ADM; acellular dermal matrix; diabetes; diabetic foot ulcers; dressing; extracellular matrix; fetal bovine acellular dermal matrix; randomised controlled trial; skin substitute; wound; wounds","Snyder","Robert","Barry University School of Podiatric Medicine, Miami, FL, US",NA
"2873","34256588","10.12968/jowc.2021.30.Sup7.S18","Fetal bovine acellular dermal matrix for the closure of diabetic foot ulcers: a prospective randomised controlled trial.","The purpose of this clinical trial was to evaluate the safety and efficacy of a fetal bovine acellular dermal matrix (FBADM) plus standard of care (SOC) for treating hard-to-heal diabetic foot ulcers (DFUs). A prospective, multi-centre, randomised controlled trial was carried out. The study included a 2-week run-in period, a 12-week treatment phase and a 4-week follow-up phase. The primary endpoint was complete wound closure at 12 weeks. Twenty-one US sites enrolled and randomised 226 patients w","2021","07","14","J Wound Care","Journal of wound care","ADM; acellular dermal matrix; diabetes; diabetic foot ulcers; dressing; extracellular matrix; fetal bovine acellular dermal matrix; randomised controlled trial; skin substitute; wound; wounds","Reyzelman","Alexander M","Department of Medicine, California School of Podiatric Medicine and UCSF Center for Limb Preservation, California School of Podiatric Medicine at Samuel Merritt University, Oakland, CA, US",NA
"2874","34256588","10.12968/jowc.2021.30.Sup7.S18","Fetal bovine acellular dermal matrix for the closure of diabetic foot ulcers: a prospective randomised controlled trial.","The purpose of this clinical trial was to evaluate the safety and efficacy of a fetal bovine acellular dermal matrix (FBADM) plus standard of care (SOC) for treating hard-to-heal diabetic foot ulcers (DFUs). A prospective, multi-centre, randomised controlled trial was carried out. The study included a 2-week run-in period, a 12-week treatment phase and a 4-week follow-up phase. The primary endpoint was complete wound closure at 12 weeks. Twenty-one US sites enrolled and randomised 226 patients w","2021","07","14","J Wound Care","Journal of wound care","ADM; acellular dermal matrix; diabetes; diabetic foot ulcers; dressing; extracellular matrix; fetal bovine acellular dermal matrix; randomised controlled trial; skin substitute; wound; wounds","Van Gils","Carl C","Foot &amp",NA
"2875","34256588","10.12968/jowc.2021.30.Sup7.S18","Fetal bovine acellular dermal matrix for the closure of diabetic foot ulcers: a prospective randomised controlled trial.","The purpose of this clinical trial was to evaluate the safety and efficacy of a fetal bovine acellular dermal matrix (FBADM) plus standard of care (SOC) for treating hard-to-heal diabetic foot ulcers (DFUs). A prospective, multi-centre, randomised controlled trial was carried out. The study included a 2-week run-in period, a 12-week treatment phase and a 4-week follow-up phase. The primary endpoint was complete wound closure at 12 weeks. Twenty-one US sites enrolled and randomised 226 patients w","2021","07","14","J Wound Care","Journal of wound care","ADM; acellular dermal matrix; diabetes; diabetic foot ulcers; dressing; extracellular matrix; fetal bovine acellular dermal matrix; randomised controlled trial; skin substitute; wound; wounds","Sigal","Felix","Foot and Ankle Clinic, Los Angeles, CA, US",NA
"2876","34256588","10.12968/jowc.2021.30.Sup7.S18","Fetal bovine acellular dermal matrix for the closure of diabetic foot ulcers: a prospective randomised controlled trial.","The purpose of this clinical trial was to evaluate the safety and efficacy of a fetal bovine acellular dermal matrix (FBADM) plus standard of care (SOC) for treating hard-to-heal diabetic foot ulcers (DFUs). A prospective, multi-centre, randomised controlled trial was carried out. The study included a 2-week run-in period, a 12-week treatment phase and a 4-week follow-up phase. The primary endpoint was complete wound closure at 12 weeks. Twenty-one US sites enrolled and randomised 226 patients w","2021","07","14","J Wound Care","Journal of wound care","ADM; acellular dermal matrix; diabetes; diabetic foot ulcers; dressing; extracellular matrix; fetal bovine acellular dermal matrix; randomised controlled trial; skin substitute; wound; wounds","Vayser","Dean","ILD Research Center, San Diego, CA, US",NA
"2877","34256588","10.12968/jowc.2021.30.Sup7.S18","Fetal bovine acellular dermal matrix for the closure of diabetic foot ulcers: a prospective randomised controlled trial.","The purpose of this clinical trial was to evaluate the safety and efficacy of a fetal bovine acellular dermal matrix (FBADM) plus standard of care (SOC) for treating hard-to-heal diabetic foot ulcers (DFUs). A prospective, multi-centre, randomised controlled trial was carried out. The study included a 2-week run-in period, a 12-week treatment phase and a 4-week follow-up phase. The primary endpoint was complete wound closure at 12 weeks. Twenty-one US sites enrolled and randomised 226 patients w","2021","07","14","J Wound Care","Journal of wound care","ADM; acellular dermal matrix; diabetes; diabetic foot ulcers; dressing; extracellular matrix; fetal bovine acellular dermal matrix; randomised controlled trial; skin substitute; wound; wounds","Caporusso","Joseph M","Futuro Clinical Trials, McAllen, TX, US",NA
"2878","34256588","10.12968/jowc.2021.30.Sup7.S18","Fetal bovine acellular dermal matrix for the closure of diabetic foot ulcers: a prospective randomised controlled trial.","The purpose of this clinical trial was to evaluate the safety and efficacy of a fetal bovine acellular dermal matrix (FBADM) plus standard of care (SOC) for treating hard-to-heal diabetic foot ulcers (DFUs). A prospective, multi-centre, randomised controlled trial was carried out. The study included a 2-week run-in period, a 12-week treatment phase and a 4-week follow-up phase. The primary endpoint was complete wound closure at 12 weeks. Twenty-one US sites enrolled and randomised 226 patients w","2021","07","14","J Wound Care","Journal of wound care","ADM; acellular dermal matrix; diabetes; diabetic foot ulcers; dressing; extracellular matrix; fetal bovine acellular dermal matrix; randomised controlled trial; skin substitute; wound; wounds","Cazzell","Shawn","Limb Preservation Platform, Valley Vascular Surgical Associates, Fresno, CA, US",NA
"2879","34256588","10.12968/jowc.2021.30.Sup7.S18","Fetal bovine acellular dermal matrix for the closure of diabetic foot ulcers: a prospective randomised controlled trial.","The purpose of this clinical trial was to evaluate the safety and efficacy of a fetal bovine acellular dermal matrix (FBADM) plus standard of care (SOC) for treating hard-to-heal diabetic foot ulcers (DFUs). A prospective, multi-centre, randomised controlled trial was carried out. The study included a 2-week run-in period, a 12-week treatment phase and a 4-week follow-up phase. The primary endpoint was complete wound closure at 12 weeks. Twenty-one US sites enrolled and randomised 226 patients w","2021","07","14","J Wound Care","Journal of wound care","ADM; acellular dermal matrix; diabetes; diabetic foot ulcers; dressing; extracellular matrix; fetal bovine acellular dermal matrix; randomised controlled trial; skin substitute; wound; wounds","Lavery","Lawrence A","University of Texas Southwestern, Dallas, TX, US",NA
"2880","34256541","10.23736/S0022-4707.21.12777-X","Anti-doping and other sport integrity challenges during the COVID-19 pandemic.","The coronavirus disease (COVID-19) pandemic has had an unprecedent impact on the world of sport and society at large. Many of the challenges with respect to integrity previously facing competitive sport have been accentuated further during the pandemic. Threats to the integrity of sporting competition include traditional doping, issues of technological fairness, and integration of transgender and intersex athletes in elite sport. The enforced lull in competitive sport provides an unprecedented o","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Lima","Giscard","University of Rome Foro Italico, Rome, Italy",NA
"2881","34256541","10.23736/S0022-4707.21.12777-X","Anti-doping and other sport integrity challenges during the COVID-19 pandemic.","The coronavirus disease (COVID-19) pandemic has had an unprecedent impact on the world of sport and society at large. Many of the challenges with respect to integrity previously facing competitive sport have been accentuated further during the pandemic. Threats to the integrity of sporting competition include traditional doping, issues of technological fairness, and integration of transgender and intersex athletes in elite sport. The enforced lull in competitive sport provides an unprecedented o","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Muniz-Pardos","Borja","GENUD Research group, Faculty of Health and Sport Sciences, University of Zaragoza, Zaragoza, Spain",NA
"2882","34256541","10.23736/S0022-4707.21.12777-X","Anti-doping and other sport integrity challenges during the COVID-19 pandemic.","The coronavirus disease (COVID-19) pandemic has had an unprecedent impact on the world of sport and society at large. Many of the challenges with respect to integrity previously facing competitive sport have been accentuated further during the pandemic. Threats to the integrity of sporting competition include traditional doping, issues of technological fairness, and integration of transgender and intersex athletes in elite sport. The enforced lull in competitive sport provides an unprecedented o","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Kolliari-Turner","Alexander","Centre for Stress and Age Related Disease, University of Brighton, Brighton, UK",NA
"2883","34256541","10.23736/S0022-4707.21.12777-X","Anti-doping and other sport integrity challenges during the COVID-19 pandemic.","The coronavirus disease (COVID-19) pandemic has had an unprecedent impact on the world of sport and society at large. Many of the challenges with respect to integrity previously facing competitive sport have been accentuated further during the pandemic. Threats to the integrity of sporting competition include traditional doping, issues of technological fairness, and integration of transgender and intersex athletes in elite sport. The enforced lull in competitive sport provides an unprecedented o","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Hamilton","Blair","Centre for Stress and Age Related Disease, University of Brighton, Brighton, UK",NA
"2884","34256541","10.23736/S0022-4707.21.12777-X","Anti-doping and other sport integrity challenges during the COVID-19 pandemic.","The coronavirus disease (COVID-19) pandemic has had an unprecedent impact on the world of sport and society at large. Many of the challenges with respect to integrity previously facing competitive sport have been accentuated further during the pandemic. Threats to the integrity of sporting competition include traditional doping, issues of technological fairness, and integration of transgender and intersex athletes in elite sport. The enforced lull in competitive sport provides an unprecedented o","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Guppy","Fergus M","Centre for Stress and Age Related Disease, University of Brighton, Brighton, UK",NA
"2885","34256541","10.23736/S0022-4707.21.12777-X","Anti-doping and other sport integrity challenges during the COVID-19 pandemic.","The coronavirus disease (COVID-19) pandemic has had an unprecedent impact on the world of sport and society at large. Many of the challenges with respect to integrity previously facing competitive sport have been accentuated further during the pandemic. Threats to the integrity of sporting competition include traditional doping, issues of technological fairness, and integration of transgender and intersex athletes in elite sport. The enforced lull in competitive sport provides an unprecedented o","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Grivas","Gerasimos","Physical Education and Sports, Division of Humanities and Political Sciences, Hellenic Naval Academy, Piraeus, Greece",NA
"2886","34256541","10.23736/S0022-4707.21.12777-X","Anti-doping and other sport integrity challenges during the COVID-19 pandemic.","The coronavirus disease (COVID-19) pandemic has had an unprecedent impact on the world of sport and society at large. Many of the challenges with respect to integrity previously facing competitive sport have been accentuated further during the pandemic. Threats to the integrity of sporting competition include traditional doping, issues of technological fairness, and integration of transgender and intersex athletes in elite sport. The enforced lull in competitive sport provides an unprecedented o","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Bosch","Andrew","Division of Exercise Science and Sports Medicine, University of Cape Town, Cape Town, South Africa",NA
"2887","34256541","10.23736/S0022-4707.21.12777-X","Anti-doping and other sport integrity challenges during the COVID-19 pandemic.","The coronavirus disease (COVID-19) pandemic has had an unprecedent impact on the world of sport and society at large. Many of the challenges with respect to integrity previously facing competitive sport have been accentuated further during the pandemic. Threats to the integrity of sporting competition include traditional doping, issues of technological fairness, and integration of transgender and intersex athletes in elite sport. The enforced lull in competitive sport provides an unprecedented o","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Borrione","Paolo","University of Rome Foro Italico, Rome, Italy",NA
"2888","34256541","10.23736/S0022-4707.21.12777-X","Anti-doping and other sport integrity challenges during the COVID-19 pandemic.","The coronavirus disease (COVID-19) pandemic has had an unprecedent impact on the world of sport and society at large. Many of the challenges with respect to integrity previously facing competitive sport have been accentuated further during the pandemic. Threats to the integrity of sporting competition include traditional doping, issues of technological fairness, and integration of transgender and intersex athletes in elite sport. The enforced lull in competitive sport provides an unprecedented o","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"DI Gianfrancesco","Alessia","University of Rome Foro Italico, Rome, Italy",NA
"2889","34256541","10.23736/S0022-4707.21.12777-X","Anti-doping and other sport integrity challenges during the COVID-19 pandemic.","The coronavirus disease (COVID-19) pandemic has had an unprecedent impact on the world of sport and society at large. Many of the challenges with respect to integrity previously facing competitive sport have been accentuated further during the pandemic. Threats to the integrity of sporting competition include traditional doping, issues of technological fairness, and integration of transgender and intersex athletes in elite sport. The enforced lull in competitive sport provides an unprecedented o","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Fossati","Chiara","University of Rome Foro Italico, Rome, Italy",NA
"2890","34256541","10.23736/S0022-4707.21.12777-X","Anti-doping and other sport integrity challenges during the COVID-19 pandemic.","The coronavirus disease (COVID-19) pandemic has had an unprecedent impact on the world of sport and society at large. Many of the challenges with respect to integrity previously facing competitive sport have been accentuated further during the pandemic. Threats to the integrity of sporting competition include traditional doping, issues of technological fairness, and integration of transgender and intersex athletes in elite sport. The enforced lull in competitive sport provides an unprecedented o","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Pigozzi","Fabio","University of Rome Foro Italico, Rome, Italy - fabio.pigozzi@uniroma4","fabio.pigozzi@uniroma4.it"
"2891","34256541","10.23736/S0022-4707.21.12777-X","Anti-doping and other sport integrity challenges during the COVID-19 pandemic.","The coronavirus disease (COVID-19) pandemic has had an unprecedent impact on the world of sport and society at large. Many of the challenges with respect to integrity previously facing competitive sport have been accentuated further during the pandemic. Threats to the integrity of sporting competition include traditional doping, issues of technological fairness, and integration of transgender and intersex athletes in elite sport. The enforced lull in competitive sport provides an unprecedented o","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Pitsiladis","Yannis","University of Rome Foro Italico, Rome, Italy",NA
"2892","34256540","10.23736/S0022-4707.21.12764-1","The role of cardiovascular magnetic resonance in the screening before the return-to-play of elite athletes after COVID-19: utility o futility?","Recent reports based on Cardiovascular Magnetic Resonance (CMR) showed a wide range of prevalence of inflammatory heart diseases in COVID-19 convalescent athletes ranging from 0.4 up to 15%. These observations had an important impact in the field of sport cardiology opening an intense debate around the best possible screening strategy before the return-to-play. The diagnostic yield of CMR for detecting acute inflammatory disease is undebatable. However, the opportunity to use it in the screening","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Filomena","Domenico","Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy",NA
"2893","34256540","10.23736/S0022-4707.21.12764-1","The role of cardiovascular magnetic resonance in the screening before the return-to-play of elite athletes after COVID-19: utility o futility?","Recent reports based on Cardiovascular Magnetic Resonance (CMR) showed a wide range of prevalence of inflammatory heart diseases in COVID-19 convalescent athletes ranging from 0.4 up to 15%. These observations had an important impact in the field of sport cardiology opening an intense debate around the best possible screening strategy before the return-to-play. The diagnostic yield of CMR for detecting acute inflammatory disease is undebatable. However, the opportunity to use it in the screening","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Birtolo","Lucia I","Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy",NA
"2894","34256540","10.23736/S0022-4707.21.12764-1","The role of cardiovascular magnetic resonance in the screening before the return-to-play of elite athletes after COVID-19: utility o futility?","Recent reports based on Cardiovascular Magnetic Resonance (CMR) showed a wide range of prevalence of inflammatory heart diseases in COVID-19 convalescent athletes ranging from 0.4 up to 15%. These observations had an important impact in the field of sport cardiology opening an intense debate around the best possible screening strategy before the return-to-play. The diagnostic yield of CMR for detecting acute inflammatory disease is undebatable. However, the opportunity to use it in the screening","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Penza","Marco","Institute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Rome, Italy",NA
"2895","34256540","10.23736/S0022-4707.21.12764-1","The role of cardiovascular magnetic resonance in the screening before the return-to-play of elite athletes after COVID-19: utility o futility?","Recent reports based on Cardiovascular Magnetic Resonance (CMR) showed a wide range of prevalence of inflammatory heart diseases in COVID-19 convalescent athletes ranging from 0.4 up to 15%. These observations had an important impact in the field of sport cardiology opening an intense debate around the best possible screening strategy before the return-to-play. The diagnostic yield of CMR for detecting acute inflammatory disease is undebatable. However, the opportunity to use it in the screening","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Gualdi","Gianfranco","Institute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Rome, Italy",NA
"2896","34256540","10.23736/S0022-4707.21.12764-1","The role of cardiovascular magnetic resonance in the screening before the return-to-play of elite athletes after COVID-19: utility o futility?","Recent reports based on Cardiovascular Magnetic Resonance (CMR) showed a wide range of prevalence of inflammatory heart diseases in COVID-19 convalescent athletes ranging from 0.4 up to 15%. These observations had an important impact in the field of sport cardiology opening an intense debate around the best possible screening strategy before the return-to-play. The diagnostic yield of CMR for detecting acute inflammatory disease is undebatable. However, the opportunity to use it in the screening","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"DI Giacinto","Barbara","Institute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Rome, Italy",NA
"2897","34256540","10.23736/S0022-4707.21.12764-1","The role of cardiovascular magnetic resonance in the screening before the return-to-play of elite athletes after COVID-19: utility o futility?","Recent reports based on Cardiovascular Magnetic Resonance (CMR) showed a wide range of prevalence of inflammatory heart diseases in COVID-19 convalescent athletes ranging from 0.4 up to 15%. These observations had an important impact in the field of sport cardiology opening an intense debate around the best possible screening strategy before the return-to-play. The diagnostic yield of CMR for detecting acute inflammatory disease is undebatable. However, the opportunity to use it in the screening","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Maestrini","Viviana","Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy - viviana.maestrini@uniroma1","viviana.maestrini@uniroma1.it"
"2898","34256538","10.23736/S0022-4707.21.12745-8","Preparing athletes and staff for the first 'pandemic' Olympic Games.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) it the virus causing coronavirus disease 2019 (COVID-19). Since the World Health Organisation declared the outbreak a pandemic on the 11th of March 2020, cases have been increasing around the World with more than 3M deaths recorded and a daily number of COVID-19 cases &gt;20 times higher than when the Olympics were postponed, at the time of writing. Governments adopted various lockdown measures forcing isolation for many weeks/months d","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Cardinale","Marco","Department of Research and Scientific Support, Aspetar Orthopaedic and Sports Medicine Hospital, Doha, Qatar - marco.cardinale@aspetar","marco.cardinale@aspetar.com"
"2899","34256534","10.23736/S0022-4707.21.12228-5","Physical activity patterns among adults population during the coronavirus pandemic: consideration of the role of resilience.","This study aims to characterize patterns of physical activity (PA) and resilience levels, and to examine whether resilience contributes to PA participation among adults during COVID-19 pandemic. This cross-sectional study was conducted during the quarantine period. The International Physical Activity Questionnaire-Short Form (IPAQ-SF) and the Brief Resilience Scale (BRS) questionnaires were used to assess the study's outcomes. The Kruskal-Wallis test was used to examine the difference in PA acro","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Baattaiah","Baian A","Department of Physical Therapy, Faculty of Medical Rehabilitation Sciences, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia",NA
"2900","34256534","10.23736/S0022-4707.21.12228-5","Physical activity patterns among adults population during the coronavirus pandemic: consideration of the role of resilience.","This study aims to characterize patterns of physical activity (PA) and resilience levels, and to examine whether resilience contributes to PA participation among adults during COVID-19 pandemic. This cross-sectional study was conducted during the quarantine period. The International Physical Activity Questionnaire-Short Form (IPAQ-SF) and the Brief Resilience Scale (BRS) questionnaires were used to assess the study's outcomes. The Kruskal-Wallis test was used to examine the difference in PA acro","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Alharbi","Mutasim D","Department of Physical Therapy, Faculty of Medical Rehabilitation Sciences, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia",NA
"2901","34256534","10.23736/S0022-4707.21.12228-5","Physical activity patterns among adults population during the coronavirus pandemic: consideration of the role of resilience.","This study aims to characterize patterns of physical activity (PA) and resilience levels, and to examine whether resilience contributes to PA participation among adults during COVID-19 pandemic. This cross-sectional study was conducted during the quarantine period. The International Physical Activity Questionnaire-Short Form (IPAQ-SF) and the Brief Resilience Scale (BRS) questionnaires were used to assess the study's outcomes. The Kruskal-Wallis test was used to examine the difference in PA acro","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Alqahtani","Abdulfattah S","Department of Rehabilitation Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Kingdom of Saudi Arabia",NA
"2902","34256534","10.23736/S0022-4707.21.12228-5","Physical activity patterns among adults population during the coronavirus pandemic: consideration of the role of resilience.","This study aims to characterize patterns of physical activity (PA) and resilience levels, and to examine whether resilience contributes to PA participation among adults during COVID-19 pandemic. This cross-sectional study was conducted during the quarantine period. The International Physical Activity Questionnaire-Short Form (IPAQ-SF) and the Brief Resilience Scale (BRS) questionnaires were used to assess the study's outcomes. The Kruskal-Wallis test was used to examine the difference in PA acro","2021","07","14","J Sports Med Phys Fitness","The Journal of sports medicine and physical fitness",NA,"Aldhahi","Monira I","Department of Rehabilitation Sciences, College of Health and Rehabilitation Sciences, Princess Nourah Bint Abdulrahman University, Riyadh, Kingdom of Saudi Arabia - Mialdhahi@pnu.edu","Mialdhahi@pnu.edu.sa"
"2903","34256532","10.52586/S555","Review article on COVID-19 and Guillain-Barré syndrome.","The tale COVID infection pandemic or as far as we might be concerned better, COVID-19, has assaulted society on a worldwide scale. For the unenlightened, the sickness is brought about by the specific infection Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). It is only from time to time that we have a pandemic seething on that has carried with itself a particularly humongous size of harm and on each and every front of the human culture, be it clinical, practical, social or pretty mu","2021","07","21","Front Biosci (Schol Ed)","Frontiers in bioscience (Scholar edition)","COVID-19; Guillain-Barré syndrome; Inflammatory; MERS-CoV; Polyneuropathy; SARS-CoV; Anosmia; COVID-19; Guillain-Barre Syndrome; Humans; Pandemics; SARS-CoV-2","Patnaik","U Juhi","Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, 442001 Sawangi Meghe, Wardha",NA
"2904","34256521","10.5578/tt.20219820","Succesful treatment of COVID-19 infection in a child with tracheostomy.",NA,"2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","COVID-19; Child; Humans; SARS-CoV-2; Tracheostomy","Gün","Emrah","Division of Pediatric Intensive Care, Ankara University Faculty of Medicine, Ankara, Turkey",NA
"2905","34256521","10.5578/tt.20219820","Succesful treatment of COVID-19 infection in a child with tracheostomy.",NA,"2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","COVID-19; Child; Humans; SARS-CoV-2; Tracheostomy","Botan","Edin","Division of Pediatric Intensive Care, Ankara University Faculty of Medicine, Ankara, Turkey",NA
"2906","34256521","10.5578/tt.20219820","Succesful treatment of COVID-19 infection in a child with tracheostomy.",NA,"2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","COVID-19; Child; Humans; SARS-CoV-2; Tracheostomy","Özdemir","Halil","Division of Pediatric Infectious Diseases, Ankara University Faculty of Medicine, Ankara, Turkey",NA
"2907","34256521","10.5578/tt.20219820","Succesful treatment of COVID-19 infection in a child with tracheostomy.",NA,"2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","COVID-19; Child; Humans; SARS-CoV-2; Tracheostomy","Kendirli","Tanil","Division of Pediatric Intensive Care, Ankara University Faculty of Medicine, Ankara, Turkey",NA
"2908","34256519","10.5578/tt.20219818","COVID-19 and thrombosis: Prophylaxis and management.","COVID-19 emerged in Wuhan, China in late December 2019, and WHO declared it a pandemic on March 11, 2020. The disease has a wide spectrum ranging from asymptomatic or mild disease to ARDS and death. There have been over 83.9 million cases with 1.8 million deaths worldwide. COVIDassociated coagulopathy appears to be an entity responsible for deaths. Thromboprophylaxis is recommended in patients with COVID-19 to prevent arterial and venous thromboembolism. Low molecular weight heparin such as enox","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Anticoagulants; COVID-19; Disease Management; Humans; Pandemics; SARS-CoV-2; Turkey; Venous Thromboembolism","Canoglu","Kadir","Clinic of Chest Diseases, Sultan 2. Abdülhamid Han Training and Research Hospital, Istanbul, Turkey",NA
"2909","34256519","10.5578/tt.20219818","COVID-19 and thrombosis: Prophylaxis and management.","COVID-19 emerged in Wuhan, China in late December 2019, and WHO declared it a pandemic on March 11, 2020. The disease has a wide spectrum ranging from asymptomatic or mild disease to ARDS and death. There have been over 83.9 million cases with 1.8 million deaths worldwide. COVIDassociated coagulopathy appears to be an entity responsible for deaths. Thromboprophylaxis is recommended in patients with COVID-19 to prevent arterial and venous thromboembolism. Low molecular weight heparin such as enox","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Anticoagulants; COVID-19; Disease Management; Humans; Pandemics; SARS-CoV-2; Turkey; Venous Thromboembolism","Saylan","Bengü","Clinic of Chest Diseases, Sultan 2. Abdülhamid Han Training and Research Hospital, Istanbul, Turkey",NA
"2910","34256519","10.5578/tt.20219818","COVID-19 and thrombosis: Prophylaxis and management.","COVID-19 emerged in Wuhan, China in late December 2019, and WHO declared it a pandemic on March 11, 2020. The disease has a wide spectrum ranging from asymptomatic or mild disease to ARDS and death. There have been over 83.9 million cases with 1.8 million deaths worldwide. COVIDassociated coagulopathy appears to be an entity responsible for deaths. Thromboprophylaxis is recommended in patients with COVID-19 to prevent arterial and venous thromboembolism. Low molecular weight heparin such as enox","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Anticoagulants; COVID-19; Disease Management; Humans; Pandemics; SARS-CoV-2; Turkey; Venous Thromboembolism","Çaliskan","Tayfun","Clinic of Chest Diseases, Sultan 2. Abdülhamid Han Training and Research Hospital, Istanbul, Turkey",NA
"2911","34256515","10.5578/tt.20219814","An unusual course of SARS-CoV-2 infection: Challenging diagnosis of Guillain-Barré Syndrome.","COVID-19, caused by severe acute respiratory syndrome coronavirus-2, typically presents with respiratory symptoms and fever, but still a variety of clinical presentations have been reported. In this study, it was aimed to report a case of COVID-19 with an atypical presentation and an atypical course. As well, the recovery phase was complicated with GBS and consequently cytomegalovirus infection. It should be kept in mind that patients with COVID-19 severe disease need to be followed for neurolog","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Aged; COVID-19; Diagnosis, Differential; Guillain-Barre Syndrome; Humans; Male; Pandemics; SARS-CoV-2; Turkey","Koca","Ayca","Department of Emergency Medicine, Ankara University Faculty of Medicine, Ankara, Turkey",NA
"2912","34256515","10.5578/tt.20219814","An unusual course of SARS-CoV-2 infection: Challenging diagnosis of Guillain-Barré Syndrome.","COVID-19, caused by severe acute respiratory syndrome coronavirus-2, typically presents with respiratory symptoms and fever, but still a variety of clinical presentations have been reported. In this study, it was aimed to report a case of COVID-19 with an atypical presentation and an atypical course. As well, the recovery phase was complicated with GBS and consequently cytomegalovirus infection. It should be kept in mind that patients with COVID-19 severe disease need to be followed for neurolog","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Aged; COVID-19; Diagnosis, Differential; Guillain-Barre Syndrome; Humans; Male; Pandemics; SARS-CoV-2; Turkey","Talan","Leyla","Division of Intensive Care, Ankara University Faculty of Medicine, Ankara, Turkey",NA
"2913","34256515","10.5578/tt.20219814","An unusual course of SARS-CoV-2 infection: Challenging diagnosis of Guillain-Barré Syndrome.","COVID-19, caused by severe acute respiratory syndrome coronavirus-2, typically presents with respiratory symptoms and fever, but still a variety of clinical presentations have been reported. In this study, it was aimed to report a case of COVID-19 with an atypical presentation and an atypical course. As well, the recovery phase was complicated with GBS and consequently cytomegalovirus infection. It should be kept in mind that patients with COVID-19 severe disease need to be followed for neurolog","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Aged; COVID-19; Diagnosis, Differential; Guillain-Barre Syndrome; Humans; Male; Pandemics; SARS-CoV-2; Turkey","Sahin","Turgut","Department of Neurology, Ankara University Faculty of Medicine, Ankara, Turkey",NA
"2914","34256515","10.5578/tt.20219814","An unusual course of SARS-CoV-2 infection: Challenging diagnosis of Guillain-Barré Syndrome.","COVID-19, caused by severe acute respiratory syndrome coronavirus-2, typically presents with respiratory symptoms and fever, but still a variety of clinical presentations have been reported. In this study, it was aimed to report a case of COVID-19 with an atypical presentation and an atypical course. As well, the recovery phase was complicated with GBS and consequently cytomegalovirus infection. It should be kept in mind that patients with COVID-19 severe disease need to be followed for neurolog","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Aged; COVID-19; Diagnosis, Differential; Guillain-Barre Syndrome; Humans; Male; Pandemics; SARS-CoV-2; Turkey","Çinar","Güle","Department of Infection Diseases and Clinical Microbiology, Ankara University Faculty of Medicine, Ankara, Turkey",NA
"2915","34256515","10.5578/tt.20219814","An unusual course of SARS-CoV-2 infection: Challenging diagnosis of Guillain-Barré Syndrome.","COVID-19, caused by severe acute respiratory syndrome coronavirus-2, typically presents with respiratory symptoms and fever, but still a variety of clinical presentations have been reported. In this study, it was aimed to report a case of COVID-19 with an atypical presentation and an atypical course. As well, the recovery phase was complicated with GBS and consequently cytomegalovirus infection. It should be kept in mind that patients with COVID-19 severe disease need to be followed for neurolog","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Aged; COVID-19; Diagnosis, Differential; Guillain-Barre Syndrome; Humans; Male; Pandemics; SARS-CoV-2; Turkey","Evren","Ebru","Department of Medical Microbiology, Ankara University Faculty of Medicine, Ankara, Turkey",NA
"2916","34256515","10.5578/tt.20219814","An unusual course of SARS-CoV-2 infection: Challenging diagnosis of Guillain-Barré Syndrome.","COVID-19, caused by severe acute respiratory syndrome coronavirus-2, typically presents with respiratory symptoms and fever, but still a variety of clinical presentations have been reported. In this study, it was aimed to report a case of COVID-19 with an atypical presentation and an atypical course. As well, the recovery phase was complicated with GBS and consequently cytomegalovirus infection. It should be kept in mind that patients with COVID-19 severe disease need to be followed for neurolog","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Aged; COVID-19; Diagnosis, Differential; Guillain-Barre Syndrome; Humans; Male; Pandemics; SARS-CoV-2; Turkey","Karahan","Zeynep Ceren","Department of Medical Microbiology, Ankara University Faculty of Medicine, Ankara, Turkey",NA
"2917","34256515","10.5578/tt.20219814","An unusual course of SARS-CoV-2 infection: Challenging diagnosis of Guillain-Barré Syndrome.","COVID-19, caused by severe acute respiratory syndrome coronavirus-2, typically presents with respiratory symptoms and fever, but still a variety of clinical presentations have been reported. In this study, it was aimed to report a case of COVID-19 with an atypical presentation and an atypical course. As well, the recovery phase was complicated with GBS and consequently cytomegalovirus infection. It should be kept in mind that patients with COVID-19 severe disease need to be followed for neurolog","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Aged; COVID-19; Diagnosis, Differential; Guillain-Barre Syndrome; Humans; Male; Pandemics; SARS-CoV-2; Turkey","Günalp","Müge","Department of Emergency Medicine, Ankara University Faculty of Medicine, Ankara, Turkey",NA
"2918","34256515","10.5578/tt.20219814","An unusual course of SARS-CoV-2 infection: Challenging diagnosis of Guillain-Barré Syndrome.","COVID-19, caused by severe acute respiratory syndrome coronavirus-2, typically presents with respiratory symptoms and fever, but still a variety of clinical presentations have been reported. In this study, it was aimed to report a case of COVID-19 with an atypical presentation and an atypical course. As well, the recovery phase was complicated with GBS and consequently cytomegalovirus infection. It should be kept in mind that patients with COVID-19 severe disease need to be followed for neurolog","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Aged; COVID-19; Diagnosis, Differential; Guillain-Barre Syndrome; Humans; Male; Pandemics; SARS-CoV-2; Turkey","Altintas","Neriman Defne","Division of Intensive Care, Ankara University Faculty of Medicine, Ankara, Turkey",NA
"2919","34256515","10.5578/tt.20219814","An unusual course of SARS-CoV-2 infection: Challenging diagnosis of Guillain-Barré Syndrome.","COVID-19, caused by severe acute respiratory syndrome coronavirus-2, typically presents with respiratory symptoms and fever, but still a variety of clinical presentations have been reported. In this study, it was aimed to report a case of COVID-19 with an atypical presentation and an atypical course. As well, the recovery phase was complicated with GBS and consequently cytomegalovirus infection. It should be kept in mind that patients with COVID-19 severe disease need to be followed for neurolog","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Aged; COVID-19; Diagnosis, Differential; Guillain-Barre Syndrome; Humans; Male; Pandemics; SARS-CoV-2; Turkey","Sener","Özden","Department of Neurology, Ankara University Faculty of Medicine, Ankara, Turkey",NA
"2920","34256512","10.5578/tt.20219811","Corticosteroid use in COVID-19 pneumonia.","Coronavirus disease 2019 (COVID-19) has a 1-2% fatality rate, where no specific treatment has yet been defined. Although corticosteroids are recommended for selected COVID-19 patients without acute respiratory distress syndrome (ARDS) and septic shock, there is no consensus regarding patient subgroups, dose, and duration. In this study, it was aimed to examine the contribution of corticosteroid treatment to the management of COVID-19 pneumonia without ARDS, septic shock both in acute and recover","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Adrenal Cortex Hormones; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Turkey","Erçen Diken","Özlem","Clinic of Chest Diseases, SBÜ Adana City Training and Research Hospital, Adana, Turkey",NA
"2921","34256512","10.5578/tt.20219811","Corticosteroid use in COVID-19 pneumonia.","Coronavirus disease 2019 (COVID-19) has a 1-2% fatality rate, where no specific treatment has yet been defined. Although corticosteroids are recommended for selected COVID-19 patients without acute respiratory distress syndrome (ARDS) and septic shock, there is no consensus regarding patient subgroups, dose, and duration. In this study, it was aimed to examine the contribution of corticosteroid treatment to the management of COVID-19 pneumonia without ARDS, septic shock both in acute and recover","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Adrenal Cortex Hormones; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Turkey","Yildirim","Fatma","Clinic of Chest Diseases, COVID Intensive Care Unite, Health Science University Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey",NA
"2922","34256512","10.5578/tt.20219811","Corticosteroid use in COVID-19 pneumonia.","Coronavirus disease 2019 (COVID-19) has a 1-2% fatality rate, where no specific treatment has yet been defined. Although corticosteroids are recommended for selected COVID-19 patients without acute respiratory distress syndrome (ARDS) and septic shock, there is no consensus regarding patient subgroups, dose, and duration. In this study, it was aimed to examine the contribution of corticosteroid treatment to the management of COVID-19 pneumonia without ARDS, septic shock both in acute and recover","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Adrenal Cortex Hormones; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Turkey","Yildiz Gülhan","Pinar","Department of Chest Diseases, Düzce University Faculty of Medicine, Düzce, Turkey",NA
"2923","34256512","10.5578/tt.20219811","Corticosteroid use in COVID-19 pneumonia.","Coronavirus disease 2019 (COVID-19) has a 1-2% fatality rate, where no specific treatment has yet been defined. Although corticosteroids are recommended for selected COVID-19 patients without acute respiratory distress syndrome (ARDS) and septic shock, there is no consensus regarding patient subgroups, dose, and duration. In this study, it was aimed to examine the contribution of corticosteroid treatment to the management of COVID-19 pneumonia without ARDS, septic shock both in acute and recover","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Adrenal Cortex Hormones; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Turkey","Özkaya","Sevket","Department of Chest Diseases, Bahçesehir University Faculty of Medicine, Istanbul, Turkey",NA
"2924","34256512","10.5578/tt.20219811","Corticosteroid use in COVID-19 pneumonia.","Coronavirus disease 2019 (COVID-19) has a 1-2% fatality rate, where no specific treatment has yet been defined. Although corticosteroids are recommended for selected COVID-19 patients without acute respiratory distress syndrome (ARDS) and septic shock, there is no consensus regarding patient subgroups, dose, and duration. In this study, it was aimed to examine the contribution of corticosteroid treatment to the management of COVID-19 pneumonia without ARDS, septic shock both in acute and recover","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Adrenal Cortex Hormones; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Turkey","Simsek","Meltem","Department of Internal Medicine, Health Science University Diskapi Yildirim Beyazit Research and Education Hospital, COVID Intensive Care Unite, Ankara, Turkey",NA
"2925","34256512","10.5578/tt.20219811","Corticosteroid use in COVID-19 pneumonia.","Coronavirus disease 2019 (COVID-19) has a 1-2% fatality rate, where no specific treatment has yet been defined. Although corticosteroids are recommended for selected COVID-19 patients without acute respiratory distress syndrome (ARDS) and septic shock, there is no consensus regarding patient subgroups, dose, and duration. In this study, it was aimed to examine the contribution of corticosteroid treatment to the management of COVID-19 pneumonia without ARDS, septic shock both in acute and recover","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Adrenal Cortex Hormones; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Turkey","Yücel","Cihan","Clinic of Chest Diseases, SBÜ Adana City Training and Research Hospital, Adana, Turkey",NA
"2926","34256512","10.5578/tt.20219811","Corticosteroid use in COVID-19 pneumonia.","Coronavirus disease 2019 (COVID-19) has a 1-2% fatality rate, where no specific treatment has yet been defined. Although corticosteroids are recommended for selected COVID-19 patients without acute respiratory distress syndrome (ARDS) and septic shock, there is no consensus regarding patient subgroups, dose, and duration. In this study, it was aimed to examine the contribution of corticosteroid treatment to the management of COVID-19 pneumonia without ARDS, septic shock both in acute and recover","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Adrenal Cortex Hormones; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Turkey","Berik Safci","Sinem","Clinic of Chest Diseases, SBÜ Adana City Training and Research Hospital, Adana, Turkey",NA
"2927","34256512","10.5578/tt.20219811","Corticosteroid use in COVID-19 pneumonia.","Coronavirus disease 2019 (COVID-19) has a 1-2% fatality rate, where no specific treatment has yet been defined. Although corticosteroids are recommended for selected COVID-19 patients without acute respiratory distress syndrome (ARDS) and septic shock, there is no consensus regarding patient subgroups, dose, and duration. In this study, it was aimed to examine the contribution of corticosteroid treatment to the management of COVID-19 pneumonia without ARDS, septic shock both in acute and recover","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Adrenal Cortex Hormones; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Turkey","Deniz","Pelin Pinar","Clinic of Chest Diseases, SBÜ Adana City Training and Research Hospital, Adana, Turkey",NA
"2928","34256512","10.5578/tt.20219811","Corticosteroid use in COVID-19 pneumonia.","Coronavirus disease 2019 (COVID-19) has a 1-2% fatality rate, where no specific treatment has yet been defined. Although corticosteroids are recommended for selected COVID-19 patients without acute respiratory distress syndrome (ARDS) and septic shock, there is no consensus regarding patient subgroups, dose, and duration. In this study, it was aimed to examine the contribution of corticosteroid treatment to the management of COVID-19 pneumonia without ARDS, septic shock both in acute and recover","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Adrenal Cortex Hormones; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Turkey","Coskun Çelik","Müge","Adana City Hospital, Clinic of Anaesthesiology and Reanimation, Adana, Turkey",NA
"2929","34256512","10.5578/tt.20219811","Corticosteroid use in COVID-19 pneumonia.","Coronavirus disease 2019 (COVID-19) has a 1-2% fatality rate, where no specific treatment has yet been defined. Although corticosteroids are recommended for selected COVID-19 patients without acute respiratory distress syndrome (ARDS) and septic shock, there is no consensus regarding patient subgroups, dose, and duration. In this study, it was aimed to examine the contribution of corticosteroid treatment to the management of COVID-19 pneumonia without ARDS, septic shock both in acute and recover","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Adrenal Cortex Hormones; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Turkey","Akdag","Devrim","Adana City Hospital, Clinic of Anaesthesiology and Reanimation, Adana, Turkey",NA
"2930","34256512","10.5578/tt.20219811","Corticosteroid use in COVID-19 pneumonia.","Coronavirus disease 2019 (COVID-19) has a 1-2% fatality rate, where no specific treatment has yet been defined. Although corticosteroids are recommended for selected COVID-19 patients without acute respiratory distress syndrome (ARDS) and septic shock, there is no consensus regarding patient subgroups, dose, and duration. In this study, it was aimed to examine the contribution of corticosteroid treatment to the management of COVID-19 pneumonia without ARDS, septic shock both in acute and recover","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Adrenal Cortex Hormones; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Turkey","Dirican","Adem","Clinic of Chest Diseases, Samsun Medikal Park Hospital, Samsun, Turkey",NA
"2931","34256511","10.5578/tt.20219810","COVID-19 phobia in healthcare workers; a cross-sectional study from a pandemic hospital.","Healthcare workers (HCWs) are at the forefront of the fight against coronavirus. The purpose of this study was to evaluate COVID-19 phobia levels of HCWs of a pandemic hospital and explore associated factors. This was a descriptive cross-sectional study conducted on HCWs employed in a pandemic hospital. A total of 365 HCWs (95 physicians, 187 nurses and 83 assistant healthcare staffs) were included in the study. In order to evaluate COVID-19 phobia, coronavirus-19 phobia scale (C19P-S) was admin","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Adult; COVID-19; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Incidence; Male; Mental Health; Pandemics; Phobic Disorders; SARS-CoV-2; Turkey","Oktay Arslan","Burcu","Clinic of Chest Diseases University of Health Sciences, Dr. Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey",NA
"2932","34256511","10.5578/tt.20219810","COVID-19 phobia in healthcare workers; a cross-sectional study from a pandemic hospital.","Healthcare workers (HCWs) are at the forefront of the fight against coronavirus. The purpose of this study was to evaluate COVID-19 phobia levels of HCWs of a pandemic hospital and explore associated factors. This was a descriptive cross-sectional study conducted on HCWs employed in a pandemic hospital. A total of 365 HCWs (95 physicians, 187 nurses and 83 assistant healthcare staffs) were included in the study. In order to evaluate COVID-19 phobia, coronavirus-19 phobia scale (C19P-S) was admin","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Adult; COVID-19; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Incidence; Male; Mental Health; Pandemics; Phobic Disorders; SARS-CoV-2; Turkey","Batum","Özgür","Clinic of Chest Diseases University of Health Sciences, Dr. Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey",NA
"2933","34256511","10.5578/tt.20219810","COVID-19 phobia in healthcare workers; a cross-sectional study from a pandemic hospital.","Healthcare workers (HCWs) are at the forefront of the fight against coronavirus. The purpose of this study was to evaluate COVID-19 phobia levels of HCWs of a pandemic hospital and explore associated factors. This was a descriptive cross-sectional study conducted on HCWs employed in a pandemic hospital. A total of 365 HCWs (95 physicians, 187 nurses and 83 assistant healthcare staffs) were included in the study. In order to evaluate COVID-19 phobia, coronavirus-19 phobia scale (C19P-S) was admin","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Adult; COVID-19; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Incidence; Male; Mental Health; Pandemics; Phobic Disorders; SARS-CoV-2; Turkey","Varol","Yelda","Clinic of Chest Diseases University of Health Sciences, Dr. Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey",NA
"2934","34256511","10.5578/tt.20219810","COVID-19 phobia in healthcare workers; a cross-sectional study from a pandemic hospital.","Healthcare workers (HCWs) are at the forefront of the fight against coronavirus. The purpose of this study was to evaluate COVID-19 phobia levels of HCWs of a pandemic hospital and explore associated factors. This was a descriptive cross-sectional study conducted on HCWs employed in a pandemic hospital. A total of 365 HCWs (95 physicians, 187 nurses and 83 assistant healthcare staffs) were included in the study. In order to evaluate COVID-19 phobia, coronavirus-19 phobia scale (C19P-S) was admin","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Adult; COVID-19; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Incidence; Male; Mental Health; Pandemics; Phobic Disorders; SARS-CoV-2; Turkey","Senel","Emre","Clinic of Intensive Care Unit, University of Health Sciences, Dr. Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey",NA
"2935","34256511","10.5578/tt.20219810","COVID-19 phobia in healthcare workers; a cross-sectional study from a pandemic hospital.","Healthcare workers (HCWs) are at the forefront of the fight against coronavirus. The purpose of this study was to evaluate COVID-19 phobia levels of HCWs of a pandemic hospital and explore associated factors. This was a descriptive cross-sectional study conducted on HCWs employed in a pandemic hospital. A total of 365 HCWs (95 physicians, 187 nurses and 83 assistant healthcare staffs) were included in the study. In order to evaluate COVID-19 phobia, coronavirus-19 phobia scale (C19P-S) was admin","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Adult; COVID-19; Cross-Sectional Studies; Female; Health Personnel; Hospitals; Humans; Incidence; Male; Mental Health; Pandemics; Phobic Disorders; SARS-CoV-2; Turkey","Uçar","Zeynep Zeren","Clinic of Chest Diseases University of Health Sciences, Dr. Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Izmir, Turkey",NA
"2936","34256510","10.5578/tt.20219809","Evaluation of mortality predictors in hospitalized COVID-19 patients: Retrospective cohort study.","Evaluation of parameters that will predict prognosis in COVID19 disease ensures correct determination of treatment strategy. In this study, it was aimed to determine the clinical, radiological and laboratory parameters affecting mortality and to evaluate the risk factors. Patients hospitalized with the diagnosis of COVID-19 in September 2020 were included in the study. Clinical features, laboratory parameters, and radiological findings at admission were recorded. The relationship of these parame","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Aged; COVID-19; Female; Humans; Inpatients; Male; Middle Aged; Pandemics; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2; Survival Rate; Turkey","Uzel Sener","Melahat","Clinic of Chest Diseases, University of Health Sciences, Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara, Turkey",NA
"2937","34256510","10.5578/tt.20219809","Evaluation of mortality predictors in hospitalized COVID-19 patients: Retrospective cohort study.","Evaluation of parameters that will predict prognosis in COVID19 disease ensures correct determination of treatment strategy. In this study, it was aimed to determine the clinical, radiological and laboratory parameters affecting mortality and to evaluate the risk factors. Patients hospitalized with the diagnosis of COVID-19 in September 2020 were included in the study. Clinical features, laboratory parameters, and radiological findings at admission were recorded. The relationship of these parame","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Aged; COVID-19; Female; Humans; Inpatients; Male; Middle Aged; Pandemics; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2; Survival Rate; Turkey","Yildiz","Murat","Clinic of Chest Diseases, University of Health Sciences, Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara, Turkey",NA
"2938","34256510","10.5578/tt.20219809","Evaluation of mortality predictors in hospitalized COVID-19 patients: Retrospective cohort study.","Evaluation of parameters that will predict prognosis in COVID19 disease ensures correct determination of treatment strategy. In this study, it was aimed to determine the clinical, radiological and laboratory parameters affecting mortality and to evaluate the risk factors. Patients hospitalized with the diagnosis of COVID-19 in September 2020 were included in the study. Clinical features, laboratory parameters, and radiological findings at admission were recorded. The relationship of these parame","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Aged; COVID-19; Female; Humans; Inpatients; Male; Middle Aged; Pandemics; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2; Survival Rate; Turkey","Kavurgaci","Suna","Clinic of Chest Diseases, University of Health Sciences, Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara, Turkey",NA
"2939","34256510","10.5578/tt.20219809","Evaluation of mortality predictors in hospitalized COVID-19 patients: Retrospective cohort study.","Evaluation of parameters that will predict prognosis in COVID19 disease ensures correct determination of treatment strategy. In this study, it was aimed to determine the clinical, radiological and laboratory parameters affecting mortality and to evaluate the risk factors. Patients hospitalized with the diagnosis of COVID-19 in September 2020 were included in the study. Clinical features, laboratory parameters, and radiological findings at admission were recorded. The relationship of these parame","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Aged; COVID-19; Female; Humans; Inpatients; Male; Middle Aged; Pandemics; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2; Survival Rate; Turkey","Öztürk Ergür","Figen","Clinic of Chest Diseases, University of Health Sciences, Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara, Turkey",NA
"2940","34256510","10.5578/tt.20219809","Evaluation of mortality predictors in hospitalized COVID-19 patients: Retrospective cohort study.","Evaluation of parameters that will predict prognosis in COVID19 disease ensures correct determination of treatment strategy. In this study, it was aimed to determine the clinical, radiological and laboratory parameters affecting mortality and to evaluate the risk factors. Patients hospitalized with the diagnosis of COVID-19 in September 2020 were included in the study. Clinical features, laboratory parameters, and radiological findings at admission were recorded. The relationship of these parame","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Aged; COVID-19; Female; Humans; Inpatients; Male; Middle Aged; Pandemics; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2; Survival Rate; Turkey","Sener","Alp","Department of Emergency Medicine, Yildirim Beyazit University Faculty of Medicine, Ankara, Turkey",NA
"2941","34256510","10.5578/tt.20219809","Evaluation of mortality predictors in hospitalized COVID-19 patients: Retrospective cohort study.","Evaluation of parameters that will predict prognosis in COVID19 disease ensures correct determination of treatment strategy. In this study, it was aimed to determine the clinical, radiological and laboratory parameters affecting mortality and to evaluate the risk factors. Patients hospitalized with the diagnosis of COVID-19 in September 2020 were included in the study. Clinical features, laboratory parameters, and radiological findings at admission were recorded. The relationship of these parame","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Aged; COVID-19; Female; Humans; Inpatients; Male; Middle Aged; Pandemics; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2; Survival Rate; Turkey","Öztürk","Ayperi","Clinic of Chest Diseases, University of Health Sciences, Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara, Turkey",NA
"2942","34256509","10.5578/tt.20219808","The effect of radiological distribution on the COVID-19 disease.","The aim of the study was to investigate the effects of radiological distribution on COVID-19 clinic and prognosis and to determine the relationship between laboratory parameters and thorax CT findings. Patients with COVID-19 were evaluated retrospectively. Laboratory parameters were obtained from medical records. Ground-glass opacities (GGO) and consolidation were evaluated on thorax CT. The presence of a single lobe lesion was considered as limited while multiple lobe lesions were considered as","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","COVID-19; Female; Humans; Lung; Male; Middle Aged; Pandemics; Prognosis; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Kuluöztürk","Mutlu","Department of Chest Diseases, Firat University Faculty of Medicine, Elazig, Turkey",NA
"2943","34256509","10.5578/tt.20219808","The effect of radiological distribution on the COVID-19 disease.","The aim of the study was to investigate the effects of radiological distribution on COVID-19 clinic and prognosis and to determine the relationship between laboratory parameters and thorax CT findings. Patients with COVID-19 were evaluated retrospectively. Laboratory parameters were obtained from medical records. Ground-glass opacities (GGO) and consolidation were evaluated on thorax CT. The presence of a single lobe lesion was considered as limited while multiple lobe lesions were considered as","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","COVID-19; Female; Humans; Lung; Male; Middle Aged; Pandemics; Prognosis; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","In","Erdal","Department of Chest Diseases, Firat University Faculty of Medicine, Elazig, Turkey",NA
"2944","34256509","10.5578/tt.20219808","The effect of radiological distribution on the COVID-19 disease.","The aim of the study was to investigate the effects of radiological distribution on COVID-19 clinic and prognosis and to determine the relationship between laboratory parameters and thorax CT findings. Patients with COVID-19 were evaluated retrospectively. Laboratory parameters were obtained from medical records. Ground-glass opacities (GGO) and consolidation were evaluated on thorax CT. The presence of a single lobe lesion was considered as limited while multiple lobe lesions were considered as","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","COVID-19; Female; Humans; Lung; Male; Middle Aged; Pandemics; Prognosis; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Turgut","Teyfik","Department of Chest Diseases, Firat University Faculty of Medicine, Elazig, Turkey",NA
"2945","34256509","10.5578/tt.20219808","The effect of radiological distribution on the COVID-19 disease.","The aim of the study was to investigate the effects of radiological distribution on COVID-19 clinic and prognosis and to determine the relationship between laboratory parameters and thorax CT findings. Patients with COVID-19 were evaluated retrospectively. Laboratory parameters were obtained from medical records. Ground-glass opacities (GGO) and consolidation were evaluated on thorax CT. The presence of a single lobe lesion was considered as limited while multiple lobe lesions were considered as","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","COVID-19; Female; Humans; Lung; Male; Middle Aged; Pandemics; Prognosis; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Aydin","Ayse Murat","Department of Radiology, Firat University Faculty of Medicine, Elazig, Turkey",NA
"2946","34256509","10.5578/tt.20219808","The effect of radiological distribution on the COVID-19 disease.","The aim of the study was to investigate the effects of radiological distribution on COVID-19 clinic and prognosis and to determine the relationship between laboratory parameters and thorax CT findings. Patients with COVID-19 were evaluated retrospectively. Laboratory parameters were obtained from medical records. Ground-glass opacities (GGO) and consolidation were evaluated on thorax CT. The presence of a single lobe lesion was considered as limited while multiple lobe lesions were considered as","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","COVID-19; Female; Humans; Lung; Male; Middle Aged; Pandemics; Prognosis; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Asçi Toraman","Zülal","Department of Microbiology, Firat University Faculty of Medicine, Elazig, Turkey",NA
"2947","34256509","10.5578/tt.20219808","The effect of radiological distribution on the COVID-19 disease.","The aim of the study was to investigate the effects of radiological distribution on COVID-19 clinic and prognosis and to determine the relationship between laboratory parameters and thorax CT findings. Patients with COVID-19 were evaluated retrospectively. Laboratory parameters were obtained from medical records. Ground-glass opacities (GGO) and consolidation were evaluated on thorax CT. The presence of a single lobe lesion was considered as limited while multiple lobe lesions were considered as","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","COVID-19; Female; Humans; Lung; Male; Middle Aged; Pandemics; Prognosis; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Deveci","Figen","Department of Chest Diseases, Firat University Faculty of Medicine, Elazig, Turkey",NA
"2948","34256508","10.5578/tt.20219807","Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings.","COVID-19 pneumonia typically presents with high fever, cough, and shortness of breath and on thorax computed tomography (CT) peripheral ground glass opacities help the diagnosis. Although typical imaging findings for COVID-19 pneumonia are specified in thorax CT, these findings can be confused with other diseases. The aim of this study is to investigate the roles of radiological imaging and laboratory findings in the differential diagnosis of COVID-19 pneumonia and acute heart failure (AHF). In ","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Acute Disease; Aged; COVID-19; Diagnosis, Differential; Female; Heart Failure; Humans; Lung; Male; Pandemics; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Kasapoglu","Umut Sabri","Clinic of Pulmonary and Critical Care Medicine, Malatya Training and Research Hospital, Malatya, Turkey",NA
"2949","34256508","10.5578/tt.20219807","Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings.","COVID-19 pneumonia typically presents with high fever, cough, and shortness of breath and on thorax computed tomography (CT) peripheral ground glass opacities help the diagnosis. Although typical imaging findings for COVID-19 pneumonia are specified in thorax CT, these findings can be confused with other diseases. The aim of this study is to investigate the roles of radiological imaging and laboratory findings in the differential diagnosis of COVID-19 pneumonia and acute heart failure (AHF). In ","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Acute Disease; Aged; COVID-19; Diagnosis, Differential; Female; Heart Failure; Humans; Lung; Male; Pandemics; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Gök","Abdullah","Clinic of Anesthesiology and Reanimation, Malatya Training and Research Hospital, Malatya, Turkey",NA
"2950","34256508","10.5578/tt.20219807","Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings.","COVID-19 pneumonia typically presents with high fever, cough, and shortness of breath and on thorax computed tomography (CT) peripheral ground glass opacities help the diagnosis. Although typical imaging findings for COVID-19 pneumonia are specified in thorax CT, these findings can be confused with other diseases. The aim of this study is to investigate the roles of radiological imaging and laboratory findings in the differential diagnosis of COVID-19 pneumonia and acute heart failure (AHF). In ","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Acute Disease; Aged; COVID-19; Diagnosis, Differential; Female; Heart Failure; Humans; Lung; Male; Pandemics; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Acun Delen","Leman","Clinic of Anesthesiology and Reanimation, Malatya Training and Research Hospital, Malatya, Turkey",NA
"2951","34256508","10.5578/tt.20219807","Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings.","COVID-19 pneumonia typically presents with high fever, cough, and shortness of breath and on thorax computed tomography (CT) peripheral ground glass opacities help the diagnosis. Although typical imaging findings for COVID-19 pneumonia are specified in thorax CT, these findings can be confused with other diseases. The aim of this study is to investigate the roles of radiological imaging and laboratory findings in the differential diagnosis of COVID-19 pneumonia and acute heart failure (AHF). In ","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Acute Disease; Aged; COVID-19; Diagnosis, Differential; Female; Heart Failure; Humans; Lung; Male; Pandemics; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Sayan","Hasan","Clinic of Anesthesiology and Reanimation, Malatya Training and Research Hospital, Malatya, Turkey",NA
"2952","34256508","10.5578/tt.20219807","Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings.","COVID-19 pneumonia typically presents with high fever, cough, and shortness of breath and on thorax computed tomography (CT) peripheral ground glass opacities help the diagnosis. Although typical imaging findings for COVID-19 pneumonia are specified in thorax CT, these findings can be confused with other diseases. The aim of this study is to investigate the roles of radiological imaging and laboratory findings in the differential diagnosis of COVID-19 pneumonia and acute heart failure (AHF). In ","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Acute Disease; Aged; COVID-19; Diagnosis, Differential; Female; Heart Failure; Humans; Lung; Male; Pandemics; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Kaçmaz","Osman","Clinic of Anesthesiology and Reanimation, Malatya Training and Research Hospital, Malatya, Turkey",NA
"2953","34256508","10.5578/tt.20219807","Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings.","COVID-19 pneumonia typically presents with high fever, cough, and shortness of breath and on thorax computed tomography (CT) peripheral ground glass opacities help the diagnosis. Although typical imaging findings for COVID-19 pneumonia are specified in thorax CT, these findings can be confused with other diseases. The aim of this study is to investigate the roles of radiological imaging and laboratory findings in the differential diagnosis of COVID-19 pneumonia and acute heart failure (AHF). In ","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Acute Disease; Aged; COVID-19; Diagnosis, Differential; Female; Heart Failure; Humans; Lung; Male; Pandemics; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Çagasar","Özlem","Clinic of Infectious Diseases and Clinical Microbiology, Malatya Training and Research Hospital, Malatya, Turkey",NA
"2954","34256508","10.5578/tt.20219807","Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings.","COVID-19 pneumonia typically presents with high fever, cough, and shortness of breath and on thorax computed tomography (CT) peripheral ground glass opacities help the diagnosis. Although typical imaging findings for COVID-19 pneumonia are specified in thorax CT, these findings can be confused with other diseases. The aim of this study is to investigate the roles of radiological imaging and laboratory findings in the differential diagnosis of COVID-19 pneumonia and acute heart failure (AHF). In ","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Acute Disease; Aged; COVID-19; Diagnosis, Differential; Female; Heart Failure; Humans; Lung; Male; Pandemics; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Karaca","Rukan","Clinic of Radiology, Malatya Training and Research Hospital, Malatya, Turkey",NA
"2955","34256508","10.5578/tt.20219807","Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings.","COVID-19 pneumonia typically presents with high fever, cough, and shortness of breath and on thorax computed tomography (CT) peripheral ground glass opacities help the diagnosis. Although typical imaging findings for COVID-19 pneumonia are specified in thorax CT, these findings can be confused with other diseases. The aim of this study is to investigate the roles of radiological imaging and laboratory findings in the differential diagnosis of COVID-19 pneumonia and acute heart failure (AHF). In ","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Acute Disease; Aged; COVID-19; Diagnosis, Differential; Female; Heart Failure; Humans; Lung; Male; Pandemics; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Günes","Ajda","Clinic of Hematology, Malatya Training and Research Hospital, Malatya, Turkey",NA
"2956","34256508","10.5578/tt.20219807","Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings.","COVID-19 pneumonia typically presents with high fever, cough, and shortness of breath and on thorax computed tomography (CT) peripheral ground glass opacities help the diagnosis. Although typical imaging findings for COVID-19 pneumonia are specified in thorax CT, these findings can be confused with other diseases. The aim of this study is to investigate the roles of radiological imaging and laboratory findings in the differential diagnosis of COVID-19 pneumonia and acute heart failure (AHF). In ","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Acute Disease; Aged; COVID-19; Diagnosis, Differential; Female; Heart Failure; Humans; Lung; Male; Pandemics; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Pembegül","Irem","Department of Nephrology, Malatya Turgut Ozal University School of Medicine, Malatya, Turkey",NA
"2957","34256508","10.5578/tt.20219807","Differential diagnosis of COVID-19 pneumonia from acute heart failure in pandemic: Importance of radiological and laboratory findings.","COVID-19 pneumonia typically presents with high fever, cough, and shortness of breath and on thorax computed tomography (CT) peripheral ground glass opacities help the diagnosis. Although typical imaging findings for COVID-19 pneumonia are specified in thorax CT, these findings can be confused with other diseases. The aim of this study is to investigate the roles of radiological imaging and laboratory findings in the differential diagnosis of COVID-19 pneumonia and acute heart failure (AHF). In ","2021","07","19","Tuberk Toraks","Tuberkuloz ve toraks","Acute Disease; Aged; COVID-19; Diagnosis, Differential; Female; Heart Failure; Humans; Lung; Male; Pandemics; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Yalçinsoy","Murat","Department of Chest Diseases, Inönü University Faculty of Medicine, Malatya, Turkey",NA
"2958","34256497","10.3760/cma.j.cn115330-20210102-00003","[Advances in the study of smell dysfunction in patients with coronavirus disease 2019].","<U+65B0><U+578B><U+51A0><U+72B6><U+75C5><U+6BD2><U+80BA><U+708E>(coronavirus disease 2019,COVID-19)<U+662F><U+7531>2019<U+65B0><U+578B><U+51A0><U+72B6><U+75C5><U+6BD2><U+5F15><U+8D77><U+7684><U+75BE><U+75C5><U+3002>COVID-19<U+7684><U+4E34><U+5E8A><U+75C7><U+72B6><U+591A><U+6837>,<U+5176><U+4E2D><U+8F7B><U+75C7><U+6216><U+65E0><U+75C7><U+72B6><U+60A3><U+8005><U+5408><U+5E76><U+55C5><U+89C9><U+529F><U+80FD><U+969C><U+788D><U+88AB><U+8D8A><U+6765><U+8D8A><U+591A><U+5730><U+62A5><U+9053><U+3002><U+672C><U+6587><U+56DE><U+987E><U+4E86><U+73B0><U+6709><U+7684><U+56FD><U+5185><U+5916><U+76F8><U+5173><U+6587><U+732E>,<U+5BF9>COVID-19<U+60A3><U+8005><U+55C5><U+89C9><U+969C><U+788D><U+7684><U+6F5C><U+5728><U+673A><U+5236><U+53CA><U+5E94><U+5BF9><U+63AA><U+65BD><U+8FDB><U+884C><U+7CFB><U+7EDF><U+6027><U+5F52><U+7EB3><U+603B><U+7ED3>,<U+4EE5><U+671F><U+5BF9><U+75AB><U+60C5><U+671F><U+95F4><U+4E0D><U+660E><U+539F><U+56E0><U+51FA><U+73B0><U+55C5><U+89C9><U+969C><U+788D><U+7684><U+60A3><U+8005><U+5F15><U+8D77><U+91CD><U+89C6><U+5E76><U+6307><U+5BFC><U+4E34><U+5E8A><U+533B><U+5E08><U+7684><U+5B9E><U+8DF5><U+3002>.","2021","07","15","Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi","Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery","COVID-19; Humans; Olfaction Disorders; SARS-CoV-2; Smell","Xu","H W","Department of Otorhinolaryngology, Lishui Municipal Central Hospital, Lishui 323000, Zhejiang Province, China",NA
"2959","34256497","10.3760/cma.j.cn115330-20210102-00003","[Advances in the study of smell dysfunction in patients with coronavirus disease 2019].","<U+65B0><U+578B><U+51A0><U+72B6><U+75C5><U+6BD2><U+80BA><U+708E>(coronavirus disease 2019,COVID-19)<U+662F><U+7531>2019<U+65B0><U+578B><U+51A0><U+72B6><U+75C5><U+6BD2><U+5F15><U+8D77><U+7684><U+75BE><U+75C5><U+3002>COVID-19<U+7684><U+4E34><U+5E8A><U+75C7><U+72B6><U+591A><U+6837>,<U+5176><U+4E2D><U+8F7B><U+75C7><U+6216><U+65E0><U+75C7><U+72B6><U+60A3><U+8005><U+5408><U+5E76><U+55C5><U+89C9><U+529F><U+80FD><U+969C><U+788D><U+88AB><U+8D8A><U+6765><U+8D8A><U+591A><U+5730><U+62A5><U+9053><U+3002><U+672C><U+6587><U+56DE><U+987E><U+4E86><U+73B0><U+6709><U+7684><U+56FD><U+5185><U+5916><U+76F8><U+5173><U+6587><U+732E>,<U+5BF9>COVID-19<U+60A3><U+8005><U+55C5><U+89C9><U+969C><U+788D><U+7684><U+6F5C><U+5728><U+673A><U+5236><U+53CA><U+5E94><U+5BF9><U+63AA><U+65BD><U+8FDB><U+884C><U+7CFB><U+7EDF><U+6027><U+5F52><U+7EB3><U+603B><U+7ED3>,<U+4EE5><U+671F><U+5BF9><U+75AB><U+60C5><U+671F><U+95F4><U+4E0D><U+660E><U+539F><U+56E0><U+51FA><U+73B0><U+55C5><U+89C9><U+969C><U+788D><U+7684><U+60A3><U+8005><U+5F15><U+8D77><U+91CD><U+89C6><U+5E76><U+6307><U+5BFC><U+4E34><U+5E8A><U+533B><U+5E08><U+7684><U+5B9E><U+8DF5><U+3002>.","2021","07","15","Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi","Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery","COVID-19; Humans; Olfaction Disorders; SARS-CoV-2; Smell","Liu","F H","Department of Otorhinolaryngology, Lishui Municipal Central Hospital, Lishui 323000, Zhejiang Province, China",NA
"2960","34256497","10.3760/cma.j.cn115330-20210102-00003","[Advances in the study of smell dysfunction in patients with coronavirus disease 2019].","<U+65B0><U+578B><U+51A0><U+72B6><U+75C5><U+6BD2><U+80BA><U+708E>(coronavirus disease 2019,COVID-19)<U+662F><U+7531>2019<U+65B0><U+578B><U+51A0><U+72B6><U+75C5><U+6BD2><U+5F15><U+8D77><U+7684><U+75BE><U+75C5><U+3002>COVID-19<U+7684><U+4E34><U+5E8A><U+75C7><U+72B6><U+591A><U+6837>,<U+5176><U+4E2D><U+8F7B><U+75C7><U+6216><U+65E0><U+75C7><U+72B6><U+60A3><U+8005><U+5408><U+5E76><U+55C5><U+89C9><U+529F><U+80FD><U+969C><U+788D><U+88AB><U+8D8A><U+6765><U+8D8A><U+591A><U+5730><U+62A5><U+9053><U+3002><U+672C><U+6587><U+56DE><U+987E><U+4E86><U+73B0><U+6709><U+7684><U+56FD><U+5185><U+5916><U+76F8><U+5173><U+6587><U+732E>,<U+5BF9>COVID-19<U+60A3><U+8005><U+55C5><U+89C9><U+969C><U+788D><U+7684><U+6F5C><U+5728><U+673A><U+5236><U+53CA><U+5E94><U+5BF9><U+63AA><U+65BD><U+8FDB><U+884C><U+7CFB><U+7EDF><U+6027><U+5F52><U+7EB3><U+603B><U+7ED3>,<U+4EE5><U+671F><U+5BF9><U+75AB><U+60C5><U+671F><U+95F4><U+4E0D><U+660E><U+539F><U+56E0><U+51FA><U+73B0><U+55C5><U+89C9><U+969C><U+788D><U+7684><U+60A3><U+8005><U+5F15><U+8D77><U+91CD><U+89C6><U+5E76><U+6307><U+5BFC><U+4E34><U+5E8A><U+533B><U+5E08><U+7684><U+5B9E><U+8DF5><U+3002>.","2021","07","15","Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi","Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery","COVID-19; Humans; Olfaction Disorders; SARS-CoV-2; Smell","Wan","B B","Department of Otorhinolaryngology, Lishui Municipal Central Hospital, Lishui 323000, Zhejiang Province, China",NA
"2961","33117894","10.12688/wellcomeopenres.16259.4","A living mapping review for COVID-19 funded research projects: nine-month update.","The coronavirus disease 2019 (COVID-19) has resulted in an unprecedented research response, demonstrating exceptional examples of rapid research and collaboration. There is however a need for greater coordination, with limited resources and the shifting global nature of the pandemic resulting in a proliferation of research projects underpowered and unable to achieve their aims. The UK Collaborative on Development Research (UKCDR) and Global Research Collaboration for Infectious Disease Preparedn","2021","07","14","Wellcome Open Res","Wellcome open research","COVID-19; Coronavirus; Living systematic review; coordination; global health policy; research funding","Norton","Alice","UK Collaborative on Development Research, London, UK",NA
"2962","33117894","10.12688/wellcomeopenres.16259.4","A living mapping review for COVID-19 funded research projects: nine-month update.","The coronavirus disease 2019 (COVID-19) has resulted in an unprecedented research response, demonstrating exceptional examples of rapid research and collaboration. There is however a need for greater coordination, with limited resources and the shifting global nature of the pandemic resulting in a proliferation of research projects underpowered and unable to achieve their aims. The UK Collaborative on Development Research (UKCDR) and Global Research Collaboration for Infectious Disease Preparedn","2021","07","14","Wellcome Open Res","Wellcome open research","COVID-19; Coronavirus; Living systematic review; coordination; global health policy; research funding","Bucher","Adrian","UK Collaborative on Development Research, London, UK",NA
"2963","33117894","10.12688/wellcomeopenres.16259.4","A living mapping review for COVID-19 funded research projects: nine-month update.","The coronavirus disease 2019 (COVID-19) has resulted in an unprecedented research response, demonstrating exceptional examples of rapid research and collaboration. There is however a need for greater coordination, with limited resources and the shifting global nature of the pandemic resulting in a proliferation of research projects underpowered and unable to achieve their aims. The UK Collaborative on Development Research (UKCDR) and Global Research Collaboration for Infectious Disease Preparedn","2021","07","14","Wellcome Open Res","Wellcome open research","COVID-19; Coronavirus; Living systematic review; coordination; global health policy; research funding","Antonio","Emilia","UK Collaborative on Development Research, London, UK",NA
"2964","33117894","10.12688/wellcomeopenres.16259.4","A living mapping review for COVID-19 funded research projects: nine-month update.","The coronavirus disease 2019 (COVID-19) has resulted in an unprecedented research response, demonstrating exceptional examples of rapid research and collaboration. There is however a need for greater coordination, with limited resources and the shifting global nature of the pandemic resulting in a proliferation of research projects underpowered and unable to achieve their aims. The UK Collaborative on Development Research (UKCDR) and Global Research Collaboration for Infectious Disease Preparedn","2021","07","14","Wellcome Open Res","Wellcome open research","COVID-19; Coronavirus; Living systematic review; coordination; global health policy; research funding","Advani","Nicole","UK Collaborative on Development Research, London, UK",NA
"2965","33117894","10.12688/wellcomeopenres.16259.4","A living mapping review for COVID-19 funded research projects: nine-month update.","The coronavirus disease 2019 (COVID-19) has resulted in an unprecedented research response, demonstrating exceptional examples of rapid research and collaboration. There is however a need for greater coordination, with limited resources and the shifting global nature of the pandemic resulting in a proliferation of research projects underpowered and unable to achieve their aims. The UK Collaborative on Development Research (UKCDR) and Global Research Collaboration for Infectious Disease Preparedn","2021","07","14","Wellcome Open Res","Wellcome open research","COVID-19; Coronavirus; Living systematic review; coordination; global health policy; research funding","Grund","Henrike","UK Collaborative on Development Research, London, UK",NA
"2966","33117894","10.12688/wellcomeopenres.16259.4","A living mapping review for COVID-19 funded research projects: nine-month update.","The coronavirus disease 2019 (COVID-19) has resulted in an unprecedented research response, demonstrating exceptional examples of rapid research and collaboration. There is however a need for greater coordination, with limited resources and the shifting global nature of the pandemic resulting in a proliferation of research projects underpowered and unable to achieve their aims. The UK Collaborative on Development Research (UKCDR) and Global Research Collaboration for Infectious Disease Preparedn","2021","07","14","Wellcome Open Res","Wellcome open research","COVID-19; Coronavirus; Living systematic review; coordination; global health policy; research funding","Mburu","Sheila","UK Collaborative on Development Research, London, UK",NA
"2967","33117894","10.12688/wellcomeopenres.16259.4","A living mapping review for COVID-19 funded research projects: nine-month update.","The coronavirus disease 2019 (COVID-19) has resulted in an unprecedented research response, demonstrating exceptional examples of rapid research and collaboration. There is however a need for greater coordination, with limited resources and the shifting global nature of the pandemic resulting in a proliferation of research projects underpowered and unable to achieve their aims. The UK Collaborative on Development Research (UKCDR) and Global Research Collaboration for Infectious Disease Preparedn","2021","07","14","Wellcome Open Res","Wellcome open research","COVID-19; Coronavirus; Living systematic review; coordination; global health policy; research funding","Clegg","Emma","UK Collaborative on Development Research, London, UK",NA
"2968","33117894","10.12688/wellcomeopenres.16259.4","A living mapping review for COVID-19 funded research projects: nine-month update.","The coronavirus disease 2019 (COVID-19) has resulted in an unprecedented research response, demonstrating exceptional examples of rapid research and collaboration. There is however a need for greater coordination, with limited resources and the shifting global nature of the pandemic resulting in a proliferation of research projects underpowered and unable to achieve their aims. The UK Collaborative on Development Research (UKCDR) and Global Research Collaboration for Infectious Disease Preparedn","2021","07","14","Wellcome Open Res","Wellcome open research","COVID-19; Coronavirus; Living systematic review; coordination; global health policy; research funding","Gollish","Marguerite","UK Collaborative on Development Research, London, UK",NA
"2969","33117894","10.12688/wellcomeopenres.16259.4","A living mapping review for COVID-19 funded research projects: nine-month update.","The coronavirus disease 2019 (COVID-19) has resulted in an unprecedented research response, demonstrating exceptional examples of rapid research and collaboration. There is however a need for greater coordination, with limited resources and the shifting global nature of the pandemic resulting in a proliferation of research projects underpowered and unable to achieve their aims. The UK Collaborative on Development Research (UKCDR) and Global Research Collaboration for Infectious Disease Preparedn","2021","07","14","Wellcome Open Res","Wellcome open research","COVID-19; Coronavirus; Living systematic review; coordination; global health policy; research funding","Jabin","Nusrat","UK Collaborative on Development Research, London, UK",NA
"2970","33117894","10.12688/wellcomeopenres.16259.4","A living mapping review for COVID-19 funded research projects: nine-month update.","The coronavirus disease 2019 (COVID-19) has resulted in an unprecedented research response, demonstrating exceptional examples of rapid research and collaboration. There is however a need for greater coordination, with limited resources and the shifting global nature of the pandemic resulting in a proliferation of research projects underpowered and unable to achieve their aims. The UK Collaborative on Development Research (UKCDR) and Global Research Collaboration for Infectious Disease Preparedn","2021","07","14","Wellcome Open Res","Wellcome open research","COVID-19; Coronavirus; Living systematic review; coordination; global health policy; research funding","Scott","Laura","UK Collaborative on Development Research, London, UK",NA
"2971","33117894","10.12688/wellcomeopenres.16259.4","A living mapping review for COVID-19 funded research projects: nine-month update.","The coronavirus disease 2019 (COVID-19) has resulted in an unprecedented research response, demonstrating exceptional examples of rapid research and collaboration. There is however a need for greater coordination, with limited resources and the shifting global nature of the pandemic resulting in a proliferation of research projects underpowered and unable to achieve their aims. The UK Collaborative on Development Research (UKCDR) and Global Research Collaboration for Infectious Disease Preparedn","2021","07","14","Wellcome Open Res","Wellcome open research","COVID-19; Coronavirus; Living systematic review; coordination; global health policy; research funding","Boily-Larouche","Genevieve","Institute of Infection and Immunity, Canadian Institutes of Health Research, Hamilton, Canada",NA
"2972","33117894","10.12688/wellcomeopenres.16259.4","A living mapping review for COVID-19 funded research projects: nine-month update.","The coronavirus disease 2019 (COVID-19) has resulted in an unprecedented research response, demonstrating exceptional examples of rapid research and collaboration. There is however a need for greater coordination, with limited resources and the shifting global nature of the pandemic resulting in a proliferation of research projects underpowered and unable to achieve their aims. The UK Collaborative on Development Research (UKCDR) and Global Research Collaboration for Infectious Disease Preparedn","2021","07","14","Wellcome Open Res","Wellcome open research","COVID-19; Coronavirus; Living systematic review; coordination; global health policy; research funding","Lay","A Morgan","Institute of Population and Public Health, Canadian Institutes of Health Research, Toronto, Canada",NA
"2973","33117894","10.12688/wellcomeopenres.16259.4","A living mapping review for COVID-19 funded research projects: nine-month update.","The coronavirus disease 2019 (COVID-19) has resulted in an unprecedented research response, demonstrating exceptional examples of rapid research and collaboration. There is however a need for greater coordination, with limited resources and the shifting global nature of the pandemic resulting in a proliferation of research projects underpowered and unable to achieve their aims. The UK Collaborative on Development Research (UKCDR) and Global Research Collaboration for Infectious Disease Preparedn","2021","07","14","Wellcome Open Res","Wellcome open research","COVID-19; Coronavirus; Living systematic review; coordination; global health policy; research funding","Carson","Gail","GloPID-R Secretariat, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK",NA
"2974","33117894","10.12688/wellcomeopenres.16259.4","A living mapping review for COVID-19 funded research projects: nine-month update.","The coronavirus disease 2019 (COVID-19) has resulted in an unprecedented research response, demonstrating exceptional examples of rapid research and collaboration. There is however a need for greater coordination, with limited resources and the shifting global nature of the pandemic resulting in a proliferation of research projects underpowered and unable to achieve their aims. The UK Collaborative on Development Research (UKCDR) and Global Research Collaboration for Infectious Disease Preparedn","2021","07","14","Wellcome Open Res","Wellcome open research","COVID-19; Coronavirus; Living systematic review; coordination; global health policy; research funding","Tufet Bayona","Marta","UK Collaborative on Development Research, London, UK",NA
"2975","34256418","10.1002/ptr.7209","Contribution of traditional Chinese medicine combined with conventional western medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta-analysis.","This study provides current evidence for efficacy and safety of treating COVID-19 with combined traditional Chinese medicine (TCM) and conventional western medicine (CWM). Six databases were searched from January 1 to December 31, 2020. Randomized controlled trials (RCTs), case-control studies (CCTs), and cohort studies on TCM or TCM combined with CWM treatment for COVID-19 were included. The quality of included RCTs was assessed by Cochrane risk of bias tool, and the Newcastle-Ottawa Scale (NOS","2021","07","13","Phytother Res","Phytotherapy research : PTR","COVID-19; integrative medicine; meta-analysis; systematic review; traditional Chinese medicine","Jiang","Fei","The Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province and School of Life Sciences, Jiangsu Normal University, Xuzhou, China",NA
"2976","34256418","10.1002/ptr.7209","Contribution of traditional Chinese medicine combined with conventional western medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta-analysis.","This study provides current evidence for efficacy and safety of treating COVID-19 with combined traditional Chinese medicine (TCM) and conventional western medicine (CWM). Six databases were searched from January 1 to December 31, 2020. Randomized controlled trials (RCTs), case-control studies (CCTs), and cohort studies on TCM or TCM combined with CWM treatment for COVID-19 were included. The quality of included RCTs was assessed by Cochrane risk of bias tool, and the Newcastle-Ottawa Scale (NOS","2021","07","13","Phytother Res","Phytotherapy research : PTR","COVID-19; integrative medicine; meta-analysis; systematic review; traditional Chinese medicine","Xu","Nana","The Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province and School of Life Sciences, Jiangsu Normal University, Xuzhou, China",NA
"2977","34256418","10.1002/ptr.7209","Contribution of traditional Chinese medicine combined with conventional western medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta-analysis.","This study provides current evidence for efficacy and safety of treating COVID-19 with combined traditional Chinese medicine (TCM) and conventional western medicine (CWM). Six databases were searched from January 1 to December 31, 2020. Randomized controlled trials (RCTs), case-control studies (CCTs), and cohort studies on TCM or TCM combined with CWM treatment for COVID-19 were included. The quality of included RCTs was assessed by Cochrane risk of bias tool, and the Newcastle-Ottawa Scale (NOS","2021","07","13","Phytother Res","Phytotherapy research : PTR","COVID-19; integrative medicine; meta-analysis; systematic review; traditional Chinese medicine","Zhou","Yanxi","School of Medical Technology, Xuzhou Medical University, Xuzhou, China",NA
"2978","34256418","10.1002/ptr.7209","Contribution of traditional Chinese medicine combined with conventional western medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta-analysis.","This study provides current evidence for efficacy and safety of treating COVID-19 with combined traditional Chinese medicine (TCM) and conventional western medicine (CWM). Six databases were searched from January 1 to December 31, 2020. Randomized controlled trials (RCTs), case-control studies (CCTs), and cohort studies on TCM or TCM combined with CWM treatment for COVID-19 were included. The quality of included RCTs was assessed by Cochrane risk of bias tool, and the Newcastle-Ottawa Scale (NOS","2021","07","13","Phytother Res","Phytotherapy research : PTR","COVID-19; integrative medicine; meta-analysis; systematic review; traditional Chinese medicine","Song","Jinxing","The Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province and School of Life Sciences, Jiangsu Normal University, Xuzhou, China",NA
"2979","34256418","10.1002/ptr.7209","Contribution of traditional Chinese medicine combined with conventional western medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta-analysis.","This study provides current evidence for efficacy and safety of treating COVID-19 with combined traditional Chinese medicine (TCM) and conventional western medicine (CWM). Six databases were searched from January 1 to December 31, 2020. Randomized controlled trials (RCTs), case-control studies (CCTs), and cohort studies on TCM or TCM combined with CWM treatment for COVID-19 were included. The quality of included RCTs was assessed by Cochrane risk of bias tool, and the Newcastle-Ottawa Scale (NOS","2021","07","13","Phytother Res","Phytotherapy research : PTR","COVID-19; integrative medicine; meta-analysis; systematic review; traditional Chinese medicine","Liu","Jinjuan","The Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province and School of Life Sciences, Jiangsu Normal University, Xuzhou, China",NA
"2980","34256418","10.1002/ptr.7209","Contribution of traditional Chinese medicine combined with conventional western medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta-analysis.","This study provides current evidence for efficacy and safety of treating COVID-19 with combined traditional Chinese medicine (TCM) and conventional western medicine (CWM). Six databases were searched from January 1 to December 31, 2020. Randomized controlled trials (RCTs), case-control studies (CCTs), and cohort studies on TCM or TCM combined with CWM treatment for COVID-19 were included. The quality of included RCTs was assessed by Cochrane risk of bias tool, and the Newcastle-Ottawa Scale (NOS","2021","07","13","Phytother Res","Phytotherapy research : PTR","COVID-19; integrative medicine; meta-analysis; systematic review; traditional Chinese medicine","Zhu","Hong","Institute of Botany, Jiangsu Province and Chinese Academy of Sciences, Nanjing, China",NA
"2981","34256418","10.1002/ptr.7209","Contribution of traditional Chinese medicine combined with conventional western medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta-analysis.","This study provides current evidence for efficacy and safety of treating COVID-19 with combined traditional Chinese medicine (TCM) and conventional western medicine (CWM). Six databases were searched from January 1 to December 31, 2020. Randomized controlled trials (RCTs), case-control studies (CCTs), and cohort studies on TCM or TCM combined with CWM treatment for COVID-19 were included. The quality of included RCTs was assessed by Cochrane risk of bias tool, and the Newcastle-Ottawa Scale (NOS","2021","07","13","Phytother Res","Phytotherapy research : PTR","COVID-19; integrative medicine; meta-analysis; systematic review; traditional Chinese medicine","Jiang","Jihong","The Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province and School of Life Sciences, Jiangsu Normal University, Xuzhou, China",NA
"2982","34256418","10.1002/ptr.7209","Contribution of traditional Chinese medicine combined with conventional western medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta-analysis.","This study provides current evidence for efficacy and safety of treating COVID-19 with combined traditional Chinese medicine (TCM) and conventional western medicine (CWM). Six databases were searched from January 1 to December 31, 2020. Randomized controlled trials (RCTs), case-control studies (CCTs), and cohort studies on TCM or TCM combined with CWM treatment for COVID-19 were included. The quality of included RCTs was assessed by Cochrane risk of bias tool, and the Newcastle-Ottawa Scale (NOS","2021","07","13","Phytother Res","Phytotherapy research : PTR","COVID-19; integrative medicine; meta-analysis; systematic review; traditional Chinese medicine","Xu","Yonghong","The Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province and School of Life Sciences, Jiangsu Normal University, Xuzhou, China",NA
"2983","34256418","10.1002/ptr.7209","Contribution of traditional Chinese medicine combined with conventional western medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta-analysis.","This study provides current evidence for efficacy and safety of treating COVID-19 with combined traditional Chinese medicine (TCM) and conventional western medicine (CWM). Six databases were searched from January 1 to December 31, 2020. Randomized controlled trials (RCTs), case-control studies (CCTs), and cohort studies on TCM or TCM combined with CWM treatment for COVID-19 were included. The quality of included RCTs was assessed by Cochrane risk of bias tool, and the Newcastle-Ottawa Scale (NOS","2021","07","13","Phytother Res","Phytotherapy research : PTR","COVID-19; integrative medicine; meta-analysis; systematic review; traditional Chinese medicine","Li","Rongpeng","The Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province and School of Life Sciences, Jiangsu Normal University, Xuzhou, China",NA
"2984","34256411","10.1055/a-1449-5158","[Update 2021: Pulmonary Sequelae of COVID-19 Pneumonia].","Acute COVID-19 pneumonia may result in persistent changes with various imaging and histopathological patterns, including organizing pneumonia and pulmonary fibrosis. In addition, SARS-CoV-2 infection is associated with increased risk of pulmonary vascular endothelialitis and thrombosis. Herein, current findings on pulmonary consequences of COVID-19 with implications for clinical management are summarized based on a selective literature review.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","Acute Disease; COVID-19; Cryptogenic Organizing Pneumonia; Follow-Up Studies; Humans; Pneumonia, Viral; Pulmonary Fibrosis","Leo","Fabian",NA,NA
"2985","34256411","10.1055/a-1449-5158","[Update 2021: Pulmonary Sequelae of COVID-19 Pneumonia].","Acute COVID-19 pneumonia may result in persistent changes with various imaging and histopathological patterns, including organizing pneumonia and pulmonary fibrosis. In addition, SARS-CoV-2 infection is associated with increased risk of pulmonary vascular endothelialitis and thrombosis. Herein, current findings on pulmonary consequences of COVID-19 with implications for clinical management are summarized based on a selective literature review.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","Acute Disease; COVID-19; Cryptogenic Organizing Pneumonia; Follow-Up Studies; Humans; Pneumonia, Viral; Pulmonary Fibrosis","Meybaum","Christian",NA,NA
"2986","34256411","10.1055/a-1449-5158","[Update 2021: Pulmonary Sequelae of COVID-19 Pneumonia].","Acute COVID-19 pneumonia may result in persistent changes with various imaging and histopathological patterns, including organizing pneumonia and pulmonary fibrosis. In addition, SARS-CoV-2 infection is associated with increased risk of pulmonary vascular endothelialitis and thrombosis. Herein, current findings on pulmonary consequences of COVID-19 with implications for clinical management are summarized based on a selective literature review.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","Acute Disease; COVID-19; Cryptogenic Organizing Pneumonia; Follow-Up Studies; Humans; Pneumonia, Viral; Pulmonary Fibrosis","Wormanns","Dag",NA,NA
"2987","34256411","10.1055/a-1449-5158","[Update 2021: Pulmonary Sequelae of COVID-19 Pneumonia].","Acute COVID-19 pneumonia may result in persistent changes with various imaging and histopathological patterns, including organizing pneumonia and pulmonary fibrosis. In addition, SARS-CoV-2 infection is associated with increased risk of pulmonary vascular endothelialitis and thrombosis. Herein, current findings on pulmonary consequences of COVID-19 with implications for clinical management are summarized based on a selective literature review.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","Acute Disease; COVID-19; Cryptogenic Organizing Pneumonia; Follow-Up Studies; Humans; Pneumonia, Viral; Pulmonary Fibrosis","Grohé","Christian",NA,NA
"2988","34256410","10.1055/a-1449-5128","[COVID-19 in GP Practice and Emergency Rooms - Update 2021].","COVID-19 continues to pose major challenges for GP practice and emergency rooms across Germany. Even if there is now a certain routine, the optimal treatment of patients is still difficult. This article provides an overview of the aspects of caring for COVID-19 patients in GP practice and emergency rooms and the changes since the beginning of the pandemic.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; Emergency Service, Hospital; General Practice; Germany; Humans; Risk Factors","Herold","Tobias",NA,NA
"2989","34256410","10.1055/a-1449-5128","[COVID-19 in GP Practice and Emergency Rooms - Update 2021].","COVID-19 continues to pose major challenges for GP practice and emergency rooms across Germany. Even if there is now a certain routine, the optimal treatment of patients is still difficult. This article provides an overview of the aspects of caring for COVID-19 patients in GP practice and emergency rooms and the changes since the beginning of the pandemic.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; Emergency Service, Hospital; General Practice; Germany; Humans; Risk Factors","Wörnle","Markus",NA,NA
"2990","34256410","10.1055/a-1449-5128","[COVID-19 in GP Practice and Emergency Rooms - Update 2021].","COVID-19 continues to pose major challenges for GP practice and emergency rooms across Germany. Even if there is now a certain routine, the optimal treatment of patients is still difficult. This article provides an overview of the aspects of caring for COVID-19 patients in GP practice and emergency rooms and the changes since the beginning of the pandemic.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; Emergency Service, Hospital; General Practice; Germany; Humans; Risk Factors","Schelling","Jörg",NA,NA
"2991","34256409","10.1055/a-1449-5098","[Update 2021: COVID-19 from the perspective of neurology].","Neurological complications, direct affection of neuronal structures in the course of infections with SARS-CoV-2 and long-term effects (""long COVID"") are evident. This article aims to summarize and evaluate the current literature on this topic.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; Humans; Nervous System Diseases; Neurology; SARS-CoV-2","Simon","Ole J",NA,NA
"2992","34256409","10.1055/a-1449-5098","[Update 2021: COVID-19 from the perspective of neurology].","Neurological complications, direct affection of neuronal structures in the course of infections with SARS-CoV-2 and long-term effects (""long COVID"") are evident. This article aims to summarize and evaluate the current literature on this topic.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; Humans; Nervous System Diseases; Neurology; SARS-CoV-2","Menzler","Katja",NA,NA
"2993","34256409","10.1055/a-1449-5098","[Update 2021: COVID-19 from the perspective of neurology].","Neurological complications, direct affection of neuronal structures in the course of infections with SARS-CoV-2 and long-term effects (""long COVID"") are evident. This article aims to summarize and evaluate the current literature on this topic.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; Humans; Nervous System Diseases; Neurology; SARS-CoV-2","Timmermann","Lars",NA,NA
"2994","34256408","10.1055/a-1449-5068","[Update 2021: COVID-19 from the perspective of nephrology].","Increasing insight into the clinical phenotype and mechanisms of SARS-CoV-2 infections and COVID-19 has identified damage of the kidneys as a key player in the course of the disease. This manuscript updates our previous summary with current knowledge on kidney involvement in COVID-19 and chronic kidney disease as a risk factor for severe COVID-19, as well as recommendations regarding SARS-CoV-2 vaccination for patients suffering from chronic kidney disease and after organ transplantation, respec","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; COVID-19 Vaccines; Humans; Organ Transplantation; Renal Insufficiency, Chronic; Risk Factors; SARS-CoV-2","Kann","Martin",NA,NA
"2995","34256408","10.1055/a-1449-5068","[Update 2021: COVID-19 from the perspective of nephrology].","Increasing insight into the clinical phenotype and mechanisms of SARS-CoV-2 infections and COVID-19 has identified damage of the kidneys as a key player in the course of the disease. This manuscript updates our previous summary with current knowledge on kidney involvement in COVID-19 and chronic kidney disease as a risk factor for severe COVID-19, as well as recommendations regarding SARS-CoV-2 vaccination for patients suffering from chronic kidney disease and after organ transplantation, respec","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; COVID-19 Vaccines; Humans; Organ Transplantation; Renal Insufficiency, Chronic; Risk Factors; SARS-CoV-2","Benzing","Thomas",NA,NA
"2996","34256407","10.1055/a-1449-5027","[Update 2021: COVID-19 from the perspective of cardiology].","More than one year ago COVID-19 emerged to a rapidly expanding global pandemic. Along with a growing number of individuals infected with SARS-CoV-2, we gained substantial knowledge on development, progression and treatment of the disease. In the light of increasing worldwide infection rates during the current ""third wave"", we will give a short update on COVID-19 from a cardiological point-of-view.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; Cardiology; Cardiomyopathies; Humans; Thromboembolism","Stremmel","Christopher",NA,NA
"2997","34256407","10.1055/a-1449-5027","[Update 2021: COVID-19 from the perspective of cardiology].","More than one year ago COVID-19 emerged to a rapidly expanding global pandemic. Along with a growing number of individuals infected with SARS-CoV-2, we gained substantial knowledge on development, progression and treatment of the disease. In the light of increasing worldwide infection rates during the current ""third wave"", we will give a short update on COVID-19 from a cardiological point-of-view.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; Cardiology; Cardiomyopathies; Humans; Thromboembolism","Kellnar","Antonia",NA,NA
"2998","34256407","10.1055/a-1449-5027","[Update 2021: COVID-19 from the perspective of cardiology].","More than one year ago COVID-19 emerged to a rapidly expanding global pandemic. Along with a growing number of individuals infected with SARS-CoV-2, we gained substantial knowledge on development, progression and treatment of the disease. In the light of increasing worldwide infection rates during the current ""third wave"", we will give a short update on COVID-19 from a cardiological point-of-view.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; Cardiology; Cardiomyopathies; Humans; Thromboembolism","Kääb","Stefan",NA,NA
"2999","34256406","10.1055/a-1449-4995","[Update 2021: COVID-19 from the perspective of intensive care].","COVID-19 continues to challenge health-care systems and ICUs around the globe more than one year into the pandemic and in spite of all advances in diagnosis and treatment of the disease caused by the novel SARS-CoV-2. Many open questions remain concerning optimal medical therapy, respiratory management and resource allocation, particuly in times of limited available health care personell. In the following short article, we summarized current knowlegde on management of COVID-19 in the ICU.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; Critical Care; Humans; Intensive Care Units","Stecher","Stephanie-Susanne",NA,NA
"3000","34256406","10.1055/a-1449-4995","[Update 2021: COVID-19 from the perspective of intensive care].","COVID-19 continues to challenge health-care systems and ICUs around the globe more than one year into the pandemic and in spite of all advances in diagnosis and treatment of the disease caused by the novel SARS-CoV-2. Many open questions remain concerning optimal medical therapy, respiratory management and resource allocation, particuly in times of limited available health care personell. In the following short article, we summarized current knowlegde on management of COVID-19 in the ICU.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; Critical Care; Humans; Intensive Care Units","Stemmler","Hans Joachim",NA,NA
"3001","34256406","10.1055/a-1449-4995","[Update 2021: COVID-19 from the perspective of intensive care].","COVID-19 continues to challenge health-care systems and ICUs around the globe more than one year into the pandemic and in spite of all advances in diagnosis and treatment of the disease caused by the novel SARS-CoV-2. Many open questions remain concerning optimal medical therapy, respiratory management and resource allocation, particuly in times of limited available health care personell. In the following short article, we summarized current knowlegde on management of COVID-19 in the ICU.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; Critical Care; Humans; Intensive Care Units","Eichenauer","Dennis A",NA,NA
"3002","34256406","10.1055/a-1449-4995","[Update 2021: COVID-19 from the perspective of intensive care].","COVID-19 continues to challenge health-care systems and ICUs around the globe more than one year into the pandemic and in spite of all advances in diagnosis and treatment of the disease caused by the novel SARS-CoV-2. Many open questions remain concerning optimal medical therapy, respiratory management and resource allocation, particuly in times of limited available health care personell. In the following short article, we summarized current knowlegde on management of COVID-19 in the ICU.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; Critical Care; Humans; Intensive Care Units","Kochanek","Matthias",NA,NA
"3003","34256406","10.1055/a-1449-4995","[Update 2021: COVID-19 from the perspective of intensive care].","COVID-19 continues to challenge health-care systems and ICUs around the globe more than one year into the pandemic and in spite of all advances in diagnosis and treatment of the disease caused by the novel SARS-CoV-2. Many open questions remain concerning optimal medical therapy, respiratory management and resource allocation, particuly in times of limited available health care personell. In the following short article, we summarized current knowlegde on management of COVID-19 in the ICU.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; Critical Care; Humans; Intensive Care Units","Shimabukuro-Vornhagen","Alexander",NA,NA
"3004","34256406","10.1055/a-1449-4995","[Update 2021: COVID-19 from the perspective of intensive care].","COVID-19 continues to challenge health-care systems and ICUs around the globe more than one year into the pandemic and in spite of all advances in diagnosis and treatment of the disease caused by the novel SARS-CoV-2. Many open questions remain concerning optimal medical therapy, respiratory management and resource allocation, particuly in times of limited available health care personell. In the following short article, we summarized current knowlegde on management of COVID-19 in the ICU.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; Critical Care; Humans; Intensive Care Units","von Bergwelt-Baildon","Michael",NA,NA
"3005","34256406","10.1055/a-1449-4995","[Update 2021: COVID-19 from the perspective of intensive care].","COVID-19 continues to challenge health-care systems and ICUs around the globe more than one year into the pandemic and in spite of all advances in diagnosis and treatment of the disease caused by the novel SARS-CoV-2. Many open questions remain concerning optimal medical therapy, respiratory management and resource allocation, particuly in times of limited available health care personell. In the following short article, we summarized current knowlegde on management of COVID-19 in the ICU.","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","COVID-19; Critical Care; Humans; Intensive Care Units","Böll","Boris",NA,NA
"3006","34256405","10.1055/a-1449-4964","[Update 2021: COVID-19 from the perspective of infectious diseases specialty].","From an infectious disease perspective, there have been outstanding findings since January 2020 far beyond the knowledge gained about SARS-CoV, which hopefully will help us to manage future pandemics. Positive highlights include the increased public awareness of infectious disease epidemiology, the increase in immunological knowledge, and the successful use of existing vaccine development platforms and technologies. This article presents a personal selection of interesting developments in recent","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","Antibodies, Viral; COVID-19; Humans; Infectious Disease Medicine; Interferon Type I; SARS-CoV-2","Khatamzas","Elham",NA,NA
"3007","34256405","10.1055/a-1449-4964","[Update 2021: COVID-19 from the perspective of infectious diseases specialty].","From an infectious disease perspective, there have been outstanding findings since January 2020 far beyond the knowledge gained about SARS-CoV, which hopefully will help us to manage future pandemics. Positive highlights include the increased public awareness of infectious disease epidemiology, the increase in immunological knowledge, and the successful use of existing vaccine development platforms and technologies. This article presents a personal selection of interesting developments in recent","2021","07","20","Dtsch Med Wochenschr","Deutsche medizinische Wochenschrift (1946)","Antibodies, Viral; COVID-19; Humans; Infectious Disease Medicine; Interferon Type I; SARS-CoV-2","Kroidl","Inge",NA,NA
